PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Borg-Graham, LJ				Borg-Graham, LJ			The computation of directional selectivity in the retina occurs presynaptic to the ganglion cell	NATURE NEUROSCIENCE			English	Article							STARBURST AMACRINE CELLS; RABBIT RETINA; DENDRITIC STRUCTURE; RECEPTIVE-FIELDS; VOLTAGE-CLAMP; BIPOLAR CELLS; TURTLE; ACETYLCHOLINE; MORPHOLOGY; RESPONSES	Directional selectivity is a response that is greater for a visual stimulus moving in one (PREF) direction than for the opposite (NULL) direction, and its computation in the vertebrate retina is a classical issue in functional neurophysiology. To date, most quantitative experimental studies have relied on extracellular responses for identifying properties of the directionally selective circuit. Here I describe an intracellular analysis using whole-cell patch recordings of the synaptic events underlying the spike response in directionally selective ganglion cells of the turtle retina. These quantitative measurements allowed me to distinguish among various explicit classes of circuit models that can, in principle, account for ganglion cell directional selectivity. I found that ganglion cell directional selectivity is due to an excitatory input that itself is directionally selective, and that the crucial shunting inhibition implicated in this computation must act on cells presynaptic to the ganglion cell.	CNRS, INAF, UPR 2191, Unite Neurosci Integrat & Computat, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); Istituto Nazionale Astrofisica (INAF); UDICE-French Research Universities; Universite Paris Saclay	Borg-Graham, LJ (corresponding author), CNRS, INAF, UPR 2191, Unite Neurosci Integrat & Computat, F-91198 Gif Sur Yvette, France.							AMMERMULLER J, 1995, J COMP NEUROL, V358, P35, DOI 10.1002/cne.903580103; ARIEL M, 1985, J NEUROPHYSIOL, V54, P1123, DOI 10.1152/jn.1985.54.5.1123; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Borg-Graham L.J., 1992, SINGLE NEURON COMPUT, P347; Borg-Graham LJ, 2000, J COMPUT NEUROSCI, V8, P209, DOI 10.1023/A:1008945925865; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; BROWN TH, 1990, ANNU REV NEUROSCI, V13, P475, DOI 10.1146/annurev.ne.13.030190.002355; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P277, DOI 10.1113/jphysiol.1978.sp012233; DEVOE RD, 1989, NEUROBIOLOGY INNER R, P235; Dowling J. E., 1987, RETINA APPROACHABLE; Grzywacz NM, 1998, J PHYSIOL-LONDON, V512, P575, DOI 10.1111/j.1469-7793.1998.575be.x; He SG, 1999, J NEUROSCI, V19, P8049; He SG, 1997, NATURE, V389, P378, DOI 10.1038/38723; JENSEN RJ, 1983, J COMP NEUROL, V217, P271, DOI 10.1002/cne.902170305; KOCH C, 1982, PHILOS T R SOC B, V298, P227, DOI 10.1098/rstb.1982.0084; KOCH C, 1990, J NEUROSCI, V10, P1728; KOLB H, 1982, PHILOS T R SOC B, V298, P355, DOI 10.1098/rstb.1982.0087; LINN DM, 1992, VISUAL NEUROSCI, V8, P97, DOI 10.1017/S0952523800009263; MARCHIAFAVA PL, 1976, J PHYSIOL-LONDON, V255, P137, DOI 10.1113/jphysiol.1976.sp011273; MASLAND RH, 1984, PROC R SOC SER B-BIO, V223, P121, DOI 10.1098/rspb.1984.0086; Massey SC, 1997, VISUAL NEUROSCI, V14, P939, DOI 10.1017/S0952523800011652; MATURANA HUMBERTO R., 1960, JOUR GEN PHYSIOL, V43, P129, DOI 10.1085/jgp.43.6.129; OMALLEY DM, 1992, J NEUROSCI, V12, P1394; Peters BN, 1996, J NEUROPHYSIOL, V75, P469, DOI 10.1152/jn.1996.75.1.469; POGGIO T, 1973, KYBERNETIK, V13, P223, DOI 10.1007/BF00274887; RODIECK RW, 1973, VERTEBRATE RETINA; Siebert W., 1986, CIRCUITS SIGNALS SYS; Smith RD, 1996, VISUAL NEUROSCI, V13, P423, DOI 10.1017/S0952523800008105; SPRUSTON N, 1993, J NEUROPHYSIOL, V70, P781, DOI 10.1152/jn.1993.70.2.781; STELZER A, 1988, SCIENCE, V241, P339, DOI 10.1126/science.2455347; Taylor WR, 2000, SCIENCE, V289, P2347, DOI 10.1126/science.289.5488.2347; TORRE V, 1978, PROC R SOC SER B-BIO, V202, P409, DOI 10.1098/rspb.1978.0075; Vaney D.I., 1990, PROGR RETINAL RES, V9, P49, DOI [10.1016/0278-4327(90)90004-2, DOI 10.1016/0278-4327(90)90004-2]; VANEY DI, 1989, NEUROBIOLOGY INNER R, P157; VANEY DI, 2000, COMPUTATIONAL NEURAL, P2; Velte TJ, 1999, J NEUROPHYSIOL, V81, P1412, DOI 10.1152/jn.1999.81.3.1412; YANG G, 1994, J NEUROSCI, V14, P5267; ZHOU ZJ, 1995, J NEUROSCI, V15, P5334	38	98	99	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2001	4	2					176	183		10.1038/84007	http://dx.doi.org/10.1038/84007			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UC	11175879				2022-12-24	WOS:000167178100017
J	Nadarajah, B; Brunstrom, JE; Grutzendler, J; Wong, ROL; Pearlman, AL				Nadarajah, B; Brunstrom, JE; Grutzendler, J; Wong, ROL; Pearlman, AL			Two modes of radial migration in early development of the cerebral cortex	NATURE NEUROSCIENCE			English	Article							GUIDED NEURONAL MIGRATION; CELL-MIGRATION; EXTRACELLULAR-MATRIX; SLICE PREPARATIONS; MAMMALIAN BRAIN; CHICK-EMBRYO; OPTIC TECTUM; NEOCORTEX; REELER; MOUSE	Layer formation in the developing cerebral cortex requires the movement of neurons from their site of origin to their final laminar position. We demonstrate, using time-lapse imaging of acute cortical slices, that two distinct forms of cell movement, locomotion and somal translocation, are responsible for the radial migration of cortical neurons. These modes are distinguished by their dynamic properties and morphological features. Locomotion and translocation are not cell-type specific; although at early ages some cells may move by translocation only, locomoting cells also translocate once their leading process reaches the marginal zone. The existence of two modes of radial migration may account for the differential effects of certain genetic mutations on cortical development.	Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Pearlman, AL (corresponding author), Washington Univ, Sch Med, Dept Neurol, 660 S Euclid Ave, St Louis, MO 63110 USA.	apearl@cellbio.wustl.edu	Grutzendler, Jaime/F-3691-2010					Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; Anton ES, 1996, J NEUROSCI, V16, P2283; BOOK KJ, 1990, J COMP NEUROL, V297, P55, DOI 10.1002/cne.902970105; BOOK KJ, 1991, EXP NEUROL, V111, P228, DOI 10.1016/0014-4886(91)90011-Z; BRITTIS PA, 1995, EXP NEUROL, V134, P1, DOI 10.1006/exnr.1995.1031; Brunstrom JE, 1997, NEURON, V18, P505, DOI 10.1016/S0896-6273(00)81250-7; Cameron RS, 1997, J COMP NEUROL, V387, P467; CAVINESS VS, 1982, DEV BRAIN RES, V4, P293, DOI 10.1016/0165-3806(82)90141-9; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; FONSECA M, 1995, J COMP NEUROL, V361, P177, DOI 10.1002/cne.903610114; Gan WB, 2000, NEURON, V27, P219, DOI 10.1016/S0896-6273(00)00031-3; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Gleeson JG, 2000, TRENDS NEUROSCI, V23, P352, DOI 10.1016/S0166-2236(00)01607-6; GOFFINET AM, 1983, J COMP NEUROL, V215, P437, DOI 10.1002/cne.902150408; GRAY GE, 1991, NEURON, V6, P211, DOI 10.1016/0896-6273(91)90357-6; HAGER G, 1995, J NEUROSCI RES, V40, P207, DOI 10.1002/jnr.490400209; HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B; Hendriks R, 1999, J NEUROSCI RES, V58, P805, DOI 10.1002/(SICI)1097-4547(19991215)58:6<805::AID-JNR7>3.0.CO;2-V; Horwitz AR, 1999, SCIENCE, V286, P1102, DOI 10.1126/science.286.5442.1102; Kakita A, 1999, NEURON, V23, P461, DOI 10.1016/S0896-6273(00)80800-4; KOMURO H, 1995, J NEUROSCI, V15, P1110; Kwon YT, 2000, CURR BIOL, V10, P363, DOI 10.1016/S0960-9822(00)00411-5; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LUSKIN MB, 1985, J COMP NEUROL, V242, P611, DOI 10.1002/cne.902420409; MARINPADILLA M, 1978, ANAT EMBRYOL, V152, P109, DOI 10.1007/BF00315920; MARINPADILLA M, 1971, Z ANAT ENTWICKLUNGS, V134, P117, DOI 10.1007/BF00519296; Meyer G, 1998, J COMP NEUROL, V397, P493; MOREST DK, 1970, Z ANAT ENTWICKLUNGS, V130, P265, DOI 10.1007/BF00520999; Morris NR, 1998, TRENDS CELL BIOL, V8, P467, DOI 10.1016/S0962-8924(98)01389-0; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; Pearlman AL, 1998, CURR OPIN NEUROBIOL, V8, P45, DOI 10.1016/S0959-4388(98)80007-X; PINTOLORD MC, 1982, DEV BRAIN RES, V4, P379, DOI 10.1016/0165-3806(82)90181-X; Rakic P, 1996, P NATL ACAD SCI USA, V93, P9218, DOI 10.1073/pnas.93.17.9218; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Rakic Pasko, 1994, Current Opinion in Neurobiology, V4, P63, DOI 10.1016/0959-4388(94)90033-7; Reinsch S, 1998, J CELL SCI, V111, P2283; RIVAS RJ, 1995, J NEUROSCI, V15, P981; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; Sheppard AM, 1997, J COMP NEUROL, V378, P173, DOI 10.1002/(SICI)1096-9861(19970210)378:2<173::AID-CNE2>3.0.CO;2-0; Sheppard AM, 1995, DEV BIOL, V172, P504, DOI 10.1006/dbio.1995.8034; SNOW RL, 1995, EXP NEUROL, V134, P13, DOI 10.1006/exnr.1995.1032; Takahashi T, 1996, J NEUROSCI, V16, P5762; Wada Y, 1998, J BIOCHEM-TOKYO, V124, P738, DOI 10.1093/oxfordjournals.jbchem.a022174; Walsh CA, 2000, CURR OPIN GENET DEV, V10, P270, DOI 10.1016/S0959-437X(00)00076-9; Walsh CA, 1999, NEURON, V23, P19, DOI 10.1016/S0896-6273(00)80749-7; Yee KT, 1999, NEURON, V24, P607, DOI 10.1016/S0896-6273(00)81116-2	50	509	521	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2001	4	2					143	150		10.1038/83967	http://dx.doi.org/10.1038/83967			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UC	11175874				2022-12-24	WOS:000167178100012
J	Wiese, S; Pei, G; Karch, C; Troppmair, J; Holtmann, B; Rapp, UR; Sendtner, M				Wiese, S; Pei, G; Karch, C; Troppmair, J; Holtmann, B; Rapp, UR; Sendtner, M			Specific function of B-Raf in mediating survival of embryonic motoneurons and sensory neurons	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH-FACTOR; DEPENDENT PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; CYCLIC-AMP; SYMPATHETIC NEURONS; PATHWAY; CAMP; DEPOLARIZATION; INHIBITION; FAMILY	Embryonic sensory and motoneurons depend on neurotrophic factors for survival. Here we show that their survival requires B-Raf, which, in this function, cannot be substituted by C-Raf. Sensory and motoneurons from b-raf-deficient mice do not respond to neurotrophic factors for their survival. However, these primary neurons can be rescued by transfection of a b-raf expression plasmid. In contrast, c-raf-deficient neurons survive in response to neurotrophic factors, similarly to neurons from wild-type mice. This points to an essential and specific function of B-Raf in mediating survival of sensory and motoneurons during development.	Univ Wurzburg, Dept Neurol, Klin Forschergrp Neuroregenerat, D-97080 Wurzburg, Germany; Univ Wurzburg, Inst Med Strahlenkunde & Zellforsch, D-97078 Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Sendtner, M (corresponding author), Univ Wurzburg, Dept Neurol, Klin Forschergrp Neuroregenerat, Josef Schneider Str 11, D-97080 Wurzburg, Germany.		Sendtner, Michael/J-1542-2012; Sendtner, Michael/M-8137-2014	Sendtner, Michael/0000-0002-4737-2974; Sendtner, Michael/0000-0002-4737-2974; Troppmair, Jakob/0000-0002-0611-3837				Anderson CNG, 1999, J NEUROSCI, V19, P664; Baloh RH, 2000, CURR OPIN NEUROBIOL, V10, P103, DOI 10.1016/S0959-4388(99)00048-3; Cai H, 1997, MOL CELL BIOL, V17, P732, DOI 10.1128/MCB.17.2.732; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; Creedon DJ, 1996, J BIOL CHEM, V271, P20713, DOI 10.1074/jbc.271.34.20713; Crowder RJ, 1999, J NEUROCHEM, V73, P466, DOI 10.1046/j.1471-4159.1999.0730466.x; Dugan LL, 1999, J BIOL CHEM, V274, P25842, DOI 10.1074/jbc.274.36.25842; EDWARDS SN, 1991, J NEUROCHEM, V57, P2140, DOI 10.1111/j.1471-4159.1991.tb06434.x; Erhardt P, 1999, MOL CELL BIOL, V19, P5308; Grewal SS, 2000, J BIOL CHEM, V275, P3722, DOI 10.1074/jbc.275.5.3722; Hanson MG, 1998, J NEUROSCI, V18, P7361; HULEIHEL M, 1986, MOL CELL BIOL, V6, P2655, DOI 10.1128/MCB.6.7.2655; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; MacNicol MC, 1999, J BIOL CHEM, V274, P13193, DOI 10.1074/jbc.274.19.13193; Maina F, 1999, NAT NEUROSCI, V2, P213, DOI 10.1038/6310; Mazzoni IE, 1999, J NEUROSCI, V19, P9716; Michaelidis TM, 1996, NEURON, V17, P75, DOI 10.1016/S0896-6273(00)80282-2; Miller TM, 1997, J BIOL CHEM, V272, P9847; MUSZYNSKI KW, 1995, J EXP MED, V181, P2189, DOI 10.1084/jem.181.6.2189; Perrelet D, 2000, EUR J NEUROSCI, V12, P2059, DOI 10.1046/j.1460-9568.2000.00098.x; SCHULTZ AM, 1985, VIROLOGY, V146, P78, DOI 10.1016/0042-6822(85)90054-6; SITHANANDAM G, 1990, ONCOGENE, V5, P1775; Soler RM, 1999, J NEUROSCI, V19, P9160; Wang HG, 1996, P NATL ACAD SCI USA, V93, P7063, DOI 10.1073/pnas.93.14.7063; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; Wiese S, 1999, EUR J NEUROSCI, V11, P1668, DOI 10.1046/j.1460-9568.1999.00585.x; Wiese S, 1999, NAT NEUROSCI, V2, P978, DOI 10.1038/14777; Wojnowski L, 1997, NAT GENET, V16, P293, DOI 10.1038/ng0797-293; Wojnowski L, 2000, MECH DEVELOP, V91, P97, DOI 10.1016/S0925-4773(99)00276-2; Wojnowski L, 1998, MECH DEVELOP, V76, P141, DOI 10.1016/S0925-4773(98)00111-7	30	92	95	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2001	4	2					137	142		10.1038/83960	http://dx.doi.org/10.1038/83960			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UC	11175873				2022-12-24	WOS:000167178100011
J	Chen, CF; Regehr, WG				Chen, CF; Regehr, WG			Developmental remodeling of the retinogeniculate synapse	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; LONG-TERM POTENTIATION; RAT VISUAL-CORTEX; EXPERIENCE-DEPENDENT PLASTICITY; CENTRAL GLUTAMATERGIC SYNAPSE; OCULAR DOMINANCE COLUMNS; NMDA RECEPTOR RESPONSES; POSTNATAL-DEVELOPMENT; MONOCULAR DEPRIVATION; SILENT SYNAPSES	Anatomical rearrangement of retinogeniculate connections contributes to the refinement of synaptic circuits in the developing visual system, but the underlying changes in synaptic function are unclear. Here, we study such changes in mouse brain slices. Each geniculate cell receives a surprisingly large number of retinal inputs (>20) well after eye-specific zones are formed. All but one to three of these inputs are eliminated over a 3-week period spanning eye opening. Remaining inputs are strengthened similar to 50-fold, in part through an increase in quantal size, but primarily through an increase in the number of release sites. Changes in release probability do not contribute significantly. Thus, a redistribution of release sites from many inputs to few inputs at this late developmental stage contributes to the precise receptive fields of thalamic relay neurons.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Chen, CF (corresponding author), Childrens Hosp, Div Neurosci, 300 Longwood Ave, Boston, MA 02115 USA.	chinfei_chen@hms.harvard.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038312, R01NS032405, K08NS002056] Funding Source: NIH RePORTER; NINDS NIH HHS [K08-NS02056, P01-NS38312, R01-NS32405] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; Bellingham MC, 1998, J PHYSIOL-LONDON, V511, P861, DOI 10.1111/j.1469-7793.1998.861bg.x; Bellingham MC, 1999, NEURON, V23, P159, DOI 10.1016/S0896-6273(00)80762-X; BENNETT MR, 1974, J PHYSIOL-LONDON, V241, P515, DOI 10.1113/jphysiol.1974.sp010670; Bi GQ, 1999, NATURE, V401, P792, DOI 10.1038/44573; BLAKEMORE C, 1986, J PHYSIOL-LONDON, V380, P453, DOI 10.1113/jphysiol.1986.sp016297; BLAKEMORE C, 1978, J PHYSIOL-LONDON, V283, P223, DOI 10.1113/jphysiol.1978.sp012498; BROWN MC, 1976, J PHYSIOL-LONDON, V261, P387, DOI 10.1113/jphysiol.1976.sp011565; CAMPBELL G, 1992, J NEUROSCI, V12, P1847; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Chuhma N, 1998, J NEUROSCI, V18, P512; CLELAND BG, 1971, NATURE-NEW BIOL, V231, P191, DOI 10.1038/newbio231191a0; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; CREPEL F, 1976, J NEUROBIOL, V7, P567, DOI 10.1002/neu.480070609; DANIELS JD, 1978, J NEUROPHYSIOL, V41, P1373, DOI 10.1152/jn.1978.41.6.1373; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; DIAMOND J, 1962, J PHYSIOL-LONDON, V162, P393, DOI 10.1113/jphysiol.1962.sp006941; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; Dittman JS, 1998, J NEUROSCI, V18, P6147; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Fraser S E, 1992, Curr Opin Neurobiol, V2, P83, DOI 10.1016/0959-4388(92)90167-J; FREEMAN RD, 1982, J NEUROPHYSIOL, V47, P139, DOI 10.1152/jn.1982.47.2.139; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Golshani P, 1998, J NEUROPHYSIOL, V80, P143, DOI 10.1152/jn.1998.80.1.143; Golshani P, 1999, J NEUROSCI, V19, P2865; Gordon JA, 1996, J NEUROSCI, V16, P3274; HAMORI J, 1991, J HIRNFORSCH, V32, P369; HAMOS JE, 1987, J COMP NEUROL, V259, P165, DOI 10.1002/cne.902590202; HAMOS JE, 1985, NATURE, V317, P618, DOI 10.1038/317618a0; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; Hohnke CD, 1999, J NEUROSCI, V19, P236, DOI 10.1523/JNEUROSCI.19-01-00236.1999; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; JACKSON H, 1982, J NEUROSCI, V2, P1736; Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7; KATO N, 1991, DEV BRAIN RES, V60, P43, DOI 10.1016/0165-3806(91)90153-A; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; KIRKWOOD A, 1993, SCIENCE, V260, P1518, DOI 10.1126/science.8502997; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; LICHTMAN JW, 1977, J PHYSIOL-LONDON, V273, P155, DOI 10.1113/jphysiol.1977.sp012087; LINDEN DC, 1981, J COMP NEUROL, V203, P189, DOI 10.1002/cne.902030204; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MARIANI J, 1981, J NEUROSCI, V1, P696, DOI 10.1523/JNEUROSCI.01-07-00696.1981; MASON CA, 1982, NEUROSCIENCE, V7, P541, DOI 10.1016/0306-4522(82)90063-X; MASTRONARDE DN, 1992, VISUAL NEUROSCI, V8, P407, DOI 10.1017/S0952523800004934; MILEDI R, 1966, NATURE, V212, P1233, DOI 10.1038/2121233a0; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MOONEY R, 1993, NEURON, V10, P815, DOI 10.1016/0896-6273(93)90198-Z; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; OBRIEN RAD, 1978, J PHYSIOL-LONDON, V282, P571, DOI 10.1113/jphysiol.1978.sp012482; PURVES D, 1980, SCIENCE, V210, P153, DOI 10.1126/science.7414326; RAFOLS JA, 1973, J COMP NEUROL, V150, P303, DOI 10.1002/cne.901500305; Ramoa AS, 1997, DEV BRAIN RES, V101, P165, DOI 10.1016/S0165-3806(97)00061-8; RAMOA AS, 1994, J NEUROSCI, V14, P2098; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Rumpel S, 1998, J NEUROSCI, V18, P8863; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; SHATZ CJ, 1984, J NEUROSCI, V4, P1378; Shi J, 1997, J NEUROSCI, V17, P6264; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SRETAVAN DW, 1986, J NEUROSCI, V6, P234; Tavazoie SF, 2000, NAT NEUROSCI, V3, P608, DOI 10.1038/75786; TOOTLE JS, 1989, J NEUROSCI, V9, P1325; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Turner JP, 1998, J PHYSIOL-LONDON, V510, P829, DOI 10.1111/j.1469-7793.1998.829bj.x; Usrey WM, 1999, J NEUROPHYSIOL, V82, P3527, DOI 10.1152/jn.1999.82.6.3527; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Xu-Friedman MA, 1999, BIOPHYS J, V76, P2029, DOI 10.1016/S0006-3495(99)77360-1	82	309	315	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	2000	28	3					955	966		10.1016/S0896-6273(00)00166-5	http://dx.doi.org/10.1016/S0896-6273(00)00166-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386JJ	11163279	Bronze			2022-12-24	WOS:000166057500029
J	Wang, SSH; Denk, W; Hausser, M				Wang, SSH; Denk, W; Hausser, M			Coincidence detection in single dendritic spines mediated by calcium release	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; CEREBELLAR PURKINJE NEURONS; PARALLEL FIBER SYNAPSES; CLIMBING FIBER; INOSITOL TRISPHOSPHATE; ACTION-POTENTIALS; CELL DENDRITES; CA2+; RECEPTORS; ACTIVATION	Cerebellar long-term depression (LTD) is a calcium-dependent process in which coincident activity of parallel fiber (PF) and climbing fiber (CF) synapses causes a long-lasting decrease in PF synaptic strength onto Purkinje cells. Here we show that pairing CF activation with bursts of PF activity triggers large (>10 muM) calcium signals in Purkinje cell dendrites. When PFs are densely activated, signals span whole dendritic branchlets and are mediated by voltage-dependent calcium entry. When PFs are sparsely activated, however, signals are restricted to single spines and blocked by metabotropic glutamate receptor antagonists. Single-spine signals and sparse-stimulation LTD are also blocked by thapsigargin, indicating that calcium must be released from stores. Single-spine signals and sparse-stimulation LTD are greatest when PF activation precedes the CF activation within 50-200 ms. This timing rule matches the properties of several forms of motor learning, providing a link between behavior and functional properties of cerebellar synaptic plasticity.	Max Planck Inst Med Res, Dept Biomed Opt, D-69120 Heidelberg, Germany; UCL, Dept Physiol, London WC1E 6BT, England; Bell Labs, Lucent Technol, Biol Computat Res Dept, Murray Hill, NJ 07974 USA	Max Planck Society; University of London; University College London; Alcatel-Lucent; Lucent Technologies; AT&T	Hausser, M (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	winfried_denk@mpimf-heidelberg.mpg.de; m.hausser@ucl.ac.uk	Hausser, Michael/AAW-6827-2020; denk, winfried/I-6627-2012	Hausser, Michael/0000-0002-2673-8957; 				Atluri PP, 1996, J NEUROSCI, V16, P5661; Batchelor AM, 1997, NATURE, V385, P74, DOI 10.1038/385074a0; BERRIDGE MJ, 1993, NATURE, V365, P388, DOI 10.1038/365388a0; Blackstone C, 1999, CELL CALCIUM, V26, P181, DOI 10.1054/ceca.1999.0071; BROWN TH, 1990, ANNU REV NEUROSCI, V13, P475, DOI 10.1146/annurev.ne.13.030190.002355; CALLAWAY JC, 1995, J NEUROSCI, V15, P2777; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; Daniel H, 1998, TRENDS NEUROSCI, V21, P401, DOI 10.1016/S0166-2236(98)01304-6; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DENK W, 1995, P NATL ACAD SCI USA, V92, P8279, DOI 10.1073/pnas.92.18.8279; Eilers J, 1997, LEARN MEMORY, V4, P159, DOI 10.1101/lm.4.1.159; EILERS J, 1995, NATURE, V373, P155, DOI 10.1038/373155a0; EKEROT CF, 1989, NEUROSCI RES, V6, P264, DOI 10.1016/0168-0102(89)90065-5; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; GORMEZANO I, 1983, PROGR PSYCHOBIOLOGY, P197; HARTELL NA, 1994, NEUROREPORT, V5, P913, DOI 10.1097/00001756-199404000-00015; Hartell NA, 1996, NEURON, V16, P601, DOI 10.1016/S0896-6273(00)80079-3; HEMART N, 1995, EUR J NEUROSCI, V7, P45, DOI 10.1111/j.1460-9568.1995.tb01019.x; IINO M, 1990, J GEN PHYSIOL, V95, P1103, DOI 10.1085/jgp.95.6.1103; Ito M, 1990, Neuroreport, V1, P129; ITO M, 1982, NEUROSCI LETT, V33, P253, DOI 10.1016/0304-3940(82)90380-9; KHODAKHAH K, 1995, J PHYSIOL-LONDON, V487, P343, DOI 10.1113/jphysiol.1995.sp020884; Khodakhah K, 1997, P NATL ACAD SCI USA, V94, P14009, DOI 10.1073/pnas.94.25.14009; LevRam V, 1997, NEURON, V18, P1025, DOI 10.1016/S0896-6273(00)80340-2; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; Maeda H, 1999, NEURON, V24, P989, DOI 10.1016/S0896-6273(00)81045-4; Mauk MD, 1998, NEURON, V20, P359, DOI 10.1016/S0896-6273(00)80978-2; MERRILL EG, 1978, J PHYSIOL-LONDON, V284, P127, DOI 10.1113/jphysiol.1978.sp012531; MIYAKAWA H, 1992, J NEUROPHYSIOL, V68, P1178, DOI 10.1152/jn.1992.68.4.1178; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; Nakazawa K, 1997, LEARN MEMORY, V3, P578, DOI 10.1101/lm.3.6.578; PERKEL DJ, 1990, P ROY SOC B-BIOL SCI, V241, P116, DOI 10.1098/rspb.1990.0074; Raymond JL, 1998, J NEUROSCI, V18, P9112; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; SCHREURS BG, 1993, BRAIN RES, V631, P235, DOI 10.1016/0006-8993(93)91540-9; Schreurs BG, 1996, J NEUROPHYSIOL, V75, P1051, DOI 10.1152/jn.1996.75.3.1051; Schulman H, 1999, CALCIUM AS A CELLULAR REGULATOR, P311; STUART G, 1994, NEURON, V13, P703, DOI 10.1016/0896-6273(94)90037-X; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; Tank DW, 1995, J NEUROSCI, V15, P7940; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Vos BP, 1999, J NEUROSCI, V19; WALTON PD, 1991, J CELL BIOL, V113, P1145, DOI 10.1083/jcb.113.5.1145; Wang SSH, 2000, P NATL ACAD SCI USA, V97, P8635, DOI 10.1073/pnas.130414597; WANG SSH, 1995, J GEN PHYSIOL, V105, P149, DOI 10.1085/jgp.105.1.149; Yuste R, 1999, J NEUROSCI, V19, P1976; Zhao MD, 1996, BIOPHYS J, V70, P896, DOI 10.1016/S0006-3495(96)79633-9	50	337	340	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2000	3	12					1266	1273		10.1038/81792	http://dx.doi.org/10.1038/81792			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UA	11100147	Bronze			2022-12-24	WOS:000167177900012
J	Clandinin, TR; Zipursky, SL				Clandinin, TR; Zipursky, SL			Afferent growth cone interactions control synaptic specificity in the Drosophila visual system	NEURON			English	Article							PATTERN-FORMATION; PLANAR POLARITY; EYE; RETINA; CELLS; GENE; DOWNSTREAM; COMPLEXITY; PHYLLOPOD; SEVENLESS	In the Drosophila compound eye, photoreceptors (R cells) that respond to light from the same point in space are distributed across the retina and connect to the same target neurons. This complex connectivity pattern reconstructs visual space in the first optic ganglion, the lamina. We have used mutations that delete specific R cell subtypes or alter their retinal organization to define the cellular mechanisms that generate this pattern. R cell axons are programmed to search for targets within a local region in the lamina but their selection of appropriate postsynaptic targets requires specific interactions among R cell growth cones. The orientation of the projections is controlled both by the spatial arrangement of R cells in the retina and by cues in the target.	Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Zipursky, SL (corresponding author), Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA.	zipursky@hhmi.ucla.edu		Zipursky, Stephen/0000-0001-5630-7181				BANERJEE U, 1987, CELL, V49, P281, DOI 10.1016/0092-8674(87)90569-1; Barth M, 1997, J NEUROSCI, V17, P1493; BRAITENBERG V, 1967, EXP BRAIN RES, V3, P271; CHANG HC, 1995, CELL, V80, P463, DOI 10.1016/0092-8674(95)90497-2; Choi KW, 1996, P NATL ACAD SCI USA, V93, P5737, DOI 10.1073/pnas.93.12.5737; CHOI KW, 1994, CELL, V78, P125, DOI 10.1016/0092-8674(94)90579-7; Daga A, 1996, GENE DEV, V10, P1194, DOI 10.1101/gad.10.10.1194; DICKSON B, 1992, NATURE, V360, P600, DOI 10.1038/360600a0; DICKSON BJ, 1995, CELL, V80, P453, DOI 10.1016/0092-8674(95)90496-4; Granderath S, 2000, MECH DEVELOP, V91, P197, DOI 10.1016/S0925-4773(99)00304-4; Gubb D, 1999, GENE DEV, V13, P2315, DOI 10.1101/gad.13.17.2315; HEISENBERG M, 1975, J COMP PHYSL, V117, P127; Hiesinger PR, 1999, J NEUROSCI, V19, P7548, DOI 10.1523/JNEUROSCI.19-17-07548.1999; HIGASHIJIMA SI, 1992, GENE DEV, V6, P50, DOI 10.1101/gad.6.1.50; Huang Z, 1998, CELL, V95, P693, DOI 10.1016/S0092-8674(00)81639-6; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Katz LC, 1999, CELL, V99, P673, DOI 10.1016/S0092-8674(00)81665-7; KIRSCHFELD K, 1967, EXP BRAIN RES, V3, P248; Koch C, 1999, SCIENCE, V284, P96, DOI 10.1126/science.284.5411.96; LAUGHLIN SB, 1987, PROC R SOC SER B-BIO, V231, P437, DOI 10.1098/rspb.1987.0054; Masland RH, 2000, ANNU REV NEUROSCI, V23, P249, DOI 10.1146/annurev.neuro.23.1.249; Meinertzhagen I.A., 1993, DEV DROSOPHILA MELAN; MLODZIK M, 1990, CELL, V60, P211, DOI 10.1016/0092-8674(90)90737-Y; Mlodzik M, 1999, EMBO J, V18, P6873, DOI 10.1093/emboj/18.24.6873; Newsome TP, 2000, DEVELOPMENT, V127, P851; O'Leary DDM, 1999, CELL, V96, P255, DOI 10.1016/S0092-8674(00)80565-6; Perez SE, 1996, J NEUROBIOL, V30, P359, DOI 10.1002/(SICI)1097-4695(199607)30:3<359::AID-NEU5>3.0.CO;2-3; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Salecker I, 1998, CELL, V95, P587, DOI 10.1016/S0092-8674(00)81627-X; Stowers RS, 1999, GENETICS, V152, P1631; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tomlinson A, 1999, DEVELOPMENT, V126, P5725; TRUJILLO.O, 1965, J ULTRA MOL STRUCT R, V13, P1, DOI 10.1016/S0022-5320(65)80086-7; VANVACTOR D, 1988, CELL, V52, P281, DOI 10.1016/0092-8674(88)90517-X; VIGLER P, 1909, PARIS CR ACAD SCI, V148, P1221; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Wolff T, 1993, DEV DROSOPHILA MELAN; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; ZHENG L, 1995, DEVELOPMENT, V121, P3045	40	82	82	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	2000	28	2					427	436		10.1016/S0896-6273(00)00122-7	http://dx.doi.org/10.1016/S0896-6273(00)00122-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	377CE	11144353	Bronze			2022-12-24	WOS:000165493700018
J	Gao, FB; Kohwi, M; Brenman, JE; Jan, LY; Jan, YN				Gao, FB; Kohwi, M; Brenman, JE; Jan, LY; Jan, YN			Control of dendritic field formation in Drosophila: The roles of flamingo and competition between homologous neurons	NEURON			English	Article							LEECH HAEMENTERIA-GHILIANII; PERIPHERAL NERVOUS-SYSTEM; RETINAL GANGLION-CELLS; SENSORY NEURONS; DEVELOPMENTAL ARBORIZATION; BRANCHING PATTERN; VISUAL-CORTEX; GROWTH; GENE; DIFFERENTIATION	Neurons elaborate dendrites with stereotypic branching patterns, thereby defining their receptive fields. These branching patterns may arise from properties intrinsic to the neurons or competition between neighboring neurons. Genetic and laser ablation studies reported here reveal that different multiple dendritic neurons in the same dorsal cluster in the Drosophila embryonic PNS do not compete with one another for dendritic fields. In contrast, when dendrites from homologous neurons in the two hemisegments meet at the dorsal midline in larval stages, they appear to repel each other. The formation of normal dendritic fields and the competition between dendrites of homologous neurons require the proper expression level of Flamingo, a G protein-coupled receptor-like protein, in embryonic neurons. Whereas Flamingo functions downstream of Frizzled in specifying planar polarity, Flamingo-dependent dendritic outgrowth is independent of Frizzled.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Jan, YN (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.	ynjan@itsa.ucsf.edu		Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299				Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; BODMER R, 1987, ROUX ARCH DEV BIOL, V196, P69, DOI 10.1007/BF00402027; BODMER R, 1989, NEURON, V3, P21, DOI 10.1016/0896-6273(89)90112-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; BREWSTER R, 1995, DEVELOPMENT, V121, P2923; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CAMPUZANO S, 1992, TRENDS GENET, V8, P202, DOI 10.1016/0168-9525(92)90234-U; Chae J, 1999, DEVELOPMENT, V126, P5421; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Franklin JL, 1999, CURR BIOL, V9, P1448, DOI 10.1016/S0960-9822(00)80114-1; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; GHYSEN A, 1988, GENE DEV, V2, P495, DOI 10.1101/gad.2.5.495; GHYSEN A, 1986, ROUX ARCH DEV BIOL, V195, P281, DOI 10.1007/BF00376060; Grueber WB, 1999, J COMP NEUROL, V404, P127, DOI 10.1002/(SICI)1096-9861(19990201)404:1<127::AID-CNE10>3.0.CO;2-M; Horch HW, 1999, NEURON, V23, P353; Jan Yuh Nung, 1993, P1207; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; KRAMER AP, 1985, J NEUROSCI, V5, P759; KRAMER AP, 1985, J NEUROSCI, V5, P768; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; LEIN P, 1995, NEURON, V15, P597, DOI 10.1016/0896-6273(95)90148-5; Lu BW, 1999, CURR BIOL, V9, P1247, DOI 10.1016/S0960-9822(99)80505-3; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; MacNeil MA, 1998, NEURON, V20, P971, DOI 10.1016/S0896-6273(00)80478-X; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; Nedivi E, 1998, SCIENCE, V281, P1863, DOI 10.1126/science.281.5384.1863; Overton MC, 2000, CURR BIOL, V10, P341, DOI 10.1016/S0960-9822(00)00386-9; PERRY VH, 1982, NATURE, V297, P683, DOI 10.1038/297683a0; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Ramon y Cajal S, 1995, HISTOLOGY NERVOUS SY; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Sharp DJ, 1997, J CELL BIOL, V138, P833, DOI 10.1083/jcb.138.4.833; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Wang HJ, 1998, J NEUROBIOL, V35, P53, DOI 10.1002/(SICI)1097-4695(199804)35:1<53::AID-NEU5>3.0.CO;2-A; WASSLE H, 1981, PROC R SOC SER B-BIO, V212, P157, DOI 10.1098/rspb.1981.0032; WASSLE H, 1981, NATURE, V292, P344, DOI 10.1038/292344a0; WASSLE H, 1978, PROC R SOC SER B-BIO, V200, P441, DOI 10.1098/rspb.1978.0026; Weber AJ, 1998, J COMP NEUROL, V390, P470; Withers GS, 2000, EUR J NEUROSCI, V12, P106, DOI 10.1046/j.1460-9568.2000.00889.x; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Yacoubian TA, 2000, NAT NEUROSCI, V3, P342, DOI 10.1038/73911	48	158	158	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	2000	28	1					91	101		10.1016/S0896-6273(00)00088-X	http://dx.doi.org/10.1016/S0896-6273(00)00088-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	370VN	11086986	Bronze			2022-12-24	WOS:000165143500013
J	Rodriguez, CI; Dymecki, SM				Rodriguez, CI; Dymecki, SM			Origin of the precerebellar system	NEURON			English	Article							SITE-SPECIFIC RECOMBINATION; FLP-RECOMBINASE; BRAIN-STEM; SELECTIVE AGGREGATION; MIGRATION PATTERNS; NEURONAL MIGRATION; CEREBELLAR SYSTEM; INFERIOR OLIVE; CELL-MIGRATION; EXPRESSION	The precerebellar system provides the principal input to the cerebellum and is essential for coordinated motor activity. Using a FLP recombinase-based fate mapping approach, we provide direct evidence in the mouse that this ventral brainstem system derives from dorsally located rhombic neuroepithelium. Moreover, by fate mapping at the resolution of a gene expression pattern, we have uncovered an unexpected subdivision within the precerebellar primordium: embryonic expression of Wnt1 appears to identify the class of precerebellar progenitors that will later project mossy fibers from the brainstem to the cerebellum, as opposed to the class of precerebellar neurons that project climbing fibers. Differential gene expression therefore appears to demarcate two populations within the precerebellar primordium, grouping progenitors by their future type of axonal projection and synaptic partner rather than by final topographical position.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Dymecki, SM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.		Rodriguez, Carolyn I/K-8479-2014	Rodriguez, Carolyn I/0000-0001-6697-1692	NHGRI NIH HHS [F31 HG000180, F31HG00180] Funding Source: Medline; NICHD NIH HHS [R01 HD30830] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD030830] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F31HG000180] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Alcantara S, 2000, DEVELOPMENT, V127, P1359; ALTMAN J, 1987, J COMP NEUROL, V257, P477, DOI 10.1002/cne.902570402; ALTMAN J, 1980, J COMP NEUROL, V194, P877, DOI 10.1002/cne.901940410; ALTMAN J, 1980, J COMP NEUROL, V194, P1, DOI 10.1002/cne.901940102; ALTMAN J, 1978, J COMP NEUROL, V179, P49, DOI 10.1002/cne.901790105; Altman J, 1997, DEV CEREBELLAR SYSTE; BALLYCUIF L, 1992, DEVELOPMENT, V115, P999; Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; BAU ZZ, 1997, J NEUROSCI, V17, P1425; BOURRAT F, 1990, J COMP NEUROL, V294, P1, DOI 10.1002/cne.902940102; BOURRAT F, 1990, ARCH ITAL BIOL, V128, P151; BRADLEY RS, 1993, J CELL BIOL, V123, P1857, DOI 10.1083/jcb.123.6.1857; BRODAL P, 1992, NEUROSCI RES, V13, P83, DOI 10.1016/0168-0102(92)90092-Q; Buchholz F, 1996, NUCLEIC ACIDS RES, V24, P4256, DOI 10.1093/nar/24.21.4256; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Clarke JDW, 1998, DEV DYNAM, V212, P14, DOI 10.1002/(SICI)1097-0177(199805)212:1<14::AID-AJA2>3.0.CO;2-5; DICKINSON ME, 1994, DEVELOPMENT, V120, P1453; Dymecki SM, 1998, DEV BIOL, V201, P57, DOI 10.1006/dbio.1998.8971; Dymecki SM, 1996, GENE, V171, P197, DOI 10.1016/0378-1119(96)00035-2; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; ECHELARD Y, 1994, DEVELOPMENT, V120, P2213; ELLENBERGER C, 1969, J COMP NEUROL, V137, P71, DOI 10.1002/cne.901370105; Engelkamp D, 1999, DEVELOPMENT, V126, P3585; Essick CR, 1912, AM J ANAT, V13, P25, DOI 10.1002/aja.1000130103; FRANKLIN BJK, 1997, MOUSE BRAIN STEREOTA; GAUTIER C, 1989, NUCLEIC ACIDS RES, V17, P8389, DOI 10.1093/nar/17.20.8389; GOLDEN JA, 1995, P NATL ACAD SCI USA, V92, P5704, DOI 10.1073/pnas.92.12.5704; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; HALLONET MER, 1993, EUR J NEUROSCI, V5, P1145, DOI 10.1111/j.1460-9568.1993.tb00969.x; HARKMARK W, 1954, J COMP NEUROL, V100, P115, DOI 10.1002/cne.901000107; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Helms AW, 1998, DEVELOPMENT, V125, P919; HEMOND SG, 1993, J NEUROSCI, V13, P1387; His W., 1891, ABHANDLUNGEN KONI MP, V29, P1; Hogan B, 1994, MANIPULATING MOUSE E; HOOPER JE, 1994, NATURE, V372, P461, DOI 10.1038/372461a0; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Jiang XB, 2000, DEVELOPMENT, V127, P1607; MARTINEZ S, 1989, EUR J NEUROSCI, V1, P549, DOI 10.1111/j.1460-9568.1989.tb00362.x; MATUS A, 1988, ANNU REV NEUROSCI, V11, P29, DOI 10.1146/annurev.neuro.11.1.29; Meissirel C, 1997, P NATL ACAD SCI USA, V94, P5900, DOI 10.1073/pnas.94.11.5900; MOON RT, 1993, DEVELOPMENT, V119, P97; Murase S, 1999, CURR OPIN CELL BIOL, V11, P549, DOI 10.1016/S0955-0674(99)00019-8; Nagai T, 1997, DEV BIOL, V182, P299, DOI 10.1006/dbio.1996.8449; Nan XS, 1996, MOL CELL BIOL, V16, P414; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; OGORMAN S, 1991, SCIENCE, V251, P1351, DOI 10.1126/science.1900642; ONO K, 1990, ANAT EMBRYOL, V182, P11; OSBORN M, 1982, CELL, V31, P303, DOI 10.1016/0092-8674(82)90122-2; Papkoff J, 1996, MOL CELL BIOL, V16, P2128; PARR BA, 1993, DEVELOPMENT, V119, P247; Rakic P, 1985, CELL CONTACT ADHESIO, P67; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; RYDER EF, 1994, NEURON, V12, P1011, DOI 10.1016/0896-6273(94)90310-7; Schlesinger A, 1999, GENE DEV, V13, P2028, DOI 10.1101/gad.13.15.2028; Serafini T, 1999, CELL, V98, P133, DOI 10.1016/S0092-8674(00)81008-9; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; TABERPIERCE E, 1966, J COMP NEUROL, V126, P219; Tada M, 2000, DEVELOPMENT, V127, P2227; TAN K, 1991, ANAT EMBRYOL, V183, P321; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; TURNER CM, 1995, MECH DEVELOP, V52, P247, DOI 10.1016/0925-4773(95)00405-P; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; WILKINSON DG, 1987, CELL, V50, P79, DOI 10.1016/0092-8674(87)90664-7; Wingate RJT, 1999, DEVELOPMENT, V126, P4395; WOODWARD JS, 1960, J COMP NEUROL, V115, P63; Yee KT, 1999, NEURON, V24, P607, DOI 10.1016/S0896-6273(00)81116-2; Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6	71	123	126	1	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	2000	27	3					475	486		10.1016/S0896-6273(00)00059-3	http://dx.doi.org/10.1016/S0896-6273(00)00059-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	359FR	11055431	Bronze			2022-12-24	WOS:000089601300012
J	DiCarlo, JJ; Maunsell, JHR				DiCarlo, JJ; Maunsell, JHR			Form representation in monkey inferotemporal cortex is virtually unaltered by free viewing	NATURE NEUROSCIENCE			English	Article							INFERIOR TEMPORAL NEURONS; SACCADIC EYE-MOVEMENTS; VISUAL-CORTEX; STRIATE CORTEX; PATTERN-RECOGNITION; NEURAL ACTIVITY; SINGLE NEURONS; VISION; RESPONSES; ATTENTION	How are objects represented in the brain during natural behavior? Visual object recognition in primates is thought to depend on the inferotemporal cortex (IT). In most neurophysiological studies of IT, monkeys hold their direction of gaze fixed while isolated visual stimuli are presented (controlled viewing). However, during natural behavior, primates visually explore cluttered environments by changing gaze direction several times each second (free viewing). We examined the effect of free viewing on IT neuronal responses in monkeys engaged in a form-recognition task. By making small, real-time stimulus adjustments, we produced nearly identically retinal stimulation during controlled and free viewing. Nearly 90% of neuronal responses were unaffected by free viewing, and average stimulus selectivity was unchanged. Thus, neuronal representations that likely underlie form recognition are virtually unaltered by free viewing.	Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA	Howard Hughes Medical Institute; Baylor College of Medicine	DiCarlo, JJ (corresponding author), Howard Hughes Med Inst, 1 Baylor Plaza,S603, Houston, TX 77030 USA.		Maunsell, John/G-5702-2010	Maunsell, John/0000-0003-0018-4439	NEI NIH HHS [EY05911] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BAHILL A T, 1975, Mathematical Biosciences, V26, P303, DOI 10.1016/0025-5564(75)90018-8; BALLARD DH, 1991, ARTIF INTELL, V48, P57, DOI 10.1016/0004-3702(91)90080-4; BAYLIS GC, 1987, J NEUROSCI, V7, P330; Booth MCA, 1998, CEREB CORTEX, V8, P510, DOI 10.1093/cercor/8.6.510; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; BURMAN DD, 1994, J NEUROPHYSIOL, V71, P1266, DOI 10.1152/jn.1994.71.3.1266; Castet E, 2000, NAT NEUROSCI, V3, P177, DOI 10.1038/72124; Cochran W.G., 1967, STAT METHODS; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Dawkins MS, 2000, NATURE, V403, P652, DOI 10.1038/35001064; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Diamond MR, 2000, J NEUROSCI, V20, P3449, DOI 10.1523/JNEUROSCI.20-09-03449.2000; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FERRERA VP, 1994, J NEUROSCI, V14, P2080; Findlay J, 1998, CURR BIOL, V8, pR640, DOI 10.1016/S0960-9822(07)00411-3; Gallant JL, 1998, NEUROREPORT, V9, P2153, DOI 10.1097/00001756-199806220-00045; Gibson JR, 1997, J NEUROPHYSIOL, V78, P1263, DOI 10.1152/jn.1997.78.3.1263; GOCHIN PM, 1994, J NEUROPHYSIOL, V71, P2325, DOI 10.1152/jn.1994.71.6.2325; GUIDO W, 1995, J NEUROPHYSIOL, V74, P1782, DOI 10.1152/jn.1995.74.4.1782; GUR M, 1987, VISION RES, V27, P2081, DOI 10.1016/0042-6989(87)90122-2; JUDGE SJ, 1980, J NEUROPHYSIOL, V43, P1133, DOI 10.1152/jn.1980.43.4.1133; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; Liu Z, 2000, J NEUROPHYSIOL, V83, P1677, DOI 10.1152/jn.2000.83.3.1677; Livingstone MS, 1996, COLD SPRING HARB SYM, V61, P27; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; MAUNSELL JHR, 1995, SCIENCE, V270, P764, DOI 10.1126/science.270.5237.764; MAUNSELL JHR, 1990, J NEUROSCI, V10, P3323; Missal M, 1999, J NEUROPHYSIOL, V82, P131, DOI 10.1152/jn.1999.82.1.131; MIYASHITA Y, 1993, ANNU REV NEUROSCI, V16, P245, DOI 10.1146/annurev.ne.16.030193.001333; Motter BC, 1998, VISION RES, V38, P1007, DOI 10.1016/S0042-6989(97)00252-6; RINGO JL, 1994, J NEUROPHYSIOL, V71, P1285, DOI 10.1152/jn.1994.71.3.1285; ROBINSON DA, 1963, IEEE T BIOMED ENG, V101, P131; Rollenhagen JE, 2000, SCIENCE, V287, P1506, DOI 10.1126/science.287.5457.1506; Ross J, 1996, BEHAV BRAIN RES, V80, P1, DOI 10.1016/0166-4328(96)00012-5; SOMMER MA, 1994, VISION RES, V34, P2023, DOI 10.1016/0042-6989(94)90030-2; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; VEGABERMUDEZ F, 1991, J NEUROPHYSIOL, V65, P531, DOI 10.1152/jn.1991.65.3.531; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; VOGELS R, 1994, J NEUROPHYSIOL, V71, P1428, DOI 10.1152/jn.1994.71.4.1428	42	61	63	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2000	3	8					814	821		10.1038/77722	http://dx.doi.org/10.1038/77722			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TU	10903575				2022-12-24	WOS:000167177300017
J	Osten, P; Khatri, L; Perez, JL; Kohr, G; Giese, G; Daly, C; Schulz, TW; Wensky, A; Lee, LM; Ziff, EB				Osten, P; Khatri, L; Perez, JL; Kohr, G; Giese, G; Daly, C; Schulz, TW; Wensky, A; Lee, LM; Ziff, EB			Mutagenesis reveals a role for ABP/GRIP binding to GluR2 in synaptic surface accumulation of the AMPA receptor	NEURON			English	Article							DOMAIN-CONTAINING PROTEIN; KINASE-C-ALPHA; HIPPOCAMPAL-NEURONS; GLUTAMATE RECEPTORS; POSTSYNAPTIC DENSITY; CHANNELS; SYNAPSES; TERMINUS; SUBUNIT; PICK1	We studied the role of PDZ proteins GRIP, ABP, and PICK1 in GluR2 AMPA receptor trafficking. An epitope-tagged MycGluR2 subunit, when expressed in hippocampal cultured neurons, was specifically targeted to the synaptic surface. With the mutant MycGluR2 Delta 1-10, which lacks the PDZ binding site, the overall dendritic intracellular transport and the synaptic surface targeting were not affected. However, over time, MycGluR2 Delta 1-10 accumulated at synapses significantly less than MycGluR2. Notably, a single residue substitution, S880A, which blocks binding to ABP/GRIP but not to PICK1, reduced synaptic accumulation to the same extent as the PDZ site truncation. We conclude that the association of GluR2 with ABP and/or GRIP but not PICK1 is essential for maintaining the synaptic surface accumulation of the receptor, possibly by limiting its endocytotic rate.	Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany; NYU, Sch Med, Dept Biochem, Howard Hughes Med Inst, New York, NY 10016 USA; Max Planck Inst Med Res, Dept Biomed Opt, D-69120 Heidelberg, Germany	Max Planck Society; Howard Hughes Medical Institute; New York University; Max Planck Society	Osten, P (corresponding author), Max Planck Inst Med Res, Dept Mol Neurobiol, Jahnstr 29, D-69120 Heidelberg, Germany.	posten@mpimf-heidelberg.mpg.de; ziffe01@med.nyu.edu		Daly, Christopher/0000-0003-3800-8174; Ziff, Edward/0000-0001-7389-8649	NATIONAL INSTITUTE ON AGING [R37AG013620, R01AG013620] Funding Source: NIH RePORTER; NIA NIH HHS [AG13620] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Allison DW, 1998, J NEUROSCI, V18, P2423; BRETSCHER MS, 1988, EMBO J, V7, P4087, DOI 10.1002/j.1460-2075.1988.tb03302.x; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Dev KK, 1999, NEUROPHARMACOLOGY, V38, P635, DOI 10.1016/S0028-3908(98)00230-5; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Dong HL, 1999, J NEUROSCI, V19, P6930, DOI 10.1523/JNEUROSCI.19-16-06930.1999; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; GREEN WN, 1995, TRENDS NEUROSCI, V18, P280, DOI 10.1016/0166-2236(95)93915-K; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; Hsueh YP, 1998, PROG BRAIN RES, V116, P123, DOI 10.1016/S0079-6123(08)60434-3; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Li P, 1998, NATURE, V393, P695, DOI 10.1038/31496; Li P, 1999, NAT NEUROSCI, V2, P972, DOI 10.1038/14771; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Malenka RC, 1997, NEURON, V19, P473, DOI 10.1016/S0896-6273(00)80362-1; Malinow R, 1998, NEURON, V21, P1226, DOI 10.1016/S0896-6273(00)80640-6; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; Takumi Y, 1998, PROG BRAIN RES, V116, P105, DOI 10.1016/S0079-6123(08)60433-1; Tejedor FJ, 1997, J NEUROSCI, V17, P152, DOI 10.1523/JNEUROSCI.17-01-00152.1997; Wenthold RJ, 1998, PROG BRAIN RES, V116, P133, DOI 10.1016/S0079-6123(08)60435-5; Wyszynski M, 1999, J NEUROSCI, V19, P6528; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1	39	235	244	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	2000	27	2					313	325		10.1016/S0896-6273(00)00039-8	http://dx.doi.org/10.1016/S0896-6273(00)00039-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	347YD	10985351	Bronze			2022-12-24	WOS:000088956000015
J	Procyk, E; Tanaka, YL; Joseph, JP				Procyk, E; Tanaka, YL; Joseph, JP			Anterior cingulate activity during routine and non-routine sequential behaviors in macaques	NATURE NEUROSCIENCE			English	Article							MOTOR AREA CELLS; FRONTAL-CORTEX; PREFRONTAL CORTEX; MONKEY; SUPPLEMENTARY; ATTENTION; MOVEMENTS; ORDER	Anterior cingulate cortex is important in monitoring action for new challenges. We recorded neuron activity in the anterior cingulate sulcus of macaques while they performed a sequential problem-solving task. By trial and error, animals determined the correct sequence for touching three fixed spatial targets. After the sequence was repeated three times, we then changed the correct solution order, requiring a new search. Irrespective of component movements or their kinematics, task-related neurons encoded the serial order of the sequence. Neurons activated with sequence components (68%) differed in activity between search and repetition. Search-related activity occurred when behavioral flexibility was required and ended as soon as the animal accumulated enough information to infer the solution, but had not yet tested it. Repetition-related activity occurred in a regime of memory-based motor performance in which attention to action is less necessary.	Espace & Act, INSERM, U94, F-69676 Bron, France; Nihon Univ, Sch Med, Dept Physiol, Itabashi Ku, Tokyo 173, Japan	Institut National de la Sante et de la Recherche Medicale (Inserm); Nihon University	Procyk, E (corresponding author), Yale Univ, Sch Med, Neurobiol Sect, 333 Cedar St,SHM B413, New Haven, CT 06510 USA.		procyk, emmanuel/H-3037-2014	procyk, emmanuel/0000-0001-7486-4993				BARONE P, 1989, EXP BRAIN RES, V78, P447; Carpenter AF, 1999, SCIENCE, V283, P1752, DOI 10.1126/science.283.5408.1752; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Clower WT, 1998, J NEUROPHYSIOL, V80, P1562, DOI 10.1152/jn.1998.80.3.1562; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; DUM RP, 1991, J NEUROSCI, V11, P667; Gabbott PLA, 1996, J COMP NEUROL, V364, P567; HANES DP, 1995, EXP BRAIN RES, V103, P85; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1313, DOI 10.1152/jn.1997.77.3.1313; KERMADI I, 1995, J NEUROPHYSIOL, V74, P911, DOI 10.1152/jn.1995.74.3.911; MATTELLI M, 1991, J COMP NEUROL, V311, P445; MILLER GA, 1986, PLANS STRUCT BEHAV, P159; Nakamura K, 1998, J NEUROPHYSIOL, V80, P2671, DOI 10.1152/jn.1998.80.5.2671; Passingham RE, 1996, PHILOS T ROY SOC B, V351, P1473, DOI 10.1098/rstb.1996.0132; PAUS T, 1993, J NEUROPHYSIOL, V70, P453, DOI 10.1152/jn.1993.70.2.453; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Posner MI, 1998, ATTENTIVE BRAIN, P401; Procyk E, 1996, BEHAV BRAIN RES, V82, P67, DOI 10.1016/S0166-4328(97)81109-6; SCHULTZ W, 1997, ASS CORTEX STRUCTURE, P67; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; Shidara M, 1998, J NEUROSCI, V18, P2613; Shima K, 1996, P NATL ACAD SCI USA, V93, P8694, DOI 10.1073/pnas.93.16.8694; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; SHIMA K, 1991, J NEUROPHYSIOL, V65, P188, DOI 10.1152/jn.1991.65.2.188; TANJI J, 1994, NATURE, V371, P413, DOI 10.1038/371413a0; Wise SP, 1996, CRIT REV NEUROBIOL, V10, P317, DOI 10.1615/CritRevNeurobiol.v10.i3-4.30; Zilles K, 1995, J ANAT, V187, P515	27	226	228	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2000	3	5					502	508		10.1038/74880	http://dx.doi.org/10.1038/74880			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309DG	10769392	Green Submitted			2022-12-24	WOS:000086752000021
J	Aizman, O; Brismar, H; Uhlen, P; Zettergren, E; Levey, AI; Forssberg, H; Greengard, P; Aperia, A				Aizman, O; Brismar, H; Uhlen, P; Zettergren, E; Levey, AI; Forssberg, H; Greengard, P; Aperia, A			Anatomical and physiological evidence for D-1 and D-2 dopamine receptor colocalization in neostriatal neurons	NATURE NEUROSCIENCE			English	Article							STRIATAL NEURONS; GENE-EXPRESSION; BASAL GANGLIA; HELA-CELLS; RAT; NA,K-ATPASE; ISOFORMS; LOCALIZATION; DARPP-32; SODIUM	Despite the importance of dopamine signaling, it remains unknown if the two major subclasses of dopamine receptors exist on the same or distinct populations of neurons. Here we used confocal microscopy to demonstrate that virtually all striatal neurons, both in vitro and in vivo, contained dopamine receptors of both classes. We also provide functional evidence for such colocalization: in essentially all neurons examined, fenoldopam, an agonist of the D-1 subclass of receptors, inhibited both the Na+/K+ pump and tetrodotoxin (TTX)-sensitive sodium channels, and quinpirole, an agonist of the Dr subclass of receptors, activated TTX-sensitive sodium channels. Thus D-1 and D-2 classes of ligands may functionally interact in virtually all dopamine-responsive neurons within the basal ganglia.	Astrid Lindgren Childrens Hosp, Karolinska Inst, Dept Woman & Child Hlth, S-17176 Stockholm, Sweden; Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA	Karolinska Institutet; Emory University; Rockefeller University	Aperia, A (corresponding author), Astrid Lindgren Childrens Hosp, Karolinska Inst, Dept Woman & Child Hlth, Q2-09, S-17176 Stockholm, Sweden.		Brismar, Hjalmar/E-8524-2011; Forssberg, Hans/A-2944-2009; Levey, Allan/F-2104-2011	Brismar, Hjalmar/0000-0003-0578-4003; Levey, Allan/0000-0002-3153-502X; Uhlen, Per/0000-0003-1446-1062; Forssberg, Hans/0000-0003-2069-6618	NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH040899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER; NIDA NIH HHS [DA 10044] Funding Source: Medline; NIMH NIH HHS [MH40899] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDERSON KD, 1991, BRAIN RES, V568, P235, DOI 10.1016/0006-8993(91)91403-N; Belusa R, 1997, J BIOL CHEM, V272, P20179, DOI 10.1074/jbc.272.32.20179; BLOCH B, 1994, TRENDS NEUROSCI, V17, P3, DOI 10.1016/0166-2236(94)90023-X; BOCKAERT J, 1986, J PHYSIOLOGY PARIS, V81, P219; Borin ML, 1997, AM J PHYSIOL-CELL PH, V272, pC428, DOI 10.1152/ajpcell.1997.272.2.C428; BORIN ML, 1993, AM J PHYSIOL, V264, pC1513, DOI 10.1152/ajpcell.1993.264.6.C1513; Castellanos FX, 1997, CLIN PEDIATR, V36, P381, DOI 10.1177/000992289703600702; CEPEDA C, 1993, P NATL ACAD SCI USA, V90, P9576, DOI 10.1073/pnas.90.20.9576; Chase TN, 1998, NEUROLOGY, V51, pS30, DOI 10.1212/WNL.51.2_Suppl_2.S30; Egan MF, 1997, CURR OPIN NEUROBIOL, V7, P701, DOI 10.1016/S0959-4388(97)80092-X; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; GERFEN CR, 1994, TRENDS NEUROSCI, V17, P2, DOI 10.1016/0166-2236(94)90022-1; GERFEN CR, 1992, TRENDS NEUROSCI, V15, P133, DOI 10.1016/0166-2236(92)90355-C; Grace A A, 1998, Adv Pharmacol, V42, P655; HEMMINGS HC, 1986, J NEUROSCI, V6, P1469; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; JOHNSON SW, 1992, SCIENCE, V258, P665, DOI 10.1126/science.1329209; Knable MB, 1997, J PSYCHOPHARMACOL, V11, P123, DOI 10.1177/026988119701100205; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; LEMOINE C, 1995, J COMP NEUROL, V355, P418, DOI 10.1002/cne.903550308; LEMOINE C, 1991, P NATL ACAD SCI USA, V88, P4205, DOI 10.1073/pnas.88.10.4205; LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P8861, DOI 10.1073/pnas.90.19.8861; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; OCONNELL DP, 1995, AM J PHYSIOL-RENAL, V268, pF1185, DOI 10.1152/ajprenal.1995.268.6.F1185; OUIMET CC, 1990, J NEUROCYTOL, V19, P39, DOI 10.1007/BF01188438; Peng L, 1997, J NEUROSCI, V17, P3488; PIETRINI G, 1992, P NATL ACAD SCI USA, V89, P8414, DOI 10.1073/pnas.89.18.8414; SATOH H, 1994, AM J PHYSIOL, V266, pH568, DOI 10.1152/ajpheart.1994.266.2.H568; Self DW, 1996, SCIENCE, V271, P1586, DOI 10.1126/science.271.5255.1586; SURMEIER DJ, 1994, TRENDS NEUROSCI, V17, P4, DOI 10.1016/0166-2236(94)90024-8; SURMEIER DJ, 1992, P NATL ACAD SCI USA, V89, P10178, DOI 10.1073/pnas.89.21.10178; SURMEIER DJ, 1993, TRENDS NEUROSCI, V16, P299, DOI 10.1016/0166-2236(93)90103-S; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Swanson J, 1998, CURR OPIN NEUROBIOL, V8, P263, DOI 10.1016/S0959-4388(98)80150-5; Yu XM, 1998, NATURE, V396, P469, DOI 10.1038/24877; YUNG KKL, 1995, NEUROSCIENCE, V65, P709, DOI 10.1016/0306-4522(94)00536-E; Zahler R, 1997, J GEN PHYSIOL, V110, P201, DOI 10.1085/jgp.110.2.201	37	311	323	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2000	3	3					226	230		10.1038/72929	http://dx.doi.org/10.1038/72929			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TE	10700253				2022-12-24	WOS:000085810500010
J	Tanaka, H; Shan, WS; Phillips, GR; Arndt, K; Bozdagi, O; Shapiro, L; Huntley, GW; Benson, DL; Colman, DR				Tanaka, H; Shan, WS; Phillips, GR; Arndt, K; Bozdagi, O; Shapiro, L; Huntley, GW; Benson, DL; Colman, DR			Molecular modification of N-cadherin in response to synaptic activity	NEURON			English	Article							LONG-TERM POTENTIATION; CELL-ADHESION MOLECULES; DEVELOPING CHICKEN BRAIN; SYNAPSIN-I; DIFFERENTIAL EXPRESSION; POSTSYNAPTIC DENSITY; HIPPOCAMPAL-NEURONS; TRANSMITTER RELEASE; INTEGRIN RECEPTORS; NERVOUS-SYSTEM	The relationship between adhesive interactions across the synaptic cleft and synaptic function has remained elusive. At certain CNS synapses, pre- to postsynaptic adhesion is mediated at least in part by neural (N-) cadherin. Here, we demonstrate that upon depolarization of hippocampal neurons in culture by K+ treatment, or application of NMDA or alpha-latrotoxin, synaptic N-cadherin dimerizes and becomes markedly protease resistant. These properties are indices of strong, stable, enhanced cadherin-mediated intercellular adhesion. N-cadherin retained protease resistance for at least 2 hr after recovery, while other surface molecules, including other cadherins, were completely degraded. The acquisition of protease resistance and dimerization of N-cadherin is not dependent on new protein synthesis, nor is it accompanied by internalization of N-cadherin. By immunocytochemistry, we found that high K+ selectively induces surface dispersion of N-cadherin, which, after recovery, returns to synaptic puncta. N-cadherin dispersion under K+ treatment parallels the rapid expansion of the presynaptic membrane consequent to the massive vesicle fusion that occurs with this type of depolarization. In contrast, with NMDA application, N-cadherin does not disperse but does acquire enhanced protease resistance and dimerizes. Our data strongly suggest that synaptic adhesion is dynamically and locally controlled, and modulated by synaptic activity.	Mt Sinai Sch Med, Program Cell Adhes, New York, NY 10029 USA; Mt Sinai Sch Med, Program Struct Biol, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Biochem & Mol Biol, New York, NY 10029 USA; Mt Sinai Sch Med, Fishberg Res Ctr Neurobiol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Colman, DR (corresponding author), Mt Sinai Sch Med, Program Cell Adhes, New York, NY 10029 USA.	colman@msvax.mssm.edu		Benson, Deanna/0000-0001-7037-1147; Huntley, George W./0000-0003-3645-6192	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037731, R01NS034659, R01NS020147, R29NS034659] Funding Source: NIH RePORTER; NINDS NIH HHS [NS37731, NS34659, NS20147] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arndt K, 1998, MOL CELL NEUROSCI, V10, P211, DOI 10.1006/mcne.1998.0665; Arndt K, 1996, J COMP NEUROL, V373, P373, DOI 10.1002/(SICI)1096-9861(19960923)373:3<373::AID-CNE5>3.0.CO;2-#; Bahr BA, 1997, J NEUROSCI, V17, P1320; BAILEY CH, 1992, SCIENCE, V256, P645, DOI 10.1126/science.1585177; Banker G., 1991, CULTURING NERVE CELL; BEKKERS JM, 1990, COLD SH Q B, V55, P131; Benson DL, 1998, J NEUROSCI, V18, P6892; BIXBY JL, 1990, J CELL BIOL, V110, P1253, DOI 10.1083/jcb.110.4.1253; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487; Buchs PA, 1996, P NATL ACAD SCI USA, V93, P8040, DOI 10.1073/pnas.93.15.8040; BUCKLEY KM, 1983, J NEUROCYTOL, V12, P93, DOI 10.1007/BF01148089; Chitaev NA, 1998, J CELL BIOL, V142, P837, DOI 10.1083/jcb.142.3.837; Colman DR, 1997, MOL CELL NEUROSCI, V10, P1, DOI 10.1006/mcne.1997.0648; Craig AM, 1998, NEURON, V21, P459, DOI 10.1016/S0896-6273(00)80555-3; Cummings DD, 1996, J NEUROSCI, V16, P5312; EDWARDS FA, 1995, PHYSIOL REV, V75, P759, DOI 10.1152/physrev.1995.75.4.759; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; FLECK MW, 1992, BRAIN RES, V580, P100, DOI 10.1016/0006-8993(92)90931-X; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; GUMBINER BM, 1993, J CELL SCI, P155; Hagler DJ, 1998, NEURON, V20, P1059, DOI 10.1016/S0896-6273(00)80486-9; HATTA K, 1986, NATURE, V320, P447, DOI 10.1038/320447a0; Hunt CA, 1996, J NEUROSCI, V16, P1380; Huntley GW, 1999, J COMP NEUROL, V407, P453; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Inoue T, 1997, DEV BIOL, V183, P183, DOI 10.1006/dbio.1996.8501; Inoue T, 1998, DEV DYNAM, V211, P338, DOI 10.1002/(SICI)1097-0177(199804)211:4<338::AID-AJA5>3.3.CO;2-R; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Korematsu K, 1997, J COMP NEUROL, V387, P291; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; MATSUNAGA M, 1988, NATURE, V334, P62, DOI 10.1038/334062a0; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; MEGE RM, 1988, P NATL ACAD SCI USA, V85, P7274, DOI 10.1073/pnas.85.19.7274; MIYATANI S, 1989, SCIENCE, V245, P631, DOI 10.1126/science.2762814; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; NOSE A, 1988, CELL, V54, P993, DOI 10.1016/0092-8674(88)90114-6; NostenBertrand M, 1996, NATURE, V379, P826, DOI 10.1038/379826a0; PERSOHN E, 1990, J NEUROCYTOL, V19, P807, DOI 10.1007/BF01186812; PERSOHN E, 1989, J COMP NEUROL, V288, P92, DOI 10.1002/cne.902880108; Peters A., 1991, FINE STRUCTURE NERVO; POKUTTA S, 1994, EUR J BIOCHEM, V223, P1019, DOI 10.1111/j.1432-1033.1994.tb19080.x; REDIES C, 1993, J COMP NEUROL, V333, P398, DOI 10.1002/cne.903330307; Reynolds AB, 1996, EXP CELL RES, V225, P328, DOI 10.1006/excr.1996.0183; Riehl R, 1996, NEURON, V17, P837, DOI 10.1016/S0896-6273(00)80216-0; Sakurai E, 1998, NEUROREPORT, V9, P881, DOI 10.1097/00001756-199803300-00022; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schuster T, 1998, J NEUROBIOL, V37, P359, DOI 10.1002/(SICI)1097-4695(19981115)37:3<359::AID-NEU2>3.0.CO;2-4; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Shapiro L, 1999, NEURON, V23, P427, DOI 10.1016/S0896-6273(00)80796-5; Shapiro L, 1998, CURR OPIN NEUROBIOL, V8, P593, DOI 10.1016/S0959-4388(98)80086-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SHIRAYOSHI Y, 1986, EMBO J, V5, P2485, DOI 10.1002/j.1460-2075.1986.tb04525.x; SHORE EM, 1991, J BIOL CHEM, V266, P19672; SIHRA TS, 1989, P NATL ACAD SCI USA, V86, P8108, DOI 10.1073/pnas.86.20.8108; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Sorra KE, 1998, J NEUROSCI, V18, P658; STAUBLI U, 1990, BEHAV NEURAL BIOL, V53, P1, DOI 10.1016/0163-1047(90)90712-F; Stone KE, 1996, DEV BIOL, V180, P297, DOI 10.1006/dbio.1996.0302; SUDHOF TC, 1987, SCIENCE, V238, P1142, DOI 10.1126/science.3120313; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; TOMASELLI KJ, 1988, NEURON, V1, P33, DOI 10.1016/0896-6273(88)90207-3; Tomschy A, 1996, EMBO J, V15, P3507, DOI 10.1002/j.1460-2075.1996.tb00719.x; TORRITARELLI F, 1990, J CELL BIOL, V110, P449, DOI 10.1083/jcb.110.2.449; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; VRENSEN G, 1981, BRAIN RES, V218, P79, DOI 10.1016/0006-8993(81)90990-2; WEILER IJ, 1995, BEHAV BRAIN RES, V66, P1, DOI 10.1016/0166-4328(94)00116-W; WICKELGREN WO, 1985, J NEUROSCI, V5, P1188; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; YAMAGATA M, 1995, J NEUROSCI, V15, P4556; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0; YOSHIDA C, 1982, CELL, V28, P217, DOI 10.1016/0092-8674(82)90339-7; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2	79	271	276	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN	2000	25	1					93	107		10.1016/S0896-6273(00)80874-0	http://dx.doi.org/10.1016/S0896-6273(00)80874-0			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279KP	10707975	Bronze			2022-12-24	WOS:000085043200013
J	Marsh-Armstrong, N; Huang, HC; Remo, BF; Liu, TT; Brown, DD				Marsh-Armstrong, N; Huang, HC; Remo, BF; Liu, TT; Brown, DD			Asymmetric growth and development of the Xenopus laevis retina during metamorphosis is controlled by type III deiodinase	NEURON			English	Article							IPSILATERAL RETINOTHALAMIC PROJECTION; GANGLION-CELLS; CLAWED FROG; THYROXINE; EXPRESSION; HORMONE; GENE; PROLIFERATION; RESORPTION; TADPOLE	During the metamorphosis of the Xenopus laevis retina, thyroid hormone (TH) preferentially induces ventral ciliary marginal zone (CMZ) cells to both increase their proliferation and give rise to ipsilaterally projecting ganglion cells. Here we show that dorsal CMZ cells express type ill deiodinase (D3), an enzyme that inactivates TH. The dorsal CMZ cells can be induced to proliferate if deiodinase activity is inhibited. D3 or dominant-negative thyroid hormone receptor transgenes inhibit both TH-induced proliferation of the ventral CMZ cells and the formation of the ipsilateral projection. Thus, the localized expression of D3 in the dorsal CMZ cells accounts for the asymmetric growth of the frog retina.	Carnegie Inst Washington, Dept Embryol, Baltimore, MD 21210 USA	Carnegie Institution for Science	Marsh-Armstrong, N (corresponding author), Carnegie Inst Washington, Dept Embryol, 115 W Univ Pkwy, Baltimore, MD 21210 USA.							BEACH DH, 1979, J COMP NEUROL, V183, P615, DOI 10.1002/cne.901830309; BEACH DH, 1979, J COMP NEUROL, V183, P625, DOI 10.1002/cne.901830310; BEACH DH, 1979, J COMP NEUROL, V183, P603, DOI 10.1002/cne.901830308; Berry DL, 1998, DEV BIOL, V203, P24, DOI 10.1006/dbio.1998.8975; Dorsky RI, 1997, NATURE, V385, P67, DOI 10.1038/385067a0; DORSKY RI, 1995, NEURON, V14, P487, DOI 10.1016/0896-6273(95)90305-4; GALTON V, 1989, ENDOCRINOLOGY, V127, P1977; GALTON VA, 1989, ENDOCRINOLOGY, V124, P2427, DOI 10.1210/endo-124-5-2427; HOSKINS SG, 1985, J NEUROSCI, V5, P930; HOSKINS SG, 1985, J NEUROSCI, V5, P911; HOSKINS SG, 1985, J NEUROSCI, V5, P920; HOSKINS SG, 1990, J NEUROBIOL, V21, P970, DOI 10.1002/neu.480210704; HOSKINS SG, 1984, NATURE, V307, P730, DOI 10.1038/307730a0; HOSKINS SG, 1986, J NEUROBIOL, V17, P203, DOI 10.1002/neu.480170306; Huang HC, 1999, P NATL ACAD SCI USA, V96, P962, DOI 10.1073/pnas.96.3.962; KENNARD C, 1981, J EMBRYOL EXP MORPH, V65, P199; Kroll KL, 1996, DEVELOPMENT, V122, P3173; LELOUP J, 1977, CR ACAD SCI D NAT, V284, P2261; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Perron M, 1998, DEV BIOL, V199, P185, DOI 10.1006/dbio.1998.8939; SCHUTTE M, 1993, J COMP NEUROL, V331, P482, DOI 10.1002/cne.903310405; STEEDMAN JG, 1979, J EMBRYOL EXP MORPH, V50, P199; STGERMAIN DL, 1994, P NATL ACAD SCI USA, V91, P7767, DOI 10.1073/pnas.91.16.7767; STGERMAIN DL, 1994, P NATL ACAD SCI USA, V91, P11282; TAY D, 1982, ANAT EMBRYOL, V164, P75, DOI 10.1007/BF00301880; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; WANG Z, 1991, P NATL ACAD SCI USA, V88, P11505, DOI 10.1073/pnas.88.24.11505; WANG Z, 1993, J BIOL CHEM, V268, P16270	28	134	136	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1999	24	4					871	878		10.1016/S0896-6273(00)81034-X	http://dx.doi.org/10.1016/S0896-6273(00)81034-X			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	269UE	10624950	Bronze			2022-12-24	WOS:000084495300015
J	Cai, HB; Wang, YS; McCarthy, D; Wen, HJ; Borchelt, DR; Price, DL; Wong, PC				Cai, HB; Wang, YS; McCarthy, D; Wen, HJ; Borchelt, DR; Price, DL; Wong, PC			BACE1 is the major beta-secretase for generation of A beta peptides by neurons	NATURE NEUROSCIENCE			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; CLEAVAGE; VARIANTS; BRAIN		Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD 21205 USA; Ciphergen Biosyst, Fremont, CA 94555 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Wong, PC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.		Cai, Huaibin/H-3359-2013	Cai, Huaibin/0000-0002-8596-6108	NATIONAL INSTITUTE ON AGING [P01AG014248] Funding Source: NIH RePORTER; NIA NIH HHS [2P50 AG05146, 1P01 AG14248] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bennett BD, 2000, J BIOL CHEM, V275, P20647, DOI 10.1074/jbc.M002688200; Buxbaum JD, 1998, J NEUROSCI, V18, P9629; Capell A, 2000, J BIOL CHEM, V275, P30849, DOI 10.1074/jbc.M003202200; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; Gouras GK, 1998, J NEUROCHEM, V71, P1920; Haniu M, 2000, J BIOL CHEM, V275, P21099, DOI 10.1074/jbc.M002095200; Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150; NASLUND J, 1994, P NATL ACAD SCI USA, V91, P8378, DOI 10.1073/pnas.91.18.8378; PIKE CJ, 1995, J BIOL CHEM, V270, P23895, DOI 10.1074/jbc.270.41.23895; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; SHI XP, 2000, J BIOL CHEM; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107	15	901	955	1	68	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2001	4	3					233	234		10.1038/85064	http://dx.doi.org/10.1038/85064			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UE	11224536				2022-12-24	WOS:000167178300007
J	Emptage, NJ; Reid, CA; Fine, A				Emptage, NJ; Reid, CA; Fine, A			Calcium stores in hippocampal synaptic boutons mediate short-term plasticity, store-operated Ca2+ entry, and spontaneous transmitter release	NEURON			English	Article							PRESYNAPTIC NERVE-TERMINALS; SINGLE ACTION-POTENTIALS; PC12 CELLS; INTRACELLULAR CALCIUM; RYANODINE RECEPTOR; DENDRITIC SPINES; NEUROTRANSMITTER RELEASE; SEQUESTRATION MECHANISM; ENDOPLASMIC-RETICULUM; CULTURED HIPPOCAMPAL	Evoked transmitter release depends upon calcium influx into synaptic boutons, but mechanisms regulating bouton calcium levels and spontaneous transmitter release are obscure. To understand these processes better, we monitored calcium transients in axons and presynaptic terminals of pyramidal neurons in hippocampal slice cultures. Action potentials reliably evoke calcium transients in axons and boutons. Calcium-induced calcium release (CICR) from internal stores contributes to the transients in boutons and to paired-pulse facilitation of EPSPs. Store depletion activates store-operated calcium channels, influencing the frequency of spontaneous transmitter release. Boutons display spontaneous Ca2+ transients; blocking CICR reduces the frequency of these transients and of spontaneous miniature synaptic events. Thus, spontaneous transmitter release is largely calcium mediated, driven by Ca2+ release from internal stores. Bouton store release is important for short-term synaptic plasticity and may also contribute to long-term plasticity.	Natl Inst Med Res, Div Neurophysiol, London NW7 1AA, England; Dalhousie Univ, Fac Med, Dept Physiol & Biophys, Halifax, NS B3H 4H7, Canada	MRC National Institute for Medical Research; Dalhousie University	Fine, A (corresponding author), Natl Inst Med Res, Div Neurophysiol, Mill Hill, London NW7 1AA, England.	afine@nimr.mrc.ac.uk	Fine, Alan/P-5936-2014; Reid, Christopher A/F-4387-2014	Fine, Alan/0000-0002-4960-6973; Reid, Christopher/0000-0002-1457-8028				AUGUSTINE GJ, 1987, ANNU REV NEUROSCI, V10, P633, DOI 10.1146/annurev.ne.10.030187.003221; Bennett DL, 1998, BIOCHEM J, V329, P349; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BLAUSTEIN MP, 1978, J GEN PHYSIOL, V72, P43, DOI 10.1085/jgp.72.1.43; BLAUSTEIN MP, 1978, J GEN PHYSIOL, V72, P15, DOI 10.1085/jgp.72.1.15; BLAUSTEIN MP, 1980, FED PROC, V39, P2790; BORNSTEIN JC, 1978, J PHYSIOL-LONDON, V282, P375, DOI 10.1113/jphysiol.1978.sp012470; BORST JGG, 1998, J PHYSL, V513, P14; Brain KL, 1997, J PHYSIOL-LONDON, V502, P521, DOI 10.1111/j.1469-7793.1997.521bj.x; Chen CF, 1999, J NEUROSCI, V19, P6257; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; CLEMENTI E, 1992, J BIOL CHEM, V267, P2164; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Cox CL, 2000, P NATL ACAD SCI USA, V97, P9724, DOI 10.1073/pnas.170278697; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; DODGE FA, 1969, J PHYSIOL-LONDON, V200, P267, DOI 10.1113/jphysiol.1969.sp008692; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Emptage N. J., 1999, Society for Neuroscience Abstracts, V25, P1255; EPTAGE NJ, 2000, EUR J NEUROSCI, V11, P366; ERULKAR SD, 1978, J PHYSIOL-LONDON, V278, P501, DOI 10.1113/jphysiol.1978.sp012320; Fomina AF, 1999, J NEUROSCI, V19, P3711; Frenguelli BG, 1996, SEMIN NEUROSCI, V8, P301, DOI 10.1006/smns.1996.0037; HARTTER DE, 1987, NEUROSCIENCE, V23, P371, DOI 10.1016/0306-4522(87)90297-1; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; HENKART MP, 1978, SCIENCE, V202, P1300, DOI 10.1126/science.725607; Jonas EA, 1999, SCIENCE, V286, P1347, DOI 10.1126/science.286.5443.1347; KANO M, 1995, J PHYSIOL-LONDON, V487, P1; KATZ B, 1967, J PHYSIOL-LONDON, V192, P407, DOI 10.1113/jphysiol.1967.sp008307; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Koizumi S, 1999, J BIOL CHEM, V274, P33327, DOI 10.1074/jbc.274.47.33327; Koizumi S, 1999, NEURON, V22, P125, DOI 10.1016/S0896-6273(00)80684-4; Korkotian E, 1998, EUR J NEUROSCI, V10, P2076, DOI 10.1046/j.1460-9568.1998.00219.x; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Krizaj D, 1999, J NEUROSCI, V19, P7249, DOI 10.1523/JNEUROSCI.19-17-07249.1999; LEE WL, 1987, BRAIN RES, V426, P250, DOI 10.1016/0006-8993(87)90879-1; LLANO I, 1991, NEURON, V7, P577, DOI 10.1016/0896-6273(91)90370-F; Llano I, 1997, J PHYSIOL-LONDON, V502, P509, DOI 10.1111/j.1469-7793.1997.509bj.x; LLINAS R, 1991, J PHYSIOL-LONDON, V436, P257, DOI 10.1113/jphysiol.1991.sp018549; MacKenzie PJ, 1996, NEURON, V16, P783, DOI 10.1016/S0896-6273(00)80098-7; Mackenzie PJ, 1998, J NEUROPHYSIOL, V80, P2089, DOI 10.1152/jn.1998.80.4.2089; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MATHES C, 1995, J GEN PHYSIOL, V106, P975, DOI 10.1085/jgp.106.5.975; MCGRAW CF, 1980, J CELL BIOL, V85, P228, DOI 10.1083/jcb.85.2.228; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; MCPHERSON PS, 1991, NEURON, V7, P17, DOI 10.1016/0896-6273(91)90070-G; MELAMED N, 1993, J NEUROSCI, V13, P632; Melamed-Book N, 1999, P NATL ACAD SCI USA, V96, P15217, DOI 10.1073/pnas.96.26.15217; MILEDI R, 1973, PROC R SOC SER B-BIO, V183, P421, DOI 10.1098/rspb.1973.0026; Narita K, 1998, J GEN PHYSIOL, V112, P593, DOI 10.1085/jgp.112.5.593; ONODERA K, 1973, JPN J PHYSIOL, V23, P587; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Peng YY, 1996, J NEUROSCI, V16, P6703; PETERSEN CCH, 1995, BIOCHEM J, V311, P41, DOI 10.1042/bj3110041; Philipp S, 1998, EMBO J, V17, P4274, DOI 10.1093/emboj/17.15.4274; Putney JW, 1999, BIOESSAYS, V21, P38; Qian J, 1999, J NEUROPHYSIOL, V81, P288, DOI 10.1152/jn.1999.81.1.288; Radcliffe KA, 1998, J NEUROSCI, V18, P7075; REGEHR WG, 1995, BIOPHYS J, V68, P2156, DOI 10.1016/S0006-3495(95)80398-X; Reyes M, 1996, J NEUROSCI, V16, P5951; Sabatini BL, 1997, J NEUROSCI, V17, P3425; SABATINI BL, 1995, NEUROPHARMACOLOGY, V34, P1453, DOI 10.1016/0028-3908(95)00129-T; SAH P, 1991, NEURON, V7, P257, DOI 10.1016/0896-6273(91)90264-Z; Savic N, 1998, EUR J NEUROSCI, V10, P3379, DOI 10.1046/j.1460-9568.1998.00342.x; SEIDLER NW, 1989, J BIOL CHEM, V264, P17816; SHARP AH, 1993, J NEUROSCI, V13, P3051; SHMIGOL A, 1994, PFLUG ARCH EUR J PHY, V426, P174, DOI 10.1007/BF00374686; SIMPSON PB, 1993, J NEUROCHEM, V61, P760; Sinha SR, 1997, BIOPHYS J, V72, P637, DOI 10.1016/S0006-3495(97)78702-2; Smith AB, 1996, J PHYSIOL-LONDON, V497, P657, DOI 10.1113/jphysiol.1996.sp021797; Smith PM, 1996, BIOCHEM J, V317, P779, DOI 10.1042/bj3170779; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; TAKEMURA H, 1991, BIOCHEM BIOPH RES CO, V180, P1518, DOI 10.1016/S0006-291X(05)81368-3; Toescu EC, 1998, NEUROSCIENCE, V86, P925, DOI 10.1016/S0306-4522(98)00123-7; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Usachev YM, 1999, J PHYSIOL-LONDON, V519, P115, DOI 10.1111/j.1469-7793.1999.0115o.x; Voronin LL, 1999, NEUROSCIENCE, V92, P399, DOI 10.1016/S0306-4522(99)00150-5; WU LG, 1994, J NEUROSCI, V14, P645; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	81	416	427	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	2001	29	1					197	208		10.1016/S0896-6273(01)00190-8	http://dx.doi.org/10.1016/S0896-6273(01)00190-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	397NX	11182091	Bronze			2022-12-24	WOS:000166702700019
J	Stuart, GJ; Hausser, M				Stuart, GJ; Hausser, M			Dendritic coincidence detection of EPSDs and action potentials	NATURE NEUROSCIENCE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; TERM SYNAPTIC PLASTICITY; EXCITATORY POSTSYNAPTIC POTENTIALS; RABBIT FOLLOWING STIMULATION; LONG-LASTING POTENTIATION; HIPPOCAMPAL-NEURONS; CALCIUM INFLUX; NMDA RECEPTORS; PERFORANT PATH; DENTATE AREA	We describe a mechanism for coincidence detection mediated by the interaction between backpropagating action potentials and EPSPs in neocortical pyramidal neurons. At distal dendritic locations, appropriately timed EPSPs or oscillations could increase the amplitude of backpropagating action potentials by three- to fourfold. This amplification was greatest when action potentials occurred at the peak of EPSPs or dendritic oscillations and could lead to somatic burst firing. The increase in amplitude required sodium channel activation but not potassium channel inactivation. The temporal characteristics of this amplification are similar to those required for changes in synaptic strength, suggesting that this mechanism may be involved in the induction of synaptic plasticity.	Australian Natl Univ, John Curtin Sch Med Res, Div Neurosci, Canberra, ACT 0200, Australia; UCL, Dept Physiol, London WC1E 6BT, England	Australian National University; John Curtin School of Medical Research; University of London; University College London	Stuart, GJ (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Div Neurosci, Canberra, ACT 0200, Australia.	greg.stuart@anu.edu.au	Hausser, Michael/AAW-6827-2020; stuart, greg j/F-7328-2011	Hausser, Michael/0000-0002-2673-8957; stuart, greg/0000-0001-9395-2219				Bekkers JM, 2000, J PHYSIOL-LONDON, V525, P611, DOI 10.1111/j.1469-7793.2000.t01-2-00611.x; Bekkers JM, 2000, J PHYSIOL-LONDON, V525, P593, DOI 10.1111/j.1469-7793.2000.t01-1-00593.x; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Gray C M, 1994, J Comput Neurosci, V1, P11, DOI 10.1007/BF00962716; Hebb Donald O., 1949, ORG BEHAV; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; HUERTA PT, 1993, NATURE, V364, P723, DOI 10.1038/364723a0; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Kamondi A, 1998, J NEUROSCI, V18, P3919; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Korngreen A, 2000, J PHYSIOL-LONDON, V525, P621, DOI 10.1111/j.1469-7793.2000.00621.x; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Linden DJ, 1999, NEURON, V22, P661, DOI 10.1016/S0896-6273(00)80726-6; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Migliore M, 1999, J COMPUT NEUROSCI, V7, P5, DOI 10.1023/A:1008906225285; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; Neville KR, 1999, NEUROREPORT, V10, P3711, DOI 10.1097/00001756-199911260-00045; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Paulsen O, 2000, CURR OPIN NEUROBIOL, V10, P172, DOI 10.1016/S0959-4388(00)00076-3; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Sourdet V, 1999, LEARN MEMORY, V6, P422, DOI 10.1101/lm.6.5.422; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart G, 1998, J NEUROSCI, V18, P3501; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; VETTER P, IN PRESS J NEUROPHYS; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Whittington MA, 1997, P NATL ACAD SCI USA, V94, P12198, DOI 10.1073/pnas.94.22.12198; Yuste R, 1999, J NEUROSCI, V19, P1976	45	247	249	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2001	4	1					63	71		10.1038/82910	http://dx.doi.org/10.1038/82910			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UB	11135646				2022-12-24	WOS:000167178000015
J	Yokoyama, N; Romero, MI; Cowan, CA; Galvan, P; Helmbacher, F; Charnay, P; Parada, LF; Henkemeyer, M				Yokoyama, N; Romero, MI; Cowan, CA; Galvan, P; Helmbacher, F; Charnay, P; Parada, LF; Henkemeyer, M			Forward signaling mediated by ephrin-B3 prevents contralateral corticospinal axons from recrossing the spinal cord midline	NEURON			English	Article							CENTRAL PATTERN GENERATORS; RECEPTOR TYROSINE KINASES; EMBRYONIC STEM-CELLS; EPH RECEPTORS; MIRROR MOVEMENTS; TRANSMEMBRANE LIGANDS; KALLMANNS-SYNDROME; TRANSGENIC MICE; TRACT; LOCOMOTION	To investigate Eph-ephrin bidirectional signaling, a series of mutations were generated in the ephrin-B3 locus. The absence of both forward and reverse signaling resulted in mice with mirror movements as typified by a hopping locomotion. The corticospinal tract was defective as axons failed to respect the midline boundary of the spinal cord and bilaterally innervated both contralateral and ipsilateral motor neuron populations. A second mutation that expresses a truncated ephrin-B3 protein lacking its cytoplasmic domain did not lead to hopping, indicating that reverse signaling is not required for corticospinal innervation. Ephrin-B3 is concentrated at the spinal cord midline, while one of its receptors, EphA4, is expressed in postnatal corticospinal neurons as their fibers pathfind down the contralateral spinal cord. Our data indicate ephrin-B3 functions as a midline-anchored repellent to stimulate forward signaling in EphA4-expressing axons.	Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Kent Waldrep Fdn, Ctr Basic Res Nerve Growth & Regenerat, Dallas, TX 75390 USA; Ecole Normale Super, INSERM, U368, F-75231 Paris, France	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Henkemeyer, M (corresponding author), Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA.	henk@utsw.swmed.edu	Romero, Mario I/K-1250-2012; Parada, luis F/B-9400-2014; Romero-Ortega, Mario/K-6097-2019; Romero-Ortega, Mario I/T-2520-2018; Helmbacher, Francoise/AAM-2318-2021	Romero-Ortega, Mario/0000-0003-2576-2629; Romero-Ortega, Mario I/0000-0003-2576-2629; Helmbacher, Francoise/0000-0001-6822-1246; Henkemeyer, Mark/0000-0002-7525-1061; Charnay, Patrick/0000-0002-3847-6042	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036671] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS36671] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKINTUNDE A, 1992, BRAIN RES, V586, P208, DOI 10.1016/0006-8993(92)91629-S; ARMSTRONG DM, 1986, PROG NEUROBIOL, V26, P273, DOI 10.1016/0301-0082(86)90021-3; Bergemann AD, 1998, ONCOGENE, V16, P471, DOI 10.1038/sj.onc.1201557; Birgbauer E, 2000, DEVELOPMENT, V127, P1231; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; Bures I., 1990, CEREBRAL CORTEX RAT, P213; CALZONETTI T, 1995, DEV BIOL, V171, P615, DOI 10.1006/dbio.1995.1309; Cohen NR, 1998, CURR BIOL, V8, P26, DOI 10.1016/S0960-9822(98)70017-X; Cowan CA, 2000, NEURON, V26, P417, DOI 10.1016/S0896-6273(00)81174-5; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Davy A, 2000, EMBO J, V19, P5396, DOI 10.1093/emboj/19.20.5396; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; Feraboli-Lohnherr D, 1999, J NEUROSCI RES, V55, P87, DOI 10.1002/(SICI)1097-4547(19990101)55:1<87::AID-JNR10>3.0.CO;2-#; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Frisen J, 1999, EMBO J, V18, P5159, DOI 10.1093/emboj/18.19.5159; Gale NW, 1996, ONCOGENE, V13, P1343; Gianino S, 1999, DEV BRAIN RES, V112, P189, DOI 10.1016/S0165-3806(98)00168-0; GOLDBERGER ME, 1990, EXP NEUROL, V107, P113, DOI 10.1016/0014-4886(90)90149-M; GRIBNAU AAM, 1986, ANAT EMBRYOL, V175, P101, DOI 10.1007/BF00315460; GRILLNER S, 1985, ANNU REV NEUROSCI, V8, P233, DOI 10.1146/annurev.ne.08.030185.001313; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; HENKEMEYER M, 1994, ONCOGENE, V9, P1001; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Herzog AG, 1992, MOVEMENT DISORDERS N, P704; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Holstege Gert, 1995, P137; Imondi R, 2000, DEVELOPMENT, V127, P1397; Joosten EAJ, 1997, PROG NEUROBIOL, V53, P1, DOI 10.1016/S0301-0082(97)00024-5; JOOSTEN EAJ, 1989, ANAT EMBRYOL, V179, P449, DOI 10.1007/BF00319587; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kiehn O, 1998, ANN NY ACAD SCI, V860, P110, DOI 10.1111/j.1749-6632.1998.tb09043.x; Krams M, 1999, NEUROLOGY, V52, P816, DOI 10.1212/WNL.52.4.816; KUANG RZ, 1994, J COMP NEUROL, V344, P270, DOI 10.1002/cne.903440208; LI CX, 1991, CAN J NEUROL SCI, V18, P28, DOI 10.1017/S0317167100031267; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Mayston MJ, 1997, BRAIN, V120, P1199, DOI 10.1093/brain/120.7.1199; Mellitzer G, 2000, CURR OPIN NEUROBIOL, V10, P400, DOI 10.1016/S0959-4388(00)00095-7; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nakagawa S, 2000, NEURON, V25, P599, DOI 10.1016/S0896-6273(00)81063-6; REGLI F, 1967, ARCH NEUROL-CHICAGO, V16, P620, DOI 10.1001/archneur.1967.00470240058007; Romero MI, 1999, J HISTOCHEM CYTOCHEM, V47, P265, DOI 10.1177/002215549904700216; SCHOTT GD, 1981, J NEUROL NEUROSUR PS, V44, P586, DOI 10.1136/jnnp.44.7.586; SCHREYER DJ, 1982, NEUROSCIENCE, V7, P1837, DOI 10.1016/0306-4522(82)90001-X; STANFIELD BB, 1992, PROG NEUROBIOL, V38, P169, DOI 10.1016/0301-0082(92)90039-H; TERASHIMA T, 1995, NEUROSCI RES, V22, P139, DOI 10.1016/0168-0102(95)00895-9; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Voiculescu O, 2000, GENESIS, V26, P123, DOI 10.1002/(SICI)1526-968X(200002)26:2<123::AID-GENE7>3.0.CO;2-O; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452; Zallen JA, 1999, DEVELOPMENT, V126, P3679	55	167	170	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	2001	29	1					85	97		10.1016/S0896-6273(01)00182-9	http://dx.doi.org/10.1016/S0896-6273(01)00182-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	397NX	11182083	Bronze			2022-12-24	WOS:000166702700011
J	Auger, C; Attwell, D				Auger, C; Attwell, D			Fast removal of synaptic glutamate by postsynaptic transporters	NEURON			English	Article							CEREBELLAR PURKINJE-CELLS; GATED CHLORIDE CHANNEL; AMINO-ACID TRANSPORTER; D-ASPARTATE RECEPTORS; BERGMANN GLIAL-CELLS; TIME-COURSE; CLIMBING FIBER; RAT-BRAIN; EXTRASYNAPTIC GLUTAMATE; PARALLEL FIBER	Glutamate transporters are believed to remove glutamate from the synaptic cleft only slowly because they cycle slowly. However, we show that when glutamate binds to postsynaptic transporters at the cerebellar climbing fiber synapse, it evokes a conformation change and inward current that reflect glutamate removal from the synaptic cleft within a few milliseconds, a time scale much faster than the overall cycle time. Contrary to present models, glutamate removal does not require binding of an extracellular proton, and the time course of transporter anion conductance activation differs from that of glutamate removal. The charge movement associated with glutamate removal is consistent with the majority of synaptically released glutamate being removed from the synaptic cleft by postsynaptic transporters.	UCL, Dept Physiol, London WC1E 6BT, England	University of London; University College London	Attwell, D (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.	d.attwell@ucl.ac.uk	Attwell, David/ABE-6750-2020					Auger C, 1998, J NEUROSCI, V18, P4532; BARBOUR B, 1991, J PHYSIOL-LONDON, V436, P169, DOI 10.1113/jphysiol.1991.sp018545; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; Bergles DE, 1997, P NATL ACAD SCI USA, V94, P14821, DOI 10.1073/pnas.94.26.14821; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Billups B, 1996, J NEUROSCI, V16, P6722; Billups B, 1996, NATURE, V379, P171, DOI 10.1038/379171a0; BILLUPS B, 1994, J PHYSIOL-LONDON, V476P, pP67; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; Clark BA, 1997, J PHYSIOL-LONDON, V502, P335, DOI 10.1111/j.1469-7793.1997.335bk.x; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Dehnes Y, 1998, J NEUROSCI, V18, P3606; Diamond JS, 1997, J NEUROSCI, V17, P4672; Eliasof S, 1996, P NATL ACAD SCI USA, V93, P4153, DOI 10.1073/pnas.93.9.4153; ERECINSKA M, 1987, FEBS LETT, V213, P61, DOI 10.1016/0014-5793(87)81465-5; Fairman WA, 1998, NAT NEUROSCI, V1, P105, DOI 10.1038/355; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Furuta A, 1997, NEUROSCIENCE, V81, P1031, DOI 10.1016/S0306-4522(97)00252-2; Hausser M, 1997, J PHYSIOL-LONDON, V501, P77; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; KUFFLER SW, 1975, J PHYSIOL-LONDON, V251, P465, DOI 10.1113/jphysiol.1975.sp011103; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; Mennerick S, 1999, J NEUROSCI, V19, P9242; Otis TS, 2000, J NEUROSCI, V20, P2749; Otis TS, 1998, J NEUROSCI, V18, P7099; Otis TS, 1997, SCIENCE, V277, P1515, DOI 10.1126/science.277.5331.1515; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; Overstreet LS, 1999, J NEUROSCI, V19, P9663; PERKEL DJ, 1990, P ROY SOC B-BIOL SCI, V241, P116, DOI 10.1098/rspb.1990.0074; RAMAN IM, 1994, J NEUROSCI, V14, P4998; RIVEROS N, 1986, BRAIN RES, V386, P405, DOI 10.1016/0006-8993(86)90181-2; Rusakov DA, 1998, J NEUROSCI, V18, P3158; SARANTIS M, 1993, NEURON, V11, P541, DOI 10.1016/0896-6273(93)90158-N; SATHER W, 1992, J PHYSIOL-LONDON, V450, P643, DOI 10.1113/jphysiol.1992.sp019148; Shibata T, 1996, NEUROREPORT, V7, P705, DOI 10.1097/00001756-199602290-00006; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Takahashi M, 1996, J PHYSIOL-LONDON, V497, P523, DOI 10.1113/jphysiol.1996.sp021785; TAKAHASHI M, 1995, J NEUROSCI, V15, P5693; Tanaka J, 1997, NEUROREPORT, V8, P2461, DOI 10.1097/00001756-199707280-00010; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; Tzingounis AV, 1998, J BIOL CHEM, V273, P17315, DOI 10.1074/jbc.273.28.17315; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zerangue N, 1996, J PHYSIOL-LONDON, V493, P419, DOI 10.1113/jphysiol.1996.sp021393	52	139	144	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	2000	28	2					547	558		10.1016/S0896-6273(00)00132-X	http://dx.doi.org/10.1016/S0896-6273(00)00132-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	377CE	11144363	Green Published, Bronze			2022-12-24	WOS:000165493700028
J	Voets, T				Voets, T			Dissection of three Ca2+-dependent steps leading to secretion in chromaffin cells from mouse adrenal slices	NEURON			English	Article							SNARE COMPLEX; CALCIUM-DEPENDENCE; SYNAPTIC VESICLES; SYNAPTOTAGMIN-I; EXOCYTOSIS; CA2+; RELEASE; FUSION; KINETICS; DEPRESSION	In neurosecretory cells, intracellular Ca2+ ([Ca2+](i)) not only acts as the trigger for secretion but also regulates earlier steps in the secretory pathway. Here, a novel approach was developed to control [Ca2+](i) over a broad concentration range, which allowed the quantification of three distinct actions of [Ca2+](i) on large dense-core vesicle (LDCV) fusion in chromaffin cells from mouse adrenal slices. Basal [Ca2+](i) regulated the transfer of vesicles toward a slowly releasable state, whereas further maturation to the readily releasable state was Ca2+ independent. [Ca2+](i) levels above 3 muM triggered exocytosis of all readily and slowly releasable vesicles in two parallel, kinetically distinct fusion reactions. In a molecular context, these results suggest that Ca2+ acts both before and after trans-SNARE complex formation to regulate fusion competence and fusion kinetics of LDCVs.	Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany	Max Planck Society	Voets, T (corresponding author), Max Planck Inst Biophys Chem, Dept Membrane Biophys, Fassberg 11, D-37077 Gottingen, Germany.		Voets, Thomas/E-2466-2012; Voets, Thomas/AAD-4389-2019	Voets, Thomas/0000-0001-5526-5821; Voets, Thomas/0000-0001-5526-5821				Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Augustine GJ, 1999, J PHYSIOL-LONDON, V520, P33, DOI 10.1111/j.1469-7793.1999.00033.x; BITTNER MA, 1992, J BIOL CHEM, V267, P16219; Blank PS, 1998, J GEN PHYSIOL, V112, P559, DOI 10.1085/jgp.112.5.559; Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; Dittman JS, 1998, J NEUROSCI, V18, P6147; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fernandez-Chacon R, 1999, ANNU REV PHYSIOL, V61, P753, DOI 10.1146/annurev.physiol.61.1.753; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gomis A, 1999, J NEUROSCI, V19, P6309; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; Kasai H, 1999, TRENDS NEUROSCI, V22, P88, DOI 10.1016/S0166-2236(98)01293-4; KONISHI M, 1991, J GEN PHYSIOL, V97, P271, DOI 10.1085/jgp.97.2.271; KUSANO K, 1975, J PHYSIOL-LONDON, V245, P13, DOI 10.1113/jphysiol.1975.sp010832; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Lonart G, 2000, J BIOL CHEM, V275, P27703; MARQUEZE B, 1995, J NEUROSCI, V15, P4906; Moser T, 1997, J NEUROSCI, V17, P2314; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Plattner H, 1997, J CELL BIOL, V139, P1709, DOI 10.1083/jcb.139.7.1709; Scales SJ, 2000, NEURON, V26, P457, DOI 10.1016/S0896-6273(00)81177-0; Smith C, 1999, J NEUROSCI, V19, P589; Smith C, 1998, NEURON, V20, P1243, DOI 10.1016/S0896-6273(00)80504-8; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; Voets T, 1999, NEURON, V23, P607, DOI 10.1016/S0896-6273(00)80812-0; Vogel SS, 1996, J CELL BIOL, V134, P329, DOI 10.1083/jcb.134.2.329; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Wei SH, 2000, EMBO J, V19, P1279, DOI 10.1093/emboj/19.6.1279; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	40	183	184	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	2000	28	2					537	545		10.1016/S0896-6273(00)00131-8	http://dx.doi.org/10.1016/S0896-6273(00)00131-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	377CE	11144362	Bronze, Green Published			2022-12-24	WOS:000165493700027
J	Zhu, JJ; Esteban, JA; Hayashi, Y; Malinow, R				Zhu, JJ; Esteban, JA; Hayashi, Y; Malinow, R			Postnatal synaptic potentiation: Delivery of GluR4-containing AMPA receptors by spontaneous activity	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CENTRAL GLUTAMATERGIC SYNAPSE; SILENT SYNAPSES; NETWORK OSCILLATIONS; HIPPOCAMPAL-NEURONS; EXCITATORY SYNAPSES; NMDA RECEPTOR; CA1 REGION; IN-VIVO; EXPRESSION	To examine how functional circuits are established in the brain, we studied excitatory transmission in early postnatal hippocampus. Spontaneous neural activity was sufficient to selectively deliver GluR4-containing AMPA receptors (AMPA-Rs) into synapses. This delivery allowed non-functional connections to transmit at resting potentials and required NMDA receptors (NMDA-Rs) but not CaMKII activation. Subsequently, these delivered receptors were exchanged with non-synaptic GluR2-containing AMPA-Rs in a manner requiring little neuronal activity. The enhanced transmission resulting from this delivery and subsequent exchange was maintained for at least several days and required an interaction between GluR2 and NSF. Thus, this sequence of subunit-specific trafficking events triggered by spontaneous activity in early postnatal development may be crucial for initial establishment of long-lasting functional circuitry.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; MIT, Ctr Learning & Memory, Cambridge, MA 02139 USA	Cold Spring Harbor Laboratory; Massachusetts Institute of Technology (MIT)	Malinow, R (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.		Hayashi, Yasunori/C-2249-2008; Esteban, Jose/L-4944-2014; Hayashi, Yasunori/AAF-1408-2019	Hayashi, Yasunori/0000-0002-7560-3004; Esteban, Jose/0000-0002-3759-3300; Hayashi, Yasunori/0000-0002-7560-3004				BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Cline HT, 1996, COLD SPRING HARB SYM, V61, P95; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Dingledine R, 1999, PHARMACOL REV, V51, P7; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; GALLI L, 1988, SCIENCE, V242, P90, DOI 10.1126/science.3175637; Garaschuk O, 1998, J PHYSIOL-LONDON, V507, P219, DOI 10.1111/j.1469-7793.1998.219bu.x; Gomperts SN, 2000, J NEUROSCI, V20, P2229; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIM HG, 1995, CEREB CORTEX, V5, P148, DOI 10.1093/cercor/5.2.148; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Liao DZ, 1996, LEARN MEMORY, V3, P138, DOI 10.1101/lm.3.2-3.138; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lisman J, 1997, SCIENCE, V276, P2001, DOI 10.1126/science.276.5321.2001; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; MALINOW R, 1999, IMAGING NEURONS LAB; Margrie TW, 1998, NAT NEUROSCI, V1, P378, DOI 10.1038/1589; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Palva JM, 2000, J NEUROSCI, V20, P1170, DOI 10.1523/JNEUROSCI.20-03-01170.2000; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Ramon y Cajal S, 1911, HISTOLOGIE SYSTEM NE; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Ruthazer ES, 1996, J NEUROSCI, V16, P7253; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhu JJ, 2000, J PHYSIOL-LONDON, V526, P571, DOI 10.1111/j.1469-7793.2000.00571.x	45	313	326	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11					1098	1106		10.1038/80614	http://dx.doi.org/10.1038/80614			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TX	11036266	Green Submitted			2022-12-24	WOS:000167177600014
J	Mendez, A; Burns, ME; Roca, A; Lem, J; Wu, LW; Simon, MI; Baylor, DA; Chen, J				Mendez, A; Burns, ME; Roca, A; Lem, J; Wu, LW; Simon, MI; Baylor, DA; Chen, J			Rapid and reproducible deactivation of rhodopsin requires multiple phosphorylation sites	NEURON			English	Article							ROD OUTER SEGMENTS; MONOCLONAL-ANTIBODIES; BOVINE RHODOPSIN; RETINAL RODS; SYNTHETIC PEPTIDES; CARBOXYL-TERMINUS; CGMP HYDROLYSIS; SINGLE PHOTONS; IN-VIVO; KINASE	Efficient single-photon detection by retinal rod photoreceptors requires timely and reproducible deactivation of rhodopsin. Like other G protein-coupled receptors, rhodopsin contains multiple sites for phosphorylation at its COOH-terminal domain. Transgenic and electrophysiological methods were used to functionally dissect the role of the multiple phosphorylation sites during deactivation of rhodopsin in intact mouse rods. Mutant rhodopsins bearing zero, one (S338), or two (S334/S338) phosphorylation sites generated single-photon responses with greatly prolonged, exponentially distributed durations. Responses from rods expressing mutant rhodopsins bearing more than two phosphorylation sites declined along smooth, reproducible time courses; the rate of recovery increased with increasing numbers of phosphorylation sites. We conclude that multiple phosphorylation of rhodopsin is necessary for rapid and reproducible deactivation.	Univ So Calif, Doheny Eye Inst, Mary D Allen Lab Vis Res, Los Angeles, CA 90089 USA; Univ So Calif, Keck Sch Med, Dept Ophthalmol & Cell & Neurobiol, Los Angeles, CA 90089 USA; Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA; Tufts Univ, Sch Med, New England Med Ctr, Ophthalmol & Mol Cardiol Res Inst,Dept Ophthalmol, Boston, MA 02111 USA; Tufts Univ, Sch Med, New England Med Ctr, Ophthalmol & Mol Cardiol Res Inst,Dept Genet, Boston, MA 02111 USA; Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; Univ So Calif, Keck Sch Med, Norris Canc Ctr, Los Angeles, CA 90089 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	Doheny Eye Institute; University of Southern California; University of Southern California; Stanford University; Tufts Medical Center; Tufts University; Tufts Medical Center; Tufts University; University of Southern California; University of Southern California; California Institute of Technology	Chen, J (corresponding author), Univ So Calif, Doheny Eye Inst, Mary D Allen Lab Vis Res, Los Angeles, CA 90089 USA.		Méndez, Ana/F-9729-2016	Méndez, Ana/0000-0001-6393-1644	NATIONAL EYE INSTITUTE [R01EY012008, R01EY012155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG012288] Funding Source: NIH RePORTER; NEI NIH HHS [EY 12155, EY 12008] Funding Source: Medline; NIA NIH HHS [AG 12288] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ADAMUS G, 1988, HYBRIDOMA, V7, P237, DOI 10.1089/hyb.1988.7.237; ADAMUS G, 1991, VISION RES, V31, P17, DOI 10.1016/0042-6989(91)90069-H; AUSUBEL F, 1995, SHORT PROTOCOLS MOL, P8; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BAYLOR DA, 1973, J PHYSIOL-LONDON, V234, P163, DOI 10.1113/jphysiol.1973.sp010340; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; Brannock MT, 1999, BIOCHEMISTRY-US, V38, P3770, DOI 10.1021/bi982419w; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; CHEN J, 1995, SCIENCE, V267, P374, DOI 10.1126/science.7824934; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; HODGES RS, 1988, J BIOL CHEM, V263, P11768; Hogan B, 1994, MANIPULATING MOUSE E; Hurley JB, 1998, VISION RES, V38, P1341, DOI 10.1016/S0042-6989(97)00459-8; Laitko U, 1998, BIOPHYS J, V74, P803, DOI 10.1016/S0006-3495(98)74005-6; Langen R, 1999, BIOCHEMISTRY-US, V38, P7918, DOI 10.1021/bi990010g; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Li TS, 1996, P NATL ACAD SCI USA, V93, P14176, DOI 10.1073/pnas.93.24.14176; MCDOWELL JH, 1993, BIOCHEMISTRY-US, V32, P4968, DOI 10.1021/bi00069a036; Mendez A, 2000, METHOD ENZYMOL, V316, P167; MILLER JL, 1984, VISION RES, V24, P1509, DOI 10.1016/0042-6989(84)90313-4; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; NAKATANI K, 1988, J PHYSIOL-LONDON, V395, P731, DOI 10.1113/jphysiol.1988.sp016943; OHGURO H, 1993, BIOCHEMISTRY-US, V32, P5718, DOI 10.1021/bi00072a030; OHGURO H, 1995, J BIOL CHEM, V270, P14259, DOI 10.1074/jbc.270.24.14259; OHGURO H, 1994, BIOCHEMISTRY-US, V33, P1023, DOI 10.1021/bi00170a022; Ohguro H, 1996, J BIOL CHEM, V271, P5215; PALCZEWSKI K, 1994, PROTEIN SCI, V3, P314; PALCZEWSKI K, 1989, BIOCHEMISTRY-US, V28, P8764, DOI 10.1021/bi00448a013; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P12949; PALCZEWSKI K, 1991, TRENDS BIOCHEM SCI, V16, P387, DOI 10.1016/0968-0004(91)90157-Q; PAPAC DI, 1993, BIOCHEMISTRY-US, V32, P5930, DOI 10.1021/bi00074a002; PFISTER C, 1983, EUR J BIOCHEM, V136, P489, DOI 10.1111/j.1432-1033.1983.tb07767.x; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; PULVERMULLER A, 1993, BIOCHEMISTRY-US, V32, P14082, DOI 10.1021/bi00214a002; Pulvermuller A, 1997, BIOCHEMISTRY-US, V36, P9253, DOI 10.1021/bi970772g; Rieke F, 1998, BIOPHYS J, V75, P1836, DOI 10.1016/S0006-3495(98)77625-8; ROSE GD, 1985, SCIENCE, V229, P834, DOI 10.1126/science.4023714; Sagoo MS, 1997, NATURE, V389, P392, DOI 10.1038/38750; SHI W, 1995, J BIOL CHEM, V270, P2112, DOI 10.1074/jbc.270.5.2112; SIBLEY DR, 1986, P NATL ACAD SCI USA, V83, P9408, DOI 10.1073/pnas.83.24.9408; SMITH WC, 1994, J BIOL CHEM, V269, P15407; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; THOMPSON P, 1984, BIOCHEM J, V220, P773, DOI 10.1042/bj2200773; Thurmond RL, 1997, P NATL ACAD SCI USA, V94, P1715, DOI 10.1073/pnas.94.5.1715; Toda K, 1999, VISUAL NEUROSCI, V16, P391, DOI 10.1017/S0952523899162187; Whitlock GG, 1999, NEURON, V23, P337, DOI 10.1016/S0896-6273(00)80784-9; WILDEN U, 1995, BIOCHEMISTRY-US, V34, P1446, DOI 10.1021/bi00004a040; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; WILDEN U, 1982, BIOCHEMISTRY-US, V21, P3014, DOI 10.1021/bi00541a032; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068; Zhang LR, 1997, J BIOL CHEM, V272, P14762, DOI 10.1074/jbc.272.23.14762	52	207	209	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	2000	28	1					153	164		10.1016/S0896-6273(00)00093-3	http://dx.doi.org/10.1016/S0896-6273(00)00093-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	370VN	11086991	Bronze			2022-12-24	WOS:000165143500018
J	Richards, DA; Guatimosim, C; Betz, WJ				Richards, DA; Guatimosim, C; Betz, WJ			Two endocytic recycling routes selectively fill two vesicle pools in frog motor nerve terminals	NEURON			English	Article							RETINAL BIPOLAR CELLS; NEUROMUSCULAR-JUNCTION; SYNAPTIC VESICLES; TRANSMITTER RELEASE; HIPPOCAMPAL SYNAPSES; RIBBON SYNAPSE; CALCIUM; EXOCYTOSIS; FLUORESCENCE; CLATHRIN	We have identified and characterized two vesicle recycling pathways in frog motor nerve terminals. We exploited the differential staining properties of FM dyes of varying hydrophobicity to label selectively two different vesicle pools, using optical imaging and electron microscopy of photoconverted dyes. During a 1 min tetanus, a rapidly recycling route places vesicles selectively into a small readily releasable pool comprising about 20% of vesicles. After the tetanus, a much slower pathway (from which FM2-10 but not FM1-43 can be rinsed) delivers vesicles via infoldings and cisternae selectively to a reserve pool with a halftime of about 8 min. Mixing between the two pools is slow. During stimulation at 30 Hz, 10-15 s is required to mobilize and release dye from the reserve pool.	Univ Colorado, Sch Med, Dept Physiol & Biophys, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Betz, WJ (corresponding author), Univ Colorado, Sch Med, Dept Physiol & Biophys, Denver, CO 80262 USA.			Richards, David/0000-0001-6154-7112				Betz WJ, 1996, CURR OPIN NEUROBIOL, V6, P365, DOI 10.1016/S0959-4388(96)80121-8; BETZ WJ, 1993, J PHYSIOL-LONDON, V460, P287, DOI 10.1113/jphysiol.1993.sp019472; BETZ WJ, 1994, J CELL BIOL, V124, P833; BIRKS R, 1961, CAN J BIOCHEM PHYS, V39, P787, DOI 10.1139/o61-081; ELMQVIST D, 1965, J PHYSIOL-LONDON, V178, P505, DOI 10.1113/jphysiol.1965.sp007639; Gad H, 1998, NEURON, V21, P607, DOI 10.1016/S0896-6273(00)80570-X; Gomis A, 1999, J NEUROSCI, V19, P6309; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; Henkel AW, 1996, J NEUROSCI, V16, P3960; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HEUSER JE, 1981, J CELL BIOL, V88, P564, DOI 10.1083/jcb.88.3.564; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; Koenig JH, 1999, J NEUROPHYSIOL, V81, P1495, DOI 10.1152/jn.1999.81.4.1495; Kraszewski K, 1996, J NEUROSCI, V16, P5905; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Kuromi H, 1999, J NEUROSCI, V19, P1557; Lagnado L, 1996, NEURON, V17, P957, DOI 10.1016/S0896-6273(00)80226-3; Palfrey HC, 1998, NEUROSCIENCE, V83, P969, DOI 10.1016/S0306-4522(97)00453-3; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Rouze NC, 1998, J NEUROSCI, V18, P8614; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Schikorski T, 1997, J NEUROSCI, V17, P5858; Smith C, 1998, NEURON, V20, P1243, DOI 10.1016/S0896-6273(00)80504-8; Stevens CF, 1998, NEURON, V21, P885, DOI 10.1016/S0896-6273(00)80603-0; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Teng HB, 1999, J NEUROSCI, V19, P4855; Vogel SS, 1999, P NATL ACAD SCI USA, V96, P5019, DOI 10.1073/pnas.96.9.5019; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Wu LG, 1996, NEURON, V17, P769, DOI 10.1016/S0896-6273(00)80208-1; Wu LG, 1998, BIOPHYS J, V74, P3003, DOI 10.1016/S0006-3495(98)78007-5	35	260	271	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	2000	27	3					551	559		10.1016/S0896-6273(00)00065-9	http://dx.doi.org/10.1016/S0896-6273(00)00065-9			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	359FR	11055437	Bronze			2022-12-24	WOS:000089601300018
J	Lawrence, CB; Celsi, F; Brennand, J; Luckman, SM				Lawrence, CB; Celsi, F; Brennand, J; Luckman, SM			Alternative role for prolactin-releasing peptide in the regulation of food intake	NATURE NEUROSCIENCE			English	Article							BODY-WEIGHT; RAT-BRAIN; EXPRESSION; LEPTIN		Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England; AstraZeneca, Alderley Edge SK10 4TQ, Cheshire, England	University of Manchester; AstraZeneca	Luckman, SM (corresponding author), Univ Manchester, Sch Biol Sci, Oxford Rd, Manchester M13 9PT, Lancs, England.		Celsi, Fulvio/H-5134-2013; Celsi, Fulvio/H-2775-2019	Celsi, Fulvio/0000-0002-9760-8463; Lawrence, Catherine/0000-0002-2372-2968; Luckman, Simon/0000-0001-5318-5473				Bhatnagar S, 1999, BRAIN RES, V851, P66, DOI 10.1016/S0006-8993(99)02108-3; BRADY LS, 1990, NEUROENDOCRINOLOGY, V52, P441, DOI 10.1159/000125626; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Hinuma S, 1998, NATURE, V393, P272, DOI 10.1038/30515; Iijima N, 1999, NEUROREPORT, V10, P1713, DOI 10.1097/00001756-199906030-00016; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Maruyama M, 1999, ENDOCRINOLOGY, V140, P2326, DOI 10.1210/en.140.5.2326; Matsumoto H, 1999, BIOCHEM BIOPH RES CO, V259, P321, DOI 10.1006/bbrc.1999.0789; Ritter RC, 1999, NEUROPEPTIDES, V33, P387, DOI 10.1054/npep.1999.0051; Roland BL, 1999, ENDOCRINOLOGY, V140, P5736, DOI 10.1210/en.140.12.5736; Samson WK, 1998, ENDOCRINE, V9, P289, DOI 10.1385/ENDO:9:3:289; Seeley RJ, 2000, J NEUROSCI, V20, P1616; Tokita R, 1999, NEUROSCI LETT, V276, P103, DOI 10.1016/S0304-3940(99)00796-X; Yamakawa K, 1999, NEUROSCI LETT, V267, P113, DOI 10.1016/S0304-3940(99)00346-8	14	178	187	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2000	3	7					645	646		10.1038/76597	http://dx.doi.org/10.1038/76597			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TT	10862694				2022-12-24	WOS:000167177200008
J	Margeta-Mitrovic, M; Jan, YN; Jan, LY				Margeta-Mitrovic, M; Jan, YN; Jan, LY			A trafficking checkpoint controls GABA(B) receptor heterodimerization	NEURON			English	Article							SUBUNIT STOICHIOMETRY; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; CELL-SURFACE; LOCALIZATION; MUTAGENESIS; EXPRESSION; CHANNELS; BINDING; CLONING	Surface expression of GABA(B) receptors requires heterodimerization of GB1 and GB2 subunits, but little is known about mechanisms that ensure efficient heterodimer assembly. We found that expression of the GB1 subunit on the cell surface is prevented through a C-terminal retention motif RXR(R); this sequence is reminiscent of the ER retention/retrieval motif RKR identified in subunits of the ATP-sensitive Kt channel. Interaction of GB1 and GB2 through their C-terminal coiled-coil alpha helices masks the retention signal in GB1, allowing the plasma membrane expression of the assembled complexes. Because individual GABA(B) receptor subunits and improperly assembled receptor complexes are not functional even if expressed on the cell surface, we conclude that a trafficking checkpoint ensures efficient assembly of functional GABA(B) receptors.	Univ Calif San Francisco, Dept Physiol, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jan, LY (corresponding author), Univ Calif San Francisco, Dept Physiol, Howard Hughes Med Inst, Box 0444, San Francisco, CA 94143 USA.			Jan, Lily/0000-0003-3938-8498; Margeta, Marta/0000-0001-6889-2488; Jan, Yuh Nung/0000-0003-1367-6299				Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; Bai M, 1998, J BIOL CHEM, V273, P23605, DOI 10.1074/jbc.273.36.23605; Benke D, 1999, J BIOL CHEM, V274, P27323, DOI 10.1074/jbc.274.38.27323; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Collins A, 1997, P NATL ACAD SCI USA, V94, P5456, DOI 10.1073/pnas.94.10.5456; Couve A, 1998, J BIOL CHEM, V273, P26361, DOI 10.1074/jbc.273.41.26361; Galvez T, 1999, J BIOL CHEM, V274, P13362, DOI 10.1074/jbc.274.19.13362; Hebert TE, 1998, BIOCHEM CELL BIOL, V76, P1, DOI 10.1139/bcb-76-1-1; Isomoto S, 1998, BIOCHEM BIOPH RES CO, V253, P10, DOI 10.1006/bbrc.1998.9706; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kammerer RA, 1999, BIOCHEMISTRY-US, V38, P13263, DOI 10.1021/bi991018t; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kaupmann K, 1998, P NATL ACAD SCI USA, V95, P14991, DOI 10.1073/pnas.95.25.14991; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; KOLAKOWSKI LF, 1994, RECEPTOR CHANNEL, V2, P1; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Malitschek B, 1999, MOL PHARMACOL, V56, P448, DOI 10.1124/mol.56.2.448; Margeta-Mitrovic M, 1999, J COMP NEUROL, V405, P299, DOI 10.1002/(SICI)1096-9861(19990315)405:3<299::AID-CNE2>3.0.CO;2-6; Martin SC, 1999, MOL CELL NEUROSCI, V13, P180, DOI 10.1006/mcne.1999.0741; Petris MJ, 1998, HUM MOL GENET, V7, P2063, DOI 10.1093/hmg/7.13.2063; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; SCHUTZE MP, 1994, EMBO J, V13, P1696, DOI 10.1002/j.1460-2075.1994.tb06434.x; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	29	557	573	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL	2000	27	1					97	106		10.1016/S0896-6273(00)00012-X	http://dx.doi.org/10.1016/S0896-6273(00)00012-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339XU	10939334	Bronze			2022-12-24	WOS:000088503800013
J	Watt, AJ; van Rossum, MCW; MacLeod, KM; Nelson, SB; Turrigiano, GG				Watt, AJ; van Rossum, MCW; MacLeod, KM; Nelson, SB; Turrigiano, GG			Activity coregulates quantal AMPA and NMDA currents at neocortical synapses	NEURON			English	Article							ACTIVITY-DEPENDENT REGULATION; EXCITATORY SYNAPTIC CURRENTS; LONG-TERM POTENTIATION; RAT VISUAL-CORTEX; GLUTAMATE-RECEPTOR CHANNELS; SILENT SYNAPSES; HIPPOCAMPAL SLICES; TIME-COURSE; SUBUNIT EXPRESSION; PYRAMIDAL NEURONS	AMPA and NMDA receptors are coexpressed at many central synapses, but the factors that control the ratio of these two receptors are not well understood. We recorded mixed miniature or evoked synaptic currents arising from coactivation of AMPA and NMDA receptors and found that long-lasting changes in activity scaled both currents up and down proportionally through changes in the number of postsynaptic receptors. The ratio of NMDA to AMPA current was similar at different synapses onto the same neuron, and this relationship was preserved following activity-dependent synaptic scaling. These data show that AMPA and NMDA receptors are tightly coregulated by activity at synapses at which they are both expressed and suggest that a mechanism exists to actively maintain a constant receptor ratio across a neuron's synapses.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Ctr Complex Syst, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Turrigiano, GG (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02454 USA.	turrigiano@brandeis.edu	van Rossum, Mark/AAF-6620-2019; MacLeod, Katrina/F-4595-2015; van Rossum, Mark/N-8426-2014	van Rossum, Mark/0000-0001-6525-6814; MacLeod, Katrina/0000-0003-0632-1158; Watt, Alanna/0000-0002-6371-6220; Nelson, Sacha/0000-0002-0108-8599	NATIONAL EYE INSTITUTE [R01EY011116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036853, F32NS010991] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY11116] Funding Source: Medline; NINDS NIH HHS [R01 NS36853, F32 NS010991-01, F32 NS010991-03, F32 NS010991, K02 NS01839, F32 NS010991-02] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON CR, 1973, J PHYSIOL-LONDON, V235, P655, DOI 10.1113/jphysiol.1973.sp010410; AUDINAT E, 1994, EUR J NEUROSCI, V6, P1792, DOI 10.1111/j.1460-9568.1994.tb00572.x; BASHIR ZI, 1991, NATURE, V349, P156, DOI 10.1038/349156a0; BEAR MF, 1987, SCIENCE, V237, P42, DOI 10.1126/science.3037696; BEAR MF, 1995, NEURON, V15, P1, DOI 10.1016/0896-6273(95)90056-X; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Catalano SM, 1997, J NEUROSCI, V17, P8376; CLARK KA, 1995, J PHYSIOL-LONDON, V482, P39, DOI 10.1113/jphysiol.1995.sp020498; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Davis GW, 1998, CURR OPIN NEUROBIOL, V8, P149, DOI 10.1016/S0959-4388(98)80018-4; DAW NW, 1993, ANNU REV NEUROSCI, V16, P207, DOI 10.1146/annurev.ne.16.030193.001231; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; EDMONDS B, 1995, ANNU REV PHYSIOL, V57, P495; Flint AC, 1997, J NEUROSCI, V17, P2469; Forti L, 1997, NATURE, V388, P874, DOI 10.1038/42251; FRERKING M, 1995, NEURON, V15, P885, DOI 10.1016/0896-6273(95)90179-5; Hansel C, 1997, EUR J NEUROSCI, V9, P2309, DOI 10.1111/j.1460-9568.1997.tb01648.x; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; Hickmott PW, 1997, J NEUROPHYSIOL, V78, P1096, DOI 10.1152/jn.1997.78.2.1096; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; JAHR CE, 1990, J NEUROSCI, V10, P1830; JONAS P, 1992, J PHYSIOL-LONDON, V455, P143, DOI 10.1113/jphysiol.1992.sp019294; JONES KA, 1991, NEURON, V7, P593, DOI 10.1016/0896-6273(91)90372-7; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCBAIN C, 1992, J NEUROPHYSIOL, V68, P16, DOI 10.1152/jn.1992.68.1.16; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; MULLER D, 1988, P NATL ACAD SCI USA, V85, P9346, DOI 10.1073/pnas.85.23.9346; Nelson S B, 1992, Curr Opin Neurobiol, V2, P484, DOI 10.1016/0959-4388(92)90184-M; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; ROBINSON HPC, 1991, BIOPHYS J, V59, P295, DOI 10.1016/S0006-3495(91)82223-8; ROSENMUND C, 1995, J NEUROSCI, V15, P2788; Rumpel S, 1998, J NEUROSCI, V18, P8863; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Rutherford LC, 1997, J NEUROSCI, V17, P4527; SCHEETZ AJ, 1994, FASEB J, V8, P745, DOI 10.1096/fasebj.8.10.8050674; SELIG DK, 1995, NEURON, V15, P417, DOI 10.1016/0896-6273(95)90045-4; SPRUSTON N, 1993, J NEUROPHYSIOL, V70, P781, DOI 10.1152/jn.1993.70.2.781; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; STERN P, 1992, J PHYSIOL-LONDON, V449, P247, DOI 10.1113/jphysiol.1992.sp019085; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Umemiya M, 1999, J PHYSIOL-LONDON, V521, P113, DOI 10.1111/j.1469-7793.1999.00113.x; Varela JA, 1999, J NEUROSCI, V19, P4293; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	65	258	264	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	2000	26	3					659	670		10.1016/S0896-6273(00)81202-7	http://dx.doi.org/10.1016/S0896-6273(00)81202-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330ZH	10896161	Bronze			2022-12-24	WOS:000087991600016
J	Budde, T; Sieg, F; Braunewell, KH; Gundelfinger, ED; Pape, HC				Budde, T; Sieg, F; Braunewell, KH; Gundelfinger, ED; Pape, HC			Ca2+-induced Ca2+ release supports the relay mode of activity in thalamocortical cells	NEURON			English	Article							CYCLIC ADP-RIBOSE; LATERAL GENICULATE-NUCLEUS; THRESHOLD CALCIUM CURRENTS; RYANODINE RECEPTOR; NITRIC-OXIDE; THALAMIC NEURONS; ELECTROPHYSIOLOGICAL PROPERTIES; SARCOPLASMIC-RETICULUM; VENTROBASAL THALAMUS; RAT THALAMUS	Ca2+ ions play an important role during rhythmic bursting of thalamocortical neurons within sleep. The function of Ca2+ during the tonic relay mode of these neurons during wakefulness is less clear. Here, we report that tonic activity in thalamocortical cells results in an increase in the intracellular Ca2+ concentration and subsequent release of Ca2+ from intracellular stores mediated via ryanodine receptors (RyRs). Blockade of Ca2+ release shifted the regular firing of single action potentials toward the generation of spike clusters. Regular spike firing and intracellular Ca2+ release thus appear to be functionally coupled in a positive feed-back manner, thereby supporting the relay mode of thalamocortical cells during wakefulness. Regulatory influences may be coupled to this system via the cyclic ADP ribose pathway.	Otto von Guericke Univ, Inst Physiol, D-39120 Magdeburg, Germany; Leibniz Inst Neurobiol, Abt Neurochem & Mol Biol, D-39008 Magdeburg, Germany	Otto von Guericke University; Leibniz Institut fur Neurobiologie (LIN)	Budde, T (corresponding author), Otto von Guericke Univ, Inst Physiol, Leipziger Str 44, D-39120 Magdeburg, Germany.			Sieg, Frank/0000-0001-9637-3239				Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BUDDE T, 1992, EUR J NEUROSCI, V4, P708, DOI 10.1111/j.1460-9568.1992.tb00180.x; Budde T, 1998, EUR J NEUROSCI, V10, P586, DOI 10.1046/j.1460-9568.1998.00067.x; Cavallaro S, 1997, P NATL ACAD SCI USA, V94, P9669, DOI 10.1073/pnas.94.18.9669; Chavis P, 1996, NATURE, V382, P719, DOI 10.1038/382719a0; Cudeiro J, 1999, TRENDS NEUROSCI, V22, P109, DOI 10.1016/S0166-2236(98)01299-5; Destexhe A, 1998, J NEUROSCI, V18, P3574, DOI 10.1523/jneurosci.18-10-03574.1998; FABIATO A, 1983, AM J PHYSIOL, V245, P14; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; FURUICHI T, 1994, J NEUROSCI, V14, P4794; GIANNINI G, 1995, J CELL BIOL, V128, P893, DOI 10.1083/jcb.128.5.893; Graeff RM, 1998, J BIOL CHEM, V273, P118, DOI 10.1074/jbc.273.1.118; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; HUA SY, 1994, NEURON, V12, P1073, DOI 10.1016/0896-6273(94)90315-8; HUGUENARD JR, 1991, J NEUROPHYSIOL, V66, P1316, DOI 10.1152/jn.1991.66.4.1316; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P205, DOI 10.1113/jphysiol.1984.sp015153; Kammermeier PJ, 1997, J NEUROPHYSIOL, V77, P465, DOI 10.1152/jn.1997.77.1.465; Koesling Doris, 1995, P43, DOI 10.1016/B978-012721985-1/50005-8; KOGUMA T, 1994, BBA-MOL CELL RES, V1223, P160, DOI 10.1016/0167-4889(94)90087-6; KOSTYUK PG, 1995, CALCIUM SIGNALING NE; KUWAJIMA G, 1992, NEURON, V9, P1133, DOI 10.1016/0896-6273(92)90071-K; MCCORMICK DA, 1988, NATURE, V334, P246, DOI 10.1038/334246a0; MCPHERSON PS, 1993, J BIOL CHEM, V268, P19785; MCPHERSON PS, 1993, J BIOL CHEM, V268, P13765; MCPHERSON PS, 1991, NEURON, V7, P17, DOI 10.1016/0896-6273(91)90070-G; MIRONOV SL, 1994, NEUROPHARMACOLOGY, V33, P1, DOI 10.1016/0028-3908(94)90091-4; Munsch T, 1997, NEUROREPORT, V8, P2411, DOI 10.1097/00001756-199707280-00001; Murayama T, 1996, J BIOL CHEM, V271, P5079; PAPE HC, 1992, NEURON, V9, P441, DOI 10.1016/0896-6273(92)90182-D; Pedroarena C, 1997, P NATL ACAD SCI USA, V94, P724, DOI 10.1073/pnas.94.2.724; Perez GJ, 1999, J GEN PHYSIOL, V113, P229, DOI 10.1085/jgp.113.2.229; REGEHR WG, 1995, BIOPHYS J, V68, P2156, DOI 10.1016/S0006-3495(95)80398-X; REINHERZ EL, 1980, P NATL ACAD SCI-BIOL, V77, P1588, DOI 10.1073/pnas.77.3.1588; Shao LR, 1999, J PHYSIOL-LONDON, V521, P135, DOI 10.1111/j.1469-7793.1999.00135.x; Shaw PJ, 1997, EUR J NEUROSCI, V9, P1507, DOI 10.1111/j.1460-9568.1997.tb01505.x; Sieg F, 1998, DEV BRAIN RES, V110, P83, DOI 10.1016/S0165-3806(98)00097-2; Sipido KR, 1998, J PHYSIOL-LONDON, V508, P439, DOI 10.1111/j.1469-7793.1998.439bq.x; SITSAPESAN R, 1990, J PHYSIOL-LONDON, V423, P425, DOI 10.1113/jphysiol.1990.sp018031; Sonnleitner A, 1998, EMBO J, V17, P2790, DOI 10.1093/emboj/17.10.2790; STERIADE M, 1993, NEUROSCIENCE, V56, P1, DOI 10.1016/0306-4522(93)90556-U; Steriade M., 1997, THALAMUS; Toth TI, 1997, NEUROREPORT, V8, P2889, DOI 10.1097/00001756-199709080-00017; Velazquez JLP, 1996, DEV BRAIN RES, V91, P164; Williams JA, 1997, J NEUROSCI, V17, P420, DOI 10.1523/JNEUROSCI.17-01-00420.1997; Williams S. R., 1996, J PHYSIOL-LONDON, V490.1, P29; Yamada M, 1997, BRAIN RES, V756, P52, DOI 10.1016/S0006-8993(97)00117-0; Zhou Q, 1997, J NEUROPHYSIOL, V77, P2816, DOI 10.1152/jn.1997.77.5.2816	50	52	52	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	2000	26	2					483	492		10.1016/S0896-6273(00)81180-0	http://dx.doi.org/10.1016/S0896-6273(00)81180-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318QZ	10839366	Bronze			2022-12-24	WOS:000087296500024
J	Cho, K; Kemp, N; Noel, J; Aggleton, JP; Brown, MW; Bashir, ZI				Cho, K; Kemp, N; Noel, J; Aggleton, JP; Brown, MW; Bashir, ZI			A new form of long-term depression in the perirhinal cortex	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; 2 DISTINCT FORMS; 1-AMINOINDAN-1,5-DICARBOXYLIC ACID; SYNAPTIC ACTIVATION; RECOGNITION MEMORY; VISUAL RECOGNITION; RAT HIPPOCAMPUS; IN-VITRO; AREA CA1; INDUCTION	We demonstrate a form of long-term depression (LTD) in the perirhinal cortex that relies on interaction between different glutamate receptors. Group II metabotropic glutamate (mGlu) receptors facilitated group 1 mGlu receptor-mediated increases in intracellular calcium. This facilitation plus NMDA receptor activation may be necessary for induction of LTD at resting membrane potentials. However, depolarization enhanced NMDA receptor function and removed the requirement of synergy between group I and group II mGlu receptors: under these conditions, activation of only NMDA and group I mGlu receptors was required for LTD. Such glutamate receptor interactions potentially provide new rules for synaptic plasticity. These forms of LTD occur in the perirhinal cortex, where long-term decreases in neuronal responsiveness may mediate recognition memory.	Univ Bristol, Dept Anat, MRC, Ctr Synapt Plast, Bristol BS8 1TD, Avon, England; Univ Nice Sophia Antipolis, Fac Sci, F-06108 Nice, France; Cardiff Univ, Sch Psychol, Cardiff CF10 3YJ, S Glam, Wales	University of Bristol; UDICE-French Research Universities; Universite Cote d'Azur; Cardiff University	Bashir, ZI (corresponding author), Univ Bristol, Dept Anat, MRC, Ctr Synapt Plast, Bristol BS8 1TD, Avon, England.			Cho, Kwangwook/0000-0001-6724-7073; Bashir, Zafar/0000-0003-3650-2136; Aggleton, John/0000-0002-5573-1308				Anwyl R, 1999, BRAIN RES REV, V29, P83, DOI 10.1016/S0165-0173(98)00050-2; BASHIR ZI, 1993, NATURE, V363, P347, DOI 10.1038/363347a0; BASHIR ZI, 1994, EXP BRAIN RES, V100, P437, DOI 10.1007/BF02738403; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Bilkey DK, 1996, BRAIN RES, V733, P297, DOI 10.1016/0006-8993(96)00789-5; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; Brown MW, 1998, PROG NEUROBIOL, V55, P149, DOI 10.1016/S0301-0082(98)00002-1; Burwell RD, 1995, HIPPOCAMPUS, V5, P390, DOI 10.1002/hipo.450050503; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; CORODIMAS KP, 1995, BEHAV NEUROSCI, V109, P613, DOI 10.1037/0735-7044.109.4.613; Doherty AJ, 1999, BRIT J PHARMACOL, V126, P205, DOI 10.1038/sj.bjp.0702297; Domenici MR, 1998, P NATL ACAD SCI USA, V95, P8310, DOI 10.1073/pnas.95.14.8310; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; EATON SA, 1993, EUR J PHARM-MOLEC PH, V244, P195, DOI 10.1016/0922-4106(93)90028-8; Fitzjohn SM, 1998, NEUROPHARMACOLOGY, V37, P1445, DOI 10.1016/S0028-3908(98)00145-2; FUJII S, 1991, BRAIN RES, V555, P112, DOI 10.1016/0006-8993(91)90867-U; Huang LQ, 1997, NEUROREPORT, V8, P687, DOI 10.1097/00001756-199702100-00022; ITO I, 1992, NEUROREPORT, V3, P1013, DOI 10.1097/00001756-199211000-00017; Kerr DS, 1996, HIPPOCAMPUS, V6, P30, DOI 10.1002/(SICI)1098-1063(1996)6:1<30::AID-HIPO6>3.3.CO;2-6; ManahanVaughan D, 1997, J NEUROSCI, V17, P3303; MANAHANVAUGHAN D, 1998, J NEUROSCI, V37, P1459; McCaffery B, 1999, NEUROSCIENCE, V93, P977, DOI 10.1016/S0306-4522(99)00205-5; MEUNIER M, 1993, J NEUROSCI, V13, P5418, DOI 10.1523/JNEUROSCI.13-12-05418.1993; Mistry R, 1998, BRIT J PHARMACOL, V123, P581, DOI 10.1038/sj.bjp.0701626; Moroni F, 1997, J PHARMACOL EXP THER, V281, P721; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Otani S, 1998, J PHYSIOL-LONDON, V511, P761, DOI 10.1111/j.1469-7793.1998.761bg.x; PELLICCIARI R, 1995, J MED CHEM, V38, P3717, DOI 10.1021/jm00019a002; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Reyes M, 1996, J NEUROSCI, V16, P5951; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; SALT TE, 1995, NEUROSCIENCE, V65, P5, DOI 10.1016/0306-4522(94)00464-G; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; Schoepp DD, 1996, NEUROPHARMACOLOGY, V35, P1661, DOI 10.1016/S0028-3908(96)00121-9; Tzounopoulos T, 1998, NEURON, V21, P837, DOI 10.1016/S0896-6273(00)80599-1; WILSCH VW, 1994, EUR J PHARMACOL, V262, P287, DOI 10.1016/0014-2999(94)90743-9; Yokoi M, 1996, SCIENCE, V273, P645, DOI 10.1126/science.273.5275.645; ZHU XO, 1995, BRAIN RES, V689, P101, DOI 10.1016/0006-8993(95)00550-A; Zhu XO, 1996, NEUROREPORT, V7, P1871, DOI 10.1097/00001756-199607290-00037; Ziakopoulos Z, 1999, NEUROSCIENCE, V92, P459, DOI 10.1016/S0306-4522(98)00764-7	44	122	124	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2000	3	2					150	156		10.1038/72093	http://dx.doi.org/10.1038/72093			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TC	10649570				2022-12-24	WOS:000085810300012
J	Field, MD; Maywood, ES; O'Brien, JA; Weaver, DR; Reppert, SM; Hastings, MH				Field, MD; Maywood, ES; O'Brien, JA; Weaver, DR; Reppert, SM; Hastings, MH			Analysis of clock proteins in mouse SCN demonstrates phylogenetic divergence of the circadian clockwork and resetting mechanisms	NEURON			English	Article							SUPRACHIASMATIC NUCLEUS; DROSOPHILA CLOCK; PERIOD HOMOLOGS; LIGHT; TIMELESS; MPER1; PHOSPHORYLATION; NEURONS; GENE	The circadian clock in the suprachiasmatic nuclei (SCN) is comprised of a cell-autonomous, autoregulatory transcriptional/translational feedback loop. Its molecular components include three period and two cryptochrome genes. We describe circadian patterns of expression of mPER2 and mPER3 in the mouse SCN that are synchronous to those for mPER1, mCRY1, and mCRY2. Coimmunoprecipitation experiments demonstrate in vivo associations of the SCN mPER proteins with each other and with the mCRY proteins, and of mCRY proteins with mTIM, but no mPER/mTIM interactions. Examination of the effects of weak and strong resetting light pulses on SCN clock proteins highlights a central role for mPER1 in photic entrainment, with no acute light effects on either the mCRY or mTIM proteins. These crock protein interactions and photic responses in mice are divergent from those described in Drosophila.	Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England; MRC, Mol Biol Lab, Div Neurobiol, Cambridge CB2 2QH, England; Massachusetts Gen Hosp, Serv Pediat, Lab Dev Chronobiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	University of Cambridge; MRC Laboratory Molecular Biology; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Hastings, MH (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge CB2 3DY, England.		Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Hastings, Michael Harvey/0000-0001-8576-6651; Weaver, David/0000-0001-7941-6719	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD014427] Funding Source: NIH RePORTER; NICHD NIH HHS [R37 HD14427] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Akiyama M, 1999, J NEUROSCI, V19, P1115; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; ASCHOFF J, 1984, HDB BEHAV NEUROBIOLO, V4; Best JD, 1999, J NEUROSCI, V19, P828; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Gastel JA, 1998, SCIENCE, V279, P1358, DOI 10.1126/science.279.5355.1358; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hastings M H, 1999, J Neurosci, V19, pRC11; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Koike N, 1998, FEBS LETT, V441, P427, DOI 10.1016/S0014-5793(98)01597-X; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; Maywood ES, 1999, P NATL ACAD SCI USA, V96, P15211, DOI 10.1073/pnas.96.26.15211; MYERS MP, 1996, SCIENCE, V271, P151; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Reppert SM, 1998, NEURON, V21, P1, DOI 10.1016/S0896-6273(00)80234-2; Saez L, 1996, NEURON, V17, P911, DOI 10.1016/S0896-6273(00)80222-6; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Takumi T, 1999, GENES CELLS, V4, P67, DOI 10.1046/j.1365-2443.1999.00238.x; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Tischkau S A, 1999, J Neurosci, V19, pRC15; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Weaver DR, 1998, J BIOL RHYTHM, V13, P100, DOI 10.1177/074873098128999952; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zylka MJ, 1998, NEURON, V21, P1115, DOI 10.1016/S0896-6273(00)80628-5; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	40	290	295	2	19	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	2000	25	2					437	447		10.1016/S0896-6273(00)80906-X	http://dx.doi.org/10.1016/S0896-6273(00)80906-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	288EL	10719897	Bronze			2022-12-24	WOS:000085549100020
J	Standley, S; Roche, KW; McCallum, J; Sans, N; Wenthold, RJ				Standley, S; Roche, KW; McCallum, J; Sans, N; Wenthold, RJ			PDZ domain suppression of an ER retention signal in NMDA receptor NR1 splice variants	NEURON			English	Article							CHANNEL SURFACE EXPRESSION; LONG-TERM DEPRESSION; ENDOPLASMIC-RETICULUM; SUBUNIT COMPOSITION; SUBCELLULAR-DISTRIBUTION; MEMBRANE-PROTEINS; AFFINITY; PHOSPHORYLATION; GLYCINE; MOTIF	The NMDA receptor NR1 subunit has four splice variants that differ in their C-terminal, cytoplasmic domain. We investigated the contribution of the C-terminal cassettes, CO, C1, C2, and C2', to trafficking of NR1 in heterologous cells and neurons. We identified an ER retention signal (RRR) in the C1 cassette of NR1, which is similar to the RXR motif in ATP-sensitive K+ channels (Zerangue et al., 1999). We found that surface expression of NR1-3, which contains C1, is due to a site on the C2' cassette, which includes the terminal 4 amino acid PDZ-interacting domain. This site suppresses ER retention of the C1 cassette and leads to surface expression. These findings suggest a role for PDZ proteins in facilitating the transition of receptors from an intracellular pool to the surface of the neuron.	Natl Inst Deafness & Commun Disorders, Neurochem Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Standley, S (corresponding author), Natl Inst Deafness & Commun Disorders, Neurochem Lab, NIH, Bethesda, MD 20892 USA.	standley@nidcd.nih.gov	Roche, Katherine/W-9893-2019; Sans, Nathalie/N-7008-2017	Sans, Nathalie/0000-0001-7658-2471; Roche, Katherine/0000-0001-7282-6539	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000003, Z01DC000003] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Banker G., 1991, CULTURING NERVE CELL; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Blahos J, 1996, J BIOL CHEM, V271, P15669, DOI 10.1074/jbc.271.26.15669; BONIFACINO JS, 1990, CELL, V63, P503, DOI 10.1016/0092-8674(90)90447-M; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Brimecombe JC, 1997, P NATL ACAD SCI USA, V94, P11019, DOI 10.1073/pnas.94.20.11019; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Chazot PL, 1997, J NEUROCHEM, V68, P507; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; Ehlers MD, 1998, J NEUROSCI, V18, P720; EHLERS MD, 1995, SCIENCE, V269, P1734, DOI 10.1126/science.7569904; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Fernandez-Larrea J, 1999, MOL CELL, V3, P423, DOI 10.1016/S1097-2765(00)80470-0; Gardiol A, 1999, J NEUROSCI, V19, P168, DOI 10.1523/JNEUROSCI.19-01-00168.1999; GRIMWOOD S, 1995, J NEUROCHEM, V64, P525; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Hall RA, 1997, J BIOL CHEM, V272, P4135, DOI 10.1074/jbc.272.7.4135; HARTVEIT E, 1994, J COMP NEUROL, V348, P570, DOI 10.1002/cne.903480407; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Huh KH, 1999, J BIOL CHEM, V274, P151, DOI 10.1074/jbc.274.1.151; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Kew JNC, 1998, J NEUROSCI, V18, P1935; KLAUSNER RD, 1990, ANNU REV CELL BIOL, V6, P403, DOI 10.1146/annurev.cb.06.110190.002155; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; LEONARD WJ, 1985, J BIOL CHEM, V260, P1872; LETOURNEUR F, 1995, J CELL BIOL, V129, P971, DOI 10.1083/jcb.129.4.971; Leuschner WD, 1999, J BIOL CHEM, V274, P16907, DOI 10.1074/jbc.274.24.16907; Lin JW, 1998, J NEUROSCI, V18, P2017; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; McIlhinney RAJ, 1998, NEUROPHARMACOLOGY, V37, P1355, DOI 10.1016/S0028-3908(98)00121-X; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Okabe S, 1999, J NEUROSCI, V19, P7781; Paudice P, 1998, EUR J NEUROSCI, V10, P2934, DOI 10.1046/j.1460-9568.1998.00302.x; Petralia RS, 1999, HANDB EXP PHARM, V141, P143; PETRALIA RS, 1994, J NEUROSCI, V14, P6102; PETRALIA RS, 1994, J NEUROSCI, V14, P667; Racca C, 2000, J NEUROSCI, V20, P2512; Roche KW, 1999, J BIOL CHEM, V274, P25953, DOI 10.1074/jbc.274.36.25953; ROCHE KW, 1995, NEUROSCIENCE, V69, P383, DOI 10.1016/0306-4522(95)00253-F; Rumbaugh G, 1999, J NEUROSCI, V19, P10603, DOI 10.1523/JNEUROSCI.19-24-10603.1999; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; SCHUTZE MP, 1994, EMBO J, V13, P1696, DOI 10.1002/j.1460-2075.1994.tb06434.x; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; TAYLOR GP, 1999, CURRENT PROTOCOLS NE; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Tiffany AM, 2000, J CELL BIOL, V148, P147, DOI 10.1083/jcb.148.1.147; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; Torre ER, 1996, J NEUROSCI, V16, P5967; Tovar KR, 1999, J NEUROSCI, V19, P4180; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; Wang JKT, 1996, J NEUROCHEM, V66, P865; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	64	288	298	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	2000	28	3					887	898		10.1016/S0896-6273(00)00161-6	http://dx.doi.org/10.1016/S0896-6273(00)00161-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386JJ	11163274	Bronze			2022-12-24	WOS:000166057500024
J	Csicsvari, J; Hirase, H; Mamiya, A; Buzsaki, G				Csicsvari, J; Hirase, H; Mamiya, A; Buzsaki, G			Ensemble patterns of hippocampal CA3-CA1 neurons during sharp wave-associated population events	NEURON			English	Article							PYRAMIDAL CELLS; PLACE; MEMORY; ORGANIZATION; SYNAPSES; EPSPS; REPRESENTATION; FLUCTUATIONS; REACTIVATION; DEPENDENCE	Transfer of neuronal patterns from the CA3 to CA1 region was studied by simultaneous recording of neuronal ensembles in the behaving rat. A nonlinear interaction among pyramidal neurons was observed during sharp wave (SPW)-related population bursts, with stronger synchrony associated with more widespread spatial coherence. SPW bursts emerged in the CA3a-b subregions and spread to CA3c before invading the CA1 area. Synchronous discharge of >10% of the CA3 within a 100 ms window was required to exert a detectable influence on CA1 pyramidal cells. Activity of some CA3 pyramidal neurons differentially predicted the ripple-related discharge of circumscribed groups of CA1 pyramidal cells. We suggest that, in SPW behavioral state, the coherent discharge of a small group of CA3 cells is the primary cause of spiking activity in CA1 pyramidal neurons.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	buzsaki@axon.rutgers.edu	Hirase, Hajime/A-3709-2012	Hirase, Hajime/0000-0003-3806-6905; Mamiya, Akira/0000-0002-3199-5341; Buzsaki, Gyorgy/0000-0002-3100-4800	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR009754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994] Funding Source: NIH RePORTER; NCRR NIH HHS [1P41RR09754] Funding Source: Medline; NIMH NIH HHS [MH54671] Funding Source: Medline; NINDS NIH HHS [NS34994] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHISSAR E, 1992, SCIENCE, V257, P1412, DOI 10.1126/science.1529342; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; ANDERSEN P, 1994, ADV SEC MESS PHOSPH, V29, P341; BRAGIN A, 1995, J NEUROPHYSIOL, V73, P1691, DOI 10.1152/jn.1995.73.4.1691; BULLOCK TH, 1995, P NATL ACAD SCI USA, V92, P11568, DOI 10.1073/pnas.92.25.11568; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; CHROBAK JJ, 1994, J NEUROSCI, V14, P6160; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Deadwyler SA, 1996, J NEUROSCI, V16, P354; EICHENBAUM H, 1989, J NEUROSCI, V9, P2764; FRIEDLANDER MJ, 1990, J NEUROSCI, V10, P814; Hampson RE, 1999, NATURE, V402, P610, DOI 10.1038/45154; Hampson RE, 1996, HIPPOCAMPUS, V6, P281, DOI 10.1002/(SICI)1098-1063(1996)6:3<281::AID-HIPO6>3.0.CO;2-Q; HASSELMO ME, 1995, J NEUROSCI, V15, P5249; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; LI XM, 1994, POTENTIAL ANAL, V3, P339, DOI 10.1007/BF01049807; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; MCNAUGHTON N, 1987, BEHAV BRAIN RES, V24, P39, DOI 10.1016/0166-4328(87)90034-9; Muller RU, 1996, J GEN PHYSIOL, V107, P663, DOI 10.1085/jgp.107.6.663; MULLER RU, 1987, J NEUROSCI, V7, P1935; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Rolls ET, 1999, HIPPOCAMPUS, V9, P467; SAYER RJ, 1989, J NEUROSCI, V9, P840; SAYER RJ, 1990, J NEUROSCI, V10, P826; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Tanila H, 1997, HIPPOCAMPUS, V7, P613, DOI 10.1002/(SICI)1098-1063(1997)7:6<613::AID-HIPO4>3.0.CO;2-F; TRAUB RD, 1982, SCIENCE, V216, P745, DOI 10.1126/science.7079735; Tsodyks M, 2000, J NEUROSCI, V20; Wiebe SP, 1999, J NEUROSCI, V19, P10562; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; WINSON J, 1977, SCIENCE, V196, P1223, DOI 10.1126/science.193192; WONG RKS, 1983, J NEUROPHYSIOL, V49, P442, DOI 10.1152/jn.1983.49.2.442; YLINEN A, 1995, J NEUROSCI, V15, P30	43	327	331	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	2000	28	2					585	594		10.1016/S0896-6273(00)00135-5	http://dx.doi.org/10.1016/S0896-6273(00)00135-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	377CE	11144366	Bronze			2022-12-24	WOS:000165493700031
J	Bruns, D; Riedel, D; Klingauf, J; Jahn, R				Bruns, D; Riedel, D; Klingauf, J; Jahn, R			Quantal release of serotonin	NEURON			English	Article							IDENTIFIED LEECH NEURONS; VESICULAR MONOAMINE TRANSPORTER-2; CULTURED HIPPOCAMPAL-NEURONS; ADRENAL CHROMAFFIN CELLS; DENSE CORE VESICLES; SYNAPTIC VESICLES; TRANSMITTER CONCENTRATION; NEUROENDOCRINE CELLS; SECRETORY GRANULES; SUBSTANTIA-NIGRA	We have studied the origin of quantal Variability for small synaptic Vesicles (SSVs) and large dense-cored vesicles (LDCVs). As a model, we used serotonergic Retzius neurons of leech that allow for combined amperometrical and morphological analyses of quantal transmitter release. We find that the transmitter amount released by a SSV varies proportionally to the volume of the vesicle, suggesting that serotonin is stored at a constant intravesicular concentration and is completely discharged during exocytosis. Transmitter discharge from LDCVs shows a higher degree of variability than is expected from their size distribution, and bulk release from LDCVs is slower than release from SSVs. On average, differences in the transmitter amount released from SSVs and LDCVs are proportional to the size differences of the organelles, suggesting that transmitter is stored at similar concentrations in SSVs and LDCVs.	Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society	Bruns, D (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, Fassberg 11, D-37077 Gottingen, Germany.	dbruns@mpibpc.gwdg.de		Jahn, Reinhard/0000-0003-1542-3498				Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; ARLUISON M, 1980, NEUROSCIENCE, V5, P229, DOI 10.1016/0306-4522(80)90100-1; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; BAUERFEIND R, 1995, P NATL ACAD SCI USA, V92, P7342, DOI 10.1073/pnas.92.16.7342; BEAUDET A, 1981, J PHYSIOLOGY PARIS, V77, P193; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; BRUNS D, 1993, NEURON, V10, P559, DOI 10.1016/0896-6273(93)90159-O; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; CARBONE E, 1987, J PHYSIOL-LONDON, V386, P547, DOI 10.1113/jphysiol.1987.sp016551; CHAZAL G, 1987, J COMP NEUROL, V259, P317, DOI 10.1002/cne.902590302; CHEN TK, 1994, ANAL CHEM, V66, P3031, DOI 10.1021/ac00091a007; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; CHOW RH, 1994, P NATL ACAD SCI USA, V91, P12765, DOI 10.1073/pnas.91.26.12765; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Chow Robert H., 1995, P245; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; Colquhoun David, 1995, P483; DELATORRE JC, 1976, HISTOCHEMISTRY, V49, P81, DOI 10.1007/BF00495672; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; Diamond JS, 1997, J NEUROSCI, V17, P4672; DIETZEL ID, 1988, DEV BIOL, V128, P277, DOI 10.1016/0012-1606(88)90290-4; DIETZEL ID, 1986, J PHYSIOL-LONDON, V372, P191, DOI 10.1113/jphysiol.1986.sp016004; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; Elhamdani A, 1998, J NEUROSCI, V18, P6230; Finnegan JM, 1996, J NEUROCHEM, V66, P1914; Fon EA, 1997, NEURON, V19, P1271, DOI 10.1016/S0896-6273(00)80418-3; Forti L, 1997, NATURE, V388, P874, DOI 10.1038/42251; Frerking M, 1996, CURR OPIN NEUROBIOL, V6, P395, DOI 10.1016/S0959-4388(96)80125-5; FRERKING M, 1995, NEURON, V15, P885, DOI 10.1016/0896-6273(95)90179-5; FRIED G, 1981, NEUROSCIENCE, V6, P787, DOI 10.1016/0306-4522(81)90162-7; GERHARDT G, 1982, ANAL CHEM, V54, P2618, DOI 10.1021/ac00251a054; Haller M, 1998, BIOPHYS J, V74, P2100, DOI 10.1016/S0006-3495(98)77917-2; HENDERSON LP, 1983, J PHYSIOL-LONDON, V339, P309, DOI 10.1113/jphysiol.1983.sp014718; HOKFELT T, 1968, HISTOCHEMISTRY, V16, P45, DOI 10.1007/BF00306211; HOKFELT T, 1968, Z ZELLFORSCH MIK ANA, V91, P1, DOI 10.1007/BF00336984; Holtje M, 2000, J NEUROSCI, V20, P2131; Jaffe EH, 1998, J NEUROSCI, V18, P3548; JAHN R, 1991, MARKERS NEURAL ENDOC, P25; KLEIN RL, 1982, NEUROTRANSMITTER VES, P65; Kleinle J, 1996, BIOPHYS J, V71, P2413, DOI 10.1016/S0006-3495(96)79435-3; Klingauf J, 1997, BIOPHYS J, V72, P674, DOI 10.1016/S0006-3495(97)78704-6; Koh DS, 1997, P NATL ACAD SCI USA, V94, P1506, DOI 10.1073/pnas.94.4.1506; KUFFLER DP, 1987, J COMP NEUROL, V256, P516, DOI 10.1002/cne.902560404; Lagnado L, 1996, NEURON, V17, P957, DOI 10.1016/S0896-6273(00)80226-3; LENT CM, 1979, J NEUROCHEM, V32, P1559, DOI 10.1111/j.1471-4159.1979.tb11099.x; Lenzi D, 1999, J NEUROSCI, V19, P119, DOI 10.1523/JNEUROSCI.19-01-00119.1999; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; LIU Y, 1997, NANN REV NEUROSCI, V20, P125; Marszalek PE, 1997, BIOPHYS J, V73, P1169, DOI 10.1016/S0006-3495(97)78149-9; MAYCOX PR, 1990, TRENDS NEUROSCI, V13, P83, DOI 10.1016/0166-2236(90)90178-D; MCADOO DJ, 1976, J NEUROCHEM, V26, P163; Moukhles H, 1997, NEUROSCIENCE, V76, P1159, DOI 10.1016/S0306-4522(96)00452-6; NIRENBERG MJ, 1995, P NATL ACAD SCI USA, V92, P8773, DOI 10.1073/pnas.92.19.8773; Nirenberg MJ, 1997, SYNAPSE, V26, P194; PALAY SL, 1974, CEREBELLAR CORTEX, P159; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; Plattner H, 1997, J CELL BIOL, V139, P1709, DOI 10.1083/jcb.139.7.1709; Pothos EN, 1998, J NEUROSCI, V18, P4106; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; RUDE S, 1969, J CELL BIOL, V41, P832, DOI 10.1083/jcb.41.3.832; SARGENT PB, 1977, J NEUROPHYSIOL, V40, P453, DOI 10.1152/jn.1977.40.2.453; SCHROEDER TJ, 1992, ANAL CHEM, V64, P3077, DOI 10.1021/ac00048a003; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Song HJ, 1997, NEURON, V18, P815, DOI 10.1016/S0896-6273(00)80320-7; STEVENS CF, 1993, CELL, V72, P55, DOI 10.1016/S0092-8674(05)80028-5; Sulzer D, 2000, REV NEUROSCIENCE, V11, P159; TANG CM, 1994, NEURON, V13, P1385, DOI 10.1016/0896-6273(94)90423-5; THURESONKLEIN A, 1983, NEUROSCIENCE, V10, P245, DOI 10.1016/0306-4522(83)90132-X; TILL R, 1976, NEUROSCIENCE, V1, P49, DOI 10.1016/0306-4522(76)90047-6; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; TRANZER JP, 1967, EXPERIENTIA, V23, P123, DOI 10.1007/BF02135955; Travis ER, 2000, P NATL ACAD SCI USA, V97, P162, DOI 10.1073/pnas.97.1.162; VANDERKLOOT W, 1991, PROG NEUROBIOL, V36, P93, DOI 10.1016/0301-0082(91)90019-W; Wahl LM, 1996, J NEUROPHYSIOL, V75, P597, DOI 10.1152/jn.1996.75.2.597; Walmsley B, 1998, TRENDS NEUROSCI, V21, P81, DOI 10.1016/S0166-2236(97)01170-3; WIGHTMAN RM, 1995, BIOPHYS J, V68, P383, DOI 10.1016/S0006-3495(95)80199-2; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; Williams J, 1997, NEURON, V18, P683, DOI 10.1016/S0896-6273(00)80308-6; Winkler H, 1997, NEUROCHEM RES, V22, P921, DOI 10.1023/A:1022410506476; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; ZHOU Z, 1995, P NATL ACAD SCI USA, V92, P6938, DOI 10.1073/pnas.92.15.6938	83	164	174	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	2000	28	1					205	220		10.1016/S0896-6273(00)00097-0	http://dx.doi.org/10.1016/S0896-6273(00)00097-0			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	370VN	11086995	Green Published, Bronze			2022-12-24	WOS:000165143500022
J	Deken, SL; Beckman, ML; Boos, L; Quick, MW				Deken, SL; Beckman, ML; Boos, L; Quick, MW			Transport rates of GABA transporters: regulation by the N-terminal domain and syntaxin 1A	NATURE NEUROSCIENCE			English	Article							PROTEIN-PROTEIN INTERACTIONS; CELL-SURFACE EXPRESSION; CFTR CHLORIDE CHANNELS; FUNCTIONAL REGULATION; RECEPTORS; RELEASE	Plasma membrane GABA transporters participate in neural signaling through re-uptake of neurotransmitter. The domains of the transporter that mediate GABA translocation and regulate transport are not well understood. In the present experiments, the N-terminal cytoplasmic domain of the GABA transporter GAT1 regulated substrate transport rates. This domain directly interacted with syntaxin 1A, a SNARE protein involved in both neurotransmitter release and modulation of calcium channels and cystic fibrosis transmembrane regulator (CFTR) chloride channels. The interaction resulted in a decrease in transporter transport rates. These data demonstrate that intracellular domains of the GABA and protein-protein interactions regulate substrate translocation, and identify a direct link between the machinery involved in transmitter release and re-uptake.	Univ Alabama, Dept Neurobiol, CIRC 446, Birmingham, AL 35294 USA; Univ Alabama, Med Sci Training Program, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Quick, MW (corresponding author), Univ Alabama, Dept Neurobiol, CIRC 446, 1719 6th Ave S, Birmingham, AL 35294 USA.				NIDA NIH HHS [DA10509] Funding Source: Medline; NIMH NIH HHS [MH61468] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010509, R29DA010509] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Beckman ML, 1998, J NEUROSCI, V18, P6103; Beckman ML, 1998, J MEMBRANE BIOL, V164, P1; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; Bernstein EM, 1999, J BIOL CHEM, V274, P889, DOI 10.1074/jbc.274.2.889; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; COREY JL, 1994, MOL MEMBR BIOL, V11, P23, DOI 10.3109/09687689409161026; Davis KE, 1998, J NEUROSCI, V18, P2475; Fenster CP, 1997, J NEUROSCI, V17, P5747; Gegelashvili G, 1997, MOL PHARMACOL, V52, P6, DOI 10.1124/mol.52.1.6; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; HILGEMANN DW, 1991, NATURE, V352, P715, DOI 10.1038/352715a0; Hoffman BJ, 1998, FRONT NEUROENDOCRIN, V19, P187, DOI 10.1006/frne.1998.0168; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; IVERSEN LL, 1975, HDB PSYCHOPHARMACOLO, P381; MACKINNON R, 1995, NEURON, V14, P889, DOI 10.1016/0896-6273(95)90327-5; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; Naren AP, 1999, SCIENCE, V286, P544, DOI 10.1126/science.286.5439.544; Naren AP, 1998, P NATL ACAD SCI USA, V95, P10972, DOI 10.1073/pnas.95.18.10972; Naren AP, 1997, NATURE, V390, P302, DOI 10.1038/36882; PARENT L, 1992, J MEMBRANE BIOL, V125, P49; Qian Y, 1997, J NEUROSCI, V17, P45, DOI 10.1523/JNEUROSCI.17-01-00045.1997; Quick Michael W., 1994, V19, P261; Quick MW, 1997, J NEUROSCI, V17, P2967; Rothman JE, 1996, PROTEIN SCI, V5, P185; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; SHENG ZH, 1996, NATURE, V378, P623; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0	28	127	131	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2000	3	10					998	1003		10.1038/79939	http://dx.doi.org/10.1038/79939			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TW	11017172				2022-12-24	WOS:000167177500017
J	Rosenbaum, RS; Priselac, S; Kohler, S; Black, SE; Gao, FQ; Nadel, L; Moscovitch, M				Rosenbaum, RS; Priselac, S; Kohler, S; Black, SE; Gao, FQ; Nadel, L; Moscovitch, M			Remote spatial memory in an amnesic person with extensive bilateral hippocampal lesions	NATURE NEUROSCIENCE			English	Article							PURE TOPOGRAPHICAL DISORIENTATION; RETROGRADE-AMNESIA; COGNITIVE MAPS; PATIENT; RECALL	The hippocampus may have a time-limited role in memory, being needed only until information is permanently stored elsewhere, or this region may permanently represent long-term allocentric spatial information or cognitive maps in memory. To test these ideas, we investigated remote spatial memory in K.C., a patient with bilateral hippocampal lesions and amnesia for autobiographical events. In his spatial knowledge, general aspects were preserved, but details were lost, a pattern that resembled his memory loss in other domains. K.C. performed normally on allocentric spatial tests of his neighborhood and the world. He had difficulty, however, in recognizing and identifying non-salient neighborhood landmarks, and in recognizing city locations on world maps. This suggests that the hippocampus is not crucial for maintenance and retrieval of remotely formed spatial representations of major landmarks, routes, distances and directions, but is necessary for specifying location details, regardless of when they were acquired.	Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; McGill Univ, Montreal Neurol Inst, Cognit Neurosci Unit, Montreal, PQ H3A 2B4, Canada; Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; Univ Arizona, Dept Psychol & Neural Syst, Memory & Aging Div, Tucson, AZ 85721 USA; Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON M6A 2E1, Canada; Baycrest Ctr Geriatr Care, Dept Psychol, Toronto, ON M6A 2E1, Canada	University of Toronto; McGill University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Arizona; University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; University Toronto Affiliates; Baycrest	Rosenbaum, RS (corresponding author), Univ Toronto, Dept Psychol, 100 St George St, Toronto, ON M5S 1A1, Canada.	shayna@psych.utoronot.ca; momos@credit.erin.uto	Black, Sandra E./C-7294-2011	Black, Sandra/0000-0001-7093-8289; Kohler, Stefan/0000-0003-1905-6453				Aguirre GK, 1999, BRAIN, V122, P1613, DOI 10.1093/brain/122.9.1613; BEATTY WW, 1987, PSYCHOL MED, V17, P657, DOI 10.1017/S0033291700025897; BEATTY WW, 1988, J CLIN PSYCHOL, V44, P61, DOI 10.1002/1097-4679(198801)44:1<61::AID-JCLP2270440113>3.0.CO;2-Y; Bohbot VD, 1998, NEUROPSYCHOLOGIA, V36, P1217, DOI 10.1016/S0028-3932(97)00161-9; Camalleri R, 1996, NEUROPSYCHOLOGIA, V34, P321, DOI 10.1016/0028-3932(95)00108-5; DERENZI E, 1985, HDB CLIN NEUROLOGY, V1, P405; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; FUJII T, IN PRESS HDB NEUROPS, V4; Golledge RG, 1985, J ENVIRON PSYCHOL, V5, P125, DOI DOI 10.1016/S0272-4944(85)80014-1; HABIB M, 1987, CORTEX, V23, P73, DOI 10.1016/S0010-9452(87)80020-5; Katayama K, 1999, CORTEX, V35, P279, DOI 10.1016/S0010-9452(08)70801-3; Kubie JL, 1999, PSYCHOBIOLOGY, V27, P313; Maguire EA, 1996, P ROY SOC B-BIOL SCI, V263, P1745, DOI 10.1098/rspb.1996.0255; Maguire EA, 1997, J NEUROSCI, V17, P7103; MILNER B, 1965, NEUROPSYCHOLOGIA, V3, P317, DOI 10.1016/0028-3932(65)90005-9; MILNER B, 1968, NEUROPSYCHOLOGIA, V6, P215, DOI 10.1016/0028-3932(68)90021-3; Moscovitch M, 2000, MEMORY, CONSCIOUSNESS, AND THE BRAIN, P331; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nadel L, 1998, NEUROPHARMACOLOGY, V37, P431, DOI 10.1016/S0028-3908(98)00057-4; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Pearce JM, 1998, NATURE, V396, P75, DOI 10.1038/23941; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; SMITH ML, 1981, NEUROPSYCHOLOGIA, V19, P781, DOI 10.1016/0028-3932(81)90090-7; SMITH ML, 1988, BRAIN COGNITION, V7, P178, DOI 10.1016/0278-2626(88)90028-0; Suzuki K, 1998, CORTEX, V34, P589, DOI 10.1016/S0010-9452(08)70516-1; Teng E, 1999, NATURE, V400, P675, DOI 10.1038/23276; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; TULVING E, 1991, J EXP PSYCHOL LEARN, V17, P595, DOI 10.1037/0278-7393.17.4.595; TULVING E, 1988, BRAIN COGNITION, V8, P3, DOI 10.1016/0278-2626(88)90035-8; WESTMACOTT R, IN PRESS NEUROCASE; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	31	202	202	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2000	3	10					1044	1048		10.1038/79867	http://dx.doi.org/10.1038/79867			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TW	11017178				2022-12-24	WOS:000167177500023
J	Gandhi, CS; Loots, E; Isacoff, EY				Gandhi, CS; Loots, E; Isacoff, EY			Reconstructing voltage sensor-pore interaction from a fluorescence scan of a voltage-gated K+ channel	NEURON			English	Article							SHAKER POTASSIUM CHANNELS; C-TYPE INACTIVATION; SELECTIVITY FILTER; S4 SEGMENT; SLOW INACTIVATION; GATING CURRENTS; CHARGE MOVEMENT; SODIUM-CHANNELS; MOLECULAR-BASIS; ION CHANNELS	X-ray crystallography has made considerable recent progress in providing static structures of ion channels. Here we describe a complementary method-systematic fluorescence scanning-that reveals the structural dynamics of a channel. Local protein motion was measured from changes in the fluorescent intensity of a fluorophore attached at one of 37 positions in the pore domain and in the S4 voltage sensor of the Shaker K+ channel. The local rearrangements that accompany activation and slow inactivation were mapped onto the homologous structure of the KcsA channel and onto models of S4. The results place clear constraints on S4 location, voltage-dependent movement, and the mechanism of coupling of S4 motion to the operation of the slow inactivation gate in the pore domain.	Univ Calif Berkeley, Lawrence Berkeley Lab, Div Cell & Mol Biol, Phys Biosci Div, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Isacoff, EY (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Cell & Mol Biol, Phys Biosci Div, 271 Life Sci Addit, Berkeley, CA 94720 USA.		isacoff, ehud/AAP-1459-2020	Isacoff, Ehud Y./0000-0003-4775-9359	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035549] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS035549-05, NS3549] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Baker OS, 1998, NEURON, V20, P1283, DOI 10.1016/S0896-6273(00)80507-3; Bao HX, 1999, J GEN PHYSIOL, V113, P139, DOI 10.1085/jgp.113.1.139; BAUKROWITZ T, 1995, NEURON, V15, P951, DOI 10.1016/0896-6273(95)90185-X; Baukrowitz T, 1996, SCIENCE, V271, P653, DOI 10.1126/science.271.5249.653; BEZANILLA F, 1994, BIOPHYS J, V66, P1011, DOI 10.1016/S0006-3495(94)80882-3; Blaustein RO, 2000, NAT STRUCT BIOL, V7, P309; BOLAND LM, 1994, BIOPHYS J, V66, P694, DOI 10.1016/S0006-3495(94)80843-4; CATTERALL WA, 1995, ANNU REV BIOCHEM, V64, P493, DOI 10.1146/annurev.biochem.64.1.493; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Cha A, 1998, J GEN PHYSIOL, V112, P391, DOI 10.1085/jgp.112.4.391; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Dart C, 1998, J PHYSIOL-LONDON, V511, P25, DOI 10.1111/j.1469-7793.1998.025bi.x; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Durell SR, 1998, J STRUCT BIOL, V121, P263, DOI 10.1006/jsbi.1998.3962; Elinder F, 1999, BIOPHYS J, V77, P1358, DOI 10.1016/S0006-3495(99)76984-5; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Gonzalez C, 2000, J GEN PHYSIOL, V115, P193, DOI 10.1085/jgp.115.2.193; Harris RE, 1998, BIOPHYS J, V74, P1808, DOI 10.1016/S0006-3495(98)77891-9; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Horn R, 2000, NEURON, V25, P511, DOI 10.1016/S0896-6273(00)81055-7; Hurst RS, 1996, FEBS LETT, V388, P59, DOI 10.1016/0014-5793(96)00516-9; Immke D, 1999, J GEN PHYSIOL, V113, P819, DOI 10.1085/jgp.113.6.819; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kiss L, 1999, BIOPHYS J, V76, P253, DOI 10.1016/S0006-3495(99)77194-8; Kiss L, 1998, BIOPHYS J, V74, P1840, DOI 10.1016/S0006-3495(98)77894-4; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; LI M, 1994, CURR BIOL, V4, P110, DOI 10.1016/S0960-9822(94)00026-6; Li-Smerin YY, 2000, NEURON, V25, P411, DOI 10.1016/S0896-6273(00)80904-6; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; LOGOTHETIS DE, 1992, NEURON, V8, P531, DOI 10.1016/0896-6273(92)90281-H; Loots E, 1998, J GEN PHYSIOL, V112, P377, DOI 10.1085/jgp.112.4.377; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; Mannuzzu LM, 2000, J GEN PHYSIOL, V115, P257, DOI 10.1085/jgp.115.3.257; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Mathur R, 1997, J GEN PHYSIOL, V109, P191, DOI 10.1085/jgp.109.2.191; Matulef K, 1999, NEURON, V24, P443, DOI 10.1016/S0896-6273(00)80857-0; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; Monks SA, 1999, J GEN PHYSIOL, V113, P415, DOI 10.1085/jgp.113.3.415; Ogielska EM, 1995, BIOPHYS J, V69, P2449, DOI 10.1016/S0006-3495(95)80114-1; Olcese R, 1997, J GEN PHYSIOL, V110, P579, DOI 10.1085/jgp.110.5.579; PANYI G, 1995, BIOPHYS J, V69, P896, DOI 10.1016/S0006-3495(95)79963-5; PeledZehavi H, 1996, BIOCHEMISTRY-US, V35, P6828, DOI 10.1021/bi952988t; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P399, DOI 10.1085/jgp.111.3.399; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P421, DOI 10.1085/jgp.111.3.421; Starace DM, 1997, NEURON, V19, P1319, DOI 10.1016/S0896-6273(00)80422-5; Starkus JG, 1997, J GEN PHYSIOL, V110, P539, DOI 10.1085/jgp.110.5.539; Starkus JG, 1998, J GEN PHYSIOL, V112, P85, DOI 10.1085/jgp.112.1.85; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; Swartz KJ, 1997, NEURON, V18, P665, DOI 10.1016/S0896-6273(00)80306-2; Tiwari-Woodruff SK, 2000, J GEN PHYSIOL, V115, P123, DOI 10.1085/jgp.115.2.123; TiwariWoodruff SK, 1997, BIOPHYS J, V72, P1489, DOI 10.1016/S0006-3495(97)78797-6; Unwin N, 1996, J MOL BIOL, V257, P586, DOI 10.1006/jmbi.1996.0187; WANG H, 1999, J PHYSL, V521, P315; Yang NB, 1997, BIOPHYS J, V73, P2260, DOI 10.1016/S0006-3495(97)78258-4; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Yusaf SP, 1996, PFLUG ARCH EUR J PHY, V433, P91, DOI 10.1007/s004240050253; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321	68	83	84	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	2000	27	3					585	595		10.1016/S0896-6273(00)00068-4	http://dx.doi.org/10.1016/S0896-6273(00)00068-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	359FR	11055440	Bronze			2022-12-24	WOS:000089601300021
J	Kara, P; Reinagel, P; Reid, RC				Kara, P; Reinagel, P; Reid, RC			Low response variability in simultaneously recorded retinal, thalamic, and cortical neurons	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; RECEPTIVE-FIELD PROPERTIES; MEDIAL INTERLAMINAR NUCLEUS; MONKEY VISUAL-CORTEX; NEURAL SPIKE TRAINS; CAT STRIATE-CORTEX; GANGLION-CELLS; SINGLE CELLS; MAINTAINED DISCHARGE; SCOTOPIC VISION	The response of a cortical cell to a repeated stimulus can be highly variable from one trial to the next. Much lower variability has been reported of retinal cells. We recorded visual responses simultaneously from three successive stages of the cat visual system: retinal ganglion cells (RGCs), thalamic (LGN) relay cells, and simple cells in layer 4 of primary visual cortex. Spike count variability was lower than that of a Poisson process at all three stages but increased at each stage. Absolute and relative refractory periods largely accounted for the reliability at all three stages. Our results show that cortical responses can be more reliable than previously thought. The differences in reliability in retina, LGN, and cortex can be explained by (1) decreasing firing rates and (2) decreasing absolute and relative refractory periods.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Reid, RC (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.		Reinagel, Pamela/ABI-7659-2020	Reinagel, Pamela/0000-0002-6338-2611	NEI NIH HHS [P30-EY12196, R01-EY10115] Funding Source: Medline; NINDS NIH HHS [T32-NS07009] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010115, P30EY012196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007009] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; Bair W, 1998, VISUAL NEUROSCI, V15, P779, DOI 10.1017/S0952523898154160; BARBERINI CL, 2000, IN PRESS COMPUTATION; BARLOW HB, 1969, J PHYSIOL-LONDON, V202, P699, DOI 10.1113/jphysiol.1969.sp008836; Berry MJ, 1997, P NATL ACAD SCI USA, V94, P5411, DOI 10.1073/pnas.94.10.5411; Berry MJ, 1998, J NEUROSCI, V18, P2200; Buracas GT, 1998, NEURON, V20, P959, DOI 10.1016/S0896-6273(00)80477-8; DEAN AF, 1981, EXP BRAIN RES, V44, P437; deCharms RC, 2000, ANNU REV NEUROSCI, V23, P613, DOI 10.1146/annurev.neuro.23.1.613; Ferster D, 1996, SCIENCE, V273, P1812, DOI 10.1126/science.273.5283.1812; FRISHMAN LJ, 1983, J PHYSIOL-LONDON, V339, P475, DOI 10.1113/jphysiol.1983.sp014728; Gazeres N, 1998, VISUAL NEUROSCI, V15, P1157, DOI 10.1017/S0952523898156158; Geisler WS, 1997, VISUAL NEUROSCI, V14, P897, DOI 10.1017/S0952523800011627; Gershon ED, 1998, J NEUROPHYSIOL, V79, P1135, DOI 10.1152/jn.1998.79.3.1135; Guido W, 1998, VISUAL NEUROSCI, V15, P231, DOI 10.1017/S0952523898152033; Gur M, 1997, J NEUROSCI, V17, P2914; HARTVEIT E, 1994, J NEUROPHYSIOL, V72, P1278, DOI 10.1152/jn.1994.72.3.1278; HEGGELUND P, 1978, EXP BRAIN RES, V32, P197; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; Kara P, 1999, J NEUROSCI, V19, P5528; Kisley MA, 1999, J NEUROSCI, V19, P10451; LANKHEET MJM, 1989, VISION RES, V29, P505, DOI 10.1016/0042-6989(89)90037-0; LEE C, 1984, J NEUROPHYSIOL, V52, P848, DOI 10.1152/jn.1984.52.5.848; LEE DY, 1992, J NEUROPHYSIOL, V68, P1235, DOI 10.1152/jn.1992.68.4.1235; Levine MW, 1996, BIOL CYBERN, V75, P219, DOI 10.1007/s004220050289; LEVINE MW, 1992, VISUAL NEUROSCI, V8, P277, DOI 10.1017/S0952523800002923; LU SM, 1992, J NEUROPHYSIOL, V68, P2185, DOI 10.1152/jn.1992.68.6.2185; McAdams CJ, 1999, NEURON, V23, P765, DOI 10.1016/S0896-6273(01)80034-9; MCCORMICK DA, 1990, NEUROSCIENCE, V39, P103, DOI 10.1016/0306-4522(90)90225-S; MERRILL EG, 1972, MED BIOL ENG, V10, P662, DOI 10.1007/BF02476084; Oram MW, 1999, J NEUROPHYSIOL, V81, P3021, DOI 10.1152/jn.1999.81.6.3021; PETTIGREW JD, 1979, INVEST OPHTH VIS SCI, V18, P490; Reich DS, 1997, J NEUROPHYSIOL, V77, P2836, DOI 10.1152/jn.1997.77.5.2836; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Reid RC, 1997, VISUAL NEUROSCI, V14, P1015, DOI 10.1017/S0952523800011743; Reinagel P, 1999, J NEUROPHYSIOL, V81, P2558, DOI 10.1152/jn.1999.81.5.2558; Reinagel P, 2000, J NEUROSCI, V20, P5392, DOI 10.1523/JNEUROSCI.20-14-05392.2000; Rieke F, 1997, SPIKES; RODIECK RW, 1967, J NEUROPHYSIOL, V30, P1043, DOI 10.1152/jn.1967.30.5.1043; SANDERSON KJ, 1971, J COMP NEUROL, V143, P101, DOI 10.1002/cne.901430107; SANDERSON KJ, 1971, EXP BRAIN RES, V13, P159; SESTOKAS AK, 1988, J NEUROPHYSIOL, V59, P317, DOI 10.1152/jn.1988.59.2.317; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Sherman SM, 1996, VISUAL NEUROSCI, V13, P205, DOI 10.1017/S0952523800007446; SKOTTUN BC, 1987, J NEUROPHYSIOL, V57, P773, DOI 10.1152/jn.1987.57.3.773; SNOWDEN RJ, 1992, EXP BRAIN RES, V88, P389, DOI 10.1007/BF02259114; SOFTKY WR, 1993, J NEUROSCI, V13, P334; STEIN RB, 1965, BIOPHYS J, V5, P173, DOI 10.1016/S0006-3495(65)86709-1; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; SWINDALE NV, 1994, EXP BRAIN RES, V99, P399; TANAKA K, 1983, J NEUROPHYSIOL, V49, P1303, DOI 10.1152/jn.1983.49.6.1303; TEICH MC, 1980, BIOL CYBERN, V38, P187, DOI 10.1007/BF00337011; TEICH MC, 1978, J OPT SOC AM, V68, P386, DOI 10.1364/JOSA.68.000386; Teich MC, 1996, IEEE ENG MED BIOL, V15, P79, DOI 10.1109/51.537063; Thurner S, 1997, FRACTALS, V5, P565, DOI 10.1142/S0218348X97000462; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; VANNUCCI G, 1978, OPT COMMUN, V25, P267, DOI 10.1016/0030-4018(78)90322-X; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; VOGELS R, 1989, EXP BRAIN RES, V77, P432, DOI 10.1007/BF00275002	60	256	260	2	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	2000	27	3					635	646		10.1016/S0896-6273(00)00072-6	http://dx.doi.org/10.1016/S0896-6273(00)00072-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	359FR	11055444	Bronze			2022-12-24	WOS:000089601300025
J	Flanagan, JR; Beltzner, MA				Flanagan, JR; Beltzner, MA			Independence of perceptual and sensorimotor predictions in the size-weight illusion	NATURE NEUROSCIENCE			English	Article							PRECISION GRIP; GRASP STABILITY; TANGENTIAL TORQUE; FINGERTIP FORCES; INTERNAL MODELS; MOTOR CONTROL; OBJECT SHAPE; MOVEMENTS; INTEGRATION; INFORMATION	The smaller of two equally weighted objects is judged to be heavier when lifted. Here we disproved a leading hypothesis that this size-weight illusion is caused by a mismatch between predicted and actual sensory feedback. We showed that when subjects repeatedly lifted equally heavy large and small objects in alternation, they learned to scale their fingertip forces precisely for the true object weights and thus exhibited accurate sensorimotor prediction. The size-weight. illusion nevertheless persisted, suggesting that the illusion can be caused by high-level cognitive and perceptual factors and indicating that the sensorimotor system can operate independently of the cognitive/perceptual system.	Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Flanagan, JR (corresponding author), Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada.							Amazeen EL, 1996, J EXP PSYCHOL HUMAN, V22, P213, DOI 10.1037/0096-1523.22.1.213; Amazeen EL, 1997, ECOL PSYCHOL, V9, P245, DOI 10.1207/s15326969eco0904_1; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Brenner E, 1996, EXP BRAIN RES, V111, P473; Charpentier A., 1891, ARCHIVE PHYSIOLOGIE, V3, P122; DAVIS CM, 1976, PERCEPT PSYCHOPHYS, V20, P33, DOI 10.3758/BF03198701; Ellis RR, 1998, PERCEPTION, V27, P193, DOI 10.1068/p270193; ELLIS RR, 1993, PERCEPT PSYCHOPHYS, V53, P315, DOI 10.3758/BF03205186; FLANAGAN JR, 1993, EXP BRAIN RES, V95, P131; Flanagan JR, 1997, J NEUROSCI, V17, P1519; Flanagan JR, 1999, J NEUROPHYSIOL, V81, P1706, DOI 10.1152/jn.1999.81.4.1706; Flournoy, 1894, ANN PSYCHOL, V1, P198, DOI [DOI 10.3406/PSY.1894.1051, 10.3406/psy.1894.1051]; GOODALE MA, 1994, CURR BIOL, V4, P604, DOI 10.1016/S0960-9822(00)00132-9; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; Goodwin AW, 1998, J NEUROSCI, V18, P10724; GORDON AM, 1991, EXP BRAIN RES, V85, P226; GORDON AM, 1991, EXP BRAIN RES, V83, P477; GORDON AM, 1991, EXP BRAIN RES, V83, P483; GORDON AM, 1993, J NEUROPHYSIOL, V69, P1789, DOI 10.1152/jn.1993.69.6.1789; GRANIT R, 1972, BRAIN, V95, P451; Jenmalm P, 1998, J NEUROPHYSIOL, V79, P1643, DOI 10.1152/jn.1998.79.4.1643; Jenmalm P, 1997, J NEUROSCI, V17, P4486; Johansson RS, 1999, EXP BRAIN RES, V128, P20, DOI 10.1007/s002210050813; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P59; JOHANSSON RS, 1994, CAN J PHYSIOL PHARM, V72, P511, DOI 10.1139/y94-075; JORDAN MI, 1992, COGNITIVE SCI, V16, P307, DOI 10.1207/s15516709cog1603_1; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Kinoshita H, 1997, J NEUROPHYSIOL, V78, P1619, DOI 10.1152/jn.1997.78.3.1619; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Milner A. D., 1995, VISUAL BRAIN ACTION; Murray DJ, 1999, PERCEPT PSYCHOPHYS, V61, P1681, DOI 10.3758/BF03213127; Nyssen R, 1955, ACTA PSYCHOL, V11, P467; ROSS HE, 1969, Q J EXP PSYCHOL, V21, P346, DOI 10.1080/14640746908400230; Seashore CE, 1899, U IOWA STUDIES PSYCH, V2, P36; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; von Holst E, 1954, BRIT J ANIM BEHAV, V2, P89, DOI DOI 10.1016/S0950-5601(54)80044-X; WESTLING G, 1987, EXP BRAIN RES, V66, P128; Wing AM, 1998, J EXP PSYCHOL HUMAN, V24, P1571, DOI 10.1037/0096-1523.24.6.1571; Wolfe H. K., 1898, PSYCHOL REV, V5, P25, DOI [DOI 10.1037/H0073342, 10.1037/h0073342]; Wolpert DM, 1997, TRENDS COGN SCI, V1, P209, DOI 10.1016/S1364-6613(97)01070-X; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; ZWISLOCKI JJ, 1980, PERCEPT PSYCHOPHYS, V28, P28, DOI 10.3758/BF03204312	43	273	278	3	26	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2000	3	7					737	741		10.1038/76701	http://dx.doi.org/10.1038/76701			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TT	10862708				2022-12-24	WOS:000167177200022
J	Prakriya, M; Mennerick, S				Prakriya, M; Mennerick, S			Selective depression of low-release probability excitatory synapses by sodium channel blockers	NEURON			English	Article							NEUROPROTECTIVE AGENT RILUZOLE; AMYOTROPHIC-LATERAL-SCLEROSIS; ACTION-POTENTIAL INITIATION; HIPPOCAMPAL-NEURONS; TRANSMITTER RELEASE; PYRAMIDAL NEURONS; CORTICAL-NEURONS; GLUTAMATE; CURRENTS; LAMOTRIGINE	Sodium channels (NaChs) play a central role in action potential generation and are uniquely poised to influence the efficacy of transmitter release. We evaluated the effect of partial NaCh blockade on two aspects of synaptic efficacy. First, we evaluated whether NaCh blockade accounts for the ability of certain drugs to selectively depress glutamate release. Second, we evaluated the contribution of NaChs to intraneuronal variability in glutamate release probability (p(r)). The antiglutamate drug riluzole nearly completely depresses glutamate excitatory postsynaptic currents (EPSCs) at concentrations that barely affect GABAergic inhibitory postsynaptic currents (IPSCs). NaCh inhibition explains the selective depression. Unlike other presynaptic depressants, partial NaCh blockade increases paired-pulse EPSC depression. This result is explained by selective depression of low-p(r) synapses. We conclude that local variations in the action potential contribute to p(r) variability among excitatory synapses.	Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Mennerick, S (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.		Mennerick, Steven/O-2806-2017	Mennerick, Steven/0000-0003-0868-0664; Prakriya, Murali/0000-0003-0781-4480	NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH045493, R01MH045493] Funding Source: NIH RePORTER; NIMH NIH HHS [MH45493] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ATWOOD HL, 1967, NATURE, V215, P57, DOI 10.1038/215057a0; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Colbert CM, 1996, J NEUROSCI, V16, P6676; DEBONO MW, 1993, EUR J PHARMACOL, V235, P283, DOI 10.1016/0014-2999(93)90147-A; Fink M, 1998, EMBO J, V17, P3297, DOI 10.1093/emboj/17.12.3297; Hashimoto K, 1998, J PHYSIOL-LONDON, V506, P391, DOI 10.1111/j.1469-7793.1998.391bw.x; HEBERT T, 1994, MOL PHARMACOL, V45, P1055; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Hille B., 1992, IONIC CHANNELS EXCIT; Hsu SF, 1996, NEURON, V17, P501, DOI 10.1016/S0896-6273(00)80182-8; Huang CS, 1997, J PHARMACOL EXP THER, V282, P1280; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; Johannes L, 1998, J NEUROCHEM, V71, P1127; Kilbride J, 1998, EUR J PHARMACOL, V356, P149, DOI 10.1016/S0014-2999(98)00526-3; LEACH MJ, 1991, EPILEPSIA, V32, pS4, DOI 10.1111/j.1528-1157.1991.tb05882.x; LEACH MJ, 1986, EPILEPSIA, V27, P490, DOI 10.1111/j.1528-1157.1986.tb03573.x; Louvel E, 1997, TRENDS PHARMACOL SCI, V18, P196, DOI 10.1016/S0165-6147(97)90623-4; MacIver MB, 1996, ANESTHESIOLOGY, V85, P626, DOI 10.1097/00000542-199609000-00023; Mackenzie PJ, 1998, J NEUROPHYSIOL, V80, P2089, DOI 10.1152/jn.1998.80.4.2089; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; MAGLEBY KL, 1987, SYNAPTIC FUNCTION, P13; MARTIN D, 1993, EUR J PHARMACOL, V250, P473, DOI 10.1016/0014-2999(93)90037-I; Martina M, 1997, J PHYSIOL-LONDON, V505, P593, DOI 10.1111/j.1469-7793.1997.593ba.x; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; MENNERICK S, 1995, J NEUROPHYSIOL, V73, P320, DOI 10.1152/jn.1995.73.1.320; MENNERICK S, 1995, J PHYSIOL-LONDON, V488, P85, DOI 10.1113/jphysiol.1995.sp020948; Msghina M, 1998, J NEUROSCI, V18, P1374; Msghina M, 1999, J NEUROSCI, V19, P8419; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Obrenovitch TP, 1998, TRENDS PHARMACOL SCI, V19, P9, DOI 10.1016/S0165-6147(97)01124-3; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; SATHER W, 1992, J PHYSIOL-LONDON, V450, P643, DOI 10.1113/jphysiol.1992.sp019148; Schikorski T, 1997, J NEUROSCI, V17, P5858; Song JH, 1997, J PHARMACOL EXP THER, V282, P707; Stefani A, 1997, EXP NEUROL, V147, P115, DOI 10.1006/exnr.1997.6554; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; TAYLOR CP, 1995, TRENDS PHARMACOL SCI, V16, P309, DOI 10.1016/S0165-6147(00)89060-4; Umemiya M, 1995, BRIT J PHARMACOL, V116, P3227, DOI 10.1111/j.1476-5381.1995.tb15128.x; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	40	84	87	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	2000	26	3					671	682		10.1016/S0896-6273(00)81203-9	http://dx.doi.org/10.1016/S0896-6273(00)81203-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330ZH	10896162	Bronze			2022-12-24	WOS:000087991600017
J	Satake, S; Saitow, F; Yamada, J; Konishi, S				Satake, S; Saitow, F; Yamada, J; Konishi, S			Synaptic activation of AMPA receptors inhibits GABA release from cerebellar interneurons	NATURE NEUROSCIENCE			English	Article							SELECTIVE GLUTAMATE RECEPTORS; KAINATE RECEPTORS; PURKINJE-CELLS; TRANSMISSION; SYNAPSES; FACILITATION; MODULATION; CURRENTS; HIPPOCAMPUS; SEROTONIN	A single neurotransmitter elicits diverse physiological responses through activation of multiple receptor subtypes and/or heterosynaptic interactions involving distinct synaptic targets. We found that a typical excitatory transmitter released from the climbing fiber (CF) in the cerebellar cortex not only excited Purkinje cells directly but also presynaptically inhibited GABAergic transmission from interneurons converging on the same Purkinje cells. Both homosynaptic and heterosynaptic actions of the CF transmitter (possibly glutamate) were mediated by activation of AMPA receptors. Dual AMPA receptor-mediated functions of excitation and disinhibition may ensure transmission of cerebellar CF signals controlling sensorimotor coordination.	Mitsubishi Kasei Inst Life Sci, Mol Neurobiol Lab, Machida, Tokyo 1948511, Japan; Japan Sci & Technol, CREST, Machida, Tokyo 1948511, Japan; Kyoto Inst Technol, Fac Text Sci, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan	Japan Science & Technology Agency (JST); Kyoto Institute of Technology	Konishi, S (corresponding author), Mitsubishi Kasei Inst Life Sci, Mol Neurobiol Lab, 11 Minamiooya, Machida, Tokyo 1948511, Japan.		Satake, Shin'Ichiro/W-2932-2019; SAITOW, Fumihito/AAF-2281-2020; Konishi, Shiro/ABA-5905-2020	Satake, Shin'Ichiro/0000-0001-9420-6277; SAITOW, Fumihito/0000-0002-5625-8460; 				BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; Bleakman D, 1998, NEUROPHARMACOLOGY, V37, P1187, DOI 10.1016/S0028-3908(98)00139-7; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Byrne JH, 1996, J NEUROSCI, V16, P425; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; CLEMENTS JD, 1990, J NEUROSCI METH, V31, P75, DOI 10.1016/0165-0270(90)90012-5; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Dingledine R, 1999, PHARMACOL REV, V51, P7; DIXON D, 1989, J NEUROPHYSIOL, V62, P1251, DOI 10.1152/jn.1989.62.6.1251; Glitsch M, 1996, J PHYSIOL-LONDON, V497, P531, DOI 10.1113/jphysiol.1996.sp021786; GOY MF, 1989, J NEUROSCI, V9, P369; Huang YY, 1996, NEURON, V16, P611, DOI 10.1016/S0896-6273(00)80080-X; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; JACOBS BL, 1993, TRENDS NEUROSCI, V16, P346, DOI 10.1016/0166-2236(93)90090-9; JAN LY, 1982, J PHYSIOL-LONDON, V327, P219, DOI 10.1113/jphysiol.1982.sp014228; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kondo S, 1997, J PHYSIOL-LONDON, V498, P165, DOI 10.1113/jphysiol.1997.sp021849; KONISHI S, 1996, PHARM REV COMMUN, V8, P169; Konishi S, 1997, ROLE ADENOSINE NERVO, P89; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; Lerma J, 1997, TRENDS NEUROSCI, V20, P9, DOI 10.1016/S0166-2236(96)20055-4; Mauk MD, 1997, NEURON, V18, P343, DOI 10.1016/S0896-6273(00)81235-0; Min MY, 1999, P NATL ACAD SCI USA, V96, P9932, DOI 10.1073/pnas.96.17.9932; Min MY, 1998, NEURON, V21, P561, DOI 10.1016/S0896-6273(00)80566-8; Mitoma H, 1996, NEUROSCI LETT, V217, P141; Mitoma H, 1999, NEUROSCIENCE, V88, P871, DOI 10.1016/S0306-4522(98)00260-7; MITOMA H, 1994, NEUROSCI LETT, V173, P127, DOI 10.1016/0304-3940(94)90165-1; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; Rodriguez-Moreno A, 1998, NEURON, V20, P1211, DOI 10.1016/S0896-6273(00)80501-2; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; VINCENT P, 1992, J PHYSIOL-LONDON, V456, P453, DOI 10.1113/jphysiol.1992.sp019346; VOLLENWEIDER FX, 1990, J NEUROCHEM, V54, P1533, DOI 10.1111/j.1471-4159.1990.tb01201.x; Wang YZ, 1997, NATURE, V389, P502, DOI 10.1038/39062; YAMADA KA, 1993, J NEUROSCI, V13, P3904	40	100	102	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2000	3	6					551	558		10.1038/75718	http://dx.doi.org/10.1038/75718			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	317WG	10816310				2022-12-24	WOS:000087249500010
J	Sawin, ER; Ranganathan, R; Horvitz, HR				Sawin, ER; Ranganathan, R; Horvitz, HR			C-elegans locomotory rate is modulated by the environment through a dopaminergic pathway and by experience through a serotonergic pathway	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; CENTRAL PATTERN GENERATOR; TRANSMITTER RELEASE; DEFECTIVE-MUTANTS; NERVOUS-SYSTEM; BEHAVIORS; RECEPTORS; NEURONS; LEECH; PROTEIN	Caenorhabditis elegans modulates its locomotory rate in response to its food, bacteria, in two ways. First, well-fed wild-type animals move more slowly in the presence of bacteria than in the absence of bacteria. This basal slowing response is mediated by a dopamine-containing neural circuit that senses a mechanical attribute of bacteria and may be an adaptive mechanism that increases the amount of time animals spend in the presence of food. Second, food-deprived wild-type animals, when transferred to bacteria, display a dramatically enhanced slowing response that ensures that the animals do not leave their newly encountered source of food. This experience-dependent response is mediated by serotonergic neurotransmission and is potentiated by fluoxetine (Prozac). The basal and enhanced slowing responses are distinct and separable neuromodulatory components of a genetically tractable paradigm of behavioral plasticity.	MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Horvitz, HR (corresponding author), MIT, Dept Biol, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	horvitz@mit.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024663, R01GM024663] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM24663] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; AVERY L, 1987, CELL, V51, P1071, DOI 10.1016/0092-8674(87)90593-9; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARNES S, 1994, J EXP BIOL, V189, P37; BRENNER S, 1974, GENETICS, V77, P71; BRODFUEHRER PD, 1995, J NEUROBIOL, V27, P403, DOI 10.1002/neu.480270312; CAMERON DL, 1993, NATURE, V366, P344, DOI 10.1038/366344a0; Choy RKM, 1999, MOL CELL, V4, P143, DOI 10.1016/S1097-2765(00)80362-7; Colbert HA, 1997, LEARN MEMORY, V4, P179, DOI 10.1101/lm.4.2.179; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; CULOTTI JG, 1978, GENETICS, V90, P243; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; Drago J, 1998, DEV NEUROSCI-BASEL, V20, P188, DOI 10.1159/000017313; Duerr JS, 1999, J NEUROSCI, V19, P72, DOI 10.1523/JNEUROSCI.19-01-00072.1999; FLICKER C, 1981, CELL MOL NEUROBIOL, V1, P123, DOI 10.1007/BF00710716; GLENNON RA, 1987, J MED CHEM, V30, P1, DOI 10.1021/jm00384a001; GROOME JR, 1993, J EXP BIOL, V182, P265; HARRISWARRICK RM, 1995, J NEUROSCI, V15, P342; HAWKINS RD, 1993, ANNU REV NEUROSCI, V16, P625, DOI 10.1146/annurev.ne.16.030193.003205; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hietala J, 1996, ANN MED, V28, P557, DOI 10.3109/07853899608999120; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; JAGDALE GB, 1994, J NEMATOL, V26, P40; Kapatos G, 1999, J NEUROCHEM, V72, P669, DOI 10.1046/j.1471-4159.1999.0720669.x; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; KOOB GF, 1992, SEMIN NEUROSCI, V4, P139; KRAVITZ EA, 1988, SCIENCE, V241, P1775, DOI 10.1126/science.2902685; KUPFERMANN I, 1995, ESSENTIALS NEURAL SC, P651; LEFKOWITZ RJ, 1993, CELL, V74, P409, DOI 10.1016/0092-8674(93)80042-D; Lints R, 1999, DEVELOPMENT, V126, P5819; LIU DWC, 1994, J NEUROSCI, V14, P1953; LOER CM, 1993, J NEUROSCI, V13, P5407, DOI 10.1523/JNEUROSCI.13-12-05407.1993; Lucki I, 1998, BIOL PSYCHIAT, V44, P151, DOI 10.1016/S0006-3223(98)00139-5; MAGUIRE G, 1994, J NEUROSCI, V14, P6094; Marsden C. D., 1992, SEMIN NEUROSCI, V4, P171; MENDEL JE, 1995, SCIENCE, V267, P1652, DOI 10.1126/science.7886455; Mori I, 1999, ANNU REV GENET, V33, P399, DOI 10.1146/annurev.genet.33.1.399; MYLECHARANE EJ, 1989, CLIN EXP PHARMACOL P, V16, P517, DOI 10.1111/j.1440-1681.1989.tb01598.x; Neckameyer WS, 1998, LEARN MEMORY, V5, P157; Nicholas W.S., 1984, BIOL FREE LIVING NEM; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; OGARA BA, 1991, J NEUROSCI, V11, P96; OSBORNE NN, 1988, NEURONAL SEROTONIN; PEREDA AE, 1994, J NEUROSCI, V14, P3704; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; RANKIN CH, 1990, BEHAV BRAIN RES, V37, P89, DOI 10.1016/0166-4328(90)90074-O; ROSEN SC, 1989, J NEUROSCI, V9, P1562; SAHLEY CL, 1995, J NEUROBIOL, V27, P434, DOI 10.1002/neu.480270314; Sawin E. R., 1996, THESIS MIT CAMBRIDGE; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; SELF DW, 1995, ANNU REV NEUROSCI, V18, P463, DOI 10.1146/annurev.neuro.18.1.463; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; TAKADA A, 1995, P S SER CENTR NERV S; TEMPEL BL, 1984, P NATL ACAD SCI-BIOL, V81, P3577, DOI 10.1073/pnas.81.11.3577; TRENT C, 1983, GENETICS, V104, P619; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; WEINSHENKER D, 1995, J NEUROSCI, V15, P6975; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wicks SR, 1997, BEHAV NEUROSCI, V111, P342, DOI 10.1037/0735-7044.111.2.342; WONG DT, 1995, ADV EXP MED BIOL, V363, P77; Wood WB, 1988, NEMATODE CAENORHABDI; [No title captured]	66	685	705	4	87	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	2000	26	3					619	631		10.1016/S0896-6273(00)81199-X	http://dx.doi.org/10.1016/S0896-6273(00)81199-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330ZH	10896158	Bronze			2022-12-24	WOS:000087991600013
J	Vanderhaeghen, P; Lu, Q; Prakash, N; Frisen, J; Walsh, CA; Frostig, RD; Flanagan, JG				Vanderhaeghen, P; Lu, Q; Prakash, N; Frisen, J; Walsh, CA; Frostig, RD; Flanagan, JG			A mapping label required for normal scale of body representation in the cortex	NATURE NEUROSCIENCE			English	Article							RECEPTOR TYROSINE KINASES; RETINAL AXON GUIDANCE; SOMATOSENSORY CORTEX; CEREBRAL-CORTEX; VISUAL-CORTEX; SYNAPTIC PLASTICITY; CORTICAL CIRCUITS; CRITICAL PERIOD; BARREL CORTEX; IN-VITRO	The neocortical primary somatosensory area (S1) consists of a map of the body surface. The cortical area devoted to different regions, such as parts of the face or hands, reflects their functional importance. Here we investigated the role of genetically determined positional labels in neocortical mapping. Ephrin-A5 was expressed in a medial > lateral gradient across S1, whereas its receptor EphA4 was in a matching gradient across the thalamic ventrobasal (VB) complex, which provides S1 input. Ephrin-A5 had topographically specific effects on VB axon guidance in vitro. Ephrin-A5 gene disruption caused graded, topographically specific distortion in the S1 body map, with medial regions contracted and lateral regions expanded, changing relative areas up to 50% in developing and adult mice. These results provide evidence for within-area thalamocortical mapping labels and show that a genetic difference can cause a lasting change in relative scale of different regions within a topographic map.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92697 USA; Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; Beth Israel Deaconess Med Ctr, Dept Neurol, Div Neurogenet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of California System; University of California Irvine; University of California System; University of California Irvine; Karolinska Institutet; Harvard University; Beth Israel Deaconess Medical Center	Flanagan, JG (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.		Flanagan, John/AAM-2995-2020	Vanderhaeghen, Pierre/0000-0001-7899-5720; Prakash, Neal/0000-0003-0288-6573				AGMON A, 1993, J NEUROSCI, V13, P5365, DOI 10.1523/JNEUROSCI.13-12-05365.1993; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Castellani V, 1998, J NEUROSCI, V18, P4663; CHEN G, 1994, BIOL CONTROL, V4, P157, DOI 10.1006/bcon.1994.1025; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; CHIAIA NL, 1992, J NEUROSCI, V12, P62; Crair MC, 1999, CURR OPIN NEUROBIOL, V9, P88, DOI 10.1016/S0959-4388(99)80011-7; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Donoghue MJ, 1999, J NEUROSCI, V19, P5967, DOI 10.1523/JNEUROSCI.19-14-05967.1999; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; FOX K, 1992, J NEUROSCI, V12, P1826; Fox K, 1996, P NATL ACAD SCI USA, V93, P5584, DOI 10.1073/pnas.93.11.5584; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Gao PP, 1998, P NATL ACAD SCI USA, V95, P5329, DOI 10.1073/pnas.95.9.5329; Gao WQ, 1998, MOL CELL NEUROSCI, V11, P247, DOI 10.1006/mcne.1998.0696; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Howe MJA, 1998, BEHAV BRAIN SCI, V21, P399, DOI 10.1017/S0140525X9800123X; Hubel DH, 1998, NEURON, V20, P401, DOI 10.1016/S0896-6273(00)80984-8; Iwasato T, 1997, NEURON, V19, P1201, DOI 10.1016/S0896-6273(00)80412-2; Kaas Jon H., 1995, P51; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KILLACKEY HP, 1995, TRENDS NEUROSCI, V18, P402, DOI 10.1016/0166-2236(95)93937-S; KILLACKEY HP, 1994, J NEUROSCI, V14, P1496, DOI 10.1523/JNEUROSCI.14-03-01496.1994; Mackarehtschian K, 1999, CEREB CORTEX, V9, P601, DOI 10.1093/cercor/9.6.601; MCCASLAND JS, 1992, P NATL ACAD SCI USA, V89, P1832, DOI 10.1073/pnas.89.5.1832; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; MOLNAR Z, 1995, TRENDS NEUROSCI, V18, P389, DOI 10.1016/0166-2236(95)93935-Q; MOLNAR Z, 1991, NATURE, V351, P475, DOI 10.1038/351475a0; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; O'Leary D D, 1994, Curr Opin Neurobiol, V4, P535, DOI 10.1016/0959-4388(94)90054-X; OLEARY DDM, 1989, TRENDS NEUROSCI, V12, P400, DOI 10.1016/0166-2236(89)90080-5; Paxinos G, 1995, RAT NERVOUS SYSTEM, V2nd; Penfield W, 1950, CEREBRAL CORTEX MAN; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RENEHAN WE, 1994, J NEUROSCI, V14, P721; RIDDLE DR, 1995, J NEUROSCI, V15, P4184; ROE AW, 1990, SCIENCE, V250, P818, DOI 10.1126/science.2237432; SCHLAGGAR BL, 1993, DEV BRAIN RES, V75, P19, DOI 10.1016/0165-3806(93)90061-E; SCHLAGGAR BL, 1991, SCIENCE, V252, P1556, DOI 10.1126/science.2047863; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; WALTER J, 1987, DEVELOPMENT, V101, P909; WELKER E, 1986, EXP BRAIN RES, V63, P650, DOI 10.1007/BF00237487; WHITE LE, 1994, NATURE, V368, P197, DOI 10.1038/368197a0; WINSLOW JW, 1995, NEURON, V14, P973, DOI 10.1016/0896-6273(95)90335-6; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; Woolsey CN, 1958, BIOL BIOCH BASES BEH, P63	50	158	160	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2000	3	4					358	365		10.1038/73929	http://dx.doi.org/10.1038/73929			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330CN	10725925				2022-12-24	WOS:000087945400016
J	Marek, KW; Ng, N; Fetter, R; Smolik, S; Goodman, CS; Davis, GW				Marek, KW; Ng, N; Fetter, R; Smolik, S; Goodman, CS; Davis, GW			A genetic analysis of synaptic development: Pre- and postsynaptic dCBP control transmitter release at the Drosophila NMJ	NEURON			English	Article							LONG-TERM POTENTIATION; RUBINSTEIN-TAYBI-SYNDROME; FUNCTIONAL COMPONENTS; CREB PHOSPHORYLATION; RETROGRADE SIGNAL; MEMORY; CBP; PLASTICITY; FACILITATION; PROTEIN	Postsynaptic dCBP (Drosophila homolog of the CREB binding protein) is required for presynaptic functional development. Viable, hypomorphic dCBP mutations have a similar to 50% reduction in presynaptic transmitter release without altering the Ca2+ cooperativity of release or synaptic ultrastructure (total bouton number is increased by 25%-30%). Exogenous expression of dCBP in muscle rescues impaired presynaptic release in the dCBP mutant background, while presynaptic dCBP expression does not. In addition, overexpression experiments indicate that elevated dCBP can also inhibit presynaptic functional development in a manner distinct from the effects of dCBP loss of function. Pre- or postsynaptic overexpression of dCBP (in wild type) reduces presynaptic release. However, we do not observe an increase in bouton number, and presynaptic overexpression impairs short-term facilitation. These data suggest that dCBP participates in a postsynaptic regulatory system that controls functional synaptic development.	Univ Calif San Francisco, Sch Med, Dept Biochem & Biophys, Cell Biol Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Biochem & Biophys, Program Neurosci, San Francisco, CA 94143 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Oregon Hlth Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Oregon Health & Science University	Davis, GW (corresponding author), Univ Calif San Francisco, Sch Med, Dept Biochem & Biophys, Cell Biol Program, San Francisco, CA 94143 USA.				PHS HHS [444908-32374] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Akimaru H, 1997, NATURE, V386, P735, DOI 10.1038/386735a0; Arancio O, 1996, CELL, V87, P1025, DOI 10.1016/S0092-8674(00)81797-3; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Buchs PA, 1996, P NATL ACAD SCI USA, V93, P8040, DOI 10.1073/pnas.93.15.8040; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Davis GW, 1998, CURR OPIN NEUROBIOL, V8, P149, DOI 10.1016/S0959-4388(98)80018-4; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Davis GW, 1998, NEURON, V20, P305, DOI 10.1016/S0896-6273(00)80458-4; Davis GW, 1997, NEURON, V19, P561, DOI 10.1016/S0896-6273(00)80372-4; Davis GW, 1996, NEURON, V17, P669, DOI 10.1016/S0896-6273(00)80199-3; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Florence B, 1998, GENETICS, V150, P1497; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Giordano A, 1999, J CELL PHYSIOL, V181, P218, DOI 10.1002/(SICI)1097-4652(199911)181:2<218::AID-JCP4>3.0.CO;2-5; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Johnston H, 1999, J BIOL CHEM, V274, P16370, DOI 10.1074/jbc.274.23.16370; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; Liu YZ, 1998, J BIOL CHEM, V273, P32400, DOI 10.1074/jbc.273.49.32400; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Oike Y, 1999, HUM MOL GENET, V8, P387, DOI 10.1093/hmg/8.3.387; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; SHIEH PB, 1997, CURR BIOL, V7, P627; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Taine L, 1998, AM J MED GENET, V78, P267, DOI 10.1002/(SICI)1096-8628(19980707)78:3<267::AID-AJMG12>3.0.CO;2-D; Tanaka Y, 1997, P NATL ACAD SCI USA, V94, P10215, DOI 10.1073/pnas.94.19.10215; Waltzer L, 1999, EMBO J, V18, P1630, DOI 10.1093/emboj/18.6.1630; Waltzer L, 1998, NATURE, V395, P521, DOI 10.1038/26785; Yin JCP, 1996, CURR OPIN NEUROBIOL, V6, P264, DOI 10.1016/S0959-4388(96)80082-1	40	37	37	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR	2000	25	3					537	547		10.1016/S0896-6273(00)81058-2	http://dx.doi.org/10.1016/S0896-6273(00)81058-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	301CY	10774723	Bronze			2022-12-24	WOS:000086291700008
J	Martinez-Conde, S; Macknik, SL; Hubel, DH				Martinez-Conde, S; Macknik, SL; Hubel, DH			Microsaccadic eye movements and firing of single cells in the striate cortex of macaque monkeys	NATURE NEUROSCIENCE			English	Article							VISUAL-CORTEX; AREA MT; NEURONS; V1	When viewing a stationary object, we unconsciously make small, involuntary eye movements or 'microsaccades'. If displacements of the retinal image are prevented, the image quickly fades from perception. To understand how microsaccades sustain perception, we studied their relationship to the firing of cells in primary visual cortex (V1). We tracked eye movements and recorded from V1 cells as macaque monkeys fixated. When an optimally oriented line was centered over a cell's receptive field, activity increased after microsaccades. Moreover, microsaccades were better correlated with bursts of spikes than with either single spikes or instantaneous firing rate. These findings may help explain maintenance of perception during normal visual fixation.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Martinez-Conde, S (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.		Macknik, Stephen L./H-7704-2019	Macknik, Stephen L./0000-0002-3143-9230				Bair W, 1998, VISUAL NEUROSCI, V15, P779, DOI 10.1017/S0952523898154160; BAIR W, 1994, J NEUROSCI, V14, P2870; BRIDGEMAN B, 1975, VISION RES, V15, P719, DOI 10.1016/0042-6989(75)90290-4; Coppola D, 1996, P NATL ACAD SCI USA, V93, P8001, DOI 10.1073/pnas.93.15.8001; Day EC, 1915, AM J PHYSIOL, V38, P369, DOI 10.1152/ajplegacy.1915.38.3.369; Dodge R, 1900, PSYCHOL REV, V7, P454, DOI 10.1037/h0067215; GERRITS HJM, 1974, VISION RES, V14, P175, DOI 10.1016/0042-6989(74)90098-4; Gur M, 1997, J NEUROSCI, V17, P2914; HUBEL DH, 1958, AM J OPHTHALMOL, V46, P110, DOI 10.1016/0002-9394(58)90060-6; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; Livingstone MS, 1996, COLD SPRING HARB SYM, V61, P27; MACKNIK SL, 1991, VISION RES, V31, P2057, DOI 10.1016/0042-6989(91)90163-Y; MAGLEBY KL, 1987, SYNAPTIC FUNCTION, P21; RIGGS LA, 1952, J OPT SOC AM, V42, P872; SANSBURY RV, 1973, J OPT SOC AM, V63, P612, DOI 10.1364/JOSA.63.000612; STEINMAN RM, 1973, SCIENCE, V181, P810, DOI 10.1126/science.181.4102.810; Usrey WM, 1998, NATURE, V395, P384, DOI 10.1038/26487; WURTZ RH, 1969, J NEUROPHYSIOL, V32, P975, DOI 10.1152/jn.1969.32.6.975; WURTZ RH, 1968, SCIENCE, V162, P1148, DOI 10.1126/science.162.3858.1148; WURTZ RH, 1969, J NEUROPHYSIOL, V32, P987, DOI 10.1152/jn.1969.32.6.987; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	23	249	255	1	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2000	3	3					251	258		10.1038/72961	http://dx.doi.org/10.1038/72961			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TE	10700257				2022-12-24	WOS:000085810500014
J	Mehta, MR; Quirk, MC; Wilson, MA				Mehta, MR; Quirk, MC; Wilson, MA			Experience-dependent asymmetric shape of hippocampal receptive fields	NEURON			English	Article							PHASE-PRECESSION; SIMPLE CELLS; DIRECTION SELECTIVITY; VELOCITY SELECTIVITY; STRIATE CORTEX; PLACE FIELDS; THETA-RHYTHM; SPATIAL MAP; NEURONS; DEPRESSION	We propose a novel parameter, namely, the skewness, or asymmetry, of the shape of a receptive field to characterize two properties of hippocampal place fields. First, a majority of hippocampal receptive fields on linear tracks are negatively skewed, such that during a single pass the firing rate is low as the rat enters the field but high as it exits. Second, while the place fields are symmetric at the beginning of a session, they become highly asymmetric with experience. Further experiments suggest that these results are likely to arise due to synaptic plasticity during behavior. Using a purely feed forward neural network model, we show that following repeated directional activation, NMDA-dependent long-term potentiation/long-term depotentiation (LTP/LTD) could result in an experience-dependent asymmetrization of receptive fields.	MIT, Ctr Learning & Memory, RIKEN,Neurosci Res Ctr, Dept Brain & Cognit Sci,Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); RIKEN	Mehta, MR (corresponding author), MIT, Ctr Learning & Memory, RIKEN,Neurosci Res Ctr, Dept Brain & Cognit Sci,Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mayank@mit.edu						ALBRECHT DG, 1991, VISUAL NEUROSCI, V7, P531, DOI 10.1017/S0952523800010336; Anderson JC, 1999, NAT NEUROSCI, V2, P820, DOI 10.1038/12194; BARNES CA, 1990, PROG BRAIN RES, V83, P287; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Blum KI, 1996, NEURAL COMPUT, V8, P85, DOI 10.1162/neco.1996.8.1.85; Chance FS, 1998, J NEUROSCI, V18, P4785; deCharms RC, 1998, SCIENCE, V280, P1439, DOI 10.1126/science.280.5368.1439; Feidler JC, 1997, NETWORK-COMP NEURAL, V8, P195, DOI 10.1088/0954-898X/8/2/006; GUSTAFSSON B, 1986, J NEUROSCI, V6, P1575; Hebb Donald O., 1949, ORG BEHAV; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Levy W. B., 1989, COMPUTATIONAL MODELS, P243, DOI DOI 10.1016/S0079-7421(08)60113-9; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; Livingstone MS, 1998, NEURON, V20, P509, DOI 10.1016/S0896-6273(00)80991-5; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; MCLEAN J, 1989, VISION RES, V29, P675, DOI 10.1016/0042-6989(89)90029-1; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; MIURA K, 1995, BIOL CYBERN, V73, P401, DOI 10.1007/BF00201474; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; REID RC, 1987, P NATL ACAD SCI USA, V84, P8740, DOI 10.1073/pnas.84.23.8740; SPIEGEL MR, 1994, SCHAUMS OUTLINE SERI; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; Wallenstein GV, 1997, J NEUROPHYSIOL, V78, P393, DOI 10.1152/jn.1997.78.1.393; Wang XJ, 1998, J NEUROPHYSIOL, V79, P1549, DOI 10.1152/jn.1998.79.3.1549; WANG XQ, 1995, NATURE, V378, P71, DOI 10.1038/378071a0; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	35	319	324	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	2000	25	3					707	715		10.1016/S0896-6273(00)81072-7	http://dx.doi.org/10.1016/S0896-6273(00)81072-7			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	301CY	10774737	Bronze			2022-12-24	WOS:000086291700022
J	Nakagawa, S; Brennan, C; Johnson, KG; Shewan, D; Harris, WA; Holt, CE				Nakagawa, S; Brennan, C; Johnson, KG; Shewan, D; Harris, WA; Holt, CE			Ephrin-B regulates the ipsilateral routing of retinal axons at the optic chiasm	NEURON			English	Article							RECEPTOR TYROSINE KINASES; FROG XENOPUS-LAEVIS; CENTRAL-NERVOUS-SYSTEM; GANGLION-CELL AXONS; RETINOTHALAMIC PROJECTION; IN-VITRO; RETINOTECTAL SYSTEM; COMMISSURAL AXONS; VISUAL-SYSTEM; NEURAL RETINA	In Xenopus tadpoles, all retinal ganglion cells (RGCs) send axons contralaterally across the optic chiasm. At metamorphosis, a subpopulation of EphB-expressing RGCs in the ventrotemporal retina begin to project ipsilaterally. However, when these metamorphic RGCs are grafted into embryos, they project contralaterally, suggesting that the embryonic chiasm lacks signals that guide axons ipsilaterally. Ephrin-B is expressed discretely at the chiasm of metamorphic but not premetamorphic Xenopus. When expressed prematurely in the embryonic chiasm, ephrin-B causes precocious ipsilateral projections from the EphB-expressing RGCs. Ephrin-B is also found in the chiasm of mammals, which have ipsilateral projections, but not in the chiasm of fish and birds, which do not. These results suggest that ephrin-B/EphB interactions play a key role in the sorting of axons at the vertebrate chiasm.	Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England; UCL, Dept Anat & Dev Biol, London WC1E 6BT, England	University of Cambridge; University of London; University College London	Nakagawa, S (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan.	nakagawa@take.biophys.kyoto-u.ac.jp	Nakagawa, Shinichi/I-4192-2014	Nakagawa, Shinichi/0000-0002-6806-7493; Holt, Christine Elizabeth/0000-0003-2829-121X; Johnson, Karl/0000-0003-3931-5985	Wellcome Trust [070568] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BEACH DH, 1979, J COMP NEUROL, V183, P615, DOI 10.1002/cne.901830309; BEACH DH, 1979, J COMP NEUROL, V183, P603, DOI 10.1002/cne.901830308; Bergemann AD, 1998, ONCOGENE, V16, P471, DOI 10.1038/sj.onc.1201557; Braisted JE, 1997, DEV BIOL, V191, P14, DOI 10.1006/dbio.1997.8706; Brennan C, 1997, DEVELOPMENT, V124, P655; CHEN G, 1994, BIOL CONTROL, V4, P157, DOI 10.1006/bcon.1994.1025; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; CHIEN CB, 1995, DEVELOPMENT, V121, P2621; COLELLO RJ, 1990, DEVELOPMENT, V108, P515; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Durbin L, 1998, GENE DEV, V12, P3096, DOI 10.1101/gad.12.19.3096; Dutting D, 1999, DEV BIOL, V216, P297, DOI 10.1006/dbio.1999.9489; Faber J., 1994, NORMAL TABLE XENOPUS, P2; FAWCETT JW, 1984, J EMBRYOL EXP MORPH, V83, P1; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Flenniken AM, 1996, DEV BIOL, V179, P382, DOI 10.1006/dbio.1996.0269; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; GLUCKSMANN A., 1940, BRIT JOUR OPHTHALMOL, V24, P153, DOI 10.1136/bjo.24.4.153; GODEMENT P, 1990, NEURON, V5, P173, DOI 10.1016/0896-6273(90)90307-2; GRANT S, 1986, J EMBRYOL EXP MORPH, V92, P43; GUILLERY RW, 1995, J NEUROSCI, V15, P4727; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Holash JA, 1995, DEV BIOL, V172, P683, DOI 10.1006/dbio.1995.8039; Holder N, 1999, DEVELOPMENT, V126, P2033; HOLLYFIELD JG, 1971, DEV BIOL, V24, P264, DOI 10.1016/0012-1606(71)90098-4; HOLT CE, 1983, NATURE, V301, P150, DOI 10.1038/301150a0; HOLT CE, 1984, J NEUROSCI, V4, P1130; HOLT CE, 1990, NEURON, V4, P203, DOI 10.1016/0896-6273(90)90095-W; HOSKINS SG, 1985, J NEUROSCI, V5, P930; HOSKINS SG, 1985, J NEUROSCI, V5, P911; HOSKINS SG, 1985, J NEUROSCI, V5, P920; HOSKINS SG, 1990, J NEUROBIOL, V21, P970, DOI 10.1002/neu.480210704; HOSKINS SG, 1984, NATURE, V307, P730, DOI 10.1038/307730a0; KENNARD C, 1981, J EMBRYOL EXP MORPH, V65, P199; Kenny D, 1995, DEV BIOL, V172, P708, DOI 10.1006/dbio.1995.8083; Marcus RC, 1999, J COMP NEUROL, V403, P346; MARCUS RC, 1995, J NEUROSCI, V15, P3716; Marcus RC, 1996, DEV BIOL, V180, P786, DOI 10.1006/dbio.1996.0347; MARCUS RC, 1995, J NEUROSCI, V15, P6389; MARCUS RC, 2000, IN PRESS DEV BIOL; Marsh-Armstrong N, 1999, NEURON, V24, P871, DOI 10.1016/S0896-6273(00)81034-X; Mason CA, 1997, CURR OPIN NEUROBIOL, V7, P647, DOI 10.1016/S0959-4388(97)80084-0; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; OLEARY DDM, 1983, DEV BRAIN RES, V10, P93, DOI 10.1016/0165-3806(83)90124-4; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; Sarnat H. B., 1981, EVOLUTION NERVOUS SY, V2nd; SRETAVAN DW, 1990, J NEUROSCI, V10, P1995; STONE J, 1966, J COMP NEUROL, V126, P585; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wang LC, 1995, NEURON, V15, P1349, DOI 10.1016/0896-6273(95)90013-6; Wang LC, 1996, NEURON, V17, P849, DOI 10.1016/S0896-6273(00)80217-2; WILLSHAW DJ, 1983, J EMBRYOL EXP MORPH, V74, P29; WIZENMANN A, 1993, DEVELOPMENT, V117, P725; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452; Zallen JA, 1999, DEVELOPMENT, V126, P3679	59	150	150	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	2000	25	3					599	610		10.1016/S0896-6273(00)81063-6	http://dx.doi.org/10.1016/S0896-6273(00)81063-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	301CY	10774728	Green Accepted, Bronze			2022-12-24	WOS:000086291700013
J	Semyanov, A; Kullmann, DM				Semyanov, A; Kullmann, DM			Modulation of GABAergic signaling among interneurons by metabotropic glutamate receptors	NEURON			English	Article							SYNAPTIC TRANSMISSION; RAT HIPPOCAMPUS; ADULT-RAT; IMMUNOHISTOCHEMICAL LOCALIZATION; PHARMACOLOGICAL PROPERTIES; KAINATE RECEPTORS; PYRAMIDAL CELLS; OLFACTORY-BULB; IN-VIVO; INHIBITION	Synapses between hippocampal interneurons are an important potential target for modulatory influences that could affect overall network behavior. We report that the selective group III metabotropic receptor agonist L(+)-2-amino-4-phosphonobutyric acid (L-AP4) depresses GABAergic transmission to interneurons more than to pyramidal neurons. The L-AP4-induced depression is accompanied by changes in trial-to-trial variability and paired-pulse depression that imply a presynaptic site of action. Brief trains of stimuli in Schaffer collaterals also depress GABAergic transmission to interneurons. This depression persists when GABA, receptors are blocked, is enhanced by blocking glutamate uptake, and is abolished by the group III metabotropic receptor antagonist alpha-methylserine-O-phosphate (MSOP). The results imply that GABAergic transmission among interneurons is modulated by glutamate spillover from excitatory afferent terminals.	UCL, Inst Neurol, Dept Clin Neurol, London WC1N 3BG, England	University of London; University College London	Kullmann, DM (corresponding author), UCL, Inst Neurol, Dept Clin Neurol, Queen Sq, London WC1N 3BG, England.	d.kullmann@ion.ucl.ac.uk	Kullmann, Dimitri M/A-3162-2009; Semyanov, Alexey/A-7654-2010	Kullmann, Dimitri M/0000-0001-6696-3545; Semyanov, Alexey/0000-0002-6800-0942				AbdulGhani AS, 1997, BRAIN RES, V755, P202, DOI 10.1016/S0006-8993(97)00098-X; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Bradley SR, 1996, J NEUROSCI, V16, P2044; BUZSAKI G, 1984, PROG NEUROBIOL, V22, P131, DOI 10.1016/0301-0082(84)90023-6; Chapman AG, 1999, EUR J PHARMACOL, V383, P23, DOI 10.1016/S0014-2999(99)00615-9; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Cossart R, 1998, NAT NEUROSCI, V1, P470, DOI 10.1038/2185; Dietrich D, 1999, EUR J NEUROSCI, V11, P1109, DOI 10.1046/j.1460-9568.1999.00549.x; Dittman JS, 1997, J NEUROSCI, V17, P9048; DURING MJ, 1993, LANCET, V341, P1607; EDWARDS FR, 1989, J PHYSIOL-LONDON, V416, P539, DOI 10.1113/jphysiol.1989.sp017776; Frerking M, 1998, NAT NEUROSCI, V1, P479, DOI 10.1038/2194; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; GEREAU RW, 1995, J NEUROSCI, V15, P6879; Ghauri M, 1996, NEUROREPORT, V7, P1469, DOI 10.1097/00001756-199606170-00005; Gulyas AI, 1996, J NEUROSCI, V16, P3397; Hardingham NR, 1998, J PHYSIOL-LONDON, V507, P249, DOI 10.1111/j.1469-7793.1998.249bu.x; HAYASHI Y, 1993, NATURE, V366, P687, DOI 10.1038/366687a0; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kinoshita A, 1998, J COMP NEUROL, V393, P332; Klapstein GJ, 1999, NEUROPHARMACOLOGY, V38, P927, DOI 10.1016/S0028-3908(99)00016-7; Koulen P, 1999, P NATL ACAD SCI USA, V96, P9909, DOI 10.1073/pnas.96.17.9909; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; Min MY, 1999, P NATL ACAD SCI USA, V96, P9932, DOI 10.1073/pnas.96.17.9932; OHISHI H, 1994, NEURON, V13, P55, DOI 10.1016/0896-6273(94)90459-6; OKAMOTO N, 1994, J BIOL CHEM, V269, P1231; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Rodriguez-Moreno A, 1998, NEURON, V20, P1211, DOI 10.1016/S0896-6273(00)80501-2; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; Rusakov DA, 1998, J NEUROSCI, V18, P3158; SALT TE, 1995, NEUROSCIENCE, V65, P5, DOI 10.1016/0306-4522(94)00464-G; Scanziani M, 1998, P NATL ACAD SCI USA, V95, P12004, DOI 10.1073/pnas.95.20.12004; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; Schoppa NE, 1997, J NEUROPHYSIOL, V78, P1468, DOI 10.1152/jn.1997.78.3.1468; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Shigemoto R, 1996, NATURE, V381, P523, DOI 10.1038/381523a0; Sodickson DL, 1996, J NEUROSCI, V16, P6374; SORRA KE, 1993, J NEUROSCI, V13, P3736; Takumi Y, 1998, PROG BRAIN RES, V116, P105, DOI 10.1016/S0079-6123(08)60433-1; TANABE Y, 1993, J NEUROSCI, V13, P1372; TIZZANO JP, 1995, NEUROPHARMACOLOGY, V34, P1063, DOI 10.1016/0028-3908(95)00083-I; van den Pol AN, 1998, J NEUROSCI, V18, P10749; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Vetter P, 1999, NEUROPHARMACOLOGY, V38, P805, DOI 10.1016/S0028-3908(99)00003-9; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; WAN H, 1995, NEUROPHARMACOLOGY, V34, P1053, DOI 10.1016/0028-3908(95)00091-J; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; Wu S, 1998, MOL BRAIN RES, V53, P88, DOI 10.1016/S0169-328X(97)00277-5; YATANI A, 1989, SCIENCE, V245, P71, DOI 10.1126/science.2544999	55	151	155	1	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR	2000	25	3					663	672		10.1016/S0896-6273(00)81068-5	http://dx.doi.org/10.1016/S0896-6273(00)81068-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	301CY	10774733	Bronze			2022-12-24	WOS:000086291700018
J	Nakagawa, S; Harris, WA				Nakagawa, S; Harris, WA			The metamorphosis antidote	NEURON			English	Editorial Material							XENOPUS-LAEVIS; EXPRESSION; MIGRATION; RETINA; EYE		Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England	University of Cambridge	Nakagawa, S (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge CB2 3DY, England.		Nakagawa, Shinichi/I-4192-2014	Nakagawa, Shinichi/0000-0002-6806-7493				BEACH DH, 1979, J COMP NEUROL, V183, P603, DOI 10.1002/cne.901830308; GLUCKSMANN A., 1940, BRIT JOUR OPHTHALMOL, V24, P153, DOI 10.1136/bjo.24.4.153; GRANT S, 1986, J EMBRYOL EXP MORPH, V92, P43; GROBSTEIN P, 1977, NATURE, V269, P54, DOI 10.1038/269054a0; HOLLYFIELD JG, 1971, DEV BIOL, V24, P264, DOI 10.1016/0012-1606(71)90098-4; HOSKINS SG, 1986, J NEUROBIOL, V17, P203, DOI 10.1002/neu.480170306; KAWAHARA A, 1991, DEVELOPMENT, V112, P933; Marsh-Armstrong N, 1999, NEURON, V24, P871, DOI 10.1016/S0896-6273(00)81034-X; Perron M, 1998, DEV BIOL, V199, P185, DOI 10.1006/dbio.1998.8939; STRAZNICKY K, 1977, J EMBRYOL EXP MORPH, V40, P175; TALBOT WS, 1993, CELL, V73, P1323, DOI 10.1016/0092-8674(93)90359-X; WANG Z, 1993, J BIOL CHEM, V268, P16270	12	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1999	24	4					763	764		10.1016/S0896-6273(00)81020-X	http://dx.doi.org/10.1016/S0896-6273(00)81020-X			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	269UE	10624936	Bronze			2022-12-24	WOS:000084495300001
J	Shoham, D; Glaser, DE; Arieli, A; Kenet, T; Wijnbergen, C; Toledo, Y; Hildesheim, R; Grinvald, A				Shoham, D; Glaser, DE; Arieli, A; Kenet, T; Wijnbergen, C; Toledo, Y; Hildesheim, R; Grinvald, A			Imaging cortical dynamics at high spatial and temporal resolution with novel blue voltage-sensitive dyes	NEURON			English	Article							CENTRAL NERVOUS-SYSTEM; SALAMANDER OLFACTORY-BULB; ELECTRICAL-ACTIVITY; NEURONAL-ACTIVITY; VISUAL-CORTEX; FUNCTIONAL ARCHITECTURE; INTRINSIC SIGNALS; ONGOING ACTIVITY; OPTICAL PROBES; RAPID CHANGES	Conventional imaging techniques have provided high-resolution imaging either in the spatial domain or in the temporal domain. Optical imaging utilizing voltage-sensitive dyes has long had the unrealized potential to achieve high resolution in both domains simultaneously, providing subcolumnar spatial detail with millisecond precision. Here, we present a series of developments in voltage-sensitive dyes and instrumentation that make functional imaging of cortical dynamics practical, in both anesthetized and awake behaving preparations, greatly facilitating exploration of the cortex. We illustrate this advance by analyzing the millisecond-by-millisecond emergence of orientation maps in cat visual cortex.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Grinvald, A (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.		GRINVALD, AMIRAM/AAH-9919-2019; Glaser, Daniel/A-3926-2010					ARIELI A, 1995, J NEUROPHYSIOL, V73, P2072, DOI 10.1152/jn.1995.73.5.2072; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; Bonhoeffer Tobias, 1996, P55; Cacciatore TW, 1999, NEURON, V23, P449, DOI 10.1016/S0896-6273(00)80799-0; COHEN LB, 1973, PHYSIOL REV, V53, P373; COHEN LB, 1968, NATURE, V218, P438, DOI 10.1038/218438a0; FLUHLER E, 1985, BIOCHEMISTRY-US, V24, P5749, DOI 10.1021/bi00342a010; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; GEORGE JS, 1995, J CLIN NEUROPHYSIOL, V12, P406, DOI 10.1097/00004691-199509010-00002; Gonzalez JE, 1997, CHEM BIOL, V4, P269, DOI 10.1016/S1074-5521(97)90070-3; GRINVALD A, 1982, BIOPHYS J, V39, P301, DOI 10.1016/S0006-3495(82)84520-7; GRINVALD A, 1982, J PHYSIOL-LONDON, V333, P269, DOI 10.1113/jphysiol.1982.sp014453; GRINVALD A, 1981, SCIENCE, V212, P1164, DOI 10.1126/science.7233210; GRINVALD A, 1981, J NEUROPHYSIOL, V45, P829, DOI 10.1152/jn.1981.45.5.829; GRINVALD A, 1988, PHYSIOL REV, V68, P1285, DOI 10.1152/physrev.1988.68.4.1285; GRINVALD A, 1984, NATURE, V308, P848, DOI 10.1038/308848a0; GRINVALD A, 1983, BIOPHYS J, V42, P195, DOI 10.1016/S0006-3495(83)84386-0; GRINVALD A, 1977, NATURE, V268, P140, DOI 10.1038/268140a0; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; GRINVALD A, 1999, MODERN TECHNIQUES NE, P894; GUPTA RK, 1981, J MEMBRANE BIOL, V58, P123, DOI 10.1007/BF01870975; HILL DK, 1949, J PHYSIOL-LONDON, V108, P278, DOI 10.1113/jphysiol.1949.sp004331; Iijima T, 1996, SCIENCE, V272, P1176, DOI 10.1126/science.272.5265.1176; KAUER JS, 1988, NATURE, V331, P166, DOI 10.1038/331166a0; KAUER JS, 1987, BRAIN RES, V418, P255, DOI 10.1016/0006-8993(87)90093-X; LOEW LM, 1978, BIOCHEMISTRY-US, V17, P4065, DOI 10.1021/bi00612a030; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nicolelis MAL, 1997, NEURON, V18, P529, DOI 10.1016/S0896-6273(00)80295-0; ORBACH HS, 1985, J NEUROSCI, V5, P1886; RATZLAFF EH, 1991, J NEUROSCI METH, V36, P127, DOI 10.1016/0165-0270(91)90038-2; ROSS WN, 1977, J MEMBRANE BIOL, V33, P141, DOI 10.1007/BF01869514; SALZBERG BM, 1977, J NEUROPHYSIOL, V40, P1281, DOI 10.1152/jn.1977.40.6.1281; SALZBERG BM, 1973, NATURE, V246, P508, DOI 10.1038/246508a0; SHOHAM D, 1997, THESIS WEIZMANN I SC; Siegel MS, 1997, NEURON, V19, P735, DOI 10.1016/S0896-6273(00)80955-1; TASAKI I, 1968, P NATL ACAD SCI USA, V61, P883, DOI 10.1073/pnas.61.3.883; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630	38	282	287	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1999	24	4					791	802		10.1016/S0896-6273(00)81027-2	http://dx.doi.org/10.1016/S0896-6273(00)81027-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	269UE	10624943	Bronze			2022-12-24	WOS:000084495300008
J	Tomoda, T; Bhatt, RS; Kuroyanagi, H; Shirasawa, T; Hatten, ME				Tomoda, T; Bhatt, RS; Kuroyanagi, H; Shirasawa, T; Hatten, ME			A mouse serine/threonine kinase homologous to C-elegans UNC51 functions in parallel fiber formation of cerebellar granule neurons	NEURON			English	Article							CAENORHABDITIS-ELEGANS; AXONAL ELONGATION; CELL SPECIFICATION; NEURITE OUTGROWTH; EXPRESSION; GUIDANCE; PROTEIN; DIFFERENTIATION; SYSTEM; UNC-51	The formation of the cerebellar circuitry depends on the outgrowth of connections between the two principal classes of neurons, granule neurons and Purkinje neurons. To identify genes that function in axon outgrowth, we have isolated a mouse homolog of C. elegans UNC51, which is required for axon formation, and tested its function in cerebellar granule neurons. Murine Unc51.1 encodes a novel serine/threonine kinase and is expressed in granule cells in the cerebellar cortex. Retroviral infection of immature granule cells with a dominant negative Unc51.1 results in inhibition of neurite outgrowth in vitro and in vivo. Moreover, infected neurons fail to express TAG-1 or neuron-specific beta-tubulin, suggesting that development is arrested prior to this initial step of differentiation. Thus, Unc51.1 signals the program of gene expression leading to the formation of granule cell axons.	Rockefeller Univ, Dev Neurobiol Lab, New York, NY 10021 USA; Tokyo Metropolitan Inst Genet, Dept Mol Genet, Tokyo 173, Japan	Rockefeller University	Hatten, ME (corresponding author), Rockefeller Univ, Dev Neurobiol Lab, 1230 York Ave, New York, NY 10021 USA.	hatten@rockvax.rockefeller.edu			NCRR NIH HHS [P41 RR001192] Funding Source: Medline; NINDS NIH HHS [NS30532-05] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS030532] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKAZAWA C, 1995, J BIOL CHEM, V270, P8730, DOI 10.1074/jbc.270.15.8730; Altman J, 1997, DEV CEREBELLAR SYSTE; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; BRENNER S, 1974, GENETICS, V77, P71; Brooks VB, 1981, HDB PHYSL NERVOUS SY, V2, P877; CAJAL SRY, 1995, HIST NERVOUS SYSTEM, P3; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Eccles JC, 1967, CEREBELLUM NEURONAL; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Fiez JA, 1996, NEURON, V16, P13, DOI 10.1016/S0896-6273(00)80018-5; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; Gao JH, 1996, SCIENCE, V272, P545, DOI 10.1126/science.272.5261.545; GAO WQ, 1991, NEURON, V6, P705, DOI 10.1016/0896-6273(91)90168-Y; GAO WQ, 1994, DEVELOPMENT, V120, P1059; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; HAN M, 1993, NATURE, V363, P133, DOI 10.1038/363133a0; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hatten ME, 1997, CURR OPIN NEUROBIOL, V7, P40, DOI 10.1016/S0959-4388(97)80118-3; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; Helms AW, 1998, DEVELOPMENT, V125, P919; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Kuroyanagi H, 1998, GENOMICS, V51, P76, DOI 10.1006/geno.1998.5340; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LILLIEN L, 1995, NATURE, V377, P158, DOI 10.1038/377158a0; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; OGURA K, 1994, GENE DEV, V8, P2389, DOI 10.1101/gad.8.20.2389; Ogura K, 1997, GENE DEV, V11, P1801, DOI 10.1101/gad.11.14.1801; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Palay S. L., 1974, CEREBELLAR CORTEX CY; Przyborski SA, 1997, DEV BRAIN RES, V100, P133, DOI 10.1016/S0165-3806(97)00031-X; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; Ridley AJ, 1996, CURR BIOL, V6, P1256, DOI 10.1016/S0960-9822(02)70711-2; Ross ME, 1996, J NEUROSCI, V16, P210; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SIDDIQUI SS, 1990, NEUROSCI RES       S, V13, P171; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yang XW, 1996, DEVELOPMENT, V122, P555	49	107	113	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1999	24	4					833	846		10.1016/S0896-6273(00)81031-4	http://dx.doi.org/10.1016/S0896-6273(00)81031-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	269UE	10624947	Bronze			2022-12-24	WOS:000084495300012
J	Goel, V; Dolan, RJ				Goel, V; Dolan, RJ			The functional anatomy of humor: segregating cognitive and affective components	NATURE NEUROSCIENCE			English	Article							BRAIN-DAMAGED PATIENTS; ORBITOFRONTAL CORTEX; LEXICAL AMBIGUITY; RIGHT-HEMISPHERE; APPRECIATION; ARTICULATION; RESOLUTION; REWARD		Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England; York Univ, Dept Psychol, N York, ON M3J 1P3, Canada; Royal Free Hosp, Sch Med, London NW3, England	University of London; University College London; York University - Canada; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Goel, V (corresponding author), Inst Neurol, Wellcome Dept Cognit Neurol, Queen Sq, London WC1N 3BG, England.			Dolan, Ray/0000-0001-9356-761X				Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; BROWNELL HH, 1984, BRAIN LANG, V22, P253, DOI 10.1016/0093-934X(84)90093-2; BROWNELL HH, 1990, NEUROPSYCHOLOGIA, V28, P375, DOI 10.1016/0028-3932(90)90063-T; Coney J, 2000, NEUROPSYCHOLOGIA, V38, P272, DOI 10.1016/S0028-3932(99)00076-7; Dronkers NF, 1996, NATURE, V384, P159, DOI 10.1038/384159a0; Faust M, 1998, NEUROPSYCHOLOGIA, V36, P827, DOI 10.1016/S0028-3932(98)00042-6; Federmeier KD, 1999, COGNITIVE BRAIN RES, V8, P373, DOI 10.1016/S0926-6410(99)00036-1; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; GARDNER H, 1975, BRAIN, V98, P399, DOI 10.1093/brain/98.3.399; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Shammi P, 1999, BRAIN, V122, P657, DOI 10.1093/brain/122.4.657; St George M, 1999, BRAIN, V122, P1317, DOI 10.1093/brain/122.7.1317; WAPNER W, 1981, BRAIN LANG, V14, P15, DOI 10.1016/0093-934X(81)90061-4; Wise RJS, 1999, LANCET, V353, P1057, DOI 10.1016/S0140-6736(98)07491-1	15	263	270	3	47	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2001	4	3					237	238		10.1038/85076	http://dx.doi.org/10.1038/85076			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UE	11224538	Green Published			2022-12-24	WOS:000167178300009
J	Warren, WH; Kay, BA; Zosh, WD; Duchon, AP; Sahuc, S				Warren, WH; Kay, BA; Zosh, WD; Duchon, AP; Sahuc, S			Optic flow is used to control human walking	NATURE NEUROSCIENCE			English	Article							MST NEURONS; PERCEPTION; MOTION; LOCOMOTION; DIRECTION; BEHAVIOR; AREA	How is human locomotion visually controlled? Fifty years ago, it was proposed that we steer to a goal using optic flow, the pattern of motion at the eye that specifies the direction of locomotion. However, we might also simply walk in the perceived direction of a goal. These two hypotheses normally predict the same behavior, but we tested them in an immersive virtual environment by displacing the optic flow from the direction of walking, violating the laws of optics. We found that people walked in the visual direction of a lone target, but increasingly relied on optic flow as it was added to the display. The visual control law for steering toward a goal is a linear combination of these two variables weighted by the magnitude of flow, thereby allowing humans to have robust locomotor control under varying environmental conditions.	Brown Univ, Dept Cognit & Linguist Sci, Providence, RI 02912 USA	Brown University	Warren, WH (corresponding author), Brown Univ, Dept Cognit & Linguist Sci, Providence, RI 02912 USA.	bill_warren@brown.edu	Warren, William H./AAX-7781-2021		NEI NIH HHS [R01 EY010923, EY10923] Funding Source: Medline; NIMH NIH HHS [K02 MH01353] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001353] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anderson KC, 1999, J NEUROSCI, V19, P2681; BRIDGEMAN B, 1981, PERCEPT PSYCHOPHYS, V29, P336, DOI 10.3758/BF03207342; COLLETT TS, 1975, J COMP PHYSIOL, V99, P1, DOI 10.1007/BF01464710; Crowell JA, 1996, VISION RES, V36, P471, DOI 10.1016/0042-6989(95)00121-2; DEJONG BM, 1994, BRAIN, V117, P1039; DUFFY CJ, 1995, J NEUROSCI, V15, P5192; Fajen BR, 2000, TRENDS COGN SCI, V4, P369, DOI 10.1016/S1364-6613(00)01532-1; Gibson JJ, 1950, PERCEPTION VISUAL WO; GRAZIANO MSA, 1994, J NEUROSCI, V14, P54; Harris JM, 1999, TRENDS COGN SCI, V3, P449, DOI 10.1016/S1364-6613(99)01411-4; HECKMANN T, 1991, PERCEPTION, V20, P285, DOI 10.1068/p200285; Li L, 2000, VISION RES, V40, P3873, DOI 10.1016/S0042-6989(00)00196-6; NAKAYAMA K, 1994, PSYCHOL REV, V101, P329, DOI 10.1037/0033-295X.101.2.329; ORBAN GA, 1992, P NATL ACAD SCI USA, V89, P2595, DOI 10.1073/pnas.89.7.2595; ROYDEN CS, 1994, VISION RES, V34, P3197, DOI 10.1016/0042-6989(94)90084-1; ROYDEN CS, 1992, NATURE, V360, P583, DOI 10.1038/360583a0; Rushton SK, 1998, CURR BIOL, V8, P1191, DOI 10.1016/S0960-9822(07)00492-7; SAITO H, 1986, J NEUROSCI, V6, P145; Schoner G, 1995, ROBOT AUTON SYST, V16, P213, DOI 10.1016/0921-8890(95)00049-6; Siegel RM, 1997, CEREB CORTEX, V7, P327, DOI 10.1093/cercor/7.4.327; SMEETS JBJ, 1995, J EXP PSYCHOL HUMAN, V21, P19, DOI 10.1037/0096-1523.21.1.19; Vaina LM, 1998, CURR OPIN NEUROBIOL, V8, P494, DOI 10.1016/S0959-4388(98)80037-8; VANDENBERG AV, 1992, VISION RES, V32, P1285, DOI 10.1016/0042-6989(92)90223-6; Wann J, 2000, TRENDS COGN SCI, V4, P319, DOI 10.1016/S1364-6613(00)01513-8; Warren W. H., 1998, HIGH LEVEL MOTION PR, P315; Warren WH, 1998, ECOL PSYCHOL, V10, P177, DOI 10.1207/s15326969eco103&4_3; WARREN WH, 1988, J EXP PSYCHOL HUMAN, V14, P646, DOI 10.1037/0096-1523.14.4.646; WARREN WH, 1988, NATURE, V336, P162, DOI 10.1038/336162a0; Wood RM, 2000, CURR BIOL, V10, pR545, DOI 10.1016/S0960-9822(00)00606-0	29	461	463	1	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2001	4	2					213	216		10.1038/84054	http://dx.doi.org/10.1038/84054			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	405UC	11175884				2022-12-24	WOS:000167178100022
J	Araneda, RC; Kini, AD; Firestein, S				Araneda, RC; Kini, AD; Firestein, S			The molecular receptive range of an odorant receptor	NATURE NEUROSCIENCE			English	Article							OLFACTORY RECEPTOR; RECOMBINANT ADENOVIRUS; RESPONSE PROPERTIES; NEURONS; EXPRESSION; IDENTIFICATION; PROTEINS; SYSTEM; CELLS; BULB	An odor perception is the brain's interpretation of the activation pattern of many peripheral sensory neurons that are differentially sensitive to a wide variety of odors. The sensitivity of these neurons is determined by which of the thousand or so odor receptor proteins they express on their surface. Understanding the odor code thus requires mapping the receptive range of odorant receptors. We have adopted a pharmacological approach that uses a large and diverse pool of odorous compounds to characterize the molecular receptive field of an odor receptor. We found a high specificity for certain molecular features, but high tolerance for others-a strategy that enables the olfactory apparatus to be both highly discriminating, and able to recognize several thousand odorous compounds.	Columbia Univ, Dept Biol Sci, New York, NY 10032 USA	Columbia University	Firestein, S (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10032 USA.		Araneda, Ricardo/AAN-1051-2020	Araneda, Ricardo/0000-0001-8728-3063				Beets M. G. J., 1978, STRUCTURE ACTIVITY R; Bikker JA, 1998, J MED CHEM, V41, P2911, DOI 10.1021/jm970767a; Bozza TC, 1998, J NEUROSCI, V18, P4560; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Duchamp-Viret P, 1999, SCIENCE, V284, P2171, DOI 10.1126/science.284.5423.2171; DuchampViret P, 1997, PROG NEUROBIOL, V53, P561, DOI 10.1016/S0301-0082(97)00049-X; FIRESTEIN S, 1993, J PHYSIOL-LONDON, V468, P1; Hashimoto M, 1996, HUM GENE THER, V7, P149, DOI 10.1089/hum.1996.7.2-149; KANEGAE Y, 1994, JPN J MED SCI BIOL, V47, P157, DOI 10.7883/yoken1952.47.157; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; MACKAYSIM A, 1994, J NEUROPHYSIOL, V71, P150, DOI 10.1152/jn.1994.71.1.150; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Marriott DP, 1999, J MED CHEM, V42, P3210, DOI 10.1021/jm980409n; MOHAMADI F, 1990, J COMPUT CHEM, V11, P44; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; OTTOSON D, 1971, HDB SENSORY PHYSL; Pilpel Y, 1999, PROTEIN SCI, V8, P969, DOI 10.1110/ps.8.5.969; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; Singer MS, 2000, CHEM SENSES, V25, P155, DOI 10.1093/chemse/25.2.155; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; YUSTE R, 2000, IMAGING NEURONS LAB; ZHAO H, 1998, SCIENCE, V279, P327; Zhao HQ, 1996, J NEUROBIOL, V30, P521, DOI 10.1002/(SICI)1097-4695(199608)30:4<521::AID-NEU7>3.0.CO;2-5	28	394	401	1	52	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2000	3	12					1248	1255		10.1038/81774	http://dx.doi.org/10.1038/81774			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UA	11100145	Bronze			2022-12-24	WOS:000167177900010
J	Fucile, S; De Saint Jan, D; de Carvalho, LP; Bregestovski, P				Fucile, S; De Saint Jan, D; de Carvalho, LP; Bregestovski, P			Fast potentiation of glycine receptor channels by intracellular calcium in neurons and transfected cells	NEURON			English	Article							PROTEIN-KINASE-C; CA2+-DEPENDENT INACTIVATION; ALPHA-SUBUNIT; ION CHANNELS; MODULATION; NMDA; CALMODULIN; CURRENTS; CA2+; GLUTAMATE	Inhibitory glycine receptors (GlyRs) are mainly expressed in the spinal cord and in the midbrain, where they control motor and sensory pathways. We describe here a fast potentiation of GlyR by intracellular Ca2+. This phenomenon was observed in rat spinal cord neurons and in transfected human cell lines. Potentiation develops in <100 ms, is proportional to Ca2+ influx, and is characterized by an increase in GlyR apparent affinity for glycine. Phosphorylation and G protein pathways appear not to be involved in the potentiation mechanism. Single-channel recordings in cell-attached and excised patches, as well as whole-cell data suggest the presence of a diffusible cytoplasmic factor that modulates the GlyR channel gating properties. Ca2+-induced potentiation may be important for rapid modulation of glycinergic synapses.	Inst Pasteur, Biol Cellulaire & Mol Lab, F-75724 Paris 15, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Bregestovski, P (corresponding author), Inst Pasteur, Biol Cellulaire & Mol Lab, 25 Rue Docteur Roux, F-75724 Paris 15, France.	pbreges@pasteur.fr	Fucile, Sergio/B-3934-2010; Bregestovski, Piotr/F-5820-2016	Fucile, Sergio/0000-0003-0698-1148; De Saint Jan, Didier/0000-0002-2459-9703				An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; BENVENISTE M, 1990, J PHYSIOL-LONDON, V428, P333, DOI 10.1113/jphysiol.1990.sp018215; BETZ H, 1992, Q REV BIOPHYS, V25, P381, DOI 10.1017/S0033583500004340; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Breitinger HG, 1998, CURR PHARM DESIGN, V4, P315; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; COLQUHOUN D, 1985, J PHYSIOL-LONDON, V369, P501, DOI 10.1113/jphysiol.1985.sp015912; Colquhoun David, 1995, P483; David-Watine B, 1999, NEUROSCIENCE, V90, P303, DOI 10.1016/S0306-4522(98)00430-8; DOLPHIN AC, 1991, BIOCHIM BIOPHYS ACTA, V1091, P68, DOI 10.1016/0167-4889(91)90224-L; Dolphin AC, 1998, J PHYSIOL-LONDON, V506, P3, DOI 10.1111/j.1469-7793.1998.003bx.x; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Fucile S, 1999, J PHYSIOL-LONDON, V517, P369, DOI 10.1111/j.1469-7793.1999.0369t.x; GASIC GP, 1992, ANNU REV PHYSIOL, V54, P507, DOI 10.1146/annurev.physiol.54.1.507; GIETZEN K, 1981, BIOCHEM BIOPH RES CO, V101, P418, DOI 10.1016/0006-291X(81)91276-6; Gu YP, 1998, J PHYSIOL-LONDON, V506, P331, DOI 10.1111/j.1469-7793.1998.331bw.x; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Henderson C.E., 1995, NERVE CELL CULTURE P, P69; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; IMREDY JP, 1994, NEURON, V12, P1301, DOI 10.1016/0896-6273(94)90446-4; Jones MV, 1998, J NEUROSCI, V18, P8590; Kozlov AS, 1999, EUR J NEUROSCI, V11, P4149, DOI 10.1046/j.1460-9568.1999.00841.x; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Kyrozis A, 1996, J PHYSIOL-LONDON, V495, P449, DOI 10.1113/jphysiol.1996.sp021606; Lee JH, 1999, J NEUROSCI, V19, P1912; LEGENDRE P, 1993, J NEUROSCI, V13, P674; Levitan IB, 1999, NEURON, V22, P645, DOI 10.1016/S0896-6273(00)80722-9; LEVITAN IB, 1994, ANNU REV PHYSIOL, V56, P193, DOI 10.1146/annurev.ph.56.030194.001205; Li M, 2000, NAT NEUROSCI, V3, P202, DOI 10.1038/72898; Margrie TW, 1998, NAT NEUROSCI, V1, P378, DOI 10.1038/1589; Medina I, 1996, J PHYSIOL-LONDON, V495, P411, DOI 10.1113/jphysiol.1996.sp021603; MEDINA I, 1994, J NEUROPHYSIOL, V72, P456, DOI 10.1152/jn.1994.72.1.456; Nabekura J, 1996, J NEUROPHYSIOL, V76, P2447, DOI 10.1152/jn.1996.76.4.2447; NISHIZAKI T, 1995, BRAIN RES, V687, P214, DOI 10.1016/0006-8993(95)00543-Y; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; Pereverzev A, 1998, EUR J NEUROSCI, V10, P916, DOI 10.1046/j.1460-9568.1998.00099.x; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; RAGOZZINO D, 1993, BRAIN RES, V628, P115, DOI 10.1016/0006-8993(93)90945-J; Rajendra S, 1997, PHARMACOL THERAPEUT, V73, P121, DOI 10.1016/S0163-7258(96)00163-5; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; SCHONROCK B, 1995, NEUROREPORT, V6, P301, DOI 10.1097/00001756-199501000-00019; Simpson RK, 1998, NEUROL RES, V20, P161; Swope SL, 1999, ADV SEC MESS PHOSPH, V33, P49; Tapia JC, 1997, BRAIN RES, V769, P203, DOI 10.1016/S0006-8993(97)00672-0; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; UCHIYAMA M, 1994, MOL BRAIN RES, V24, P295, DOI 10.1016/0169-328X(94)90142-2; Wang RA, 1996, J NEUROPHYSIOL, V75, P2651, DOI 10.1152/jn.1996.75.6.2651; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Xu TL, 1999, J PHYSIOL-LONDON, V514, P701, DOI 10.1111/j.1469-7793.1999.701ad.x; Xu TL, 1996, J PHYSIOL-LONDON, V496, P491, DOI 10.1113/jphysiol.1996.sp021701; Zhang S, 1998, NEURON, V21, P443, DOI 10.1016/S0896-6273(00)80553-X; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	55	59	66	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	2000	28	2					571	583		10.1016/S0896-6273(00)00134-3	http://dx.doi.org/10.1016/S0896-6273(00)00134-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	377CE	11144365	Bronze			2022-12-24	WOS:000165493700030
J	Tanda, G; Munzar, P; Goldberg, SR				Tanda, G; Munzar, P; Goldberg, SR			Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys	NATURE NEUROSCIENCE			English	Article							RHESUS-MONKEYS; RECEPTOR; CANNABINOIDS		NIDA, Preclin Pharmacol Sect, Behav Neurosci Branch, NIH, Baltimore, MD 21224 USA; Georgetown Univ, Sch Med, Dept Pharmacol, Washington, DC 20007 USA; Univ Cagliari, Dept Toxicol, I-09126 Cagliari, Italy; Univ Cagliari, CNR, Ctr Neuropharmacol, I-09126 Cagliari, Italy	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Georgetown University; University of Cagliari; Consiglio Nazionale delle Ricerche (CNR); University of Cagliari	Goldberg, SR (corresponding author), NIDA, Preclin Pharmacol Sect, Behav Neurosci Branch, NIH, 5500 Nathan Shock Dr, Baltimore, MD 21224 USA.		Tanda, Gianluigi/Q-4976-2019; Tanda, Gianluigi/B-3318-2009	Tanda, Gianluigi/0000-0001-9526-9878; Tanda, Gianluigi/0000-0001-9526-9878	NATIONAL INSTITUTE ON DRUG ABUSE [ZIFDA000001, ZIADA000001, Z01DA000001, Z02DA000001] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		AGURELL S, 1986, PHARMACOL REV, V38, P21; CARNEY JM, 1977, PHARMACOL BIOCHEM BE, V7, P357, DOI 10.1016/0091-3057(77)90232-5; GOLDBERG SR, 1981, SCIENCE, V214, P573; HARRIS RT, 1974, PSYCHOPHARMACOLOGIA, V37, P23, DOI 10.1007/BF00426679; KAYMAKCALAN S, 1973, B NARCOTICS, V25, P39; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; MANSBACH RS, 1994, BEHAV PHARMACOL, V5, P219, DOI 10.1097/00008877-199404000-00014; MANTILLAPLATA B, 1975, TOXICOL APPL PHARM, V34, P292, DOI 10.1016/0041-008X(75)90034-4; OLSEN JL, 1973, J PHARM PHARMACOL, V25, P344, DOI 10.1111/j.2042-7158.1973.tb10023.x; PICKENS R, 1973, BAYER S, V4, P78; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; SPEAR DJ, 1991, PHARMACOL BIOCHEM BE, V38, P411, DOI 10.1016/0091-3057(91)90300-Q; Tanda G, 1997, SCIENCE, V276, P2048, DOI 10.1126/science.276.5321.2048; Young A. M., 1986, BEHAVIORAL ANAL DRUG, P9	14	251	262	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11					1073	1074		10.1038/80577	http://dx.doi.org/10.1038/80577			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TX	11036260				2022-12-24	WOS:000167177600008
J	Thannickal, TC; Moore, RY; Nienhuis, R; Ramanathan, L; Gulyani, S; Aldrich, M; Cornford, M; Siegel, JM				Thannickal, TC; Moore, RY; Nienhuis, R; Ramanathan, L; Gulyani, S; Aldrich, M; Cornford, M; Siegel, JM			Reduced number of hypocretin neurons in human narcolepsy	NEURON			English	Article							CANINE NARCOLEPSY; OREXIN; HYPOTHALAMUS; HAPLOTYPE; SYSTEMS; GENE	Murine and canine narcolepsy can be caused by mutations of the hypocretin (Hcrt) (orexin) precursor or Hcrt receptor genes. In contrast to these animal models, most human narcolepsy is not familial, is discordant in identical twins, and has not been linked to mutations of the Hcrt system. Thus, the cause of human narcolepsy remains unknown. Here we show that human narcoleptics have an 85%-95% reduction in the number of Hcrt neurons. Melanin-concentrating hormone (MCH) neurons, which are intermixed with Hcrt cells in the normal brain, are not reduced in number, indicating that cell loss is relatively specific for Hcrt neurons. The presence of gliosis in the hypocretin cell region is consistent with a degenerative process being the cause of the Hcrt cell loss in narcolepsy.	Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Inst Brain Res, Los Angeles, CA 90024 USA; VA Greater Los Angeles Healthcare Syst, N Hills, CA 91343 USA; Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15213 USA; Univ Michigan, Med Ctr, Ann Arbor, MI 48109 USA; Harbor UCLA Med Ctr, Dept Pathol, Torrance, CA 90509 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Siegel, JM (corresponding author), Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90024 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041370, R37HL041370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS014610, R01NS014610] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL6029C, R37 HL041370, HL41370, R01 HL041370] Funding Source: Medline; NIMH NIH HHS [R01 MH064109] Funding Source: Medline; NINDS NIH HHS [R01 NS014610, NS14610, R37 NS014610] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Broberger C, 1998, J COMP NEUROL, V402, P460; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; ERLICH SS, 1986, SLEEP, V9, P126, DOI 10.1093/sleep/9.1.126; FARACO JH, 2000, SLEEP S2, V23, pA90; Fisher F., 1878, ARCH PSYCHIAT, V8, P200; FOGDELL A, 1995, TISSUE ANTIGENS, V46, P333, DOI 10.1111/j.1399-0039.1995.tb02503.x; Gelineau JBE, 1880, GAZ HOP PARIS, V54, P635; GUILLEMINAULT C, 1994, PRINCIPLES PRACTICE, P549; Hinze-Selch D, 1998, NEUROLOGY, V50, P1149, DOI 10.1212/WNL.50.4.1149; Honda Y, 1984, FOLIA PSYCHIATR NEUR, V38, P360; Howard C, 1998, UNBIASED STEREOLOGY; HUBLIN C, 1994, ANN NEUROL, V35, P709, DOI 10.1002/ana.410350612; Jiao Y, 1999, J NEUROSCI METH, V93, P149, DOI 10.1016/S0165-0270(99)00142-9; John J, 2000, Sleep Res Online, V3, P23; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Mignot E, 1998, NEUROLOGY, V50, pS16, DOI 10.1212/WNL.50.2_Suppl_1.S16; Mondal MS, 1999, BIOCHEM BIOPH RES CO, V256, P495, DOI 10.1006/bbrc.1999.0362; MOORE RY, 2000, IN PRESS ARCH ITAL B; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; OLERUP O, 1990, IMMUNOGENETICS, V32, P41, DOI 10.1007/BF01787327; Peyron C, 1998, J NEUROSCI, V18, P9996; Siegel JM, 1999, J NEUROSCI, V19, P248, DOI 10.1523/JNEUROSCI.19-01-00248.1999; Siegel JM, 1999, CELL, V98, P409, DOI 10.1016/S0092-8674(00)81969-8; STROHMAIER P, 1988, HUM IMMUNOL, V22, P221, DOI 10.1016/0198-8859(88)90001-8; Thannickal T.C., 2000, SLEEP, V23, pA296; Westphal C., 1877, ARCH PSYCHIAT NERVEN, V7, P631; Wu MF, 1999, NEUROSCIENCE, V91, P1389, DOI 10.1016/S0306-4522(98)00600-9	28	1448	1484	1	75	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	2000	27	3					469	474		10.1016/S0896-6273(00)00058-1	http://dx.doi.org/10.1016/S0896-6273(00)00058-1			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	359FR	11055430	Green Accepted, Bronze			2022-12-24	WOS:000089601300011
J	Whitney, D; Cavanagh, P				Whitney, D; Cavanagh, P			Motion distorts visual space: shifting the perceived position of remote stationary objects	NATURE NEUROSCIENCE			English	Article							INDUCED MOVEMENT; MACAQUE MONKEY; FUNCTIONAL-PROPERTIES; ATTENTION SHIFT; AREA MT; EXTRAPOLATION; DISPLACEMENT; DIRECTION; STIMULI; NEURONS	To perceive the relative positions of objects in the visual field, the visual system must assign locations to each stimulus. This assignment is determined by the object's retinal position, the direction of gaze, eye movements, and the motion of the object itself. Here we show that perceived location is also influenced by motion signals that originate in distant regions of the visual field. When a pair of stationary lines are flashed, straddling but not overlapping a rotating radial grating, the lines appear displaced in a direction consistent with that of the grating's motion, even when the lines are a substantial distance from the grating. The results indicate that motion's influence on position is not restricted to the moving object itself, and that even the positions of stationary objects are coded by mechanisms that receive input from motion-sensitive neurons.	Harvard Univ, Vis Sci Lab, Cambridge, MA 02138 USA	Harvard University	Whitney, D (corresponding author), Harvard Univ, Vis Sci Lab, 33 Kirkland St, Cambridge, MA 02138 USA.							ANSTIS SM, 1976, VISION RES, V16, P1391, DOI 10.1016/0042-6989(76)90157-7; BALDO MVC, 1995, NATURE, V378, P565, DOI 10.1038/378565a0; Berry MJ, 1999, NATURE, V398, P334, DOI 10.1038/18678; Cai RH, 1997, NATURE, V386, P601, DOI 10.1038/386601a0; CAVANAGH P, 1992, SCIENCE, V257, P1563, DOI 10.1126/science.1523411; CROPPER SJ, 1994, VISION RES, V34, P49, DOI 10.1016/0042-6989(94)90256-9; DANIEL PM, 1961, J PHYSIOL-LONDON, V159, P203, DOI 10.1113/jphysiol.1961.sp006803; Deubel H, 1996, VISION RES, V36, P985, DOI 10.1016/0042-6989(95)00203-0; DEVALOIS RL, 1991, VISION RES, V31, P1619, DOI 10.1016/0042-6989(91)90138-U; DICHGANS J, 1972, SCIENCE, V178, P1217, DOI 10.1126/science.178.4066.1217; Duncker K, 1929, PSYCHOL FORSCH, V12, P180, DOI 10.1007/BF02409210; Eagleman DM, 2000, SCIENCE, V287, P2036, DOI 10.1126/science.287.5460.2036; EDELMAN GM, 1978, MINDFUL BRAIN CORTIC, P55; FELLEMAN DJ, 1984, J NEUROPHYSIOL, V52, P488, DOI 10.1152/jn.1984.52.3.488; FREYD JJ, 1987, J EXP PSYCHOL, V19, P369; FROHLICH FW, 1929, EMPFINDUNGSZEIT; GOGEL WC, 1972, PERCEPT PSYCHOPHYS, V11, P309, DOI 10.3758/BF03210385; HUGHES PC, 1972, PERCEPT PSYCHOPHYS, V11, P135, DOI 10.3758/BF03210359; KELLY DH, 1979, J OPT SOC AM, V69, P1340, DOI 10.1364/JOSA.69.001340; KERTESZ AE, 1969, VISION RES, V9, P995, DOI 10.1016/0042-6989(69)90105-9; KHURANA B, 1995, NATURE, V378, P566, DOI 10.1038/378566a0; LEVI DM, 1990, VISION RES, V30, P557, DOI 10.1016/0042-6989(90)90068-V; MATIN L, 1976, PERCEPT PSYCHOPHYS, V20, P138, DOI 10.3758/BF03199445; MATIN L, 1972, HDB SENSORY PHYSIOLO, V7, P331; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1148, DOI 10.1152/jn.1983.49.5.1148; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MERKER BH, 1981, VISION RES, V21, P543, DOI 10.1016/0042-6989(81)90099-7; MIKAMI A, 1986, J NEUROPHYSIOL, V55, P1328, DOI 10.1152/jn.1986.55.6.1328; NAKAYAMA K, 1984, VISION RES, V24, P293, DOI 10.1016/0042-6989(84)90054-3; NAKAYAMA K, 1985, VISION RES, V25, P625, DOI 10.1016/0042-6989(85)90171-3; NAWROT M, 1990, VISION RES, V30, P1439, DOI 10.1016/0042-6989(90)90025-G; NIJHAWAN R, 1994, NATURE, V370, P256, DOI 10.1038/370256b0; Nishida S, 1999, NATURE, V397, P610, DOI 10.1038/17600; Purushothaman G, 1998, NATURE, V396, P424, DOI 10.1038/24766; RAMACHANDRAN VS, 1987, NATURE, V328, P645, DOI 10.1038/328645a0; RAMACHANDRAN VS, 1990, PERCEPTION, V19, P611, DOI 10.1068/p190611; REINHARDTRUTLAND AH, 1988, PSYCHOL BULL, V103, P57, DOI 10.1037/0033-2909.103.1.57; Rock I., 1990, LEGACY SOLOMON ASCH, P243; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; Schlag J, 2000, NATURE, V403, P38, DOI 10.1038/47402; Snowden RJ, 1998, CURR BIOL, V8, P1343, DOI 10.1016/S0960-9822(07)00567-2; SNOWDEN RJ, 1989, VISION RES, V29, P1777, DOI 10.1016/0042-6989(89)90160-0; TANAKA K, 1989, J NEUROPHYSIOL, V62, P626, DOI 10.1152/jn.1989.62.3.626; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; VERSTRATEN F, IN PRESS VISION RES; Whitney D, 2000, VISION RES, V40, P137, DOI 10.1016/S0042-6989(99)00166-2; Whitney D, 1998, NAT NEUROSCI, V1, P656, DOI 10.1038/3659; WITKIN HA, 1948, J EXP PSYCHOL, V38, P762, DOI 10.1037/h0053671; ZEKI S, 1990, CODING EFFICIENCY, P321	49	172	173	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2000	3	9					954	959		10.1038/78878	http://dx.doi.org/10.1038/78878			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TV	10966628				2022-12-24	WOS:000167177400024
J	Schmitz, D; Frerking, M; Nicoll, RA				Schmitz, D; Frerking, M; Nicoll, RA			Synaptic activation of presynaptic kainate receptors on hippocampal mossy fiber synapses	NEURON			English	Article							RAT HIPPOCAMPUS; EXTRACELLULAR POTASSIUM; MEDIATED RESPONSES; PARALLEL FIBERS; NERVOUS-SYSTEM; BINDING-SITES; INHIBITION; TRANSMISSION; RELEASE; CA1	Kainate receptors (KARs) are a poorly understood family of ionotropic glutamate receptors. A role for these receptors in the presynaptic control of transmitter release has been proposed but remains controversial. Here, KAR agonists are shown to enhance fiber excitability, and a number of experiments show that this is a direct effect of KARs on the presynaptic fibers. In addition, KAR activation inhibits evoked transmitter release from mossy fiber synapses. Synaptic release of glutamate from either neighboring mossy fiber synapses or associational/commisural (A/C) synapses results in the activation of these presynaptic ionotropic KARs. These results, along with previous studies, indicate that KARs, through the endogenous release of glutamate, mediate excitatory postsynaptic potentials (EPSPs), alter presynaptic excitability, and modulate transmitter release.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.			Schmitz, Dietmar/0000-0003-2741-5241				AGRAWAL SG, 1986, BRIT J PHARMACOL, V87, P345, DOI 10.1111/j.1476-5381.1986.tb10823.x; BAHN S, 1994, J NEUROSCI, V14, P5525; Bleakman D, 1998, NEUROPHARMACOLOGY, V37, P1187, DOI 10.1016/S0028-3908(98)00139-7; Bureau I, 1999, J NEUROSCI, V19, P653; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; Cossart R, 1998, NAT NEUROSCI, V1, P470, DOI 10.1038/2185; Frerking M, 1998, NAT NEUROSCI, V1, P479, DOI 10.1038/2194; Frerking M, 1999, P NATL ACAD SCI USA, V96, P12917, DOI 10.1073/pnas.96.22.12917; Frerking M, 2000, CURR OPIN NEUROBIOL, V10, P342, DOI 10.1016/S0959-4388(00)00094-5; HEINEMANN U, 1977, EXP BRAIN RES, V27, P237; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; Kamiya H, 1998, J PHYSIOL-LONDON, V509, P833, DOI 10.1111/j.1469-7793.1998.833bm.x; Kamiya H, 2000, J PHYSIOL-LONDON, V523, P653, DOI 10.1111/j.1469-7793.2000.t01-1-00653.x; KOCSIS JD, 1983, J PHYSIOL-LONDON, V334, P225, DOI 10.1113/jphysiol.1983.sp014491; Lerma J, 1997, NEURON, V19, P1155, DOI 10.1016/S0896-6273(00)80407-9; LUX HD, 1973, EXP BRAIN RES, V17, P190; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; MALENKA RC, 1981, SCIENCE, V214, P339, DOI 10.1126/science.7280695; MERRILL EG, 1978, J PHYSIOL-LONDON, V284, P127, DOI 10.1113/jphysiol.1978.sp012531; Min MY, 1999, P NATL ACAD SCI USA, V96, P9932, DOI 10.1073/pnas.96.17.9932; MONAGHAN DT, 1982, BRAIN RES, V252, P91, DOI 10.1016/0006-8993(82)90981-7; PATERNAIN AV, 1995, NEURON, V14, P185, DOI 10.1016/0896-6273(95)90253-8; Paternain AV, 2000, J NEUROSCI, V20, P196, DOI 10.1523/JNEUROSCI.20-01-00196.2000; Penttonen M, 1997, HIPPOCAMPUS, V7, P437, DOI 10.1002/(SICI)1098-1063(1997)7:4<437::AID-HIPO9>3.0.CO;2-F; PETRALIA RS, 1994, J COMP NEUROL, V349, P85, DOI 10.1002/cne.903490107; RAYMOND SA, 1979, J PHYSIOL-LONDON, V290, P273, DOI 10.1113/jphysiol.1979.sp012771; REPRESA A, 1987, NEUROSCIENCE, V20, P739, DOI 10.1016/0306-4522(87)90237-5; Rodriguez-Moreno A, 2000, P NATL ACAD SCI USA, V97, P1293, DOI 10.1073/pnas.97.3.1293; Rodriguez-Moreno A, 1998, NEURON, V20, P1211, DOI 10.1016/S0896-6273(00)80501-2; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; Scanziani M, 1996, NATURE, V380, P446, DOI 10.1038/380446a0; Veselovsky NS, 1996, PFLUG ARCH EUR J PHY, V432, P351, DOI 10.1007/s004240050143; Vignes M, 1998, NEUROPHARMACOLOGY, V37, P1269, DOI 10.1016/S0028-3908(98)00148-8; WALL PD, 1958, J PHYSIOL-LONDON, V142, P1; WEIGHT FF, 1976, SCIENCE, V193, P1023, DOI 10.1126/science.7839; WILDING TJ, 1995, MOL PHARMACOL, V47, P582; Wisden W, 1993, Curr Opin Neurobiol, V3, P291, DOI 10.1016/0959-4388(93)90120-N	39	171	176	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG	2000	27	2					327	338		10.1016/S0896-6273(00)00040-4	http://dx.doi.org/10.1016/S0896-6273(00)00040-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	347YD	10985352	Bronze			2022-12-24	WOS:000088956000016
J	DiAntonio, A				DiAntonio, A			Regulating receptor levels at a developing synapse	NEURON			English	Editorial Material							NEUROMUSCULAR-JUNCTION; GLUTAMATE RECEPTORS; GENETIC-ANALYSIS; DROSOPHILA		Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL)	DiAntonio, A (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA.			DiAntonio, Aaron/0000-0002-7262-0968				BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; BROADIE K, 1993, NEURON, V11, P607, DOI 10.1016/0896-6273(93)90073-Z; BROADIE K, 1993, NATURE, V361, P350, DOI 10.1038/361350a0; Craig AM, 1998, NEURON, V21, P459, DOI 10.1016/S0896-6273(00)80555-3; Davis GW, 1998, CURR OPIN NEUROBIOL, V8, P149, DOI 10.1016/S0959-4388(98)80018-4; DiAntonio A, 1999, J NEUROSCI, V19, P3023; Featherstone DE, 2000, NEURON, V27, P71, DOI 10.1016/S0896-6273(00)00010-6; Jabaudon D, 1999, P NATL ACAD SCI USA, V96, P8733, DOI 10.1073/pnas.96.15.8733; Lissin DV, 1999, J NEUROSCI, V19, P1263; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Saitoe M, 1997, DEV BIOL, V184, P48, DOI 10.1006/dbio.1996.8480; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389	12	0	0	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL	2000	27	1					5	7		10.1016/S0896-6273(00)00022-2	http://dx.doi.org/10.1016/S0896-6273(00)00022-2			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339XU	10939323	Bronze			2022-12-24	WOS:000088503800003
J	Furukawa, T; Mukherjee, S; Bao, ZZ; Morrow, EM; Cepko, CL				Furukawa, T; Mukherjee, S; Bao, ZZ; Morrow, EM; Cepko, CL			rax, hes1, and notch1 promote the formation of Muller glia by postnatal retinal progenitor cells	NEURON			English	Article							MAMMALIAN NEURONAL DIFFERENTIATION; VERTEBRATE RETINA; HOMEOBOX GENE; EYE DEVELOPMENT; XENOPUS RETINA; EXPRESSION; DROSOPHILA; MOUSE; FATE; GLIOGENESIS	We are interested in the mechanisms of glial cell development in the vertebrate central nervous system. We have identified genes that can direct the formation of glia in the retina, rax, a homeobox gene, Hes1, a basic helix-loop-helix gene, and notch1, a transmembrane receptor gene, are expressed in retinal progenitor cells, downregulated in differentiated neurons, and expressed in Muller glia. Retroviral transduction of any of these genes resulted in expression of glial markers. In contrast, misexpression of a dominant-negative Hes1 gene reduced the number of glia. Cotransfection of rax with reporter constructs containing the Hes1 or notch1 regulatory regions led to the upregulation of reporter transcription. These data suggest a regulatory heirarchy that controls the formation of glia at the expense of neurons.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Cepko, CL (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	cepko@genetics.med.harvard.edu	Morrow, Eric/J-2767-2013	Morrow, Eric/0000-0003-3430-3520	NEI NIH HHS [EY06726-01, EYO 8064] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008064] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bao ZZ, 1997, J NEUROSCI, V17, P1425; BARNSTABLE CJ, 1985, DEV BRAIN RES, V20, P286, DOI 10.1016/0165-3806(85)90116-6; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; BUNTMILAM AH, 1983, J CELL BIOL, V97, P703, DOI 10.1083/jcb.97.3.703; CEPKO C, 1997, CURRENT PROTOCALS MO; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; COFFMAN CR, 1993, CELL, V73, P659, DOI 10.1016/0092-8674(93)90247-N; DORSKY RI, 1995, NEURON, V14, P487, DOI 10.1016/0896-6273(95)90305-4; Ezzeddine ZD, 1997, DEVELOPMENT, V124, P1055; Furukawa T, 1997, P NATL ACAD SCI USA, V94, P3088, DOI 10.1073/pnas.94.7.3088; Granderath S, 1999, CURR OPIN NEUROBIOL, V9, P531, DOI 10.1016/S0959-4388(99)00008-2; Harris WA, 1997, CURR OPIN GENET DEV, V7, P651, DOI 10.1016/S0959-437X(97)80013-5; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kageyama R, 1997, INT J BIOCHEM CELL B, V29, P1389, DOI 10.1016/S1357-2725(97)89968-2; Kim JS, 1998, P NATL ACAD SCI USA, V95, P12364, DOI 10.1073/pnas.95.21.12364; Levine EM, 2000, DEV BIOL, V219, P299, DOI 10.1006/dbio.2000.9622; Lewis AK, 1998, MECH DEVELOP, V78, P159, DOI 10.1016/S0925-4773(98)00165-8; LILLIEN L, 1995, NATURE, V377, P158, DOI 10.1038/377158a0; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; Molday RS, 1989, PROG RET RES, V8, P173; Morrow EM, 1999, DEVELOPMENT, V126, P23; NYE JS, 1994, DEVELOPMENT, V120, P2421; Ohnuma S, 1999, CELL, V99, P499, DOI 10.1016/S0092-8674(00)81538-X; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; OSBORNE NN, 1991, VISUAL NEUROSCI, V7, P637, DOI 10.1017/S0952523800010427; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Rajan P, 1998, J NEUROSCI, V18, P3620; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; ROE TY, 1993, EMBO J, V12, P2099, DOI 10.1002/j.1460-2075.1993.tb05858.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1; SARTHY V, 1995, DNA CELL BIOL, V14, P313, DOI 10.1089/dna.1995.14.313; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Strom A, 1997, GENE DEV, V11, P3168, DOI 10.1101/gad.11.23.3168; TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150; Tomita K, 1996, NEURON, V16, P723, DOI 10.1016/S0896-6273(00)80093-8; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	39	403	418	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	2000	26	2					383	394		10.1016/S0896-6273(00)81171-X	http://dx.doi.org/10.1016/S0896-6273(00)81171-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318QZ	10839357	Bronze			2022-12-24	WOS:000087296500015
J	Gehring, WJ; Knight, RT				Gehring, WJ; Knight, RT			Prefrontal-cingulate interactions in action monitoring	NATURE NEUROSCIENCE			English	Article							ERROR-DETECTION; NEURAL SYSTEM; CORTEX; BEHAVIOR; TASK; COMPENSATION; PERFORMANCE; POTENTIALS; SELECTION	We found that medial frontal cortex activity associated with action monitoring (detecting errors and behavioral conflict) depended on activity in the lateral prefrontal cortex. We recorded the error-related negativity (ERN), an event-related brain potential proposed to reflect anterior cingulate action monitoring, from individuals with lateral prefrontal damage or age-matched or young control participants. In controls, error trials generated greater ERN activity than correct trials. In individuals with lateral prefrontal damage, however, correct-trial ERN activity was equal to error-trial ERN activity. Lateral prefrontal damage also affected corrective behavior. Thus the lateral prefrontal cortex seemed to interact with the anterior cingulate cortex in monitoring behavior and in guiding compensatory systems.	Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of Michigan System; University of Michigan; University of California System; University of California Berkeley	Gehring, WJ (corresponding author), Univ Michigan, Dept Psychol, 525 E Univ Ave, Ann Arbor, MI 48109 USA.				NINDS NIH HHS [1 F32 NS09577-01, NS21135] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021135, F32NS009577] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baddeley A., 2007, WORKING MEMORY THOUG; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Bush G, 1998, HUM BRAIN MAPP, V6, P270, DOI 10.1002/(SICI)1097-0193(1998)6:4<270::AID-HBM6>3.0.CO;2-0; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; COHEN JD, 1992, PSYCHOL REV, V99, P45, DOI 10.1037/0033-295X.99.1.45; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; FALKENSTEIN M, 1995, PERSPECTIVES EVENT S, V44, P287; FRITH CD, 1991, NEUROPSYCHOLOGIA, V29, P1137, DOI 10.1016/0028-3932(91)90029-8; Gehring WJ, 2000, PSYCHOL SCI, V11, P1, DOI 10.1111/1467-9280.00206; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; GEHRING WJ, 1995, PERSPECTIVES EVENT R, V44, P261; Goldman-Rakic P. S., 2011, COMPR PHYSIOL, DOI [10.1002/CPHY.CP010509, DOI 10.1002/CPHY.CP010509]; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Holroyd CB, 1998, NEUROSCI LETT, V242, P65, DOI 10.1016/S0304-3940(98)00035-4; INSEL TR, 1992, ARCH GEN PSYCHIAT, V49, P739; KIEHL KA, IN PRESS PSYCHOPHYSI; LOGAN GD, 1985, ACTA PSYCHOL, V60, P193, DOI 10.1016/0001-6918(85)90055-1; LUU P, IN PRESS J EXP PSYCH; Meyer DE, 1997, PSYCHOL REV, V104, P3, DOI 10.1037/0033-295X.104.1.3; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; Norman D.A., 1986, CONSCIOUSNESS SELF R, P1, DOI DOI 10.1007/978-1-4757-0629-1_1; PETERSEN SE, 1988, NATURE, V331, P583; Posner MI, 1998, ATTENTIVE BRAIN, P401; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; Scheffers MK, 1996, PSYCHOPHYSIOLOGY, V33, P42, DOI 10.1111/j.1469-8986.1996.tb02107.x; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Stuss D.T., 1986, FRONTAL LOBES; TAYLOR SF, 1994, NEUROPSYCHOLOGIA, V32, P249, DOI 10.1016/0028-3932(94)90010-8; Tucker DM, 1999, BIOL PSYCHOL, V50, P103, DOI 10.1016/S0301-0511(99)00005-8; Turken AU, 1999, NAT NEUROSCI, V2, P920, DOI 10.1038/13224	32	665	678	2	49	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2000	3	5					516	520		10.1038/74899	http://dx.doi.org/10.1038/74899			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	309DG	10769394				2022-12-24	WOS:000086752000023
J	Roos, J; Hummel, T; Ng, N; Klambt, C; Davis, GW				Roos, J; Hummel, T; Ng, N; Klambt, C; Davis, GW			Drosophila Futsch regulates synaptic microtubule organization and is necessary for synaptic growth	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; TYROSINE KINASE; HIPPOCAMPAL-NEURONS; AXONAL GROWTH; PROTEIN; PHOSPHORYLATION; CONES; LOCALIZATION; PLASTICITY; OUTGROWTH	We present evidence that Futsch, a novel protein with MAP1B homology, controls synaptic growth at the Drosophila neuromuscular junction through the regulation of the synaptic microtubule cytoskeleton. Futsch colocalizes with microtubules and identifies cytoskeletal loops that traverse the lateral margin of select synaptic boutons. An apparent rearrangement of microtubule loop architecture occurs during bouton division, and a genetic analysis indicates that Futsch is necessary for this process. futsch mutations disrupt synaptic microtubule organization, reduce bouton number, and increase bouton size. These deficits can be partially rescued by neuronal overexpression of a futsch MAP1B homology domain. Finally, genetic manipulations that increase nerve-terminal branching correlate with increased synaptic microtubule loop formation, and both processes require normal Futsch function. These data suggest a common microtubule-based growth mechanism at the synapse and growth cone.	Univ Calif San Francisco, Dept Biochem & Biophys, Cell Biol Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Program Neurosci, San Francisco, CA 94143 USA; Univ Muenster, Inst Neurobiol, D-48149 Muenster, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Davis, GW (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Cell Biol Program, San Francisco, CA 94143 USA.				NATIONAL CANCER INSTITUTE [T32CA009270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039313, R01NS015927] Funding Source: NIH RePORTER; NCI NIH HHS [T32-CA 09270-23] Funding Source: Medline; NINDS NIH HHS [NS15927, NS39313-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALETTA JM, 1988, J CELL BIOL, V106, P1573, DOI 10.1083/jcb.106.5.1573; BLOOM GS, 1985, P NATL ACAD SCI USA, V82, P5404, DOI 10.1073/pnas.82.16.5404; BRUGG B, 1988, J CELL BIOL, V107, P643, DOI 10.1083/jcb.107.2.643; CACERES A, 1986, J NEUROSCI, V6, P714; CALLAHAN CA, 1994, P NATL ACAD SCI USA, V91, P5972, DOI 10.1073/pnas.91.13.5972; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Davis GW, 1997, NEURON, V19, P561, DOI 10.1016/S0896-6273(00)80372-4; Dent EW, 1999, J NEUROSCI, V19, P8894, DOI 10.1523/JNEUROSCI.19-20-08894.1999; DIAZNIDO J, 1988, J CELL BIOL, V106, P2057, DOI 10.1083/jcb.106.6.2057; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Gallo G, 1999, J NEUROSCI, V19, P3860; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Goold RG, 1999, J CELL SCI, V112, P3373; GORDON M, 1993, ADHD REPORT, V1, P5; GORDONWEEKS PR, 1997, BRAIN MICROTUBULE PR, P53; GRANT SGN, 1995, GENE DEV, V9, P1909, DOI 10.1101/gad.9.15.1909; Halpain S, 1998, J NEUROSCI, V18, P9835; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Ito K, 1997, CELL TISSUE RES, V290, P1, DOI 10.1007/s004410050901; Keshishian H, 1996, ANNU REV NEUROSCI, V19, P545, DOI 10.1146/annurev.ne.19.030196.002553; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; Luo LQ, 1997, CURR OPIN NEUROBIOL, V7, P81, DOI 10.1016/S0959-4388(97)80124-9; Mansfield SG, 1991, J NEUROCYTOL, V21, P1007; MULLER R, 1994, MICROTUBULES, P141; Pedrotti B, 1996, FEBS LETT, V384, P147, DOI 10.1016/0014-5793(96)00308-0; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; SHAW G, 1985, EUR J CELL BIOL, V39, P205; TANAKA E, 1995, J CELL BIOL, V128, P127, DOI 10.1083/jcb.128.1.127; TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2; TANAKA E, 1995, J CELL BIOL, V128, P139, DOI 10.1083/jcb.128.1.139; TANAKA EM, 1991, J CELL BIOL, V115, P345, DOI 10.1083/jcb.115.2.345; Togel M, 1998, J CELL BIOL, V143, P695, DOI 10.1083/jcb.143.3.695; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; TSUI HCT, 1984, J NEUROSCI, V4, P3002; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	40	282	284	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	2000	26	2					371	382		10.1016/S0896-6273(00)81170-8	http://dx.doi.org/10.1016/S0896-6273(00)81170-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318QZ	10839356	Bronze			2022-12-24	WOS:000087296500014
J	Xu, F; Gainetdinov, RR; Wetsel, WC; Jones, SR; Bohn, LM; Miller, GW; Wang, YM; Caron, MG				Xu, F; Gainetdinov, RR; Wetsel, WC; Jones, SR; Bohn, LM; Miller, GW; Wang, YM; Caron, MG			Mice lacking the norepinephrine transporter ave supersensitive to psychostimulants	NATURE NEUROSCIENCE			English	Article							CONDITIONED PLACE PREFERENCE; VENTRAL TEGMENTAL AREA; DOPAMINE-TRANSPORTER; KNOCKOUT MICE; COCAINE; NORADRENALINE; RAT; RELEASE; AMPHETAMINE; DEPRESSION	The action of norepinephrine (NE) is terminated, in part, by its uptake into presynaptic noradrenergic neurons by the plasma-membrane NE transporter (NET), which is a target for antidepressants and psychostimulants. Disruption of the NET gene in mice prolonged the clearance of NE and elevated extracellular levels of this catecholamine. In a classical test for antidepressant drugs, the NET-deficient (NET-/-) animals behaved like antidepressant-treated wild-type mice. Mutants were hyper-responsive to locomotor stimulation by cocaine or amphetamine. These responses were accompanied by dopamine D-2/D-3 receptor supersensitivity. Thus altering NET expression significantly modulates midbrain dopaminergic function, an effect that may be an important component of the actions of antidepressants and psychostimulants.	Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med Endocrinol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Duke University	Caron, MG (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Dept Cell Biol, Durham, NC 27710 USA.		Jones, Sara R/K-4816-2014; Bohn, Laura/A-4412-2008; Bohn, Laura M/A-7483-2014; Gainetdinov, Raul R/G-5875-2011	Jones, Sara R/0000-0002-3424-7576; Bohn, Laura M/0000-0002-6474-8179; Gainetdinov, Raul R/0000-0003-2951-6038	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH040159, P30MH040159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-36015] Funding Source: Medline; NIMH NIH HHS [MH-40159] Funding Source: Medline; NINDS NIH HHS [NS-19576] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Axelrod J, 1969, Prog Brain Res, V31, P21; BACKSTROM IT, 1989, J NEUROCHEM, V52, P1099, DOI 10.1111/j.1471-4159.1989.tb01853.x; Bengel D, 1998, MOL PHARMACOL, V53, P649, DOI 10.1124/mol.53.4.649; CARR GD, 1989, NEUROPHARMACOLOGICAL, P265; Cragg SJ, 1997, J NEUROPHYSIOL, V77, P863, DOI 10.1152/jn.1997.77.2.863; FELDMAN RS, 1992, PRINCIPLES NEUROPSYC, P324; Fritz JD, 1998, J NEUROCHEM, V70, P2241; Gainetdinov RR, 1998, BRAIN RES REV, V26, P148, DOI 10.1016/S0165-0173(97)00063-5; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GIROS B, 1994, J BIOL CHEM, V269, P15985; GIROS B, 1993, TRENDS PHARMACOL SCI, V14, P43, DOI 10.1016/0165-6147(93)90029-J; Gong WH, 1996, BRAIN RES, V707, P64, DOI 10.1016/0006-8993(95)01222-2; GRENHOFF J, 1989, EUR J PHARMACOL, V165, P11, DOI 10.1016/0014-2999(89)90765-6; HORNIG A, 1997, DEPRESSION NEUROBIOL; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Jones SR, 1999, NAT NEUROSCI, V2, P649, DOI 10.1038/10204; KROBERT KA, 1994, J NEUROCHEM, V62, P2233; Leonard BE, 1997, J PSYCHOPHARMACOL, V11, pS39; LINDVALL O, 1983, CHEM NEUROANATOMY, P229; MANN JJ, 1995, CLIN NEUROPHARMACOL, V18, pS57; Markou A, 1998, NEUROPSYCHOPHARMACOL, V18, P135, DOI 10.1016/S0893-133X(97)00113-9; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; PACHOLCZYK T, 1991, NATURE, V350, P350, DOI 10.1038/350350a0; PALIJ P, 1992, BRAIN RES, V587, P137, DOI 10.1016/0006-8993(92)91438-K; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; REITH MEA, 1997, NEUROTRANSMITTER TRA, P345; Richelson E, 1996, J CLIN PSYCHOPHARM, V16, pS1, DOI 10.1097/00004714-199606002-00001; Rinken A, 1999, BIOCHEM PHARMACOL, V57, P155, DOI 10.1016/S0006-2952(98)00287-1; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rocha BA, 1998, NAT NEUROSCI, V1, P132, DOI 10.1038/381; ROSSETTI ZL, 1991, EUR J PHARMACOL, V201, P243, DOI 10.1016/0014-2999(91)90353-R; Sora I, 1998, P NATL ACAD SCI USA, V95, P7699, DOI 10.1073/pnas.95.13.7699; SPYRAKI C, 1981, EUR J PHARMACOL, V74, P195, DOI 10.1016/0014-2999(81)90531-8; STERU L, 1987, PROG NEURO-PSYCHOPH, V11, P659; Wang YM, 1997, NEURON, V19, P1285, DOI 10.1016/S0896-6273(00)80419-5; WILLNER P, 1995, CLIN NEUROPHARMACOL, V18, pS49; Willner P, 1997, INT CLIN PSYCHOPHARM, V12, pS7, DOI 10.1097/00004850-199707003-00002; Yavich L, 1997, EUR J PHARMACOL, V339, P113, DOI 10.1016/S0014-2999(97)01375-7	40	328	334	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2000	3	5					465	471		10.1038/74839	http://dx.doi.org/10.1038/74839			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309DG	10769386				2022-12-24	WOS:000086752000015
J	Fayyazuddin, A; Villarroel, A; Le Goff, A; Lerma, J; Neyton, J				Fayyazuddin, A; Villarroel, A; Le Goff, A; Lerma, J; Neyton, J			Four residues of the extracellular N-terminal domain of the NR2A subunit control high-affinity Zn2+ binding to NMDA receptors	NEURON			English	Article							D-ASPARTATE RECEPTOR; GLUTAMATE-RECEPTOR; ZINC INHIBITION; AMINO-ACID; PROTEIN STRUCTURES; METAL SITES; CHANNEL; NEURONS; MODULATION; COMPLEX	NMDA receptors are allosterically inhibited by Zn2+ ions in a voltage-independent manner. The apparent affinity for Zn2+ of the heteromeric NMDA receptors is determined by the subtype of NR2 subunit expressed, with NR2A-containing receptors being the most sensitive (IC50, similar to 20 nM) and NR2C-containing receptors being the least sensitive (IC50, similar to 30 mu M). Using chimeras constructed from these two NR2 subtypes, we show that the N-terminal LIVBP-like domain of the NR2A subunit controls the high-affinity Zn2+ inhibition. Mutations at four residues in this domain markedly reduce Zn2+ affinity (by up to >500-fold) without affecting either receptor activation by glutamate and glycine or inhibition by extracellular protons and Ni2+ ions, indicating that these residues most likely participate in high-affinity Zn2+ binding.	CNRS, Ecole Normale Super, Neurobiol Lab, UMR 8544, F-75005 Paris, France; CSIC, Inst Cajal, E-28002 Madrid, Spain	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Neyton, J (corresponding author), CNRS, Ecole Normale Super, Neurobiol Lab, UMR 8544, 46 Rue Ulm, F-75005 Paris, France.		Lerma, Juan/G-7907-2015; Villarroel, Alvaro/H-5580-2015	Lerma, Juan/0000-0001-7838-5199; 				Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; BURLEY SK, 1992, J MOL BIOL, V224, P113, DOI 10.1016/0022-2836(92)90580-D; Buy C, 1996, BIOCHEMISTRY-US, V35, P9880, DOI 10.1021/bi960532l; Chen NS, 1997, MOL PHARMACOL, V51, P1015, DOI 10.1124/mol.51.6.1015; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; CHRISTIANSON DW, 1991, ADV PROTEIN CHEM, V42, P281; CHRISTINE CW, 1990, J NEUROSCI, V10, P108; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Dingledine R, 1999, PHARMACOL REV, V51, P7; GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P1; Harvey RJ, 1999, J PHYSIOL-LONDON, V520, P53, DOI 10.1111/j.1469-7793.1999.00053.x; Horenstein J, 1998, MOL PHARMACOL, V53, P870; ISHII T, 1993, J BIOL CHEM, V268, P2836; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Karlin S, 1997, P NATL ACAD SCI USA, V94, P14231, DOI 10.1073/pnas.94.26.14231; Kashiwagi K, 1996, MOL PHARMACOL, V49, P1131; Kashiwagi K, 1997, MOL PHARMACOL, V52, P701, DOI 10.1124/mol.52.4.701; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; KOHR G, 1994, NEURON, V12, P1031, DOI 10.1016/0896-6273(94)90311-5; Krupp JJ, 1998, NEURON, V20, P317, DOI 10.1016/S0896-6273(00)80459-6; Kuner T, 1996, NEURON, V17, P343, DOI 10.1016/S0896-6273(00)80165-8; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAUBE B, 1995, J PHYSIOL-LONDON, V483, P613, DOI 10.1113/jphysiol.1995.sp020610; LEGENDRE P, 1990, J PHYSIOL-LONDON, V429, P429, DOI 10.1113/jphysiol.1990.sp018266; LIPPARD SJ, 1997, PRINCIPLES BIOCH MIN, V505, P641; Martell A. E., 1989, CRITICAL STABILITY C, V1; Masuko T, 1999, MOL PHARMACOL, V55, P957, DOI 10.1124/mol.55.6.957; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; PAOLETTI P, 1995, NEURON, V15, P1109, DOI 10.1016/0896-6273(95)90099-3; Paoletti P, 1997, J NEUROSCI, V17, P5711; PARK IS, 1995, SCIENCE, V267, P1156, DOI 10.1126/science.7855593; PARKER DR, 1995, CHEM EQUILIBRIUM REA; Schneggenburger R, 1997, NEURON, V18, P167, DOI 10.1016/S0896-6273(01)80055-6; Soloviev MM, 1996, J BIOL CHEM, V271, P32572, DOI 10.1074/jbc.271.51.32572; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; SULLIVAN JM, 1994, NEURON, V13, P929, DOI 10.1016/0896-6273(94)90258-5; Traynelis SF, 1998, J NEUROSCI, V18, P6163; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; VALLEE BL, 1993, P NATL ACAD SCI USA, V90, P2715, DOI 10.1073/pnas.90.7.2715; VIELES P, 1972, J CHIM PHYS PCB, V69, P869, DOI 10.1051/jcp/1972690869; Villarroel A, 1998, NEURON, V20, P329, DOI 10.1016/S0896-6273(00)80460-2; Volbeda A, 1996, CURR OPIN STRUC BIOL, V6, P804, DOI 10.1016/S0959-440X(96)80011-X; Weber WM, 1999, J MEMBRANE BIOL, V170, P1, DOI 10.1007/s002329900532; Williams K, 1995, MOL PHARMACOL, V48, P1087; Williams K, 1996, NEUROSCI LETT, V215, P9, DOI 10.1016/S0304-3940(96)12924-4; Wooltorton JRA, 1997, J PHYSIOL-LONDON, V505, P633, DOI 10.1111/j.1469-7793.1997.633ba.x; Zheng X, 1999, NEUROSCIENCE, V93, P125, DOI 10.1016/S0306-4522(99)00154-2	49	133	136	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR	2000	25	3					683	694		10.1016/S0896-6273(00)81070-3	http://dx.doi.org/10.1016/S0896-6273(00)81070-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	301CY	10774735	Green Submitted, Bronze			2022-12-24	WOS:000086291700020
J	Man, HY; Lin, JW; Ju, WH; Ahmadian, G; Liu, LD; Becker, LE; Sheng, M; Wang, YT				Man, HY; Lin, JW; Ju, WH; Ahmadian, G; Liu, LD; Becker, LE; Sheng, M; Wang, YT			Regulation of AMPA receptor-mediated synaptic transmission by clathrin-dependent receptor internalization	NEURON			English	Article							LONG-TERM POTENTIATION; COATED VESICLE FORMATION; SILENT SYNAPSES; INSULIN; INDUCTION; PROTEIN; CELLS; LTP; HIPPOCAMPUS; ENDOCYTOSIS	Redistribution of postsynaptic AMPA- (alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid-) subtype glutamate receptors may regulate synaptic strength at glutamatergic synapses, but the mediation of the redistribution is poorly understood. We show that AMPA receptors underwent clathrin-dependent endocytosis, which was accelerated by insulin in a GluR2 subunit-dependent manner. Insulin-stimulated endocytosis rapidly decreased AMPA receptor numbers in the plasma membrane, resulting in long-term depression (LTD) of AMPA receptor-mediated synaptic transmission in hippocampal CA1 neurons. Moreover, insulin-induced LTD and low-frequency stimulation-(LFS-) induced homosynaptic CA1 LTD were found to be mutually occlusive and were both blocked by inhibiting postsynaptic clathrin-mediated endocytosis. Thus, controlling postsynaptic receptor numbers through endocytosis may be an important mechanism underlying synaptic plasticity in the mammalian CNS.	Hosp Sick Children, Programme Brain & Behav, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Div Pathol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L5, Canada; Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Neurobiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Wang, YT (corresponding author), Hosp Sick Children, Programme Brain & Behav, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	y.t.wang@utoronto.ca	Wang, Yu Tian/J-8255-2015; Wang, Yu Tian/A-4729-2008	Sheng, Morgan/0000-0002-8703-5366; Liu, Lidong/0000-0002-7026-690X	NINDS NIH HHS [NS35050] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035050] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott MA, 1999, J NEUROSCI, V19, P7300, DOI 10.1523/JNEUROSCI.19-17-07300.1999; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chu P, 1997, J BIOL CHEM, V272, P27124, DOI 10.1074/jbc.272.43.27124; Craig AM, 1998, NEURON, V21, P459, DOI 10.1016/S0896-6273(00)80555-3; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; HANSEN SH, 1993, J CELL BIOL, V121, P61, DOI 10.1083/jcb.121.1.61; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Jonas EA, 1997, NATURE, V385, P343, DOI 10.1038/385343a0; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; Karoor V, 1998, J BIOL CHEM, V273, P33035, DOI 10.1074/jbc.273.49.33035; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; Li P, 1999, NAT NEUROSCI, V2, P972, DOI 10.1038/14771; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lin JW, 1998, NEURON, V21, P267, DOI 10.1016/S0896-6273(00)80534-6; Lissin DV, 1999, J NEUROSCI, V19, P1263; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 1998, NEURON, V21, P1226, DOI 10.1016/S0896-6273(00)80640-6; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; MORGAN DO, 1987, P NATL ACAD SCI USA, V84, P41, DOI 10.1073/pnas.84.1.41; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Pessin JE, 1999, J BIOL CHEM, V274, P2593, DOI 10.1074/jbc.274.5.2593; Rao AW, 1998, J BIOL CHEM, V273, P25450, DOI 10.1074/jbc.273.39.25450; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; vanDelft S, 1997, J CELL BIOL, V136, P811, DOI 10.1083/jcb.136.4.811; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; Wang QH, 1998, FEBS LETT, V427, P193, DOI 10.1016/S0014-5793(98)00423-2; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Wickelgren I, 1998, SCIENCE, V280, P517, DOI 10.1126/science.280.5363.517; WOZNIAK M, 1993, NEUROCHEM INT, V22, P1, DOI 10.1016/0197-0186(93)90062-A; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3	44	543	554	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	2000	25	3					649	662		10.1016/S0896-6273(00)81067-3	http://dx.doi.org/10.1016/S0896-6273(00)81067-3			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	301CY	10774732	Bronze			2022-12-24	WOS:000086291700017
J	Scharff, C; Kirn, JR; Grossman, M; Macklis, JD; Nottebohm, F				Scharff, C; Kirn, JR; Grossman, M; Macklis, JD; Nottebohm, F			Targeted neuronal death affects neuronal replacement and vocal behavior in adult songbirds	NEURON			English	Article							RAT DENTATE GYRUS; SONG CONTROL NUCLEUS; LARVAL FROG RETINA; CELL-DEATH; PROJECTION NEURONS; ZEBRA FINCH; EMBRYONIC NEURONS; CANARY FOREBRAIN; CEREBRAL-CORTEX; STEM-CELLS	In the high vocal center (HVC) of adult songbirds, increases in spontaneous neuronal replacement correlate with song changes and with cell death. We experimentally induced death of specific HVC neuron types in adult male zebra finches using targeted photolysis. Induced death of a projection neuron type that normally turns over resulted in compensatory replacement of the same type. Induced death of the normally nonreplaced type did not stimulate their replacement. In juveniles, death of the latter type increased recruitment of the replaceable kind. We infer that neuronal death regulates the recruitment of replaceable neurons. Song deteriorated in some birds only after elimination of replaceable neurons. Behavioral deficits were transient and followed by variable degrees of recovery. This raises the possibility that induced neuronal replacement can restore a learned behavior.	Rockefeller Univ, Dept Anim Behav, New York, NY 10021 USA; Wesleyan Univ, Dept Biol, Middletown, CT 06457 USA; Harvard Univ, Sch Med, Childrens Hosp, Div Neurosci, Boston, MA 02115 USA	Rockefeller University; Wesleyan University; Harvard University; Boston Children's Hospital; Harvard Medical School	Scharff, C (corresponding author), Rockefeller Univ, Dept Anim Behav, 1230 York Ave, New York, NY 10021 USA.		Scharff, Constance/HHN-0673-2022		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH018343, R01MH018343] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD28478] Funding Source: Medline; NIMH NIH HHS [MH18343] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Akutagawa E, 1998, P NATL ACAD SCI USA, V95, P11429, DOI 10.1073/pnas.95.19.11429; ALVAREZBUYLLA A, 1990, SCIENCE, V249, P1444, DOI 10.1126/science.1698312; ALVAREZBUYLLA A, 1992, J NEUROBIOL, V23, P396, DOI 10.1002/neu.480230406; ALVAREZBUYLLA A, 1988, J NEUROSCI METH, V25, P165, DOI 10.1016/0165-0270(88)90155-0; ALVAREZBUYLLA A, 1988, P NATL ACAD SCI USA, V85, P8722, DOI 10.1073/pnas.85.22.8722; ALVAREZBUYLLA A, 1990, J NEUROSCI METH, V33, P129, DOI 10.1016/0165-0270(90)90016-9; BAYER SA, 1982, SCIENCE, V216, P890, DOI 10.1126/science.7079742; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; BRAISTED JE, 1994, DEVELOPMENT, V120, P2409; BURD GD, 1985, J COMP NEUROL, V240, P143, DOI 10.1002/cne.902400204; Calof AL, 1996, J NEUROBIOL, V30, P67; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Cepko CL, 1999, CURR OPIN NEUROBIOL, V9, P37, DOI 10.1016/S0959-4388(99)80005-1; Clayton DF, 1997, J NEUROBIOL, V33, P549; Doe CQ, 1998, J NEUROBIOL, V36, P111, DOI 10.1002/(SICI)1097-4695(199808)36:2<111::AID-NEU2>3.0.CO;2-4; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; GAHR M, 1990, J COMP NEUROL, V294, P30, DOI 10.1002/cne.902940104; Gould E, 1996, DEV NEUROSCI-BASEL, V18, P22, DOI 10.1159/000111392; Gould E, 1997, NEUROSCIENCE, V80, P427, DOI 10.1016/S0306-4522(97)00127-9; GOULD E, 1992, J NEUROSCI, V12, P3642; Gould E, 1993, Curr Opin Neurobiol, V3, P676, DOI 10.1016/0959-4388(93)90138-O; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Graziadei P. P., 1978, DEV SENSORY SYSTEMS, V9, P55; HernitGrant CS, 1996, EXP NEUROL, V139, P131, DOI 10.1006/exnr.1996.0088; HINDS JW, 1968, J COMP NEUROL, V134, P287, DOI 10.1002/cne.901340304; Holzenberger M, 1997, J NEUROSCI, V17, P6974; Iyengar S, 1999, J NEUROSCI, V19, P6037, DOI 10.1523/JNEUROSCI.19-14-06037.1999; KAPLAN MS, 1985, J COMP NEUROL, V239, P117, DOI 10.1002/cne.902390110; KIRN J, 1994, P NATL ACAD SCI USA, V91, P7844, DOI 10.1073/pnas.91.17.7844; KIRN JR, 1991, J NEUROSCI, V11, P1756; Kirn JR, 1999, J COMP NEUROL, V411, P487; Leavitt BR, 1999, EXP NEUROL, V157, P43, DOI 10.1006/exnr.1999.6982; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; MACKLIS JD, 1993, J NEUROSCI, V13, P3848; MADISON RD, 1993, EXP NEUROL, V121, P153, DOI 10.1006/exnr.1993.1082; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; NEGISHI K, 1982, SCIENCE, V216, P747, DOI 10.1126/science.7079736; Nordeen KW, 1997, J NEUROBIOL, V33, P532, DOI 10.1002/(SICI)1097-4695(19971105)33:5<532::AID-NEU4>3.0.CO;2-5; NORDEEN KW, 1993, BEHAV NEURAL BIOL, V59, P79, DOI 10.1016/0163-1047(93)91215-9; NOTTEBOHM F, 1985, ANN NY ACAD SCI, V457, P143, DOI 10.1111/j.1749-6632.1985.tb20803.x; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; REH TA, 1987, J NEUROSCI, V7, P3317; REH TA, 1986, DEV BIOL, V114, P463, DOI 10.1016/0012-1606(86)90210-1; SCHARFF C, 1991, J NEUROSCI, V11, P2896; SHEEN VL, 1994, EXP NEUROL, V130, P67, DOI 10.1006/exnr.1994.1186; Sheen VL, 1995, J NEUROSCI, V15, P8378; Sheen VL, 1999, EXP NEUROL, V158, P47, DOI 10.1006/exnr.1999.7104; Shen Q, 1998, J NEUROBIOL, V36, P162, DOI 10.1002/(SICI)1097-4695(199808)36:2<162::AID-NEU5>3.0.CO;2-#; SIMPSON HB, 1990, J NEUROSCI, V10, P1541; Snyder EY, 1997, P NATL ACAD SCI USA, V94, P11663, DOI 10.1073/pnas.94.21.11663; SOHRABJI F, 1990, BEHAV NEURAL BIOL, V53, P51, DOI 10.1016/0163-1047(90)90797-A; STOKES TM, 1974, J COMP NEUROL, V156, P337, DOI 10.1002/cne.901560305; Wang YZ, 1998, EXP NEUROL, V154, P389, DOI 10.1006/exnr.1998.6965; Watanabe D, 1998, CELL, V95, P17, DOI 10.1016/S0092-8674(00)81779-1; WILLIAMS H, 1992, J NEUROBIOL, V23, P1006, DOI 10.1002/neu.480230807; Woolley SMN, 1997, J NEUROSCI, V17, P6380; [No title captured]	59	223	228	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	2000	25	2					481	492		10.1016/S0896-6273(00)80910-1	http://dx.doi.org/10.1016/S0896-6273(00)80910-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	288EL	10719901	Bronze			2022-12-24	WOS:000085549100024
J	Tsen, G; Williams, B; Allaire, P; Zhou, YD; Ikonomov, O; Kondova, I; Jacob, MH				Tsen, G; Williams, B; Allaire, P; Zhou, YD; Ikonomov, O; Kondova, I; Jacob, MH			Receptors with opposing functions are in postsynaptic microdomains under one presynaptic terminal	NATURE NEUROSCIENCE			English	Article							CILIARY GANGLION NEURONS; NICOTINIC ACETYLCHOLINE-RECEPTOR; GAMMA-AMINOBUTYRIC ACID; RAT SPINAL-CORD; GLYCINE RECEPTOR; MONOCLONAL-ANTIBODIES; ALPHA-BUNGAROTOXIN; CELLS; GEPHYRIN; SUBUNIT	Fast excitatory synaptic transmission through vertebrate autonomic ganglia is mediated by postsynaptic nicotinic acetylcholine receptors (nAChRs), We demonstrate a unique postsynaptic receptor microheterogeneity on chick parasympathetic ciliary ganglion neurons-under one presynaptic terminal, nAChRs and glycine receptors formed separate but proximal clusters. Terminals were loaded with [H-3]glycine via the glycine transporter-1 (GlyT-1), which localized to the cholinergic: presynaptic terminal membrane; depolarization evoked [H-3]glycine release that was calcium independent and blocked by the GlyT-1 inhibitor sarcosine. Ganglionic synaptic transmission mediated by nAChRs was attenuated by glycine. Coexistence of separate clusters of receptors with opposing functions under one terminal contradicts Dale's principle and provides a new mechanism for modulating synaptic activity in vivo.	Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; Blackstone Millville Reg High Sch, Blackstone, MA 01504 USA; Wayne State Univ, Med Ctr, Dept Psychiat, Detroit, MI 48201 USA; Tufts Univ, Sch Vet Med, Dept Infect Dis, Grafton, MA 01536 USA	Tufts University; Detroit Medical Center; Wayne State University; Tufts University	Jacob, MH (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, 136 Harrison Ave, Boston, MA 02111 USA.	mjacob@opal.tufts.edu		Zhou, Yu-Dong/0000-0002-6364-3869	PHS HHS [NIH 21725] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ARENELLA LS, 1993, J NEUROSCI, V13, P4525; ATTWELL D, 1993, NEURON, V11, P401, DOI 10.1016/0896-6273(93)90145-H; BARTEL P, 1993, BIOTECHNIQUES, V14, P920; BOYD RT, 1991, J NEUROBIOL, V22, P1, DOI 10.1002/neu.480220102; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; Coggan JS, 1997, J NEUROSCI, V17, P5798; Colin I, 1998, J COMP NEUROL, V398, P359; DALE HENRY, 1935, PROC ROY SOC MED, V28, P319; Dumoulin A, 1999, J CELL SCI, V112, P811; ENGISCH KL, 1992, J NEUROSCI, V12, P1115; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; HOLLENBACH D, 1995, RESPONSIVE COMMUNITY, V5, P15; Horch HLW, 1996, J NEUROSCI, V16, P1720; Horch HLW, 1995, J NEUROSCI, V15, P7778; Ikonomov OC, 1998, J NEUROSCI, V18, P6331; JACOB MH, 1986, J CELL BIOL, V103, P205, DOI 10.1083/jcb.103.1.205; JACOB MH, 1984, P NATL ACAD SCI-BIOL, V81, P3223, DOI 10.1073/pnas.81.10.3223; JACOB MH, 1991, J NEUROSCI, V11, P1701; JACOB MH, 1988, J NEUROSCI, V8, P3838; JACOB MH, 1983, J NEUROSCI, V3, P260; Jo YH, 1999, NAT NEUROSCI, V2, P241, DOI 10.1038/6344; Kins S, 1999, EUR J NEUROSCI, V11, P740, DOI 10.1046/j.1460-9568.1999.00527.x; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; LANDMESSER L, 1972, J PHYSIOL-LONDON, V222, P691, DOI 10.1113/jphysiol.1972.sp009822; LANDMESSER L, 1974, J PHYSIOL-LONDON, V241, P737, DOI 10.1113/jphysiol.1974.sp010681; LIU W, 1994, BBA-BIOMEMBRANES, V1194, P176, DOI 10.1016/0005-2736(94)90218-6; MARTIN AR, 1963, J PHYSIOL-LONDON, V168, P464, DOI 10.1113/jphysiol.1963.sp007203; MARTIN AR, 1963, J PHYSIOL-LONDON, V168, P443, DOI 10.1113/jphysiol.1963.sp007202; MARWITT R, 1971, BRAIN RES, V25, P317, DOI 10.1016/0006-8993(71)90441-0; MCEACHERN AE, 1985, J NEUROSCI, V5, P2690; MCGALE EHF, 1977, J NEUROCHEM, V29, P291, DOI 10.1111/j.1471-4159.1977.tb09621.x; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Nicoll RA, 1998, SCIENCE, V281, P360, DOI 10.1126/science.281.5375.360; OMALLEY DM, 1992, J NEUROSCI, V12, P1394; PFEIFFER F, 1984, P NATL ACAD SCI-BIOL, V81, P7224, DOI 10.1073/pnas.81.22.7224; Pow DV, 1998, J NEUROCHEM, V70, P2628; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; REINER A, 1991, VISUAL NEUROSCI, V6, P451, DOI 10.1017/S0952523800001310; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHRODER S, 1991, BIOCHEMISTRY-US, V30, P42, DOI 10.1021/bi00215a007; SCHWARTZ EA, 1987, SCIENCE, V238, P350, DOI 10.1126/science.2443977; SMITH MA, 1985, J NEUROSCI, V5, P2726; Sorimachi M, 1997, J NEUROCHEM, V69, P797; VERNALLIS AB, 1993, NEURON, V10, P451, DOI 10.1016/0896-6273(93)90333-M; WANG BL, 1985, HISTOCHEMISTRY, V83, P47, DOI 10.1007/BF00495299; Williams BM, 1998, NAT NEUROSCI, V1, P557, DOI 10.1038/2792; ZAFRA F, 1995, J NEUROSCI, V15, P3952; ZHANG ZW, 1995, J PHYSIOL-LONDON, V487, P395, DOI 10.1113/jphysiol.1995.sp020888; ZHANG ZW, 1994, NEURON, V12, P167, DOI 10.1016/0896-6273(94)90161-9	50	40	47	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2000	3	2					126	132		10.1038/72066	http://dx.doi.org/10.1038/72066			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TC	10649567				2022-12-24	WOS:000085810300009
J	Cummings, CJ; Reinstein, E; Sun, YL; Antalffy, B; Jiang, YH; Ciechanover, A; Orr, HT; Beaudet, AL; Zoghbi, HY				Cummings, CJ; Reinstein, E; Sun, YL; Antalffy, B; Jiang, YH; Ciechanover, A; Orr, HT; Beaudet, AL; Zoghbi, HY			Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice	NEURON			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; SPINOCEREBELLAR ATAXIA; TRANSGENIC MICE; PURKINJE-CELLS; PROTEIN; PROTEASOME; REPEAT; P53; NEURODEGENERATION; AGGREGATION	Mutant ataxin-1, the expanded polyglutamine protein causing spinocerebellar ataxia type 1 (SCA1), aggregates in ubiquitin-positive nuclear inclusions (NI) that alter proteasome distribution in affected SCA1 patient neurons. Here, we observed that ataxin-1 is degraded by the ubiquitin-proteasome pathway. While ataxin-1 [2Q] and mutant ataxin-1 [92Q] are polyubiquitinated equally well in vitro, the mutant form is three times more resistant to degradation. Inhibiting proteasomal degradation promotes ataxin-1 aggregation in transfected cells. And in mice, Purkinje cells that express mutant ataxin-1 but not a ubiquitin-protein ligase have significantly fewer Nls. Nonetheless, the Purkinje cell pathology is markedly worse than that of SCA1 mice. Taken together, Nts are not necessary to induce neurodegeneration, but impaired proteasomal degradation of mutant ataxin-1 may contribute to SCA1 pathogenesis.	Baylor Coll Med, Cell & Mol Biol Program, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Technion Israel Inst Technol, Dept Biochem, IL-31096 Haifa, Israel; Univ Minnesota, Dept Lab Med, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Pathol, Minneapolis, MN 55455 USA; Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Technion Israel Institute of Technology; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Zoghbi, HY (corresponding author), Baylor Coll Med, Cell & Mol Biol Program, Houston, TX 77030 USA.		Ciechanover, Aaron J/C-9166-2017	Orr, Harry/0000-0001-6118-741X; Zoghbi, Huda/0000-0002-0700-3349	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027699, R01NS022920, R37NS022920, R01NS027699] Funding Source: NIH RePORTER; NICHD NIH HHS [HD37283] Funding Source: Medline; NINDS NIH HHS [NS22920, NS27699] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; Alves-Rodrigues A, 1998, TRENDS NEUROSCI, V21, P516, DOI 10.1016/S0166-2236(98)01276-4; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Clark HB, 1997, J NEUROSCI, V17, P7385; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Dick LR, 1996, J BIOL CHEM, V271, P7273, DOI 10.1074/jbc.271.13.7273; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Glickman MH, 1999, MOL BIOL REP, V26, P21, DOI 10.1023/A:1006928316738; Hayashi Y, 1998, ACTA NEUROPATHOL, V95, P479, DOI 10.1007/s004010050828; Holmberg M, 1998, HUM MOL GENET, V7, P913, DOI 10.1093/hmg/7.5.913; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P5249, DOI 10.1073/pnas.92.11.5249-a; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; Huynh DP, 1999, ANN NEUROL, V45, P232, DOI 10.1002/1531-8249(199902)45:2<232::AID-ANA14>3.0.CO;2-7; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Jiang YH, 1999, AM J HUM GENET, V65, P1, DOI 10.1086/302473; Kalchman MA, 1996, J BIOL CHEM, V271, P19385, DOI 10.1074/jbc.271.32.19385; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Lee DH, 1996, MOL CELL BIOL, V16, P4773; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Levitskaya J, 1997, P NATL ACAD SCI USA, V94, P12616, DOI 10.1073/pnas.94.23.12616; Li M, 1998, ANN NEUROL, V44, P249, DOI 10.1002/ana.410440216; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Matilla A, 1998, J NEUROSCI, V18, P5508, DOI 10.1523/JNEUROSCI.18-14-05508.1998; Matilla A, 1997, NATURE, V389, P974, DOI 10.1038/40159; MAYER RJ, 1998, UBIQUITIN BIOL CELL, P429; Mourre C, 1997, BRAIN RES, V778, P405, DOI 10.1016/S0006-8993(97)01165-7; NORMAN DJ, 1995, DEVELOPMENT, V121, P1183; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Paulson HL, 1999, AM J HUM GENET, V64, P339, DOI 10.1086/302269; Perutz MF, 1999, TRENDS BIOCHEM SCI, V24, P58, DOI 10.1016/S0968-0004(98)01350-4; Reddy PH, 1998, NAT GENET, V20, P198, DOI 10.1038/2510; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Schwartz AL, 1999, ANNU REV MED, V50, P57; Sharipo A, 1998, NAT MED, V4, P939, DOI 10.1038/nm0898-939; Sisodia SS, 1998, CELL, V95, P1, DOI 10.1016/S0092-8674(00)81743-2; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; STEINER M, 1998, UBIQUITIN BIOL CELL, P147; Talis AL, 1998, J BIOL CHEM, V273, P6439, DOI 10.1074/jbc.273.11.6439; Wells R.D., 1998, GENETIC INSTABILITIE; Williams C A, 1995, Curr Probl Pediatr, V25, P216, DOI 10.1016/S0045-9380(06)80036-8; Wood JD, 1998, MOL CELL NEUROSCI, V11, P149, DOI 10.1006/mcne.1998.0677; ZOGHBI HY, 1988, ANN NEUROL, V23, P580, DOI 10.1002/ana.410230609	54	413	426	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1999	24	4					879	892		10.1016/S0896-6273(00)81035-1	http://dx.doi.org/10.1016/S0896-6273(00)81035-1			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	269UE	10624951	Bronze			2022-12-24	WOS:000084495300016
J	Mellor, J; Nicoll, RA				Mellor, J; Nicoll, RA			Hippocampal mossy fiber LTP is independent of postsynaptic calcium	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CA3 PYRAMIDAL NEURONS; SYNAPSES; TRANSMISSION; CHANNELS; FORMS		Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.		MELLOR, Jack/B-4548-2019	MELLOR, Jack/0000-0002-7706-8105				CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; Henze DA, 1997, J NEUROPHYSIOL, V77, P1075, DOI 10.1152/jn.1997.77.3.1075; ITO I, 1991, NEUROREPORT, V2, P333, DOI 10.1097/00001756-199106000-00008; JAFFE D, 1990, J NEUROPHYSIOL, V64, P948, DOI 10.1152/jn.1990.64.3.948; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; Kapur A, 1998, J NEUROPHYSIOL, V79, P2181, DOI 10.1152/jn.1998.79.4.2181; KATSUKI H, 1991, NEUROSCI RES, V12, P393, DOI 10.1016/0168-0102(91)90070-F; WILLIAMS S, 1989, NEURON, V3, P583, DOI 10.1016/0896-6273(89)90268-7; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	11	88	90	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2001	4	2					125	126		10.1038/83941	http://dx.doi.org/10.1038/83941			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UC	11175870				2022-12-24	WOS:000167178100008
J	Poeck, B; Fischer, S; Gunning, D; Zipursky, SL; Salecker, I				Poeck, B; Fischer, S; Gunning, D; Zipursky, SL; Salecker, I			Glial cells mediate target layer selection of retinal axons in the developing visual system of Drosophila	NEURON			English	Article							SH2/SH3 ADAPTER PROTEIN; OLFACTORY GLOMERULI; NERVOUS-SYSTEM; HOMEOBOX GENE; MELANOGASTER; NEURONS; CONNECTIONS; GUIDANCE; RECEPTOR; INSECT	In the fly visual system, each class of photoreceptor neurons (R cells) projects to a different synaptic layer in the brain. R1-R6 axons terminate in the lamina, while R7 and R8 axons pass through the lamina and stop in the medulla. As R cell axons enter the lamina, they encounter both glial cells and neurons. The cellular requirement for R1-R6 targeting was determined using loss-of-function mutations affecting different cell types in the lamina. nonstop (encoding a ubiquitin-specific protease) is required for glial cell development and hedgehog for neuronal development. Removal of glial cells but not neurons disrupts R1-R6 targeting. We propose that glial cells provide the initial stop signal promoting growth cone termination in the lamina. These findings uncover a novel function for neuron-glial interactions in regulating target specificity.	Univ Calif Los Angeles, Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Regensburg, Inst Zool, Lehrstuhl Entwicklungsbiol, D-93053 Regensburg, Germany	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Regensburg	Zipursky, SL (corresponding author), Univ Calif Los Angeles, Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA.		Salecker, Iris/V-1228-2018	Salecker, Iris/0000-0003-3775-7763; Zipursky, Stephen/0000-0001-5630-7181				Auld V, 1999, CELL MOL LIFE SCI, V55, P1377, DOI 10.1007/s000180050378; Bailey MS, 1999, J COMP NEUROL, V415, P423; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bulfone A, 1998, NEURON, V21, P1273, DOI 10.1016/S0896-6273(00)80647-9; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; D'Andrea A, 1998, CRIT REV BIOCHEM MOL, V33, P337, DOI 10.1080/10409239891204251; Deak P, 1997, GENETICS, V147, P1697; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; FROHLICH A, 1982, J NEUROCYTOL, V11, P159, DOI 10.1007/BF01258010; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; GHOSH A, 1993, DEVELOPMENT, V117, P1031; Gibbs SM, 1998, NEURON, V20, P83, DOI 10.1016/S0896-6273(00)80436-5; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Granderath S, 2000, MECH DEVELOP, V91, P197, DOI 10.1016/S0925-4773(99)00304-4; HALTER DA, 1995, DEVELOPMENT, V121, P317; HARRISON SD, 1995, GENETICS, V139, P1701; HEBERLEIN U, 1993, CELL, V75, P913, DOI 10.1016/0092-8674(93)90535-X; Hu G, 1997, GENE DEV, V11, P2701, DOI 10.1101/gad.11.20.2701; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; Huang Z, 1998, CELL, V95, P693, DOI 10.1016/S0092-8674(00)81639-6; Huang Z, 1998, DEVELOPMENT, V125, P3753; Jaquenoud M, 1998, EMBO J, V17, P5360, DOI 10.1093/emboj/17.18.5360; JONES B, 1993, DEVELOPMENT, V117, P793; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kikuno R, 1999, DNA Res, V6, P197, DOI 10.1093/dnares/6.3.197; MARDON G, 1994, DEVELOPMENT, V120, P3473; MARTIN KA, 1995, NEURON, V14, P229, DOI 10.1016/0896-6273(95)90281-3; Meinertzhagen Ian A., 1993, P1363; Newsome TP, 2000, DEVELOPMENT, V127, P851; OLAND LA, 1988, J NEUROSCI, V8, P353; OLAND LA, 1988, J COMP NEUROL, V278, P377, DOI 10.1002/cne.902780307; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Perez SE, 1996, J NEUROBIOL, V30, P359, DOI 10.1002/(SICI)1097-4695(199607)30:3<359::AID-NEU5>3.0.CO;2-3; POECK B, 1993, DEVELOPMENT, V117, P1017; Rao Y, 2000, P NATL ACAD SCI USA, V97, P5966, DOI 10.1073/pnas.110135297; ROBINOW S, 1988, SCIENCE, V242, P1570, DOI 10.1126/science.3144044; Rorth P, 2000, MOL CELL, V6, P23; Rossler W, 1999, J NEUROSCI, V19, P9865; Ruan WJ, 1999, NEURON, V24, P595, DOI 10.1016/S0896-6273(00)81115-0; SALECKER I, 1995, J COMP NEUROL, V352, P33, DOI 10.1002/cne.903520104; Salecker I, 1998, CELL, V95, P587, DOI 10.1016/S0092-8674(00)81627-X; SAVILLE KJ, 1993, P NATL ACAD SCI USA, V90, P8842, DOI 10.1073/pnas.90.19.8842; Senti KA, 2000, DEVELOPMENT, V127, P2291; Spradling AC, 1999, GENETICS, V153, P135; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Super H, 1998, J NEUROSCI, V18, P4616; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wilkinson KD, 1998, UBIQUITIN BIOL CELL, P99; WINBERG ML, 1992, DEVELOPMENT, V115, P903; XU T, 1993, DEVELOPMENT, V117, P1223	52	140	144	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	2001	29	1					99	113		10.1016/S0896-6273(01)00183-0	http://dx.doi.org/10.1016/S0896-6273(01)00183-0			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	397NX	11182084	Bronze			2022-12-24	WOS:000166702700012
J	Sasaki, S; Shionoya, A; Ishida, M; Gambello, MJ; Yingling, J; Wynshaw-Boris, A; Hirotsune, S				Sasaki, S; Shionoya, A; Ishida, M; Gambello, MJ; Yingling, J; Wynshaw-Boris, A; Hirotsune, S			A LIS1/NUDEL/cytoplasmic dynein heavy chain complex in the developing and adult nervous system	NEURON			English	Article							CYCLIN-DEPENDENT KINASE-5; LISSENCEPHALY GENE LIS1; CYTOPLASMIC DYNEIN; NUCLEAR MIGRATION; ASPERGILLUS-NIDULANS; NEURONAL MIGRATION; DROSOPHILA HOMOLOG; MICE LACKING; PROTEIN; BRAIN	Mutations in mammalian Lis1 (Pafah1b1) result in neuronal migration defects. Several lines of evidence suggest that LIS1 participates in pathways regulating microtubule function, but the molecular mechanisms are unknown. Here, we demonstrate that LIS1 directly interacts with the cytoplasmic dynein heavy chain (CDHC) and NUDEL, a murine homolog of the Aspergillus nidulans nuclear migration mutant NudE. LIS1 and NUDEL colocalize predominantly at the centrosome in early neuroblasts but redistribute to axons in association with retrograde dynein motor proteins. NUDEL is phosphorylated by Cdk5/p35, a complex essential for neuronal migration. NUDEL and LIS1 regulate the distribution of CDHC along microtubules, and establish a direct functional link between LIS1, NUDEL, and microtubule motors. These results suggest that LIS1 and NUDEL regulate CDHC activity during neuronal migration and axonal retrograde transport in a Cdk5/p35-dependent fashion.	Shirakawa Inst Anim Genet, Fukushima 9618061, Japan; Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Ctr Canc, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Wynshaw-Boris, A (corresponding author), Shirakawa Inst Anim Genet, Fukushima 9618061, Japan.	awynshawboris@ucsd.edu; shinjih@cocoa.ocn.ne.jp			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS039404] Funding Source: NIH RePORTER; NINDS NIH HHS [1PO1NS39404-01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baas PW, 1999, NEURON, V22, P23, DOI 10.1016/S0896-6273(00)80675-3; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chiu YH, 1997, MOL BIOL CELL, V8, P1735, DOI 10.1091/mbc.8.9.1735; Cunniff J, 1997, MECH DEVELOP, V66, P55, DOI 10.1016/S0925-4773(97)00085-3; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DOBYNS WB, 1993, JAMA-J AM MED ASSOC, V270, P2838, DOI 10.1001/jama.270.23.2838; Efimov VP, 2000, J CELL BIOL, V150, P681, DOI 10.1083/jcb.150.3.681; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; GOFFINET AM, 1984, BRAIN RES REV, V7, P261, DOI 10.1016/0165-0173(84)90013-4; Hanlon DW, 1997, NEURON, V18, P439, DOI 10.1016/S0896-6273(00)81244-1; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; HIROTSUNE S, 1995, NAT GENET, V10, P77, DOI 10.1038/ng0595-77; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; Liu Z, 1999, DEVELOPMENT, V126, P4477; LoNigro C, 1997, HUM MOL GENET, V6, P157, DOI 10.1093/hmg/6.2.157; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Minke PF, 1999, MOL MICROBIOL, V32, P1065, DOI 10.1046/j.1365-2958.1999.01421.x; Morris NR, 2000, J CELL BIOL, V148, P1097, DOI 10.1083/jcb.148.6.1097; Morris SM, 1998, CURR BIOL, V8, P603, DOI 10.1016/S0960-9822(98)70232-5; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Nevill-Manning CG, 1998, P NATL ACAD SCI USA, V95, P5865, DOI 10.1073/pnas.95.11.5865; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; PASCHAL BM, 1991, METHOD ENZYMOL, V196, P181; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; PAUDEL HK, 1993, J BIOL CHEM, V268, P23512; PORTER ME, 1989, ANNU REV CELL BIOL, V5, P119; Qi Z, 1998, J BIOL CHEM, V273, P2329, DOI 10.1074/jbc.273.4.2329; RAKIC P, 1995, NEURON, V14, P1101, DOI 10.1016/0896-6273(95)90258-9; REINER O, 1995, J NEUROSCI, V15, P3730; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Rice DS, 1999, GENE DEV, V13, P2758, DOI 10.1101/gad.13.21.2758; Sharma P, 1998, BIOCHEMISTRY-US, V37, P4759, DOI 10.1021/bi972746o; Sheffield PJ, 2000, PROTEINS, V39, P1, DOI 10.1002/(SICI)1097-0134(20000401)39:1<1::AID-PROT1>3.0.CO;2-N; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Stukenberg PT, 1997, CURR BIOL, V7, P338, DOI 10.1016/S0960-9822(06)00157-6; Suelmann R, 1997, MOL MICROBIOL, V25, P757, DOI 10.1046/j.1365-2958.1997.5131873.x; Swan A, 1999, NAT CELL BIOL, V1, P444, DOI 10.1038/15680; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Vallee RB, 2000, BBA-MOL CELL RES, V1496, P89, DOI 10.1016/S0167-4889(00)00011-2; VALLEE RB, 1990, ANNU REV BIOCHEM, V59, P909, DOI 10.1146/annurev.biochem.59.1.909; Willins DA, 1997, MOL GEN GENET, V255, P194, DOI 10.1007/s004380050489; Xia CH, 1998, GENOMICS, V52, P209, DOI 10.1006/geno.1998.5427; XIANG X, 1995, MOL BIOL CELL, V6, P297, DOI 10.1091/mbc.6.3.297; XIANG X, 1994, P NATL ACAD SCI USA, V91, P2100, DOI 10.1073/pnas.91.6.2100	52	420	437	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	2000	28	3					681	696		10.1016/S0896-6273(00)00146-X	http://dx.doi.org/10.1016/S0896-6273(00)00146-X			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386JJ	11163259	Bronze			2022-12-24	WOS:000166057500009
J	Ivic, L; Pyrski, MM; Margolis, JW; Richards, LJ; Firestein, S; Margolis, FL				Ivic, L; Pyrski, MM; Margolis, JW; Richards, LJ; Firestein, S; Margolis, FL			Adenoviral vector-mediated rescue of the OMP-null phenotype in vivo	NATURE NEUROSCIENCE			English	Article							OLFACTORY MARKER PROTEIN; GENE DELETION CAUSES; RECEPTOR; NEURONS; CELLS; MOUSE; CONSTRUCTION; SENSITIVITY; UNIQUE; CILIA	The use of gene deletion by homologous recombination to determine gene or protein function has wide application in vertebrate neurobiology. An ideal complement to gene deletion would be subsequent gene replacement to demonstrate re-acquisition of function. Here we used an adenoviral vector to replace the olfactory marker protein (OMP) gene in olfactory receptor neurons of adult OMP-null mice and demonstrated the subsequent re-acquisition of function. Our results show that short-term expression of OMP restores the kinetics of electrophysiological responses of OMP-null mice to those of the control phenotype. This adenoviral-mediated rescue of the OMP-null phenotype is consistent with involvement of OMP in olfactory transduction.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA	Columbia University; University System of Maryland; University of Maryland Baltimore	Firestein, S (corresponding author), Columbia Univ, Dept Biol Sci, 923 Fairchild,MC 2438, New York, NY 10027 USA.		; Richards AO, Linda/P-6372-2014	Pyrski, Martina/0000-0002-5751-178X; Richards AO, Linda/0000-0002-7590-7390	NIDCD NIH HHS [DCR01-03112] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003112] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Buiakova OI, 1996, P NATL ACAD SCI USA, V93, P9858, DOI 10.1073/pnas.93.18.9858; BUIAKOVA OI, 1994, GENOMICS, V20, P452, DOI 10.1006/geno.1994.1200; Farbman AI, 1998, ANN NY ACAD SCI, V855, P248, DOI 10.1111/j.1749-6632.1998.tb10576.x; FRINGS S, 1991, J GEN PHYSIOL, V97, P1, DOI 10.1085/jgp.97.1.1; Griff ER, 2000, BRAIN RES, V866, P227, DOI 10.1016/S0006-8993(00)02291-5; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Holtmaat AJGD, 1996, MOL BRAIN RES, V41, P148, DOI 10.1016/0169-328X(96)00085-X; HORWITZ MS, 1990, VIROLOGY, P01679; KELLER A, 1976, J BIOL CHEM, V251, P6232; KIM DG, 1992, MOL CELL BIOL, V12, P3636, DOI 10.1128/MCB.12.8.3636; Kleene SJ, 1999, J NEUROPHYSIOL, V81, P2675, DOI 10.1152/jn.1999.81.6.2675; KRISHNA NSR, 1992, BRAIN RES, V593, P295; MARGOLIS FL, 1972, P NATL ACAD SCI USA, V69, P1221, DOI 10.1073/pnas.69.5.1221; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; SYDOR W, 1986, ARCH BIOCHEM BIOPHYS, V249, P351, DOI 10.1016/0003-9861(86)90011-1; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; Youngentob SL, 1999, NEUROREPORT, V10, P15, DOI 10.1097/00001756-199901180-00003; ZHAO H, 1998, SCIENCE, V279, P327; Zhao HQ, 1996, J NEUROBIOL, V30, P521, DOI 10.1002/(SICI)1097-4695(199608)30:4<521::AID-NEU7>3.0.CO;2-5	20	60	61	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11					1113	1120		10.1038/80632	http://dx.doi.org/10.1038/80632			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TX	11036268				2022-12-24	WOS:000167177600016
J	Cantallops, I; Haas, K; Cline, HT				Cantallops, I; Haas, K; Cline, HT			Postsynaptic CPG15 promotes synaptic maturation and presynaptic axon arbor elaboration in vivo	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; IN-VIVO; DENDRITIC GROWTH; AMPA RECEPTORS; MAP FORMATION; SYNAPSES; PLASTICITY; XENOPUS; NEURONS; EXPRESSION	The formation of CNS circuits is characterized by the coordinated development of neuronal structure and synaptic function. The activity-regulated candidate plasticity gene 15 (cpg15) encodes a glycosylphosphatidylinositol (GPI)-linked protein whose in vivo expression increases the dendritic arbor growth rate of Xenopus optic tectal cells. We now demonstrate that tectal cell expression of CPG15 significantly increases the elaboration of presynaptic retinal axons by decreasing rates of branch retractions. Whole-cell recordings from optic tectal neurons indicate that CPG15 expression promotes retinotectal synapse maturation by recruiting functional AMPA receptors to synapses. Expression of truncated CPG15, lacking its GPI anchor, does not promote axon arbor growth and blocks synaptic maturation. These results suggest that CPG15 coordinately increases the growth of pre- and postsynaptic structures and the number and strength of their synaptic contacts.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Cline, HT (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.		Haas, Kurt/B-3812-2009	Haas, Kurt/0000-0003-4754-1560				ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; CLINE HT, 1999, IMAGING LAB MANUAL; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Corriveau RA, 1999, J NEUROSCI, V19, P7999, DOI 10.1523/jneurosci.19-18-07999.1999; Cremer H, 1998, P NATL ACAD SCI USA, V95, P13242, DOI 10.1073/pnas.95.22.13242; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; FaivreSarrailh C, 1997, MOL CELL NEUROSCI, V9, P109, DOI 10.1006/mcne.1997.0609; Feldman DE, 1996, SCIENCE, V271, P525, DOI 10.1126/science.271.5248.525; Fiala J.C., 1999, DENDRITES, P1, DOI DOI 10.1093/ACPROF:OSO/9780198566564.003.0001; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; FUJISAWA H, 1987, J COMP NEUROL, V260, P127, DOI 10.1002/cne.902600110; Gao WQ, 1998, MOL CELL NEUROSCI, V11, P247, DOI 10.1006/mcne.1998.0696; GAZE RM, 1979, J EMBRYOL EXP MORPH, V53, P103; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HICKMOTT PW, 1993, J NEUROSCI, V13, P4339; Horejsi V, 1999, IMMUNOL TODAY, V20, P356, DOI 10.1016/S0167-5699(99)01489-9; ISAAC JTR, 1997, NEURON, V18, P1; Jankowsky JL, 1999, MOL CELL NEUROSCI, V14, P273, DOI 10.1006/mcne.1999.0792; Li P, 1998, NATURE, V393, P695, DOI 10.1038/31496; Liao DZ, 1996, LEARN MEMORY, V3, P138, DOI 10.1101/lm.3.2-3.138; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; MALINOW R, 1991, SCIENCE, V252, P722, DOI 10.1126/science.1850871; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; Naeve GS, 1997, P NATL ACAD SCI USA, V94, P2648, DOI 10.1073/pnas.94.6.2648; Nedivi E, 1999, J NEUROBIOL, V41, P135, DOI 10.1002/(SICI)1097-4695(199910)41:1<135::AID-NEU17>3.0.CO;2-F; Nedivi E, 1998, SCIENCE, V281, P1863, DOI 10.1126/science.281.5384.1863; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Nedivi E, 1996, P NATL ACAD SCI USA, V93, P2048, DOI 10.1073/pnas.93.5.2048; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; OROURKE NA, 1990, NEURON, V5, P159, DOI 10.1016/0896-6273(90)90306-Z; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Rajan I, 1998, J NEUROSCI, V18, P7836; REH TA, 1984, J NEUROSCI, V4, P442; SAKAGUCHI DS, 1985, J NEUROSCI, V5, P3228; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Spruston N., 1999, DENDRITES, P231; WALSH FS, 1991, CELL BIOL INT REP, V15, P1151, DOI 10.1016/0309-1651(91)90061-M; Witte S, 1996, J NEUROBIOL, V31, P219, DOI 10.1002/(SICI)1097-4695(199610)31:2<219::AID-NEU7>3.0.CO;2-E; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Wu GY, 1999, J NEUROSCI, V19, P4472; WU GY, 1995, NEURON, V14, P681, DOI 10.1016/0896-6273(95)90211-2; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Yacoubian TA, 2000, NAT NEUROSCI, V3, P342, DOI 10.1038/73911; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zhang LI, 2000, NAT NEUROSCI, V3, P708, DOI 10.1038/76665; Zou DJ, 1999, J NEUROSCI, V19, P8909, DOI 10.1523/JNEUROSCI.19-20-08909.1999; Zou DJ, 1996, NEURON, V16, P529, DOI 10.1016/S0896-6273(00)80072-0	48	120	126	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2000	3	10					1004	1011		10.1038/79823	http://dx.doi.org/10.1038/79823			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TW	11017173				2022-12-24	WOS:000167177500018
J	Scholz, H; Ramond, J; Singh, CM; Heberlein, U				Scholz, H; Ramond, J; Singh, CM; Heberlein, U			Functional ethanol tolerance in Drosophila	NEURON			English	Article							RECOMBINANT INBRED MICE; STRUCTURAL BRAIN MUTANT; CENTRAL COMPLEX; ALCOHOL TOLERANCE; GENETIC-ANALYSIS; MUSHROOM BODIES; MELANOGASTER; DEPENDENCE; OCTOPAMINE; EXPRESSION	In humans, repeated alcohol consumption leads to the development of tolerance, manifested as a reduced physiological and behavioral response to a particular dose of alcohol. Here we show that adult Drosophila develop tolerance to the sedating and motor-impairing effects of ethanol with kinetics of acquisition and dissipation that mimic those seen in mammals. Importantly, this tolerance is not caused by changes in ethanol absorption or metabolism. Rather, the development of tolerance requires the functional and structural integrity of specific central brain regions. Mutants unable to synthesize the catecholamine octopamine are also impaired in their ability to develop tolerance. Taken together, these data show that Drosophila is a suitable model system in which to study the molecular and neuroanatomical bases of ethanol tolerance.	Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Gallo Ctr, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Biol Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Scholz, H (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	henrike@itsa.ucsf.edu; ulrike@itsa.ucsf.edu	Scholz, Henrike/ABE-1063-2020		NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010035] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA10035] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUCK KJ, 1991, J PHARMACOL EXP THER, V257, P984; COHAN FM, 1986, GENETICS, V114, P145; CRABBE JC, 1979, J PHARMACOL EXP THER, V208, P128; CRABBE JC, 1980, BEHAV GENET, V10, P139, DOI 10.1007/BF01066264; CRABBE JC, 1994, SCIENCE, V264, P1715, DOI 10.1126/science.8209252; CUNNINGHAM CL, 1983, PHARMACOL THERAPEUT, V23, P365, DOI 10.1016/0163-7258(83)90019-0; deBelle JS, 1996, P NATL ACAD SCI USA, V93, P9875, DOI 10.1073/pnas.93.18.9875; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; DUDAI Y, 1987, J COMP PHYSIOL A, V161, P739, DOI 10.1007/BF00605015; Erwin VG, 1996, J PHARMACOL EXP THER, V279, P1310; Evans P.D., 1980, Advances in Insect Physiology, V15, P317, DOI 10.1016/S0065-2806(08)60143-5; Fadda F, 1998, PROG NEUROBIOL, V56, P385, DOI 10.1016/S0301-0082(98)00032-X; FISCHBACH KF, 1981, P NATL ACAD SCI-BIOL, V78, P1105, DOI 10.1073/pnas.78.2.1105; FISCHBACH KF, 1984, J EXP BIOL, V112, P65; Gallaher EJ, 1996, J PHARMACOL EXP THER, V277, P604; GEER BW, 1988, J NUTR, V118, P398, DOI 10.1093/jn/118.3.398; GEER BW, 1993, COMP BIOCHEM PHYS B, V105, P203, DOI 10.1016/0305-0491(93)90221-P; Hammer M, 1998, LEARN MEMORY, V5, P146; Han KA, 1998, J NEUROSCI, V18, P3650; HANESCH U, 1989, CELL TISSUE RES, V257, P343, DOI 10.1007/BF00261838; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; HEISENBERG M, 1979, Z NATURFORSCH C, V34, P143; HOTTA Y, 1972, NATURE, V240, P527, DOI 10.1038/240527a0; ILIUS M, 1994, J NEUROGENET, V9, P189, DOI 10.3109/01677069409167279; KALANT H, 1971, PHARMACOL REV, V23, P135; KERVER JWM, 1985, HEREDITY, V55, P355, DOI 10.1038/hdy.1985.118; Khanna J M, 1980, Int Rev Physiol, V21, P275; KHANNA JM, 1991, PHARMACOL BIOCHEM BE, V38, P427, DOI 10.1016/0091-3057(91)90302-I; Le A. D., 1996, PHARM TOXIC, P251; LE AD, 1981, J PHARMACOL EXP THER, V218, P525; LE AD, 1982, EUR J PHARMACOL, V80, P337; LE AD, 1979, SCIENCE, V206, P1109, DOI 10.1126/science.493999; MANSFIELD JG, 1980, J COMP PHYSIOL PSYCH, V94, P962, DOI 10.1037/h0077824; Martin JR, 1999, J COMP PHYSIOL A, V185, P277, DOI 10.1007/s003590050387; McClung C, 1999, CURR BIOL, V9, P853, DOI 10.1016/S0960-9822(99)80389-3; MLODZIK M, 1992, METHODS NEUROSCIENCE, V9, P397; Monastirioti M, 1999, MICROSC RES TECHNIQ, V45, P106, DOI 10.1002/(SICI)1097-0029(19990415)45:2<106::AID-JEMT5>3.3.CO;2-V; Monastirioti M, 1996, J NEUROSCI, V16, P3900; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; ODELL KMC, 1993, HEREDITY, V70, P393, DOI 10.1038/hdy.1993.55; QIU YH, 1991, J MOL BIOL, V222, P553, DOI 10.1016/0022-2836(91)90496-S; Renn SCP, 1999, J NEUROBIOL, V41, P189; Restifo L.L., 1990, Advances in Insect Physiology, V22, P115, DOI 10.1016/S0065-2806(08)60006-5; RITZMANN RF, 1976, NATURE, V263, P418, DOI 10.1038/263418a0; Roeder T, 1999, PROG NEUROBIOL, V59, P533, DOI 10.1016/S0301-0082(99)00016-7; SAVVATEEVA E, 1991, J NEUROGENET, V7, P145; Singh CM, 2000, ALCOHOL CLIN EXP RES, V24, P1127, DOI 10.1111/j.1530-0277.2000.tb02075.x; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; STRAUSS R, 1992, J NEUROGENET, V8, P125, DOI 10.3109/01677069209083444; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; SZABO G, 1988, J PHARMACOL EXP THER, V247, P536; SZABO G, 1995, EUR J PHARMACOL, V287, P35, DOI 10.1016/0014-2999(95)00466-3; TABAKOFF B, 1986, ANN EMERG MED, V15, P1005, DOI 10.1016/S0196-0644(86)80119-6; TABAKOFF B, 1977, J PHARMACOL EXP THER, V203, P319; TOLERANCE E, 1994, ANN NY ACAD SCI, V739, P168, DOI 10.1111/j.1749-6632.1994.tb19818.x; WEBER KE, 1988, INEBRIOMETER, V67, P91; WENGER JR, 1981, SCIENCE, V213, P575; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	61	170	170	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	2000	28	1					261	271		10.1016/S0896-6273(00)00101-X	http://dx.doi.org/10.1016/S0896-6273(00)00101-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	370VN	11086999	Bronze			2022-12-24	WOS:000165143500026
J	Bergeron, A; Guitton, D				Bergeron, A; Guitton, D			Fixation neurons in the superior colliculus encode distance between current and desired gaze positions	NATURE NEUROSCIENCE			English	Article							STEM OMNIPAUSE NEURONS; HEAD-FREE CAT; ALERT CAT; TECTORETICULOSPINAL SYSTEM; DISCHARGE CHARACTERISTICS; MOTOR MAP; MONKEY; EYE; STIMULATION; PATTERNS	A visual scene is scrutinized during sequential periods of steady fixation, connected by saccades that shift the visual axis (gaze) to new positions. During such exploratory scan paths, gaze frequently strays from and then returns to salient features. How the brain keeps track of major end-gears and intermediate subgoals is not understood. We studied the discharge of fixation neurons of the brainstem's superior colliculus during multiple-step gaze shifts composed of a sequence of saccades made in the dark and separated by short periods of steady fixation. Cells were initially silent. As sequential gaze saccades approached the goal, firing began; its frequency increased progressively and peaked when gaze was on the remembered target location. We conclude that these fixation neurons encode the error between desired and actual gaze positions, irrespective of trajectory characteristics.	McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University	Guitton, D (corresponding author), McGill Univ, Dept Neurol & Neurosurg, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.							Buttner-Ennever JA, 1999, J COMP NEUROL, V413, P55, DOI 10.1002/(SICI)1096-9861(19991011)413:1<55::AID-CNE3>3.0.CO;2-K; Everling S, 1998, J NEUROPHYSIOL, V79, P511, DOI 10.1152/jn.1998.79.2.511; EVINGER C, 1982, J NEUROPHYSIOL, V47, P827, DOI 10.1152/jn.1982.47.5.827; Freedman EG, 1997, J NEUROPHYSIOL, V78, P1669, DOI 10.1152/jn.1997.78.3.1669; Gandhi NJ, 1997, J NEUROPHYSIOL, V78, P2221, DOI 10.1152/jn.1997.78.4.2221; GRANTYN A, 1985, EXP BRAIN RES, V57, P417; GRANTYN A, 1982, EXP BRAIN RES, V46, P243; GUITTON D, 1984, J NEUROPHYSIOL, V52, P1030, DOI 10.1152/jn.1984.52.6.1030; Hanes DP, 1998, J NEUROPHYSIOL, V79, P817, DOI 10.1152/jn.1998.79.2.817; JEANNEROD M, 1968, VISION RES, V8, P81, DOI 10.1016/0042-6989(68)90066-7; Krauzlis RJ, 1997, SCIENCE, V276, P1693, DOI 10.1126/science.276.5319.1693; MACPHERSON JM, 1979, BRAIN RES, V175, P183, DOI 10.1016/0006-8993(79)90530-4; Munoz DP, 1998, J NEUROPHYSIOL, V79, P1193, DOI 10.1152/jn.1998.79.3.1193; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2334, DOI 10.1152/jn.1995.73.6.2334; MUNOZ DP, 1993, J NEUROPHYSIOL, V70, P576, DOI 10.1152/jn.1993.70.2.576; MUNOZ DP, 1993, J NEUROPHYSIOL, V70, P559, DOI 10.1152/jn.1993.70.2.559; MUNOZ DP, 1991, J NEUROPHYSIOL, V66, P1624, DOI 10.1152/jn.1991.66.5.1624; MUNOZ DP, 1989, REV NEUROL-FRANCE, V145, P567; MUNOZ DP, 1991, J NEUROPHYSIOL, V66, P1642, DOI 10.1152/jn.1991.66.5.1642; Pare M, 1998, J NEUROPHYSIOL, V79, P3060, DOI 10.1152/jn.1998.79.6.3060; PARE M, 1994, EXP BRAIN RES, V101, P109; PARE M, 1994, EXP BRAIN RES, V101, P123; Peck CK, 1997, EXP BRAIN RES, V113, P291, DOI 10.1007/BF02450327; Petit L, 1999, HUM BRAIN MAPP, V8, P28, DOI 10.1002/(SICI)1097-0193(1999)8:1<28::AID-HBM3>3.0.CO;2-T; RICHMOND BJ, 1987, J NEUROPHYSIOL, V57, P132, DOI 10.1152/jn.1987.57.1.132; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; ROUCOUX A, 1980, EXP BRAIN RES, V39, P75; Yarbus A.L., 1967, EYE MOVEMENT VISION; ZUSNE L, 1964, PERCEPT MOTOR SKILL, V18, P11, DOI 10.2466/pms.1964.18.1.11	29	24	24	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2000	3	9					932	939		10.1038/78847	http://dx.doi.org/10.1038/78847			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TV	10966625				2022-12-24	WOS:000167177400021
J	Fischer, M; Kaech, S; Wagner, U; Brinkhaus, H; Matus, A				Fischer, M; Kaech, S; Wagner, U; Brinkhaus, H; Matus, A			Glutamate receptors regulate actin-based plasticity in dendritic spines	NATURE NEUROSCIENCE			English	Article							EXCITATORY POSTSYNAPTIC POTENTIALS; EXPERIENCE-DEPENDENT PLASTICITY; CENTRAL-NERVOUS-SYSTEM; AMPA RECEPTORS; HIPPOCAMPAL-NEURONS; PYRAMIDAL NEURONS; CA2+ PERMEABILITY; CALCIUM CHANNELS; SINGLE SPINES; SYNAPSES	Dendritic spines at excitatory synapses undergo rapid, actin-dependent shape changes which may contribute to plasticity in brain circuits. Here we show that actin dynamics in spines are potently inhibited by activation of either AMPA or NMDA subtype glutamate receptors. Activation of either receptor type inhibited actin-based protrusive activity from the spine head. This blockade of motility caused spines to round up so that spine morphology became both more stable and more regular. Inhibition of spine motility by AMPA receptors was dependent on postsynaptic membrane depolarization and influx of Ca2+ through voltage-activated channels. In combination with previous studies, our results suggest a two-step process in which spines initially formed in response to NMDA receptor activation are subsequently stabilized by AMPA receptors.	Friedrich Miescher Inst, CH-4002 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Matus, A (corresponding author), Friedrich Miescher Inst, POB 2543, CH-4002 Basel, Switzerland.			Kaech Petrie, Stefanie/0000-0002-6246-6434				Allison DW, 1998, J NEUROSCI, V18, P2423; Avery RB, 1996, J NEUROSCI, V16, P5567; Banker G, 1991, CULTURING NERVE CELL, P251; BARTLETT WP, 1984, J NEUROSCI, V4, P1954; Boyer C, 1998, J NEUROSCI, V18, P5294, DOI 10.1523/JNEUROSCI.18-14-05294.1998; CARLIN RK, 1983, P NATL ACAD SCI-BIOL, V80, P3517, DOI 10.1073/pnas.80.11.3517; CHOI DW, 1994, PROG BRAIN RES, V100, P47; Dailey ME, 1996, J NEUROSCI, V16, P2983; DENK W, 1995, P NATL ACAD SCI USA, V92, P8279, DOI 10.1073/pnas.92.18.8279; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Feldman DE, 1998, NEURON, V20, P1067, DOI 10.1016/S0896-6273(00)80488-2; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Frotscher M, 1975, J Hirnforsch, V16, P443; Furukawa K, 1997, J NEUROSCI, V17, P8178, DOI 10.1523/jneurosci.17-21-08178.1997; GAHWILER BH, 1984, NEUROSCIENCE, V11, P751, DOI 10.1016/0306-4522(84)90192-1; GAHWILER BH, 1991, CULTURING NERVE CELL, P379; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; GRAY EG, 1959, NATURE, V183, P1592, DOI 10.1038/1831592a0; GUTHRIE PB, 1991, NATURE, V354, P76, DOI 10.1038/354076a0; Halpain S, 1998, J NEUROSCI, V18, P9835; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Kaech S, 1997, J NEUROSCI, V17, P9565; KATER SB, 1991, J NEUROSCI, V11, P891; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MARINPADILLA M, 1967, J COMP NEUROL, V131, P475, DOI 10.1002/cne.901310407; MARKRAM H, 1994, P NATL ACAD SCI USA, V91, P5207, DOI 10.1073/pnas.91.11.5207; Matus A, 1999, CURR OPIN NEUROBIOL, V9, P561, DOI 10.1016/S0959-4388(99)00018-5; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; McDonough SI, 1998, MOL PHARMACOL, V54, P1080, DOI 10.1124/mol.54.6.1080; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; Muller D, 1997, REV NEUROSCIENCE, V8, P77; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SPACEK J, 1983, ANAT EMBRYOL, V167, P289, DOI 10.1007/BF00298517; Svoboda K, 1999, NEURON, V22, P427, DOI 10.1016/S0896-6273(00)80698-4; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	47	367	378	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2000	3	9					887	894		10.1038/78791	http://dx.doi.org/10.1038/78791			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TV	10966619				2022-12-24	WOS:000167177400015
J	Denisenko-Nehrbass, NI; Jarvis, E; Scharff, C; Nottebohm, F; Mello, CV				Denisenko-Nehrbass, NI; Jarvis, E; Scharff, C; Nottebohm, F; Mello, CV			Site-specific retinoic acid production in the brain of adult songbirds	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; RECOMBINANT HUMAN MITOCHONDRIAL; HUMAN NEUROBLASTOMA-CELLS; HIGH VOCAL CENTER; ALDEHYDE DEHYDROGENASE; ZEBRA FINCHES; AUDITORY PATHWAYS; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; TAENIOPYGIA-GUTTATA	The song system of songbirds, a set of brain nuclei necessary for song learning and production, has distinctive morphological and functional properties. Utilizing differential display, we searched for molecular components involved in song system regulation. We identified a cDNA (zRalDH) that encodes a class 1 aldehyde dehydrogenase. zRalDH was highly expressed in various song nuclei and synthesized retinoic acid efficiently. Brain areas expressing zRalDH generated retinoic acid. Within song nucleus HVC, only projection neurons not undergoing adult neurogenesis expressed zRalDH. Blocking zRalDH activity in the HVC of juveniles interfered with normal song development. Our results provide conclusive evidence for localized retinoic acid synthesis in an adult vertebrate brain and indicate that the retinoic acid-generating system plays a significant role in the maturation of a learned behavior.	Rockefeller Univ, Lab Anim Behav, New York, NY 10021 USA	Rockefeller University	Mello, CV (corresponding author), Rockefeller Univ, Lab Anim Behav, New York, NY 10021 USA.	mello@rockvax.rockefeller.edu	Scharff, Constance/HHN-0673-2022; Jarvis, Erich D/A-2319-2008	Jarvis, Erich D/0000-0001-8931-5049; Mello, Claudio/0000-0002-9826-8421	NIDCD NIH HHS [DC02853] Funding Source: Medline; NIMH NIH HHS [MH18343] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH018343, R01MH018343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002853, R29DC002853] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ALTABA ARI, 1991, DEVELOPMENT, V112, P945; ALVAREZBUYLLA A, 1990, SCIENCE, V249, P1444, DOI 10.1126/science.1698312; ALVAREZBUYLLA A, 1992, J NEUROBIOL, V23, P396, DOI 10.1002/neu.480230406; AlvarezBuylla A, 1997, J NEUROBIOL, V33, P585, DOI 10.1002/(SICI)1097-4695(19971105)33:5<585::AID-NEU7>3.0.CO;2-0; Anchan RM, 1997, J COMP NEUROL, V379, P171; ARNOLD AP, 1976, J COMP NEUROL, V165, P487, DOI 10.1002/cne.901650406; BAILEY JS, 1988, J BIOL CHEM, V263, P9326; Blumberg B, 1997, DEVELOPMENT, V124, P373; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; BOTTJER SW, 1989, J COMP NEUROL, V279, P312, DOI 10.1002/cne.902790211; BOTTJER SW, 1985, J NEUROSCI, V5, P1556, DOI 10.1523/jneurosci.05-06-01556.1985; BRYANT SV, 1992, DEV BIOL, V152, P1, DOI 10.1016/0012-1606(92)90152-7; CHEN YP, 1992, DEV DYNAM, V195, P142, DOI 10.1002/aja.1001950209; Cheung WMW, 1996, NEUROREPORT, V7, P1204, DOI 10.1097/00001756-199604260-00022; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLAYTON DF, 1988, NEURON, V1, P249, DOI 10.1016/0896-6273(88)90146-8; COLBERT MC, 1993, P NATL ACAD SCI USA, V90, P6572, DOI 10.1073/pnas.90.14.6572; DEV S, 1993, BRAIN RES, V632, P325, DOI 10.1016/0006-8993(93)91170-W; Drager UC, 1998, J NUTR, V128, p463S, DOI 10.1093/jn/128.2.463S; Driscoll WJ, 1999, MOL PHARMACOL, V55, P1067, DOI 10.1124/mol.55.6.1067; DURSTON AJ, 1989, NATURE, V340, P140, DOI 10.1038/340140a0; FORTUNE ES, 1995, J COMP NEUROL, V360, P413, DOI 10.1002/cne.903600305; Foster EF, 1997, J COMP NEUROL, V382, P364, DOI 10.1002/cne.903820305; GALLI C, 1995, J NEUROSCI, V15, P1172; GODBOUT R, 1992, EXP EYE RES, V54, P297, DOI 10.1016/S0014-4835(05)80219-2; GREENFIELD NJ, 1977, BIOCHIM BIOPHYS ACTA, V483, P35, DOI 10.1016/0005-2744(77)90005-5; HEMPEL J, 1993, PROTEIN SCI, V2, P1890, DOI 10.1002/pro.5560021111; Hempel J, 1997, ADV EXP MED BIOL, V414, P9; Holzenberger M, 1997, J NEUROSCI, V17, P6974; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; JOHNSON CT, 1987, ALCOHOL CLIN EXP RES, V11, P60, DOI 10.1111/j.1530-0277.1987.tb01264.x; JOHNSON KJ, 1992, DEV DYNAM, V193, P185, DOI 10.1002/aja.1001930210; Johnston BM, 1996, J CLIN INVEST, V97, P300, DOI 10.1172/JCI118416; KAPLAN DR, 1993, NEURON, V11, P321, DOI 10.1016/0896-6273(93)90187-V; Karten H J, 1989, J Cogn Neurosci, V1, P291, DOI 10.1162/jocn.1989.1.4.291; KATZ LC, 1981, BRAIN RES, V221, P192, DOI 10.1016/0006-8993(81)91073-8; Kharasch ED, 1999, DRUG METAB DISPOS, V27, P717; KIRN JR, 1991, J NEUROSCI, V11, P1756; Kirn JR, 1999, J COMP NEUROL, V411, P487; KONISHI M, 1985, NATURE, V315, P145, DOI 10.1038/315145a0; Krezel W, 1999, NEUROSCIENCE, V89, P1291, DOI 10.1016/S0306-4522(98)00342-X; Lam JP, 1997, BIOCHEMISTRY-US, V36, P13748, DOI 10.1021/bi970948e; Leonardo A, 1999, NATURE, V399, P466, DOI 10.1038/20933; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; MADEN M, 1991, DEVELOPMENT, P87; MANTHEY CL, 1990, CANCER RES, V50, P4991; Margoliash D, 1997, J NEUROBIOL, V33, P671, DOI 10.1002/(SICI)1097-4695(19971105)33:5<671::AID-NEU12>3.0.CO;2-C; Mays DC, 1998, BIOCHEM PHARMACOL, V55, P1099, DOI 10.1016/S0006-2952(97)00686-2; MCCAFFERY P, 1994, P NATL ACAD SCI USA, V91, P7194, DOI 10.1073/pnas.91.15.7194; MELINO G, 1993, NEUROSCI LETT, V151, P187, DOI 10.1016/0304-3940(93)90017-F; Mello C V, 1997, Methods Mol Biol, V85, P205; MELLO CV, 1994, J NEUROSCI, V14, P6652; Mello CV, 1998, J COMP NEUROL, V395, P137; MELLO CV, 1999, TEC BEHAV N, V13, P200; Mey J, 1997, J NEUROSCI, V17, P7441; MIYAUCHI K, 1993, CELL STRUCT FUNCT, V18, P427, DOI 10.1247/csf.18.427; NAPOLI JL, 1987, ARCH BIOCHEM BIOPHYS, V255, P95, DOI 10.1016/0003-9861(87)90298-0; NAPOLI JL, 1992, BIOCHIM BIOPHYS ACTA, V1120, P183, DOI 10.1016/0167-4838(92)90267-H; Napoli JL, 1996, FASEB J, V10, P993, DOI 10.1096/fasebj.10.9.8801182; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; NORDEEN KW, 1992, BEHAV NEURAL BIOL, V57, P58, DOI 10.1016/0163-1047(92)90757-U; NOTTEBOHM F, 1989, SCI AM, V260, P74, DOI 10.1038/scientificamerican0289-74; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; OKUHATA S, 1987, BRAIN RES BULL, V18, P35, DOI 10.1016/0361-9230(87)90031-1; POSCH KC, 1989, ARCH BIOCHEM BIOPHYS, V274, P171, DOI 10.1016/0003-9861(89)90428-1; Rasika S, 1999, NEURON, V22, P53, DOI 10.1016/S0896-6273(00)80678-9; Sakaguchi H, 1996, DEV BRAIN RES, V95, P245, DOI 10.1016/S0165-3806(96)00085-5; SCADDING SR, 1994, DEV BIOL, V162, P608, DOI 10.1006/dbio.1994.1114; Scharff C, 2000, NEURON, V25, P481, DOI 10.1016/S0896-6273(00)80910-1; SCHARFF C, 1991, J NEUROSCI, V11, P2896; SMITH SM, 1989, DEVELOPMENT, V107, P121; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; SOHRABJI F, 1990, BEHAV NEURAL BIOL, V53, P51, DOI 10.1016/0163-1047(90)90797-A; Sporn M.B., 1994, RETINOIDS BIOL CHEM; SUNDIN O, 1992, DEVELOPMENT, V114, P841; TABIN CJ, 1991, CELL, V66, P199, DOI 10.1016/0092-8674(91)90612-3; THALLER C, 1987, NATURE, V327, P625, DOI 10.1038/327625a0; VALLARI RC, 1982, SCIENCE, V216, P637, DOI 10.1126/science.7071604; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; Veverka KA, 1997, BIOCHEM PHARMACOL, V53, P511, DOI 10.1016/S0006-2952(96)00767-8; Vincent TS, 1996, PEDIATR PATHOL LAB M, V16, P777, DOI 10.1080/107710496175390; WAGNER M, 1992, DEVELOPMENT, V116, P55; Wang XS, 1996, J BIOL CHEM, V271, P16288, DOI 10.1074/jbc.271.27.16288; Wild JM, 1997, J NEUROBIOL, V33, P653, DOI 10.1002/(SICI)1097-4695(19971105)33:5<653::AID-NEU11>3.0.CO;2-A; Wolbach SB, 1925, J EXP MED, V42, P753, DOI 10.1084/jem.42.6.753; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871; ZETTERSTROM RH, 1994, NEUROSCIENCE, V62, P899, DOI 10.1016/0306-4522(94)90482-0; Zetterstrom RH, 1999, EUR J NEUROSCI, V11, P407, DOI 10.1046/j.1460-9568.1999.00444.x; Zhao D, 1996, EUR J BIOCHEM, V240, P15, DOI 10.1111/j.1432-1033.1996.0015h.x; [No title captured]	92	76	78	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	2000	27	2					359	370		10.1016/S0896-6273(00)00043-X	http://dx.doi.org/10.1016/S0896-6273(00)00043-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	347YD	10985355	Green Published, Bronze			2022-12-24	WOS:000088956000019
J	Yuan, A; Dourado, M; Butler, A; Walton, N; Wei, AG; Salkoff, L				Yuan, A; Dourado, M; Butler, A; Walton, N; Wei, AG; Salkoff, L			SLO-2, a K+ channel with an unusual Cl- dependence	NATURE NEUROSCIENCE			English	Article							ACTIVATED POTASSIUM CHANNELS; LARGE-CONDUCTANCE; CALCIUM SENSITIVITY; ION CHANNELS; GENE; CLONING; RECORDINGS; EXPRESSION; SEGMENTS; CURRENTS	The gating of different potassium channels depends on many diverse factors. We now report a unique example of a K+ channel with a Cl- dependence. The slo-2 gene was cloned from Caenorhabditis elegans and is widely expressed in both neurons and muscles; it was highly abundant, as suggested by its high representation in the C. elegans EST database. SLO-2, like its paralogue, SLO-1, was also dependent on Ca2+. We show by site-directed mutagenesis that its requirements for both Cl- and Ca2+ are synergistic and associated with the same functional domain. SLO-2's dependence on Cl- implies that intracellular Cl- homeostasis may be important in regulating cellular excitability through this unusual K+ channel.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Univ Calif San Francisco, Div Oral Biol, San Francisco, CA 94143 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); University of California System; University of California San Francisco; Washington University (WUSTL)	Salkoff, L (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid, St Louis, MO 63110 USA.	salkoffl@thalamus.wustl.edu		Yuan, Alex/0000-0003-0191-8035	NIGMS NIH HHS [GM07200] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; BABCOCK DF, 1987, J BIOL CHEM, V262, P15041; BARRETT JN, 1982, J PHYSIOL-LONDON, V331, P211, DOI 10.1113/jphysiol.1982.sp014370; BLATZ AL, 1987, TRENDS NEUROSCI, V10, P463, DOI 10.1016/0166-2236(87)90101-9; BRAYDEN JE, 1992, SCIENCE, V256, P532, DOI 10.1126/science.1373909; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; DWORETZKY SI, 1994, MOL BRAIN RES, V27, P189, DOI 10.1016/0169-328X(94)90203-8; FLORMAN HM, 1994, DEV BIOL, V165, P152, DOI 10.1006/dbio.1994.1242; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; HIRONAKA T, 1980, JPN J PHYSIOL, V30, P357; Joiner WJ, 1998, NAT NEUROSCI, V1, P462, DOI 10.1038/2176; Knaus HG, 1996, J NEUROSCI, V16, P955; LATORRE R, 1982, P NATL ACAD SCI-BIOL, V79, P805, DOI 10.1073/pnas.79.3.805; LEWIS RS, 1983, NATURE, V304, P538, DOI 10.1038/304538a0; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; MARTY A, 1981, NATURE, V291, P497, DOI 10.1038/291497a0; MCCOBB DP, 1995, AM J PHYSIOL-HEART C, V269, pH767, DOI 10.1152/ajpheart.1995.269.3.H767; Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Navaratnam DS, 1997, NEURON, V19, P1077, DOI 10.1016/S0896-6273(00)80398-0; Owens DF, 1996, J NEUROSCI, V16, P6414; PALLANCK L, 1994, HUM MOL GENET, V3, P1239, DOI 10.1093/hmg/3.8.1239; PALLOTTA BS, 1981, NATURE, V293, P471, DOI 10.1038/293471a0; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; Pauling L, 1960, NATURE CHEM BOND, VThird, P644; PEREZ GJ, 1993, AM J OBSTET GYNECOL, V168, P652, DOI 10.1016/0002-9378(93)90513-I; PETERSEN OH, 1984, NATURE, V307, P693, DOI 10.1038/307693a0; Ramanathan K, 1999, SCIENCE, V283, P215, DOI 10.1126/science.283.5399.215; REINHART PH, 1989, NEURON, V2, P1031, DOI 10.1016/0896-6273(89)90227-4; ROBITAILLE R, 1992, J NEUROSCI, V12, P297; Salkoff L, 1999, CURR TOP MEMBR, V46, P9; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Schreiber M, 1999, NAT NEUROSCI, V2, P416, DOI 10.1038/8077; Schreiber M, 1998, J BIOL CHEM, V273, P3509, DOI 10.1074/jbc.273.6.3509; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; STEELE JA, 1990, J CELL PHYSIOL, V142, P603, DOI 10.1002/jcp.1041420321; TABCHARANI JA, 1989, BIOCHIM BIOPHYS ACTA, V982, P62, DOI 10.1016/0005-2736(89)90174-0; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; Wagner S, 1997, NATURE, V387, P598, DOI 10.1038/42468; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; Wei A, 1996, NEUROPHARMACOLOGY, V35, P805, DOI 10.1016/0028-3908(96)00126-8	43	90	97	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2000	3	8					771	779		10.1038/77670	http://dx.doi.org/10.1038/77670			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TU	10903569				2022-12-24	WOS:000167177300011
J	Costanzo, EM; Barry, JA; Ribchester, RR				Costanzo, EM; Barry, JA; Ribchester, RR			Competition at silent synapses in reinnervated skeletal muscle	NATURE NEUROSCIENCE			English	Article							DENERVATED RAT MUSCLE; MOTOR-NERVE TERMINALS; INNERVATED NEUROMUSCULAR-JUNCTIONS; CAT VISUAL-CORTEX; POLYNEURONAL INNERVATION; NEUROTROPHIC FACTOR; MOUSE MUSCLE; ELIMINATION; RELEASE; TERM	Synaptic connections are made and broken in an activity-dependent manner in diverse regions of the nervous system. However, whether activity is strictly necessary for synapse elimination has not been resolved directly. Here we report that synaptic terminals occupying motor endplates made electrically silent by tetrodotoxin and alpha -bungarotoxin block were frequently displaced by regenerating axons that were also both inactive and synaptically ineffective. Thus, neither evoked nor spontaneous activation of acetylcholine receptors is required for competitive reoccupation of neuromuscular synaptic sites by regenerating motor axons.	Univ Edinburgh, Sch Med, Dept Neurosci, Edinburgh EH8 9LE, Midlothian, Scotland	University of Edinburgh	Ribchester, RR (corresponding author), Univ Edinburgh, Sch Med, Dept Neurosci, Edinburgh EH8 9LE, Midlothian, Scotland.			Ribchester, Richard/0000-0003-2670-6995				Angleson JK, 1999, NAT NEUROSCI, V2, P440, DOI 10.1038/8107; BALICEGORDON RJ, 1994, NATURE, V372, P519, DOI 10.1038/372519a0; BARRY JA, 1995, J NEUROSCI, V15, P6327; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BETZ WJ, 1979, J PHYSIOL-LONDON, V297, P463, DOI 10.1113/jphysiol.1979.sp013051; BROWN MC, 1981, ANNU REV NEUROSCI, V4, P17, DOI 10.1146/annurev.ne.04.030181.000313; BROWN MC, 1976, J PHYSIOL-LONDON, V261, P387, DOI 10.1113/jphysiol.1976.sp011565; BROWN MC, 1982, J PHYSIOL-LONDON, V329, P439, DOI 10.1113/jphysiol.1982.sp014312; CALLAWAY EM, 1989, J NEUROSCI, V9, P1806; Chang Q, 1997, BIOESSAYS, V19, P271, DOI 10.1002/bies.950190402; Costanzo EM, 1999, J PHYSIOL-LONDON, V521, P365, DOI 10.1111/j.1469-7793.1999.00365.x; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; Fitzsimonds RM, 1997, NATURE, V388, P439, DOI 10.1038/41267; GRINNELL AD, 1995, PHYSIOL REV, V75, P789, DOI 10.1152/physrev.1995.75.4.789; Keddy P.A., 1989, COMPETITION; LIU DWC, 1990, J NEUROSCI, V10, P3947, DOI 10.1523/JNEUROSCI.10-12-03947.1990; Lohof AM, 1996, REV NEUROSCIENCE, V7, P85; Nguyen QT, 1998, SCIENCE, V279, P1725, DOI 10.1126/science.279.5357.1725; PURVES D, 1974, J PHYSIOL-LONDON, V239, P125, DOI 10.1113/jphysiol.1974.sp010559; Purves D, 1994, NEURAL ACTIVITY GROW; Ribchester RR, 1998, J PHYSIOL-LONDON, V512, P635, DOI 10.1111/j.1469-7793.1998.635bd.x; RIBCHESTER RR, 1993, J PHYSIOL-LONDON, V466, P421; RIBCHESTER RR, 1983, J PHYSIOL-LONDON, V344, P89, DOI 10.1113/jphysiol.1983.sp014926; RIBCHESTER RR, 1984, J PHYSIOL-LONDON, V347, P497, DOI 10.1113/jphysiol.1984.sp015078; RIBCHESTER RR, 1988, J PHYSIOL-LONDON, V401, P53, DOI 10.1113/jphysiol.1988.sp017151; RIBCHESTER RR, 1994, EXP PHYSIOL, V79, P465, DOI 10.1113/expphysiol.1994.sp003781; RICH MM, 1989, J NEUROSCI, V9, P1781, DOI 10.1523/jneurosci.09-05-01781.1989; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sengpiel F, 1999, NAT NEUROSCI, V2, P727, DOI 10.1038/11192; SHYNG SL, 1990, J NEUROSCI, V10, P3905, DOI 10.1523/JNEUROSCI.10-12-03905.1990; Snider WD, 1996, MOL CELL NEUROSCI, V7, P433, DOI 10.1006/mcne.1996.0031; Son YJ, 1996, TRENDS NEUROSCI, V19, P280, DOI 10.1016/S0166-2236(96)10032-1; van Ooyen A, 1999, P ROY SOC B-BIOL SCI, V266, P883; VYSKOCIL F, 1993, EUR J NEUROSCI, V5, P1677, DOI 10.1111/j.1460-9568.1993.tb00235.x; Zoubine MN, 1996, DEV BIOL, V179, P447, DOI 10.1006/dbio.1996.0274	37	59	59	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2000	3	7					694	700		10.1038/76649	http://dx.doi.org/10.1038/76649			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TT	10862702	Green Published			2022-12-24	WOS:000167177200016
J	Savic, I; Gulyas, B; Larsson, M; Roland, P				Savic, I; Gulyas, B; Larsson, M; Roland, P			Olfactory functions are mediated by parallel and hierarchical processing	NEURON			English	Article							POSITRON EMISSION TOMOGRAPHY; ODOR RECOGNITION; MEMORY; CORTEX; BRAIN; PET; INFORMATION; RETRIEVAL; AMYGDALA; REGIONS	How the human brain processes the perception, discrimination, and recognition of odors has not been systematically explored. Cerebral activations were therefore studied with PET during five different olfactory tasks: monorhinal smelling of odorless air (AS), single odors (OS), discrimination of odor intensity (OD-i), discrimination of odor quality (OD-q), and odor recognition memory (OM). OS activated amygdala-piriform, orbitofrontal, insular, and cingulate cortices and right thalamus. OD-i and OD-q both engaged left insula and right cerebellum. OD-q also involved other areas, including right caudate and subiculum. OM did not activate the insula, but instead, the piriform cortex. With the exception of caudate and subiculum, it shared the remaining activations with the OD-q, and engaged, in addition, the temporal and parietal cortices. These findings indicate that olfactory functions are organized in a parallel and hierarchical manner.	Karolinska Inst, Dept Neurosci, Div Human Brain Res, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Neurol, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Clin Neurosci Neurotech, S-17177 Stockholm, Sweden; Uppsala Univ, Dept Psychol, S-75142 Uppsala, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Uppsala University	Savic, I (corresponding author), Karolinska Inst, Dept Neurosci, Div Human Brain Res, Berzelisvag 3, S-17177 Stockholm, Sweden.		Gulyas, Balazs/F-9508-2015					AGGLETON JP, 1986, EXP BRAIN RES, V64, P515, DOI 10.1007/BF00340489; [Anonymous], 1983, CANADIAN PSYCHOL; BARBAS H, 1990, J COMP NEUROL, V300, P549, DOI 10.1002/cne.903000409; BERGSTROM M, 1981, J COMPUT ASSIST TOMO, V5, P136, DOI 10.1097/00004728-198102000-00027; BERRIDGE MS, 1991, J CEREBR BLOOD F MET, V11, P707, DOI 10.1038/jcbfm.1991.127; BUCKNER RL, 1995, J NEUROSCI, V15, P12; Buckner RL, 1996, J NEUROSCI, V16, P6219; Bunsey M, 1996, NATURE, V379, P255, DOI 10.1038/379255a0; Cabeza R, 1997, J COGNITIVE NEUROSCI, V9, P1, DOI 10.1162/jocn.1997.9.1.1; Cahill L, 1996, P NATL ACAD SCI USA, V93, P8016, DOI 10.1073/pnas.93.15.8016; COSTANZO RM, 1997, NEUROBIOLOGY TASTE S, P233; Dade LA, 1998, ANN NY ACAD SCI, V855, P572, DOI 10.1111/j.1749-6632.1998.tb10626.x; DAHLSTROM A, 1964, ACTA PHYSIOL SCAND, V62, P1; DUVERNOY H, 1991, HUMAN BRAIN; EICHENBAUM H, 1983, BRAIN, V106, P459, DOI 10.1093/brain/106.2.459; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FRISTON KJ, 1995, J CEREBR BLOOD F MET, V15, P361, DOI 10.1038/jcbfm.1995.45; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; GLOOR P, 1997, TEMPORAL LOBE LIMBIC, P648; GORDON HW, 1969, NEUROPSYCHOLOGIA, V7, P111, DOI 10.1016/0028-3932(69)90009-8; HABERLY LB, 1985, CHEM SENSES, V10, P219, DOI 10.1093/chemse/10.2.219; HOLTHAUS L, 1978, PSYCHOL BULL, V77, P375; JONESGOTMAN M, 1993, BRAIN COGNITION, V22, P182, DOI 10.1006/brcg.1993.1033; Kettenmann B, 1997, CHEM SENSES, V22, P493, DOI 10.1093/chemse/22.5.493; KETTENMANN B, 1999, ACHEMS, V21, pS67; KIRKSMITH MD, 1983, BIOL PSYCHOL, V17, P221, DOI 10.1016/0301-0511(83)90020-0; Larsson M, 1997, MEMORY, V5, P361; LAWLESS H, 1975, CHEM SENS FLAVOUR, P331; Ledberg A, 1998, NEUROIMAGE, V8, P113, DOI 10.1006/nimg.1998.0336; Mesulam M-M., 1985, CEREB CORTEX, P179, DOI DOI 10.1007/978-1-4757-9619-3_5; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; MEYER E, 1989, J NUCL MED, V30, P1069; MORECRAFT RJ, 1992, J COMP NEUROL, V323, P341, DOI 10.1002/cne.903230304; Nyberg L, 1995, NEUROREPORT, V7, P249, DOI 10.1097/00001756-199512000-00060; Owen AM, 1998, P NATL ACAD SCI USA, V95, P7721, DOI 10.1073/pnas.95.13.7721; POWELL TPS, 1965, J ANAT, V99, P791; POWELL Y, 1990, PERCEPT PSYCHOPHYS, V47, P526; Roland P E, 1994, Hum Brain Mapp, V1, P173, DOI 10.1002/hbm.460010303; Roland PE, 1998, P NATL ACAD SCI USA, V95, P3295, DOI 10.1073/pnas.95.6.3295; Savic I, 1997, ARCH NEUROL-CHICAGO, V54, P162, DOI 10.1001/archneur.1997.00550140038010; SAVIC I, 2000, IN PRESS CHEM SENSES; Schacter DL, 1996, P NATL ACAD SCI USA, V93, P321, DOI 10.1073/pnas.93.1.321; SCHACTER DL, 1995, NATURE, V376, P587, DOI 10.1038/376587a0; SELWAY R, 1990, PHYSIOL BEHAV, V47, P249, DOI 10.1016/0031-9384(90)90138-T; SIARLE SR, 1971, LINEAR MODELS; SIMMONDS A, 1997, NEUROIMAGE, V5, pS196; Sobel N, 1998, J NEUROSCI, V18, P8990; Sobel N, 1998, NATURE, V392, P282, DOI 10.1038/32654; Talairach J., 1988, COPLANAR STEREOTAXIC; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; WILLIAMS SCR, 1997, NEUROIMAGE, V5, pS197; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; ZATORRE RJ, 1991, BRAIN, V114, P71; ZATORRE RJ, 1992, NATURE, V360, P339, DOI 10.1038/360339a0	55	288	291	1	24	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	2000	26	3					735	745		10.1016/S0896-6273(00)81209-X	http://dx.doi.org/10.1016/S0896-6273(00)81209-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	330ZH	10896168	Bronze			2022-12-24	WOS:000087991600023
J	Yazejian, B; Sun, XP; Grinnell, AD				Yazejian, B; Sun, XP; Grinnell, AD			Tracking presynaptic Ca2+ dynamics during neurotransmitter release with Ca2+-activated K+ channels	NATURE NEUROSCIENCE			English	Article							ACTIVATED POTASSIUM CHANNELS; FROG NEUROMUSCULAR-JUNCTION; SACCULAR HAIR-CELLS; TRANSMITTER RELEASE; CALCIUM CHANNELS; SYNAPTIC TRANSMISSION; TIME COURSE; DIFFUSION; MICRODOMAINS; CULTURE	Neurotransmitter release during action potentials is thought to require transient, localized [Ca2+](i) as high as hundreds of micromolar near presynaptic release sites. Most experimental attempts to characterize the magnitude and time course of these Ca2+ domains involve optical methods that sample large volumes, require washout of endogenous buffers and often affect Ca2+ kinetics and transmitter release. Endogenous calcium-activated potassium (K-Ca) channels colocalize with presynaptic Ca2+ channels in Xenopus nerve-muscle cultures. We used these channels to quantify the rapid, dynamic changes in [Ca2+](i) at active zones during synaptic activity. Confirming Ca2+-domain predictions, these K-Ca channels revealed [Ca2+](i) over 100 mu M during synaptic activity and much faster buildup and decay of Ca2+ domains than shown using other techniques.	Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Jerry Lewis Neuromuscular Res Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Grinnell, AD (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.							ADLER EM, 1991, J NEUROSCI, V11, P1496; ART JJ, 1995, J GEN PHYSIOL, V105, P49, DOI 10.1085/jgp.105.1.49; BLUNDON JA, 1995, J NEUROPHYSIOL, V73, P178, DOI 10.1152/jn.1995.73.1.178; BLUNDON JA, 1993, P NATL ACAD SCI USA, V90, P9388, DOI 10.1073/pnas.90.20.9388; BUCHANAN J, 1989, J NEUROSCI, V9, P1540; CHAD JE, 1984, BIOPHYS J, V45, P993, DOI 10.1016/S0006-3495(84)84244-7; DiGregorio DA, 1997, J PHYSIOL-LONDON, V505, P585, DOI 10.1111/j.1469-7793.1997.585ba.x; DiGregorio DA, 1999, J NEUROSCI, V19, P7846; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; FOGELSON AL, 1985, BIOPHYS J, V48, P1003, DOI 10.1016/S0006-3495(85)83863-7; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HEUSER JE, 1981, J CELL BIOL, V88, P564, DOI 10.1083/jcb.88.3.564; HILLE B, 1992, IONIC CHANNELS EXCIT, P83; HUDSPETH AJ, 1988, J PHYSIOL-LONDON, V400, P237, DOI 10.1113/jphysiol.1988.sp017119; Katz B., 1969, RELEASE NEURAL TRANS; Kim K, 1997, P NATL ACAD SCI USA, V94, P14782, DOI 10.1073/pnas.94.26.14782; Klingauf J, 1997, BIOPHYS J, V72, P674, DOI 10.1016/S0006-3495(97)78704-6; LLINAS R, 1995, NEUROPHARMACOLOGY, V34, P1443, DOI 10.1016/0028-3908(95)00150-5; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674; MCCLESKEY EW, 1987, P NATL ACAD SCI USA, V84, P4327, DOI 10.1073/pnas.84.12.4327; MCMANUS OB, 1991, J BIOENERG BIOMEMBR, V23, P537, DOI 10.1007/BF00785810; PARNAS H, 1989, BIOPHYS J, V55, P859, DOI 10.1016/S0006-3495(89)82885-1; Pawson PA, 1998, J NEUROCYTOL, V27, P361, DOI 10.1023/A:1006942909544; Prakriya M, 1996, J NEUROSCI, V16, P4344; Rettig J, 1997, J NEUROSCI, V17, P6647; ROBERTS WM, 1994, J NEUROSCI, V14, P3246; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; Sakaba T, 1997, NEUROSCI RES, V27, P219, DOI 10.1016/S0168-0102(97)01155-3; Sheng ZH, 1998, J BIOENERG BIOMEMBR, V30, P335, DOI 10.1023/A:1021985521748; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; SPITZER NC, 1976, P NATL ACAD SCI USA, V73, P1641, DOI 10.1073/pnas.73.5.1641; Tabti N., 1991, CULTURING NERVE CELL, P137; WATSKY MA, 1991, INVEST OPHTH VIS SCI, V32, P106; WELDON PR, 1979, J NEUROCYTOL, V8, P239, DOI 10.1007/BF01175564; Wiser O, 1999, P NATL ACAD SCI USA, V96, P248, DOI 10.1073/pnas.96.1.248; Wu YC, 1996, BIOPHYS J, V71, P2256, DOI 10.1016/S0006-3495(96)79429-8; YAMADA WM, 1992, BIOPHYS J, V61, P671, DOI 10.1016/S0006-3495(92)81872-6; Yazejian B, 1997, J NEUROSCI, V17, P2990; ZUCKER RS, 1986, P NATL ACAD SCI USA, V83, P3032, DOI 10.1073/pnas.83.9.3032	42	78	80	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2000	3	6					566	571		10.1038/75737	http://dx.doi.org/10.1038/75737			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	317WG	10816312				2022-12-24	WOS:000087249500012
J	Hummel, T; Krukkert, K; Roos, J; Davis, G; Klambt, C				Hummel, T; Krukkert, K; Roos, J; Davis, G; Klambt, C			Drosophila Futsch/22C10 is a MAP1B-like protein required for dendritic and axonal development	NEURON			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; CULTURED CEREBELLAR MACRONEURONS; TAU-ANTISENSE OLIGONUCLEOTIDES; CENTRAL-NERVOUS-SYSTEM; NEURONAL DEVELOPMENT; MONOCLONAL-ANTIBODIES; GENOMIC ORGANIZATION; NEURITE OUTGROWTH; BINDING DOMAIN; RAT-BRAIN	Here we report the description of the Drosophila gene futsch, which encodes a protein recognized by the monoclonal antibody 22C10 that has been widely used to visualize neuronal morphology and axonal projections. The Futsch protein is 5327 amino acids in length. It localizes to the microtubule compartment of the cell and associates with microtubules in vitro. The N- and C-terminal domains of Futsch are homologous to the vertebrate MAP1B microtubule-associated protein. The central domain of the Futsch protein is highly repetitive and shows sequence similarity to neurofilament proteins of which no Drosophila homologs have been reported. Loss-of-function analyses demonstrate that during embryogenesis Futsch is necessary for dendritic and axonal growth. Gain-of-function analyses demonstrate a functional interaction of Futsch with other MAPs. In addition, we show that during development, futsch expression is negatively regulated in non-neuronal tissues.	Univ Munster, Inst Neurobiol, D-48149 Munster, Germany; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of Munster; University of California System; University of California San Francisco	Klambt, C (corresponding author), Univ Munster, Inst Neurobiol, Badestr 9, D-48149 Munster, Germany.	klaembt@mail.uni-muenster.de			NCI NIH HHS [T32-CA 09270-23] Funding Source: Medline; NINDS NIH HHS [NS39313-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039313] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALCANTARA AA, 1995, BRAIN RES, V701, P47, DOI 10.1016/0006-8993(95)00953-X; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRUGG B, 1993, NEUROSCIENCE, V52, P489, DOI 10.1016/0306-4522(93)90401-Z; CACERES A, 1992, NEURON, V9, P607, DOI 10.1016/0896-6273(92)90025-9; CACERES A, 1991, J NEUROSCI, V11, P1515; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; CALLAHAN CA, 1994, P NATL ACAD SCI USA, V91, P5972, DOI 10.1073/pnas.91.13.5972; CAMBIAZO V, 1995, J NEUROCHEM, V64, P1288; CANAL I, 1986, J NEUROGENET, V3, P293, DOI 10.3109/01677068609106856; DiTella MC, 1996, J CELL SCI, V109, P467; DOTTI CG, 1987, NEUROSCIENCE, V23, P121, DOI 10.1016/0306-4522(87)90276-4; DUNINBORKOWSKI OM, 1995, DEV BIOL, V168, P689, DOI 10.1006/dbio.1995.1115; Edelmann W, 1996, P NATL ACAD SCI USA, V93, P1270, DOI 10.1073/pnas.93.3.1270; Estes PS, 1996, J NEUROSCI, V16, P5443; Fink JK, 1996, GENOMICS, V35, P577, DOI 10.1006/geno.1996.0400; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; Giesen K, 1997, DEVELOPMENT, V124, P2307; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; GOLDSTEIN LSB, 1986, J CELL BIOL, V102, P2076, DOI 10.1083/jcb.102.6.2076; GOODMAN CS, 1984, SCIENCE, V225, P1271, DOI 10.1126/science.6474176; Gordon-Weeks PR, 2000, MICROSC RES TECHNIQ, V48, P63, DOI 10.1002/(SICI)1097-0029(20000115)48:2<63::AID-JEMT2>3.0.CO;2-1; HAMMARBACK JA, 1991, NEURON, V7, P129, DOI 10.1016/0896-6273(91)90081-A; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; HOCH M, 1994, DEVELOPMENT, V120, P3439; Hurd DD, 1996, GENETICS, V144, P1075; IRMINGERFINGER I, 1990, J CELL BIOL, V111, P2563, DOI 10.1083/jcb.111.6.2563; Ito K, 1997, CELL TISSUE RES, V290, P1, DOI 10.1007/s004410050901; KANIA A, 1995, GENETICS, V139, P1663; KIRKPATRICK LL, 1994, J NEUROSCI, V14, P7440; KLAES A, 1994, CELL, V78, P149, DOI 10.1016/0092-8674(94)90581-9; KOSIK KS, 1987, J NEUROSCI, V7, P3142; Kutschera W, 1998, GENOMICS, V49, P430, DOI 10.1006/geno.1998.5294; Landon, 1977, Methods Enzymol, V47, P145; LANGKOPF A, 1992, J BIOL CHEM, V267, P16561; LIEN LL, 1994, GENOMICS, V22, P273, DOI 10.1006/geno.1994.1384; Mack TGA, 2000, MOL CELL NEUROSCI, V15, P51, DOI 10.1006/mcne.1999.0802; MATUS A, 1981, P NATL ACAD SCI-BIOL, V78, P3010, DOI 10.1073/pnas.78.5.3010; MATUS A, 1991, J CELL SCI, P61; NOBLE M, 1989, J CELL BIOL, V109, P3367, DOI 10.1083/jcb.109.6.3367; PENG I, 1986, J CELL BIOL, V102, P252, DOI 10.1083/jcb.102.1.252; PEREIRA A, 1992, J CELL BIOL, V116, P377, DOI 10.1083/jcb.116.2.377; Phillis R, 1996, DEVELOPMENT, V122, P2955; REICHMUTH C, 1995, MOL BRAIN RES, V32, P45, DOI 10.1016/0169-328X(95)00058-Z; ROBERTSON HM, 1988, GENETICS, V118, P461; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Rorth P, 1998, DEVELOPMENT, V125, P1049; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Salzberg A, 1997, GENETICS, V147, P1723; SALZBERG A, 1994, NEURON, V13, P269, DOI 10.1016/0896-6273(94)90346-8; SAXTON WM, 1991, CELL, V64, P1093, DOI 10.1016/0092-8674(91)90264-Y; SCHOENFELD TA, 1994, INT REV CYTOL, V151, P67, DOI 10.1016/S0074-7696(08)62631-5; Scholz H, 1997, MECH DEVELOP, V64, P137; SHEA TB, 1994, MOL BIOL CELL, V5, P863, DOI 10.1091/mbc.5.8.863; SRINIVASAN S, 1995, BRAIN RES, V701, P39, DOI 10.1016/0006-8993(95)00952-8; Takei Y, 1997, J CELL BIOL, V137, P1615, DOI 10.1083/jcb.137.7.1615; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Tissot M, 1997, J NEUROBIOL, V32, P281, DOI 10.1002/(SICI)1097-4695(199703)32:3<281::AID-NEU3>3.0.CO;2-3; TIX S, 1989, DEVELOPMENT, V105, P739; Tonge DA, 1996, NEUROSCIENCE, V73, P541, DOI 10.1016/0306-4522(96)00077-2; VAN AN, 1993, INT J MINER PROCESS, V37, P1; Veeranna, 1998, J NEUROSCI, V18, P4008; WANDOSELL F, 1987, J CELL BIOCHEM, V35, P83, DOI 10.1002/jcb.240350202; ZAUNER W, 1992, EUR J CELL BIOL, V57, P66; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	66	332	336	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	2000	26	2					357	370		10.1016/S0896-6273(00)81169-1	http://dx.doi.org/10.1016/S0896-6273(00)81169-1			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318QZ	10839355	Bronze			2022-12-24	WOS:000087296500013
J	Rothenfluh, A; Young, MW; Saez, L				Rothenfluh, A; Young, MW; Saez, L			A TIMELESS-independent function for PERIOD proteins in the Drosophila clock	NEURON			English	Article							CIRCADIAN BEHAVIORAL RHYTHMS; NUCLEAR-LOCALIZATION; FEEDBACK LOOP; TIM COMPLEX; LIGHT; GENE; TRANSCRIPTION; ENTRAINMENT; MUTANT; CRYPTOCHROME	The mutation timeless(UL) generates 33 hr rhythms, prolonged nuclear localization of PERIOD/TIMELESSUL protein complexes, and protracted derepression of period (per) and timeless (tim) transcription. Light-induced elimination of TIMUL from nuclear PER/TIMUL complexes gives strong downregulation of per and tim expression. Thus, in the absence of TIM, nuclear PER can function as a potent negative transcriptional regulator. Two additional studies support this role for PER: (1) Drosophila expressing PER that constitutively localizes to nuclei produce dominant behavioral arrhythmicity, and (2) constitutively nuclear PER represses dCLOCk/CYCLE-mediated transcription of per in cultured cells without TIM. Conversion of PER/TIM heterodimers to nuclear PER proteins appears to be required to complete transcriptional repression and terminate each circadian molecular cycle.	Rockefeller Univ, Genet Lab, New York, NY 10021 USA; Rockefeller Univ, Natl Sci Fdn, Sci & Technol Ctr Biol Timing, New York, NY 10021 USA	Rockefeller University; National Science Foundation (NSF); NSF - Center for Biological Timing; Rockefeller University	Young, MW (corresponding author), Rockefeller Univ, Genet Lab, 1230 York Ave, New York, NY 10021 USA.	young@rockvax.rockefeller.edu	, 机智的马小跳和机智的羊不愁/ABC-5169-2020	Rothenfluh, Adrian/0000-0002-3813-5723	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054339, R37GM054339] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-54339] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; BAYLIES MK, 1992, MOL GENETICS BIOL RH, P123; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; GEKAKIS N, 1995, SCIENCE, V270, P811, DOI 10.1126/science.270.5237.811; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; Hall JC, 1998, ADV GENET, V38, P135, DOI 10.1016/S0065-2660(08)60143-1; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Hardin PE, 1998, CURR OPIN NEUROBIOL, V8, P642, DOI 10.1016/S0959-4388(98)80093-7; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Lee C, 1999, MOL CELL BIOL, V19, P5316; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; LEWIS EB, 1968, DROSOPHILA INFORM SE, V43, P193; Marrus SB, 1996, EMBO J, V15, P6877, DOI 10.1002/j.1460-2075.1996.tb01080.x; Matsumoto A, 1999, MOL CELL BIOL, V19, P4343; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; MYERS MP, 1995, SCIENCE, V270, P805, DOI 10.1126/science.270.5237.805; Myers MP, 1997, NUCLEIC ACIDS RES, V25, P4710, DOI 10.1093/nar/25.23.4710; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; PETERSEN G, 1988, EMBO J, V7, P3939, DOI 10.1002/j.1460-2075.1988.tb03280.x; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; PRICE JL, 1995, EMBO J, V14, P4044, DOI 10.1002/j.1460-2075.1995.tb00075.x; Qiu J, 1996, MOL CELL BIOL, V16, P4182; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Reppert SM, 1998, NEURON, V21, P1, DOI 10.1016/S0896-6273(00)80234-2; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Rutila JE, 1996, NEURON, V17, P921, DOI 10.1016/S0896-6273(00)80223-8; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Saez L, 1996, NEURON, V17, P911, DOI 10.1016/S0896-6273(00)80222-6; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; So WV, 1997, EMBO J, V16, P7146, DOI 10.1093/emboj/16.23.7146; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; VOSSHALL LB, 1994, SCIENCE, V263, P1606, DOI 10.1126/science.8128247; Young MW, 1996, COLD SPRING HARB SYM, V61, P279; Young MW, 1998, ANNU REV BIOCHEM, V67, P135, DOI 10.1146/annurev.biochem.67.1.135; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0; ZENG HK, 1994, EMBO J, V13, P3590, DOI 10.1002/j.1460-2075.1994.tb06666.x; ZERR DM, 1990, J NEUROSCI, V10, P2749	47	128	130	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	2000	26	2					505	514		10.1016/S0896-6273(00)81182-4	http://dx.doi.org/10.1016/S0896-6273(00)81182-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318QZ	10839368	Bronze			2022-12-24	WOS:000087296500026
J	Sheth, BR; Nijhawan, R; Shimojo, S				Sheth, BR; Nijhawan, R; Shimojo, S			Changing objects lead briefly flashed ones	NATURE NEUROSCIENCE			English	Article							SINGLE-CELL PROPERTIES; MONKEY STRIATE CORTEX; PSYCHOMETRIC FUNCTIONS; VISIBLE PERSISTENCE; PERCEIVED POSITION; EXTRAPOLATION; STIMULI; MOTION; PERCEPTION; MACAQUE	Continuous, predictable events and spontaneous events may coincide in the visual environment. For a continuously moving object, the brain compensates for delays in transmission between a retinal event and neural responses in higher visual areas. Here we show that it similarly compensated for other smoothly changing features. A disk was flashed briefly during the presentation of another disk of continuously changing color, and observers compared the colors of the disks at the moment of flash. We also tested luminance, spatial frequency and pattern entropy; for all features, the continuously changing item led the flashed item in feature space. Thus the visual system's ability to compensate for delays in information about a continuously changing stimulus may extend to all features. We propose a model based on backward masking and priming to explain the phenomenon.	CALTECH 139 74, Pasadena, CA 91125 USA	California Institute of Technology	Sheth, BR (corresponding author), CALTECH 139 74, Pasadena, CA 91125 USA.							ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; Bachmann T., 1994, PSYCHOPHYSIOLOGY VIS; BALDO MVC, 1995, NATURE, V378, P565, DOI 10.1038/378565a0; BARTRAM DJ, 1974, COGNITIVE PSYCHOL, V6, P325, DOI 10.1016/0010-0285(74)90016-4; Berry MJ, 1999, NATURE, V398, P334, DOI 10.1038/18678; BLAKEMOR.C, 1969, SCIENCE, V166, P245, DOI 10.1126/science.166.3902.245; BOYNTON RM, 1968, SCIENCE, V161, P366, DOI 10.1126/science.161.3839.366; Brainard D. H., 1997, SPATIAL VISION, V10, P443, DOI DOI 10.1163/156856897X00357; Breitmeyer B.G., 1984, VISUAL MASKING INTEG; CAMPBELL FW, 1969, J PHYSIOL-LONDON, V203, P223, DOI 10.1113/jphysiol.1969.sp008861; Cavanagh P, 1997, NATURE, V386, P19, DOI 10.1038/386019a0; COLTHEART M, 1980, PERCEPT PSYCHOPHYS, V27, P183, DOI 10.3758/BF03204258; DILOLLO V, 1995, PSYCHOL BULL, V118, P223, DOI 10.1037/0033-2909.118.2.223; DILOLLO V, 1980, J EXP PSYCHOL GEN, V109, P75, DOI 10.1037/0096-3445.109.1.75; Eagleman DM, 2000, SCIENCE, V287, P2036, DOI 10.1126/science.287.5460.2036; EFRON R, 1973, PERCEPT PSYCHOPHYS, V14, P518, DOI 10.3758/BF03211193; Finney D.J., 1971, PROBIT ANAL; FOSTER DH, 1991, PSYCHOL BULL, V109, P152, DOI 10.1037/0033-2909.109.1.152; HAMMOND P, 1975, EXP BRAIN RES, V22, P427; HARTLINE HK, 1938, AM J PSYCHOL, V57, P243; HUBEL DH, 1961, J PHYSIOL-LONDON, V155, P385, DOI 10.1113/jphysiol.1961.sp006635; JONIDES J, 1988, PERCEPT PSYCHOPHYS, V43, P346, DOI 10.3758/BF03208805; KHURANA B, 1995, NATURE, V378, P565; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; MARCEL AJ, 1983, COGNITIVE PSYCHOL, V15, P238, DOI 10.1016/0010-0285(83)90010-5; MAUNSELL JHR, 1992, J NEUROPHYSIOL, V68, P1332, DOI 10.1152/jn.1992.68.4.1332; MCKEE SP, 1985, PERCEPT PSYCHOPHYS, V37, P286, DOI 10.3758/BF03211350; Nijhawan R, 1997, NATURE, V386, P66, DOI 10.1038/386066a0; Nishida S, 1999, NATURE, V397, P610, DOI 10.1038/17600; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Purushothaman G, 1998, NATURE, V396, P424, DOI 10.1038/24766; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1288, DOI 10.1152/jn.1976.39.6.1288; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1334, DOI 10.1152/jn.1976.39.6.1334; Snowden RJ, 1998, CURR BIOL, V8, P1343, DOI 10.1016/S0960-9822(07)00567-2; Suzuki S, 1997, J EXP PSYCHOL HUMAN, V23, P443, DOI 10.1037/0096-1523.23.2.443; TURVEY MT, 1973, PSYCHOL REV, V80, P1, DOI 10.1037/h0033872; VONHELMHOLTZ H, 1909, HDB PHYSL OPTIK, V2, P240; Whitney D, 1998, NAT NEUROSCI, V1, P656, DOI 10.1038/3659; Wohlgemuth A., 1911, AFTER EFFECT SEEN MO, V1; ZEKI S, 1980, NATURE, V284, P412, DOI 10.1038/284412a0	40	112	112	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2000	3	5					489	495		10.1038/74865	http://dx.doi.org/10.1038/74865			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	309DG	10769390				2022-12-24	WOS:000086752000019
J	Rieke, F; Baylor, DA				Rieke, F; Baylor, DA			Origin and functional impact of dark noise in retinal cones	NEURON			English	Article							MONKEY MACACA-FASCICULARIS; ROD PHOTORECEPTORS; SALAMANDER; TRANSDUCTION; SENSITIVITY; ADAPTATION; CELLS	Spontaneous fluctuations in the electrical signals of the retina's photoreceptors impose a fundamental limit on visual sensitivity. While noise in the rods has been studied extensively, relatively little is known about the noise of cones. We show that the origin of the dark noise in salamander cones varies with cone type. Most of the noise in long wavelength-sensitive (L) cones arose from spontaneous activation of the photopigment, which is a million-fold less stable than the rod photopigment rhodopsin. Most of the noise in short wavelength-sensitive (S) cones arose in a later stage of the transduction cascade, as the photopigment was relatively stable. Spontaneous pigment activation effectively light adapted L cones in darkness, causing them to have a smaller and briefer dim flash response than S cones.	Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	University of Washington; University of Washington Seattle; Stanford University	Rieke, F (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.				NATIONAL EYE INSTITUTE [R01EY001543, R37EY001543, R01EY011850] Funding Source: NIH RePORTER; NEI NIH HHS [EY01543, EY11850] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AHO AC, 1988, NATURE, V334, P348, DOI 10.1038/334348a0; BARLOW HB, 1957, NATURE, V179, P255, DOI 10.1038/179255b0; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; BIALEK W, 1990, BIOPHYS J, V58, P1227, DOI 10.1016/S0006-3495(90)82463-2; HAMILTON SE, 1990, J BIOL CHEM, V265, P11259; Koskelainen A, 2000, NATURE, V403, P220, DOI 10.1038/35003242; LAGNADO L, 1994, NATURE, V367, P273, DOI 10.1038/367273a0; LAMB TD, 1977, J PHYSIOL-LONDON, V272, P435, DOI 10.1113/jphysiol.1977.sp012053; LEIBROCK CS, 1994, VISION RES, V34, P2787, DOI 10.1016/0042-6989(94)90048-5; Makino CL, 1996, J GEN PHYSIOL, V108, P27, DOI 10.1085/jgp.108.1.27; PERRY RJ, 1991, J PHYSIOL-LONDON, V433, P561, DOI 10.1113/jphysiol.1991.sp018444; Rieke F, 1996, BIOPHYS J, V71, P2553, DOI 10.1016/S0006-3495(96)79448-1; Rieke F, 1998, REV MOD PHYS, V70, P1027, DOI 10.1103/RevModPhys.70.1027; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; Schneeweis DM, 1999, J NEUROSCI, V19, P1203; Vu TQ, 1997, J PHYSIOL-LONDON, V505, P193, DOI 10.1111/j.1469-7793.1997.193bc.x	17	111	113	0	17	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	2000	26	1					181	186		10.1016/S0896-6273(00)81148-4	http://dx.doi.org/10.1016/S0896-6273(00)81148-4			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309MA	10798402	Bronze			2022-12-24	WOS:000086770500018
J	Romo, R; Hernandez, A; Zainos, A; Brody, CD; Lemus, L				Romo, R; Hernandez, A; Zainos, A; Brody, CD; Lemus, L			Sensing without touching: Psychophysical performance based on cortical microstimulation	NEURON			English	Article							DISCRIMINATION TASK; MONKEYS; CORTEX; DIRECTION; FLUTTER; NEURONS	Unequivocal proof that the activity of a localized cortical neuronal population provides sufficient basis for a specific cognitive function has rarely been obtained. We looked for such proof in monkeys trained to discriminate between two mechanical flutter stimuli applied sequentially to the fingertips. Microelectrodes were inserted into clusters of quickly adapting (QA) neurons of the primary somatosensory cortex (S1), and the first or both stimuli were then substituted with trains of current pulses during the discrimination task. Psychophysical performance with artificial stimulus frequencies was almost identical to that measured with the natural stimulus frequencies. Our results indicate that microstimutation can be used to elicit a memorizable and discriminable analog range of percepts, and shows that activation of the QA circuit of S1 is sufficient to initiate all subsequent neural processes associated with flutter discrimination.	Natl Autonomous Univ Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Romo, R (corresponding author), Natl Autonomous Univ Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico.		Lemus, Luis/E-6760-2019	Lemus, Luis/0000-0002-6608-3684; romo, ranulfo/0000-0003-3529-3635; zainos, antonio/0000-0001-6137-1794				Britten KH, 1998, NAT NEUROSCI, V1, P59, DOI 10.1038/259; Hernandez A, 1997, J NEUROSCI, V17, P6391; JONES EG, 1975, SCIENCE, V190, P572, DOI 10.1126/science.810887; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; MOUNTCASTLE VB, 1990, J NEUROSCI, V10, P3032; MOUNTCASTLE VB, 1991, J NEUROSCI METH, V36, P77, DOI 10.1016/0165-0270(91)90140-U; OCHOA J, 1983, J PHYSIOL-LONDON, V342, P633, DOI 10.1113/jphysiol.1983.sp014873; POWELL TPS, 1959, B JOHNS HOPKINS HOSP, V105, P133; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1071, DOI 10.1152/jn.1992.67.5.1071; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; Seidemann E, 1998, NATURE, V394, P72, DOI 10.1038/27906; SUR M, 1981, SCIENCE, V212, P1059, DOI 10.1126/science.7233199; SUR M, 1984, J NEUROPHYSIOL, V51, P724, DOI 10.1152/jn.1984.51.4.724; Vallbo Ake B., 1995, P237; [No title captured]	18	206	214	0	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	2000	26	1					273	278		10.1016/S0896-6273(00)81156-3	http://dx.doi.org/10.1016/S0896-6273(00)81156-3			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309MA	10798410	Bronze			2022-12-24	WOS:000086770500026
J	Wang, YT; Linden, DJ				Wang, YT; Linden, DJ			Expression of cerebellar long-term depression requires postsynaptic clathrin-mediated endocytosis	NEURON			English	Article							GROWTH-FACTOR-I; PROTEIN-KINASE-C; PURKINJE-CELLS; ADULT-RATS; GLUTAMATE SENSITIVITY; CLIMBING FIBER; INSULIN; CALCIUM; INDUCTION; RECEPTOR	Cerebellar long-term depression (LTD) is a cellular model system of information storage that may underlie certain forms of motor learning. While cerebellar LTD is expressed as a selective modification of postsynaptic AMPA receptors, this might involve changes in receptor number/distribution, unitary conductance, kinetics, or glutamate affinity. The observation that GluR2-containing synaptic AMPA receptors could be internalized by regulated clathrin-mediated endocytosis suggested that this process could underlie LTD expression. To test this hypothesis, we postsynaptically applied dynamin and amphiphysin peptides that interfere with the clathrin endocytotic complex and found that they blocked LTD expression in cultured Purkinje neurons. In addition, induction of LTD and attenuation of AMPA responses by stimulation of clathrin-mediated endocytosis occluded each other. These findings suggest that the expression of cerebellar LTD requires clathrin-mediated internalization of postsynaptic AMPA receptors.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Hosp Sick Children, Programme Brain & Behav, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Div Pathol, Toronto, ON M5G 1X8, Canada	Johns Hopkins University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Linden, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.		Wang, Yu Tian/A-4729-2008; Wang, Yu Tian/J-8255-2015		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051106, R37MH051106, R29MH051106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036842] Funding Source: NIH RePORTER; NIMH NIH HHS [MH51106, MH01590] Funding Source: Medline; NINDS NIH HHS [NS36842] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott MA, 1999, J NEUROSCI, V19, P7300, DOI 10.1523/JNEUROSCI.19-17-07300.1999; AJIMA A, 1995, NEUROREPORT, V6, P297, DOI 10.1097/00001756-199501000-00018; Barylko B, 1998, J BIOL CHEM, V273, P3791, DOI 10.1074/jbc.273.6.3791; Blair LAC, 1997, NEURON, V19, P421, DOI 10.1016/S0896-6273(00)80950-2; BONDY C, 1992, NEUROSCIENCE, V46, P909, DOI 10.1016/0306-4522(92)90193-6; BURNASHEV N, 1992, SCIENCE, V256, P1566, DOI 10.1126/science.1317970; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; CASTROALAMANCOS MA, 1994, P NATL ACAD SCI USA, V91, P10203, DOI 10.1073/pnas.91.21.10203; CASTROALAMANCOS MA, 1993, P NATL ACAD SCI USA, V90, P7386, DOI 10.1073/pnas.90.15.7386; CastroAlamancos MA, 1996, NEUROSCIENCE, V70, P843, DOI 10.1016/0306-4522(95)00472-6; Craft S, 1998, NEUROLOGY, V50, P164, DOI 10.1212/WNL.50.1.164; CREPEL F, 1988, BRAIN RES, V458, P397, DOI 10.1016/0006-8993(88)90486-6; Daniel H, 1998, TRENDS NEUROSCI, V21, P401, DOI 10.1016/S0166-2236(98)01304-6; Engisch KL, 1998, J PHYSIOL-LONDON, V506, P591, DOI 10.1111/j.1469-7793.1998.591bv.x; GarciaSegura LM, 1997, J NEUROCYTOL, V26, P479, DOI 10.1023/A:1018581407804; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; HARTELL NA, 1994, NEUROREPORT, V5, P833, DOI 10.1097/00001756-199403000-00024; HEIDENREICH KA, 1993, ANN NY ACAD SCI, V692, P72; HEMART N, 1994, NEUROSCI RES, V19, P213, DOI 10.1016/0168-0102(94)90145-7; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; Kasahara J, 1998, NEUROSCI LETT, V247, P139, DOI 10.1016/S0304-3940(98)00299-7; Khodakhah K, 1997, P NATL ACAD SCI USA, V94, P14009, DOI 10.1073/pnas.94.25.14009; Klein DE, 1998, J BIOL CHEM, V273, P27725, DOI 10.1074/jbc.273.42.27725; KLEPPISCH T, 1992, BRAIN RES, V591, P283, DOI 10.1016/0006-8993(92)91709-N; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; KULL FC, 1983, J BIOL CHEM, V258, P6561; Lai MM, 1999, J BIOL CHEM, V274, P25963, DOI 10.1074/jbc.274.37.25963; Lannert H, 1998, BEHAV NEUROSCI, V112, P1199, DOI 10.1037/0735-7044.112.5.1199; LevRam V, 1997, NEURON, V18, P1025, DOI 10.1016/S0896-6273(00)80340-2; Liao GY, 1999, J NEUROCHEM, V73, P1510, DOI 10.1046/j.1471-4159.1999.0731510.x; Linden D J, 1994, Learn Mem, V1, P121; LINDEN DJ, 1993, NEURON, V11, P1093, DOI 10.1016/0896-6273(93)90222-D; LINDEN DJ, 1995, J NEUROSCI, V15, P5098; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; Linden DJ, 1997, NEURON, V18, P983, DOI 10.1016/S0896-6273(00)80337-2; Linden DJ, 1999, J NEUROSCI, V19, P10221; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Markowska AL, 1998, NEUROSCIENCE, V87, P559, DOI 10.1016/S0306-4522(98)00143-2; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; MORGAN DO, 1987, P NATL ACAD SCI USA, V84, P41, DOI 10.1073/pnas.84.1.41; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Narasimhan K, 1998, J NEUROPHYSIOL, V80, P2963, DOI 10.1152/jn.1998.80.6.2963; Narasimhan K, 1996, NEURON, V17, P333, DOI 10.1016/S0896-6273(00)80164-6; O'Dell T J, 1994, Learn Mem, V1, P129; PIETRZKOWSKI Z, 1992, CANCER RES, V52, P6447; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; ROSEMUND C, 1992, J NEUROPHYSIOL, V68, P1901, DOI 10.1152/jn.1992.68.5.1901; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; SELINFREUND RH, 1994, MOL PHARMACOL, V45, P1215; Sherrard RM, 1997, DEV BRAIN RES, V98, P102, DOI 10.1016/S0165-3806(96)00174-5; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Slepnev VI, 1998, SCIENCE, V281, P821, DOI 10.1126/science.281.5378.821; Tempia F, 1996, J NEUROSCI, V16, P456; Torres-Aleman I, 1998, NEUROSCIENCE, V83, P321, DOI 10.1016/S0306-4522(97)00367-9; WERTHER GA, 1990, MOL ENDOCRINOL, V4, P773, DOI 10.1210/mend-4-5-773	61	376	387	0	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR	2000	25	3					635	647		10.1016/S0896-6273(00)81066-1	http://dx.doi.org/10.1016/S0896-6273(00)81066-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	301CY	10774731	Bronze			2022-12-24	WOS:000086291700016
J	Protti, DA; Flores-Herr, N; von Gersdorff, H				Protti, DA; Flores-Herr, N; von Gersdorff, H			Light evokes Ca2+ spikes in the axon terminal of a retinal bipolar cell	NEURON			English	Article							TIGER-SALAMANDER RETINA; SENSITIVE CALCIUM CURRENT; GOLDFISH RETINA; CARP RETINA; SYNAPTIC TERMINALS; GANGLION-CELLS; AMACRINE CELLS; RAT RETINA; 2-AMINO-4-PHOSPHONOBUTYRIC ACID; MORPHOLOGICAL IDENTIFICATION	Bipolar cells in the vertebrate retina have been characterized as nonspiking interneurons. Using patch-clamp recordings from goldfish retinal slices, we find, however, that the morphologically well-defined Mb1 bipolar cell is capable of generating spikes. Surprisingly, in dark-adapted retina, spikes were reliably evoked by light flashes and had a long (1-2 s) refractory period. In light-adapted retina, most Mb1 cells did not spike. However, an L-type Ca2+ channel agonist could induce periodic spiking in these cells. Spikes were determined to be Ca2+ action potentials triggered at the axon terminal and were abolished by 2-amino-4-phosphonobutyric acid (APB), an agonist that mimics glutamate. Signaling via spikes in a specific class of bipolar cells may serve to accelerate and amplify small photoreceptor signals, thereby securing the synaptic transmission of dim and rapidly changing visual input.	Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; Max Planck Inst Brain Res, D-60528 Frankfurt, Germany; Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA	Max Planck Society; Max Planck Society; Oregon Health & Science University	Protti, DA (corresponding author), Max Planck Inst Biophys Chem, Fassberg, D-37077 Gottingen, Germany.							Armstrong CE, 1998, J NEUROSCI, V18, P2962; ASHMORE JF, 1980, J PHYSIOL-LONDON, V300, P115, DOI 10.1113/jphysiol.1980.sp013155; BAYLOR DA, 1973, J PHYSIOL-LONDON, V234, P163, DOI 10.1113/jphysiol.1973.sp010340; BELGUM JH, 1982, J PHYSIOL-LONDON, V326, P91, DOI 10.1113/jphysiol.1982.sp014179; Burrone J, 1997, J PHYSIOL-LONDON, V505, P571, DOI 10.1111/j.1469-7793.1997.571ba.x; Cohen ED, 1998, J NEUROPHYSIOL, V80, P2975, DOI 10.1152/jn.1998.80.6.2975; CUENCA N, 1993, NEUROSCI LETT, V162, P34, DOI 10.1016/0304-3940(93)90553-W; DACHEUX RF, 1986, J NEUROSCI, V6, P331; DELAVILLA P, 1995, J NEUROSCI, V15, P3571; DIXON DB, 1992, J PHYSIOL-LONDON, V449, P589, DOI 10.1113/jphysiol.1992.sp019103; Dong CJ, 1998, J NEUROPHYSIOL, V79, P2171, DOI 10.1152/jn.1998.79.4.2171; DOWLING JE, 1986, TRENDS NEUROSCI, V9, P236, DOI 10.1016/0166-2236(86)90065-2; Euler T, 1996, J NEUROSCI, V16, P2934; FAIN GL, 1980, J PHYSIOL-LONDON, V303, P495, DOI 10.1113/jphysiol.1980.sp013300; Fan SF, 1999, VISUAL NEUROSCI, V16, P141, DOI 10.1017/S0952523899161091; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; Grant GB, 1996, J NEUROPHYSIOL, V76, P3842, DOI 10.1152/jn.1996.76.6.3842; Hartveit E, 1999, J NEUROPHYSIOL, V81, P2923, DOI 10.1152/jn.1999.81.6.2923; HEIDELBERGER R, 1992, J PHYSIOL-LONDON, V447, P235, DOI 10.1113/jphysiol.1992.sp019000; HIRANO AA, 1991, P NATL ACAD SCI USA, V88, P805, DOI 10.1073/pnas.88.3.805; ISHIDA AT, 1980, J COMP NEUROL, V191, P315, DOI 10.1002/cne.901910302; KANEKO A, 1985, J PHYSIOL-LONDON, V358, P131, DOI 10.1113/jphysiol.1985.sp015544; KANEKO A, 1970, J PHYSIOL-LONDON, V207, P623, DOI 10.1113/jphysiol.1970.sp009084; KARSCHIN A, 1990, J NEUROPHYSIOL, V63, P860, DOI 10.1152/jn.1990.63.4.860; KLUMPP DJ, 1995, J NEUROSCI, V15, P5005; KOBAYASHI K, 1995, J PHYSIOL-LONDON, V483, P79, DOI 10.1113/jphysiol.1995.sp020569; KUJIRAOKA T, 1988, J GEN PHYSIOL, V92, P475, DOI 10.1085/jgp.92.4.475; KYROZIS A, 1995, J NEUROSCI METH, V57, P27, DOI 10.1016/0165-0270(94)00116-X; MARICQ AV, 1988, NEURON, V1, P503, DOI 10.1016/0896-6273(88)90181-X; Marty A., 1983, SINGLE CHANNEL RECOR, P107; Masland RH, 1996, CURR OPIN NEUROBIOL, V6, P467, DOI 10.1016/S0959-4388(96)80051-1; MATTHEWS G, 1994, J NEUROSCI, V14, P1079, DOI 10.1523/JNEUROSCI.14-03-01079.1994; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; Mennerick S, 1997, J NEUROPHYSIOL, V78, P51, DOI 10.1152/jn.1997.78.1.51; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; MILLS SL, 1992, J COMP NEUROL, V321, P133, DOI 10.1002/cne.903210112; NAWY S, 1990, VISION RES, V30, P967, DOI 10.1016/0042-6989(90)90105-T; NAWY S, 1990, NATURE, V346, P269, DOI 10.1038/346269a0; Neves G, 1999, J PHYSIOL-LONDON, V515, P181, DOI 10.1111/j.1469-7793.1999.181ad.x; Nirenberg S, 1997, NEURON, V18, P637, DOI 10.1016/S0896-6273(00)80304-9; NOWYCKY MC, 1985, P NATL ACAD SCI USA, V82, P2178, DOI 10.1073/pnas.82.7.2178; OKADA T, 1995, NEUROSCI RES, V23, P297, DOI 10.1016/0168-0102(95)00955-8; Protti DA, 1998, J NEUROSCI, V18, P3715; RIEKE F, 1994, NEURON, V13, P863, DOI 10.1016/0896-6273(94)90252-6; Robinson DW, 1997, CURR BIOL, V7, P366, DOI 10.1016/S0960-9822(06)00184-9; Rouze NC, 1998, J NEUROSCI, V18, P8614; SAITO T, 1988, J GEN PHYSIOL, V91, P275, DOI 10.1085/jgp.91.2.275; SAITO T, 1979, J GEN PHYSIOL, V73, P73, DOI 10.1085/jgp.73.1.73; SAITO T, 1982, J COMP NEUROL, V205, P161, DOI 10.1002/cne.902050207; Sakaba T, 1997, NEUROSCI RES, V27, P357, DOI 10.1016/S0168-0102(97)01168-1; SCHWARTZ EA, 1974, J PHYSIOL-LONDON, V236, P211, DOI 10.1113/jphysiol.1974.sp010431; SHERRY DM, 1993, J COMP NEUROL, V329, P188, DOI 10.1002/cne.903290204; SHIELLS RA, 1990, P ROY SOC B-BIOL SCI, V242, P91, DOI 10.1098/rspb.1990.0109; Shiells RA, 1999, J PHYSIOL-LONDON, V514, P343, DOI 10.1111/j.1469-7793.1999.343ae.x; SHIELLS RA, 1981, NATURE, V294, P592, DOI 10.1038/294592a0; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; STERLING P, 1998, SYNAPTIC ORG BRAIN, P205; TACHIBANA M, 1987, P NATL ACAD SCI USA, V84, P3501, DOI 10.1073/pnas.84.10.3501; TACHIBANA M, 1993, J NEUROSCI, V13, P2898; TESSIERLAVIGNE M, 1988, J GEN PHYSIOL, V91, P49, DOI 10.1085/jgp.91.1.49; TIAN N, 1995, VISUAL NEUROSCI, V12, P755, DOI 10.1017/S0952523800009019; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; vonGersdorff H, 1996, J NEUROSCI, V16, P115; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; Witkovsky P, 1997, J NEUROSCI, V17, P7297; Wong WT, 1998, J NEUROSCI, V18, P8839; Wyszecki G., 2000, COLOR SCI CONCEPTS M, V2nd ed., P117; YAMASHITA M, 1991, J NEUROSCI, V11, P2372; Yang XL, 1997, J NEUROPHYSIOL, V78, P2662, DOI 10.1152/jn.1997.78.5.2662; Yazulla S, 1998, J COMP NEUROL, V396, P131, DOI 10.1002/(SICI)1096-9861(19980622)396:1<131::AID-CNE10>3.0.CO;2-S; Zenisek D, 1998, VISUAL NEUROSCI, V15, P69, DOI 10.1017/S0952523898151064	71	88	88	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	2000	25	1					215	227		10.1016/S0896-6273(00)80884-3	http://dx.doi.org/10.1016/S0896-6273(00)80884-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279KP	10707985	Bronze			2022-12-24	WOS:000085043200023
J	Augsburger, A; Schuchardt, A; Hoskins, S; Dodd, J; Butler, S				Augsburger, A; Schuchardt, A; Hoskins, S; Dodd, J; Butler, S			BMPs as mediators of roof plate repulsion of commissural neurons	NEURON			English	Article							BONE MORPHOGENETIC PROTEINS; RAT SPINAL-CORD; PRIMITIVE STREAK FORMATION; DEVELOPING NEURAL-TUBE; OSTEOGENIC PROTEIN-1; GROWTH CONES; FLOOR PLATE; TGF-BETA; NERVOUS-SYSTEM; AXON GUIDANCE	During spinal cord development, commissural (C) neurons, located near the dorsal midline, send axons ventrally and across the floor plate (FP). The trajectory of these axons toward the FP is guided in part by netrins. The mechanisms that guide the early phase of C axon extension, however, have not been resolved. We show that the roof plate (RP) expresses a diffusible activity that repels C axons and orients their growth within the dorsal spinal cord. Bone morphogenetic proteins (BMPs) appear to act as RP-derived chemorepellents that guide the early trajectory of the axons of C neurons in the developing spinal cord: BMP7 mimics the RP repellent activity for C axons in vitro, can act directly to collapse C growth cones, and appears to serve an essential function in RP repulsion of C axons.	Columbia Univ, Ctr Neurobiol & Behav, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Columbia University	Dodd, J (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, Dept Physiol & Cellular Biophys, New York, NY 10032 USA.	jd18@columbia.edu			NINDS NIH HHS [NS 27113] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027113] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1; BASLER K, 1993, CELL, V73, P687, DOI 10.1016/0092-8674(93)90249-P; Bergemann AD, 1998, ONCOGENE, V16, P471, DOI 10.1038/sj.onc.1201557; BIRGBAUER E, 1991, J NEUROSCI RES, V30, P232; BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; BOVOLENTA P, 1991, DEVELOPMENT, V113, P625; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; CELESTE AJ, 1990, P NATL ACAD SCI USA, V87, P9843, DOI 10.1073/pnas.87.24.9843; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Choi SE, 1999, CELL SIGNAL, V11, P71, DOI 10.1016/S0898-6568(98)00033-3; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Colavita A, 1998, SCIENCE, V281, P706, DOI 10.1126/science.281.5377.706; CUNNINGHAM NS, 1992, P NATL ACAD SCI USA, V89, P11740, DOI 10.1073/pnas.89.24.11740; Dale JK, 1997, CELL, V90, P257, DOI 10.1016/S0092-8674(00)80334-7; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Dudley AT, 1997, DEV DYNAM, V208, P349; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; Eichmann A, 1997, MECH DEVELOP, V65, P111, DOI 10.1016/S0925-4773(97)00063-4; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FAN JH, 1995, NEURON, V14, P263, DOI 10.1016/0896-6273(95)90284-8; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Gale NW, 1996, ONCOGENE, V13, P1343; Gitelman SE, 1997, MAMM GENOME, V8, P212, DOI 10.1007/s003359900391; GOSLIN K, 1989, J CELL BIOL, V109, P1621, DOI 10.1083/jcb.109.4.1621; GRAHAM A, 1994, NATURE, V372, P684, DOI 10.1038/372684a0; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Guo X, 1998, NEUROSCI LETT, V245, P131, DOI 10.1016/S0304-3940(98)00192-X; GUTHRIE S, 1995, NEURON, V14, P1117, DOI 10.1016/0896-6273(95)90260-0; HAHN GV, 1992, GENOMICS, V14, P759, DOI 10.1016/S0888-7543(05)80181-8; HALSTEAD J, 1995, J BIOL CHEM, V270, P13600, DOI 10.1074/jbc.270.23.13600; Helms AW, 1998, DEVELOPMENT, V125, P919; HOGAN BLM, 1994, CURR BIOL, V4, P1122, DOI 10.1016/S0960-9822(00)00252-9; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; HOLLEY JA, 1982, J COMP NEUROL, V205, P360, DOI 10.1002/cne.902050405; HOLLEY JA, 1982, J COMP NEUROL, V205, P371, DOI 10.1002/cne.902050406; HUME CR, 1993, DEVELOPMENT, V119, P1147; Israel DI, 1996, GROWTH FACTORS, V13, P291, DOI 10.3109/08977199609003229; JONES CM, 1991, DEVELOPMENT, V111, P531; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kretzschmar M, 1998, CURR OPIN GENET DEV, V8, P103, DOI 10.1016/S0959-437X(98)80069-5; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Lee YS, 1997, J CELL PHYSIOL, V170, P153, DOI 10.1002/(SICI)1097-4652(199702)170:2<153::AID-JCP7>3.0.CO;2-N; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Loschinger J, 1997, J NEUROBIOL, V33, P825, DOI 10.1002/(SICI)1097-4695(19971120)33:6<825::AID-NEU9>3.0.CO;2-B; LUMSDEN AGS, 1986, NATURE, V323, P538, DOI 10.1038/323538a0; LUO YL, 1995, NEURON, V14, P1131, DOI 10.1016/0896-6273(95)90261-9; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; LYONS KM, 1995, MECH DEVELOP, V50, P71, DOI 10.1016/0925-4773(94)00326-I; MARTI E, 1995, DEVELOPMENT, V121, P2537; McFarlane S, 1998, DEVELOPMENT, V125, P3967; McFarlane S, 1996, NEURON, V17, P245, DOI 10.1016/S0896-6273(00)80156-7; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; NORNES HO, 1974, BRAIN RES, V73, P121, DOI 10.1016/0006-8993(74)91011-7; OPPENHEIM RW, 1988, J COMP NEUROL, V275, P159, DOI 10.1002/cne.902750202; PARR BA, 1993, DEVELOPMENT, V119, P247; PERIDES G, 1993, J BIOL CHEM, V268, P25197; PLACZEK M, 1990, DEVELOPMENT, V110, P19; PLACZEK M, 1991, DEVELOPMENT, P105; POSTLETHWAITE AE, 1994, J CELL PHYSIOL, V161, P562, DOI 10.1002/jcp.1041610320; Ramon y Cajal S., 1909, HISTOLOGIE SYSTEME N, DOI [DOI 10.5962/BHL.TITLE.48637, 10.5962/bhl.title.48637]; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; ROELINK H, 1991, GENE DEV, V5, P381, DOI 10.1101/gad.5.3.381; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; SHAH NM, 1996, EXP NEUROL, V140, P331; Shah SB, 1997, DEVELOPMENT, V124, P5127; SILOSSANTIAGO I, 1992, J COMP NEUROL, V325, P514, DOI 10.1002/cne.903250405; SNOW DM, 1990, DEV BIOL, V138, P359, DOI 10.1016/0012-1606(90)90203-U; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; SPIEGELMAN BM, 1979, CELL, V16, P253, DOI 10.1016/0092-8674(79)90003-5; STERN CD, 1990, DEVELOPMENT, V110, P1271; STOECKLI ET, 1995, NEURON, V14, P1165, DOI 10.1016/0896-6273(95)90264-3; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VUKICEVIC S, 1994, BIOCHEM BIOPH RES CO, V198, P693, DOI 10.1006/bbrc.1994.1100; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; WENTWORTH LE, 1984, J COMP NEUROL, V222, P96, DOI 10.1002/cne.902220109; YAGINUMA H, 1991, J COMP NEUROL, V304, P78, DOI 10.1002/cne.903040107; YAMASHITA H, 1995, J CELL BIOL, V130, P217, DOI 10.1083/jcb.130.1.217; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	92	204	211	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1999	24	1					127	141		10.1016/S0896-6273(00)80827-2	http://dx.doi.org/10.1016/S0896-6273(00)80827-2			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241QC	10677032	hybrid			2022-12-24	WOS:000082893200014
J	O'Connor, R; Tessier-Lavigne, M				O'Connor, R; Tessier-Lavigne, M			Identification of maxillary factor, a maxillary process-derived chemoattractant for developing trigeminal sensory axons	NEURON			English	Article							NERVE GROWTH-FACTOR; DEVELOPMENTAL-CHANGES; NEUROTROPHIC FACTOR; NEURONAL DEATH; IN-VIVO; EXPRESSION; SURVIVAL; GUIDANCE; SYSTEM; BDNF	Trigeminal sensory axons project to several epithelial targets, including those of the maxillary and mandibular processes. Previous studies identified a chemoattractant activity, termed Maxillary Factor, secreted by these processes, which can attract developing trigeminal axons in vitro. We report that Maxillary Factor activity is composed of two neurotrophins, neurotrophin-3 (NT-3) and Brain-Derived Neurotrophic Factor (BDNF), which are produced by both target epithelium and pathway mesenchyme and which are therefore more likely to have a trophic effect on the neurons or their axons than to provide directional information, at least at initial stages of trigeminal axon growth. Consistent with this, the initial trajectories of trigeminal sensory axons are largely or completely normal in mice deficient in both BDNF and NT-3, indicating that other cues must be sufficient for the initial stages of trigeminal axon guidance.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Tessier-Lavigne, M (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA.	marctl@itsa.ucsf.edu			NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P01DE008973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010300] Funding Source: NIH RePORTER; NIDCR NIH HHS [P01-DEO8973] Funding Source: Medline; NINDS NIH HHS [F32-NS10300] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARUMAE U, 1993, J CELL BIOL, V122, P1053, DOI 10.1083/jcb.122.5.1053; BUCHMAN VL, 1993, DEVELOPMENT, V118, P989; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; DAVIES A, 1984, J COMP NEUROL, V223, P124, DOI 10.1002/cne.902230110; DAVIES AM, 1981, DEV NEUROSCI-BASEL, V4, P150, DOI 10.1159/000112751; DAVIES AM, 1995, EMBO J, V14, P4482, DOI 10.1002/j.1460-2075.1995.tb00127.x; DAVIES AM, 1987, NATURE, V326, P353, DOI 10.1038/326353a0; DAVIES AM, 1986, J COMP NEUROL, V253, P13, DOI 10.1002/cne.902530103; DIAMOND J, 1987, P NATL ACAD SCI USA, V84, P6596, DOI 10.1073/pnas.84.18.6596; DIAMOND J, 1992, J NEUROSCI, V12, P1454; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; ElShamy WM, 1996, DEVELOPMENT, V122, P2405; Elshamy WM, 1996, DEVELOPMENT, V122, P491; EMFORS P, 1994, NATURE, V368, P147; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; FAN CM, 1994, CELL, V79, P1175, DOI 10.1016/0092-8674(94)90009-4; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Gilliland G., 1990, PCR PROTOCOLS GUIDE, P60; GUNDERSEN RW, 1979, SCIENCE, V206, P1079, DOI 10.1126/science.493992; HEFFNER CD, 1990, SCIENCE, V247, P217, DOI 10.1126/science.2294603; HOYLE GW, 1993, NEURON, V10, P1019, DOI 10.1016/0896-6273(93)90051-R; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kennedy Timothy E., 1995, Current Opinion in Neurobiology, V5, P83, DOI 10.1016/0959-4388(95)80091-3; Lentz SI, 1999, J NEUROSCI, V19, P1038; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LIU X, 1995, NATURE, V375, P238, DOI 10.1038/375238a0; LUMSDEN AGS, 1986, NATURE, V323, P538, DOI 10.1038/323538a0; LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0; LUMSDEN AGS, 1988, MAKING NERVOUS SYSTE, P166; Menesini Chen M G, 1978, Arch Ital Biol, V116, P53; Patapoutian A, 1999, SCIENCE, V283, P1180, DOI 10.1126/science.283.5405.1180; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; Pinon LGP, 1996, DEVELOPMENT, V122, P3255; Reichardt L. F., 1997, MOL CELLULAR APPROAC, P220; ROMIJN HJ, 1981, DEV BRAIN RES, V2, P583, DOI 10.1016/0165-3806(81)90026-2; SCOTT J, 1983, NATURE, V302, P538, DOI 10.1038/302538a0; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; SHELTON DL, 1995, J NEUROSCI, V15, P477, DOI 10.1523/jneurosci.15-01-00477.1995; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; TESSIERLAVIGNE M, 1991, TRENDS NEUROSCI, V14, P303, DOI 10.1016/0166-2236(91)90142-H; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; THEILER, 1989, HOUSE MOUSE ATLAS EM; Tuttle R, 1998, MOL CELL NEUROSCI, V11, P1, DOI 10.1006/mcne.1998.0671; Wilkinson GA, 1996, J NEUROSCI, V16, P7661; WYATT S, 1993, DEVELOPMENT, V119, P635	49	94	94	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1999	24	1					165	178		10.1016/S0896-6273(00)80830-2	http://dx.doi.org/10.1016/S0896-6273(00)80830-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241QC	10677035	Bronze			2022-12-24	WOS:000082893200017
J	Fernandez, PA; Tang, DG; Cheng, LL; Prochiantz, A; Mudge, AW; Raff, MC				Fernandez, PA; Tang, DG; Cheng, LL; Prochiantz, A; Mudge, AW; Raff, MC			Evidence that axon-derived neuregulin promotes oligodendrocyte survival in the developing rat optic nerve	NEURON			English	Article							NEU DIFFERENTIATION FACTOR; NEURONAL SURVIVAL; PROGENITOR CELLS; GLIAL-CELLS; RECEPTORS; PROLIFERATION; BRAIN; EXPRESSION; ISOFORMS; LINEAGE	It was previously shown that newly formed oligodendrocytes depend on axons for their survival, but the nature of the axon-derived survival signal(s) remained unknown. We show here that neuregulin (NRG) supports the survival of purified oligodendrocytes and aged oligodendrocyte precursor cells (OPCs) but not of young OPCs. We demonstrate that axons promote the survival of purified oligodendrocytes and that this effect is inhibited if NRG is neutralized. In the developing rat optic nerve, we provide evidence that delivery of NRG decreases both normal oligodendrocyte death and the extra oligodendrocyte death induced by nerve transection, whereas neutralization of endogenous NRG increases the normal death. These results suggest that NRG is an axon-associated survival signal for developing oligodendrocytes.	UCL, MRC, Dev Neurobiol Programme, Mol Cell Biol Lab, London WC1E 6BT, England; UCL, Dept Biol, London WC1E 6BT, England; Ecole Normale Super, CNRS, UMR 8542, F-75230 Paris 05, France	University of London; University College London; University of London; University College London; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Raff, MC (corresponding author), UCL, MRC, Dev Neurobiol Programme, Mol Cell Biol Lab, Mortimer St, London WC1E 6BT, England.	dmcbmar@ucl.ac.uk	Tang, Dean/AAI-3457-2020; Messier, Claude/A-2322-2008	Tang, Dean/0000-0001-5029-1174; Messier, Claude/0000-0002-4791-1763				BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; Barres BA, 1999, J CELL BIOL, V147, P1123, DOI 10.1083/jcb.147.6.1123; BARRES BA, 1993, CURR BIOL, V3, P489, DOI 10.1016/0960-9822(93)90039-Q; BARRES BA, 1994, DEVELOPMENT, V120, P1097; BerminghamMcDonogh O, 1996, DEVELOPMENT, V122, P1427; BOYES BE, 1986, NEUROSCIENCE, V17, P857, DOI 10.1016/0306-4522(86)90050-3; Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825; BROCKES JP, 1980, J BIOL CHEM, V255, P8374; Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4; Burne JF, 1996, J NEUROSCI, V16, P2064; Butt AM, 1999, GLIA, V26, P84, DOI 10.1002/(SICI)1098-1136(199903)26:1<84::AID-GLIA9>3.3.CO;2-C; Canoll PD, 1999, MOL CELL NEUROSCI, V13, P79, DOI 10.1006/mcne.1998.0733; Canoll PD, 1996, NEURON, V17, P229, DOI 10.1016/S0896-6273(00)80155-5; CHENG L, 1995, J CELL BIOL, V129, P789, DOI 10.1083/jcb.129.3.789; Cheng LL, 1998, MOL CELL NEUROSCI, V12, P141, DOI 10.1006/mcne.1998.0706; CORFAS G, 1995, NEURON, V14, P103, DOI 10.1016/0896-6273(95)90244-9; DONG Z, 1995, NEURON, V15, P585, DOI 10.1016/0896-6273(95)90147-7; Eilam R, 1998, P NATL ACAD SCI USA, V95, P1888, DOI 10.1073/pnas.95.4.1888; EISENBARTH GS, 1979, P NATL ACAD SCI USA, V76, P4913, DOI 10.1073/pnas.76.10.4913; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; FFRENCHCONSTANT C, 1986, NATURE, V319, P499, DOI 10.1038/319499a0; Frost EE, 1999, CURR BIOL, V9, P1251, DOI 10.1016/S0960-9822(99)80506-5; FULTON BP, 1992, J NEUROSCI, V12, P4816; Gassmann M, 1997, CURR OPIN NEUROBIOL, V7, P87, DOI 10.1016/S0959-4388(97)80125-0; HART IK, 1989, DEVELOPMENT, V105, P595; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; MEYER D, 1994, P NATL ACAD SCI USA, V91, P1064, DOI 10.1073/pnas.91.3.1064; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Morris JK, 1999, NEURON, V23, P273, DOI 10.1016/S0896-6273(00)80779-5; PERRY VH, 1991, EUR J NEUROSCI, V3, P102, DOI 10.1111/j.1460-9568.1991.tb00815.x; Pollock GS, 1999, EUR J NEUROSCI, V11, P769, DOI 10.1046/j.1460-9568.1999.00484.x; Raabe TD, 1998, NEUROCHEM RES, V23, P311, DOI 10.1023/A:1022449231651; Raabe TD, 1997, J NEUROSCI RES, V50, P755; RAFF MC, 1978, NATURE, V274, P813, DOI 10.1038/274813a0; RAFF MC, 1978, CELL, V15, P720; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; Shelly M, 1998, J BIOL CHEM, V273, P10496, DOI 10.1074/jbc.273.17.10496; Shi JY, 1998, J NEUROSCI, V18, P4627; Tang DG, 2000, J CELL BIOL, V148, P971, DOI 10.1083/jcb.148.5.971; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; Trapp BD, 1997, J CELL BIOL, V137, P459, DOI 10.1083/jcb.137.2.459; VARTANIAN T, 1994, P NATL ACAD SCI USA, V91, P11626, DOI 10.1073/pnas.91.24.11626; Vartanian T, 1999, P NATL ACAD SCI USA, V96, P731, DOI 10.1073/pnas.96.2.731; Vartanian T, 1997, J CELL BIOL, V137, P211, DOI 10.1083/jcb.137.1.211; WOLSWIJK G, 1989, DEVELOPMENT, V105, P387; WOOD JN, 1981, BIOSCIENCE REP, V1, P263, DOI 10.1007/BF01114913	46	133	138	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	2000	28	1					81	90		10.1016/S0896-6273(00)00087-8	http://dx.doi.org/10.1016/S0896-6273(00)00087-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	370VN	11086985	Bronze			2022-12-24	WOS:000165143500012
J	Smith, TC; Howe, JR				Smith, TC; Howe, JR			Concentration-dependent substrate behavior of native AMPA receptors	NATURE NEUROSCIENCE			English	Article							CEREBELLAR GRANULE CELLS; SINGLE-CHANNEL PROPERTIES; EXCITATORY AMINO-ACIDS; VARIANCE-MEAN ANALYSIS; OUTSIDE-OUT PATCHES; ION CHANNELS; KAINATE RECEPTORS; OPEN PROBABILITY; SYNAPTIC CLEFT; BINDING-SITES	AMPA-type glutamate receptors mediate most excitatory postsynaptic currents (EPSCs) at central synapses, and their conductance determines in part the size of EPSCs. The conductance of a recombinant AMPA receptor depends on the number of agonist molecules bound to the channel. Here we tested whether native AMPA and kainate receptors show this behavior in outside-out patches from neurons in situ by measuring conductance levels of single channels over a wide range of agonist concentrations. We found that the conductance of AMPA, but not kainate, receptors depended strongly on agonist concentration. Our results suggest that alterations in the glutamate concentration in the synaptic cleft may change the apparent unitary conductance of postsynaptic AMPA receptors.	Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University	Howe, JR (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058926] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM58926] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASCHER P, 1988, J PHYSIOL-LONDON, V399, P207; BAHN S, 1994, J NEUROSCI, V14, P5525; Belcher SM, 1997, MOL BRAIN RES, V52, P130, DOI 10.1016/S0169-328X(97)00252-0; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BENVENISTE M, 1991, BIOPHYS J, V59, P560, DOI 10.1016/S0006-3495(91)82272-X; CLEMENTS JD, 1991, NEURON, V7, P605, DOI 10.1016/0896-6273(91)90373-8; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; CULLCANDY SG, 1987, NATURE, V325, P525, DOI 10.1038/325525a0; CULLCANDY SG, 1988, J PHYSIOL-LONDON, V400, P189, DOI 10.1113/jphysiol.1988.sp017117; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Diamond JS, 1997, J NEUROSCI, V17, P4672; Dingledine R, 1999, PHARMACOL REV, V51, P7; DONEVAN SD, 1993, NEURON, V10, P51, DOI 10.1016/0896-6273(93)90241-I; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; HOWE JR, 1991, J PHYSIOL-LONDON, V432, P143, DOI 10.1113/jphysiol.1991.sp018381; Howe JR, 1996, J NEUROPHYSIOL, V76, P510, DOI 10.1152/jn.1996.76.1.510; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; PATLAK JB, 1988, J GEN PHYSIOL, V92, P413, DOI 10.1085/jgp.92.4.413; Pemberton KE, 1998, J PHYSIOL-LONDON, V510, P401, DOI 10.1111/j.1469-7793.1998.401bk.x; Reid CA, 1999, J PHYSIOL-LONDON, V518, P121, DOI 10.1111/j.1469-7793.1999.0121r.x; Ripellino JA, 1998, NEUROSCIENCE, V82, P485; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Smith TC, 1999, J PHYSIOL-LONDON, V517, P51, DOI 10.1111/j.1469-7793.1999.0051z.x; Smith TC, 2000, J NEUROSCI, V20, P2073; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; STEVENS CF, 1993, NEURON S, V10, P55; Swanson GT, 1996, J PHYSIOL-LONDON, V492, P129, DOI 10.1113/jphysiol.1996.sp021295; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Traynelis SF, 1997, J PHYSIOL-LONDON, V503, P513, DOI 10.1111/j.1469-7793.1997.513bg.x; TRAYNELIS SF, 1993, NEURON, V11, P279, DOI 10.1016/0896-6273(93)90184-S; Wilding TJ, 1997, J NEUROSCI, V17, P2713; WYLLIE DJA, 1993, J PHYSIOL-LONDON, V463, P193, DOI 10.1113/jphysiol.1993.sp019591	40	109	113	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2000	3	10					992	997		10.1038/79931	http://dx.doi.org/10.1038/79931			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TW	11017171				2022-12-24	WOS:000167177500016
J	Dyer, MA; Cepko, CL				Dyer, MA; Cepko, CL			Control of Muller glial cell proliferation and activation following retinal injury	NATURE NEUROSCIENCE			English	Article							LINEAGE ANALYSIS; MICE LACKING; INHIBITORS; HISTOPATHOLOGY; HYPERPLASIA; EXPRESSION; PROGENITOR; P21(CIP1); GLIOSIS; FAMILY	Muller glial cells are the major support cell for neurons in the vertebrate retina. Following neuronal damage, Muller cells undergo reactive gliosis, which is characterized by proliferation and changes in gene expression. We have found that downregulation of the tumor supressor protein p27(Kip1) and entry into the cell cycle occurs within the first 24 hours after retinal injury. Shortly thereafter, Muller glial cells upregulate genes typical of gliosis and then downregulate cyclin D3, in concert with an exit from mitosis. Mice lacking p27(Kip1) showed a constitutive form of reactive gliosis, which leads to retinal dysplasia and vascular abnormalities reminiscent of diabetic retinopathy. We conclude that p27(Kip1) regulates Muller glial cell proliferation during reactive gliosis.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Cepko, CL (corresponding author), Harvard Univ, Sch Med, Dept Genet, 200 Longwood Ave, Boston, MA 02115 USA.	cepko@rascal.med.harvard.edu			NEI NIH HHS [EY0-8064, EY06803-02] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY006803, R01EY008064] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Amin RH, 1997, INVEST OPHTH VIS SCI, V38, P36; BERGER B, 1979, CAN J OPHTHALMOL, V14, P285; BIRNBACH CD, 1994, OPHTHALMOLOGY, V101, P1211; Cepko CL, 1998, METHODS, V14, P393, DOI 10.1006/meth.1998.0594; Cepko CL, 1998, CURR TOP DEV BIOL, V36, P51; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; COGAN D G, 1971, Birth Defects Original Article Series, V7, P41; Dithmar S, 1997, KLIN MONATSBL AUGENH, V211, P338, DOI 10.1055/s-2008-1035144; Dowling J. E., 1987, RETINA APPROACHABLE; DYER MA, IN PRESS DEVELOPMENT; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Fariss RN, 2000, AM J OPHTHALMOL, V129, P215, DOI 10.1016/S0002-9394(99)00401-8; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; FIELDSBERRY SC, 1992, P NATL ACAD SCI USA, V89, P693, DOI 10.1073/pnas.89.2.693; Foisner R, 1997, BIOESSAYS, V19, P297, DOI 10.1002/bies.950190407; Hengst L, 1998, CURR TOP MICROBIOL, V227, P25; Hjelmeland L.M., 1988, Progress in Retinal Research, V7, P259, DOI 10.1016/0278-4327(88)90011-9; HUMPHREY MF, 1993, J COMP NEUROL, V334, P545, DOI 10.1002/cne.903340404; Ide CF, 1996, PROG BRAIN RES, V108, P365, DOI 10.1016/S0079-6123(08)62552-2; Kimura H, 1999, INVEST OPHTH VIS SCI, V40, P524; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kuhrt H, 1997, J BRAIN RES, V38, P223; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Levine EM, 2000, DEV BIOL, V219, P299, DOI 10.1006/dbio.2000.9622; LI ZY, 1995, OPHTHALMOLOGY, V102, P805, DOI 10.1016/S0161-6420(95)30953-0; MacLaren RE, 1996, BRIT J OPHTHALMOL, V80, P458, DOI 10.1136/bjo.80.5.458; MADIGAN MC, 1994, RETINA-J RET VIT DIS, V14, P65, DOI 10.1097/00006982-199401000-00014; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; Morrow EM, 1998, J NEUROSCI, V18, P3738; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; NORK TM, 1986, ARCH OPHTHALMOL-CHIC, V104, P1383, DOI 10.1001/archopht.1986.01050210137041; NORK TM, 1987, ARCH OPHTHALMOL-CHIC, V105, P1424; Reichenbach A, 1997, OPHTHALMIC RES, V29, P326, DOI 10.1159/000268031; RICH KA, 1995, EXP EYE RES, V61, P235, DOI 10.1016/S0014-4835(05)80043-0; Ridet JL, 1998, TRENDS NEUROSCI, V21, P80; ROBISON WG, 1990, EXP EYE RES, V50, P355, DOI 10.1016/0014-4835(90)90136-I; RUTKA JT, 1993, CANCER RES, V53, P3624; Sahel J A, 1990, Ophtalmologie, V4, P13; SAHEL JA, 1991, EXP EYE RES, V53, P657, DOI 10.1016/0014-4835(91)90226-5; Sanchez I, 1996, CURR OPIN CELL BIOL, V8, P318, DOI 10.1016/S0955-0674(96)80004-4; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Streit WJ, 2000, TOXICOL PATHOL, V28, P28, DOI 10.1177/019262330002800104; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Sueishi Katsuo, 1996, Polish Journal of Pharmacology, V48, P307; Taomoto M, 1998, GRAEF ARCH CLIN EXP, V236, P688, DOI 10.1007/s004170050142; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Unger JW, 1998, MICROSC RES TECHNIQ, V43, P24, DOI 10.1002/(SICI)1097-0029(19981001)43:1<24::AID-JEMT4>3.0.CO;2-P; Wilson JX, 1997, CAN J PHYSIOL PHARM, V75, P1149, DOI 10.1139/cjpp-75-10-11-1149; Yee Amy S., 1998, Frontiers in Bioscience, V3, pD532	49	355	362	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2000	3	9					873	880		10.1038/78774	http://dx.doi.org/10.1038/78774			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TV	10966617				2022-12-24	WOS:000167177400013
J	Meegan, DV; Aslin, RN; Jacobs, RA				Meegan, DV; Aslin, RN; Jacobs, RA			Motor timing learned without motor training	NATURE NEUROSCIENCE			English	Article							PERCEPTION; DISCRIMINATION; RESPONSES; MOVEMENT		Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; Univ Guelph, Dept Psychol, Guelph, ON N1G 2W1, Canada	University of Rochester; University of Guelph	Meegan, DV (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, Meliora Hall, Rochester, NY 14627 USA.	meegan@psy.uoguelph.ca	Jacobs, Robert/B-7670-2013	Jacobs, Robert/0000-0001-6607-908X	NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH054770, T32MH019942] Funding Source: NIH RePORTER; NIMH NIH HHS [T32-MH19942, R29-MH54770] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BUONOMANO DV, 1994, NEURAL COMPUT, V6, P38, DOI 10.1162/neco.1994.6.1.38; Clarke S., 1996, ADV PSYCHOL, V115, P257, DOI [10.1016/S0166-4115(96)80063-X, DOI 10.1016/S0166-4115(96)80063-X]; CORDO PJ, 1997, MOTOR LEARNING SYNAP; Ivry R B, 1989, J Cogn Neurosci, V1, P136, DOI 10.1162/jocn.1989.1.2.136; IVRY RB, 1995, J EXP PSYCHOL HUMAN, V21, P3, DOI 10.1037/0096-1523.21.1.3; Ivry RB, 1996, CURR OPIN NEUROBIOL, V6, P851, DOI 10.1016/S0959-4388(96)80037-7; JUEPTNER M, 1995, NEUROLOGY, V45, P1540, DOI 10.1212/WNL.45.8.1540; KAERNBACH C, 1991, PERCEPT PSYCHOPHYS, V49, P227, DOI 10.3758/BF03214307; Karni A, 1997, CURR OPIN NEUROBIOL, V7, P530, DOI 10.1016/S0959-4388(97)80033-5; Middleton FA, 1998, TRENDS COGN SCI, V2, P348, DOI 10.1016/S1364-6613(98)01220-0; TREISMAN M, 1992, Q J EXP PSYCHOL-A, V45, P235, DOI 10.1080/14640749208401326; Welsh JP, 1997, PROG BRAIN RES, V114, P449; WING AM, 1973, PERCEPT PSYCHOPHYS, V14, P5, DOI 10.3758/BF03198607; Wright BA, 1997, J NEUROSCI, V17, P3956	14	93	94	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2000	3	9					860	862		10.1038/78757	http://dx.doi.org/10.1038/78757			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TV	10966614				2022-12-24	WOS:000167177400010
J	Song, S; Miller, KD; Abbott, LF				Song, S; Miller, KD; Abbott, LF			Competitive Hebbian learning through spike-timing-dependent synaptic plasticity	NATURE NEUROSCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; LONG-TERM POTENTIATION; RECEPTIVE-FIELDS; PYRAMIDAL CELLS; MODEL; RAT; DEPRESSION; EFFICACY; CORTEX; LTP	Hebbian models of development and learning require both activity-dependent synaptic plasticity and a mechanism that induces competition between different synapses. One form of experimentally observed long-term synaptic plasticity, which we call spike-timing-dependent plasticity (STDP), depends on the relative timing of pre- and postsynaptic action potentials. In modeling studies, we find that this form of synaptic modification can automatically balance synaptic strengths to make postsynaptic firing irregular but more sensitive to presynaptic spike timing. It has been argued that neurons in vivo operate in such a balanced regime. Synapses modifiable by STDP compete for control of the timing of postsynaptic action potentials. Inputs that fire the postsynaptic neuron with short latency or that act in correlated groups are able to compete most successfully and develop strong synapses, while synapses of longer-latency or less-effective inputs are weakened.	Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02254 USA; Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; Univ Calif San Francisco, Sloan Ctr Theoret Neurobiol, WM Keck Ctr Integrat Neurosci, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sloan Ctr Theoret Neurobiol, WM Keck Ctr Integrat Neurosci, Dept Otolaryngol,Neurosci Grad Program, San Francisco, CA 94143 USA	Brandeis University; Brandeis University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Abbott, LF (corresponding author), Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02254 USA.				NATIONAL EYE INSTITUTE [R01EY011001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058754] Funding Source: NIH RePORTER; NEI NIH HHS [R01-EY11001] Funding Source: Medline; NIMH NIH HHS [MH58754] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abbott LF, 1996, CEREB CORTEX, V6, P406, DOI 10.1093/cercor/6.3.406; Abbott LF, 1999, ADV NEUR IN, V11, P69; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Bekkers JM, 1996, J NEUROPHYSIOL, V75, P1250, DOI 10.1152/jn.1996.75.3.1250; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Blum KI, 1996, NEURAL COMPUT, V8, P85, DOI 10.1162/neco.1996.8.1.85; Bugmann G, 1997, NEURAL COMPUT, V9, P985, DOI 10.1162/neco.1997.9.5.985; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; DEBANNE D, 1994, P NATL ACAD SCI USA, V91, P1148, DOI 10.1073/pnas.91.3.1148; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; GERSTNER W, 1993, BIOL CYBERN, V69, P503, DOI 10.1007/BF00199450; Gerstner W, 1997, COMPUTATIONAL NEUROSCIENCE: TRENDS IN RESEARCH, 1997, P665; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Gerstner W, 1997, J COMPUT NEUROSCI, V4, P79, DOI 10.1023/A:1008820728122; GUILLERY RW, 1972, J COMP NEUROL, V144, P117, DOI 10.1002/cne.901440106; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Kempter R, 1999, PHYS REV E, V59, P4498, DOI 10.1103/PhysRevE.59.4498; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; Mehta MR, 2000, NEUROCOMPUTING, V32, P905, DOI 10.1016/S0925-2312(00)00259-9; Miller K. D., 1996, MODELS NEURAL NETWOR, P55, DOI [10.1007/978-1-4612-0723-8_2, DOI 10.1007/978-1-4612-0723-8_2]; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; MILLER KD, 1994, NEURAL COMPUT, V6, P100, DOI 10.1162/neco.1994.6.1.100; Minai A. A., 1993, INNS WORLD C NEUR NE, P505; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Rao RPN, 2000, ADV NEUR IN, V12, P164; Roberts PD, 1999, J COMPUT NEUROSCI, V7, P235, DOI 10.1023/A:1008910918445; Scanziani M, 1996, NATURE, V380, P446, DOI 10.1038/380446a0; SEJNOWSKI TJ, 1977, J MATH BIOL, V4, P303, DOI 10.1007/BF00275079; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; STRYKER MP, 1986, BIOL CHANGE OTOLARYN, P211; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Troyer TW, 1997, NEURAL COMPUT, V9, P971, DOI 10.1162/neco.1997.9.5.971; Troyer TW, 1997, COMPUTATIONAL NEUROSCIENCE: TRENDS IN RESEARCH, 1997, P197; Tsodyks M., 1995, NETWORK, V6, P1; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; van Vreeswijk C, 1998, NEURAL COMPUT, V10, P1321, DOI 10.1162/089976698300017214; Yuste R, 1999, J NEUROSCI, V19, P1976; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	50	1714	1778	12	275	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2000	3	9					919	926		10.1038/78829	http://dx.doi.org/10.1038/78829			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TV	10966623				2022-12-24	WOS:000167177400019
J	Kerr, R; Lev-Ram, V; Baird, G; Vincent, P; Tsien, RY; Schafer, WR				Kerr, R; Lev-Ram, V; Baird, G; Vincent, P; Tsien, RY; Schafer, WR			Optical imaging of calcium transients in neurons and pharyngeal muscle of C-elegans	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; NERVOUS-SYSTEM; CA2+; EXCITATION; CAMELEONS; GENETICS; SUBUNIT; CHANNEL	Electrophysiology and optical indicators have been used in vertebrate systems to investigate excitable cell firing and calcium transients, but both techniques have been difficult to apply in organisms with powerful reverse genetics. To overcome this limitation, we expressed cameleon proteins, genetically encoded calcium indicators, in the pharyngeal muscle of the nematode worm Caenorhabditis elegans. In intact transgenic animals expressing cameleons, fluorescence ratio changes accompanied muscular contraction, verifying detection of calcium transients. By comparing the magnitude and duration of calcium influx in wild-type and mutant animals, we were able to determine the effects of calcium channel proteins on pharyngeal calcium transients. We also successfully used cameleons to detect electrically evoked calcium transients in individual C. elegans neurons. This technique therefore should have broad applications in analyzing the regulation of excitable cell activity in genetically tractable organisms.	Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Schafer, WR (corresponding author), Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA.	wschafer@ucsd.edu	Vincent, Pierre/A-1055-2012	Vincent, Pierre/0000-0002-8479-1908; Schafer, William/0000-0002-6676-8034	NIDA NIH HHS [DA11556] Funding Source: Medline; NINDS NIH HHS [NS27177] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027177, R37NS027177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA011556] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Avery L, 1995, METHOD CELL BIOL, V48, P251; AVERY L, 1993, GENETICS, V133, P897; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; AVERY L, 1997, C ELEGANS, V2, P679, DOI [10.1101/087969532.33.679, DOI 10.1101/087969532.33.679]; Bangalore R, 1996, AM J PHYSIOL-HEART C, V270, pH1521, DOI 10.1152/ajpheart.1996.270.5.H1521; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; BRENNER S, 1974, GENETICS, V77, P71; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Dal Santo P, 1999, CELL, V98, P757, DOI 10.1016/S0092-8674(00)81510-X; DAVIS RE, 1989, J NEUROSCI, V9, P403; DEWAARD M, 1995, J PHYSIOL-LONDON, V485, P619, DOI 10.1113/jphysiol.1995.sp020757; Fan GY, 1999, BIOPHYS J, V76, P2412, DOI 10.1016/S0006-3495(99)77396-0; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Lee RYN, 1997, EMBO J, V16, P6066, DOI 10.1093/emboj/16.20.6066; MADURO M, 1995, GENETICS, V141, P977; Mello C, 1995, METHOD CELL BIOL, V48, P451; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; OKKEMA PG, 1993, GENETICS, V135, P385; RAIZEN DM, 1995, GENETICS, V141, P1365; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; Sun BH, 1999, P NATL ACAD SCI USA, V96, P10438, DOI 10.1073/pnas.96.18.10438; TRENT C, 1983, GENETICS, V104, P619; Tsien Roger Y., 1995, P459; White J., 1988, NEMATODE CAENORHABDI, V17, P81; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	27	292	303	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	2000	26	3					583	594		10.1016/S0896-6273(00)81196-4	http://dx.doi.org/10.1016/S0896-6273(00)81196-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330ZH	10896155	Bronze			2022-12-24	WOS:000087991600010
J	Ye, B; Liao, DZ; Zhang, XQ; Zhang, PS; Dong, HL; Huganir, RL				Ye, B; Liao, DZ; Zhang, XQ; Zhang, PS; Dong, HL; Huganir, RL			GRASP-1: A neuronal RasGEF associated with the AMPA receptor/GRIP complex	NEURON			English	Article							LONG-TERM POTENTIATION; GUANINE-NUCLEOTIDE EXCHANGE; DOMAIN-CONTAINING PROTEIN; SYNAPTIC PLASTICITY; GLUTAMATE RECEPTORS; DISSOCIATION STIMULATOR; POSTSYNAPTIC DENSITY; SIGNALING PATHWAY; SILENT SYNAPSES; PDZ DOMAINS	The PDZ domain-containing proteins, such as PSD-95 and GRIP, have been suggested to be involved in the targeting of glutamate receptors, a process that plays a critical role in the efficiency of synaptic transmission and plasticity. To address the molecular mechanisms underlying AMPA receptor synaptic localization, we have identified several GRIP-associated proteins (GRASPs) that bind to distinct PDZ domains within GRIP. GRASP-1 is a neuronal rasGEF associated with GRIP and AMPA receptors in vivo. Overexpression of GRASP-1 in cultured neurons specifically reduced the synaptic targeting of AMPA receptors. In addition, the subcellular distribution of both AMPA receptors and GRASP-1 was rapidly regulated by the activation of NMDA receptors. These results suggest that GRASP-1 may regulate neuronal ras signaling and contribute to the regulation of AMPA receptor distribution by NMDA receptor activity.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Howard Hughes Med Inst, Baltimore, MD 21205 USA.		Ye, Bing/V-1306-2018	Ye, Bing/0000-0002-8828-4065				ALBRIGHT CF, 1993, EMBO J, V12, P339, DOI 10.1002/j.1460-2075.1993.tb05662.x; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.3.CO;2-B; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; COAN EJ, 1987, NEUROSCI LETT, V80, P111, DOI 10.1016/0304-3940(87)90505-2; COLLINGRIDGE G, 1987, NATURE, V330, P604, DOI 10.1038/330604a0; DAVIES SN, 1989, NATURE, V338, P500, DOI 10.1038/338500a0; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Dong HL, 1999, J NEUROSCI, V19, P6930, DOI 10.1523/JNEUROSCI.19-16-06930.1999; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Ghosh MM, 1995, BIOREMED SER, V3, P15; Goslin K., 1991, CULTURING NERVE CELL, P251; HOFER F, 1994, P NATL ACAD SCI USA, V91, P11089, DOI 10.1073/pnas.91.23.11089; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; KIKUCHI A, 1994, MOL CELL BIOL, V14, P7483, DOI 10.1128/MCB.14.11.7483; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee CHJ, 1996, J NEUROSCI, V16, P6784; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lissin DV, 1999, J NEUROSCI, V19, P1263; Luo JH, 1997, MOL PHARMACOL, V51, P79, DOI 10.1124/mol.51.1.79; Malenka RC, 1997, NEURON, V19, P473, DOI 10.1016/S0896-6273(00)80362-1; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULLER D, 1988, SCIENCE, V242, P1694, DOI 10.1126/science.2904701; OLIVIER JP, 1993, CELL, V73, P179, DOI 10.1016/0092-8674(93)90170-U; Orban PC, 1999, TRENDS NEUROSCI, V22, P38, DOI 10.1016/S0166-2236(98)01306-X; Petralia RS, 1997, J COMP NEUROL, V385, P456, DOI 10.1002/(SICI)1096-9861(19970901)385:3<456::AID-CNE9>3.0.CO;2-2; PETRALIA RS, 1994, J NEUROSCI, V14, P667; QUILLIAM LA, 1994, P NATL ACAD SCI USA, V91, P8512, DOI 10.1073/pnas.91.18.8512; QUILLIAM LA, 1995, BIOESSAYS, V17, P395, DOI 10.1002/bies.950170507; RAYMOND LA, 1993, TRENDS NEUROSCI, V16, P147, DOI 10.1016/0166-2236(93)90123-4; RAYMOND LA, 1993, NATURE, V361, P637, DOI 10.1038/361637a0; Roche Katherine W., 1994, Current Opinion in Neurobiology, V4, P383, DOI 10.1016/0959-4388(94)90100-7; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; Saras J, 1996, TRENDS BIOCHEM SCI, V21, P455, DOI 10.1016/S0968-0004(96)30044-3; SCHULER GD, 1991, PROTEINS, V9, P180, DOI 10.1002/prot.340090304; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Silva AJ, 1997, NAT GENET, V15, P281, DOI 10.1038/ng0397-281; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; SPAARGAREN M, 1994, P NATL ACAD SCI USA, V91, P12609, DOI 10.1073/pnas.91.26.12609; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; STRAUS D, 1990, P NATL ACAD SCI USA, V87, P1889, DOI 10.1073/pnas.87.5.1889; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Urano T, 1996, EMBO J, V15, P810, DOI 10.1002/j.1460-2075.1996.tb00416.x; Wes PD, 1996, EMBO J, V15, P5839, DOI 10.1002/j.1460-2075.1996.tb00971.x; Widmann C, 1998, MOL CELL BIOL, V18, P2416, DOI 10.1128/MCB.18.4.2416; Wyszynski M, 1998, NEUROPHARMACOLOGY, V37, P1335, DOI 10.1016/S0028-3908(98)00120-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Xia ZG, 1996, J NEUROSCI, V16, P5425; YAMAGATA K, 1994, J BIOL CHEM, V269, P16333; Yee WM, 1997, MOL CELL BIOL, V17, P921, DOI 10.1128/MCB.17.2.921; Yun HY, 1998, P NATL ACAD SCI USA, V95, P5773, DOI 10.1073/pnas.95.10.5773; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhong WM, 1997, DEVELOPMENT, V124, P1887	82	123	134	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	2000	26	3					603	617		10.1016/S0896-6273(00)81198-8	http://dx.doi.org/10.1016/S0896-6273(00)81198-8			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330ZH	10896157	Bronze			2022-12-24	WOS:000087991600012
J	Huang, YZ; Won, S; Ali, DW; Wang, Q; Tanowitz, M; Du, QS; Pelkey, KA; Yang, DJ; Xiong, WC; Salter, MW; Mei, L				Huang, YZ; Won, S; Ali, DW; Wang, Q; Tanowitz, M; Du, QS; Pelkey, KA; Yang, DJ; Xiong, WC; Salter, MW; Mei, L			Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses	NEURON			English	Article							RECEPTOR GENE-EXPRESSION; NEU DIFFERENTIATION FACTOR; TUMOR-SUPPRESSOR GENE; DENSITY PROTEIN PSD-95; LONG-TERM POTENTIATION; POSTSYNAPTIC DENSITY; GROWTH-FACTOR; TYROSINE KINASES; NERVOUS-SYSTEM; RAT-BRAIN	Neuregulins (NRGs) and their receptors, the ErbB protein tyrosine kinases, are essential for neuronal development, but their functions in the adult CNS are unknown. We report that ErbB4 is enriched in the postsynaptic density (PSD) and associates with PSD-95. Heterologous expression of PSD-95 enhanced NRG activation of ErbB4 and MAP kinase. Conversely, inhibiting expression of PSD-95 in neurons attenuated NRG-mediated activation of MAP kinase. PSD-95 formed a ternary complex with two molecules of ErbB4, suggesting that PSD-95 facilitates ErbB4 dimerization. Finally, NRG suppressed induction of long-term potentiation in the hippocampal CA1 region without affecting basal synaptic transmission. Thus, NRG signaling may be synaptic and regulated by PSD-95. A role of NRG signaling in the adult CNS may be modulation of synaptic plasticity.	Univ Alabama Birmingham, Dept Neurobiol Pathol & Phys Med & Rehabil, Birmingham, AL 35294 USA; Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; Chinese Acad Sci, Inst Neurosci, Mol Neurobiol Lab, Shanghai 200031, Peoples R China; Shanghai Res Ctr Life Sci, Shanghai 200031, Peoples R China; Univ Toronto, Hosp Sick Children, Dept Physiol, Program Brain & Behav, Toronto, ON M5G 1X8, Canada; Univ Toronto, Hosp Sick Children, Dept Physiol, Cell Biol Program, Toronto, ON M5G 1X8, Canada; Georgetown Univ, Vincent T Lombardi Canc Res Ctr, Washington, DC 20007 USA; Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Virginia; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Georgetown University; University of Alabama System; University of Alabama Birmingham	Mei, L (corresponding author), Univ Alabama Birmingham, Dept Neurobiol Pathol & Phys Med & Rehabil, Birmingham, AL 35294 USA.	lmei@nrc.uab.edu	Ali, Declan W/A-2611-2014; Mei, Lin/G-8755-2012; Ali, Declan/A-2611-2014	Ali, Declan W/0000-0002-8461-4864; Ali, Declan/0000-0001-7614-2484; Du, Quansheng/0000-0003-4079-8662				ALTIOK N, 1995, EMBO J, V14, P4258, DOI 10.1002/j.1460-2075.1995.tb00100.x; Altiok N, 1997, EMBO J, V16, P717, DOI 10.1093/emboj/16.4.717; Anton ES, 1997, DEVELOPMENT, V124, P3501; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Beerli RR, 1996, J BIOL CHEM, V271, P6071, DOI 10.1074/jbc.271.11.6071; Bianco C, 1999, J BIOL CHEM, V274, P8624, DOI 10.1074/jbc.274.13.8624; BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4; Busfield SJ, 1997, MOL CELL BIOL, V17, P4007, DOI 10.1128/MCB.17.7.4007; CARR A, 1994, REV MED VIROL, V4, P5, DOI 10.1002/rmv.1980040104; Carraway KL, 1997, NATURE, V387, P512, DOI 10.1038/387512a0; CARRAWAY KL, 1994, J BIOL CHEM, V269, P14661; Chang H, 1997, NATURE, V387, P509, DOI 10.1038/387509a0; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; CHEN MS, 1994, J COMP NEUROL, V349, P389, DOI 10.1002/cne.903490306; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; CORFAS G, 1995, NEURON, V14, P103, DOI 10.1016/0896-6273(95)90244-9; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Deguchi M, 1998, J BIOL CHEM, V273, P26269, DOI 10.1074/jbc.273.41.26269; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; DONG Z, 1995, NEURON, V15, P585, DOI 10.1016/0896-6273(95)90147-7; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; Fischbach GD, 1997, ANNU REV NEUROSCI, V20, P429, DOI 10.1146/annurev.neuro.20.1.429; FRANCOEUR JR, 1995, J NEUROSCI RES, V41, P836, DOI 10.1002/jnr.490410614; Garner CC, 1996, TRENDS CELL BIOL, V6, P429, DOI 10.1016/S0962-8924(96)10036-2; Gassmann M, 1997, CURR OPIN NEUROBIOL, V7, P87, DOI 10.1016/S0959-4388(97)80125-0; GUARENTE L, 1983, CELL, V32, P1279, DOI 10.1016/0092-8674(83)90309-4; Harari D, 1999, ONCOGENE, V18, P2681, DOI 10.1038/sj.onc.1202631; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; JO SA, 1995, NATURE, V373, P158, DOI 10.1038/373158a0; Jones JT, 1998, J BIOL CHEM, V273, P11667, DOI 10.1074/jbc.273.19.11667; KARUNAGARAN D, 1995, J BIOL CHEM, V270, P9982, DOI 10.1074/jbc.270.17.9982; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim E, 1998, J BIOL CHEM, V273, P1591, DOI 10.1074/jbc.273.3.1591; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Lumeng C, 1999, NAT NEUROSCI, V2, P611, DOI 10.1038/10165; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; Meyer D, 1997, DEVELOPMENT, V124, P3575; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; MOSCOSO LM, 1995, DEV BIOL, V172, P158, DOI 10.1006/dbio.1995.0012; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Niethammer M, 1996, J NEUROSCI, V16, P2157; Ozaki M, 1997, NATURE, V390, P691, DOI 10.1038/37795; PELES E, 1993, EMBO J, V12, P961, DOI 10.1002/j.1460-2075.1993.tb05737.x; PELES E, 1992, CELL, V69, P205, DOI 10.1016/0092-8674(92)90131-U; PETERS MF, 1994, NEUROREPORT, V5, P1577, DOI 10.1097/00001756-199408150-00009; PLOWMAN GD, 1993, P NATL ACAD SCI USA, V90, P1746, DOI 10.1073/pnas.90.5.1746; PLOWMAN GD, 1993, NATURE, V366, P473, DOI 10.1038/366473a0; Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Sheng M, 1997, BIOESSAYS, V19, P847, DOI 10.1002/bies.950191004; Si JT, 1996, J BIOL CHEM, V271, P19752, DOI 10.1074/jbc.271.33.19752; Si JT, 1999, J NEUROSCI, V19, P8498; Spencer KSR, 2000, J CELL BIOL, V148, P385, DOI 10.1083/jcb.148.2.385; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Tanowitz M, 1999, J NEUROSCI, V19, P9426; Tansey MG, 1996, J CELL BIOL, V134, P465, DOI 10.1083/jcb.134.2.465; Tejedor FJ, 1997, J NEUROSCI, V17, P152, DOI 10.1523/JNEUROSCI.17-01-00152.1997; WALLASCH C, 1995, EMBO J, V14, P4267, DOI 10.1002/j.1460-2075.1995.tb00101.x; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; WILLOTT E, 1993, P NATL ACAD SCI USA, V90, P7834, DOI 10.1073/pnas.90.16.7834; Wolpowitz D, 2000, NEURON, V25, P79, DOI 10.1016/S0896-6273(00)80873-9; Won S, 1999, J NEUROCHEM, V73, P2358, DOI 10.1046/j.1471-4159.1999.0732358.x; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Yang X, 1998, NEURON, V20, P255, DOI 10.1016/S0896-6273(00)80454-7; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674; Zhang DX, 1997, P NATL ACAD SCI USA, V94, P9562, DOI 10.1073/pnas.94.18.9562; ZHU XJ, 1995, EMBO J, V14, P5842, DOI 10.1002/j.1460-2075.1995.tb00272.x	83	310	325	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	2000	26	2					443	455		10.1016/S0896-6273(00)81176-9	http://dx.doi.org/10.1016/S0896-6273(00)81176-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318QZ	10839362	Bronze			2022-12-24	WOS:000087296500020
J	Hopfinger, JB; Buonocore, MH; Mangun, GR				Hopfinger, JB; Buonocore, MH; Mangun, GR			The neural mechanisms of top-down attentional control	NATURE NEUROSCIENCE			English	Article							SPATIAL SELECTIVE ATTENTION; WORKING-MEMORY; FUNCTIONAL MRI; VISUAL-CORTEX; RETINOTOPIC ORGANIZATION; VISUOSPATIAL ATTENTION; DIRECTING ATTENTION; PARIETAL CORTEX; AREAS; PET	Selective visual attention involves dynamic interplay between attentional control systems and sensory brain structures. We used event-related functional magnetic resonance imaging (fMRI) during a cued spatial-attention task to dissociate brain activity related to attentional control from that related to selective processing of target stimuli. Distinct networks were engaged by attention-directing cues versus subsequent targets. Superior frontal, inferior parietal and superior temporal cortex were selectively activated by cues, indicating that these structures are part of a network for voluntary attentional control. This control biased activity in multiple visual cortical areas, resulting in selective sensory processing of relevant visual targets.	Duke Univ, Ctr Cognit Neurosci, Durham, NC 27708 USA; Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA; Univ Calif Davis, Med Ctr, Dept Radiol, Sacramento, CA 95817 USA	Duke University; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Mangun, GR (corresponding author), Duke Univ, Ctr Cognit Neurosci, LSRC Bldg,Rm B203, Durham, NC 27708 USA.		Li, Chong/F-4265-2015		NIMH NIH HHS [MH55714, MH57138] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH055714, R01MH057138, R56MH055714] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; BUCKNER RL, 1996, P NATL ACAD SCI USA, V93, P14302; Buonocore MH, 1997, MAGNET RESON MED, V38, P89, DOI 10.1002/mrm.1910380114; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Corbetta M, 1998, ATTENTIVE BRAIN, P95; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Coull JT, 1998, J NEUROSCI, V18, P7426; D'Esposito M, 1998, NEUROIMAGE, V8, P274, DOI 10.1006/nimg.1998.0364; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Friedrich FJ, 1998, NEUROPSYCHOLOGY, V12, P193, DOI 10.1037/0894-4105.12.2.193; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gitelman DR, 1999, BRAIN, V122, P1093, DOI 10.1093/brain/122.6.1093; Harter M R, 1989, J Cogn Neurosci, V1, P223, DOI 10.1162/jocn.1989.1.3.223; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; HENIK A, 1994, J COGNITIVE NEUROSCI, V6, P400, DOI 10.1162/jocn.1994.6.4.400; Jonides J, 1998, P NATL ACAD SCI USA, V95, P8410, DOI 10.1073/pnas.95.14.8410; JONIDES J, 1993, NATURE, V363, P623, DOI 10.1038/363623a0; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; KOJIMA S, 1982, BRAIN RES, V248, P43, DOI 10.1016/0006-8993(82)91145-3; LaBar KS, 1999, NEUROIMAGE, V10, P695, DOI 10.1006/nimg.1999.0503; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P887, DOI 10.1037/0096-1523.20.4.887; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Mangun GR, 1997, HUM BRAIN MAPP, V5, P273, DOI 10.1002/(SICI)1097-0193(1997)5:4<273::AID-HBM12>3.0.CO;2-F; MANGUN GR, 1991, J EXP PSYCHOL HUMAN, V17, P1057, DOI 10.1037/0096-1523.17.4.1057; Mangun GR, 1998, HUM BRAIN MAPP, V6, P383, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<383::AID-HBM10>3.0.CO;2-Z; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; McCarthy G, 1997, J NEUROPHYSIOL, V77, P1630, DOI 10.1152/jn.1997.77.3.1630; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Pashler HE., 1998, PSYCHOL ATTENTION, DOI [10.7551/mitpress/5677.001.0001, DOI 10.7551/MITPRESS/5677.001.0001]; Petit L, 1999, HUM BRAIN MAPP, V8, P28, DOI 10.1002/(SICI)1097-0193(1999)8:1<28::AID-HBM3>3.0.CO;2-T; POSNER MI, 1984, J NEUROSCI, V4, P1863; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Posner MI, 1998, ATTENTIVE BRAIN, P401; Rosen AC, 1999, J COGNITIVE NEUROSCI, V11, P135, DOI 10.1162/089892999563283; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Talairach J., 1988, COPLANAR STEREOTAXIC; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; VANVOORHIS S, 1977, PERCEPT PSYCHOPHYS, V22, P54, DOI 10.3758/BF03206080; WATSON RT, 1994, ARCH NEUROL-CHICAGO, V51, P1014, DOI 10.1001/archneur.1994.00540220060015; Woldorff MG, 1997, HUM BRAIN MAPP, V5, P280, DOI 10.1002/(SICI)1097-0193(1997)5:4<280::AID-HBM13>3.0.CO;2-I	50	1369	1394	5	171	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2000	3	3					284	291		10.1038/72999	http://dx.doi.org/10.1038/72999			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	292TE	10700262				2022-12-24	WOS:000085810500019
J	Chaudhari, N; Landin, MA; Roper, SD				Chaudhari, N; Landin, MA; Roper, SD			A metabotropic glutamate receptor variant functions as a taste receptor	NATURE NEUROSCIENCE			English	Article							MONOSODIUM GLUTAMATE; BINDING-PROTEINS; ALPHA-SUBUNIT; RAT; BUDS; EXPRESSION; IDENTIFICATION; RESPONSES; GUSTDUCIN; PATTERNS	Sensory transduction for many taste stimuli such as sugars, some bitter compounds and amino acids is thought to be mediated via G protein-coupled receptors (GPCRs), although no such receptors that respond to taste stimuli are yet identified. Monosodium L-glutamate (L-MSG), a natural component of many foods, is an important gustatory stimulus believed to signal dietary protein. We describe a GPCR cloned from rat taste buds and functionally expressed in CHO cells. The receptor couples negatively to a cAMP cascade and shows an unusual concentration-response relationship. The similarity of its properties to MSG taste suggests that this receptor is a taste receptor for glutamate.	Univ Miami, Sch Med, Dept Physiol & Biophys, Miami, FL 33101 USA; Univ Miami, Sch Med, Program Neurosci, Miami, FL 33101 USA	University of Miami; University of Miami	Chaudhari, N (corresponding author), Univ Miami, Sch Med, Dept Physiol & Biophys, POB 016430 R430, Miami, FL 33101 USA.			Roper, Stephen/0000-0001-6049-8320	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P01DC003013] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC 03013] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ABE K, 1993, J BIOL CHEM, V268, P12033; Bigiani A, 1997, J NEUROPHYSIOL, V77, P3048, DOI 10.1152/jn.1997.77.6.3048; Bradley SR, 1996, J NEUROSCI, V16, P2044; CAICEDO A, IN PRESS J COMP NEUR; Chaudhari N, 1998, ANN NY ACAD SCI, V855, P398, DOI 10.1111/j.1749-6632.1998.tb10598.x; Chaudhari N, 1996, J NEUROSCI, V16, P3817; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; DELAY ER, IN PRESS CHEM SENSES; FAURION A, 1991, PHYSIOL BEHAV, V49, P905, DOI 10.1016/0031-9384(91)90202-Y; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Han GM, 1999, J BIOL CHEM, V274, P10008, DOI 10.1074/jbc.274.15.10008; Hayashi Y, 1996, BIOPHYS J, V71, P1057, DOI 10.1016/S0006-3495(96)79306-2; Hettinger TP, 1996, CHEM SENSES, V21, P341, DOI 10.1093/chemse/21.3.341; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Huang LQ, 1999, NAT NEUROSCI, V2, P1055, DOI 10.1038/15981; Kretz O, 1999, J HISTOCHEM CYTOCHEM, V47, P51, DOI 10.1177/002215549904700106; Kurihara K, 1998, ANN NY ACAD SCI, V855, P393, DOI 10.1111/j.1749-6632.1998.tb10597.x; Kusakabe Y, 1996, CHEM SENSES, V21, P335, DOI 10.1093/chemse/21.3.335; Kusakabe Y, 1998, BBA-MOL CELL RES, V1403, P265, DOI 10.1016/S0167-4889(98)00062-7; Lin WH, 1999, J COMP NEUROL, V405, P406, DOI 10.1002/(SICI)1096-9861(19990315)405:3<406::AID-CNE10>3.0.CO;2-F; Lin WH, 1999, J NEUROPHYSIOL, V82, P2061, DOI 10.1152/jn.1999.82.5.2061; Lindemann B, 1999, NAT MED, V5, P381, DOI 10.1038/7377; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; MATSUOKA I, 1993, BIOCHEM BIOPH RES CO, V194, P504, DOI 10.1006/bbrc.1993.1848; MCLAUGHLIN SK, 1994, PHYSIOL BEHAV, V56, P1157, DOI 10.1016/0031-9384(94)90360-3; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Ming D, 1998, P NATL ACAD SCI USA, V95, P8933, DOI 10.1073/pnas.95.15.8933; Misaka T, 1997, J BIOL CHEM, V272, P22623, DOI 10.1074/jbc.272.36.22623; Monastyrskaia K, 1999, BRIT J PHARMACOL, V128, P1027, DOI 10.1038/sj.bjp.0702885; NINOMIYA Y, 1991, PHYSIOL BEHAV, V49, P913, DOI 10.1016/0031-9384(91)90203-Z; OGAWA S, 1998, NATURE, V395, P555; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; PIN JP, 1992, P NATL ACAD SCI USA, V89, P10331, DOI 10.1073/pnas.89.21.10331; RIFKIN B, 1980, PHYSIOL BEHAV, V24, P1169, DOI 10.1016/0031-9384(80)90066-9; Sako N, 1999, NEUROSCI LETT, V261, P109, DOI 10.1016/S0304-3940(99)00019-1; TAKAHASHI K, 1993, J BIOL CHEM, V268, P19341; TANABE Y, 1992, NEURON, V8, P169, DOI 10.1016/0896-6273(92)90118-W; TANABE Y, 1993, J NEUROSCI, V13, P1372; Thomsen C, 1997, NEUROPHARMACOLOGY, V36, P21, DOI 10.1016/S0028-3908(96)00153-0; TORII K, 1980, BIOCHIM BIOPHYS ACTA, V627, P313; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Yamaguchi S, 1998, J NEUROCHEM, V71, P60; YAMAMOTO T, 1991, PHYSIOL BEHAV, V49, P919, DOI 10.1016/0031-9384(91)90204-2; Yang H, 1999, J HISTOCHEM CYTOCHEM, V47, P431, DOI 10.1177/002215549904700402	45	436	490	1	58	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2000	3	2					113	119		10.1038/72053	http://dx.doi.org/10.1038/72053			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TC	10649565				2022-12-24	WOS:000085810300007
J	Kay, AR; Alfonso, A; Alford, S; Cline, HT; Holgado, AM; Sakmann, B; Snitsarev, VA; Stricker, TP; Takahashi, M; Wu, LG				Kay, AR; Alfonso, A; Alford, S; Cline, HT; Holgado, AM; Sakmann, B; Snitsarev, VA; Stricker, TP; Takahashi, M; Wu, LG			Imaging synaptic activity in intact brain and slices with FM1-43 in C-elegans, lamprey, and rat	NEURON			English	Article							CAENORHABDITIS-ELEGANS; CYCLODEXTRIN; TERMINALS; NEURONS; GENOME	The fluorescent probe FM1-43 has been used extensively for imaging vesicle recycling; however, high nonspecific adsorption resulting in elevated background levels has precluded its use in certain tissues, notably brain slices. We have found that a sulfobutylated derivative of beta-cyclodextrin (ADVASEP-7) has a higher affinity for FM1-43 than the plasma membrane. ADVASEP-7 was used as a carrier to remove FM1-43 nonspecifically bound to the outer leaf let of the plasma membrane or extracellular molecules, significantly reducing background staining. This has enabled us to visualize synaptic vesicle recycling in the nematode C. elegans, intact lamprey spinal cord, and rat brain slices.	Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA; Univ Illinois, Dept Biol Sci, Chicago, IL USA; Northwestern Univ, Sch Med, Dept Physiol, Chicago, IL 60611 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Max Planck Inst Med Res, Zellphysiol Abt, D-69120 Heidelberg, Germany	University of Iowa; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; Cold Spring Harbor Laboratory; Max Planck Society	Kay, AR (corresponding author), Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA.	alan-kay@uiowa.edu	Snitsarev, Vladislav/AAP-5599-2020	Snitsarev, Vladislav/0000-0001-5518-5899; Alford, Simon/0000-0002-0454-4246				Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; Chalfie M, 1998, TRENDS GENET, V14, P506, DOI 10.1016/S0168-9525(98)01623-0; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; FORSYTHE ID, 1994, J PHYSIOL-LONDON, V479, P381, DOI 10.1113/jphysiol.1994.sp020303; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Kirchgessner AL, 1996, J COMP NEUROL, V371, P270; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; Lehn J. M., 1995, SUPRAMOLECULAR CHEM; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; Pyle JL, 1999, NEURON, V24, P803, DOI 10.1016/S0896-6273(00)81028-4; RAIZEN DM, 1994, NEURON, V12, P483, DOI 10.1016/0896-6273(94)90207-0; Rebek J, 1999, ACCOUNTS CHEM RES, V32, P278, DOI 10.1021/ar970201g; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Schote U, 1998, BBA-BIOMEMBRANES, V1415, P135, DOI 10.1016/S0005-2736(98)00188-6; Szejtli J, 1998, CHEM REV, V98, P1743, DOI 10.1021/cr970022c; TAIT RJ, 1992, J PHARMACEUT BIOMED, V10, P615, DOI 10.1016/0731-7085(92)80088-5; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	22	123	124	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1999	24	4					809	817		10.1016/S0896-6273(00)81029-6	http://dx.doi.org/10.1016/S0896-6273(00)81029-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	269UE	10624945	Bronze			2022-12-24	WOS:000084495300010
J	Cossart, R; Dinocourt, C; Hirsch, JC; Merchan-Perez, A; De Felipe, J; Ben-Ari, Y; Esclapez, M; Bernard, C				Cossart, R; Dinocourt, C; Hirsch, JC; Merchan-Perez, A; De Felipe, J; Ben-Ari, Y; Esclapez, M; Bernard, C			Dendritic but not somatic GABAergic inhibition is decreased in experimental epilepsy	NATURE NEUROSCIENCE			English	Article							TEMPORAL-LOBE EPILEPSY; GAMMA-AMINOBUTYRIC-ACID; CA1 PYRAMIDAL NEURONS; STRATUM-ORIENS-ALVEUS; RAT HIPPOCAMPUS; GLUTAMATE-DECARBOXYLASE; SELECTIVE LOSS; DENTATE GYRUS; 2 FORMS; POSTSYNAPTIC CURRENTS	Impaired inhibition is thought to be important in temporal lobe epilepsy (TLE), the most common form of epilepsy in adult patients. We report that, in experimental TLE, spontaneous GABAergic inhibition was increased in the soma but reduced in the dendrites of pyramidal neurons. The former resulted from the hyperactivity of somatic projecting interneurons, whereas the latter was probably due to the degeneration of a subpopulation of dendritic projecting interneurons. A deficit in dendritic inhibition could reduce seizure threshold, whereas enhanced somatic inhibition would prevent the continuous occurrence of epileptiform activity.	INSERM, U29, INMED, F-13273 Marseille 09, France; CSIC, Inst Cajal, E-28002 Madrid, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Ben-Ari, Y (corresponding author), INSERM, U29, INMED, Ave Luminy,BP 13, F-13273 Marseille 09, France.		bernard, christophe/S-5937-2016; DEFELIPE, JAVIER/D-1195-2014; bernard, christophe/A-4929-2012; Merchan-Perez, Angel/AAY-8947-2020; Merchan-Perez, Angel/D-7417-2014; Esclapez, Monique/O-6509-2016; Cossart, Rosa/AAT-7934-2020; Cossart, Rosa/E-7674-2014	bernard, christophe/0000-0003-3014-1966; DEFELIPE, JAVIER/0000-0001-5484-0660; bernard, christophe/0000-0003-3014-1966; Merchan-Perez, Angel/0000-0002-7228-5821; Merchan-Perez, Angel/0000-0002-7228-5821; Esclapez, Monique/0000-0002-8558-1363; Cossart, Rosa/0000-0003-2111-6638; Cossart, Rosa/0000-0003-2111-6638; Ben-Ari, Yehezkel/0000-0001-6208-8480				Buckmaster PS, 1999, J NEUROSCI, V19, P9519; Buhl EH, 1996, SCIENCE, V271, P369, DOI 10.1126/science.271.5247.369; Chen K, 1999, NAT MED, V5, P888, DOI 10.1038/11330; Cohen I, 2000, J PHYSIOL-LONDON, V524, P485, DOI 10.1111/j.1469-7793.2000.00485.x; Cossart R, 2000, NEUROSCIENCE, V99, P593, DOI 10.1016/S0306-4522(00)00231-1; DELANEROLLE NC, 1989, BRAIN RES, V495, P387, DOI 10.1016/0006-8993(89)90234-5; Esclapez M, 1997, P NATL ACAD SCI USA, V94, P12151, DOI 10.1073/pnas.94.22.12151; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Esclapez M, 1999, J COMP NEUROL, V408, P449, DOI 10.1002/(SICI)1096-9861(19990614)408:4<449::AID-CNE1>3.0.CO;2-R; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fricker D, 1999, J PHYSIOL-LONDON, V517, P791, DOI 10.1111/j.1469-7793.1999.0791s.x; Gibbs JW, 1997, J NEUROPHYSIOL, V77, P1924, DOI 10.1152/jn.1997.77.4.1924; GOODMAN RH, 1982, J BIOL CHEM, V257, P1156; Hirsch JC, 1996, J NEUROPHYSIOL, V76, P4185, DOI 10.1152/jn.1996.76.6.4185; Hirsch JC, 1999, NAT NEUROSCI, V2, P499, DOI 10.1038/9142; Holmes WR, 1997, J NEUROPHYSIOL, V78, P103, DOI 10.1152/jn.1997.78.1.103; Houser C R, 1999, Adv Neurol, V79, P743; HOUSER CR, 1994, HIPPOCAMPUS, V4, P530, DOI 10.1002/hipo.450040503; Houser CR, 1996, EPILEPSY RES, V26, P207, DOI 10.1016/S0920-1211(96)00054-X; Johnston D, 1999, CURR OPIN NEUROBIOL, V9, P288, DOI 10.1016/S0959-4388(99)80042-7; Kapur A, 1997, J NEUROPHYSIOL, V78, P2546, DOI 10.1152/jn.1997.78.5.2546; Katona I, 1999, NEUROSCIENCE, V88, P37, DOI 10.1016/S0306-4522(98)00302-9; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; KAUFMAN DL, 1986, SCIENCE, V232, P1138, DOI 10.1126/science.3518061; LACAILLE JC, 1990, NEUROSCIENCE, V36, P349, DOI 10.1016/0306-4522(90)90431-3; LIU Z, 1994, EPILEPSY RES, V17, P237; Loup F, 2000, J NEUROSCI, V20, P5401, DOI 10.1523/JNEUROSCI.20-14-05401.2000; Maccaferri G, 2000, J PHYSIOL-LONDON, V524, P91, DOI 10.1111/j.1469-7793.2000.t01-3-00091.x; MACCAFERRI G, 1995, NEURON, V15, P137, DOI 10.1016/0896-6273(95)90071-3; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; MATHERN GW, 1995, J NEUROSCI, V15, P3990; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Morin F, 1998, EPILEPSY RES, V32, P363, DOI 10.1016/S0920-1211(98)00033-3; NADLER JV, 1981, LIFE SCI, V29, P2031; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; OBENAUS A, 1993, J NEUROSCI, V13, P4470; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; OTIS TS, 1994, P NATL ACAD SCI USA, V91, P7698, DOI 10.1073/pnas.91.16.7698; Perez Y, 1996, EUR J NEUROSCI, V8, P736, DOI 10.1111/j.1460-9568.1996.tb01259.x; Peters A, 1996, J NEUROCYTOL, V25, P687, DOI 10.1007/BF02284835; PRINCE DA, 1978, ANNU REV NEUROSCI, V1, P395, DOI 10.1146/annurev.ne.01.030178.002143; Prince DA, 1998, EPILEPSY RES, V32, P83, DOI 10.1016/S0920-1211(98)00042-4; PYAPALI GK, 1994, BRAIN RES, V652, P279, DOI 10.1016/0006-8993(94)90238-0; Rempe DA, 1997, J NEUROPHYSIOL, V78, P1504, DOI 10.1152/jn.1997.78.3.1504; ROBBINS RJ, 1991, ANN NEUROL, V29, P325, DOI 10.1002/ana.410290316; Ross ST, 2000, J NEUROPHYSIOL, V83, P2916, DOI 10.1152/jn.2000.83.5.2916; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; TOTH K, 1992, NEUROSCIENCE, V49, P793, DOI 10.1016/0306-4522(92)90357-8; Yanovsky Y, 1997, NEUROSCIENCE, V77, P87, DOI 10.1016/S0306-4522(96)00461-7	49	438	446	0	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2001	4	1					52	62		10.1038/82900	http://dx.doi.org/10.1038/82900			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UB	11135645				2022-12-24	WOS:000167178000014
J	Paratcha, G; Ledda, F; Baars, L; Coulpier, M; Besset, V; Anders, J; Scott, R; Ibanez, CF				Paratcha, G; Ledda, F; Baars, L; Coulpier, M; Besset, V; Anders, J; Scott, R; Ibanez, CF			Released GFR alpha 1 potentiates downstream signaling, neuronal survival, and differentiation via a novel mechanism of recruitment of c-Ret to lipid rafts	NEURON			English	Article							NEUROTROPHIC FACTOR; TYROSINE KINASE; GDNFR-ALPHA; RECEPTOR; ACTIVATION; PROTEIN; EXPRESSION; MEMBRANE; COMPLEXES; PATHWAYS	Although both c-Ret and GFR alpha1 are required for responsiveness to GDNF, GFR alpha1 is widely expressed in the absence of c-Ret, suggesting alternative roles for "ectopic" sites of GFR alpha1 expression. We show that GFR alpha1 is released by neuronal cells, Schwann cells, and injured sciatic nerve. c-Ret stimulation in trans by soluble or immobilized GFR alpha1 potentiates downstream signaling, neurite outgrowth, and neuronal survival, and elicits dramatic localized expansions of axons and growth cones. Soluble GFR alpha1 mediates robust recruitment of c-Ret to lipid rafts via a novel mechanism requiring the c-Ret tyrosine kinase. Activated c-Ret associates with different adaptor proteins inside and outside lipid rafts. These results provide an explanation for the tissue distribution of GFR alpha1, supporting the physiological importance of c-Ret activation in trans as a novel mechanism to potentiate and diversify the biological responses to GDNF.	Karolinska Inst, Dept Neurosci, Div Mol Neurobiol, S-17177 Stockholm, Sweden	Karolinska Institutet	Ibanez, CF (corresponding author), Karolinska Inst, Dept Neurosci, Div Mol Neurobiol, S-17177 Stockholm, Sweden.	carlos@cajal.mbb.ki.se	Scott, Rizaldy/AAC-5264-2020; Scott, Rizaldy/Y-7584-2019	Scott, Rizaldy/0000-0002-0288-8862; Paratcha, Gustavo/0000-0002-0804-4433; Coulpier, Muriel/0000-0001-5400-8727				Airaksinen MS, 1999, MOL CELL NEUROSCI, V13, P313, DOI 10.1006/mcne.1999.0754; Besset V, 2000, J BIOL CHEM, V275, P39159, DOI 10.1074/jbc.M006908200; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; DAVIS S, 1993, SCIENCE, V259, P1736, DOI 10.1126/science.7681218; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Durbec P, 1996, NATURE, V381, P789, DOI 10.1038/381789a0; Eketjall S, 1999, EMBO J, V18, P5901, DOI 10.1093/emboj/18.21.5901; FaivreSarrailh C, 1997, MOL CELL NEUROSCI, V9, P109, DOI 10.1006/mcne.1997.0609; Fundin BT, 1999, DEVELOPMENT, V126, P2597; Huang C, 1999, J BIOL CHEM, V274, P36707, DOI 10.1074/jbc.274.51.36707; Ikonen E, 1998, SEMIN CELL DEV BIOL, V9, P503, DOI 10.1006/scdb.1998.0258; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Klein RD, 1997, NATURE, V387, P717, DOI 10.1038/42722; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Ledesma MD, 1998, P NATL ACAD SCI USA, V95, P3966, DOI 10.1073/pnas.95.7.3966; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Mineo C, 1999, J BIOL CHEM, V274, P30636, DOI 10.1074/jbc.274.43.30636; Naveilhan P, 1997, EUR J NEUROSCI, V9, P1450, DOI 10.1111/j.1460-9568.1997.tb01499.x; Poteryaev D, 1999, FEBS LETT, V463, P63, DOI 10.1016/S0014-5793(99)01590-2; SALAZARGRUESO EF, 1991, NEUROREPORT, V2, P505, DOI 10.1097/00001756-199109000-00002; Sanicola M, 1997, P NATL ACAD SCI USA, V94, P6238, DOI 10.1073/pnas.94.12.6238; Sariola H, 1999, INT J DEV BIOL, V43, P413; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Tansey MG, 2000, NEURON, V25, P611, DOI 10.1016/S0896-6273(00)81064-8; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Trupp M, 1999, J BIOL CHEM, V274, P20885, DOI 10.1074/jbc.274.30.20885; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; Trupp M, 1998, MOL CELL NEUROSCI, V11, P47, DOI 10.1006/mcne.1998.0667; Trupp M, 1997, J NEUROSCI, V17, P3554; Vega QC, 1996, P NATL ACAD SCI USA, V93, P10657, DOI 10.1073/pnas.93.20.10657; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; WHITE LA, 1994, J NEUROSCI, V14, P6744; Worley DS, 2000, DEVELOPMENT, V127, P4383; Yu T, 1998, J NEUROSCI, V18, P4684	37	226	232	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	2001	29	1					171	184		10.1016/S0896-6273(01)00188-X	http://dx.doi.org/10.1016/S0896-6273(01)00188-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	397NX	11182089	Green Published, Bronze			2022-12-24	WOS:000166702700017
J	Kamal, A; Stokin, GB; Yang, ZH; Xia, CH; Goldstein, LSB				Kamal, A; Stokin, GB; Yang, ZH; Xia, CH; Goldstein, LSB			Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I	NEURON			English	Article							HEAVY-CHAIN; ALZHEIMERS-DISEASE; CYTOPLASMIC DYNEIN; NERVOUS-SYSTEM; TAIL DOMAIN; DROSOPHILA; MOTOR; MOTILITY; KINECTIN; MOUSE	We analyzed the mechanism of axonal transport of the amyloid precursor protein (APP), which plays a major role in the development of Alzheimer's disease. Coimmunoprecipitation, sucrose gradient, and direct in vitro binding demonstrated that APP forms a complex with the microtubule motor, conventional kinesin (kinesin-1), by binding directly to the TPR domain of the kinesin light chain (KLC) subunit. The estimated apparent K-d for binding is 15-20 nM, with a binding stoichiometry of two APP per KLC. In addition, association of APP with microtubules and axonal transport of APP is greatly decreased in a gene-targeted mouse mutant of the neuronally enriched KLC1 gene. We propose that one of the normal functions of APP may be as a membrane cargo receptor for kinesin-1 and that KLC is important for kinesin-1-driven transport of APP into axons.	Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Goldstein, LSB (corresponding author), Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Stokin, Gorazd Bernard/D-9480-2015	Stokin, Gorazd Bernard/0000-0001-8430-8755	NIGMS NIH HHS [GM35252] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035252] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMARATUNGA A, 1995, J NEUROCHEM, V64, P2374; Bi GQ, 1997, J CELL BIOL, V138, P999, DOI 10.1083/jcb.138.5.999; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Bowman AB, 1999, J CELL BIOL, V146, P165; BOWMAN AB, 2000, IN PRESS CELL, V103; BRADY ST, 1985, NATURE, V317, P73, DOI 10.1038/317073a0; CHECLER F, 1995, J NEUROCHEM, V65, P1431; Coy DL, 1999, NAT CELL BIOL, V1, P288, DOI 10.1038/13001; De Strooper B, 2000, J CELL SCI, V113, P1857; DECUEVAS M, 1992, J CELL BIOL, V116, P957, DOI 10.1083/jcb.116.4.957; Diefenbach RJ, 1998, BIOCHEMISTRY-US, V37, P16663, DOI 10.1021/bi981163r; FERREIRA A, 1992, J CELL BIOL, V117, P595, DOI 10.1083/jcb.117.3.595; FERREIRA A, 1993, J NEUROSCI, V13, P3112; Friedman DS, 1999, NAT CELL BIOL, V1, P293, DOI 10.1038/13008; GAUGER AK, 1993, J BIOL CHEM, V268, P13657; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; Gindhart JG, 1996, TRENDS BIOCHEM SCI, V21, P52, DOI 10.1016/0968-0004(96)80865-6; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Goldstein LSB, 1999, ANNU REV CELL DEV BI, V15, P141, DOI 10.1146/annurev.cellbio.15.1.141; Hackney DD, 2000, NAT CELL BIOL, V2, P257, DOI 10.1038/35010525; HACKNEY DD, 1992, J BIOL CHEM, V267, P8696; Hanlon DW, 1997, NEURON, V18, P439, DOI 10.1016/S0896-6273(00)81244-1; HIROKAWA N, 1989, CELL, V56, P867, DOI 10.1016/0092-8674(89)90691-0; Hurd DD, 1996, GENETICS, V142, P195; Hurd DD, 1996, GENETICS, V144, P1075; Ikin AF, 1996, J BIOL CHEM, V271, P31783, DOI 10.1074/jbc.271.50.31783; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kamal A, 2000, CURR OPIN CELL BIOL, V12, P503, DOI 10.1016/S0955-0674(00)00123-X; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; KUMAR J, 1995, SCIENCE, V267, P1834, DOI 10.1126/science.7892610; Marszalek JR, 1999, J CELL BIOL, V145, P469, DOI 10.1083/jcb.145.3.469; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; OTSUKA AJ, 1991, NEURON, V6, P113, DOI 10.1016/0896-6273(91)90126-K; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Rahman A, 1998, J BIOL CHEM, V273, P15395, DOI 10.1074/jbc.273.25.15395; Rahman A, 1999, J CELL BIOL, V146, P1277, DOI 10.1083/jcb.146.6.1277; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Seiler S, 2000, NAT CELL BIOL, V2, P333, DOI 10.1038/35014022; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; SISODIA SS, 1993, J NEUROSCI, V13, P3136; SKOUFIAS DA, 1994, J BIOL CHEM, V269, P1477; STEINBERG G, 1995, MOL BIOL CELL, V6, P1605, DOI 10.1091/mbc.6.11.1605; Stenoien DL, 1997, MOL BIOL CELL, V8, P675, DOI 10.1091/mbc.8.4.675; Stock MF, 1999, J BIOL CHEM, V274, P14617, DOI 10.1074/jbc.274.21.14617; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Torroja L, 1999, CURR BIOL, V9, P489, DOI 10.1016/S0960-9822(99)80215-2; TOYOSHIMA I, 1992, J CELL BIOL, V118, P1121, DOI 10.1083/jcb.118.5.1121; Toyoshima I, 1996, NEUROSCI LETT, V211, P171, DOI 10.1016/0304-3940(96)12752-X; Verhey KJ, 1998, J CELL BIOL, V143, P1053, DOI 10.1083/jcb.143.4.1053; Xia CH, 1998, GENOMICS, V52, P209, DOI 10.1006/geno.1998.5427; YAMAZAKI T, 1995, J CELL BIOL, V129, P431, DOI 10.1083/jcb.129.2.431; YANG JT, 1989, CELL, V56, P879, DOI 10.1016/0092-8674(89)90692-2; Yonekawa Y, 1998, J CELL BIOL, V141, P431, DOI 10.1083/jcb.141.2.431; Zheng PZ, 1998, P NATL ACAD SCI USA, V95, P14745, DOI 10.1073/pnas.95.25.14745	57	421	438	0	20	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	2000	28	2					449	459		10.1016/S0896-6273(00)00124-0	http://dx.doi.org/10.1016/S0896-6273(00)00124-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	377CE	11144355	Bronze			2022-12-24	WOS:000165493700020
J	Legan, PK; Lukashkina, VA; Goodyear, RJ; Kossl, M; Russell, IJ; Richardson, GP				Legan, PK; Lukashkina, VA; Goodyear, RJ; Kossl, M; Russell, IJ; Richardson, GP			A targeted deletion in alpha-tectorin reveals that the tectorial membrane is required for the gain and timing of cochlear feedback	NEURON			English	Article							GUINEA-PIG COCHLEA; OUTER HAIR-CELLS; BASILAR-MEMBRANE; INNER-EAR; RESPONSES; BUNDLES; AMPLIFICATION; ORGANIZATION; NONLINEARITY; STIMULATION	alpha -tectorin is an extracellular matrix molecule of the inner ear. Mice homozygous for a targeted deletion in a-tectorin have tectorial membranes that are detached from the cochlear epithelium and lack all noncollagenous matrix, but the architecture of the organ of Corti is otherwise normal. The basilar membranes of wild-type and alpha -tectorin mutant mice are tuned, but the alpha -tectorin mutants are 35 dB less sensitive. Basilar membrane responses of wild-type mice exhibit a second resonance, indicating that the tectorial membrane provides an inertial mass against which outer hair cells can exert forces. Cochlear microphonics recorded in alpha -tectorin mutants differ in both phase and symmetry relative to those of wild-type mice. Thus, the tectorial membrane ensures that outer hair cells can effectively respond to basilar membrane motion and that feedback is delivered with the appropriate gain and timing required for amplification.	Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England; Inst Zool, D-8033 Munich, Germany	University of Sussex	Richardson, GP (corresponding author), Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England.			Legan, P. Kevin/0000-0002-7403-6415; Russell, Ian/0000-0002-4915-2772; Lukashkina, Victoria/0000-0002-9154-8746				Abnet CC, 2000, HEARING RES, V144, P29, DOI 10.1016/S0378-5955(00)00041-1; BROOKES AJ, 1993, TRANSGENIC RES, V2, P238, DOI 10.1007/BF01977354; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; CODY AR, 1987, J PHYSIOL-LONDON, V383, P551; Cohen-Salmon M, 1997, P NATL ACAD SCI USA, V94, P14450, DOI 10.1073/pnas.94.26.14450; COOPER NP, 1992, HEARING RES, V63, P191, DOI 10.1016/0378-5955(92)90084-Z; FREEMAN DM, 1990, HEARING RES, V48, P31, DOI 10.1016/0378-5955(90)90197-W; GASKILL SA, 1990, J ACOUST SOC AM, V88, P821, DOI 10.1121/1.399732; GEISLER CD, 1995, HEARING RES, V86, P132, DOI 10.1016/0378-5955(95)00064-B; GOODYEAR R, 1992, J COMP NEUROL, V325, P243, DOI 10.1002/cne.903250208; Gummer AW, 1996, P NATL ACAD SCI USA, V93, P8727, DOI 10.1073/pnas.93.16.8727; HASKO JA, 1988, HEARING RES, V35, P21, DOI 10.1016/0378-5955(88)90037-8; KEMP DT, 1979, ARCH OTO-RHINO-LARYN, V224, P37, DOI 10.1007/BF00455222; Killick R, 1997, HEARING RES, V103, P131, DOI 10.1016/S0378-5955(96)00174-8; KIM DO, 1980, J ACOUST SOC AM, V67, P1704, DOI 10.1121/1.384297; Kimura R S, 1966, Acta Otolaryngol, V61, P55, DOI 10.3109/00016486609127043; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; Malumbres M, 1997, BIOTECHNIQUES, V22, P1114, DOI 10.2144/97226st03; MARKIN VS, 1995, BIOPHYS J, V69, P138, DOI 10.1016/S0006-3495(95)79883-6; Mountain D. C., 1983, MECH HEARING, P119; MOUNTAIN DC, 1980, SCIENCE, V210, P71, DOI 10.1126/science.7414321; Murugasu E, 1996, J NEUROSCI, V16, P325; Nuttall AL, 1996, J ACOUST SOC AM, V99, P1556, DOI 10.1121/1.414732; PATUZZI RB, 1989, HEARING RES, V42, P47, DOI 10.1016/0378-5955(89)90117-2; Rau A, 1999, J COMP NEUROL, V405, P271; RICHARDSON GP, 1987, HEARING RES, V25, P45, DOI 10.1016/0378-5955(87)90078-5; Ruggero MA, 1997, J ACOUST SOC AM, V101, P2151, DOI 10.1121/1.418265; RUSSELL IJ, 1986, HEARING RES, V22, P199, DOI 10.1016/0378-5955(86)90096-1; RUSSELL IJ, 1992, PHILOS T ROY SOC B, V336, P317, DOI 10.1098/rstb.1992.0064; SELLICK PM, 1982, J ACOUST SOC AM, V72, P131, DOI 10.1121/1.387996; Simmler MC, 2000, NAT GENET, V24, P139, DOI 10.1038/72793; SLEPECKY NB, 1992, CELL TISSUE RES, V267, P413, DOI 10.1007/BF00319363; SLEPECKY NB, 1992, MATRIX, V12, P80, DOI 10.1016/S0934-8832(11)80108-3; THALMANN I, 1987, LARYNGOSCOPE, V97, P357; von Bekesy G, 1960, EXPT HEARING; Wurst W., 1993, Gene targeting: a practical approach., P33; YATES GK, 1990, HEARING RES, V45, P203, DOI 10.1016/0378-5955(90)90121-5; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	38	236	238	0	17	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	2000	28	1					273	285		10.1016/S0896-6273(00)00102-1	http://dx.doi.org/10.1016/S0896-6273(00)00102-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	370VN	11087000	Bronze			2022-12-24	WOS:000165143500027
J	Dulabon, L; Olson, EC; Taglienti, MG; Eisenhuth, S; McGrath, B; Walsh, CA; Kreidberg, JA; Anton, ES				Dulabon, L; Olson, EC; Taglienti, MG; Eisenhuth, S; McGrath, B; Walsh, CA; Kreidberg, JA; Anton, ES			Reelin binds alpha 3 beta 1 integrin and inhibits neuronal migration	NEURON			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; LAMINAR ORGANIZATION; EXTRACELLULAR-MATRIX; CORTICAL-NEURONS; BETA-1 INTEGRIN; CEREBRAL-CORTEX; MONOCLONAL-ANTIBODY; NEURITE OUTGROWTH; DEVELOPING BRAIN; NERVOUS-SYSTEM	Mice that are mutant for Reelin or Dab1, or doubly mutant for the VLDL receptor (VLDLR) and ApoE receptor 2 (ApoER2), show disorders of cerebral cortical lamination. How Reelin and its receptors regulate laminar organization of cerebral cortex is unknown. We show that Reelin inhibits migration of cortical neurons and enables detachment of neurons from radial glia. Recombinant and native Reelin associate with alpha 3 beta 1 integrin, which regulates neuron-glia interactions and is required to achieve proper laminar organization. The effect of Reelin on cortical neuronal migration in vitro and in vivo depends on interactions between Reelin and alpha 3 alpha 1 integrin. Absence of alpha 3 beta 1 leads to a reduction of Dab1, a signaling protein acting downstream of Reelin. Thus, Reelin may arrest neuronal migration and promote normal cortical lamination by binding alpha 3 beta 1 integrin and modulating integrin-mediated cellular adhesion.	Penn State Univ, Dept Biol & Neurosci, University Pk, PA 16802 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Harvard Inst Med, Beth Israel Deaconess Med Ctr,Dept Neurol, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Anton, ES (corresponding author), Univ N Carolina, Sch Med, Ctr Neurosci, Chapel Hill, NC 27599 USA.	esa5@psu.edu		Eisenhuth, Scott/0000-0003-2608-2174	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS039404, R01NS038097] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS39404, R01 NS38097] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andressen C, 1998, NEUROSCI LETT, V251, P165, DOI 10.1016/S0304-3940(98)00535-7; Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; BUSK M, 1992, J BIOL CHEM, V267, P5790; CAVINESS VS, 1973, J COMP NEUROL, V148, P141, DOI 10.1002/cne.901480202; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Condic ML, 1997, NATURE, V389, P852, DOI 10.1038/39878; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DArcangelo G, 1996, MOL BRAIN RES, V39, P234, DOI 10.1016/0169-328X(96)00046-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; de Rouvroit CL, 1999, EXP NEUROL, V156, P214, DOI 10.1006/exnr.1998.7007; DEDHAR S, 1992, EXP CELL RES, V203, P270, DOI 10.1016/0014-4827(92)90064-F; DEFREITAS MF, 1995, NEURON, V15, P333, DOI 10.1016/0896-6273(95)90038-1; DiPersio CM, 1997, J CELL BIOL, V137, P729, DOI 10.1083/jcb.137.3.729; FISHMAN RB, 1993, J NEUROSCI, V13, P3485; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; GALILEO DS, 1992, NEURON, V9, P1117, DOI 10.1016/0896-6273(92)90070-T; Georges-Labouesse E, 1998, CURR BIOL, V8, P983, DOI 10.1016/S0960-9822(98)70402-6; Gonzalez JL, 1997, J NEUROSCI, V17, P9204; Grabham PW, 1997, J NEUROSCI, V17, P5455; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Hodivala-Dilke KM, 1998, J CELL BIOL, V142, P1357, DOI 10.1083/jcb.142.5.1357; HOFFARTH RM, 1995, J NEUROSCI, V15, P4838; Homayouni R, 1999, J NEUROSCI, V19, P7507, DOI 10.1523/JNEUROSCI.19-17-07507.1999; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Howell BW, 1999, MOL CELL BIOL, V19, P5179; KAPRIELIAN Z, 1993, J NEUROSCI, V13, P2495, DOI 10.1523/JNEUROSCI.13-06-02495.1993; Komuro H, 1998, J NEUROBIOL, V37, P110, DOI 10.1002/(SICI)1097-4695(199810)37:1<110::AID-NEU9>3.3.CO;2-Q; Law DA, 1999, NATURE, V401, P808, DOI 10.1038/44599; LIESI P, 1990, EXPERIENTIA, V46, P900, DOI 10.1007/BF01939382; Maeda N, 1998, J CELL BIOL, V142, P203, DOI 10.1083/jcb.142.1.203; Miyata T, 1997, J NEUROSCI, V17, P3599; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Patel DD, 1997, BIOCHEM J, V324, P371, DOI 10.1042/bj3240371; PINTOLORD MC, 1982, DEV BRAIN RES, V4, P379, DOI 10.1016/0165-3806(82)90181-X; Poindexter K, 1999, GENE, V237, P61, DOI 10.1016/S0378-1119(99)00302-9; Pol A, 1997, BIOCHEM J, V323, P435, DOI 10.1042/bj3230435; RAUB TJ, 1989, EXP CELL RES, V184, P407, DOI 10.1016/0014-4827(89)90340-6; Rice DS, 1998, DEVELOPMENT, V125, P3719; Senzaki K, 1999, CELL, V99, P635, DOI 10.1016/S0092-8674(00)81552-4; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; TOLLESHAUG H, 1982, CELL, V30, P715, DOI 10.1016/0092-8674(82)90276-8; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Walsh CA, 1999, NEURON, V23, P19, DOI 10.1016/S0896-6273(00)80749-7; Ware ML, 1997, NEURON, V19, P239, DOI 10.1016/S0896-6273(00)80936-8; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; Zhang ZQ, 1998, J NEUROSCI, V18, P6928	52	460	479	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	2000	27	1					33	44		10.1016/S0896-6273(00)00007-6	http://dx.doi.org/10.1016/S0896-6273(00)00007-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339XU	10939329	Bronze			2022-12-24	WOS:000088503800008
J	Chakfe, Y; Bourque, CW				Chakfe, Y; Bourque, CW			Excitatory peptides and osmotic pressure modulate mechanosensitive cation channels in concert	NATURE NEUROSCIENCE			English	Article							RAT SUPRAOPTIC NUCLEUS; VASOPRESSIN RELEASE; ANGIOTENSIN-II; IN-VITRO; NEUROSECRETORY-CELLS; DEPOLARIZING ACTION; GASTRIN RECEPTOR; NEURONS INVITRO; HYPOTHALAMUS; NEUROTENSIN	Behavioral and neuroendocrine responses underlying systemic osmoregulation are synergistically controlled by osmoreceptors and neuropeptides released within the hypothalamus. Although mechanisms underlying osmoreception are understood, the cellular basis for the integration of osmotic and peptidergic signals remains unknown. Here we show that the excitatory effects of angiotensin II, cholecystokinin and neurotensin on supraoptic neurosecretory neurons are due to the stimulation of the stretch-inactivated cation channels responsible for osmoreception. This molecular convergence underlies the facilitatory effects of neuropeptides on responses to osmotic stimulation and provides a basis for the gating effects of plasma osmolality on the responsiveness of osmoregulatory neurons to peptidergic stimulation.	Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada; McGill Univ, Montreal, PQ H3G 1A4, Canada	McGill University; McGill University	Bourque, CW (corresponding author), Montreal Gen Hosp, Ctr Res Neurosci, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	mdbq@musica.mcgill.ca		Bourque, Charles/0000-0002-1594-742X				AKAISHI T, 1980, BRAIN RES, V188, P499, DOI 10.1016/0006-8993(80)90048-7; ANDREW RD, 1984, J NEUROPHYSIOL, V51, P552, DOI 10.1152/jn.1984.51.3.552; BICKNELL RJ, 1988, J EXP BIOL, V139, P51; Bourque CW, 1997, ANNU REV PHYSIOL, V59, P601, DOI 10.1146/annurev.physiol.59.1.601; Bourque CW, 1998, PROG BRAIN RES, V119, P59; BOURQUE CW, 1994, FRONT NEUROENDOCRIN, V15, P231, DOI 10.1006/frne.1994.1010; Bourque CW, 1998, CELL MOL NEUROBIOL, V18, P3, DOI 10.1023/A:1022566924921; DRAPEAU P, 1990, NEURON, V4, P875, DOI 10.1016/0896-6273(90)90140-B; DUNN FL, 1973, J CLIN INVEST, V52, P3212, DOI 10.1172/JCI107521; Gabreels BATF, 1998, J CLIN ENDOCR METAB, V83, P4026, DOI 10.1210/jc.83.11.4026; GUHARAY F, 1984, J PHYSIOL-LONDON, V352, P685, DOI 10.1113/jphysiol.1984.sp015317; Hakansson ML, 1998, J NEUROSCI, V18, P559; Hiruma H, 1995, J PHYSIOL-LONDON, V489, P805, DOI 10.1113/jphysiol.1995.sp021093; HU B, 1992, J PHYSIOL-LONDON, V458, P667, DOI 10.1113/jphysiol.1992.sp019440; Hunyady L, 1996, TRENDS PHARMACOL SCI, V17, P135, DOI 10.1016/0165-6147(96)81588-4; JARVIS CR, 1992, J PHYSIOL-LONDON, V458, P621, DOI 10.1113/jphysiol.1992.sp019437; JENNES L, 1982, J COMP NEUROL, V210, P211, DOI 10.1002/cne.902100302; JHAMANDAS JH, 1989, BRAIN RES, V487, P52, DOI 10.1016/0006-8993(89)90939-6; KIMURA S, 1994, J NEUROENDOCRINOL, V6, P503, DOI 10.1111/j.1365-2826.1994.tb00612.x; KIRKPATRICK K, 1995, J PHYSIOL-LONDON, V482, P373, DOI 10.1113/jphysiol.1995.sp020524; KOPIN AS, 1992, P NATL ACAD SCI USA, V89, P3605, DOI 10.1073/pnas.89.8.3605; LEE YM, 1993, J BIOL CHEM, V268, P8164; LENG G, 1989, J NEUROENDOCRINOL, V1, P35, DOI 10.1111/j.1365-2826.1989.tb00074.x; MORRIS CE, 1989, SCIENCE, V243, P807, DOI 10.1126/science.2536958; MURASE T, 1993, NEUROENDOCRINOLOGY, V57, P1092, DOI 10.1159/000126475; MURPHY TJ, 1991, NATURE, V351, P233, DOI 10.1038/351233a0; NEUMANN I, 1994, AM J PHYSIOL-REG I, V267, pR1626, DOI 10.1152/ajpregu.1994.267.6.R1626; OLIET SHR, 1993, AM J PHYSIOL, V265, pR1475, DOI 10.1152/ajpregu.1993.265.6.R1475; OLIET SHR, 1992, J PHYSIOL-LONDON, V455, P291, DOI 10.1113/jphysiol.1992.sp019302; Oliet SHR, 1996, NEURON, V16, P175, DOI 10.1016/S0896-6273(00)80034-3; OLIET SHR, 1993, NATURE, V364, P341, DOI 10.1038/364341a0; OLIET SHR, 1995, J NEUROENDOCRINOL, V7, P661, DOI 10.1111/j.1365-2826.1995.tb00806.x; POULAIN DA, 1982, NEUROSCIENCE, V7, P773, DOI 10.1016/0306-4522(82)90044-6; RENAUD LP, 1991, PROG NEUROBIOL, V36, P131, DOI 10.1016/0301-0082(91)90020-2; RENAUD LP, 1992, PROG BRAIN RES, V92, P277, DOI 10.1016/S0079-6123(08)61183-8; Richard D, 1995, J PHYSIOL-LONDON, V489, P567, DOI 10.1113/jphysiol.1995.sp021073; SAWCHENKO PE, 1995, BRAIN RES, V694, P233, DOI 10.1016/0006-8993(95)00760-N; SENATOROV VV, 1993, J NEUROENDOCRINOL, V5, P533, DOI 10.1111/j.1365-2826.1993.tb00518.x; Setiadji VS, 1998, J NEUROENDOCRINOL, V10, P927; Shibuya I, 1998, J NEUROENDOCRINOL, V10, P759, DOI 10.1046/j.1365-2826.1998.00260.x; SLADEK CD, 1982, ENDOCRINOLOGY, V111, P599, DOI 10.1210/endo-111-2-599; Smith BN, 1996, J PHYSIOL-LONDON, V495, P465, DOI 10.1113/jphysiol.1996.sp021607; VENETIKOU MS, 1990, REGUL PEPTIDES, V29, P163, DOI 10.1016/0167-0115(90)90079-C; Vincent JP, 1999, TRENDS PHARMACOL SCI, V20, P302, DOI 10.1016/S0165-6147(99)01357-7; Voisin DL, 1999, NEURON, V24, P453, DOI 10.1016/S0896-6273(00)80858-2; WANK SA, 1992, P NATL ACAD SCI USA, V89, P8691, DOI 10.1073/pnas.89.18.8691; WILSON BC, 1994, J ENDOCRINOL, V141, P75, DOI 10.1677/joe.0.1410075; YANG CR, 1992, AM J PHYSIOL, V263, pR1333, DOI 10.1152/ajpregu.1992.263.6.R1333; YANG CR, 1991, J PHYSIOL-LONDON, V443, P405, DOI 10.1113/jphysiol.1991.sp018840	49	67	70	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2000	3	6					572	579		10.1038/75744	http://dx.doi.org/10.1038/75744			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	317WG	10816313				2022-12-24	WOS:000087249500013
J	Darian-Smith, C; Brown, S				Darian-Smith, C; Brown, S			Functional changes at periphery and cortex following dorsal root lesions in adult monkeys	NATURE NEUROSCIENCE			English	Article							PRIMARY SOMATOSENSORY CORTEX; SPINAL-CORD; DIGIT AMPUTATION; NERVE INJURY; PARTIAL DEAFFERENTATION; SENSORY SYSTEMS; MAP CHANGES; REORGANIZATION; NEURONS; PLASTICITY	Chronic peripheral nerve injuries produce neural changes at different levers of the somatosensory pathway, but these responses remain poorly defined. We selectively removed cutaneous input from the index finger and thumb in young adult macaque monkeys by lesioning dorsal rootlets to examine both immediate and long-term systemic responses to this deficit. Corresponding digit representations within somatosensory cortex (SI) were initially silenced, but two to seven months later again responded to cutaneous stimulation of the 'deafferented' digits. We remapped cutaneous receptive fields (RFs) within adjacent intact dorsal rootlets two to four months after lesioning. RF distributions had greatly expanded, so that rootlets previously innervating adjacent hand regions now responded to stimulation of the index finger and/or thumb. Thus our results demonstrate peripherally mediated central reorganization.	Univ Melbourne, Dept Anat & Cell Biol, Parkville, Vic 3010, Australia	University of Melbourne	Darian-Smith, C (corresponding author), Univ Melbourne, Dept Anat & Cell Biol, Parkville, Vic 3010, Australia.	c.darian-smith@anatomy.unimelb.edu.au		Darian-Smith, Corinna/0000-0002-4753-4574				BASBAUM AI, 1976, BRAIN RES, V116, P181, DOI 10.1016/0006-8993(76)90899-4; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; CALFORD MB, 1988, NATURE, V332, P446, DOI 10.1038/332446a0; CAMERON AA, 1992, BRAIN RES, V575, P151, DOI 10.1016/0006-8993(92)90436-D; DARIANSMITH C, 1995, J NEUROSCI, V15, P1631, DOI 10.1523/JNEUROSCI.15-03-01631.1995; DEVOR M, 1978, NATURE, V276, P75, DOI 10.1038/276075a0; Edeline JM, 1999, PROG NEUROBIOL, V57, P165, DOI 10.1016/S0301-0082(98)00042-2; FITZGERALD M, 1990, J COMP NEUROL, V300, P370, DOI 10.1002/cne.903000308; Florence SL, 1996, NATURE, V381, P69, DOI 10.1038/381069a0; FLORENCE SL, 1993, BRAIN RES, V601, P343, DOI 10.1016/0006-8993(93)91734-A; Florence SL, 1995, J NEUROSCI, V15, P8083; Galea MP, 1997, J COMP NEUROL, V381, P282; GILBERT CD, 1995, 5 C NEUR LEARN MEM, P293; Healy C, 1996, BRAIN, V119, P2063, DOI 10.1093/brain/119.6.2063; HEINEN SJ, 1991, EXP BRAIN RES, V83, P670; Jain N, 1997, NATURE, V386, P495, DOI 10.1038/386495a0; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; Jones EG, 1998, SCIENCE, V282, P1121, DOI 10.1126/science.282.5391.1121; Kaas JH, 1999, NEURON, V22, P657, DOI 10.1016/S0896-6273(00)80725-4; Kaas JH, 1997, ADV NEUROL, V73, P147; KAAS JH, 1979, SCIENCE, V204, P521, DOI 10.1126/science.107591; KAAS JH, 1991, ANNU REV NEUROSCI, V14, P137, DOI 10.1146/annurev.neuro.14.1.137; KELAHAN AM, 1984, SOMATOSENS RES, V2, P49, DOI 10.3109/07367228409144560; KOERBER HR, 1995, J NEUROPHYSIOL, V73, P693, DOI 10.1152/jn.1995.73.2.693; LAMOTTE CC, 1993, J COMP NEUROL, V330, P83, DOI 10.1002/cne.903300107; MCMAHON SB, 1991, J COMP NEUROL, V304, P307, DOI 10.1002/cne.903040211; MENDELL LM, 1978, J PHYSIOL-LONDON, V285, P299, DOI 10.1113/jphysiol.1978.sp012572; MERZENICH MM, 1983, NEUROSCIENCE, V10, P639, DOI 10.1016/0306-4522(83)90208-7; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; NELSON RJ, 1980, J COMP NEUROL, V192, P611, DOI 10.1002/cne.901920402; PONS TP, 1991, SCIENCE, V252, P1857, DOI 10.1126/science.1843843; RAUSELL E, 1992, P NATL ACAD SCI USA, V89, P2571, DOI 10.1073/pnas.89.7.2571; RODIN BE, 1983, J COMP NEUROL, V215, P187, DOI 10.1002/cne.902150206; SEDIVEC MJ, 1983, J NEUROSCI, V3, P1511; Sherrington CS, 1900, TXB PHYSL, P920; Snow P, 1991, PROGR SENSORY PHYSL; Sunderland S, 1991, NERVE INJURIES THEIR; Tong YG, 1999, J COMP NEUROL, V404, P143; Willis Jr W. D., 1991, SENSORY MECH SPINAL; WOOLF CJ, 1992, NATURE, V355, P75, DOI 10.1038/355075a0	40	48	50	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2000	3	5					476	481		10.1038/74852	http://dx.doi.org/10.1038/74852			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309DG	10769388				2022-12-24	WOS:000086752000017
J	Garaschuk, O; Linn, J; Eilers, J; Konnerth, A				Garaschuk, O; Linn, J; Eilers, J; Konnerth, A			Large-scale oscillatory calcium waves in the immature cortex	NATURE NEUROSCIENCE			English	Article							GLYCINE-RECEPTOR ACTIVATION; VISUAL-CORTEX; NEOCORTICAL DEVELOPMENT; NEONATAL HIPPOCAMPUS; RETINAL WAVES; GROWTH-CONE; AREA CA1; NEURONS; RAT; SYNAPSES	Two-photon imaging of large neuronal networks in cortical slices of newborn rats revealed synchronized oscillations in intracellular Ca2+ concentration. These spontaneous Ca2+ waves usually started in the posterior cortex and propagated slowly (2.1 mm per second) toward its anterior end. Ca2+ waves were associated with field-potential changes and required activation of AMPA and NMDA receptors. Although GABA(A) receptors were not involved in wave initiation, the developmental transition of GABAergic transmission from depolarizing to hyperpolarizing (around postnatal day 7) stopped the oscillatory activity. Thus we identified a type of large-scare Ca2+ wave that may regulate long-distance wiring in the immature cortex.	Tech Univ Munich, Inst Physiol, D-80802 Munich, Germany; Univ Saarland, Inst Physiol, D-66421 Homburg, Germany	Technical University of Munich; Saarland University	Konnerth, A (corresponding author), Tech Univ Munich, Inst Physiol, D-80802 Munich, Germany.	konnerth@physiol.med.tu-muenchen.de	Linn, Jennifer/H-8202-2013; Linn, Jennifer/AAE-1567-2021; Garaschuk, Olga/G-5633-2015; Eilers, Jens/E-6251-2012	Eilers, Jens/0000-0003-0497-5625; Linn, Jennifer/0000-0003-0797-2761				BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; BLAKE JF, 1989, BRIT J PHARMACOL, V97, P71, DOI 10.1111/j.1476-5381.1989.tb11925.x; BLUE ME, 1983, J NEUROCYTOL, V12, P599, DOI 10.1007/BF01181526; BLUE ME, 1983, J NEUROCYTOL, V12, P697, DOI 10.1007/BF01181531; BRAITENBERG V, 1991, ANATOMY CORTEX, P141; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; DALVA MB, 1994, SCIENCE, V265, P255, DOI 10.1126/science.7912852; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Feller MB, 1997, NEURON, V19, P293, DOI 10.1016/S0896-6273(00)80940-X; Flint AC, 1999, P NATL ACAD SCI USA, V96, P12144, DOI 10.1073/pnas.96.21.12144; Flint AC, 1998, NEURON, V20, P43, DOI 10.1016/S0896-6273(00)80433-X; Galuske RAW, 1996, CEREB CORTEX, V6, P417, DOI 10.1093/cercor/6.3.417; Garaschuk O, 1998, J PHYSIOL-LONDON, V507, P219, DOI 10.1111/j.1469-7793.1998.219bu.x; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Gu XN, 1997, DEV NEUROSCI-BASEL, V19, P33, DOI 10.1159/000111183; Hanse E, 1997, SEMIN CELL DEV BIOL, V8, P35, DOI 10.1006/scdb.1996.0119; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; JURASKA JM, 1979, J COMP NEUROL, V183, P257, DOI 10.1002/cne.901830204; Kandler K, 1998, J NEUROSCI, V18, P1419; KATER SB, 1988, TRENDS NEUROSCI, V11, P315, DOI 10.1016/0166-2236(88)90094-X; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kirsch J, 1998, NATURE, V392, P717, DOI 10.1038/33694; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; KONNERTH A, 1990, TRENDS NEUROSCI, V13, P321, DOI 10.1016/0166-2236(90)90137-Y; KONNERTH A, 1984, NATURE, V307, P69, DOI 10.1038/307069a0; Kullmann DM, 1996, NEURON, V17, P461, DOI 10.1016/S0896-6273(00)80178-6; Leinekugel X, 1998, J NEUROSCI, V18, P6349; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Owens DF, 1996, J NEUROSCI, V16, P6414; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Schwartz TH, 1998, NEURON, V20, P541, DOI 10.1016/S0896-6273(00)80993-9; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; SPITZER NC, 1994, TRENDS NEUROSCI, V17, P115, DOI 10.1016/0166-2236(94)90120-1; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; WELIKY M, 1994, J NEUROSCI, V14, P7291; WILLIAMS RM, 1994, FASEB J, V8, P804, DOI 10.1096/fasebj.8.11.8070629; WONG ROL, 1995, NATURE, V374, P716, DOI 10.1038/374716a0; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S; YUSTE R, 1995, NEURON, V14, P7, DOI 10.1016/0896-6273(95)90236-8	46	373	385	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2000	3	5					452	459		10.1038/74823	http://dx.doi.org/10.1038/74823			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309DG	10769384				2022-12-24	WOS:000086752000013
J	Wan, HI; DiAntonio, A; Fetter, RD; Bergstrom, K; Strauss, R; Goodman, CS				Wan, HI; DiAntonio, A; Fetter, RD; Bergstrom, K; Strauss, R; Goodman, CS			Highwire regulates synaptic growth in Drosophila	NEURON			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; FASCICLIN-II; GENETIC-ANALYSIS; FUNCTIONAL COMPONENTS; ADHESION MOLECULE; GIANT PROTEIN; RAB PROTEINS; PLASTICITY; MUTANTS; REVEALS	The formation, stabilization, and growth of synaptic connections are dynamic and highly regulated processes. The glutamatergic neuromuscular junction (NMJ) in Drosophila grows new boutons and branches throughout larval development. A primary walking behavior screen followed by a secondary anatomical screen led to the identification of the highwire (hiw) gene. In hiw mutants, the specificity of motor axon pathfinding and synapse formation appears normal. However, NMJ synapses grow exuberantly and are greatly expanded in both the number of boutons and the extent and length of branches. These synapses appear normal ultrastructurally but have reduced quantal content physiologically. hiw encodes a large protein found at presynaptic terminals. Within presynaptic terminals, HIW is localized to the periactive zone surrounding active zones; Fasciclin II (Fas II), which also controls synaptic growth, is found at the same location.	Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Theodor Boveri Inst Biowissensch, LS Genet, D-97074 Wurzburg, Germany	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Goodman, CS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, 229 Stanley Hall, Berkeley, CA 94720 USA.	goodman@uclink4.berkeley.edu		DiAntonio, Aaron/0000-0002-7262-0968	NICHD NIH HHS [HD-21294] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021294, R37HD021294] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; BAILEY CH, 1992, SCIENCE, V256, P645, DOI 10.1126/science.1585177; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; BUDNIK V, 1990, J NEUROSCI, V10, P3754; CasesLanghoff C, 1996, EUR J CELL BIOL, V69, P214; Davis GW, 1997, NEURON, V19, P561, DOI 10.1016/S0896-6273(00)80372-4; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; DOHERTY P, 1995, J NEUROBIOL, V26, P437, DOI 10.1002/neu.480260315; DRYSDALE R, 1991, GENETICS, V127, P497; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; Fields RD, 1996, TRENDS NEUROSCI, V19, P473, DOI 10.1016/S0166-2236(96)30013-1; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Guo QB, 1998, P NATL ACAD SCI USA, V95, P9172, DOI 10.1073/pnas.95.16.9172; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; JOHANSEN J, 1989, J NEUROSCI, V9, P710; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; MARTIN AR, 1955, J PHYSIOL-LONDON, V130, P114, DOI 10.1113/jphysiol.1955.sp005397; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Renault L, 1998, NATURE, V392, P97, DOI 10.1038/32204; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; Rosa JL, 1997, ONCOGENE, V15, P1, DOI 10.1038/sj.onc.1201170; Rosa JL, 1996, EMBO J, V15, P4262, DOI 10.1002/j.1460-2075.1996.tb00801.x; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Schachner M, 1997, CURR OPIN CELL BIOL, V9, P627, DOI 10.1016/S0955-0674(97)80115-9; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; STRAUSS R, 1995, J NEUROGENET, V10, P53; STRAUSS R, 1995, NERVOUS SYSTEMS BEHA, P22; Toba G, 1999, GENETICS, V151, P725; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Wang XL, 1999, J CELL BIOL, V147, P151, DOI 10.1083/jcb.147.1.151; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967; ZHONG Y, 1992, J NEUROSCI, V12, P644; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	51	315	324	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	2000	26	2					313	329		10.1016/S0896-6273(00)81166-6	http://dx.doi.org/10.1016/S0896-6273(00)81166-6			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318QZ	10839352	Bronze			2022-12-24	WOS:000087296500010
J	Huang, ML; Hsu, CH; Chien, CT				Huang, ML; Hsu, CH; Chien, CT			The proneural gene amos promotes multiple dendritic neuron formation in the Drosophila peripheral nervous system	NEURON			English	Article							ACHAETE-SCUTE COMPLEX; SENSORY ORGAN DEVELOPMENT; LOOP-HELIX DOMAIN; SEX DETERMINATION; CELL FATES; EXPRESSION; DAUGHTERLESS; MELANOGASTER; NEUROGENESIS; IDENTITY	In the Drosophila peripheral nervous system, proneural genes direct the formation of different types of sensory organs. Here, we show that amos is a novel proneural gene that promotes multiple dendritic (MD) neuron formation. amos encodes a basic-helix-loop-helix (bHLH) protein of the Atonal family. During embryonic development, amos is expressed in patches of ectodermal cells, and the expression is quickly restricted to sensory organ precursors. Loss of amos function eliminates MD neurons that remain in ASC;atonal mutants. Misexpression of amos generates ectopic MD and other types of neurons. Amos interacts with the ubiquitously expressed Daughterless protein in vivo and in vitro. Our final misexpression experiments suggest that a domain located outside the DNA-binding domain of Amos determines the MD neuronal specificity.	Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Chien, CT (corresponding author), Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan.		Chien, Cheng-Ting/AAA-5200-2021	Chien, Cheng-Ting/0000-0002-7906-7173				Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; ALONSO MC, 1988, EMBO J, V7, P2585, DOI 10.1002/j.1460-2075.1988.tb03108.x; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; BARTEL P, 1993, BIOTECHNIQUES, V14, P920; Bartel P. L., 1993, CELLULAR INTERACTION, P153; BenArie N, 1996, HUM MOL GENET, V5, P1207, DOI 10.1093/hmg/5.9.1207; BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322; BODMER R, 1987, ROUX ARCH DEV BIOL, V196, P69, DOI 10.1007/BF00402027; BODMER R, 1987, CELL, V51, P293, DOI 10.1016/0092-8674(87)90156-5; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRAND M, 1993, DEVELOPMENT, V119, P1; BREWSTER R, 1995, DEVELOPMENT, V121, P2923; CABRERA CV, 1991, EMBO J, V10, P2965, DOI 10.1002/j.1460-2075.1991.tb07847.x; CAMPOSORTEGA JA, 1997, EMBRYONIC DEV DROSOP, P183; CAMPUZANO S, 1992, TRENDS GENET, V8, P202, DOI 10.1016/0168-9525(92)90234-U; CAUDY M, 1988, CELL, V55, P1061, DOI 10.1016/0092-8674(88)90250-4; CAUDY M, 1988, GENE DEV, V2, P843, DOI 10.1101/gad.2.7.843; Chien CT, 1996, P NATL ACAD SCI USA, V93, P13239, DOI 10.1073/pnas.93.23.13239; CHRONMILLER C, 1993, MECH DEVELOP, V42, P159; CUBAS P, 1991, GENE DEV, V5, P996, DOI 10.1101/gad.5.6.996; Culi J, 1998, GENE DEV, V12, P2036, DOI 10.1101/gad.12.13.2036; DAMBLYCHAUDIERE C, 1987, GENE DEV, V1, P297, DOI 10.1101/gad.1.3.297; GHYSEN A, 1993, GENE DEV, V7, P723, DOI 10.1101/gad.7.5.723; GHYSEN A, 1993, BIOESSAYS, V15, P293, DOI 10.1002/bies.950150502; Giebel B, 1997, MECH DEVELOP, V63, P75, DOI 10.1016/S0925-4773(97)00029-4; GONZALEZ F, 1989, EMBO J, V8, P3553, DOI 10.1002/j.1460-2075.1989.tb08527.x; Goulding SE, 2000, NEURON, V25, P69, DOI 10.1016/S0896-6273(00)80872-7; Gupta BP, 1997, GENES CELLS, V2, P225, DOI 10.1046/j.1365-2443.1997.d01-312.x; HAUPTMANN G, 1994, TRENDS GENET, V10, P266, DOI 10.1016/0168-9525(90)90008-T; HINZ U, 1994, CELL, V76, P77, DOI 10.1016/0092-8674(94)90174-0; JAN YN, 1993, P NATL ACAD SCI USA, V90, P8305, DOI 10.1073/pnas.90.18.8305; JAN YN, 1994, ANNU REV GENET, V28, P373, DOI 10.1146/annurev.ge.28.120194.002105; JARMAN AP, 1993, DEVELOPMENT, V119, P19; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; Jarman AP, 1998, MECH DEVELOP, V76, P117, DOI 10.1016/S0925-4773(98)00116-6; Juven-Gershon T, 1998, MOL CELL BIOL, V18, P3974, DOI 10.1128/MCB.18.7.3974; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Misquitta L, 1999, P NATL ACAD SCI USA, V96, P1451, DOI 10.1073/pnas.96.4.1451; PATEL NH, 1994, PRACTICAL USES CELL, P446; RODRIGUEZ I, 1990, EMBO J, V9, P3583, DOI 10.1002/j.1460-2075.1990.tb07569.x; ROMANI S, 1989, GENE DEV, V3, P997, DOI 10.1101/gad.3.7.997; SCHWEISGUTH F, 1994, DEVELOPMENT, V120, P1433; SINGSON A, 1994, GENE DEV, V8, P2058, DOI 10.1101/gad.8.17.2058; SKEATH JB, 1991, GENE DEV, V5, P984, DOI 10.1101/gad.5.6.984; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; VAESSIN H, 1994, DEVELOPMENT, V120, P935; Verdi JM, 1999, P NATL ACAD SCI USA, V96, P10472, DOI 10.1073/pnas.96.18.10472; Vervoort M, 1997, DEVELOPMENT, V124, P2819; VERVOORT M, 1995, DEVELOPMENT, V121, P3111; VILLARES R, 1987, CELL, V50, P415, DOI 10.1016/0092-8674(87)90495-8; VINCENT JP, 1992, CELL, V68, P923, DOI 10.1016/0092-8674(92)90035-B; Wang SW, 1997, DEVELOPMENT, V124, P4435	54	82	85	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	2000	25	1					57	67		10.1016/S0896-6273(00)80871-5	http://dx.doi.org/10.1016/S0896-6273(00)80871-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279KP	10707972	Bronze			2022-12-24	WOS:000085043200010
J	Gainetdinov, RR; Bohn, LM; Walker, JKL; Laporte, SA; Macrae, AD; Caron, MG; Lefkowitz, RJ; Premont, RT				Gainetdinov, RR; Bohn, LM; Walker, JKL; Laporte, SA; Macrae, AD; Caron, MG; Lefkowitz, RJ; Premont, RT			Muscarinic supersensitivity and impaired receptor desensitization in G protein-coupled receptor kinase 5-deficient mice	NEURON			English	Article							IN-VIVO; SENSITIVITY; GRK5; PHOSPHORYLATE; SEQUESTRATION; PURIFICATION; DISRUPTION; DEPRESSION; AGONISTS; FAMILY	G protein-coupled receptor kinase 5 (GRK5) is a member of a family of enzymes that phosphorylate activated G protein-coupled receptors (GPCR). To address the physiological importance of GRK5-mediated regulation of GPCRs, mice bearing targeted deletion of the GRK5 gene (GRK5-KO) were generated. GRK5-KO mice exhibited mild spontaneous hypothermia as well as pronounced behavioral supersensitivity upon challenge with the nonselective muscarinic agonist oxotremorine. Classical cholinergic responses such as hypothermia, hypoactivity, tremor, and salivation were enhanced in GRK5-KO animals. The antinociceptive effect of oxotremorine was also potentiated and prolonged. Muscarinic receptors in brains from GRK5-KO mice resisted oxotremorine-induced desensitization, as assessed by oxotremorine-stimulated [S-35]GTP gamma S binding. These data demonstrate that elimination of GRK5 results in cholinergic supersensitivity and impaired muscarinic receptor desensitization and suggest that a deficit of GPCR desensitization may be an underlying cause of behavioral supersensitivity.	Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Dept Biochem, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Dept Med, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Dept Cell Biol, Durham, NC 27710 USA.		Bohn, Laura M/A-7483-2014; Laporte, Stephane/ABC-4228-2021; Bohn, Laura/A-4412-2008; Laporte, Stephane A/F-3282-2012; Gainetdinov, Raul R/G-5875-2011; Lefkowitz, Robert/AAW-2649-2021; Walker, Julia/R-7585-2017	Bohn, Laura M/0000-0002-6474-8179; Laporte, Stephane/0000-0002-0633-543X; Gainetdinov, Raul R/0000-0003-2951-6038; Premont, Richard/0000-0002-8053-5026	NHLBI NIH HHS [HL-16037] Funding Source: Medline; NIMH NIH HHS [MH-40159] Funding Source: Medline; NINDS NIH HHS [NS-19576] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016037, R37HL016037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH040159, P30MH040159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bernard V, 1998, J NEUROSCI, V18, P10207; BIRDSALL NJM, 1978, MOL PHARMACOL, V14, P723; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; DICKEY BF, 1993, HDB EXPT PHARM, V108; DILSAVER SC, 1988, PROG NEURO-PSYCHOPH, V12, P1, DOI 10.1016/0278-5846(88)90058-9; Galeotti N, 1996, EUR J PHARMACOL, V308, P125, DOI 10.1016/0014-2999(96)00299-3; GILLARD M, 1987, MOL PHARMACOL, V32, P100; Gomeza J, 1999, P NATL ACAD SCI USA, V96, P1692, DOI 10.1073/pnas.96.4.1692; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HARTVIG P, 1989, TRENDS PHARMACOL SCI, P75; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; HOGAN B, 1994, MANIPULATION MOUSE E; INGLESE J, 1993, J BIOL CHEM, V268, P23735; Jaber M, 1996, P NATL ACAD SCI USA, V93, P12974, DOI 10.1073/pnas.93.23.12974; JANOWSKY DS, 1994, AM J MED GENET, V54, P335, DOI 10.1002/ajmg.1320540412; Konig M, 1996, NATURE, V383, P535, DOI 10.1038/383535a0; KUNAPULI P, 1994, J BIOL CHEM, V269, P1099; LAZARENO S, 1999, MEASUREMENT AGONIST, V106; Lomax P, 1970, Int Rev Neurobiol, V12, P1; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; Markou A, 1998, NEUROPSYCHOPHARMACOL, V18, P135, DOI 10.1016/S0893-133X(97)00113-9; Menard L, 1996, BIOCHEMISTRY-US, V35, P4155, DOI 10.1021/bi952961+; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; Oppermann M, 1996, P NATL ACAD SCI USA, V93, P7649, DOI 10.1073/pnas.93.15.7649; Overstreet DH, 1996, TOXICOLOGY, V111, P119, DOI 10.1016/0300-483X(96)03370-7; Overstreet DH, 1998, PHARMACOL BIOCHEM BE, V59, P777, DOI 10.1016/S0091-3057(97)00514-5; Peppel K, 1997, J BIOL CHEM, V272, P25425, DOI 10.1074/jbc.272.41.25425; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Premont RT, 1999, J BIOL CHEM, V274, P29381, DOI 10.1074/jbc.274.41.29381; PREMONT RT, 1994, J BIOL CHEM, V269, P6832; PREMONT RT, 1995, FASEB J, V9, P175, DOI 10.1096/fasebj.9.2.7781920; Rockman HA, 1998, J BIOL CHEM, V273, P18180, DOI 10.1074/jbc.273.29.18180; Rockman HA, 1996, P NATL ACAD SCI USA, V93, P9954, DOI 10.1073/pnas.93.18.9954; SALIGAUT C, 1985, METHOD FIND EXP CLIN, V7, P5; Sapolsky RM, 1998, NATURE, V393, P308, DOI 10.1038/30606; Tsuga H, 1998, J PHARMACOL EXP THER, V284, P1218; Walker JKL, 1999, AM J PHYSIOL-REG I, V276, pR1214, DOI 10.1152/ajpregu.1999.276.4.R1214; Wang YM, 1997, NEURON, V19, P1285, DOI 10.1016/S0896-6273(00)80419-5; WILCOX RE, 1980, PHARMACOL BIOCHEM BE, V12, P29, DOI 10.1016/0091-3057(80)90411-6	39	170	177	1	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1999	24	4					1029	1036		10.1016/S0896-6273(00)81048-X	http://dx.doi.org/10.1016/S0896-6273(00)81048-X			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	269UE	10624964	Bronze			2022-12-24	WOS:000084495300029
J	Pyle, JL; Kavalali, ET; Choi, S; Tsien, RW				Pyle, JL; Kavalali, ET; Choi, S; Tsien, RW			Visualization of synaptic activity in hippocampal slices with FM1-43 enabled by fluorescence quenching	NEURON			English	Article							SYNAPTOGENESIS; SYNAPSES; BOUTONS; FROG	Fluorescence imaging of presynaptic uptake and release of styryl dyes such as FM1-43 has provided valuable insights into synaptic function. However, in studies of CNS neurons, the utility of these dyes has been severely limited by nonsynaptic background fluorescence. This has thwarted the use of FM dyes in systems more intact than dissociated neuronal cultures. Here, we describe an approach to selectively reduce undesired fluorescence through quenching of the surface-bound FM1-43 signal. The introduction of sulfo-rhodamine, a fluorophore that is not taken up by synaptic vesicles, selectively reduced the nonsynaptic fluorescence in FM1-43-labeled hippocampal cultures. When applied to rat hippocampal slices, this procedure allowed us to observe activity-dependent staining and destaining of functional synapses. Extending the usefulness of styryl dyes to slice preparations may help make functional synaptic networks amenable to optical measurements.	Stanford Univ, Sch Med, Beckman Ctr, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University	Tsien, RW (corresponding author), Univ Texas, SW Med Ctr, Dept Neurosci, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.							Betz WJ, 1996, CURR OPIN NEUROBIOL, V6, P365, DOI 10.1016/S0959-4388(96)80121-8; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; DAILEY ME, 1994, J NEUROSCI, V14, P1060, DOI 10.1523/JNEUROSCI.14-03-01060.1994; Dailey ME, 1996, J NEUROSCI, V16, P2983; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; LICHTMAN JW, 1985, NATURE, V314, P357, DOI 10.1038/314357a0; LICHTMAN JW, 1987, J NEUROSCI, V7, P1215; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MCMAHAN UJ, 1971, PROC R SOC SER B-BIO, V177, P485, DOI 10.1098/rspb.1971.0044; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Rouze NC, 1998, J NEUROSCI, V18, P8614; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	17	62	64	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1999	24	4					803	808		10.1016/S0896-6273(00)81028-4	http://dx.doi.org/10.1016/S0896-6273(00)81028-4			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	269UE	10624944	Bronze			2022-12-24	WOS:000084495300009
J	Schneider, C; Wicht, H; Enderich, J; Wegner, M; Rohrer, H				Schneider, C; Wicht, H; Enderich, J; Wegner, M; Rohrer, H			Bone morphogenetic proteins are required in vivo for the generation of sympathetic neurons	NEURON			English	Article							ACHAETE-SCUTE HOMOLOG-1; NEURAL CREST CULTURES; INT-1 PROTOONCOGENE; SPEMANN ORGANIZER; NERVOUS-SYSTEM; MICE DEFICIENT; SPINAL-CORD; CELL FATES; EXPRESSION; DIFFERENTIATION	Bone morphogenetic proteins (BMPs) induce autonomic neurogenesis in neural crest cultures and stimulate sympathetic neuron development when overexpressed in vivo. We demonstrate that inhibition of BMPs in the chick embryo by the BMP antagonist Noggin prevents sympathetic neuron generation. In Noggin-treated embryos, the noradrenergic marker genes tyrosine hydroxylase (TH) and dopamine-beta-hydroxylase (DBH), panneuronal neurofilament 160 (NF160) and SCG10 genes, and the transcriptional regulators Phox2b and Phox2a are not expressed in sympathetic ganglia. Whereas initial ganglion development is not affected, the expression of the basic helix-loop-helix transcription factor cash-1 is strongly reduced. These results demonstrate that BMPs are essential for sympathetic neuron development and establish Cash-1 and Phox2 genes as downstream effecters of BMPs in this lineage.	Max Planck Inst Hirnforsch, Neurochem Abt, D-60528 Frankfurt, Germany; Univ Frankfurt Klinikum, D-60590 Frankfurt, Germany; Univ Hamburg, Klinikum Eppendorf, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany	Max Planck Society; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf	Rohrer, H (corresponding author), Max Planck Inst Hirnforsch, Neurochem Abt, Deutschordenstr 46, D-60528 Frankfurt, Germany.			Wegner, Michael/0000-0002-4586-3294				AONO A, 1995, BIOCHEM BIOPH RES CO, V210, P670, DOI 10.1006/bbrc.1995.1712; BRONNERFRASER M, 1986, DEV BIOL, V115, P44, DOI 10.1016/0012-1606(86)90226-5; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Dudley AT, 1997, DEV DYNAM, V208, P349; Durbec PL, 1996, DEVELOPMENT, V122, P349; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; EMSBERGER U, 1989, NEURON, V2, P1275; ERNSBERGER U, 1995, MECH DEVELOP, V52, P125, DOI 10.1016/0925-4773(95)00396-I; Ernsberger U, 1997, MECH DEVELOP, V68, P115, DOI 10.1016/S0925-4773(97)00135-4; GROVES AK, 1995, DEVELOPMENT, V121, P887; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hirsch MR, 1998, DEVELOPMENT, V125, P599; JASONI CL, 1994, DEVELOPMENT, V120, P769; JESSELL TM, 1998, MOL CELLULAR APPROAC, P290; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; Jones CM, 1998, DEV BIOL, V194, P12, DOI 10.1006/dbio.1997.8752; JONES CM, 1991, DEVELOPMENT, V111, P531; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; LaBonne C, 1998, DEVELOPMENT, V125, P2403; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; LO LC, 1991, GENE DEV, V5, P1524, DOI 10.1101/gad.5.9.1524; Lo LC, 1998, DEVELOPMENT, V125, P609; Lo LC, 1997, CURR BIOL, V7, P440, DOI 10.1016/S0960-9822(06)00191-6; Lo LC, 1999, NEURON, V22, P693, DOI 10.1016/S0896-6273(00)80729-1; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; LYONS KM, 1995, MECH DEVELOP, V50, P71, DOI 10.1016/0925-4773(94)00326-I; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Morin X, 1997, NEURON, V18, P411, DOI 10.1016/S0896-6273(00)81242-8; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Reissmann E, 1996, DEVELOPMENT, V122, P2079; Reshef R, 1998, GENE DEV, V12, P290, DOI 10.1101/gad.12.3.290; ROHRER H, 1986, J NEUROSCI, V6, P2616; SAITOH O, 1993, NUCLEIC ACIDS RES, V21, P2503, DOI 10.1093/nar/21.10.2503; Selleck MAJ, 1998, DEVELOPMENT, V125, P4919; Shah NM, 1997, P NATL ACAD SCI USA, V94, P11369, DOI 10.1073/pnas.94.21.11369; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Stanke M, 1999, DEVELOPMENT, V126, P4087; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; TUCKER GC, 1986, DEV BIOL, V116, P439, DOI 10.1016/0012-1606(86)90145-4; VARLEY JE, 1995, DEV DYNAM, V203, P434, DOI 10.1002/aja.1002030406; Varley JE, 1996, EXP NEUROL, V140, P84, DOI 10.1006/exnr.1996.0118; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Zhang HB, 1996, DEVELOPMENT, V122, P2977; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6; ZOPF D, 1987, GENE DEV, V1, P699, DOI 10.1101/gad.1.7.699	52	226	234	3	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1999	24	4					861	870		10.1016/S0896-6273(00)81033-8	http://dx.doi.org/10.1016/S0896-6273(00)81033-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	269UE	10624949	Bronze			2022-12-24	WOS:000084495300014
J	Critchley, HD; Mathias, CT; Dolan, RJ				Critchley, HD; Mathias, CT; Dolan, RJ			Neuroanatomical basis for first- and second-order representations of bodily states	NATURE NEUROSCIENCE			English	Article							MULTIPLE-SYSTEM ATROPHY; PURE AUTONOMIC FAILURE; CINGULATE CORTEX; ACTIVATION; RESPONSES; CONJUNCTION; ATTENTION; EMOTIONS; MEMORY; RAT	Changes in bodily states, particularly those mediated by the autonomic nervous system, are crucial to ongoing emotional experience. A theoretical model proposes a first-order autoregulatory representation of bodily state at the level of dorsal pens, and a second-order experience-dependent re-mapping of changes in bodily state within structures such as cingulate and medial parietal cortices. We tested these anatomical predictions using positron emission tomography and a human neurological model (pure autonomic failure), in which peripheral autonomic denervation prevents the emergence of autonomic responses. Compared to controls, we observed task-independent differences in activity of dorsal pens and context-induced differences in cingulate and medial parietal activity in PAF patients. An absence of afferent feedback concerning autonomically generated bodily states was associated with subtle impairments of emotional responses in PAF patients. Our findings provide empirical support for a theory proposing a hierarchical representation of bodily states.	UCL, Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England; UCL, Natl Hosp Neurol & Neurosurg, Autonom Unit, London WC1N 3BG, England; St Marys Hosp, ICSM, Neurovasc Med Unit, London W2 1NY, England	University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Imperial College London	Dolan, RJ (corresponding author), UCL, Inst Neurol, Wellcome Dept Cognit Neurol, 12 Queen Sq, London WC1N 3BG, England.	r.dolan@fil.ion.ucl.ac.uk	critchley, hugo d/G-9267-2011	critchley, hugo d/0000-0002-2445-9284; Dolan, Ray/0000-0001-9356-761X				Adolphs R, 2000, J NEUROSCI, V20, P2683; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Bouscein W., 1992, ELECTRODERMAL ACTIVI; Cahill L, 1997, ANN NY ACAD SCI, V821, P238, DOI 10.1111/j.1749-6632.1997.tb48283.x; CECHETTO DF, 1987, J COMP NEUROL, V262, P27, DOI 10.1002/cne.902620104; CHAMBERLIN NL, 1992, J COMP NEUROL, V326, P245, DOI 10.1002/cne.903260207; CLARK CV, 1988, DOC OPHTHALMOL, V70, P309, DOI 10.1007/BF00157061; Cohen RA, 1999, NEUROLOGY, V53, P819, DOI 10.1212/WNL.53.4.819; COLEBATCH JG, 1991, J NEUROPHYSIOL, V65, P1392, DOI 10.1152/jn.1991.65.6.1392; Collet C, 1997, J AUTONOM NERV SYST, V62, P45, DOI 10.1016/S0165-1838(96)00108-7; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Critchley HD, 2000, J NEUROSCI, V20, P3033; Damasio A.R., 1994, DESCARTES ERROR EMOT; Damasio A. R., 1999, FEELING WHAT HAPPENS; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Hamilton M, 1969, BRIT J PSYCHIAT, V3, P76, DOI DOI 10.1037/T04100-000; JAMES W, 1994, PSYCHOL REV, V101, P205, DOI 10.1037/0033-295X.101.2.205; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kimber JR, 1997, LANCET, V349, P1877, DOI 10.1016/S0140-6736(96)10168-9; Lane RD, 1997, NEUROREPORT, V8, P3969, DOI 10.1097/00001756-199712220-00024; Magnifico F, 1998, CLIN AUTON RES, V8, P133, DOI 10.1007/BF02281117; Mathias CJ, 1999, J NEUROL, V246, P893, DOI 10.1007/s004150050479; Mathias CJ, 1999, AUTONOMIC FAILURE TX, V4, P169; MATHIAS CJ, 2000, NEUROLOGY CLIN PRACT, P2131; MATTHEWS M, 1999, AUTONOMIC FAILURE TX, P169; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; Saleh TM, 1997, AM J PHYSIOL-REG I, V272, pR1631, DOI 10.1152/ajpregu.1997.272.5.R1631; SPYER KM, 1909, AUTONOMIC FAILURE TX, P45; Talairach J., 1988, COPLANAR STEREOTAXIC; VANDERPLAS J, 1995, BRAIN RES BULL, V38, P447, DOI 10.1016/0361-9230(95)02012-G; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Xi MC, 1999, J NEUROPHYSIOL, V82, P2015, DOI 10.1152/jn.1999.82.4.2015	38	227	228	2	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2001	4	2					207	212		10.1038/84048	http://dx.doi.org/10.1038/84048			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UC	11175883	Green Published			2022-12-24	WOS:000167178100021
J	Andrew, D; Craig, AD				Andrew, D; Craig, AD			Spinothalamic lamina I neurons selectively sensitive to histamine: a central neural pathway for itch	NATURE NEUROSCIENCE			English	Article							DORSAL-HORN NEURONS; HUMAN SKIN; EPIDURAL MORPHINE; CAT; CAPSAICIN; FIBERS; NOCICEPTORS; PROJECTIONS; SENSATION; RESPONSES	We found a class of lamina I spinothalamic tract (STT) neurons selectively excited by iontophoretic histamine. The responses of this class of neurons parallel the pure itching sensation this stimulus elicits in humans, and match the responses of peripheral C-fibers that have similar selectivity. These neurons have distinct central conduction velocities and thalamic projections, indicating that they constitute a unique subset of STT neurons. These findings can explain why a lesion of the lateral STT disrupts itch along with pain and temperature sensations. Our findings provide strong evidence that itch is subserved by specific neural elements both peripherally and centrally.	Barrow Neurol Inst, Div Neurosurg, Atkinson Pain Res Lab, Phoenix, AZ 85013 USA	Barrow Neurological Institute	Andrew, D (corresponding author), Barrow Neurol Inst, Div Neurosurg, Atkinson Pain Res Lab, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	dandrew@chw.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025616] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 25616] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BALLANTYNE JC, 1988, PAIN, V33, P149, DOI 10.1016/0304-3959(88)90085-1; Bickford RG, 1938, CLIN SCI, V3, P377; Carstens E, 1997, J NEUROPHYSIOL, V77, P2499, DOI 10.1152/jn.1997.77.5.2499; CRAIG AD, 1991, J COMP NEUROL, V313, P377, DOI 10.1002/cne.903130212; CRAIG AD, 1985, J PHYSIOL-LONDON, V365, P197, DOI 10.1113/jphysiol.1985.sp015767; CRAIG AD, 1994, BRAIN RES, V636, P233, DOI 10.1016/0006-8993(94)91022-7; CRAIG AD, 1991, BRAIN RES, V558, P93, DOI 10.1016/0006-8993(91)90719-C; Craig AD, 1995, FRONTIER PAIN RES, P13; CRAIG AD, 1994, SCIENCE, V265, P252, DOI 10.1126/science.8023144; DUFFY BL, 1981, ANAESTHESIA, V36, P67, DOI 10.1111/j.1365-2044.1981.tb08609.x; GRAHAM DT, 1951, J CLIN INVEST, V30, P37, DOI 10.1172/JCI102414; GREEN BG, 1990, PERCEPT PSYCHOPHYS, V48, P12, DOI 10.3758/BF03205007; HALES P, 1980, LANCET, V2, P204; Han ZS, 1998, NAT NEUROSCI, V1, P218, DOI 10.1038/665; HANDWERKER HO, 1991, J NEUROPHYSIOL, V66, P307, DOI 10.1152/jn.1991.66.1.307; HSIEH JC, 1994, J NEUROPHYSIOL, V72, P3004, DOI 10.1152/jn.1994.72.6.3004; Hyndman OR, 1943, ARCH NEURO PSYCHIATR, V50, P129, DOI 10.1001/archneurpsyc.1943.02290200029002; Jinks SL, 2000, J NEUROPHYSIOL, V84, P616, DOI 10.1152/jn.2000.84.2.616; Keele C., 1964, SUBSTANCES PRODUCING; KRESS M, 1996, NEUROBIOLOGY NOCICEP, P284; LAMOTTE RH, 1991, J NEUROPHYSIOL, V66, P190, DOI 10.1152/jn.1991.66.1.190; LaMotte RH, 1996, NEUROBIOLOGY NOCICEP, P390; MAGERL W, 1990, J INVEST DERMATOL, V94, P347, DOI 10.1111/1523-1747.ep12874474; MCMAHON SB, 1992, TRENDS NEUROSCI, V15, P497, DOI 10.1016/0166-2236(92)90102-E; MUSIL SY, 1988, J COMP NEUROL, V272, P203, DOI 10.1002/cne.902720205; NATHAN PW, 1990, J NEUROL NEUROSUR PS, V53, P935, DOI 10.1136/jnnp.53.11.935; REEH PW, 1986, BRAIN RES, V384, P42, DOI 10.1016/0006-8993(86)91217-5; Schmelz M, 2000, BRAIN, V123, P560, DOI 10.1093/brain/123.3.560; Schmelz M, 1997, J NEUROSCI, V17, P8003; SCHMIDT R, 1995, J NEUROSCI, V15, P333; SCOTT DW, 1989, CORNELL BOOK CATS, P177; SIMONE DA, 1987, SOMATOSENS MOT RES, V5, P81, DOI 10.3109/07367228709144620; SIMONE DA, 1991, SOMATOSENS MOT RES, V8, P271, DOI 10.3109/08990229109144750; TUCKETT RP, 1987, BRAIN RES, V413, P95, DOI 10.1016/0006-8993(87)90157-0; YASUI Y, 1988, J COMP NEUROL, V274, P91, DOI 10.1002/cne.902740109; Zhang ET, 1996, J COMP NEUROL, V367, P537	36	392	412	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2001	4	1					72	77		10.1038/82924	http://dx.doi.org/10.1038/82924			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UB	11135647				2022-12-24	WOS:000167178000016
J	Delgado, R; Maureira, C; Oliva, C; Kidokoro, Y; Labarca, P				Delgado, R; Maureira, C; Oliva, C; Kidokoro, Y; Labarca, P			Size of vesicle pools, rates of mobilization, and recycling at neuromuscular synapses of a Drosophila mutant, shibire	NEURON			English	Article							SYNAPTIC VESICLES; HIPPOCAMPAL SYNAPSES; TRANSMITTER RELEASE; JUNCTION; ENDOCYTOSIS; EXOCYTOSIS; MEMBRANE; MUSCLES; BOUTONS; LARVAE	Two vesicle pools, readily releasable (RRP) and reserve (RP) pools, are present at Drosophila neuromuscular junctions. Using a temperature-sensitive mutant, shibire(ts), we studied pool sizes and vesicle mobilization rates. In shibire(ts), due to lack of endocytosis at nonpermissive temperatures, synaptic currents continuously declined during tetanic stimulation until they ceased as the result of vesicle depletion. By then, similar to 84,000 quanta were released. Vesicles were mobilized from RP at a rate 1/7-1/10 of RRP. Cytochalasin D inhibited mobilization of vesicles from RP, allowing us to estimate the size of RRP as 14%-19% of all vesicles. Vesicle recycling supports synaptic transmission during prolonged tetanic stimulation and the maximum recycling rate was 1000 vesicles/s.	Ctr Estudios Cient, Valdivia, Chile; Univ Chile, Fac Ciencias, Escuele Postgrad, Santiago, Chile; Gunma Univ, Sch Med, Maebashi, Gumma 3718511, Japan	Universidad de Chile; Gunma University	Labarca, P (corresponding author), Ctr Estudios Cient, Arturo Prat 514, Valdivia, Chile.	plabarca@cecs.cl	Oliva, Carolina/AAF-3887-2019	Oliva, Carolina/0000-0002-5917-9856; Maureira, Carlos/0000-0002-2245-9053				Acharya JK, 1998, NEURON, V20, P1219, DOI 10.1016/S0896-6273(00)80502-4; Atwood H. L., 1997, Invertebrate Neuroscience, V3, P81, DOI 10.1007/BF02480362; ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BIRKS R, 1961, CAN J BIOCHEM PHYS, V39, P787, DOI 10.1139/o61-081; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; DeCamilli P, 1996, NEURON, V16, P481, DOI 10.1016/S0896-6273(00)80068-9; Estes PS, 1996, J NEUROSCI, V16, P5443; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; KOENIG JH, 1989, J NEUROSCI, V9, P1937; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; KOENIG JH, 1989, J NEUROSCI, V9, P3844; KURDYAK P, 1994, J COMP NEUROL, V350, P463, DOI 10.1002/cne.903500310; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Kuromi H, 2000, NEURON, V27, P133, DOI 10.1016/S0896-6273(00)00015-5; Kuromi H, 1999, J NEUROSCI, V19, P1557; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; PLERIBONE VA, 1995, NATURE, V375, P493; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; Smith TW, 1998, ANN BEHAV MED, V20, P243, DOI 10.1007/BF02886373; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967; ZIMMERMANN H, 1977, NEUROSCIENCE, V2, P715, DOI 10.1016/0306-4522(77)90025-2; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	29	148	153	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	2000	28	3					941	953		10.1016/S0896-6273(00)00165-3	http://dx.doi.org/10.1016/S0896-6273(00)00165-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386JJ	11163278	Bronze			2022-12-24	WOS:000166057500028
J	Lin, JW; Ju, W; Foster, K; Lee, SH; Ahmadian, G; Wyszynski, M; Wang, YT; Sheng, M				Lin, JW; Ju, W; Foster, K; Lee, SH; Ahmadian, G; Wyszynski, M; Wang, YT; Sheng, M			Distinct molecular mechanisms and divergent endocytotic pathways of AMPA receptors internalization	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; DOMAIN-CONTAINING PROTEIN; GLUTAMATE RECEPTORS; HIPPOCAMPAL-NEURONS; SURFACE EXPRESSION; MEMBRANE-FUSION; SYNAPTIC AMPA; C-TERMINUS; IN-VITRO; EEA1	Internalization of postsynaptic AMPA receptors depresses excitatory transmission, but the underlying dynamics and mechanisms of this process are unclear. Using immunofluorescence and surface biotinylation, we characterized and quantified basal and regulated AMPA receptor endocytosis in cultured hippocampal neurons, in response to synaptic activity, AMPA and insulin. AMPA-induced AMPA receptor internalization is mediated in part by secondary activation of voltage-dependent calcium channels, and in part by ligand binding independent of receptor activation. Although both require dynamin, insulin- and AMPA-induced AMPA receptor internalization are differentially dependent on protein phosphatases and sequence determinants within the cytoplasmic tails of GluR1 and GluR2 subunits. AMPA receptors internalized in response to AMPA stimulation enter a recycling endosome system, whereas those internalized in response to insulin diverge into a distinct compartment. Thus, the molecular mechanisms and intracellular sorting of AMPA receptors are diverse, and depend on the internalizing stimulus.	Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Hosp Sick Children, Programme Brain & Behav, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Div Pathol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X8, Canada	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Lin, JW (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Wellman 423,50 Blossom St, Boston, MA 02114 USA.		Wang, Yu Tian/A-4729-2008; Lee, Sang/R-7518-2019; Wang, Yu Tian/J-8255-2015	Lee, Sang H./0000-0001-5467-0331	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035050] Funding Source: NIH RePORTER; NINDS NIH HHS [NS35050] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Advani RJ, 1998, J BIOL CHEM, V273, P10317, DOI 10.1074/jbc.273.17.10317; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Gaullier JM, 2000, J BIOL CHEM, V275, P24595, DOI 10.1074/jbc.M906554199; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5; Lai MM, 1999, J BIOL CHEM, V274, P25963, DOI 10.1074/jbc.274.37.25963; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Li P, 1999, NAT NEUROSCI, V2, P972, DOI 10.1038/14771; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Mammen AL, 1997, J NEUROSCI, V17, P7351; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; MERLIN LR, 1993, BRAIN RES, V627, P330, DOI 10.1016/0006-8993(93)90338-N; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; OBrien RJ, 1997, J NEUROSCI, V17, P7339; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Prekeris R, 1998, J CELL BIOL, V143, P957, DOI 10.1083/jcb.143.4.957; Semsarian C, 1999, NATURE, V400, P576, DOI 10.1038/23054; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Turrigiano GG, 2000, NEURON, V26, P5, DOI 10.1016/S0896-6273(00)81131-9; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Willins DL, 1999, NEUROSCIENCE, V91, P599, DOI 10.1016/S0306-4522(98)00653-8; Wyszynski M, 1999, J NEUROSCI, V19, P6528; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; YAMASHIRO DJ, 1984, CELL, V37, P789, DOI 10.1016/0092-8674(84)90414-8	50	388	406	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2000	3	12					1282	1290		10.1038/81814	http://dx.doi.org/10.1038/81814			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UA	11100149	Bronze			2022-12-24	WOS:000167177900014
J	Sakai, R; Henderson, JT; O'Bryan, JP; Elia, AJ; Saxton, TM; Pawson, T				Sakai, R; Henderson, JT; O'Bryan, JP; Elia, AJ; Saxton, TM; Pawson, T			The mammalian ShcB and ShcC phosphotyrosine docking proteins function in the maturation of sensory and sympathetic neurons	NEURON			English	Article							NERVE GROWTH-FACTOR; SIGNAL-TRANSDUCTION PATHWAYS; MICE LACKING GDNF; ADAPTER PROTEIN; SRC HOMOLOGY-2; TRK RECEPTORS; SH2 DOMAIN; CUTANEOUS MECHANORECEPTORS; NEUROTROPHIC FACTOR; BINDING DOMAINS	Shc proteins possess SH2 and PTB domains and serve a scaffolding function in signaling by a variety of receptor tyrosine kinases. There are three known mammalian She genes, of which ShcB and ShcC are primarily expressed in the nervous system. We have generated null mutations in ShcB and ShcC and have obtained mice lacking either ShcB or ShcC or both gene products. ShcB-deficient animals exhibit a loss of peptidergic and nonpeptidergic nociceptive sensory neurons, which is not enhanced by additional loss of ShcC. Mice lacking both ShcB and ShcC exhibit a significant loss of neurons within the superior cervical ganglia, which is not observed in either mutant alone. The results indicate that these She family members possess both unique and overlapping functions in regulating neural development and suggest physiological roles for ShcB/ShcC in TrkA signaling.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; Amgen Inst, Toronto, ON M5G 2C1, Canada; Natl Canc Ctr, Res Inst, Div Virol, Chuo Ku, Tokyo 1040045, Japan; NIEHS, Natl Inst Hlth, Res Triangle Pk, NC 27709 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; National Cancer Center - Japan; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Pawson, T (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.		Pawson, Tony J/E-4578-2013	Sakai, Ryuichi/0000-0001-6833-1103; O'Bryan, John/0000-0001-5386-1080	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES090091, Z01ES090090] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Airaksinen MS, 1996, NEURON, V16, P287, DOI 10.1016/S0896-6273(00)80047-1; AUSUBEL FM, 1991, CURRENT PROTOCOLS MO, P1411; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; BASU T, 1994, ONCOGENE, V9, P3483; Bennett DLH, 1996, EUR J NEUROSCI, V8, P2204; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; Conover JC, 1997, REV NEUROSCIENCE, V8, P13; Conti L, 1997, P NATL ACAD SCI USA, V94, P8185, DOI 10.1073/pnas.94.15.8185; Creedon DJ, 1997, P NATL ACAD SCI USA, V94, P7018, DOI 10.1073/pnas.94.13.7018; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; CRUZORIVE LM, 1990, AM J PHYSIOL, V258, pL148, DOI 10.1152/ajplung.1990.258.4.L148; DIAMOND J, 1992, J NEUROSCI, V12, P1454; DIKIC I, 1995, J BIOL CHEM, V270, P15125, DOI 10.1074/jbc.270.25.15125; DOUBLEDAY B, 1992, BRAIN RES, V593, P179, DOI 10.1016/0006-8993(92)91306-Y; Durbec PL, 1996, DEVELOPMENT, V122, P349; Elshamy WM, 1996, DEVELOPMENT, V122, P491; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; Fagan AM, 1996, J NEUROSCI, V16, P6208; Francis NJ, 1999, ANNU REV NEUROSCI, V22, P541, DOI 10.1146/annurev.neuro.22.1.541; Fundin BT, 1997, DEV BIOL, V190, P94, DOI 10.1006/dbio.1997.8658; Ganju P, 1998, EUR J NEUROSCI, V10, P1995, DOI 10.1046/j.1460-9568.1998.00209.x; Granholm ACE, 1997, J NEUROSCI, V17, P1168; Gu HH, 2000, MOL CELL BIOL, V20, P7109, DOI 10.1128/MCB.20.19.7109-7120.2000; Hallberg B, 1998, ONCOGENE, V17, P691, DOI 10.1038/sj.onc.1201980; Hashimoto A, 1999, J BIOL CHEM, V274, P20139, DOI 10.1074/jbc.274.29.20139; Heuckeroth RO, 1999, NEURON, V22, P253, DOI 10.1016/S0896-6273(00)81087-9; INAGAKI N, 1995, EUR J NEUROSCI, V7, P1125, DOI 10.1111/j.1460-9568.1995.tb01102.x; Kinkelin I, 1999, EUR J NEUROSCI, V11, P3963, DOI 10.1046/j.1460-9568.1999.00822.x; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Lai KMV, 2000, GENE DEV, V14, P1132; Laminet AA, 1996, J BIOL CHEM, V271, P264, DOI 10.1074/jbc.271.1.264; Liu L, 1997, J BIOL CHEM, V272, P8983; Lomaga MA, 2000, J NEUROSCI, V20, P7384; Lorenzo MJ, 1997, ONCOGENE, V14, P763, DOI 10.1038/sj.onc.1200894; Luschnig S, 2000, MOL CELL, V5, P231, DOI 10.1016/S1097-2765(00)80419-0; Mazzoni IE, 1999, J NEUROSCI, V19, P9716; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Minichiello L, 1998, NEURON, V21, P335, DOI 10.1016/S0896-6273(00)80543-7; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nakamura T, 1996, ONCOGENE, V13, P1111; Nakamura T, 1998, J BIOL CHEM, V273, P6960, DOI 10.1074/jbc.273.12.6960; O'Bryan JP, 1998, J BIOL CHEM, V273, P20431, DOI 10.1074/jbc.273.32.20431; OBERMEIER A, 1994, EMBO J, V13, P1585, DOI 10.1002/j.1460-2075.1994.tb06421.x; OBryan JP, 1996, P NATL ACAD SCI USA, V93, P2729, DOI 10.1073/pnas.93.7.2729; OBryan JP, 1996, J BIOL CHEM, V271, P11787, DOI 10.1074/jbc.271.20.11787; Okabayashi Y, 1996, J BIOL CHEM, V271, P5265; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pelicci G, 1996, ONCOGENE, V13, P633; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Pinon LGP, 1996, DEVELOPMENT, V122, P3255; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; SILOSSANTIAGO I, 1995, J NEUROSCI, V15, P5929; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; Stucky CL, 1999, J NEUROSCI, V19, P8509; vanderGeer P, 1996, CURR BIOL, V6, P1435, DOI 10.1016/S0960-9822(96)00748-8; VANDERGEER P, 1995, CURR BIOL, V5, P404, DOI 10.1016/S0960-9822(95)00081-9; WENG ZG, 1994, MOL CELL BIOL, V14, P4509, DOI 10.1128/MCB.14.7.4509; Wyatt S, 1997, EMBO J, V16, P3115, DOI 10.1093/emboj/16.11.3115	65	85	88	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	2000	28	3					819	833		10.1016/S0896-6273(00)00156-2	http://dx.doi.org/10.1016/S0896-6273(00)00156-2			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386JJ	11163269	Bronze			2022-12-24	WOS:000166057500019
J	Erickson, CA; Jagadeesh, B; Desimone, R				Erickson, CA; Jagadeesh, B; Desimone, R			Clustering of perirhinal neurons with similar properties following visual experience in adult monkeys	NATURE NEUROSCIENCE			English	Article							INFERIOR TEMPORAL CORTEX; FREQUENCY-DISCRIMINATION TASK; SOMATOSENSORY CORTICAL MAP; OCULAR DOMINANCE COLUMNS; PRIMARY MOTOR CORTEX; LONG-TERM-MEMORY; INFEROTEMPORAL CORTEX; RECOGNITION MEMORY; OWL MONKEYS; HIPPOCAMPAL-FORMATION	The functional organization of early visual areas seems to be largely determined during development. However, the organization of areas important for learning and memory, such as perirhinal cortex, may be modifiable in adults. To test this hypothesis, we recorded from pairs of neurons in perirhinal cortex of macaques while they viewed multiple complex stimuli. For novel stimuli, neuronal response preferences for pairs of nearby neurons and far-apart neurons were uncorrelated. However, after one day of experience with the stimuli, response preferences of nearby neurons became more similar. We conclude that specific visual experience induces development of clusters of perirhinal neurons with similar stimulus preferences.	NIMH, Neuropsychol Lab, Bethesda, MD 20892 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Washington; University of Washington Seattle	Erickson, CA (corresponding author), NIMH, Neuropsychol Lab, Bldg 49,Room 1B80, Bethesda, MD 20892 USA.		Erickson, Cynthia/AAO-4916-2020; Desimone, Robert/G-1121-2018					ALBRIGHT TD, 1984, J NEUROPHYSIOL, V51, P16, DOI 10.1152/jn.1984.51.1.16; BAYLIS GC, 1987, EXP BRAIN RES, V65, P614; BROWN MW, 1987, BRAIN RES, V409, P158, DOI 10.1016/0006-8993(87)90753-0; Buffalo EA, 1999, LEARN MEMORY, V6, P572, DOI 10.1101/lm.6.6.572; DESIMONE R, 1979, BRAIN RES, V178, P363, DOI 10.1016/0006-8993(79)90699-1; Erickson CA, 1999, J NEUROSCI, V19, P10404; ESKANDAR EN, 1992, J NEUROPHYSIOL, V68, P1277, DOI 10.1152/jn.1992.68.4.1277; FAHY FL, 1993, EXP BRAIN RES, V96, P457; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; Gawne TJ, 1996, CEREB CORTEX, V6, P482, DOI 10.1093/cercor/6.3.482; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; GOCHIN PM, 1994, J NEUROPHYSIOL, V71, P2325, DOI 10.1152/jn.1994.71.6.2325; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; GROSS CG, 1992, PHILOS T ROY SOC B, V335, P3, DOI 10.1098/rstb.1992.0001; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; GROSS CG, 1967, J NEUROPHYSIOL, V30, P833, DOI 10.1152/jn.1967.30.4.833; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; Keppel G., 1973, DESIGN ANAL RES HDB; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; Lee D, 1998, J NEUROSCI, V18, P1161; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; LI L, 1993, J NEUROPHYSIOL, V69, P1918, DOI 10.1152/jn.1993.69.6.1918; LOGOTHETIS NK, 1995, CEREB CORTEX, V5, P270, DOI 10.1093/cercor/5.3.270; Manger PR, 1996, P ROY SOC B-BIOL SCI, V263, P933, DOI 10.1098/rspb.1996.0138; MCNAUGHTON BL, 1983, J NEUROSCI METH, V8, P391, DOI 10.1016/0165-0270(83)90097-3; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; MEUNIER M, 1993, J NEUROSCI, V13, P5418, DOI 10.1523/JNEUROSCI.13-12-05418.1993; MILLER EK, 1994, SCIENCE, V263, P520, DOI 10.1126/science.8290960; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; MURRAY EA, 1986, J NEUROSCI, V6, P1991; MURRAY EA, 2000, NEW COGNITIVE NEUROS, P753; NUDO RJ, 1992, J NEUROSCI, V12, P2918, DOI 10.1523/JNEUROSCI.12-08-02918.1992; Nudo RJ, 1996, J NEUROSCI, V16, P785; PONS TP, 1991, SCIENCE, V252, P1857, DOI 10.1126/science.1843843; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1015, DOI 10.1152/jn.1992.67.5.1015; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1057, DOI 10.1152/jn.1992.67.5.1057; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; SOBOTKA S, 1994, BRAIN RES, V646, P95, DOI 10.1016/0006-8993(94)90061-2; SOBOTKA S, 1993, EXP BRAIN RES, V96, P28, DOI 10.1007/BF00230436; SUZUKI WA, 1993, J NEUROSCI, V13, P2430, DOI 10.1523/JNEUROSCI.13-06-02430.1993; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Thornton JA, 1997, J NEUROSCI, V17, P8536; Wang G, 1996, SCIENCE, V272, P1665, DOI 10.1126/science.272.5268.1665; Wang Y, 2000, NAT NEUROSCI, V3, P807, DOI 10.1038/77712; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0; ZOLAMORGAN S, 1989, J NEUROSCI, V9, P4355; ZOLAMORGAN S, 1993, J NEUROSCI, V13, P251	50	88	89	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11					1143	1148		10.1038/80664	http://dx.doi.org/10.1038/80664			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TX	11036272				2022-12-24	WOS:000167177600020
J	Kiselev, A; Socolich, M; Vinos, J; Hardy, RW; Zuker, CS; Ranganathan, R				Kiselev, A; Socolich, M; Vinos, J; Hardy, RW; Zuker, CS; Ranganathan, R			A molecular pathway for light-dependent photoreceptor apoptosis in Drosophila	NEURON			English	Article							PROTEIN-COUPLED RECEPTORS; PROGRAMMED CELL-DEATH; DEGENERATION-C RDGC; RETINAL-DEGENERATION; RETINITIS-PIGMENTOSA; INDUCED PHOSPHORYLATION; RHODOPSIN MUTATIONS; GENETIC DISSECTION; VISUAL RECEPTORS; PHOSRESTIN-I	Light-induced photoreceptor apoptosis occurs in many forms of inherited retinal degeneration resulting in blindness in both vertebrates and invertebrates. Though mutations in several photoreceptor signaling proteins have been implicated in triggering this process, the molecular events relating light activation of rhodopsin to photoreceptor death are yet unclear. Here, we uncover a pathway by which activation of rhodopsin in Drosophila mediates apoptosis through a G protein-independent mechanism. This process involves the formation of membrane complexes of phosphorylated, activated rhodopsin and its inhibitory protein arrestin, and subsequent clathrin-dependent endocytosis of these complexes into a cytoplasmic compartment Together, these data define the proapoptotic molecules in Drosophila photoreceptors and indicate a novel signaling pathway for light-activated rhodopsin molecules in control of photoreceptor viability.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego; University of California System; University of California San Diego	Ranganathan, R (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.			Socolich, Michael/0000-0002-0702-1061				Adler R, 1996, ARCH OPHTHALMOL-CHIC, V114, P79, DOI 10.1001/archopht.1996.01100130075012; Alloway PG, 2000, NEURON, V28, P129, DOI 10.1016/S0896-6273(00)00091-X; Alloway PG, 1999, P NATL ACAD SCI USA, V96, P6072, DOI 10.1073/pnas.96.11.6072; Bangs P, 2000, DEV DYNAM, V218, P68, DOI 10.1002/(SICI)1097-0177(200005)218:1<68::AID-DVDY6>3.0.CO;2-9; Baylor DA, 1998, EYE, V12, P521, DOI 10.1038/eye.1998.140; BAZINET C, 1993, GENETICS, V134, P1119; Bentrop J, 1998, ACTA ANAT, V162, P85; Bergmann A, 1998, ONCOGENE, V17, P3215, DOI 10.1038/sj.onc.1202586; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; BYK T, 1993, P NATL ACAD SCI USA, V90, P1907, DOI 10.1073/pnas.90.5.1907; COTMAN CW, 1995, MOL NEUROBIOL, V10, P19, DOI 10.1007/BF02740836; Davidson FF, 1998, NATURE, V391, P587, DOI 10.1038/35385; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; GRIGLIATTI TA, 1973, MOL GEN GENET, V120, P107, DOI 10.1007/BF00267238; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; HARRIS WA, 1977, J GEN PHYSIOL, V69, P261, DOI 10.1085/jgp.69.3.261; HARRIS WA, 1976, J PHYSIOL-LONDON, V256, P415; HOTTA Y, 1970, P NATL ACAD SCI USA, V67, P1156, DOI 10.1073/pnas.67.3.1156; Huang XZ, 1998, J BIOL CHEM, V273, P1462, DOI 10.1074/jbc.273.3.1462; KEEN TJ, 1991, GENOMICS, V11, P199, DOI 10.1016/0888-7543(91)90119-Y; Kibbey RG, 1998, J CELL BIOL, V142, P59, DOI 10.1083/jcb.142.1.59; Kim TW, 1997, SCIENCE, V277, P373, DOI 10.1126/science.277.5324.373; KISELEV A, 1994, SCIENCE, V266, P1369, DOI 10.1126/science.7973725; Kiselev A, 1997, BIOCHEMISTRY-US, V36, P2188, DOI 10.1021/bi9621268; KUHN H, 1987, J RECEPTOR RES, V7, P283, DOI 10.3109/10799898709054990; KURADA P, 1995, NEURON, V14, P571, DOI 10.1016/0896-6273(95)90313-5; Laporte SA, 2000, J BIOL CHEM, V275, P23120, DOI 10.1074/jbc.M002581200; Lee RD, 1996, MICROSC RES TECHNIQ, V35, P418, DOI 10.1002/(SICI)1097-0029(19961215)35:6<418::AID-JEMT2>3.0.CO;2-E; LEE YJ, 1990, NEURON, V5, P889, DOI 10.1016/0896-6273(90)90349-K; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; LEVINE H, 1990, MECH DEVELOP, V33, P19, DOI 10.1016/0925-4773(90)90131-5; LI TS, 1995, P NATL ACAD SCI USA, V92, P3551, DOI 10.1073/pnas.92.8.3551; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; MATSUMOTO H, 1991, BIOCHEM BIOPH RES CO, V177, P1306, DOI 10.1016/0006-291X(91)90683-X; MATSUMOTO H, 1994, NEURON, V12, P997, DOI 10.1016/0896-6273(94)90309-3; McClure SJ, 1996, MOL MEMBR BIOL, V13, P189, DOI 10.3109/09687689609160598; MEYERTHOLEN EP, 1987, J COMP PHYSIOL A, V161, P793, DOI 10.1007/BF00610221; Miller DT, 1998, DEVELOPMENT, V125, P2327; MINKE B, 1986, MOL MECHANISM PHOTOR, P241; Montini E, 1997, HUM MOL GENET, V6, P1137, DOI 10.1093/hmg/6.7.1137; Namura S, 1998, J NEUROSCI, V18, P3659; PAK WL, 1994, MOL GENETICS INHERIT, P29; PLANGGER A, 1994, J BIOL CHEM, V269, P26969; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; RAFF MC, 1994, PHILOS T ROY SOC B, V345, P265, DOI 10.1098/rstb.1994.0104; Raghu P, 2000, NEURON, V26, P169, DOI 10.1016/S0896-6273(00)81147-2; RANGANATHAN R, 1995, CELL, V81, P841, DOI 10.1016/0092-8674(95)90004-7; RIM J, 1995, BIOCHEMISTRY-US, V34, P11938, DOI 10.1021/bi00037a035; SAPP RJ, 1991, J NEUROCYTOL, V20, P597, DOI 10.1007/BF01215267; Sherman PM, 1997, P NATL ACAD SCI USA, V94, P11639, DOI 10.1073/pnas.94.21.11639; SMITH DP, 1990, P NATL ACAD SCI USA, V87, P1003, DOI 10.1073/pnas.87.3.1003; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; STARK WS, 1987, J NEUROGENET, V4, P227, DOI 10.3109/01677068709102343; STARK WS, 1989, J NEUROGENET, V5, P49, DOI 10.3109/01677068909167264; STEELE F, 1990, NEURON, V4, P883, DOI 10.1016/0896-6273(90)90141-2; STEELE FR, 1992, CELL, V69, P669, DOI 10.1016/0092-8674(92)90230-A; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Van Soest S, 1999, SURV OPHTHALMOL, V43, P321, DOI 10.1016/S0039-6257(98)00046-0; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Vinos J, 1997, SCIENCE, V277, P687, DOI 10.1126/science.277.5326.687; WILDEN U, 1986, FEBS LETT, V207, P292, DOI 10.1016/0014-5793(86)81507-1; Yoon J, 2000, J NEUROSCI, V20, P649, DOI 10.1523/JNEUROSCI.20-02-00649.2000	66	197	200	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	2000	28	1					139	152		10.1016/S0896-6273(00)00092-1	http://dx.doi.org/10.1016/S0896-6273(00)00092-1			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	370VN	11086990	Bronze			2022-12-24	WOS:000165143500017
J	Ress, D; Backus, BT; Heeger, DJ				Ress, D; Backus, BT; Heeger, DJ			Activity in primary visual cortex predicts performance in a visual detection task	NATURE NEUROSCIENCE			English	Article							STATE DEPENDENT ACTIVITY; SPATIAL ATTENTION; CORTICAL AREAS; SELECTIVE ATTENTION; SENSORY STIMULATION; NEURAL MECHANISMS; MACAQUE MONKEY; BRAIN ACTIVITY; COLOR SIGNALS; V4	Visual attention can affect both neural activity and behavior in humans. To quantify possible links between the two, we measured activity in early visual cortex (V1, V2 and V3) during a challenging pattern-detection task. Activity was dominated by a large response that was independent of the presence or absence of the stimulus pattern. The measured activity quantitatively predicted the subject's pattern-detection performance: when activity was greater, the subject was more likely to correctly discern the presence or absence of the pattern. This stimulus-independent activity had several characteristics of visual attention, suggesting that attentional mechanisms modulate activity in early visual cortex, and that this attention-related activity strongly influences performance.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University	Heeger, DJ (corresponding author), Stanford Univ, Dept Psychol, 450 Serra Mall,Bldg 420-400, Stanford, CA 94305 USA.				NATIONAL EYE INSTITUTE [F32EY006952, R01EY011794, F32EY006899] Funding Source: NIH RePORTER; NEI NIH HHS [F32-EY06952, F32-EY06899, R01-EY11794] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; BELLIVEAU JW, 1991, SCIENCE, V254, P716, DOI 10.1126/science.1948051; Boynton GM, 1999, VISION RES, V39, P257, DOI 10.1016/S0042-6989(98)00113-8; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Carandini M, 1997, J NEUROSCI, V17, P8621; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; DEMB J, 1997, J NEUROSCI, V17, P8621; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Efron B., 1994, INTRO BOOTSTRAP; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Glover GH, 1998, MAGN RESON MED, V39, P361, DOI 10.1002/mrm.1910390305; Glover GH, 1999, MAGNET RESON MED, V42, P412, DOI 10.1002/(SICI)1522-2594(199908)42:2<412::AID-MRM25>3.0.CO;2-U; Graham N.V.S, 1989, VISUAL PATTERN ANAL; GREEN DM, 1988, SIGNAL DETECTION THE; HAENNY PE, 1988, EXP BRAIN RES, V69, P225, DOI 10.1007/BF00247569; HAENNY PE, 1988, EXP BRAIN RES, V69, P245, DOI 10.1007/BF00247570; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; Heeger DJ, 2000, NAT NEUROSCI, V3, P631, DOI 10.1038/76572; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; McAdams CJ, 1999, NEURON, V23, P765, DOI 10.1016/S0896-6273(01)80034-9; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Pashler HE, 1998, PSYCHOL ATTENTION; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Seidemann E, 1999, NEURON, V24, P911, DOI 10.1016/S0896-6273(00)81038-7; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shulman GL, 1999, J NEUROSCI, V19, P9480; Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Wandell BA, 1999, NEURON, V24, P901, DOI 10.1016/S0896-6273(00)81037-5	49	395	401	2	26	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2000	3	9					940	945		10.1038/78856	http://dx.doi.org/10.1038/78856			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TV	10966626				2022-12-24	WOS:000167177400022
J	Atwal, JK; Massie, B; Miller, FD; Kaplan, DR				Atwal, JK; Massie, B; Miller, FD; Kaplan, DR			The TrkB-Shc site signals neuronal survival and local axon growth via MEK and PI3-kinase	NEURON			English	Article							RAT SYMPATHETIC NEURONS; PATHWAYS INVOLVING SHC; MAP KINASE KINASE; PROTEIN-KINASE; TRANSCRIPTION FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOLIPASE C-GAMMA-1; NEUROTROPHIC FACTORS; NEURITE OUTGROWTH; RETROGRADE SIGNAL	To determine how signals emanating from Trk transmit neurotrophin actions in primary neurons, we tested the ability of TrkB mutated at defined effector binding sites to promote sympathetic neuron survival or local axon growth. TrkB stimulated signaling proteins and induced survival and growth in a manner similar to TrkA. TrkB mutated at the Shc binding site supported survival and growth poorly relative to wild-type TrkB, whereas TrkB mutated at the PLC-gamma 1 binding site supported growth and survival well. TrkB-mediated neuronal survival was dependent on PI3-kinase and to a lesser extent MEK activity, while growth depended upon both MEK and PI3-kinase activities. These results indicate that the TrkB-Shc site mediates both neuronal survival and axonal outgrowth by activating the PI3-kinase and MEK signaling pathways.	McGill Univ, Ctr Neuronal Survival, Montreal, PQ H3A 2B4, Canada; McGill Univ, Montreal Neurol Inst, Brain Tumor Res Ctr, Montreal, PQ H3A 2B4, Canada; Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada	McGill University; McGill University; National Research Council Canada	Miller, FD (corresponding author), McGill Univ, Ctr Neuronal Survival, Montreal, PQ H3A 2B4, Canada.	mcdv@musica.mcgill.ca						ALBERS KM, 1994, J NEUROSCI, V14, P1422, DOI 10.1523/JNEUROSCI.14-03-01422.1994; Anderson CNG, 1999, J NEUROSCI, V19, P664; Ashcroft M, 1999, ONCOGENE, V18, P4586, DOI 10.1038/sj.onc.1202814; BAXTER RM, 1995, EUR J BIOCHEM, V234, P84, DOI 10.1111/j.1432-1033.1995.084_c.x; Belliveau DJ, 1997, J CELL BIOL, V136, P375, DOI 10.1083/jcb.136.2.375; Bhattacharyya A, 1997, J NEUROSCI, V17, P7007; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; CAMPENOT RB, 1994, J NEUROBIOL, V25, P599, DOI 10.1002/neu.480250603; CHUN LLY, 1977, J CELL BIOL, V75, P694, DOI 10.1083/jcb.75.3.694; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Creedon DJ, 1996, J BIOL CHEM, V271, P20713, DOI 10.1074/jbc.271.34.20713; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; EDWARDS RH, 1989, CELL, V58, P161, DOI 10.1016/0092-8674(89)90412-1; Fagan AM, 1996, J NEUROSCI, V16, P6208; GARCIAROCHA M, 1995, DEV BRAIN RES, V89, P47; GREENE LA, 1977, DEV BIOL, V58, P96, DOI 10.1016/0012-1606(77)90076-8; Hallberg B, 1998, ONCOGENE, V17, P691, DOI 10.1038/sj.onc.1201980; Henderson CE, 1996, CURR OPIN NEUROBIOL, V6, P64, DOI 10.1016/S0959-4388(96)80010-9; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; KAPELLER R, 1995, J BIOL CHEM, V270, P25985, DOI 10.1074/jbc.270.43.25985; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Klesse LJ, 1998, J NEUROSCI, V18, P10420; Korhonen JM, 1999, J BIOL CHEM, V274, P37307, DOI 10.1074/jbc.274.52.37307; LOEB DM, 1994, J BIOL CHEM, V269, P8901; MA Y, 1992, J CELL BIOL, V117, P135, DOI 10.1083/jcb.117.1.135; MASSIE B, 1995, BIO-TECHNOL, V13, P602, DOI 10.1038/nbt0695-602; Massie B, 1998, J VIROL, V72, P2289, DOI 10.1128/JVI.72.3.2289-2296.1998; Mazzoni IE, 1999, J NEUROSCI, V19, P9716; McCarty JH, 1999, J RECEPT SIGNAL TR R, V19, P953, DOI 10.3109/10799899909038434; Meakin SO, 1999, J BIOL CHEM, V274, P9861, DOI 10.1074/jbc.274.14.9861; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; MIDDLEMAS DS, 1994, J BIOL CHEM, V269, P5458; MILLER FD, 1994, DEV BIOL, V161, P206, DOI 10.1006/dbio.1994.1021; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Minichiello L, 1998, NEURON, V21, P335, DOI 10.1016/S0896-6273(00)80543-7; OBERMEIER A, 1994, EMBO J, V13, P1585, DOI 10.1002/j.1460-2075.1994.tb06421.x; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; PENG X, 1995, NEURON, V15, P395, DOI 10.1016/0896-6273(95)90043-8; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; RODER HM, 1993, BIOCHEM BIOPH RES CO, V193, P639, DOI 10.1006/bbrc.1993.1672; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Senger DL, 1997, J CELL BIOL, V138, P411, DOI 10.1083/jcb.138.2.411; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; Veeranna, 1998, J NEUROSCI, V18, P4008; Virdee K, 1996, J NEUROCHEM, V67, P1801	54	342	347	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	2000	27	2					265	277		10.1016/S0896-6273(00)00035-0	http://dx.doi.org/10.1016/S0896-6273(00)00035-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	347YD	10985347	Bronze			2022-12-24	WOS:000088956000011
J	Atzori, M; Lau, D; Tansey, EP; Chow, A; Ozaita, A; Rudy, B; McBain, CJ				Atzori, M; Lau, D; Tansey, EP; Chow, A; Ozaita, A; Rudy, B; McBain, CJ			H-2 histamine receptor-phosphorylation of Kv3.2 modulates interneuron fast spiking	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL PYRAMIDAL CELLS; CHANNEL SUBUNIT KV3.1B; HIGH-FREQUENCY OSCILLATIONS; GATED K+ CHANNELS; POTASSIUM-CHANNEL; RAT HIPPOCAMPUS; NEOCORTICAL INTERNEURONS; DIFFERENTIAL EXPRESSION; BEHAVING RAT; CNS NEURONS	Histamine-containing neurons of the tuberomammilary nucleus project to the hippocampal formation to innervate H-1 and H-2 receptors on both principal and inhibitory interneurons. Here we show that H-2 receptor activation negatively modulates outward currents through Kv3.2-containing potassium channels by a mechanism involving PKA phosphorylation in inhibitory interneurons. PKA phosphorylation of Kv3.2 lowered the maximum firing frequency of inhibitory neurons, which in turn negatively modulated high-frequency population oscillations recorded in principal cell layers. All these effects were absent in a Kv3.2 knockout mouse. These data reveal a novel pathway for histamine-dependent regulation of high-frequency oscillations within the hippocampal formation.	NICHD, Lab Cellular & Mol Neurophysiol, NIH, Bethesda, MD 20892 USA; NYU, Sch Med, Dept Physiol & Neurosci, New York, NY 10016 USA; NYU, Sch Med, Dept Biochem, New York, NY 10016 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); New York University; New York University	McBain, CJ (corresponding author), NICHD, Lab Cellular & Mol Neurophysiol, NIH, Rm 5A72,Bldg 49,Convent Dr, Bethesda, MD 20892 USA.	chrismcb@codon.nih.gov	Ozaita, Andres/H-3411-2015	Ozaita, Andres/0000-0002-2239-7403; Rudy, Bernardo/0000-0001-5748-6900	NINDS NIH HHS [NS30989, NS35215] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035215, R01NS030989] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aoki T, 2000, J NEUROPHYSIOL, V83, P3453, DOI 10.1152/jn.2000.83.6.3453; BARBIN G, 1976, J NEUROCHEM, V26, P259, DOI 10.1111/j.1471-4159.1976.tb04474.x; Brown RE, 1996, J PHYSIOL-LONDON, V496, P175, DOI 10.1113/jphysiol.1996.sp021675; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Catterall WA, 1997, ADV SEC MESS PHOSPH, V31, P159; Chow A, 1999, J NEUROSCI, V19, P9332; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; DEMIERA EV, 1994, HDB MEMBRANE CHANNEL, P41; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Du J, 1996, J NEUROSCI, V16, P506; Erisir A, 1999, J NEUROPHYSIOL, V82, P2476, DOI 10.1152/jn.1999.82.5.2476; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; GARBARG M, 1976, BRAIN RES, V106, P333, DOI 10.1016/0006-8993(76)91029-5; GELLER HM, 1984, CAN J PHYSIOL PHARM, V62, P715, DOI 10.1139/y84-118; GREENE RW, 1990, NEUROSCIENCE, V34, P299, DOI 10.1016/0306-4522(90)90140-Y; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; HAAS HL, 1983, NATURE, V302, P432, DOI 10.1038/302432a0; HAAS HL, 1986, EXP BRAIN RES, V62, P123; Hernandez-Pineda R, 1999, J NEUROPHYSIOL, V82, P1512, DOI 10.1152/jn.1999.82.3.1512; HOUGH LB, 1998, BASIC NEUROCHEMISTRY, V6, P293; INAGAKI N, 1988, J COMP NEUROL, V273, P283, DOI 10.1002/cne.902730302; Martina M, 1998, J NEUROSCI, V18, P8111; Massengill JL, 1997, J NEUROSCI, V17, P3136; MORENO H, 1995, J NEUROSCI, V15, P5486; PANULA P, 1989, NEUROSCIENCE, V28, P585, DOI 10.1016/0306-4522(89)90007-9; PELLMAR TC, 1986, J NEUROPHYSIOL, V55, P727, DOI 10.1152/jn.1986.55.4.727; PERNEY TM, 1992, J NEUROPHYSIOL, V68, P756, DOI 10.1152/jn.1992.68.3.756; Rudy B, 1999, ANN NY ACAD SCI, V868, P304, DOI 10.1111/j.1749-6632.1999.tb11295.x; SASTRY BSR, 1976, EUR J PHARMACOL, V38, P269, DOI 10.1016/0014-2999(76)90329-0; SCHWARTZ JC, 1991, PHYSIOL REV, V71, P1, DOI 10.1152/physrev.1991.71.1.1; SEGAL M, 1981, BRAIN RES, V213, P443, DOI 10.1016/0006-8993(81)90251-1; Sekirnjak C, 1997, BRAIN RES, V766, P173, DOI 10.1016/S0006-8993(97)00527-1; SPRINGFIELD SA, 1988, CELL MOL NEUROBIOL, V8, P431, DOI 10.1007/BF00711227; Traub RD, 2000, J NEUROSCI, V20, P2086; Vizuete ML, 1997, NEUROSCIENCE, V80, P321, DOI 10.1016/S0306-4522(97)00010-9; VOROBJEV VS, 1993, NEURON, V11, P837, DOI 10.1016/0896-6273(93)90113-6; WADA H, 1991, TRENDS NEUROSCI, V14, P415, DOI 10.1016/0166-2236(91)90034-R; Wang LY, 1998, J PHYSIOL-LONDON, V509, P183, DOI 10.1111/j.1469-7793.1998.183bo.x; WEISER M, 1995, J NEUROSCI, V15, P4298; WEISER M, 1994, J NEUROSCI, V14, P949, DOI 10.1523/JNEUROSCI.14-03-00949.1994; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Yanovsky Y, 1998, NEUROSCI LETT, V240, P110, DOI 10.1016/S0304-3940(97)00925-7; YLINEN A, 1995, J NEUROSCI, V15, P30; ZHANG L, 1995, J PHYSIOL-LONDON, V488, P647, DOI 10.1113/jphysiol.1995.sp020997	47	86	101	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2000	3	8					791	798		10.1038/77693	http://dx.doi.org/10.1038/77693			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TU	10903572				2022-12-24	WOS:000167177300014
J	Lei, SB; Jackson, MF; Jia, ZP; Roder, J; Bai, DL; Orser, BA; MacDonald, JF				Lei, SB; Jackson, MF; Jia, ZP; Roder, J; Bai, DL; Orser, BA; MacDonald, JF			Cyclic GMP-dependent feedback inhibition of AMPA receptors is independent of PKG	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; NUCLEOTIDE-GATED CHANNEL; CENTRAL-NERVOUS-SYSTEM; NITRIC-OXIDE; PROTEIN-KINASE; NMDA RECEPTORS; REGULATORY PHOSPHORYLATION; SYNAPTIC TRANSMISSION; GLUTAMATE RECEPTORS; HIPPOCAMPAL-NEURONS	In central neurons, the second messenger cGMP is believed to induce long-term changes in efficacy at glutamatergic synapses through activation of protein kinase C (PKC). Stimulating nitric oxide synthase, activating soluble guanylyl cyclase or elevating concentrations of intracellular cGMP depressed excitatory synaptic transmission in CA1 hippocampal neurons. Unexpectedly, intracellular cGMP depressed responses of AMPA receptors and inhibited excitatory postsynaptic currents in hippocampal neurons independently of phosphorylation. Our findings demonstrate that cGMP's modulation of excitatory transmission may involve a coupling of AMPA channel activity to levels of cGMP.	Univ Toronto, Dept Physiol & Pharmacol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; Univ Toronto, Mt Sinai Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Anaesthesia, Anaesthesia Res Lab, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	MacDonald, JF (corresponding author), Univ Toronto, Dept Physiol & Pharmacol, Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.		Jackson, Mike/H-5573-2012; Jia, zhengping/AAZ-4190-2021; Roder, John/G-6468-2013; Bai, Donglin/ABB-9924-2021; Bai, Donglin/A-5799-2008	Jackson, Mike/0000-0002-4730-201X; Bai, Donglin/0000-0003-1112-6947; Bai, Donglin/0000-0003-1112-6947				ALLEN CN, 1988, BRAIN RES, V458, P147, DOI 10.1016/0006-8993(88)90507-0; Bai DL, 1999, J NEUROSCI, V19, P10635, DOI 10.1523/JNEUROSCI.19-24-10635.1999; Baltrons MA, 1997, EUR J NEUROSCI, V9, P2497, DOI 10.1111/j.1460-9568.1997.tb01667.x; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bol'shakov K B, 1999, Ross Fiziol Zh Im I M Sechenova, V85, P1480; BOULTON CL, 1994, EUR J NEUROSCI, V6, P1528, DOI 10.1111/j.1460-9568.1994.tb00543.x; Bradley J, 1997, J NEUROSCI, V17, P1993; Calabresi P, 1999, J NEUROSCI, V19, P2489; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; Finn JT, 1997, NATURE, V385, P815, DOI 10.1038/385815a0; Fleck MW, 1996, J NEUROPHYSIOL, V75, P2322, DOI 10.1152/jn.1996.75.6.2322; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; Hjelmstad GO, 1999, J NEUROPHYSIOL, V81, P3096, DOI 10.1152/jn.1999.81.6.3096; Hsueh YP, 1998, PROG BRAIN RES, V116, P123, DOI 10.1016/S0079-6123(08)60434-3; Jaffrey SR, 1995, ANNU REV CELL DEV BI, V11, P417; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; Kawada T, 1997, EUR J PHARMACOL, V323, P75, DOI 10.1016/S0014-2999(97)00028-9; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Leidenheimer NJ, 1996, MOL BRAIN RES, V42, P131, DOI 10.1016/S0169-328X(96)00153-2; Levenes C, 1998, PROG NEUROBIOL, V55, P79, DOI 10.1016/S0301-0082(97)00096-8; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; PARTIN KM, 1994, MOL PHARMACOL, V46, P129; SAH P, 1989, SCIENCE, V246, P815, DOI 10.1126/science.2573153; SATHER W, 1992, J PHYSIOL-LONDON, V450, P643, DOI 10.1113/jphysiol.1992.sp019148; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; SCHMIDT MJ, 1985, J PHARMACOL EXP THER, V232, P764; Snyder SH, 1998, BRAIN RES REV, V26, P167, DOI 10.1016/S0165-0173(97)00032-5; WANG LY, 1995, J PHYSIOL-LONDON, V486, P83, DOI 10.1113/jphysiol.1995.sp020792; WANG LY, 1991, SCIENCE, V253, P1132, DOI 10.1126/science.1653455; Wei JY, 1998, J MOL NEUROSCI, V10, P53, DOI 10.1007/BF02737085; Wei JY, 1998, PROG NEUROBIOL, V56, P37, DOI 10.1016/S0301-0082(98)00029-X; Wu JQ, 1998, J NEUROSCI, V18, P3589	38	37	38	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2000	3	6					559	565		10.1038/75729	http://dx.doi.org/10.1038/75729			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	317WG	10816311				2022-12-24	WOS:000087249500011
J	Gaiano, N; Nye, JS; Fishell, G				Gaiano, N; Nye, JS; Fishell, G			Radial glial identity is promoted by Notch1 signaling in the murine forebrain	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; DEVELOPING CEREBRAL-CORTEX; ADULT MAMMALIAN FOREBRAIN; FETAL MONKEY NEOCORTEX; NEURAL STEM-CELLS; SUBEPENDYMAL CELLS; VENTRICULAR ZONE; PRECURSOR CELLS; DIFFERENTIATION; BRAIN	In vertebrates, Notch signaling is generally thought to inhibit neural differentiation. However, whether Notch can also promote specific early cell fates in this context is unknown. We introduced activated Notch1 (NIC) into the mouse forebrain, before the onset of neurogenesis, using a retroviral vector and ultrasound imaging. During embryogenesis, NIC-infected cells became radial glia, the first specialized cell type evident in the forebrain. Thus, rather than simply inhibiting differentiation, Notch1 signaling promoted the acquisition of an early cellular phenotype. Postnatally, many NIC-infected cells became periventricular astrocytes, cells previously shown to be neural stem cells in the adult. These results suggest that Notch1 promotes radial glial identity during embryogenesis, and that radial glia may be lineally related to stem cells in the adult nervous system.	NYU, Sch Med, Dept Cell Biol, Skirball Inst Biomol Med,Dev Genet Program, New York, NY 10016 USA; Northwestern Univ, Sch Med, Chicago, IL 60611 USA	New York University; Northwestern University	Fishell, G (corresponding author), NYU, Sch Med, Dept Cell Biol, Skirball Inst Biomol Med,Dev Genet Program, New York, NY 10016 USA.		Nye, Jeffrey/G-6520-2012	Nye, Jeffrey/0000-0002-6056-281X; Fishell, Gordon/0000-0002-9640-9278	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035566, R01NS032993] Funding Source: NIH RePORTER; NINDS NIH HHS [NS35566, NS32993] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALVAREZBUYLLA A, 1990, NEURON, V5, P101, DOI 10.1016/0896-6273(90)90038-H; ANGEVINE JB, 1970, ANAT REC, V166, P257, DOI 10.1002/ar.1091660214; Anton ES, 1997, DEVELOPMENT, V124, P3501; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bao ZZ, 1997, J NEUROSCI, V17, P1425; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; CHOI BH, 1978, BRAIN RES, V148, P295, DOI 10.1016/0006-8993(78)90721-7; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; DORSKY RI, 1995, NEURON, V14, P487, DOI 10.1016/0896-6273(95)90305-4; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; FENG L, 1995, DEVELOPMENT, V121, P1719; Franklin JL, 1999, CURR BIOL, V9, P1448, DOI 10.1016/S0960-9822(00)80114-1; FREDERIKSEN K, 1988, NEURON, V1, P439, DOI 10.1016/0896-6273(88)90175-4; Gaiano N, 1999, NAT NEUROSCI, V2, P812, DOI 10.1038/12186; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; GRAY GE, 1992, DEVELOPMENT, V114, P271; HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Lardelli M, 1996, MECH DEVELOP, V59, P177, DOI 10.1016/0925-4773(96)00589-8; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LEVITT P, 1983, DEV BIOL, V96, P472, DOI 10.1016/0012-1606(83)90184-7; Lewis J, 1998, SEMIN CELL DEV BIOL, V9, P583, DOI 10.1006/scdb.1998.0266; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; Liu AM, 1998, MECH DEVELOP, V75, P107, DOI 10.1016/S0925-4773(98)00090-2; Misson JP, 1991, CEREB CORTEX, V1, P221, DOI 10.1093/cercor/1.3.221; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; NYE JS, 1995, CURR BIOL, V5, P966, DOI 10.1016/S0960-9822(95)00189-8; NYE JS, 1994, DEVELOPMENT, V120, P2421; Nye JS, 1999, CURR BIOL, V9, pR118, DOI 10.1016/S0960-9822(99)80076-1; OKA C, 1995, DEVELOPMENT, V121, P3291; Olsson M, 1997, NEURON, V19, P761, DOI 10.1016/S0896-6273(00)80959-9; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1995, P NATL ACAD SCI USA, V92, P11323, DOI 10.1073/pnas.92.25.11323; RAKIC P, 1971, BRAIN RES, V33, P471, DOI 10.1016/0006-8993(71)90119-3; Ramon y Cajal S, 1911, HISTOLOGY NERVOUS SY; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; ROEHL H, 1993, NATURE, V364, P632, DOI 10.1038/364632a0; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Takahashi T, 1996, J NEUROSCI, V16, P6183; Toresson H, 1999, DEVELOPMENT, V126, P1317; VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Weinmaster G, 1997, MOL CELL NEUROSCI, V9, P91, DOI 10.1006/mcne.1997.0612	53	577	593	1	19	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	2000	26	2					395	404		10.1016/S0896-6273(00)81172-1	http://dx.doi.org/10.1016/S0896-6273(00)81172-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318QZ	10839358	Bronze			2022-12-24	WOS:000087296500016
J	Lu, YM; Mansuy, IM; Kandel, ER; Roder, J				Lu, YM; Mansuy, IM; Kandel, ER; Roder, J			Calcineurin-mediated LTD of GABAergic inhibition underlies the increased excitability of CA1 neurons associated with LTP	NEURON			English	Article							LONG-TERM POTENTIATION; RABBIT FOLLOWING STIMULATION; EPSP SPIKE DISSOCIATION; RAT HIPPOCAMPAL SLICES; E-S COMPONENT; SYNAPTIC TRANSMISSION; LASTING POTENTIATION; PERFORANT PATH; POSTSYNAPTIC CALCIUM; DENTATE GYRUS	Coincident pre- and postsynaptic activity generates long-term potentiation (LTP), a possible cellular model of learning and memory. LTP has two components: (1) an increase in the excitatory postsynaptic potential (EPSP), and (2) an increase in the ability of the EPSP to generate a spike (ES coupling of LTP). We have used pharmacological and genetic approaches to address the molecular nature of E-S coupling in CA1 pyramidal neurons. Blockade of the Ca2+-sensitive phosphatase, calcineurin, prevents induction of ES coupling without interfering with LTP of the EPSP. Calcineurin produces its effect on E-S coupling by inducing a long-lasting depression (LTD) of the GABA,mediated inhibitory postsynaptic potentials (IPSPs). This LTD of the IPSP was prevented by blockade of NMDA receptors. Thus, the tetanus that elicits NMDA-dependent LTP mediates a coordinately regulated double function. It produces LTP of the EPSP and, concomitantly, LTD of the IPSP that leads to enhancement of E-S coupling.	Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Howard Hughes Med Inst, New York, NY 10032 USA; Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada	Columbia University; Howard Hughes Medical Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Kandel, ER (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Howard Hughes Med Inst, 722 W 168th St, New York, NY 10032 USA.		Roder, John/G-6468-2013; Mansuy, Isabelle M/N-3042-2015	Mansuy, Isabelle M/0000-0001-7785-5371				ABRAHAM WC, 1987, J PHYSIOL-LONDON, V394, P367, DOI 10.1113/jphysiol.1987.sp016875; ABRAHAM WC, 1985, J PHYSIOL-LONDON, V363, P335, DOI 10.1113/jphysiol.1985.sp015714; ALGER BE, 1980, BRAIN RES, V200, P195, DOI 10.1016/0006-8993(80)91108-7; ANDERSEN P, 1987, J PHYSIOL-LONDON, V383, P509; ANDERSEN P, 1980, J PHYSIOL-LONDON, V302, P463; BARRIONUEVO G, 1983, P NATL ACAD SCI-BIOL, V80, P7347, DOI 10.1073/pnas.80.23.7347; BLISS T V P, 1988, P3; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CATTERALL WA, 1981, J NEUROSCI, V1, P777, DOI 10.1523/JNEUROSCI.01-07-00777.1981; CHAVEZNORIEGA LE, 1990, EXP BRAIN RES, V79, P633; CHAVEZNORIEGA LE, 1989, NEUROSCI LETT, V104, P58, DOI 10.1016/0304-3940(89)90329-7; CHEN QX, 1995, J PHYSIOL-LONDON, V482, P353, DOI 10.1113/jphysiol.1995.sp020522; GRIFFITH WH, 1986, J NEUROPHYSIOL, V55, P767, DOI 10.1152/jn.1986.55.4.767; HAAS HL, 1982, J PHYSIOL-LONDON, V329, P541, DOI 10.1113/jphysiol.1982.sp014318; HASHIMOTO Y, 1990, J BIOL CHEM, V265, P1924; HOCHNER B, 1986, P NATL ACAD SCI USA, V83, P8794, DOI 10.1073/pnas.83.22.8794; Hodgkiss JP, 1995, BRAIN RES, V705, P241, DOI 10.1016/0006-8993(95)01168-4; HU GY, 1992, J PHYSIOL-LONDON, V453, P663, DOI 10.1113/jphysiol.1992.sp019250; JESTER JM, 1995, J PHYSIOL-LONDON, V484, P689, DOI 10.1113/jphysiol.1995.sp020696; Jones MV, 1997, J NEUROSCI, V17, P7626; KAIRISS EW, 1987, BRAIN RES, V401, P87, DOI 10.1016/0006-8993(87)91167-X; Linden DJ, 1999, NEURON, V22, P661, DOI 10.1016/S0896-6273(00)80726-6; Lu YF, 1996, BRAIN RES, V729, P142, DOI 10.1016/0006-8993(96)00568-9; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; MACKINTOSH C, 1992, TRENDS BIOCHEM SCI, V12, P444; MALENKA RC, 1992, NEURON, V9, P121, DOI 10.1016/0896-6273(92)90227-5; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; MOORE JW, 1983, J PHYSIOL-LONDON, V336, P285, DOI 10.1113/jphysiol.1983.sp014581; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; O'Dell T J, 1994, Learn Mem, V1, P129; ODELL TJ, 1991, NATURE, V353, P558, DOI 10.1038/353558a0; RICHTER DW, 1974, EXP BRAIN RES, V21, P193; STELZER A, 1987, NATURE, V326, P698, DOI 10.1038/326698a0; TAUBE JS, 1988, J NEUROSCI, V8, P1632; TOMASULO RA, 1991, BRAIN RES, V561, P27, DOI 10.1016/0006-8993(91)90745-H; TURNER RW, 1993, NEUROSCIENCE, V53, P949, DOI 10.1016/0306-4522(93)90480-4; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; WYLLIE DJA, 1994, NEURON, V13, P635, DOI 10.1016/0896-6273(94)90031-0; YAMAMOTO C, 1978, EXP NEUROL, V58, P242, DOI 10.1016/0014-4886(78)90137-1	43	223	227	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	2000	26	1					197	205		10.1016/S0896-6273(00)81150-2	http://dx.doi.org/10.1016/S0896-6273(00)81150-2			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309MA	10798404	Bronze			2022-12-24	WOS:000086770500020
J	Marois, R; Leung, HC; Gore, JC				Marois, R; Leung, HC; Gore, JC			A stimulus-driven approach to object identity and location processing in the human brain	NEURON			English	Article							TEMPORAL VISUAL AREA; HUMAN EXTRASTRIATE CORTEX; SELECTIVE ATTENTION; PARIETAL CORTEX; FUNCTIONAL-PROPERTIES; CORTICAL CONNECTIONS; NEURAL SYSTEMS; PATHWAYS; FMRI; REPRESENTATION	The primate visual system is considered to be segregated into ventral and dorsal streams specialized for processing object identity and location, respectively. We reexamined the dorsal/ventral model using a stimulus-driven approach to object identity and location processing. While looking at repeated presentations of a standard object at a standard location, subjects monitored for any infrequent "oddball" changes in object identity, location, or identity and location (conjunction). While the identity and location oddballs preferentially activated Ventral and dorsal brain regions respectively, each oddball type activated both pathways. Furthermore, all oddball types recruited the lateral temporal cortex and the temporo-parietal junction. These findings suggest that a strict dorsal/ventral dual-stream model does not fully account for the perception of novel objects in space.	Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06511 USA	Vanderbilt University; Yale University	Marois, R (corresponding author), Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA.	rene.marois@vanderbilt.edu						Aguirre GK, 1997, J NEUROSCI, V17, P2512; Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; ANDERSON TJ, 1994, BRAIN, V117, P1073, DOI 10.1093/brain/117.5.1073; Anstis S., 1986, HDB PERCEPTION HUMAN, V1; Beauchamp MS, 1997, J NEUROPHYSIOL, V78, P516, DOI 10.1152/jn.1997.78.1.516; Behrmann M., 2000, NEW COGNITIVE NEUROS, P651; Belger A, 1998, HUM BRAIN MAPP, V6, P14, DOI 10.1002/(SICI)1097-0193(1998)6:1<14::AID-HBM2>3.0.CO;2-O; BOUSSAOUD D, 1990, J COMP NEUROL, V296, P462, DOI 10.1002/cne.902960311; BREITMEYER BG, 1976, PSYCHOL REV, V83, P1, DOI 10.1037/0033-295X.83.1.1; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Clark VP, 1996, NEUROIMAGE, V4, P1, DOI 10.1006/nimg.1996.0025; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; CORBETTA M, 1991, J NEUROSCI, V11, P2383; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Coull JT, 1998, J NEUROSCI, V18, P7426; Courtney SM, 1996, CEREB CORTEX, V6, P39, DOI 10.1093/cercor/6.1.39; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; DEYOE EA, 1988, TRENDS NEUROSCI, V11, P219, DOI 10.1016/0166-2236(88)90130-0; DISTLER C, 1993, J COMP NEUROL, V334, P125, DOI 10.1002/cne.903340111; Driver J, 1998, NAT NEUROSCI, V1, P17, DOI 10.1038/217; DUNCAN J, 1993, PERCEPT PSYCHOPHYS, V54, P425, DOI 10.3758/BF03211764; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fink GR, 1997, BRAIN, V120, P2013, DOI 10.1093/brain/120.11.2013; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Gray CM, 1999, NEURON, V24, P31, DOI 10.1016/S0896-6273(00)80820-X; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; HAXBY JV, 1994, J NEUROSCI, V14, P6336; HUMPHREYS GW, 1994, NATURE, V372, P357, DOI 10.1038/372357a0; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Knight RT, 1997, J COGNITIVE NEUROSCI, V9, P75, DOI 10.1162/jocn.1997.9.1.75; KOHLER S, 1995, NEUROREPORT, V6, P1865, DOI 10.1097/00001756-199510020-00011; KOURTZI Z, 2000, IN PRESS J COGN NEUR; Le TH, 1998, J NEUROPHYSIOL, V79, P1535, DOI 10.1152/jn.1998.79.3.1535; LHERMITTE F, 1985, ARCH NEUROL-CHICAGO, V42, P567, DOI 10.1001/archneur.1985.04060060069011; Luna B, 1998, CEREB CORTEX, V8, P40, DOI 10.1093/cercor/8.1.40; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; McCarthy G, 1997, J NEUROPHYSIOL, V77, P1630, DOI 10.1152/jn.1997.77.3.1630; Menon V, 1997, NEUROREPORT, V8, P3029, DOI 10.1097/00001756-199709290-00007; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; Milner A. D., 1995, VISUAL BRAIN ACTION; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; Opitz B, 1999, CEREB CORTEX, V9, P379, DOI 10.1093/cercor/9.4.379; RAFAL R, 1996, CONVERGING OPERATION; ROBERTSON IH, 1993, UNILATERAL NEGLECT C; Robertson L, 1997, J COGNITIVE NEUROSCI, V9, P295, DOI 10.1162/jocn.1997.9.3.295; Robertson L. C., 2000, NEW COGNITIVE NEUROS, P633; Robson MD, 1998, NEUROIMAGE, V7, P185, DOI 10.1006/nimg.1998.0322; Rosen AC, 1999, J COGNITIVE NEUROSCI, V11, P135, DOI 10.1162/089892999563283; Roskies AL, 1999, NEURON, V24, P7, DOI 10.1016/S0896-6273(00)80817-X; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Singh LN, 1998, NEUROREPORT, V9, P1861, DOI 10.1097/00001756-199806010-00036; TAIRA M, 1990, EXP BRAIN RES, V83, P29; Talairach J., 1988, COPLANAR STEREOTAXIC; THEEUWES J, 1995, PERCEPT PSYCHOPHYS, V57, P637, DOI 10.3758/BF03213269; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Tootell RBH, 1996, TRENDS NEUROSCI, V19, P481, DOI 10.1016/S0166-2236(96)10053-9; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Treisman A., 1993, ATTENTION SELECTION, P5; Treisman AM, 1998, CURR OPIN NEUROBIOL, V8, P218, DOI 10.1016/S0959-4388(98)80143-8; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; UNGERLEIDER LG, 1995, SCIENCE, V270, P769, DOI 10.1126/science.270.5237.769; VALLAR G, 1986, NEUROPSYCHOLOGIA, V24, P609, DOI 10.1016/0028-3932(86)90001-1; Vandenberghe R, 1997, J NEUROSCI, V17, P3739; VANESSEN DC, 1981, J COMP NEUROL, V199, P293, DOI 10.1002/cne.901990302; VanOostende S, 1997, CEREB CORTEX, V7, P690, DOI 10.1093/cercor/7.7.690; VERLEGER R, 1994, COGNITIVE BRAIN RES, V2, P103, DOI 10.1016/0926-6410(94)90007-8; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7; YANTIS S, 1994, J EXP PSYCHOL HUMAN, V20, P95, DOI 10.1037/0096-1523.20.1.95; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601	86	111	111	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	2000	25	3					717	728		10.1016/S0896-6273(00)81073-9	http://dx.doi.org/10.1016/S0896-6273(00)81073-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	301CY	10774738	Bronze			2022-12-24	WOS:000086291700023
J	Porciatti, V; Bonanni, P; Fiorentini, A; Guerrini, R				Porciatti, V; Bonanni, P; Fiorentini, A; Guerrini, R			Lack of cortical contrast gain control in human photosensitive epilepsy	NATURE NEUROSCIENCE			English	Article							VISUAL-CORTEX; RESPONSES; CAT; LUMINANCE; FREQUENCY; CELLS; COLOR	Television and video games may be powerful triggers for visually induced epileptic seizures. To better understand the triggering elements of visual stimuli and cortical mechanisms of hyperexcitability, we examined eleven patients with idiopathic photosensitive epilepsy by recording visually evoked potentials (VEPs) in response to temporally modulated patterns of different contrast. For stimuli of low-medium, but not high, temporal frequency, the contrast dependence of VEP amplitude and latency is remarkably abnormal for luminance contrast (black-white), but not so for chromatic contrast (equiluminant red-green) stimuli. We conclude that cortical mechanisms of contrast gain control for pattern stimuli of relatively low temporal frequency and high luminance contrast are lacking or severely impaired in photosensitive subjects.	CNR, Inst Neurophysiol, Area Ric, I-56100 Pisa, Italy; Univ Pisa, Inst Dev Neurol & Psychiat, I-56018 Pisa, Italy; IRCCS Stella Maris, Med Res Inst, I-56018 Pisa, Italy; Kings Coll Hosp London, Div Neurosci, London SE5 9RS, England	Consiglio Nazionale delle Ricerche (CNR); University of Pisa; IRCCS Fondazione Stella Maris; King's College Hospital NHS Foundation Trust; King's College Hospital	Porciatti, V (corresponding author), CNR, Inst Neurophysiol, Area Ric, 1 Via Alfieri, I-56100 Pisa, Italy.	porciatt@in.pi.cnr.it	bonanni, paolo/T-7360-2017	bonanni, paolo/0000-0002-9448-9059; Guerrini, Renzo/0000-0002-7272-7079; Porciatti, Vittorio/0000-0002-1592-3532				ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; BERNARDETE EA, 1999, VISUAL NEUROSCI, V16, P355; BINNIE CD, 1985, ELECTROEN CLIN NEURO, V61, P1, DOI 10.1016/0013-4694(85)91065-X; BINNIE CD, 1998, REFLEX EPILEPSIES RE, P123; BINNIE CD, 1994, EPILEPTIC SEIZURES S, P49; CAMPBELL FW, 1970, J PHYSIOL-LONDON, V207, P635, DOI 10.1113/jphysiol.1970.sp009085; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Carandini M, 1997, J NEUROSCI, V17, P8621; CHRISTIE T, 1993, SUN             0121, P5; Fiorentini A, 1996, VISION RES, V36, P3557, DOI 10.1016/0042-6989(96)00032-6; GEISLER WS, 1992, VISION RES, V8, P149; Guerrini R, 1997, EPILEPSIA, V38, P777, DOI 10.1111/j.1528-1157.1997.tb01464.x; GUERRINI R, 1995, EPILEPSIA, V36, P883, DOI 10.1111/j.1528-1157.1995.tb01631.x; Guerrini Renzo, 1998, V75, P159; Harding G., 1994, PHOTOSENSITIVE EPILE; Ishida S, 1998, EPILEPSIA, V39, P1340, DOI 10.1111/j.1528-1157.1998.tb01334.x; MORRONE C, 1994, VISUAL NEUROSCI, V11, P861, DOI 10.1017/S0952523800003825; MORRONE MC, 1987, EXP BRAIN RES, V67, P635; MULLEN KT, 1985, J PHYSIOL-LONDON, V359, P381, DOI 10.1113/jphysiol.1985.sp015591; NEWMARK ME, 1979, PHOTOSNESITIVITY EPI; Porciatti V, 1997, VISION RES, V37, P1975, DOI 10.1016/S0042-6989(97)00018-7; PORCIATTI V, 1992, VISION RES, V32, P1199, DOI 10.1016/0042-6989(92)90214-4; SHAPLEY RM, 1981, J PHYSIOL-LONDON, V318, P161; SIMON F, 1992, VISION RES, V32, P591, DOI 10.1016/0042-6989(92)90175-I; SPEKREIJSE H, 1973, VISION RES, V13, P1577, DOI 10.1016/0042-6989(73)90016-3; SULLIVAN K, 1997, HERALD INT TRIB 1219, P5; TRENITE DGA, 1998, REFLEX EPILEPSIES RE, P99; WILKINS A, 1989, REFLEX SEIZURES REFL, P153; WILKINS AJ, 1979, BRAIN, V102, P1, DOI 10.1093/brain/102.1.1	30	120	123	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2000	3	3					259	263		10.1038/72972	http://dx.doi.org/10.1038/72972			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TE	10700258				2022-12-24	WOS:000085810500015
J	Liu, C; Reppert, SM				Liu, C; Reppert, SM			GABA synchronizes clock cells within the suprachiasmatic circadian clock	NEURON			English	Article							GABAERGIC SYSTEM; NUCLEUS; NEURONS; PERIOD; RAT; RHYTHMICITY; EXPRESSION; MPER1; LIGHT	The master clock in the suprachiasmatic nuclei (SCN) is composed of multiple, single-cell circadian clocks. We test the postulate that these individual "clock cells" can be synchronized to each other by the inhibitory transmitter gamma-aminobutyric acid (GABA). For these experiments, we monitored the firing rate rhythm of individual clock cells on fixed multielectrode plates in culture and tested the effects of GABA. The results show that the daily variation in responsiveness of the SCN to phase-shifting agents is manifested at the level of individual neurons. Moreover, GABA, acting through A-type receptors, can both phase shift and synchronize clock cells. We propose that GABA is an important synchronizer of SCN neurons in vivo.	Massachusetts Gen Hosp, Lab Dev Chronobiol, Serv Pediat, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Reppert, SM (corresponding author), Massachusetts Gen Hosp, Lab Dev Chronobiol, Serv Pediat, Boston, MA 02114 USA.		Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD014427] Funding Source: NIH RePORTER; NICHD NIH HHS [R37 HD14427] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AGUILARROBLERO R, 1993, NEUROSCI LETT, V157, P199, DOI 10.1016/0304-3940(93)90736-5; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Batschelet E, 1981, CIRCULAR STAT BIOL; CARD JP, 1984, NEUROSCIENCE, V13, P415, DOI 10.1016/0306-4522(84)90240-9; Cardinali DP, 1998, NEUROCHEM RES, V23, P607, DOI 10.1023/A:1022426519297; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gribkoff VK, 1999, J BIOL RHYTHM, V14, P126, DOI 10.1177/074873099129000515; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; GROSS GW, 1977, NEUROSCI LETT, V6, P101, DOI 10.1016/0304-3940(77)90003-9; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Honma S, 1998, NEUROSCI LETT, V250, P157, DOI 10.1016/S0304-3940(98)00464-9; IKEDA I, 1997, AM J PHYSIOL, V273, pR359; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Liu C, 1997, NEURON, V19, P91, DOI 10.1016/S0896-6273(00)80350-5; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; MASON R, 1991, BRAIN RES, V552, P53, DOI 10.1016/0006-8993(91)90659-J; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; MOORE RY, 1993, NEUROSCI LETT, V150, P112, DOI 10.1016/0304-3940(93)90120-A; OBRIETAN K, 1995, J NEUROSCI, V15, P5065; OHARA BF, 1995, MOL BRAIN RES, V28, P239, DOI 10.1016/0169-328X(94)00212-W; OKAMURA H, 1989, NEUROSCI LETT, V102, P131, DOI 10.1016/0304-3940(89)90067-0; Reppert SM, 1998, NEURON, V21, P1, DOI 10.1016/S0896-6273(00)80234-2; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; VANDENPOL AN, 1986, NEUROSCIENCE, V17, P643, DOI 10.1016/0306-4522(86)90037-0; Wagner S, 1997, NATURE, V387, P598, DOI 10.1038/42468; Welsh DK, 1996, BRAIN RES, V706, P30, DOI 10.1016/0006-8993(95)01172-2; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Whiting PJ, 1999, ANN NY ACAD SCI, V868, P645, DOI 10.1111/j.1749-6632.1999.tb11341.x	33	256	262	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	2000	25	1					123	128		10.1016/S0896-6273(00)80876-4	http://dx.doi.org/10.1016/S0896-6273(00)80876-4			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279KP	10707977	Bronze			2022-12-24	WOS:000085043200015
J	Ghosh, A				Ghosh, A			Transcriptional control of cortical connectivity	NEURON			English	Editorial Material							POSTNATAL-DEVELOPMENT; CORTEX; BRAIN; OTX1; RAT		Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Ghosh, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.							Acampora D, 1996, NAT GENET, V14, P218, DOI 10.1038/ng1096-218; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; STANFIELD BB, 1985, J COMP NEUROL, V238, P236, DOI 10.1002/cne.902380210; STANFIELD BB, 1982, NATURE, V298, P371, DOI 10.1038/298371a0; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2	6	1	1	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1999	24	4					764	765		10.1016/S0896-6273(00)81021-1	http://dx.doi.org/10.1016/S0896-6273(00)81021-1			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	269UE	10624937	Bronze			2022-12-24	WOS:000084495300002
J	Maeda, H; Ellis-Davies, GCR; Ito, K; Miyashita, Y; Kasai, H				Maeda, H; Ellis-Davies, GCR; Ito, K; Miyashita, Y; Kasai, H			Supralinear Ca2+ signaling by cooperative and mobile Ca2+ buffering in Purkinje neurons	NEURON			English	Article							LONG-TERM DEPRESSION; BOVINE CHROMAFFIN CELLS; RAT CEREBELLAR SLICES; CALCIUM-BINDING; CLIMBING FIBER; INTRACELLULAR CALCIUM; SYNAPTIC DEPRESSION; INOSITOL 1,4,5-TRISPHOSPHATE; PROTEINS; RELEASE	Endogenous high-affinity Ca2+ buffering and its roles were investigated in mouse cerebellar Purkinje cells with the use of a low-affinity Ca2+ indicator and a high-affinity caged Ca2+ compound. Increases in the cytosolic Ca2+ concentration ([Ca2+](i)) were markedly facilitated during repetitive depolarization, resulting in the generation of steep micromolar Ca2+ gradients along dendrites. Such supralinear Ca2+ responses were attributed to the saturation of a large concentration (0.36 mM) of a mobile, high-affinity (dissociation constant, 0.37 mu M) Ca2+ buffer with cooperative Ca2+ binding sites, resembling calbindin-D-28K, and to an immobile, low-affinity Ca2+ buffer. These data suggest that the high-affinity Ca2+ buffer operates as the neuronal computational element that enables efficient coincidence detection of the Ca2+ signal and that facilitates spatiotemporal integration of the Ca2+ signal at submicromolar [Ca2+](i).	Univ Tokyo, Fac Med, Dept Physiol, Bunkyo Ku, Tokyo 113, Japan; Natl Inst Physiol Sci, Okazaki, Aichi 444, Japan; Med Coll Penn & Hahnemann Univ, Dept Pharmacol & Physiol, Philadelphia, PA 19129 USA	University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Drexel University	Kasai, H (corresponding author), Univ Tokyo, Fac Med, Dept Physiol, Bunkyo Ku, Tokyo 113, Japan.		Miyashita, Yasushi/B-7171-2019	Miyashita, Yasushi/0000-0003-3496-8637; Kasai, Haruo/0000-0003-2327-9027				AHMED Z, 1988, CELL CALCIUM, V9, P57, DOI 10.1016/0143-4160(88)90025-5; Airaksinen MS, 1997, EUR J NEUROSCI, V9, P120, DOI 10.1111/j.1460-9568.1997.tb01360.x; Airaksinen MS, 1997, P NATL ACAD SCI USA, V94, P1488, DOI 10.1073/pnas.94.4.1488; ALBALDAWI NF, 1995, CELL CALCIUM, V17, P422, DOI 10.1016/0143-4160(95)90088-8; ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; Arnold DB, 1997, P NATL ACAD SCI USA, V94, P8842, DOI 10.1073/pnas.94.16.8842; BAIMBRIDGE KG, 1982, BRAIN RES, V239, P519, DOI 10.1016/0006-8993(82)90526-1; BAKER PF, 1978, J PHYSIOL-LONDON, V276, P103, DOI 10.1113/jphysiol.1978.sp012222; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; CALVET MC, 1985, BRAIN RES, V331, P235, DOI 10.1016/0006-8993(85)91549-5; CHARD PS, 1993, J PHYSIOL-LONDON, V472, P341, DOI 10.1113/jphysiol.1993.sp019950; CHEUNG WT, 1993, EUR J BIOCHEM, V215, P401, DOI 10.1111/j.1432-1033.1993.tb18047.x; DelPrincipe F, 1999, CELL CALCIUM, V25, P85, DOI 10.1054/ceca.1998.0009; EILERS J, 1995, NATURE, V373, P155, DOI 10.1038/373155a0; EILERS J, 1995, P NATL ACAD SCI USA, V92, P10272, DOI 10.1073/pnas.92.22.10272; EKEROT CF, 1989, NEUROSCI RES, V6, P264, DOI 10.1016/0168-0102(89)90065-5; Ellis-Davies GCR, 1998, TETRAHEDRON LETT, V39, P953, DOI 10.1016/S0040-4039(97)10668-2; FALKE JJ, 1994, Q REV BIOPHYS, V27, P219, DOI 10.1017/S0033583500003012; Fierro L, 1998, J PHYSIOL-LONDON, V510, P499, DOI 10.1111/j.1469-7793.1998.499bk.x; Fierro L, 1996, J PHYSIOL-LONDON, V496, P617, DOI 10.1113/jphysiol.1996.sp021713; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Gabso M, 1997, NEURON, V18, P473, DOI 10.1016/S0896-6273(00)81247-7; Hartell NA, 1996, NEURON, V16, P601, DOI 10.1016/S0896-6273(00)80079-3; Hashimoto T, 1996, J PHYSIOL-LONDON, V497, P611, DOI 10.1113/jphysiol.1996.sp021794; HEIZMANN CW, 1992, TRENDS NEUROSCI, V15, P259, DOI 10.1016/0166-2236(92)90067-I; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; HIRANO T, 1990, NEUROSCI LETT, V119, P145, DOI 10.1016/0304-3940(90)90819-U; HIRANO T, 1986, P NATL ACAD SCI USA, V83, P1945, DOI 10.1073/pnas.83.6.1945; Hirose K, 1998, J PHYSIOL-LONDON, V506, P407, DOI 10.1111/j.1469-7793.1998.407bw.x; HOCKBERGER PE, 1989, J NEUROSCI, V9, P2272; HOUNSGAARD J, 1989, J PHYSIOL-LONDON, V409, P157, DOI 10.1113/jphysiol.1989.sp017490; Ito K, 1999, J CELL BIOL, V146, P405, DOI 10.1083/jcb.146.2.405; Ito K, 1997, EMBO J, V16, P242, DOI 10.1093/emboj/16.2.242; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; Kaftan EJ, 1997, J GEN PHYSIOL, V110, P529, DOI 10.1085/jgp.110.5.529; KANO M, 1995, J PHYSIOL-LONDON, V487, P1; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; Kasai H, 1999, PHILOS T ROY SOC B, V354, P331, DOI 10.1098/rstb.1999.0384; KASAI H, 1994, TRENDS NEUROSCI, V17, P95, DOI 10.1016/0166-2236(94)90112-0; KASAI H, 1993, NEUROSCI RES, V16, P1, DOI 10.1016/0168-0102(93)90002-8; KOBAYASHI K, 1995, J PHYSIOL-LONDON, V483, P79, DOI 10.1113/jphysiol.1995.sp020569; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; KOSAKA T, 1993, EXP BRAIN RES, V93, P483; LevRam V, 1997, NEURON, V18, P1025, DOI 10.1016/S0896-6273(00)80340-2; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; Linden DJ, 1999, NEURON, V22, P661, DOI 10.1016/S0896-6273(00)80726-6; LLANO I, 1994, NEURON, V12, P663, DOI 10.1016/0896-6273(94)90221-6; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; Markram H, 1998, J COMPUT NEUROSCI, V5, P331, DOI 10.1023/A:1008891229546; MATTSON MP, 1991, NEURON, V6, P41, DOI 10.1016/0896-6273(91)90120-O; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; MIYAKAWA H, 1992, J NEUROPHYSIOL, V68, P1178, DOI 10.1152/jn.1992.68.4.1178; Molinari S, 1996, P NATL ACAD SCI USA, V93, P8028, DOI 10.1073/pnas.93.15.8028; MULLER TH, 1993, PFLUG ARCH EUR J PHY, V425, P499, DOI 10.1007/BF00374877; Naraghi M, 1998, BIOPHYS J, V75, P1635, DOI 10.1016/S0006-3495(98)77606-4; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; NEHER E, 1995, NEUROPHARMACOLOGY, V34, P1423, DOI 10.1016/0028-3908(95)00144-U; Neher E, 1998, CELL CALCIUM, V24, P345, DOI 10.1016/S0143-4160(98)90058-6; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Ninomiya Y, 1997, EMBO J, V16, P929, DOI 10.1093/emboj/16.5.929; PUSH M, 1988, PFLUGERS ARCH, V411, P204; ROBERTS WM, 1993, NATURE, V363, P74, DOI 10.1038/363074a0; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; SCHNEGGENBURGER R, 1993, NEURON, V11, P133, DOI 10.1016/0896-6273(93)90277-X; Schwiening CJ, 1996, J PHYSIOL-LONDON, V491, P621, DOI 10.1113/jphysiol.1996.sp021244; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; SOBEL EC, 1994, SCIENCE, V263, P823, DOI 10.1126/science.263.5148.823; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; TATSUMI H, 1993, J PHYSIOL-LONDON, V464, P165, DOI 10.1113/jphysiol.1993.sp019628; TSE A, 1994, J PHYSIOL-LONDON, V477, P511, DOI 10.1113/jphysiol.1994.sp020212; WANG SSH, 1995, NEURON, V15, P755, DOI 10.1016/0896-6273(95)90167-1; Xu T, 1997, BIOPHYS J, V73, P532, DOI 10.1016/S0006-3495(97)78091-3; YAMAKUNI T, 1987, J NEUROCHEM, V48, P1590, DOI 10.1111/j.1471-4159.1987.tb05706.x; ZADOR A, 1994, J NEUROSCI, V14, P4705; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813	76	100	102	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1999	24	4					989	1002		10.1016/S0896-6273(00)81045-4	http://dx.doi.org/10.1016/S0896-6273(00)81045-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	269UE	10624961	Bronze			2022-12-24	WOS:000084495300026
J	Ringstad, N; Gad, H; Low, P; Di Paolo, G; Brodin, L; Shupliakov, O; De Camilli, P				Ringstad, N; Gad, H; Low, P; Di Paolo, G; Brodin, L; Shupliakov, O; De Camilli, P			Endophilin/SH3p4 is required for the transition from early to late stages in clathrin-mediated synaptic vesicle endocytosis	NEURON			English	Article							TRANSMITTER RELEASE; COATED VESICLES; ALPHA-ADAPTIN; DYNAMIN; PROTEINS; BINDING; DOMAIN; SYNAPTOJANIN; AMPHIPHYSIN; MEMBRANE	Endophilin/SH3p4 is a protein highly enriched in nerve terminals that binds the GTPase dynamin and the polyphosphoinositide phosphatase synaptojanin, two proteins implicated in synaptic vesicle endocytosis. We show here that antibody-mediated disruption of endophilin function in a tonically stimulated synapse leads to a block in the invagination of clathrin-coated pits adjacent to the active zone and therefore to a block of synaptic vesicle recycling. Mle also show that in a cell-free system, endophilin is not associated with clathrin coats and is a functional partner of dynamin. Our findings suggest that endophilin is part of a biochemical machinery that acts in trans to the clathrin coat from early stages to vesicle fission.	Karolinska Inst, Dept Neurosci, Nobel Inst Neurophysiol, S-17177 Stockholm, Sweden; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA	Karolinska Institutet; Howard Hughes Medical Institute; Yale University; Yale University	Shupliakov, O (corresponding author), Karolinska Inst, Dept Neurosci, Nobel Inst Neurophysiol, S-17177 Stockholm, Sweden.		Shupliakov, Oleg/R-9148-2016; Gad, Helge/J-2238-2014	Shupliakov, Oleg/0000-0001-5352-6848; Gad, Helge/0000-0001-6530-1443	NCI NIH HHS [CA46128] Funding Source: Medline; NIGMS NIH HHS [T32GM07527] Funding Source: Medline; NINDS NIH HHS [NS36251] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA046128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036251] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baba T, 1999, J HISTOCHEM CYTOCHEM, V47, P637, DOI 10.1177/002215549904700506; BALL CL, 1995, J CELL SCI, V108, P2865; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331; DECAMILLI P, 1983, J CELL BIOL, V96, P1355, DOI 10.1083/jcb.96.5.1355; deHeuvel E, 1997, J BIOL CHEM, V272, P8710, DOI 10.1074/jbc.272.13.8710; Faundez V, 1998, CELL, V93, P423, DOI 10.1016/S0092-8674(00)81170-8; Gad H, 1998, NEURON, V21, P607, DOI 10.1016/S0896-6273(00)80570-X; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Guo SL, 1999, J BIOL CHEM, V274, P12990, DOI 10.1074/jbc.274.19.12990; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; HEUSER J, 1980, J CELL BIOL, V84, P560, DOI 10.1083/jcb.84.3.560; HEUSER J, 1989, J CELL BIOL, V108, P401, DOI 10.1083/jcb.108.2.401; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; KIRCHHAUSEN T, 1981, CELL, V23, P755, DOI 10.1016/0092-8674(81)90439-6; KOENIG JH, 1989, J NEUROSCI, V9, P3844; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Micheva KD, 1997, J BIOL CHEM, V272, P27239, DOI 10.1074/jbc.272.43.27239; PFEFFER SR, 1985, CELL, V40, P949, DOI 10.1016/0092-8674(85)90355-1; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; Qualmann B, 1999, MOL BIOL CELL, V10, P501, DOI 10.1091/mbc.10.2.501; Raucher D, 1999, J CELL BIOL, V144, P497, DOI 10.1083/jcb.144.3.497; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; SHUPLIAKOV O, 1995, EUR J NEUROSCI, V7, P1111, DOI 10.1111/j.1460-9568.1995.tb01099.x; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Smith CJ, 1998, EMBO J, V17, P4943, DOI 10.1093/emboj/17.17.4943; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; ter Haar E, 1998, CELL, V95, P563, DOI 10.1016/S0092-8674(00)81623-2; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9	40	258	263	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	1999	24	1					143	154		10.1016/S0896-6273(00)80828-4	http://dx.doi.org/10.1016/S0896-6273(00)80828-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241QC	10677033	Bronze			2022-12-24	WOS:000082893200015
J	Suh, JH; Lu, NR; Nicot, A; Tatsuno, I; DiCicco-Bloom, E				Suh, JH; Lu, NR; Nicot, A; Tatsuno, I; DiCicco-Bloom, E			PACAP is an anti-mitogenic signal in developing cerebral cortex	NATURE NEUROSCIENCE			English	Article							FIBROBLAST-GROWTH-FACTOR; RECEPTOR; EXPRESSION; NEUROGENESIS; SYSTEM; MICE		Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; Chiba Univ, Sch Med, Dept Internal Med 2, Chuou Ku, Chiba 2608670, Japan	Rutgers State University New Brunswick; Rutgers State University Medical Center; Chiba University	DiCicco-Bloom, E (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, 675 Hoes Lane, Piscataway, NJ 08854 USA.		Nicot, Arnaud/L-8898-2016	Nicot, Arnaud/0000-0003-2695-3304	NINDS NIH HHS [R01 NS32401] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032401] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; DiCicco-Bloom E, 2000, DEV BIOL, V219, P197, DOI 10.1006/dbio.2000.9604; DRAGO J, 1991, P NATL ACAD SCI USA, V88, P2199, DOI 10.1073/pnas.88.6.2199; GHOSH A, 1995, NEURON, V15, P89, DOI 10.1016/0896-6273(95)90067-5; Lu NR, 1997, P NATL ACAD SCI USA, V94, P3357, DOI 10.1073/pnas.94.7.3357; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Moro O, 1999, J BIOL CHEM, V274, P23103, DOI 10.1074/jbc.274.33.23103; Sheward WJ, 1996, NEUROSCI LETT, V216, P45; Takahashi T, 1996, J NEUROSCI, V16, P6183; TATSUNO I, 1994, PEPTIDES, V15, P55, DOI 10.1016/0196-9781(94)90170-8; Vaccarino FM, 1999, NAT NEUROSCI, V2, P246, DOI 10.1038/6350; Waschek JA, 1998, P NATL ACAD SCI USA, V95, P9602, DOI 10.1073/pnas.95.16.9602	12	109	110	1	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2001	4	2					123	124		10.1038/83936	http://dx.doi.org/10.1038/83936			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UC	11175869				2022-12-24	WOS:000167178100007
J	Llano, I; Gonzalez, J; Caputo, C; Lai, FA; Blayney, LM; Tan, YP; Marty, A				Llano, I; Gonzalez, J; Caputo, C; Lai, FA; Blayney, LM; Tan, YP; Marty, A			Presynaptic calcium stores underlie large-amplitude miniature IPSCs and spontaneous calcium transients	NATURE NEUROSCIENCE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; CEREBELLAR PURKINJE-CELLS; CA2+ RELEASE CHANNELS; SYNAPTIC-TRANSMISSION; RYANODINE RECEPTOR; IMMUNOHISTOCHEMICAL LOCALIZATION; NEUROTRANSMITTER RELEASE; QUANTAL ANALYSIS; MUSCLE; TERMINALS	The cellular mechanisms responsible for large miniature currents in some brain synapses remain undefined. In Purkinje cells, we found that large-amplitude miniature inhibitory postsynaptic currents (mIPSCs) were inhibited by ryanodine or by long-term removal of extracellular Ca2+. Two-photon Ca2+ imaging revealed random, ryanodine-sensitive intracellular Ca2+ transients, spatially constrained at putative presynaptic terminals. At high concentration, ryanodine decreased action-potential-evoked rises in intracellular Ca2+. Immuno-localization showed ryanodine receptors in these terminals. Our data suggest that large mIPSCs are multivesicular events regulated by Ca2+ release from ryanodine-sensitive presynaptic Ca2+ stores.	Max Planck Inst Biophys Chem, Arbeitsgrp Zellulare Neurobiol, D-37077 Gottingen, Germany; Inst Venezolano Invest Cient, Ctr Biofis, Caracas 1020A, Venezuela; Univ Wales Coll Cardiff, Div Med Cardiol, Cardiff CF4 4XN, S Glam, Wales; Bogazici Univ, Istanbul, Turkey	Max Planck Society; Venezuelan Institute Science Research; Cardiff University; Bogazici University	Llano, I (corresponding author), Max Planck Inst Biophys Chem, Arbeitsgrp Zellulare Neurobiol, D-37077 Gottingen, Germany.	illano@gwdg.de		Lai, Tony/0000-0003-2852-8547				ANDERSON K, 1989, J BIOL CHEM, V264, P1329; Auger C, 1997, NEURON, V19, P139, DOI 10.1016/S0896-6273(00)80354-2; Bekkers John M., 1994, Current Opinion in Neurobiology, V4, P360, DOI 10.1016/0959-4388(94)90097-3; BENNETT MR, 1995, PROG NEUROBIOL, V46, P331, DOI 10.1016/0301-0082(94)00061-L; BERRIDGE MJ, 1996, RYANODINE RECEPTORS, P120; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; Bureau I, 1998, J PHYSIOL-LONDON, V509, P817, DOI 10.1111/j.1469-7793.1998.817bm.x; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Forti L, 2000, J PHYSIOL-LONDON, V527, P33, DOI 10.1111/j.1469-7793.2000.00033.x; Frerking M, 1997, J NEUROPHYSIOL, V78, P1293, DOI 10.1152/jn.1997.78.3.1293; Glitsch M, 1999, J NEUROSCI, V19, P511; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; KATZ B, 1969, SHERRINGTON LECTURES, P1; Koizumi S, 1999, NEURON, V22, P125, DOI 10.1016/S0896-6273(00)80684-4; Kondo S, 1997, J PHYSIOL-LONDON, V498, P165, DOI 10.1113/jphysiol.1997.sp021849; Krizaj D, 1999, J NEUROSCI, V19, P7249, DOI 10.1523/JNEUROSCI.19-17-07249.1999; KUWAJIMA G, 1992, NEURON, V9, P1133, DOI 10.1016/0896-6273(92)90071-K; Lacampagne A, 1999, J GEN PHYSIOL, V113, P187, DOI 10.1085/jgp.113.2.187; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; LLANO I, 1994, NEURON, V12, P663, DOI 10.1016/0896-6273(94)90221-6; Llano I, 1997, J PHYSIOL-LONDON, V502, P509, DOI 10.1111/j.1469-7793.1997.509bj.x; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; Mackrill JJ, 1997, BIOCHEM J, V327, P251, DOI 10.1042/bj3270251; MACONOCHIE DJ, 1994, NEURON, V12, P61, DOI 10.1016/0896-6273(94)90152-X; MEISSNER G, 1989, J BIOL CHEM, V264, P1715; Mothet JP, 1998, J PHYSIOL-LONDON, V507, P405, DOI 10.1111/j.1469-7793.1998.405bt.x; NAKANISHI S, 1991, J NEUROSCI, V11, P2075; Narita K, 2000, J GEN PHYSIOL, V115, P519, DOI 10.1085/jgp.115.4.519; Narita K, 1998, J GEN PHYSIOL, V112, P593, DOI 10.1085/jgp.112.5.593; Niggli E, 1999, ANNU REV PHYSIOL, V61, P311, DOI 10.1146/annurev.physiol.61.1.311; Palay S. L., 1974, CEREBELLAR CORTEX CY; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; PENG YW, 1991, NEURON, V6, P525, DOI 10.1016/0896-6273(91)90055-5; Peng YY, 1996, J NEUROSCI, V16, P6703; Pouzat C, 1999, J NEUROSCI, V19, P1675; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; Rios E, 1997, ANNU REV BIOPH BIOM, V26, P47, DOI 10.1146/annurev.biophys.26.1.47; Savic N, 1998, EUR J NEUROSCI, V10, P3379, DOI 10.1046/j.1460-9568.1998.00342.x; Sellin LC, 1996, PFLUG ARCH EUR J PHY, V431, P325, DOI 10.1007/BF02207269; SHARP AH, 1993, J NEUROSCI, V13, P3051; Smith AB, 1996, J PHYSIOL-LONDON, V497, P657, DOI 10.1113/jphysiol.1996.sp021797; STELZER A, 1988, SCIENCE, V241, P339, DOI 10.1126/science.2455347; Tan YP, 1999, J PHYSIOL-LONDON, V520, P65, DOI 10.1111/j.1469-7793.1999.00065.x; Tan YP, 1999, J NEUROSCI METH, V92, P123, DOI 10.1016/S0165-0270(99)00103-X; Tunwell REA, 1996, BIOCHEM J, V318, P477, DOI 10.1042/bj3180477; Vincent P, 1996, J PHYSIOL-LONDON, V494, P183, DOI 10.1113/jphysiol.1996.sp021484; Walliser B, 1998, J EVOL ECON, V8, P67, DOI 10.1007/s001910050056; YOSHIDA S, 1994, CELL MOL NEUROBIOL, V14, P227, DOI 10.1007/BF02088322	49	319	325	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2000	3	12					1256	1265		10.1038/81781	http://dx.doi.org/10.1038/81781			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UA	11100146	Bronze			2022-12-24	WOS:000167177900011
J	Harris, RA; O'Carroll, DC; Laughlin, SB				Harris, RA; O'Carroll, DC; Laughlin, SB			Contrast gain reduction in fly motion adaptation	NEURON			English	Article							CAT STRIATE CORTEX; DIRECTION-SELECTIVE ADAPTATION; FIGURE-GROUND DISCRIMINATION; RECEPTIVE-FIELD ORGANIZATION; SENSITIVE NEURON H-1; OPTIC FLOW STIMULI; VISUAL INTERNEURONS; RESPONSE SELECTIVITY; OPTOMOTOR SYSTEM; COMPLEX CELLS	In many species, including humans, exposure to high image velocities induces motion adaptation, but the neural mechanisms are unclear. We have isolated two mechanisms that act on directionally selective motion-sensitive neurons in the fly's visual system. Both are driven strongly by movement and weakly, if at all, by flicker. The first mechanism, a subtractive process, is directional and is only activated by stimuli that excite the neuron. The second, a reduction in contrast gain, is strongly recruited by motion in any direction, even if the adapting stimulus does not excite the cell. These mechanisms are well designed to operate effectively within the context of motion coding. They can prevent saturation at susceptible nonlinear stages in processing, cope with rapid changes in direction, and preserve fine structure within receptive fields.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Laughlin, SB (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.		O'Carroll, David C/C-4320-2008	O'Carroll, David C/0000-0002-2352-4320; Laughlin, Simon/0000-0003-4659-6543				BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Bex PJ, 1999, J OPT SOC AM A, V16, P2817, DOI 10.1364/JOSAA.16.002817; BORST A, 1995, J COMPUT NEUROSCI, V2, P5, DOI 10.1007/BF00962705; BORST A, 1987, BIOL CYBERN, V56, P209, DOI 10.1007/BF00365215; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Buchner E, 1984, PHOTORECEPTION VISIO; Clifford CWG, 1997, VISUAL NEUROSCI, V14, P741, DOI 10.1017/S0952523800012694; Clifford CWG, 1996, CURR BIOL, V6, P1340, DOI 10.1016/S0960-9822(02)70721-5; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1346, DOI 10.1152/jn.1991.65.6.1346; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; DURR V, 1998, THESIS U BIELEFELD G; Edwards A.L., 1976, INTRO LINEAR REGRESS; EGELHAAF M, 1995, J NEUROPHYSIOL, V73, P2540, DOI 10.1152/jn.1995.73.6.2540; EGELHAAF M, 1985, BIOL CYBERN, V52, P123, DOI 10.1007/BF00364003; GIASCHI D, 1993, J NEUROPHYSIOL, V70, P2024, DOI 10.1152/jn.1993.70.5.2024; Haag J, 1996, NATURE, V379, P639, DOI 10.1038/379639a0; HAMMOND P, 1985, EXP BRAIN RES, V60, P411; Harris RA, 1999, VISION RES, V39, P2603, DOI 10.1016/S0042-6989(98)00297-1; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; HAUSEN K, 1982, BIOL CYBERN, V46, P67, DOI 10.1007/BF00335352; HAUSEN K, 1993, VISUAL MOTION ITS RO; Hausen K, 1989, FACETS VISION; Ibbotson MR, 1998, J NEUROPHYSIOL, V79, P1481, DOI 10.1152/jn.1998.79.3.1481; Krapp HG, 1998, J NEUROPHYSIOL, V79, P1902, DOI 10.1152/jn.1998.79.4.1902; Krapp HG, 1996, NATURE, V384, P463, DOI 10.1038/384463a0; KRAPP HG, 1999, INT REV NEUROBIOLOGY, V44; LAUGHLIN SB, 1994, PROG RETIN EYE RES, V13, P165, DOI 10.1016/1350-9462(94)90009-4; MADDESS T, 1986, PROC R SOC SER B-BIO, V228, P433, DOI 10.1098/rspb.1986.0062; MADDESS T, 1985, PROC R SOC SER B-BIO, V225, P251, DOI 10.1098/rspb.1985.0061; MAFFEI L, 1973, SCIENCE, V182, P1036, DOI 10.1126/science.182.4116.1036; MARLIN SG, 1988, J NEUROPHYSIOL, V59, P1314, DOI 10.1152/jn.1988.59.4.1314; MATHER G, 1998, MOTION AFTER EFFECT; MULLER R, 1994, VISION RES, V34, P2071, DOI 10.1016/0042-6989(94)90318-2; OCarroll DC, 1997, VISION RES, V37, P3427, DOI 10.1016/S0042-6989(97)00170-3; REICHARDT W, 1983, BIOL CYBERN, V46, P1, DOI 10.1007/BF00595226; Reichardt W., 1961, S PRINC SENS COMM 19, P302; Shapley R, 1984, PROG RETIN RES, V3, P263, DOI DOI 10.1016/0278-4327(84)90011-7; Single S, 1997, J NEUROSCI, V17, P6023; SRINIVASAN MV, 1979, VISION RES, V19, P1435, DOI 10.1016/0042-6989(79)90220-7; STONE LS, 1992, VISION RES, V32, P1535, DOI 10.1016/0042-6989(92)90209-2; THOMPSON P, 1981, VISION RES, V21, P337, DOI 10.1016/0042-6989(81)90161-9; THOMPSON P, 1982, VISION RES, V22, P377, DOI 10.1016/0042-6989(82)90153-5; VANSANTEN JPH, 1985, J OPT SOC AM A, V2, P300, DOI 10.1364/JOSAA.2.000300; VANSTEVENINCK RRD, 1986, BIOL CYBERN, V54, P223, DOI 10.1007/BF00318418; VAUTIN RG, 1977, J NEUROPHYSIOL, V40, P1051, DOI 10.1152/jn.1977.40.5.1051; VONDERHEYDT R, 1978, ARCH ITAL BIOL, V116, P248; WOLFOBERHOLLENZER F, 1994, J NEUROPHYSIOL, V71, P1559, DOI 10.1152/jn.1994.71.4.1559	47	118	118	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	2000	28	2					595	606		10.1016/S0896-6273(00)00136-7	http://dx.doi.org/10.1016/S0896-6273(00)00136-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	377CE	11144367	Bronze			2022-12-24	WOS:000165493700032
J	Kikuchi-Yorioka, Y; Sawaguchi, T				Kikuchi-Yorioka, Y; Sawaguchi, T			Parallel visuospatial and audiospatial working memory processes in the monkey dorsolateral prefrontal cortex	NATURE NEUROSCIENCE			English	Article							FRONTAL-CORTEX; NEURONS; LOCALIZATION; TASK		Hokkaido Univ, Sch Med, Neurobiol Lab, Kita Ku, Sapporo, Hokkaido 0608638, Japan; Hokkaido Univ, Dept Psychol, Kita Ku, Sapporo, Hokkaido 0600810, Japan	Hokkaido University; Hokkaido University	Sawaguchi, T (corresponding author), Hokkaido Univ, Sch Med, Neurobiol Lab, Kita Ku, N15 W7, Sapporo, Hokkaido 0608638, Japan.			Kikuchi, Yukiko/0000-0002-0365-0397				AZUMA M, 1984, BRAIN RES, V298, P343, DOI 10.1016/0006-8993(84)91434-3; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; Bushara KO, 1999, NAT NEUROSCI, V2, P759, DOI 10.1038/11239; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; CHAVIS DA, 1976, BRAIN RES, V117, P369, DOI 10.1016/0006-8993(76)90089-5; FUNAHASHI S, 1990, J NEUROPHYSIOL, V63, P814, DOI 10.1152/jn.1990.63.4.814; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Fuster J.M., 1989, PREFRONTAL CORTEX; Fuster JM, 2000, NATURE, V405, P347, DOI 10.1038/35012613; Goldman-Rakic P. S., 2011, COMPR PHYSIOL, DOI [10.1002/CPHY.CP010509, DOI 10.1002/CPHY.CP010509]; Mazzoni P, 1996, J NEUROPHYSIOL, V75, P1233, DOI 10.1152/jn.1996.75.3.1233; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Sawaguchi T, 1999, J NEUROPHYSIOL, V82, P2070, DOI 10.1152/jn.1999.82.5.2070; VAADIA E, 1986, J NEUROPHYSIOL, V56, P934, DOI 10.1152/jn.1986.56.4.934	15	41	43	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11					1075	1076		10.1038/80581	http://dx.doi.org/10.1038/80581			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TX	11036261				2022-12-24	WOS:000167177600009
J	Orger, MB; Smear, MC; Anstis, SM; Baier, H				Orger, MB; Smear, MC; Anstis, SM; Baier, H			Perception of Fourier and non-Fourier motion by larval zebrafish	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; 2ND-ORDER MOTION; VISUAL-CORTEX; BEHAVIORAL SCREEN; DANIO-RERIO; CONTRAST; MECHANISMS; LUMINANCE; REVERSAL; MOVEMENT	A moving grating elicits innate optomotor behavior in zebrafish larvae; they swim in the direction of perceived motion. We took advantage of this behavior, using computer-animated displays, to del:ermine what attributes of motion are extracted by the fish visual system. As in humans, first-order (luminance-defined or Fourier) signals dominated motion perception in fish; edges or other features had little or no effect when presented with these signals. Humans can see complex movements that lack first-order cues, an ability that is usually ascribed to higher-level processing in the visual cortex. Here we show that second-order (non-Fourier) motion displays induced optomotor behavior in zebrafish larvae, which do not have a cortex. We suggest that second-order motion is extracted early in the lower vertebrate visual pathway.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA; Univ Calif San Francisco, Genet Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Human Genet, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Dev Biol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Diego; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Baier, H (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444,Room S762,513 Parnassus, San Francisco, CA 94143 USA.			Orger, Michael/0000-0002-9763-8902				ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; ALBRIGHT TD, 1992, SCIENCE, V255, P1141, DOI 10.1126/science.1546317; ANSTIS SM, 1970, VISION RES, V10, P1411, DOI 10.1016/0042-6989(70)90092-1; ANSTIS SM, 1975, VISION RES, V15, P957, DOI 10.1016/0042-6989(75)90236-9; Baier H, 1996, DEVELOPMENT, V123, P415; Baker CL, 1999, CURR OPIN NEUROBIOL, V9, P461, DOI 10.1016/S0959-4388(99)80069-5; BROCKERHOFF SE, 1995, P NATL ACAD SCI USA, V92, P10545, DOI 10.1073/pnas.92.23.10545; CAVANAGH P, 1989, Spatial Vision, V4, P103, DOI 10.1163/156856889X00077; CHUBB C, 1989, P NATL ACAD SCI USA, V86, P2985, DOI 10.1073/pnas.86.8.2985; CHUBB C, 1988, J OPT SOC AM A, V5, P1986, DOI 10.1364/JOSAA.5.001986; Clark DT, 1981, VISUAL RESPONSES DEV; Demb JB, 1999, J NEUROSCI, V19, P9756; DERRINGTON AM, 1993, CURR BIOL, V3, P800, DOI 10.1016/0960-9822(93)90037-O; Driever W, 1996, DEVELOPMENT, V123, P37; Easter SS, 1996, DEV BIOL, V180, P646; Haffter P, 1996, DEVELOPMENT, V123, P1; HAMMETT ST, 1993, VISION RES, V33, P1119, DOI 10.1016/0042-6989(93)90245-R; Neuhauss SCF, 1999, J NEUROSCI, V19, P8603; Nieder A, 1999, NAT NEUROSCI, V2, P660, DOI 10.1038/10217; Ohzawa I, 1999, NAT NEUROSCI, V2, P586, DOI 10.1038/10135; RAMACHAN.VS, 1973, VISION RES, V13, P1399, DOI 10.1016/0042-6989(73)90219-8; REICHARDT W, 1957, Z NATURFORSCH 2B, V12, P447, DOI DOI 10.1515/ZNB-1957-0707; Scott-Samuel NE, 1999, VISION RES, V39, P2853, DOI 10.1016/S0042-6989(98)00316-2; SHAPLEY RM, 1978, J PHYSIOL-LONDON, V285, P275, DOI 10.1113/jphysiol.1978.sp012571; Smith AT, 1997, VISION RES, V37, P45, DOI 10.1016/S0042-6989(96)00147-2; Smith AT, 1998, J NEUROSCI, V18, P3816; WILSON HR, 1992, VISUAL NEUROSCI, V9, P79, DOI 10.1017/S0952523800006386; ZHOU YX, 1993, SCIENCE, V261, P98, DOI 10.1126/science.8316862	28	130	131	0	27	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11					1128	1133		10.1038/80649	http://dx.doi.org/10.1038/80649			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TX	11036270				2022-12-24	WOS:000167177600018
J	Takahashi, M; Dore, S; Ferris, CD; Tomita, T; Sawa, A; Wolosker, H; Borchelt, DR; Iwatsubo, T; Kim, SH; Thinakaran, G; Sisodia, SS; Snyder, SH				Takahashi, M; Dore, S; Ferris, CD; Tomita, T; Sawa, A; Wolosker, H; Borchelt, DR; Iwatsubo, T; Kim, SH; Thinakaran, G; Sisodia, SS; Snyder, SH			Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer's disease	NEURON			English	Article							TRANSGENIC MICE; OXIDATIVE STRESS; BETA-PROTEIN; IN-VITRO; MOLECULAR-CLONING; CARBON-MONOXIDE; EXPRESSION; BRAIN; IRON; TOXICITY	Amyloid precursor protein (APP) generates the beta -amyloid peptide, postulated to participate in the neurotoxicity of Alzheimer's disease. We report that APP and APLP bind to heme oxygenase (HO), an enzyme whose product, bilirubin, is antioxidant and neuroprotective. The binding of APP inhibits HO activity, and APP with mutations linked to the familiar Alzheimer's disease (FAD) provides substantially greater inhibition of HO activity than wild-type APP. Cortical cultures from transgenic mice expressing Swedish mutant APP have greatly reduced bilirubin levels, establishing that mutant APP inhibits HO activity in vivo. Oxidative neurotoxicity is markedly greater in cerebral cortical cultures from APP Swedish mutant transgenic mice than wild-type cultures. These findings indicate that augmented neurotoxicity caused by APP-HO interactions may contribute to neuronal cell death in Alzheimer's disease.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Anesthesiol Crit Care Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; Univ Tokyo, Fac Pharmaceut Sci, Dept Neuropathol & Neurosci, Tokyo 113, Japan; Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Tokyo; University of Chicago	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.		Dore, Sylvain/AAG-1470-2020; Tomita, Taisuke/L-5427-2015	Dore, Sylvain/0000-0003-3771-5109; Tomita, Taisuke/0000-0002-0075-5943; Wolosker, Herman/0000-0001-5508-9194	NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER; NIDA NIH HHS [DA-00266, DA 00074] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ABRAHAM NG, 1995, P NATL ACAD SCI USA, V92, P6798, DOI 10.1073/pnas.92.15.6798; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; BUSCIGLIO J, 1995, NATURE, V378, P776, DOI 10.1038/378776a0; Calhoun ME, 1998, NATURE, V395, P755, DOI 10.1038/27351; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; Crain BJ, 1996, AM J PATHOL, V149, P1087; Dennery PA, 1997, J BIOL CHEM, V272, P14937, DOI 10.1074/jbc.272.23.14937; Dennery PA, 1998, J CLIN INVEST, V101, P1001, DOI 10.1172/JCI448; Doan A, 1996, NEURON, V17, P1023, DOI 10.1016/S0896-6273(00)80232-9; Dore S, 1997, P NATL ACAD SCI USA, V94, P4772, DOI 10.1073/pnas.94.9.4772; Dore S, 1999, MOL MED, V5, P656, DOI 10.1007/BF03401984; Dore S, 1999, P NATL ACAD SCI USA, V96, P2445, DOI 10.1073/pnas.96.5.2445; DRUMMOND GS, 1981, P NATL ACAD SCI-BIOL, V78, P6466, DOI 10.1073/pnas.78.10.6466; Ferris CD, 1999, NAT CELL BIOL, V1, P152, DOI 10.1038/11072; Gabbita SP, 1998, J NEUROCHEM, V71, P2034, DOI 10.1046/j.1471-4159.1998.71052034.x; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GOOD PF, 1992, ANN NEUROL, V31, P286, DOI 10.1002/ana.410310310; Hansen TWR, 1999, MOL GENET METAB, V68, P404, DOI 10.1006/mgme.1999.2899; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Hardy J, 1997, P NATL ACAD SCI USA, V94, P2095, DOI 10.1073/pnas.94.6.2095; HARROW E, 1988, ANTIBODIES LAB MANUA, V1, P522; HINO Y, 1979, BIOCHEM J, V178, P331, DOI 10.1042/bj1780331; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kim SH, 2000, NEUROBIOL DIS, V7, P99, DOI 10.1006/nbdi.1999.0280; Lee PJ, 1996, P NATL ACAD SCI USA, V93, P10393, DOI 10.1073/pnas.93.19.10393; LOEFFLER DA, 1995, J NEUROCHEM, V65, P710; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; McNamara MJ, 1998, BRAIN RES, V804, P45, DOI 10.1016/S0006-8993(98)00653-2; Mucke L, 1996, ANN NY ACAD SCI, V777, P82, DOI 10.1111/j.1749-6632.1996.tb34405.x; OTTO JC, 1994, J BIOL CHEM, V269, P19868; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; Pappolla MA, 1998, AM J PATHOL, V152, P871; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; ROTENBERG MO, 1990, J BIOL CHEM, V265, P7501; Sawa A, 1997, MOL BRAIN RES, V48, P53, DOI 10.1016/S0169-328X(97)00078-8; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SCHIPPER HM, 1995, ANN NEUROL, V37, P758, DOI 10.1002/ana.410370609; Selkoe DJ, 1996, J BIOL CHEM, V271, P18295, DOI 10.1074/jbc.271.31.18295; SHIBAHARA S, 1985, P NATL ACAD SCI USA, V82, P7865, DOI 10.1073/pnas.82.23.7865; SLUNT HH, 1994, J BIOL CHEM, V269, P2637; SMITH JA, 1994, CURR PROT MOL BIOL, V1; Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x; Smith MA, 1996, NATURE, V382, P120, DOI 10.1038/382120b0; SMITH MA, 1994, AM J PATHOL, V145, P42; SPRECHER CA, 1993, BIOCHEMISTRY-US, V32, P4481, DOI 10.1021/bi00068a002; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; THINAKARAN G, 1995, J NEUROSCI, V15, P6314; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; VANLENTEN BJ, 1995, J CLIN INVEST, V95, P2104, DOI 10.1172/JCI117898; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Walensky LD, 1998, J CELL BIOL, V141, P143, DOI 10.1083/jcb.141.1.143; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758; White AR, 1998, J NEUROSCI, V18, P6207; Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4; YOSHIDA T, 1989, BIOCHEM BIOPH RES CO, V163, P1086, DOI 10.1016/0006-291X(89)92332-2; YOSHINAGA T, 1982, J BIOL CHEM, V257, P7778; YOUNKIN SG, 1995, ANN NEUROL, V37, P287, DOI 10.1002/ana.410370303; Zakhary R, 1996, P NATL ACAD SCI USA, V93, P795, DOI 10.1073/pnas.93.2.795; Zakhary R, 1997, P NATL ACAD SCI USA, V94, P14848, DOI 10.1073/pnas.94.26.14848; Zhang FY, 1997, J NEUROSCI, V17, P7655, DOI 10.1523/jneurosci.17-20-07655.1997; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	68	147	157	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	2000	28	2					461	473		10.1016/S0896-6273(00)00125-2	http://dx.doi.org/10.1016/S0896-6273(00)00125-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	377CE	11144356	Bronze			2022-12-24	WOS:000165493700021
J	Mansvelder, HD; McGehee, DS				Mansvelder, HD; McGehee, DS			Long-term potentiation of excitatory inputs to brain reward areas by nicotine	NEURON			English	Article							VENTRAL TEGMENTAL AREA; MIDBRAIN DOPAMINE NEURONS; RAT NUCLEUS-ACCUMBENS; FREELY MOVING RATS; METHYL-D-ASPARTATE; ACETYLCHOLINE-RECEPTORS; SYNAPTIC TRANSMISSION; NMDA RECEPTORS; RELEASE; SYSTEM	Nicotine reinforces smoking behavior by activating nicotinic acetylcholine receptors (nAChRs) in the mid-brain dopaminergic (DA) reward centers, including the ventral tegmental area (VTA). Although nicotine induces prolonged excitation of the VTA in vivo, the nAChRs on the DA neurons desensitize in seconds. Here, we show that activation of nAChRs on presynaptic terminals in the VTA enhances glutamatergic inputs to DA neurons. Under conditions where the released glutamate can activate NMDA receptors, long-term potentiation (LTP) of the excitatory inputs is induced. Both the short- and the long-term effects of nicotine required activation of presynaptic alpha 7 subunit-containing nAChRs. These results can explain the long-term excitation of brain reward areas induced by a brief nicotine exposure. They also show that nicotine alters synaptic function through mechanisms that are linked to learning and memory.	Univ Chicago, Dept Anesthesia & Crit Care, Whitman Lab, Chicago, IL 60637 USA	University of Chicago	McGehee, DS (corresponding author), Univ Chicago, Dept Anesthesia & Crit Care, Whitman Lab, Box 428, Chicago, IL 60637 USA.		Mansvelder, Huibert/N-6138-2018	Mansvelder, Huibert/0000-0003-1365-5340	NINDS NIH HHS [NS 35090] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035090] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBUQUERQUE EX, 1995, SEMIN NEUROSCI, V7, P91, DOI 10.1006/smns.1995.0011; Alkondon M, 1996, J PHARMACOL EXP THER, V278, P1460; ALKONDON M, 1993, J PHARMACOL EXP THER, V265, P1455; Aramakis VB, 1998, J NEUROSCI, V18, P8485; Bonci A, 1999, J NEUROSCI, V19, P3723; Broide RS, 1999, MOL NEUROBIOL, V20, P1, DOI 10.1007/BF02741361; CALABRESI P, 1989, BRIT J PHARMACOL, V98, P135, DOI 10.1111/j.1476-5381.1989.tb16873.x; CHARLETY PJ, 1991, ACTA PHYSIOL SCAND, V142, P105, DOI 10.1111/j.1748-1716.1991.tb09134.x; CHERGUI K, 1993, EUR J NEUROSCI, V5, P137, DOI 10.1111/j.1460-9568.1993.tb00479.x; CLARKE PBS, 1993, PROG BRAIN RES, V98, P77; CORRIGALL WA, 1994, BRAIN RES, V653, P278, DOI 10.1016/0006-8993(94)90401-4; CORRIGALL WA, 1991, PSYCHOPHARMACOLOGY, V104, P171, DOI 10.1007/BF02244174; Dani JA, 1996, NEURON, V16, P905, DOI 10.1016/S0896-6273(00)80112-9; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Drisdel RC, 2000, J NEUROSCI, V20, P133, DOI 10.1523/JNEUROSCI.20-01-00133.2000; Fujii S, 1999, BRAIN RES, V846, P137, DOI 10.1016/S0006-8993(99)01982-4; Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0; HENNINGFIELD JE, 1993, DRUG ALCOHOL DEPEN, V33, P23, DOI 10.1016/0376-8716(93)90030-T; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; IMPERATO A, 1986, EUR J PHARMACOL, V132, P337, DOI 10.1016/0014-2999(86)90629-1; JOHNSON SW, 1992, SCIENCE, V258, P665, DOI 10.1126/science.1329209; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; KALIVAS PW, 1989, J PHARMACOL EXP THER, V251, P378; KOOB GF, 1992, TRENDS PHARMACOL SCI, V13, P177, DOI 10.1016/0165-6147(92)90060-J; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; MERCURI NB, 1995, EUR J NEUROSCI, V7, P462, DOI 10.1111/j.1460-9568.1995.tb00342.x; MURASE S, 1993, NEUROSCI LETT, V157, P53, DOI 10.1016/0304-3940(93)90641-W; NESTLER EJ, 1992, J NEUROSCI, V12, P2439; NISELL M, 1994, SYNAPSE, V16, P36, DOI 10.1002/syn.890160105; Overton PG, 1999, NEUROREPORT, V10, P221, DOI 10.1097/00001756-199902050-00004; Peto R, 1999, NAT MED, V5, P15, DOI 10.1038/4691; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; Pidoplichko VI, 1997, NATURE, V390, P401, DOI 10.1038/37120; Pontieri FE, 1996, NATURE, V382, P255, DOI 10.1038/382255a0; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Schilstrom B, 1998, NEUROSCIENCE, V85, P1005, DOI 10.1016/S0306-4522(98)00114-6; Schilstrom B, 1998, NEUROSCIENCE, V82, P781; SEGUELA P, 1993, J NEUROSCI, V13, P596; SESACK SR, 1992, J COMP NEUROL, V320, P145, DOI 10.1002/cne.903200202; STOLERMAN IP, 1995, MED RES REV, V15, P47, DOI 10.1002/med.2610150105; SUAUDCHAGNY MF, 1992, NEUROSCIENCE, V49, P63, DOI 10.1016/0306-4522(92)90076-E; TABER MT, 1995, J NEUROCHEM, V65, P1407; Vanderschuren LJMJ, 1999, J NEUROSCI, V19, P9579, DOI 10.1523/jneurosci.19-21-09579.1999; WADA E, 1989, J COMP NEUROL, V284, P314, DOI 10.1002/cne.902840212; WANG T, 1993, BRAIN RES, V627, P299, DOI 10.1016/0006-8993(93)90334-J; WANG T, 1993, SYNAPSE, V13, P270, DOI 10.1002/syn.890130310; Yu CR, 1998, J PHYSIOL-LONDON, V509, P651, DOI 10.1111/j.1469-7793.1998.651bm.x	50	566	577	0	38	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG	2000	27	2					349	357		10.1016/S0896-6273(00)00042-8	http://dx.doi.org/10.1016/S0896-6273(00)00042-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	347YD	10985354	Bronze			2022-12-24	WOS:000088956000018
J	Thiele, A; Dobkins, KR; Albright, TD				Thiele, A; Dobkins, KR; Albright, TD			Neural correlates of contrast detection at threshold	NEURON			English	Article							TRANSPARENT MOTION PERCEPTION; CAT STRIATE CORTEX; VISUAL AREA MT; DIRECTIONAL SELECTIVITY; SIMPLE CELLS; LINEAR-MODEL; HUMAN-VISION; NEURONS; MACAQUE; MONKEY	Human psychophysical studies have demonstrated that, for stimuli near the threshold of visibility, detection of motion in one direction is unaffected by the superimposition of motion in the opposite direction. To investigate the neural basis for this perceptual phenomenon, we recorded from directionally selective neurons in macaque visual area MT (middle temporal visual area). Contrast thresholds obtained for single gratings moving in a neuron's preferred direction were compared with those obtained for motion presented simultaneously in the neuron's preferred and anti-preferred directions. A simple model based on probability summation between neurons tuned to opposite directions could sufficiently account for contrast thresholds revealed psychophysically, suggesting that area MT is likely to provide the neural basis for contrast detection of stimuli modulated in time.	Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; Salk Institute	Dobkins, KR (corresponding author), Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA.	kdobkins@ucsd.edu		Thiele, Alexander/0000-0003-4894-0213	PHS HHS [7605] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; ALBRECHT DG, 1991, VISUAL NEUROSCI, V7, P531, DOI 10.1017/S0952523800010336; DEAN AF, 1980, J PHYSIOL-LONDON, V308, pP84; DEVALOIS RL, 1974, VISION RES, V14, P75, DOI 10.1016/0042-6989(74)90118-7; Dobkins KR, 1996, VISION RES, V36, P281, DOI 10.1016/0042-6989(95)00094-G; DOBKINS KR, 1994, J NEUROSCI, V14, P4854; GEGENFURTNER KR, 1994, VISUAL NEUROSCI, V11, P455, DOI 10.1017/S095252380000239X; GEISLER WS, 1992, VISION RES, V32, P1409, DOI 10.1016/0042-6989(92)90196-P; GOLOMB B, 1985, VISION RES, V25, P813, DOI 10.1016/0042-6989(85)90189-0; Graham N.V.S, 1989, VISUAL PATTERN ANAL; Green D. M., 1974, SIGNAL DETECTION THE; HEEGER DJ, 1993, J NEUROPHYSIOL, V70, P1885, DOI 10.1152/jn.1993.70.5.1885; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; LEVINSON E, 1975, J PHYSIOL-LONDON, V250, P347, DOI 10.1113/jphysiol.1975.sp011058; Movshon JA, 1985, STUDY GROUP PATTERN, P117, DOI [DOI 10.1007/978-3-662-09224-8_7., DOI 10.1007/978-3-662-09224-8_]; NACHMIAS J, 1981, VISION RES, V21, P215, DOI 10.1016/0042-6989(81)90115-2; PASTERNAK T, 1986, VISION RES, V26, P1187, DOI 10.1016/0042-6989(86)90100-8; PELLI DG, 1991, VISION RES, V31, P1337, DOI 10.1016/0042-6989(91)90055-A; QIAN N, 1994, J NEUROSCI, V14, P7367; QIAN N, 1995, EXP BRAIN RES, V103, P41; QIAN N, 1994, J NEUROSCI, V14, P7357; QUICK RF, 1974, KYBERNETIK, V16, P65, DOI 10.1007/BF00271628; Raymond J, 1996, VISION RES, V36, P1931, DOI 10.1016/0042-6989(95)00241-3; Recanzone GH, 1997, J NEUROPHYSIOL, V78, P2904, DOI 10.1152/jn.1997.78.6.2904; REID RC, 1987, P NATL ACAD SCI USA, V84, P8740, DOI 10.1073/pnas.84.23.8740; RODMAN HR, 1989, EXP BRAIN RES, V75, P53; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; SNOWDEN RJ, 1991, J NEUROSCI, V11, P2768; STONER GR, 1994, VISUAL DETECTION MOT, P253; STROMEYER CF, 1984, J OPT SOC AM A, V1, P876, DOI 10.1364/JOSAA.1.000876; TOLHURST DJ, 1991, VISUAL NEUROSCI, V6, P421, DOI 10.1017/S0952523800001280; Tolhurst DJ, 1997, VISUAL NEUROSCI, V14, P19, DOI 10.1017/S0952523800008725; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; VANSANTEN JPH, 1985, J OPT SOC AM A, V2, P300, DOI 10.1364/JOSAA.2.000300; WATSON AB, 1980, VISION RES, V20, P341, DOI 10.1016/0042-6989(80)90020-6; WATSON AB, 1979, VISION RES, V19, P515, DOI 10.1016/0042-6989(79)90136-6; WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293; Zemany L, 1998, VISION RES, V38, P795, DOI 10.1016/S0042-6989(97)00225-3	39	38	38	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	2000	26	3					715	724		10.1016/S0896-6273(00)81207-6	http://dx.doi.org/10.1016/S0896-6273(00)81207-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330ZH	10896166	Bronze			2022-12-24	WOS:000087991600021
J	Tresch, MC; Kiehn, O				Tresch, MC; Kiehn, O			Motor coordination without action potentials in the mammalian spinal cord	NATURE NEUROSCIENCE			English	Article							METHYL-D-ASPARTATE; VITRO NEONATAL RAT; IN-VITRO; VOLTAGE OSCILLATIONS; MEMBRANE-PROPERTIES; LOCOMOTOR-ACTIVITY; NEURAL MECHANISMS; NEURONS; MOTONEURONS; PACEMAKER	Coordination of neuronal activity to produce movement is generally thought to depend on spike activity in premotor interneuronal networks. Here we show that even without such activity, the neonatal rat spinal cord could produce a stable motor rhythm mediated by the synchronization of motor neuron oscillations across gap junctions. These rhythms, however, were not coordinated between motor pools in different parts of the spinal cord. We further showed that neural coordination through gap junctions contributed to the fundamental organization and function of spinal motor systems. These results suggest that neural coordination across gap junctions is important in motor-pattern generation in the mammalian spinal cord.	Univ Copenhagen, Panum Inst, Dept Physiol, Sect Neurophysiol, DK-2200 Copenhagen N, Denmark	University of Copenhagen	Kiehn, O (corresponding author), Univ Copenhagen, Panum Inst, Dept Physiol, Sect Neurophysiol, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	O.Kiehn@mfi.ku.dk	kiehn, ole/AAB-1262-2019; Kiehn, Ole/C-4679-2008; Tresch, Matthew C/B-7634-2009; kiehn, ole/AAT-7881-2021					Bennett MVL, 1997, J NEUROCYTOL, V26, P349, DOI 10.1023/A:1018560803261; Bernstein N.A., 1967, COORDINATION REGULAT; CAZALETS JR, 1992, J PHYSIOL-LONDON, V455, P187, DOI 10.1113/jphysiol.1992.sp019296; Chang Q, 1999, J NEUROSCI, V19, P10813, DOI 10.1523/JNEUROSCI.19-24-10813.1999; Chang QA, 2000, J NEUROSCI, V20, P674, DOI 10.1523/JNEUROSCI.20-02-00674.2000; COWLEY KC, 1994, NEUROSCI LETT, V171, P147, DOI 10.1016/0304-3940(94)90626-2; FULTON BP, 1980, PROC R SOC SER B-BIO, V208, P115, DOI 10.1098/rspb.1980.0045; HARRISWARRICK RM, 1991, ANNU REV NEUROSCI, V14, P39, DOI 10.1146/annurev.ne.14.030191.000351; HAYDON DA, 1986, J PHYSIOL-LONDON, V373, P311, DOI 10.1113/jphysiol.1986.sp016049; Hille B., 1992, IONIC CHANNELS EXCIT; HOCHMAN S, 1994, J NEUROPHYSIOL, V72, P565, DOI 10.1152/jn.1994.72.2.565; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; JOHNSON SM, 1994, J NEUROPHYSIOL, V72, P2598, DOI 10.1152/jn.1994.72.6.2598; Kandler Karl, 1995, Current Opinion in Neurobiology, V5, P98, DOI 10.1016/0959-4388(95)80093-X; KEPLER TB, 1990, SCIENCE, V248, P83, DOI 10.1126/science.2321028; Kiehn O, 1996, NEUROSCIENCE, V75, P263, DOI 10.1016/0306-4522(96)00250-3; Kiehn O, 1996, J NEUROPHYSIOL, V75, P1472, DOI 10.1152/jn.1996.75.4.1472; Kiehn O, 1998, ANN NY ACAD SCI, V860, P110, DOI 10.1111/j.1749-6632.1998.tb09043.x; KIEHN O, 1997, NEURONS NETWORKS MOT, P47; Koshiya N, 1999, NATURE, V400, P360, DOI 10.1038/22540; KUDO N, 1987, NEUROSCI LETT, V75, P43, DOI 10.1016/0304-3940(87)90072-3; KUDO N, 1987, J PHYSIOL-LONDON, V389, P441, DOI 10.1113/jphysiol.1987.sp016665; MacLean JN, 1997, EUR J NEUROSCI, V9, P2702, DOI 10.1111/j.1460-9568.1997.tb01699.x; Manor Y, 1997, J NEUROPHYSIOL, V77, P2736, DOI 10.1152/jn.1997.77.5.2736; MATSUSHIMA T, 1992, J NEUROPHYSIOL, V67, P373, DOI 10.1152/jn.1992.67.2.373; Milner LD, 1999, J NEUROSCI, V19, P3007; Moore LE, 1999, J NEUROSCI, V19, P8271; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Prime L, 1999, J NEUROPHYSIOL, V82, P1069, DOI 10.1152/jn.1999.82.2.1069; Raastad M, 1998, P NATL ACAD SCI USA, V95, P10251, DOI 10.1073/pnas.95.17.10251; Rash JE, 1996, P NATL ACAD SCI USA, V93, P4235, DOI 10.1073/pnas.93.9.4235; Rekling JC, 1998, ANNU REV PHYSIOL, V60, P385, DOI 10.1146/annurev.physiol.60.1.385; Rekling JC, 1997, J NEUROPHYSIOL, V78, P3508, DOI 10.1152/jn.1997.78.6.3508; SHERMAN A, 1992, P NATL ACAD SCI USA, V89, P2471, DOI 10.1073/pnas.89.6.2471; SILLAR KT, 1994, EUR J MORPHOL, V32, P185; SILLAR KT, 1994, EUR J MORPHOL, V32, P293; SMITH JC, 1988, FASEB J, V2, P2283, DOI 10.1096/fasebj.2.7.2450802; SMOLEN P, 1993, BIOPHYS J, V64, P1668, DOI 10.1016/S0006-3495(93)81539-X; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; van der Want JJL, 1998, BRAIN RES, V779, P342, DOI 10.1016/S0006-8993(97)01238-9; WALLEN P, 1987, J NEUROSCI, V7, P2745; WALTON KD, 1991, J PHYSIOL-LONDON, V433, P283, DOI 10.1113/jphysiol.1991.sp018426	42	132	132	2	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2000	3	6					593	599		10.1038/75768	http://dx.doi.org/10.1038/75768			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	317WG	10816316				2022-12-24	WOS:000087249500016
J	Askwith, CC; Cheng, C; Ikuma, M; Benson, C; Price, MP; Welsh, MJ				Askwith, CC; Cheng, C; Ikuma, M; Benson, C; Price, MP; Welsh, MJ			Neuropeptide FF and FMRFamide potentiate acid-evoked currents from sensory neurons and proton-gated DEG/ENaC channels	NEURON			English	Article							MET-ARG-PHE; RAT SPINAL-CORD; MAMMALIAN DEGENERIN MDEG; INDUCED SODIUM CURRENT; ROOT GANGLION NEURONS; NA+ CHANNEL; ION-CHANNEL; INDUCED ANALGESIA; CATION CHANNEL; CAENORHABDITIS-ELEGANS	Acidosis is associated with inflammation and ischemia and activates cation channels in sensory neurons. Inflammation also induces expression of FMRFamide-like neuropeptides, which modulate pain. We found that neuropeptide FF (Phe-Leu-Phe-G In-Pro-Gln-Arg-Phe amide) and FMRFamide (Phe-Met-Arg-Phe amide) generated no current on their own but potentiated H+-gated currents from cultured sensory neurons and heterologously expressed ASIC and DRASIC channels. The neuropeptides slowed inactivation and induced sustained currents during acidification. The effects were specific; different channels showed distinct responses to the various peptides. These results suggest that acid-sensing ion channels may integrate multiple extracellular signals to modify sensory perception.	Univ Iowa, Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa	Welsh, MJ (corresponding author), Univ Iowa, Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA.	mjwelsh@blue.weeg.uiowa.edu	Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051; Benson, Christopher/0000-0001-6600-8193; Welsh, Michael/0000-0002-1646-6206				Adams CM, 1998, J BIOL CHEM, V273, P30204, DOI 10.1074/jbc.273.46.30204; AKAIKE N, 1994, PROG NEUROBIOL, V43, P73, DOI 10.1016/0301-0082(94)90016-7; AKAIKE N, 1990, J NEUROPHYSIOL, V63, P805, DOI 10.1152/jn.1990.63.4.805; Allard M, 1999, PEPTIDES, V20, P327, DOI 10.1016/S0196-9781(99)00039-X; ALLARD M, 1989, BRAIN RES, V500, P169, DOI 10.1016/0006-8993(89)90311-9; Babinski K, 1999, J NEUROCHEM, V72, P51, DOI 10.1046/j.1471-4159.1999.0720051.x; Bassilana F, 1997, J BIOL CHEM, V272, P28819, DOI 10.1074/jbc.272.46.28819; Benson CJ, 1999, CIRC RES, V84, P921; BEVAN S, 1994, TRENDS NEUROSCI, V17, P509, DOI 10.1016/0166-2236(94)90149-X; BEVAN S, 1991, J PHYSIOL-LONDON, V433, P145, DOI 10.1113/jphysiol.1991.sp018419; BRUSSAARD AB, 1989, PEPTIDES, V10, P735, DOI 10.1016/0196-9781(89)90105-8; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Coscoy S, 1998, J BIOL CHEM, V273, P8317, DOI 10.1074/jbc.273.14.8317; Cottrell GA, 1997, J EXP BIOL, V200, P2377; DAVIES NW, 1988, J PHYSIOL-LONDON, V400, P159, DOI 10.1113/jphysiol.1988.sp017116; de Weille JR, 1998, FEBS LETT, V433, P257, DOI 10.1016/S0014-5793(98)00916-8; DEVILLERS JP, 1995, BRAIN RES, V700, P173, DOI 10.1016/0006-8993(95)00948-P; FERRARESE C, 1986, REGUL PEPTIDES, V13, P245, DOI 10.1016/0167-0115(86)90043-1; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; GAYTON RJ, 1982, NATURE, V298, P275, DOI 10.1038/298275a0; Gherardi N, 1997, PEPTIDES, V18, P577, DOI 10.1016/S0196-9781(97)00071-5; GOUARDERES C, 1993, EUR J PHARMACOL, V237, P73, DOI 10.1016/0014-2999(93)90095-Y; GREENBERG MJ, 1992, PROG BRAIN RES, V92, P25, DOI 10.1016/S0079-6123(08)61162-0; KAVALIERS M, 1985, NEUROPEPTIDES, V6, P485, DOI 10.1016/0143-4179(85)90110-6; KAVALIERS M, 1987, BRAIN RES, V415, P380, DOI 10.1016/0006-8993(87)90225-3; Kontinen VK, 1997, PEPTIDES, V18, P287, DOI 10.1016/S0196-9781(96)00287-2; KOVALCHUK YN, 1990, NEUROSCI LETT, V115, P237, DOI 10.1016/0304-3940(90)90461-H; KRISHTAL OA, 1981, NEUROSCI LETT, V24, P243, DOI 10.1016/0304-3940(81)90164-6; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; MAJANE EA, 1987, PEPTIDES, V8, P657, DOI 10.1016/0196-9781(87)90041-6; MAJANE EA, 1989, BRAIN RES, V494, P1, DOI 10.1016/0006-8993(89)90137-6; Mano I, 1999, BIOESSAYS, V21, P568, DOI 10.1002/(SICI)1521-1878(199907)21:7&lt;568::AID-BIES5&gt;3.0.CO;2-L; MUES G, 1982, LIFE SCI, V31, P2555, DOI 10.1016/0024-3205(82)90728-7; Muthal AV, 1997, NEUROPEPTIDES, V31, P319, DOI 10.1016/S0143-4179(97)90065-2; Nelson LS, 1998, MOL BRAIN RES, V58, P103, DOI 10.1016/S0169-328X(98)00106-5; Nishimura M, 2000, HYPERTENSION, V35, P443, DOI 10.1161/01.HYP.35.1.443; Olson TH, 1998, NEUROREPORT, V9, P1109, DOI 10.1097/00001756-199804200-00028; PAYZA K, 1993, J NEUROCHEM, V60, P1894, DOI 10.1111/j.1471-4159.1993.tb13417.x; Perry SJ, 1997, FEBS LETT, V409, P426, DOI 10.1016/S0014-5793(97)00557-7; Price MP, 1996, J BIOL CHEM, V271, P7879, DOI 10.1074/jbc.271.14.7879; RAFFA RB, 1986, NEUROSCI LETT, V65, P94, DOI 10.1016/0304-3940(86)90126-6; RAFFA RB, 1988, PEPTIDES, V9, P915, DOI 10.1016/0196-9781(88)90141-6; RAFFA RB, 1992, NEUROPEPTIDES, V22, P195, DOI 10.1016/0143-4179(92)90162-P; Reeh PW, 1996, PROG BRAIN RES, V113, P143, DOI 10.1016/S0079-6123(08)61085-7; Roumy M, 1998, EUR J PHARMACOL, V345, P1, DOI 10.1016/S0014-2999(97)01604-X; SCHILD L, 1995, P NATL ACAD SCI USA, V92, P5699, DOI 10.1073/pnas.92.12.5699; SCHNEIDER LE, 1988, P NATL ACAD SCI USA, V85, P1993, DOI 10.1073/pnas.85.6.1993; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; SORENSON RL, 1984, PEPTIDES, V5, P777, DOI 10.1016/0196-9781(84)90021-4; TANG J, 1984, P NATL ACAD SCI-BIOL, V81, P5002, DOI 10.1073/pnas.81.15.5002; TELEGDY G, 1987, NEUROPEPTIDES, V10, P157, DOI 10.1016/0143-4179(87)90017-5; THIEMERMANN C, 1991, BIOCHEM BIOPH RES CO, V175, P318, DOI 10.1016/S0006-291X(05)81237-9; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Vilim FS, 1999, MOL PHARMACOL, V55, P804; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; YANG HYT, 1985, P NATL ACAD SCI USA, V82, P7757, DOI 10.1073/pnas.82.22.7757	62	184	195	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	2000	26	1					133	141		10.1016/S0896-6273(00)81144-7	http://dx.doi.org/10.1016/S0896-6273(00)81144-7			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309MA	10798398	Bronze			2022-12-24	WOS:000086770500014
J	Awasaki, T; Saito, M; Sone, M; Suzuki, E; Sakai, R; Ito, K; Hama, C				Awasaki, T; Saito, M; Sone, M; Suzuki, E; Sakai, R; Ito, K; Hama, C			The Drosophila trio plays an essential role in patterning of axons by regulating their directional extension	NEURON			English	Article							MUSHROOM BODIES; SMALL GTPASES; HIKARU-GENKI; RHO-GTPASES; RAC GTPASE; PROTEIN; GUIDANCE; CELL; MELANOGASTER; SEGMENTATION	We identified the Drosophila trio gene, which encodes a Dbl family protein carrying two Dbl homology (DH) domains, each of which potentially activates Rho family GTPases. Trio was distributed along axons in the central nervous system (CNS) of embryos and was strongly expressed in subsets of brain regions, including the mushroom body (MB). Loss-of-function trio mutations resulted in the misdirection or stall of axons in embryos and also caused malformation of the MB. The MB phenotypes were attributed to alteration in the intrinsic nature of neurites, as revealed by clonal analyses. Thus, Trio is essential in order for neurites to faithfully extend on the correct pathways. In addition, the localization of Trio in the adult brain suggests its postdevelopmental role in neurite terminals.	NCNP, Natl Inst Neurosci, Dept Mol Genet, Tokyo 1878502, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan; Japan Sci & Technol Corp, PRESTO, Kawaguchi, Saitama 3320012, Japan; Univ Tokyo, Inst Med Sci, Dept Fine Morphol, Minato Ku, Tokyo 1088639, Japan; Natl Inst Basic Biol, Aichi 4448585, Japan	National Center for Neurology & Psychiatry - Japan; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Hama, C (corresponding author), NCNP, Natl Inst Neurosci, Dept Mol Genet, 4-1-1 Ogawahigashi, Tokyo 1878502, Japan.		Sone, Masaki/Q-9058-2019; AWASAKI, Takeshi/AAO-7579-2021	AWASAKI, Takeshi/0000-0003-2662-6389; Suzuki, Emiko/0000-0002-4005-0542				Barrett K, 1997, CELL, V91, P905, DOI 10.1016/S0092-8674(00)80482-1; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Cook G, 1998, CURR OPIN NEUROBIOL, V8, P64, DOI 10.1016/S0959-4388(98)80009-3; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Deak P, 1997, GENETICS, V147, P1697; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Gallo G, 1998, CURR BIOL, V8, pR80, DOI 10.1016/S0960-9822(98)70051-X; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; GODT D, 1993, DEVELOPMENT, V119, P799; Grigliati T., 1986, DROSOPHILA PRACTICAL, P39; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Harden N, 1996, MOL CELL BIOL, V16, P1896; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; HOSHINO M, 1993, NEURON, V10, P395, DOI 10.1016/0896-6273(93)90329-P; Hoshino M, 1996, DEVELOPMENT, V122, P589; Ito K, 1998, LEARN MEMORY, V5, P52; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; NEWSOME TP, 2000, IN PRESS CELL, V101; NOBES C, 1994, CURR OPIN GENET DEV, V4, P77, DOI 10.1016/0959-437X(94)90094-9; Sone M, 1997, SCIENCE, V275, P543, DOI 10.1126/science.275.5299.543; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Van Vactor D, 1998, CURR OPIN NEUROBIOL, V8, P80, DOI 10.1016/S0959-4388(98)80011-1; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Whitehead IP, 1997, BBA-REV CANCER, V1332, pF1, DOI 10.1016/S0304-419X(96)00040-6; Zipkin ID, 1997, CELL, V90, P883, DOI 10.1016/S0092-8674(00)80353-0	38	172	172	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	2000	26	1					119	131		10.1016/S0896-6273(00)81143-5	http://dx.doi.org/10.1016/S0896-6273(00)81143-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309MA	10798397	Bronze			2022-12-24	WOS:000086770500013
J	Todorov, E				Todorov, E			Direct cortical control of muscle activation in voluntary arm movements: a model	NATURE NEUROSCIENCE			English	Article							PRIMATE MOTOR CORTEX; SIMILAR HAND PATHS; REACHING MOVEMENTS; NEURAL DISCHARGE; ISOMETRIC FORCE; CELLS; TASK; NEURONS; JOINT; SPACE	What neural activity in motor cortex represents and how it controls ongoing movement remain unclear. Suggestions that cortex generates low-level muscle control are discredited by correlations with higher-level parameters of hand movement, but no coherent alternative exists. I argue that the view of low-level control is in principle correct, and that seeming contradictions result from overlooking known properties of the motor periphery. Assuming direct motor cortical activation of muscle groups and taking into account the state dependence of muscle-force production and multijoint mechanics, I show that cortical population output must correlate with hand kinematics in quantitative agreement with experimental observations. The model reinterprets the 'neural population vector' to afford unified control of posture, movement and force production.	UCL, Gatsby Computat Neurosci Unit, London WC1N 3AR, England	University of London; University College London	Todorov, E (corresponding author), UCL, Gatsby Computat Neurosci Unit, 17 Queen Sq, London WC1N 3AR, England.	emo@gatsby.ucl.ac.uk						ALEXANDER GE, 1990, J NEUROPHYSIOL, V64, P164, DOI 10.1152/jn.1990.64.1.164; ASHE J, 1994, CEREB CORTEX, V4, P590, DOI 10.1093/cercor/4.6.590; BENNETT DJ, 1992, EXP BRAIN RES, V88, P433, DOI 10.1007/BF02259118; BIZZI E, 1991, SCIENCE, V253, P287, DOI 10.1126/science.1857964; Bullock D, 1998, CEREB CORTEX, V8, P48, DOI 10.1093/cercor/8.1.48; CAMINITI R, 1990, J NEUROSCI, V10, P2039; Carpenter AF, 1999, SCIENCE, V283, P1752, DOI 10.1126/science.283.5408.1752; Crammond DJ, 1996, EXP BRAIN RES, V108, P45; DUM RP, 1991, J NEUROSCI, V11, P667; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; Evarts EV, 1981, HDB PHYSL NERVOUS SY, VII, P1083; FETZ EE, 1992, BEHAV BRAIN SCI, V15, P679; FETZ EE, 1980, J NEUROPHYSIOL, V44, P751, DOI 10.1152/jn.1980.44.4.751; FETZ EE, 1989, PROG BRAIN RES, V80, P437; FLAMENT D, 1988, J NEUROPHYSIOL, V60, P1268, DOI 10.1152/jn.1988.60.4.1268; FU QG, 1995, J NEUROPHYSIOL, V73, P836, DOI 10.1152/jn.1995.73.2.836; FU QG, 1993, J NEUROPHYSIOL, V70, P2097, DOI 10.1152/jn.1993.70.5.2097; GALAGAN J, 1999, THESIS MIT; GEORGOPOULOS AP, 1989, SCIENCE, V243, P234, DOI 10.1126/science.2911737; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Gomi H, 1996, SCIENCE, V272, P117, DOI 10.1126/science.272.5258.117; Gottlieb GL, 1996, J NEUROPHYSIOL, V76, P3207, DOI 10.1152/jn.1996.76.5.3207; HOCHERMAN S, 1991, EXP BRAIN RES, V83, P285; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Humphrey D R, 1983, Adv Neurol, V39, P347; JOHNSON PB, 1992, CONTROL ARM MOVEMENT; JOYCE GC, 1969, J PHYSIOL-LONDON, V204, P461, DOI 10.1113/jphysiol.1969.sp008924; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; KALASKA JF, 1992, SCIENCE, V255, P1517, DOI 10.1126/science.1549781; KALASKA JF, 1989, J NEUROSCI, V9, P2080; KALASKA JF, 1992, CONTROL ARM MOVEMENT; KETTNER RE, 1988, J NEUROSCI, V8, P2938; KHATIB O, 1987, IEEE T ROBOTIC AUTOM, V3, P43, DOI 10.1109/JRA.1987.1087068; Miller LE, 1998, J NEUROPHYSIOL, V80, P59, DOI 10.1152/jn.1998.80.1.59; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; MUSSAIVALDI FA, 1988, NEUROSCI LETT, V91, P106, DOI 10.1016/0304-3940(88)90257-1; SANES JN, 1995, CAN J PHYSIOL PHARM, V73, P223, DOI 10.1139/y95-033; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; SCHWARTZ AB, 1994, SCIENCE, V265, P540, DOI 10.1126/science.8036499; Scott SH, 1997, J NEUROPHYSIOL, V77, P1016, DOI 10.1152/jn.1997.77.2.1016; Scott SH, 1997, J NEUROPHYSIOL, V77, P826, DOI 10.1152/jn.1997.77.2.826; SCOTT SH, 1995, J NEUROPHYSIOL, V73, P2563, DOI 10.1152/jn.1995.73.6.2563; Sergio LE, 1998, J NEUROPHYSIOL, V80, P1577, DOI 10.1152/jn.1998.80.3.1577; Taira M, 1996, EXP BRAIN RES, V109, P367; TANAKA S, 1994, NEUROSCI LETT, V180, P83, DOI 10.1016/0304-3940(94)90493-6; THACH WT, 1978, J NEUROPHYSIOL, V41, P654, DOI 10.1152/jn.1978.41.3.654; TSUJI T, 1995, BIOL CYBERN, V72, P475, DOI 10.1007/BF00199890; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359	50	284	301	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2000	3	4					391	398		10.1038/73964	http://dx.doi.org/10.1038/73964			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330CN	10725930				2022-12-24	WOS:000087945400021
J	Huerta, PT; Sun, LD; Wilson, MA; Tonegawa, S				Huerta, PT; Sun, LD; Wilson, MA; Tonegawa, S			Formation of temporal memory requires NMDA receptors within CA1 pyramidal neurons	NEURON			English	Article							MEDIAL PREFRONTAL CORTEX; LONG-TERM POTENTIATION; HIPPOCAMPAL; RATS; FEAR; ANTAGONIST; RESPONSES; AMYGDALA; KNOCKOUT; LESIONS	In humans the hippocampus is required for episodic memory, which extends into the spatial and temporal domains. Work on the rodent hippocampus has shown that NMDA receptor (NMDAR)-mediated plasticity is essential for spatial memory. Here, we have examined whether hippocampal NMDARs are also needed for temporal memory. We applied trace fear conditioning to knockout mice lacking NMDARs only in hippocampal CA1 pyramidal cells. This paradigm requires temporal processing because the conditional and unconditional stimuli are separated by 30 s (trace). We found that knockout mice failed to memorize this association but were indistinguishable from normal animals when the trace was removed. Thus, NMDARs in CA1 are crucial for the formation of memories that associate events across time.	MIT, Howard Hughes Med Inst, Ctr Learning & Memory, Dept Biol, Cambridge, MA 02139 USA; MIT, RIKEN MIT Neurosci Res Ctr, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); RIKEN	Tonegawa, S (corresponding author), MIT, Howard Hughes Med Inst, Ctr Learning & Memory, Dept Biol, Cambridge, MA 02139 USA.			Huerta, Patricio/0000-0003-0270-2308				BERGER TW, 1976, SCIENCE, V192, P483, DOI 10.1126/science.1257783; CHIBA AA, 1994, BEHAV NEURAL BIOL, V61, P123, DOI 10.1016/S0163-1047(05)80065-2; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; DAVIS M, 1994, TRENDS NEUROSCI, V17, P208, DOI 10.1016/0166-2236(94)90106-6; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; FANSELOW MS, 1990, ANIM LEARN BEHAV, V18, P264, DOI 10.3758/BF03205285; Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0; Jackson PA, 1998, NEUROBIOL LEARN MEM, V70, P328, DOI 10.1006/nlme.1998.3859; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; Kim JJ, 1997, TRENDS NEUROSCI, V20, P177, DOI 10.1016/S0166-2236(96)10081-3; LEDOUX JE, 1993, BEHAV BRAIN RES, V58, P69, DOI 10.1016/0166-4328(93)90091-4; LYFORD GL, 1993, NEUROPSYCHOLOGIA, V31, P1079, DOI 10.1016/0028-3932(93)90034-W; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McEchron MD, 1997, J NEUROPHYSIOL, V78, P1030, DOI 10.1152/jn.1997.78.2.1030; McEchron MD, 1998, HIPPOCAMPUS, V8, P638, DOI 10.1002/(SICI)1098-1063(1998)8:6<638::AID-HIPO6>3.0.CO;2-Q; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; MECK WH, 1984, BEHAV NEUROSCI, V98, P3, DOI 10.1037/0735-7044.98.1.3; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; MULLER RU, 1987, J NEUROSCI, V7, P1951; Nadel L., 1991, Hippocampus, V1, P221, DOI 10.1002/hipo.450010302; NADEL L., 1991, HIPPOCAMPUS, V1, P230; O'Keefe J, 1999, HIPPOCAMPUS, V9, P352, DOI 10.1002/(SICI)1098-1063(1999)9:4<352::AID-HIPO3>3.0.CO;2-1; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1987, EXP BRAIN RES, V68, P1; OLTON DS, 1989, HIPPOCAMPUS NEW VIST, P411; PHILLIPS RG, 1994, LEARN MEMORY, V1, P34; QUIRK GJ, 1990, J NEUROSCI, V10, P2008; Radulovic J, 1998, BEHAV BRAIN RES, V95, P179, DOI 10.1016/S0166-4328(98)00039-4; RAWLINS JNP, 1985, BEHAV BRAIN SCI, V8, P479, DOI 10.1017/S0140525X00001291; Recce M, 1996, HIPPOCAMPUS, V6, P735, DOI 10.1002/(SICI)1098-1063(1996)6:6<735::AID-HIPO15>3.0.CO;2-1; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Sakurai Y, 1996, J NEUROSCI, V16, P2809; Schacter D. L., 1994, MEMORY SYSTEMS 1994; SQUIRE LR, 1999, SCI AM LIB, V69; Tonegawa S, 1996, COLD SPRING HARB SYM, V61, P225; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605	41	248	252	1	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	2000	25	2					473	480		10.1016/S0896-6273(00)80909-5	http://dx.doi.org/10.1016/S0896-6273(00)80909-5			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	288EL	10719900	Bronze			2022-12-24	WOS:000085549100023
J	Jensen, KB; Dredge, BK; Stefani, G; Zhong, R; Buckanovich, RJ; Okano, HJ; Yang, YYL; Darnell, RB				Jensen, KB; Dredge, BK; Stefani, G; Zhong, R; Buckanovich, RJ; Okano, HJ; Yang, YYL; Darnell, RB			Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability	NEURON			English	Article							RNA-BINDING PROTEIN; INHIBITORY GLYCINE RECEPTOR; NMDA RECEPTOR; SPASMODIC MOUSE; ALPHA-1 SUBUNIT; SEX-LETHAL; IN-VIVO; HNRNP-K; GENE; CELL	We have combined genetic and biochemical approaches to analyze the function of the RNA-binding protein Nova-1, the paraneoplastic opsoclonus-myoclonus ataxia (POMA) antigen. Nova-1 null mice die postnatally from a motor deficit associated with apoptotic death of spinal and brainstem neurons. Nova-1 null mice show specific splicing defects in two inhibitory receptor pre-mRNAs, glycine alpha 2 exon 3A (GlyR alpha 2 E3A) and GABA(A) exon gamma 2L. Nova protein in brain extracts specifically bound to a previously identified GlyR alpha 2 intronic (UCAUY)(3) Nova target sequence, and Nova-1 acted directly on this element to increase E3A splicing in cotransfection assays. We conclude that Nova-1 binds RNA in a sequence-specific manner to regulate neuronal pre-mRNA alternative splicing; the defect in splicing in Nova-1 null mice provides a model for understanding the motor dysfunction in POMA.	Rockefeller Univ, Mol Neurooncol Lab, New York, NY 10021 USA	Rockefeller University	Darnell, RB (corresponding author), Rockefeller Univ, Mol Neurooncol Lab, 1230 York Ave, New York, NY 10021 USA.		Jensen, Kirk/B-4756-2008; Darnell, Robert B/B-9022-2008; Jensen, Kirk/AAL-5883-2020; Stefani, Giovanni/P-6179-2015	Jensen, Kirk/0000-0002-2084-1734; Darnell, Robert B/0000-0002-5134-8088; Jensen, Kirk/0000-0002-2084-1734; Okano, Hirotaka James/0000-0003-4611-7098; Stefani, Giovanni/0000-0002-8782-6811; Dredge, Kate/0000-0002-6103-5165	NINDS NIH HHS [R01 NS34389] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034389] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albert ML, 1998, NAT MED, V4, P1321, DOI 10.1038/3315; ALBERT ML, 1999, IN PRESS ANN NEUROL; AMARA SG, 1982, NATURE, V298, P240, DOI 10.1038/298240a0; ARNARA GSG, 1982, NATURE, V298, P240; Arning S, 1996, RNA, V2, P794; ASHIYA M, 1995, NUCL ACIDS S SER, V33, P215; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; AverbuchHeller L, 1996, SEMIN NEUROL, V16, P21, DOI 10.1055/s-2008-1040955; BAKER BS, 1989, NATURE, V340, P521, DOI 10.1038/340521a0; Black DL, 1998, NEURON, V20, P165, DOI 10.1016/S0896-6273(00)80444-4; BLACK DL, 1992, CELL, V69, P795, DOI 10.1016/0092-8674(92)90291-J; Buckanovich RJ, 1996, J NEUROSCI, V16, P1114; BUCKANOVICH RJ, 1993, NEURON, V11, P657, DOI 10.1016/0896-6273(93)90077-5; Buckanovich RJ, 1997, MOL CELL BIOL, V17, P3194, DOI 10.1128/MCB.17.6.3194; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; Caviness JN, 1996, MAYO CLIN PROC, V71, P679; Chan RCC, 1997, MOL CELL BIOL, V17, P4667, DOI 10.1128/MCB.17.8.4667; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chou MY, 1999, MOL CELL BIOL, V19, P69; Claeysen S, 1998, ANN NY ACAD SCI, V861, P49, DOI 10.1111/j.1749-6632.1998.tb10172.x; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Darnell RB, 1996, P NATL ACAD SCI USA, V93, P4529, DOI 10.1073/pnas.93.10.4529; Darnell RB, 1998, NEURON, V21, P947, DOI 10.1016/S0896-6273(00)80613-3; Ehlers MD, 1998, J NEUROSCI, V18, P720; EHLERS MD, 1995, SCIENCE, V269, P1734, DOI 10.1126/science.7569904; ENGEBRECHT J, 1990, MOL CELL BIOL, V10, P2379, DOI 10.1128/MCB.10.5.2379; FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; FLETCHER CF, 1997, IN PRESS GENOMICS; FOLEY KP, 1993, TRENDS GENET, V9, P380, DOI 10.1016/0168-9525(93)90137-7; Fuks Z, 1995, Cancer J Sci Am, V1, P62; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Grabowski PJ, 1998, CELL, V92, P709, DOI 10.1016/S0092-8674(00)81399-9; Hertel KJ, 1997, CURR OPIN CELL BIOL, V9, P350, DOI 10.1016/S0955-0674(97)80007-5; HOLLMANN M, 1993, NEURON, V10, P943, DOI 10.1016/0896-6273(93)90209-A; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HOROWITZ DS, 1994, TRENDS GENET, V10, P100, DOI 10.1016/0168-9525(94)90233-X; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; KUHSE J, 1991, FEBS LETT, V283, P73, DOI 10.1016/0014-5793(91)80557-J; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Lewis HA, 1999, STRUCTURE, V7, P191, DOI 10.1016/S0969-2126(99)80025-2; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; Lou H, 1999, MOL CELL BIOL, V19, P78; LUQUE FA, 1991, ANN NEUROL, V29, P241, DOI 10.1002/ana.410290303; MACDONALD RL, 1995, P NATL ACAD SCI USA, V92, P3633, DOI 10.1073/pnas.92.9.3633; MARTINEZ R, 1987, SCIENCE, V237, P411, DOI 10.1126/science.2440106; Michael WM, 1997, EMBO J, V16, P3587, DOI 10.1093/emboj/16.12.3587; Min HS, 1997, GENE DEV, V11, P1023, DOI 10.1101/gad.11.8.1023; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Okano HJ, 1999, GENE DEV, V13, P2087, DOI 10.1101/gad.13.16.2087; Okano HJ, 1997, J NEUROSCI, V17, P3024; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Ostareck-Lederer A, 1998, TRENDS BIOCHEM SCI, V23, P409, DOI 10.1016/S0968-0004(98)01301-2; Petersen-Mahrt SK, 1999, EMBO J, V18, P1014, DOI 10.1093/emboj/18.4.1014; Picetti R, 1997, CRIT REV NEUROBIOL, V11, P121, DOI 10.1615/CritRevNeurobiol.v11.i2-3.20; Rajendra S, 1997, PHARMACOL THERAPEUT, V73, P121, DOI 10.1016/S0163-7258(96)00163-5; Rothwell JC, 1995, CLIN NEUROSCI, V3, P214; RYAN SG, 1994, NAT GENET, V7, P131, DOI 10.1038/ng0694-131; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; SAUL B, 1994, FEBS LETT, V350, P71, DOI 10.1016/0014-5793(94)00736-5; Serafini T, 1999, CELL, V98, P133, DOI 10.1016/S0092-8674(00)81008-9; SHIANG R, 1993, NAT GENET, V5, P351, DOI 10.1038/ng1293-351; SIEBEL CW, 1995, GENE DEV, V9, P269, DOI 10.1101/gad.9.3.269; Singer JH, 1998, J NEUROPHYSIOL, V80, P2608, DOI 10.1152/jn.1998.80.5.2608; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; SZABO A, 1991, CELL, V67, P325, DOI 10.1016/0092-8674(91)90184-Z; Tacke R, 1999, P SOC EXP BIOL MED, V220, P59, DOI 10.1046/j.1525-1373.1999.d01-10.x; TIAN M, 1992, SCIENCE, V256, P237, DOI 10.1126/science.1566072; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; VALCARCEL J, 1993, NATURE, V362, P171, DOI 10.1038/362171a0; Wakamatsu Y, 1997, DEVELOPMENT, V124, P3449; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Wang ZH, 1996, RNA, V2, P1241; Wei N, 1997, RNA, V3, P1275; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yang YYL, 1998, P NATL ACAD SCI USA, V95, P13254, DOI 10.1073/pnas.95.22.13254; Zaki PA, 1996, ANNU REV PHARMACOL, V36, P379; Zhang L, 1999, RNA, V5, P117, DOI 10.1017/S1355838299981530	82	305	311	1	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	2000	25	2					359	371		10.1016/S0896-6273(00)80900-9	http://dx.doi.org/10.1016/S0896-6273(00)80900-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	288EL	10719891	Bronze			2022-12-24	WOS:000085549100014
J	Zhou, Q; Wang, SL; Anderson, DJ				Zhou, Q; Wang, SL; Anderson, DJ			Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors	NEURON			English	Article							SPINAL-CORD OLIGODENDROCYTES; ACHAETE-SCUTE HOMOLOG-1; CENTRAL-NERVOUS-SYSTEM; VENTRAL NEURAL-TUBE; RAT OPTIC-NERVE; SONIC HEDGEHOG; MONOCLONAL-ANTIBODY; PROGENITOR CELLS; GENE-EXPRESSION; PRONEURAL GENE	Basic helix-loop-helix (bHLH) transcription factors have been identified for neurons and their precursors but not for glial cells. We have identified two bHLH factors, Oligo1 and Oligo2, that are specifically expressed in zones of neuroepithelium from which oligodendrocyte precursors emerge, as well as in the precursors themselves. Expression of Oligo2 in the spinal cord precedes that of platelet-derived growth factor receptor alpha (PDGFR alpha), the earliest known marker of oligodendrocyte precursors, by several days. Ectopic expression of Oligo2 in vivo causes ectopic expression of Sox10, an HMG-box transcription factor expressed in oligodendrocyte and other glial precursors. These data identify Oligo genes as the earliest known markers of oligodendrocyte lineage determination and suggest they play a causal role in this process.	CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA; Stanford Univ, Sch Med, Dept Neurobiol, Palo Alto, CA 94304 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; Stanford University	Anderson, DJ (corresponding author), CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.		Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763; Zhou, Qiao/0000-0002-0099-3909	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023476] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS23476] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1; Anderson DJ, 1999, CURR OPIN NEUROBIOL, V9, P517, DOI 10.1016/S0959-4388(99)00015-X; BARRES BA, 1994, NEURON, V12, P935, DOI 10.1016/0896-6273(94)90305-0; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BARRES BA, 1993, DEVELOPMENT, V118, P283; BARTHOLOMA A, 1994, MECH DEVELOP, V48, P217, DOI 10.1016/0925-4773(94)90061-2; BHATTACHARYYA A, 1991, NEURON, V7, P831, DOI 10.1016/0896-6273(91)90285-8; BRONNERFRASER M, 1986, DEV BIOL, V115, P44, DOI 10.1016/0012-1606(86)90226-5; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; CHEN ZF, 1998, IN PRESS NAT GENET, V20; CHRIST B, 1995, ANAT EMBRYOL, V191, P381, DOI 10.1007/BF00304424; COLLARINI EJ, 1992, DEVELOPMENT, V116, P193; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DUPIN E, 1990, P NATL ACAD SCI USA, V87, P1119, DOI 10.1073/pnas.87.3.1119; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; FEKETE DM, 1993, MOL CELL BIOL, V13, P2604, DOI 10.1128/MCB.13.4.2604; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; Frank H, 1993, ENVIRON SCI POLLUT R, V1, P1; GARRELL J, 1991, BIOESSAYS, V13, P493, DOI 10.1002/bies.950131002; Gerber AN, 1997, GENE DEV, V11, P436, DOI 10.1101/gad.11.4.436; Gradwohl G, 1996, DEV BIOL, V180, P227, DOI 10.1006/dbio.1996.0297; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Hall A, 1996, DEVELOPMENT, V122, P4085; Hardy RJ, 1996, DEVELOPMENT, V122, P2059; Inoue K, 1999, ANN NEUROL, V46, P313, DOI 10.1002/1531-8249(199909)46:3<313::AID-ANA6>3.0.CO;2-7; JAN YN, 1993, CELL, V75, P827, DOI 10.1016/0092-8674(93)90525-U; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; JOHNSON JE, 1992, DEVELOPMENT, V114, P75; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; Kawakami A, 1997, MECH DEVELOP, V66, P119, DOI 10.1016/S0925-4773(97)00097-X; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Kume H, 1996, BIOCHEM BIOPH RES CO, V219, P526, DOI 10.1006/bbrc.1996.0267; LEBER SM, 1990, J NEUROSCI, V10, P2451; Lee JE, 1997, CURR OPIN NEUROBIOL, V7, P13, DOI 10.1016/S0959-4388(97)80115-8; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; LO LC, 1991, GENE DEV, V5, P1524, DOI 10.1101/gad.5.9.1524; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Miller RH, 1996, TRENDS NEUROSCI, V19, P92, DOI 10.1016/S0166-2236(96)80036-1; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; MORGAN BA, 1996, METHODS AVIAN EMBRYO, P185; Mujtaba T, 1999, DEV BIOL, V214, P113, DOI 10.1006/dbio.1999.9418; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; NORNES HO, 1974, BRAIN RES, V73, P121, DOI 10.1016/0006-8993(74)91011-7; ONO K, 1995, DEVELOPMENT, V121, P1743; Orentas DM, 1996, DEV BIOL, V177, P43, DOI 10.1006/dbio.1996.0143; Orentas DM, 1999, DEVELOPMENT, V126, P2419; Perez SE, 1999, DEVELOPMENT, V126, P1715; Poncet C, 1996, MECH DEVELOP, V60, P13, DOI 10.1016/S0925-4773(96)00595-3; Pringle NP, 1998, NEURON, V20, P883, DOI 10.1016/S0896-6273(00)80470-5; Pringle NP, 1996, DEV BIOL, V177, P30, DOI 10.1006/dbio.1996.0142; PRINGLE NP, 1993, DEVELOPMENT, V117, P525; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; Rao MS, 1998, P NATL ACAD SCI USA, V95, P3996, DOI 10.1073/pnas.95.7.3996; SHIMIZU C, 1995, EUR J BIOCHEM, V229, P239, DOI 10.1111/j.1432-1033.1995.0239l.x; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; SRIVASTAVA D, 1995, SCIENCE, V270, P1995, DOI 10.1126/science.270.5244.1995; Sun T, 1998, MOL CELL NEUROSCI, V12, P228, DOI 10.1006/mcne.1998.0711; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; TEMPLE S, 1994, DEVELOPMENT, V120, P999; TIMSIT S, 1995, J NEUROSCI, V15, P1012; WARF BC, 1991, J NEUROSCI, V11, P2477; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; White PM, 1999, DEVELOPMENT, V126, P4351; WILLIAMS BP, 1991, NEURON, V7, P685, DOI 10.1016/0896-6273(91)90381-9; YU WP, 1994, NEURON, V12, P1353, DOI 10.1016/0896-6273(94)90450-2; Yun KS, 1996, CURR OPIN CELL BIOL, V8, P877, DOI 10.1016/S0955-0674(96)80091-3	76	598	627	0	17	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	2000	25	2					331	343		10.1016/S0896-6273(00)80898-3	http://dx.doi.org/10.1016/S0896-6273(00)80898-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	288EL	10719889	Bronze			2022-12-24	WOS:000085549100012
J	Wang, YL; Wright, NJD; Guo, HF; Xie, ZP; Svoboda, K; Malinow, R; Smith, DP; Zhong, Y				Wang, YL; Wright, NJD; Guo, HF; Xie, ZP; Svoboda, K; Malinow, R; Smith, DP; Zhong, Y			Genetic manipulation of the odor-evoked distributed neural activity in the Drosophila mushroom body	NEURON			English	Article							OLFACTORY RECEPTOR NEURONS; VOLTAGE-SENSITIVE DYE; ANTENNAL LOBE; BULB; MELANOGASTER; RAT; COMBINATORIAL; STIMULATION; RESPONSES; BODIES	Odor-induced neural activity was recorded by Ca2+ imaging in the cell body region of the Drosophila mushroom body (MB), which is the second relay of the olfactory central nervous system. The signals recorded are mainly from the cell layers on the brain surface because of the limited penetration of Ca2+-sensitive dyes. The densely packed cell bodies and their accessibility allow visualization of odor-induced population neural activity. It is revealed that odors evoke diffused neural activities in the MB. Although the signals cannot be attributed to individual neurons, patterns of the population neural activity can be analyzed. The activity pattern, but not the amplitude, of an odor-induced population response is specific for the chemical identity of an odor and its concentration. The distribution pattern of neural activity can be altered specifically by genetic manipulation of an odor binding protein and this alteration is closely associated with a behavioral defect of odor preference. These results suggest that the spatial pattern of the distributed neural activity may contribute to coding of odor information at the second relay of the olfactory system.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Tsing Hua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75235 USA	Cold Spring Harbor Laboratory; Tsinghua University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Zhong, Y (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.		Wang, Yalin/C-8362-2011	Zhong, Yi/0000-0001-7810-9899; Zhong, Yi/0000-0002-7927-5976	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD033098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034779] Funding Source: NIH RePORTER; NICHD NIH HHS [HD33098] Funding Source: Medline; NINDS NIH HHS [NS34779] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AYER RK, 1991, P NATL ACAD SCI USA, V88, P5467, DOI 10.1073/pnas.88.12.5467; BIEDENBACH MA, 1969, J NEUROPHYSIOL, V32, P204, DOI 10.1152/jn.1969.32.2.204; BOWER JM, 1990, INTRO NEURAL ELECTRO, P3; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CINELLI AR, 1995, J NEUROPHYSIOL, V73, P2053, DOI 10.1152/jn.1995.73.5.2053; Clyne PJ, 1999, NEURON, V22, P339, DOI 10.1016/S0896-6273(00)81094-6; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; DEBELLE JS, 1994, SCIENCE, V263, P69; Distler PG, 1998, BRAIN RES, V805, P263, DOI 10.1016/S0006-8993(98)00715-X; Duchamp-Viret P, 1999, SCIENCE, V284, P2171, DOI 10.1126/science.284.5423.2171; DUDAI Y, 1979, J COMP PHYSIOL, V130, P271, DOI 10.1007/BF00614614; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Galizia CG, 1999, NAT NEUROSCI, V2, P473, DOI 10.1038/8144; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; GUTHRIE KM, 1995, CHEM SENSES, V20, P271, DOI 10.1093/chemse/20.2.271; HekmatScafe DS, 1997, J NEUROSCI, V17, P1616; HELFAND SL, 1989, P NATL ACAD SCI USA, V86, P2908, DOI 10.1073/pnas.86.8.2908; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; IMAMURA K, 1992, J NEUROPHYSIOL, V68, P1986, DOI 10.1152/jn.1992.68.6.1986; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; KAUER JS, 1987, BRAIN RES, V418, P255, DOI 10.1016/0006-8993(87)90093-X; Kim MS, 1998, GENETICS, V150, P711; Krishnan B, 1999, NATURE, V400, P375, DOI 10.1038/22566; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Laurent G, 1998, LEARN MEMORY, V5, P124; Litaudon P, 1997, PROG NEUROBIOL, V52, P485, DOI 10.1016/S0301-0082(97)00027-0; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MCKENNA M, 1989, P NATL ACAD SCI USA, V86, P8118, DOI 10.1073/pnas.86.20.8118; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; PELOSI P, 1994, CRIT REV BIOCHEM MOL, V29, P199, DOI 10.3109/10409239409086801; RODRIGUES V, 1988, BRAIN RES, V453, P299, DOI 10.1016/0006-8993(88)90170-9; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P751, DOI 10.1152/jn.1995.74.2.751; SHARP FR, 1975, BRAIN RES, V98, P596, DOI 10.1016/0006-8993(75)90377-7; SHARP FR, 1977, J NEUROPHYSIOL, V40, P800, DOI 10.1152/jn.1977.40.4.800; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Trimarchi JR, 1997, J NEUROSCI, V17, P4700; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Vickers NJ, 1998, J COMP NEUROL, V400, P35; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; WANG Y, 2000, SOC NEUROSCI, V30; Wilson M, 1988, NEURAL INFORMATION P, P114; WOODARD C, 1989, GENETICS, V123, P315; WRIGHT NJD, 1995, J NEUROSCI, V15, P1025; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119	49	75	77	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	2001	29	1					267	276		10.1016/S0896-6273(01)00196-9	http://dx.doi.org/10.1016/S0896-6273(01)00196-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	397NX	11182097	Bronze			2022-12-24	WOS:000166702700025
J	Lim, DA; Tramontin, AD; Trevejo, JM; Herrera, DG; Garcia-Verdugo, JM; Alvarez-Buylla, A				Lim, DA; Tramontin, AD; Trevejo, JM; Herrera, DG; Garcia-Verdugo, JM; Alvarez-Buylla, A			Noggin antagonizes BMP signaling to create a niche for adult neurogenesis	NEURON			English	Article							BONE MORPHOGENETIC PROTEINS; CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; SUBVENTRICULAR ZONE; MAMMALIAN BRAIN; OLFACTORY-BULB; GROWTH-FACTOR; SPEMANN ORGANIZER; DOPAMINERGIC-NEURONS; CELLULAR COMPOSITION	Large numbers of new neurons are born continuously in the adult subventricular zone (SVZ). The molecular niche of SVZ stem cells is poorly understood. Here, we show that the bone morphogenetic protein (BMP) antagonist Noggin is expressed by ependymal cells adjacent to the SVZ. SVZ cells were found to express BMPs as well as their cognate receptors. BMPs potently inhibited neurogenesis both in vitro and in vivo. BMP signaling cell-autonomously blocked the production of neurons by SVZ precursors by directing glial differentiation. Purified mouse Noggin protein promoted neurogenesis in vitro and inhibited glial cell differentiation. Ectopic Noggin promoted neuronal differentiation of SVZ cells grafted to the striatum. We thus propose that ependymal Noggin production creates a neurogenic environment in the adjacent SVZ by blocking endogenous BMP signaling.	Rockefeller Univ, New York, NY 10021 USA; Univ Valencia, E-46100 Burjassot, Spain; Cornell Univ, Weill Med Coll, New York, NY 10021 USA	Rockefeller University; University of Valencia; Cornell University	Alvarez-Buylla, A (corresponding author), Univ Calif San Francisco, 3rd & Parnassus Ave, San Francisco, CA 94143 USA.	alvarez@mail.rockefeller.edu	García-Verdugo, José Manuel/L-8421-2017	García-Verdugo, José Manuel/0000-0001-9872-6499; Alvarez-Buylla, Arturo/0000-0003-4426-8925; Lim, Daniel/0000-0001-7221-3425	NICHD NIH HHS [HD32116] Funding Source: Medline; NIGMS NIH HHS [GM07739] Funding Source: Medline; NINDS NIH HHS [NS28478] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032116] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS028478, R01NS028478, R37NS028478] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akiyama S, 1997, EXP CELL RES, V235, P362, DOI 10.1006/excr.1997.3680; ALVAREZBUYLLA A, 1988, J NEUROSCI METH, V25, P165, DOI 10.1016/0165-0270(88)90155-0; ALVAREZBUYLLA A, 1987, J COMP NEUROL, V264, P159, DOI 10.1002/cne.902640203; Bachiller D, 2000, NATURE, V403, P658, DOI 10.1038/35001072; Barde Y A, 1994, Prog Clin Biol Res, V390, P45; BONFANTI L, 1994, NEUROSCIENCE, V62, P291, DOI 10.1016/0306-4522(94)90333-6; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Chen D, 1998, J CELL BIOL, V142, P295, DOI 10.1083/jcb.142.1.295; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Craig CG, 1996, J NEUROSCI, V16, P2649; Deprimo SE, 1996, TRANSGENIC RES, V5, P459, DOI 10.1007/BF01980211; DIDIER M, 1986, CELL TISSUE RES, V245, P343; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Ebendal T, 1998, J NEUROSCI RES, V51, P139, DOI 10.1002/(SICI)1097-4547(19980115)51:2<139::AID-JNR2>3.0.CO;2-E; Espejo M, 1999, NEUROSCI LETT, V275, P13, DOI 10.1016/S0304-3940(99)00708-9; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gaiano N, 1999, NAT NEUROSCI, V2, P812, DOI 10.1038/12186; Garcia-Verdugo J, 1998, J NEUROBIOL, V36, P234, DOI 10.1002/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E; Goldman SA, 1997, J NEUROBIOL, V32, P554, DOI 10.1002/(SICI)1097-4695(19970605)32:6<554::AID-NEU2>3.0.CO;2-Z; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Graham A, 1996, MOL CELL NEUROSCI, V8, P76, DOI 10.1006/mcne.1996.0046; Grinspan JB, 2000, J NEUROBIOL, V43, P1; Gritti A, 1999, J NEUROSCI, V19, P3287; Grondona JM, 1996, J NEUROPATH EXP NEUR, V55, P999, DOI 10.1097/00005072-199609000-00007; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Hattori A, 1999, J NEUROCHEM, V72, P2264, DOI 10.1046/j.1471-4159.1999.0722264.x; Herrera DG, 1999, ANN NEUROL, V46, P867, DOI 10.1002/1531-8249(199912)46:6<867::AID-ANA9>3.0.CO;2-Z; Jankovski A, 1996, J COMP NEUROL, V371, P376; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Jordan J, 1997, EUR J NEUROSCI, V9, P1699, DOI 10.1111/j.1460-9568.1997.tb01527.x; KIRSCHENBAUM B, 1995, P NATL ACAD SCI USA, V92, P210, DOI 10.1073/pnas.92.1.210; Kretzschmar M, 1997, GENE DEV, V11, P984, DOI 10.1101/gad.11.8.984; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Kuhn HG, 1996, J NEUROSCI, V16, P2027; LAMB TM, 1993, SCIENCE, V262, P713, DOI 10.1126/science.8235591; Li WW, 2000, DEV NEUROSCI-BASEL, V22, P68, DOI 10.1159/000017428; Li WW, 1998, J NEUROSCI, V18, P8853; Lim DA, 1999, P NATL ACAD SCI USA, V96, P7526, DOI 10.1073/pnas.96.13.7526; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Mabie PC, 1999, J NEUROSCI, V19, P7077, DOI 10.1523/JNEUROSCI.19-16-07077.1999; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Merino R, 1999, ANN NY ACAD SCI, V887, P120, DOI 10.1111/j.1749-6632.1999.tb07927.x; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Palmer TD, 1999, J NEUROSCI, V19, P8487; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; ROUGON G, 1986, J CELL BIOL, V103, P2429, DOI 10.1083/jcb.103.6.2429; ROUSSELOT P, 1995, J COMP NEUROL, V351, P51, DOI 10.1002/cne.903510106; Shah NM, 1997, P NATL ACAD SCI USA, V94, P11369, DOI 10.1073/pnas.94.21.11369; Shou J, 1999, NAT NEUROSCI, V2, P339, DOI 10.1038/7251; SMITH WC, 1993, NATURE, V361, P547, DOI 10.1038/361547a0; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Soderstrom S, 1996, CELL TISSUE RES, V286, P269, DOI 10.1007/s004410050697; Tropepe V, 1997, J NEUROSCI, V17, P7850; VALENZUELA DM, 1995, J NEUROSCI, V15, P6077; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Weiss S, 1996, J NEUROSCI, V16, P7599; Wilson PA, 1997, NEURON, V18, P699, DOI 10.1016/S0896-6273(00)80311-6; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Zhang DM, 1998, J NEUROSCI, V18, P3314; Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	71	821	899	3	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	2000	28	3					713	726		10.1016/S0896-6273(00)00148-3	http://dx.doi.org/10.1016/S0896-6273(00)00148-3			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386JJ	11163261	Bronze			2022-12-24	WOS:000166057500011
J	Pleasure, SJ; Anderson, S; Hevner, R; Bagri, A; Marin, O; Lowenstein, DH; Rubenstein, JLR				Pleasure, SJ; Anderson, S; Hevner, R; Bagri, A; Marin, O; Lowenstein, DH; Rubenstein, JLR			Cell migration from the ganglionic eminences is required for the development of hippocampal GABAergic interneurons	NEURON			English	Article							DEVELOPING CEREBRAL-CORTEX; DECARBOXYLASE IMMUNOREACTIVE CELLS; CAJAL-RETZIUS CELLS; RAT HIPPOCAMPUS; NEUROPEPTIDE-Y; MESSENGER-RNA; DENTATE GYRUS; HOMEOBOX GENE; DLX GENES; NEURONS	GABAergic interneurons have major roles in hippocampal function and dysfunction. Here we provide evidence that, in mice, virtually all of these cells originate from progenitors in the basal telencephalon. Immature interneurons tangentially migrate from the basal telencephalon through the neocortex to take up their final positions in the hippocampus. Disrupting differentiation in the embryonic basal telencephalon (lateral and medial ganglionic eminences) through loss of Dlx1/2 homeobox function blocks the migration of virtually ail GABAergic interneurons to the hippocampus. On the other hand, disrupting specification of the medial ganglionic eminence through loss of Nkw2.1 homeobox function depletes the hippocampus of a distinct subset of hippocampal interneurons. Loss of hippocampal interneurons does not appear to have major effects on the early development of hippocampal projection neurons nor on the pathfinding of afferrent tracts.	Harvard Univ, Sch Med, Program Brain Plast & Epileptogenesis, Boston, MA 02115 USA; Univ Calif San Francisco, Dept Neurol, Neurodev Disorders Lab, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94143 USA; Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Beth Israel Deaconess Medical Center	Lowenstein, DH (corresponding author), Harvard Univ, Sch Med, Program Brain Plast & Epileptogenesis, Boston, MA 02115 USA.	daniel_lowenstein@hms.harvard.edu; jlrr@cgl.ucsf.edu	Marin, Oscar/F-3856-2012	Marin, Oscar/0000-0001-6264-7027	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049428, R01MH051561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012462] Funding Source: NIH RePORTER; NIDA NIH HHS [R01DA12462] Funding Source: Medline; NIMH NIH HHS [R01 MH49428-01, R01 MH51561-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Acsady L, 1998, J NEUROSCI, V18, P3386; Alcantara S, 1996, EUR J NEUROSCI, V8, P1329, DOI 10.1111/j.1460-9568.1996.tb01595.x; Anderson S, 1999, CEREB CORTEX, V9, P646, DOI 10.1093/cercor/9.6.646; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; AvishaiEliner S, 1996, DEV BRAIN RES, V91, P159, DOI 10.1016/0165-3806(95)00158-1; Baraban SC, 1997, J NEUROSCI, V17, P8927, DOI 10.1523/jneurosci.17-23-08927.1997; Borrell V, 1999, EXP NEUROL, V156, P268, DOI 10.1006/exnr.1999.7022; Borrell V, 1999, J NEUROSCI, V19, P1345; Bulfone A, 1998, NEURON, V21, P1273, DOI 10.1016/S0896-6273(00)80647-9; Casarosa S, 1999, DEVELOPMENT, V126, P525; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; DELECEA L, 1995, MOL BRAIN RES, V32, P1, DOI 10.1016/0169-328X(95)00056-X; deLecea L, 1997, J NEUROSCI, V17, P5868; Deller T, 1999, EXP NEUROL, V156, P254, DOI 10.1006/exnr.1999.7021; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; Fode C, 2000, GENE DEV, V14, P67; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Galceran J, 2000, DEVELOPMENT, V127, P469; GALL C, 1984, NEUROSCIENCE, V11, P359, DOI 10.1016/0306-4522(84)90029-0; Grove EA, 1999, CEREB CORTEX, V9, P551, DOI 10.1093/cercor/9.6.551; GROVE EA, 1992, NEURON, V8, P217, DOI 10.1016/0896-6273(92)90289-P; HILL JM, 1994, J COMP NEUROL, V342, P186, DOI 10.1002/cne.903420204; Keverne EB, 1999, BRAIN RES BULL, V48, P467, DOI 10.1016/S0361-9230(99)00025-8; Lavdas AA, 1996, CEREB CORTEX, V6, P490, DOI 10.1093/cercor/6.3.490; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Lee SMK, 2000, DEVELOPMENT, V127, P457; LUSKIN MB, 1993, J NEUROSCI, V13, P1730; Mallamaci A, 2000, J NEUROSCI, V20, P1109, DOI 10.1523/JNEUROSCI.20-03-01109.2000; Marin O, 2000, J NEUROSCI, V20, P6063; Meyer G, 1999, CEREB CORTEX, V9, P765, DOI 10.1093/cercor/9.8.765; Mione MC, 1997, J NEUROSCI, V17, P2018; MIONE MC, 1994, J NEUROSCI, V14, P107; Parnavelas JG, 1991, CEREB CORTEX, V1, P463, DOI 10.1093/cercor/1.6.463; Pearlman AL, 1998, CURR OPIN NEUROBIOL, V8, P45, DOI 10.1016/S0959-4388(98)80007-X; Pellegrini M, 1996, DEVELOPMENT, V122, P3893; Porter FD, 1997, DEVELOPMENT, V124, P2935; PORTEUS MH, 1994, J NEUROSCI, V14, P6370; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Sloviter RS, 1996, J COMP NEUROL, V373, P593; SORIANO E, 1986, DEV BRAIN RES, V30, P88, DOI 10.1016/0165-3806(86)90134-3; SORIANO E, 1989, J COMP NEUROL, V281, P603, DOI 10.1002/cne.902810409; SORIANO E, 1989, J COMP NEUROL, V281, P586, DOI 10.1002/cne.902810408; Super H, 1998, J NEUROSCI, V18, P4616; Sussel L, 1999, DEVELOPMENT, V126, P3359; Swann J W, 1999, Adv Neurol, V79, P203; TAKEDA K, 1989, J NEUROCHEM, V53, P772, DOI 10.1111/j.1471-4159.1989.tb11772.x; Tamamaki N, 1997, J NEUROSCI, V17, P8313; TAN SS, 1993, NATURE, V362, P638, DOI 10.1038/362638a0; Tan SS, 1998, NEURON, V21, P295, DOI 10.1016/S0896-6273(00)80539-5; Tole S, 2000, J NEUROSCI, V20, P2618; Vezzani A, 1996, EPILEPSY RES, V26, P267, DOI 10.1016/S0920-1211(96)00059-9; Vezzani A, 1999, TRENDS NEUROSCI, V22, P25, DOI 10.1016/S0166-2236(98)01284-3; WALSH C, 1993, NATURE, V362, P632, DOI 10.1038/362632a0; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Yoshida M, 1997, DEVELOPMENT, V124, P101; Zhao YU, 1999, SCIENCE, V284, P1155, DOI 10.1126/science.284.5417.1155	60	281	285	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	2000	28	3					727	740		10.1016/S0896-6273(00)00149-5	http://dx.doi.org/10.1016/S0896-6273(00)00149-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386JJ	11163262	Bronze			2022-12-24	WOS:000166057500012
J	Taupin, P; Ray, J; Fischer, WH; Suhr, ST; Hakansson, K; Grubb, A; Gage, FH				Taupin, P; Ray, J; Fischer, WH; Suhr, ST; Hakansson, K; Grubb, A; Gage, FH			FGF-2-responsive neural stem cell proliferation requires CCg, a novel autocrine/paracrine cofactor	NEURON			English	Article							FIBROBLAST-GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; ADULT-MOUSE BRAIN; RAT CYSTATIN-C; DENTATE GYRUS; SUBVENTRICULAR ZONE; PROGENITOR CELLS; CYSTEINE PROTEINASES; GAMMA-TRACE; FACTOR-II	We have purified and characterized a factor, from the conditioned medium of neural stem cell cultures, which is required for fibroblast growth factor 2's (FGF-2) mitogenic activity on neural stem cells. This autocrine/paracrine cofactor is a glycosylated form of cystatin C (CCg), whose N-glycosylation is required for its activity. We further demonstrated that, both in vitro and in vivo, neural stem cells undergoing cell division are immunopositive for cystatin C. Finally, we showed in vivo functional activity of CCg by demonstrating that the combined delivery of FGF-2 and CCg to the adult dentate gyrus stimulated neurogenesis. We propose that the process of neurogenesis is controlled by the cooperation between trophic factors and autocrine/paracrine cofactors, of which CCS is a prototype.	Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Peptide Biol Lab, La Jolla, CA 92037 USA; Univ Lund Hosp, Dept Clin Chem, S-22185 Lund, Sweden	Salk Institute; Salk Institute; Lund University; Skane University Hospital	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Grubb, Anders/0000-0002-0125-3662	NIA NIH HHS [AG06088, AG08514, AG05131] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG008514, R01AG006088, R37AG008514] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baird Andrew, 1994, Current Opinion in Neurobiology, V4, P78, DOI 10.1016/0959-4388(94)90035-3; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P771; Caldwell MA, 1998, EXP NEUROL, V152, P1, DOI 10.1006/exnr.1998.6815; CAVINESS VS, 1973, J COMP NEUROL, V151, P113, DOI 10.1002/cne.901510203; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; ERICKSON CA, 1995, DEVELOPMENT, V121, P915; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; ESNARD A, 1988, BIOL CHEM H-S, V369, P219; ESNARD F, 1990, BIOL CHEM H-S, V371, P161; FISCHER WH, 1991, METHODS NEUROSCI, V6, P69; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; Galko MJ, 2000, SCIENCE, V289, P1365, DOI 10.1126/science.289.5483.1365; GONZALEZ AM, 1994, BRAIN RES, V665, P285, DOI 10.1016/0006-8993(94)91349-8; GOULD E, 1992, J NEUROSCI, V12, P3642; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; Gritti A, 1996, J NEUROSCI, V16, P1091; Hakansson K, 1996, COMP BIOCHEM PHYS B, V114, P303, DOI 10.1016/0305-0491(96)00025-9; HAMES BD, 1981, ELECTROPHORESIS PROT; Huh CG, 1999, J CLIN PATHOL-MOL PA, V52, P332, DOI 10.1136/mp.52.6.332; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; KEINANEN KP, 1988, BIOCHEM J, V256, P719, DOI 10.1042/bj2560719; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; KILPATRICK TJ, 1993, NEURON, V10, P255, DOI 10.1016/0896-6273(93)90316-J; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lein ES, 1999, P NATL ACAD SCI USA, V96, P13491, DOI 10.1073/pnas.96.23.13491; LEUNGTACK J, 1990, EXP CELL RES, V188, P16, DOI 10.1016/0014-4827(90)90272-C; LOFBERG H, 1979, SCAND J CLIN LAB INV, V39, P619, DOI 10.3109/00365517909108866; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MACHLEIDT W, 1989, FEBS LETT, V243, P234, DOI 10.1016/0014-5793(89)80135-8; MONTELARO RC, 1987, ELECTROPHORESIS, V8, P432, DOI 10.1002/elps.1150080912; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Palmer TD, 1999, J NEUROSCI, V19, P8487; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9; RAY J, 1995, J NEUROCHEM, V64, P503; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RICHARDS LJ, 1992, P NATL ACAD SCI USA, V89, P8591, DOI 10.1073/pnas.89.18.8591; ROGELJ S, 1988, NATURE, V331, P173, DOI 10.1038/331173a0; Roy NS, 2000, NAT MED, V6, P271; SAIRAM MR, 1989, FASEB J, V3, P1915, DOI 10.1096/fasebj.3.8.2542111; Shihabuddin LS, 1997, EXP NEUROL, V148, P577, DOI 10.1006/exnr.1997.6697; SLOANE BF, 1990, CANCER METAST REV, V9, P333, DOI 10.1007/BF00049523; SOLEM M, 1990, BIOCHEM BIOPH RES CO, V172, P945, DOI 10.1016/0006-291X(90)90767-H; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.3.CO;2-H; Takahashi M, 1998, MOL CELL NEUROSCI, V12, P340, DOI 10.1006/mcne.1998.0721; TEMPLE S, 1989, NATURE, V340, P471, DOI 10.1038/340471a0; TURK V, 1991, FEBS LETT, V285, P213, DOI 10.1016/0014-5793(91)80804-C; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A; Wagner JP, 1999, J NEUROSCI, V19, P6006, DOI 10.1523/JNEUROSCI.19-14-06006.1999; WARFEL AH, 1987, J EXP MED, V166, P1912, DOI 10.1084/jem.166.6.1912; YASUHARA O, 1993, BRAIN RES, V628, P85, DOI 10.1016/0006-8993(93)90941-F	64	266	286	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	2000	28	2					385	397		10.1016/S0896-6273(00)00119-7	http://dx.doi.org/10.1016/S0896-6273(00)00119-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	377CE	11144350	Bronze			2022-12-24	WOS:000165493700015
J	Alloway, PG; Howard, L; Dolph, PJ				Alloway, PG; Howard, L; Dolph, PJ			The formation of stable rhodopsin-arrestin complexes induces apoptosis and photoreceptor cell degeneration	NEURON			English	Article							DOMINANT RETINITIS-PIGMENTOSA; NORPA PHOTOTRANSDUCTION MUTANT; LIGHT-SENSITIVE CHANNELS; RETINAL DEGENERATION; DROSOPHILA-MELANOGASTER; PROTEIN-KINASE; GENETIC DISSECTION; VISUAL ARRESTIN; BETA-ARRESTIN; WILD-TYPE	Although many different mutations in humans and Drosophila cause retinal degeneration, in most cases, a molecular mechanism for the degeneration has not been found. We now demonstrate the existence of stable, persistent complexes between rhodopsin and its regulatory protein arrestin in several different retinal degeneration mutants. Elimination of these rhodopsin-arrestin complexes by removing either rhodopsin or arrestin rescues the degeneration phenotype. Furthermore, we show that the accumulation of these complexes triggers apoptotic cell death and that the observed retinal degeneration requires the endocytic machinery. This suggests that the endocytosis of rhodopsin-arrestin complexes is a molecular mechanism for the initiation of retinal degeneration. We propose that an identical mechanism may be responsible for the pathology found in a subset of human retinal degenerative disorders.	Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA	Dartmouth College	Dolph, PJ (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.				NEI NIH HHS [R01 EY11534-02] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011534] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Alloway PG, 1999, P NATL ACAD SCI USA, V96, P6072, DOI 10.1073/pnas.96.11.6072; ALMAGHTHEH M, 1993, HUM MUTAT, V2, P249, DOI 10.1002/humu.1380020403; BENTROP J, 1993, EUR J BIOCHEM, V216, P67, DOI 10.1111/j.1432-1033.1993.tb18117.x; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; BHATTACHARYA S, 1991, LANCET, V337, P185, DOI 10.1016/0140-6736(91)90858-M; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Davidson FF, 1998, NATURE, V391, P587, DOI 10.1038/35385; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; DOLPH PJ, 1994, NATURE, V370, P59, DOI 10.1038/370059a0; DRYJA TP, 1992, EYE, V6, P1; DRYJA TP, 1995, HUM MOL GENET, V4, P1739, DOI 10.1093/hmg/4.suppl_1.1739; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; GRIGLIATTI TA, 1973, MOL GEN GENET, V120, P107, DOI 10.1007/BF00267238; HARDIE RC, 1991, P ROY SOC B-BIOL SCI, V245, P203, DOI 10.1098/rspb.1991.0110; HARRIS WA, 1977, J GEN PHYSIOL, V69, P261, DOI 10.1085/jgp.69.3.261; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hirosawa K., 1982, P45; HOTTA Y, 1970, P NATL ACAD SCI USA, V67, P1156, DOI 10.1073/pnas.67.3.1156; Kahn ES, 1997, J NEUROCHEM, V68, P169; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; LARRIVEE DC, 1981, J GEN PHYSIOL, V78, P521, DOI 10.1085/jgp.78.5.521; LI TS, 1995, P NATL ACAD SCI USA, V92, P3551, DOI 10.1073/pnas.92.8.3551; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; Liu CD, 1999, J NEUROSCI, V19, P4778; MATSUMOTO H, 1982, SCIENCE, V217, P839, DOI 10.1126/science.7100927; MATSUMOTO H, 1994, NEURON, V12, P997, DOI 10.1016/0896-6273(94)90309-3; MEYERTHOLEN EP, 1987, J COMP PHYSIOL A, V161, P793, DOI 10.1007/BF00610221; NICHOLS R, 1985, DROSOPH INF SERV, V61, P195; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; OSTROY SE, 1978, J GEN PHYSIOL, V72, P717, DOI 10.1085/jgp.72.5.717; Paetkau DW, 1999, GENETICS, V151, P713; RANGANATHAN R, 1991, NATURE, V354, P230, DOI 10.1038/354230a0; RAO VR, 1994, NATURE, V367, P639, DOI 10.1038/367639a0; RIM J, 1995, BIOCHEMISTRY-US, V34, P11938, DOI 10.1021/bi00037a035; ROBINSON PR, 1994, P NATL ACAD SCI USA, V91, P5411, DOI 10.1073/pnas.91.12.5411; ROBINSON PR, 1992, NEURON, V9, P719, DOI 10.1016/0896-6273(92)90034-B; SAHLY I, 1994, VISUAL NEUROSCI, V11, P763, DOI 10.1017/S0952523800003060; SHOKRAVI MT, 1993, INT OPHTHALMOL CLIN, V33, P219, DOI 10.1097/00004397-199303320-00020; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; STARK WS, 1983, J INSECT PHYSIOL, V29, P123, DOI 10.1016/0022-1910(83)90135-X; STARK WS, 1989, J NEUROGENET, V5, P49, DOI 10.3109/01677068909167264; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; SUNG CH, 1993, J BIOL CHEM, V268, P26645; Van Soest S, 1999, SURV OPHTHALMOL, V43, P321, DOI 10.1016/S0039-6257(98)00046-0; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; WILSON MJ, 1987, J COMP PHYSIOL A, V161, P785, DOI 10.1007/BF00610220; ZINKL GM, 1990, VISUAL NEUROSCI, V5, P429, DOI 10.1017/S0952523800000559; Zuker Charles S., 1992, Current Opinion in Neurobiology, V2, P622, DOI 10.1016/0959-4388(92)90029-K	52	185	189	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	2000	28	1					129	138		10.1016/S0896-6273(00)00091-X	http://dx.doi.org/10.1016/S0896-6273(00)00091-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	370VN	11086989	Bronze			2022-12-24	WOS:000165143500016
J	Edmonds, B; Reyes, R; Schwaller, B; Roberts, WM				Edmonds, B; Reyes, R; Schwaller, B; Roberts, WM			Calretinin modifies presynaptic calcium signaling in frog saccular hair cells	NATURE NEUROSCIENCE			English	Article							BINDING PROTEIN; NEUROTRANSMITTER RELEASE; MONOCLONAL-ANTIBODIES; SYNAPTIC TRANSMISSION; NERVOUS-SYSTEM; CA2+; MICRODOMAINS; CALBINDIN; NEURONS; BUFFER	To determine whether the concentrations of calcium-binding proteins present in some neurons and sensory cells are sufficient to influence presynaptic calcium signaling, we studied the predominant calcium-binding protein in a class of sensory hair cells in the frog ear. Based on antibody affinity and molecular weight, we identified this protein as calretinin. We measured its cytoplasmic concentration to be similar to1.2 mM, sufficient to bind similar to6 mM Ca2+. Calcium signaling was altered when the diffusible cytoplasmic components were replaced by an intracellular solution lacking any fast calcium buffer, and was restored by the addition of 1.2 mM exogenous calretinin to the intracellular solution. We conclude that calretinin, when present at millimolar concentration, can serve as a diffusionally mobile calcium buffer/transporter capable of regulating calcium signaling over nanometer distances at presynaptic sites.	Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; Univ Fribourg, Inst Histol & Gen Embryol, CH-1705 Fribourg, Switzerland	University of Oregon; University of Fribourg	Edmonds, B (corresponding author), Univ Calif Los Angeles, Med Ctr, Dept Neurobiol, 650 Charles E Young Dr S, Los Angeles, CA 90095 USA.			Roberts, William/0000-0001-9762-4255; Schwaller, Beat/0000-0002-8277-7555				ADLER EM, 1991, J NEUROSCI, V11, P1496; Airaksinen MS, 1997, EUR J NEUROSCI, V9, P120, DOI 10.1111/j.1460-9568.1997.tb01360.x; Armstrong CE, 1998, J NEUROSCI, V18, P2962; BAIMBRIDGE KG, 1992, TRENDS NEUROSCI, V15, P303, DOI 10.1016/0166-2236(92)90081-I; Billing-Marczak K, 1999, POL J PHARMACOL, V51, P173; CELIO MR, 1990, CELL CALCIUM, V11, P599, DOI 10.1016/0143-4160(90)90014-L; Chabbert CH, 1997, PFLUG ARCH EUR J PHY, V435, P82, DOI 10.1007/s004240050486; Dong WJ, 1996, J BIOL CHEM, V271, P688, DOI 10.1074/jbc.271.2.688; Gillespie PG, 1997, ANAL BIOCHEM, V246, P239, DOI 10.1006/abio.1997.2019; GONA AG, 1986, BRAIN BEHAV EVOLUT, V29, P176, DOI 10.1159/000118679; Hall JD, 1997, BIOPHYS J, V73, P1243, DOI 10.1016/S0006-3495(97)78157-8; Kuznicki J, 1996, BBA-MOL CELL RES, V1313, P194, DOI 10.1016/0167-4889(96)00089-4; Lenzi D, 1999, J NEUROSCI, V19, P119, DOI 10.1523/JNEUROSCI.19-01-00119.1999; Lephart ED, 1999, NEUROSCI LETT, V267, P41, DOI 10.1016/S0304-3940(99)00326-2; LUMPKIN EA, 1995, P NATL ACAD SCI USA, V92, P10297, DOI 10.1073/pnas.92.22.10297; MOFFAT AJM, 1976, J COMP PHYSIOL, V105, P1, DOI 10.1007/BF01380048; Naraghi M, 1997, J NEUROSCI, V17, P6961; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; OBERHOLTZER JC, 1988, P NATL ACAD SCI USA, V85, P3387, DOI 10.1073/pnas.85.10.3387; Ohana O, 1998, J PHYSIOL-LONDON, V513, P135, DOI 10.1111/j.1469-7793.1998.135by.x; Ouanounou A, 1996, NEUROSCIENCE, V75, P99, DOI 10.1016/0306-4522(96)00319-3; PINOL MR, 1990, J NEUROCHEM, V54, P1827, DOI 10.1111/j.1471-4159.1990.tb04879.x; Ricci AJ, 1998, J NEUROSCI, V18, P8261; ROBERTS WM, 1993, NATURE, V363, P74, DOI 10.1038/363074a0; ROBERTS WM, 1994, J NEUROSCI, V14, P3246; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; ROGERS JH, 1987, J CELL BIOL, V105, P1343, DOI 10.1083/jcb.105.3.1343; Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0; Schwartz RD, 1997, CAN J SOCIOL, V22, P272, DOI 10.2307/3341757; SHEPHERD GMG, 1989, P NATL ACAD SCI USA, V86, P4973, DOI 10.1073/pnas.86.13.4973; Stevens J, 1997, PROTEIN EXPRES PURIF, V9, P171, DOI 10.1006/prep.1996.0677; Tucker TR, 1996, J PHYSIOL-LONDON, V494, P613, DOI 10.1113/jphysiol.1996.sp021519; Winsky L, 1996, J NEUROCHEM, V66, P764; Wu YC, 1996, BIOPHYS J, V71, P2256, DOI 10.1016/S0006-3495(96)79429-8	34	108	110	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2000	3	8					786	790		10.1038/77687	http://dx.doi.org/10.1038/77687			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TU	10903571				2022-12-24	WOS:000167177300013
J	Janssen, P; Vogels, R; Orban, GA				Janssen, P; Vogels, R; Orban, GA			Three-dimensional shape coding in inferior temporal cortex	NEURON			English	Article							MACAQUE MONKEY; INFEROTEMPORAL CORTEX; RHESUS-MONKEY; VISUAL IMAGES; NEURONS; DISPARITY; SELECTIVITY; SENSITIVITY; STEREOPSIS; SURFACES	Neurons in the rostral lower bank of the superior temporal sulcus (TEs), part of the inferior temporal cortex, respond selectively to three-dimensional (3D) shapes. We have investigated how these neurons represent disparity-defined 3D structure. Most neurons were selective for either first-order (disparity gradients) or second-order (disparity curvature) disparities. The latter selectivity proved remarkably vulnerable to disparity discontinuities, such as sharp edges or steps in disparity. The majority of the neurons remained selective for small disparity variations within the stimulus. 3D shape selectivity was preserved when the fronto-parallel position or the stimulus size was altered. Thus, in TEs, 3D shape is coded by first- and second-order disparity-selective neurons, which are highly sensitive to spatial variations of disparity.	Katholieke Univ Leuven, Sch Med, Neuro & Psychofysiol Lab, B-3000 Louvain, Belgium	KU Leuven	Orban, GA (corresponding author), Katholieke Univ Leuven, Sch Med, Neuro & Psychofysiol Lab, Campus Gasthuisberg,Herestr 49, B-3000 Louvain, Belgium.	guy.orban@med.kuleuven.ac.be		Orban, Guy/0000-0002-8179-9584				BAIZER JS, 1991, J NEUROSCI, V11, P168; BURKHALTER A, 1986, J NEUROSCI, V6, P2327; Cumming BG, 1999, J NEUROSCI, V19, P5602; DEAN P, 1976, PSYCHOL BULL, V83, P41, DOI 10.1037/0033-2909.83.1.41; DESIMONE R, 1979, BRAIN RES, V178, P363, DOI 10.1016/0006-8993(79)90699-1; DESIMONE R, 1984, J NEUROSCI, V4, P2051; GATTASS R, 1988, J NEUROSCI, V8, P1831; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; HARWERTH RS, 1995, VISION RES, V35, P1755, DOI 10.1016/0042-6989(94)00256-L; HARWERTH RS, 1979, VISION RES, V19, P985, DOI 10.1016/0042-6989(79)90223-2; Howard IP, 1995, BINOCULAR VISION STE; ITO M, 1995, J NEUROPHYSIOL, V73, P218, DOI 10.1152/jn.1995.73.1.218; IWAI E, 1969, EXP NEUROL, V25, P585, DOI 10.1016/0014-4886(69)90101-0; Janssen P, 2000, SCIENCE, V288, P2054, DOI 10.1126/science.288.5473.2054; Janssen P, 1999, P NATL ACAD SCI USA, V96, P8217, DOI 10.1073/pnas.96.14.8217; Janssen P, 1998, DOC OPHTHALMOL, V95, P247, DOI 10.1023/A:1001848105993; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kirk R.E., 1968, EXPT DESIGN PROCEDUR; KOENDERINK JJ, 1976, BIOL CYBERN, V21, P29, DOI 10.1007/BF00326670; KOMATSU H, 1992, J NEUROSCI, V12, P408; LOWE D, 1986, PERCEPTUAL ORG 3 DIM; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1148, DOI 10.1152/jn.1983.49.5.1148; NORMAN JF, 1991, PERCEPTION, V20, P789, DOI 10.1068/p200789; POGGIO GF, 1988, J NEUROSCI, V8, P4531; POGGIO GF, 1977, J NEUROPHYSIOL, V40, P1392, DOI 10.1152/jn.1977.40.6.1392; Prince SJD, 1998, VISION RES, V38, P2533, DOI 10.1016/S0042-6989(98)00118-7; ROGERS B, 1989, NATURE, V339, P135, DOI 10.1038/339135a0; ROY JP, 1992, J NEUROSCI, V12, P2478; SARY G, 1993, SCIENCE, V260, P995, DOI 10.1126/science.8493538; SATO T, 1980, EXP BRAIN RES, V38, P313; SCHWARTZ EL, 1983, P NATL ACAD SCI-BIOL, V80, P5776, DOI 10.1073/pnas.80.18.5776; SELTZER B, 1978, BRAIN RES, V149, P1, DOI 10.1016/0006-8993(78)90584-X; Shikata E, 1996, NEUROREPORT, V7, P2389, DOI 10.1097/00001756-199610020-00022; STEVENS KA, 1988, VISION RES, V28, P371, DOI 10.1016/0042-6989(88)90180-0; Taira M, 2000, J NEUROPHYSIOL, V83, P3140, DOI 10.1152/jn.2000.83.5.3140; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Vogels R, 1999, EUR J NEUROSCI, V11, P1239, DOI 10.1046/j.1460-9568.1999.00531.x; WEISKRANTZ L, 1984, BRAIN, V107, P1033, DOI 10.1093/brain/107.4.1033	39	143	146	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	2000	27	2					385	397		10.1016/S0896-6273(00)00045-3	http://dx.doi.org/10.1016/S0896-6273(00)00045-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	347YD	10985357	Green Published, Bronze			2022-12-24	WOS:000088956000021
J	Spanswick, D; Smith, MA; Mirshamsi, S; Routh, VH; Ashford, MLJ				Spanswick, D; Smith, MA; Mirshamsi, S; Routh, VH; Ashford, MLJ			Insulin activates ATP-sensitive K+ channels in hypothalamic neurons of lean, but not obese rats	NATURE NEUROSCIENCE			English	Article							REDUCES FOOD-INTAKE; LEPTIN RECEPTOR; FATTY MUTATION; BODY-WEIGHT; ZUCKER RATS; EXPRESSION		Univ Aberdeen, Aberdeen Ctr Energy Regulat & Obes, Inst Med Sci, Dept Biomed Sci, Aberdeen AB25 2ZD, Scotland	University of Aberdeen	Ashford, MLJ (corresponding author), Univ Aberdeen, Aberdeen Ctr Energy Regulat & Obes, Inst Med Sci, Dept Biomed Sci, Aberdeen AB25 2ZD, Scotland.		Smith, Mark/K-5792-2017	Smith, Mark/0000-0003-1474-5225; Ashford, Michael/0000-0002-0861-7676				Anai M, 1998, DIABETES, V47, P13, DOI 10.2337/diabetes.47.1.13; ASHFORD MLJ, 1990, PFLUG ARCH EUR J PHY, V415, P479, DOI 10.1007/BF00373626; ASHFORD MLJ, 1990, BRIT J PHARMACOL, V101, P531, DOI 10.1111/j.1476-5381.1990.tb14116.x; Crouse JA, 1998, J BIOL CHEM, V273, P18365, DOI 10.1074/jbc.273.29.18365; da Silva BA, 1998, ENDOCRINOLOGY, V139, P3681, DOI 10.1210/en.139.9.3681; Harvey J, 2000, J BIOL CHEM, V275, P4660, DOI 10.1074/jbc.275.7.4660; IKEDA H, 1986, APPETITE, V7, P381, DOI 10.1016/S0195-6663(86)80006-X; Jiang ZY, 1999, J CLIN INVEST, V104, P447, DOI 10.1172/JCI5971; Phillips MS, 1996, NAT GENET, V13, P18, DOI 10.1038/ng0596-18; SCHWARTZ MW, 1992, ENDOCR REV, V13, P387, DOI 10.1210/er.13.3.387; Seeley RJ, 1996, HORM METAB RES, V28, P664, DOI 10.1055/s-2007-979874; Shepherd PR, 1998, BIOCHEM J, V333, P471, DOI 10.1042/bj3330471; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; White DW, 1997, P NATL ACAD SCI USA, V94, P10657, DOI 10.1073/pnas.94.20.10657; Yamashita T, 1997, DIABETES, V46, P1077, DOI 10.2337/diabetes.46.6.1077	15	402	430	0	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2000	3	8					757	758		10.1038/77660	http://dx.doi.org/10.1038/77660			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TU	10903566				2022-12-24	WOS:000167177300008
J	Kuromi, H; Kidokoro, Y				Kuromi, H; Kidokoro, Y			Tetanic stimulation recruits vesicles from reserve pool via a cAMP-mediated process in Drosophila synapses	NEURON			English	Article							NEUROMUSCULAR-JUNCTION; SYNAPTIC VESICLES; CALCIUM CALMODULIN; ADENYLATE-CYCLASE; PROTEIN-KINASE; DISTINCT POOLS; CELLS; MELANOGASTER; MOBILIZATION; RUTABAGA	At Drosophila neuromuscular junctions, there are two synaptic vesicle pools, namely the exo/endo cycling pool (ECP) and the reserve pool (RP). We studied the recruitment process from RP using a fluorescent dye, FM1-43. During high-frequency nerve stimulation, vesicles in RP were recruited for release, and endocytosed vesicles were incorporated into both pools, whereas with low-frequency stimulation, vesicles were incorporated into and released from ECP. Release of vesicles from RP was detected electrophysiologically after emptying vesicles in the ECP of transmitter by a H+ pump inhibitor. Recruitment from RP was depressed by inhibitors of steps in the cAMP/PKA cascade and enhanced by their activators. In rutabaga (rut) with low cAMP levels, mobilization of vesicles from RP during tetanic stimulation was depressed, while it was enhanced in dunce (dnc) with high cAMP levels.	Gunma Univ, Sch Med, Inst Behav Sci, Maebashi, Gumma 3718511, Japan	Gunma University	Kuromi, H (corresponding author), Gunma Univ, Sch Med, Inst Behav Sci, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan.							AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BIRKS R, 1961, CAN J BIOCHEM PHYS, V39, P787, DOI 10.1139/o61-081; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; BYERS D, 1981, NATURE, V289, P79, DOI 10.1038/289079a0; Cousin MA, 1997, J NEUROCHEM, V69, P1927; DIXON D, 1989, J NEUROSCI, V9, P4246; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; HARRIS DN, 1979, J CYCLIC NUCL PROT, V5, P125; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; KOENIG JH, 1993, J NEUROSCI, V13, P2313, DOI 10.1523/JNEUROSCI.13-06-02313.1993; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Kuromi H, 1997, NEUROSCI RES, V27, P101, DOI 10.1016/S0168-0102(96)01132-7; Kuromi H, 1999, J NEUROSCI, V19, P1557; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P5656, DOI 10.1073/pnas.86.14.5656; PARKERBOTELHO LH, 1988, METHOD ENZYMOL, V159, P159; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; PRADO MAM, 1992, J NEUROCHEM, V59, P544, DOI 10.1111/j.1471-4159.1992.tb09404.x; Prekeris R, 1997, J CELL BIOL, V137, P1589, DOI 10.1083/jcb.137.7.1589; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; SANDBERG M, 1991, BIOCHEM J, V279, P521, DOI 10.1042/bj2790521; SIMPSON LL, 1994, J PHARMACOL EXP THER, V269, P256; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Zhang DW, 1999, NEUROPHARMACOLOGY, V38, P645, DOI 10.1016/S0028-3908(98)00232-9; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967	29	136	137	1	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL	2000	27	1					133	143		10.1016/S0896-6273(00)00015-5	http://dx.doi.org/10.1016/S0896-6273(00)00015-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339XU	10939337	Bronze			2022-12-24	WOS:000088503800016
J	Hansel, C; Linden, DJ				Hansel, C; Linden, DJ			Long-term depression of the cerebellar climbing fiber-Purkinje neuron synapse	NEURON			English	Article							PROTEIN-KINASE-C; NITRIC-OXIDE SYNTHASE; ELECTRO-PHYSIOLOGICAL PROPERTIES; RECEPTOR DELTA-2 SUBUNIT; MICE LACKING MGLUR1; RAT CEREBELLUM; GLUTAMATE RECEPTORS; MUTANT MICE; CELLULAR MECHANISMS; MOTOR COORDINATION	In classic Marr-Albus-Ito models of cerebellar function, coactivation of the climbing fiber (CF) synapse, which provides massive, invariant excitation of Purkinje neurons (coding the unconditioned stimulus), together with a graded parallel fiber synaptic array (coding the conditioned stimulus) leads to long-term depression (LTD) of parallel fiber-Purkinje neuron synapses, underlying production of a conditioned response. Here, we show that the supposedly invariant CF synapse can also express LTD. Brief 5 Hz stimulation of the CF resulted in a sustained depression of CF EPSCs that did not spread to neighboring parallel fiber synapses. Like parallel fiber LTD, CF LTD required postsynaptic Ca2+ elevation, activation of group 1 mGluRs, and activation of PKC. CF LTD is potentially relevant for models of cerebellar motor control and learning and the developmental conversion from multiple to single CF innervation of Purkinje neurons.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Erasmus Univ, Dept Anat, NL-3000 DR Rotterdam, Netherlands	Johns Hopkins University; Erasmus University Rotterdam	Linden, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051106, R37MH051106, R29MH051106] Funding Source: NIH RePORTER; NIMH NIH HHS [MH01590, MH51106] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Aizenman CD, 2000, NAT NEUROSCI, V3, P109, DOI 10.1038/72049; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; ASE K, 1988, J NEUROSCI, V8, P3850; Batchelor AM, 1997, NATURE, V385, P74, DOI 10.1038/385074a0; BAUDE A, 1994, J NEUROSCI, V14, P2830; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; Callaway JC, 1997, J NEUROPHYSIOL, V77, P145, DOI 10.1152/jn.1997.77.1.145; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; CREPEL F, 1988, BRAIN RES, V458, P397, DOI 10.1016/0006-8993(88)90486-6; CREPEL F, 1976, J NEUROBIOL, V7, P567, DOI 10.1002/neu.480070609; Daniel H, 1998, TRENDS NEUROSCI, V21, P401, DOI 10.1016/S0166-2236(98)01304-6; De Zeeuw CI, 1998, TRENDS NEUROSCI, V21, P391, DOI 10.1016/S0166-2236(98)01310-1; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; DESCHUTTER E, 1995, TRENDS NEUROSCI, V18, P291, DOI 10.1016/0166-2236(95)93916-L; Dittman JS, 1998, J NEUROSCI, V18, P6147; ECCLES JC, 1966, J PHYSIOL-LONDON, V182, P268, DOI 10.1113/jphysiol.1966.sp007824; HARTELL NA, 1994, NEUROREPORT, V5, P833, DOI 10.1097/00001756-199403000-00024; Hashimoto K, 1998, J PHYSIOL-LONDON, V506, P391, DOI 10.1111/j.1469-7793.1998.391bw.x; HASHIMOTO T, 1988, J NEUROSCI, V8, P1678; HIRANO T, 1995, NEUROREPORT, V6, P524, DOI 10.1097/00001756-199502000-00029; IKEDA M, 1993, NEUROSCI LETT, V155, P148, DOI 10.1016/0304-3940(93)90694-G; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; Ito M, 1984, CEREBELLUM NEURAL CO; Jeromin A, 1996, J NEUROPHYSIOL, V76, P3578, DOI 10.1152/jn.1996.76.5.3578; Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7; KANO M, 1987, NATURE, V325, P276, DOI 10.1038/325276a0; Kano M, 1997, NEURON, V18, P71, DOI 10.1016/S0896-6273(01)80047-7; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; Kano M, 1998, P NATL ACAD SCI USA, V95, P15724, DOI 10.1073/pnas.95.26.15724; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Kim JJ, 1997, TRENDS NEUROSCI, V20, P177, DOI 10.1016/S0166-2236(96)10081-3; KNOPFEL T, 1991, EUR J NEUROSCI, V3, P343, DOI 10.1111/j.1460-9568.1991.tb00821.x; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; KRUPA M, 1990, EUR J NEUROSCI, V2, P312, DOI 10.1111/j.1460-9568.1990.tb00423.x; Landsend AS, 1997, J NEUROSCI, V17, P834, DOI 10.1523/jneurosci.17-02-00834.1997; LASSERROSS N, 1992, P ROY SOC B-BIOL SCI, V247, P35, DOI 10.1098/rspb.1992.0006; LevRam V, 1997, NEURON, V18, P1025, DOI 10.1016/S0896-6273(00)80340-2; LEVRAM V, 1995, NEURON, V15, P407, DOI 10.1016/0896-6273(95)90044-6; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; Llinas R, 1997, LEARN MEMORY, V3, P445, DOI 10.1101/lm.3.6.445; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; Lohof AM, 1996, REV NEUROSCIENCE, V7, P85; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; NUSSER Z, 1994, NEUROSCIENCE, V61, P421, DOI 10.1016/0306-4522(94)90421-9; Offermanns S, 1997, P NATL ACAD SCI USA, V94, P14089, DOI 10.1073/pnas.94.25.14089; PELLICCIARI R, 1995, J MED CHEM, V38, P3717, DOI 10.1021/jm00019a002; PERKEL DJ, 1990, P ROY SOC B-BIOL SCI, V241, P116, DOI 10.1098/rspb.1990.0074; ROSEMUND C, 1992, J NEUROPHYSIOL, V68, P1901, DOI 10.1152/jn.1992.68.5.1901; ROSS WN, 1987, J PHYSIOL-LONDON, V389, P319, DOI 10.1113/jphysiol.1987.sp016659; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; SHIGEMOTO R, 1994, NEURON, V12, P1245, DOI 10.1016/0896-6273(94)90441-3; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Simpson JI, 1996, BEHAV BRAIN SCI, V19, P384, DOI 10.1017/S0140525X00081486; Strata P, 1998, TRENDS NEUROSCI, V21, P407, DOI 10.1016/S0166-2236(98)01305-8; STUART G, 1994, NEURON, V13, P703, DOI 10.1016/0896-6273(94)90037-X; VINCENT SR, 1992, NEUROSCIENCE, V46, P755, DOI 10.1016/0306-4522(92)90184-4; YOKOYAMA CT, 1995, J NEUROSCI, V15, P6419; Zhao HM, 1998, J NEUROSCI, V18, P5517, DOI 10.1523/JNEUROSCI.18-14-05517.1998; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	64	177	178	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	2000	26	2					473	482		10.1016/S0896-6273(00)81179-4	http://dx.doi.org/10.1016/S0896-6273(00)81179-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318QZ	10839365	Bronze			2022-12-24	WOS:000087296500023
J	Liebl, EC; Forsthoefel, DJ; Franco, LS; Sample, SH; Hess, JE; Cowger, JA; Chandler, MP; Shupert, AM; Seeger, MA				Liebl, EC; Forsthoefel, DJ; Franco, LS; Sample, SH; Hess, JE; Cowger, JA; Chandler, MP; Shupert, AM; Seeger, MA			Dosage-sensitive, reciprocal genetic interactions between the Abl tyrosine kinase and the putative GEF trio reveal trio's role in axon pathfinding	NEURON			English	Article							EXCHANGE FACTOR DOMAINS; DROSOPHILA-ABL; ACTIN CYTOSKELETON; SUBCELLULAR-LOCALIZATION; SEVENLESS PROTEIN; PHOSPHATASE DLAR; SMALL GTPASES; FASCICLIN-I; GUIDANCE; RECEPTOR	The Abelson tyrosine kinase (Abl) is integrated into signal transduction networks regulating axon outgrowth. We have identified the Drosophila trio gene through a mutation that exacerbates the Abl mutant phenotype. Drosophila Trio is an ortholog of mammalian Trio, a protein that contains multiple spectrin-like repeats and two Dbl homology (DH) domains that affect actin cytoskeletal dynamics via the small GTPases Rho and Rac. Phenotypic analysis demonstrates that trio and Abl cooperate in regulating axon outgrowth in the embryonic central nervous system (CNS). Dosage-sensitive interactions between trio and Abl, failed axon connections (fax), and enabled (ena) indicate that Trio is integrated into common signaling networks with these gene products. These observations suggest a mechanism by which Abl-mediated signaling networks influence the actin cytoskeleton in neuronal growth cones.	Denison Univ, Dept Biol, Granville, OH 43023 USA; Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; Ohio State Univ, Neurobiotechnol Ctr, Columbus, OH 43210 USA	Denison University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Liebl, EC (corresponding author), Denison Univ, Dept Biol, Granville, OH 43023 USA.	liebl@denison.edu	Hess, Jon/F-5124-2012	Hess, Jon/0000-0002-3643-202X; Cowger, Jennifer/0000-0002-0791-6594; Forsthoefel, David/0000-0002-8583-4383	NATIONAL CANCER INSTITUTE [R15CA070890] Funding Source: NIH RePORTER; NCI NIH HHS [R15-CA70890] Funding Source: Medline; NINDS NIH HHS [NS-32836] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahern-Djamali SM, 1998, MOL BIOL CELL, V9, P2157, DOI 10.1091/mbc.9.8.2157; Alam MR, 1997, J BIOL CHEM, V272, P12667, DOI 10.1074/jbc.272.19.12667; Ashburner M., 1989, DROSOPHILA LAB HDB; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Bate Michael, 1993, P1013; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Bellanger JM, 1998, ONCOGENE, V16, P147, DOI 10.1038/sj.onc.1201532; BENDER W, 1983, SCIENCE, V221, P23, DOI 10.1126/science.221.4605.23; BENNETT RL, 1992, DEVELOPMENT, V116, P953; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROWER DL, 1989, NATURE, V342, P285, DOI 10.1038/342285a0; CALLAHAN CA, 1995, NATURE, V376, P171, DOI 10.1038/376171a0; Comer AR, 1998, MOL CELL BIOL, V18, P152, DOI 10.1128/MCB.18.1.152; Deak P, 1997, GENETICS, V147, P1697; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; EATON S, 1995, J CELL BIOL, V131, P151, DOI 10.1083/jcb.131.1.151; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; Elshamy WM, 1996, DEVELOPMENT, V122, P491; Frommer G, 1996, EMBO J, V15, P1642, DOI 10.1002/j.1460-2075.1996.tb00509.x; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; GERTLER FB, 1989, CELL, V58, P103, DOI 10.1016/0092-8674(89)90407-8; GERTLER FB, 1990, SCIENCE, V248, P857, DOI 10.1126/science.2188361; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; GERTLER FB, 1993, GENE DEV, V7, P441, DOI 10.1101/gad.7.3.441; Giniger E, 1998, NEURON, V20, P667, DOI 10.1016/S0896-6273(00)81007-7; GUARENTE L, 1993, TRENDS GENET, V9, P362, DOI 10.1016/0168-9525(93)90042-G; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HARDEN N, 1995, DEVELOPMENT, V121, P903; Harden N, 1999, J CELL SCI, V112, P273; HENKEMEYER M, 1990, CELL, V63, P949, DOI 10.1016/0092-8674(90)90498-4; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; HILL KK, 1995, GENETICS, V141, P595; HOFFMANN FM, 1991, TRENDS GENET, V7, P351, DOI 10.1016/0168-9525(91)90254-F; Hu S, 1998, J NEUROBIOL, V35, P77, DOI 10.1002/(SICI)1097-4695(199804)35:1<77::AID-NEU7>3.0.CO;2-8; Kaufmann N, 1998, DEVELOPMENT, V125, P453; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; Lowell CA, 1996, GENE DEV, V10, P1845, DOI 10.1101/gad.10.15.1845; Luo LQ, 1997, CURR OPIN NEUROBIOL, V7, P81, DOI 10.1016/S0959-4388(97)80124-9; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; McFarlane S, 1996, NEURON, V17, P245, DOI 10.1016/S0896-6273(00)80156-7; Menon KP, 1998, DEVELOPMENT, V125, P4121; MLODZIK M, 1990, GENE DEV, V4, P1848, DOI 10.1101/gad.4.11.1848; NEWSOME TP, 2000, IN PRESS CELL, V101; ONEILL JW, 1994, BIOTECHNIQUES, V17, P870; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; ROGGE RD, 1991, CELL, V64, P39, DOI 10.1016/0092-8674(91)90207-F; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Seipel K, 1999, J CELL SCI, V112, P1825; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; Soisson SM, 1998, CELL, V95, P259, DOI 10.1016/S0092-8674(00)81756-0; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Sun Q, 2000, DEVELOPMENT, V127, P801; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Worley T, 1996, J NEUROSCI, V16, P2294; WU DY, 1993, J CELL BIOL, V123, P653, DOI 10.1083/jcb.123.3.653	66	162	164	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	2000	26	1					107	118		10.1016/S0896-6273(00)81142-3	http://dx.doi.org/10.1016/S0896-6273(00)81142-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309MA	10798396	Bronze			2022-12-24	WOS:000086770500012
J	Rampon, C; Tang, YP; Goodhouse, J; Shimizu, E; Kyin, M; Tsien, JZ				Rampon, C; Tang, YP; Goodhouse, J; Shimizu, E; Kyin, M; Tsien, JZ			Enrichment induces structural changes and recovery from nonspatial memory deficits in CA1 NMDAR1-knockout mice	NATURE NEUROSCIENCE			English	Article							DENDRITIC SPINE DENSITY; LONG-TERM POTENTIATION; NMDAR1 KNOCKOUT MICE; SYNAPTIC PLASTICITY; NUMERICAL DENSITY; RATS; HIPPOCAMPUS; SYNAPSES; PATTERNS; RECEPTOR	We produced CA1-specific NMDA receptor 1 subunit-knockout (CA1-KO) mice to determine the NMDA receptor dependence of nonspatial memory formation and of experience-induced structural plasticity in the CA1 region. CA1-KO mice were profoundly impaired in object recognition, olfactory discrimination and contextual fear memories. Surprisingly, these deficits could be rescued by enriching experience. Using stereological electron microscopy, we found that enrichment induced an increase of the synapse density in the CA1 region in knockouts as well as control littermates. Therefore, our data indicate that CA1 NMDA receptor activity is critical in hippocampus-dependent nonspatial memory, but is not essential for experience-induced synaptic structural changes.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08540 USA	Princeton University	Tsien, JZ (corresponding author), Princeton Univ, Dept Mol Biol, Washington Rd, Princeton, NJ 08540 USA.	jtsien@molbio.princeton.edu	Tang, Ya-Ping/A-1035-2011; Shimizu, Eiji/K-4637-2017	Shimizu, Eiji/0000-0002-6741-9338; Tang, Ya-Ping/0000-0002-0445-4072; rampon, claire/0000-0001-8551-8682				BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Bunsey M, 1995, HIPPOCAMPUS, V5, P546, DOI 10.1002/hipo.450050606; DALRYMPLEALFORD JC, 1984, BEHAV NEUROSCI, V98, P23, DOI 10.1037/0735-7044.98.1.23; DEGROOT DMG, 1986, J NEUROSCI METH, V18, P79, DOI 10.1016/0165-0270(86)90113-5; Diamond M.C., 1988, ENRICHING HEREDITY; FIALA BA, 1978, EXP NEUROL, V59, P372, DOI 10.1016/0014-4886(78)90229-7; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; GABBOTT PL, 1984, J NEUROSCI METH, V11, P221, DOI 10.1016/0165-0270(84)90084-0; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GRAY EG, 1959, J ANAT, V93, P420; GREENOUGH WT, 1990, SYMP MED H, V23, P159; GUNDERSEN HJG, 1977, J MICROSC-OXFORD, V111, P219, DOI 10.1111/j.1365-2818.1977.tb00062.x; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kirov SA, 1999, NAT NEUROSCI, V2, P878, DOI 10.1038/13178; KOGAN JH, 1996, CURR BIOL, V7, P1; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; Mumby DG, 1996, BEHAV NEUROSCI, V110, P266, DOI 10.1037/0735-7044.110.2.266; Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Rosene D. L., 1987, CEREB CORTEX, V6, P345, DOI DOI 10.1007/978-1-4615-6616-8_9; ROSENZWE.MR, 1966, AM PSYCHOL, V21, P321, DOI 10.1037/h0023555; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Sorra KE, 1998, J COMP NEUROL, V398, P225; Sorra KE, 1998, J NEUROSCI, V18, P658; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Stevens CF, 1998, CURR BIOL, V8, pR151, DOI 10.1016/S0960-9822(98)70097-1; STRUPP BJ, 1984, J COMP PSYCHOL, V98, P257, DOI 10.1037/0735-7036.98.3.257; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605; Woolf NJ, 1998, PROG NEUROBIOL, V55, P59, DOI 10.1016/S0301-0082(97)00094-4; WOOLLEY CS, 1990, J NEUROSCI, V10, P4035, DOI 10.1523/JNEUROSCI.10-12-04035.1990; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	41	611	629	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2000	3	3					238	244		10.1038/72945	http://dx.doi.org/10.1038/72945			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	292TE	10700255				2022-12-24	WOS:000085810500012
J	Seal, RP; Leighton, BH; Amara, SG				Seal, RP; Leighton, BH; Amara, SG			A model for the topology of excitatory amino acid transporters determined by the extracellular accessibility of substituted cysteines	NEURON			English	Article							HUMAN GLUTAMATE TRANSPORTERS; RAT-BRAIN; MEMBRANE TOPOLOGY; ESCHERICHIA-COLI; HIGH-AFFINITY; ASPARTATE TRANSPORTER; FUNCTIONAL-ANALYSIS; TIGER SALAMANDER; ION FLUXES; IDENTIFICATION	Excitatory amino acid transporters (EAATs) function as both substrate transporters and ligand-gated anion channels. Characterization of the transporter's general topology is the first requisite step in defining the structural bases for these distinct activities. While the first six hydrophobic domains can be readily modeled as conventional transmembrane segments, the organization of the C-terminal hydrophobic domains, which have been implicated in both substrate and ion interactions, has been controversial. Here, we report the results of a comprehensive evaluation of the C-terminal topology of EAAT1 determined by the chemical modification of introduced cysteine residues. Our data support a model in which two membrane-spanning domains flank a central region that is highly accessible to the extracellular milieu and contains at least one reentrant loop domain.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97201 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Amara, SG (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.	amaras@ohsu.edu		Amara, Susan/0000-0001-8914-1106; Seal, Rebecca/0000-0003-4955-703X	NIMH NIH HHS [F31 MH011673, MH11673] Funding Source: Medline; NINDS NIH HHS [NS33273] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH011673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033273] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Boileau AJ, 1999, J NEUROSCI, V19, P4847; Chen JG, 1998, J BIOL CHEM, V273, P12675, DOI 10.1074/jbc.273.20.12675; CONRADT M, 1995, J BIOL CHEM, V270, P25207, DOI 10.1074/jbc.270.42.25207; CONRADT M, 1995, EUR J BIOCHEM, V229, P682, DOI 10.1111/j.1432-1033.1995.tb20514.x; DeFelice LJ, 1996, BIOPHYS J, V70, P579, DOI 10.1016/S0006-3495(96)79604-2; Diamond JS, 1997, J NEUROSCI, V17, P4672; Eliasof S, 1998, J NEUROSCI, V18, P698; ELIASOF S, 1993, J NEUROSCI, V13, P402; ENGELKE T, 1989, J BACTERIOL, V171, P5551, DOI 10.1128/jb.171.10.5551-5560.1989; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Gaal L, 1998, J NEUROPHYSIOL, V79, P190, DOI 10.1152/jn.1998.79.1.190; GRUNEWALD M, 1995, J BIOL CHEM, V270, P17017, DOI 10.1074/jbc.270.28.17017; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; JAVITCH JA, 1995, NEURON, V14, P825, DOI 10.1016/0896-6273(95)90226-0; JORDING D, 1993, MOL GEN GENET, V241, P106, DOI 10.1007/BF00280207; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LESTER HA, 1994, ANNU REV PHARMACOL, V34, P219; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; MACKINNON R, 1995, NEURON, V14, P889, DOI 10.1016/0896-6273(95)90327-5; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; Mitrovic AD, 1998, J BIOL CHEM, V273, P14698, DOI 10.1074/jbc.273.24.14698; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; PICAUD S, 1995, P NATL ACAD SCI USA, V92, P9417, DOI 10.1073/pnas.92.20.9417; PINES G, 1995, J BIOL CHEM, V270, P17093, DOI 10.1074/jbc.270.29.17093; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; Seal RP, 1998, METHOD ENZYMOL, V296, P318; Seal RP, 1998, NEURON, V21, P1487, DOI 10.1016/S0896-6273(00)80666-2; Seal RP, 1999, ANNU REV PHARMACOL, V39, P431, DOI 10.1146/annurev.pharmtox.39.1.431; SHI LB, 1995, BIOCHEMISTRY-US, V34, P8250, DOI 10.1021/bi00026a006; Slotboom DJ, 1996, J BIOL CHEM, V271, P31317, DOI 10.1074/jbc.271.49.31317; Sonders MS, 1996, CURR OPIN NEUROBIOL, V6, P294, DOI 10.1016/S0959-4388(96)80111-5; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; TOLNER B, 1992, MOL MICROBIOL, V6, P2845, DOI 10.1111/j.1365-2958.1992.tb01464.x; TOLNER B, 1992, J BACTERIOL, V174, P2391, DOI 10.1128/JB.174.7.2391-2393.1992; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; VANDENBERG RJ, 1995, J BIOL CHEM, V270, P17668, DOI 10.1074/jbc.270.30.17668; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Wahle S, 1996, J CELL BIOL, V135, P1867, DOI 10.1083/jcb.135.6.1867; Zarbiv R, 1998, J BIOL CHEM, V273, P14231, DOI 10.1074/jbc.273.23.14231; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751	53	109	112	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	2000	25	3					695	706		10.1016/S0896-6273(00)81071-5	http://dx.doi.org/10.1016/S0896-6273(00)81071-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	301CY	10774736	Bronze			2022-12-24	WOS:000086291700021
J	Li-Smerin, YY; Hackos, DH; Swartz, KJ				Li-Smerin, YY; Hackos, DH; Swartz, KJ			A localized interaction surface for voltage-sensing domains on the pore domain of a K+ channel	NEURON			English	Article							SHAKER POTASSIUM CHANNEL; TRYPTOPHAN-SCANNING MUTAGENESIS; GATING CURRENTS; TRANSMEMBRANE SEGMENTS; STREPTOMYCES-LIVIDANS; ELECTROSTATIC INTERACTIONS; SUBUNIT STOICHIOMETRY; MOLECULAR-BASIS; TEA BLOCKADE; S4 SEGMENT	Voltage-gated K+ channels contain a central pore domain and four surrounding voltage-sensing domains. How and where changes in the structure of the voltage-sensing domains couple to the pore domain so as to gate ion conduction is not understood. The crystal structure of KcsA, a bacterial K+ channel homologous to the pore domain of voltage-gated K+ channels, provides a starting point for addressing this question. Guided by this structure, we used tryptophan-scanning mutagenesis on the transmembrane shell of the pore domain in the Shaker voltage-gated K+ channel to localize potential protein-protein and protein-lipid interfaces. Some mutants cause only minor changes in gating and when mapped onto the KcsA structure cluster away from the interface between pore domain subunits. In contrast, mutants producing large changes in gating tend to cluster near this interface. These results imply that voltage-sensing domains interact with localized regions near the interface between adjacent pore domain subunits.	NINDS, Mol Physiol & Biophys Unit, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Swartz, KJ (corresponding author), NINDS, Mol Physiol & Biophys Unit, NIH, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002945] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA NS002945-13] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; Armstrong CM, 1998, NEURON, V20, P371, DOI 10.1016/S0896-6273(00)80981-2; Bezanilla F, 1998, METHOD ENZYMOL, V293, P331; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Choe S, 1995, P NATL ACAD SCI USA, V92, P12046, DOI 10.1073/pnas.92.26.12046; Collins A, 1997, P NATL ACAD SCI USA, V94, P5456, DOI 10.1073/pnas.94.10.5456; Cuello LG, 1998, BIOCHEMISTRY-US, V37, P3229, DOI 10.1021/bi972997x; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741; Holmgren M, 1998, NEURON, V21, P617, DOI 10.1016/S0896-6273(00)80571-1; Holmgren M, 1997, J GEN PHYSIOL, V109, P527, DOI 10.1085/jgp.109.5.527; Hong KH, 2000, J GEN PHYSIOL, V115, P51, DOI 10.1085/jgp.115.1.51; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1994, J GEN PHYSIOL, V103, P249, DOI 10.1085/jgp.103.2.249; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; Kanevsky M, 1999, J GEN PHYSIOL, V114, P215, DOI 10.1085/jgp.114.2.215; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; LI M, 1994, CURR BIOL, V4, P110, DOI 10.1016/S0960-9822(94)00026-6; Li-Smerin Y, 1998, P NATL ACAD SCI USA, V95, P8585, DOI 10.1073/pnas.95.15.8585; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Monks SA, 1999, J GEN PHYSIOL, V113, P415, DOI 10.1085/jgp.113.3.415; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; Perozo E, 1998, NAT STRUCT BIOL, V5, P459, DOI 10.1038/nsb0698-459; PEROZO E, 1992, BIOPHYS J, V62, P160, DOI 10.1016/S0006-3495(92)81802-7; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; PEROZO E, 1994, BIOPHYS J, V66, P345, DOI 10.1016/S0006-3495(94)80783-0; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; PLANELLSCASES R, 1995, P NATL ACAD SCI USA, V92, P94222; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; Schomburg E, 1998, PHYSICA E, V2, P295, DOI 10.1016/S1386-9477(98)00062-9; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; Schoppa NE, 1998, J GEN PHYSIOL, V111, P271, DOI 10.1085/jgp.111.2.271; SCHREMPF H, 1995, EMBO J, V14, P5170, DOI 10.1002/j.1460-2075.1995.tb00201.x; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SHARP LL, 1995, BIOCHEMISTRY-US, V34, P9166, DOI 10.1021/bi00028a028; SHARP LL, 1995, P NATL ACAD SCI USA, V92, P7946, DOI 10.1073/pnas.92.17.7946; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P399, DOI 10.1085/jgp.111.3.399; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P421, DOI 10.1085/jgp.111.3.421; Tatulian SA, 1998, FEBS LETT, V423, P205, DOI 10.1016/S0014-5793(98)00091-X; TiwariWoodruff SK, 1997, BIOPHYS J, V72, P1489, DOI 10.1016/S0006-3495(97)78797-6; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yang YS, 1997, J GEN PHYSIOL, V109, P779, DOI 10.1085/jgp.109.6.779; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0; Yusaf SP, 1996, PFLUG ARCH EUR J PHY, V433, P91, DOI 10.1007/s004240050253; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279	62	108	110	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	2000	25	2					411	423		10.1016/S0896-6273(00)80904-6	http://dx.doi.org/10.1016/S0896-6273(00)80904-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	288EL	10719895	Bronze			2022-12-24	WOS:000085549100018
J	Bichet, D; Cornet, V; Geib, S; Carlier, E; Volsen, S; Hoshi, T; Mori, Y; De Waard, M				Bichet, D; Cornet, V; Geib, S; Carlier, E; Volsen, S; Hoshi, T; Mori, Y; De Waard, M			The I-II loop of the Ca2+ channel alpha(1) subunit contains an endoplasmic reticulum retention signal antagonized by the beta subunit	NEURON			English	Article							DEPENDENT CALCIUM CHANNELS; FUNCTIONAL EXPRESSION; XENOPUS OOCYTES; CHARGE MOVEMENT; AUXILIARY SUBUNITS; IONIC CURRENT; CELL-LINE; DIHYDROPYRIDINE; MEMBRANE; PROTEIN	The auxiliary beta subunit is essential for functional expression of high voltage-activated Ca2+ channels. This effect is partly mediated by a facilitation of the intracellular trafficking of alpha(1) subunit toward the plasma membrane. Here, we demonstrate that the I-II loop of the a, subunit contains an endoplasmic reticulum (ER) retention signal that severely restricts the plasma membrane incorporation of alpha(1) subunit. Coimmunolabeling reveals that the I-II loop restricts expression of a chimera CD8-I-II protein to the ER. The beta subunit reverses the inhibition imposed by the retention signal. Extensive deletion of this retention signal in full-length alpha(1) subunit facilitates the cell surface expression of the channel in the absence of beta subunit. Our data suggest that the beta subunit favors Ca2+ channel plasma membrane expression by inhibiting an expression brake contained in beta-binding alpha(1) sequences.	Fac Med Nord, INSERM, U464, F-13916 Marseille, France; Eli Lilly & Co, Lilly Res Ctr Ltd, Windlesham GU20 6PH, Surrey, England; Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Natl Inst Physiol Sci, Dept Informat Physiol, Okazaki, Aichi 444, Japan	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Eli Lilly; University of Iowa; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Mori, Y (corresponding author), Fac Med Nord, INSERM, U464, Blvd Pierre Dramard, F-13916 Marseille, France.		De Waard, Michel/G-7406-2014	De Waard, Michel/0000-0002-2782-9615; Bichet, Delphine/0000-0002-9601-089X				Berrow NS, 1997, EUR J NEUROSCI, V9, P739, DOI 10.1111/j.1460-9568.1997.tb01422.x; Beurg M, 1997, BIOPHYS J, V73, P807, DOI 10.1016/S0006-3495(97)78113-X; Brice NL, 1997, EUR J NEUROSCI, V9, P749, DOI 10.1111/j.1460-9568.1997.tb01423.x; BRUST PF, 1993, NEUROPHARMACOLOGY, V32, P1089, DOI 10.1016/0028-3908(93)90004-M; CASTELLANO A, 1993, J BIOL CHEM, V268, P12359; CHIEN AJ, 1995, J BIOL CHEM, V270, P30036; Costantin J, 1998, J PHYSIOL-LONDON, V507, P93, DOI 10.1111/j.1469-7793.1998.093bu.x; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; DEWAARD M, 1995, J PHYSIOL-LONDON, V485, P619, DOI 10.1113/jphysiol.1995.sp020757; DEWAARD M, 1994, NEURON, V13, P495, DOI 10.1016/0896-6273(94)90363-8; Dolphin AC, 1998, J PHYSIOL-LONDON, V506, P3, DOI 10.1111/j.1469-7793.1998.003bx.x; EPPIG JJ, 1976, IN VITRO CELL DEV B, V12, P418; Felix R, 1997, J NEUROSCI, V17, P6884; FLOCKERZI V, 1986, NATURE, V323, P66, DOI 10.1038/323066a0; FUNGLEUNG WP, 1993, EUR J IMMUNOL, V23, P2834, DOI 10.1002/eji.1830231117; Gao TY, 1999, J BIOL CHEM, V274, P2137, DOI 10.1074/jbc.274.4.2137; Gurnett CA, 1996, J BIOL CHEM, V271, P27975, DOI 10.1074/jbc.271.45.27975; HENDERSHOT L, 1987, J CELL BIOL, V104, P761, DOI 10.1083/jcb.104.3.761; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; Josephson IR, 1996, BIOPHYS J, V70, P1285, DOI 10.1016/S0006-3495(96)79685-6; Kamp TJ, 1996, J PHYSIOL-LONDON, V492, P89, DOI 10.1113/jphysiol.1996.sp021291; KRIZANOVA O, 1995, BIOCHEM BIOPH RES CO, V211, P921, DOI 10.1006/bbrc.1995.1900; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; LETOURNEUR F, 1995, J CELL BIOL, V129, P971, DOI 10.1083/jcb.129.4.971; Meir A, 1998, NEURON, V20, P341, DOI 10.1016/S0896-6273(00)80461-4; MILLER RJ, 1992, J BIOL CHEM, V267, P1403; MITTERDORFER J, 1994, FEBS LETT, V352, P141, DOI 10.1016/0014-5793(94)00938-4; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Nagaya N, 1997, J BIOL CHEM, V272, P3022, DOI 10.1074/jbc.272.5.3022; NEELY A, 1995, AM J PHYSIOL-CELL PH, V268, pC732, DOI 10.1152/ajpcell.1995.268.3.C732; NEELY A, 1993, SCIENCE, V262, P575, DOI 10.1126/science.8211185; Neuhuber B, 1998, J BIOL CHEM, V273, P9110, DOI 10.1074/jbc.273.15.9110; Neuhuber B, 1998, P NATL ACAD SCI USA, V95, P5015, DOI 10.1073/pnas.95.9.5015; NISHIMURA S, 1993, FEBS LETT, V324, P283, DOI 10.1016/0014-5793(93)80135-H; PEREZGARCIA MT, 1995, J GEN PHYSIOL, V105, P289, DOI 10.1085/jgp.105.2.289; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; QU YS, 1995, J BIOL CHEM, V270, P25696, DOI 10.1074/jbc.270.43.25696; RAJAGOPALAN S, 1994, SCIENCE, V263, P387, DOI 10.1126/science.8278814; Raymond C, 1999, NEUROSCIENCE, V90, P269, DOI 10.1016/S0306-4522(98)00378-9; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; SHISTIK E, 1995, J PHYSIOL-LONDON, V489, P55, DOI 10.1113/jphysiol.1995.sp021029; Stephens GJ, 1997, PFLUG ARCH EUR J PHY, V433, P523, DOI 10.1007/s004240050308; Strube C, 1996, BIOPHYS J, V71, P2531, DOI 10.1016/S0006-3495(96)79446-8; Tareilus E, 1997, P NATL ACAD SCI USA, V94, P1703, DOI 10.1073/pnas.94.5.1703; WAKAMORI M, 1993, BIOCHEM BIOPH RES CO, V196, P1170, DOI 10.1006/bbrc.1993.2374; WAKAMORI M, 1999, IN PRESS J PHYSL; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9; Walker D, 1999, J BIOL CHEM, V274, P12383, DOI 10.1074/jbc.274.18.12383; Walker D, 1998, J BIOL CHEM, V273, P2361, DOI 10.1074/jbc.273.4.2361; Wei X, 1996, RECEPTOR CHANNEL, V4, P205; WEI XY, 1994, J BIOL CHEM, V269, P1635; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; WITCHER DR, 1993, SCIENCE, V261, P486, DOI 10.1126/science.8392754; Yamaguchi H, 1998, J BIOL CHEM, V273, P19348, DOI 10.1074/jbc.273.30.19348; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; ZHANG JF, 1994, NATURE, V372, P97, DOI 10.1038/372097a0	59	286	293	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	2000	25	1					177	190		10.1016/S0896-6273(00)80881-8	http://dx.doi.org/10.1016/S0896-6273(00)80881-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279KP	10707982	Bronze			2022-12-24	WOS:000085043200020
J	Floyd, JA; Hamilton, BA				Floyd, JA; Hamilton, BA			Intranuclear inclusions and the ubiquitin-proteasome pathway: Digestion of a red herring?	NEURON			English	Editorial Material							MICE		Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Floyd, JA (corresponding author), Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA.			Hamilton, Bruce/0000-0001-5599-9139	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059207] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM008666] Funding Source: Medline; NIMH NIH HHS [R01 MH059207] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; Huynh DP, 1999, ANN NEUROL, V45, P232, DOI 10.1002/1531-8249(199902)45:2<232::AID-ANA14>3.0.CO;2-7; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; Perez MK, 1998, J CELL BIOL, V143, P1457, DOI 10.1083/jcb.143.6.1457; Sanchez I, 1999, NEURON, V22, P623, DOI 10.1016/S0896-6273(00)80716-3; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1	10	12	12	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1999	24	4					765	766		10.1016/S0896-6273(00)81022-3	http://dx.doi.org/10.1016/S0896-6273(00)81022-3			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	269UE	10624938	Bronze			2022-12-24	WOS:000084495300003
J	Kirchgessner, AL; Liu, MT				Kirchgessner, AL; Liu, MT			Orexin synthesis and response in the gut	NEURON			English	Article							PIG SMALL-INTESTINE; SUBMUCOUS NEURONS; MYENTERIC PLEXUS; FOOD-INTAKE; HYPOTHALAMUS; IDENTIFICATION; PROJECTIONS; RECEPTORS; RATS; IMMUNOREACTIVITY	Orexin (hypocretin) appears to play a role in the regulation of energy balances. Previous reports have indicated that orexin-containing neurons are found only in the lateral hypothalamic (LH) area. We show that a subset of neurons in the gut which also express leptin receptors display orexin-like immunoreactivity and express functional orexin receptors. Orexin excites secretomotor neurons in the guinea pig submucosal plexus and increases motility. Moreover, fasting upregulates the phosphorylated form of cAMP response element-binding protein (pCREB) in orexin-immunoreactive neurons, indicating a functional response to food status in these cells. Together, these data suggest that orexin in the gut may play an even more intimate role in regulating energy homeostasis than it does in the CNS.	SUNY Hlth Sci Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; Columbia Univ Coll Phys & Surg, Dept Anat & Cell Biol, New York, NY 10032 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Columbia University	Kirchgessner, AL (corresponding author), SUNY Hlth Sci Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027645, R01NS035951] Funding Source: NIH RePORTER; NINDS NIH HHS [NS27645, NS35951] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BORNSTEIN JC, 1986, J PHYSIOL-LONDON, V381, P465, DOI 10.1113/jphysiol.1986.sp016339; BORNSTEIN JC, 1988, J AUTONOM NERV SYST, V25, P1, DOI 10.1016/0165-1838(88)90002-1; Bray GA, 1998, RECENT PROG HORM RES, V53, P95; BULBRING E, 1958, J PHYSIOL-LONDON, V140, P381; Cooke HJ, 1997, J AUTONOM NERV SYST, V66, P105, DOI 10.1016/S0165-1838(97)00075-1; Cooke HJ, 1998, NEWS PHYSIOL SCI, V13, P269; Curzon G, 1997, TRENDS PHARMACOL SCI, V18, P21, DOI 10.1016/S0165-6147(96)01003-6; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Edwards CMB, 1999, J ENDOCRINOL, V160, pR7, DOI 10.1677/joe.0.160R007; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; FoxxOrenstein AE, 1996, AM J PHYSIOL-GASTR L, V271, pG433, DOI 10.1152/ajpgi.1996.271.3.G433; Furness JB, 1998, PROG NEUROBIOL, V54, P1, DOI 10.1016/S0301-0082(97)00051-8; Furness JB., 1987, ENTERIC NERVOUS SYST; GASIC G, 1995, NEURON, V15, P507, DOI 10.1016/0896-6273(95)90140-X; Gautvik KM, 1996, P NATL ACAD SCI USA, V93, P8733, DOI 10.1073/pnas.93.16.8733; Gershon Michael D., 1994, P381; GRUNDY D, 1989, HDB PHYSL 6, V1, P593; Hakansson ML, 1998, J NEUROSCI, V18, P559; Hillsley K, 1998, J PHYSIOL-LONDON, V506, P551, DOI 10.1111/j.1469-7793.1998.551bw.x; HIRST GDS, 1975, J PHYSIOL-LONDON, V249, P369, DOI 10.1113/jphysiol.1975.sp011020; Horvath TL, 1999, J NEUROSCI, V19, P1072; Ichikawa T, 1998, COMP BIOCHEM PHYS A, V121, P223, DOI 10.1016/S1095-6433(98)10137-X; Ida T, 1999, BRAIN RES, V821, P526, DOI 10.1016/S0006-8993(99)01131-2; Inui A, 1999, TRENDS NEUROSCI, V22, P62, DOI 10.1016/S0166-2236(98)01292-2; JIANG MM, 1993, AM J PHYSIOL, V264, pG86, DOI 10.1152/ajpgi.1993.264.1.G86; Kirchgessner AL, 1999, J COMP NEUROL, V409, P85, DOI 10.1002/(SICI)1096-9861(19990621)409:1<85::AID-CNE7>3.0.CO;2-X; KIRCHGESSNER AL, 1992, J NEUROSCI, V12, P235; KIRCHGESSNER AL, 1990, J NEUROSCI, V10, P1626; Kirchgessner AL, 1998, J COMP NEUROL, V390, P497; Kirchgessner AL, 1996, J COMP NEUROL, V371, P270; KIRCHGESSNER AL, 1988, J COMP NEUROL, V277, P487, DOI 10.1002/cne.902770403; KIRCHGESSNER AL, 1991, J COMP NEUROL, V306, P1; Liu MT, 1997, J NEUROSCI, V17, P4764; Mondal MS, 1999, BIOCHEM BIOPH RES CO, V256, P495, DOI 10.1006/bbrc.1999.0362; Oomura Y, 1983, Adv Metab Disord, V10, P31; Peyron C, 1998, J NEUROSCI, V18, P9996; POWLEY TL, 1970, J COMP PHYSIOL PSYCH, V70, P25, DOI 10.1037/h0028390; SAHU A, 1988, PEPTIDES, V9, P83, DOI 10.1016/0196-9781(88)90013-7; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Song ZM, 1998, J COMP NEUROL, V399, P255, DOI 10.1002/(SICI)1096-9861(19980921)399:2<255::AID-CNE8>3.0.CO;2-#; Sugimoto Y, 1996, EUR J PHARMACOL, V316, P15, DOI 10.1016/S0014-2999(96)00660-7; Sweet DC, 1999, BRAIN RES, V821, P535, DOI 10.1016/S0006-8993(99)01136-1; van den Pol AN, 1998, J NEUROSCI, V18, P7962; van den Pol AN, 1999, J NEUROSCI, V19, P3171; Wade PR, 1996, J NEUROSCI, V16, P2352; Walsh J.H, 1994, GUT PEPTIDES, P1; Yamamoto Y, 1999, MOL BRAIN RES, V65, P14, DOI 10.1016/S0169-328X(98)00320-9; YAMASHITA J, 1994, INT J OBESITY, V18, P429; YAU WM, 1989, AM J PHYSIOL, V256, pG233, DOI 10.1152/ajpgi.1989.256.1.G233; YOUNG A, 1990, GUT, V31, P43, DOI 10.1136/gut.31.1.43	51	251	279	1	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1999	24	4					941	951		10.1016/S0896-6273(00)81041-7	http://dx.doi.org/10.1016/S0896-6273(00)81041-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	269UE	10624957	hybrid			2022-12-24	WOS:000084495300022
J	Weimann, JM; Zhang, YA; Levin, ME; Devine, WP; Brulet, P; McConnell, SK				Weimann, JM; Zhang, YA; Levin, ME; Devine, WP; Brulet, P; McConnell, SK			Cortical neurons require Otx1 for the refinement of exuberant axonal projections to subcortical targets	NEURON			English	Article							CAT VISUAL-CORTEX; SOMATIC SENSORY CORTEX; CENTRAL-NERVOUS-SYSTEM; POSTNATAL-DEVELOPMENT; CEREBRAL-CORTEX; CORTICOSPINAL PROJECTION; ANTERIOR NEUROECTODERM; HOMEODOMAIN PROTEIN; CORPUS-CALLOSUM; MICE LACKING	Information processing in the nervous system depends on the creation of specific synaptic connections between neurons and targets during development. The homeodomain transcription factor Otx1 is expressed in early-generated neurons of the developing cerebral cortex. Within layer 5, Otx1 is expressed by neurons with subcortical axonal projections to the midbrain and spinal cord. Otx1 is also expressed in the precursors of these neurons, but is localized to the cytoplasm. Nuclear translocation of Otx1 occurs when layer 5 neurons enter a period of axonal refinement and eliminate a subset of their long-distance projections. Otx1 mutant mice are defective in the refinement of these exuberant projections, suggesting that Otx1 is required for the development of normal axonal connectivity and the generation of coordinated motor behavior.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Inst Pasteur, Unite Embryol Mol, F-75724 Paris, France	Stanford University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	McConnell, SK (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	suemcc@stanford.edu			NATIONAL EYE INSTITUTE [R01EY008411] Funding Source: NIH RePORTER; NEI NIH HHS [EY06524, EY08411] Funding Source: Medline; NICHD NIH HHS [HD08346] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ACAMPORA D, 1995, DEVELOPMENT, V121, P3279; Acampora D, 1999, TRENDS NEUROSCI, V22, P116, DOI 10.1016/S0166-2236(98)01387-3; Acampora D, 1998, DEVELOPMENT, V125, P1229; Acampora D, 1996, NAT GENET, V14, P218, DOI 10.1038/ng1096-218; Aspland SE, 1997, DEVELOPMENT, V124, P741; BATES CA, 1984, DEV BRAIN RES, V13, P265, DOI 10.1016/0165-3806(84)90161-5; Bergemann AD, 1998, ONCOGENE, V16, P471, DOI 10.1038/sj.onc.1201557; BERMAN NE, 1983, BRAIN RES, V274, P201, DOI 10.1016/0006-8993(83)90697-2; Bossing T, 1996, MECH DEVELOP, V55, P53, DOI 10.1016/0925-4773(95)00490-4; BRUCE LL, 1993, DEV BRAIN RES, V73, P47, DOI 10.1016/0165-3806(93)90045-C; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Cheng J, 1997, J BIOL CHEM, V272, P7264, DOI 10.1074/jbc.272.11.7264; Chuang CK, 1996, DEV GENET, V19, P231, DOI 10.1002/(SICI)1520-6408(1996)19:3<231::AID-DVG6>3.0.CO;2-A; DRAGER UC, 1981, J COMP NEUROL, V201, P555, DOI 10.1002/cne.902010407; EDWARDS MA, 1986, J COMP NEUROL, V248, P410, DOI 10.1002/cne.902480309; FRANTZ GD, 1994, J NEUROSCI, V14, P472; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; Frantz GD, 1996, NEURON, V17, P55, DOI 10.1016/S0896-6273(00)80280-9; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; GINIGER E, 1994, DEVELOPMENT, V120, P1385; HARVEY AR, 1990, J COMP NEUROL, V298, P281, DOI 10.1002/cne.902980303; HEFFNER CD, 1990, SCIENCE, V247, P217, DOI 10.1126/science.2294603; Kaffman A, 1998, NATURE, V396, P482, DOI 10.1038/24898; Kandel E.R., 1991, PRINC NEUROSCI; KASPER EM, 1994, J COMP NEUROL, V339, P495, DOI 10.1002/cne.903390404; KATZ LC, 1987, J NEUROSCI, V7, P1223; KAWAGUCHI Y, 1993, J NEUROPHYSIOL, V70, P387, DOI 10.1152/jn.1993.70.1.387; Khachab MY, 1999, DEV BRAIN RES, V112, P145, DOI 10.1016/S0165-3806(98)00159-X; KOESTER SE, 1993, DEV BIOL, V160, P1, DOI 10.1006/dbio.1993.1281; LI CP, 1995, DEV BRAIN RES, V89, P227, DOI 10.1016/0165-3806(95)00119-X; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Liou HC, 1993, CURR OPIN CELL BIOL, V5, P477, DOI 10.1016/0955-0674(93)90014-H; LUND JS, 1975, J COMP NEUROL, V164, P287, DOI 10.1002/cne.901640303; Mann RS, 1996, NATURE, V383, P630, DOI 10.1038/383630a0; MARTIN KAC, 1984, J PHYSIOL-LONDON, V353, P463, DOI 10.1113/jphysiol.1984.sp015347; Mastick GS, 1997, DEVELOPMENT, V124, P1985; MCCONNELL SK, 1994, J NEUROSCI, V14, P1892; MCCONNELL SK, 1995, J NEUROSCI, V15, P6987; MCCONNELL SK, 1988, BRAIN RES REV, V13, P1, DOI 10.1016/0165-0173(88)90002-1; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; MILLER MW, 1988, CEREB CORTEX, V7, P133; MORIN CL, 1994, CEREB CORTEX, V4, P119, DOI 10.1093/cercor/4.2.119; Nguyen QT, 1996, CURR OPIN NEUROBIOL, V6, P104, DOI 10.1016/S0959-4388(96)80015-8; OLEARY DDM, 1993, NEURON, V10, P991, DOI 10.1016/0896-6273(93)90049-W; OLEARY DDM, 1985, BRAIN RES, V336, P326, DOI 10.1016/0006-8993(85)90661-4; OLEARY DDM, 1991, DEVELOPMENT, P123; Prasad BC, 1998, DEVELOPMENT, V125, P1561; REINHARD E, 1994, J NEUROSCI RES, V37, P256, DOI 10.1002/jnr.490370211; Rieckhof GE, 1997, CELL, V91, P171, DOI 10.1016/S0092-8674(00)80400-6; Schaeren-Wiemers N, 1997, EUR J NEUROSCI, V9, P2687, DOI 10.1111/j.1460-9568.1997.tb01698.x; SEGRAVES MA, 1985, J NEUROSCI, V5, P2107; SEGRAVES MA, 1982, NEUROSCIENCE, V2, P1079; SHATZ CJ, 1977, J COMP NEUROL, V173, P497, DOI 10.1002/cne.901730307; SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; STANFIELD BB, 1985, J COMP NEUROL, V238, P236, DOI 10.1002/cne.902380210; STANFIELD BB, 1982, NATURE, V298, P371, DOI 10.1038/298371a0; WISE SP, 1976, J COMP NEUROL, V168, P313, DOI 10.1002/cne.901680302; WISE SP, 1977, J COMP NEUROL, V175, P129, DOI 10.1002/cne.901750202	63	162	165	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1999	24	4					819	831		10.1016/S0896-6273(00)81030-2	http://dx.doi.org/10.1016/S0896-6273(00)81030-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	269UE	10624946	Bronze			2022-12-24	WOS:000084495300011
J	Wei, F; Wang, GD; Kerchner, GA; Kim, SJ; Xu, HM; Chen, ZF; Zhuo, M				Wei, F; Wang, GD; Kerchner, GA; Kim, SJ; Xu, HM; Chen, ZF; Zhuo, M			Genetic enhancement of inflammatory pain by forebrain NR2B overexpression	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; NMDA RECEPTORS; FORMALIN TEST; GLUTAMATE RECEPTORS; VISUAL-CORTEX; RAT; BRAIN; STIMULATION; RESPONSES; MICE	N-methyl-D-aspartate (NMDA) receptors contribute to many brain functions. We studied the effect of forebrain-targeted overexpression of the NMDA receptor subunit NR2B on the response of mice to tissue injury and inflammation. Transgenic mice exhibited prominent NR2B expression and enhanced NMDA receptor-mediated synaptic responses in two pain-related forebrain areas, the anterior cingulate cortex and insular cortex, but not in the spinal cord. Although transgenic and wild type mice were indistinguishable in tests of acute pain, transgenic mice exhibited enhanced responsiveness to peripheral injection of two inflammatory stimuli, formalin and complete Freund's adjuvant. Genetic modification of forebrain NMDA receptors can therefore influence pain perception, which suggests that forebrain-selective NMDA receptor antagonists, including NR2B-selective agents, may be useful analgesics for persistent pain.	Washington Univ, Sch Med, Pain Ctr, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Zhuo, M (corresponding author), Washington Univ, Sch Med, Pain Ctr, Campus Box 8054,660 S Euclid Ave, St Louis, MO 63110 USA.	zhuom@morpheus.wustl.edu	Xu, Haiming/A-2238-2014; Zhuo, Min/A-2072-2008	Zhuo, Min/0000-0001-9062-3241				BIRREN SJ, 1993, DEVELOPMENT, V119, P597; Calejesan AA, 2000, EUR J PAIN, V4, P83, DOI 10.1053/eujp.1999.0158; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Casey KL, 1999, P NATL ACAD SCI USA, V96, P7668, DOI 10.1073/pnas.96.14.7668; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; CODERRE TJ, 1993, PAIN, V52, P259, DOI 10.1016/0304-3959(93)90161-H; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; FRANKLIN KBJ, 1997, MOUSE BRAINS TEREOTA; HALEY JE, 1990, BRAIN RES, V518, P218, DOI 10.1016/0006-8993(90)90975-H; Herrera DG, 1996, PROG NEUROBIOL, V50, P83, DOI 10.1016/S0301-0082(96)00021-4; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; KATO N, 1991, DEV BRAIN RES, V60, P43, DOI 10.1016/0165-3806(91)90153-A; Kim SJ, 1999, BRAIN RES, V829, P185, DOI 10.1016/S0006-8993(99)01353-0; Lee DE, 1999, BRAIN RES, V845, P117, DOI 10.1016/S0006-8993(99)01956-3; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Munglani R, 1995, PROG BRAIN RES, V104, P283; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; SAH P, 1991, J PHYSIOL-LONDON, V433, P615, DOI 10.1113/jphysiol.1991.sp018446; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; TAYLOR BK, 1995, J NEUROSCI, V15, P7575; Teng CJ, 1998, PAIN, V76, P337, DOI 10.1016/S0304-3959(98)00065-7; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; Wei F, 1999, J NEUROSCI, V19, P9346; Woolf CJ, 1999, P NATL ACAD SCI USA, V96, P7723, DOI 10.1073/pnas.96.14.7723; YAKSH TL, 1993, CURR OPIN NEUROL NEU, V6, P250	31	247	260	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2001	4	2					164	169		10.1038/83993	http://dx.doi.org/10.1038/83993			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UC	11175877				2022-12-24	WOS:000167178100015
J	Land, MF; McLeod, P				Land, MF; McLeod, P			From eye movements to actions: how batsmen hit the ball	NATURE NEUROSCIENCE			English	Article							GAMES; TIME	In cricket, a batsman watches a fast bowler's ball come toward him at a high and unpredictable speed, bouncing off ground of uncertain hardness. Although he views the trajectory for little more than half a second, he can accurately judge where and when the bail will reach him. Batsmen's eye movements monitor the moment when the ball is released, make a predictive saccade to the place where they expect it to hit the ground, wait for it to bounce, and follow its trajectory for 100-200 ms after the bounce. We show how information provided by these fixations may allow precise prediction of the ball's timing and placement. Comparing players with different skill levels, we found that a short latency for the first saccade distinguished good from poor batsmen, and that a cricket player's eye movement strategy contributes to his skill in the game.	Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Sussex; University of Oxford	Land, MF (corresponding author), Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England.							ADAIR R, 1990, PHYSICS BASEBALL; BAHILL AT, 1984, AM SCI, V72, P249; BOOTSMA RJ, 1990, J EXP PSYCHOL HUMAN, V16, P21, DOI 10.1037/0096-1523.16.1.21; Furneaux S, 1999, P ROY SOC B-BIOL SCI, V266, P2435, DOI 10.1098/rspb.1999.0943; HALLETT PE, 1991, LIMITS VISION VISION, V5, P44; LAND MF, 1994, NATURE, V369, P742, DOI 10.1038/369742a0; Land MF, 1997, PHILOS T ROY SOC B, V352, P1231, DOI 10.1098/rstb.1997.0105; LAND MF, 1983, IEEE P SMC C TOUQ, V3, P490; LEE DN, 1983, Q J EXP PSYCHOL-A, V35, P333, DOI 10.1080/14640748308402138; LEWES T, 1994, MCC MASTERCLASS NEW; MCLEOD P, 1987, PERCEPTION, V16, P49, DOI 10.1068/p160049; MCLEOD P, 1991, INT J SPORT PSYCHOL, V22, P279; Regan D, 2000, TRENDS COGN SCI, V4, P99, DOI 10.1016/S1364-6613(99)01442-4; REGAN D, 1992, PERCEPTION, V21, P91, DOI 10.1068/p210091; Ripoll H., 1987, EYE MOVEMENTS PHYSL, P616	15	477	483	0	64	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2000	3	12					1340	1345		10.1038/81887	http://dx.doi.org/10.1038/81887			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	405UA	11100157	Bronze			2022-12-24	WOS:000167177900022
J	Liu, J; Siegelbaum, SA				Liu, J; Siegelbaum, SA			Change of pore helix conformational state upon opening of cyclic nucleotide-gated channels	NEURON			English	Article							SHAKER POTASSIUM CHANNEL; K+-CHANNEL; MOLECULAR-BASIS; ION-CHANNEL; RESIDUES; ACCESSIBILITY; ACTIVATION; TOPOLOGY; MOVEMENT; REGION	The structure of the pore region of the cu subunit of the bovine rod cyclic nucleotide-gated channel was probed using cysteine-scanning mutagenesis and hydrophilic sulfhydryl-reactive methanethiosulfonate (MTS) reagents. A region homologous to the pore helix in the X-ray crystal structure of the KcsA K+ channel showed a helical pattern of reactivity with externally applied MTS reagents. Surprisingly, three out of four of the reactive residues, all on one face of the pore helix, only reacted with MTS reagents in the closed state. A residue on the opposite face of the helix only reacted with MTS reagents in the open state. These results indicate that the pore helix (or its surroundings) undergoes a change in conformation, perhaps involving a rotation around its long axis, that opens a gate localized to the selectivity filter of the channel.	Columbia Univ, Howard Hughes Med Inst, Ctr Neurobiol & Behav, Dept Pharmacol, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Siegelbaum, SA (corresponding author), Columbia Univ, Howard Hughes Med Inst, Ctr Neurobiol & Behav, Dept Pharmacol, New York, NY 10032 USA.				NINDS NIH HHS [R01-NS36685] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Becchetti A, 1999, J GEN PHYSIOL, V114, P377, DOI 10.1085/jgp.114.3.377; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FLYNN GE, 1999, BIOPHYS J, pA337; Fodor AA, 1997, J GEN PHYSIOL, V110, P591, DOI 10.1085/jgp.110.5.591; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; GORDON SE, 1992, NEURON, V9, P739, DOI 10.1016/0896-6273(92)90036-D; GOULDING EH, 1993, NATURE, V364, P61, DOI 10.1038/364061a0; GOULDING EH, 1992, NEURON, V8, P45, DOI 10.1016/0896-6273(92)90107-O; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; Gross A, 1996, NEURON, V16, P399, DOI 10.1016/S0896-6273(00)80057-4; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KURZ LL, 1995, BIOPHYS J, V68, P900, DOI 10.1016/S0006-3495(95)80266-3; Liu DT, 1996, NEURON, V16, P983, DOI 10.1016/S0896-6273(00)80121-X; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; LU Q, 1995, SCIENCE, V268, P304, DOI 10.1126/science.7716526; Meuser D, 1999, FEBS LETT, V462, P447, DOI 10.1016/S0014-5793(99)01579-3; Molokanova E, 1999, J NEUROSCI, V19, P4786; PASCUAL JM, 1995, BIOPHYS J, V69, P428, DOI 10.1016/S0006-3495(95)79915-5; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; ROOT MJ, 1994, SCIENCE, V265, P1852, DOI 10.1126/science.7522344; ROOT MJ, 1993, NEURON, V11, P459, DOI 10.1016/0896-6273(93)90150-P; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Sun ZP, 1996, NEURON, V16, P141, DOI 10.1016/S0896-6273(00)80031-8; Williams DB, 1999, BIOPHYS J, V77, P2563, DOI 10.1016/S0006-3495(99)77091-8; Wilson GG, 2000, J GEN PHYSIOL, V115, P93, DOI 10.1085/jgp.115.2.93; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315	33	68	72	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	2000	28	3					899	909		10.1016/S0896-6273(00)00162-8	http://dx.doi.org/10.1016/S0896-6273(00)00162-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386JJ	11163275	Bronze			2022-12-24	WOS:000166057500025
J	Bolshakov, VY; Carboni, L; Cobb, MH; Siegelbaum, SA; Belardetti, F				Bolshakov, VY; Carboni, L; Cobb, MH; Siegelbaum, SA; Belardetti, F			Dual MAP kinase pathways mediate opposing forms of long-term plasticity at CA3-CA1 synapses	NATURE NEUROSCIENCE			English	Article							ACTIVATED PROTEIN-KINASE; METABOTROPIC GLUTAMATE-RECEPTOR; ARACHIDONIC-ACID; RAT HIPPOCAMPUS; AREA CA1; DEPRESSION; INDUCTION; PHOSPHORYLATION; POTENTIATION; INVOLVEMENT	Although the function of the p42/p44 mitogen-activated protein (MAP) kinase pathway in longterm potentiation at hippocampal CA3-CA1 synapses has been well described, relatively little is known about the importance of the p38 MAP kinase pathway in synaptic plasticity. Here we show that the p38 MAP kinase pathway, a parallel signaling cascade activated by distinct upstream kinases, mediates the induction of metabotropic glutamate receptor-dependent long-term depression at CA3-CA1 synapses. Thus, two parallel MAP kinase pathways contribute to opposing forms of long-term plasticity at a central synapse.	Columbia Univ, Howard Hughes Med Inst, Ctr Neurobiol & Behav, Dept Pharmacol, New York, NY 10032 USA; Harvard Univ, Sch Med, McLean Hosp, Dept Psychiat, Belmont, MA 02478 USA; Glaxo Wellcome Med Res Ctr, Dept Biol, I-37135 Verona, Italy; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75235 USA	Columbia University; Howard Hughes Medical Institute; Harvard University; McLean Hospital; GlaxoSmithKline; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Siegelbaum, SA (corresponding author), Columbia Univ, Howard Hughes Med Inst, Ctr Neurobiol & Behav, Dept Pharmacol, 722 W 168 St, New York, NY 10032 USA.	sas8@columbia.edu	Carboni, Lucia/AAY-9824-2021	Carboni, Lucia/0000-0001-9335-3312; Cobb, Melanie/0000-0003-0833-5473	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034128, R37DK034128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS029832] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK34128] Funding Source: Medline; NINDS NIH HHS [NS29832] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAUDRY M, 1981, DEV BRAIN RES, V1, P37, DOI 10.1016/0165-3806(81)90092-4; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; BOLSHAKOV VY, 1995, NEUROPHARMACOLOGY, V34, P1581, DOI 10.1016/0028-3908(95)00127-R; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; BorschHaubold AG, 1997, EUR J BIOCHEM, V245, P751, DOI 10.1111/j.1432-1033.1997.t01-1-00751.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Christie BR, 1997, J NEUROPHYSIOL, V77, P1651, DOI 10.1152/jn.1997.77.3.1651; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; Ferraguti F, 1998, J COMP NEUROL, V400, P391; Fitzjohn SM, 1999, NEUROPHARMACOLOGY, V38, P1577, DOI 10.1016/S0028-3908(99)00123-9; Gasparini F, 1999, NEUROPHARMACOLOGY, V38, P1493, DOI 10.1016/S0028-3908(99)00082-9; Goda Y, 1996, CURR BIOL, V6, P375, DOI 10.1016/S0960-9822(02)00499-2; Hii CST, 1998, J BIOL CHEM, V273, P19277, DOI 10.1074/jbc.273.30.19277; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Khokhlatchev A, 1997, J BIOL CHEM, V272, P11057; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Normandin M, 1996, BRAIN RES, V730, P40; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Otani S, 1998, J PHYSIOL-LONDON, V511, P761, DOI 10.1111/j.1469-7793.1998.761bg.x; Overstreet LS, 1997, NEUROPHARMACOLOGY, V36, P831, DOI 10.1016/S0028-3908(97)00031-2; Sutton KG, 1999, NATURE, V401, P800, DOI 10.1038/44586; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92; Wilk-Blaszczak MA, 1998, J NEUROSCI, V18, P112; Winder DG, 1999, NEURON, V24, P715, DOI 10.1016/S0896-6273(00)81124-1; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451	39	185	189	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11					1107	1112		10.1038/80624	http://dx.doi.org/10.1038/80624			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TX	11036267				2022-12-24	WOS:000167177600015
J	Maquet, P; Laureys, S; Peigneux, P; Fuchs, S; Petiau, C; Phillips, C; Aerts, J; Del Fiore, G; Degueldre, C; Meulemans, T; Luxen, A; Franck, G; Van der Linden, M; Smith, C; Cleeremans, A				Maquet, P; Laureys, S; Peigneux, P; Fuchs, S; Petiau, C; Phillips, C; Aerts, J; Del Fiore, G; Degueldre, C; Meulemans, T; Luxen, A; Franck, G; Van der Linden, M; Smith, C; Cleeremans, A			Experience-dependent changes in cerebral activation during human REM sleep	NATURE NEUROSCIENCE			English	Article							FUNCTIONAL NEUROANATOMY; MOTOR CORTEX; MEMORY; RAT; CONSOLIDATION; PET; REACTIVATION; EXPRESSION; MOVEMENTS; SEQUENCES	The function of rapid-eye-movement (REM) sleep is still unknown. One prevailing hypothesis suggests that REM sleep is important in processing memory traces. Here, using positron emission tomography (PET) and regional cerebral blood flow measurements, we show that waking experience influences regional brain activity during subsequent sleep. Several brain areas activated during the execution of a serial reaction time task during wakefulness were significantly more active during REM sleep in subjects previously trained on the task than in non-trained subjects. These results support the hypothesis that memory traces are processed during REM sleep in humans.	Univ Liege, Cyclotron Res Ctr, B-4000 Liege, Belgium; Univ Liege, Dept Neuropsychol, B-4000 Liege, Belgium; Trent Univ, Dept Psychol, Peterborough, ON K9J 7B8, Canada; Free Univ Brussels, Cognit Sci Res Unit, B-1050 Brussels, Belgium	University of Liege; University of Liege; Trent University; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Maquet, P (corresponding author), UCL, Inst Neurol, Wellcome Dept Cognit Neurol, 12 Queen Sq, London WC1N 3BG, England.	maquet@pet.crc.ulg.ac.be	Laureys, Steven/AAN-2097-2021; luxen, andre/C-2116-2009; Laureys, Steven/A-3349-2011; Phillips, Christophe/M-3025-2017	Laureys, Steven/0000-0002-3096-3807; Peigneux, Philippe/0000-0003-4745-1434; Phillips, Christophe/0000-0002-4990-425X; , Pierre/0000-0003-3106-3357				Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Bailey Craig H., 1995, P19; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Cleeremans A, 1998, TRENDS COGN SCI, V2, P406, DOI 10.1016/S1364-6613(98)01232-7; CLEEREMANS A, 1991, J EXP PSYCHOL GEN, V120, P235, DOI 10.1037/0096-3445.120.3.235; CORBETTA M, 1993, J NEUROSCI, V13, P1202; DELACOUR J, 1990, NEUROSCIENCE, V34, P1, DOI 10.1016/0306-4522(90)90299-J; Frackowiak RS., 1997, HUMAN BRAIN FUNCTION; Grafton ST, 1996, CEREB CORTEX, V6, P226, DOI 10.1093/cercor/6.2.226; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; HENNEVIN E, 1995, BEHAV BRAIN RES, V69, P125, DOI 10.1016/0166-4328(95)00013-J; Jimenez L, 1996, J EXP PSYCHOL LEARN, V22, P948, DOI 10.1037/0278-7393.22.4.948; JUEPTNER M, 1995, NEUROIMAGE, V2, P148, DOI 10.1006/nimg.1995.1017; JULIANO SL, 1991, P NATL ACAD SCI USA, V88, P780, DOI 10.1073/pnas.88.3.780; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Karni A, 1997, CURR OPIN NEUROBIOL, V7, P530, DOI 10.1016/S0959-4388(97)80033-5; Kavanau JL, 1997, NEUROSCIENCE, V79, P7, DOI 10.1016/S0306-4522(96)00610-0; Kleim JA, 1996, J NEUROSCI, V16, P4529; KRUEGER JM, 1993, J SLEEP RES, V2, P63, DOI 10.1111/j.1365-2869.1993.tb00064.x; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lejeune H, 1997, NEUROSCI LETT, V235, P21, DOI 10.1016/S0304-3940(97)00698-8; Maquet P, 1996, NATURE, V383, P163, DOI 10.1038/383163a0; Maquet P, 1997, J NEUROSCI, V17, P2807; MARKS GA, 1995, BEHAV BRAIN RES, V69, P1, DOI 10.1016/0166-4328(95)00018-O; MATELLI M, 1993, NEUROREPORT, V4, P1295, DOI 10.1097/00001756-199309150-00002; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; RECHTSCHAFFEN A, 1989, SLEEP, V12, P68; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Ribeiro S, 1999, LEARN MEMORY, V6, P500, DOI 10.1101/lm.6.5.500; Schacter D. L., 1994, MEMORY SYSTEMS 1994; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; Shen WD, 1998, ACTA PHYS SIN-OV ED, V7, P1; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Skaggs WE, 1998, J NEUROSCI, V18, P8455; SMITH C, 1995, BEHAV BRAIN RES, V69, P137, DOI 10.1016/0166-4328(95)00024-N; STEPHAN KM, 1995, J NEUROPHYSIOL, V73, P373, DOI 10.1152/jn.1995.73.1.373; Steriade M, 1993, Curr Opin Neurobiol, V3, P619, DOI 10.1016/0959-4388(93)90064-6; Steriade M., 1990, BRAINSTEM CONTROL WA; Stickgold R, 1998, TRENDS COGN SCI, V2, P484, DOI 10.1016/S1364-6613(98)01258-3; TALAIRACH J, 1988, COPLANAR TEREOTAXIC; TOBLER I, 1995, BEHAV BRAIN RES, V69, P35, DOI 10.1016/0166-4328(95)00025-O; WEBB WB, 1983, SLEEP MECHANISMS FUN, P1; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	48	455	467	2	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2000	3	8					831	836		10.1038/77744	http://dx.doi.org/10.1038/77744			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TU	10903578	Green Submitted			2022-12-24	WOS:000167177300020
J	Delmas, P; Abogadie, FC; Buckley, NJ; Brown, DA				Delmas, P; Abogadie, FC; Buckley, NJ; Brown, DA			Calcium channel gating and modulation by transmitters depend on cellular compartmentalization	NATURE NEUROSCIENCE			English	Article							RAT SYMPATHETIC NEURONS; HIPPOCAMPAL CA3 NEURONS; G-PROTEIN INHIBITION; BETA-GAMMA-SUBUNITS; N-TYPE; CA2+ CHANNELS; PYRAMIDAL NEURONS; PHARMACOLOGICAL PROPERTIES; PERIPHERAL NEURONS; ACTION-POTENTIALS	Voltage-gated Ca2+ channels participate in dendritic integration, yet functional properties of Ca2+ channels and mechanisms of their modulation by neurotransmitters in dendrites are unknown. Here we report how pharmacologically identified Ca2+ channels behave in different neural compartments. Whole-cell and cell-attached patch-clamp recordings were made on both cell bodies and electrically isolated dendrites of sympathetic neurons. We found not only that Ca2+ channel populations differentially contribute to somatic and dendritic currents but also that families of Ca2+ channels display gating properties and neurotransmitter modulation that depend on channel compartmentalization. By comparison with their somatic counterparts,; dendritic N-type Ca2+ currents were hypersensitive to neurotransmitters and C proteins. Single-channel analysis showed that dendrites express a unique N-type channel that has enhanced interaction with G beta gamma. Thus Ca2+ channels in dendrites seem to be specialized elements with unique regulatory mechanisms.	UCL, Dept Pharmacol, Wellcome Lab Mol Pharmacol, London WC1E 6BT, England	University of London; University College London	Delmas, P (corresponding author), UCL, Dept Pharmacol, Wellcome Lab Mol Pharmacol, Gower St, London WC1E 6BT, England.	ucklpds@ucl.ac.uk	Buckley, Noel J/B-9675-2012; Brown, David A/J-9019-2012	Buckley, Noel J/0000-0003-1152-0653; 				BOLAND LM, 1994, J NEUROSCI, V14, P5011; BOSSU JL, 1994, EUR J NEUROSCI, V6, P335, DOI 10.1111/j.1460-9568.1994.tb00276.x; Bourinet E, 1999, NAT NEUROSCI, V2, P407, DOI 10.1038/8070; Carabelli V, 1996, BIOPHYS J, V70, P2144, DOI 10.1016/S0006-3495(96)79780-1; DELCOUR AH, 1993, J NEUROSCI, V13, P181; Delmas P, 1999, J PHYSIOL-LONDON, V518, P23, DOI 10.1111/j.1469-7793.1999.0023r.x; Delmas P, 1998, EUR J NEUROSCI, V10, P1654, DOI 10.1046/j.1460-9568.1998.00170.x; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; Dolphin AC, 1998, J PHYSIOL-LONDON, V506, P3, DOI 10.1111/j.1469-7793.1998.003bx.x; ELLINOR PT, 1994, NATURE, V372, P272, DOI 10.1038/372272a0; ELLIOTT EM, 1995, J NEUROSCI, V15, P6433; Elmslie KS, 1997, J NEUROSCI, V17, P2658; Garcia DE, 1998, J NEUROSCI, V18, P9163; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; IKEDA SR, 1991, J PHYSIOL-LONDON, V439, P181, DOI 10.1113/jphysiol.1991.sp018663; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Kavalali ET, 1997, NEURON, V18, P651, DOI 10.1016/S0896-6273(00)80305-0; KOSIK KS, 1987, J NEUROSCI, V7, P3142; Lee HK, 1999, J GEN PHYSIOL, V113, P111, DOI 10.1085/jgp.113.1.111; Lin ZX, 1996, J MOL NEUROSCI, V7, P257, DOI 10.1007/BF02737063; Lin ZX, 1997, NEURON, V18, P153, DOI 10.1016/S0896-6273(01)80054-4; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1; Meir A, 1998, NEURON, V20, P341, DOI 10.1016/S0896-6273(00)80461-4; Mermelstein PG, 1999, J NEUROSCI, V19, P7268, DOI 10.1523/JNEUROSCI.19-17-07268.1999; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; MOGUL DJ, 1991, J PHYSIOL-LONDON, V433, P259, DOI 10.1113/jphysiol.1991.sp018425; NAKAI J, 1994, P NATL ACAD SCI USA, V91, P1014, DOI 10.1073/pnas.91.3.1014; Namkung Y, 1998, P NATL ACAD SCI USA, V95, P12010, DOI 10.1073/pnas.95.20.12010; Patil PG, 1996, BIOPHYS J, V71, P2509, DOI 10.1016/S0006-3495(96)79444-4; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; Randall AD, 1997, NEUROPHARMACOLOGY, V36, P879, DOI 10.1016/S0028-3908(97)00086-5; RITTENHOUSE AR, 1994, J PHYSIOL-LONDON, V474, P87, DOI 10.1113/jphysiol.1994.sp020005; SATHER WA, 1993, NEURON, V11, P291, DOI 10.1016/0896-6273(93)90185-T; SHAPIRO MS, 1993, NEURON, V10, P11, DOI 10.1016/0896-6273(93)90237-L; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Tsien Richard W., 1995, Trends in Neurosciences, V18, P52, DOI 10.1016/0166-2236(95)93867-W; UMEMIYA M, 1995, J NEUROSCI, V15, P2218, DOI 10.1523/JNEUROSCI.15-03-02218.1995; Wakamori M, 1999, J PHYSIOL-LONDON, V517, P659, DOI 10.1111/j.1469-7793.1999.0659s.x; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; WESTON JE, 1981, SOLID STATE IONICS, V2, P347, DOI 10.1016/0167-2738(81)90038-2; Williams S, 1997, J NEUROSCI, V17, P1625; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; Zamponi GW, 1998, P NATL ACAD SCI USA, V95, P4035, DOI 10.1073/pnas.95.7.4035	50	47	49	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2000	3	7					670	678		10.1038/76621	http://dx.doi.org/10.1038/76621			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TT	10862699				2022-12-24	WOS:000167177200013
J	Zukerberg, LR; Patrick, GN; Nikolic, M; Humbert, S; Wu, CL; Lanier, LM; Gertler, FB; Vidal, M; Van Etten, RA; Tsai, LH				Zukerberg, LR; Patrick, GN; Nikolic, M; Humbert, S; Wu, CL; Lanier, LM; Gertler, FB; Vidal, M; Van Etten, RA; Tsai, LH			Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth	NEURON			English	Article							CYCLIN-DEPENDENT KINASE-5; UBIQUITIN-PROTEASOME PATHWAY; NEURONAL-SPECIFIC ACTIVATOR; PROTEIN-KINASE; BOVINE BRAIN; CDC2-LIKE KINASE; IDENTIFICATION; BINDING; MOUSE; MICE	Cyclin-dependent kinase 5 (Cdk5) is a small serine/threonine kinase that plays a pivotal role during development of the CNS. Cables, a novel protein, interacts with Cdk5 in brain lysates. Cables also binds to and is a substrate of the c-Abl tyrosine kinase. Active c-Abl kinase leads to Cdk5 tyrosine phosphorylation, and this phosphorylation is enhanced by Cables. Phosphorylation of Cdk5 by c-Abl occurs on tyrosine 15 (Y15), which is stimulatory for p35/Cdk5 kinase activity. Expression of antisense Cables in primary cortical neurons inhibited neurite outgrowth. Furthermore, expression of active Abl resulted in lengthening of neurites. The data provide evidence for a Cables-mediated interplay between the Cdk5 and c-Abl signaling pathways in the developing nervous system.	Harvard Univ, Sch Med, Dept Pathol, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Ctr Blood Res, Boston, MA 02115 USA; MIT, Dept Biol, Cambridge, MA 02129 USA; Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02139 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital	Tsai, LH (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Howard Hughes Med Inst, Boston, MA 02115 USA.		Humbert, Sandrine/S-2981-2016	Humbert, Sandrine/0000-0002-9501-2658	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037007] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS37007] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEAUDETTE KN, 1993, J BIOL CHEM, V268, P20825; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; CICCHETTI P, 1992, SCIENCE, V257, P803, DOI 10.1126/science.1379745; DAI ZH, 1995, GENE DEV, V9, P2569, DOI 10.1101/gad.9.21.2569; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; GERTLER FB, 1989, CELL, V58, P103, DOI 10.1016/0092-8674(89)90407-8; GERTLER FB, 1993, GENE DEV, V7, P441, DOI 10.1101/gad.7.3.441; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Hu G, 1997, GENE DEV, V11, P2701, DOI 10.1101/gad.11.20.2701; ISHIGURO K, 1994, FEBS LETT, V342, P203, DOI 10.1016/0014-5793(94)80501-6; JACKSON P, 1989, EMBO J, V8, P449, DOI 10.1002/j.1460-2075.1989.tb03397.x; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Kamiguchi H, 1998, J NEUROSCI, V18, P3749, DOI 10.1523/jneurosci.18-10-03749.1998; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; KRUH GD, 1990, P NATL ACAD SCI USA, V87, P5802, DOI 10.1073/pnas.87.15.5802; Kwon YT, 2000, CURR BIOL, V10, P363, DOI 10.1016/S0960-9822(00)00411-5; Lazaro JB, 1996, NEUROSCI LETT, V218, P21; LEW J, 1992, J BIOL CHEM, V267, P13383; LEW J, 1995, TRENDS BIOCHEM SCI, V20, P33, DOI 10.1016/S0968-0004(00)88948-3; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Matsuura I, 1996, J BIOL CHEM, V271, P5443, DOI 10.1074/jbc.271.10.5443; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Patrick GN, 1998, J BIOL CHEM, V273, P24057, DOI 10.1074/jbc.273.37.24057; PENDERGAST AM, 1991, P NATL ACAD SCI USA, V88, P5927, DOI 10.1073/pnas.88.13.5927; Poon RYC, 1997, J BIOL CHEM, V272, P5703, DOI 10.1074/jbc.272.9.5703; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; SCHWARTZBERG PL, 1991, CELL, V65, P1165, DOI 10.1016/0092-8674(91)90012-N; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; SHETTY KT, 1993, P NATL ACAD SCI USA, V90, P6844, DOI 10.1073/pnas.90.14.6844; SHI YG, 1995, GENE DEV, V9, P2583, DOI 10.1101/gad.9.21.2583; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; TANG DM, 1995, J BIOL CHEM, V270, P26897, DOI 10.1074/jbc.270.45.26897; Tang DM, 1997, J BIOL CHEM, V272, P12318, DOI 10.1074/jbc.272.19.12318; TSAI LH, 1993, DEVELOPMENT, V119, P1029; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; VANETTEN RA, 1994, J CELL BIOL, V124, P325, DOI 10.1083/jcb.124.3.325; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10315, DOI 10.1073/pnas.93.19.10315; Ware ML, 1997, NEURON, V19, P239, DOI 10.1016/S0896-6273(00)80936-8; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Wen ST, 1996, EMBO J, V15, P1583, DOI 10.1002/j.1460-2075.1996.tb00503.x; XIONG Y, 1992, CELL, V71, P505, DOI 10.1016/0092-8674(92)90518-H	48	308	324	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	2000	26	3					633	646		10.1016/S0896-6273(00)81200-3	http://dx.doi.org/10.1016/S0896-6273(00)81200-3			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330ZH	10896159	Bronze, Green Published			2022-12-24	WOS:000087991600014
J	Burack, MA; Silverman, MA; Banker, G				Burack, MA; Silverman, MA; Banker, G			The role of selective transport in neuronal protein sorting	NEURON			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL-NEURONS; MEMBRANE-PROTEINS; SYNAPTIC VESICLE; IN-VIVO; POLARITY ORIENTATION; TRANSFERRIN RECEPTOR; NEURITE OUTGROWTH; LIVING CELLS; TRAFFICKING	To assess whether selective microtubule-based vesicle transport underlies the polarized distribution of neuronal proteins, we expressed green fluorescent protein- (GFP-) tagged chimeras of representative axonal and dendritic membrane proteins in cultured hippocampal neurons and visualized the transport of carrier vesicles containing these proteins in living cells. Vesicles containing a dendritic protein, transferrin receptor (TfR), were preferentially transported into dendrites and excluded from axons. In contrast, vesicles containing the axonal protein NgCAM (neuron-glia cell adhesion molecule) were transported into both dendrites and axons. These data demonstrate that neurons utilize two distinct mechanisms for the targeting of polarized membrane proteins, one (for dendritic proteins) based on selective transport, the other (for axonal proteins) based on a selectivity "filter" that occurs downstream of transport.	Oregon Hlth Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA	Oregon Health & Science University	Banker, G (corresponding author), Oregon Hlth Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA.			Silverman, Michael A./0000-0001-6967-4917	NINDS NIH HHS [NS17112] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017112] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAAS PW, 1989, J CELL BIOL, V109, P3085, DOI 10.1083/jcb.109.6.3085; BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; BLACK MM, 1989, TRENDS NEUROSCI, V12, P211, DOI 10.1016/0166-2236(89)90124-0; CAMERON PL, 1991, J CELL BIOL, V115, P151, DOI 10.1083/jcb.115.1.151; Chao DS, 1999, J CELL BIOL, V144, P869, DOI 10.1083/jcb.144.5.869; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; CRAIG AM, 1995, NATURE, V375, P592, DOI 10.1038/375592a0; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Foletti DL, 1999, NEURON, V23, P641, DOI 10.1016/S0896-6273(01)80022-2; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; GALLI T, 1995, NEUROPHARMACOLOGY, V34, P1351, DOI 10.1016/0028-3908(95)00113-K; GELLER AI, 1988, SCIENCE, V241, P1667, DOI 10.1126/science.2843986; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; Goslin K., 1998, CULTURING NERVE CELL, P339; Hanlon DW, 1997, NEURON, V18, P439, DOI 10.1016/S0896-6273(00)81244-1; Hazuka CD, 1999, J NEUROSCI, V19, P1324; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; HO DY, 1994, METHOD CELL BIOL, V43, P191; Jareb M, 1998, NEURON, V20, P855, DOI 10.1016/S0896-6273(00)80468-7; Kamiguchi H, 1998, J NEUROSCI, V18, P5311, DOI 10.1523/JNEUROSCI.18-14-05311.1998; Keller P, 1997, J CELL SCI, V110, P3001; LEE KD, 1995, J BIOL CHEM, V270, P5600, DOI 10.1074/jbc.270.10.5600; LOPEZ LA, 1993, CELL MOTIL CYTOSKEL, V24, P1, DOI 10.1002/cm.970240102; LOPEZ LA, 1995, J BIOL CHEM, V270, P12511, DOI 10.1074/jbc.270.21.12511; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Marszalek JR, 1999, J CELL BIOL, V145, P469, DOI 10.1083/jcb.145.3.469; MCILVAIN JM, 1994, J BIOL CHEM, V269, P19176; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Prekeris R, 1999, J NEUROSCI, V19, P10324; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Reilein AR, 1998, J CELL BIOL, V142, P803, DOI 10.1083/jcb.142.3.803; Saito N, 1997, NEURON, V18, P425, DOI 10.1016/S0896-6273(00)81243-X; SatoHarada R, 1996, CELL STRUCT FUNCT, V21, P283, DOI 10.1247/csf.21.283; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Stowell JN, 1999, NEURON, V22, P525, DOI 10.1016/S0896-6273(00)80707-2; Toomre D, 1999, J CELL SCI, V112, P21; Trinczek B, 1999, J CELL SCI, V112, P2355; VANDENPOL AN, 1993, J COMP NEUROL, V332, P237, DOI 10.1002/cne.903320208; Vogt L, 1996, CURR BIOL, V6, P1153, DOI 10.1016/S0960-9822(02)70682-9; Warren RA, 1997, J BIOL CHEM, V272, P2116; West AE, 1997, J NEUROSCI, V17, P6038; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Winckler B, 1999, NEURON, V23, P637, DOI 10.1016/S0896-6273(01)80021-0; Yeaman C, 1999, PHYSIOL REV, V79, P73, DOI 10.1152/physrev.1999.79.1.73	49	216	218	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	2000	26	2					465	472		10.1016/S0896-6273(00)81178-2	http://dx.doi.org/10.1016/S0896-6273(00)81178-2			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318QZ	10839364	Bronze			2022-12-24	WOS:000087296500022
J	Schaefer, AM; Hadwiger, GD; Nonet, ML				Schaefer, AM; Hadwiger, GD; Nonet, ML			rpm-1, a conserved neuronal gene that regulates targeting and synaptogenesis in C-elegans	NEURON			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; VERTEBRATE NEUROMUSCULAR-JUNCTION; NEMATODE CAENORHABDITIS-ELEGANS; GLR-1 GLUTAMATE-RECEPTOR; CHROMOSOME CONDENSATION; PRESYNAPTIC DIFFERENTIATION; CULTURED NEURONS; BINDING PROTEIN; GIANT PROTEIN; RAB PROTEINS	Little is known of mechanisms regulating presynaptic differentiation. We identified rpm-1 in a screen for mutants with defects in patterning of a presynaptic marker at certain interneuronal synapses. The predicted RPM-1 protein contains zinc binding, RCC1, and other conserved motifs. In rpm-1 mutants, mechanosensory neurons fail to accumulate tagged vesicles, retract synaptic branches, and ectopically extend axons. Some motor neurons branch and overgrow; others show altered synaptic organization. Expression of RPM-1 in the presynaptic mechanosensory neurons is sufficient to rescue phenotypes in these cells. Certain rpm-1 phenotypes are temperature sensitive, revealing that RPM-1 function can be bypassed by maintaining mutants at the permissive temperature at stages commensurate with synapse formation in wild-type animals. These results indicate that RPM-1 functions cell autonomously during synaptogenesis to regulate neuronal morphology.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Nonet, ML (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	nonetm@thalamus.wustl.edu			NIGMS NIH HHS [GM07067] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; Borden KLB, 1998, BIOCHEM CELL BIOL, V76, P351, DOI 10.1139/bcb-76-2-3-351; Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHALFIE M, 1989, SCIENCE, V243, P1027, DOI 10.1126/science.2646709; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Craig AM, 1998, NEURON, V21, P459, DOI 10.1016/S0896-6273(00)80555-3; Dai ZS, 1996, SEMIN NEUROSCI, V8, P97, DOI 10.1006/smns.1996.0013; DAI ZS, 1995, J NEUROSCI, V15, P5466; EMMONS SW, 1997, C ELEGANS, V2, P295; GARRITY PA, 1995, CELL, V83, P177, DOI 10.1016/0092-8674(95)90159-0; Guo QB, 1998, P NATL ACAD SCI USA, V95, P9172, DOI 10.1073/pnas.95.16.9172; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HAMELIN M, 1992, EMBO J, V11, P2885, DOI 10.1002/j.1460-2075.1992.tb05357.x; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Knobel KM, 1999, DEVELOPMENT, V126, P4489; Lehman AL, 1998, P NATL ACAD SCI USA, V95, P9436, DOI 10.1073/pnas.95.16.9436; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; Meindl A, 1996, NAT GENET, V13, P35, DOI 10.1038/ng0596-35; Mello C, 1995, CAENORHABDITIS ELEGA, P451; MITANI S, 1993, DEVELOPMENT, V119, P773; NISHIMOTO T, 1981, J CELL PHYSIOL, V109, P299, DOI 10.1002/jcp.1041090213; NISHIMOTO T, 1978, CELL, V15, P475, DOI 10.1016/0092-8674(78)90017-X; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; Nonet ML, 1998, J NEUROSCI, V18, P70; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; OHTSUBO M, 1987, GENE DEV, V1, P585, DOI 10.1101/gad.1.6.585; Peckol EL, 1999, DEVELOPMENT, V126, P1891; Renault L, 1998, NATURE, V392, P97, DOI 10.1038/32204; Rosa JL, 1997, ONCOGENE, V15, P1, DOI 10.1038/sj.onc.1201170; Rosa JL, 1996, EMBO J, V15, P4262, DOI 10.1002/j.1460-2075.1996.tb00801.x; Saifee O, 1998, MOL BIOL CELL, V9, P1235, DOI 10.1091/mbc.9.6.1235; Sanes JR, 1997, CURR OPIN NEUROBIOL, V7, P93, DOI 10.1016/S0959-4388(97)80126-2; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Schuman EM, 1999, NEURON, V23, P645, DOI 10.1016/S0896-6273(01)80023-4; Son YJ, 1999, EUR J NEUROSCI, V11, P3457, DOI 10.1046/j.1460-9568.1999.00766.x; Sone M, 1997, SCIENCE, V275, P543, DOI 10.1126/science.275.5299.543; Sulston J., 1988, NEMATODE CAENORHABDI, P587; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Uhlmann J, 1999, FEBS LETT, V460, P153, DOI 10.1016/S0014-5793(99)01333-2; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WILLIAMS BD, 1992, GENETICS, V131, P609; Yuan J, 1998, ONCOGENE, V17, P1109, DOI 10.1038/sj.onc.1202036; ZHAO H, 2000, IN PRESS DEVELOPMENT; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8	56	202	209	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	2000	26	2					345	356		10.1016/S0896-6273(00)81168-X	http://dx.doi.org/10.1016/S0896-6273(00)81168-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318QZ	10839354	Bronze			2022-12-24	WOS:000087296500012
J	Zhen, M; Huang, X; Bamber, B; Jin, Y				Zhen, M; Huang, X; Bamber, B; Jin, Y			Regulation of presynaptic terminal organization by C-elegans RPM-1, a putative guanine nucleotide exchanger with a RING-H2 finger domain	NEURON			English	Article							TUMOR-SUPPRESSOR GENE; CAENORHABDITIS-ELEGANS; NEUROMUSCULAR-JUNCTION; POSTSYNAPTIC DENSITY; SYNAPTIC VESICLES; NERVOUS-SYSTEM; ACTIVE ZONE; PROTEIN; DROSOPHILA; MUTANTS	Presynaptic terminals contain highly organized subcellular structures to facilitate neurotransmitter release. In C. elegans, the typical presynaptic terminal has an electron-dense active zone surrounded by synaptic vesicles. Loss-of-function mutations in the rpm-1 gene result in abnormally structured presynaptic terminals in GABAergic neuromuscular junctions (NMJs), most often manifested as a single presynaptic terminal containing multiple active zones. The RPM-1 protein has an RCC1-like guanine nucleotide exchange factor (GEF) domain and a RING-HP finger. RPM-1 is most similar to the Drosophila presynaptic protein Highwire (HIW) and the mammalian Myc binding protein Pam. RPM-1 is localized to the presynaptic region independent of synaptic vesicles and functions cell autonomously. The temperature-sensitive period of rpm-1 coincides with the time of synaptogenesis. rpm-1 may regulate the spatial arrangement, or restrict the formation, of presynaptic structures.	Univ Calif Santa Cruz, Sinsheimer Labs, Dept Biol, Santa Cruz, CA 95064 USA; Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	University of California System; University of California Santa Cruz; Utah System of Higher Education; University of Utah	Jin, Y (corresponding author), Univ Calif Santa Cruz, Sinsheimer Labs, Dept Biol, Santa Cruz, CA 95064 USA.	jin@biology.ucsc.edu	Zhen, Mei/A-4967-2012	Zhen, Mei/0000-0003-0086-9622; Huang, Xun/0000-0002-2653-8293; Jin, Yishi/0000-0002-9371-9860	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035546] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-35546] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Azuma Y, 1996, J BIOCHEM-TOKYO, V120, P82; Bamber BA, 1999, J NEUROSCI, V19, P5348; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; BRENNER S, 1974, GENETICS, V77, P71; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; BURNS ME, 1995, CELL, V83, P187, DOI 10.1016/0092-8674(95)90160-4; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Gramates LS, 1999, INT REV NEUROBIOL, V43, P93, DOI 10.1016/S0074-7742(08)60542-5; Guo QB, 1998, P NATL ACAD SCI USA, V95, P9172, DOI 10.1073/pnas.95.16.9172; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; Hallam SJ, 1998, NATURE, V395, P78, DOI 10.1038/25757; Harlow E., 1999, USING ANTIBODIES LAB; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Heuser JE, 1977, HDB PHYSL, VI, P261; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; Inouye C, 1997, SCIENCE, V278, P103, DOI 10.1126/science.278.5335.103; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; Jin YS, 1999, J NEUROSCI, V19, P539; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; JORGENSEN EM, 1997, C ELEGANS, V2, P769; KENNEDY MB, 1983, P NATL ACAD SCI-BIOL, V80, P7357, DOI 10.1073/pnas.80.23.7357; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; KISTNER U, 1993, J BIOL CHEM, V268, P4580; Koh YH, 1999, CELL, V98, P353, DOI 10.1016/S0092-8674(00)81964-9; LANDIS DMD, 1988, NEURON, V1, P201, DOI 10.1016/0896-6273(88)90140-7; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; NGUYEN M, 1995, GENETICS, V140, P527; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; Rand James B., 1997, Cold Spring Harbor Monograph Series, V33, P611; Renault L, 1998, NATURE, V392, P97, DOI 10.1038/32204; Rosa JL, 1996, EMBO J, V15, P4262, DOI 10.1002/j.1460-2075.1996.tb00801.x; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; SULSTON JE, 1976, PHILOS T ROY SOC B, V275, P287, DOI 10.1098/rstb.1976.0084; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wang XL, 1999, J CELL BIOL, V147, P151, DOI 10.1083/jcb.147.1.151; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Yochem J, 1998, GENETICS, V149, P1323; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297; ZOLLER MJ, 1987, METHOD ENZYMOL, V154, P329	59	188	200	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	2000	26	2					331	343		10.1016/S0896-6273(00)81167-8	http://dx.doi.org/10.1016/S0896-6273(00)81167-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318QZ	10839353	Bronze			2022-12-24	WOS:000087296500011
J	Barcelo, F; Suwazono, S; Knight, RT				Barcelo, F; Suwazono, S; Knight, RT			Prefrontal modulation of visual processing in humans	NATURE NEUROSCIENCE			English	Article							EVENT-RELATED POTENTIALS; NORMAL HUMAN CORTEX; SPATIAL ATTENTION; SELECTIVE ATTENTION; NEURAL MECHANISMS; BRAIN POTENTIALS; CYTOARCHITECTONIC DEFINITION; AREAS 9; OBJECT; PET	Single neuron, evoked potential and metabolic techniques show that attention influences visual processing in extrastriate cortex. We provide anatomical, electrophysiological and behavioral evidence that prefrontal cortex regulates neuronal activity in extrastriate cortex during visual discrimination. Event-related potentials (ERPs) were recorded during a visual detection task in patients with damage in dorsolateral prefrontal cortex. Prefrontal damage reduced neuronal activity in extrastriate cortex of the lesioned hemisphere. These electrophysiological abnormalities, beginning 125 ms after stimulation and lasting for another 500 ms, were accompanied by behavioral deficits in detection ability in the contralesional hemifield. The results provide evidence for intrahemispheric prefrontal modulation of visual processing.	Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; Univ Complutense, Fac Psychol, Dept Psychobiol, Madrid 28223, Spain; Niigata Univ, Brain Res Inst, Dept Integrated Neurosci, Niigata 95021, Japan	University of California System; University of California Berkeley; Complutense University of Madrid; Niigata University	Knight, RT (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.	rtknight@socrates.berkeley.edu	Barceló, Francisco/B-3629-2011	Barceló, Francisco/0000-0001-6012-7116; Suwazono, Shugo/0000-0003-1286-9718	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021135] Funding Source: NIH RePORTER; NINDS NIH HHS [NS21135] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Buchel C, 1997, CEREB CORTEX, V7, P768, DOI 10.1093/cercor/7.8.768; Chao LL, 1998, J COGNITIVE NEUROSCI, V10, P167, DOI 10.1162/089892998562636; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Clark V.P., 1994, HUMAN BRAIN MAPPING, V2, P170, DOI [10.1002/hbm.460020306, DOI 10.1002/HBM.460020306]; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; CORBETTA M, 1993, J NEUROSCI, V13, P1202; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; HANSEN JC, 1980, ELECTROEN CLIN NEURO, V49, P277, DOI 10.1016/0013-4694(80)90222-9; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Hillyard Steven A., 1995, P665; Karayanidis F, 1997, ELECTROEN CLIN NEURO, V103, P282, DOI 10.1016/S0013-4694(97)96077-6; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Knight RT, 1998, J CLIN NEUROPHYSIOL, V15, P3, DOI 10.1097/00004691-199801000-00003; KNIGHT RT, 1984, ELECTROEN CLIN NEURO, V59, P9, DOI 10.1016/0168-5597(84)90016-9; Knight RT, 1997, J COGNITIVE NEUROSCI, V9, P75, DOI 10.1162/jocn.1997.9.1.75; Luck SJ, 1995, BEHAV BRAIN RES, V71, P113, DOI 10.1016/0166-4328(95)00041-0; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MANGUN GR, 1995, PSYCHOPHYSIOLOGY, V32, P4, DOI 10.1111/j.1469-8986.1995.tb03400.x; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; MCCARTHY G, 1985, ELECTROEN CLIN NEURO, V62, P203, DOI 10.1016/0168-5597(85)90015-2; MCINTOSH AR, 1994, J NEUROSCI, V14, P655; Miller EK, 1999, NEURON, V22, P15, DOI 10.1016/S0896-6273(00)80673-X; Muller MM, 1998, NAT NEUROSCI, V1, P631, DOI 10.1038/2865; Nielsen-Bohlman L, 1999, COGNITIVE BRAIN RES, V8, P299, DOI 10.1016/S0926-6410(99)00035-X; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; RAJKOWSKA G, 1995, CEREB CORTEX, V5, P323, DOI 10.1093/cercor/5.4.323; RAJKOWSKA G, 1995, CEREB CORTEX, V5, P307, DOI 10.1093/cercor/5.4.307; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; Rees G, 1997, SCIENCE, V275, P835, DOI 10.1126/science.275.5301.835; ROSAHL SK, 1995, CEREB CORTEX, V5, P123, DOI 10.1093/cercor/5.2.123; Smid HGOM, 1999, PSYCHOPHYSIOLOGY, V36, P264, DOI 10.1017/S0048577299971135; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Valdes-Sosa M, 1998, J COGNITIVE NEUROSCI, V10, P137, DOI 10.1162/089892998563743; WEBSTER MJ, 1994, CEREB CORTEX, V4, P470, DOI 10.1093/cercor/4.5.470; Webster MJ, 1998, ATTENTIVE BRAIN, P19; Wijers AA, 1997, PSYCHOPHYSIOLOGY, V34, P553, DOI 10.1111/j.1469-8986.1997.tb01742.x; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836; Woldorff MG, 1997, HUM BRAIN MAPP, V5, P280, DOI 10.1002/(SICI)1097-0193(1997)5:4<280::AID-HBM13>3.0.CO;2-I	41	289	313	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2000	3	4					399	403		10.1038/73975	http://dx.doi.org/10.1038/73975			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330CN	10725931				2022-12-24	WOS:000087945400022
J	Choi, S; Klingauf, J; Tsien, RW				Choi, S; Klingauf, J; Tsien, RW			Postfusional regulation of cleft glutamate concentration during LTP at 'silent synapses'	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CULTURED HIPPOCAMPAL-NEURONS; SYNAPTICALLY RELEASED GLUTAMATE; METHYL-D-ASPARTATE; TRANSPORTER CURRENTS; TRANSMITTER RELEASE; KAINATE RECEPTORS; FUSION PORE; TIME-COURSE; AMPA	'Silent synapses' show responses from high-affinity NMDA receptors (NMDARs) but not low-affinity AMPA receptors (AMPARs), but gain AMPAR responses upon long-term potentiation (LTP). Using the rapidly reversible NMDAR antagonist L-AP5 to assess cleft glutamate concentration ([glu](cleft)), we found that it peaked at <<170 mu M at silent neonatal synapses, but greatly increased after potentiation. Cyclothiazide (CTZ), a potentiator of AMPAR, revealed slowly rising AMPA EPSCs at silent synapses; LTP shortened their rise times. Thus, LTP at silent synapses increased rate-of-rise and peak amplitude of [glu](cleft). Release probability reported by NMDARs remained unchanged during LTP, implying that [glu](cleft) increases arose from immediately presynaptic terminals. Our data suggest that changes in the dynamics of fusion-pore opening contribute to LTP.	Stanford Univ, Sch Med, Beckman Ctr, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Stanford University	Tsien, RW (corresponding author), Stanford Univ, Sch Med, Beckman Ctr, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.							Bekkers JM, 1996, J NEUROPHYSIOL, V75, P1250, DOI 10.1152/jn.1996.75.3.1250; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; Bellingham MC, 1999, NEURON, V23, P159, DOI 10.1016/S0896-6273(00)80762-X; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; Diamond JS, 1997, J NEUROSCI, V17, P4672; Diamond JS, 1998, NEURON, V21, P425, DOI 10.1016/S0896-6273(00)80551-6; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Dzubay JA, 1999, J NEUROSCI, V19, P5265; Glavinovic MI, 1998, PFLUG ARCH EUR J PHY, V435, P193; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Kullmann DM, 1999, NATURE, V399, P111, DOI 10.1038/20089; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lollike K, 1998, BIOPHYS J, V75, P53, DOI 10.1016/S0006-3495(98)77494-6; Luscher C, 1998, NEURON, V21, P435, DOI 10.1016/S0896-6273(00)80552-8; Ma L, 1999, NAT NEUROSCI, V2, P24, DOI 10.1038/4525; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; OLVERMAN HJ, 1988, NEUROSCIENCE, V26, P17, DOI 10.1016/0306-4522(88)90124-8; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; PERKEL DJ, 1993, J PHYSIOL-LONDON, V471, P481, DOI 10.1113/jphysiol.1993.sp019911; Pothos EN, 1998, J NEUROSCI, V18, P4106; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; Rumpel S, 1998, J NEUROSCI, V18, P8863; Ryan TA, 1996, NEURON, V17, P125, DOI 10.1016/S0896-6273(00)80286-X; Scepek S, 1998, EMBO J, V17, P4340, DOI 10.1093/emboj/17.15.4340; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SPRUCE AE, 1990, NEURON, V4, P643, DOI 10.1016/0896-6273(90)90192-I; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; YAMADA KA, 1993, J NEUROSCI, V13, P3904; Zhou Z, 1996, BIOPHYS J, V70, P1543, DOI 10.1016/S0006-3495(96)79718-7	43	197	200	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2000	3	4					330	336		10.1038/73895	http://dx.doi.org/10.1038/73895			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330CN	10725921				2022-12-24	WOS:000087945400012
J	Tamas, G; Buhl, EH; Lorincz, A; Somogyi, P				Tamas, G; Buhl, EH; Lorincz, A; Somogyi, P			Proximally targeted GABAergic synapses and gap junctions synchronize cortical interneurons	NATURE NEUROSCIENCE			English	Article							SYNAPTIC RELEASE SITES; HIPPOCAMPUS IN-VITRO; CAT VISUAL-CORTEX; INHIBITORY INTERNEURONS; SOMATOSENSORY CORTEX; NEOCORTICAL NEURONS; PYRAMIDAL CELLS; NETWORKS; OSCILLATIONS; RAT	Networks of GABAergic interneurons are implicated in synchronizing cortical activity at gamma frequencies (30-70 Hz). Here we demonstrate that the combined electrical and GABAergic synaptic coupling of basket cells instantaneously entrained gamma-frequency postsynaptic firing in layers 2/3 of rat somatosensory cortex. This entrainment was mediated by rapid curtailment of gap junctional coupling potentials by GABA(A) receptor-mediated IPSPs. Electron microscopy revealed spatial proximity of gap junctions and GABAergic synapses on somata and dendrites. Electrical coupling alone entrained postsynaptic firing with a phase lag, whereas unitary GABAergic connections were ineffective in gamma-frequency phasing. These observations demonstrate precise spatiotemporal mechanisms underlying action potential timing in oscillating interneuronal networks.	Univ Szeged, Dept Comparat Physiol, H-6726 Szeged, Hungary; Univ Oxford, Univ Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England	Szeged University; University of Oxford	Tamas, G (corresponding author), Univ Szeged, Dept Comparat Physiol, Kozepfasor 52, H-6726 Szeged, Hungary.	gtamas@sol.cc.u-szeged.hu	Tamas, Gabor/AAG-9305-2020	Tamas, Gabor/0000-0002-7905-6001				Buhl EH, 1998, J PHYSIOL-LONDON, V513, P117, DOI 10.1111/j.1469-7793.1998.117by.x; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; CHRISTIE MJ, 1989, J NEUROSCI, V9, P3584; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; CONNORS BW, 1983, J NEUROSCI, V3, P773; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Jefferys JGR, 1996, TRENDS NEUROSCI, V19, P202, DOI 10.1016/S0166-2236(96)10023-0; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; KOSAKA T, 1985, J COMP NEUROL, V231, P150, DOI 10.1002/cne.902310203; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; LYTTON WW, 1991, J NEUROPHYSIOL, V66, P1059, DOI 10.1152/jn.1991.66.3.1059; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Mann-Metzer P, 1999, J NEUROSCI, V19, P3298; NAKAJIMA Y, 1974, J COMP NEUROL, V156, P375, DOI 10.1002/cne.901560402; NIEDERMEYER Ernst, 1982, ELECTROEN CLIN NEURO; PAPPAS GD, 1966, ANN NY ACAD SCI, V137, P495, DOI 10.1111/j.1749-6632.1966.tb50177.x; PEINADO A, 1993, NEURON, V10, P103, DOI 10.1016/0896-6273(93)90246-N; Peters A, 1980, Adv Neurol, V27, P21; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; SLOPER JJ, 1972, BRAIN RES, V44, P640, DOI 10.1016/0006-8993(72)90327-7; Swadlow HA, 1998, J NEUROPHYSIOL, V79, P567, DOI 10.1152/jn.1998.79.2.567; Tamas G, 1997, J NEUROSCI, V17, P6352; Tamas G, 1997, J PHYSIOL-LONDON, V500, P715, DOI 10.1113/jphysiol.1997.sp022054; Tamas G, 1998, J NEUROSCI, V18, P4255; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; YLINEN A, 1995, HIPPOCAMPUS, V5, P78, DOI 10.1002/hipo.450050110	35	504	507	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2000	3	4					366	371		10.1038/73936	http://dx.doi.org/10.1038/73936			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330CN	10725926				2022-12-24	WOS:000087945400017
J	Morris, LG; Thuma, JB; Hooper, SL				Morris, LG; Thuma, JB; Hooper, SL			Muscles express motor patterns of non-innervating neural networks by filtering broad-band input	NATURE NEUROSCIENCE			English	Article							LOBSTER PANULIRUS-INTERRUPTUS; STOMATOGASTRIC NERVOUS-SYSTEM; CHANGING NEURONAL INPUT; GENE-EXPRESSION; SPINY LOBSTER; PRESYNAPTIC CALCIUM; HOMARUS-AMERICANUS; PYRAMIDAL NEURONS; CANCER-BOREALIS; SPIKE FREQUENCY	We describe three slow muscles that responded to low-frequency modulation of a high-frequency neuronal input and, consequently, could express the motor patterns of neural networks whose neurons did not directly innervate the muscles. Two of these muscles responded to different frequency components present in the same input, and as a result each muscle expressed the motor pattern of a different, non-innervating, neural network. In an analogous manner, the distinct dynamics of the multiple intracellular processes that most cells possess may allow each process to respond to, and hence differentiate among, specific frequency ranges present in broad-band input.	Ohio Univ, Dept Biol Sci, Neurosci Program, Athens, OH 45701 USA; CUNY Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA	University System of Ohio; Ohio University; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Hooper, SL (corresponding author), Ohio Univ, Dept Biol Sci, Neurosci Program, Irvine Hall, Athens, OH 45701 USA.		Morris, Lee/W-8544-2018					BELTZ B, 1984, J EXP BIOL, V109, P35; Blitz DM, 1999, J NEUROSCI, V19, P5449; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; Brezina V, 1997, P NATL ACAD SCI USA, V94, P10444, DOI 10.1073/pnas.94.19.10444; Chatton JY, 1998, BIOPHYS J, V74, P523, DOI 10.1016/S0006-3495(98)77809-9; CLAIBORNE BJ, 1984, J COMP PHYSIOL, V154, P27, DOI 10.1007/BF00605386; Clarac F, 1996, EXP BRAIN RES, V112, P163; DELANEY KR, 1989, J NEUROSCI, V9, P3558; DELANEY KR, 1994, J NEUROSCI, V14, P5885; DICKINSON PS, 1983, J EXP BIOL, V105, P59; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; EVANS PD, 1982, J PHYSIOL-LONDON, V324, P93, DOI 10.1113/jphysiol.1982.sp014102; Feller MB, 1996, J NEUROPHYSIOL, V76, P381, DOI 10.1152/jn.1996.76.1.381; Fields RD, 1997, J NEUROSCI, V17, P7252; FIELDS RD, 1993, J NEUROBIOL, V25, P281; FLAMM RE, 1986, J NEUROPHYSIOL, V55, P847, DOI 10.1152/jn.1986.55.5.847; GAMBLE E, 1987, SCIENCE, V236, P1311, DOI 10.1126/science.3495885; GOVIND CK, 1975, J COMP PHYSIOL, V96, P185, DOI 10.1007/BF00612694; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; HOOPER SL, 1987, J NEUROSCI, V7, P2097; ITOH K, 1995, SCIENCE, V270, P1369, DOI 10.1126/science.270.5240.1369; JorgeRivera JC, 1996, J COMP PHYSIOL A, V179, P741; KATZ PS, 1990, J NEUROSCI, V10, P1495; KENNEDY MB, 1992, INTRO MOL NEUROBIOLO, P463; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Liu Z, 1998, J NEUROSCI, V18, P2309; MAYNARD DM, 1975, J COMP PHYSIOL, V100, P161, DOI 10.1007/BF00613967; MAYNARD DM, 1974, PHILOS T ROY SOC B, V268, P161, DOI 10.1098/rstb.1974.0024; MEYRAND P, 1986, J COMP PHYSIOL A, V158, P489, DOI 10.1007/BF00603795; MEYRAND P, 1991, J NEUROSCI, V11, P1150; Morris LG, 1997, J NEUROSCI, V17, P5956; Morris LG, 1998, J NEUROSCI, V18, P3433; MULLONEY B, 1977, J COMP PHYSIOL, V122, P227, DOI 10.1007/BF00611892; Norris BJ, 1996, J NEUROPHYSIOL, V75, P97, DOI 10.1152/jn.1996.75.1.97; NUSBAUM MP, 1988, J EXP BIOL, V135, P165; NUSBAUM MP, 1989, J NEUROSCI, V9, P1600; PARTRIDGE LD, 1966, AM J PHYSIOL, V210, P1178, DOI 10.1152/ajplegacy.1966.210.5.1178; Pivovarova NB, 1999, J NEUROSCI, V19, P6372; REGEHR WG, 1994, J NEUROSCI, V14, P523; RUSSELL DF, 1981, BRAIN RES, V223, P19, DOI 10.1016/0006-8993(81)90803-9; Selverston A I, 1976, Prog Neurobiol, V7, P215, DOI 10.1016/0301-0082(76)90008-3; SHENG HZ, 1993, J NEUROSCI RES, V35, P459, DOI 10.1002/jnr.490350502; SIGVARDT KA, 1982, J EXP BIOL, V97, P137; SMITH SJ, 1983, NATURE, V304, P350, DOI 10.1038/304350a0; Stevenson PA, 1997, J EXP BIOL, V200, P633; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; Turrigiano Gina G., 1992, P197; WANG SSH, 1995, J GEN PHYSIOL, V105, P149, DOI 10.1085/jgp.105.1.149; Wang XJ, 1998, J NEUROPHYSIOL, V79, P1549, DOI 10.1152/jn.1998.79.3.1549; WEISS KR, 1992, EXPERIENTIA, V48, P456, DOI 10.1007/BF01928164	50	34	34	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2000	3	3					245	250		10.1038/72955	http://dx.doi.org/10.1038/72955			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TE	10700256				2022-12-24	WOS:000085810500013
J	Scanziani, M				Scanziani, M			GABA spillover activates postsynaptic GABA(B) receptors to control rhythmic hippocampal activity	NEURON			English	Article							GAMMA-AMINOBUTYRIC-ACID; INHIBITORY SYNAPTIC POTENTIALS; RECTIFYING K+ CHANNELS; PYRAMIDAL CELLS; RAT HIPPOCAMPUS; GUINEA-PIG; GABAERGIC INTERNEURONS; SLICE CULTURES; THETA-ACTIVITY; NEURONS	In the hippocampus, interneurons provide synaptic inhibition via the transmitter GABA, which can activate GABA(A) and GABA(B) receptors (GABA(A)Rs and GABA(B)Rs). Generally, however, GABA released by a single interneuron activates only GABA(A)Rs on its targets, despite the abundance of GABA(B)Rs. Here, I show that during hippocampal rhythmic activity, simultaneous release of GABA from several interneurons activates postsynaptic GABA(B)Rs and that block of GABA(B)Rs increases oscillation frequency. Furthermore, if GABA uptake is inhibited, even GABA released by a single interneuron is enough to activate GABA(B)Rs. This occurs also on cells not directly contacted by that interneuron, indicating that GABA has to overcome uptake and exit the synaptic cleft to reach GABA(B)Rs. Thus, activation of extrasynaptic GABA(B)Rs by pooling of GABA is an important mechanism regulating hippocampal network activity.	Univ Zurich, Brain Res Inst, CH-8057 Zurich, Switzerland	University of Zurich	Scanziani, M (corresponding author), Univ Zurich, Brain Res Inst, Winterthurerstr 190, CH-8057 Zurich, Switzerland.							Ali AB, 1999, EUR J NEUROSCI, V11, P1741, DOI 10.1046/j.1460-9568.1999.00592.x; ALLEN GI, 1977, PROC R SOC SER B-BIO, V198, P363, DOI 10.1098/rspb.1977.0103; BRAESTRUP C, 1990, J NEUROCHEM, V54, P639, DOI 10.1111/j.1471-4159.1990.tb01919.x; BREITWIESER GE, 1988, J GEN PHYSIOL, V91, P469, DOI 10.1085/jgp.91.4.469; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; DESTEXHE A, 1995, P NATL ACAD SCI USA, V92, P9515, DOI 10.1073/pnas.92.21.9515; DOLPHIN AC, 1987, J PHYSIOL-LONDON, V386, P1; Doupnik CA, 1997, P NATL ACAD SCI USA, V94, P10461, DOI 10.1073/pnas.94.19.10461; DUTAR P, 1988, NATURE, V332, P156, DOI 10.1038/332156a0; Fischer Y, 1999, J PHYSIOL-LONDON, V519, P405, DOI 10.1111/j.1469-7793.1999.0405m.x; Frerking M, 1999, P NATL ACAD SCI USA, V96, P12917, DOI 10.1073/pnas.96.22.12917; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; GAHWILER BH, 1981, J NEUROSCI METH, V4, P329, DOI 10.1016/0165-0270(81)90003-0; GAHWILER BH, 1984, NEUROSCIENCE, V11, P751, DOI 10.1016/0306-4522(84)90192-1; GAHWILER BH, 1985, P NATL ACAD SCI USA, V82, P1558, DOI 10.1073/pnas.82.5.1558; GENESERJENSEN FA, 1971, Z ZELLFORSCH MIK ANA, V114, P460, DOI 10.1007/BF00325634; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; ITO H, 1992, J GEN PHYSIOL, V99, P961, DOI 10.1085/jgp.99.6.961; Jefferys JGR, 1996, TRENDS NEUROSCI, V19, P202, DOI 10.1016/S0166-2236(96)10023-0; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kahana MJ, 1999, NATURE, V399, P781, DOI 10.1038/21645; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kim U, 1997, SCIENCE, V278, P130, DOI 10.1126/science.278.5335.130; KONOPACKI J, 1987, BRAIN RES, V405, P196, DOI 10.1016/0006-8993(87)91009-2; KRAPIVINSKY G, 1995, J BIOL CHEM, V270, P29059, DOI 10.1074/jbc.270.49.29059; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; MILES R, 1984, J PHYSIOL-LONDON, V356, P97, DOI 10.1113/jphysiol.1984.sp015455; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; NEWBERRY NR, 1985, J PHYSIOL-LONDON, V360, P161, DOI 10.1113/jphysiol.1985.sp015610; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; OTIS TS, 1993, J PHYSIOL-LONDON, V463, P391, DOI 10.1113/jphysiol.1993.sp019600; OTIS TS, 1992, J NEUROPHYSIOL, V67, P227, DOI 10.1152/jn.1992.67.1.227; PITLER TA, 1992, J PHYSIOL-LONDON, V450, P127, DOI 10.1113/jphysiol.1992.sp019119; REKLING JC, 1990, BRIT J PHARMACOL, V99, P103, DOI 10.1111/j.1476-5381.1990.tb14661.x; Saitoh O, 1997, NATURE, V390, P525, DOI 10.1038/37385; SCHOLZ KP, 1991, J PHYSIOL-LONDON, V444, P669, DOI 10.1113/jphysiol.1991.sp018900; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Sodickson DL, 1996, J NEUROSCI, V16, P6374; SOLIS J, 1992, PHARM COMMUN, V2, P32; SOLTESZ I, 1993, J NEUROPHYSIOL, V70, P97, DOI 10.1152/jn.1993.70.1.97; SPRUSTON N, 1993, J NEUROPHYSIOL, V70, P781, DOI 10.1152/jn.1993.70.2.781; STREIT P, 1989, EUR J NEUROSCI, V1, P603, DOI 10.1111/j.1460-9568.1989.tb00366.x; THOMPSON SM, 1992, J NEUROPHYSIOL, V67, P1698, DOI 10.1152/jn.1992.67.6.1698; Thomson AM, 1999, NEUROSCIENCE, V92, P1193, DOI 10.1016/S0306-4522(99)00021-4; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Williams JH, 1997, J NEUROPHYSIOL, V78, P2631, DOI 10.1152/jn.1997.78.5.2631	50	291	297	1	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR	2000	25	3					673	681		10.1016/S0896-6273(00)81069-7	http://dx.doi.org/10.1016/S0896-6273(00)81069-7			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	301CY	10774734	Bronze			2022-12-24	WOS:000086291700019
J	Sawatari, A; Callaway, EM				Sawatari, A; Callaway, EM			Diversity and cell type specificity of local excitatory connections to neurons in layer 3B of monkey primary visual cortex	NEURON			English	Article							MACAQUE STRIATE CORTEX; LATERAL GENICULATE-NUCLEUS; CYTOCHROME-OXIDASE BLOBS; FUNCTIONAL-ANATOMY; CIRCUIT NEURONS; AREA V2; LASER PHOTOSTIMULATION; CORTICAL CONNECTIONS; PROCESSING STREAMS; SPATIAL-FREQUENCY	In the primary visual cortex of macaque monkeys, laminar and columnar axonal specificity are correlated with functional differences between locations. We describe evidence that embedded within this anatomical framework is finer specificity of functional connections. Photostimulation-based mapping of functional input to 31 layer 3B neurons revealed that input sources to individual cells were highly diverse. Although some input differences were correlated with neuronal anatomy, no 2 neurons received excitatory input from the same cortical layers. Thus, input diversity reveals far more cell types than does anatomical diversity. This implies relatively little functional redundancy; despite trends related to laminar or columnar position, pools of neurons contributing uniquely to visual processing are likely relatively small. These results also imply that similarities in the anatomy of circuits in different cortical areas or species may not indicate similar functional connectivity.	Salk Inst Biol Studies, Syst Neurobiol Labs, La Jolla, CA 92037 USA	Salk Institute	Callaway, EM (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Callaway, Edward/D-4336-2011	Callaway, Edward/0000-0002-6366-5267	NATIONAL EYE INSTITUTE [R01EY010742] Funding Source: NIH RePORTER; NEI NIH HHS [EY10742] Funding Source: Medline; NIGMS NIH HHS [GM08107] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON JC, 1993, CEREB CORTEX, V3, P412, DOI 10.1093/cercor/3.5.412; BEAULIEU C, 1992, CEREB CORTEX, V2, P295, DOI 10.1093/cercor/2.4.295; BENEVENTO LA, 1982, BRAIN RES, V252, P161, DOI 10.1016/0006-8993(82)90991-X; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BULLIER J, 1983, EXP BRAIN RES, V53, P168; BULLIER J, 1995, CURR OPIN NEUROBIOL, V5, P497, DOI 10.1016/0959-4388(95)80011-5; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Callaway EM, 1996, VISUAL NEUROSCI, V13, P907, DOI 10.1017/S0952523800009159; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; CASAGRANDE VA, 1994, TRENDS NEUROSCI, V17, P305, DOI 10.1016/0166-2236(94)90065-5; DALVA MB, 1994, SCIENCE, V265, P255, DOI 10.1126/science.7912852; Desimone R., 1989, HDB NEUROPSYCHOLOGY, P267; DEYOE EA, 1985, NATURE, V317, P58, DOI 10.1038/317058a0; DEYOE EA, 1994, NATURE, V371, P151, DOI 10.1038/371151a0; EDWARDS DP, 1995, VISION RES, V35, P1501, DOI 10.1016/0042-6989(94)00253-I; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1987, J NEUROSCI, V7, P3378; HUBEL DH, 1974, J COMP NEUROL, V158, P267, DOI 10.1002/cne.901580304; HUBENER M, 1992, J COMP NEUROL, V324, P67, DOI 10.1002/cne.903240106; KATZ LC, 1989, J NEUROSCI, V9, P1389; KATZ LC, 1994, J NEUROSCI METH, V54, P205, DOI 10.1016/0165-0270(94)90194-5; LACHICA EA, 1992, P NATL ACAD SCI USA, V89, P3566, DOI 10.1073/pnas.89.8.3566; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P2830; LIVINGSTONE MS, 1983, NATURE, V304, P531, DOI 10.1038/304531a0; LUND JS, 1991, J COMP NEUROL, V311, P234, DOI 10.1002/cne.903110206; LUND JS, 1988, J COMP NEUROL, V276, P1, DOI 10.1002/cne.902760102; LUND JS, 1987, J COMP NEUROL, V257, P60, DOI 10.1002/cne.902570106; MacNeil MA, 1998, NEURON, V20, P971, DOI 10.1016/S0896-6273(00)80478-X; MALACH R, 1992, J COMP NEUROL, V315, P303, DOI 10.1002/cne.903150306; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; Parra P, 1998, NEURON, V20, P983, DOI 10.1016/S0896-6273(00)80479-1; ROCKLAND KS, 1979, BRAIN RES, V179, P3, DOI 10.1016/0006-8993(79)90485-2; Sawatari A, 1996, NATURE, V380, P442, DOI 10.1038/380442a0; Shipp S, 1995, J ANAT, V187, P547; SHIPP S, 1985, NATURE, V315, P322, DOI 10.1038/315322a0; Stevens CF, 1998, CURR BIOL, V8, pR708, DOI 10.1016/S0960-9822(98)70454-3; TOOTELL RBH, 1988, J NEUROSCI, V8, P1610; TOOTELL RBH, 1988, J NEUROSCI, V8, P1500; TOOTELL RBH, 1988, J NEUROSCI, V8, P1594; TSO DY, 1986, J NEUROSCI, V6, P1160; Wiser AK, 1996, J NEUROSCI, V16, P2724; Yabuta NH, 1998, VISUAL NEUROSCI, V15, P1007, DOI 10.1017/S0952523898156018; Yabuta NH, 1998, J NEUROSCI, V18, P9489; YOSHIOKA T, 1994, VISUAL NEUROSCI, V11, P467, DOI 10.1017/S0952523800002406; YUKIE M, 1985, BRAIN RES, V346, P383, DOI 10.1016/0006-8993(85)90875-3; ZEKI S, 1989, EUR J NEUROSCI, V1, P494, DOI 10.1111/j.1460-9568.1989.tb00356.x	49	64	64	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	2000	25	2					459	471		10.1016/S0896-6273(00)80908-3	http://dx.doi.org/10.1016/S0896-6273(00)80908-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	288EL	10719899	Bronze			2022-12-24	WOS:000085549100022
J	Fischer, AJ; Reh, TA				Fischer, AJ; Reh, TA			Muller glia are a potential source of neural regeneration in the postnatal chicken retina	NATURE NEUROSCIENCE			English	Article							NEURONAL PRODUCTION; H3 PHOSPHORYLATION; NERVOUS-SYSTEM; OKADAIC ACID; EYE GROWTH; ADULT; CELLS; INDUCTION; DIFFERENTIATION; PROLIFERATION	The retina of warm-blooded vertebrates is believed to be incapable of neural regeneration. Here we provide evidence that the retina of postnatal chickens has the potential to generate new neurons. In response to acute damage, numerous Muller glia re-entered the cell cycle, and shortly thereafter, expressed CASH-1, Pax6 and Chx10, transcription factors expressed by embryonic retinal progenitors. These progenitor-like cells transiently expressed neurofilament. Newly formed cells became distributed throughout the inner and outer nuclear layers of the retina, and remained for at least three weeks after damage. Some of these newly formed cells differentiated into retinal neurons, a few formed Muller glia, and most remained undifferentiated, with continued expression of Pax6 and Chx10. These cells continued to proliferate when grown in culture, with some differentiating into retinal neurons or Muller glia. We propose that, in response to damage, Muller glia in the retina are a potential source of neural regeneration.	Univ Washington, Hlth Sci Ctr, Sch Med, Dept Biol Struct, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Reh, TA (corresponding author), Univ Washington, Hlth Sci Ctr, Sch Med, Dept Biol Struct, POB 357420, Seattle, WA 98195 USA.	tomreh@u.washington.edu	Fischer, Andy J./AAE-9817-2022; Fischer, Andy J./AFF-1827-2022; Fischer, Andrew J/E-3061-2011	Fischer, Andy J./0000-0001-6123-7405; Fischer, Andy J./0000-0001-6123-7405; 	NINDS NIH HHS [NS28308] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028308] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ajiro K, 1996, J BIOL CHEM, V271, P13197, DOI 10.1074/jbc.271.22.13197; ANCHAN RM, 1991, NEURON, V6, P923, DOI 10.1016/0896-6273(91)90233-P; BARRINGTON M, 1989, CURR EYE RES, V8, P781, DOI 10.3109/02713688909000868; BeleckyAdams T, 1997, INVEST OPHTH VIS SCI, V38, P1293; BRAISTED JE, 1994, DEVELOPMENT, V122, P1427; CHADEE DN, 1995, J BIOL CHEM, V270, P20098, DOI 10.1074/jbc.270.34.20098; COULOMBRE JL, 1965, DEV BIOL, V12, P79, DOI 10.1016/0012-1606(65)90022-9; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; EHRLICH D, 1990, CIBA F SYMP, V155, P63; Fischer AJ, 2000, DEV BIOL, V220, P197, DOI 10.1006/dbio.2000.9640; Fischer AJ, 1998, J COMP NEUROL, V393, P1; FISCHER AJ, 1999, J NEUROCYTOL, V58, P697; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; Gould E, 1997, NEUROSCIENCE, V80, P427, DOI 10.1016/S0306-4522(97)00127-9; JASONI CL, 1994, DEVELOPMENT, V120, P769; JOHNS PR, 1981, NATURE, V293, P141, DOI 10.1038/293141a0; JOHNS PR, 1982, J NEUROSCI, V176, P343; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; MAHADEVAN LC, 1991, CELL, V65, P775, DOI 10.1016/0092-8674(91)90385-C; NEGISHI K, 1991, DEV BRAIN RES, V63, P71, DOI 10.1016/0165-3806(91)90068-T; OESTERIE EC, 1996, ANN NY ACAD SCI, V78, P34; PARK CM, 1989, DEV BIOL, V134, P201, DOI 10.1016/0012-1606(89)90089-4; PRADA C, 1991, EUR J NEUROSCI, V3, P559, DOI 10.1111/j.1460-9568.1991.tb00843.x; Raymond P A, 1997, Adv Neurol, V72, P171; REH TA, 1987, J NEUROSCI, V7, P3317; REH TA, 1995, SEMIN CELL BIOL, V6, P137, DOI 10.1006/scel.1995.0019; REH TA, 1988, J NEUROBIOL, V80, P206; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Scharff C, 2000, NEURON, V25, P481, DOI 10.1016/S0896-6273(00)80910-1; Takahashi M, 1998, MOL CELL NEUROSCI, V12, P340, DOI 10.1006/mcne.1998.0721; Tomita K, 1996, GENES CELLS, V1, P765, DOI 10.1111/j.1365-2443.1996.tb00016.x; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; TUNG NN, 1990, VISUAL NEUROSCI, V4, P217, DOI 10.1017/S0952523800003369; WILLBOLD E, 1992, EUR J NEUROSCI, V4, P210, DOI 10.1111/j.1460-9568.1992.tb00869.x	34	431	459	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2001	4	3					247	252		10.1038/85090	http://dx.doi.org/10.1038/85090			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UE	11224540				2022-12-24	WOS:000167178300011
J	Wu, GY; Deisseroth, K; Tsien, RW				Wu, GY; Deisseroth, K; Tsien, RW			Spaced stimuli stabilize MAPK pathway activation and its effects on dendritic morphology	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE CASCADE; LONG-TERM FACILITATION; ELEMENT-BINDING PROTEIN; SYNAPTIC ACTIVITY; CREB PHOSPHORYLATION; DEPENDENT REGULATION; RECEPTOR ACTIVATION; SIGNALING PATHWAY; HIPPOCAMPAL SLICE; SENSORY NEURONS	Memory storage in mammalian neurons probably depends on both biochemical events and morphological alterations in dendrites. Here we report an activity-dependent stabilization of the MAP kinase (MAPK) pathway, prominent in hippocampal dendrites. The longevity of the signal in these dendrites was increased to hours when multiple spaced stimuli were used. Likewise, spaced stimuli and MAPK activation were critical for protrusion of new dendritic filopodia that also remained stable for hours. Our experiments define a new role for stimulus-specific responses of MAPK signaling in activity-dependent neuronal plasticity. The local biochemical signaling in dendrites complements MAPK signaling in gene expression. Together, these processes may support long-lasting behavioral changes.	Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Stanford University; Stanford University	Tsien, RW (corresponding author), Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.							Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Bailey CH, 1997, NEURON, V18, P913, DOI 10.1016/S0896-6273(00)80331-1; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Blum S, 1999, J NEUROSCI, V19, P3535; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; CHANG FLF, 1984, BRAIN RES, V309, P35, DOI 10.1016/0006-8993(84)91008-4; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; EDWARDS FA, 1995, PHYSIOL REV, V75, P759, DOI 10.1152/physrev.1995.75.4.759; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Enslen H, 1996, P NATL ACAD SCI USA, V93, P10803, DOI 10.1073/pnas.93.20.10803; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fields RD, 1997, J NEUROSCI, V17, P7252; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; HOSOKAWA T, 1995, J NEUROSCI, V15, P5560; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Iyengar R, 1996, SCIENCE, V271, P461, DOI 10.1126/science.271.5248.461; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; Kogan JH, 1997, CURR BIOL, V7, P1, DOI 10.1016/S0960-9822(06)00022-4; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; Mauelshagen J, 1998, LEARN MEMORY, V5, P246; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Michael D, 1998, P NATL ACAD SCI USA, V95, P1864, DOI 10.1073/pnas.95.4.1864; Murphy DD, 1997, P NATL ACAD SCI USA, V94, P1482, DOI 10.1073/pnas.94.4.1482; MURPHY TH, 1994, J NEUROSCI, V14, P1320, DOI 10.1523/JNEUROSCI.14-03-01320.1994; Raught B, 1999, INT J BIOCHEM CELL B, V31, P43, DOI 10.1016/S1357-2725(98)00131-9; Roberson ED, 1999, J NEUROSCI, V19, P4337; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Schafe GE, 1999, LEARN MEMORY, V6, P97; Schuman EM, 1999, NEURON, V23, P645, DOI 10.1016/S0896-6273(01)80023-4; Seidel MG, 1999, J BIOL CHEM, V274, P25833, DOI 10.1074/jbc.274.36.25833; Sorra KE, 1998, J COMP NEUROL, V398, P225; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Winder DG, 1999, NEURON, V24, P715, DOI 10.1016/S0896-6273(00)81124-1; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	50	323	331	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2001	4	2					151	158		10.1038/83976	http://dx.doi.org/10.1038/83976			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UC	11175875				2022-12-24	WOS:000167178100013
J	Bomze, HM; Bulsara, KR; Iskandar, BJ; Caroni, P; Skene, JHP				Bomze, HM; Bulsara, KR; Iskandar, BJ; Caroni, P; Skene, JHP			Spinal axon regeneration evoked by replacing two growth cone proteins in adult neurons	NATURE NEUROSCIENCE			English	Article							PRIMARY SENSORY NEURONS; CENTRAL-NERVOUS-SYSTEM; NEURITE OUTGROWTH; PERIPHERAL-NERVE; CORTICOSPINAL TRACT; FUNCTIONAL RECOVERY; GAP-43 EXPRESSION; MESSENGER-RNAS; GANGLION-CELLS; MAMMALIAN CNS	In contrast to peripheral nerves, damaged axons in the mammalian brain and spinal cord rarely regenerate. Peripheral nerve injury stimulates neuronal expression of many genes that are not generally induced by CNS lesions, but it is not known which of these genes are required for regeneration. Here we show that co-expressing two major growth cone proteins, GAP-43 and GAP-23, can elicit long axon extension by adult dorsal root ganglion (DRG) neurons in vitro. Moreover, this expression triggers a 60-fold increase in regeneration of DRG axons in adult mice after spinal cord injury in vivo. Replacing key growth cone components, therefore, could be an effective way to stimulate regeneration of CNS axons.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Div Neurosurg, Durham, NC 27710 USA; Univ Wisconsin, Dept Neurol Surg, Madison, WI 53792 USA; Friedrich Miescher Inst, CH-4058 Basel, Switzerland	Duke University; Duke University; University of Wisconsin System; University of Wisconsin Madison; Friedrich Miescher Institute for Biomedical Research	Skene, JHP (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Bryan Res Bldg, Durham, NC 27710 USA.			Skene, Pate/0000-0003-3205-0697				AIGNER L, 1995, J CELL BIOL, V128, P647, DOI 10.1083/jcb.128.4.647; AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Buffo A, 1997, J NEUROSCI, V17, P8778; CAMPBELL G, 1991, EXP BRAIN RES, V87, P67; Caroni P, 1997, BIOESSAYS, V19, P767, DOI 10.1002/bies.950190906; Caroni P, 1997, J CELL BIOL, V136, P679, DOI 10.1083/jcb.136.3.679; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; CHONG MS, 1994, J NEUROSCI, V14, P4375; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; DOSTER SK, 1991, NEURON, V6, P1; Fernandes KJL, 1999, J COMP NEUROL, V414, P495, DOI 10.1002/(SICI)1096-9861(19991129)414:4<495::AID-CNE6>3.0.CO;2-S; Fidler PS, 1999, J NEUROSCI, V19, P8778, DOI 10.1523/JNEUROSCI.19-20-08778.1999; Frey D, 2000, J CELL BIOL, V149, P1443, DOI 10.1083/jcb.149.7.1443; FRIEDMAN B, 1985, J NEUROSCI, V5, P1616; Goldberg JL, 2000, NATURE, V403, P369, DOI 10.1038/35000309; Higo N, 1999, CEREB CORTEX, V9, P317, DOI 10.1093/cercor/9.4.317; HIMI T, 1994, BRAIN RES, V655, P177, DOI 10.1016/0006-8993(94)91612-8; Huang DW, 1999, NEURON, V24, P639, DOI 10.1016/S0896-6273(00)81118-6; KALIL K, 1986, J NEUROSCI, V6, P2563; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Li Y, 1997, SCIENCE, V277, P2000, DOI 10.1126/science.277.5334.2000; Maekawa S, 1999, J BIOL CHEM, V274, P21369, DOI 10.1074/jbc.274.30.21369; Maier DL, 1999, P NATL ACAD SCI USA, V96, P9397, DOI 10.1073/pnas.96.16.9397; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; McNamara RK, 1997, J COMP NEUROL, V379, P48; Meiri KF, 1998, J NEUROSCI, V18, P10429; Mosevitsky MI, 1997, BIOCHIMIE, V79, P373, DOI 10.1016/S0300-9084(97)80032-6; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; NEVE RL, 1988, P NATL ACAD SCI USA, V85, P3638, DOI 10.1073/pnas.85.10.3638; Qiu J, 2000, GLIA, V29, P166, DOI 10.1002/(SICI)1098-1136(20000115)29:2<166::AID-GLIA10>3.0.CO;2-G; Ramon-Cueto A, 2000, NEURON, V25, P425, DOI 10.1016/S0896-6273(00)80905-8; RICHARDSON PM, 1986, J NEUROCYTOL, V15, P585, DOI 10.1007/BF01611859; RICHARDSON PM, 1984, J NEUROCYTOL, V13, P165, DOI 10.1007/BF01148324; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; SCHADEN H, 1994, J NEUROBIOL, V25, P1570, DOI 10.1002/neu.480251209; SCHREYER DJ, 1993, J NEUROBIOL, V24, P959, DOI 10.1002/neu.480240709; SKENE JHP, 1989, ANNU REV NEUROSCI, V12, P127, DOI 10.1146/annurev.ne.12.030189.001015; SKENE JHP, 1981, J CELL BIOL, V89, P96, DOI 10.1083/jcb.89.1.96; Smith DS, 1997, J NEUROSCI, V17, P646; SO KF, 1985, BRAIN RES, V328, P349, DOI 10.1016/0006-8993(85)91047-9; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; STRITTMATTER SM, 1995, CELL, V80, P445, DOI 10.1016/0092-8674(95)90495-6; Sugiura Y, 1995, DEV BRAIN RES, V90, P73, DOI 10.1016/0165-3806(96)83488-2; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; Wiederkehr A, 1997, EXP CELL RES, V236, P103, DOI 10.1006/excr.1997.3709; Zhu QZ, 1999, EXP NEUROL, V155, P228, DOI 10.1006/exnr.1998.6989	49	295	311	0	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2001	4	1					38	43		10.1038/82881	http://dx.doi.org/10.1038/82881			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UB	11135643				2022-12-24	WOS:000167178000012
J	Ko, GYP; Ko, ML; Dryer, SE				Ko, GYP; Ko, ML; Dryer, SE			Circadian regulation of cGMP-gated cationic channels of chick retinal cones: Erk MAP kinase and Ca2+/calmodulin-dependent protein kinase II	NEURON			English	Article							JAPANESE-QUAIL RETINA; CYCLIC-GMP; SUPRACHIASMATIC NUCLEUS; CALCIUM HOMEOSTASIS; ROD PHOTORECEPTORS; TERMINAL MITOSIS; MESSENGER-RNA; PINEAL-GLAND; ION CHANNELS; IN-VITRO	cGMP-gated channels are essential for phototransduction in the vertebrate retina. Here we show that the affinity of these channels for cGMP in chick cones is substantially higher during the subjective night than during the subjective day. This effect persists in constant environmental conditions after entrainment to 12:12 hr light-dark cycles in vitro or in ovo. Circadian modulation of ligand affinity is a posttranslational effect and is driven by rhythms in the activities of two protein kinases: Erk and Ca2+/calmodulin-dependent protein kinase II (CaMKII). Erk is maximally active during the subjective night, whereas CaMKII is maximally active during the subjective day. Acute inhibition of these signaling pathways causes phase-dependent changes in the affinity of the channels for cGMP.	Univ Houston, Dept Biol & Biochem, Biol Clocks Program, Houston, TX 77204 USA	University of Houston System; University of Houston	Dryer, SE (corresponding author), Univ Houston, Dept Biol & Biochem, Biol Clocks Program, Houston, TX 77204 USA.	sdryer@uh.edu			NATIONAL EYE INSTITUTE [R01EY011973] Funding Source: NIH RePORTER; NEI NIH HHS [EY11973] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADLER R, 1989, SCIENCE, V243, P391, DOI 10.1126/science.2911751; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; ANDERSON CR, 1973, J PHYSIOL-LONDON, V235, P655, DOI 10.1113/jphysiol.1973.sp010410; Bauer PJ, 1996, J PHYSIOL-LONDON, V494, P675, DOI 10.1113/jphysiol.1996.sp021523; BeleckyAdams T, 1996, DEV BIOL, V178, P304, DOI 10.1006/dbio.1996.0220; BLOCK G, 1995, CIBA F SYMP, V183, P51; Bonigk W, 1999, J NEUROSCI, V19, P5332; CAHILL GM, 1993, NEURON, V10, P573, DOI 10.1016/0896-6273(93)90160-S; Cameron JS, 2000, J NEUROPHYSIOL, V84, P2767, DOI 10.1152/jn.2000.84.6.2767; COBBS WH, 1985, NATURE, V317, P64, DOI 10.1038/317064a0; COBBS WH, 1985, NATURE, V313, P585, DOI 10.1038/313585a0; CORRENT G, 1978, SCIENCE, V202, P977, DOI 10.1126/science.309655; DRYER SE, 1991, NATURE, V353, P756, DOI 10.1038/353756a0; DRYER SE, 1993, J COMP PHYSIOL A, V172, P271, DOI 10.1007/BF00216609; DSouza T, 1996, NATURE, V382, P165, DOI 10.1038/382165a0; GLEASON E, 1992, VISUAL NEUROSCI, V8, P315, DOI 10.1017/S0952523800005058; GORDON SE, 1992, NEURON, V9, P739, DOI 10.1016/0896-6273(92)90036-D; GORDON SE, 1995, J PHYSIOL-LONDON, V486, P533, DOI 10.1113/jphysiol.1995.sp020832; Green CB, 1996, P NATL ACAD SCI USA, V93, P14884, DOI 10.1073/pnas.93.25.14884; Hackos DH, 1997, J GEN PHYSIOL, V110, P515, DOI 10.1085/jgp.110.5.515; Haynes LW, 1997, VISUAL NEUROSCI, V14, P233, DOI 10.1017/S0952523800011378; HAYNES LW, 1995, J GEN PHYSIOL, V106, P485, DOI 10.1085/jgp.106.3.485; HAYNES LW, 1990, J PHYSIOL-LONDON, V429, P451, DOI 10.1113/jphysiol.1990.sp018267; HSU YT, 1993, NATURE, V361, P76, DOI 10.1038/361076a0; Jiang ZG, 1997, J PHYSIOL-LONDON, V499, P141, DOI 10.1113/jphysiol.1997.sp021917; KAWAMURA S, 1991, NATURE, V349, P420, DOI 10.1038/349420a0; KORENBROT JI, 1989, NATURE, V337, P454, DOI 10.1038/337454a0; Krishnan B, 1999, NATURE, V400, P375, DOI 10.1038/22566; LAGNADO L, 1994, NATURE, V367, P273, DOI 10.1038/367273a0; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; Li GY, 1998, J MOL NEUROSCI, V11, P135, DOI 10.1385/JMN:11:2:135; LU J, 1991, VISION RES, V31, P717; Manglapus MK, 1999, J NEUROSCI, V19, P4132; Manglapus MK, 1998, J NEUROSCI, V18, P4775; McGoogan JM, 1999, AM J PHYSIOL-REG I, V277, pR1418, DOI 10.1152/ajpregu.1999.277.5.R1418; MICHEL S, 1993, SCIENCE, V259, P239, DOI 10.1126/science.8421785; Miller James L., 1994, Current Opinion in Neurobiology, V4, P488, DOI 10.1016/0959-4388(94)90048-5; MILLER JL, 1994, J GEN PHYSIOL, V104, P909, DOI 10.1085/jgp.104.5.909; Molokanova E, 1997, J NEUROSCI, V17, P9068; Molokanova E, 2000, J GEN PHYSIOL, V115, P685, DOI 10.1085/jgp.115.6.685; PIERCE ME, 1993, NEURON, V10, P579, DOI 10.1016/0896-6273(93)90161-J; Rebrik TI, 1998, J GEN PHYSIOL, V112, P537, DOI 10.1085/jgp.112.5.537; REPKA A, 1992, DEV BIOL, V153, P242, DOI 10.1016/0012-1606(92)90109-T; Roenneberg T, 1999, J BIOL RHYTHM, V14, P449, DOI 10.1177/074873099129001019; Sanada K, 2000, J NEUROSCI, V20, P986, DOI 10.1523/JNEUROSCI.20-03-00986.2000; Shapley R, 1984, PROG RETIN RES, V3, P263, DOI DOI 10.1016/0278-4327(84)90011-7; SHIBATA S, 1982, BRAIN RES, V247, P154, DOI 10.1016/0006-8993(82)91041-1; TORRE V, 1992, P ROY SOC B-BIOL SCI, V250, P209, DOI 10.1098/rspb.1992.0151; Wang Y, 1996, P NATL ACAD SCI USA, V93, P4655, DOI 10.1073/pnas.93.10.4655; YOSHIDA K, 1993, NEURON, V10, P1049, DOI 10.1016/0896-6273(93)90053-T; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315	51	106	107	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	2001	29	1					255	266		10.1016/S0896-6273(01)00195-7	http://dx.doi.org/10.1016/S0896-6273(01)00195-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	397NX	11182096	Bronze			2022-12-24	WOS:000166702700024
J	Niethammer, M; Smith, DS; Ayala, R; Peng, JM; Ko, J; Lee, MS; Morabito, M; Tsai, LH				Niethammer, M; Smith, DS; Ayala, R; Peng, JM; Ko, J; Lee, MS; Morabito, M; Tsai, LH			NUDEL is a novel Cdk5 substrate that associates with LIS1 and cytoplasmic dynein	NEURON			English	Article							PLATELET-ACTIVATING-FACTOR; DIEKER LISSENCEPHALY GENE; FACTOR ACETYLHYDROLASE; ASPERGILLUS-NIDULANS; NUCLEAR MIGRATION; NEURONAL MIGRATION; AXONAL-TRANSPORT; POSTSYNAPTIC DENSITY; CORTICAL DEVELOPMENT; INTERMEDIATE CHAIN	Disruption of one allele of the LIS1 gene causes a severe developmental brain abnormality, type I lissencephaly. In Aspergillus nidulans, the LIS1 homolog, NUDE, and cytoplasmic dynein are genetically linked and regulate nuclear movements during hyphal growth. Recently, we demonstrated that mammalian LIS1 regulates dynein functions. Here we characterize NUDEL, a novel LIS1-interacting protein with sequence homology to gene products also implicated in nuclear distribution in fungi. Like LIS1, NUDEL is robustly expressed in brain, enriched at centrosomes and neuronal growth cones, and interacts with cytoplasmic dynein. Furthermore, NUDEL is a substrate of Cdk5, a kinase known to be critical during neuronal migration. Inhibition of Cdk5 modifies NUDEL distribution in neurons and affects neuritic morphology. Our findings point to crosstalk between two prominent pathways that regulate neuronal migration.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Tsai, LH (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 200 Longwood Ave, Boston, MA 02115 USA.	li-huei_tsai@hms.harvard.edu	Peng, Junmin/N-2614-2018; Smith, Deanna/AFU-2285-2022	Peng, Junmin/0000-0003-0472-7648; Smith, Deanna/0000-0002-3014-641X				Abe TK, 1997, BIOCHEM BIOPH RES CO, V233, P295, DOI 10.1006/bbrc.1997.6447; ADACHI H, 1995, BIOCHEM BIOPH RES CO, V214, P180, DOI 10.1006/bbrc.1995.2272; Adachi T, 1997, NEUROSCI LETT, V235, P133, DOI 10.1016/S0304-3940(97)00742-8; Ahmad FJ, 1998, J CELL BIOL, V140, P391, DOI 10.1083/jcb.140.2.391; Albrecht U, 1996, DEV BIOL, V180, P579, DOI 10.1006/dbio.1996.0330; Allen MJ, 1999, J NEUROSCI, V19, P9374; Beckwith SM, 1998, J CELL BIOL, V143, P1239, DOI 10.1083/jcb.143.5.1239; Berrueta L, 1999, CURR BIOL, V9, P425, DOI 10.1016/S0960-9822(99)80190-0; Bloom K, 2000, NAT CELL BIOL, V2, pE96, DOI 10.1038/35014089; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Dillman JF, 1996, J NEUROSCI, V16, P6742; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Efimov VP, 2000, J CELL BIOL, V150, P681, DOI 10.1083/jcb.150.3.681; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; Gilmore EC, 2000, CURR BIOL, V10, pR162, DOI 10.1016/S0960-9822(00)00332-8; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Hattori M, 1995, J BIOL CHEM, V270, P31345, DOI 10.1074/jbc.270.52.31345; HATTORI M, 1994, J BIOL CHEM, V269, P23150; HATTORI M, 1994, NATURE, V370, P216, DOI 10.1038/370216a0; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Homayouni R, 2000, CURR BIOL, V10, pR331, DOI 10.1016/S0960-9822(00)00459-0; Humbert S, 2000, J CELL SCI, V113, P975; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; Kennedy M B, 1993, Curr Opin Neurobiol, V3, P732, DOI 10.1016/0959-4388(93)90145-O; Kwon YT, 2000, CURR BIOL, V10, P363, DOI 10.1016/S0960-9822(00)00411-5; Kwon YT, 1998, J COMP NEUROL, V395, P510, DOI 10.1002/(SICI)1096-9861(19980615)395:4<510::AID-CNE7>3.0.CO;2-4; Kwon YT, 2000, RES PRO CEL, V30, P241; Lee L, 2000, SCIENCE, V287, P2260, DOI 10.1126/science.287.5461.2260; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Manya H, 1999, J BIOL CHEM, V274, P31827, DOI 10.1074/jbc.274.45.31827; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Minke PF, 1999, MOL MICROBIOL, V32, P1065, DOI 10.1046/j.1365-2958.1999.01421.x; Morris NR, 2000, J CELL BIOL, V148, P1097, DOI 10.1083/jcb.148.6.1097; Murphey RK, 1999, DEV BIOL, V209, P86, DOI 10.1006/dbio.1999.9217; Naisbitt S, 2000, J NEUROSCI, V20, P4524, DOI 10.1523/JNEUROSCI.20-12-04524.2000; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; OSHIMA T, 1996, P NATL ACAD SCI USA, V93, P11173; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Phillis R, 1996, DEVELOPMENT, V122, P2955; Purohit A, 1999, J CELL BIOL, V147, P481, DOI 10.1083/jcb.147.3.481; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Reiner O, 1998, INT J MOL MED, V1, P849; Rice DS, 1999, GENE DEV, V13, P2758, DOI 10.1101/gad.13.21.2758; Robinson JT, 1999, J CELL BIOL, V146, P597, DOI 10.1083/jcb.146.3.597; Sapir T, 1999, EUR J BIOCHEM, V265, P181, DOI 10.1046/j.1432-1327.1999.00711.x; Sapir T, 1997, EMBO J, V16, P6977, DOI 10.1093/emboj/16.23.6977; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; SCHNAPP BJ, 1989, P NATL ACAD SCI USA, V86, P1548, DOI 10.1073/pnas.86.5.1548; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Stukenberg PT, 1997, CURR BIOL, V7, P338, DOI 10.1016/S0960-9822(06)00157-6; Swan A, 1999, NAT CELL BIOL, V1, P444, DOI 10.1038/15680; TAKADA K, 1988, CLIN NEUROPATHOL, V7, P111; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10321, DOI 10.1073/pnas.93.19.10321; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10315, DOI 10.1073/pnas.93.19.10315; Walsh CA, 2000, CURR OPIN GENET DEV, V10, P270, DOI 10.1016/S0959-437X(00)00076-9; WatermanStorer CM, 1997, P NATL ACAD SCI USA, V94, P12180, DOI 10.1073/pnas.94.22.12180; Xiang X, 2000, CURR BIOL, V10, P603, DOI 10.1016/S0960-9822(00)00488-7; Xiang X, 1999, CURR GENET, V35, P626, DOI 10.1007/s002940050461; XIANG X, 1995, MOL BIOL CELL, V6, P297, DOI 10.1091/mbc.6.3.297; XIANG X, 1994, P NATL ACAD SCI USA, V91, P2100, DOI 10.1073/pnas.91.6.2100; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3; [No title captured]	71	407	427	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	2000	28	3					697	711		10.1016/S0896-6273(00)00147-1	http://dx.doi.org/10.1016/S0896-6273(00)00147-1			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386JJ	11163260	Bronze			2022-12-24	WOS:000166057500010
J	Walters, RJ; Hadley, SH; Morris, KDW; Amin, J				Walters, RJ; Hadley, SH; Morris, KDW; Amin, J			Benzodiazepines act an GABA(A) receptors via two distinct and separable mechanisms	NATURE NEUROSCIENCE			English	Article							AMINOBUTYRIC ACID(A) RECEPTORS; SINGLE AMINO-ACID; CONFERS BARBITURATE SENSITIVITY; A-RECEPTOR; BINDING-SITE; ALPHA-SUBUNIT; C-RECEPTOR; XENOPUS OOCYTES; MODULATION; AGONIST	Benzodiazepines (BZs) act on gamma -aminobutyric acid type A (GABA(A)) receptors such as alpha (1)beta (2)gamma (2) through key residues within the N-terminal region of a subunits, to render their sedative and anxiolytic actions. However, the molecular mechanisms underlying the BZs' other clinical actions are not known. Here we show that, with low concentrations of GABA, diazepam produces a biphasic potentiation for the alpha (1)beta (2)gamma (2)-receptor channel, with distinct components in the nanomolar and micromolar concentration ranges. Mutations at equivalent residues within the second transmembrane domains (TM2) of alpha, beta and gamma subunits, proven important for the action of other anesthetics, abolish the micromolar, but not the nanomolar component. Converse mutation of the corresponding TM2 residue and a TM3 residue within rho (1) subunits confers diazepam sensitivity on homo-oligomeric rho (1)-receptor channels that are otherwise insensitive to BZs. Thus, specific and distinct residues contribute to a previously unresolved component (micromolar) of diazepam action, indicating that diazepam can modulate the GABA(A)-receptor channel through two separable mechanisms.	Univ S Florida, Dept Pharmacol & Therapeut Physiol & Biophys, Tampa, FL 33612 USA; Univ S Florida, Inst Biomol Sci, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Amin, J (corresponding author), Univ S Florida, Dept Pharmacol & Therapeut Physiol & Biophys, Tampa, FL 33612 USA.	jamin@hsc.usf.edu	Amin, Jahanshah/I-7174-2012		NATIONAL EYE INSTITUTE [R29EY011531] Funding Source: NIH RePORTER; NEI NIH HHS [EY11531] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Amin J, 1999, MOL PHARMACOL, V55, P411; Amin J, 1997, MOL PHARMACOL, V51, P833, DOI 10.1124/mol.51.5.833; Barnard EA, 1998, PHARMACOL REV, V50, P291; Belelli D, 1997, P NATL ACAD SCI USA, V94, P11031, DOI 10.1073/pnas.94.20.11031; Belelli D, 1999, BRIT J PHARMACOL, V127, P601, DOI 10.1038/sj.bjp.0702611; BOND AJ, 1977, BRIT J CLIN PHARMACO, V4, P51, DOI 10.1111/j.1365-2125.1977.tb00666.x; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Buhr A, 1997, MOL PHARMACOL, V52, P676, DOI 10.1124/mol.52.4.676; CASALOTTI SO, 1986, J BIOL CHEM, V261, P5013; DENG L, 1986, BIOCHEM BIOPH RES CO, V138, P1308, DOI 10.1016/S0006-291X(86)80425-9; DRAGUHN A, 1990, NEURON, V5, P781, DOI 10.1016/0896-6273(90)90337-F; Duncalfe LL, 1996, J BIOL CHEM, V271, P9209, DOI 10.1074/jbc.271.16.9209; Dunn SMJ, 1999, MOL PHARMACOL, V56, P768; Francis WL, 1998, LEGIS STUD QUART, V23, P1; GARATTINI A, 1973, BENZODIAZEPINES, P75; GREENBLATT DJ, 1983, BRIT J ANAESTH, V55, P985, DOI 10.1093/bja/55.10.985; HUNKELER W, 1981, NATURE, V290, P514, DOI 10.1038/290514a0; Lavoie AM, 1996, NEUROPHARMACOLOGY, V35, P1383, DOI 10.1016/S0028-3908(96)00077-9; LERMA J, 1986, BRAIN RES, V384, P145, DOI 10.1016/0006-8993(86)91230-8; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; McKernan RM, 1998, MOL PHARMACOL, V54, P33, DOI 10.1124/mol.54.1.33; MELLOR JR, 1996, J PHYSIOL-LONDON, V503, P359; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; MOHLER H, 1984, EUR J PHARMACOL, V102, P191, DOI 10.1016/0014-2999(84)90358-3; Morris KDW, 1999, MOL PHARMACOL, V56, P752; Olsen RW, 1998, TOXICOL LETT, V101, P193, DOI 10.1016/S0378-4274(98)00185-4; PRITCHETT DB, 1991, P NATL ACAD SCI USA, V88, P1421, DOI 10.1073/pnas.88.4.1421; PRITCHETT DB, 1989, NATURE, V338, P582, DOI 10.1038/338582a0; REVES J.G., 2000, ANESTHESIA, P228; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; SHIMADA S, 1992, MOL PHARMACOL, V41, P683; SIEGHART W, 1995, PHARMACOL REV, V47, P181; Sigel E, 1997, TRENDS PHARMACOL SCI, V18, P425, DOI 10.1016/S0165-6147(97)90675-1; SMART TG, 1991, BRIT J PHARMACOL, V103, P1837, DOI 10.1111/j.1476-5381.1991.tb12337.x; STEPHENSON FA, 1990, J BIOL CHEM, V265, P21160; TOSSMAN U, 1986, ACTA PHYSIOL SCAND, V127, P533, DOI 10.1111/j.1748-1716.1986.tb07938.x; TWYMAN RE, 1990, J PHYSIOL-LONDON, V423, P193, DOI 10.1113/jphysiol.1990.sp018018; Ueno S, 1999, BRIT J PHARMACOL, V127, P377, DOI 10.1038/sj.bjp.0702563; Wall MJ, 1998, NAT NEUROSCI, V1, P675, DOI 10.1038/3677; Whitesides J. F., 1995, Equine Athlete, V8, P9; WIELAND HA, 1992, J BIOL CHEM, V267, P1426; WINGROVE PB, 1994, P NATL ACAD SCI USA, V91, P4569, DOI 10.1073/pnas.91.10.4569; Wingrove PB, 1997, MOL PHARMACOL, V52, P874, DOI 10.1124/mol.52.5.874; Wisden W, 1999, NATURE, V401, P751, DOI 10.1038/44482	45	197	199	2	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2000	3	12					1274	1281		10.1038/81800	http://dx.doi.org/10.1038/81800			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UA	11100148	Bronze			2022-12-24	WOS:000167177900013
J	Karst, H; Karten, YJG; Reichardt, HM; de Kloet, ER; Schutz, G; Joels, M				Karst, H; Karten, YJG; Reichardt, HM; de Kloet, ER; Schutz, G; Joels, M			Corticosteroid actions in hippocampus require DNA binding of glucocorticoid receptor homodimers	NATURE NEUROSCIENCE			English	Article							PYRAMIDAL NEURONS; BRAIN; ACTIVATION; STRESS; MODULATION; HORMONES		Univ Amsterdam, Inst Neurobiol, NL-1098 SM Amsterdam, Netherlands; German Canc Res Ctr, D-69120 Heidelberg, Germany; Leiden Univ, Sylvius Lab, NL-2300 RA Leiden, Netherlands	University of Amsterdam; Helmholtz Association; German Cancer Research Center (DKFZ); Leiden University; Leiden University - Excl LUMC	Joels, M (corresponding author), Univ Amsterdam, Inst Neurobiol, Kruislaan 320, NL-1098 SM Amsterdam, Netherlands.		Joëls, Marian/P-6415-2016; Reichardt, Holger/AAF-3048-2020	Reichardt, Holger/0000-0003-4647-057X; de Kloet, Ron/0000-0001-9176-1830; Joels, Marian/0000-0002-4826-6209				ANDRADE R, 1987, J PHYSIOL-LONDON, V394, P99, DOI 10.1113/jphysiol.1987.sp016862; Beck SG, 1996, NEUROPSYCHOPHARMACOL, V14, P27, DOI 10.1016/S0893-133X(96)80056-X; DEKLOET ER, 1991, FRONT NEUROENDOCRIN, V12, P95; Hesen W, 1996, J NEUROSCI, V16, P6766; Hesen W, 1996, J NEUROENDOCRINOL, V8, P433, DOI 10.1046/j.1365-2826.1996.04724.x; Holsboer F, 1996, ENDOCR REV, V17, P187, DOI 10.1210/er.17.2.187; Joels M, 1997, FRONT NEUROENDOCRIN, V18, P2, DOI 10.1006/frne.1996.0144; KARST H, 1994, BRAIN RES, V649, P234, DOI 10.1016/0006-8993(94)91069-3; KERR DS, 1992, P NATL ACAD SCI USA, V89, P8527, DOI 10.1073/pnas.89.18.8527; Kim JJ, 1998, TRENDS NEUROSCI, V21, P505, DOI 10.1016/S0166-2236(98)01322-8; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Porter NM, 1998, NAT NEUROSCI, V1, P3, DOI 10.1038/196; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Reichardt HM, 1998, MOL CELL ENDOCRINOL, V146, P1, DOI 10.1016/S0303-7207(98)00208-1; SATHER W, 1992, J PHYSIOL-LONDON, V450, P643, DOI 10.1113/jphysiol.1992.sp019148	15	128	131	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2000	3	10					977	978		10.1038/79910	http://dx.doi.org/10.1038/79910			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TW	11017168				2022-12-24	WOS:000167177500013
J	Miyata, M; Finch, EA; Khiroug, L; Hashimoto, K; Hayasaka, S; Oda, SI; Inouye, M; Takagishi, Y; Augustine, GJ; Kano, M				Miyata, M; Finch, EA; Khiroug, L; Hashimoto, K; Hayasaka, S; Oda, SI; Inouye, M; Takagishi, Y; Augustine, GJ; Kano, M			Local calcium release in dendritic spines required for long-term synaptic depression	NEURON			English	Article							CEREBELLAR PURKINJE NEURONS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; GAMMA MUTANT MICE; DILUTE COAT COLOR; CLIMBING FIBER; GLUTAMATE RECEPTORS; ENDOPLASMIC-RETICULUM; MOTOR COORDINATION; CELL DENDRITES; INDUCTION	We have used rats and mice with mutations in myosin-Va to evaluate the range and function of IP3-mediated Ca2+ signaling in dendritic spines. In these mutants, the endoplasmic reticulum and its attendant IP3 receptors do not enter the postsynaptic spines of parallel fiber synapses on cerebellar Purkinje cells. Long-term synaptic depression (LTD) is absent at the parallel fiber synapses of the mutants, even though the structure and function of these synapses otherwise appear normal. This loss of LTD is associated with selective changes in IP3-mediated Ca2+ signaling in spines and can be rescued by photolysis of a caged Ca2+ compound. Our results reveal that IP3 must release Ca2+ locally in the dendritic spines to produce LTD and indicate that one function of dendritic spines is to target IP3-mediated Ca2+ release to the proper subcellular domain.	RIKEN, Brain Sci Inst, Lab Cellular Neurophysiol, Wako, Saitama 3510198, Japan; Tokyo Womens Med Univ, Dept Physiol, Shinjuku Ku, Tokyo 1628666, Japan; Kanazawa Univ, Sch Med, Dept Physiol, Kanazawa, Ishikawa 9208640, Japan; Nagoya Univ, Environm Med Res Inst, Sch Agr Sci, Nagoya, Aichi 4648601, Japan; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	RIKEN; Tokyo Women's Medical University; Kanazawa University; Nagoya University; Duke University	Kano, M (corresponding author), RIKEN, Brain Sci Inst, Lab Cellular Neurophysiol, Wako, Saitama 3510198, Japan.		Augustine, George James/J-9228-2013	Kano, Masanobu/0000-0002-0725-3292; Hashimoto, Kouichi/0000-0002-3884-8213				AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; BERRIDGE MJ, 1993, NATURE, V365, P388, DOI 10.1038/365388a0; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Berridge MJ, 1997, J PHYSIOL-LONDON, V499, P291, DOI 10.1113/jphysiol.1997.sp021927; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; BLACKSTONE CD, 1989, P NATL ACAD SCI USA, V86, P4316, DOI 10.1073/pnas.86.11.4316; Bridgman PC, 1999, J CELL BIOL, V146, P1045, DOI 10.1083/jcb.146.5.1045; Chen C, 1995, CELL, V83, P1233, DOI 10.1016/0092-8674(95)90148-5; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; Chittajallu R, 1998, CELL CALCIUM, V24, P377, DOI 10.1016/S0143-4160(98)90061-6; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; CREPEL F, 1991, J PHYSIOL-LONDON, V432, P123, DOI 10.1113/jphysiol.1991.sp018380; Daniel H, 1999, NEUROSCIENCE, V92, P1, DOI 10.1016/S0306-4522(99)00136-0; Daniel H, 1998, TRENDS NEUROSCI, V21, P401, DOI 10.1016/S0166-2236(98)01304-6; DEKKEROHNO K, 1993, LAB ANIM SCI, V43, P370; DekkerOhno K, 1996, BRAIN RES, V714, P226, DOI 10.1016/0006-8993(95)01560-4; DENK W, 1995, P NATL ACAD SCI USA, V92, P8279, DOI 10.1073/pnas.92.18.8279; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; Eilers J, 1997, LEARN MEMORY, V4, P159, DOI 10.1101/lm.4.1.159; EILERS J, 1995, NATURE, V373, P155, DOI 10.1038/373155a0; Ellis-Davies GCR, 1998, TETRAHEDRON LETT, V39, P953, DOI 10.1016/S0040-4039(97)10668-2; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Futaki S, 2000, MAMM GENOME, V11, P649, DOI 10.1007/s003350010121; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; HARTELL NA, 1994, NEUROREPORT, V5, P913, DOI 10.1097/00001756-199404000-00015; Hartell NA, 1996, NEURON, V16, P601, DOI 10.1016/S0896-6273(00)80079-3; Hashimoto K, 1998, J PHYSIOL-LONDON, V506, P391, DOI 10.1111/j.1469-7793.1998.391bw.x; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Inoue T, 1998, J NEUROSCI, V18, P5366, DOI 10.1523/JNEUROSCI.18-14-05366.1998; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; Kano M, 1995, NEUROSCI RES, V24, P87, DOI 10.1016/0168-0102(95)00978-7; Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7; KARACHOT L, 1994, NEUROSCI RES, V21, P161, DOI 10.1016/0168-0102(94)90158-9; KASAI H, 1994, TRENDS NEUROSCI, V17, P95, DOI 10.1016/0166-2236(94)90112-0; KASONO K, 1995, NEUROREPORT, V6, P569, DOI 10.1097/00001756-199502000-00040; Kennedy MB, 1998, BRAIN RES REV, V26, P243, DOI 10.1016/S0165-0173(97)00043-X; Khiroug L., 1999, Society for Neuroscience Abstracts, V25, P986; Khodakhah K, 1997, P NATL ACAD SCI USA, V94, P14009, DOI 10.1073/pnas.94.25.14009; KOHDA K, 1995, J NEUROPHYSIOL, V74, P2184, DOI 10.1152/jn.1995.74.5.2184; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; LLINAS R, 1995, NEUROPHARMACOLOGY, V34, P1443, DOI 10.1016/0028-3908(95)00150-5; MARTONE ME, 1993, J NEUROSCI, V13, P4636; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; MIYAKAWA H, 1992, J NEUROPHYSIOL, V68, P1178, DOI 10.1152/jn.1992.68.4.1178; Miyata M, 1999, NEURON, V22, P763, DOI 10.1016/S0896-6273(00)80735-7; Narasimhan K, 1998, J NEUROPHYSIOL, V80, P2963, DOI 10.1152/jn.1998.80.6.2963; Narasimhan K, 1996, NEURON, V17, P333, DOI 10.1016/S0896-6273(00)80164-6; NUSSER Z, 1994, NEUROSCIENCE, V61, P421, DOI 10.1016/0306-4522(94)90421-9; ROSS WN, 1987, J PHYSIOL-LONDON, V389, P319, DOI 10.1113/jphysiol.1987.sp016659; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; SCHWEIZER FE, 1995, NEURON, V14, P689, DOI 10.1016/0896-6273(95)90213-9; Sheng M, 1999, ANN NY ACAD SCI, V868, P483, DOI 10.1111/j.1749-6632.1999.tb11317.x; Shibuki K, 1996, NEURON, V16, P587, DOI 10.1016/S0896-6273(00)80078-1; SHIGEMOTO R, 1994, NEURON, V12, P1245, DOI 10.1016/0896-6273(94)90441-3; Silva AJ, 1997, NEURON, V19, P755, DOI 10.1016/S0896-6273(00)80958-7; Stanley EF, 1997, TRENDS NEUROSCI, V20, P404, DOI 10.1016/S0166-2236(97)01091-6; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Takagishi Y, 1996, NEUROSCI LETT, V215, P169, DOI 10.1016/S0304-3940(96)12967-0; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; WALKER JW, 1989, BIOCHEMISTRY-US, V28, P3272, DOI 10.1021/bi00434a023; WALTON PD, 1991, J CELL BIOL, V113, P1145, DOI 10.1083/jcb.113.5.1145; Wang SSH, 1999, CALCIUM AS A CELLULAR REGULATOR, P545; Wang SSH, 2000, P NATL ACAD SCI USA, V97, P8635, DOI 10.1073/pnas.130414597; WANG SSH, 1995, NEURON, V15, P755, DOI 10.1016/0896-6273(95)90167-1; Womack MD, 2000, J GEN PHYSIOL, V115, P339, DOI 10.1085/jgp.115.3.339; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	77	199	202	1	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	2000	28	1					233	244		10.1016/S0896-6273(00)00099-4	http://dx.doi.org/10.1016/S0896-6273(00)00099-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	370VN	11086997	Bronze			2022-12-24	WOS:000165143500024
J	Leskov, IB; Klenchin, VA; Handy, JW; Whitlock, GG; Govardovskii, VI; Bownds, MD; Lamb, TD; Pugh, EN; Arshavsky, VY				Leskov, IB; Klenchin, VA; Handy, JW; Whitlock, GG; Govardovskii, VI; Bownds, MD; Lamb, TD; Pugh, EN; Arshavsky, VY			The gain of rod phototransduction: Reconciliation of biochemical and electrophysiological measurements	NEURON			English	Article							CGMP-BINDING-SITES; LIGHT-ACTIVATED PHOSPHODIESTERASE; CYCLIC-GMP PHOSPHODIESTERASE; SINGLE-PHOTON RESPONSES; OUTER SEGMENTS; RETINAL RODS; PHOTORECEPTOR PHOSPHODIESTERASE; VISUAL TRANSDUCTION; NUCLEOTIDE CASCADE; DISK MEMBRANE	We have resolved a central and long-standing paradox in understanding the amplification of rod phototransduction by making direct measurements of the gains of the underlying enzymatic amplifiers. We find that under optimized conditions a single photoisomerized rhodopsin activates transducin molecules and phosphodiesterase (PDE) catalytic subunits at rates of 120-150/s, much lower than indirect estimates from lightscattering experiments. Further, we measure the Michaelis constant, K-m, of the rod PDE activated by transducin to be 10 mu M, at least 10-fold lower than published estimates. Thus, the gain of cGMP hydrolysis (determined by k(cat)/K-m) is at least 10-fold higher than reported in the literature. Accordingly, our results now provide a quantitative account of the overall gain of the rod cascade in terms of directly measured factors.	IM Sechenov Evolutionary Physiol & Biochem Inst, St Petersburg 194223, Russia; Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA; Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA; Univ Cambridge, Dept Physiol, Cambridge CB2 3EG, England; Univ Penn, Sch Med, Dept Ophthalmol, Philadelphia, PA 19104 USA	North-Western State Medical University named after I.I. Mechnikov; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry; Harvard University; Harvard Medical School; University of Wisconsin System; University of Wisconsin Madison; University of Cambridge; University of Pennsylvania	Arshavsky, VY (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA.		Lamb, Trevor/C-9755-2009; Govardovskii, Victor I/K-2655-2018	Whitlock, Gary/0000-0003-3070-1281	NEI NIH HHS [EY-00463, EY-10336, EY-02660] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010336, R01EY002660] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARSHAVSKY VY, 1992, J BIOL CHEM, V267, P24501; ARSHAVSKY VY, 1991, J BIOL CHEM, V266, P18530; BARKDOLL AE, 1988, J NEUROCHEM, V50, P839, DOI 10.1111/j.1471-4159.1988.tb02989.x; BARKDOLL AE, 1989, J GEN PHYSIOL, V93, P1091, DOI 10.1085/jgp.93.6.1091; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BIERNBAUM MS, 1985, J GEN PHYSIOL, V85, P83, DOI 10.1085/jgp.85.1.83; BOWNDS D, 1971, J GEN PHYSIOL, V58, P225, DOI 10.1085/jgp.58.3.225; BOWNDS MD, 1995, BEHAV BRAIN SCI, V18, P415, DOI 10.1017/S0140525X00039170; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; CHABRE M, 1989, EUR J BIOCHEM, V179, P255, DOI 10.1111/j.1432-1033.1989.tb14549.x; COTE RH, 1993, J BIOL CHEM, V268, P17190; COTE RH, 1994, P NATL ACAD SCI USA, V91, P4845, DOI 10.1073/pnas.91.11.4845; Crank J., 1956, MATH DIFFUSION; D'Amours MR, 1999, BIOCHEM J, V340, P863, DOI 10.1042/0264-6021:3400863; DUMKE CL, 1994, J GEN PHYSIOL, V103, P1071, DOI 10.1085/jgp.103.6.1071; EDIDIN M, 1987, CURR TOP MEMBR TRANS, V29, P91; FERSHT A, 1977, ENZYME STRUCTURE MEH; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; FUNG BKK, 1981, P NATL ACAD SCI-BIOL, V78, P152, DOI 10.1073/pnas.78.1.152; GILLESPIE PG, 1988, J BIOL CHEM, V263, P8133; GRAYKELLER MP, 1990, J BIOL CHEM, V265, P15323; HAYNES LW, 1986, NATURE, V321, P66, DOI 10.1038/321066a0; HURLEY JB, 1982, J BIOL CHEM, V257, P1094; KAHLERT M, 1991, BIOPHYS J, V59, P375, DOI 10.1016/S0006-3495(91)82231-7; KAMPS KMP, 1985, FEBS LETT, V188, P15; KUHN H, 1981, CURR TOP MEMBR TRANS, V15, P171; LAMB TD, 1994, BIOPHYS J, V67, P1439, DOI 10.1016/S0006-3495(94)80617-4; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; LIEBMAN PA, 1982, METHOD ENZYMOL, V81, P532; Melia TJ, 2000, J BIOL CHEM, V275, P3535, DOI 10.1074/jbc.275.5.3535; Melia TJ, 1997, BIOPHYS J, V73, P3182, DOI 10.1016/S0006-3495(97)78344-9; Mukhopadhyay S, 1999, P NATL ACAD SCI USA, V96, P9539, DOI 10.1073/pnas.96.17.9539; Nikonov S, 1998, J GEN PHYSIOL, V111, P7, DOI 10.1085/jgp.111.1.7; Pugh EN, 1999, NEURON, V23, P205, DOI 10.1016/S0896-6273(00)80772-2; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; ROSS EM, 1989, NEURON, V3, P141, DOI 10.1016/0896-6273(89)90027-5; SHINITZKY M, 1983, BIOCHIM BIOPHYS ACTA, V738, P251, DOI 10.1016/0304-419X(83)90007-0; Smith NP, 1997, VISION RES, V37, P2943, DOI 10.1016/S0042-6989(97)00094-1; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; VUONG TM, 1984, NATURE, V311, P659, DOI 10.1038/311659a0; VUONG TM, 1991, P NATL ACAD SCI USA, V88, P9813, DOI 10.1073/pnas.88.21.9813; Whitlock GG, 1999, NEURON, V23, P337, DOI 10.1016/S0896-6273(00)80784-9; WU CF, 1978, J GEN PHYSIOL, V71, P249, DOI 10.1085/jgp.71.3.249; ZIMMERMAN AL, 1986, NATURE, V321, P70, DOI 10.1038/321070a0; Zuker CS, 1996, P NATL ACAD SCI USA, V93, P571, DOI 10.1073/pnas.93.2.571	47	141	149	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	2000	27	3					525	537		10.1016/S0896-6273(00)00063-5	http://dx.doi.org/10.1016/S0896-6273(00)00063-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	359FR	11055435	Bronze			2022-12-24	WOS:000089601300016
J	Miller, KG; Emerson, MD; McManus, JR; Rand, JB				Miller, KG; Emerson, MD; McManus, JR; Rand, JB			RIC-8 (synembryn): A novel conserved protein that is required for G(q)alpha signaling in the C-elegans nervous system	NEURON			English	Article							GTPASE-ACTIVATING PROTEINS; CAENORHABDITIS-ELEGANS; SYNAPTIC TRANSMISSION; DIACYLGLYCEROL KINASE; ALPHA-SUBUNITS; GENE; RELEASE; BEHAVIORS; G(O)ALPHA; ALDICARB	Recent studies describe a network of signaling proteins centered around G(o)alpha and G(q)alpha that regulates neurotransmitter secretion in C. elegans by controlling the production and consumption of diacylglycerol (DAG). We sought other components of the G(o)alpha-G(o)alpha signaling network by screening for aldicarb-resistant mutants with phenotypes similar to egl-30 (G(o)alpha) mutants. In so doing, we identified ric-8, which encodes a novel protein named RIC-8 (synembryn). Through cDNA analysis, we show that RIC-8 is conserved in vertebrates. Through immunostaining, we show that RIC-8 is concentrated in the cytoplasm of neurons. Exogenous application of phorbol esters or loss of DGK-1 (diacylglycerol kinase) rescues ric-8 mutant phenotypes. A genetic analysis suggests that RIC-8 functions upstream of, or in conjunction with, EGL-30 (G(o)alpha).	Oklahoma Med Res Fdn, Program Mol & Cell Biol, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation	Rand, JB (corresponding author), Oklahoma Med Res Fdn, Program Mol & Cell Biol, 825 Ne 13Th St, Oklahoma City, OK 73104 USA.	randj@omrf.ouhsc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS009565, R01NS033187] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM059642] Funding Source: Medline; NINDS NIH HHS [NS33187, F32 NS009565] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; BRENNER S, 1974, GENETICS, V77, P71; Brundage L, 1996, NEURON, V16, P999, DOI 10.1016/S0896-6273(00)80123-3; CAMBON C, 1979, TOXICOL APPL PHARM, V49, P203, DOI 10.1016/0041-008X(79)90242-4; Duerr JS, 1999, J NEUROSCI, V19, P72, DOI 10.1523/JNEUROSCI.19-01-00072.1999; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hajdu-Cronin YM, 1999, GENE DEV, V13, P1780, DOI 10.1101/gad.13.14.1780; Huang LS, 1995, METHOD CELL BIOL, V48, P97; Hunt TW, 1996, NATURE, V383, P175, DOI 10.1038/383175a0; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Leberer E, 1997, CURR OPIN GENET DEV, V7, P59, DOI 10.1016/S0959-437X(97)80110-4; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MENDEL JE, 1995, SCIENCE, V267, P1652, DOI 10.1126/science.7886455; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; MILLER KG, 2001, IN PRESS GENETICS; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; NONET ML, 1999, FR MOLEC B, V23, P265; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; Rand James B., 1997, Cold Spring Harbor Monograph Series, V33, P611; RISHER JF, 1987, ENVIRON HEALTH PERSP, V72, P267, DOI 10.1289/ehp.8772267; RUSHFORTH AM, 1993, MOL CELL BIOL, V13, P902, DOI 10.1128/MCB.13.2.902; Sakane F, 1997, INT J BIOCHEM CELL B, V29, P1139, DOI 10.1016/S1357-2725(97)00037-X; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; SHAPIRA R, 1987, NATURE, V325, P58, DOI 10.1038/325058a0; Singer WD, 1997, ANNU REV BIOCHEM, V66, P475, DOI 10.1146/annurev.biochem.66.1.475; Stevens CF, 1998, NEURON, V21, P885, DOI 10.1016/S0896-6273(00)80603-0; TRENT C, 1983, GENETICS, V124, P855; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Watson S., 1994, G PROTEIN LINKED REC; WILLIAMS BD, 1992, GENETICS, V131, P609; Zwaal RR, 1996, CELL, V86, P619, DOI 10.1016/S0092-8674(00)80135-X	37	86	94	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	2000	27	2					289	299		10.1016/S0896-6273(00)00037-4	http://dx.doi.org/10.1016/S0896-6273(00)00037-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	347YD	10985349	Bronze, Green Accepted			2022-12-24	WOS:000088956000013
J	Haverkamp, S; Grunert, U; Wassle, H				Haverkamp, S; Grunert, U; Wassle, H			The cone pedicle, a complex synapse in the retina	NEURON			English	Article							GLUTAMATE-RECEPTOR SUBUNITS; MACAQUE MONKEY RETINA; OUTER PLEXIFORM LAYER; BIPOLAR CELLS; IMMUNOCYTOCHEMICAL LOCALIZATION; MAMMALIAN RETINA; RAT RETINA; GABA TRANSPORTER; HORIZONTAL CELLS; GOLDFISH RETINA	Cone pedicles, the synaptic terminals of cone photoreceptors, are connected in the macaque monkey retina to several hundred postsynaptic dendrites. Using light and electron microscopy, we found underneath each cone pedicle a laminated distribution of dendritic processes of bipolar and horizontal cells. Superimposed were three strata of glutamate receptor (GluR) aggregates, including a novel layer of glutamate receptors clustered at desmosome-like junctions. They are, most likely, postsynaptic densities on horizontal cell dendrites. GABAA and GABA, receptors are aggregated on bipolar cell dendrites in a narrow band underneath the cone pedicle. Glutamate released from cone pedicles and GABA released from horizontal cell dendrites act not only through direct synaptic contacts but also (more so) through diffusion to the appropriate receptors.	Max Planck Inst Hirnforsch, Neuroanat Abt, D-60528 Frankfurt, Germany; Univ Sydney, Dept Physiol F13, Sydney, NSW 2006, Australia	Max Planck Society; University of Sydney	Wassle, H (corresponding author), Max Planck Inst Hirnforsch, Neuroanat Abt, Deutschordenstr 46, D-60528 Frankfurt, Germany.	waessle@mpih-frankfurt.mpg.de	Grunert, Ulrike/A-5194-2012	Grunert, Ulrike/0000-0002-9595-8152				ATTWELL D, 1993, NEURON, V11, P401, DOI 10.1016/0896-6273(93)90145-H; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; BOYCOTT BB, 1993, J NEUROCYTOL, V22, P765, DOI 10.1007/BF01181322; Brandstatter JH, 1998, VISION RES, V38, P1385, DOI 10.1016/S0042-6989(97)00176-4; Brandstatter JH, 1999, EUR J NEUROSCI, V11, P3683, DOI 10.1046/j.1460-9568.1999.00793.x; Calkins DJ, 1996, VISION RES, V36, P3373, DOI 10.1016/0042-6989(95)00333-9; CAMMACK JN, 1994, NEURON, V13, P949, DOI 10.1016/0896-6273(94)90260-7; Chun MH, 1996, VISION RES, V36, P3383, DOI 10.1016/0042-6989(95)00334-7; DEROUICHE A, 1995, J NEUROSCI RES, V42, P131, DOI 10.1002/jnr.490420115; DOWLING JE, 1966, PROC R SOC SER B-BIO, V166, P80, DOI 10.1098/rspb.1966.0086; Enz R, 1996, J NEUROSCI, V16, P4479; GREFERATH U, 1994, CELL TISSUE RES, V276, P295, DOI 10.1007/s004410050092; GRUNERT U, 1990, J COMP NEUROL, V297, P509, DOI 10.1002/cne.902970405; GRUNERT U, 1994, J COMP NEUROL, V348, P607, DOI 10.1002/cne.903480410; GRUNERT U, 1993, J COMP NEUROL, V335, P523, DOI 10.1002/cne.903350405; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hack I, 1999, P NATL ACAD SCI USA, V96, P14130, DOI 10.1073/pnas.96.24.14130; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HONDA S, 1995, MOL BRAIN RES, V33, P319, DOI 10.1016/0169-328X(95)00150-Q; Hu M, 1999, ACTA OPHTHALMOL SCAN, V77, P255, DOI 10.1034/j.1600-0420.1999.770302.x; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Johnson J, 1996, J COMP NEUROL, V375, P212; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Koulen P, 1998, J COMP NEUROL, V397, P326; Koulen P, 1998, J NEUROSCI, V18, P10136; Lee BB, 1999, P NATL ACAD SCI USA, V96, P14611, DOI 10.1073/pnas.96.25.14611; LINBERG KA, 1988, J COMP NEUROL, V268, P281, DOI 10.1002/cne.902680211; Massey S.C., 1990, Progress in Retinal Research, V9, P399, DOI 10.1016/0278-4327(90)90013-8; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Missotten L, 1965, ULTRASTRUCTURE HUMAN; Morgans CW, 1999, EUR J NEUROSCI, V11, P2989, DOI 10.1046/j.1460-9568.1999.00719.x; Morigiwa K, 1999, J COMP NEUROL, V405, P173, DOI 10.1002/(SICI)1096-9861(19990308)405:2<173::AID-CNE3>3.0.CO;2-L; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; Paffenholz R, 1999, EXP CELL RES, V250, P452, DOI 10.1006/excr.1999.4534; Pow DV, 1999, CELL TISSUE RES, V297, P57, DOI 10.1007/s004410051333; Qin P, 1999, VISUAL NEUROSCI, V16, P169, DOI 10.1017/S0952523899161121; Qin P, 1996, BRAIN RES, V710, P303, DOI 10.1016/0006-8993(95)01476-4; RAOMIROTZNIK R, 1995, NEURON, V14, P561, DOI 10.1016/0896-6273(95)90312-7; Rauen T, 1998, CELL TISSUE RES, V291, P19; RAVIOLA E, 1975, J CELL BIOL, V65, P192, DOI 10.1083/jcb.65.1.192; ROHRENBECK J, 1989, EUR J NEUROSCI, V1, P407, DOI 10.1111/j.1460-9568.1989.tb00349.x; Sagne C, 1997, FEBS LETT, V417, P177, DOI 10.1016/S0014-5793(97)01279-9; SARANTIS M, 1992, BRAIN RES, V584, P299, DOI 10.1016/0006-8993(92)90909-S; SASSOEPOGNETTO M, 1994, J NEUROSCI, V14, P5131; Schmitz Y, 1997, NEUROSCIENCE, V78, P1209, DOI 10.1016/S0306-4522(96)00678-1; SCHNEEWEIS DM, 1995, SCIENCE, V268, P1053, DOI 10.1126/science.7754386; Schneeweis DM, 1999, J NEUROSCI, V19, P1203; Schultz K, 1997, J NEUROCYTOL, V26, P651, DOI 10.1023/A:1018597811439; Schwartz E. A., 1999, P93; SCHWARTZ EA, 1987, SCIENCE, V238, P350, DOI 10.1126/science.2443977; Vandenbranden CAV, 1996, VISION RES, V36, P3859, DOI 10.1016/S0042-6989(96)00134-4; VARDI N, 1992, J COMP NEUROL, V320, P394, DOI 10.1002/cne.903200310; VARDI N, 1994, VISION RES, V34, P1235, DOI 10.1016/0042-6989(94)90198-8; Vardi N, 1998, VISION RES, V38, P1359, DOI 10.1016/S0042-6989(98)00007-8; VARDI N, 1994, VISUAL NEUROSCI, V11, P135, DOI 10.1017/S0952523800011172; WU SM, 1994, ANNU REV PHYSIOL, V56, P141; Yazulla S, 1999, J NEUROCYTOL, V28, P63, DOI 10.1023/A:1007015801586; Yazulla Stephen, 1995, P249	58	175	177	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	2000	27	1					85	95		10.1016/S0896-6273(00)00011-8	http://dx.doi.org/10.1016/S0896-6273(00)00011-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339XU	10939333	Bronze			2022-12-24	WOS:000088503800012
J	Pan, ZZ; Hirakawa, N; Fields, HL				Pan, ZZ; Hirakawa, N; Fields, HL			A cellular mechanism for the bidirectional pain-modulating actions of orphanin FQ/nociceptin	NEURON			English	Article							ROSTRAL VENTROMEDIAL MEDULLA; KAPPA-OPIOID RECEPTOR; NEURONS IN-VITRO; NOCICEPTIN/ORPHANIN FQ; PERIAQUEDUCTAL GRAY; ORL(1) RECEPTOR; GENE FAMILY; TISSUE DISTRIBUTION; MOLECULAR-CLONING; NUCLEUS NEURONS	Orphanin FQ/nociceptin (OFQ/N) and its receptor share substantial structural features and cellular actions with classic opioid peptides and receptors, but have distinct pharmacological profiles and behavioral effects. Currently there is an active debate about whether OFQ/N produces hyperalgesia or analgesia. Using a well-defined brainstem pain-modulating circuit, we show that OFQ/N can cause either an apparent hyperalgesia by antagonizing mu opioid-induced analgesia or a net analgesic effect by reducing the hyperalgesia during opioid abstinence. It presumably produces these two opposite actions by inhibiting two distinct groups of neurons whose activation mediates the two effects of opioid administration. OFQ/N antagonism of the hyperalgesia may have significance for the treatment of opioid withdrawal and sensitized pain.	Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Pan, ZZ (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.		Fields, Howard/ABG-9073-2020					Allen CN, 1999, J NEUROSCI, V19, P2152; Anton B, 1996, J COMP NEUROL, V368, P229; BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; BEDERSON JB, 1990, SOMATOSENS MOT RES, V7, P185, DOI 10.3109/08990229009144706; BUNZOW JR, 1994, FEBS LETT, V347, P284, DOI 10.1016/0014-5793(94)00561-3; CHEN Y, 1994, FEBS LETT, V347, P279, DOI 10.1016/0014-5793(94)00560-5; Chieng B, 1996, J NEUROSCI, V16, P7128; Civelli O, 1998, CRIT REV NEUROBIOL, V12, P163, DOI 10.1615/CritRevNeurobiol.v12.i3.10; Connor M, 1996, BRIT J PHARMACOL, V119, P1614, DOI 10.1111/j.1476-5381.1996.tb16080.x; Darland T, 1998, TRENDS NEUROSCI, V21, P215, DOI 10.1016/S0166-2236(97)01204-6; FIELDS HL, 1991, ANNU REV NEUROSCI, V14, P219, DOI 10.1146/annurev.neuro.14.1.219; FUKUDA K, 1994, FEBS LETT, V343, P42, DOI 10.1016/0014-5793(94)80603-9; GRUDT TJ, 1995, REV NEUROSCIENCE, V6, P279; Heinricher MM, 1997, J NEUROPHYSIOL, V78, P3351, DOI 10.1152/jn.1997.78.6.3351; Henderson G, 1997, TRENDS PHARMACOL SCI, V18, P293, DOI 10.1016/S0165-6147(97)90645-3; KAPLAN H, 1991, J NEUROSCI, V11, P1433; King M, 1998, BIOCHEM PHARMACOL, V55, P1537, DOI 10.1016/S0006-2952(98)00023-9; Meis S, 1998, J NEUROSCI, V18, P8133; MEUNIER JC, 1995, NATURE, V377, P532, DOI 10.1038/377532a0; Meunier JC, 1997, EUR J PHARMACOL, V340, P1, DOI 10.1016/S0014-2999(97)01411-8; Mogil JS, 1996, NEUROSCIENCE, V75, P333, DOI 10.1016/0306-4522(96)00338-7; MOLLEREAU C, 1994, FEBS LETT, V341, P33, DOI 10.1016/0014-5793(94)80235-1; Monteillet-Agius G, 1998, J COMP NEUROL, V399, P373, DOI 10.1002/(SICI)1096-9861(19980928)399:3<373::AID-CNE6>3.0.CO;2-Y; NORTH RA, 1987, P NATL ACAD SCI USA, V84, P5487, DOI 10.1073/pnas.84.15.5487; Pan ZZ, 1998, TRENDS PHARMACOL SCI, V19, P94, DOI 10.1016/S0165-6147(98)01169-9; Pan ZZ, 1997, NATURE, V389, P382, DOI 10.1038/38730; PAN ZZ, 1990, J PHYSIOL-LONDON, V427, P519, DOI 10.1113/jphysiol.1990.sp018185; REINSCHEID RK, 1995, SCIENCE, V270, P792, DOI 10.1126/science.270.5237.792; Roychowdhury SM, 1996, NEUROSCIENCE, V74, P863, DOI 10.1016/0306-4522(96)00180-7; Schulz S, 1996, NEUROREPORT, V7, P3021, DOI 10.1097/00001756-199611250-00045; Tian JH, 1997, BRIT J PHARMACOL, V120, P676, DOI 10.1038/sj.bjp.0700942; Urban MO, 1999, NEUROSCIENCE, V90, P349, DOI 10.1016/S0306-4522(99)00002-0; Vaughan CW, 1996, BRIT J PHARMACOL, V117, P1609, DOI 10.1111/j.1476-5381.1996.tb15329.x; Vaughan CW, 1997, J NEUROSCI, V17, P996; Wagner EJ, 1998, NEUROENDOCRINOLOGY, V67, P73, DOI 10.1159/000054301; WANG JB, 1994, FEBS LETT, V348, P75, DOI 10.1016/0014-5793(94)00557-5; WICK MJ, 1994, MOL BRAIN RES, V27, P37, DOI 10.1016/0169-328X(94)90181-3; Yamamoto T, 1999, PROG NEUROBIOL, V57, P527, DOI 10.1016/S0301-0082(98)00067-7	38	124	126	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	2000	26	2					515	522		10.1016/S0896-6273(00)81183-6	http://dx.doi.org/10.1016/S0896-6273(00)81183-6			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318QZ	10839369	Bronze			2022-12-24	WOS:000087296500027
J	Ratcliffe, CF; Qu, YS; McCormick, KA; Tibbs, VC; Dixon, JE; Scheuer, T; Catterall, WA				Ratcliffe, CF; Qu, YS; McCormick, KA; Tibbs, VC; Dixon, JE; Scheuer, T; Catterall, WA			A sodium channel signaling complex: modulation by associated receptor protein tyrosine phosphatase beta	NATURE NEUROSCIENCE			English	Article							EXTRACELLULAR-MATRIX; TENASCIN-R; HIPPOCAMPAL-NEURONS; CHONDROITIN SULFATE; NERVOUS-SYSTEM; RPTP-BETA; RAT-BRAIN; KINASE-C; SRC; SUBUNIT	Voltage-gated sodium channels in brain neurons were found to associate with receptor protein tyrosine phosphatase beta (RPTP beta) and its catalytically inactive, secreted isoform phosphacan, and this interaction was regulated during development. Both the extracellular domain and the intracellular catalytic domain of RPTP beta interacted with sodium channels. Sodium channels were tyrosine phosphorylated and were modulated by the associated catalytic domains of RPTP beta. Dephosphorylation slowed sodium channel inactivation, positively shifted its voltage dependence, and increased whole-cell sodium current. Our results define a sodium channel signaling complex containing RPTP beta, which acts to regulate sodium channel modulation by tyrosine phosphorylation.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan	Catterall, WA (corresponding author), Univ Washington, Dept Pharmacol, Mailstop 357280, Seattle, WA 98195 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025704] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM18848] Funding Source: Medline; NINDS NIH HHS [NS25704] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AULD VJ, 1990, P NATL ACAD SCI USA, V87, P323, DOI 10.1073/pnas.87.1.323; BARNEA G, 1994, J BIOL CHEM, V269, P14349; BLISKA JB, 1992, J EXP MED, V176, P1625, DOI 10.1084/jem.176.6.1625; Canoll PD, 1996, J NEUROSCI RES, V44, P199, DOI 10.1002/(SICI)1097-4547(19960501)44:3<199::AID-JNR1>3.0.CO;2-B; Cantrell AR, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-17-j0003.1999; Cantrell AR, 1997, J NEUROSCI, V17, P7330; Cantrell AR, 1996, NEURON, V16, P1019, DOI 10.1016/S0896-6273(00)80125-7; CATTERALL WA, 1992, PHYSIOL REV, V72, P15; DENHERTOG J, 1993, EMBO J, V12, P3789, DOI 10.1002/j.1460-2075.1993.tb06057.x; EVANS GA, 1994, J BIOL CHEM, V269, P23407; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; GORDON D, 1988, BIOCHEMISTRY-US, V27, P7032, DOI 10.1021/bi00418a054; HARTSHORNE RP, 1984, J BIOL CHEM, V259, P1667; Hilborn MD, 1998, J NEUROSCI, V18, P590; Holmes TC, 1996, SCIENCE, V274, P2089, DOI 10.1126/science.274.5295.2089; Hu XQ, 1998, J BIOL CHEM, V273, P5337, DOI 10.1074/jbc.273.9.5337; Isom LL, 1996, NATURE, V383, P307, DOI 10.1038/383307b0; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; JURMAN ME, 1994, BIOTECHNIQUES, V17, P876; KIM JS, 1993, PROTEIN SCI, V2, P348; Kokel M, 1998, GENE DEV, V12, P1425, DOI 10.1101/gad.12.10.1425; LEVY JB, 1993, J BIOL CHEM, V268, P10573; MAUREL P, 1995, DNA SEQUENCE, V5, P323, DOI 10.3109/10425179509030989; MAUREL P, 1994, P NATL ACAD SCI USA, V91, P2512, DOI 10.1073/pnas.91.7.2512; McCormick KA, 1999, J BIOL CHEM, V274, P32638, DOI 10.1074/jbc.274.46.32638; MEYERPUTTLITZ B, 1995, J NEUROCHEM, V65, P2327; Nishiwaki T, 1998, J BIOCHEM-TOKYO, V123, P458; PELES E, 1995, CELL, V82, P251, DOI 10.1016/0092-8674(95)90312-7; QU YS, 1994, P NATL ACAD SCI USA, V91, P3289, DOI 10.1073/pnas.91.8.3289; Sakurai T, 1997, J CELL BIOL, V136, P907, DOI 10.1083/jcb.136.4.907; Snyder SE, 1996, MOL BRAIN RES, V40, P79; Sobko A, 1998, EMBO J, V17, P4723, DOI 10.1093/emboj/17.16.4723; Srinivasan J, 1998, P NATL ACAD SCI USA, V95, P15753, DOI 10.1073/pnas.95.26.15753; Tsai W, 1999, EMBO J, V18, P109, DOI 10.1093/emboj/18.1.109; Weber P, 1999, J NEUROSCI, V19, P4245, DOI 10.1523/jneurosci.19-11-04245.1999; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; Wischmeyer E, 1998, J BIOL CHEM, V273, P34063, DOI 10.1074/jbc.273.51.34063; Xiao ZC, 1999, J BIOL CHEM, V274, P26511, DOI 10.1074/jbc.274.37.26511; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674	39	154	154	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2000	3	5					437	444		10.1038/74805	http://dx.doi.org/10.1038/74805			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309DG	10769382				2022-12-24	WOS:000086752000011
J	Fan, G; Egles, C; Sun, Y; Minichiello, L; Renger, JJ; Klein, R; Liu, GS; Jaenisch, R				Fan, G; Egles, C; Sun, Y; Minichiello, L; Renger, JJ; Klein, R; Liu, GS; Jaenisch, R			Knocking the NT4 gene into the BDNF locus rescues BDNF deficient mice and reveals distinct NT4 and BDNF activities	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH-FACTOR; TYROSINE PROTEIN-KINASE; NEUROTROPHIC FACTOR; MOLECULAR-CLONING; FUNCTIONAL INTERACTIONS; SYNAPTIC TRANSMISSION; NEURON DEVELOPMENT; KNOCKOUT MICE; FACTOR FAMILY; LACKING NT4	To directly compare biological activities of the neurotrophins NT4 and BDNF in vivo, we replaced the BDNF coding sequence with the NT4 sequence in mice (Bdnf(nt4-ki)). Mice expressing NT4 in place of BDNF were viable, in contrast with BDNF null mutants, which die shortly after birth. Although the Bdnf(nt4-ki/nt4-ki) and wild-type Bdnf(+/+) alleles yielded similar levels of NT4 and BDNF proteins, NT4 supported more sensory neurons than BDNF and promoted functional synapse formation in cultured hippocampal neurons. Homozygous Bdnf(nt4-ki/nt4-ki) mice showed reduced body weight, infertility and skin lesions, suggesting unique biological activities of NT4 in vivo. The distinct activities of NT4 and BDNF may result partly from differential activation of the TrkB receptor and its down-stream signals.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Ctr Learning & Memory, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; European Mol Biol Lab, D-69117 Heidelberg, Germany	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; European Molecular Biology Laboratory (EMBL)	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		Minichiello, Liliana/AAA-7190-2022; Klein, Ruediger/C-6147-2008	Klein, Ruediger/0000-0002-3109-0163; Fan, Guoping/0000-0001-5235-6410; EGLES, Christophe/0000-0003-0982-7752				BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; Bianchi LM, 1996, DEVELOPMENT, V122, P1965; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; Brunstrom JE, 1997, NEURON, V18, P505, DOI 10.1016/S0896-6273(00)81250-7; Carroll P, 1998, NAT NEUROSCI, V1, P42, DOI 10.1038/242; CHAO MV, 1994, J NEUROBIOL, V25, P1373, DOI 10.1002/neu.480251106; CONOVER JC, 1995, NATURE, V375, P235, DOI 10.1038/375235a0; CURTIS R, 1995, NEURON, V14, P1201, DOI 10.1016/0896-6273(95)90267-8; DAVIES AM, 1993, NEURON, V11, P565, DOI 10.1016/0896-6273(93)90069-4; ElShamy WM, 1997, J NEUROSCI, V17, P8667; Erickson JT, 1996, J NEUROSCI, V16, P5361; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; Fan G, 1999, NEUROSCIENCE, V90, P259, DOI 10.1016/S0306-4522(98)00432-1; FISCHER W, 1994, P NATL ACAD SCI USA, V91, P8607, DOI 10.1073/pnas.91.18.8607; FLETCHER TL, 1994, J NEUROSCI, V14, P6695; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; HYMAN C, 1994, J NEUROSCI, V14, P335; Ibanez CF, 1996, NEUROCHEM RES, V21, P787, DOI 10.1007/BF02532301; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; JONES KR, 1990, P NATL ACAD SCI USA, V87, P8060, DOI 10.1073/pnas.87.20.8060; KLEIN R, 1992, NEURON, V8, P947, DOI 10.1016/0896-6273(92)90209-V; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; LIU X, 1995, NATURE, V375, P238, DOI 10.1038/375238a0; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Minichiello L, 1998, NEURON, V21, P335, DOI 10.1016/S0896-6273(00)80543-7; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; RYDEN M, 1995, EMBO J, V14, P1979, DOI 10.1002/j.1460-2075.1995.tb07190.x; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Strohmaier C, 1996, EMBO J, V15, P3332, DOI 10.1002/j.1460-2075.1996.tb00698.x; Stucky CL, 1998, J NEUROSCI, V18, P7040; Vicario-Abejon C, 1998, J NEUROSCI, V18, P7256	50	80	81	2	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2000	3	4					350	357		10.1038/73921	http://dx.doi.org/10.1038/73921			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330CN	10725924				2022-12-24	WOS:000087945400015
J	Smidt, MP; Asbreuk, CHJ; Cox, JJ; Chen, H; Johnson, RL; Burbach, JPH				Smidt, MP; Asbreuk, CHJ; Cox, JJ; Chen, H; Johnson, RL; Burbach, JPH			A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b	NATURE NEUROSCIENCE			English	Article							NAIL-PATELLA SYNDROME; MUTANT MICE; PARKINSONS-DISEASE; LIMB DEVELOPMENT; MOTOR-NEURONS; MIDBRAIN; DEFECTS; BRAIN; EXPRESSION; SPECIFICATION	We identified the LIM homeodomain transcription factor Lmx1b in the mesencephalic dopamine (mesDA) systems of embryos and adults. Analysis of spatiotemporal expression in Lmx1b null mutants and wild-type mice implicated a cascade involving Lmx1b in the early development of mesDA neurons. Although disruption of this cascade did not block induction of tyrosine hydroxylase (TH), a key enzyme in DA synthesis, or Nurr1, a nuclear hormone receptor, Lmx1b knockout mice failed to induce the mesDA-specific homeodomain gene Ptx3 in TH-positive neurons. Eventually, this small set of TH-positive neurons was lost during embryonic maturation. The data suggest that at least two molecular cascades operate during the specification of the mesDA system, one specifying neurotransmitter phenotype and another essential for other aspects of mesDA neuron differentiation.	Univ Utrecht, Fac Med, Dept Med Pharmacol, Rudolf Magnus Inst Neurosci,Sect Mol Neurosci, NL-3584 CG Utrecht, Netherlands; Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Utrecht University; Utrecht University Medical Center; University of Texas System; UTMD Anderson Cancer Center	Burbach, JPH (corresponding author), Univ Utrecht, Fac Med, Dept Med Pharmacol, Rudolf Magnus Inst Neurosci,Sect Mol Neurosci, Univ Weg 100, NL-3584 CG Utrecht, Netherlands.			Smidt, Marten/0000-0002-8815-747X				Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Chen H, 1998, NAT GENET, V19, P51, DOI 10.1038/ng0598-51; Chen HX, 1998, DEV GENET, V22, P314, DOI 10.1002/(SICI)1520-6408(1998)22:4<314::AID-DVG2>3.0.CO;2-9; Danielian PS, 1996, NATURE, V383, P332, DOI 10.1038/383332a0; Date I, 1996, CELL TRANSPLANT, V5, pS17, DOI 10.1016/0963-6897(96)00032-2; Dreyer SD, 1998, NAT GENET, V19, P47, DOI 10.1038/ng0598-47; Favor J, 1996, P NATL ACAD SCI USA, V93, P13870, DOI 10.1073/pnas.93.24.13870; Grace AA, 1997, TRENDS NEUROSCI, V20, P31, DOI 10.1016/S0166-2236(96)10064-3; GRIMA B, 1985, P NATL ACAD SCI USA, V82, P617, DOI 10.1073/pnas.82.2.617; HANKS M, 1995, SCIENCE, V269, P679, DOI 10.1126/science.7624797; Hynes M, 1999, CURR OPIN NEUROBIOL, V9, P26, DOI 10.1016/S0959-4388(99)80004-X; HYNES M, 1995, NEURON, V15, P35, DOI 10.1016/0896-6273(95)90062-4; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5; Kordower JH, 1996, J COMP NEUROL, V370, P203; PERLOW MJ, 1987, NEUROSURGERY, V20, P335, DOI 10.1227/00006123-198702000-00026; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Shamim H, 1999, DEVELOPMENT, V126, P945; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Smidt MP, 1997, P NATL ACAD SCI USA, V94, P13305, DOI 10.1073/pnas.94.24.13305; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Tucker AS, 1999, DEVELOPMENT, V126, P221; Urbanek P, 1997, P NATL ACAD SCI USA, V94, P5703, DOI 10.1073/pnas.94.11.5703; WURST W, 1994, DEVELOPMENT, V120, P2065; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	26	316	329	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2000	3	4					337	341		10.1038/73902	http://dx.doi.org/10.1038/73902			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330CN	10725922				2022-12-24	WOS:000087945400013
J	Corbetta, M; Kincade, JM; Ollinger, JM; McAvoy, MP; Shulman, GL				Corbetta, M; Kincade, JM; Ollinger, JM; McAvoy, MP; Shulman, GL			Voluntary orienting is dissociated from target detection in human posterior parietal cortex	NATURE NEUROSCIENCE			English	Article							POSITRON EMISSION TOMOGRAPHY; SELECTIVE VISUAL-ATTENTION; HUMAN WORKING-MEMORY; VISUOSPATIAL ATTENTION; UNILATERAL NEGLECT; BRAIN ACTIVATION; SYSTEM; FMRI; DISENGAGEMENT; LOCALIZATION	Human ability to attend to visual stimuli based on their spatial locations requires the parietal cortex. One hypothesis maintains that parietal cortex controls the voluntary orienting of attention toward a location of interest. Another hypothesis emphasizes its role in reorienting attention toward visual targets appearing at unattended locations. Here, using event-related functional magnetic resonance (ER-fMRI), we show that distinct parietal regions mediated these different attentional processes. Cortical activation occurred primarily in the intraparietal sulcus when a location was attended before visual-target presentation, but in the right temporoparietal junction when the target was detected, particularly at an unattended location.	Washington Univ, Sch Med, Dept Neurol & Neurol Surg, St Louis, MO 63110 USA; Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Psychol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Corbetta, M (corresponding author), Washington Univ, Sch Med, Dept Neurol & Neurol Surg, 4525 Scott Ave, St Louis, MO 63110 USA.		Corbetta, Maurizio/AAZ-5219-2020	CORBETTA, MAURIZIO/0000-0001-8295-3304	NEI NIH HHS [EY12148, EY00379] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012148] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANTONUCCI G, 1995, J CLIN EXP NEUROPSYC, V17, P383, DOI 10.1080/01688639508405131; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; COLBY CL, 1988, J COMP NEUROL, V238, P1257; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DIPELLEGRINO G, 1995, NEUROPSYCHOLOGIA, V33, P353, DOI 10.1016/0028-3932(94)00106-Y; Dupont P, 1997, CEREB CORTEX, V7, P283, DOI 10.1093/cercor/7.3.283; FOOTE SL, 1987, ANNU REV NEUROSCI, V10, P67, DOI 10.1146/annurev.ne.10.030187.000435; Friedrich FJ, 1998, NEUROPSYCHOLOGY, V12, P193, DOI 10.1037/0894-4105.12.2.193; Friston KJ, 1998, MAGNET RESON MED, V39, P41, DOI 10.1002/mrm.1910390109; Gitelman DR, 1996, ANN NEUROL, V39, P174, DOI 10.1002/ana.410390206; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; HALLIGAN PW, 1994, COGNITIVE NEUROPSYCH, V11, P167, DOI 10.1080/02643299408251973; Heilman K.M., 1985, INT J CLIN NEUROPSYC, V2nd, P243; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Knight RT, 1998, J CLIN NEUROPHYSIOL, V15, P3, DOI 10.1097/00004691-199801000-00003; Le TH, 1998, J NEUROPHYSIOL, V79, P1535, DOI 10.1152/jn.1998.79.3.1535; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Mendola JD, 1999, J NEUROSCI, V19, P8560; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; MORROW LA, 1988, PSYCHOBIOLOGY, V16, P261; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; Parasuraman R, 1998, ATTENTIVE BRAIN, P221; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1984, J NEUROSCI, V4, P1863; RACZKOWSKI D, 1974, NEUROPSYCHOLOGIA, V12, P43, DOI 10.1016/0028-3932(74)90025-6; Robertson IH, 1998, NATURE, V395, P169, DOI 10.1038/25993; Shulman GL, 1999, J NEUROSCI, V19, P9480; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Vandenberghe R, 1996, BRAIN, V119, P1263, DOI 10.1093/brain/119.4.1263; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; WEINBERG J, 1977, ARCH PHYS MED REHAB, V58, P479; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zarahn E, 1997, NEUROIMAGE, V6, P122, DOI 10.1006/nimg.1997.0279	46	1389	1422	10	110	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2000	3	3					292	297		10.1038/73009	http://dx.doi.org/10.1038/73009			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TE	10700263				2022-12-24	WOS:000085810500020
J	Jontes, JD; Buchanan, J; Smith, SJ				Jontes, JD; Buchanan, J; Smith, SJ			Growth cone and dendrite dynamics in zebrafish embryos: early events in synaptogenesis imaged in vivo	NATURE NEUROSCIENCE			English	Article							RETICULOSPINAL NEURONS; SPINAL-CORD; IN-VIVO; IDENTIFIED MOTONEURONES; CORTICORUBRAL AXONS; TIME-LAPSE; ARBORS; ULTRASTRUCTURE; INTERNEURONS; PROTRUSIONS	We used time-lapse fluorescence microscopy to observe the growth of Mauthner cell axone and their postsynaptic targets, the primary motor neurons, in spinal cords of developing zebrafish embryos. Upon reaching successive motor neurons, the Mauthner growth cone paused briefly before continuing along its path. Varicosities formed at regular intervals and were preferentially associated with the target regions of the primary motor neurons. In addition, the postsynaptic motor neurons showed highly dynamic filopodia, which transiently interacted with both the growth cone and the axon. Both Mauthner cell and motor neurons were highly active, each showing motility sufficient to initiate synaptogenesis.	Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Stanford University	Smith, SJ (corresponding author), Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.							CELIO MR, 1979, J NEUROCYTOL, V8, P19, DOI 10.1007/BF01206455; Dailey ME, 1996, J NEUROSCI, V16, P2983; DIAMOND J, 1971, FISH PHYSIOL, V5, P265; Dynes JL, 1998, NEURON, V20, P1081, DOI 10.1016/S0896-6273(00)80490-0; EISEN JS, 1986, NATURE, V320, P269, DOI 10.1038/320269a0; FETCHO JR, 1988, J NEUROSCI, V8, P4192; Fiala JC, 1998, J NEUROSCI, V18, P8900; HARRIS WA, 1987, DEVELOPMENT, V101, P123; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; KAETHNER RJ, 1992, J NEUROSCI, V12, P3257, DOI 10.1523/JNEUROSCI.12-08-03257.1992; KIMMEL CB, 1982, J COMP NEUROL, V205, P112, DOI 10.1002/cne.902050203; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; LIU DW, 1988, J PHYSIOL-LONDON, V403, P73, DOI 10.1113/jphysiol.1988.sp017239; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MENDELSON B, 1986, J COMP NEUROL, V251, P160, DOI 10.1002/cne.902510203; MENDELSON B, 1986, J COMP NEUROL, V251, P172, DOI 10.1002/cne.902510204; METCALFE WK, 1986, J COMP NEUROL, V251, P147, DOI 10.1002/cne.902510202; MYERS PZ, 1985, J COMP NEUROL, V236, P555, DOI 10.1002/cne.902360411; MYERS PZ, 1986, J NEUROSCI, V6, P2278; OROURKE NA, 1990, NEURON, V5, P159, DOI 10.1016/0896-6273(90)90306-Z; OROURKE NA, 1994, NEURON, V12, P921, DOI 10.1016/0896-6273(94)90343-3; Saint-Amant L, 1998, J NEUROBIOL, V37, P622, DOI 10.1002/(SICI)1097-4695(199812)37:4<622::AID-NEU10>3.0.CO;2-S; SAITO Y, 1992, NEUROSCI LETT, V147, P81, DOI 10.1016/0304-3940(92)90779-7; Saito Y, 1997, J NEUROSCI, V17, P8792; Shoji W, 1998, DEVELOPMENT, V125, P1275; WESTERFIELD M, 1986, J NEUROSCI, V6, P2267; Westerfield M, 1995, ZEBRAFISH BOOK; Witte S, 1996, J NEUROBIOL, V31, P219, DOI 10.1002/(SICI)1097-4695(199610)31:2<219::AID-NEU7>3.0.CO;2-E; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; YASARGIL GM, 1968, NATURE, V220, P241, DOI 10.1038/220241a0; YASARGIL GM, 1990, J NEUROCYTOL, V19, P111, DOI 10.1007/BF01188443; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	34	160	162	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2000	3	3					231	237		10.1038/72936	http://dx.doi.org/10.1038/72936			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TE	10700254				2022-12-24	WOS:000085810500011
J	Nick, TA; Ribera, AB				Nick, TA; Ribera, AB			Synaptic activity modulates presynaptic excitability	NATURE NEUROSCIENCE			English	Article							DEVELOPING NEUROMUSCULAR SYNAPSES; LONG-TERM POTENTIATION; SPINAL-CORD; XENOPUS-LAEVIS; IONIC CURRENTS; NEURONS; RELEASE; DIFFERENTIATION; CELLS; ACETYLCHOLINE	Synaptic activity modulates synaptic efficacy and is important in learning and development. Here we show that development of excitability in presynaptic motor neurons required synaptic activation of postsynaptic muscle cells. Synaptic blockade broadened action potentials and decreased repetitive firing of presynaptic neurons. Consistent with these findings, synaptic blockade also decreased potassium-current density in the presynaptic cell. Application of neurotrophin-3, but not related neurotrophins, prevented these changes. Recordings from patches of somatic membrane indicated that modifications of presynaptic potassium and sodium currents occurred in a remote, nonsynaptic compartment, Thus, activity-dependent postsynaptic signals modulated presynaptic excitability, potentially regulating transmission at all synapses of the presynaptic cell.	Univ Colorado, Hlth Sci Ctr, Dept Physiol & Biophys, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Nick, TA (corresponding author), CALTECH, Div Biol, 216-76, Pasadena, CA 91125 USA.			Ribera, Angie/0000-0002-0966-5856				BERG MM, 1992, J BIOL CHEM, V267, P13; BIXBY JL, 1984, J PHYSIOL-LONDON, V353, P143, DOI 10.1113/jphysiol.1984.sp015328; BIXBY JL, 1982, J PHYSIOL-LONDON, V330, P513, DOI 10.1113/jphysiol.1982.sp014356; Boulanger L, 1999, NAT NEUROSCI, V2, P346, DOI 10.1038/7258; Cash S, 1996, SCIENCE, V272, P998, DOI 10.1126/science.272.5264.998; Cash S, 1996, NEURON, V16, P745, DOI 10.1016/S0896-6273(00)80095-1; CASTROALAMANCOS MA, 1995, J NEUROSCI, V15, P5324; DAHM LM, 1991, J NEUROSCI, V11, P238; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Desai NS, 1999, LEARN MEMORY, V6, P284; Fu WM, 1998, J NEUROSCI, V18, P9954; FULTON BP, 1986, J PHYSIOL-LONDON, V370, P651, DOI 10.1113/jphysiol.1986.sp015956; Golowasch J, 1999, J NEUROSCI, V19, part. no., DOI 10.1523/JNEUROSCI.19-20-j0004.1999; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HENDERSON LP, 1984, J NEUROSCI, V4, P3140; HENDERSON LP, 1986, DEV BIOL, V113, P381, DOI 10.1016/0012-1606(86)90173-9; HUANG YY, 1992, SCIENCE, V255, P730, DOI 10.1126/science.1346729; KELLERTH JO, 1971, ACTA PHYSIOL SCAND, V83, P31, DOI 10.1111/j.1748-1716.1971.tb05048.x; KULLBERG RW, 1977, DEV BIOL, V60, P101, DOI 10.1016/0012-1606(77)90113-0; KUPPER J, 1995, PFLUG ARCH EUR J PHY, V430, P1, DOI 10.1007/BF00373833; Lesser SS, 1997, MOL CELL NEUROSCI, V10, P173, DOI 10.1006/mcne.1997.0656; Liou JC, 1997, J NEUROSCI, V17, P2459; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; MALINOW R, 1991, SCIENCE, V252, P722, DOI 10.1126/science.1850871; MAROM S, 1993, RECEPTOR CHANNEL, V1, P81; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; MULLER D, 1995, NEURON, V14, P599, DOI 10.1016/0896-6273(95)90316-X; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; OTANI S, 1995, LEARN MEMORY, V2, P101, DOI 10.1101/lm.2.2.101; PERRINS R, 1994, J PHYSIOL-LONDON, V478, P221, DOI 10.1113/jphysiol.1994.sp020244; Purves D, 1985, PRINCIPLES NEURAL DE, P131; Ruthazer ES, 1996, J NEUROSCI, V16, P7253; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SCHILLING K, 1991, NEURON, V7, P891, DOI 10.1016/0896-6273(91)90335-W; Sherrard RM, 1998, CLIN EXP PHARMACOL P, V25, P487, DOI 10.1111/j.1440-1681.1998.tb02241.x; Sherwood NT, 1997, P NATL ACAD SCI USA, V94, P5917, DOI 10.1073/pnas.94.11.5917; SPITZER NC, 1976, P NATL ACAD SCI USA, V73, P1641, DOI 10.1073/pnas.73.5.1641; SPITZER NC, 1991, J NEUROBIOL, V22, P659, DOI 10.1002/neu.480220702; Spitzer NC, 1999, NAT NEUROSCI, V2, P489, DOI 10.1038/9132; Stemmler M, 1999, NAT NEUROSCI, V2, P521, DOI 10.1038/9173; STOOP R, 1995, SCIENCE, V267, P695, DOI 10.1126/science.7839148; Tabti N., 1991, CULTURING NERVE CELL, P137; VINCENT P, 1993, NEURON, V11, P885, DOI 10.1016/0896-6273(93)90118-B; WANG T, 1995, J NEUROSCI, V15, P4796; Wang XH, 1997, NEURON, V19, P825, DOI 10.1016/S0896-6273(00)80964-2; XIE HW, 1995, J NEUROSCI, V15, P5900; Xie KW, 1997, J NEUROSCI, V17, P2947; ZISKINDCONHAIM L, 1988, DEV BIOL, V128, P21, DOI 10.1016/0012-1606(88)90262-X	50	53	53	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2000	3	2					142	149		10.1038/72082	http://dx.doi.org/10.1038/72082			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TC	10649569				2022-12-24	WOS:000085810300011
J	McBride, SMJ; Giuliani, G; Choi, C; Krause, P; Correale, D; Watson, K; Baker, G; Siwicki, KK				McBride, SMJ; Giuliani, G; Choi, C; Krause, P; Correale, D; Watson, K; Baker, G; Siwicki, KK			Mushroom body ablation impairs short-term memory and long-term memory of courtship conditioning in Drosophila melanogaster	NEURON			English	Article							CENTRAL NERVOUS-SYSTEM; POSTEMBRYONIC NEUROBLASTS; PREFERENTIAL EXPRESSION; GENETIC DISSECTION; MUTANT DROSOPHILA; SEXUAL-BEHAVIOR; BODIES; BRAIN; RESPONSES; MUTATIONS	We have evaluated the role of the Drosophila mushroom bodies (MBs) in courtship conditioning, in which experience with mated females causes males to reduce their courtship toward virgins (Siegel and Hall, 1979). Whereas previous studies indicated that MB ablation abolished learning in an olfactory conditioning paradigm (deBelle and Heisenberg, 1994), MB-ablated males were able to learn in the courtship paradigm. They resumed courting at naive levels within 30 min after training, however, while the courtship of control males remained depressed 1 hr after training. We also describe a novel courtship conditioning paradigm that established long-term memory, lasting 9 days. In MB-ablated males, memory dissipated completely within 1 day. Our results indicate that the MBs are not required for learning and immediate recall of courtship conditioning but are required for consolidation of short-term and long-term associative memories.	Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA	Swarthmore College	Siwicki, KK (corresponding author), Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA.	ksiwick1@swarthmore.edu						ACKERMAN SL, 1986, J NEUROGENET, V3, P111, DOI 10.3109/01677068609106898; ANTONY C, 1982, J INSECT PHYSIOL, V28, P873, DOI 10.1016/0022-1910(82)90101-9; Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; Barth M, 1997, LEARN MEMORY, V4, P219, DOI 10.1101/lm.4.2.219; BASTOCK M, 1956, EVOLUTION, V10, P421, DOI 10.2307/2407002; BASTOCK M., 1955, BEHAVIOR, V8, P85, DOI 10.1163/156853955X00184; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bubis JA, 1998, ANIM BEHAV, V55, P1637, DOI 10.1006/anbe.1997.0723; Clyne PJ, 1999, NEURON, V22, P339, DOI 10.1016/S0896-6273(00)81094-6; Cobb M, 1995, BEHAV PROCESS, V35, P35, DOI 10.1016/0376-6357(95)00052-6; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; CONNOLLY K, 1973, BEHAVIOUR, V44, P142, DOI 10.1163/156853973X00364; COOK R, 1980, BIOL CYBERN, V37, P41, DOI 10.1007/BF00347641; DAUWALDER B, 1995, J NEUROSCI, V15, P3490; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; ERBER J, 1980, PHYSIOL ENTOMOL, V5, P343, DOI 10.1111/j.1365-3032.1980.tb00244.x; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; Ferveur JF, 1996, P ROY SOC B-BIOL SCI, V263, P967, DOI 10.1098/rspb.1996.0143; GAILEY DA, 1984, GENETICS, V106, P613; GAILEY DA, 1991, J COMP PHYSIOL A, V169, P685; GREENSPAN RJ, 1995, NEURON, V15, P747, DOI 10.1016/0896-6273(95)90165-5; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; HALL JC, 1979, GENETICS, V92, P437; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Han PL, 1996, J NEUROBIOL, V31, P88, DOI 10.1002/(SICI)1097-4695(199609)31:1<88::AID-NEU8>3.0.CO;2-B; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; Heisenberg M, 1980, Basic Life Sci, V16, P373; HEISENBERG M, 1995, J NEUROSCI, V15, P1951, DOI 10.1523/JNEUROSCI.15-03-01951.1995; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; HEISENBERG M, 1979, Z NATURFORSCH C, V34, P143; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; JOINER MA, 1999, DROSOPHILA LEARN MEM, V6, P177; Joiner MLA, 1997, J NEUROSCI, V17, P9384; Kane NS, 1997, NEURON, V18, P307, DOI 10.1016/S0896-6273(00)80270-6; KYRIACOU CP, 1980, P NATL ACAD SCI-BIOL, V77, P6729, DOI 10.1073/pnas.77.11.6729; MENZEL R, 1994, MUSHROOM BODIES HONE; MURPHEY RK, 1989, J COMP NEUROL, V290, P185, DOI 10.1002/cne.902900203; NIGHORN A, 1991, NEURON, V6, P455, DOI 10.1016/0896-6273(91)90253-V; PROKOP A, 1994, DEV BIOL, V161, P321, DOI 10.1006/dbio.1994.1034; PROKOP A, 1991, DEVELOPMENT, V111, P79; ROBERTSON HM, 1983, EXPERIENTIA, V39, P333, DOI 10.1007/BF01955335; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; SOKOLOWSKI MB, 1984, ANIM BEHAV, V32, P645, DOI 10.1016/S0003-3472(84)80139-6; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; STOCKER RF, 1989, BEHAV GENET, V19, P371, DOI 10.1007/BF01066165; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Strausfeld NJ, 1995, NERVOUS SYSTEM INVER, P349; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; Sturtevant A. H., 1915, Journal of Animal Behavior Boston, V5, DOI 10.1037/h0074109; TOMPKINS L, 1982, BEHAV GENET, V12, P295, DOI 10.1007/BF01067849; TOMPKINS L, 1983, BEHAV GENET, V13, P565, DOI 10.1007/BF01076402; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; VANSWINDEREN B, 1995, LEARN MEMORY, V2, P49, DOI 10.1101/lm.2.2.49; Villella A, 1996, GENETICS, V143, P331; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; WILLMUND R, 1982, ANIM BEHAV, V30, P209, DOI 10.1016/S0003-3472(82)80256-X; Wolf R, 1998, LEARN MEMORY, V5, P166; Yamamoto D, 1997, ANNU REV ENTOMOL, V42, P551, DOI 10.1146/annurev.ento.42.1.551; YANG MY, 1995, NEURON, V15, P45	64	204	209	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1999	24	4					967	977		10.1016/S0896-6273(00)81043-0	http://dx.doi.org/10.1016/S0896-6273(00)81043-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	269UE	10624959	Bronze			2022-12-24	WOS:000084495300024
J	Li, HS; Xu, XZS; Montell, C				Li, HS; Xu, XZS; Montell, C			Activation of a TRPC3-dependent cation current through the neurotrophin BDNF	NEURON			English	Article							CAPACITATIVE CALCIUM-ENTRY; TRP CA2+ CHANNEL; DROSOPHILA TRP; STORE DEPLETION; MOLECULAR-CLONING; HUMAN HOMOLOG; MOUSE-BRAIN; RECEPTOR; EXPRESSION; PROTEIN	Nonvoltage-gated cation currents, which are activated following stimulation of phospholipase C (PLC), appear to be major modes for Ca2+ and Na+ entry in mammalian cells. The TRPC channels may mediate some of these conductances since their expression in vitro leads to PLC-dependent cation influx. We! found that the TRPC3 protein was highly enriched in neurons of the central nervous system (CNS). The temporal and spatial distribution of TRPC3 paralleled that of the neurotrophin receptor TrkB. Activation of TrkB by brain-derived nerve growth factor (BDNF) led to production of a PLC-dependent, nonselective cation conductance in pontine neurons. Evidence is provided that TRPC3 contributes to this current in vivo. Thus, activation of TrkB and PLC leads to a TRPC3-dependent cation influx in CNS neurons.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Montell, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.		Montell, Craig/AAH-3357-2021	Montell, Craig/0000-0001-5637-1482	NATIONAL EYE INSTITUTE [R01EY010852] Funding Source: NIH RePORTER; NEI NIH HHS [EY10852] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BARBACID M, 1995, CURR OPIN CELL BIOL, V7, P148, DOI 10.1016/0955-0674(95)80022-0; Berninger B, 1996, CURR OPIN NEUROBIOL, V6, P324, DOI 10.1016/S0959-4388(96)80115-2; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Bonhoeffer T, 1996, CURR OPIN NEUROBIOL, V6, P119, DOI 10.1016/S0959-4388(96)80017-1; Boulay G, 1997, J BIOL CHEM, V272, P29672, DOI 10.1074/jbc.272.47.29672; CHEN P, 1994, J CELL BIOL, V127, P847, DOI 10.1083/jcb.127.3.847; Farinas I, 1998, NEURON, V21, P325, DOI 10.1016/S0896-6273(00)80542-5; Fryer RH, 1996, J COMP NEUROL, V374, P21, DOI 10.1002/(SICI)1096-9861(19961007)374:1<21::AID-CNE2>3.0.CO;2-P; Funayama M, 1996, MOL BRAIN RES, V43, P259, DOI 10.1016/S0169-328X(96)00208-2; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Garcia RL, 1997, BIOCHEM BIOPH RES CO, V239, P279, DOI 10.1006/bbrc.1997.7458; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Henderson CE, 1996, CURR OPIN NEUROBIOL, V6, P64, DOI 10.1016/S0959-4388(96)80010-9; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hurst RS, 1998, FEBS LETT, V422, P333, DOI 10.1016/S0014-5793(98)00035-0; JAN LY, 1992, CELL, V69, P715, DOI 10.1016/0092-8674(92)90280-P; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; LO DC, 1995, NEURON, V15, P979, DOI 10.1016/0896-6273(95)90085-3; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; MONTELL C, 1988, CELL, V52, P757, DOI 10.1016/0092-8674(88)90413-8; MONTELL C, 1985, SCIENCE, V230, P1040, DOI 10.1126/science.3933112; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Mori Y, 1998, NEUROREPORT, V9, P507; Okada T, 1998, J BIOL CHEM, V273, P10279, DOI 10.1074/jbc.273.17.10279; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; PETERSEN CCH, 1995, BIOCHEM J, V311, P41, DOI 10.1042/bj3110041; Philipp S, 1996, EMBO J, V15, P6166, DOI 10.1002/j.1460-2075.1996.tb01004.x; Philipp S, 1998, EMBO J, V17, P4274, DOI 10.1093/emboj/17.15.4274; PUTNEY JW, 1993, SCIENCE, V262, P676, DOI 10.1126/science.8235587; PUTNEY JW, 1994, TRENDS ENDOCRIN MET, V5, P256, DOI 10.1016/1043-2760(94)P3085-L; Reichardt L. F., 1997, MOL CELLULAR APPROAC, P220; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Shieh PB, 1997, CURR BIOL, V7, pR627, DOI 10.1016/S0960-9822(06)00319-8; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; TWYMAN RE, 1995, NEURON, V14, P755, DOI 10.1016/0896-6273(95)90219-8; VACA L, 1994, AM J PHYSIOL-CELL PH, V267, pC1501, DOI 10.1152/ajpcell.1994.267.5.C1501; Vannier B, 1999, P NATL ACAD SCI USA, V96, P2060, DOI 10.1073/pnas.96.5.2060; Vannier B, 1998, J BIOL CHEM, V273, P8675, DOI 10.1074/jbc.273.15.8675; WES PD, 1995, P NATL ACAD SCI USA, V92, P9652, DOI 10.1073/pnas.92.21.9652; Xu XZS, 1997, CELL, V89, P1155, DOI 10.1016/S0092-8674(00)80302-5; Yan Q, 1997, J COMP NEUROL, V378, P135; ZHU X, 1995, FEBS LETT, V373, P193, DOI 10.1016/0014-5793(95)01038-G; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7; Zitt C, 1996, NEURON, V16, P1189, DOI 10.1016/S0896-6273(00)80145-2; Zitt C, 1997, J CELL BIOL, V138, P1333, DOI 10.1083/jcb.138.6.1333	52	276	285	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	1999	24	1					261	273		10.1016/S0896-6273(00)80838-7	http://dx.doi.org/10.1016/S0896-6273(00)80838-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241QC	10677043	hybrid			2022-12-24	WOS:000082893200025
J	Nurrish, S; Segalat, L; Kaplan, JM				Nurrish, S; Segalat, L; Kaplan, JM			Serotonin inhibition of synaptic transmission: G alpha(o) decreases the abundance of UNC-13 at release sites	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; PROTEIN-KINASE-C; PHORBOL ESTER RECEPTOR; NERVOUS-SYSTEM; RICH REGION; NEURONS; MUTANTS; BEHAVIOR; CALCIUM; GENE	We show that serotonin inhibits synaptic transmission at C. elegans neuromuscular junctions, and we describe a signaling pathway that mediates this effect. Release of acetylcholine from motor neurons was assayed by measuring the sensitivity of intact animals to the acetylcholinesterase inhibitor aldicarb. Fly this assay, exogenous serotonin inhibited acetylcholine release, whereas serotonin antagonists stimulated release. The effects of serotonin on synaptic transmission were mediated by GOA-1 (a G alpha(o) subunit) and DGK-1 (a diacylglycerol [DAG] kinase), both of which act in the ventral cord motor neurons. Mutants lacking goa-1 Got, accumulated abnormally high levels of the DAG-binding protein UNC-13 at motor neuron nerve terminals, suggesting that serotonin inhibits synaptic transmission by decreasing the abundance of UNC-13 at release sites.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France	University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Kaplan, JM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.			Nurrish, Stephen/0000-0002-2653-9384				AHMED S, 1992, BIOCHEM J, V287, P995, DOI 10.1042/bj2870995; ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; Berman ME, 1997, CLIN PSYCHOL REV, V17, P651, DOI 10.1016/S0272-7358(97)00039-1; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; Brundage L, 1996, NEURON, V16, P999, DOI 10.1016/S0896-6273(00)80123-3; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; Crabbe JC, 1996, NAT GENET, V14, P98, DOI 10.1038/ng0996-98; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; Duerr JS, 1999, J NEUROSCI, V19, P72, DOI 10.1523/JNEUROSCI.19-01-00072.1999; Edwards DH, 1997, CURR OPIN NEUROBIOL, V7, P812, DOI 10.1016/S0959-4388(97)80140-7; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Houssa B, 1999, J BIOL CHEM, V274, P6820, DOI 10.1074/jbc.274.11.6820; Houssa B, 1997, J BIOL CHEM, V272, P10422; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P10777, DOI 10.1074/jbc.270.18.10777; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; LOCHRIE MA, 1991, CELL REGUL, V2, P135, DOI 10.1091/mbc.2.2.135; MAES M, 1994, PSYCHOPHARMACOLOGY 4, P813; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; MARUYAMA IN, 1991, P NATL ACAD SCI USA, V88, P5729, DOI 10.1073/pnas.88.13.5729; McDearmid JR, 1997, J PHYSIOL-LONDON, V503, P111, DOI 10.1111/j.1469-7793.1997.111bi.x; MENDEL JE, 1995, SCIENCE, V267, P1652, DOI 10.1126/science.7886455; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; NGUYEN M, 1995, GENETICS, V140, P527; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; RAND JB, 1997, C ELEGANS, V2, P1049; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; SAUDOU F, 1994, SCIENCE, V265, P1875, DOI 10.1126/science.8091214; Sawin E. R., 1996, THESIS MIT CAMBRIDGE; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; SEGAL M, 1989, NEUROSCI LETT, V101, P169, DOI 10.1016/0304-3940(89)90525-9; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; SHAPIRA R, 1987, NATURE, V325, P58, DOI 10.1038/325058a0; Singer JH, 1996, J NEUROPHYSIOL, V76, P799, DOI 10.1152/jn.1996.76.2.799; SOUBRIE P, 1988, NEURONAL SEROTONIN; Stevens CF, 1998, NEURON, V21, P885, DOI 10.1016/S0896-6273(00)80603-0; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Tolias KF, 1998, MOL CELL BIOL, V18, P762, DOI 10.1128/MCB.18.2.762; Topham MK, 1999, J BIOL CHEM, V274, P11447, DOI 10.1074/jbc.274.17.11447; TRENT C, 1983, GENETICS, V104, P619; Waggoner LE, 1998, NEURON, V21, P203, DOI 10.1016/S0896-6273(00)80527-9; Wang C, 1998, NEURON, V21, P155, DOI 10.1016/S0896-6273(00)80523-1; WEINSHENKER D, 1995, J NEUROSCI, V15, P6975; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	47	240	252	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	1999	24	1					231	242		10.1016/S0896-6273(00)80835-1	http://dx.doi.org/10.1016/S0896-6273(00)80835-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241QC	10677040	Bronze			2022-12-24	WOS:000082893200022
J	Zhu, YX; King, MA; Schuller, AGP; Nitsche, JF; Reidl, M; Elde, RP; Unterwald, E; Pasternak, GW; Pintar, JE				Zhu, YX; King, MA; Schuller, AGP; Nitsche, JF; Reidl, M; Elde, RP; Unterwald, E; Pasternak, GW; Pintar, JE			Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice	NEURON			English	Article							PHARMACOLOGICAL CHARACTERIZATION; MESSENGER-RNA; EXPRESSION; DEPENDENCE; SUBTYPES; BINDING; MOUSE; ANTINOCICEPTION; NALTRINDOLE; WITHDRAWAL	Gene targeting was used to delete exon 2 of mouse DOR-1, which encodes the delta opioid receptor. Essentially all 3H-[D-Pen(2),D-Pen(5)]enkephalin (H-3-DPDPE) and 3H-[D-Ala(2),D-Glu(4)]deltorphin (H-3-deltorphin-2) binding is absent from mutant mice, demonstrating that DOR-1 encodes both delta(1) and delta(2) receptor subtypes. Homozygous mutant mice display markedly reduced spinal 6 analgesia, but peptide 6 agonists retain supraspinal analgesic potency that is only partially antagonized by naltrindole. Retained DPDPE analgesia is also demonstrated upon formalin testing, while the nonpeptide 6 agonist BW373U69 exhibits enhanced activity in DOR-l mutant mice. Together, these findings suggest the existence of a second delta-like analgesic system. Finally, DOR-1 mutant mice do not develop analgesic tolerance to morphine, genetically demonstrating a central role for DOR-1 in this process.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA; Univ Minnesota, Dept Cell Biol & Neuroanat, Minneapolis, MN 55455 USA; Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Memorial Sloan Kettering Cancer Center; University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Pintar, JE (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA.				NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007242, R01DA009040, R37DA007242] Funding Source: NIH RePORTER; NIDA NIH HHS [DA-00220, DA-09040, DA-07242] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ABDELHAMID EE, 1991, J PHARMACOL EXP THER, V258, P299; ARVIDSSON U, 1995, J NEUROSCI, V15, P1215; CALCAGNETTI DJ, 1988, EUR J PHARMACOL, V153, P117, DOI 10.1016/0014-2999(88)90595-X; CHANG KJ, 1993, J PHARMACOL EXP THER, V267, P852; COWAN A, 1988, J PHARMACOL EXP THER, V246, P950; Ellison Neil M., 1993, P185; EVANS CJ, 1992, SCIENCE, V258, P1952, DOI 10.1126/science.1335167; HALEY TJ, 1957, BRIT J PHARM CHEMOTH, V12, P12, DOI 10.1111/j.1476-5381.1957.tb01354.x; Hepburn MJ, 1997, J PHARMACOL EXP THER, V281, P1350; HERZ A, 1993, HDB EXPT PHARM, V114; HEYMAN JS, 1987, BRAIN RES, V420, P100, DOI 10.1016/0006-8993(87)90244-7; HEYMAN JS, 1988, TRENDS PHARMACOL SCI, V9, P134, DOI 10.1016/0165-6147(88)90195-2; Hiller JM, 1996, BRAIN RES, V719, P85, DOI 10.1016/0006-8993(96)00090-X; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Kest B, 1996, BRAIN RES BULL, V39, P185, DOI 10.1016/0361-9230(95)02092-6; Kieffer BL, 1995, CELL MOL NEUROBIOL, V15, P615, DOI 10.1007/BF02071128; KIEFFER BL, 1992, P NATL ACAD SCI USA, V89, P12048, DOI 10.1073/pnas.89.24.12048; Konig M, 1996, NATURE, V383, P535, DOI 10.1038/383535a0; LUKE MC, 1988, LIFE SCI, V43, P1249, DOI 10.1016/0024-3205(88)90215-9; MALDONADO R, 1992, NEUROPHARMACOLOGY, V31, P1231, DOI 10.1016/0028-3908(92)90051-P; MANSOUR A, 1993, J CHEM NEUROANAT, V6, P351, DOI 10.1016/0891-0618(93)90010-2; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; MATTIA A, 1991, J PHARMACOL EXP THER, V258, P583; MATTIA A, 1992, J PHARMACOL EXP THER, V260, P518; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Olianas MC, 1995, J PHARMACOL EXP THER, V275, P1560; PASTERNAK GW, 1993, CLIN NEUROPHARMACOL, V16, P1, DOI 10.1097/00002826-199302000-00001; PORTOGHESE PS, 1988, EUR J PHARMACOL, V146, P185, DOI 10.1016/0014-2999(88)90502-X; RAPAKA RS, 1991, PHARM RES-DORDR, V8, P1, DOI 10.1023/A:1015809702296; RAYNOR K, 1994, MOL PHARMACOL, V45, P330; Rossi GC, 1997, BRAIN RES, V753, P176, DOI 10.1016/S0006-8993(97)00081-4; Roy S, 1998, MOL BRAIN RES, V61, P190, DOI 10.1016/S0169-328X(98)00212-5; Rubinstein M, 1996, P NATL ACAD SCI USA, V93, P3995, DOI 10.1073/pnas.93.9.3995; Schuller AGP, 1999, NAT NEUROSCI, V2, P151, DOI 10.1038/5706; Simonin F, 1998, EMBO J, V17, P886, DOI 10.1093/emboj/17.4.886; Sora I, 1997, P NATL ACAD SCI USA, V94, P1544, DOI 10.1073/pnas.94.4.1544; STANDIFER KM, 1994, NEURON, V12, P805, DOI 10.1016/0896-6273(94)90333-6; Tian MT, 1997, J EXP MED, V185, P1517, DOI 10.1084/jem.185.8.1517; TISEO PJ, 1993, EUR J PHARMACOL, V236, P89, DOI 10.1016/0014-2999(93)90230-F; UNTERWALD EM, 1994, NEUROREPORT, V5, P1613, DOI 10.1097/00001756-199408150-00018; WILD KD, 1993, J PHARMACOL EXP THER, V267, P858; ZHENG M, 1995, METH NEUROSCI, V23, P45; Zhu YX, 1998, BIOL REPROD, V59, P925, DOI 10.1095/biolreprod59.4.925; Zhu YX, 1998, J NEUROSCI, V18, P2538	44	333	349	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	1999	24	1					243	252		10.1016/S0896-6273(00)80836-3	http://dx.doi.org/10.1016/S0896-6273(00)80836-3			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241QC	10677041	Bronze			2022-12-24	WOS:000082893200023
J	Holloway, CC; Clayton, DE				Holloway, CC; Clayton, DE			Estrogen synthesis in the male brain triggers development of the avian song control pathway in vitro	NATURE NEUROSCIENCE			English	Article							ZEBRA FINCH BRAIN; SEXUAL-DIFFERENTIATION; CEREBRAL-CORTEX; ORGANOTYPIC CULTURE; AXONAL CONNECTIONS; AROMATASE-ACTIVITY; MESSENGER-RNA; ADULT MALE; SYSTEM; BEHAVIOR	Sexual differentiation of the brain is determined in part by steroids such as estrogen, which are generally assumed to arise from the gonads. Here we show that estrogens are produced autonomously in cultured juvenile male zebra finch brain slices, and this brain-derived estrogen is both necessary and sufficient to trigger formation in vitro of a key male-specific synaptic connection in the telencephalic song control circuit. Male-like development was stimulated in female slices cultured with male slices or exposed to estrogen, and estrogen antagonists inhibited song circuit development in slices of either sex. These results reveal a new mode of sex-specific neural development, induced not by differential exposure to gonadal steroids, but rather by differential synthesis of steroids in the brain.	Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA; Univ Illinois, Beckman Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Clayton, DE (corresponding author), Univ Illinois, Dept Cell & Struct Biol, B107 CLS Labs,601 S Goodwin Ave, Urbana, IL 61801 USA.		Clayton, David/B-2190-2008	Clayton, David/0000-0002-6395-3488	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025742] Funding Source: NIH RePORTER; NIMH NIH HHS [MH52086] Funding Source: Medline; NINDS NIH HHS [NS25742] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AdkinsRegan E, 1996, BEHAVIOUR, V133, P847, DOI 10.1163/156853996X00279; ADKINSREGAN E, 1990, GEN COMP ENDOCR, V78, P93, DOI 10.1016/0016-6480(90)90051-M; Arnold AP, 1997, J NEUROBIOL, V33, P572, DOI 10.1002/(SICI)1097-4695(19971105)33:5<572::AID-NEU6>3.3.CO;2-6; BALTHAZART J, 1994, BEHAVIOUR, V131, P225, DOI 10.1163/156853994X00451; Bottjer SW, 1997, BIOESSAYS, V19, P1109, DOI 10.1002/bies.950191210; Brenowitz EA, 1997, J NEUROBIOL, V33, P495, DOI 10.1002/(SICI)1097-4695(19971105)33:5<495::AID-NEU1>3.3.CO;2-D; Cooke B, 1998, FRONT NEUROENDOCRIN, V19, P323, DOI 10.1006/frne.1998.0171; Dailey ME, 1996, J NEUROSCI, V16, P2983; DISTLER PG, 1992, DEV BRAIN RES, V67, P181, DOI 10.1016/0165-3806(92)90218-L; Dittrich F, 1999, P NATL ACAD SCI USA, V96, P8241, DOI 10.1073/pnas.96.14.8241; Foster EF, 1998, J COMP NEUROL, V397, P118; GAHR M, 1988, P NATL ACAD SCI USA, V85, P7380, DOI 10.1073/pnas.85.19.7380; Gahr M, 1999, J NEUROSCI, V19, P2628; GOLDMAN SA, 1992, J NEUROSCI, V12, P2532; GURNEY ME, 1980, SCIENCE, V208, P1380, DOI 10.1126/science.208.4450.1380; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; HUTCHISON JB, 1984, J ENDOCRINOL, V103, P363, DOI 10.1677/joe.0.1030363; Jacobs EC, 1999, DEV NEUROSCI-BASEL, V21, P453, DOI 10.1159/000017413; KONISHI M, 1985, NATURE, V315, P145, DOI 10.1038/315145a0; MacGregor JI, 1998, PHARMACOL REV, V50, P151; MACLUSKY NJ, 1994, MOL CELL NEUROSCI, V5, P691, DOI 10.1006/mcne.1994.1083; MATHEWS GA, 1991, J NEUROBIOL, V22, P957, DOI 10.1002/neu.480220907; MATHEWS GA, 1990, GEN COMP ENDOCR, V80, P48, DOI 10.1016/0016-6480(90)90147-E; Molnar Z, 1999, EXP NEUROL, V156, P363, DOI 10.1006/exnr.1999.7032; MOONEY R, 1994, J NEUROSCI, V14, P6532; Mooney R, 1999, CURR OPIN NEUROBIOL, V9, P121, DOI 10.1016/S0959-4388(99)80015-4; NIBLOCK MM, 1995, DEV BRAIN RES, V85, P288, DOI 10.1016/0165-3806(95)00002-U; NORDEEN EJ, 1987, J COMP NEUROL, V259, P393, DOI 10.1002/cne.902590307; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; SCHLINGER BA, 1992, ENDOCRINOLOGY, V130, P289, DOI 10.1210/en.130.1.289; SCHLINGER BA, 1992, P NATL ACAD SCI USA, V89, P7650, DOI 10.1073/pnas.89.16.7650; SCHLINGER BA, 1991, P NATL ACAD SCI USA, V88, P4191, DOI 10.1073/pnas.88.10.4191; Schlinger BA, 1997, J NEUROBIOL, V33, P619, DOI 10.1002/(SICI)1097-4695(19971105)33:5<619::AID-NEU9>3.0.CO;2-7; SCHLINGER BA, 1994, J NEUROSCI, V14, P7541; SIMPSON HB, 1991, J NEUROBIOL, V22, P755, DOI 10.1002/neu.480220710; SIMPSON HB, 1991, J NEUROBIOL, V22, P777, DOI 10.1002/neu.480220711; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Toran-Allerand CD, 1999, FRONT NEUROENDOCRIN, V20, P97, DOI 10.1006/frne.1999.0177; TORANALLERAND CD, 1991, PSYCHONEUROENDOCRINO, V16, P7, DOI 10.1016/0306-4530(91)90068-5; Vanson A, 1996, GEN COMP ENDOCR, V102, P342, DOI 10.1006/gcen.1996.0077; VOCKEL A, 1990, BRAIN RES, V511, P291, DOI 10.1016/0006-8993(90)90174-A; WADE J, 1994, BRAIN RES, V639, P347, DOI 10.1016/0006-8993(94)91752-3; Wade J, 1996, P NATL ACAD SCI USA, V93, P5264, DOI 10.1073/pnas.93.11.5264; WADE J, 1994, GEN COMP ENDOCR, V94, P53, DOI 10.1006/gcen.1994.1059; WADE J, 1995, J NEUROBIOL, V27, P240, DOI 10.1002/neu.480270210; WRAY S, 1993, MICROSC RES TECHNIQ, V25, P46, DOI 10.1002/jemt.1070250108	46	172	178	0	78	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2001	4	2					170	175		10.1038/84001	http://dx.doi.org/10.1038/84001			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UC	11175878				2022-12-24	WOS:000167178100016
J	Stobrawa, SM; Breiderhoff, T; Takamori, S; Engel, D; Schweizer, M; Zdebik, AA; Bosl, MR; Ruether, K; Jahn, H; Draguhn, A; Jahn, R; Jentsch, TJ				Stobrawa, SM; Breiderhoff, T; Takamori, S; Engel, D; Schweizer, M; Zdebik, AA; Bosl, MR; Ruether, K; Jahn, H; Draguhn, A; Jahn, R; Jentsch, TJ			Disruption of CIC-3, a chloride channel expressed on synaptic vesicles, leads to a loss of the hippocampus	NEURON			English	Article							FUNCTIONAL EXPRESSION; GLUTAMATE TRANSPORTER; MEMBRANE; LOCALIZATION; PROTEIN; GENE; IDENTIFICATION; CLC-5; GABA; MUTATIONS	Several plasma membrane chloride channels are well characterized, but much less is known about the molecular identity and function of intracellular Cl- channels. ClC-3 is thought to mediate swelling-activated plasma membrane currents, but we now show that this broadly expressed chloride channel is present in endosomal compartments and synaptic vesicles of neurons. While swelling-activated currents are unchanged in mice with disrupted ClC-3, acidification of synaptic vesicles is impaired and there is severe postnatal degeneration of the retina and the hippocampus. Electrophysiological analysis of juvenile hippocampal slices revealed no major functional abnormalities despite slightly increased amplitudes of miniature excitatory postsynaptic currents. Mice almost lacking the hippocampus survive and show several behavioral abnormalities but are still able to acquire motor skills.	Univ Hamburg, Zentrum Mol Neurobiol Hamburg, D-20246 Hamburg, Germany; Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; Humboldt Univ, Johannes Muller Inst Physiol, D-10117 Berlin, Germany; Univ Hamburg, Klin Augenheilkunde, D-20246 Hamburg, Germany; Univ Hamburg, Psychiat Klin, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Max Planck Society; Humboldt University of Berlin; University of Hamburg; University of Hamburg	Jentsch, TJ (corresponding author), Univ Hamburg, Zentrum Mol Neurobiol Hamburg, Martinistr 52, D-20246 Hamburg, Germany.	jentsch@uke.uni-hamburg.de	Jahn, Holger/A-9255-2008; Breiderhoff, Tilman/X-9364-2019	Jahn, Holger/0000-0003-3607-7651; Breiderhoff, Tilman/0000-0002-1676-7498; Engel, Dominique/0000-0002-5962-3152; Jahn, Reinhard/0000-0003-1542-3498; Jentsch, Thomas/0000-0002-3509-2553				Adler DA, 1997, P NATL ACAD SCI USA, V94, P9244, DOI 10.1073/pnas.94.17.9244; ALAWQATI Q, 1995, CURR OPIN CELL BIOL, V7, P504, DOI 10.1016/0955-0674(95)80006-9; Bellocchio EE, 1998, J NEUROSCI, V18, P8648; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; BORSANI G, 1995, GENOMICS, V27, P131, DOI 10.1006/geno.1995.1015; BRAUN M, 1989, EMBO J, V8, P3633, DOI 10.1002/j.1460-2075.1989.tb08537.x; CHAPMAN RE, 1994, EMBO J, V13, P2305, DOI 10.1002/j.1460-2075.1994.tb06514.x; Coutureau E, 2000, EXP BRAIN RES, V131, P381, DOI 10.1007/s002219900301; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; Davis-Kaplan SR, 1998, P NATL ACAD SCI USA, V95, P13641, DOI 10.1073/pnas.95.23.13641; Dittmer F, 1999, J CELL SCI, V112, P1591; Duan D, 1997, NATURE, V390, P417, DOI 10.1038/37151; FACCI L, 1990, J NEUROSCI RES, V27, P202, DOI 10.1002/jnr.490270210; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; Gasnier B, 2000, BIOCHIMIE, V82, P327, DOI 10.1016/S0300-9084(00)00221-2; Gaxiola RA, 1998, P NATL ACAD SCI USA, V95, P4046, DOI 10.1073/pnas.95.7.4046; GREENE JR, 1993, MOL GEN GENET, V241, P542, DOI 10.1007/BF00279896; Grooms SY, 2000, P NATL ACAD SCI USA, V97, P3631, DOI 10.1073/pnas.050586497; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; HARTINGER J, 1993, J BIOL CHEM, V268, P23122; HARTMANN D, 1995, DEV NEUROSCI-BASEL, V17, P246, DOI 10.1159/000111293; Haverkamp S, 2000, J COMP NEUROL, V424, P1; HELL JW, 1988, EMBO J, V7, P3023, DOI 10.1002/j.1460-2075.1988.tb03166.x; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Jentsch TJ, 1999, PFLUG ARCH EUR J PHY, V437, P783, DOI 10.1007/s004240050847; KAWASAKI M, 1995, NEURON, V14, P1285, DOI 10.1016/0896-6273(95)90275-9; KAWASAKI M, 1994, NEURON, V12, P597, DOI 10.1016/0896-6273(94)90215-1; KOMAK U, 2001, IN PRESS CELL, V104; Li Y, 1999, MOL CELL BIOL, V19, P3588; LINSTEDT AD, 1991, NEURON, V7, P309, DOI 10.1016/0896-6273(91)90269-6; Liu YJ, 1997, J CELL BIOL, V139, P907, DOI 10.1083/jcb.139.4.907; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Matsumura Y, 1999, NAT GENET, V21, P95, DOI 10.1038/5036; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Neuhoff H, 1999, EUR J NEUROSCI, V11, P4241, DOI 10.1046/j.1460-9568.1999.00856.x; NUNN JA, 1994, BEHAV BRAIN RES, V62, P41, DOI 10.1016/0166-4328(94)90036-1; Owe-Larsson B, 1999, EUR J NEUROSCI, V11, P1981, DOI 10.1046/j.1460-9568.1999.00614.x; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; Reimer RJ, 1998, CURR OPIN NEUROBIOL, V8, P405, DOI 10.1016/S0959-4388(98)80068-8; Ruether K, 1997, INVEST OPHTH VIS SCI, V38, P710; Schwappach B, 1998, J BIOL CHEM, V273, P15110, DOI 10.1074/jbc.273.24.15110; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shimada K, 2000, AM J PHYSIOL-GASTR L, V279, pG268, DOI 10.1152/ajpgi.2000.279.2.G268; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; STEINMEYER K, 1991, NATURE, V354, P304, DOI 10.1038/354304a0; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Szewczyk A, 1998, MOL MEMBR BIOL, V15, P49, DOI 10.3109/09687689809027518; Takamori S, 2000, J NEUROSCI, V20, P4904; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; TAMIR H, 1994, ENDOCRINOLOGY, V135, P2045, DOI 10.1210/en.135.5.2045; Zdebik A, 1997, PFLUG ARCH EUR J PHY, V434, P188, DOI 10.1007/s004240050382; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x	55	400	426	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	2001	29	1					185	196		10.1016/S0896-6273(01)00189-1	http://dx.doi.org/10.1016/S0896-6273(01)00189-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	397NX	11182090	Bronze			2022-12-24	WOS:000166702700018
J	Morrone, MC; Tosetti, M; Montanaro, D; Fiorentini, A; Cioni, G; Burr, DC				Morrone, MC; Tosetti, M; Montanaro, D; Fiorentini, A; Cioni, G; Burr, DC			A cortical area that responds specifically to optic flow, revealed by fMRI	NATURE NEUROSCIENCE			English	Article							FUNCTIONAL-ANALYSIS; HEADING PERCEPTION; VISUAL-CORTEX; MST NEURONS; MOTION; MECHANISMS; SELECTIVITY; ACTIVATION; SYSTEMS; BRAIN	The continuously changing optic flow on the retina provides information about direction of heading and about the three-dimensional structure of the environment. Here we use functional magnetic resonance Imaging (fMRI) to demonstrate that an area in human cortex responds selectively to components of optic flow, such as circular and radial motion. This area is within the region commonly referrred to as V5/MT complex, but is distinct from the part of this region that responds to translation. The functional properties of these two areas of the V5/MT complex are also different; the response to optic flow was obtained only with changing flow stimuli, whereas response to translation occurred during exposure to continuous motion.	CNR, Ist Neurofisiol, I-56127 Pisa, Italy; Ist Sci Stella Maris, Pisa, Italy; Univ Pisa, Div Neuropsichiat Infantile, Pisa, Italy; Univ Florence, Dipartimento Psicol, I-50125 Florence, Italy; Univ Vita Salute San Raffaele, Fac Psicol, I-20132 Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); IRCCS Fondazione Stella Maris; University of Pisa; University of Florence; Vita-Salute San Raffaele University	Morrone, MC (corresponding author), CNR, Ist Neurofisiol, Via G Moruzzi 1, I-56127 Pisa, Italy.	concetta@in.-pi.cnr.it	Cioni, Giovanni/A-4178-2015; Morrone, Maria Concetta/C-6756-2014; Montanaro, Domenico/AAB-9718-2022; Tosetti, Michela/K-5749-2016	Cioni, Giovanni/0000-0002-6526-5566; Morrone, Maria Concetta/0000-0002-1025-0316; Montanaro, Domenico/0000-0002-9895-7016; Tosetti, Michela/0000-0002-2515-7560; Burr, David/0000-0003-1541-8832				Anderson SJ, 1996, P ROY SOC B-BIOL SCI, V263, P423, DOI 10.1098/rspb.1996.0064; BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Braddick OJ, 2000, CURR BIOL, V10, P731, DOI 10.1016/S0960-9822(00)00540-6; Bradley DC, 1996, SCIENCE, V273, P1544, DOI 10.1126/science.273.5281.1544; Britten KH, 1998, NAT NEUROSCI, V1, P59, DOI 10.1038/259; Burr DC, 1998, VISION RES, V38, P1731, DOI 10.1016/S0042-6989(97)00346-5; Chen W, 1998, MAGN RESON MED, V39, P89, DOI 10.1002/mrm.1910390115; CHENG K, 1995, J NEUROPHYSIOL, V74, P413, DOI 10.1152/jn.1995.74.1.413; DEJONG BM, 1994, BRAIN, V117, P1039; Duffy CJ, 1997, EXP BRAIN RES, V114, P472, DOI 10.1007/PL00005656; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; Dupont P, 1997, CEREB CORTEX, V7, P283, DOI 10.1093/cercor/7.3.283; Ellermann JM, 1998, J MAGN RESON, V131, P272, DOI 10.1006/jmre.1998.1379; Gibson JJ, 1950, PERCEPTION VISUAL WO; GRAZIANO MSA, 1994, J NEUROSCI, V14, P54; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; HELMHOLTZ H, 1858, CRELLES J, V55, P25, DOI DOI 10.1515/CRLL.1858.55.25; Howard RJ, 1996, CURR BIOL, V6, P1015, DOI 10.1016/S0960-9822(02)00646-2; KOENDERINK JJ, 1986, VISION RES, V26, P161, DOI 10.1016/0042-6989(86)90078-7; MIKAMI A, 1986, J NEUROPHYSIOL, V55, P1308, DOI 10.1152/jn.1986.55.6.1308; MORRONE MC, 1995, NATURE, V376, P507, DOI 10.1038/376507a0; Morrone MC, 1999, CURR BIOL, V9, P763, DOI 10.1016/S0960-9822(99)80338-8; Paolini M, 2000, J NEUROPHYSIOL, V84, P730, DOI 10.1152/jn.2000.84.2.730; Previc FH, 2000, EXP BRAIN RES, V131, P393, DOI 10.1007/s002219900298; QIAN N, 1994, J NEUROSCI, V14, P7367; REGAN D, 1979, SCIENCE, V205, P311, DOI 10.1126/science.451604; ROYDEN CS, 1992, NATURE, V360, P583, DOI 10.1038/360583a0; SAITO H, 1986, J NEUROSCI, V6, P145; Smith AT, 1998, J NEUROSCI, V18, P3816; Snowden RJ, 1996, J COGNITIVE NEUROSCI, V8, P435, DOI 10.1162/jocn.1996.8.5.435; TALAIRACH J, 1988, STEREOTACTIC COPOLAN; TANAKA K, 1989, J NEUROPHYSIOL, V62, P642, DOI 10.1152/jn.1989.62.3.642; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Tootell RBH, 1997, J NEUROSCI, V17, P7060; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; Xiong JH, 1995, HUM BRAIN MAPP, V3, P287, DOI 10.1002/hbm.460030404	37	300	304	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2000	3	12					1322	1328		10.1038/81860	http://dx.doi.org/10.1038/81860			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UA	11100154	Bronze			2022-12-24	WOS:000167177900019
J	Simpson, JH; Kidd, T; Bland, KS; Goodman, CS				Simpson, JH; Kidd, T; Bland, KS; Goodman, CS			Short-range and long-range guidance by slit and its robo receptors: Robo and robo2 play distinct roles in midline guidance	NEURON			English	Article							CELL-ADHESION MOLECULE; GROWTH CONE GUIDANCE; CNS MIDLINE; AXON GUIDANCE; GENETIC-ANALYSIS; DROSOPHILA; FASCICULATION; PHENOTYPES; ROUNDABOUT; CONNECTIN	Previous studies showed that Roundabout (Robo) in Drosophila is a repulsive axon guidance receptor that binds to Slit, a repellent secreted by midline glia. In robe mutants, growth cones cross and recross the midline, while, in slit mutants, growth cones enter the midline but fail to leave it. This difference suggests that Slit must have more than one receptor controlling midline guidance. In the absence of Robe, some other Slit receptor ensures that growth cones do not stay at the midline, even though they cross and recross it. Here we show that the Drosophila genome encodes three Robe receptors and that Robe and Robo2 have distinct functions, which together control repulsive axon guidance at the midline. The robo,robo2 double mutant is largely identical to slit.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Howard Hughes Med Inst, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Goodman, CS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Howard Hughes Med Inst, Berkeley, CA 94720 USA.		Kidd, Thomas/AAT-9993-2020	Kidd, Thomas/0000-0001-7190-4208; Bland, Kimberly/0000-0003-4863-6772; Simpson, Julie/0000-0002-6793-7100	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018366] Funding Source: NIH RePORTER; NINDS NIH HHS [NS18366] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; CHEN G, 1994, BIOL CONTROL, V4, P157, DOI 10.1006/bcon.1994.1025; Goodman C. S., 1993, DEV DROSOPHILA MELAN, VII, P1131; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; Hidalgo A, 1997, DEVELOPMENT, V124, P3253; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; MEADOWS LA, 1994, J CELL SCI, V107, P321; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; NOSE A, 1992, CELL, V70, P553, DOI 10.1016/0092-8674(92)90426-D; PATEL NH, 1994, METHOD CELL BIOL, V44, P7; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; ROTHBERG JM, 1988, CELL, V55, P1047, DOI 10.1016/0092-8674(88)90249-8; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; SIMPSON JH, 2000, IN PRESS CELL, V103; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Yuan SSF, 1999, DEV BIOL, V207, P62, DOI 10.1006/dbio.1998.9141; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2	28	191	192	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	2000	28	3					753	766		10.1016/S0896-6273(00)00151-3	http://dx.doi.org/10.1016/S0896-6273(00)00151-3			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386JJ	11163264	Bronze			2022-12-24	WOS:000166057500014
J	Krieglstein, K; Richter, S; Farkas, L; Schuster, N; Dunker, N; Oppenheim, RW; Unsicker, K				Krieglstein, K; Richter, S; Farkas, L; Schuster, N; Dunker, N; Oppenheim, RW; Unsicker, K			Reduction of endogenous transforming growth factors beta prevents ontogenetic neuron death	NATURE NEUROSCIENCE			English	Article							PROGRAMMED CELL-DEATH; NEUROTROPHIC FACTOR; SPINAL-CORD; NERVOUS-SYSTEM; CHICK-EMBRYO; IN-VIVO; ACTIVITY BLOCKADE; BCL-2 TRANSGENE; MOTOR-NEURONS; CNS NEURONS	We show that following immunoneutralization of endogenous transforming growth factors beta (TGF-beta) in the chick embryo, ontogenetic neuron death of ciliary, dorsal root and spinal motor neurons was largely prevented, and neuron losses following limb bud ablation were greatly reduced. Likewise, preventing TGF-beta signaling by treatment with a T betaR-II fusion protein during the period of ontogenetic cell death in the ciliary ganglion rescued all neurons that normally die. TUNEL staining revealed decreased numbers of apoptotic cells following antibody treatment. Exogenous TGF-beta rescued the TGF-beta -deprived phenotype. We conclude that TGF-beta is critical in regulating ontogenetic neuron death as well as cell death following neuronal target deprivation.	Univ Saarland, Fac Med, Dept Anat, D-66421 Homburg, Germany; Univ Heidelberg, Interdisciplinary Ctr Neurosci, Dept Neuroanat, D-69120 Heidelberg, Germany; Wake Forest Univ, Bowman Gray Sch Med, Neurosci Program, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Neurobiol & Anat, Winston Salem, NC 27157 USA	Saarland University; Ruprecht Karls University Heidelberg; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Krieglstein, K (corresponding author), Univ Saarland, Fac Med, Dept Anat, Bldg 61, D-66421 Homburg, Germany.			Dunker, Nicole/0000-0003-1273-0644	NINDS NIH HHS [NS20402] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020402] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arsura M, 1996, IMMUNITY, V5, P31, DOI 10.1016/S1074-7613(00)80307-6; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Barker PA, 1998, CELL DEATH DIFFER, V5, P346, DOI 10.1038/sj.cdd.4400375; Buske C, 1997, LEUKEMIA, V11, P386, DOI 10.1038/sj.leu.2400586; Caldero J, 1998, J NEUROSCI, V18, P356; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; DAHM LM, 1991, J NEUROSCI, V11, P238; DAHM LM, 1988, DEV BIOL, V130, P621, DOI 10.1016/0012-1606(88)90357-0; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; deLuca A, 1996, J NEUROSCI, V16, P4174; FARLIE PG, 1995, P NATL ACAD SCI USA, V92, P4397, DOI 10.1073/pnas.92.10.4397; FLANDERS KC, 1991, DEVELOPMENT, V113, P183; Frade JM, 1999, DEVELOPMENT, V126, P683; Frade JM, 1996, NATURE, V383, P166; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Goumans MJ, 2000, INT J DEV BIOL, V44, P253; Graham A, 1996, MOL CELL NEUROSCI, V8, P76, DOI 10.1006/mcne.1996.0046; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; HAMBURGER V, 1958, AM J ANAT, V102, P365, DOI 10.1002/aja.1001020303; HAMBURGER V, 1975, J COMP NEUROL, V160, P535, DOI 10.1002/cne.901600408; HELLER S, 1995, DEVELOPMENT, V121, P2681; HOLLYDAY M, 1976, J COMP NEUROL, V170, P311, DOI 10.1002/cne.901700304; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; KORSCHING S, 1993, J NEUROSCI, V13, P2739; Krieglstein K, 1998, J NEUROBIOL, V37, P563, DOI 10.1002/(SICI)1097-4695(199812)37:4<563::AID-NEU5>3.3.CO;2-1; Krieglstein K, 1998, J NEUROSCI, V18, P9822; KRIEGLSTEIN K, 1995, INT J DEV NEUROSCI, V13, P301, DOI 10.1016/0736-5748(94)00062-8; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; LANDMESSER L, 1974, J PHYSIOL-LONDON, V241, P715, DOI 10.1113/jphysiol.1974.sp010680; Lewis G, 1996, INT REV PSYCHIATR, V8, P289, DOI 10.3109/09540269609051546; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; NISHI R, 1994, J NEUROBIOL, V25, P612, DOI 10.1002/neu.480250604; Oppenheim RW, 1999, MOL CELL NEUROSCI, V13, P348, DOI 10.1006/mcne.1999.0755; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; OPPENHEIM RW, 1993, J NEUROBIOL, V24, P1065, DOI 10.1002/neu.480240806; OPPENHEIM RW, 1978, J COMP NEUROL, V177, P87, DOI 10.1002/cne.901770107; Oppenheim RW, 1996, NEURON, V17, P195, DOI 10.1016/S0896-6273(00)80151-8; Parsadanian AS, 1998, J NEUROSCI, V18, P1009; Pettmann B, 1998, NEURON, V20, P633, DOI 10.1016/S0896-6273(00)81004-1; Raoul C, 1999, J CELL BIOL, V147, P1049, DOI 10.1083/jcb.147.5.1049; Roberts AB, 1990, HDB EXPT PHARM, V95, P419; Schober A, 1999, J NEUROSCI, V19, P2008; THOENEN H, 1990, HDB EXPT PHARM, V33, P813; UNSICKER K, 1991, NEUROSCIENCE, V44, P613, DOI 10.1016/0306-4522(91)90082-Y; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zanjani HS, 1996, J COMP NEUROL, V374, P332, DOI 10.1002/(SICI)1096-9861(19961021)374:3<332::AID-CNE2>3.0.CO;2-2	48	130	137	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11					1085	1090		10.1038/80598	http://dx.doi.org/10.1038/80598			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TX	11036264				2022-12-24	WOS:000167177600012
J	Mori, Y; Imaizumi, K; Katayama, T; Yoneda, T; Tohyama, M				Mori, Y; Imaizumi, K; Katayama, T; Yoneda, T; Tohyama, M			Two cis-acting elements in the 3 ' untranslated region of alpha-CaMKII regulate its dendritic targeting	NATURE NEUROSCIENCE			English	Article							LOCAL PROTEIN-SYNTHESIS; LONG-TERM POTENTIATION; MESSENGER-RNA TRANSPORT; HIPPOCAMPAL-NEURONS; BINDING PROTEIN; MEMORY STORAGE; LIVING NEURONS; RAT-BRAIN; KINASE-II; LOCALIZATION	Dendritic localization of the or subunit of Ca2+/calmodulin-dependent protein kinase II (alpha CaMKII) mRNA in CNS neurons requires its 3' untranslated region (3'UTR). We investigated this targeting mechanism by identifying two cis-acting elements in the 3'UTR. One is a 30-nucleotide element that mediated dendritic translocation. A homologous sequence in the 3'UTR of neurogranin, transcripts of which also reside in dendrites, also funtioned in cis to promote its dendritic transport. Other putative elements in the alpha CaMKII mRNA inhibit its transport in a resting state. This inhibition was removed in depolarized neurons, and such activity-dependent derepression was a primary requirement for their dendritic targeting.	Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Suita, Osaka 5650871, Japan; Tanabe Seiyaku Corp, Discovery Res Lab, Yodogawa Ku, Osaka 5320031, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan	Osaka University; Mitsubishi Tanabe Pharma Corporation; Japan Science & Technology Agency (JST)	Mori, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.							Ainger K, 1997, J CELL BIOL, V138, P1077, DOI 10.1083/jcb.138.5.1077; AINGER K, 1993, J CELL BIOL, V123, P431, DOI 10.1083/jcb.123.2.431; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; BANGI C, 2000, J NEUROSCI, V20, pRC76; Bashirullah A, 1998, ANNU REV BIOCHEM, V67, P335, DOI 10.1146/annurev.biochem.67.1.335; BENSON DL, 1992, NEUROSCIENCE, V46, P851, DOI 10.1016/0306-4522(92)90189-9; Blichenberg A, 1999, J NEUROSCI, V19, P8818, DOI 10.1523/JNEUROSCI.19-20-08818.1999; BROCKE L, 1995, J NEUROSCI, V15, P6797; BURGIN KE, 1990, J NEUROSCI, V10, P1788; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Chakravarthy B, 1999, TRENDS NEUROSCI, V22, P12, DOI 10.1016/S0166-2236(98)01288-0; Deshler JO, 1998, CURR BIOL, V8, P489, DOI 10.1016/S0960-9822(98)70200-3; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; Gomi F, 2000, J NEUROSCI, V20, P3206, DOI 10.1523/JNEUROSCI.20-09-03206.2000; Hoek KS, 1998, BIOCHEMISTRY-US, V37, P7021, DOI 10.1021/bi9800247; IMAIZUMI K, 1991, BRAIN RES, V551, P36, DOI 10.1016/0006-8993(91)90910-N; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kiebler MA, 2000, NEURON, V25, P19, DOI 10.1016/S0896-6273(00)80868-5; Knowles RB, 1996, J NEUROSCI, V16, P7812; Kuhl D, 1998, CURR OPIN NEUROBIOL, V8, P600, DOI 10.1016/S0959-4388(98)80087-1; LANDRENEAU RJ, 1994, CANC PRINCIPLES PRAC, V8, P1; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; MIYASHIRO K, 1994, P NATL ACAD SCI USA, V91, P10800, DOI 10.1073/pnas.91.23.10800; Muslimov IA, 1997, J NEUROSCI, V17, P4722; Oleynikov Y, 1998, TRENDS CELL BIOL, V8, P381, DOI 10.1016/S0962-8924(98)01348-8; Ouyang Y, 1999, J NEUROSCI, V19, P7823; Racca C, 1997, J NEUROSCI, V17, P1691; RAO A, 1991, J NEUROSCI, V11, P2881; Righi M, 2000, J NEUROSCI, V20, P3165, DOI 10.1523/JNEUROSCI.20-09-03165.2000; Roegiers F, 2000, TRENDS CELL BIOL, V10, P220, DOI 10.1016/S0962-8924(00)01767-0; Rook MS, 2000, J NEUROSCI, V20, P6385, DOI 10.1523/JNEUROSCI.20-17-06385.2000; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; Schuman EM, 1999, NEURON, V23, P645, DOI 10.1016/S0896-6273(01)80023-4; Severt WL, 1999, J CELL SCI, V112, P3691; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; STEWARD O, 1988, J NEUROSCI, V8, P176; Steward O, 1997, NEURON, V18, P9, DOI 10.1016/S0896-6273(01)80041-6; STJOHNSTON D, 1995, CELL, V81, P161, DOI 10.1016/0092-8674(95)90324-0; Tiedge H, 1999, SCIENCE, V283, P186, DOI 10.1126/science.283.5399.186; Tiedge H, 1996, J NEUROSCI, V16, P7171; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3	47	138	139	1	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11					1079	1084		10.1038/80591	http://dx.doi.org/10.1038/80591			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TX	11036263				2022-12-24	WOS:000167177600011
J	Xia, J; Chung, HJ; Wihler, C; Huganir, RL; Linden, DJ				Xia, J; Chung, HJ; Wihler, C; Huganir, RL; Linden, DJ			Cerebellar long-term depression requires PKC-regulated interactions between GluR2/3 and PDZ domain-containing proteins	NEURON			English	Article							AMPA RECEPTORS; PURKINJE-CELLS; KINASE-C; GLUTAMATE RECEPTORS; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL-NEURONS; LATE-PHASE; INDUCTION; EXPRESSION; MODULATION	Cerebellar LTD requires activation of PKC and is expressed, at least in part, as postsynaptic AMPA receptor internalization. Recently, it was shown that AMPA receptor internalization requires clathrin-mediated endocytosis and depends upon the carboxy-terminal region of GluR2/3. Phosphorylation of Ser-880 in this region by PKC differentially regulates the binding of the PDZ domain-containing proteins GRIP/ABP and PICK1. Peptides, corresponding to the phosphorylated and dephosphorylated GluR2 carboxy-terminal PDZ binding motif, were perfused in cerebellar Purkinje cells grown in culture. Both the dephospho form (which blocks binding of GRIP/ABP and PICK1) and the phospho form (which selectively blocks PICK1) attenuated LTD induction by glutamate/depolarization pairing, as did antibodies directed against the PDZ domain of PICK1. These findings indicate that expression of cerebellar LTD requires PKC-regulated interactions between the carboxy-terminal of GluR2/3 and PDZ domain-containing proteins.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Linden, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	dlinden@jhmi.edu	; Xia, Jun/C-7234-2009	Chung, Hee Jung/0000-0002-5555-9907; Xia, Jun/0000-0001-9308-2188	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051106, R37MH051106, R29MH051106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036715] Funding Source: NIH RePORTER; NIMH NIH HHS [MH01590, MH51106] Funding Source: Medline; NINDS NIH HHS [R01 NS036715, NS36715] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahn S, 1999, NEURON, V23, P559, DOI 10.1016/S0896-6273(00)80808-9; AJIMA A, 1995, NEUROREPORT, V6, P297, DOI 10.1097/00001756-199501000-00018; Bear MF, 2001, SYNAPSES, P455; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; Braithwaite SP, 2000, NEUROPHARMACOLOGY, V39, P919, DOI 10.1016/S0028-3908(99)00171-9; Burette A, 1999, J COMP NEUROL, V411, P601; Carroll RC, 1998, J NEUROPHYSIOL, V80, P2797, DOI 10.1152/jn.1998.80.5.2797; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chung HJ, 2000, J NEUROSCI, V20, P7258; CREPEL F, 1988, BRAIN RES, V458, P397, DOI 10.1016/0006-8993(88)90486-6; Daniel H, 1998, TRENDS NEUROSCI, V21, P401, DOI 10.1016/S0166-2236(98)01304-6; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Dev KK, 1999, NEUROPHARMACOLOGY, V38, P635, DOI 10.1016/S0028-3908(98)00230-5; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Dong HL, 1999, J NEUROSCI, V19, P6930, DOI 10.1523/JNEUROSCI.19-16-06930.1999; Freeman JH, 1998, NEUROREPORT, V9, P2237, DOI 10.1097/00001756-199807130-00016; Furuya S, 1998, BRAIN RES PROTOC, V3, P192, DOI 10.1016/S1385-299X(98)00040-3; Hansel C, 2000, NEURON, V26, P473, DOI 10.1016/S0896-6273(00)81179-4; HARTELL NA, 1994, NEUROREPORT, V5, P833, DOI 10.1097/00001756-199403000-00024; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; ITO M, 1990, SEMIN NEUROSCI, V2, P381; Kasahara J, 1998, NEUROSCI LETT, V247, P139, DOI 10.1016/S0304-3940(98)00299-7; Kim JH, 1999, CURR OPIN CELL BIOL, V11, P248, DOI 10.1016/S0955-0674(99)80033-7; Kullmann DM, 1999, NEURON, V24, P288, DOI 10.1016/S0896-6273(00)80841-7; Landsend AS, 1997, J NEUROSCI, V17, P834, DOI 10.1523/jneurosci.17-02-00834.1997; Li P, 1998, NATURE, V393, P695, DOI 10.1038/31496; Li P, 1999, NAT NEUROSCI, V2, P972, DOI 10.1038/14771; Linden D J, 1994, Learn Mem, V1, P121; LINDEN DJ, 1993, NEURON, V11, P1093, DOI 10.1016/0896-6273(93)90222-D; LINDEN DJ, 1995, J NEUROSCI, V15, P5098; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; Linden DJ, 1996, NEURON, V17, P483, DOI 10.1016/S0896-6273(00)80180-4; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; Matsuda S, 2000, EMBO J, V19, P2765, DOI 10.1093/emboj/19.12.2765; Mauk MD, 1997, NEURON, V18, P343, DOI 10.1016/S0896-6273(00)81235-0; Murashima M, 1999, J NEUROSCI, V19, P7326, DOI 10.1523/JNEUROSCI.19-17-07326.1999; Narasimhan K, 1998, J NEUROPHYSIOL, V80, P2963, DOI 10.1152/jn.1998.80.6.2963; Narasimhan K, 1996, NEURON, V17, P333, DOI 10.1016/S0896-6273(00)80164-6; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Otani S, 1998, J PHYSIOL-LONDON, V511, P761, DOI 10.1111/j.1469-7793.1998.761bg.x; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; STANTON PK, 1991, NEUROSCI LETT, V127, P61, DOI 10.1016/0304-3940(91)90895-Z; Turrigiano GG, 2000, NEURON, V26, P5, DOI 10.1016/S0896-6273(00)81131-9; WANG LY, 1994, J PHYSIOL-LONDON, V475, P431, DOI 10.1113/jphysiol.1994.sp020083; Wang Y, 1998, J PHYSIOL-LONDON, V513, P467, DOI 10.1111/j.1469-7793.1998.467bb.x; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Wyszynski M, 1998, NEUROPHARMACOLOGY, V37, P1335, DOI 10.1016/S0028-3908(98)00120-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; YANG XD, 1994, J NEUROPHYSIOL, V71, P1586, DOI 10.1152/jn.1994.71.4.1586; Zhao HM, 1998, J NEUROSCI, V18, P5517, DOI 10.1523/JNEUROSCI.18-14-05517.1998	63	304	315	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	2000	28	2					499	510		10.1016/S0896-6273(00)00128-8	http://dx.doi.org/10.1016/S0896-6273(00)00128-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	377CE	11144359	Bronze			2022-12-24	WOS:000165493700024
J	Bozdagi, O; Shan, W; Tanaka, H; Benson, DL; Huntley, GW				Bozdagi, O; Shan, W; Tanaka, H; Benson, DL; Huntley, GW			Increasing numbers of synaptic puncta during late-phase LTP: N-cadherin is synthesized, recruited to synaptic sites, and required for potentiation	NEURON			English	Article							LONG-TERM POTENTIATION; CELL-ADHESION MOLECULES; HIPPOCAMPAL CA1 REGION; POSTSYNAPTICALLY SILENT SYNAPSES; LOCAL PROTEIN-SYNTHESIS; EXCITATORY SYNAPSES; DENDRITIC SPINES; AMPA RECEPTORS; TRANSMITTER RELEASE; PRESYNAPTIC BOUTONS	It is an open question whether new synapses form during hippocampal LTP. Here, we show that late-phase LTP (L-LTP) is associated with a significant increase in numbers of synaptic puncta identified by synaptophysin and N-cadherin, an adhesion protein involved in synapse formation during development. During potentiation, protein levels of N-cadherin are significantly elevated and N-cadherin dimerization is enhanced. The increases in synaptic number and N-cadherin levels are dependent on cAMP-dependent protein kinase (PKA) and protein synthesis, both of which are also required for L-LTP. Blocking N-cadherin adhesion prevents the induction of L-LTP, but not the early-phase of LTP (E-LTP). Our data suggest that N-cadherin is synthesized during the induction of L-LTP and recruited to newly forming synapses. N-cadherin may play a critical role in L-LTP by hording nascent pre- and postsynaptic membranes in apposition, enabling incipient synapses to acquire function and contribute to potentiation.	Mt Sinai Sch Med, Fishberg Res Ctr Neurobiol, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Biochem & Mol Biol, Program Cell Adhes, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Huntley, GW (corresponding author), Mt Sinai Sch Med, Fishberg Res Ctr Neurobiol, 1425 Madison Ave, New York, NY 10029 USA.			Benson, Deanna/0000-0001-7037-1147; Huntley, George W./0000-0003-3645-6192	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034659, R01NS020147, R29NS034659, R01NS037731] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS037731-03, R01 NS037731-02, R01 NS037731, R01 NS037731-02S1, NS20147, R01 NS037731-04, R01 NS037731-01A1, NS37731, NS34659] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABEL T, 1997, CELL, V88, P614; Andersen P, 1998, BRAIN RES REV, V26, P353, DOI 10.1016/S0165-0173(97)00042-8; Arndt K, 1998, MOL CELL NEUROSCI, V10, P211, DOI 10.1006/mcne.1998.0665; Bahr BA, 1997, J NEUROSCI, V17, P1320; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Benson DL, 1998, J NEUROSCI, V18, P6892; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487; Buchs PA, 1996, P NATL ACAD SCI USA, V93, P8040, DOI 10.1073/pnas.93.15.8040; Calhoun ME, 1996, J NEUROCYTOL, V25, P821, DOI 10.1007/BF02284844; CAMPAGNE MV, 1991, J HISTOCHEM CYTOCHEM, V39, P1267, DOI 10.1177/39.9.1833448; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; CHANG FLF, 1984, BRAIN RES, V309, P35, DOI 10.1016/0006-8993(84)91008-4; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; CHAVEZNORIEGA LE, 1994, J NEUROSCI, V14, P310; CHEN KS, 1995, NEUROSCIENCE, V68, P19, DOI 10.1016/0306-4522(95)00099-5; Colman DR, 1997, MOL CELL NEUROSCI, V10, P1, DOI 10.1006/mcne.1997.0648; COVAULT J, 1991, MOL BRAIN RES, V11, P11, DOI 10.1016/0169-328X(91)90015-P; Craig AM, 1996, J NEUROSCI, V16, P3166; Einheber S, 1996, J COMP NEUROL, V370, P105; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Fields RD, 1996, TRENDS NEUROSCI, V19, P473, DOI 10.1016/S0166-2236(96)30013-1; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; GEIGER B, 1990, J CELL SCI, V97, P607; GEINISMAN Y, 1993, HIPPOCAMPUS, V3, P435, DOI 10.1002/hipo.450030405; Gomperts SN, 1998, NEURON, V21, P1443, DOI 10.1016/S0896-6273(00)80662-5; Halpain S, 1998, J NEUROSCI, V18, P9835; Huang YY, 1996, LEARN MEMORY, V3, P74, DOI 10.1101/lm.3.2-3.74; Huntley GW, 1999, J COMP NEUROL, V407, P453; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; JENSEN FE, 1989, J NEUROSCI METH, V29, P217, DOI 10.1016/0165-0270(89)90146-5; Kirov SA, 1999, NAT NEUROSCI, V2, P878, DOI 10.1038/13178; Kirov SA, 1999, J NEUROSCI, V19, P2876; KRUCKER T, 2000, IN PRESS P NATL ACAD; LIAO D, 1992, NEURON, V9, P1089, DOI 10.1016/0896-6273(92)90068-O; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; LINNEMANN D, 1994, INT J DEV NEUROSCI, V12, P441, DOI 10.1016/0736-5748(94)90028-0; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; Ma L, 1999, NAT NEUROSCI, V2, P24, DOI 10.1038/4525; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Manabe T, 2000, MOL CELL NEUROSCI, V15, P534, DOI 10.1006/mcne.2000.0849; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; NAVONE F, 1989, J CELL BIOL, V109, P3425, DOI 10.1083/jcb.109.6.3425; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; PERSOHN E, 1989, J COMP NEUROL, V288, P92, DOI 10.1002/cne.902880108; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; POKUTTA S, 1994, EUR J BIOCHEM, V223, P1019, DOI 10.1111/j.1432-1033.1994.tb19080.x; Qi M, 1996, P NATL ACAD SCI USA, V93, P1571, DOI 10.1073/pnas.93.4.1571; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; SEGAL M, 1995, NEUROSCI LETT, V193, P73, DOI 10.1016/0304-3940(95)11665-J; Shapiro L, 1999, NEURON, V23, P427, DOI 10.1016/S0896-6273(00)80796-5; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SHIRAYOSHI Y, 1986, EMBO J, V5, P2485, DOI 10.1002/j.1460-2075.1986.tb04525.x; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Sorra KE, 1998, J COMP NEUROL, V398, P225; Sorra KE, 1998, J NEUROSCI, V18, P658; Squire LR, 1997, PHILOS T R SOC B, V352, P1663, DOI 10.1098/rstb.1997.0148; STAUBLI U, 1990, BEHAV NEURAL BIOL, V53, P1, DOI 10.1016/0163-1047(90)90712-F; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; Woolley CS, 1996, J COMP NEUROL, V373, P108; YAMAGATA M, 1995, J NEUROSCI, V15, P4556; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; YOSHIDA C, 1982, CELL, V28, P217, DOI 10.1016/0092-8674(82)90339-7	85	312	316	2	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	2000	28	1					245	259		10.1016/S0896-6273(00)00100-8	http://dx.doi.org/10.1016/S0896-6273(00)00100-8			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	370VN	11086998	Bronze			2022-12-24	WOS:000165143500025
J	Damasio, AR; Grabowski, TJ; Bechara, A; Damasio, H; Ponto, LLB; Parvizi, J; Hichwa, RD				Damasio, AR; Grabowski, TJ; Bechara, A; Damasio, H; Ponto, LLB; Parvizi, J; Hichwa, RD			Subcortical and cortical brain activity during the feeling of self-generated emotions	NATURE NEUROSCIENCE			English	Article							HUMAN AMYGDALA; FUNCTIONAL NEUROANATOMY; PET; ACTIVATION; REGISTRATION; RECOGNITION; DEPRESSION; HAPPINESS; SADNESS; ANXIETY	In a series of [O-15]PET experiments aimed at investigating the neural basis of emotion and feeling, 41 normal subjects recalled and re-experienced personal life episodes marked by sadness, happiness, anger or fear. We tested the hypothesis that the process of feeling emotions requires the participation of brain regions, such as the somatosensory cortices and the upper brainstem nuclei, that are involved in the mapping and/or regulation of internal organism states. Such areas were indeed engaged, underscoring the close relationship between emotion and homeostasis. The findings also lend support to the idea that the subjective process of feeling emotions is partly grounded in dynamic neural maps, which represent several aspects of the organism's continuously changing internal state.	Univ Iowa, Coll Med, Dept Neurol, Div Cognit Nauroscu, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, PET Imaging Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Damasio, AR (corresponding author), Univ Iowa, Coll Med, Dept Neurol, Div Cognit Nauroscu, 200 Hawkins Dr, Iowa City, IA 52242 USA.	antonio-damasio@uiowa.edu	Damasio, Antonio/AAD-1342-2019; anand, amit/A-7222-2009	Ponto, Laura/0000-0003-1197-6714	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P50DC003189] Funding Source: NIH RePORTER; NIDCD NIH HHS [1 P50 DC 03189-01A1] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adolphs R, 1996, J NEUROSCI, V16, P7678; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; BANDLER R, 1994, TRENDS NEUROSCI, V17, P379, DOI 10.1016/0166-2236(94)90047-7; BEHBEHANI MM, 1995, PROG NEUROBIOL, V46, P575, DOI 10.1016/0301-0082(95)00009-K; Bejjani BP, 1999, NEW ENGL J MED, V340, P1476, DOI 10.1056/NEJM199905133401905; Bernard JF, 1998, J COMP NEUROL, V401, P429; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Damasio A.R., 1994, DESCARTES ERROR EMOT; Damasio A. R., 1999, FEELING WHAT HAPPENS; Damasio AR, 1997, NATURE, V386, P769, DOI 10.1038/386769a0; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; Dolan RJ, 1996, NEUROIMAGE, V4, P194, DOI 10.1006/nimg.1996.0070; Dolan RJ, 1998, BRAIN, V121, P545, DOI 10.1093/brain/121.4.545; Dougherty DD, 1999, BIOL PSYCHIAT, V46, P466, DOI 10.1016/S0006-3223(99)00063-3; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Frank RJ, 1997, NEUROIMAGE, V5, P13, DOI 10.1006/nimg.1996.0250; Friston KJ, 1996, HUM BRAIN MAPP, V4, P140, DOI 10.1002/(SICI)1097-0193(1996)4:2<140::AID-HBM5>3.0.CO;2-3; Gemar M C, 1996, Depression, V4, P81, DOI 10.1002/(SICI)1522-7162(1996)4:2<81::AID-DEPR8>3.0.CO;2-I; GEORGE MS, 1995, AM J PSYCHIAT, V152, P341; Grabowski TJ, 1996, HUM BRAIN MAPP, V4, P23, DOI 10.1002/(SICI)1097-0193(1996)4:1<23::AID-HBM2>3.0.CO;2-R; HICHWA RD, 1995, CHEMISTS' VIEWS OF IMAGING CENTERS, P401; Kimbrell TA, 1999, BIOL PSYCHIAT, V46, P454, DOI 10.1016/S0006-3223(99)00103-1; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; Lane RD, 1997, AM J PSYCHIAT, V154, P926; LeDoux J. E., 1996, EMOTIONAL BRAIN MYST; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Panksepp J, 1997, ANN NY ACAD SCI, V807, P78, DOI 10.1111/j.1749-6632.1997.tb51914.x; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; PARDO JV, 1993, AM J PSYCHIAT, V150, P713; Rauch SL, 1997, BIOL PSYCHIAT, V42, P446, DOI 10.1016/S0006-3223(97)00145-5; Reiman EM, 1997, AM J PSYCHIAT, V154, P918; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Whalen PJ, 1998, J NEUROSCI, V18, P411; Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; Woods RP, 1999, HUM BRAIN MAPP, V8, P73, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<73::AID-HBM1>3.0.CO;2-7; WORSLEY KJ, 1994, ADV APPL PROBAB, V26, P13, DOI 10.2307/1427576	39	1397	1429	1	184	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2000	3	10					1049	1056		10.1038/79871	http://dx.doi.org/10.1038/79871			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TW	11017179				2022-12-24	WOS:000167177500024
J	Kuner, T; Augustine, GJ				Kuner, T; Augustine, GJ			A genetically encoded ratiometric indicator for chloride: Capturing chloride transients in cultured hippocampal neurons	NEURON			English	Article							GREEN-FLUORESCENT PROTEIN; GAMMA-AMINOBUTYRIC-ACID; PH REGULATION; INTRACELLULAR CHLORIDE; PYRAMIDAL CELLS; VOLTAGE-CLAMP; CNS NEURONS; GABA; CL; RECEPTOR	We constructed a novel optical indicator for chloride ions by fusing the chloride-sensitive yellow fluorescent protein with the chloride-insensitive cyan fluorescent protein. The ratio of FRET-dependent emission of these fluorophores varied in proportion to the concentration of CI- and was used to measure intracellular chloride concentration ([CI-](i)) in cultured hippocampal neurons. [CI-](i) decreased during neuronal development, consistent with the shift from excitation to inhibition during maturation of GABAergic synapses. Focal activation of GABA(A) receptors caused large changes in [CI-](i) that could underlie use-dependent depression of GABA-dependent synaptic transmission. GABA-induced changes in somatic [CI-](i) spread into dendrites, suggesting that [CI-](i) can signal the location of synaptic activity. This genetically encoded indicator will permit new approaches ranging from high-throughput drug screening to direct recordings of synaptic CI- signals in vivo.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Augustine, GJ (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	georgea@neuro.duke.edu	Augustine, George James/J-9228-2013; Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051	NINDS NIH HHS [NS-21624, NS-34045] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034045, R01NS021624] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKAIKE N, 1987, J PHYSIOL-LONDON, V391, P219, DOI 10.1113/jphysiol.1987.sp016735; ALGER BE, 1979, NATURE, V281, P315, DOI 10.1038/281315a0; Amos BJ, 1996, EXP PHYSIOL, V81, P261, DOI 10.1113/expphysiol.1996.sp003930; ASCHER P, 1976, J PHYSIOL-LONDON, V256, P441, DOI 10.1113/jphysiol.1976.sp011332; BALLANYI K, 1985, J PHYSIOL-LONDON, V365, P41, DOI 10.1113/jphysiol.1985.sp015758; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; BARKER JL, 1978, J PHYSIOL-LONDON, V280, P331, DOI 10.1113/jphysiol.1978.sp012387; Bekar LK, 1999, J NEUROPHYSIOL, V82, P248, DOI 10.1152/jn.1999.82.1.248; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; Bevensee MO, 1996, J PHYSIOL-LONDON, V494, P315, DOI 10.1113/jphysiol.1996.sp021494; BIWERSI J, 1991, BIOCHEMISTRY-US, V30, P7879, DOI 10.1021/bi00246a001; BIWERSI J, 1992, AM J PHYSIOL, V262, pC243, DOI 10.1152/ajpcell.1992.262.1.C243; BIWERSI J, 1994, ANAL BIOCHEM, V219, P139, DOI 10.1006/abio.1994.1242; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC844, DOI 10.1152/ajpcell.1988.255.6.C844; BRIGHT GR, 1989, METHOD CELL BIOL, V30, P157; BROWN TH, 1983, J NEUROPHYSIOL, V50, P487, DOI 10.1152/jn.1983.50.2.487; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; Dallwig R, 1999, PFLUG ARCH EUR J PHY, V437, P289, DOI 10.1007/s004240050782; ENGBLOM AC, 1991, BRAIN RES, V568, P55, DOI 10.1016/0006-8993(91)91378-E; Frech MJ, 1999, J NEUROBIOL, V40, P386, DOI 10.1002/(SICI)1097-4695(19990905)40:3<386::AID-NEU10>3.0.CO;2-D; HARA M, 1992, NEUROSCI LETT, V143, P135, DOI 10.1016/0304-3940(92)90250-B; HARRIS RA, 1985, SCIENCE, V228, P1108, DOI 10.1126/science.2581319; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; HOFFMANN EK, 1989, PHYSIOL REV, V69, P315, DOI 10.1152/physrev.1989.69.2.315; HOPPE D, 1989, NEUROSCI LETT, V97, P334, DOI 10.1016/0304-3940(89)90620-4; HUGUENARD JR, 1986, J NEUROPHYSIOL, V56, P1; ILLSLEY NP, 1987, BIOCHEMISTRY-US, V26, P1215, DOI 10.1021/bi00379a002; Inglefield JR, 1999, METHOD ENZYMOL, V307, P469; INOUE M, 1991, NEUROSCI LETT, V134, P75, DOI 10.1016/0304-3940(91)90512-R; Jayaraman S, 1999, AM J PHYSIOL-CELL PH, V276, pC747, DOI 10.1152/ajpcell.1999.276.3.C747; Jayaraman S, 2000, J BIOL CHEM, V275, P6047, DOI 10.1074/jbc.275.9.6047; KAILA K, 1994, PROG NEUROBIOL, V42, P489, DOI 10.1016/0301-0082(94)90049-3; KAILA K, 1992, J PHYSIOL-LONDON, V453, P627, DOI 10.1113/jphysiol.1992.sp019248; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kneen M, 1998, BIOPHYS J, V74, P1591, DOI 10.1016/S0006-3495(98)77870-1; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; MCCARREN M, 1985, J NEUROPHYSIOL, V53, P557, DOI 10.1152/jn.1985.53.2.557; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nakamura T, 1997, NEUROSCI LETT, V237, P5, DOI 10.1016/S0304-3940(97)00794-5; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; RINK TJ, 1982, J CELL BIOL, V95, P189, DOI 10.1083/jcb.95.1.189; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Romoser VA, 1997, J BIOL CHEM, V272, P13270, DOI 10.1074/jbc.272.20.13270; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SCHWARTZ RD, 1985, J NEUROSCI, V5, P2963; Schwartz RD, 1995, J NEUROSCI METH, V62, P185, DOI 10.1016/0165-0270(95)00075-5; SEGAL M, 1984, J NEUROPHYSIOL, V51, P500, DOI 10.1152/jn.1984.51.3.500; SHIANG R, 1993, NAT GENET, V5, P351, DOI 10.1038/ng1293-351; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; Staley KJ, 1999, J PHYSIOL-LONDON, V519, P693, DOI 10.1111/j.1469-7793.1999.0693n.x; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Teruel MN, 1999, J NEUROSCI METH, V93, P37, DOI 10.1016/S0165-0270(99)00112-0; Thomas RC, 1978, ION SENSITIVE INTRAC; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P501, DOI 10.1152/jn.1989.61.3.501; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; VERKMAN AS, 1989, ANAL BIOCHEM, V178, P355, DOI 10.1016/0003-2697(89)90652-0; Wachter RM, 1999, CURR BIOL, V9, pR628, DOI 10.1016/S0960-9822(99)80408-4; Wagner S, 1997, NATURE, V387, P598, DOI 10.1038/42468; WONG RKS, 1982, J NEUROPHYSIOL, V48, P938, DOI 10.1152/jn.1982.48.4.938	65	327	338	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	2000	27	3					447	459		10.1016/S0896-6273(00)00056-8	http://dx.doi.org/10.1016/S0896-6273(00)00056-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	359FR	11055428	Bronze			2022-12-24	WOS:000089601300009
J	Wong, ST; Trinh, K; Hacker, B; Chan, GCK; Lowe, G; Gaggar, A; Xia, ZG; Gold, GH; Storm, DR				Wong, ST; Trinh, K; Hacker, B; Chan, GCK; Lowe, G; Gaggar, A; Xia, ZG; Gold, GH; Storm, DR			Disruption of the type III adenylyl cyclase gene leads to peripheral and behavioral anosmia in transgenic mice	NEURON			English	Article							OLFACTORY RECEPTOR-CELLS; 2ND MESSENGER PATHWAYS; BETA-GAMMA-SUBUNITS; IN-VIVO; SIGNAL-TRANSDUCTION; GERM-CELLS; KINASE-II; PROTEIN; ODORANT; INHIBITION	Cyclic nucleotide-gated ion channels in olfactory sensory neurons (OSNs) are hypothesized to play a critical role in olfaction. However, it has not been demonstrated that the cAMP signaling is required for olfactory-based behavioral responses, and the contributions of specific adenylyl cyclases to olfaction have not been defined. Here, we report the presence of adenylyl cyclases 2, 3, and 4 in olfactory cilia. To evaluate the role of AC3 in olfactory responses, we disrupted the gene for AC3 in mice. Interestingly, electroolfactogram (EOG) responses stimulated by either cAMP- or inositol 1,4,5-triphosphate- (IP3-) inducing odorants were completely ablated in AC3 mutants, despite the presence of AC2 and AC4 in olfactory cilia. Furthermore, AC3 mutants failed several olfaction-based behavioral tests, indicating that AC3 and cAMP signaling are critical for olfactory-dependent behavior.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Dept Environm Hlth & Toxicol, Seattle, WA 98195 USA; Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Monell Chemical Senses Center	Storm, DR (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	dstorm@u.washington.edu			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004156] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC04156] Funding Source: Medline; NINDS NIH HHS [NS357056] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANHOLT RRH, 1994, TRENDS NEUROSCI, V17, P37, DOI 10.1016/0166-2236(94)90033-7; ANHOLT RRH, 1990, BIOCHEMISTRY-US, V29, P4049, DOI 10.1021/bi00469a004; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; Baker LP, 1999, J NEUROSCI, V19, P180, DOI 10.1523/JNEUROSCI.19-01-00180.1999; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Berghard A, 1996, P NATL ACAD SCI USA, V93, P2365, DOI 10.1073/pnas.93.6.2365; BOEHM N, 1990, PHYSIOL BEHAV, V48, P367, DOI 10.1016/0031-9384(90)90329-3; BOEKHOFF I, 1990, EMBO J, V9, P2453, DOI 10.1002/j.1460-2075.1990.tb07422.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREER H, 1991, CHEM SENSES, V16, P19, DOI 10.1093/chemse/16.1.19; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CHOI EJ, 1993, BIOCHEMISTRY-US, V32, P1891, DOI 10.1021/bi00059a001; CHU TC, 1988, AM J PHYSIOL, V255, pC724, DOI 10.1152/ajpcell.1988.255.6.C724; COOPER AJ, 1976, BIOL NEONATE, V29, P56, DOI 10.1159/000240848; CROOK RB, 1994, INVEST OPHTH VIS SCI, V35, P3374; Defer N, 1998, FEBS LETT, V424, P216, DOI 10.1016/S0014-5793(98)00178-1; Ecelbarger CA, 1999, AM J PHYSIOL-RENAL, V277, pF235, DOI 10.1152/ajprenal.1999.277.2.F235; Fabbri E, 1995, NEUROCHEM RES, V20, P1511, DOI 10.1007/BF00970601; FEINSTEIN PG, 1991, P NATL ACAD SCI USA, V88, P10173, DOI 10.1073/pnas.88.22.10173; FIRESTEIN S, 1989, SCIENCE, V244, P79, DOI 10.1126/science.2704991; FRINGS S, 1992, J GEN PHYSIOL, V100, P45, DOI 10.1085/jgp.100.1.45; FRINGS S, 1991, J GEN PHYSIOL, V97, P725, DOI 10.1085/jgp.97.4.725; Gautier-Courteille C, 1998, ENDOCRINOLOGY, V139, P2588, DOI 10.1210/en.139.5.2588; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARDING JW, 1978, BRAIN RES, V140, P271, DOI 10.1016/0006-8993(78)90460-2; HILL HD, 1988, ANAL BIOCHEM, V170, P203, DOI 10.1016/0003-2697(88)90109-1; Hogan B, 1994, MANIPULATING MOUSE E; HUQUE T, 1986, BIOCHEM BIOPH RES CO, V137, P36, DOI 10.1016/0006-291X(86)91172-1; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; LANCET D, 1986, ANNU REV NEUROSCI, V9, P329, DOI 10.1146/annurev.ne.09.030186.001553; Leinders-Zufall T, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-14-j0005.1999; LEVY NS, 1991, J STEROID BIOCHEM, V39, P633, DOI 10.1016/0960-0760(91)90262-4; LOWE G, 1991, J PHYSIOL-LONDON, V442, P147, DOI 10.1113/jphysiol.1991.sp018787; LOWE G, 1989, P NATL ACAD SCI USA, V86, P5641, DOI 10.1073/pnas.86.14.5641; LYNCH JW, 1989, BIOPHYS J, V55, P755, DOI 10.1016/S0006-3495(89)82874-7; MARGOLIS FL, 1985, TRENDS NEUROSCI, V8, P542, DOI 10.1016/0166-2236(85)90192-4; Nielsen MD, 1996, J BIOL CHEM, V271, P33308, DOI 10.1074/jbc.271.52.33308; OKANO M, 1974, J PHYSIOL-LONDON, V242, P353, DOI 10.1113/jphysiol.1974.sp010711; OTTOSON D, 1956, ACTA PHYSIOL SCAND, V35, P7; PACE U, 1985, NATURE, V316, P255, DOI 10.1038/316255a0; Parent A, 1998, J NEUROPHYSIOL, V79, P3295, DOI 10.1152/jn.1998.79.6.3295; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; PFEUFFER E, 1989, J BIOL CHEM, V264, P18803; Prasad BC, 1999, TRENDS GENET, V15, P150, DOI 10.1016/S0168-9525(99)01695-9; Schild D, 1998, PHYSIOL REV, V78, P429, DOI 10.1152/physrev.1998.78.2.429; SHIRLEY SG, 1986, BIOCHEM J, V240, P605, DOI 10.1042/bj2400605; SKLAR PB, 1986, J BIOL CHEM, V261, P5538; Smith DR, 1998, NEUROSCIENCE, V86, P135, DOI 10.1016/S0306-4522(97)00608-8; Sunahara RK, 1996, ANNU REV PHARMACOL, V36, P461, DOI 10.1146/annurev.pa.36.040196.002333; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; THOMMESEN G, 1977, ACTA PHYSIOL SCAND, V99, P270, DOI 10.1111/j.1748-1716.1977.tb10380.x; WANG MM, 1993, MOL CELL BIOL, V13, P5805, DOI 10.1128/MCB.13.9.5805; WAYMAN GA, 1994, J BIOL CHEM, V269, P25400; WAYMAN GA, 1995, J BIOL CHEM, V270, P21480, DOI 10.1074/jbc.270.37.21480; WEATHERLY LS, 1996, BRAIN RES, V716, P1; Wei J, 1998, NEURON, V21, P495, DOI 10.1016/S0896-6273(00)80561-9; Wei J, 1996, J BIOL CHEM, V271, P24231, DOI 10.1074/jbc.271.39.24231; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Xia ZG, 1997, CURR OPIN NEUROBIOL, V7, P391, DOI 10.1016/S0959-4388(97)80068-2; Zimmermann G, 1996, J BIOL CHEM, V271, P27161, DOI 10.1074/jbc.271.43.27161; ZUFALL F, 1991, P ROY SOC B-BIOL SCI, V246, P225, DOI 10.1098/rspb.1991.0148; ZUFALL F, 1994, ANNU REV BIOPH BIOM, V23, P577, DOI 10.1146/annurev.bb.23.060194.003045	66	334	356	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	2000	27	3					487	497		10.1016/S0896-6273(00)00060-X	http://dx.doi.org/10.1016/S0896-6273(00)00060-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	359FR	11055432	Bronze			2022-12-24	WOS:000089601300013
J	Dantzker, JL; Callaway, EM				Dantzker, JL; Callaway, EM			Laminar sources of synaptic input to cortical inhibitory interneurons and pyramidal neurons	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; RAT FRONTAL-CORTEX; DUAL INTRACELLULAR-RECORDINGS; SPINY STELLATE NEURONS; GABAERGIC INTERNEURONS; AXONAL PROJECTIONS; LOCAL CIRCUITS; MACAQUE MONKEY; STRIATE CORTEX; BASKET CELLS	The functional role of an individual neuron within a cortical circuit is largely determined by that neuron's synaptic input. We examined the laminar sources of local input to subtypes of cortical neurons in layer 2/3 of rat visual cortex using laser scanning photostimulation. We identified three distinct laminar patterns of excitatory input that correspond to physiological and morphological subtypes of neurons. Fast-spiking inhibitory basket cells and excitatory pyramidal neurons received strong excitatory input from middle cortical layers. In contrast, adapting inhibitory interneurons received their strongest excitatory input either from deep layers or laterally from within layer 2/3. Thus, differential laminar sources of excitatory inputs contribute to the functional diversity of cortical inhibitory interneurons.	Salk Inst Biol Studies, Syst Neurobiol Labs, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego	Dantzker, JL (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dantzker@salk.edu	Callaway, Edward/D-4336-2011	Callaway, Edward/0000-0002-6366-5267				Ahmed B, 1997, J COMP NEUROL, V380, P230; ANDERSON JC, 1994, J COMP NEUROL, V341, P25, DOI 10.1002/cne.903410104; Braitenberg V, 1991, ANATOMY CORTEX; BURKHALTER A, 1989, J COMP NEUROL, V279, P171, DOI 10.1002/cne.902790202; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Cauli B, 1997, J NEUROSCI, V17, P3894; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; DeFelipe J, 1999, J COMP NEUROL, V412, P515, DOI 10.1002/(SICI)1096-9861(19990927)412:3<515::AID-CNE10>3.0.CO;2-1; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FREUND TF, 1986, NEUROSCIENCE, V19, P1133, DOI 10.1016/0306-4522(86)90129-6; FREUND TF, 1991, J COMP NEUROL, V314, P187, DOI 10.1002/cne.903140117; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Gonchar Y, 1999, CEREB CORTEX, V9, P683, DOI 10.1093/cercor/9.7.683; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; HORNUNG JP, 1992, J COMP NEUROL, V320, P457, DOI 10.1002/cne.903200404; JONES EG, 1984, CEREB CORTEX, V1, P309, DOI DOI 10.1007/978-1-4615-6610-6; KATZ LC, 1994, J NEUROSCI METH, V54, P205, DOI 10.1016/0165-0270(94)90194-5; KAWABATA TT, 1995, FUND APPL TOXICOL, V26, P8, DOI 10.1006/faat.1995.1070; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kawaguchi Y, 1998, NEUROSCIENCE, V85, P677, DOI 10.1016/S0306-4522(97)00685-4; KAWAGUCHI Y, 1993, J NEUROPHYSIOL, V69, P416, DOI 10.1152/jn.1993.69.2.416; KIM HG, 1995, J NEUROPHYSIOL, V74, P1810, DOI 10.1152/jn.1995.74.4.1810; KISVARDAY ZF, 1985, J COMP NEUROL, V241, P111, DOI 10.1002/cne.902410202; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Meskenaite V, 1997, J COMP NEUROL, V379, P113; PARNAVELAS JG, 1992, PROG BRAIN RES, V90, P523; Parra P, 1998, NEURON, V20, P983, DOI 10.1016/S0896-6273(00)80479-1; PETERS A, 1981, J COMP NEUROL, V203, P685, DOI 10.1002/cne.902030408; Reyes A, 1999, J NEUROSCI, V19, P3827; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Rockland KS, 1998, CURR OPIN NEUROBIOL, V8, P545, DOI 10.1016/S0959-4388(98)80044-5; SOMOGYI P, 1977, BRAIN RES, V136, P345, DOI 10.1016/0006-8993(77)90808-3; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; SOMOGYI P, 1983, NEUROSCIENCE, V10, P261, DOI 10.1016/0306-4522(83)90133-1; Staiger JF, 1996, EUR J NEUROSCI, V8, P2273, DOI 10.1111/j.1460-9568.1996.tb01191.x; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Tamas G, 1998, J NEUROSCI, V18, P4255; Tarczy-Hornoch K, 1999, CEREB CORTEX, V9, P833, DOI 10.1093/cercor/9.8.833; Thomson AM, 1998, NEUROSCIENCE, V84, P669, DOI 10.1016/S0306-4522(97)00557-5; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; Zhang ZW, 1997, J NEUROSCI, V17, P6365	46	245	247	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2000	3	7					701	707		10.1038/76656	http://dx.doi.org/10.1038/76656			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TT	10862703				2022-12-24	WOS:000167177200017
J	DeZazzo, J; Sandstrom, D; de Belle, S; Velinzon, K; Smith, P; Grady, L; DelVecchio, M; Ramaswami, M; Tully, T				DeZazzo, J; Sandstrom, D; de Belle, S; Velinzon, K; Smith, P; Grady, L; DelVecchio, M; Ramaswami, M; Tully, T			nalyot, a mutation of the Drosophila Myb-related Adf1 transcription factor, disrupts synapse formation and olfactory memory	NEURON			English	Article							LONG-TERM FACILITATION; MUSHROOM BODIES; GENETIC DISSECTION; MELANOGASTER; EXPRESSION; ENCODES; LATHEO; MUTANT; CREB; IDENTIFICATION	nalyot (nal) is a novel olfactory memory mutant of Drosophila, encoding Adf1, a myb-related transcription factor. Following extended training sessions, Adf1 mutants show normal early memory but defective longterm memory. Adf1 shows widespread spatiotemporal expression, yet mutant alleles reveal no discernible disruptions in gross morphology of the nervous system. Studies at the larval neuromuscular junction, however, reveal a role for Adf1 in the modulation of synaptic growth-in contrast to the role established for dCREB2 in the control of synaptic function (Davis et at., 1996). These findings suggest that Adf1 and dCREB2 regulate distinct transcriptional cascades involved in terminal stages of synapse maturation. More generally, Adf1 provides a novel link between molecular mechanisms of developmental and behavioral plasticity.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Arizona, Arizona Res Labs, Div Neurobiol, Tucson, AZ 85721 USA; Univ Nevada, Dept Biol Sci, Las Vegas, NV 89154 USA	Cold Spring Harbor Laboratory; University of Arizona; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Tully, T (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	tully@cshl.org		Sandstrom, David/0000-0001-6235-7118; Ramaswami, Mani/0000-0001-7631-0468	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034889, K02NS002001, R01NS032480] Funding Source: NIH RePORTER; NINDS NIH HHS [NS34889, KO2-NS02001, NS32480] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; BALLING A, 1987, J NEUROGENET, V4, P65, DOI 10.3109/01677068709102334; Barth M, 1997, LEARN MEMORY, V4, P219, DOI 10.1101/lm.4.2.219; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; BOLWIG GM, 1995, NEURON, V15, P829, DOI 10.1016/0896-6273(95)90174-4; BOYNTON S, 1992, GENETICS, V131, P655; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROADIE K, 1993, NEURON, V11, P607, DOI 10.1016/0896-6273(93)90073-Z; Clark KA, 1996, DEVELOPMENT, V122, P937; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Cutler G, 1998, MOL CELL BIOL, V18, P2252, DOI 10.1128/MCB.18.4.2252; DASH PK, 1991, P NATL ACAD SCI USA, V88, P5061, DOI 10.1073/pnas.88.11.5061; Davis GW, 1996, NEURON, V17, P669, DOI 10.1016/S0896-6273(00)80199-3; deBelle JS, 1996, P NATL ACAD SCI USA, V93, P9875, DOI 10.1073/pnas.93.18.9875; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; DeZazzo J, 1999, J NEUROSCI, V19, P8740, DOI 10.1523/JNEUROSCI.19-20-08740.1999; DEZAZZO J, 1995, TRENDS NEUROSCI, V18, P212, DOI 10.1016/0166-2236(95)93905-D; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; DURA JM, 1993, J NEUROGENET, V9, P1, DOI 10.3109/01677069309167272; ENGLAND BP, 1992, P NATL ACAD SCI USA, V89, P683, DOI 10.1073/pnas.89.2.683; ENGLAND BP, 1990, J BIOL CHEM, V265, P5086; Estes PS, 1996, J NEUROSCI, V16, P5443; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Gramates LS, 1999, INT REV NEUROBIOL, V43, P93, DOI 10.1016/S0074-7742(08)60542-5; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; HANNAN F, 1998, INT REV NEUROBIOL, P119; HEBERLEIN U, 1985, CELL, V41, P965, DOI 10.1016/S0092-8674(85)80077-5; HEISENBERG M, 1995, J NEUROSCI, V15, P1951, DOI 10.1523/JNEUROSCI.15-03-01951.1995; HIDALGO A, 1995, DEVELOPMENT, V121, P3703; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Pinto S, 1999, NEURON, V23, P45, DOI 10.1016/S0896-6273(00)80752-7; Rohrbough J, 1999, NEURON, V23, P55, DOI 10.1016/S0896-6273(00)80753-9; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; SAITOE M, 2000, IN PRESS THEORY NEUR; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SHATZ CJ, 1990, COLD SPRING HARB SYM, V55, P469; Simon AF, 1998, MECH DEVELOP, V76, P45, DOI 10.1016/S0925-4773(98)00104-X; Sokal RR, 1997, BIOMETRY; Stimson DT, 1998, J NEUROSCI, V18, P9638; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	48	62	64	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	2000	27	1					145	158		10.1016/S0896-6273(00)00016-7	http://dx.doi.org/10.1016/S0896-6273(00)00016-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339XU	10939338	Bronze			2022-12-24	WOS:000088503800017
J	Yu, C; Levi, DM				Yu, C; Levi, DM			Surround modulation in human vision unmasked by masking experiments	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; SPATIAL INTERACTIONS; APPARENT CONTRAST; PATTERN-VISION; FACILITATION; MECHANISMS; SUPPRESSION; FREQUENCY; RESPONSES; STIMULI	The responses of neurons in cat and monkey primary visual cortex are modulated by stimuli outside the classical receptive field. Here we report psychophysical evidence from masking experiments for two distinct types of surround modulation, one narrowly tuned to iso-orientation (stimuli with center and surround at the same orientation) and the other broadly tuned to cross-orientation (center and surround at perpendicular orientations). Surround modulation at iso- and cross-orientations showed distinct contrast dependencies, and high-contrast cross-oriented surrounds were able to completely eliminate masking. Surround modulation was modeled by subtracting divisive inhibition that raised the gain of spatial filters.	Univ Houston, Coll Optometry, Houston, TX 77204 USA	University of Houston System; University of Houston	Yu, C (corresponding author), Univ Houston, Coll Optometry, Houston, TX 77204 USA.		Levi, Dennis/J-7836-2019	Levi, Dennis/0000-0002-5350-8639	NEI NIH HHS [R01EY01728, P30EY07551] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY001728, P30EY007551] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adini Y, 1997, P NATL ACAD SCI USA, V94, P10426, DOI 10.1073/pnas.94.19.10426; CANNON MW, 1991, VISION RES, V31, P1985, DOI 10.1016/0042-6989(91)90193-9; Das A, 1999, NATURE, V399, P655, DOI 10.1038/21371; Ellemberg D, 1998, J OPT SOC AM A, V15, P1733, DOI 10.1364/JOSAA.15.001733; FOLEY JM, 1994, J OPT SOC AM A, V11, P1710, DOI 10.1364/JOSAA.11.001710; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; LEGGE GE, 1980, J OPT SOC AM, V70, P1458, DOI 10.1364/JOSA.70.001458; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; Olzak LA, 1999, VISION RES, V39, P231, DOI 10.1016/S0042-6989(98)00122-9; POLAT U, 1993, VISION RES, V33, P993, DOI 10.1016/0042-6989(93)90081-7; POLAT U, 1994, VISION RES, V34, P73, DOI 10.1016/0042-6989(94)90258-5; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; Sengpiel F, 1997, EXP BRAIN RES, V116, P216, DOI 10.1007/PL00005751; SILLITO AM, 1995, NATURE, V378, P492, DOI 10.1038/378492a0; Solomon JA, 2000, VISION RES, V40, P279, DOI 10.1016/S0275-5408(99)00059-9; Toth LJ, 1996, P NATL ACAD SCI USA, V93, P9869, DOI 10.1073/pnas.93.18.9869; TREISMAN A, 1985, COMPUT VISION GRAPH, V31, P156, DOI 10.1016/S0734-189X(85)80004-9; WILSON HR, 1984, J OPT SOC AM A, V1, P124, DOI 10.1364/JOSAA.1.000124; Yu C, 1997, J OPT SOC AM A, V14, P2346, DOI 10.1364/JOSAA.14.002346	20	50	50	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2000	3	7					724	728		10.1038/76687	http://dx.doi.org/10.1038/76687			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TT	10862706				2022-12-24	WOS:000167177200020
J	Xu, XZS; Chien, F; Butler, A; Salkoff, L; Montell, C				Xu, XZS; Chien, F; Butler, A; Salkoff, L; Montell, C			TRP gamma, a Drosophila TRP-related subunit, forms a regulated cation channel with TRPL	NEURON			English	Article							CAPACITATIVE CA2+ ENTRY; INTEGRAL MEMBRANE-PROTEIN; LIGHT-SENSITIVE CHANNELS; STORE-OPERATED CHANNEL; SF9 INSECT CELLS; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; HUMAN HOMOLOG; IN-VIVO; RECEPTOR	TRP and TRPL are two light-sensitive cation channel subunits required for the Drosophila photoresponse; however, our understanding of the identities, subunit composition, and function of the light-responsive channels is incomplete. To explain the residual photoresponse that remains in the trp mutant, a third TRP-related subunit has previously been proposed to function with TRPL. Here, we identify such a subunit, TRP gamma. We show that TRP gamma is highly enriched in photoreceptor cells and preferentially heteromultimerizes with TRPL in vitro and in vivo. The N-terminal domain of TRP gamma dominantly suppressed the TRPL-dependent photoresponse, indicating that TRP gamma-TRPL heteromultimers contribute to the photoresponse. While TRPL and TRP gamma homomultimers are constitutively active, we demonstrate that TRPL-TRP gamma heteromultimers form a regulated phospholipase C- (PLC-) stimulated channel.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Washington Univ, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Johns Hopkins University; Johns Hopkins University; Washington University (WUSTL)	Montell, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.		Montell, Craig/AAH-3357-2021	Montell, Craig/0000-0001-5637-1482	NEI NIH HHS [EY10852] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010852] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; Boulay G, 1997, J BIOL CHEM, V272, P29672, DOI 10.1074/jbc.272.47.29672; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chang AS, 1997, FEBS LETT, V415, P335, DOI 10.1016/S0014-5793(97)01155-1; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; DONG YJ, 1995, AM J PHYSIOL-CELL PH, V269, pC1332, DOI 10.1152/ajpcell.1995.269.5.C1332; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Funayama M, 1996, MOL BRAIN RES, V43, P259, DOI 10.1016/S0169-328X(96)00208-2; Garcia RL, 1997, BIOCHEM BIOPH RES CO, V239, P279, DOI 10.1006/bbrc.1997.7458; Gillo B, 1996, P NATL ACAD SCI USA, V93, P14146, DOI 10.1073/pnas.93.24.14146; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; HARTENECK C, 1995, FEBS LETT, V358, P297, DOI 10.1016/0014-5793(94)01455-A; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; HOTTA Y, 1970, P NATL ACAD SCI USA, V67, P1156, DOI 10.1073/pnas.67.3.1156; HU YF, 1995, BIOCHEM J, V305, P605, DOI 10.1042/bj3050605; HU YF, 1994, BIOCHEM BIOPH RES CO, V201, P1050, DOI 10.1006/bbrc.1994.1808; Hurst RS, 1998, FEBS LETT, V422, P333, DOI 10.1016/S0014-5793(98)00035-0; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Liu DT, 1996, NEURON, V16, P983, DOI 10.1016/S0896-6273(00)80121-X; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; MONTELL C, 1988, CELL, V52, P757, DOI 10.1016/0092-8674(88)90413-8; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Okada T, 1998, J BIOL CHEM, V273, P10279, DOI 10.1074/jbc.273.17.10279; Okada T, 1999, J BIOL CHEM, V274, P27359, DOI 10.1074/jbc.274.39.27359; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; PETERSEN CCH, 1995, BIOCHEM J, V311, P41, DOI 10.1042/bj3110041; Philipp S, 1996, EMBO J, V15, P6166, DOI 10.1002/j.1460-2075.1996.tb01004.x; Philipp S, 1998, EMBO J, V17, P4274, DOI 10.1093/emboj/17.15.4274; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; PORTER JA, 1992, J CELL BIOL, V116, P683, DOI 10.1083/jcb.116.3.683; Putney JW, 1999, BIOESSAYS, V21, P38; Reuss H, 1997, NEURON, V19, P1249, DOI 10.1016/S0896-6273(00)80416-X; Scott K, 1997, CELL, V91, P375, DOI 10.1016/S0092-8674(00)80421-3; STEELE F, 1990, NEURON, V4, P883, DOI 10.1016/0896-6273(90)90141-2; VACA L, 1994, AM J PHYSIOL-CELL PH, V267, pC1501, DOI 10.1152/ajpcell.1994.267.5.C1501; Vannier B, 1999, P NATL ACAD SCI USA, V96, P2060, DOI 10.1073/pnas.96.5.2060; Wes PD, 1999, NAT NEUROSCI, V2, P447, DOI 10.1038/8116; WES PD, 1995, P NATL ACAD SCI USA, V92, P9652, DOI 10.1073/pnas.92.21.9652; Xu XZS, 1997, CELL, V89, P1155, DOI 10.1016/S0092-8674(00)80302-5; Xu XZS, 1998, J CELL BIOL, V142, P545, DOI 10.1083/jcb.142.2.545; Yang J, 1995, NEURON, V15, P1441, DOI 10.1016/0896-6273(95)90021-7; Zhu X, 1998, NEWS PHYSIOL SCI, V13, P211; ZHU X, 1995, FEBS LETT, V373, P193, DOI 10.1016/0014-5793(95)01038-G; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7; Zitt C, 1997, J CELL BIOL, V138, P1333, DOI 10.1083/jcb.138.6.1333	54	127	136	1	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	2000	26	3					647	657		10.1016/S0896-6273(00)81201-5	http://dx.doi.org/10.1016/S0896-6273(00)81201-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330ZH	10896160	Bronze			2022-12-24	WOS:000087991600015
J	Cowan, CA; Yokoyama, N; Bianchi, LM; Henkemeyer, M; Fritzsch, B				Cowan, CA; Yokoyama, N; Bianchi, LM; Henkemeyer, M; Fritzsch, B			EphB2 guides axons at the midline and is necessary for normal vestibular function	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; INNER-EAR; TRANSMEMBRANE LIGANDS; MOLECULAR-BIOLOGY; COMMISSURAL AXONS; EPHRINB LIGANDS; BINDING-PROTEIN; PLASMA-MEMBRANE; EGF RECEPTOR; DARK CELLS	Mice lacking the EphB2 receptor tyrosine kinase display a cell-autonomous, strain-specific circling behavior that is associated with vestibular phenotypes. In mutant embryos, the contralateral inner ear efferent growth cones exhibit inappropriate pathway selection at the midline, while in mutant adults, the endolymph-filled lumen of the semicircular canals is severely reduced. EphB2 is expressed in the endolymph-producing dark cells in the inner ear epithelium, and these cells show ultrastructural defects in the mutants. A molecular link to fluid regulation is provided by demonstrating that PDZ domain-containing proteins that bind the C termini of EphB2 and B-ephrins can also recognize the cytoplasmic tails of anion exchangers and aquaporins. This suggests EphB2 may regulate ionic homeostasis and endolymph fluid production through macromolecular associations with membrane channels that transport chloride, bicarbonate, and water.	Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Kent Waldrep Fdn, Ctr Basic Neurosci Res, Dallas, TX 75235 USA; Oberlin Coll, Neurosci Program, Oberlin, OH 44074 USA; Creighton Univ, Dept Biomed Sci, Omaha, NE 68178 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Oberlin College; Creighton University	Henkemeyer, M (corresponding author), Univ Texas, SW Med Ctr, Ctr Dev Biol, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.	henk@utsw.swmed.edu		Bianchi, Lynne/0000-0002-5064-6972; Henkemeyer, Mark/0000-0002-7525-1061; Fritzsch, Bernd/0000-0002-4882-8398	NIDCD NIH HHS [2P01 DC00215-14A1, DC03121] Funding Source: Medline; NINDS NIH HHS [NS36671] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC003121, P01DC000215] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; [Anonymous], 1997, Cell, V90, P403; BEITZ E, 1999, HEARING RES, V99, P76; Bergemann AD, 1998, ONCOGENE, V16, P471, DOI 10.1038/sj.onc.1201557; Bianchi LM, 1998, HEARING RES, V117, P161, DOI 10.1016/S0378-5955(98)00010-0; Bianchi LM, 1999, ANAT REC, V254, P127; Birgbauer E, 2000, DEVELOPMENT, V127, P1231; Borgnia M, 1999, ANNU REV BIOCHEM, V68, P425, DOI 10.1146/annurev.biochem.68.1.425; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; Casey JR, 1998, BIOCHEM CELL BIOL, V76, P709, DOI 10.1139/bcb-76-5-709; Daniel TO, 1996, KIDNEY INT, V50, pS73; Deen PMT, 1998, CURR OPIN CELL BIOL, V10, P435, DOI 10.1016/S0955-0674(98)80055-0; DENKER BM, 1988, J BIOL CHEM, V263, P15634; DEOL MS, 1966, GENET RES, V7, P363, DOI 10.1017/S0016672300009812; DIETRICH W, 1992, GENETICS, V131, P423; Ferrary E, 1998, KIDNEY INT, pS98; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Frisen J, 1999, EMBO J, V18, P5159, DOI 10.1093/emboj/18.19.5159; FRITZSCH B, 1993, HEARING RES, V65, P51, DOI 10.1016/0378-5955(93)90200-K; Fritzsch B, 1996, ANN NY ACAD SCI, V781, P21, DOI 10.1111/j.1749-6632.1996.tb15690.x; Fritzsch B., 1995, AUDIT NEUROSCI, V1, P401; Gale NW, 1996, ONCOGENE, V13, P1343; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; HENKEMEYER M, 1994, ONCOGENE, V9, P1001; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; HIGHSTEIN SM, 1991, NEUROSCI RES, V12, P13, DOI 10.1016/0168-0102(91)90096-H; Hock B, 1998, P NATL ACAD SCI USA, V95, P9779, DOI 10.1073/pnas.95.17.9779; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Jons T, 1998, EUR J CELL BIOL, V75, P232; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kim J, 1999, AM J PHYSIOL-RENAL, V276, pF498, DOI 10.1152/ajprenal.1999.276.4.F498; Kumagami H, 1998, PFLUG ARCH EUR J PHY, V436, P970, DOI 10.1007/s004240050731; Kury P, 2000, MOL CELL NEUROSCI, V15, P123, DOI 10.1006/mcne.1999.0812; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; Lin JJ, 1996, MOL CELL DIFFER, V4, P317; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P7275, DOI 10.1073/pnas.90.15.7275; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; Orlowski J, 1997, J BIOL CHEM, V272, P22373, DOI 10.1074/jbc.272.36.22373; Penniston JT, 1998, J MEMBRANE BIOL, V165, P101, DOI 10.1007/s002329900424; RinkwitzBrandt S, 1996, HEARING RES, V99, P129, DOI 10.1016/S0378-5955(96)00093-7; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; SIMON H, 1993, NEURON, V11, P209, DOI 10.1016/0896-6273(93)90179-U; Stankovic KM, 1997, HEARING RES, V114, P21, DOI 10.1016/S0378-5955(97)00072-5; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; Takahashi T, 1998, KIDNEY INT, V53, P826, DOI 10.1046/j.1523-1755.1998.00822.x; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; VarelaEchavarria A, 1997, GENE DEV, V11, P545, DOI 10.1101/gad.11.5.545; Vetter DE, 1996, NEURON, V17, P1251, DOI 10.1016/S0896-6273(00)80255-X; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wangemann P, 1996, HEARING RES, V100, P201, DOI 10.1016/0378-5955(96)00127-X; WANGEMANN P, 1995, HEARING RES, V90, P149, DOI 10.1016/0378-5955(95)00157-2	56	176	181	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	2000	26	2					417	430		10.1016/S0896-6273(00)81174-5	http://dx.doi.org/10.1016/S0896-6273(00)81174-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318QZ	10839360	Bronze			2022-12-24	WOS:000087296500018
J	Knierim, JJ; McNaughton, BL; Poe, GR				Knierim, JJ; McNaughton, BL; Poe, GR			Three-dimensional spatial selectivity of hippocampal neurons during space flight	NATURE NEUROSCIENCE			English	Article							HEAD-DIRECTION CELLS; FREELY-MOVING RATS		Univ Arizona, Arizona Res Labs, Div Neural Syst Memory & Aging, Tucson, AZ 85724 USA; Univ Texas, Sch Med, Dept Neurobiol & Anat, Houston, TX 77225 USA; Univ Texas, Sch Med, WM Keck Ctr Neurobiol Learning & Memory, Houston, TX 77225 USA	University of Arizona; University of Texas System; University of Texas System	McNaughton, BL (corresponding author), Univ Arizona, Arizona Res Labs, Div Neural Syst Memory & Aging, 384 Life Sci N Bldg, Tucson, AZ 85724 USA.			Poe, Gina/0000-0003-3388-2858	NINDS NIH HHS [NS20331, NS33471] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS020331, U01NS033471, R01NS020331] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], 1999, COGNITIVE MAP; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Goodridge JP, 1998, BEHAV NEUROSCI, V112, P749, DOI 10.1037/0735-7044.112.4.749; Gothard KM, 1996, J NEUROSCI, V16, P823; Jeffery KJ, 1999, EXP BRAIN RES, V127, P151, DOI 10.1007/s002210050785; KNIERIM JJ, 1995, J NEUROSCI, V15, P1648, DOI 10.1523/JNEUROSCI.15-03-01648.1995; McNaughton BL, 1996, J EXP BIOL, V199, P173; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; MULLER RU, 1987, J NEUROSCI, V7, P1951; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OMAN CM, 1988, P S VEST ORG ALT FOR, P25; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Taube JS, 1998, PROG NEUROBIOL, V55, P225, DOI 10.1016/S0301-0082(98)00004-5; TAUBE JS, 1990, J NEUROSCI, V10, P420; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520	15	61	63	1	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2000	3	3					209	210		10.1038/72910	http://dx.doi.org/10.1038/72910			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TE	10700250				2022-12-24	WOS:000085810500007
J	Treue, S; Hol, K; Rauber, HJ				Treue, S; Hol, K; Rauber, HJ			Seeing multiple directions of motion - physiology and psychophysics	NATURE NEUROSCIENCE			English	Article							VECTORIAL TRANSPARENT MOTION; VISUAL AREA MT; GLOBAL DIRECTION; MACAQUE MONKEY; CORTICAL AREA; MST NEURONS; PERCEPTION; MODEL; RESPONSES; STIMULI	Dot patterns sliding transparently across one another are normally perceived as independently moving surfaces. Recordings from direction-selective neurons in area MT of the macaque suggested that this perceptual segregation did not depend on the presence of two peaks in the population activity. Rather, the visual system seemed to use overall shape of the population response to determine the number and directions of motion components. This approach explained a number of perceptual phenomena, including susceptibility of the motion system to direction metamers, motion patterns combining three or five directions incorrectly perceived by subjects as comprising only two directions. Our findings offer insights into the coding of multi-valued sensory signals and provide constraints for biologically based computational models.	Univ Tubingen, Dept Neurol, Cognit Neurosci Lab, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Treue, S (corresponding author), Univ Tubingen, Dept Neurol, Cognit Neurosci Lab, Morgenstelle 15, D-72076 Tubingen, Germany.	treue@uni-tuebingen.de						ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; Braddick O, 1997, PERCEPTION, V26, P995, DOI 10.1068/p260995; BRADLEY DC, 1995, NATURE, V373, P609, DOI 10.1038/373609a0; Britten KH, 1998, J NEUROPHYSIOL, V80, P762, DOI 10.1152/jn.1998.80.2.762; Croner LJ, 1997, VISION RES, V37, P1415, DOI 10.1016/S0042-6989(96)00299-4; Croner LJ, 1999, J NEUROSCI, V19, P3935; DeAngelis GC, 1998, NATURE, V394, P677, DOI 10.1038/29299; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; GRAZIANO MSA, 1994, J NEUROSCI, V14, P54; Grunewald A, 1996, NATURE, V384, P358, DOI 10.1038/384358a0; JASINSCHI R, 1992, J OPT SOC AM A, V9, P1865, DOI 10.1364/JOSAA.9.001865; MARSHAK W, 1979, SCIENCE, V205, P1399, DOI 10.1126/science.472756; MATHER G, 1980, Q J EXP PSYCHOL, V32, P325, DOI 10.1080/14640748008401168; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1148, DOI 10.1152/jn.1983.49.5.1148; MILLIGAN JB, 1992, INVEST OPHTHALMOL S; PASTERNAK T, 1990, J NEUROSCI, V10, P3079; QIAN N, 1994, J NEUROSCI, V14, P7357; QIAN N, 1994, J NEUROSCI, V14, P7381; Rauber HJ, 1999, VISION RES, V39, P3187, DOI 10.1016/S0042-6989(99)00025-5; Recanzone GH, 1997, J NEUROPHYSIOL, V78, P2904, DOI 10.1152/jn.1997.78.6.2904; SAITO H, 1989, EXP BRAIN RES, V75, P1; SALZMAN CD, 1994, SCIENCE, V264, P231, DOI 10.1126/science.8146653; SCHOPPMANN A, 1976, NEUROSCI LETT, V2, P177, DOI 10.1016/0304-3940(76)90011-2; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; SNOWDEN RJ, 1992, EXP BRAIN RES, V88, P389, DOI 10.1007/BF02259114; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; van der Smagt MJ, 1999, NAT NEUROSCI, V2, P595, DOI 10.1038/10150; vanWezel RJA, 1996, VISION RES, V36, P2805, DOI 10.1016/0042-6989(95)00324-X; VERSTRATEN FAJ, 1994, VISION RES, V34, P349, DOI 10.1016/0042-6989(94)90093-0; Wang RY, 1997, J COMPUT NEUROSCI, V4, P287, DOI 10.1023/A:1008868232355; WATAMANIUK SNJ, 1993, J OPT SOC AM A, V10, P16, DOI 10.1364/JOSAA.10.000016; WATAMANIUK SNJ, 1992, VISION RES, V32, P931, DOI 10.1016/0042-6989(92)90036-I; WILLIAMS D, 1991, VISION RES, V31, P275, DOI 10.1016/0042-6989(91)90118-O; WILLIAMS DW, 1984, VISION RES, V24, P55, DOI 10.1016/0042-6989(84)90144-5; WILSON HR, 1994, VISUAL NEUROSCI, V11, P1205, DOI 10.1017/S0952523800007008; ZEKI S, 1983, PROC R SOC SER B-BIO, V217, P449, DOI 10.1098/rspb.1983.0020; Zemel RS, 1998, NEURAL COMPUT, V10, P403, DOI 10.1162/089976698300017818; ZEMEL RS, ADV NEURAL INFORMATI, V11; Zohary E, 1996, VISION RES, V36, P2321, DOI 10.1016/0042-6989(95)00287-1	39	165	166	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2000	3	3					270	276		10.1038/72985	http://dx.doi.org/10.1038/72985			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TE	10700260	Green Published			2022-12-24	WOS:000085810500017
J	Treisman, A				Treisman, A			Solutions to the binding problem: Progress through controversy and convergence	NEURON			English	Editorial Material									Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Princeton University	Treisman, A (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.								0	191	197	0	23	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	1999	24	1					105	110		10.1016/S0896-6273(00)80826-0	http://dx.doi.org/10.1016/S0896-6273(00)80826-0			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241QC	10677031	Bronze			2022-12-24	WOS:000082893200013
J	Lu, WY; Man, HY; Ju, W; Trimble, WS; MacDonald, JF; Wang, YT				Lu, WY; Man, HY; Ju, W; Trimble, WS; MacDonald, JF; Wang, YT			Activation of synaptic NMDA receptors induces membrane insertion of new AMPA receptors and LTP in cultured hippocampal neurons	NEURON			English	Article							LONG-TERM POTENTIATION; POSTSYNAPTICALLY SILENT SYNAPSES; GLUTAMATE RECEPTORS; RELEASE	Long-term potentiation (LTP) of excitatory transmission in the hippocampus likely contributes to learning and memory. The mechanisms underlying LTP at these synapses are not well understood, although phosphorylation and redistribution of AMPA receptors may be responsible for this form of synaptic plasticity. We show here that miniature excitatory postsynaptic currents (mEPSCs) in cultured hippocampal neurons reliably demonstrate LTP when postsynaptic NMDA receptors are briefly stimulated with glycine. LTP of these synapses is accompanied by a rapid insertion of native AMPA receptors and by increased clustering of AMPA receptors at the surface of dendritic membranes. Both LTP and glycine-facilitated AMPA receptor insertion are blocked by intracellular tetanus toxin (TeTx), providing evidence that AMPA receptors are inserted into excitatory synapses via a SNARE-dependent exocytosis during LTP.	Univ Toronto, Hosp Sick Children, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Hosp Sick Children, Dept Pharmacol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Hosp Sick Children, Dept Biochem, Toronto, ON M5S 1A8, Canada; Univ Toronto, Hosp Sick Children, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	MacDonald, JF (corresponding author), Univ Toronto, Hosp Sick Children, Dept Physiol, 100 Coll St, Toronto, ON M5S 1A8, Canada.		Wang, Yu Tian/J-8255-2015; Lu, Wei-Yang/K-4404-2013; Wang, Yu Tian/A-4729-2008					Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; EISEL U, 1993, EMBO J, V12, P3365, DOI 10.1002/j.1460-2075.1993.tb06010.x; GAISANO HY, 1994, J BIOL CHEM, V269, P17062; Gomperts SN, 1998, NEURON, V21, P1443, DOI 10.1016/S0896-6273(00)80662-5; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hua SY, 1999, NAT NEUROSCI, V2, P1078, DOI 10.1038/16005; Hua SY, 1998, J NEUROPHYSIOL, V80, P3233, DOI 10.1152/jn.1998.80.6.3233; Isaac JTR, 1999, CAN J PHYSIOL PHARM, V77, P735, DOI 10.1139/cjpp-77-9-735; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lin JW, 1998, NEURON, V21, P267, DOI 10.1016/S0896-6273(00)80534-6; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; MACDONALD JF, 1989, J PHYSIOL-LONDON, V414, P17, DOI 10.1113/jphysiol.1989.sp017674; MACDONALD JF, 1990, TRENDS PHARMACOL SCI, V11, P167, DOI 10.1016/0165-6147(90)90070-O; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Maletic-Savatic M, 1998, J NEUROSCI, V18, P6814; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; Musleh W, 1997, P NATL ACAD SCI USA, V94, P9451, DOI 10.1073/pnas.94.17.9451; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Turrigiano GG, 2000, NEURON, V26, P5, DOI 10.1016/S0896-6273(00)81131-9; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1	35	670	683	0	54	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	2001	29	1					243	254		10.1016/S0896-6273(01)00194-5	http://dx.doi.org/10.1016/S0896-6273(01)00194-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	397NX	11182095	Bronze			2022-12-24	WOS:000166702700023
J	Geiger, JRP; Jonas, P				Geiger, JRP; Jonas, P			Dynamic control of presynaptic ca2+inflow by fast-inactivating K+ channels in hippocampal mossy fiber boutons	NEURON			English	Article							LONG-TERM POTENTIATION; GATED POTASSIUM CHANNELS; VOLTAGE-CLAMP ANALYSIS; SQUID GIANT SYNAPSE; RAT HIPPOCAMPUS; NERVE-TERMINALS; TRANSMITTER RELEASE; EXCITATORY SYNAPSES; MAMMALIAN BRAIN; CALCIUM CURRENT	Analysis of presynaptic determinants of synaptic strength has been difficult at cortical synapses, mainly due to the lack of direct access to presynaptic elements. Here we report patch-clamp recordings from mossy fiber boutons (MFBs) in rat hippocampal slices. The presynaptic action potential is very short during low-frequency stimulation but is prolonged up to 3-fold during high-frequency stimulation. Voltage-gated K+ channels in MFBs inactivate rapidly but recover from inactivation very slowly, suggesting that cumulative K+ channel inactivation mediates activity-dependent spike broadening. Prolongation of the presynaptic voltage waveform leads to an increase in the number of Ca2+ ions entering the terminal per action potential and to a consecutive potentiation of evoked excitatory postsynaptic currents at MFB-CA3 pyramidal cell synapses. Thus, inactivation of presynaptic K+ channels contributes to the control of efficacy of a glutamatergic synapse in the cortex.	Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany	University of Freiburg	Jonas, P (corresponding author), Univ Freiburg, Inst Physiol, Hermann Herder Str 7, D-79104 Freiburg, Germany.	jonasp@uni-freiburg.de		Jonas, Peter/0000-0001-5001-4804				Acsady L, 1998, J NEUROSCI, V18, P3386; ALDRICH RW, 1979, J PHYSIOL-LONDON, V291, P531, DOI 10.1113/jphysiol.1979.sp012829; AMARAL DG, 1981, J COMP NEUROL, V195, P51, DOI 10.1002/cne.901950106; AUGUSTINE GJ, 1990, J PHYSIOL-LONDON, V431, P343, DOI 10.1113/jphysiol.1990.sp018333; Bischofberger J, 1997, J PHYSIOL-LONDON, V504, P359, DOI 10.1111/j.1469-7793.1997.359be.x; BLACKSTAD T, 1961, J COMP NEUROL, V117, P133, DOI 10.1002/cne.901170202; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; Borst JGG, 1999, PHILOS T R SOC B, V354, P347, DOI 10.1098/rstb.1999.0386; BROWN TH, 1983, J NEUROPHYSIOL, V50, P487, DOI 10.1152/jn.1983.50.2.487; Byrne JH, 1996, J NEUROSCI, V16, P425; CHANDY KG, 1995, LIGAND VOLTAGE GATED, P1; Cooper EC, 1998, J NEUROSCI, V18, P965; DERRICK BE, 1994, P NATL ACAD SCI USA, V91, P10290, DOI 10.1073/pnas.91.22.10290; DRAIN P, 1994, NEURON, V12, P1097, DOI 10.1016/0896-6273(94)90317-4; FORSYTHE ID, 1994, J PHYSIOL-LONDON, V479, P381, DOI 10.1113/jphysiol.1994.sp020303; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; GRIFFITH WH, 1990, J NEUROPHYSIOL, V63, P491, DOI 10.1152/jn.1990.63.3.491; HOPKINS WF, 1984, SCIENCE, V226, P350, DOI 10.1126/science.6091272; JACKSON MB, 1991, P NATL ACAD SCI USA, V88, P380, DOI 10.1073/pnas.88.2.380; JOHNSTON D, 1992, ANNU REV PHYSIOL, V54, P489; JONAS P, 1989, P NATL ACAD SCI USA, V86, P7238, DOI 10.1073/pnas.86.18.7238; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; Ma MH, 1996, J NEUROSCI, V16, P4089; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; QUATTROCKI EA, 1994, NEURON, V12, P73, DOI 10.1016/0896-6273(94)90153-8; REGEHR WG, 1991, NEURON, V7, P451, DOI 10.1016/0896-6273(91)90297-D; REGEHR WG, 1994, J NEUROSCI, V14, P523; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Rhodes KJ, 1997, J NEUROSCI, V17, P8246; Roeper J, 1998, NATURE, V391, P390, DOI 10.1038/34916; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; Sabatini BL, 1999, ANNU REV PHYSIOL, V61, P521, DOI 10.1146/annurev.physiol.61.1.521; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; Simmons ML, 1996, MOL PHARMACOL, V50, P80; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Southan AP, 1998, J NEUROSCI, V18, P948; SPENCER AN, 1989, NATURE, V340, P636, DOI 10.1038/340636a0; Spruston N, 1997, J COMP NEUROL, V385, P427; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; STANLEY EF, 1991, NEURON, V7, P585, DOI 10.1016/0896-6273(91)90371-6; STEINHAUSER C, 1993, HIPPOCAMPUS, V3, P113; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; THORN PJ, 1991, J PHYSIOL-LONDON, V432, P313, DOI 10.1113/jphysiol.1991.sp018386; VERHAGE M, 1991, NEURON, V6, P517, DOI 10.1016/0896-6273(91)90054-4; Villacres EC, 1998, J NEUROSCI, V18, P3186; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; WANG H, 1994, J NEUROSCI, V14, P4588; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Wheeler DB, 1996, J NEUROSCI, V16, P2226; Wiebe SP, 1999, J NEUROSCI, V19, P10562; Yeckel MF, 1998, J NEUROSCI, V18, P438; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	59	442	447	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	2000	28	3					927	939		10.1016/S0896-6273(00)00164-1	http://dx.doi.org/10.1016/S0896-6273(00)00164-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386JJ	11163277	Bronze			2022-12-24	WOS:000166057500027
J	Gonsalves, B; Paller, KA				Gonsalves, B; Paller, KA			Neural events that underlie remembering something that never happened	NATURE NEUROSCIENCE			English	Article							FALSE RECOGNITION; MODALITY CONFUSION; MENTAL-IMAGERY; VISUAL-IMAGERY; BRAIN ACTIVITY; MEMORY; RETRIEVAL; INSIGHTS; RECALL; CORTEX	We induced people to experience a false-memory illusion by first asking them to visualize common objects when cued with the corresponding word; on some trials, a photograph of the object was presented 1800 ms after the cue word. We then tested their memory for the photographs. Posterior brain potentials in response to words at encoding were more positive if the corresponding object was later falsely remembered as a photograph. Similar brain potentials during the memory test were more positive for true than for false memories. These results implicate visual imagery in the generation of false memories and provide neural correlates of processing differences between true and false memories.	Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA	Northwestern University	Paller, KA (corresponding author), Northwestern Univ, Dept Psychol, 2029 Sheridan Rd, Evanston, IL 60208 USA.	kap@northwestern.edu	Paller, Ken/M-2676-2019	Paller, Ken/0000-0003-4415-4143	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS034639, R01NS034639] Funding Source: NIH RePORTER; NINDS NIH HHS [NS34639] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		COLTHEART M, 1981, Q J EXP PSYCHOL-A, V33, P497, DOI 10.1080/14640748108400805; CRAVERLEMLEY C, 1992, PSYCHOL REV, V99, P633, DOI 10.1037/0033-295X.99.4.633; DEESE J, 1959, J EXP PSYCHOL, V58, P17, DOI 10.1037/h0046671; DEsposito M, 1997, NEUROPSYCHOLOGIA, V35, P725, DOI 10.1016/S0028-3932(96)00121-2; DURSO FT, 1980, J VERB LEARN VERB BE, V19, P416, DOI 10.1016/S0022-5371(80)90294-7; FABIANI M, 1986, PSYCHOPHYSIOLOGY, V23, P298, DOI 10.1111/j.1469-8986.1986.tb00636.x; FABIANI M, INPRESS J COGN NEURO; Farah M., 1990, J COGNITIVE NEUROSCI, V1, P302; Fletcher PC, 1996, BRAIN, V119, P1587, DOI 10.1093/brain/119.5.1587; FLETCHER PC, 1995, NEUROIMAGE, V2, P195, DOI 10.1006/nimg.1995.1025; Friedman D, 2000, NEUROPSYCHOLOGIA, V38, P542, DOI 10.1016/S0028-3932(99)00122-0; Gonsalves B, 2000, MEM COGNITION, V28, P321, DOI 10.3758/BF03198547; Hyman IE, 1996, J MEM LANG, V35, P101; Johnson MK, 1997, PSYCHOL SCI, V8, P250, DOI 10.1111/j.1467-9280.1997.tb00421.x; JOHNSON MK, 1981, PSYCHOL REV, V88, P67, DOI 10.1037/0033-295X.88.1.67; KAPUR S, 1995, NEUROREPORT, V6, P1880, DOI 10.1097/00001756-199510020-00014; Kosslyn S. M., 1994, IMAGE BRAIN; Kosslyn SM, 1999, SCIENCE, V284, P167, DOI 10.1126/science.284.5411.167; KOSSLYN SM, 1993, J COGNITIVE NEUROSCI, V5, P263, DOI 10.1162/jocn.1993.5.3.263; LANE SM, 1995, MEM COGNITION, V23, P607, DOI 10.3758/BF03197262; Mather M, 1997, MEM COGNITION, V25, P826, DOI 10.3758/BF03211327; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Norman KA, 1997, MEM COGNITION, V25, P838, DOI 10.3758/BF03211328; Nyberg L, 2000, J COGNITIVE NEUROSCI, V12, P163, DOI 10.1162/089892900561805; PALLER KA, 1987, ELECTROEN CLIN NEURO, V67, P360, DOI 10.1016/0013-4694(87)90124-6; Paller KA, 1997, MEMORY, V5, P73, DOI 10.1080/741941150; ROEDIGER HL, 1995, J EXP PSYCHOL LEARN, V21, P803, DOI 10.1037/0278-7393.21.4.803; Rugg M., 1995, ELECTROPHYSIOLOGY MI; SANQUIST TF, 1980, PSYCHOPHYSIOLOGY, V17, P568, DOI 10.1111/j.1469-8986.1980.tb02299.x; Schacter DL, 1997, NEUROIMAGE, V6, P259, DOI 10.1006/nimg.1997.0305; Schacter DL, 1996, NEURON, V17, P267, DOI 10.1016/S0896-6273(00)80158-0; SOMMER W, 1991, ELECTROEN CLIN NEURO, V79, P457, DOI 10.1016/0013-4694(91)90165-Z; Squire L. R., 1987, MEMORY BRAIN; VanPetten C, 1996, PSYCHOPHYSIOLOGY, V33, P491; Wagner AD, 1999, PHILOS T R SOC B, V354, P1307, DOI 10.1098/rstb.1999.0481	35	84	87	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2000	3	12					1316	1321		10.1038/81851	http://dx.doi.org/10.1038/81851			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	405UA	11100153	Bronze			2022-12-24	WOS:000167177900018
J	Galli, R; Borello, U; Gritti, A; Minasi, AG; Bjornson, C; Coletta, M; Mora, M; De Angelis, MGC; Fiocco, R; Cossu, G; Vescovi, AL				Galli, R; Borello, U; Gritti, A; Minasi, AG; Bjornson, C; Coletta, M; Mora, M; De Angelis, MGC; Fiocco, R; Cossu, G; Vescovi, AL			Skeletal myogenic potential of human and mouse neural stem cells	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; TURNING BRAIN; BONE-MARROW; ASTROCYTES; MUSCLE; TRANSPLANTATION; POPULATION; EXPRESSION; FOREBRAIN; NEURONS	Distinct cell lineages established early in development are usually maintained throughout adulthood. Thus, adult stem cells have been thought to generate differentiated cells specific to the tissue in which they reside. This view has been challenged; for example, neural stem cells can generate cells that normally originate from a different germ layer. Here we show that acutely isolated and clonally derived neural stem cells from mice and humans could produce skeletal myotubes in vitro and in vivo, the latter following transplantation into adult animals. Myogenic conversion in vitro required direct exposure to myoblasts, and was blocked if neural cells were clustered. Thus, a community effect between neural cells may override such myogenic induction. We conclude that neural stem cells, which generate neurons, glia and blood cells, can also produce skeletal muscle cells, and can undergo various patterns of differentiation depending on exposure to appropriate epigenetic signals in mature tissues.	Natl Neurol Inst C Besta, I-20133 Milan, Italy; HS Raffaele, Stem Cell Res Inst, I-20133 Milan, Italy; Univ Rome La Sapienza, Dept Histol & Med Embryol, Fdn Pasteur Cenci Bolognetti, I-00161 Rome, Italy; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Pavia, Dept Expt Med, I-27100 Pavia, Italy	IRCCS Istituto Neurologico Besta; Fondazione Cenci Bolognetti; Sapienza University Rome; University of Washington; University of Washington Seattle; University of Pavia	Vescovi, AL (corresponding author), Natl Neurol Inst C Besta, Via Celoria 11, I-20133 Milan, Italy.		Gritti, Angela/K-2729-2016; Borello, Ugo/M-5213-2014; Vescovi, Angelo Luigi/A-4919-2015; Mora, Marina/J-2883-2018	Gritti, Angela/0000-0002-9845-0370; Borello, Ugo/0000-0001-9812-579X; Vescovi, Angelo Luigi/0000-0002-1742-4112; Mora, Marina/0000-0002-5765-2320; Cusella De Angelis, Maria Gabriella/0000-0003-2642-3346	Telethon [E.1246] Funding Source: Medline	Telethon(Fondazione Telethon)		Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; BERESFORD WA, 1990, CELL DIFFER DEV, V29, P81, DOI 10.1016/0922-3371(90)90026-S; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Daubas P, 2000, DEVELOPMENT, V127, P319; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Eguchi G, 1993, CURR OPIN CELL BIOL, V5, P1023, DOI 10.1016/0955-0674(93)90087-7; FAUST C, 1993, CURR OPIN GENET DEV, V3, P491, DOI 10.1016/0959-437X(93)90125-9; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Fuchs E, 2000, CELL, V100, P143, DOI 10.1016/S0092-8674(00)81691-8; Gritti A, 1999, J NEUROSCI, V19, P3287; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Johansson CB, 1999, EXP CELL RES, V253, P733, DOI 10.1006/excr.1999.4678; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; KELLY R, 1995, J CELL BIOL, V129, P383, DOI 10.1083/jcb.129.2.383; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Loeffler Markus, 1997, P1, DOI 10.1016/B978-012563455-7/50002-7; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Moore MAS, 1999, NEW ENGL J MED, V341, P605, DOI 10.1056/NEJM199908193410811; PATAPOUTIAN A, 1995, DEVELOPMENT, V121, P3347; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; TAJBAKHSH S, 1994, NEURON, V13, P813, DOI 10.1016/0896-6273(94)90248-8; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998	26	365	404	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2000	3	10					986	991		10.1038/79924	http://dx.doi.org/10.1038/79924			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TW	11017170				2022-12-24	WOS:000167177500015
J	Kawaguchi, S; Hirano, T				Kawaguchi, S; Hirano, T			Suppression of inhibitory synaptic potentiation by presynaptic activity through postsynaptic GABA(B) receptors in a Purkinje neuron	NEURON			English	Article							LONG-TERM DEPRESSION; PROTEIN-KINASE-C; CEREBELLAR LTD; REBOUND POTENTIATION; HIPPOCAMPAL-NEURONS; MEDIATED CURRENTS; PYRAMIDAL CELLS; RAT CEREBELLUM; B RECEPTORS; SYNAPSES	At inhibitory synapses on a cerebellar Purkinje neuron, the depolarization caused by heterosynaptic climbing fiber activation induces long-lasting potentiation accompanied by an increase in GABA(A) receptor responsiveness. Here we show that activation of a presynaptic inhibitory interneuron during the conditioning postsynaptic depolarization suppresses the potentiation. The suppression is due to postsynaptic GABA(B) receptor activation by GABA released from presynaptic terminals. The results suggest that GABA(B) receptor activation decreases the activity of cAMP-dependent protein kinase through the G(j)/G(o) proteins. The presynaptic activity-dependent suppression of synaptic plasticity is a novel regulatory mechanism of synaptic efficacy at individual synapses and may contribute to the learning and computational ability of the cerebellar cortex.	Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan; Japan Sci & Technol Corp, Kawaguchi, Saitama 3320012, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Hirano, T (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.		Kawaguchi, Shin-ya/X-4166-2018	Kawaguchi, Shin-ya/0000-0002-8386-1185				AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; BATCHELOR AM, 1992, EUR J NEUROSCI, V4, P1059, DOI 10.1111/j.1460-9568.1992.tb00132.x; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOLSER DC, 1995, J PHARMACOL EXP THER, V274, P1393; CHEN QX, 1990, J PHYSIOL-LONDON, V420, P207, DOI 10.1113/jphysiol.1990.sp017908; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; Daniel H, 1998, TRENDS NEUROSCI, V21, P401, DOI 10.1016/S0166-2236(98)01304-6; DAVIES CH, 1991, NATURE, V349, P609, DOI 10.1038/349609a0; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; DUTAR P, 1988, NEURON, V1, P585, DOI 10.1016/0896-6273(88)90108-0; Glitsch M, 1996, J PHYSIOL-LONDON, V497, P531, DOI 10.1113/jphysiol.1996.sp021786; Hashimoto T, 1996, J PHYSIOL-LONDON, V497, P611, DOI 10.1113/jphysiol.1996.sp021794; HIRANO T, 1994, NEUROSCI LETT, V182, P172, DOI 10.1016/0304-3940(94)90790-0; HIRANO T, 1993, J NEUROPHYSIOL, V70, P1316, DOI 10.1152/jn.1993.70.4.1316; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; Jaeger D, 1999, J NEUROSCI, V19, P6090, DOI 10.1523/JNEUROSCI.19-14-06090.1999; Jarolimek W, 1997, J NEUROSCI, V17, P1025; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; KANO M, 1992, NEUROREPORT, V3, P563, DOI 10.1097/00001756-199207000-00004; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; Kano M, 1996, P NATL ACAD SCI USA, V93, P13351, DOI 10.1073/pnas.93.23.13351; KANO M, 1995, NEUROSCI RES, V21, P177, DOI 10.1016/0168-0102(94)00860-I; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; KASONO K, 1994, NEUROREPORT, V6, P17, DOI 10.1097/00001756-199412300-00006; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Komatsu Y, 1996, J NEUROSCI, V16, P6342; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; KRISHEK BJ, 1994, NEURON, V12, P1081, DOI 10.1016/0896-6273(94)90316-6; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; LAMBERT NA, 1990, J PHARMACOL EXP THER, V255, P90; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; Lisberger SG, 1998, CELL, V92, P701, DOI 10.1016/S0092-8674(00)81397-5; LLANO I, 1995, J PHYSIOL-LONDON, V486, P163, DOI 10.1113/jphysiol.1995.sp020800; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; McDonald BJ, 1998, NAT NEUROSCI, V1, P23, DOI 10.1038/223; MINTZ IM, 1993, NEURON, V10, P889, DOI 10.1016/0896-6273(93)90204-5; MISGELD U, 1995, PROG NEUROBIOL, V46, P423, DOI 10.1016/0301-0082(95)00012-K; MOTT DD, 1991, SCIENCE, V252, P1718, DOI 10.1126/science.1675489; NEWBERRY NR, 1984, NATURE, V308, P450, DOI 10.1038/308450a0; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; Oda Y, 1998, NATURE, V394, P182, DOI 10.1038/28172; Ross H. S., 1995, EARLY EDUC DEV, V6, P335, DOI [10.1207/s15566935eed0604_4, DOI 10.1207/S15566935EED0604_4]; Smart TG, 1997, CURR OPIN NEUROBIOL, V7, P358, DOI 10.1016/S0959-4388(97)80063-3; VINCENT P, 1992, J PHYSIOL-LONDON, V456, P453, DOI 10.1113/jphysiol.1992.sp019346; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Yamada K, 1996, J PHYSIOL-LONDON, V496, P439, DOI 10.1113/jphysiol.1996.sp021697	50	47	47	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG	2000	27	2					339	347		10.1016/S0896-6273(00)00041-6	http://dx.doi.org/10.1016/S0896-6273(00)00041-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	347YD	10985353	Bronze			2022-12-24	WOS:000088956000017
J	Dellovade, TL; Chan, J; Vennstrom, B; Forrest, D; Pfaff, DW				Dellovade, TL; Chan, J; Vennstrom, B; Forrest, D; Pfaff, DW			The two thyroid hormone receptor genes have opposite effects on estrogen-stimulated sex behaviors	NATURE NEUROSCIENCE			English	Article							REPRODUCTIVE NEUROENDOCRINE ACTIVITY; BLOCKS SEASONAL SUPPRESSION; HYPOTHALAMIC NEURONS; BETA; MICE; EXPRESSION; GLAND; TEMPERATURE; THYROXINE; SECRETION	The two genes coding for thyroid hormone receptors (TR) alpha 1 and beta have opposite effects on female sex behaviors. Deletion of TR alpha 1 reduced them, whereas deletion of TRP actually increased them. These results could not be attributed to altered levers of hormones in the blood, general alterations in estrogen responsiveness or altered general activity. Instead, they indicate a previously unknown molecular mechanism upon which the two TR genes exert opposite influences.	Rockefeller Univ, Neurobiol & Behav Lab, New York, NY 10021 USA; Karolinska Inst, Dept Cell & Mol Biol, Dev Biol Lab, Stockholm, Sweden; CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA	Rockefeller University; Karolinska Institutet; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Pfaff, DW (corresponding author), Rockefeller Univ, Neurobiol & Behav Lab, 1230 York Ave, New York, NY 10021 USA.							Barros AC, 1998, NEUROREPORT, V9, P2933, DOI 10.1097/00001756-199809140-00003; Carter C S, 1997, Ann N Y Acad Sci, V807, pxiii, DOI 10.1111/j.1749-6632.1997.tb51909.x; Cohen RN, 1998, MOL ENDOCRINOL, V12, P1567, DOI 10.1210/me.12.10.1567; DAHL GE, 1995, BIOL REPROD, V52, P690, DOI 10.1095/biolreprod52.3.690; Dellovade TL, 1999, NEUROENDOCRINOLOGY, V70, P168, DOI 10.1159/000054473; Dellovade TL, 1999, J NEUROENDOCRINOL, V11, P1, DOI 10.1046/j.1365-2826.1999.00250.x; Dellovade TL, 1996, P NATL ACAD SCI USA, V93, P12581, DOI 10.1073/pnas.93.22.12581; FAHRBACH SE, 1986, PHYSIOL BEHAV, V37, P135, DOI 10.1016/0031-9384(86)90396-3; Forrest D, 1996, EMBO J, V15, P3006, DOI 10.1002/j.1460-2075.1996.tb00664.x; Gauthier K, 1999, EMBO J, V18, P623, DOI 10.1093/emboj/18.3.623; Goldblatt PG, 1984, MONOGR SYST BOT, V8, P1; GOLDSMITH AR, 1984, GEN COMP ENDOCR, V54, P256, DOI 10.1016/0016-6480(84)90179-5; Gothe S, 1999, GENE DEV, V13, P1329, DOI 10.1101/gad.13.10.1329; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Johansson C, 1999, AM J PHYSIOL-HEART C, V276, pH2006, DOI 10.1152/ajpheart.1999.276.6.H2006; Johansson C, 1998, AM J PHYSIOL-REG I, V275, pR640, DOI 10.1152/ajpregu.1998.275.2.R640; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MOENTER SM, 1991, ENDOCRINOLOGY, V128, P1337, DOI 10.1210/endo-128-3-1337; MORGAN M, IN PRESS HORM BEHAV; Neumann I, 1996, J NEUROENDOCRINOL, V8, P227, DOI 10.1046/j.1365-2826.1996.04557.x; Neumann ID, 1998, J PHYSIOL-LONDON, V508, P289, DOI 10.1111/j.1469-7793.1998.289br.x; Pedersen C.A., 1992, ANN NY ACAD SCI, V652; Pfaff D. W., 1999, DRIVE NEURAL MOL MEC; Rusch A, 1998, P NATL ACAD SCI USA, V95, P15758, DOI 10.1073/pnas.95.26.15758; Sandhofer C, 1998, MOL CELL ENDOCRINOL, V137, P109, DOI 10.1016/S0303-7207(98)00005-7; Thrun LA, 1997, ENDOCRINOLOGY, V138, P3402, DOI 10.1210/en.138.8.3402; WEBSTER JR, 1991, ENDOCRINOLOGY, V129, P176, DOI 10.1210/endo-129-1-176; WEBSTER JR, 1991, ENDOCRINOLOGY, V129, P1635, DOI 10.1210/endo-129-3-1635; Wikstrom L, 1998, EMBO J, V17, P455, DOI 10.1093/emboj/17.2.455; Young LJ, 1998, TRENDS NEUROSCI, V21, P71, DOI 10.1016/S0166-2236(97)01167-3; Zhu YS, 1996, P NATL ACAD SCI USA, V93, P12587, DOI 10.1073/pnas.93.22.12587	31	53	55	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2000	3	5					472	475		10.1038/74846	http://dx.doi.org/10.1038/74846			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309DG	10769387				2022-12-24	WOS:000086752000016
J	Numaguchi, H; Johnson, JP; Petersen, CI; Balser, JR				Numaguchi, H; Johnson, JP; Petersen, CI; Balser, JR			A sensitive mechanism for cation modulation of potassium current	NATURE NEUROSCIENCE			English	Article							K+ CURRENT; CHANNEL; RECTIFICATION; SELECTIVITY; PERMEATION; CELLS		Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Balser, JR (corresponding author), Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37232 USA.			Johnson Jr., J.P./0000-0002-5762-5138	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046681] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL46681] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arcangeli A, 1997, EUR J NEUROSCI, V9, P2596, DOI 10.1111/j.1460-9568.1997.tb01689.x; Chiesa N, 1997, J PHYSIOL-LONDON, V501, P313, DOI 10.1111/j.1469-7793.1997.313bn.x; HAGIWARA S, 1974, J MEMBRANE BIOL, V18, P61, DOI 10.1007/BF01870103; HESS P, 1984, NATURE, V309, P453, DOI 10.1038/309453a0; Johns DC, 1997, J BIOL CHEM, V272, P31598, DOI 10.1074/jbc.272.50.31598; KORN SJ, 1995, SCIENCE, V269, P410, DOI 10.1126/science.7618108; Ogielska EM, 1998, J GEN PHYSIOL, V112, P243, DOI 10.1085/jgp.112.2.243; Roden DM, 1996, CIRCULATION, V94, P1996, DOI 10.1161/01.CIR.94.8.1996; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; SCAMPS F, 1989, AM J PHYSIOL, V257, pC1086, DOI 10.1152/ajpcell.1989.257.6.C1086; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Wang SM, 1996, FEBS LETT, V389, P167, DOI 10.1016/0014-5793(96)00570-4; Wang SM, 1997, J PHYSIOL-LONDON, V502, P45, DOI 10.1111/j.1469-7793.1997.045bl.x; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438	15	55	57	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2000	3	5					429	430		10.1038/74793	http://dx.doi.org/10.1038/74793			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309DG	10769379				2022-12-24	WOS:000086752000008
J	Dale, AM; Liu, AK; Fischl, BR; Buckner, RL; Belliveau, JW; Lewine, JD; Halgren, E				Dale, AM; Liu, AK; Fischl, BR; Buckner, RL; Belliveau, JW; Lewine, JD; Halgren, E			Dynamic statistical parametric mapping: Combining fMRI and MEG for high-resolution imaging of cortical activity	NEURON			English	Article							MEDIAL TEMPORAL-LOBE; DEPTH-RECORDED POTENTIALS; SURFACE-BASED ANALYSIS; HUMAN BRAIN ACTIVITY; CEREBRAL BLOOD-FLOW; HUMAN VISUAL-CORTEX; INTRACEREBRAL POTENTIALS; FIELD POTENTIALS; FUNCTIONAL MRI; RARE TARGET	Functional magnetic resonance imaging (fMRI) can provide maps of brain activation with millimeter spatial resolution but is limited in its temporal resolution to the order of seconds. Here, we describe a technique that combines structural and functional MRI with magnetoencephalography (MEG) to obtain spatiotemporal maps of human brain activity with millisecond temporal resolution. This new technique was used to obtain dynamic statistical parametric maps of cortical activity during semantic processing of visually presented words. An initial wave of activity was found to spread rapidly from occipital visual cortex to temporal, parietal, and frontal areas within 185 ms, with a high degree of temporal overlap between different areas. Repetition effects were observed in many of the same areas following this initial wave of activation, providing evidence for the involvement of feedback mechanisms in repetition priming.	Massachusetts Gen Hosp, Nucl Magnet Resonance Ctr, Charlestown, MA 02129 USA; Univ Utah, Dept Radiol, Salt Lake City, UT 84108 USA; INSERM, F-13258 Marseille, France; Washington Univ, Dept Psychol Anat & Neurobiol & Radiol, St Louis, MO 63130 USA	Harvard University; Massachusetts General Hospital; Utah System of Higher Education; University of Utah; Institut National de la Sante et de la Recherche Medicale (Inserm); Washington University (WUSTL)	Dale, AM (corresponding author), Massachusetts Gen Hosp, Nucl Magnet Resonance Ctr, Charlestown, MA 02129 USA.	dale@nmr.mgh.harvard.edu	Dale, Anders M/A-5180-2010		NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR013609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018741] Funding Source: NIH RePORTER; NCRR NIH HHS [R01-RR13609] Funding Source: Medline; NINDS NIH HHS [R01 NS018741, R01-NS18741] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahlfors SP, 1999, J NEUROPHYSIOL, V82, P2545, DOI 10.1152/jn.1999.82.5.2545; AMARAL D G, 1992, P1; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; BARTH DS, 1991, J NEUROPHYSIOL, V65, P891, DOI 10.1152/jn.1991.65.4.891; Barth DS, 1996, NATURE, V383, P78, DOI 10.1038/383078a0; BAUDENA P, 1995, ELECTROEN CLIN NEURO, V94, P251, DOI 10.1016/0013-4694(95)98476-O; BELLIVEAU JW, 1991, SCIENCE, V254, P716, DOI 10.1126/science.1948051; BENSON DF, 1979, APHASIA ALEXIA AGRAP; Benson RR, 1996, CAN J NEUROL SCI, V23, P213, DOI 10.1017/S0317167100038543; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Buckner RL, 1998, P NATL ACAD SCI USA, V95, P891, DOI 10.1073/pnas.95.3.891; CHAUVEL P, 1987, REV NEUROL, V143, P443; CHURCHLAND PS, 1988, SCIENCE, V242, P741, DOI 10.1126/science.3055294; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Fernandez G, 1999, SCIENCE, V285, P1582, DOI 10.1126/science.285.5433.1582; Fiez JA, 1998, P NATL ACAD SCI USA, V95, P914, DOI 10.1073/pnas.95.3.914; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; FOX PT, 1988, SCIENCE, V241, P462, DOI 10.1126/science.3260686; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; GEORGE J, 1995, HUM BRAIN MAPP S, V1, P89; Gobbele R, 1998, EVOKED POTENTIAL, V108, P182, DOI 10.1016/S0168-5597(97)00100-7; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Guillem F, 1999, J COGNITIVE NEUROSCI, V11, P437, DOI 10.1162/089892999563526; HALGREN E, 1994, J PHYSIOL-PARIS, V88, P51, DOI 10.1016/0928-4257(94)90093-0; HALGREN E, 1994, J PHYSIOL-PARIS, V88, P1, DOI 10.1016/0928-4257(94)90092-2; HALGREN E, 1995, ELECTROEN CLIN NEURO, V94, P191, DOI 10.1016/0013-4694(94)00259-N; HALGREN E, 1995, ELECTROEN CLIN NEURO, V94, P229, DOI 10.1016/0013-4694(95)98475-N; Halgren E., 1990, NEUROBIOLOGY COGNITI, P103; HALGREN E, 1994, MEMORY SYSTEM BRAIN, P69; Halgren Eric, 1995, P1137; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hamalainen MS, 1984, TKKFA559 U TECHN DEP; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Kutas M., 1988, ADV PSYCHOPHYSIOLOGY, VVol. 3, P139; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Liu AK, 1998, P NATL ACAD SCI USA, V95, P8945, DOI 10.1073/pnas.95.15.8945; LIU AK, 2000, THESIS MIT CAMBRIDGE; Mangun GR, 1998, HUM BRAIN MAPP, V6, P383, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<383::AID-HBM10>3.0.CO;2-Z; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; Mazziotta J C, 1983, Hum Neurobiol, V2, P11; MCCARTHY G, 1995, J NEUROSCI, V15, P1080; Menendez RGDP, 1997, HUM BRAIN MAPP, V5, P454, DOI 10.1002/(SICI)1097-0193(1997)5:6<454::AID-HBM6>3.0.CO;2-2; Menke W.., 1989, GEOPHYSICAL DATA ANA; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; MOSHER JC, 1992, IEEE T BIO-MED ENG, V39, P541, DOI 10.1109/10.141192; Murray EA, 1999, TRENDS COGN SCI, V3, P142, DOI 10.1016/S1364-6613(99)01303-0; NENOV VI, 1991, BEHAV BRAIN RES, V44, P101; NICHOLSON C, 1975, J NEUROPHYSIOL, V38, P356, DOI 10.1152/jn.1975.38.2.356; NOBRE AC, 1995, J NEUROSCI, V15, P1090; NOBRE AC, 1994, NATURE, V372, P260, DOI 10.1038/372260a0; Nunez P.L., 1981, ELECT FIELDS BRAIN; OOSTENDORP TF, 1992, BIOMAGNETIC LOCALIZA; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Portin K, 1998, CEREB CORTEX, V8, P253, DOI 10.1093/cercor/8.3.253; Press W., 1994, NUMERICAL RECIPES C; PRICHARD J, 1991, P NATL ACAD SCI USA, V88, P5829, DOI 10.1073/pnas.88.13.5829; Puce A, 1997, HUM BRAIN MAPP, V5, P298, DOI 10.1002/(SICI)1097-0193(1997)5:4<298::AID-HBM16>3.0.CO;2-A; Raichle M. E., 1987, HDB PHYSL NERVOUS SY, V1, P643; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Reese TG, 1995, JMRI-J MAGN RESON IM, V5, P739, DOI 10.1002/jmri.1880050621; Regan D., 1989, HUMAN BRAIN ELECTROP; Schmidt DM, 1999, HUM BRAIN MAPP, V7, P195, DOI 10.1002/(SICI)1097-0193(1999)7:3<195::AID-HBM4>3.0.CO;2-F; Schroeder CE, 1995, EEG CL N SU, P55; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; SHERG M, 1985, CLIN NEUROPHYSIOL, V62, P32; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; SMITH ME, 1986, ELECTROEN CLIN NEURO, V63, P145, DOI 10.1016/0013-4694(86)90008-8; SNYDER AZ, 1995, P NATL ACAD SCI USA, V92, P1689, DOI 10.1073/pnas.92.5.1689; Sukov W, 1998, J NEUROPHYSIOL, V79, P2875, DOI 10.1152/jn.1998.79.6.2875; Talairach J, 1967, ATLAS ANATOMIE STERE; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; van Oosterom A, 1999, IEEE T BIO-MED ENG, V46, P778, DOI 10.1109/10.771187	79	1132	1144	3	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	2000	26	1					55	67		10.1016/S0896-6273(00)81138-1	http://dx.doi.org/10.1016/S0896-6273(00)81138-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309MA	10798392	Bronze			2022-12-24	WOS:000086770500008
J	Yacoubian, TA; Lo, DC				Yacoubian, TA; Lo, DC			Truncated and full-length TrkB receptors regulate distinct modes of dendritic growth	NATURE NEUROSCIENCE			English	Article							VISUAL CORTICAL-NEURONS; NEUROTROPHIC FACTOR; GENE-EXPRESSION; KINASE-ACTIVITY; IN-VIVO; ISOFORMS; CELLS; CORTEX; RAT; MORPHOLOGY	Neurotrophin regulation of neuronal morphology is complex and may involve differential action of alternative Trk receptor isoforms. We transfected ferret visual cortical slices with full-length and truncated TrkB receptors to examine their roles in regulating cortical dendrite development. These TrkB isoforms had differential effects on dendritic arborization: whereas full-length TrkB increased proximal dendritic branching, truncated TrkB promoted net elongation of distal dendrites. The morphological effects of each receptor isoform were distinct, yet their actions inhibited one another. Actions of the truncated TrkB receptor did not involve unmasking of endogenous TrkC signaling. These results suggest that TrkB receptors do not regulate dendritic growth per se but, rather, the mode of such growth.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Lo, DC (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.				NATIONAL EYE INSTITUTE [R01EY011553] Funding Source: NIH RePORTER; NEI NIH HHS [EY11553] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALLENDOERFER KL, 1994, J NEUROSCI, V14, P1795; ARMANINI MP, 1995, EUR J NEUROSCI, V7, P1403, DOI 10.1111/j.1460-9568.1995.tb01132.x; ARNOLD D, 1994, P NATL ACAD SCI USA, V91, P9970, DOI 10.1073/pnas.91.21.9970; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Barker PA, 1998, CELL DEATH DIFFER, V5, P346, DOI 10.1038/sj.cdd.4400375; Baxter GT, 1997, J NEUROSCI, V17, P2683; BERG MM, 1992, J BIOL CHEM, V267, P13; BIFFO S, 1995, DEVELOPMENT, V121, P2461; Boeshore KL, 1999, J NEUROSCI, V19, P4739; Bonhoeffer T, 1996, CURR OPIN NEUROBIOL, V6, P119, DOI 10.1016/S0959-4388(96)80017-1; Cabelli RJ, 1997, NEURON, V19, P63, DOI 10.1016/S0896-6273(00)80348-7; Cellerino A, 1996, PROG NEUROBIOL, V49, P53, DOI 10.1016/0301-0082(96)00008-1; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Dechant G, 1997, CURR OPIN NEUROBIOL, V7, P413, DOI 10.1016/S0959-4388(97)80071-2; Eide FF, 1996, J NEUROSCI, V16, P3123; ESCANDON E, 1994, J NEUROSCI, V14, P2054; FRISEN J, 1993, P NATL ACAD SCI USA, V90, P4971, DOI 10.1073/pnas.90.11.4971; Fryer RH, 1997, EXP NEUROL, V148, P616, DOI 10.1006/exnr.1997.6699; Fryer RH, 1996, J COMP NEUROL, V374, P21, DOI 10.1002/(SICI)1096-9861(19961007)374:1<21::AID-CNE2>3.0.CO;2-P; Galuske RAW, 1996, EUR J NEUROSCI, V8, P1554, DOI 10.1111/j.1460-9568.1996.tb01618.x; Garner AS, 1996, J NEUROSCI, V16, P1740; Haapasalo A, 1999, ONCOGENE, V18, P1285, DOI 10.1038/sj.onc.1202401; HOLTZMAN DM, 1992, NEURON, V9, P465, DOI 10.1016/0896-6273(92)90184-F; JACKSON CA, 1989, J NEUROSCI, V9, P1242; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; KNUSEL B, 1994, J NEUROSCI, V14, P1542, DOI 10.1523/JNEUROSCI.14-03-01542.1994; Kryl D, 1999, J NEUROSCI, V19, P5823, DOI 10.1523/JNEUROSCI.19-14-05823.1999; LAMBALLE F, 1993, EMBO J, V12, P3083, DOI 10.1002/j.1460-2075.1993.tb05977.x; Lentz SI, 1999, J NEUROSCI, V19, P1038; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LO DC, 1994, NEURON, V13, P1263, DOI 10.1016/0896-6273(94)90412-X; Lom B, 1999, J NEUROSCI, V19, P9928; MAFFEI L, 1992, J NEUROSCI, V12, P4651; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; Ninkina N, 1997, J BIOL CHEM, V272, P13019, DOI 10.1074/jbc.272.20.13019; Ninkina N, 1996, EMBO J, V15, P6385, DOI 10.1002/j.1460-2075.1996.tb01029.x; PURVES D, 1988, NATURE, V336, P123, DOI 10.1038/336123a0; RUDGE JS, 1994, EUR J NEUROSCI, V6, P693, DOI 10.1111/j.1460-9568.1994.tb00981.x; Shimada A, 1998, J NEUROSCI, V18, P8559; SHOLL DA, 1953, J ANAT, V87, P387; SNIDER WD, 1988, J NEUROSCI, V8, P2628; Strohmaier C, 1996, EMBO J, V15, P3332, DOI 10.1002/j.1460-2075.1996.tb00698.x; TAPLEY P, 1992, ONCOGENE, V7, P371; Tsoulfas P, 1996, J BIOL CHEM, V271, P5691, DOI 10.1074/jbc.271.10.5691; VALENZUELA DM, 1993, NEURON, V10, P963, DOI 10.1016/0896-6273(93)90211-9; WETMORE C, 1995, J COMP NEUROL, V353, P143, DOI 10.1002/cne.903530113; Wu GY, 1999, J NEUROSCI, V19, P4472; Zervas M, 1999, J COMP NEUROL, V413, P429, DOI 10.1002/(SICI)1096-9861(19991025)413:3<429::AID-CNE6>3.0.CO;2-7	50	224	227	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2000	3	4					342	349		10.1038/73911	http://dx.doi.org/10.1038/73911			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330CN	10725923				2022-12-24	WOS:000087945400014
J	Li, Z; Van Aelst, L; Cline, HT				Li, Z; Van Aelst, L; Cline, HT			Rho GTPases regulate distinct aspects of dendritic arbor growth in Xenopus central neurons in vivo	NATURE NEUROSCIENCE			English	Article							IN-VIVO; CEREBRAL-CORTEX; AXON GUIDANCE; RAC; KINASE; FAMILY; PHOSPHORYLATION; SYNAPTOGENESIS; FILOPODIA; DYNAMICS	The development and structural plasticity of dendritic arbors are governed by several factors, including synaptic activity, neurotrophins and other growth-regulating molecules. The signal transduction pathways leading to dendritic structural changes are unknown, but likely include cytoskeleton regulatory components. To test whether GTPases regulate dendritic arbor development, we collected time-lapse images of single optic tectal neurons in albino Xenopus tadpoles expressing dominant negative or constitutively active forms of Rac, Cdc42 or RhoA. Analysis of images collected at two-hour intervals over eight hours indicated that enhanced Rac activity selectively increased branch additions and retractions, as did Cdc42 to a lesser extent. Activation of endogenous RhoA decreased branch extension without affecting branch additions and retractions, whereas dominant-negative RhoA increased branch extension. Finally, we provide data suggesting that RhoA mediates the promotion of normal dendritic arbor development by NMDA receptor activation.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Cline, HT (corresponding author), Cold Spring Harbor Lab, Beckman Bldg,1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	cline@cshl.org	Li, Zheng/I-8016-2014	Li, Zheng/0000-0002-2978-2531				Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bentley David, 1994, Current Opinion in Neurobiology, V4, P43, DOI 10.1016/0959-4388(94)90030-2; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; CLINE HT, 1999, IMAGING LAB MANUAL; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Fiala JC, 1998, J NEUROSCI, V18, P8900; Gebbink MFBG, 1997, J CELL BIOL, V137, P1603, DOI 10.1083/jcb.137.7.1603; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; Jin Z, 1997, J NEUROSCI, V17, P6256; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kaufmann N, 1998, DEVELOPMENT, V125, P453; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; KOESTER SE, 1994, PROG BRAIN RES, V102, P207; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Kuhn TB, 1998, J NEUROBIOL, V37, P524, DOI 10.1002/(SICI)1097-4695(199812)37:4<524::AID-NEU3>3.0.CO;2-H; Kuhn TB, 1999, J NEUROSCI, V19, P1965; LEE T, IN PRESS NEURON; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; MACKETT M, 1985, DNA CLONING PRACTICA; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Miskevich F, 1998, MOL CELL NEUROSCI, V12, P240, DOI 10.1006/mcne.1998.0718; Narumiya S, 1996, J BIOCHEM-TOKYO, V120, P215; Obermeier A, 1998, EMBO J, V17, P4328, DOI 10.1093/emboj/17.15.4328; OROURKE NA, 1994, NEURON, V12, P921, DOI 10.1016/0896-6273(94)90343-3; PURPURA DP, 1975, ADV NEUROL, V12, P91; Rajan I, 1998, J NEUROSCI, V18, P7836; Rajan I, 1999, J NEUROBIOL, V38, P357, DOI 10.1002/(SICI)1097-4695(19990215)38:3<357::AID-NEU5>3.0.CO;2-#; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ruchhoeft ML, 1999, J NEUROSCI, V19, P8454; Stuart G., 1999, DENDRITES; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Witte S, 1996, J NEUROBIOL, V31, P219, DOI 10.1002/(SICI)1097-4695(199610)31:2<219::AID-NEU7>3.0.CO;2-E; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Wu GY, 1999, J NEUROSCI, V19, P4472; WU GY, 1995, NEURON, V14, P681, DOI 10.1016/0896-6273(95)90211-2; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zipkin ID, 1997, CELL, V90, P883, DOI 10.1016/S0092-8674(00)80353-0; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	48	252	255	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2000	3	3					217	225		10.1038/72920	http://dx.doi.org/10.1038/72920			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TE	10700252				2022-12-24	WOS:000085810500009
J	Lim, ST; Antonucci, DE; Scannevin, RH; Trimmer, JS				Lim, ST; Antonucci, DE; Scannevin, RH; Trimmer, JS			A novel targeting signal for proximal clustering of the KV2.1 K+ channel in hippocampal neurons	NEURON			English	Article							BETA-SUBUNIT POLYPEPTIDES; RAT-BRAIN; TRANSFERRIN RECEPTOR; CYTOPLASMIC DOMAIN; POTASSIUM CHANNEL; ALPHA-SUBUNITS; FASCICLIN-II; IN-VIVO; LOCALIZATION; EXPRESSION	The discrete localization of ion channels is a critical determinant of neuronal excitability. We show here that the dendritic K+ channels Kv2.1 and Kv2.2 were differentially targeted in cultured hippocampal neurons. Kv2.1 was found in high-density clusters on the soma and proximal dendrites, while Kv2.2 was uniformly distributed throughout the soma and dendrites. Chimeras revealed a proximal restriction and clustering domain on the cytoplasmic tail of Kv2.1. Truncations and internal deletions revealed a 26-amino acid targeting signal within which four residues were critical for localization. This signal is not related to other known sequences for neuronal and epithelial membrane protein targeting and represents a novel cytoplasmic signal responsible for proximal restriction and clustering.	SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Trimmer, JS (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.			Scannevin, Robert/0000-0002-5749-2785; Antonucci, Dana/0000-0001-8857-0865	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS034375] Funding Source: NIH RePORTER; NINDS NIH HHS [NS34375, R01 NS042225] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Baranauskas G, 1999, J NEUROSCI, V19, P6394; BekeleArcuri Z, 1996, NEUROPHARMACOLOGY, V35, P851, DOI 10.1016/0028-3908(96)00128-1; Brenman JE, 1998, J NEUROSCI, V18, P8805; CHANDY KG, 1995, LIGAND VOLTAGE GATED, P1; DARGEMONT C, 1993, EMBO J, V12, P1713, DOI 10.1002/j.1460-2075.1993.tb05816.x; DEHOOP M, 1995, J CELL BIOL, V130, P1447, DOI 10.1083/jcb.130.6.1447; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; Du J, 1998, NEUROSCIENCE, V84, P37, DOI 10.1016/S0306-4522(97)00519-8; Epperson A, 1999, AM J PHYSIOL-GASTR L, V277, pG127, DOI 10.1152/ajpgi.1999.277.1.G127; Garaschuk O, 1997, J PHYSIOL-LONDON, V502, P13, DOI 10.1111/j.1469-7793.1997.013bl.x; Goslin K., 1991, CULTURING NERVE CELL, P251; Hata Y, 1998, NEUROSCI RES, V32, P1, DOI 10.1016/S0168-0102(98)00069-8; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; HILFE B, 1992, IONIC CHANNELS EXCIT; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; HUMPHREY JS, 1993, J CELL BIOL, V120, P1123, DOI 10.1083/jcb.120.5.1123; HWANG PM, 1993, J NEUROSCI, V13, P1569; Jareb M, 1998, NEURON, V20, P855, DOI 10.1016/S0896-6273(00)80468-7; Keller P, 1997, J CELL SCI, V110, P3001; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kim JH, 1999, CURR OPIN CELL BIOL, V11, P248, DOI 10.1016/S0955-0674(99)80033-7; Korkotian E, 1997, J NEUROSCI, V17, P1670; Laube G, 1996, MOL BRAIN RES, V42, P51, DOI 10.1016/S0169-328X(96)00120-9; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MALETICSAVATIC M, 1995, J NEUROSCI, V15, P3840; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Murakoshi H, 1999, J NEUROSCI, V19, P1728; Murakoshi H, 1997, MOL PHARMACOL, V52, P821, DOI 10.1124/mol.52.5.821; Nakahira K, 1996, J BIOL CHEM, V271, P7084, DOI 10.1074/jbc.271.12.7084; NEAME SJ, 1993, J CELL BIOL, V121, P1299, DOI 10.1083/jcb.121.6.1299; Pongs O, 1999, FEBS LETT, V452, P31, DOI 10.1016/S0014-5793(99)00535-9; Rhodes KJ, 1997, J NEUROSCI, V17, P8246; RHODES KJ, 1995, J NEUROSCI, V15, P5360; Scannevin RH, 1996, J CELL BIOL, V135, P1619, DOI 10.1083/jcb.135.6.1619; Shamotienko OG, 1997, BIOCHEMISTRY-US, V36, P8195, DOI 10.1021/bi970237g; SHARMA N, 1993, J CELL BIOL, V123, P1835, DOI 10.1083/jcb.123.6.1835; Sheng M, 1999, ANN NY ACAD SCI, V868, P483, DOI 10.1111/j.1749-6632.1999.tb11317.x; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; SHI GY, 1994, J BIOL CHEM, V269, P23204; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stowell JN, 1999, NEURON, V22, P525, DOI 10.1016/S0896-6273(00)80707-2; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; SWANSON R, 1990, NEURON, V4, P929, DOI 10.1016/0896-6273(90)90146-7; Tejedor FJ, 1997, J NEUROSCI, V17, P152, DOI 10.1523/JNEUROSCI.17-01-00152.1997; Thomas U, 1997, NEURON, V19, P787, DOI 10.1016/S0896-6273(00)80961-7; Trimmer JS, 1999, NEURON, V22, P411, DOI 10.1016/S0896-6273(00)80692-3; Trimmer JS, 1998, CURR OPIN NEUROBIOL, V8, P370, DOI 10.1016/S0959-4388(98)80063-9; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; VANDONGEN AMJ, 1990, NEURON, V5, P433, DOI 10.1016/0896-6273(90)90082-Q; West AE, 1997, J NEUROSCI, V17, P6038; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1	53	207	247	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	2000	25	2					385	397		10.1016/S0896-6273(00)80902-2	http://dx.doi.org/10.1016/S0896-6273(00)80902-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	288EL	10719893	Bronze			2022-12-24	WOS:000085549100016
J	Chen, H; Bagri, A; Zupicich, JA; Zou, YM; Stoeckli, E; Pleasure, SJ; Lowenstein, DH; Skarnes, WC; Chedotal, A; Tessier-Lavigne, M				Chen, H; Bagri, A; Zupicich, JA; Zou, YM; Stoeckli, E; Pleasure, SJ; Lowenstein, DH; Skarnes, WC; Chedotal, A; Tessier-Lavigne, M			Neuropilin-2 regulates the development of select cranial and sensory nerves and hippocampal mossy fiber projections	NEURON			English	Article							NERVOUS-SYSTEM; SEMAPHORIN-III; RECEPTOR; AXONS; GROWTH; GUIDANCE; IV; EXPRESSION; NETRIN-1; MEMBRANE	Neuropilin-1 and neuropilin-2 bind differentially to different class 3 semaphorins and are thought to provide the ligand-binding moieties in receptor complexes mediating repulsive responses to these semaphorins. Here, we have studied the function of neuropilin-2 through analysis of a neuropilin-2 mutant mouse, which is viable and fertile. Repulsive responses of sympathetic and hippocampal neurons to Sema3F but not to Sema3A are abolished in the mutant. Marked defects are observed in the development of several cranial nerves, in the initial central projections of spinal sensory axons, and in the anterior commissure, habenulo-interpeduncular tract, and the projections of hippocampal mossy fiber axons in the infrapyramidal bundle. Our results show that neuropilin-2 is an essential component of the Sema3F receptor and identify key roles for neuropilin-2 in axon guidance in the PNS and CNS.	Univ Calif San Francisco, Dept Anat, San Francisco, CA 94243 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Howard Hughes Med Inst, San Francisco, CA 94243 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94243 USA; Hop La Pitie Salpetriere, INSERM, U106, F-75013 Paris, France; Univ Basel, Dept Integrat Biol, CH-4051 Basel, Switzerland; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Basel; University of California System; University of California Berkeley	Chedotal, A (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94243 USA.	chedotal@infobiogen.fr	Chedotal, Alain/F-2750-2017	Chedotal, Alain/0000-0001-7577-3794; Stoeckli, Esther/0000-0002-8485-0648; Schick, Joel/0000-0002-8623-4910	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010273] Funding Source: NIH RePORTER; NINDS NIH HHS [F32 NS010273] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Chedotal A, 1998, DEVELOPMENT, V125, P4313; Chen H, 1998, NEURON, V21, P1283, DOI 10.1016/S0896-6273(00)80648-0; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Chisholm A, 1999, CURR OPIN NEUROBIOL, V9, P603, DOI 10.1016/S0959-4388(99)00021-5; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; Cremer H, 1997, MOL CELL NEUROSCI, V8, P323, DOI 10.1006/mcne.1996.0588; de Castro F, 1999, J NEUROSCI, V19, P4428; Giger RJ, 1998, NEURON, V21, P1079, DOI 10.1016/S0896-6273(00)80625-X; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; Goodman CS, 1999, CELL, V97, P551, DOI 10.1016/S0092-8674(00)80766-7; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Kawakami A, 1996, J NEUROBIOL, V29, P1, DOI 10.1002/(SICI)1097-4695(199601)29:1<1::AID-NEU1>3.0.CO;2-F; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Keynes R, 1997, NEURON, V18, P889, DOI 10.1016/S0896-6273(00)80329-3; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Kolodkin AL, 1998, PROG BRAIN RES, V117, P115; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Makinen T, 1999, J BIOL CHEM, V274, P21217, DOI 10.1074/jbc.274.30.21217; Migdal M, 1998, J BIOL CHEM, V273, P22272, DOI 10.1074/jbc.273.35.22272; Nakamura F, 1998, NEURON, V21, P1093, DOI 10.1016/S0896-6273(00)80626-1; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; Parent M, 1999, J CHEM NEUROANAT, V16, P153, DOI 10.1016/S0891-0618(99)00008-3; PIMENTA AF, 1995, NEURON, V15, P287, DOI 10.1016/0896-6273(95)90034-9; Schopke R, 1991, Hippocampus, V1, P315, DOI 10.1002/hipo.450010322; SCHWEGLER H, 1995, BEHAV BRAIN RES, V67, P29, DOI 10.1016/0166-4328(95)91998-3; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Shirasaki R, 1996, NEURON, V17, P1079, DOI 10.1016/S0896-6273(00)80241-X; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Steup A, 1999, EUR J NEUROSCI, V11, P729, DOI 10.1046/j.1460-9568.1999.00517.x; SUPER H, 1994, J COMP NEUROL, V344, P101, DOI 10.1002/cne.903440108; TAKAGI S, 1991, NEURON, V7, P295, DOI 10.1016/0896-6273(91)90268-5; TAKAGI S, 1995, DEV BIOL, V170, P207, DOI 10.1006/dbio.1995.1208; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8	45	294	300	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	2000	25	1					43	56		10.1016/S0896-6273(00)80870-3	http://dx.doi.org/10.1016/S0896-6273(00)80870-3			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279KP	10707971	Bronze, Green Accepted			2022-12-24	WOS:000085043200009
J	Schinder, AF; Berninger, B; Poo, MM				Schinder, AF; Berninger, B; Poo, MM			Postsynaptic target specificity of neurotrophin-induced presynaptic potentiation	NEURON			English	Article							LONG-TERM POTENTIATION; NERVE GROWTH-FACTOR; CULTURED HIPPOCAMPAL-NEURONS; PAIRED-PULSE FACILITATION; SYNAPTIC TRANSMISSION; CA1 REGION; MONOCULAR DEPRIVATION; TRANSMITTER RELEASE; CORTICAL-NEURONS; DENDRITIC GROWTH	The role of the target cell in neurotrophin-induced modifications of glutamatergic synaptic transmission was examined in cultured hippocampal neurons. Brain-derived neurotrophic factor (BDNF) induced rapid and persistent potentiation of evoked glutamate release when the postsynaptic neuron was glutamatergic, or excitatory (E-->E), but not when it was GABAergic, or inhibitory (E-->I). This target-specific action of BDNF was also found at divergent outputs of a single presynaptic neuron innervating both glutamatergic and GABAergic neurons, suggesting that individual terminals can be independently modified. Surprisingly, BDNF increased the frequency of miniature postsynaptic currents at both E-->E and E-->I, although it had no effect on evoked currents at E-->I. Finally, potentiation by neurotrophin-3 (NT-3) was also target specific. The selective effect at E-->E suggests that retrograde signaling by the postsynaptic target cell endows a localized presynaptic action of neurotrophins.	Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Poo, MM (corresponding author), Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA.		Berninger, Benedikt/H-4098-2019	Berninger, Benedikt/0000-0003-2652-2782; Schinder, Alejandro/0000-0003-4863-8348	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037831] Funding Source: NIH RePORTER; NINDS NIH HHS [NS37831] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akaneya Y, 1997, J NEUROSCI, V17, P6707; Baldelli P, 1999, EUR J NEUROSCI, V11, P1127, DOI 10.1046/j.1460-9568.1999.00523.x; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; Bellingham MC, 1999, NEURON, V23, P159, DOI 10.1016/S0896-6273(00)80762-X; BERNINGER B, 1993, NEUROREPORT, V4, P1303, DOI 10.1097/00001756-199309150-00004; Berninger B, 1999, LEARN MEMORY, V6, P232; Berninger B, 1996, CURR OPIN NEUROBIOL, V6, P324, DOI 10.1016/S0959-4388(96)80115-2; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Binder DK, 1999, J NEUROSCI, V19, P1424; Bloechl A., 1995, European Journal of Neuroscience, V7, P1220; Boulanger L, 1999, SCIENCE, V284, P1982, DOI 10.1126/science.284.5422.1982; BROADIE K, 1994, P NATL ACAD SCI USA, V91, P10727, DOI 10.1073/pnas.91.22.10727; Cabelli RJ, 1997, NEURON, V19, P63, DOI 10.1016/S0896-6273(00)80348-7; DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5; DOMENICI L, 1991, P NATL ACAD SCI USA, V88, P8811, DOI 10.1073/pnas.88.19.8811; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Frerking M, 1998, J NEUROPHYSIOL, V80, P3383, DOI 10.1152/jn.1998.80.6.3383; GALL CM, 1989, SCIENCE, V245, P758, DOI 10.1126/science.2549634; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Goodman LJ, 1996, MOL CELL NEUROSCI, V7, P222, DOI 10.1006/mcne.1996.0017; Gottschalk W, 1998, J NEUROSCI, V18, P6830; HESTRIN S, 1993, NEURON, V11, P1083, DOI 10.1016/0896-6273(93)90221-C; Horch HW, 1999, NEURON, V23, P353; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; KIM HG, 1994, P NATL ACAD SCI USA, V91, P12341, DOI 10.1073/pnas.91.25.12341; KOKAIA M, 1995, EXP NEUROL, V133, P215, DOI 10.1006/exnr.1995.1024; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Korte M, 1996, P NATL ACAD SCI USA, V93, P12547, DOI 10.1073/pnas.93.22.12547; Lessmann V, 1998, NEUROSCIENCE, V86, P399; LESSMANN V, 1994, NEUROREPORT, V6, P21; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; Levine ES, 1998, P NATL ACAD SCI USA, V95, P10235, DOI 10.1073/pnas.95.17.10235; Li YX, 1998, J NEUROSCI, V18, P10231; Li YX, 1998, P NATL ACAD SCI USA, V95, P10884, DOI 10.1073/pnas.95.18.10884; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; Maccaferri G, 1998, SCIENCE, V279, P1368, DOI 10.1126/science.279.5355.1368; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; Marty S, 1997, TRENDS NEUROSCI, V20, P198, DOI 10.1016/S0166-2236(96)01026-0; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; McMahon LL, 1997, NEURON, V18, P295, DOI 10.1016/S0896-6273(00)80269-X; Messaoudi E, 1998, J NEUROPHYSIOL, V79, P496, DOI 10.1152/jn.1998.79.1.496; Ming GL, 1997, J NEUROSCI, V17, P7860; Morimoto T, 1998, NEUROSCIENCE, V82, P969; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; RIDDLE DR, 1995, NATURE, V378, P189, DOI 10.1038/378189a0; Rocamora N, 1996, J NEUROSCI, V16, P3991; ROSENMUND C, 1993, J PHYSIOL-LONDON, V470, P705, DOI 10.1113/jphysiol.1993.sp019884; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; SAKMANN B, 1998, CENTRAL SYNAPSES QUA, P64; SCHINDER AF, 1993, FEBS LETT, V332, P44, DOI 10.1016/0014-5793(93)80480-I; SEELEY PJ, 1983, P NATL ACAD SCI-BIOL, V80, P2789, DOI 10.1073/pnas.80.9.2789; Sherwood NT, 1999, J NEUROSCI, V19, P7025, DOI 10.1523/JNEUROSCI.19-16-07025.1999; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; STOOP R, 1995, SCIENCE, V267, P695, DOI 10.1126/science.7839148; Suen PC, 1997, P NATL ACAD SCI USA, V94, P8191, DOI 10.1073/pnas.94.15.8191; Tanaka T, 1997, J NEUROSCI, V17, P2959; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; Wang X, 1998, WORLD J GASTROENTERO, V4, P18, DOI 10.3748/wjg.v4.i1.18; Wang XH, 1997, NEURON, V19, P825, DOI 10.1016/S0896-6273(00)80964-2; WEISSKOPF MG, 1995, NATURE, V376, P256, DOI 10.1038/376256a0; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; ZAFRA F, 1991, P NATL ACAD SCI USA, V88, P10037, DOI 10.1073/pnas.88.22.10037	77	137	140	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	2000	25	1					151	163		10.1016/S0896-6273(00)80879-X	http://dx.doi.org/10.1016/S0896-6273(00)80879-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279KP	10707980	Bronze			2022-12-24	WOS:000085043200018
J	Brose, N; Rosenmund, C				Brose, N; Rosenmund, C			SV2: SVeeping up excess Ca2+ or TranSVorming presynaptic Ca2+ sensors?	NEURON			English	Editorial Material							SYNAPTIC VESICLES; IDENTIFICATION; PROTEINS		AG Mol Neurobiol, Max Planck Inst Expt Med, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, Abt Membranbiophys, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society	Brose, N (corresponding author), AG Mol Neurobiol, Max Planck Inst Expt Med, Hermann Rein Str 3, D-37077 Gottingen, Germany.		Rosenmund, Christian/AAC-3596-2020	Rosenmund, Christian/0000-0002-3905-2444				BAJJALIEH SM, 1992, SCIENCE, V257, P1271, DOI 10.1126/science.1519064; BAJJALIEH SM, 1993, P NATL ACAD SCI USA, V90, P2150, DOI 10.1073/pnas.90.6.2150; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; Crowder KM, 1999, P NATL ACAD SCI USA, V96, P15268, DOI 10.1073/pnas.96.26.15268; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; FAENY MB, 1992, CELL, V70, P861; GINGRICH JA, 1992, FEBS LETT, V312, P115, DOI 10.1016/0014-5793(92)80917-6; Janz R, 1998, J NEUROSCI, V18, P9269; LOWE AW, 1988, J CELL BIOL, V106, P51, DOI 10.1083/jcb.106.1.51; OORSCHOT DE, 1987, CURRENT TOPICS RES S, P85; Schivell AE, 1996, J BIOL CHEM, V271, P27770, DOI 10.1074/jbc.271.44.27770	11	10	10	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1999	24	4					766	768		10.1016/S0896-6273(00)81023-5	http://dx.doi.org/10.1016/S0896-6273(00)81023-5			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	269UE	10624939	Bronze			2022-12-24	WOS:000084495300004
J	Abbott, LF				Abbott, LF			The timing game	NATURE NEUROSCIENCE			English	News Item								In two publications presented as a contest, Hopfield and Brody propose a mechanism for detecting groups of neurons receiving similar levels of sensory input.	Brandeis Univ, Volen Ctr, Waltham, MA 02454 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Abbott, LF (corresponding author), Brandeis Univ, Volen Ctr, Waltham, MA 02454 USA.	abbott@brandeis.edu						Hopfield IJ, 2000, P NATL ACAD SCI USA, V97, P13919, DOI 10.1073/pnas.250483697; HOPFIELD JJ, IN PRESS P NATL ACAD; Van Vreeswijk C, 1994, J Comput Neurosci, V1, P313	3	9	9	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2001	4	2					115	116		10.1038/83920	http://dx.doi.org/10.1038/83920			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UC	11175864				2022-12-24	WOS:000167178100003
J	White, PM; Morrison, SJ; Orimoto, K; Kubu, CJ; Verdi, JM; Anderson, DJ				White, PM; Morrison, SJ; Orimoto, K; Kubu, CJ; Verdi, JM; Anderson, DJ			Neural crest stem cells undergo cell-intrinsic developmental changes in sensitivity to instructive differentiation signals	NEURON			English	Article							DEVELOPING SYMPATHETIC NEURONS; BONE MORPHOGENETIC PROTEIN-4; CENTRAL-NERVOUS-SYSTEM; IN-VIVO; PROGENITOR CELLS; TRANSPLANTATION; EXPRESSION; BRAIN; RAT; IDENTIFICATION	Rat neural crest stem cells (NCSCs) prospectively isolated from uncultured E14.5 sciatic nerve and transplanted into chick embryos generate fewer neurons than do NCSCs isolated from E10.5 neural tube explants. In addition, they differentiate primarily to cholinergic parasympathetic neurons, although in culture they can also generate noradrenergic sympathetic neurons. This in vivo behavior can be explained, at least in part, by a reduced sensitivity of sciatic nerve-derived NCSCs to the neurogenic signal BMP2 and by the observation that cholinergic neurons differentiate at a lower BMP2 concentration than do noradrenergic neurons in vitro. These results demonstrate that neural stem cells can undergo cell-intrinsic changes in their sensitivity to instructive signals, while maintaining multipotency and self-renewal capacity. They also suggest that the choice between sympathetic and parasympathetic fates may be determined by the local concentration of BMP2.	CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Western Ontario, Robarts Res Inst, Lab Neural Stem Cell Biol, London, ON NKA 568, Canada	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Western University (University of Western Ontario)	Anderson, DJ (corresponding author), CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA.	mancusog@its.caltech.edu	Morrison, Sean/ABD-5326-2021	Morrison, Sean/0000-0003-1587-8329				Anderson DJ, 1997, TRENDS GENET, V13, P276, DOI 10.1016/S0168-9525(97)01187-6; BRONNERFRASER M, 1991, DEVELOPMENT, P17; Brustle O, 1998, NAT BIOTECHNOL, V16, P1040, DOI 10.1038/3481; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Dale L, 1999, BIOESSAYS, V21, P751, DOI 10.1002/(SICI)1521-1878(199909)21:9<751::AID-BIES6>3.0.CO;2-I; Ernsberger U, 1999, CELL TISSUE RES, V297, P339, DOI 10.1007/s004410051363; FJORNSON CRR, 1999, SCIENCE, V283, P534; Francis NJ, 1999, ANNU REV NEUROSCI, V22, P541, DOI 10.1146/annurev.neuro.22.1.541; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; Gage FH, 1998, CURR OPIN NEUROBIOL, V8, P671, DOI 10.1016/S0959-4388(98)80098-6; Greenwood AL, 1999, DEVELOPMENT, V126, P3545; GROVES AK, 1995, DEVELOPMENT, V121, P887; Guidry G L, 1998, Adv Pharmacol, V42, P895; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; Kaufman M.H., 1992, ATLAS MOUSE DEV; KEAST JR, 1989, CELL TISSUE RES, V256, P105, DOI 10.1007/BF00224723; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Le Douarin NM, 1999, NEURAL CREST, V2; LEDOUARIN NM, 1980, NATURE, V286, P663, DOI 10.1038/286663a0; LEDOUARIN NM, 1986, SCIENCE, V231, P1515, DOI 10.1126/science.3952494; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; LO LC, 1995, NEURON, V15, P527, DOI 10.1016/0896-6273(95)90142-6; Lopez-Coviella I, 2000, SCIENCE, V289, P313, DOI 10.1126/science.289.5477.313; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; PATTERSON PH, 1978, ANNU REV NEUROSCI, V1, P1, DOI 10.1146/annurev.ne.01.030178.000245; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Reissmann E, 1996, DEVELOPMENT, V122, P2079; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; Schneider C, 1999, NEURON, V24, P861, DOI 10.1016/S0896-6273(00)81033-8; Shah NM, 1997, P NATL ACAD SCI USA, V94, P11369, DOI 10.1073/pnas.94.21.11369; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; SMITH JC, 1995, CURR OPIN CELL BIOL, V7, P856, DOI 10.1016/0955-0674(95)80070-0; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; VARLEY JE, 1995, DEV DYNAM, V203, P434, DOI 10.1002/aja.1002030406; Varley JE, 1996, EXP NEUROL, V140, P84, DOI 10.1006/exnr.1996.0118; Verdi JM, 1996, NEURON, V16, P515, DOI 10.1016/S0896-6273(00)80071-9; VERDI JM, 1994, NEURON, V13, P1359, DOI 10.1016/0896-6273(94)90421-9; White PM, 1999, DEVELOPMENT, V126, P4351; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	53	105	125	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	2001	29	1					57	71		10.1016/S0896-6273(01)00180-5	http://dx.doi.org/10.1016/S0896-6273(01)00180-5			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	397NX	11182081	Bronze			2022-12-24	WOS:000166702700009
J	Lee, T; Marticke, S; Sung, C; Robinow, S; Luo, LQ				Lee, T; Marticke, S; Sung, C; Robinow, S; Luo, LQ			Cell-autonomous requirement of the USP/EcR-B ecdysone receptor for mushroom body neuronal remodeling in Drosophila	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; RETINOID-X RECEPTOR; STEROID-HORMONE; BROAD-COMPLEX; DENDRITIC REORGANIZATION; HOMOLOG ULTRASPIRACLE; INSECT METAMORPHOSIS; GENE-EXPRESSION; INDUCIBLE GENE; EARLY PUFF	Neuronal process remodeling occurs widely in the construction of both invertebrate and vertebrate nervous systems. During Drosophila metamorphosis, gamma neurons of the mushroom bodies (MBs), the center for olfactory learning in insects, undergo pruning of larval-specific dendrites and axons followed by outgrowth of adult-specific processes. To elucidate the underlying molecular mechanisms, we conducted a genetic mosaic screen and identified one ultraspiracle (usp) allele defective in larval process pruning. Consistent with the notion that USP forms a heterodimer with the ecdysone receptor (EcR), we found that the EcR-B1 isoform is specifically expressed in the MB gamma neurons, and is required for the pruning of larval processes. Surprisingly, most identified primary EcR/USP targets are dispensable for MB neuronal remodeling. Our study demonstrates cell-autonomous roles for EcR/USP in controlling neuronal remodeling, potentially through novel downstream targets.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Univ Hawaii, Dept Zool, Honolulu, HI 96822 USA	Stanford University; University of Hawaii System	Lee, T (corresponding author), Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA.	tzumin@life.uiuc.edu		Luo, Liqun/0000-0001-5467-9264	NINDS NIH HHS [NS36623] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036623] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARNOLD AP, 1984, ANNU REV NEUROSCI, V7, P413, DOI 10.1146/annurev.ne.07.030184.002213; ASHBURNER M, 1973, COLD SPRING HARB SYM, V38, P655; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Bender M, 1997, CELL, V91, P777, DOI 10.1016/S0092-8674(00)80466-3; BRAND AH, 1993, DEVELOPMENT, V118, P401; BURTIS KC, 1990, CELL, V61, P85, DOI 10.1016/0092-8674(90)90217-3; Buszczak M, 1999, DEVELOPMENT, V126, P4581; Crittenden JR, 1998, LEARN MEMORY, V5, P38; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; DIBELLO PR, 1991, GENETICS, V129, P385; FLETCHER JC, 1995, GENETICS, V141, P1025; FLETCHER JC, 1995, DEVELOPMENT, V121, P1455; FLETCHER JC, 1995, DEVELOPMENT, V121, P1411; Hall BL, 1998, DEVELOPMENT, V125, P4709; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; HENRICH VC, 1994, DEV BIOL, V165, P38, DOI 10.1006/dbio.1994.1232; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; HUET F, 1993, DEVELOPMENT, V118, P613; INNOCENTI GM, 1981, SCIENCE, V212, P824, DOI 10.1126/science.7221566; Ito K, 1997, DEVELOPMENT, V124, P761; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; JACOBS GA, 1990, J NEUROSCI, V10, P1341; KATZ LC, 1992, ANNU REV NEUROSCI, V15, P31; KISS I, 1988, GENETICS, V118, P247; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; Kraft R, 1998, J NEUROSCI, V18, P8886; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; LEVINE RB, 1985, J NEUROSCI, V5, P2424; Levine Richard B., 1995, Current Opinion in Neurobiology, V5, P28, DOI 10.1016/0959-4388(95)80083-2; LEWIS EB, 1968, DROSOPHILA INFORM SE, V43, P193; LI CP, 1995, DEV BRAIN RES, V89, P227, DOI 10.1016/0165-3806(95)00119-X; Liu L, 1999, NATURE, V400, P753, DOI 10.1038/23456; Liu YR, 1999, DEVELOPMENT, V126, P1869; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; Martini SR, 2000, DEVELOPMENT, V127, P2663; Newsome TP, 2000, DEVELOPMENT, V127, P851; OLEARY DDM, 1993, NEURON, V10, P991, DOI 10.1016/0896-6273(93)90049-W; OLEARY DDM, 1981, DEV BRAIN RES, V1, P607, DOI 10.1016/0165-3806(81)90012-2; ORO AE, 1992, DEVELOPMENT, V115, P449; PRUGH J, 1992, DEV BIOL, V154, P331, DOI 10.1016/0012-1606(92)90072-O; RASTINEJAD F, 1995, NATURE, V375, P203, DOI 10.1038/375203a0; RESTIFO LL, 1991, DEV BIOL, V148, P174, DOI 10.1016/0012-1606(91)90328-Z; ROBINOW S, 1993, DEVELOPMENT, V119, P1251; Schubiger M, 1998, DEVELOPMENT, V125, P2053; Schubiger M, 2000, DEVELOPMENT, V127, P1151; SEGRAVES WA, 1990, GENE DEV, V4, P204, DOI 10.1101/gad.4.2.204; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; STANFIELD BB, 1982, NATURE, V298, P371, DOI 10.1038/298371a0; TALBOT WS, 1993, CELL, V73, P1323, DOI 10.1016/0092-8674(93)90359-X; TECHNAU G, 1982, NATURE, V295, P405, DOI 10.1038/295405a0; THOMAS HE, 1993, NATURE, V362, P471, DOI 10.1038/362471a0; Thummel CS, 1996, TRENDS GENET, V12, P306, DOI 10.1016/0168-9525(96)10032-9; TRUMAN JW, 1990, J NEUROBIOL, V21, P1072, DOI 10.1002/neu.480210711; TRUMAN JW, 1994, DEVELOPMENT, V120, P219; TRUMAN JW, 1976, SCIENCE, V192, P477, DOI 10.1126/science.1257782; WALKER VK, 1981, CELL, V26, P269, DOI 10.1016/0092-8674(81)90309-3; WEEKS JC, 1985, J NEUROSCI, V5, P2290; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; XU T, 1993, DEVELOPMENT, V117, P1223; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F; Zelhof AC, 1997, DEVELOPMENT, V124, P2499	65	207	209	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	2000	28	3					807	818		10.1016/S0896-6273(00)00155-0	http://dx.doi.org/10.1016/S0896-6273(00)00155-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386JJ	11163268	Bronze			2022-12-24	WOS:000166057500018
J	Schmitz, F; Konigstorfer, A; Sudhof, TC				Schmitz, F; Konigstorfer, A; Sudhof, TC			RIBEYE, a component of synaptic ribbons: A protein's journey through evolution provides insight into synaptic ribbon function	NEURON			English	Article							RETINAL BIPOLAR NEURONS; SACCULAR HAIR-CELLS; MAMMALIAN RETINA; TRANSCRIPTIONAL REPRESSION; VESICLE PROTEINS; SYNAPSES; PHOTORECEPTOR; COMPLEX; SYNAPTOPHYSIN; ENDOCYTOSIS	Photoreceptor cells utilize ribbon synapses to transmit sensory signals at high resolution. Ribbon synapses release neurotransmitters tonically, with a high release rate made possible by continuous docking of synaptic vesicles on presynaptic ribbons. We have partially purified synaptic ribbons from retina and identified a major protein component called RIBEYE. RIBEYE is composed of a unique A domain specific for ribbons, and a B domain identical with CtBP2, a transcriptional repressor that in turn is related to 2-hydroxyacid dehydrogenases. The A domain mediates assembly of RIBEYE into large structures, whereas the B domain binds NAD(+) with high affinity, similar to 2-hydroxyacid dehydrogenases. Our results define a unique component of synaptic ribbons and suggest that RIBEYE evolved in vertebrates under utilization of a preexisting protein to build a unique scaffold for a specialized synapse.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Ctr Basic Neurosci,Dept Mol Genet, Dallas, TX 75390 USA; Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; Leibniz Inst Neurobiol, Abt Neurochem Mol Biol, D-39118 Magdeburg, Germany	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Max Planck Society; Leibniz Institut fur Neurobiologie (LIN)	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Ctr Basic Neurosci,Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.							Borjigin J, 1999, ANNU REV PHARMACOL, V39, P53, DOI 10.1146/annurev.pharmtox.39.1.53; Brandstatter JH, 1996, J COMP NEUROL, V370, P1, DOI 10.1002/(SICI)1096-9861(19960617)370:1<1::AID-CNE1>3.0.CO;2-7; Brandstatter JH, 1996, EUR J NEUROSCI, V8, P823, DOI 10.1111/j.1460-9568.1996.tb01268.x; Brandstatter JH, 1999, EUR J NEUROSCI, V11, P3683, DOI 10.1046/j.1460-9568.1999.00793.x; DIGIROLAMO M, 1995, P NATL ACAD SCI USA, V92, P7065, DOI 10.1073/pnas.92.15.7065; Dowling J. E., 1987, RETINA APPROACHABLE; Fernandez-Chacon R, 1999, ANNU REV PHYSIOL, V61, P753, DOI 10.1146/annurev.physiol.61.1.753; GEPPERT M, 1994, EMBO J, V13, P3720, DOI 10.1002/j.1460-2075.1994.tb06681.x; GOLDBERG JD, 1994, J MOL BIOL, V236, P1123, DOI 10.1016/0022-2836(94)90016-7; GRAY EG, 1971, BRAIN RES, V35, P1, DOI 10.1016/0006-8993(71)90591-9; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HEIDELBERGER R, 1992, J PHYSIOL-LONDON, V447, P235, DOI 10.1113/jphysiol.1992.sp019000; HOPSU VK, 1964, EXP CELL RES, V37, P484; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; JASTROW H, 1997, CELL TISSUE RES, V287, P55; JOHNSTON PA, 1989, J BIOL CHEM, V264, P1268; Juusola M, 1996, TRENDS NEUROSCI, V19, P292, DOI 10.1016/S0166-2236(96)10028-X; Katsanis N, 1998, GENOMICS, V47, P294, DOI 10.1006/geno.1997.5115; Lenzi D, 1999, J NEUROSCI, V19, P119, DOI 10.1523/JNEUROSCI.19-01-00119.1999; MANDELL JW, 1990, NEURON, V5, P19, DOI 10.1016/0896-6273(90)90030-J; Morgans CW, 1996, J NEUROSCI, V16, P6713; Muresan V, 1999, J NEUROSCI, V19, P1027; Nachman-Clewner M, 1999, J COMP NEUROL, V415, P1, DOI 10.1002/(SICI)1096-9861(19991206)415:1<1::AID-CNE1>3.0.CO;2-G; NAEGELE JR, 1991, BRAIN RES, V559, P118, DOI 10.1016/0006-8993(91)90294-6; NAVONE F, 1986, J CELL BIOL, V103, P2511, DOI 10.1083/jcb.103.6.2511; Nibu Y, 1998, EMBO J, V17, P7009, DOI 10.1093/emboj/17.23.7009; PARSONS TD, 1994, NEURON, V13, P875, DOI 10.1016/0896-6273(94)90253-4; Poortinga G, 1998, EMBO J, V17, P2067, DOI 10.1093/emboj/17.7.2067; RAOMIROTZNIK R, 1995, NEURON, V14, P561, DOI 10.1016/0896-6273(95)90312-7; Rieke F, 1996, J PHYSIOL-LONDON, V493, P1; Rohrbough J, 1999, NEURON, V23, P55, DOI 10.1016/S0896-6273(00)80753-9; Sambrook J., 2002, MOL CLONING LAB MANU; SCHAEFFER SF, 1982, J COMP NEUROL, V204, P253, DOI 10.1002/cne.902040305; SCHAEPER U, 1995, P NATL ACAD SCI USA, V92, P10467, DOI 10.1073/pnas.92.23.10467; Schluter OM, 1999, J NEUROSCI, V19, P5834, DOI 10.1523/JNEUROSCI.19-14-05834.1999; SCHMITZ F, 1993, HISTOCHEMISTRY, V100, P35, DOI 10.1007/BF00268876; Schmitz F, 1996, J NEUROSCI, V16, P7109; SCHMITZ F, 1997, HISTOCHEM CELL BIOL, V108, P245; SMITH CA, 1961, J ULTRA MOL STRUCT R, V5, P523, DOI 10.1016/S0022-5320(61)80025-7; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; THOMPSON ST, 1976, P NATL ACAD SCI USA, V73, P361, DOI 10.1073/pnas.73.2.361; TRUJILLOCENOZ O, 1972, HDB SENSORY PHYSL, V2, P5; Turner J, 1998, EMBO J, V17, P5129, DOI 10.1093/emboj/17.17.5129; ULLRICH B, 1994, J PHYSIOL-PARIS, V88, P249, DOI 10.1016/0928-4257(94)90088-4; von Kriegstein K, 1999, EUR J NEUROSCI, V11, P1335, DOI 10.1046/j.1460-9568.1999.00542.x; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Weigert R, 1999, NATURE, V402, P429, DOI 10.1038/46587; Zhang HL, 1999, P NATL ACAD SCI USA, V96, P535, DOI 10.1073/pnas.96.2.535	50	395	410	0	16	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	2000	28	3					857	872		10.1016/S0896-6273(00)00159-8	http://dx.doi.org/10.1016/S0896-6273(00)00159-8			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386JJ	11163272	Bronze			2022-12-24	WOS:000166057500022
J	Conover, JC; Doetsch, F; Garcia-Verdugo, JM; Gale, NW; Yancopoulos, GD; Alvarez-Buylla, A				Conover, JC; Doetsch, F; Garcia-Verdugo, JM; Gale, NW; Yancopoulos, GD; Alvarez-Buylla, A			Disruption of Eph/ephrin signaling affects migration and proliferation in the adult subventricular zone	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; RECEPTOR TYROSINE KINASES; NEURAL CREST MIGRATION; EPH RECEPTORS; NEURONAL MIGRATION; MAMMALIAN BRAIN; STEM-CELLS; TRANSMEMBRANE LIGANDS; GROWTH-FACTOR; POLYSIALIC ACID	The subventricular zone (SVZ) of the lateral ventricles, the largest remaining germinal zone of the adult mammalian brain, contains an extensive network of neuroblasts migrating rostrally to the olfactory bulb. Little is known about the endogenous proliferation signals for SVZ neural stem cells or guidance cues along the migration pathway. Here we show that the receptor tyrosine kinases EphB1-3 and EphA4 and their transmembrane ligands, ephrins-B2/3, are expressed by cells of the SVZ. Electron microscopy revealed ephrin-B ligands associated with SVZ astrocytes, which function as stem cells in this germinal zone. A three-day infusion of the ectodomain of either EphB2 or ephrin-B2 into the lateral ventricle disrupted migration of neuroblasts and increased cell proliferation. These results suggest that Eph/ephrin signaling is involved in the migration of neuroblasts in the adult SVZ and in either direct or indirect regulation of cell proliferation.	Rockefeller Univ, New York, NY 10021 USA; Ecole Normale Super, CNRS, URA 1414, Paris, France; Univ Valencia, Valencia, Spain; Regeneron Pharmaceut Inc, Tarrytown, NY 10804 USA	Rockefeller University; Centre National de la Recherche Scientifique (CNRS); University of Valencia; Regeneron	Conover, JC (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.		García-Verdugo, José Manuel/L-8421-2017	García-Verdugo, José Manuel/0000-0001-9872-6499; Alvarez-Buylla, Arturo/0000-0003-4426-8925				ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; Alvarez-Buylla A, 1998, J NEUROSCI, V18, P1020; ALVAREZBUYLLA A, 1988, J NEUROSCI METH, V25, P165, DOI 10.1016/0165-0270(88)90155-0; BRAMBILLA R, 1995, EMBO J, V14, P3116, DOI 10.1002/j.1460-2075.1995.tb07314.x; Bruce V, 1999, BRAIN RES, V821, P169, DOI 10.1016/S0006-8993(99)01112-9; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; Chazal G, 2000, J NEUROSCI, V20, P1446; Craig CG, 1996, J NEUROSCI, V16, P2649; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; DRESCHER U, 1997, CURR BIOL, V7, P799; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; Gale NW, 1997, CELL TISSUE RES, V290, P227, DOI 10.1007/s004410050927; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Holder N, 1999, DEVELOPMENT, V126, P2033; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Krull CE, 1997, CURR BIOL, V7, P571, DOI 10.1016/S0960-9822(06)00256-9; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; Orioli D, 1997, TRENDS GENET, V13, P354, DOI 10.1016/S0168-9525(97)01220-1; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Smith A, 1997, CURR BIOL, V7, P561, DOI 10.1016/S0960-9822(06)00255-7; Stein E, 1996, J BIOL CHEM, V271, P23588, DOI 10.1074/jbc.271.38.23588; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; TANG JC, 1994, NEURON, V13, P405, DOI 10.1016/0896-6273(94)90356-5; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tropepe V, 1997, J NEUROSCI, V17, P7850; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; Weiss S, 1996, TRENDS NEUROSCI, V19, P387, DOI 10.1016/S0166-2236(96)10035-7; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; WINSLOW JW, 1995, NEURON, V14, P973, DOI 10.1016/0896-6273(95)90335-6; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yancopoulos GD, 1998, CELL, V93, P661, DOI 10.1016/S0092-8674(00)81426-9	50	394	424	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11					1091	1097		10.1038/80606	http://dx.doi.org/10.1038/80606			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TX	11036265				2022-12-24	WOS:000167177600013
J	Renzi, MJ; Wexler, TL; Raper, JA				Renzi, MJ; Wexler, TL; Raper, JA			Olfactory sensory axons expressing a dominant-negative semaphorin receptor enter the CNS early and overshoot their target	NEURON			English	Article							ENDOTHELIAL GROWTH-FACTOR; PERIPHERAL-NERVE PROJECTION; SECRETED SEMAPHORINS; SPINAL-CORD; NEUROPILIN; GUIDANCE; BULB; COLLAPSIN-1; XENOPUS; CELLS	Sensory axons extend from the chick olfactory epithelium to the telencephalon well before the maturation of their target, the olfactory bulb. During a waiting period of several days, olfactory axons arrive and accumulate outside the CNS while the bulb differentiates beneath them. Semephorin-3A is expressed in the telencephalon during this period and has been proposed to prevent their entry into the CNS. We show that the misexpression of a dominant-negative neuropilin-1 that blocks SEMA-3A-mediated signaling in olfactory sensory axons induces many of them to enter the telencephalon prematurely and to overshoot the olfactory bulb. These results suggest that chemorepellents can prevent the premature innervation of immature targets.	Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania	Raper, JA (corresponding author), Univ Penn, Sch Med, Dept Neurosci, 1115 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026527] Funding Source: NIH RePORTER; NICHD NIH HHS [T32HD07516] Funding Source: Medline; NINDS NIH HHS [R01-NS26527] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams RH, 1997, EMBO J, V16, P6077, DOI 10.1093/emboj/16.20.6077; Bagnard D, 1998, DEVELOPMENT, V125, P5043; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; BYRD CA, 1993, J COMP NEUROL, V331, P551, DOI 10.1002/cne.903310410; BYRD CA, 1991, J COMP NEUROL, V314, P79, DOI 10.1002/cne.903140108; BYRD CA, 1993, J NEUROBIOL, V24, P1229, DOI 10.1002/neu.480240909; Catalano SM, 1998, MOL CELL NEUROSCI, V11, P173, DOI 10.1006/mcne.1998.0687; Chedotal A, 1998, DEVELOPMENT, V125, P4313; Chen H, 1998, NEURON, V21, P1283, DOI 10.1016/S0896-6273(00)80648-0; Clauss M, 1996, J BIOL CHEM, V271, P17629, DOI 10.1074/jbc.271.30.17629; DOUCETTE R, 1989, J COMP NEUROL, V285, P514, DOI 10.1002/cne.902850407; Feiner L, 1997, NEURON, V19, P539, DOI 10.1016/S0896-6273(00)80370-0; Giger RJ, 1998, NEURON, V21, P1079, DOI 10.1016/S0896-6273(00)80625-X; GONG QH, 1995, NEURON, V14, P91, DOI 10.1016/0896-6273(95)90243-0; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; HINDS JW, 1972, J COMP NEUROL, V146, P253, DOI 10.1002/cne.901460208; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Kobayashi H, 1997, J NEUROSCI, V17, P8339; Kolodkin AL, 1998, PROG BRAIN RES, V117, P115; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Koppel AM, 1997, NEURON, V19, P531, DOI 10.1016/S0896-6273(00)80369-4; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Migdal M, 1998, J BIOL CHEM, V273, P22272, DOI 10.1074/jbc.273.35.22272; Mulrenin EM, 1999, ENDOCRINOLOGY, V140, P422, DOI 10.1210/en.140.1.422; Nakamura F, 1998, NEURON, V21, P1093, DOI 10.1016/S0896-6273(00)80626-1; PARK JE, 1994, J BIOL CHEM, V269, P25646; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Renzi MJ, 1999, J NEUROSCI, V19, P7870; SANTACANA M, 1992, DEV BRAIN RES, V70, P213, DOI 10.1016/0165-3806(92)90200-G; Shepherd I, 1996, DEV BIOL, V173, P185, DOI 10.1006/dbio.1996.0016; Shepherd IT, 1997, DEVELOPMENT, V124, P1377; Shimizu M, 2000, J CELL BIOL, V148, P1283, DOI 10.1083/jcb.148.6.1283; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Yu HH, 1999, NEURON, V22, P11, DOI 10.1016/S0896-6273(00)80672-8	43	63	63	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	2000	28	2					437	447		10.1016/S0896-6273(00)00123-9	http://dx.doi.org/10.1016/S0896-6273(00)00123-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	377CE	11144354	Bronze			2022-12-24	WOS:000165493700019
J	Dragoi, V; Sharma, J; Sur, M				Dragoi, V; Sharma, J; Sur, M			Adaptation-induced plasticity of orientation tuning in adult visual cortex	NEURON			English	Article							CAT STRIATE CORTEX; SYNAPTIC DEPRESSION; ORIENTED CONTOURS; RECEPTIVE-FIELDS; GAIN-CONTROL; SELECTIVITY; EXPERIENCE; CELLS; MAPS; DYNAMICS	A key emergent property of the primary visual cortex (V1) is the orientation selectivity of its neurons. The extent to which adult visual cortical neurons can exhibit changes in orientation selectivity is unknown. Here we use single-unit recording and intrinsic signal imaging in V1 of adult cats to demonstrate systematic repulsive shifts in orientation preference following short-term exposure (adaptation) to one stimulus orientation. In contrast to the common view of adaptation as a passive process by which responses around the adapting orientation are reduced, we show that changes in orientation tuning also occur due to response increases at orientations away from the adapting stimulus. Adaptation-induced orientation plasticity is thus an active time-dependent process that involves network interactions and includes both response depression and enhancement.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Dragoi, V (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.				NEI NIH HHS [EY07023] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; BENEVENTO LA, 1972, NATURE-NEW BIOL, V238, P124, DOI 10.1038/newbio238124a0; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; BLAKEMORE C, 1971, J PHYSIOL-LONDON, V213, P157, DOI 10.1113/jphysiol.1971.sp009374; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V200, pP11; BLAKEMORE C, 1977, PHILOS T ROY SOC B, V278, P425, DOI 10.1098/rstb.1977.0052; BLAKEMORE C, 1970, NATURE, V228, P477, DOI 10.1038/228477a0; Blakemore C., 2010, VISION CODING EFFICI, P363, DOI 10.1017/cbo9780511626197.034; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Carandini M, 1997, PHILOS T R SOC B, V352, P1149, DOI 10.1098/rstb.1997.0098; Carandini M, 1998, NEUROPHARMACOLOGY, V37, P501, DOI 10.1016/S0028-3908(98)00069-0; CELEBRINI S, 1993, VISUAL NEUROSCI, V10, P811, DOI 10.1017/S0952523800006052; Chance FS, 1998, J NEUROSCI, V18, P4785; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P4002, DOI 10.1073/pnas.95.7.4002; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Dragoi V, 2000, J NEUROPHYSIOL, V83, P1019, DOI 10.1152/jn.2000.83.2.1019; FERSTER D, 1986, J NEUROSCI, V6, P1284; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; FREGNAC Y, 1978, J PHYSIOL-LONDON, V278, P27, DOI 10.1113/jphysiol.1978.sp012290; GANZ L, 1966, PSYCHOL REV, V73, P128, DOI 10.1037/h0022952; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; Gibson JJ, 1933, J EXP PSYCHOL, V16, P1, DOI 10.1037/h0074626; Godecke I, 1997, EUR J NEUROSCI, V9, P1754; GREENLEE MW, 1987, VISION RES, V27, P1041, DOI 10.1016/0042-6989(87)90017-4; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; HAMMOND P, 1985, EXP BRAIN RES, V60, P411; HAMMOND P, 1989, VISION RES, V29, P1671, DOI 10.1016/0042-6989(89)90149-1; HAMMOND P, 1986, VISION RES, V26, P1055, DOI 10.1016/0042-6989(86)90039-8; HIRSCH HVB, 1970, SCIENCE, V168, P869, DOI 10.1126/science.168.3933.869; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; KOHLER W, 1944, P AM PHILOS SOC, V88, P306; MAFFEI L, 1973, SCIENCE, V182, P1036, DOI 10.1126/science.182.4116.1036; MAGNUSSEN S, 1980, SCIENCE, V207, P908, DOI 10.1126/science.7355271; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; NELSON SB, 1991, J NEUROSCI, V11, P344; OHZAWA I, 1982, NATURE, V298, P266, DOI 10.1038/298266a0; Rao SC, 1997, J COMP NEUROL, V387, P358; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; SAUL AB, 1989, VISUAL NEUROSCI, V2, P593, DOI 10.1017/S0952523800003527; Sengpiel F, 1999, NAT NEUROSCI, V2, P727, DOI 10.1038/11192; Sheth BR, 1996, SCIENCE, V274, P2110, DOI 10.1126/science.274.5295.2110; SHEVELEV IA, 1993, NEUROSCIENCE, V56, P865, DOI 10.1016/0306-4522(93)90133-Z; SILLITO AM, 1980, BRAIN RES, V194, P517, DOI 10.1016/0006-8993(80)91234-2; SOMERS DC, 1995, J NEUROSCI, V15, P5448; STRYKER MP, 1978, J NEUROPHYSIOL, V41, P896, DOI 10.1152/jn.1978.41.4.896; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411; TOLHURST DJ, 1975, VISION RES, V15, P967, DOI 10.1016/0042-6989(75)90238-2; Toth LJ, 1997, CEREB CORTEX, V7, P703, DOI 10.1093/cercor/7.8.703; Wainwright MJ, 1999, VISION RES, V39, P3960, DOI 10.1016/S0042-6989(99)00101-7; Whitaker D, 2000, NAT NEUROSCI, V3, P13, DOI 10.1038/71088; WOLFE JM, 1984, VISION RES, V24, P1959, DOI 10.1016/0042-6989(84)90030-0; WORGOTTER F, 1991, EXP BRAIN RES, V83, P665; WORGOTTER F, 1991, J NEUROSCI, V11, P1959	59	343	348	0	31	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	2000	28	1					287	298		10.1016/S0896-6273(00)00103-3	http://dx.doi.org/10.1016/S0896-6273(00)00103-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	370VN	11087001	Green Published, Bronze			2022-12-24	WOS:000165143500028
J	Mirnics, K; Middleton, FA; Marquez, A; Lewis, DA; Levitt, P				Mirnics, K; Middleton, FA; Marquez, A; Lewis, DA; Levitt, P			Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex	NEURON			English	Article							MEDIAL TEMPORAL-LOBE; DECREASED HIPPOCAMPAL EXPRESSION; MAGNETIC-RESONANCE SPECTROSCOPY; GLUTAMATE RECEPTOR GENE; NEURON AXON TERMINALS; MESSENGER-RNAS; CDNA MICROARRAYS; CEREBRAL-CORTEX; SYNAPSIN-I; RAT-BRAIN	Microarray expression profiling of prefrontal cortex from matched pairs of schizophrenic and control subjects and hierarchical data analysis revealed that transcripts encoding proteins involved in the regulation of presynaptic function (PSYN) were decreased in all subjects with schizophrenia. Genes of the PSYN group showed a different combination of decreased expression across subjects. Over 250 other gene groups did not show altered expression. Selected PSYN microarray observations were verified by in situ hybridization. Two of the most consistently changed transcripts in the PSYN functional gene group, N-ethylmaleimide sensitive factor and synapsin II, were decreased in ten of ten and nine of ten subjects with schizophrenia, respectively. The combined data suggest that subjects with schizophrenia share a common abnormality in presynaptic function. We set forth a predictive, testable model.	Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Neurosci, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, PittArray, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mirnics, K (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA.	karoly+@pitt.edu	Mirnics, Karoly/E-6730-2010; Lewis, David A/G-4053-2014	Mirnics, Karoly/0000-0002-5521-0254; Lewis, David A/0000-0002-3225-6778	NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH018273, P50MH045156] Funding Source: NIH RePORTER; NIMH NIH HHS [MH45156, T32 MH18273] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AKBARIAN S, 1995, CEREB CORTEX, V5, P550, DOI 10.1093/cercor/5.6.550; Akbarian S, 1996, J NEUROSCI, V16, P19; AKBARIAN S, 1995, ARCH GEN PSYCHIAT, V52, P258, DOI 10.1001/archpsyc.1995.03950160008002; AKBARIAN S, 1995, BRAIN RES, V699, P297, DOI 10.1016/0006-8993(95)00922-D; Akil M, 1999, AM J PSYCHIAT, V156, P1580, DOI 10.1176/ajp.156.10.1580; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; ANDERSON SA, 1995, NEUROSCIENCE, V67, P7, DOI 10.1016/0306-4522(95)00051-J; Andreasen NC, 1996, NEURON, V16, P697, DOI 10.1016/S0896-6273(00)80090-2; Andreasen NC, 1997, LANCET, V349, P1730, DOI 10.1016/S0140-6736(96)08258-X; Bajjalieh SM, 1999, CURR OPIN NEUROBIOL, V9, P321, DOI 10.1016/S0959-4388(99)80047-6; BARTON AJL, 1993, J NEUROCHEM, V61, P1, DOI 10.1111/j.1471-4159.1993.tb03532.x; Bertolino A, 2000, AM J PSYCHIAT, V157, P26, DOI 10.1176/ajp.157.1.26; Bird TD, 1997, NEUROLOGY, V48, P949, DOI 10.1212/WNL.48.4.949; BOURGEOIS JP, 1994, CEREB CORTEX, V4, P78, DOI 10.1093/cercor/4.1.78; BOURGEOIS JP, 2001, HDB DEV COGNITIVE NE; Brandt SA, 1998, EXP BRAIN RES, V118, P197, DOI 10.1007/s002210050272; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; BROWNING MD, 1993, BIOL PSYCHIAT, V34, P529, DOI 10.1016/0006-3223(93)90195-J; Burrows RC, 2000, NEUROSCIENCE, V96, P825, DOI 10.1016/S0306-4522(99)00558-8; Campbell DB, 1999, EXP NEUROL, V160, P268, DOI 10.1006/exnr.1999.7171; CARPENTER WT, 1994, NEW ENGL J MED, V330, P681, DOI 10.1056/NEJM199403103301006; Chafee MV, 2000, J NEUROPHYSIOL, V83, P1550, DOI 10.1152/jn.2000.83.3.1550; Chen ACH, 1998, MOL BRAIN RES, V54, P92; COLLINGE J, 1991, BRIT J PSYCHIAT, V159, P857, DOI 10.1192/bjp.159.6.857; Davidsson P, 1999, SCHIZOPHR RES, V40, P23, DOI 10.1016/S0920-9964(99)00037-7; Dean B, 1997, J NEURAL TRANSM, V104, P1371, DOI 10.1007/BF01294738; Duggan DJ, 1999, NAT GENET, V21, P10, DOI 10.1038/4434; EASTWOOD SL, 1995, MOL BRAIN RES, V29, P211, DOI 10.1016/0169-328X(94)00247-C; Eastwood SL, 1997, BIOL PSYCHIAT, V41, P636, DOI 10.1016/S0006-3223(96)00220-X; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ferguson GD, 2000, P NATL ACAD SCI USA, V97, P5598, DOI 10.1073/pnas.100104597; Fernandez-Chacon R, 1999, J BIOL CHEM, V274, P32551, DOI 10.1074/jbc.274.46.32551; Frederikse M, 2000, AM J PSYCHIAT, V157, P422, DOI 10.1176/appi.ajp.157.3.422; Garey LJ, 1998, J NEUROL NEUROSUR PS, V65, P446, DOI 10.1136/jnnp.65.4.446; Gearon JS, 2000, SCHIZOPHR RES, V43, P65, DOI 10.1016/S0920-9964(99)00175-9; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Glantz LA, 1997, ARCH GEN PSYCHIAT, V54, P943; GLANTZ LA, 2000, IN PRESS BIOL PSYCHI; Goldstein JM, 1999, ARCH GEN PSYCHIAT, V56, P537, DOI 10.1001/archpsyc.56.6.537; HARRISON PJ, 1991, LANCET, V337, P450, DOI 10.1016/0140-6736(91)93392-M; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Harrison PJ, 1997, SCHIZOPHR RES, V26, P93, DOI 10.1016/S0920-9964(97)00048-0; Harrison PJ, 1998, LANCET, V352, P1669, DOI 10.1016/S0140-6736(98)03341-8; Hudson C, 1999, BIOL PSYCHIAT, V46, P401, DOI 10.1016/S0006-3223(99)00010-4; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Hyman SE, 2000, B WORLD HEALTH ORGAN, V78, P455; Hyman SE, 2000, BIOL PSYCHIAT, V47, P1, DOI 10.1016/S0006-3223(99)00077-3; Inglehearn CF, 1998, EYE, V12, P571, DOI 10.1038/eye.1998.147; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Janz R, 1999, NEURON, V24, P687, DOI 10.1016/S0896-6273(00)81122-8; Johnson SA, 1999, J PHARMACOL EXP THER, V289, P392; Karayiorgou M, 1997, NEURON, V19, P967, DOI 10.1016/S0896-6273(00)80390-6; Karson C. N., 1996, Society for Neuroscience Abstracts, V22, P1677; Karson CN, 1999, MOL PSYCHIATR, V4, P39, DOI 10.1038/sj.mp.4000459; LEWIS D, 2000, IN PRESS NEURON; Lewis DA, 2000, NEUROSCIENTIST, V6, P208, DOI 10.1177/107385840000600311; Linial M, 1997, J NEUROCHEM, V69, P1781; Long JM, 1999, J GERONTOL A-BIOL, V54, pB407, DOI 10.1093/gerona/54.10.B407; MatusLeibovitch N, 1997, MOL BRAIN RES, V45, P301, DOI 10.1016/S0169-328X(96)00265-3; McCarley RW, 1999, BIOL PSYCHIAT, V45, P1099, DOI 10.1016/S0006-3223(99)00018-9; MeadorWoodruff JH, 1997, ARCH GEN PSYCHIAT, V54, P1089; MELLONI RH, 1993, J COMP NEUROL, V327, P507, DOI 10.1002/cne.903270404; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; Nakahara T, 1998, MOL BRAIN RES, V61, P238, DOI 10.1016/S0169-328X(98)00230-7; PAKKENBERG B, 1993, BIOL PSYCHIAT, V34, P768, DOI 10.1016/0006-3223(93)90065-L; PerroneBizzozero NI, 1996, P NATL ACAD SCI USA, V93, P14182, DOI 10.1073/pnas.93.24.14182; PETTEGREW JW, 1993, SCHIZOPHRENIA BULL, V19, P35, DOI 10.1093/schbul/19.1.35; Pierri JN, 1999, AM J PSYCHIAT, V156, P1709; Porton B, 1999, J NEUROCHEM, V73, P2266, DOI 10.1046/j.1471-4159.1999.0732266.x; Pulver AE, 2000, BIOL PSYCHIAT, V47, P221; Rajkowska G, 1998, ARCH GEN PSYCHIAT, V55, P215, DOI 10.1001/archpsyc.55.3.215; RISCH N, 1984, AM J HUM GENET, V36, P1039; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Sanfilipo M, 2000, ARCH GEN PSYCHIAT, V57, P471, DOI 10.1001/archpsyc.57.5.471; Seeman M V, 2000, Medscape Womens Health, V5, P2; Selemon LD, 1999, BIOL PSYCHIAT, V46, P161, DOI 10.1016/S0006-3223(99)00113-4; Selemon LD, 1999, BIOL PSYCHIAT, V45, P17, DOI 10.1016/S0006-3223(98)00281-9; Selemon LD, 1998, J COMP NEUROL, V392, P402; SELEMON LD, 1995, ARCH GEN PSYCHIAT, V52, P805; Shimon H, 1998, BIOL PSYCHIAT, V44, P428, DOI 10.1016/S0006-3223(98)00071-7; STAMM JS, 1969, J COMP PHYSIOL PSYCH, V67, P535, DOI 10.1037/h0027294; Stanley JA, 1996, SCHIZOPHRENIA BULL, V22, P597, DOI 10.1093/schbul/22.4.597; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Tcherepanov AA, 1997, J NEUROSCI RES, V49, P639, DOI 10.1002/(SICI)1097-4547(19970901)49:5<639::AID-JNR14>3.0.CO;2-Q; Tolar LA, 1998, J NEUROSCI, V18, P10250; Tsuang M, 2000, BIOL PSYCHIAT, V47, P210, DOI 10.1016/S0006-3223(99)00289-9; Van Soest S, 1999, SURV OPHTHALMOL, V43, P321, DOI 10.1016/S0039-6257(98)00046-0; VOLK DV, 2000, IN PRESS ARCH GEN PS; Weinberger DR, 1999, BIOL PSYCHIAT, V46, P3; WEINBERGER DR, 1995, LANCET, V346, P552, DOI 10.1016/S0140-6736(95)91386-6; WEINBERGER DR, 1986, ARCH GEN PSYCHIAT, V43, P114; Whitney LW, 1999, ANN NEUROL, V46, P425; Woo TU, 1998, P NATL ACAD SCI USA, V95, P5341, DOI 10.1073/pnas.95.9.5341; Wood GK, 1997, DEV BRAIN RES, V101, P17, DOI 10.1016/S0165-3806(97)00050-3	97	708	728	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	2000	28	1					53	67		10.1016/S0896-6273(00)00085-4	http://dx.doi.org/10.1016/S0896-6273(00)00085-4			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	370VN	11086983	Bronze			2022-12-24	WOS:000165143500010
J	Qian, XM; Shen, Q; Goderie, SK; He, WL; Capela, A; Davis, AA; Temple, S				Qian, XM; Shen, Q; Goderie, SK; He, WL; Capela, A; Davis, AA; Temple, S			Timing of CNS cell generation: A programmed sequence of neuron and glial cell production from isolated murine cortical stem cells	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD OLIGODENDROCYTES; DEVELOPING CEREBRAL-CORTEX; RAT OPTIC-NERVE; PROGENITOR-CELL; DEVELOPMENTAL-CHANGES; CAENORHABDITIS-ELEGANS; PRECURSOR CELLS; SONIC HEDGEHOG; EMBRYONIC CNS	Multipotent stem cells that generate both neurons and glia are widespread components of the early neuroepithelium. During CNS development, neurogenesis largely precedes gliogenesis: how is this timing achieved? Using clonal cell culture combined with long-term time-lapse video microscopy, we show that isolated stem cells from the embryonic mouse cerebral cortex exhibit a distinct order of cell-type production: neuroblasts first and glioblasts later. This is accompanied by changes in their capacity to make neurons versus glia and in their response to the mitogen EGF. Hence, multipotent stem cells alter their properties over time and undergo distinct phases of development that play a key role in scheduling production of diverse CNS cells.	Albany Med Coll, Dept Pharmacol & Neurosci, Albany, NY 12208 USA; Amgen Inc, Thousand Oaks, CA 91320 USA	Albany Medical College; Amgen	Temple, S (corresponding author), Albany Med Coll, Dept Pharmacol & Neurosci, Albany, NY 12208 USA.				NINDS NIH HHS [R01 NS 33529] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033529] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABNEY ER, 1981, DEV BIOL, V83, P301, DOI 10.1016/0012-1606(81)90476-0; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Barres BA, 1999, J CELL BIOL, V147, P1123, DOI 10.1083/jcb.147.6.1123; BATE CM, 1976, J EMBRYOL EXP MORPH, V35, P107; Bayer S.A., 1991, NEOCORTICAL DEV; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; Burne JF, 1996, J NEUROSCI, V16, P2064; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Cameron HA, 1998, J NEUROBIOL, V36, P287, DOI 10.1002/(SICI)1097-4695(199808)36:2<287::AID-NEU13>3.0.CO;2-B; CAMERON RS, 1991, GLIA, V4, P124, DOI 10.1002/glia.440040204; CONDRON BG, 1994, J NEUROSCI, V14, P5766; CUI X, 1992, DEVELOPMENT, V116, P943; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; DOE CQ, 1985, DEV BIOL, V111, P193, DOI 10.1016/0012-1606(85)90445-2; Frantz GD, 1996, NEURON, V17, P55, DOI 10.1016/S0896-6273(00)80280-9; Fuerstenberg S, 1998, INT J DEV BIOL, V42, P379; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GARD AL, 1990, NEURON, V5, P615, DOI 10.1016/0896-6273(90)90216-3; Giesen K, 1997, DEVELOPMENT, V124, P2307; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; Jacobson M., 1991, DEV NEUROBIOLOGY; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; KILPATRICK TJ, 1995, MOL CELL NEUROSCI, V6, P2, DOI 10.1006/mcne.1995.1002; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; LANSDORP PM, 1995, EXP HEMATOL, V23, P187; Lavdas AA, 1999, J NEUROSCI, V19, P7881; LEBER SM, 1990, J NEUROSCI, V10, P2451; Levine JM, 1996, PERSPECT DEV NEUROBI, V3, P245; LEVISON SW, 1993, DEVELOPMENT, V119, P611; Lin HF, 1997, TRENDS GENET, V13, P33, DOI 10.1016/S0168-9525(96)10050-0; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; MACLEISH PR, 1988, NEURON, V1, P751, DOI 10.1016/0896-6273(88)90173-0; Marmur R, 1998, DEV BIOL, V204, P577, DOI 10.1006/dbio.1998.9099; MayerProschel M, 1997, NEURON, V19, P773, DOI 10.1016/S0896-6273(00)80960-5; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Mione MC, 1997, J NEUROSCI, V17, P2018; MISSON JP, 1991, GLIA, V4, P138, DOI 10.1002/glia.440040205; MORRISON SJ, 1997, CELL, V88, P297; Mujtaba T, 1999, DEV BIOL, V214, P113, DOI 10.1006/dbio.1999.9418; Orentas DM, 1996, DEV BIOL, V177, P43, DOI 10.1006/dbio.1996.0143; Parnavelas JG, 1999, EXP NEUROL, V156, P418, DOI 10.1006/exnr.1999.7044; Poncet C, 1996, MECH DEVELOP, V60, P13, DOI 10.1016/S0925-4773(96)00595-3; Pringle NP, 1996, DEV BIOL, V177, P30, DOI 10.1006/dbio.1996.0142; Qian XM, 1998, DEVELOPMENT, V125, P3143; Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; Rao MS, 1999, ANAT RECORD, V257, P137; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Richardson WD, 1997, DEV NEUROSCI-BASEL, V19, P58, DOI 10.1159/000111186; Schmid A, 1999, DEVELOPMENT, V126, P4653; Shen Q, 1998, J NEUROBIOL, V36, P162, DOI 10.1002/(SICI)1097-4695(199808)36:2<162::AID-NEU5>3.0.CO;2-#; SKOFF RP, 1990, DEV BIOL, V139, P149, DOI 10.1016/0012-1606(90)90285-Q; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Tan SS, 1998, NEURON, V21, P295, DOI 10.1016/S0896-6273(00)80539-5; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; TEMPLE S, 1994, DEVELOPMENT, V120, P999; TEMPLE S, 1995, NEURON, V15, P249, DOI 10.1016/0896-6273(95)90030-6; Temple S, 1996, CURR OPIN NEUROBIOL, V6, P11, DOI 10.1016/S0959-4388(96)80003-1; TEMPLE S, 1989, NATURE, V340, P471, DOI 10.1038/340471a0; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3; Zhu G, 1999, J NEUROSCI RES, V56, P131, DOI 10.1002/(SICI)1097-4547(19990415)56:2<131::AID-JNR3>3.0.CO;2-I	71	643	667	1	31	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	2000	28	1					69	80		10.1016/S0896-6273(00)00086-6	http://dx.doi.org/10.1016/S0896-6273(00)00086-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	370VN	11086984	Bronze			2022-12-24	WOS:000165143500011
J	Uchida, N; Takahashi, YK; Tanifuji, M; Mori, K				Uchida, N; Takahashi, YK; Tanifuji, M; Mori, K			Odor maps in the mammalian olfactory bulb: domain organization and odorant structural features	NATURE NEUROSCIENCE			English	Article							MITRAL TUFTED CELLS; FUNCTIONAL EXPRESSION; 2-DEOXYGLUCOSE UPTAKE; HOMOLOGOUS SERIES; RECEPTOR; RABBIT; COMBINATORIAL; REPRESENTATIONS; IDENTIFICATION; PROJECTIONS	Psychophysical studies indicate that structural features of odorants differentially influence their perceived odor. In the olfactory bulb (OB), odorants are represented by ensembles of activated glomeruli. Here we used optical imaging of intrinsic signals to examine how these structural features are represented spatially in the sensory map of the rat OB. We found that the dorsal OB contained two topographically fixed domains; constituent glomeruli in each domain could be activated by odorants with particular functional groups. Within each domain, other structural features such as carbon chain length and branching were represented by local differences in patterns. These results suggest that structural features are categorized into two classes, primary features (functional groups) that characterize each domain, and secondary features that are represented by local positions within each domain. Such hierarchical representations of different structural features correlate well with psychophysical structure-odor relationships.	RIKEN, Brain Sci Inst, Lab Integrat Neural Syst, Wako, Saitama 3510198, Japan; Univ Tokyo, Grad Sch Med, Dept Physiol, Tokyo 1130033, Japan; RIKEN, Brain Sci Inst, Lab Neuronal Recognit Mol, Wako, Saitama 3510198, Japan	RIKEN; University of Tokyo; RIKEN	Uchida, N (corresponding author), Cold Spring Harbor Lab, POB 100,1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	uchida@cshl.org	Tanifuji, Manabu/H-1744-2019	Tanifuji, Manabu/0000-0001-7754-7774; Uchida, Naoshige/0000-0002-5755-9409; Mori, Kensaku/0000-0001-7853-9370				AMOORE JE, 1964, SCI AM, V210, P42, DOI 10.1038/scientificamerican0264-42; BEETS MGJ, 1970, PHARMACOL REV, V22, P1; BONHOEFFER T, 1995, BRAIN MAPPING METHOD, P55; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 2000, CELL, V100, P611, DOI 10.1016/S0092-8674(00)80698-4; Friedrich RW, 1998, J NEUROSCI, V18, P9977; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; GUTHRIE KM, 1993, P NATL ACAD SCI USA, V90, P3329, DOI 10.1073/pnas.90.8.3329; GUTHRIE KM, 1995, CHEM SENSES, V20, P271, DOI 10.1093/chemse/20.2.271; IMAMURA K, 1992, J NEUROPHYSIOL, V68, P1986, DOI 10.1152/jn.1992.68.6.1986; Johnson BA, 1999, J COMP NEUROL, V409, P529; Johnson BA, 1998, J COMP NEUROL, V393, P457, DOI 10.1002/(SICI)1096-9861(19980420)393:4<457::AID-CNE5>3.0.CO;2-#; JOURDAN F, 1980, BRAIN RES, V188, P139, DOI 10.1016/0006-8993(80)90563-6; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; KATOH K, 1993, J NEUROPHYSIOL, V70, P2161, DOI 10.1152/jn.1993.70.5.2161; KLOPPING HL, 1971, J AGR FOOD CHEM, V19, P999, DOI 10.1021/jf60177a002; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Laska M, 1999, CHEM SENSES, V24, P263, DOI 10.1093/chemse/24.3.263; Laurent G, 1996, TRENDS NEUROSCI, V19, P489, DOI 10.1016/S0166-2236(96)10054-0; LIDE DR, 1996, CRC HDB CHEM PHYSICS; MACLEOD AJ, 1980, S ZOOL SOC LOND, V45, P15; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 1999, ANNU REV NEUROSCI, V22, P487, DOI 10.1146/annurev.neuro.22.1.487; Moncrieff R.W., 1967, CHEM SENSES, V3rd; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; MORI K, 1992, J NEUROPHYSIOL, V67, P786, DOI 10.1152/jn.1992.67.3.786; POLAK EH, 1973, J THEOR BIOL, V40, P469, DOI 10.1016/0022-5193(73)90005-2; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Rupe H, 1900, BER DTSCH CHEM GES, V33, P3401, DOI 10.1002/cber.190003303120; SALLAZ M, 1993, NEUROREPORT, V4, P55, DOI 10.1097/00001756-199301000-00014; SHARP FR, 1975, BRAIN RES, V98, P596, DOI 10.1016/0006-8993(75)90377-7; SHARP FR, 1977, J NEUROPHYSIOL, V40, P800, DOI 10.1152/jn.1977.40.4.800; SKEEN LC, 1977, J COMP NEUROL, V172, P1, DOI 10.1002/cne.901720102; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; Tsuboi A, 1999, J NEUROSCI, V19, P8409; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Weinstein M, 1998, P NATL ACAD SCI USA, V95, P9378, DOI 10.1073/pnas.95.16.9378; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; Yoshihara Y, 1997, J NEUROSCI, V17, P5830; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237	44	398	404	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2000	3	10					1035	1043		10.1038/79857	http://dx.doi.org/10.1038/79857			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TW	11017177				2022-12-24	WOS:000167177500022
J	Christensen, TA; Pawlowski, VM; Lei, H; Hildebrand, JG				Christensen, TA; Pawlowski, VM; Lei, H; Hildebrand, JG			Multi-unit recordings reveal context-dependent modulation of synchrony in odor-specific neural ensembles	NATURE NEUROSCIENCE			English	Article							MOTH MANDUCA-SEXTA; ANTENNAL LOBES; PROJECTION NEURONS; OLFACTORY-BULB; INFORMATION; DYNAMICS; CELLS; BRAIN; REPRESENTATIONS; GLOMERULUS	We used neural ensemble recording to examine odor-evoked ensemble patterns in the moth antennal (olfactory) lobe. Different odors are thought to evoke unique spatiotemporal patterns of glomerular activity, but little is known about the population dynamics underlying formation of these patterns. Using a silicon multielectrode array, we observed dynamic network interactions within and between glomeruli. Whereas brief odor pulses repeatedly triggered activity in the same coding ensemble, the temporal pattern of synchronous activity superimposed on the ensemble was neither oscillatory nor odor specific. Rather, synchrony strongly depended on contextual variables such as odor intensity and intermittency. Also, because of emergent inhibitory circuit interactions, odor blends evoked temporal ensemble patterns that could not be predicted from the responses to the individual odorants. Thus even at this early stage of information processing, the timing of odor-evoked neural representations is modulated by key stimulus factors unrelated to the molecular identity of the odor.	Univ Arizona, Div Neurobiol, Arizona Res Labs, Tucson, AZ 85721 USA	University of Arizona	Christensen, TA (corresponding author), Univ Arizona, Div Neurobiol, Arizona Res Labs, POB 210077, Tucson, AZ 85721 USA.			Pawlowski, Vincent/0000-0003-0821-7610				AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; BUONVISO N, 1990, J NEUROPHYSIOL, V63, P447, DOI 10.1152/jn.1990.63.3.447; BUONVISO N, 1992, J NEUROPHYSIOL, V68, P417, DOI 10.1152/jn.1992.68.2.417; CHRISTENSEN TA, 1987, J COMP PHYSIOL A, V160, P553, DOI 10.1007/BF00611929; Christensen TA, 1998, J NEUROSCI, V18, P5999; Christensen TA, 1997, J NEUROPHYSIOL, V77, P775, DOI 10.1152/jn.1997.77.2.775; CHRISTENSEN TA, 1993, J COMP PHYSIOL A, V173, P385, DOI 10.1007/BF00193512; CHRISTENSEN TA, IN PRESS NEUROBIOLOG, V2; DALY KC, IN PRESS J EXP BIOL; Distler PG, 1998, BRAIN RES, V805, P263, DOI 10.1016/S0006-8993(98)00715-X; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; Gelperin A, 1999, J EXP BIOL, V202, P1855; Hansson Bill S., 1999, P125; Hartlieb E, 1996, NATURWISSENSCHAFTEN, V83, P87, DOI 10.1007/s001140050253; Heinbockel T, 1999, J COMP NEUROL, V409, P1; Heinbockel T, 1998, J COMP PHYSIOL A, V182, P703, DOI 10.1007/s003590050215; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; King JR, 2000, J NEUROSCI, V20, P2391; Mori Kensaku, 1994, Seminars in Cell Biology, V5, P65, DOI 10.1006/scel.1994.1009; Murlis J, 1997, INSECT PHEROMONE RESEARCH, P221; Rieke F., 1997, SPIKES EXPLORING NEU; RODRIGUES V, 1988, BRAIN RES, V453, P299, DOI 10.1016/0006-8993(88)90170-9; ROSPARS JP, 1992, CELL TISSUE RES, V270, P205, DOI 10.1007/BF00328007; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Stopfer Mark, 1999, P163; [No title captured]	28	97	102	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2000	3	9					927	931		10.1038/78840	http://dx.doi.org/10.1038/78840			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TV	10966624				2022-12-24	WOS:000167177400020
J	Kawasaki, F; Hazen, M; Ordway, RW				Kawasaki, F; Hazen, M; Ordway, RW			Fast synaptic fatigue in shibire mutants reveals a rapid requirement for dynamin in synaptic vesicle membrane trafficking	NATURE NEUROSCIENCE			English	Article							ADRENAL CHROMAFFIN CELLS; NEUROMUSCULAR-JUNCTIONS; DROSOPHILA; ENDOCYTOSIS; EXOCYTOSIS; MUTATION		Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Ordway, RW (corresponding author), Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA.							Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; BETZ WJ, 1995, CURR BIOL, V5, P1098, DOI 10.1016/S0960-9822(95)00220-X; COSTELLO WJ, 1986, J NEUROSCI, V6, P3634; Kawasaki F, 1998, J NEUROSCI, V18, P10241; Kawasaki F, 2000, J NEUROSCI, V20, P4885; KOSAKA T, 1983, J NEUROBIOL, V14, P207, DOI 10.1002/neu.480140305; POODRY CA, 1979, J CELL BIOL, V81, P520, DOI 10.1083/jcb.81.3.520; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; ROBINSON PJ, 1994, TRENDS NEUROSCI, V17, P348, DOI 10.1016/0166-2236(94)90179-1; SALKOFF L, 1978, NATURE, V273, P156, DOI 10.1038/273156a0; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; Smith C, 1997, J CELL BIOL, V139, P885, DOI 10.1083/jcb.139.4.885; von Gersdorff H, 1999, ANNU REV PHYSIOL, V61, P725, DOI 10.1146/annurev.physiol.61.1.725; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645	15	94	95	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2000	3	9					859	860		10.1038/78753	http://dx.doi.org/10.1038/78753			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TV	10966613				2022-12-24	WOS:000167177400009
J	Reddi, BAJ; Carpenter, RHS				Reddi, BAJ; Carpenter, RHS			The influence of urgency on decision time	NATURE NEUROSCIENCE			English	Article							SACCADIC EYE-MOVEMENTS; NEURAL MECHANISMS; SELECTION	A fruitful quantitative approach to understanding how the brain makes decisions has been to look at the time needed to make a decision, and how it is affected by factors such as the supply of information, or an individual's expectations. This approach has led to a model of decision-making, consistent with recent neurophysiological data, that explains the observed variability of reaction times and correctly predicts the effects of altered expectations. Can it also predict what happens when the urgency of making the response changes? We asked subjects to make eye movements to low-visibility targets either as fast or as accurately as possible, and found that the model does indeed predict the timing of their responses: the degree of urgency seems to influence the criterion level at which a decision signal triggers a response.	Univ Cambridge, Physiol Lab, Cambridge CB2 3EG, England	University of Cambridge	Carpenter, RHS (corresponding author), Univ Cambridge, Physiol Lab, Downing St, Cambridge CB2 3EG, England.			Carpenter, Roger/0000-0003-2572-1448				BECKER W, 1992, EYE MOVEMENTS, P95; Bichot NP, 1999, NAT NEUROSCI, V2, P549, DOI 10.1038/9205; Carpenter R. H. S., 1999, J CONSCIOUSNESS STUD, V6, P13; Carpenter R H S, 1992, EYE MOVEMENTS, P1; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Carpenter RHS, 1988, MOVEMENTS EYES; CARPENTER RHS, 1994, CONT OCULAR MOTOR VE, V480, pP4; Carpenter RHS, 1981, EYE MOVEMENTS COGNIT, P237; Guitton D., 1992, EYE MOVEMENTS, P244; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Kolmogorov A, 1941, ANN MATH STAT, V23, P525; Schall JD, 1998, CURR OPIN NEUROBIOL, V8, P211, DOI 10.1016/S0959-4388(98)80142-6; Schall JD, 1998, NEURAL NETWORKS, V11, P1241, DOI 10.1016/S0893-6080(98)00059-8; SPARKS DL, 1986, PHYSIOL REV, V66, P118, DOI 10.1152/physrev.1986.66.1.118; Wurtz R. H, 1989, NEUROBIOLOGY SACCADI	16	320	324	2	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2000	3	8					827	830		10.1038/77739	http://dx.doi.org/10.1038/77739			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TU	10903577				2022-12-24	WOS:000167177300019
J	Kreitzer, AC; Gee, KR; Archer, EA; Regehr, WG				Kreitzer, AC; Gee, KR; Archer, EA; Regehr, WG			Monitoring presynaptic calcium dynamics in projection fibers by in vivo loading of a novel calcium indicator	NEURON			English	Article							PURKINJE-CELL SYNAPSES; BIOTINYLATED DEXTRAN-AMINE; MAMMALIAN BRAIN SLICE; CLIMBING FIBER; SYNAPTIC CURRENTS; RAT CEREBELLUM; GRANULE CELL; SPINAL-CORD; IN-VIVO; FURA-2	Fluorometric calcium measurements have revealed presynaptic residual calcium (Ca-res) to be an important regulator of synaptic strength. However, in the mammalian brain, it has not been possible to monitor Ca-res in fibers that project from one brain region to another. Here, we label neuronal projections by injecting dextran-conjugated calcium indicators into brain nuclei in vivo. Currently available dextran conjugates distort Ca-res due to their high affinity for calcium. Therefore, we synthesized a low-affinity indicator, fluo-4 dextran, that can more accurately measure the amplitude and time course of Ca-res. We then demonstrate the utility of fluo-4 dextran by measuring Ca-res at climbing fiber presynaptic terminals. This method promises to facilitate the study of many synapses in the mammalian CNS, both in brain slices and in vivo.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Mol Probes Inc, Eugene, OR 97402 USA	Harvard University; Harvard Medical School	Regehr, WG (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.				NINDS NIH HHS [R01-NS32405-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032405] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANWYL R, 1991, BRAIN RES REV, V16, P265, DOI 10.1016/0165-0173(91)90010-6; Atluri PP, 1996, J NEUROSCI, V16, P5661; BLATTER LA, 1990, BIOPHYS J, V58, P1491, DOI 10.1016/S0006-3495(90)82494-2; Cajal S. R., 1911, HISTOLOGIE SYSTEME N; CREPEL F, 1982, TRENDS NEUROSCI, V5, P266, DOI 10.1016/0166-2236(82)90168-0; CREPEL F, 1976, J NEUROBIOL, V7, P567, DOI 10.1002/neu.480070609; DESCLIN JC, 1976, ANAT EMBRYOL, V149, P87, DOI 10.1007/BF00315087; Dittman JS, 1998, J NEUROSCI, V18, P6147; ECCLES JC, 1966, J PHYSIOL-LONDON, V182, P268, DOI 10.1113/jphysiol.1966.sp007824; Edwards JA, 1999, J NEUROPHYSIOL, V81, P895, DOI 10.1152/jn.1999.81.2.895; EUKERS H, 2000, IMAGING NEURONS LAB; FETCHO JR, 1995, J NEUROPHYSIOL, V73, P399, DOI 10.1152/jn.1995.73.1.399; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; GLOVER JC, 1986, J NEUROSCI METH, V18, P243, DOI 10.1016/0165-0270(86)90011-7; Hashimoto K, 1998, J PHYSIOL-LONDON, V506, P391, DOI 10.1111/j.1469-7793.1998.391bw.x; Haugland R., 1996, HDB FLUORESCENT PROB; KAO JPY, 1988, BIOPHYS J, V53, P635, DOI 10.1016/S0006-3495(88)83142-4; Konishi M, 1995, J GEN PHYSIOL, V106, P1123, DOI 10.1085/jgp.106.6.1123; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; LEVTOV A, 1995, J NEUROPHYSIOL, V74, P1324, DOI 10.1152/jn.1995.74.3.1324; MAGLEBY KL, 1987, SYNAPTIC FUNCTION, P21; MATTHEWS G, 1996, ANNU REV NEUROSCI, V19, P19; McPherson DR, 1997, BRAIN RES PROTOC, V1, P157, DOI 10.1016/S1385-299X(96)00024-4; MINTA A, 1989, J BIOL CHEM, V264, P8171; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Palay S.L., 1974, CEREBELLAR CORTEX; PAPE HC, 1989, NATURE, V340, P715, DOI 10.1038/340715a0; PERKEL DJ, 1990, P ROY SOC B-BIOL SCI, V241, P116, DOI 10.1098/rspb.1990.0074; REGEHR WG, 1991, J NEUROSCI METH, V37, P111, DOI 10.1016/0165-0270(91)90121-F; REGEHR WG, 1995, BIOPHYS J, V68, P2156, DOI 10.1016/S0006-3495(95)80398-X; REGEHR WG, 1994, NEURON, V12, P605, DOI 10.1016/0896-6273(94)90216-X; REGEHR WG, 2000, IMAGING NEURONS LAB; Reid RC, 1996, CURR OPIN NEUROBIOL, V6, P475, DOI 10.1016/S0959-4388(96)80052-3; ROE MW, 1990, CELL CALCIUM, V11, P63, DOI 10.1016/0143-4160(90)90060-8; Sabatini BL, 1998, BIOPHYS J, V74, P1549, DOI 10.1016/S0006-3495(98)77867-1; SABATINI BL, 1995, NEUROPHARMACOLOGY, V34, P1453, DOI 10.1016/0028-3908(95)00129-T; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Sugihara I, 1999, J COMP NEUROL, V414, P131; Sun WC, 1997, J ORG CHEM, V62, P6469, DOI 10.1021/jo9706178; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; TSIEN RY, 1981, NATURE, V290, P527, DOI 10.1038/290527a0; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; VEENMAN CL, 1992, J NEUROSCI METH, V41, P239, DOI 10.1016/0165-0270(92)90089-V; Zhao MD, 1996, BIOPHYS J, V70, P896, DOI 10.1016/S0006-3495(96)79633-9; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	45	67	69	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL	2000	27	1					25	32		10.1016/S0896-6273(00)00006-4	http://dx.doi.org/10.1016/S0896-6273(00)00006-4			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339XU	10939328	Bronze			2022-12-24	WOS:000088503800007
J	Reynolds, JH; Pasternak, T; Desimone, R				Reynolds, JH; Pasternak, T; Desimone, R			Attention increases sensitivity of V4 neurons	NEURON			English	Article							SPATIAL SELECTIVE ATTENTION; MONKEY VISUAL-CORTEX; STRIATE CORTEX; RESPONSE AMPLITUDE; NEURAL MECHANISMS; STIMULUS CONTRAST; CORTICAL-NEURONS; FEATURE BINDING; AREAS V1; ORIENTATION	When attention is directed to a location in the visual field, sensitivity to stimuli at that location is increased. At the neuronal level, this could arise either through a multiplicative increase in firing rate or through an increase in the effective strength of the stimulus. To test conflicting predictions of these alternative models, we recorded responses of V4 neurons to stimuli across a range of luminance contrasts and measured the change in response when monkeys attended to them in order to discriminate a target stimulus from nontargets. Attention caused greater increases in response at low contrast than at high contrast, consistent with an increase in effective stimulus strength. On average, attention increased the effective contrast of the attended stimulus by a factor of 1.51, an increase of 51% of its physical contrast.	NIMH, Neuropsychol Lab, NIH, Bethesda, MD 20892 USA; Univ Rochester, Med Ctr, Dept Neurobiol & Anat, Rochester, NY 14642 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Rochester	Desimone, R (corresponding author), NIMH, Neuropsychol Lab, NIH, Bldg 9, Bethesda, MD 20892 USA.		Desimone, Robert/G-1121-2018	Desimone, Robert/0000-0002-5938-4227				ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; BASHINSKI HS, 1980, PERCEPT PSYCHOPHYS, V28, P241, DOI 10.3758/BF03204380; Blaser E, 1999, P NATL ACAD SCI USA, V96, P11681, DOI 10.1073/pnas.96.20.11681; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Conner CE, 1997, J NEUROSCI, V17, P3201; Connor CE, 1996, J NEUROPHYSIOL, V75, P1306, DOI 10.1152/jn.1996.75.3.1306; DEAN AF, 1981, J PHYSIOL-LONDON, V318, P413; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DOWNING CJ, 1988, J EXP PSYCHOL HUMAN, V14, P188, DOI 10.1037/0096-1523.14.2.188; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; FRIEDMANHILL SR, 1995, SCIENCE, V269, P853, DOI 10.1126/science.7638604; Gawne TJ, 1996, J NEUROPHYSIOL, V76, P1356, DOI 10.1152/jn.1996.76.2.1356; HAENNY PE, 1988, EXP BRAIN RES, V69, P245, DOI 10.1007/BF00247570; HAWKINS HL, 1990, J EXP PSYCHOL HUMAN, V16, P802, DOI 10.1037/0096-1523.16.4.802; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Lee DK, 1997, VISION RES, V37, P2409, DOI 10.1016/S0042-6989(97)00055-2; Lu ZL, 1998, VISION RES, V38, P1183, DOI 10.1016/S0042-6989(97)00273-3; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P887, DOI 10.1037/0096-1523.20.4.887; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MAFFEI L, 1973, VISION RES, V13, P1255, DOI 10.1016/0042-6989(73)90201-0; MANGUN GR, 1995, PSYCHOPHYSIOLOGY, V32, P4, DOI 10.1111/j.1469-8986.1995.tb03400.x; Mangun GR, 1998, HUM BRAIN MAPP, V6, P383, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<383::AID-HBM10>3.0.CO;2-Z; MAUNSELL JHR, 1991, VISUAL NEUROSCI, V7, P561, DOI 10.1017/S095252380001035X; McAdams CJ, 1999, NEURON, V23, P765, DOI 10.1016/S0896-6273(01)80034-9; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; McNicol D., 1972, PRIMER SIGNAL DETECT, P1; MILLER EK, 1993, J NEUROSCI, V13, P1460; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; MULLER HJ, 1991, J EXP PSYCHOL HUMAN, V17, P107, DOI 10.1037/0096-1523.17.1.107; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; QUICK RF, 1974, KYBERNETIK, V16, P65, DOI 10.1007/BF00271628; REINITZ MT, 1990, PERCEPT PSYCHOPHYS, V47, P497, DOI 10.3758/BF03208183; Reynolds JH, 1999, J NEUROSCI, V19, P1736; SCLAR G, 1982, EXP BRAIN RES, V46, P457; SKOTTUN BC, 1987, J NEUROPHYSIOL, V57, P773, DOI 10.1152/jn.1987.57.3.773; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; TOLHURST DJ, 1981, EXP BRAIN RES, V41, P414; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419	40	724	734	2	48	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	2000	26	3					703	714		10.1016/S0896-6273(00)81206-4	http://dx.doi.org/10.1016/S0896-6273(00)81206-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	330ZH	10896165	Bronze			2022-12-24	WOS:000087991600020
J	Livingston, FS; White, SA; Mooney, R				Livingston, FS; White, SA; Mooney, R			Slow NMDA-EPSCs at synapses critical for song development are not required for song learning in zebra finches	NATURE NEUROSCIENCE			English	Article							ANTERIOR FOREBRAIN; SYNAPTIC CURRENTS; POEPHILA-GUTTATA; VISUAL-CORTEX; NUCLEUS; NEURONS; PLASTICITY; RECEPTORS; ACQUISITION; MAINTENANCE	Birdsong, like human speech, is learned via auditory experience during a developmentally restricted sensitive period. Within projection neurons of two avian forebrain nuclei, NMDA receptor-mediated EPSCs (NMDA-EPSCs) become fast during song development, a transition posited to limit learning. To discover whether slow NMDA-EPSCs at these synapses are required for learning, we delayed song learning beyond its normal endpoint, post-hatch day (PHD) 65, by raising zebra finches in isolation from song tutors. At PHD45, before learning, isolation delayed NMDA-EPSC maturation, but only transiently. By PHD65, NMDA-EPSCs in isolates were fast and adult-like, yet isolates presented with tutors readily learned song. Thus song learning did not require slow NMDA-EPSCs at synapses critical for song development.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Mooney, R (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.			Mooney, Richard/0000-0002-3308-1367	NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH011872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002524] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC02524, R01 DC002524] Funding Source: Medline; NIMH NIH HHS [F31 MH11872] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AAMODT SM, 1995, J NEUROBIOL, V27, P76, DOI 10.1002/neu.480270108; ARNOLD AP, 1975, J EXP ZOOL, V191, P261, DOI 10.1002/jez.1401910212; Basham ME, 1996, NEUROBIOL LEARN MEM, V66, P295, DOI 10.1006/nlme.1996.0071; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; BOTTJER SW, 1992, J NEUROBIOL, V23, P337, DOI 10.1002/neu.480230402; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Doupe AJ, 1997, J NEUROSCI, V17, P1147; EALES LA, 1985, ANIM BEHAV, V33, P1293, DOI 10.1016/S0003-3472(85)80189-5; Flint AC, 1997, J NEUROSCI, V17, P2469; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Immelmann K., 1969, P61; Jones AE, 1996, J COMP PSYCHOL, V110, P354; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; KORSIA S, 1991, J NEUROSCI, V11, P2362; Livingston FS, 1997, J NEUROSCI, V17, P8997; MARLER P, 1988, NATURE, V336, P770, DOI 10.1038/336770a0; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCCASLAND JS, 1987, J NEUROSCI, V7, P23; MOONEY R, 1992, J NEUROSCI, V12, P2464; MORRISON RG, 1993, J NEUROBIOL, V24, P1045, DOI 10.1002/neu.480240805; NORDEEN KW, 1992, BEHAV NEURAL BIOL, V57, P58, DOI 10.1016/0163-1047(92)90757-U; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; PRICE PH, 1979, J COMP PHYSIOL PSYCH, V93, P260, DOI 10.1037/h0077553; PROVE E, 1983, HORMONES BEHAV HIGHE, P368; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; ROBERTS A, 1987, J FAM VIOLENCE, V2, P81, DOI DOI 10.1007/BF00976372; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Shi J, 1997, J NEUROSCI, V17, P6264; Stark LL, 1999, J NEUROSCI, V19, P9107, DOI 10.1523/JNEUROSCI.19-20-09107.1999; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; WALLHAUSSERFRANKE E, 1995, NEUROBIOL LEARN MEM, V64, P25, DOI 10.1006/nlme.1995.1041; White SA, 1999, J NEUROPHYSIOL, V82, P2221, DOI 10.1152/jn.1999.82.5.2221; Wingfield J., 1987, PSYCHOBIOLOGY REPROD, P149; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	38	67	68	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2000	3	5					482	488		10.1038/74857	http://dx.doi.org/10.1038/74857			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	309DG	10769389				2022-12-24	WOS:000086752000018
J	Lorenzo, A; Yuan, ML; Zhang, ZH; Paganetti, PA; Sturchler-Pierrat, C; Staufenbiel, M; Mautino, J; Sol Vigo, F; Sommer, B; Yankner, BA				Lorenzo, A; Yuan, ML; Zhang, ZH; Paganetti, PA; Sturchler-Pierrat, C; Staufenbiel, M; Mautino, J; Sol Vigo, F; Sommer, B; Yankner, BA			Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease	NATURE NEUROSCIENCE			English	Article							WILD-TYPE; INTRACELLULAR ACCUMULATION; OXIDATIVE STRESS; IN-VIVO; NEUROTOXICITY; PEPTIDE; CELL; ADHESION; NEURONS; DEGENERATION	Amyloid beta protein (A beta) deposition in the brain is a hallmark of Alzheimer's disease (AD). The fibrillar form of A beta is neurotoxic, although the mechanism of its toxicity is unknown. We showed that conversion of A beta to the fibrillar form markedly increased binding to specific neuronal membrane proteins, including amyloid precursor protein (APP). Nanomolar concentrations of fibrillar A beta bound cell-surface holo-APP in cortical neurons. Reduced vulnerability of cultured APP-null neurons to A beta neurotoxicity suggested that AP neurotoxicity involves APP. Thus A beta toxicity may be mediated by the interaction of fibrillar AP with neuronal membrane proteins, notably APP. An A beta-APP interaction reminiscent of the pathogenic mechanism of prions may thus contribute to neuronal degeneration in AD.	Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Inst Invest Med Mercedes & Martin Ferreyra, RA-5000 Cordoba, Argentina; Novartis Pharma Ltd, Preclin Res, CH-4002 Basel, Switzerland	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Novartis	Yankner, BA (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Enders 260,300 Longwood Ave, Boston, MA 02115 USA.		Paganetti, Paolo/AAF-8039-2020	Paganetti, Paolo/0000-0003-1896-6324	NINDS NIH HHS [NS33325, NS30352] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030352, R01NS033325] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; BREEN KC, 1991, J NEUROSCI RES, V28, P90, DOI 10.1002/jnr.490280109; Brown DR, 1996, NATURE, V380, P345, DOI 10.1038/380345a0; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Bursztajn S, 1998, J NEUROSCI, V18, P9790; BUSCIGLIO J, 1995, NEURON, V14, P879, DOI 10.1016/0896-6273(95)90232-5; BUSCIGLIO J, 1992, NEUROBIOL AGING, V13, P609, DOI 10.1016/0197-4580(92)90065-6; CHEN M, 1991, NEUROSCI LETT, V125, P223, DOI 10.1016/0304-3940(91)90034-Q; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; CONDRESCU M, 1984, BIOCHIM BIOPHYS ACTA, V769, P261, DOI 10.1016/0005-2736(84)90031-2; DAVISSALINAS J, 1995, J NEUROCHEM, V65, P931; Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Hegde RS, 1999, NATURE, V402, P822, DOI 10.1038/45574; HENSLEY K, 1994, P NATL ACAD SCI USA, V91, P3270, DOI 10.1073/pnas.91.8.3270; HOWLETT DR, 1995, NEURODEGENERATION, V4, P23, DOI 10.1006/neur.1995.0003; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KIBBEY MC, 1993, P NATL ACAD SCI USA, V90, P10150, DOI 10.1073/pnas.90.21.10150; LEDERMANN B, 1991, EXP CELL RES, V197, P254, DOI 10.1016/0014-4827(91)90430-3; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; MATTSON MP, 1993, BRAIN RES, V621, P35, DOI 10.1016/0006-8993(93)90295-X; MAY PC, 1993, J NEUROCHEM, V61, P2330, DOI 10.1111/j.1471-4159.1993.tb07480.x; MILWARD EA, 1992, NEURON, V9, P129, DOI 10.1016/0896-6273(92)90228-6; Nishimura I, 1998, J NEUROSCI, V18, P2387, DOI 10.1523/jneurosci.18-07-02387.1998; Paganetti PA, 1996, J NEUROSCI RES, V46, P283, DOI 10.1002/(SICI)1097-4547(19961101)46:3<283::AID-JNR1>3.0.CO;2-G; Perez RG, 1997, J NEUROSCI, V17, P9407; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Russo T, 1998, FEBS LETT, V434, P1, DOI 10.1016/S0014-5793(98)00941-7; SAITOH T, 1989, CELL, V58, P615, DOI 10.1016/0092-8674(89)90096-2; Savage MJ, 1998, J NEUROSCI, V18, P1743; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SCHUBERT D, 1993, BRAIN RES, V629, P275, DOI 10.1016/0006-8993(93)91331-L; SCHUBERT D, 1989, NEURON, V3, P689, DOI 10.1016/0896-6273(89)90237-7; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Uetsuki T, 1999, J NEUROSCI, V19, P6955, DOI 10.1523/JNEUROSCI.19-16-06955.1999; White AR, 1999, J NEUROSCI, V19, P9170; White AR, 1998, J NEUROSCI, V18, P6207; Xu X, 1999, P NATL ACAD SCI USA, V96, P7547, DOI 10.1073/pnas.96.13.7547; Yamatsuji T, 1996, SCIENCE, V272, P1349, DOI 10.1126/science.272.5266.1349; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yang AJ, 1999, J BIOL CHEM, V274, P20650, DOI 10.1074/jbc.274.29.20650; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4; YOSHIKAWA K, 1992, NATURE, V359, P64, DOI 10.1038/359064a0; ZHANG C, 1994, J BIOL CHEM, V269, P25247; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	50	224	241	1	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2000	3	5					460	464		10.1038/74833	http://dx.doi.org/10.1038/74833			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309DG	10769385				2022-12-24	WOS:000086752000014
J	Khasar, SG; Lin, YH; Martin, A; Dadgar, J; McMahon, T; Wang, D; Hundle, B; Aley, KO; Isenberg, W; McCarter, G; Green, PG; Hodge, CW; Levine, JD; Messing, RO				Khasar, SG; Lin, YH; Martin, A; Dadgar, J; McMahon, T; Wang, D; Hundle, B; Aley, KO; Isenberg, W; McCarter, G; Green, PG; Hodge, CW; Levine, JD; Messing, RO			A novel nociceptor signaling pathway revealed in protein kinase C epsilon mutant mice	NEURON			English	Article							NERVE GROWTH-FACTOR; ADULT-RAT; NEURITE OUTGROWTH; SENSORY NEURONS; PHORBOL ESTERS; CELLS; HYPERALGESIA; LOCALIZATION; PAIN; ANTINOCICEPTION	There is great interest in discovering new targets for pain therapy since current methods of analgesia are often only partially successful. Although protein kinase C (PKC) enhances nociceptor function, it is not known which PKC isozymes contribute. Here, we show that epinephrine-induced mechanical and thermal hyperalgesia and acetic acid-associated hyperalgesia are markedly attenuated in PKC epsilon mutant mice, but baseline nociceptive thresholds are normal. Moreover, epinephrine-, carrageenan-, and nerve growth factor- (NGF-) induced hyperalgesia in normal rats, and epinephrine-induced enhancement of tetrodotoxin-resistant Na+ current (TTX-R I-Na) in cultured rat dorsal root ganglion (DRG) neurons, are inhibited by a PKC epsilon-selectiive inhibitor peptide. Our findings indicate that PKC epsilon regulates nociceptor function and suggest that PKC epsilon inhibitors could prove useful in the treatment of pain.	Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Pain Ctr, Natl Inst Hlth, Dept Internal Med & Oral Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; National Institutes of Health (NIH) - USA; University of California System; University of California San Francisco	Messing, RO (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Dept Neurol, San Francisco, CA 94143 USA.	romes@itsa.ucsf.edu	Messing, Robert/D-3642-2015; Green, Paul/C-5943-2011	Messing, Robert/0000-0002-5345-4431; Green, Paul/0000-0001-7648-6826; Hodge, Clyde/0000-0002-6860-7955	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010036] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA10036] Funding Source: Medline; NINDS NIH HHS [NS21647] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHLGREN SC, 1994, J NEUROPHYSIOL, V72, P684, DOI 10.1152/jn.1994.72.2.684; Aley KO, 1996, NEUROSCIENCE, V73, P259, DOI 10.1016/0306-4522(96)00020-6; Aley KO, 1997, J NEUROSCI, V17, P3907; ANDREEV NY, 1995, PAIN, V63, P109, DOI 10.1016/0304-3959(95)00024-M; BJORKMAN R, 1995, ACTA ANAESTH SCAND, V39, P3; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; Choi B, 1997, PAIN, V69, P55, DOI 10.1016/S0304-3959(96)03245-9; Csukai M, 1997, J BIOL CHEM, V272, P29200, DOI 10.1074/jbc.272.46.29200; CUNHA FQ, 1991, BRIT J PHARMACOL, V104, P765, DOI 10.1111/j.1476-5381.1991.tb12502.x; FERREIRA SH, 1988, NATURE, V334, P698, DOI 10.1038/334698a0; Gold MS, 1996, P NATL ACAD SCI USA, V93, P1108, DOI 10.1073/pnas.93.3.1108; Gray MO, 1997, J BIOL CHEM, V272, P30945, DOI 10.1074/jbc.272.49.30945; Hundle B, 1997, J BIOL CHEM, V272, P15028, DOI 10.1074/jbc.272.23.15028; HUNDLE B, 1995, J BIOL CHEM, V270, P30134; HUNTER SE, 1995, DEV BRAIN RES, V85, P239, DOI 10.1016/0165-3806(94)00219-P; Jett MF, 1999, J PHARMACOL EXP THER, V288, P1288; Johnson JA, 1996, J BIOL CHEM, V271, P24962, DOI 10.1074/jbc.271.40.24962; KEENEY S, 1990, MUTAT RES, V236, P239, DOI 10.1016/0921-8777(90)90008-S; Khasar SG, 1999, J NEUROPHYSIOL, V81, P1104, DOI 10.1152/jn.1999.81.3.1104; KINNMAN E, 1995, NEUROSCIENCE, V64, P751, DOI 10.1016/0306-4522(94)00435-8; LEPERS A, 1990, BIOCHIMIE, V72, P1, DOI 10.1016/0300-9084(90)90166-E; LEWIN GR, 1993, TRENDS NEUROSCI, V16, P353, DOI 10.1016/0166-2236(93)90092-Z; LEWIN GR, 1993, J NEUROSCI, V13, P2136; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; MCCARTHY BG, 1995, NEUROLOGY, V45, P1848, DOI 10.1212/WNL.45.10.1848; MCGUIRK SM, 1992, NEUROSCIENCE, V49, P117, DOI 10.1016/0306-4522(92)90079-H; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; Mikhailov V. V., 1993, Byulleten' Eksperimental'noi Biologii i Meditsiny, V116, P472; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; OHMICHI M, 1993, BIOCHEM J, V295, P767, DOI 10.1042/bj2950767; Petruska JC, 1997, SOMATOSENS MOT RES, V14, P17, DOI 10.1080/08990229771187; ROIVAINEN R, 1993, BRAIN RES, V624, P85, DOI 10.1016/0006-8993(93)90063-S; SAFIEHGARABEDIAN B, 1995, BRIT J PHARMACOL, V115, P1265, DOI 10.1111/j.1476-5381.1995.tb15035.x; SAITO N, 1993, BRAIN RES, V607, P241, DOI 10.1016/0006-8993(93)91512-Q; SCHAAP D, 1989, FEBS LETT, V243, P351, DOI 10.1016/0014-5793(89)80160-7; SCHEPELMANN K, 1993, EXP BRAIN RES, V92, P391; SCHULZ I, 1990, METHOD ENZYMOL, V192, P280; SCROGGS RS, 1994, J NEUROPHYSIOL, V71, P271, DOI 10.1152/jn.1994.71.1.271; TAIWO YO, 1991, NEUROSCIENCE, V44, P131, DOI 10.1016/0306-4522(91)90255-M; THOMPSON S, 1989, CELL, V56, P313, DOI 10.1016/0092-8674(89)90905-7; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; WARD SJ, 1983, J PHARMACOL EXP THER, V224, P525; WOOLF CJ, 1994, NEUROSCIENCE, V62, P327, DOI 10.1016/0306-4522(94)90366-2; Yedovitzky M, 1997, J BIOL CHEM, V272, P1417, DOI 10.1074/jbc.272.3.1417	46	371	386	2	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1999	24	1					253	260		10.1016/S0896-6273(00)80837-5	http://dx.doi.org/10.1016/S0896-6273(00)80837-5			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241QC	10677042	Bronze			2022-12-24	WOS:000082893200024
J	Meier, J; Vannier, C; Serge, A; Triller, A; Choquet, D				Meier, J; Vannier, C; Serge, A; Triller, A; Choquet, D			Fast and reversible trapping of surface glycine receptors by gephyrin	NATURE NEUROSCIENCE			English	Article							SINGLE-PARTICLE TRACKING; LONG-TERM DEPRESSION; SPINAL NEURONS; NEUROMUSCULAR-JUNCTION; LATERAL DIFFUSION; GABA(A) RECEPTORS; AMPA RECEPTORS; BETA SUBUNIT; SYNAPSES; MEMBRANE	Variations in receptor number at a given synapse are known to contribute to synaptic plasticity, but methods used to establish this idea usually do not allow for the determination of the dynamics of these phenomena. We used single-particle tracking to follow in real time, on the cell surface, movements of the glycine receptor (GlyR) with or without the GlyR stabilizing protein gephyrin. GlyR alternated within seconds between diffusive and confined states. In the absence of gephyrin, GlyR were mostly freely diffusing. Gephyrin induced long confinement periods spatially associated with submembranous clusters of gephyrin. However, even when most receptors were stabilized, they still frequently made transitions through the diffusive state. These data show that receptor number in a cluster results from a dynamic equilibrium between the pools of stabilized and freely mobile receptors. Modification of this equilibrium could be involved in regulation of the number of receptors at synapses.	CNRS, Inst Francois Magendie, UMR 5091, F-33077 Bordeaux, France; Ecole Normale Super, INSERM, U497, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Choquet, D (corresponding author), CNRS, Inst Francois Magendie, UMR 5091, Rue Camille St Saens, F-33077 Bordeaux, France.	dchoquet@u-bordeaux2.fr	Choquet, Daniel/K-7893-2018; Choquet, Daniel/E-4203-2013; Sergé, Arnauld/N-4828-2019; Choquet, Daniel/GOJ-8825-2022; Serge, Aho Glele Ludwig/AAP-8863-2021; Serge, Arnauld/AAP-1525-2020	Choquet, Daniel/0000-0003-4726-9763; Sergé, Arnauld/0000-0003-4271-3706; Choquet, Daniel/0000-0003-4726-9763; Serge, Aho Glele Ludwig/0000-0001-7590-8644; Serge, Arnauld/0000-0002-1280-6277; Meier, Jochen/0000-0001-5574-3336; TRILLER, Antoine/0000-0002-7530-1233				Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; Bechade C, 1996, EUR J NEUROSCI, V8, P429, DOI 10.1111/j.1460-9568.1996.tb01226.x; BETZ H, 1992, Q REV BIOPHYS, V25, P381, DOI 10.1017/S0033583500004340; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; CHARPIER S, 1995, P NATL ACAD SCI USA, V92, P117, DOI 10.1073/pnas.92.1.117; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Colin I, 1996, J COMP NEUROL, V374, P467, DOI 10.1002/(SICI)1096-9861(19961021)374:3<467::AID-CNE10>3.0.CO;2-S; Colin I, 1998, J COMP NEUROL, V398, P359; CRAIG AM, 1994, P NATL ACAD SCI USA, V91, P12373, DOI 10.1073/pnas.91.26.12373; Dumoulin A, 2000, EUR J NEUROSCI, V12, P3883, DOI 10.1046/j.1460-9568.2000.00271.x; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Felsenfeld DP, 1996, NATURE, V383, P438, DOI 10.1038/383438a0; FROEHNER SC, 1993, ANNU REV NEUROSCI, V16, P347, DOI 10.1146/annurev.ne.16.030193.002023; GRENNINGLOH G, 1990, NEURON, V4, P963, DOI 10.1016/0896-6273(90)90149-A; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Kirsch J, 1998, NATURE, V392, P717, DOI 10.1038/33694; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; KIRSCH J, 1995, J NEUROSCI, V15, P4148; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Krisch J, 1999, CURR OPIN NEUROBIOL, V9, P329, DOI 10.1016/S0959-4388(99)80048-8; Kucik DF, 1999, BIOPHYS J, V76, P314, DOI 10.1016/S0006-3495(99)77198-5; KUROMI H, 1985, DEV BIOL, V109, P165, DOI 10.1016/0012-1606(85)90357-4; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Levi S, 1998, J CELL SCI, V111, P335; Levi S, 1999, J NEUROSCI, V19, P7434, DOI 10.1523/JNEUROSCI.19-17-07434.1999; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Meier J, 2000, J CELL SCI, V113, P2783; MeunierDurmort C, 1997, GENE THER, V4, P808, DOI 10.1038/sj.gt.3300450; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Morishita W, 1996, J NEUROPHYSIOL, V76, P59, DOI 10.1152/jn.1996.76.1.59; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; ODA Y, 1995, J NEUROPHYSIOL, V74, P1056, DOI 10.1152/jn.1995.74.3.1056; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; SAFFMAN PG, 1976, J FLUID MECH, V73, P593, DOI 10.1017/S0022112076001511; SAKO Y, 1994, J CELL BIOL, V125, P1251, DOI 10.1083/jcb.125.6.1251; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SAXTON MJ, 1993, BIOPHYS J, V64, P1766, DOI 10.1016/S0006-3495(93)81548-0; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; SIMSON R, 1995, BIOPHYS J, V69, P989, DOI 10.1016/S0006-3495(95)79972-6; SONTHEIMER H, 1989, NEURON, V2, P1491, DOI 10.1016/0896-6273(89)90195-5; TODD AJ, 1990, NEUROSCIENCE, V39, P387, DOI 10.1016/0306-4522(90)90275-9; TRILLER A, 1985, J CELL BIOL, V101, P683, DOI 10.1083/jcb.101.2.683; Turrigiano GG, 2000, NEURON, V26, P5, DOI 10.1016/S0896-6273(00)81131-9; Vannier C, 1997, INT REV CYTOL, V176, P201, DOI 10.1016/S0074-7696(08)61611-3; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2	47	209	215	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2001	4	3					253	260		10.1038/85099	http://dx.doi.org/10.1038/85099			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UE	11224541				2022-12-24	WOS:000167178300012
J	Beaver, CJ; Ti, QH; Fischer, QS; Daw, NW				Beaver, CJ; Ti, QH; Fischer, QS; Daw, NW			Cyclic AMP-dependent protein kinase mediates ocular dominance shifts in cat visual cortex	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; NITRIC-OXIDE SYNTHASE; HIPPOCAMPAL-NEURONS; CRITICAL PERIOD; MONOCULAR DEPRIVATION; GLUTAMATE RECEPTORS; ADENYLATE-CYCLASE; CAMP LEVELS; LATE-PHASE; IN-VITRO	Visual experience during a critical period early in postnatal development can change connections within mammalian visual cortex. In a kitten at the peak of the critical period (similar to P28-42), brief monocular deprivation can lead to complete dominance by the open eye, an ocular dominance shift. This process is driven by activity from the eyes, and depends on N-methyl-D-aspartate (NMDA) receptor activation. The components of the intracellular signaling cascade underlying these changes have not all been identified. Here we show that inhibition of protein kinase A (PKA) by Rp-8-C1-cAMPS blocks ocular dominance shifts that occur following monocular deprivation early in the critical period. Inhibition of protein kinase G by Rp-8-Br-PET-cGMPS had no effect, indicating a specificity for the PKA pathway. Enhancement of PKA activity late in the critical period with Sp-8-C1-cAMPS did not increase plasticity. PKA is a necessary component of the pathway leading to cortical plasticity during the critical period.	Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06520 USA	Yale University	Beaver, CJ (corresponding author), Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, 333 Cedar St, New Haven, CT 06520 USA.			Fischer, Quentin/0000-0002-7803-1179	NEI NIH HHS [R01 EY00053] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY000053] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abel T, 1998, BRAIN RES REV, V26, P360, DOI 10.1016/S0165-0173(97)00050-7; Amieux PS, 1997, J BIOL CHEM, V272, P3993, DOI 10.1074/jbc.272.7.3993; Bach ME, 1999, P NATL ACAD SCI USA, V96, P5280, DOI 10.1073/pnas.96.9.5280; BEAR MF, 1990, J NEUROSCI, V10, P909; BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; BLACKSTONE C, 1994, J NEUROSCI, V14, P7585; Bois P, 1997, J PHYSIOL-LONDON, V501, P565, DOI 10.1111/j.1469-7793.1997.565bm.x; Brandon EP, 1997, CURR OPIN NEUROBIOL, V7, P397, DOI 10.1016/S0959-4388(97)80069-4; Butt E, 1995, BRIT J PHARMACOL, V116, P3110, DOI 10.1111/j.1476-5381.1995.tb15112.x; CERNE R, 1993, NEUROSCI LETT, V161, P124, DOI 10.1016/0304-3940(93)90275-P; CHAVEZNORIEGA LE, 1994, J NEUROSCI, V14, P310; CHETKOVICH DM, 1991, P NATL ACAD SCI USA, V88, P6467, DOI 10.1073/pnas.88.15.6467; Daw NW, 1999, J NEUROPHYSIOL, V81, P204, DOI 10.1152/jn.1999.81.1.204; DIXON D, 1989, J NEUROSCI, V9, P4246; DOSTMANN WRG, 1990, J BIOL CHEM, V265, P10484; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; Gage AT, 1997, HIPPOCAMPUS, V7, P286; GORDON B, 1991, DEV BRAIN RES, V62, P61, DOI 10.1016/0165-3806(91)90190-T; GREENGARD P, 1991, SCIENCE, V253, P1135, DOI 10.1126/science.1716001; Hensch TK, 1998, J NEUROSCI, V18, P2108; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Imamura K, 1999, P ROY SOC B-BIOL SCI, V266, P1507, DOI 10.1098/rspb.1999.0808; KANO M, 1992, NEUROREPORT, V3, P563, DOI 10.1097/00001756-199207000-00004; Kramer RH, 1996, J NEUROSCI, V16, P1285; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Mower GD, 1999, MOL BRAIN RES, V64, P264, DOI 10.1016/S0169-328X(98)00333-7; MOWER GD, 1991, DEV BRAIN RES, V58, P151, DOI 10.1016/0165-3806(91)90001-Y; OLSON CR, 1980, EXP BRAIN RES, V39, P17; Pham TA, 1999, NEURON, V22, P63, DOI 10.1016/S0896-6273(00)80679-0; Poisbeau P, 1999, J NEUROSCI, V19, P674; Reid SNM, 1996, J NEUROSCI, V16, P7619; Reid SNM, 1996, J PHYSIOL-LONDON, V494, P511, DOI 10.1113/jphysiol.1996.sp021509; Roberson ED, 1996, J BIOL CHEM, V271, P30436, DOI 10.1074/jbc.271.48.30436; Ruthazer ES, 1996, J PHYSIOL-LONDON, V494, P519, DOI 10.1113/jphysiol.1996.sp021510; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Trudeau LE, 1996, NEURON, V17, P789, DOI 10.1016/S0896-6273(00)80210-X; Tzounopoulos T, 1998, NEURON, V21, P837, DOI 10.1016/S0896-6273(00)80599-1; WANG LY, 1991, SCIENCE, V253, P1132, DOI 10.1126/science.1653455; Wei JY, 1996, BIOCHEMISTRY-US, V35, P16815, DOI 10.1021/bi961763v; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; ZHUO M, 1994, SCIENCE, V269, P635	43	68	69	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2001	4	2					159	163		10.1038/83985	http://dx.doi.org/10.1038/83985			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UC	11175876				2022-12-24	WOS:000167178100014
J	Fried, I; Wilson, CL; Morrow, JW; Cameron, KA; Behnke, ED; Ackerson, LC; Maidment, NT				Fried, I; Wilson, CL; Morrow, JW; Cameron, KA; Behnke, ED; Ackerson, LC; Maidment, NT			Increased dopamine release in the human amygdala during performance of cognitive tasks	NATURE NEUROSCIENCE			English	Article							PREFRONTAL CORTEX; WORKING-MEMORY; CONDITIONED FEAR; DRUG-ADDICTION; REWARD; MODULATION; NEURONS; MICRODIALYSIS; RESPONSES; SENSITIZATION	Accumulating data support a critical involvement of dopamine in the modulation of neuronal activity related to cognitive processing. The amygdala is a major target of midbrain dopaminergic neurons and is implicated in learning and memory processes, particularly those involving associations between novel stimuli and reward. We used intracerebral microdialysis to directly sample extracellular dopamine in the human amygdala during the performance of cognitive tasks. The initial transition from rest to either a working memory or a reading task was accompanied by significant increases in extracellular dopamine concentration of similar magnitude. During a sustained word paired-associates learning protocol, increase in dopamine release in the amygdala related to teaming performance. These data provide evidence for sustained activation of the human mesolimbic dopaminergic system during performance of cognitive tasks.	Univ Calif Los Angeles, Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Div Neurosurg, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Maidment, NT (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Psychiat & Biobehav Sci, Box 951759,740 Westwood Plaza, Los Angeles, CA 90095 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033310, P01NS002808, R01NS033221, R56NS033221, R37NS033310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA005010] Funding Source: NIH RePORTER; NIDA NIH HHS [P50 DA005010] Funding Source: Medline; NINDS NIH HHS [NS02808, NS33221, NS33310] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CHESSELET MF, 1984, NEUROSCIENCE, V12, P347, DOI 10.1016/0306-4522(84)90058-7; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; Di Chiara G, 1999, ANN NY ACAD SCI, V877, P461; Durstewitz D, 1999, J NEUROSCI, V19, P2807; Everitt BJ, 1999, ANN NY ACAD SCI, V877, P412, DOI 10.1111/j.1749-6632.1999.tb09280.x; FALLON JH, 1978, J COMP NEUROL, V180, P509, DOI 10.1002/cne.901800308; Fried I, 1999, J NEUROSURG, V91, P697, DOI 10.3171/jns.1999.91.4.0697; Garcia R, 1999, NATURE, V402, P294, DOI 10.1038/46286; Goldman-Rakic P S, 1998, Adv Pharmacol, V42, P707; HORI K, 1993, BRAIN RES, V621, P296, DOI 10.1016/0006-8993(93)90119-8; Kalivas PW, 1999, CURR OPIN NEUROBIOL, V9, P223, DOI 10.1016/S0959-4388(99)80031-2; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; Koob GF, 1999, ANN NY ACAD SCI, V877, P445, DOI 10.1111/j.1749-6632.1999.tb09282.x; LJUNGBERG T, 1991, BRAIN RES, V567, P337, DOI 10.1016/0006-8993(91)90816-E; LJUNGBERG T, 1992, J NEUROPHYSIOL, V67, P145, DOI 10.1152/jn.1992.67.1.145; Maren S, 1996, NEURON, V16, P237, DOI 10.1016/S0896-6273(00)80041-0; Nader K, 1999, BEHAV NEUROSCI, V113, P891, DOI 10.1037/0735-7044.113.5.891; Pierce RC, 1997, BRAIN RES REV, V25, P192, DOI 10.1016/S0165-0173(97)00021-0; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rosenkranz JA, 1999, J NEUROSCI, V19, P11027, DOI 10.1523/JNEUROSCI.19-24-11027.1999; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Spanagel R, 1999, TRENDS NEUROSCI, V22, P521, DOI 10.1016/S0166-2236(99)01447-2; Thomas MJ, 2000, J NEUROSCI, V20, P5581, DOI 10.1523/JNEUROSCI.20-15-05581.2000; Watanabe M, 1997, J NEUROPHYSIOL, V78, P2795, DOI 10.1152/jn.1997.78.5.2795; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; Young AMJ, 1998, NEUROSCI LETT, V249, P49, DOI 10.1016/S0304-3940(98)00390-5	28	77	81	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2001	4	2					201	206		10.1038/84041	http://dx.doi.org/10.1038/84041			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UC	11175882				2022-12-24	WOS:000167178100020
J	Contractor, A; Swanson, G; Heinemann, SF				Contractor, A; Swanson, G; Heinemann, SF			Kainate receptors are involved in short- and long-term plasticity at mossy fiber synapses in the hippocampus	NEURON			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; SYNAPTIC TRANSMISSION; GLUR6-DEFICIENT MICE; CA3 NEURONS; LATE-PHASE; POTENTIATION; ACTIVATION; LTP; RESPONSES; FORMS	Kainate receptors alter the excitability of mossy fiber axons and have been reported to play a role in the induction of long-term potentiation (LTP) at mossy fiber synapses in the hippocampus. These previous studies have relied primarily on the use of compounds whose selectivity is unclear. In this report, we investigate short- and long-term facilitation of mossy fiber synaptic transmission in kainate receptor knockout mice. We find that LTP is reduced in mice lacking the GluR6, but not the GluR5, kainate receptor subunit. Additionally, short-term synaptic facilitation is impaired in GluR6 knockout mice, suggesting that kainate receptors act as presynaptic autoreceptors on mossy fiber terminals to facilitate synaptic transmission. These data demonstrate that kainate receptors containing the GluR6 subunit are important modulators of mossy fiber synaptic strength.	Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute	Contractor, A (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Contractor, Anis/0000-0002-5131-2536				BAHN S, 1994, J NEUROSCI, V14, P5525; BASHIR ZI, 1993, NATURE, V363, P347, DOI 10.1038/363347a0; Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; Bureau I, 1999, J NEUROSCI, V19, P653; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; Contractor A, 2000, J NEUROSCI, V20, P8269, DOI 10.1523/JNEUROSCI.20-22-08269.2000; Cossart R, 1998, NAT NEUROSCI, V1, P470, DOI 10.1038/2185; Domenici MR, 1998, P NATL ACAD SCI USA, V95, P8310, DOI 10.1073/pnas.95.14.8310; Frerking M, 1998, NAT NEUROSCI, V1, P479, DOI 10.1038/2194; Frerking M, 1999, P NATL ACAD SCI USA, V96, P12917, DOI 10.1073/pnas.96.22.12917; Frerking M, 2000, CURR OPIN NEUROBIOL, V10, P342, DOI 10.1016/S0959-4388(00)00094-5; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; HOPKINS WF, 1988, J NEUROPHYSIOL, V59, P667, DOI 10.1152/jn.1988.59.2.667; HSIA AY, 1995, NEUROPHARMACOLOGY, V34, P1567, DOI 10.1016/0028-3908(95)00115-M; Huang YY, 1996, NEURON, V16, P611, DOI 10.1016/S0896-6273(00)80080-X; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; ITO I, 1991, NEUROREPORT, V2, P333, DOI 10.1097/00001756-199106000-00008; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; Kamiya H, 2000, J PHYSIOL-LONDON, V523, P653, DOI 10.1111/j.1469-7793.2000.t01-1-00653.x; MANZONI OJ, 1994, EUR J NEUROSCI, V6, P1050, DOI 10.1111/j.1460-9568.1994.tb00599.x; Mulle C, 2000, NEURON, V28, P475, DOI 10.1016/S0896-6273(00)00126-4; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; REGEHR WG, 1994, J NEUROSCI, V14, P523; REPRESA A, 1987, NEUROSCIENCE, V20, P739, DOI 10.1016/0306-4522(87)90237-5; Rodriguez-Moreno A, 2000, P NATL ACAD SCI USA, V97, P1293, DOI 10.1073/pnas.97.3.1293; Rodriguez-Moreno A, 1998, NEURON, V20, P1211, DOI 10.1016/S0896-6273(00)80501-2; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Urban NN, 1996, J NEUROSCI, V16, P4293; Vignes M, 1998, NEUROPHARMACOLOGY, V37, P1269, DOI 10.1016/S0028-3908(98)00148-8; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; WEISSKOPF MG, 1995, NATURE, V376, P256, DOI 10.1038/376256a0; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	39	250	255	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	2001	29	1					209	216		10.1016/S0896-6273(01)00191-X	http://dx.doi.org/10.1016/S0896-6273(01)00191-X			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	397NX	11182092	Bronze			2022-12-24	WOS:000166702700020
J	Penzes, P; Johnson, RC; Sattler, R; Zhang, XQ; Huganir, RL; Kambampati, V; Mains, RE; Eipper, BA				Penzes, P; Johnson, RC; Sattler, R; Zhang, XQ; Huganir, RL; Kambampati, V; Mains, RE; Eipper, BA			The neuronal Rho-GEF Kalirin-7 interacts with PDZ domain-containing proteins and regulates dendritic morphogenesis	NEURON			English	Article							TUMOR-SUPPRESSOR PROTEIN; PEPTIDE-PROCESSING ENZYME; FILAMENT-BINDING PROTEIN; ACTIN FILAMENT; MOLECULAR CHARACTERIZATION; HIPPOCAMPAL-NEURONS; GLUTAMATE RECEPTORS; AMPA RECEPTORS; RAC GTPASE; SPINES	Spine function requires precise control of the actin cytoskeleton. Kalirin-7, a GDP/GTP exchange factor for Rad, interacts with PDZ proteins such as PSD-95, colocalizing with PSD-95 at synapses of cultured hippocampal neurons. PSD-95 and Kalirin-7 interact in vivo and in heterologous expression systems. In primary cortical neurons, transfected Kalirin-7 is targeted to spines and increases the number and size of spine-like structures. A Kalirin-7 mutant unable to interact with PDZ proteins remains in the cell soma, inducing local formation of aberrant filopodial neurites. Kalirin-7 with an inactivated GEF domain reduces the number of spines below control levels. These results provide evidence that PDZ proteins target Kalirin-7 to the PSD, where it regulates dendritic morphogenesis through Rad signaling to the actin cytoskeleton.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Eipper, BA (corresponding author), Univ Connecticut, Ctr Hlth, Dept Neurosci, 263 Farmington Ave, Farmington, CT 06030 USA.		Penzes, Peter/L-3987-2016	Penzes, Peter/0000-0001-5449-1640	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032948, R56DK032948, R37DK032948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER; NIDA NIH HHS [DA-00266] Funding Source: Medline; NIDDK NIH HHS [DK-32948] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alam MR, 1997, J BIOL CHEM, V272, P12667, DOI 10.1074/jbc.272.19.12667; Alam MR, 1996, J BIOL CHEM, V271, P28636, DOI 10.1074/jbc.271.45.28636; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Allison DW, 1998, J NEUROSCI, V18, P2423; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Banker G., 1991, CULTURING NERVE CELL; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Borg JP, 1998, J BIOL CHEM, V273, P14761, DOI 10.1074/jbc.273.24.14761; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Colomer V, 1997, HUM MOL GENET, V6, P1519, DOI 10.1093/hmg/6.9.1519; De Vries L, 1998, P NATL ACAD SCI USA, V95, P12340, DOI 10.1073/pnas.95.21.12340; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Dobrosotskaya I, 1997, J BIOL CHEM, V272, P31589, DOI 10.1074/jbc.272.50.31589; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fanning AS, 1999, J CLIN INVEST, V103, P767, DOI 10.1172/JCI6509; Fernandez-Larrea J, 1999, MOL CELL, V3, P423, DOI 10.1016/S1097-2765(00)80470-0; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; Halpain S, 1998, J NEUROSCI, V18, P9835; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; ITOH M, 1993, J CELL BIOL, V121, P491, DOI 10.1083/jcb.121.3.491; JESAITIS LA, 1994, J CELL BIOL, V124, P949, DOI 10.1083/jcb.124.6.949; Johnson RC, 2000, J BIOL CHEM, V275, P19324, DOI 10.1074/jbc.M000676200; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kim CH, 1999, J NEUROSCI, V19, P4314; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Liu XH, 1998, CELL, V95, P269, DOI 10.1016/S0092-8674(00)81757-2; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Mains RE, 1999, J BIOL CHEM, V274, P2929, DOI 10.1074/jbc.274.5.2929; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Matus A, 1999, CURR OPIN NEUROBIOL, V9, P561, DOI 10.1016/S0959-4388(99)00018-5; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Nakanishi H, 1997, J CELL BIOL, V139, P951, DOI 10.1083/jcb.139.4.951; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Okamoto M, 1997, J BIOL CHEM, V272, P31459, DOI 10.1074/jbc.272.50.31459; PAPA M, 1995, J NEUROSCI, V15, P1; Penzes P, 2000, J BIOL CHEM, V275, P6395, DOI 10.1074/jbc.275.9.6395; PONTING CP, 1995, TRENDS BIOCHEM SCI, V20, P265, DOI 10.1016/S0968-0004(00)89040-4; Ratovitski EA, 1999, J BIOL CHEM, V274, P993, DOI 10.1074/jbc.274.2.993; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sheng M, 1999, ANN NY ACAD SCI, V868, P483, DOI 10.1111/j.1749-6632.1999.tb11317.x; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Ullmer C, 1998, FEBS LETT, V424, P63, DOI 10.1016/S0014-5793(98)00141-0; van Rossum D, 1999, TRENDS NEUROSCI, V22, P290, DOI 10.1016/S0166-2236(99)01404-6; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	66	295	304	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	2001	29	1					229	242		10.1016/S0896-6273(01)00193-3	http://dx.doi.org/10.1016/S0896-6273(01)00193-3			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	397NX	11182094	Bronze			2022-12-24	WOS:000166702700022
J	Leiserson, WM; Harkins, EW; Keshishian, H				Leiserson, WM; Harkins, EW; Keshishian, H			Fray, a Drosophila serine/threonine kinase homologous to mammalian PASK, is required for axonal ensheathment	NEURON			English	Article							BLOOD-NERVE BARRIER; CELL FATES; GENE; PROTEIN; MELANOGASTER; EMBRYOS; GLIA; PHENOTYPES; DIFFERENTIATION; CLASSIFICATION	Fray is a serine/threonine kinase expressed by the peripheral glia of Drosophila, whose function is required for normal axonal ensheathment. Null fray mutants die early in larval development and have nerves with severe swelling and axonal defasciculation. The phenotype is associated with a failure of the ensheathing glia to correctly wrap peripheral axons. When the fray cDNA is expressed in the ensheathing glia of fray mutants, normal nerve morphology is restored. Fray belongs to a novel family of Ser/Thr kinases, the PF kinases, whose closest relatives are the PAK kinases. Rescue of the Drosophila mutant phenotype with PASK, the rat homolog of Fray, demonstrates a functional homology among these proteins and suggests that the Fray signaling pathway is widely conserved.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Leiserson, WM (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.		Leiserson, William/A-5721-2013	Leiserson, William/0000-0001-5477-0674				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AULD VJ, 1995, CELL, V81, P757, DOI 10.1016/0092-8674(95)90537-5; AULD VJ, 1996, GLIAL CELL DEV, P229; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; Bellen HJ, 1998, TRENDS NEUROSCI, V21, P444, DOI 10.1016/S0166-2236(98)01267-3; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brown ED, 1996, MAR POLICY, V20, P1, DOI 10.1016/0308-597X(96)90023-8; CAMPBELL G, 1994, DEVELOPMENT, V120, P2957; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Carlson SD, 1998, INT J INSECT MORPHOL, V27, P61, DOI 10.1016/S0020-7322(98)00004-X; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; EDWARDS JS, 1993, J COMP NEUROL, V333, P301, DOI 10.1002/cne.903330214; FREDIEU JR, 1989, DEVELOPMENT, V106, P739; Gelbart WM, 1999, NUCLEIC ACIDS RES, V27, P85, DOI 10.1093/nar/27.1.85; GORCZYCA MG, 1994, DEVELOPMENT, V120, P2143; HALPERN ME, 1991, J NEUROSCI, V11, P3227; HALTER DA, 1995, DEVELOPMENT, V121, P317; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HARTL DL, 1994, P NATL ACAD SCI USA, V91, P6824, DOI 10.1073/pnas.91.15.6824; Hurd DD, 1996, GENETICS, V144, P1075; ITO K, 1995, ROUX ARCH DEV BIOL, V204, P284, DOI 10.1007/BF02179499; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; JESSEN KR, 1996, GLIAL CELL DEV BASIC; JOHANSEN J, 1989, J NEUROSCI, V9, P710; JOHANSEN J, 1989, J NEUROSCI, V9, P4318; KARPEN GH, 1992, GENETICS, V132, P737; KESHISHIAN H, 1993, J NEUROBIOL, V24, P757, DOI 10.1002/neu.480240606; KLAMBT C, 1991, GLIA, V4, P205, DOI 10.1002/glia.440040212; Knaus UG, 1998, INT J BIOCHEM CELL B, V30, P857, DOI 10.1016/S1357-2725(98)00059-4; LAMING P, 1998, GLIAL CELLS THEIR RO; Leiserson W. M., 1999, Society for Neuroscience Abstracts, V25, P10; Lim L, 1996, EUR J BIOCHEM, V242, P171, DOI 10.1111/j.1432-1033.1996.0171r.x; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Manser E, 1999, Prog Mol Subcell Biol, V22, P115; Perrimon N, 1996, GENETICS, V144, P1681; Peters A., 1991, FINE STRUCTURE NERVO; Petitt M, 1998, MOL BIOL CELL, V9, p43A; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sambrook J., 2002, MOL CLONING LAB MANU; Sepp KJ, 2000, GLIA, V30, P122, DOI 10.1002/(SICI)1098-1136(200004)30:2<122::AID-GLIA2>3.0.CO;2-B; Sepp KJ, 1999, GENETICS, V151, P1093; Spradling AC, 1999, GENETICS, V153, P135; Tamari M, 1999, J HUM GENET, V44, P116, DOI 10.1007/s100380050121; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Tsutsumi T, 2000, J BIOL CHEM, V275, P9157, DOI 10.1074/jbc.275.13.9157; Ushiro H, 1998, ARCH BIOCHEM BIOPHYS, V355, P233, DOI 10.1006/abbi.1998.0736	47	96	96	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	2000	28	3					793	806		10.1016/S0896-6273(00)00154-9	http://dx.doi.org/10.1016/S0896-6273(00)00154-9			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386JJ	11163267	Bronze			2022-12-24	WOS:000166057500017
J	Wu, CWH; Kaas, JH				Wu, CWH; Kaas, JH			Spinal cord atrophy and reorganization of motoneuron connections following long-standing limb loss in primates	NEURON			English	Article							PRIMARY MOTOR CORTEX; NEURON-SPECIFIC EPITOPE; ISCHEMIC NERVE BLOCK; SELECTIVE REINNERVATION; MEDIAL GASTROCNEMIUS; GAMMA-MOTONEURONS; NEUROMUSCULAR-JUNCTION; HORSERADISH-PEROXIDASE; INTERCOSTAL MUSCLES; PARTIAL DENERVATION	Primates with long-standing therapeutic amputations of a limb at a young age were used to investigate the possibility that deefferented motor nerves sprout to new muscle targets. Injections of anatomical tracers into the muscles proximal to the amputated stump labeled a larger extent of motoneurons than matched injections on the intact side or in normal animals, including motoneurons that would normally supply only the missing limb muscles. Although the total numbers of distal limb motoneurons remained normal, some distal limb motoneurons on the amputated side were smaller in size and simpler in form. These results suggest that deprived motoneurons survive and retain function by reinnervating new muscle targets. The sprouted motor efferents may account for some of the reorganization of primary motor cortex that follows long-standing amputation.	Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; NINDS, Human Cortic Physiol Sect, NIH, Bethesda, MD 20892 USA	Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Kaas, JH (corresponding author), Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA.	jon.kaas@vanderbilt.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016446] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 16446] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALDSKOGIUS H, 1986, BRAIN RES, V375, P126, DOI 10.1016/0006-8993(86)90965-0; Angelucci A, 1996, J NEUROSCI METH, V65, P101, DOI 10.1016/0165-0270(95)00155-7; Bisby MA, 1996, EUR J NEUROSCI, V8, P1240, DOI 10.1111/j.1460-9568.1996.tb01292.x; BOSS V, 1992, J COMP NEUROL, V322, P490, DOI 10.1002/cne.903220404; BRASILNETO JP, 1993, BRAIN, V116, P511, DOI 10.1093/brain/116.3.511; BROWN MC, 1984, TRENDS NEUROSCI, V7, P10, DOI 10.1016/S0166-2236(84)80180-0; BROWN MC, 1981, ANNU REV NEUROSCI, V4, P17, DOI 10.1146/annurev.ne.04.030181.000313; BROWNE KM, 1950, J COMP NEUROL, V93, P441, DOI 10.1002/cne.900930308; BRYAN RN, 1972, BRAIN RES, V38, P193, DOI 10.1016/0006-8993(72)90602-6; BURKE RE, 1977, J NEUROPHYSIOL, V40, P667, DOI 10.1152/jn.1977.40.3.667; CARLSON J, 1979, J NEUROPATH EXP NEUR, V38, P579, DOI 10.1097/00005072-197911000-00002; CHEN EW, 1995, J NEUROSCI, V15, P1556; Chen R, 1998, J NEUROSCI, V18, P3443; CHIU AY, 1993, J COMP NEUROL, V328, P351, DOI 10.1002/cne.903280303; CONNOR EA, 1994, J NEUROBIOL, V25, P722, DOI 10.1002/neu.480250611; CULLHEIM S, 1979, NEUROSCI LETT, V13, P47, DOI 10.1016/0304-3940(79)90073-9; DENNIS MJ, 1981, ANNU REV NEUROSCI, V4, P43, DOI 10.1146/annurev.ne.04.030181.000355; DONOGHUE JP, 1988, J NEUROSCI, V8, P3221; EINSIEDEL L, 1992, EXP BRAIN RES, V90, P369; FOEHRING RC, 1986, J NEUROPHYSIOL, V55, P947, DOI 10.1152/jn.1986.55.5.947; GENESERJENSEN FA, 1971, Z ZELLFORSCH MIK ANA, V114, P460, DOI 10.1007/BF00325634; GIBSON AR, 1984, BRAIN RES, V298, P235, DOI 10.1016/0006-8993(84)91423-9; Goering JH, 1928, J COMP NEUROL, V46, P125, DOI 10.1002/cne.900460104; Greensmith L, 1997, DEV BRAIN RES, V98, P281, DOI 10.1016/S0165-3806(96)00200-3; HALL EJ, 1990, NEUROSCI LETT, V116, P379, DOI 10.1016/0304-3940(90)90105-I; HARDMAN VJ, 1987, J NEUROSCI, V7, P1031; HASHIZUME K, 1988, J COMP NEUROL, V269, P425, DOI 10.1002/cne.902690309; JACOBS KM, 1991, SCIENCE, V251, P944, DOI 10.1126/science.2000496; JANSEN JKS, 1990, PROG NEUROBIOL, V34, P39, DOI 10.1016/0301-0082(90)90025-C; JENNY AB, 1983, J NEUROSCI, V3, P567; Jones EG, 1998, SCIENCE, V282, P1121, DOI 10.1126/science.282.5391.1121; KEW JJM, 1994, J NEUROPHYSIOL, V72, P2517, DOI 10.1152/jn.1994.72.5.2517; Kishino A, 1997, EXP NEUROL, V144, P273, DOI 10.1006/exnr.1996.6367; KOLIATSOS VE, 1993, NEURON, V10, P359, DOI 10.1016/0896-6273(93)90326-M; KUNO M, 1990, NEUROSCI RES, V9, P155, DOI 10.1016/0168-0102(90)90001-U; KUYPERS HGJM, 1982, PROG BRAIN RES, V57, P381, DOI 10.1016/S0079-6123(08)64138-2; LASKOWSKI MB, 1988, J NEUROSCI, V8, P3094; Manger PR, 1996, P ROY SOC B-BIOL SCI, V263, P933, DOI 10.1098/rspb.1996.0138; MITTAL KR, 1987, J GERONTOL, V42, P8, DOI 10.1093/geronj/42.1.8; NISHI R, 1994, J NEUROBIOL, V25, P612, DOI 10.1002/neu.480250604; Novikov L, 1997, NEUROSCIENCE, V79, P765, DOI 10.1016/S0306-4522(96)00665-3; OJEMANN JG, 1995, J NEUROSURG, V82, P641, DOI 10.3171/jns.1995.82.4.0641; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; PascualLeone A, 1996, NEUROREPORT, V7, P2068, DOI 10.1097/00001756-199609020-00002; PINTER MJ, 1989, J NEUROPHYSIOL, V62, P311, DOI 10.1152/jn.1989.62.2.311; Preuss TM, 1997, BRAIN RES, V767, P148, DOI 10.1016/S0006-8993(97)00704-X; Qi HX, 2000, J NEUROPHYSIOL, V84, P2133, DOI 10.1152/jn.2000.84.4.2133; RAMACHANDRAN VS, 1993, P NATL ACAD SCI USA, V90, P10413, DOI 10.1073/pnas.90.22.10413; Ranson W, 1906, J COMP NEUROL PSYCHO, V16, P265; Reed AF, 1940, J COMP NEUROL, V72, P187, DOI 10.1002/cne.900720107; REXED B, 1952, J COMP NEUROL, V96, P415, DOI 10.1002/cne.900960303; RiveroMelian C, 1996, J COMP NEUROL, V364, P651, DOI 10.1002/(SICI)1096-9861(19960122)364:4<651::AID-CNE4>3.0.CO;2-2; ROMANES GJ, 1951, J COMP NEUROL, V94, P313, DOI 10.1002/cne.900940209; ROMANES GJ, 1946, J ANAT, V80, P117; Rouiller EM, 1996, EUR J NEUROSCI, V8, P1055, DOI 10.1111/j.1460-9568.1996.tb01592.x; SANES JN, 1990, EXP BRAIN RES, V79, P479; Schieber MH, 1997, SOMATOSENS MOT RES, V14, P157; SCHMALBRUCH H, 1984, J COMP NEUROL, V224, P252, DOI 10.1002/cne.902240206; STRICK PL, 1976, BRAIN RES, V113, P582, DOI 10.1016/0006-8993(76)90059-7; Sunderland S., 1978, NERVES NERVE INJURIE; SWETT JE, 1991, J COMP NEUROL, V304, P234, DOI 10.1002/cne.903040207; TOPKA H, 1991, NEUROLOGY, V41, P1276, DOI 10.1212/WNL.41.8.1276; VANDENNOVEN S, 1993, EXP NEUROL, V123, P147; WESTBURY DR, 1982, J PHYSIOL-LONDON, V325, P79, DOI 10.1113/jphysiol.1982.sp014137; WIGSTON DJ, 1985, J NEUROSCI, V5, P1208; WIGSTON DJ, 1987, J NEUROSCI, V7, P1857; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; Woods TM, 2000, J NEUROSCI, V20, P3884, DOI 10.1523/JNEUROSCI.20-10-03884.2000; WOOLSEY CN, 1979, J NEUROSURG, V17, P266; Wu CWH, 1999, J NEUROSCI, V19, P7679, DOI 10.1523/JNEUROSCI.19-17-07679.1999; Wu CWH, 2000, J COMP NEUROL, V423, P140, DOI 10.1002/1096-9861(20000717)423:1<140::AID-CNE12>3.0.CO;2-3; Ziemann U, 1998, J NEUROSCI, V18, P7000; Ziemann U, 1998, J NEUROSCI, V18, P1115	73	40	40	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	2000	28	3					967	978		10.1016/S0896-6273(00)00167-7	http://dx.doi.org/10.1016/S0896-6273(00)00167-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386JJ	11163280	Bronze			2022-12-24	WOS:000166057500030
J	Tokuyama, W; Okuno, H; Hashimoto, T; Li, YX; Miyashita, Y				Tokuyama, W; Okuno, H; Hashimoto, T; Li, YX; Miyashita, Y			BDNF upregulation during declarative memory formation in monkey inferior temporal cortex	NATURE NEUROSCIENCE			English	Article							MESSENGER-RNA EXPRESSION; LONG-TERM-MEMORY; NEUROTROPHIC FACTOR; PERIRHINAL CORTEX; STIMULUS ASSOCIATION; HIPPOCAMPAL SUBREGIONS; SYNAPTIC PLASTICITY; PREFRONTAL CORTEX; RAT HIPPOCAMPUS; VISUAL-CORTEX	In primates, visual long-term memory of objects is presumably stored in the inferior temporal (IT) cortex. Because brain-derived neurotrophic factor (BDNF) is involved in activity-dependent neural reorganization, we tested the hypothesis that BDNF would be upregulated in IT cortex during formation of visual pair-association memory. To eliminate genetic and cognitive variations between individual animals, we used split-brain monkeys for intra-animal comparison in PCR-based mRNA quantitation. The monkeys learned a pair-association (PA) task using one hemisphere and a control visual task using the other, to balance the amount of visual input. We found that BDNF was upregulated selectively in area 36 of IT cortex during PA learning, but not in areas involved in earlier stages of visual processing. In situ hybridization showed that BDNF-expressing cells were localized in a patchlike cluster. The results suggest that BDNF contributes to reorganization of neural circuits for visual long-term memory formation in the primate.	Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 1130033, Japan; Japan Sci & Technol Corp, ICORP, Mind Articulat Project, Bunkyo Ku, Tokyo 1130034, Japan; Natl Inst Physiol Sci, Aichi 4448585, Japan	University of Tokyo; Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Miyashita, Y (corresponding author), Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.		Miyashita, Yasushi/B-7171-2019	Miyashita, Yasushi/0000-0003-3496-8637; OKUNO, HIROYUKI/0000-0001-6237-6503				Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Bonhoeffer T, 1996, CURR OPIN NEUROBIOL, V6, P119, DOI 10.1016/S0959-4388(96)80017-1; Buckley MJ, 1997, BEHAV NEUROSCI, V111, P467, DOI 10.1037/0735-7044.111.3.467; Buckley MJ, 1998, NEUROPSYCHOLOGIA, V36, P535, DOI 10.1016/S0028-3932(97)00120-6; Buffalo EA, 1999, LEARN MEMORY, V6, P572, DOI 10.1101/lm.6.6.572; Cabelli RJ, 1997, NEURON, V19, P63, DOI 10.1016/S0896-6273(00)80348-7; CASTREN E, 1992, P NATL ACAD SCI USA, V89, P9444, DOI 10.1073/pnas.89.20.9444; Dragunow M, 1997, MOL BRAIN RES, V46, P274, DOI 10.1016/S0169-328X(97)00021-1; EACOTT MJ, 1994, EUR J NEUROSCI, V6, P1466, DOI 10.1111/j.1460-9568.1994.tb01008.x; Erickson CA, 1999, J NEUROSCI, V19, P10404; FALKENBERG T, 1992, NEUROSCIENCE, V51, P883, DOI 10.1016/0306-4522(92)90527-9; FENDRICH R, 1989, NEUROPSYCHOLOGIA, V27, P273, DOI 10.1016/0028-3932(89)90018-3; GAFFAN D, 1991, BRAIN, V114, P2133, DOI 10.1093/brain/114.5.2133; Gause William C., 1995, P293; GAZZANIGA MS, 1995, NEURON, V14, P217, DOI 10.1016/0896-6273(95)90280-5; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Hasegawa I, 1998, SCIENCE, V281, P814, DOI 10.1126/science.281.5378.814; Hashimoto T, 2000, NEUROSCIENCE, V95, P1003; Higuchi S, 1996, P NATL ACAD SCI USA, V93, P739, DOI 10.1073/pnas.93.2.739; HUGHES P, 1993, NEUROSCIENCE, V57, P319, DOI 10.1016/0306-4522(93)90065-N; HUNTLEY GW, 1992, DEV BRAIN RES, V70, P53, DOI 10.1016/0165-3806(92)90103-4; Jones EG, 2000, ANNU REV NEUROSCI, V23, P1, DOI 10.1146/annurev.neuro.23.1.1; Kawamoto Y, 1999, BRAIN RES, V821, P341, DOI 10.1016/S0006-8993(99)01082-3; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Liu Z, 2000, J NEUROPHYSIOL, V83, P1677, DOI 10.1152/jn.2000.83.3.1677; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Mishkin M, 1997, PHILOS T R SOC B, V352, P1461, DOI 10.1098/rstb.1997.0132; Miyashita Y, 2000, CURR OPIN NEUROBIOL, V10, P187, DOI 10.1016/S0959-4388(00)00071-4; MIYASHITA Y, 1993, ANNU REV NEUROSCI, V16, P245, DOI 10.1146/annurev.ne.16.030193.001333; MURRAY EA, 1993, J NEUROSCI, V13, P4549; NEEPER SA, 1995, NATURE, V373, P109, DOI 10.1038/373109a0; Okuno H, 1996, EUR J NEUROSCI, V8, P2118, DOI 10.1111/j.1460-9568.1996.tb00733.x; Okuno H, 1999, J COMP NEUROL, V408, P378; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; ROLLS ET, 1995, BEHAV BRAIN RES, V66, P177, DOI 10.1016/0166-4328(94)00138-6; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; STONE J, 1973, J COMP NEUROL, V150, P333, DOI 10.1002/cne.901500306; SUGISHITA M, 1994, NEUROPSYCHOLOGIA, V32, P399, DOI 10.1016/0028-3932(94)90086-8; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Tokuyama W, 1999, BRAIN RES PROTOC, V4, P407, DOI 10.1016/S1385-299X(99)00046-X; Tokuyama W, 1998, MOL BRAIN RES, V62, P206, DOI 10.1016/S0169-328X(98)00261-7; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; VANESSEN DC, 1984, VISION RES, V24, P429, DOI 10.1016/0042-6989(84)90041-5; Wechsler D, 1987, WMS R WECHSLER MEMOR; Xiang JZ, 1999, EUR J NEUROSCI, V11, P3715, DOI 10.1046/j.1460-9568.1999.00790.x; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; ZOLAMORGAN S, 1989, J NEUROSCI, V9, P4355	50	108	113	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11					1134	1142		10.1038/80655	http://dx.doi.org/10.1038/80655			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TX	11036271				2022-12-24	WOS:000167177600019
J	Bence-Hanulec, KK; Marshall, J; Blair, LAC				Bence-Hanulec, KK; Marshall, J; Blair, LAC			Potentiation of neuronal L calcium channels by IGF-1 requires phosphorylation of the alpha 1 subunit on a specific tyrosine residue	NEURON			English	Article							GROWTH-FACTOR-I; CEREBELLAR GRANULE CELLS; CA2+ CHANNELS; SRC-FAMILY; SYNAPTIC ACTIVATION; PROTEIN-KINASE; RAT-BRAIN; CLASS-C; RECEPTOR; MODULATION	Insulin-like growth factor 1 (IGF-1) rapidly potentiates N and L calcium channel currents in cerebellar granule neurons by an unknown mechanism. Here, we show that the L channel alpha 1C subunit is tyrosine phosphorylated in response to IGF-1. Moreover, expression of kinase-dead c-Src in neurons or acute block of Src family kinases with a cell-permeable inhibitor specifically blocks L channel potentiation. Purified Src kinase phosphorylates tyrosine residue Y2122 of the C terminus of neuronal alpha 1C in vitro, and c- and v-Src directly bind the C terminus. When expressed in neuroblastoma cells, point mutation of Y2122 prevents both tyrosine phosphorylation of alpha 1C and IGF-1 potentiation. Our data provide a biochemical mechanism whereby phosphorylation of a single specific tyrosine residue rapidly modifies ion channel physiology.	Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA	Brown University; Cornell University	Marshall, J (corresponding author), Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.	John_Marshall@Brown.edu		Bence, Kendra/0000-0002-5879-4726	NINDS NIH HHS [R01 NS37676-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037676] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Apfel SC, 1999, EUR NEUROL, V41, P27, DOI 10.1159/000052077; Arbet-Engels C, 1999, J BIOL CHEM, V274, P5422, DOI 10.1074/jbc.274.9.5422; Barale E, 1998, NEUROREPORT, V9, P2513, DOI 10.1097/00001756-199808030-00016; Blair LAC, 1999, METHOD ENZYMOL, V302, P213, DOI 10.1016/S0076-6879(99)02021-2; Blair LAC, 1997, NEURON, V19, P421, DOI 10.1016/S0896-6273(00)80950-2; Blair LAC, 1999, J NEUROSCI, V19, P1940; BONDY C, 1992, NEUROSCIENCE, V46, P909, DOI 10.1016/0306-4522(92)90193-6; Cataldi M, 1996, J BIOL CHEM, V271, P9441, DOI 10.1074/jbc.271.16.9441; CHENG HC, 1992, J BIOL CHEM, V267, P9248; CHIEN AJ, 1995, J BIOL CHEM, V270, P30036; CONLEY EC, 1999, ION CHANNEL FACTS; DAngelo E, 1997, J NEUROPHYSIOL, V78, P1631, DOI 10.1152/jn.1997.78.3.1631; DeJongh KS, 1996, BIOCHEMISTRY-US, V35, P10392, DOI 10.1021/bi953023c; DErcole AJ, 1996, MOL NEUROBIOL, V13, P227, DOI 10.1007/BF02740625; Evans GJO, 1999, EUR J NEUROSCI, V11, P279, DOI 10.1046/j.1460-9568.1999.00427.x; Fadool DA, 1998, J NEUROSCI, V18, P6126; Finkbeiner S, 1996, NEURON, V16, P233, DOI 10.1016/S0896-6273(00)80040-9; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; GALLI C, 1995, J NEUROSCI, V15, P1172; GALLO V, 1987, J NEUROSCI, V7, P2203; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Gray PC, 1998, NEURON, V20, P1017, DOI 10.1016/S0896-6273(00)80482-1; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hayashi T, 1999, NATURE, V397, P72, DOI 10.1038/16269; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Hilborn MD, 1998, J NEUROSCI, V18, P590; Hirota K, 1997, NEUROSCI LETT, V223, P169, DOI 10.1016/S0304-3940(97)13434-6; Holmes TC, 1996, SCIENCE, V274, P2089, DOI 10.1126/science.274.5295.2089; Hu XQ, 1998, J BIOL CHEM, V273, P5337, DOI 10.1074/jbc.273.9.5337; Jacobs JM, 1997, J NEUROSCI, V17, P4129; KAR S, 1993, J COMP NEUROL, V333, P375, DOI 10.1002/cne.903330306; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; Kohr G, 1996, J PHYSIOL-LONDON, V492, P445; KOZMA LM, 1990, MOL CELL BIOL, V10, P3626, DOI 10.1128/MCB.10.7.3626; Leski ML, 1999, BRAIN RES, V828, P27, DOI 10.1016/S0006-8993(99)01270-6; LEVITAN IB, 1994, ANNU REV PHYSIOL, V56, P193, DOI 10.1146/annurev.ph.56.030194.001205; MARSHALL J, 1995, NEURON, V14, P211, DOI 10.1016/0896-6273(95)90279-1; Mathews CC, 1996, J CELL PHYSIOL, V166, P323; MOSS SJ, 1995, NATURE, V377, P344, DOI 10.1038/377344a0; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; Pearson RB, 1998, SEL METH EN, P65; Peterson JE, 1996, J BIOL CHEM, V271, P31562, DOI 10.1074/jbc.271.49.31562; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; RANDALL A, 1995, J NEUROSCI, V15, P2995; REEVE HL, 1994, EUR J NEUROSCI, V6, P943, DOI 10.1111/j.1460-9568.1994.tb00588.x; SELINFREUND RH, 1994, MOL PHARMACOL, V45, P1215; Singleton JR, 1996, CANCER RES, V56, P4522; Sparks AB, 1996, P NATL ACAD SCI USA, V93, P1540, DOI 10.1073/pnas.93.4.1540; Spitzer NC, 1998, J NEUROBIOL, V37, P190, DOI 10.1002/(SICI)1097-4695(199810)37:1<190::AID-NEU14>3.3.CO;2-2; Stewart CEH, 1996, PHYSIOL REV, V76, P1005, DOI 10.1152/physrev.1996.76.4.1005; Strauss O, 1997, FASEB J, V11, P859, DOI 10.1096/fasebj.11.11.9285484; SUDOL M, 1988, ONCOGENE RES, V2, P345; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; TOMLINSON WJ, 1993, NEUROPHARMACOLOGY, V32, P1117, DOI 10.1016/0028-3908(93)90006-O; UMEMORI H, 1992, MOL BRAIN RES, V16, P303, DOI 10.1016/0169-328X(92)90239-8; Wagner K R, 1991, Curr Opin Neurobiol, V1, P65, DOI 10.1016/0959-4388(91)90011-U; Wang ZM, 1999, J PHYSIOL-LONDON, V516, P331, DOI 10.1111/j.1469-7793.1999.0331v.x; Wijetunge S, 1996, FEBS LETT, V399, P63, DOI 10.1016/S0014-5793(96)01177-5; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674	60	79	81	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	2000	27	1					121	131		10.1016/S0896-6273(00)00014-3	http://dx.doi.org/10.1016/S0896-6273(00)00014-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339XU	10939336	Bronze			2022-12-24	WOS:000088503800015
J	Born, RT; Groh, JM; Zhao, R; Lukasewycz, SJ				Born, RT; Groh, JM; Zhao, R; Lukasewycz, SJ			Segregation of object and background motion in visual area MT: Effects of microstimulation on eye movements	NEURON			English	Article							MOVING TEXTURED BACKGROUNDS; SUPERIOR TEMPORAL SULCUS; MACAQUE MONKEY; FUNCTIONAL-PROPERTIES; PURSUIT; NEURONS; DIRECTION; SACCADES; CORTEX; HUMANS	To track a moving object, its motion must first be distinguished from that of the background. The center-surround properties of neurons in the middle temporal visual area (MT) may be important for signaling the relative motion between object and background. To test this, we microstimulated within MT and measured the effects on monkeys' eye movements to moving targets. We found that stimulation at "local motion" sites, where receptive fields possessed antagonistic surrounds, shifted pursuit in the preferred direction of the neurons, whereas stimulation at "wide-field motion" sites shifted pursuit in the opposite, or null, direction. We propose that activating wide-field sites simulated background motion, thus inducing a target motion signal in the opposite direction. Our results support the hypothesis that neuronal center-surround mechanisms contribute to the behavioral segregation of objects from the background.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Dartmouth Coll, Ctr Cognit Neurosci, Hanover, NH 03755 USA; Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; Harvard Univ, Dept Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Dartmouth College; Dartmouth College; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University	Born, RT (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.		Born, Richard/M-6454-2019	Born, Richard/0000-0003-4360-427X; Groh, Jennifer/0000-0002-6435-3935	NEI NIH HHS [EY11379, EY12196] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY012196, R01EY011379] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALBRIGHT TD, 1989, VISUAL NEUROSCI, V2, P177, DOI 10.1017/S0952523800012037; ALLMAN J, 1985, PERCEPTION, V14, P105, DOI 10.1068/p140105; BARLOW HB, 1981, PROC R SOC SER B-BIO, V212, P1, DOI 10.1098/rspb.1981.0022; BORN RT, 1992, NATURE, V357, P497, DOI 10.1038/357497a0; BRADDICK O, 1993, TRENDS NEUROSCI, V16, P263, DOI 10.1016/0166-2236(93)90179-P; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; COLLETT T, 1971, NATURE, V232, P127, DOI 10.1038/232127a0; DeAngelis GC, 1999, J NEUROSCI, V19, P1398; DESIMONE R, 1986, J COMP NEUROL, V248, P164, DOI 10.1002/cne.902480203; Duncker K, 1929, PSYCHOL FORSCH, V12, P180, DOI 10.1007/BF02409210; EGELHAAF M, 1988, TRENDS NEUROSCI, V11, P351, DOI 10.1016/0166-2236(88)90057-4; FISHER NI, 1983, BIOMETRIKA, V70, P327, DOI 10.1093/biomet/70.2.327; FROST BJ, 1981, EXP BRAIN RES, V43, P173; FROST BJ, 1983, SCIENCE, V220, P744, DOI 10.1126/science.6836313; GATTASS R, 1981, J NEUROPHYSIOL, V46, P621, DOI 10.1152/jn.1981.46.3.621; GELLMAN RS, 1991, EXP BRAIN RES, V84, P660; Groh JM, 1997, J NEUROSCI, V17, P4312; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KELLER E, 1990, EXP BRAIN RES, V80, P525; Keller EL, 1996, J NEUROPHYSIOL, V76, P3573, DOI 10.1152/jn.1996.76.5.3573; KOMATSU H, 1989, J NEUROPHYSIOL, V62, P31, DOI 10.1152/jn.1989.62.1.31; KOMATSU H, 1988, J NEUROPHYSIOL, V60, P580, DOI 10.1152/jn.1988.60.2.580; LAGAE L, 1989, BRAIN RES, V496, P361, DOI 10.1016/0006-8993(89)91089-5; Lamme VAF, 1998, CURR OPIN NEUROBIOL, V8, P529, DOI 10.1016/S0959-4388(98)80042-1; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; LISBERGER SG, 1985, J NEUROSCI, V5, P1662; MASSON G, 1995, VISION RES, V35, P837, DOI 10.1016/0042-6989(94)00185-O; Maunsell JH, 1986, MATTERS INTELLIGENCE, P59; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MIKAMI A, 1986, J NEUROPHYSIOL, V55, P1308, DOI 10.1152/jn.1986.55.6.1308; MILES FA, 1991, REPRESENTATIONS VISI, P185; NEWSOME WT, 1985, J NEUROSCI, V5, P825; Niemann T, 1997, EXP BRAIN RES, V115, P531, DOI 10.1007/PL00005723; RAIGUEL S, 1995, EUR J NEUROSCI, V7, P2064, DOI 10.1111/j.1460-9568.1995.tb00629.x; RASHBASS C, 1961, J PHYSIOL-LONDON, V159, P326, DOI 10.1113/jphysiol.1961.sp006811; REINHARDTRUTLAND AH, 1988, PSYCHOL BULL, V103, P57, DOI 10.1037/0033-2909.103.1.57; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; RON S, 1989, VISION RES, V29, P1103, DOI 10.1016/0042-6989(89)90059-X; Rubin E., 1915, SYNSOPLEVEDE FIGURER; Schwarz U, 1999, NEUROREPORT, V10, P2477, DOI 10.1097/00001756-199908200-00008; STERLING P, 1969, J NEUROPHYSIOL, V32, P1, DOI 10.1152/jn.1969.32.1.1; TANAKA K, 1986, J NEUROSCI, V6, P134; TOOTELL R B H, 1990, Investigative Ophthalmology and Visual Science, V31, P238; Upton G. J. G., 1989, SPATIAL DATA ANAL EX, V2; VANESSEN DC, 1981, J COMP NEUROL, V199, P293, DOI 10.1002/cne.901990302; VONGRUNAU M, 1983, EXP BRAIN RES, V49, P84, DOI 10.1007/BF00235544; Wertheimer M, 1912, Z PSYCHOL PHYSIOL SI, V61, P161; XIAO DK, 1995, P NATL ACAD SCI USA, V92, P11303, DOI 10.1073/pnas.92.24.11303; Zar J. H., 1996, BIOSTATISTICAL ANAL	49	136	137	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	2000	26	3					725	734		10.1016/S0896-6273(00)81208-8	http://dx.doi.org/10.1016/S0896-6273(00)81208-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330ZH	10896167	Bronze			2022-12-24	WOS:000087991600022
J	Scales, SJ; Chen, YA; Yoo, BY; Patel, SM; Doung, YC; Scheller, RH				Scales, SJ; Chen, YA; Yoo, BY; Patel, SM; Doung, YC; Scheller, RH			SNAREs contribute to the specificity of membrane fusion	NEURON			English	Article							ENDOPLASMIC-RETICULUM; VESICULAR TRANSPORT; SYNAPTIC EXOCYTOSIS; VESICLE TRAFFICKING; SYNTAXIN FAMILY; PROTEIN; COMPLEX; SNAP-25; CELLS; IDENTIFICATION	Intracellular membrane fusion is mediated by the formation of a four-helix bundle comprised of SNARE proteins. Every cell expresses a large number of SNARE proteins that are localized to particular membrane compartments, suggesting that the fidelity of vesicle trafficking might in part be determined by specific SNARE pairing. However, the promiscuity of SNARE pairing in vitro suggests that the information for membrane compartment organization is not encoded in the inherent ability of SNAREs to form complexes. Here, we show that exocytosis of norepinephrine from PC12 cells is only inhibited or rescued by specific SNAREs. The data suggest that SNARE pairing does underlie vesicle trafficking fidelity, and that specific SNARE interactions with other proteins may facilitate the correct pairing.	Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Howard Hughes Med Inst, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Scheller, RH (corresponding author), Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Howard Hughes Med Inst, Stanford, CA 94305 USA.		Scales, Suzie J./H-4507-2019	Scales, Suzie J./0000-0003-2544-0283				Advani RJ, 1999, J CELL BIOL, V146, P765, DOI 10.1083/jcb.146.4.765; Advani RJ, 1998, J BIOL CHEM, V273, P10317, DOI 10.1074/jbc.273.17.10317; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Bock JB, 1996, J BIOL CHEM, V271, P17961, DOI 10.1074/jbc.271.30.17961; Bock JB, 1999, P NATL ACAD SCI USA, V96, P12227, DOI 10.1073/pnas.96.22.12227; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; DASCHER C, 1994, J BIOL CHEM, V269, P29363; Davanger S, 1997, MOL BIOL CELL, V8, P1261, DOI 10.1091/mbc.8.7.1261; ELFERINK LA, 1989, J BIOL CHEM, V264, P11061; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Gonzalo S, 1998, MOL BIOL CELL, V9, P585, DOI 10.1091/mbc.9.3.585; Grote E, 1999, MOL BIOL CELL, V10, P4149, DOI 10.1091/mbc.10.12.4149; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; Hay JC, 1997, CELL, V89, P149, DOI 10.1016/S0092-8674(00)80191-9; Hazzard J, 1999, J BIOMOL NMR, V14, P203, DOI 10.1023/A:1008382027065; Hua SY, 1999, NAT NEUROSCI, V2, P1078, DOI 10.1038/16005; Lin RC, 1997, NEURON, V19, P1087, DOI 10.1016/S0896-6273(00)80399-2; Low SH, 1998, J CELL BIOL, V141, P1503, DOI 10.1083/jcb.141.7.1503; Low SH, 1996, MOL BIOL CELL, V7, P2007, DOI 10.1091/mbc.7.12.2007; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; MONTECUCCO C, 1994, MOL MICROBIOL, V13, P1, DOI 10.1111/j.1365-2958.1994.tb00396.x; Nakamura N, 2000, J BIOL CHEM, V275, P6523, DOI 10.1074/jbc.275.9.6523; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; Patel SK, 1998, CELL, V92, P611, DOI 10.1016/S0092-8674(00)81129-0; Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799; Prekeris R, 1999, MOL BIOL CELL, V10, P3891, DOI 10.1091/mbc.10.11.3891; Prekeris R, 1998, J CELL BIOL, V143, P957, DOI 10.1083/jcb.143.4.957; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; Ravichandran V, 1996, J BIOL CHEM, V271, P13300, DOI 10.1074/jbc.271.23.13300; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Steegmaier M, 1999, MOL BIOL CELL, V10, P1957, DOI 10.1091/mbc.10.6.1957; Steegmaier M, 1998, J BIOL CHEM, V273, P34171, DOI 10.1074/jbc.273.51.34171; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tsui MMK, 2000, J CELL SCI, V113, P145; Ungermann C, 1999, J CELL BIOL, V145, P1435, DOI 10.1083/jcb.145.7.1435; vonMollard GF, 1997, J CELL BIOL, V137, P1511, DOI 10.1083/jcb.137.7.1511; Wang H, 1997, GENE, V199, P39, DOI 10.1016/S0378-1119(97)00343-0; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wong SH, 1998, MOL BIOL CELL, V9, P1549, DOI 10.1091/mbc.9.6.1549; Wong SH, 1999, MOL BIOL CELL, V10, P119, DOI 10.1091/mbc.10.1.119; Wong SH, 1998, J BIOL CHEM, V273, P375, DOI 10.1074/jbc.273.1.375; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649; Zhong PY, 1997, BIOCHEMISTRY-US, V36, P4317, DOI 10.1021/bi9625408	46	163	168	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	2000	26	2					457	464		10.1016/S0896-6273(00)81177-0	http://dx.doi.org/10.1016/S0896-6273(00)81177-0			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318QZ	10839363	Bronze			2022-12-24	WOS:000087296500021
J	Kohda, K; Wang, Y; Yuzaki, M				Kohda, K; Wang, Y; Yuzaki, M			Mutation of a glutamate receptor motif reveals its role in gating and delta 2 receptor channel properties	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; RAT HIPPOCAMPAL-NEURONS; METHYL-D-ASPARTATE; PURKINJE-CELLS; AMPA RECEPTORS; ACTIVATION KINETICS; CA2+ PERMEABILITY; NMDA RECEPTORS; BINDING-SITES; SUBUNIT	Despite its importance in the cerebellum, the functions of the orphan glutamate receptor delta 2 are unknown. We examined a mutant delta 2 receptor channel in lurcher mice that was constitutively active in the absence of ligand. Because this mutation was within a highly conserved motif (YTANLAAF), we tested its effect on several glutamate receptors. Mutant delta 2 receptors showed distinct channel properties, including double rectification of the current-voltage relationship, sensitivity to a polyamine antagonist and moderate Ca2+ permeability, whereas other constitutively active mutant glutamate channels resembled wildtype channels in these respects. Moreover, the kinetics of ligand-activated currents were strikingly altered. We conclude that the delta 2 receptor has a functional ion channel pore similar to that of glutamate receptors. The motif may have a role in the channel gating of glutamate receptors.	St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Yuzaki, M (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	michi.yuzaki@stjude.org	Yuzaki, Michisuke/K-5328-2013; Kohda, Kazuhisa/L-4731-2013	Yuzaki, Michisuke/0000-0002-5750-3544; 	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036925] Funding Source: NIH RePORTER; NCI NIH HHS [CA21765] Funding Source: Medline; NINDS NIH HHS [NS36925] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARAKI K, 1993, BIOCHEM BIOPH RES CO, V197, P1267, DOI 10.1006/bbrc.1993.2614; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; BLASCHKE M, 1993, P NATL ACAD SCI USA, V90, P6528, DOI 10.1073/pnas.90.14.6528; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Burnashev N, 1996, J PHYSIOL-LONDON, V496, P165, DOI 10.1113/jphysiol.1996.sp021674; Clements JD, 1998, J NEUROSCI, V18, P119; CLEMENTS JD, 1991, NEURON, V7, P605, DOI 10.1016/0896-6273(91)90373-8; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Hayashi T, 1999, NATURE, V397, P72, DOI 10.1038/16269; HIRANO T, 1995, NEUROREPORT, V6, P524, DOI 10.1097/00001756-199502000-00029; HIRANO T, 1994, NEUROSCI LETT, V182, P172, DOI 10.1016/0304-3940(94)90790-0; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Holmgren M, 1998, NEURON, V21, P617, DOI 10.1016/S0896-6273(00)80571-1; IINO M, 1990, J PHYSIOL-LONDON, V424, P151, DOI 10.1113/jphysiol.1990.sp018060; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; Jeromin A, 1996, J NEUROPHYSIOL, V76, P3578, DOI 10.1152/jn.1996.76.5.3578; JOHANSEN TH, 1995, MOL PHARMACOL, V48, P946; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; KOHLER M, 1993, NEURON, V10, P491, DOI 10.1016/0896-6273(93)90336-P; Koike M, 1997, NEUROSCI RES, V29, P27, DOI 10.1016/S0168-0102(97)00067-9; Krupp JJ, 1998, NEURON, V20, P317, DOI 10.1016/S0896-6273(00)80459-6; Landsend AS, 1997, J NEUROSCI, V17, P834, DOI 10.1523/jneurosci.17-02-00834.1997; LESTER RAJ, 1992, J NEUROSCI, V12, P635; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; LOMELI H, 1993, FEBS LETT, V315, P318, DOI 10.1016/0014-5793(93)81186-4; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; OZAWA S, 1984, Neuroscience Research, V1, P275, DOI 10.1016/0168-0102(84)90034-8; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; PARTIN KM, 1995, NEURON, V14, P833, DOI 10.1016/0896-6273(95)90227-9; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; Seeburg PH, 1998, BRAIN RES REV, V26, P217, DOI 10.1016/S0165-0173(97)00062-3; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Wang YZ, 1997, NATURE, V389, P502, DOI 10.1038/39062; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; Yamada KA, 1996, BRIT J PHARMACOL, V117, P1663, DOI 10.1111/j.1476-5381.1996.tb15337.x; Yuzaki M, 1996, SCIENCE, V273, P1112, DOI 10.1126/science.273.5278.1112; Yuzaki M, 1996, J NEUROSCI, V16, P4651; ZUKIN RS, 1995, TRENDS NEUROSCI, V18, P306, DOI 10.1016/0166-2236(95)93920-S; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	43	173	176	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2000	3	4					315	322		10.1038/73877	http://dx.doi.org/10.1038/73877			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330CN	10725919				2022-12-24	WOS:000087945400010
J	Okuda, T; Haga, T; Kanai, Y; Endou, H; Ishihara, T; Katsura, I				Okuda, T; Haga, T; Kanai, Y; Endou, H; Ishihara, T; Katsura, I			Identification and characterization of the high-affinity choline transporter	NATURE NEUROSCIENCE			English	Article							VESICULAR ACETYLCHOLINE TRANSPORTER; RAT-BRAIN SYNAPTOSOMES; ALZHEIMERS-DISEASE; H-3 HEMICHOLINIUM-3; GENE; ACETYLTRANSFERASE; EXPRESSION; ELEGANS; BINDING; NEURONS	In cholinergic neurons, high-affinity choline uptake in presynaptic terminals is the rate-limiting step in acetylcholine synthesis. Using information provided by the Caenorhabditis elegans Genome Project, we cloned a cDNA encoding the high-affinity choline transporter from C. elegans (cho-1). We subsequently used this clone to isolate the corresponding cDNA from rat (CHT1). CHT1 is not homologous to neurotransmitter transporters, but is homologous to members of the Na+-dependent glucose transporter family. Expression of CHT1 mRNA is restricted to cholinergic neurons. The characteristics of CHT1-mediated choline uptake essentially match those of high-affinity choline uptake in rat brain synaptosomes.	Univ Tokyo, Fac Med, Dept Neurochem, Bunkyo Ku, Tokyo 1130033, Japan; Japan Sci & Technol Corp, CREST, Bunkyo Ku, Tokyo 1130033, Japan; Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Tokyo 1818611, Japan; Japan Sci & Technol Corp, PRESTO, Tokyo 1818611, Japan; Grad Univ Adv Studies, Sch Life Sci, Dept Genet, Mishima, Shizuoka 4118540, Japan; Grad Univ Adv Studies, Natl Inst Genet, Struct Biol Ctr, Mishima, Shizuoka 4118540, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Kyorin University; Japan Science & Technology Agency (JST); Graduate University for Advanced Studies - Japan; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Okuda, T (corresponding author), Univ Tokyo, Fac Med, Dept Neurochem, Bunkyo Ku, Tokyo 1130033, Japan.	okuda@m.u-tokyo.ac.jp						ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; BARKER LA, 1975, J PHARMACOL EXP THER, V192, P86; Beeri R, 1997, J NEUROCHEM, V69, P2441; BEJANIN S, 1994, J BIOL CHEM, V269, P21944; BERRARD S, 1987, P NATL ACAD SCI USA, V84, P9280, DOI 10.1073/pnas.84.24.9280; BIERER LM, 1995, J NEUROCHEM, V64, P749; Bissette G, 1996, ANN NY ACAD SCI, V777, P197, DOI 10.1111/j.1749-6632.1996.tb34419.x; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cassata G, 1998, GENE, V212, P127, DOI 10.1016/S0378-1119(98)00137-1; DUTAR P, 1995, PHYSIOL REV, V75, P393, DOI 10.1152/physrev.1995.75.2.393; ERICKSON JD, 1994, J BIOL CHEM, V269, P21929; HAGA T, 1971, J NEUROCHEM, V18, P781, DOI 10.1111/j.1471-4159.1971.tb12008.x; HAGA T, 1973, BIOCHIM BIOPHYS ACTA, V291, P564, DOI 10.1016/0005-2736(73)90508-7; HAPPE HK, 1993, J NEUROCHEM, V60, P1191, DOI 10.1111/j.1471-4159.1993.tb03277.x; HEDIGER MA, 1994, PHYSIOL REV, V74, P993, DOI 10.1152/physrev.1994.74.4.993; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; Kar S, 1998, J NEUROCHEM, V70, P2179; KUHAR MJ, 1978, J NEUROCHEM, V31, P251, DOI 10.1111/j.1471-4159.1978.tb12456.x; KUHAR MJ, 1973, J NEUROCHEM, V20, P581, DOI 10.1111/j.1471-4159.1973.tb12157.x; KUHAR MJ, 1978, J NEUROCHEM, V30, P15, DOI 10.1111/j.1471-4159.1978.tb07029.x; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MURRIN LC, 1976, MOL PHARMACOL, V12, P1082; Nelson N, 1998, J NEUROCHEM, V71, P1785; NIKAWA J, 1990, J BIOL CHEM, V265, P15996; OH JD, 1992, NEUROSCIENCE, V47, P807, DOI 10.1016/0306-4522(92)90031-V; PASCUAL J, 1991, BRAIN RES, V552, P170, DOI 10.1016/0006-8993(91)90676-M; ROGHANI A, 1994, P NATL ACAD SCI USA, V91, P10620, DOI 10.1073/pnas.91.22.10620; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANDBERG K, 1985, BRAIN RES, V348, P321, DOI 10.1016/0006-8993(85)90451-2; SCHLOSS P, 1994, BIOCHEM BIOPH RES CO, V198, P637, DOI 10.1006/bbrc.1994.1093; SIMON JR, 1975, NATURE, V255, P162, DOI 10.1038/255162a0; TUCEK S, 1985, J NEUROCHEM, V44, P11, DOI 10.1111/j.1471-4159.1985.tb07106.x; VICKROY TW, 1984, LIFE SCI, V35, P2335, DOI 10.1016/0024-3205(84)90525-3; Vogelsberg V, 1997, J NEUROCHEM, V68, P1062; WINKLER J, 1995, NATURE, V375, P484, DOI 10.1038/375484a0; WURTMAN RJ, 1992, TRENDS NEUROSCI, V15, P117, DOI 10.1016/0166-2236(92)90351-8; YAMAMURA HI, 1972, SCIENCE, V178, P626, DOI 10.1126/science.178.4061.626	37	254	271	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2000	3	2					120	125		10.1038/72059	http://dx.doi.org/10.1038/72059			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TC	10649566				2022-12-24	WOS:000085810300008
J	Pesavento, E; Margotti, E; Righi, M; Cattaneo, A; Domenici, L				Pesavento, E; Margotti, E; Righi, M; Cattaneo, A; Domenici, L			Blocking the NGF-TrkA interaction rescues the developmental loss of LTP in the rat visual cortex: Role of the cholinergic system	NEURON			English	Article							NERVE GROWTH-FACTOR; LONG-TERM POTENTIATION; MONOCLONAL-ANTIBODIES; MONOCULAR DEPRIVATION; NEUROTROPHIC FACTOR; BASAL FOREBRAIN; POSTNATAL-DEVELOPMENT; HIPPOCAMPAL SLICES; RECEPTOR PROTEINS; CORTICAL-NEURONS	Although nerve growth factor (NGF) is a crucial factor in the activity-dependent development and plasticity of visual cortex, its role in synaptic efficacy changes is largely undefined. We demonstrate that the maintenance phase of long-term potentiation (LTP) is blocked by local application of exogenous NGF in rat visual cortex at an early stage of postnatal development. Long-term depression (LTD) and bidirectional plasticity are unaffected. At later postnatal ages, blockade of either endogenous NGF by immunoadhesin (TrkA-IgG) or TrkA receptors by monoclonal antibody rescues LTP. Muscarinic receptor activation/inhibition suggests that LTP dependence on NGF is mediated by the cholinergic system. These results indicate that NGF regulates synaptic strength in well-characterized cortical circuitries.	Scuola Int Super Studi Avanzati, Program Neurosci, I-34014 Trieste, Italy; CNR, Ist Neurofisiol, I-56127 Pisa, Italy	International School for Advanced Studies (SISSA); Consiglio Nazionale delle Ricerche (CNR)	Domenici, L (corresponding author), Scuola Int Super Studi Avanzati, Program Neurosci, I-34014 Trieste, Italy.	domenici@sissa.it	Cattaneo, Antonino/AAA-7252-2019; CATTANEO, ANTONINO/K-4471-2016	Domenici, Luciano/0000-0003-2923-9421; CATTANEO, ANTONINO/0000-0002-6975-8923				Akaneya Y, 1997, J NEUROSCI, V17, P6707; ARTOLA A, 1987, NATURE, V330, P649, DOI 10.1038/330649a0; Ashkenazi A, 1997, CURR OPIN IMMUNOL, V9, P195, DOI 10.1016/S0952-7915(97)80135-5; Auerbach JM, 1996, J PHYSIOL-LONDON, V492, P479, DOI 10.1113/jphysiol.1996.sp021323; BERARDI N, 1994, P NATL ACAD SCI USA, V91, P684, DOI 10.1073/pnas.91.2.684; Bonhoeffer T, 1996, CURR OPIN NEUROBIOL, V6, P119, DOI 10.1016/S0959-4388(96)80017-1; BROCHER S, 1992, BRAIN RES, V573, P27, DOI 10.1016/0006-8993(92)90110-U; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; CATTANEO A, 1988, J NEUROCHEM, V50, P1003, DOI 10.1111/j.1471-4159.1988.tb10565.x; CATTANEO A, 1999, IN PRESS J NEUROSCI; Caulfield MP, 1998, PHARMACOL REV, V50, P279; Cellerino A, 1996, PROG NEUROBIOL, V49, P53, DOI 10.1016/0301-0082(96)00008-1; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; DOMENICI L, 1991, P NATL ACAD SCI USA, V88, P8811, DOI 10.1073/pnas.88.19.8811; DOMENICI L, 1993, P ROY SOC B-BIOL SCI, V251, P25, DOI 10.1098/rspb.1993.0004; DOMENICI L, 1992, NEUROSCIENCE, V51, P19, DOI 10.1016/0306-4522(92)90466-F; DOMENICI L, 1994, NEUROREPORT, V5, P2041, DOI 10.1097/00001756-199410270-00013; DUDEK SM, 1993, J NEUROSCI, V13, P2910; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kawaguchi Y, 1997, J NEUROPHYSIOL, V78, P1743, DOI 10.1152/jn.1997.78.3.1743; KIRKWOOD A, 1994, J NEUROSCI, V14, P1634, DOI 10.1523/JNEUROSCI.14-03-01634.1994; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; Kirkwood Alfredo, 1995, Biological Research, V28, P73; KNIPPER M, 1994, EUR J NEUROSCI, V6, P668, DOI 10.1111/j.1460-9568.1994.tb00312.x; LARKFORS L, 1987, J IMMUNOL METHODS, V97, P41, DOI 10.1016/0022-1759(87)90103-7; LEVEY AI, 1991, J NEUROSCI, V11, P3218; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LI YW, 1995, J NEUROSCI, V15, P2888; MAFFEI L, 1992, J NEUROSCI, V12, P4651; MAYSINGER D, 1992, BRAIN RES, V577, P300, DOI 10.1016/0006-8993(92)90287-J; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; MCDONALD AJ, 1992, NEUROREPORT, V3, P821, DOI 10.1097/00001756-199210000-00001; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Molnar M, 1998, EUR J NEUROSCI, V10, P3127, DOI 10.1046/j.1460-9568.1998.00314.x; MRZLJAK L, 1993, P NATL ACAD SCI USA, V90, P5194, DOI 10.1073/pnas.90.11.5194; Mrzljak L, 1998, J COMP NEUROL, V390, P112; Pizzorusso T, 1999, EUR J NEUROSCI, V11, P204, DOI 10.1046/j.1460-9568.1999.00417.x; Riddle DR, 1996, COLD SPRING HARB SYM, V61, P85; Rouse ST, 1997, LIFE SCI, V60, P1031, DOI 10.1016/S0024-3205(97)00044-1; Sala R, 1998, EUR J NEUROSCI, V10, P2185, DOI 10.1046/j.1460-9568.1998.00227.x; SATO H, 1987, J NEUROPHYSIOL, V58, P765, DOI 10.1152/jn.1987.58.4.765; SCHOUPS AA, 1995, DEV BRAIN RES, V86, P326, DOI 10.1016/0165-3806(95)00043-D; SEILER M, 1984, BRAIN RES, V300, P33, DOI 10.1016/0006-8993(84)91338-6; Sermasi E, 1999, NEUROSCIENCE, V91, P163, DOI 10.1016/S0306-4522(98)00598-3; Sermasi E, 1999, DEV BRAIN RES, V113, P61, DOI 10.1016/S0165-3806(98)00190-4; SOBREVIELA T, 1994, J COMP NEUROL, V350, P587, DOI 10.1002/cne.903500407; SOKOLOV MV, 1995, BRAIN RES, V672, P281, DOI 10.1016/0006-8993(94)01376-S; STEININGER TL, 1993, BRAIN RES, V612, P330, DOI 10.1016/0006-8993(93)91681-H; TANCREDI V, 1993, NEUROREPORT, V4, P147, DOI 10.1097/00001756-199302000-00008; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; VALENZUELA DM, 1993, NEURON, V10, P963, DOI 10.1016/0896-6273(93)90211-9; WHITTEMORE SR, 1986, P NATL ACAD SCI USA, V83, P817, DOI 10.1073/pnas.83.3.817; Xiang ZX, 1998, SCIENCE, V281, P985, DOI 10.1126/science.281.5379.985	60	47	55	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	2000	25	1					165	175		10.1016/S0896-6273(00)80880-6	http://dx.doi.org/10.1016/S0896-6273(00)80880-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279KP	10707981	Bronze			2022-12-24	WOS:000085043200019
J	Zenisek, D; Matthews, G				Zenisek, D; Matthews, G			The role of mitochondria in presynaptic calcium handling at a ribbon synapse	NEURON			English	Article							MOTOR-NERVE TERMINALS; ROOT GANGLION NEURONS; RED-CELL MEMBRANES; BIPOLAR CELLS; POSTTETANIC POTENTIATION; INTRACELLULAR CALCIUM; GOLDFISH RETINA; SQUID AXONS; EXTRUSION MECHANISMS; VANADATE INHIBITION	Mitochondria are thought to be important in clearing calcium from synaptic terminals. It is unclear, however, whether the principal role of mitochondria in presynaptic calcium handling is to take up Ca2+ directly or to fuel Ca2+ removal by other mechanisms. We used patch clamp techniques and fluorescence imaging to examine calcium clearance mechanisms, including mitochondrial uptake, in single synaptic terminals of retinal bipolar neurons. We found that extrusion through the ATP-dependent Ca2+ pump of the plasma membrane is the dominant form of Ca2+ removal in the synaptic terminal. Calcium uptake into mitochondria was sometimes evident with large Ca2+ loads but was consistently observed only when plasma membrane extrusion was inhibited. We conclude that mitochondria act primarily as an energy source in clearance of Ca2+ from bipolar cell synaptic terminals.	SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Matthews, G (corresponding author), SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA.		Zenisek, David/C-6555-2011		NATIONAL EYE INSTITUTE [R01EY003821] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY003821, EY03821] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Baker P F, 1972, Prog Biophys Mol Biol, V24, P177, DOI 10.1016/0079-6107(72)90007-7; BARRABIN H, 1980, BIOCHIM BIOPHYS ACTA, V600, P796, DOI 10.1016/0005-2736(80)90482-4; BLAUSTEIN MP, 1975, J MEMBRANE BIOL, V22, P285, DOI 10.1007/BF01868176; BOND GH, 1980, BIOCHIM BIOPHYS ACTA, V600, P781, DOI 10.1016/0005-2736(80)90480-0; Budd SL, 1996, J NEUROCHEM, V66, P403, DOI 10.1046/j.1471-4159.1996.66010403.x; Budd SL, 1996, J NEUROCHEM, V67, P2282; CARAFOLI E, 1991, PHYSIOL REV, V71, P129, DOI 10.1152/physrev.1991.71.1.129; Castilho RF, 1998, J NEUROSCI, V18, P10277; David G, 1998, J PHYSIOL-LONDON, V509, P59, DOI 10.1111/j.1469-7793.1998.059bo.x; DELANEY KR, 1989, J NEUROSCI, V9, P3558; DIPOLO R, 1982, BIOCHIM BIOPHYS ACTA, V688, P237, DOI 10.1016/0005-2736(82)90599-5; DIPOLO R, 1983, ANNU REV PHYSIOL, V45, P313, DOI 10.1146/annurev.ph.45.030183.001525; DIPOLO R, 1978, NATURE, V274, P390, DOI 10.1038/274390a0; Duchen MR, 1998, J CELL BIOL, V142, P975, DOI 10.1083/jcb.142.4.975; DUCHEN MR, 1990, J PHYSIOL-LONDON, V424, P411, DOI 10.1113/jphysiol.1990.sp018074; FRIEL DD, 1994, J NEUROSCI, V14, P4007; HEIDELBERGER R, 1992, J PHYSL, V207, P623; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; Herrington J, 1996, NEURON, V16, P219, DOI 10.1016/S0896-6273(00)80038-0; JOHNSON LV, 1981, J CELL BIOL, V88, P526, DOI 10.1083/jcb.88.3.526; KIMURA J, 1986, NATURE, V319, P596, DOI 10.1038/319596a0; KOBAYASHI K, 1995, J PHYSIOL-LONDON, V483, P79, DOI 10.1113/jphysiol.1995.sp020569; Krizaj D, 1998, NEURON, V21, P249, DOI 10.1016/S0896-6273(00)80531-0; LOEW LM, 1994, P NATL ACAD SCI USA, V91, P12579, DOI 10.1073/pnas.91.26.12579; Mennerick S, 1997, J NEUROPHYSIOL, V78, P51, DOI 10.1152/jn.1997.78.1.51; Morgans CW, 1998, J NEUROSCI, V18, P2467; MULKEY RM, 1992, J NEUROSCI, V12, P4327; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; NICHOLLS D, 1982, BIOCHIM BIOPHYS ACTA, V683, P57, DOI 10.1016/0304-4173(82)90013-1; NICHOLLS D G, 1980, Biochemical Society Transactions, V8, P264; NOHMI M, 1992, J PHYSIOL-LONDON, V458, P171, DOI 10.1113/jphysiol.1992.sp019412; Pivovarova NB, 1999, J NEUROSCI, V19, P6372; REGEHR WG, 1995, BIOPHYS J, V68, P2156, DOI 10.1016/S0006-3495(95)80398-X; ROSSI JPFC, 1981, BIOCHIM BIOPHYS ACTA, V648, P145, DOI 10.1016/0005-2736(81)90029-8; Sinha SR, 1997, BIOPHYS J, V72, P637, DOI 10.1016/S0006-3495(97)78702-2; STEUNKEL EL, 1994, J PHYSL, V481, P251; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; TACHIBANA M, 1991, J NEUROSCI, V11, P2199; TACHIBANA M, 1993, J NEUROSCI, V13, P2898; Tang YG, 1997, NEURON, V18, P483, DOI 10.1016/S0896-6273(00)81248-9; THAYER SA, 1990, J PHYSIOL-LONDON, V425, P85, DOI 10.1113/jphysiol.1990.sp018094; Tucker T, 1995, NEURON, V15, P1323, DOI 10.1016/0896-6273(95)90011-X; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; WERTH JL, 1994, J NEUROSCI, V14, P348	45	126	128	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	2000	25	1					229	237		10.1016/S0896-6273(00)80885-5	http://dx.doi.org/10.1016/S0896-6273(00)80885-5			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279KP	10707986	Bronze			2022-12-24	WOS:000085043200024
J	Stevens, CF; Wesseling, JF				Stevens, CF; Wesseling, JF			Identification of a novel process limiting the rate of synaptic vesicle cycling at hippocampal synapses	NEURON			English	Article							PRESYNAPTIC CALCIUM CURRENT; READILY RELEASABLE POOL; LONG-TERM DEPRESSION; EXCITATORY SYNAPSES; SYMPATHETIC NEURONS; TRANSMISSION; MICROCULTURES; BOUTONS; SIZE; POTENTIATION	During intense presynaptic activity, the readily releasable pool (RRP) of synaptic vesicles empties more quickly than it can be refilled, and short-term depression results. Ordinarily, the pool refills within 20 s, but long, high-frequency trains of action potentials often induce a form of shout-term depression that persists for a much longer time. Here, we report that replenishment of the RRP is governed by two simple processes: the previously identified mechanism termed refilling, and another process that appears after extensive exocytosis and produces a transient decrease in the capacity of the pool, lasting for several minutes. The data presented here place stringent constraints on the types of kinetic models that can be used to describe synaptic vesicular cycling and are inconsistent with the traditional multipool models of vesicular mobilization.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute	Stevens, CF (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA.		Wesseling, John F/AAB-7941-2019	Wesseling, John F/0000-0002-7565-2594	NINDS NIH HHS [NS 12961] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012961] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Banker G., 1991, CULTURING NERVE CELL; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Bellingham MC, 1999, NEURON, V23, P159, DOI 10.1016/S0896-6273(00)80762-X; BIRKS R, 1961, CAN J BIOCHEM PHYS, V39, P787, DOI 10.1139/o61-081; Brenowitz S, 1998, NEURON, V20, P135, DOI 10.1016/S0896-6273(00)80441-9; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; ELMQVIST D, 1965, J PHYSIOL-LONDON, V178, P505, DOI 10.1113/jphysiol.1965.sp007639; FURSHPAN EJ, 1976, P NATL ACAD SCI USA, V73, P4225, DOI 10.1073/pnas.73.11.4225; FURSHPAN EJ, 1986, J NEUROSCI, V6, P1061; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Goda Y, 1998, P NATL ACAD SCI USA, V95, P1283, DOI 10.1073/pnas.95.3.1283; Goda Y, 1996, NEURON, V16, P103, DOI 10.1016/S0896-6273(00)80027-6; Katz B., 1969, RELEASE NEURAL TRANS; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; LILEY AW, 1953, J NEUROPHYSIOL, V16, P509, DOI 10.1152/jn.1953.16.5.509; LIU G, 1995, NEUROPHARMACOLOGY, V34, P1407, DOI 10.1016/0028-3908(95)00143-T; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; MAGLEBY KL, 1987, SYNAPTIC FUNCTION, P21; Murthy VN, 1999, NAT NEUROSCI, V2, P503, DOI 10.1038/9149; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Otis T, 1996, J NEUROSCI, V16, P7496; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Ryan TA, 1996, NEURON, V17, P125, DOI 10.1016/S0896-6273(00)80286-X; Schikorski T, 1997, J NEUROSCI, V17, P5858; SEGAL MM, 1990, J NEUROPHYSIOL, V64, P1390, DOI 10.1152/jn.1990.64.5.1390; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Stevens CF, 1999, NEURON, V22, P139, DOI 10.1016/S0896-6273(00)80685-6; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; Takahashi T, 1996, SCIENCE, V274, P594, DOI 10.1126/science.274.5287.594; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; WITTICH B, 1994, J NEUROCHEM, V63, P927; Wu LG, 1998, BIOPHYS J, V74, P3003, DOI 10.1016/S0006-3495(98)78007-5; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	42	70	71	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1999	24	4					1017	1028		10.1016/S0896-6273(00)81047-8	http://dx.doi.org/10.1016/S0896-6273(00)81047-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	269UE	10624963	Bronze			2022-12-24	WOS:000084495300028
J	Aksay, E; Gamkrelidze, G; Seung, HS; Baker, R; Tank, DW				Aksay, E; Gamkrelidze, G; Seung, HS; Baker, R; Tank, DW			In vivo intracellular recording and perturbation of persistent activity in a neural integrator	NATURE NEUROSCIENCE			English	Article							EYE-POSITION; BRAIN-STEM; PLATEAU POTENTIALS; OCULOMOTOR SYSTEM; PYRAMIDAL NEURONS; MOTOR-NEURONS; ALERT CAT; MEMORY; MOVEMENTS; GOLDFISH	To investigate the mechanisms of persistent neural activity, we obtained in vivo intracellular recordings from neurons in an oculomotor neural integrator of the goldfish during spontaneous saccades and fixations. Persistent changes in firing rate following saccades were associated with step changes in interspike membrane potential that were correlated with changes in eye position. Perturbation of persistent activity with brief intracellular current pulses designed to mimic saccadic input only induced transient changes of firing rate and membrane potential. When neurons were hyperpolarized below action potential threshold, position-correlated step changes in membrane potential remained. Membrane potential fluctuations were greater during more depolarized steps. These results suggest that sustained changes in firing rate are supported not by either membrane multistability or changes in pacemaker currents, but rather by persistent changes in the rate or amplitude of synaptic inputs.	Bell Labs, Lucent Technol, Biol Computat Res Dept, Murray Hill, NJ 07974 USA; NYU, Sch Med, Dept Physiol & Neurosci, New York, NY 10016 USA; MIT, Howard Hughes Med Inst, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Alcatel-Lucent; Lucent Technologies; AT&T; New York University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Baker, R (corresponding author), Bell Labs, Lucent Technol, Biol Computat Res Dept, 700 Mt Ave, Murray Hill, NJ 07974 USA.		Gamkrelidze, Georgi/ABC-6891-2021	Aksay, Emre/0000-0002-4561-4175; Baker, Robert/0000-0001-7920-1769				Aksay E, 2000, J NEUROPHYSIOL, V84, P1035, DOI 10.1152/jn.2000.84.2.1035; AMITAI Y, 1994, NEUROSCIENCE, V63, P151, DOI 10.1016/0306-4522(94)90013-2; CANNON SC, 1983, BIOL CYBERN, V49, P127, DOI 10.1007/BF00320393; CANNON SC, 1987, J NEUROPHYSIOL, V57, P1383, DOI 10.1152/jn.1987.57.5.1383; Catterall W A, 1999, Adv Neurol, V79, P441; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; EASTER SS, 1971, VISION RES, V11, P333, DOI 10.1016/0042-6989(71)90244-6; Ermentrout B, 1998, NEURAL COMPUT, V10, P1721, DOI 10.1162/089976698300017106; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Fuster JM, 1995, MEMORY CEREBRAL CORT; GODAUX E, 1989, EXP BRAIN RES, V77, P94; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; HOUNSGAARD J, 1988, J PHYSIOL-LONDON, V405, P345, DOI 10.1113/jphysiol.1988.sp017336; KAMATH BY, 1976, MATH BIOSCI, V30, P341, DOI 10.1016/0025-5564(76)90073-0; KATZ B, 1973, J PHYSIOL-LONDON, V230, P707, DOI 10.1113/jphysiol.1973.sp010213; KELLER EL, 1971, J NEUROPHYSIOL, V34, P908, DOI 10.1152/jn.1971.34.5.908; KIEHN O, 1991, TRENDS NEUROSCI, V14, P68, DOI 10.1016/0166-2236(91)90023-N; Kiehn O, 1998, CURR OPIN NEUROBIOL, V8, P746, DOI 10.1016/S0959-4388(98)80117-7; LLINAS R, 1986, J PHYSIOL-LONDON, V376, P163, DOI 10.1113/jphysiol.1986.sp016147; LOPEZBARNEO J, 1982, J NEUROPHYSIOL, V47, P329, DOI 10.1152/jn.1982.47.2.329; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; MCFARLAND JL, 1992, J NEUROPHYSIOL, V68, P319, DOI 10.1152/jn.1992.68.1.319; PASTOR AM, 1991, J NEUROPHYSIOL, V66, P2125, DOI 10.1152/jn.1991.66.6.2125; PASTOR AM, 1994, P NATL ACAD SCI USA, V91, P807, DOI 10.1073/pnas.91.2.807; Perrier JF, 1999, J NEUROPHYSIOL, V82, P730, DOI 10.1152/jn.1999.82.2.730; Prut Y, 1999, NATURE, V401, P590, DOI 10.1038/44145; REUVENI I, 1993, J NEUROSCI, V13, P4609; ROBINSON DA, 1989, ANNU REV NEUROSCI, V12, P33, DOI 10.1146/annurev.neuro.12.1.33; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Robinson DA., 1981, HDB PHYSL AM PHYSL 1, V2, P1275; ROSEN MJ, 1972, IEEE T BIO-MED ENG, VBM19, P362, DOI 10.1109/TBME.1972.324139; SCHULTZ W, 1992, EXP BRAIN RES, V91, P363; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; SHEN L, 1989, BIOL CYBERN, V61, P319, DOI 10.1007/BF00203180; SKAVENSKI AA, 1973, J NEUROPHYSIOL, V36, P724, DOI 10.1152/jn.1973.36.4.724; Wang XJ, 1998, J NEUROPHYSIOL, V79, P1549, DOI 10.1152/jn.1998.79.3.1549; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	38	139	141	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2001	4	2					184	193		10.1038/84023	http://dx.doi.org/10.1038/84023			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UC	11175880				2022-12-24	WOS:000167178100018
J	Sankaranarayanan, S; Ryan, TA				Sankaranarayanan, S; Ryan, TA			Calcium accelerates endocytosis of vSNAREs at hippocampal synapses	NATURE NEUROSCIENCE			English	Article							FROG NEUROMUSCULAR-JUNCTION; SYNAPTIC VESICLE MEMBRANE; ADRENAL CHROMAFFIN CELLS; TRANSMITTER RELEASE; RAPID ENDOCYTOSIS; V-ATPASES; DYNAMIN; TRANSMISSION; EXOCYTOSIS; INHIBITION	A pH-sensitive form of green-fluorescent protein (GFP) fused to the lumenal domain of VAMP (synapto-pHluorin) provides a sensitive optical probe to track the net balance between exocytosis and endocytosis of this protein at small synaptic terminals of the central nervous system. Here we used a reversible proton-pump blocker that prevents vesicle re-acidification upon endocytosis to trap vesicles in the alkaline state during recycling. In combination with optical measurements of synapto-pHluorin, we used alkaline trapping to examine the kinetic components of exocytosis and endocytosis separately at synaptic terminals. Using this approach, we show that, in addition to controlling exocytosis, intracellular calcium levels tightly regulate the speed of endocytosis, increasing it to a maximal speed of approximately one vesicle per second.	Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA	Cornell University	Ryan, TA (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10021 USA.		Ryan, Timothy/AAO-8286-2020	Ryan, Timothy/0000-0003-2533-9548	NINDS NIH HHS [NS24692] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Artalejo CR, 1996, NEURON, V16, P195, DOI 10.1016/S0896-6273(00)80036-7; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; AUGUSTINE GJ, 1986, J PHYSIOL-LONDON, V381, P619, DOI 10.1113/jphysiol.1986.sp016347; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Cousin MA, 1997, J NEUROCHEM, V69, P1927; Drose S, 1997, J EXP BIOL, V200, P1; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; KOENIG JH, 1989, J NEUROSCI, V9, P3844; LIU JP, 1994, SCIENCE, V265, P970, DOI 10.1126/science.8052858; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; NELSON N, 1992, J EXP BIOL, V172, P149; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Slepnev VI, 1998, SCIENCE, V281, P821, DOI 10.1126/science.281.5378.821; Takahashi T, 1996, SCIENCE, V274, P594, DOI 10.1126/science.274.5287.594; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; Wu LG, 1996, NEURON, V17, P769, DOI 10.1016/S0896-6273(00)80208-1; WYTHRICH K, 1986, NMR PROTEINS NUCL AC; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x	28	231	238	2	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2001	4	2					129	136		10.1038/83949	http://dx.doi.org/10.1038/83949			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UC	11175872				2022-12-24	WOS:000167178100010
J	DeVries, SH				DeVries, SH			Bipolar cells use kainate and AMPA receptors to filter visual information into separate channels	NEURON			English	Article							RETINAL GANGLION-CELLS; SYNAPTIC TRANSMISSION; GROUND-SQUIRREL; GLUTAMATE RECEPTORS; HORIZONTAL CELLS; SPINAL-CORD; CAT RETINA; NEURONS; DESENSITIZATION; RESPONSES	Unlike cone photoreceptors, whose light responses have a uniform time course, retinal ganglion cells are tuned to respond to different temporal components in a changing visual scene. The signals in a mammalian cone flow to three to five morphologically distinct "OFF" bipolar cells at a sign-conserving, glutamatergic synapse. By recording simultaneously from pairs of synaptically connected cones and OFF bipolar cells, I now show that each morphological type of OFF bipolar cell receives its signal through a different AMPA or kainate receptor. The characteristic rate at which each receptor recovers from desensitization divides the cone signal into temporal components. Temporal processing begins at the first synapse in the visual system.	Univ Texas, Hlth Sci Ctr, Dept Ophthalmol & Visual Sci, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	DeVries, SH (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Ophthalmol & Visual Sci, Houston, TX 77030 USA.				NATIONAL EYE INSTITUTE [R01EY012141] Funding Source: NIH RePORTER; NEI NIH HHS [EY12141] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Awatramani GB, 2000, J NEUROSCI, V20, P7087, DOI 10.1523/JNEUROSCI.20-18-07087.2000; BETTLER B, 1995, NEUROPHARMACOLOGY, V34, P123, DOI 10.1016/0028-3908(94)00141-E; BOYCOTT BB, 1991, EUR J NEUROSCI, V3, P1069, DOI 10.1111/j.1460-9568.1991.tb00043.x; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; CLELAND BG, 1971, J PHYSIOL-LONDON, V217, P473, DOI 10.1113/jphysiol.1971.sp009581; COHEN E, 1990, PHILOS T R SOC B, V330, P323, DOI 10.1098/rstb.1990.0202; DeVries SH, 1999, NATURE, V397, P157, DOI 10.1038/16462; DeVries SH, 1997, J NEUROPHYSIOL, V78, P2048, DOI 10.1152/jn.1997.78.4.2048; Donevan SD, 1998, J PHARMACOL EXP THER, V285, P539; DOWLING JE, 1973, NATURE, V242, P101, DOI 10.1038/242101a0; Eliasof S, 1997, VISUAL NEUROSCI, V14, P13, DOI 10.1017/S0952523800008713; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; EULER T, 1995, J COMP NEUROL, V361, P461, DOI 10.1002/cne.903610310; FAMIGLIETTI EV, 1976, SCIENCE, V194, P193, DOI 10.1126/science.959847; Freed MA, 2000, J NEUROSCI, V20, P3956; Gardner SM, 1999, J NEUROSCI, V19, P8721, DOI 10.1523/JNEUROSCI.19-20-08721.1999; Hack I, 1999, P NATL ACAD SCI USA, V96, P14130, DOI 10.1073/pnas.96.24.14130; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Jacoby RA, 2000, J COMP NEUROL, V416, P6, DOI 10.1002/(SICI)1096-9861(20000103)416:1<6::AID-CNE2>3.0.CO;2-X; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Jones KA, 1997, NEUROPHARMACOLOGY, V36, P853, DOI 10.1016/S0028-3908(97)00066-X; KNAPP AG, 1990, P NATL ACAD SCI USA, V87, P767, DOI 10.1073/pnas.87.2.767; Li P, 1999, NATURE, V397, P161, DOI 10.1038/16469; Linberg KA, 1996, J COMP NEUROL, V365, P173, DOI 10.1002/(SICI)1096-9861(19960205)365:2<173::AID-CNE1>3.0.CO;2-2; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; Mills SL, 1999, VISUAL NEUROSCI, V16, P1029, DOI 10.1017/S0952523899166057; Morigiwa K, 1999, J COMP NEUROL, V405, P173, DOI 10.1002/(SICI)1096-9861(19990308)405:2<173::AID-CNE3>3.0.CO;2-L; Nirenberg S, 1997, NEURON, V18, P637, DOI 10.1016/S0896-6273(00)80304-9; Paternain AV, 1998, NEUROPHARMACOLOGY, V37, P1249, DOI 10.1016/S0028-3908(98)00098-7; PATERNAIN AV, 1995, NEURON, V14, P185, DOI 10.1016/0896-6273(95)90253-8; Paternain AV, 2000, J NEUROSCI, V20, P196, DOI 10.1523/JNEUROSCI.20-01-00196.2000; PATERNAIN AV, 2000, NEUROPHARMACOLOGY, V20, P196; Protti DA, 2000, NEURON, V25, P215, DOI 10.1016/S0896-6273(00)80884-3; Qin P, 1999, VISUAL NEUROSCI, V16, P169, DOI 10.1017/S0952523899161121; Rieke F, 1996, J PHYSIOL-LONDON, V493, P1; Rivera N, 1998, J COMP NEUROL, V396, P105, DOI 10.1002/(SICI)1096-9861(19980622)396:1<105::AID-CNE8>3.0.CO;2-4; SAITO T, 1983, J GEN PHYSIOL, V81, P589, DOI 10.1085/jgp.81.4.589; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; Shields CR, 2000, J NEUROSCI, V20, P2673; TONG G, 1994, J NEUROPHYSIOL, V72, P754, DOI 10.1152/jn.1994.72.2.754; Traynelis SF, 1997, J PHYSIOL-LONDON, V503, P513, DOI 10.1111/j.1469-7793.1997.513bg.x; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; WEST RW, 1976, J COMP NEUROL, V168, P355, DOI 10.1002/cne.901680304; WISDEN W, 1993, J NEUROSCI, V13, P3582	47	299	302	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	2000	28	3					847	856		10.1016/S0896-6273(00)00158-6	http://dx.doi.org/10.1016/S0896-6273(00)00158-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386JJ	11163271	Bronze			2022-12-24	WOS:000166057500021
J	Erkman, L; Yates, PA; McLaughlin, T; McEvilly, RJ; Whisenhunt, T; O'Connell, SM; Krones, AI; Kirby, MA; Rapaport, DH; Bermingham, JR; O'Leary, DDM; Rosenfeld, MG				Erkman, L; Yates, PA; McLaughlin, T; McEvilly, RJ; Whisenhunt, T; O'Connell, SM; Krones, AI; Kirby, MA; Rapaport, DH; Bermingham, JR; O'Leary, DDM; Rosenfeld, MG			A POU domain transcription factor-dependent program regulates axon pathfinding in the vertebrate visual system	NEURON			English	Article							GANGLION-CELL DIFFERENTIATION; MOUSE OPTIC CHIASM; MESSENGER-RNA; LIM DOMAINS; TOPOGRAPHIC ORDER; ACTIN-BINDING; FACTOR BRN-3B; GUIDANCE; GENE; EXPRESSION	Axon pathfinding relies on the ability of the growth cone to detect and interpret guidance cues and to modulate cytoskeletal changes in response to these signals. We report that the murine POU domain transcription factor Brn-3.2 regulates pathfinding in retinal ganglion cell (RGC) axons at multiple points along their pathways and the establishment of topographic order in the superior colliculus. Using representational difference analysis, we identified Brn-3.2 gene targets likely to act on axon guidance at the levels of transcription, cell-cell interaction, and signal transduction, including the actin-binding LIM domain protein abLIM. We present evidence that abLIM plays a crucial role in RGC axon pathfinding, sharing functional similarity with its C. elegans homolog, UNC-115. Our findings provide insights into a Brn-3.2-directed hierarchical program linking signaling events to cytoskeletal changes required for axon pathfinding.	Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Surg, La Jolla, CA 92093 USA; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Loma Linda Univ, Dept Pediat & Anat, Loma Linda, CA 92350 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute; Loma Linda University	Erkman, L (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	lerkman@ucsd.edu; doleary@salk.edu; mrosenfeld@ucsd.edu		Kirby, Ph.D., Michael/0000-0002-0859-374X	NEI NIH HHS [EY07025, EY11875] Funding Source: Medline; NINDS NIH HHS [NS34934] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Bertuzzi S, 1999, GENE DEV, V13, P3092, DOI 10.1101/gad.13.23.3092; Birgbauer E, 2000, DEVELOPMENT, V127, P1231; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Certel SJ, 2000, DEVELOPMENT, V127, P2395; Cohen DR, 2000, MECH DEVELOP, V91, P317, DOI 10.1016/S0925-4773(99)00263-4; Dawid IB, 1998, TRENDS GENET, V14, P156, DOI 10.1016/S0168-9525(98)01424-3; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; DRAGER UC, 1985, PROC R SOC SER B-BIO, V224, P57, DOI 10.1098/rspb.1985.0021; Duggan A, 1998, DEVELOPMENT, V125, P4107; Erkman L, 1996, NATURE, V381, P603, DOI 10.1038/381603a0; Erskine L, 2000, J NEUROSCI, V20, P4975; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Frisen J, 1999, EMBO J, V18, P5159, DOI 10.1093/emboj/18.19.5159; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Gan L, 1999, DEV BIOL, V210, P469, DOI 10.1006/dbio.1999.9280; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Garel S, 1997, DEV DYNAM, V210, P191, DOI 10.1002/(SICI)1097-0177(199711)210:3<191::AID-AJA1>3.0.CO;2-B; Grillenzoni N, 1998, DEVELOPMENT, V125, P3563; HALFTER W, 1985, J COMP NEUROL, V232, P466, DOI 10.1002/cne.902320405; Hallonet M, 1999, GENE DEV, V13, P3106, DOI 10.1101/gad.13.23.3106; HOLT CE, 1989, J NEUROSCI, V9, P3123; Homburger SA, 1996, DEV DYNAM, V206, P112, DOI 10.1002/(SICI)1097-0177(199605)206:1<112::AID-AJA10>3.0.CO;2-7; Huang EJ, 1999, DEVELOPMENT, V126, P2869; HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640; Kikuchi Y, 1997, NEURON, V18, P369, DOI 10.1016/S0896-6273(00)81239-8; KIRBY MA, 1988, DEV BRAIN RES, V44, P37, DOI 10.1016/0165-3806(88)90116-2; LISITSYN NA, 1994, NAT GENET, V6, P57, DOI 10.1038/ng0194-57; Lundquist EA, 1998, NEURON, V21, P385, DOI 10.1016/S0896-6273(00)80547-4; Marcus RC, 1999, J COMP NEUROL, V403, P346; MARCUS RC, 1995, J NEUROSCI, V15, P6389; McEvilly RJ, 2000, PROG NUCLEIC ACID RE, V63, P223, DOI 10.1016/S0079-6603(08)60724-2; McEvilly RJ, 1996, NATURE, V384, P574, DOI 10.1038/384574a0; MCLOON SC, 1982, EXP BRAIN RES, V45, P277; Morris ME, 1998, SCIENCE, V279, P1544, DOI 10.1126/science.279.5356.1544; Naeve GS, 1997, P NATL ACAD SCI USA, V94, P2648, DOI 10.1073/pnas.94.6.2648; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; Niclou SP, 2000, J NEUROSCI, V20, P4962; Niwa H, 1997, ENDOCRINOLOGY, V138, P1419, DOI 10.1210/en.138.4.1419; O'Keefe DD, 1998, DEVELOPMENT, V125, P3915; O'Leary DDM, 1999, CELL, V96, P255, DOI 10.1016/S0092-8674(00)80565-6; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; OLEARY DDM, 1983, DEV BRAIN RES, V10, P93, DOI 10.1016/0165-3806(83)90124-4; Prasad BC, 1998, DEVELOPMENT, V125, P1561; Ringstedt T, 2000, J NEUROSCI, V20, P4983; Roof DJ, 1997, J CELL BIOL, V138, P575, DOI 10.1083/jcb.138.3.575; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Seeger MA, 1999, CELL, V97, P821, DOI 10.1016/S0092-8674(00)80793-X; SIMMONS DM, 1990, GENE DEV, V4, P695, DOI 10.1101/gad.4.5.695; SIMON DK, 1992, J NEUROSCI, V12, P1212; SIMON DK, 1992, P NATL ACAD SCI USA, V89, P10593, DOI 10.1073/pnas.89.22.10593; SIMON DK, 1994, DEV BIOL, V162, P384, DOI 10.1006/dbio.1994.1095; Sornson MW, 1996, NATURE, V384, P327, DOI 10.1038/384327a0; Sretavan DW, 1998, J NEUROSCI, V18, P10502; Sze JY, 1997, DEVELOPMENT, V124, P1159; Tear G, 1999, TRENDS GENET, V15, P113, DOI 10.1016/S0168-9525(98)01686-2; THANOS S, 1984, J COMP NEUROL, V224, P407, DOI 10.1002/cne.902240308; Torres MA, 1996, DEVELOPMENT, V122, P3381; Tuttle R, 1998, DEVELOPMENT, V125, P791; Wang SS, 1997, J NEUROSCI, V17, P4149; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WILLIAMS RW, 1986, J COMP NEUROL, V246, P32, DOI 10.1002/cne.902460104; Williams RW, 1996, J NEUROSCI, V16, P7193; Xiang MQ, 1996, P NATL ACAD SCI USA, V93, P11950, DOI 10.1073/pnas.93.21.11950; Xiang MQ, 1998, DEV BIOL, V197, P155, DOI 10.1006/dbio.1998.8868; Xiang MQ, 1997, P NATL ACAD SCI USA, V94, P9445, DOI 10.1073/pnas.94.17.9445; XUE D, 1992, EMBO J, V11, P4969, DOI 10.1002/j.1460-2075.1992.tb05604.x; Zhu QZ, 1999, EXP NEUROL, V155, P228, DOI 10.1006/exnr.1998.6989	68	133	139	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	2000	28	3					779	792		10.1016/S0896-6273(00)00153-7	http://dx.doi.org/10.1016/S0896-6273(00)00153-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386JJ	11163266	Bronze			2022-12-24	WOS:000166057500016
J	Boudin, H; Doan, A; Xia, J; Shigemoto, R; Huganir, RL; Worley, P; Craig, AM				Boudin, H; Doan, A; Xia, J; Shigemoto, R; Huganir, RL; Worley, P; Craig, AM			Presynaptic clustering of mGluR7a requires the PICK1PDZ domain binding site	NEURON			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; PROTEIN-KINASE-C; POSTSYNAPTIC DENSITY PROTEINS; PDZ PROTEINS; IMMUNOHISTOCHEMICAL LOCALIZATION; SYNAPTIC TRANSMISSION; SIGNAL-TRANSDUCTION; AMPA RECEPTORS; CELL-ADHESION; FAMILY	Aggregation of neurotransmitter receptors at pre- and postsynaptic structures is crucial for efficient neuronal communication. In contrast to the wealth of information about postsynaptic specializations, little is known about the molecular organization of presynaptic membrane proteins. We show here that the metabotropic glutamate receptor mGluR7a, which localizes specifically to presynaptic active zones, interacts in vitro and in vivo with PICK1. Coexpression in heterologous systems induces coclustering dependent upon the extreme C terminus of mGluR7a and the PDZ domain of PICK1, mGluR7a and PICK1 localize to excitatory synapses in hippocampal neurons. Furthermore, whereas transfected mGluR7a clusters at presynaptic sites, mGluR7a Delta3 lacking the PICK1 binding site targets to axons but does not cluster. These results suggest that PICK1 is a component of the presynaptic machinery involved in mGluR7a aggregation and in modulation of glutamate neurotransmission.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; CREST Japan Sci & Technol Corp, Natl Inst Physiol Sci, Okazaki, Aichi 4448585, Japan	Washington University (WUSTL); University of Illinois System; University of Illinois Urbana-Champaign; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Craig, AM (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	acraig@thalamus.wustl.edu	Craig, Ann Marie/M-2054-2014; Shigemoto, Ryuichi/E-3628-2013; Boudin, Helene/K-2400-2015; Xia, Jun/C-7234-2009	Shigemoto, Ryuichi/0000-0001-8761-9444; Boudin, Helene/0000-0002-9714-2384; Xia, Jun/0000-0001-9308-2188	NIMH NIH HHS [K02MH01152] Funding Source: Medline; NINDS NIH HHS [NS33184, NS39286] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039286, R01NS033184] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bai M, 1998, J BIOL CHEM, V273, P23605, DOI 10.1074/jbc.273.36.23605; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Bradley SR, 1996, J NEUROSCI, V16, P2044; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Brandstatter JH, 1996, J NEUROSCI, V16, P4749; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Bushell TJ, 1999, NEUROPHARMACOLOGY, V38, P1553, DOI 10.1016/S0028-3908(99)00103-3; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; CasesLanghoff C, 1996, EUR J CELL BIOL, V69, P214; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Ciruela F, 2000, MOL CELL NEUROSCI, V15, P36, DOI 10.1006/mcne.1999.0808; Ciruela F, 1999, BIOCHEM J, V341, P795, DOI 10.1042/0264-6021:3410795; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Cvejic S, 1997, J BIOL CHEM, V272, P26959, DOI 10.1074/jbc.272.43.26959; Dev KK, 1999, NEUROPHARMACOLOGY, V38, P635, DOI 10.1016/S0028-3908(98)00230-5; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; Goslin K., 1998, CULTURING NERVE CELL, P339; Hata Y, 1996, J NEUROSCI, V16, P2488; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; James P, 1996, GENETICS, V144, P1425; Jo K, 1999, J NEUROSCI, V19, P4189, DOI 10.1523/jneurosci.19-11-04189.1999; Kato A, 1997, FEBS LETT, V412, P183, DOI 10.1016/S0014-5793(97)00775-8; Kato A, 1998, J BIOL CHEM, V273, P23969, DOI 10.1074/jbc.273.37.23969; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kim JH, 1999, CURR OPIN CELL BIOL, V11, P248, DOI 10.1016/S0955-0674(99)80033-7; Kinoshita A, 1998, J COMP NEUROL, V393, P332; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kosinski CM, 1999, J COMP NEUROL, V415, P266; Lau LF, 1996, J BIOL CHEM, V271, P21622, DOI 10.1074/jbc.271.35.21622; Lujan R, 1997, J CHEM NEUROANAT, V13, P219, DOI 10.1016/S0891-0618(97)00051-3; Macek TA, 1998, J NEUROSCI, V18, P6138; Masugi M, 1999, J NEUROSCI, V19, P955; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Nakajima Y, 1999, J BIOL CHEM, V274, P27573, DOI 10.1074/jbc.274.39.27573; NAKANISHI S, 1994, NEURON, V13, P1031, DOI 10.1016/0896-6273(94)90043-4; Nakanishi S, 1998, BRAIN RES REV, V26, P230, DOI 10.1016/S0165-0173(97)00033-7; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; O'Connor V, 1999, SCIENCE, V286, P1180, DOI 10.1126/science.286.5442.1180; OHISHI H, 1994, NEURON, V13, P55, DOI 10.1016/0896-6273(94)90459-6; OKAMOTO N, 1994, J BIOL CHEM, V269, P1231; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Roche KW, 1999, J BIOL CHEM, V274, P25953, DOI 10.1074/jbc.274.36.25953; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Sheng M, 1999, ANN NY ACAD SCI, V868, P483, DOI 10.1111/j.1749-6632.1999.tb11317.x; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Shigemoto R, 1996, NATURE, V381, P523, DOI 10.1038/381523a0; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; Stowell JN, 1999, NEURON, V22, P525, DOI 10.1016/S0896-6273(00)80707-2; Tadokoro S, 1999, P NATL ACAD SCI USA, V96, P13801, DOI 10.1073/pnas.96.24.13801; Takahashi T, 1996, SCIENCE, V274, P594, DOI 10.1126/science.274.5287.594; Takeya R, 2000, BIOCHEM BIOPH RES CO, V267, P149, DOI 10.1006/bbrc.1999.1932; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Wang XL, 1999, J CELL BIOL, V147, P151, DOI 10.1083/jcb.147.1.151; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wu LG, 1999, J NEUROSCI, V19, P726; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7	71	123	131	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	2000	28	2					485	497		10.1016/S0896-6273(00)00127-6	http://dx.doi.org/10.1016/S0896-6273(00)00127-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	377CE	11144358	Bronze			2022-12-24	WOS:000165493700023
J	LaMantia, AS; Bhasin, N; Rhodes, K; Heemskerk, J				LaMantia, AS; Bhasin, N; Rhodes, K; Heemskerk, J			Mesenchymal/epithelial induction mediates olfactory pathway formation	NEURON			English	Article							MIDBRAIN CREST CELLS; CARDIAC NEURAL CREST; RETINOIC-ACID; SONIC-HEDGEHOG; SMALL-EYE; BULB DEVELOPMENT; CHICK-EMBRYOS; AXONAL GROWTH; MOUSE EMBRYOS; ADULT-RAT	In the olfactory pathway, as in the limbs, branchial arches, and heart, mesenchymal/epithelial induction, mediated by retinoic acid (RA), FGF8, sonic hedgehog (shh), and the BMPs, defines patterning, morphogenesis, and differentiation. Neuronal differentiation in the olfactory epithelium and directed growth of axons in the nascent olfactory nerve depend critically upon this inductive interaction. When RA, FGF8, shh, or BMP signaling is disrupted, distinct aspects of olfactory pathway patterning and differentiation are compromised. Thus, a cellular and molecular mechanism that facilitates musculoskeletal and vascular development elsewhere in the embryo has been adapted to guide the differentiation of the olfactory pathway in the developing forebrain.	Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; NINDS, Bethesda, MD 20892 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	LaMantia, AS (corresponding author), Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029178, R29HD029178] Funding Source: NIH RePORTER; NICHD NIH HHS [HD29178] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Anchan RM, 1997, J COMP NEUROL, V379, P171; BAHILLER D, 2000, NATURE, V403, P658; Balinsky B I, 1933, Wilhelm Roux Arch Entwickl Mech Org, V130, P704, DOI 10.1007/BF01380617; Barlow AJ, 1999, DEV DYNAM, V214, P291, DOI 10.1002/(SICI)1097-0177(199904)214:4<291::AID-AJA2>3.0.CO;2-E; Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; BENOWITZ LI, 1988, J NEUROSCI, V8, P339; BYRD CA, 1993, J COMP NEUROL, V331, P551, DOI 10.1002/cne.903310410; CALOF AL, 1989, NEURON, V3, P115, DOI 10.1016/0896-6273(89)90120-7; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; COLBERT MC, 1993, P NATL ACAD SCI USA, V90, P6572, DOI 10.1073/pnas.90.14.6572; CONNOR MJ, 1987, BIOCHEM J, V244, P489, DOI 10.1042/bj2440489; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Creazzo TL, 1998, ANNU REV PHYSIOL, V60, P267, DOI 10.1146/annurev.physiol.60.1.267; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; CROUCHER SJ, 1989, DEVELOPMENT, V106, P493; CUSCHIERI A, 1975, J ANAT, V119, P277; DEHAMER MK, 1994, NEURON, V13, P1083, DOI 10.1016/0896-6273(94)90047-7; Dellovade TL, 1998, J COMP NEUROL, V402, P402; Dorkin TJ, 1999, ONCOGENE, V18, P2755, DOI 10.1038/sj.onc.1202624; DOUCETTE R, 1990, GLIA, V3, P433, DOI 10.1002/glia.440030602; DRISCOLL DA, 1996, MENTAL RETARD DEV DI, V2, P130; EASTER SS, 1993, J NEUROSCI, V13, P285; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Farbman AI., 1988, MOL NEUROBIOLOGY OLF, P319; FARBMAN AI, 1992, CELL BIOL OLFACTION, P167; Francis-West P, 1998, MECH DEVELOP, V75, P3, DOI 10.1016/S0925-4773(98)00082-3; FRANCISWEST PH, 1994, DEV DYNAM, V201, P168, DOI 10.1002/aja.1002010207; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Golden JA, 1999, P NATL ACAD SCI USA, V96, P2439, DOI 10.1073/pnas.96.5.2439; GONG QH, 1995, NEURON, V14, P91, DOI 10.1016/0896-6273(95)90243-0; Goodman AB, 1998, P NATL ACAD SCI USA, V95, P7240, DOI 10.1073/pnas.95.13.7240; GRAHAM A, 1994, NATURE, V372, P684, DOI 10.1038/372684a0; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; HEIKINHEIMO M, 1994, MECH DEVELOP, V48, P129, DOI 10.1016/0925-4773(94)90022-1; Helms JA, 1997, DEV BIOL, V187, P25, DOI 10.1006/dbio.1997.8589; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HINDS JW, 1968, J COMP NEUROL, V134, P305, DOI 10.1002/cne.901340305; JACOBSON AG, 1963, J EXP ZOOL, V154, P273, DOI 10.1002/jez.1401540303; KEY B, 1990, J CELL BIOL, V110, P1729, DOI 10.1083/jcb.110.5.1729; LaMantia AS, 1999, BIOL PSYCHIAT, V46, P19, DOI 10.1016/S0006-3223(99)00002-5; LAMANTIA AS, 1993, NEURON, V10, P1035, DOI 10.1016/0896-6273(93)90052-S; LAMB TM, 1995, DEVELOPMENT, V121, P3627; LAMB TM, 1993, SCIENCE, V262, P713, DOI 10.1126/science.8235591; Lanoue L, 1997, AM J MED GENET, V73, P24; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; LELEIVRE CS, 1975, J EMBRYOL EXP MORPH, V34, P125; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43900; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; LUMSDEN AGS, 1988, DEVELOPMENT, V103, P155; Mansouri A, 1996, DEVELOPMENT, V122, P831; MARSHARMSTRONG N, 1994, P NATL ACAD SCI USA, V91, P7286, DOI 10.1073/pnas.91.15.7286; MATSUO T, 1993, NAT GENET, V3, P299, DOI 10.1038/ng0493-299; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; MIRAGALL F, 1989, DEV BIOL, V135, P272, DOI 10.1016/0012-1606(89)90179-6; Neubuser A, 1997, CELL, V90, P247, DOI 10.1016/S0092-8674(00)80333-5; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; O'Connor R, 1999, NEURON, V24, P165, DOI 10.1016/S0896-6273(00)80830-2; OsumiYamashita N, 1997, DEV GROWTH DIFFER, V39, P53; OSUMIYAMASHITA N, 1994, DEV BIOL, V164, P409, DOI 10.1006/dbio.1994.1211; Patapoutian A, 1999, SCIENCE, V283, P1180, DOI 10.1126/science.283.5405.1180; RICHMAN JM, 1989, DEV BIOL, V136, P201, DOI 10.1016/0012-1606(89)90142-5; ROLLHAUSRTERHOR.RJ, 1975, ANAT EMBRYOL, V147, P337; Ros MA, 1997, DEVELOPMENT, V124, P1821; Roskams AJI, 1998, NEUROSCIENCE, V83, P191, DOI 10.1016/S0306-4522(97)00344-8; Rubenstein JLR, 1998, CURR OPIN NEUROBIOL, V8, P18, DOI 10.1016/S0959-4388(98)80004-4; SCHWANZELFUKUDA M, 1992, J COMP NEUROL, V321, P1, DOI 10.1002/cne.903210102; SECHRIST J, 1993, DEVELOPMENT, V118, P691; SERBEDZIJA GN, 1992, DEVELOPMENT, V116, P297; SHENEFELT RE, 1972, TERATOLOGY, V5, P104; SHOOBRIDGE R, 1983, J EXP ZOOL, V225, P73, DOI 10.1002/jez.1402250110; Shou J, 1999, NAT NEUROSCI, V2, P339, DOI 10.1038/7251; SLACK JMW, 1995, NATURE, V374, P217, DOI 10.1038/374217a0; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; STOUT RP, 1980, NEUROSCIENCE, V5, P2175, DOI 10.1016/0306-4522(80)90134-7; SULIK KK, 1993, ANN NY ACAD SCI, V678, P8; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; TICKLE C, 1994, ANNU REV CELL BIOL, V10, P121; Trumpp A, 1999, GENE DEV, V13, P3136, DOI 10.1101/gad.13.23.3136; Vogel A, 1996, DEVELOPMENT, V122, P1737; WADDINGTON JL, 1993, LANCET, V341, P531, DOI 10.1016/0140-6736(93)90288-R; Waldo KL, 1996, DEV DYNAM, V205, P281, DOI 10.1002/(SICI)1097-0177(199603)205:3<281::AID-AJA8>3.0.CO;2-E; Weston AD, 2000, J CELL BIOL, V148, P679, DOI 10.1083/jcb.148.4.679; Whitesides JG, 1996, J COMP NEUROL, V373, P240, DOI 10.1002/(SICI)1096-9861(19960916)373:2<240::AID-CNE7>3.0.CO;2-3; Wilming LG, 1997, HUM MOL GENET, V6, P247, DOI 10.1093/hmg/6.2.247; WRAY S, 1989, P NATL ACAD SCI USA, V86, P8132, DOI 10.1073/pnas.86.20.8132; Yamagishi H, 1999, SCIENCE, V283, P1158, DOI 10.1126/science.283.5405.1158; Yoshida M, 1997, DEVELOPMENT, V124, P101; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zhao D, 1996, EUR J BIOCHEM, V240, P15, DOI 10.1111/j.1432-1033.1996.0015h.x; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	92	129	131	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	2000	28	2					411	425		10.1016/S0896-6273(00)00121-5	http://dx.doi.org/10.1016/S0896-6273(00)00121-5			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	377CE	11144352	Green Published, Bronze			2022-12-24	WOS:000165493700017
J	Mulle, C; Sailer, A; Swanson, GT; Brana, C; O'Gorman, S; Bettler, B; Heinemann, SF				Mulle, C; Sailer, A; Swanson, GT; Brana, C; O'Gorman, S; Bettler, B; Heinemann, SF			Subunit composition of kainate receptors in hippocampal interneurons	NEURON			English	Article							RAT HIPPOCAMPUS; SYNAPTIC TRANSMISSION; GLUR6-DEFICIENT MICE; STEM-CELLS; GERM-LINE; GLUTAMATE; GLUR5; ACTIVATION; INHIBITION; NEURONS	Kainate receptor activation affects GABAergic inhibition in the hippocampus by mechanisms that are thought to involve the GluR5 subunit. We report that disruption of the GluR5 subunit gene does not cause the loss of functional KARs in CA1 interneurons, nor does it prevent kainate-induced inhibition of evoked GABAergic synaptic transmission onto CA1 pyramidal cells. However, KAR function is abolished in mice lacking both GluR5 and GluR6 subunits, indicating that KARs in CA1 stratum radiatum interneurons are heteromeric receptors composed of both subunits. In addition, we show the presence of presynaptic KARs comprising the GluR6 but not the GluR5 subunit that modulate synaptic transmission between inhibitory interneurons. The existence of two separate populations of KARs in hippocampal interneurons adds to the complexity of KAR localization and function.	Univ Bordeaux 2, CNRS, UMR 5091, Inst Francois Magendie, F-33000 Bordeaux, France; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Salk Institute; Salk Institute	Mulle, C (corresponding author), Univ Bordeaux 2, CNRS, UMR 5091, Inst Francois Magendie, F-33000 Bordeaux, France.		bettler, bernhard/AAO-8018-2020; Sailer, Andreas/M-9913-2016	Bettler, Bernhard/0000-0003-0842-8207; Sailer, Andreas/0000-0002-9015-7946; Mulle, Christophe/0000-0003-2709-6615				BETTLER B, 1995, NEUROPHARMACOLOGY, V34, P123, DOI 10.1016/0028-3908(94)00141-E; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; Bischoff S, 1997, J COMP NEUROL, V379, P541, DOI 10.1002/(SICI)1096-9861(19970324)379:4<541::AID-CNE6>3.0.CO;2-2; Bleakman D, 1996, MOL PHARMACOL, V49, P581; Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; Bureau I, 2000, P NATL ACAD SCI USA, V97, P6838, DOI 10.1073/pnas.97.12.6838; Bureau I, 1999, J NEUROSCI, V19, P653; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Cauli B, 2000, P NATL ACAD SCI USA, V97, P6144, DOI 10.1073/pnas.97.11.6144; Chittajallu R, 1999, TRENDS PHARMACOL SCI, V20, P26, DOI 10.1016/S0165-6147(98)01286-3; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; Cossart R, 1998, NAT NEUROSCI, V1, P470, DOI 10.1038/2185; Cui CH, 1999, J NEUROSCI, V19, P8281; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; Frerking M, 1998, NAT NEUROSCI, V1, P479, DOI 10.1038/2194; Frerking M, 2000, CURR OPIN NEUROBIOL, V10, P342, DOI 10.1016/S0959-4388(00)00094-5; FREUND TF, 1988, NATURE, V336, P170, DOI 10.1038/336170a0; Gulyas AI, 1996, J NEUROSCI, V16, P3397; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; Kamiya H, 1998, J PHYSIOL-LONDON, V509, P833, DOI 10.1111/j.1469-7793.1998.833bm.x; Kamiya H, 2000, J PHYSIOL-LONDON, V523, P653, DOI 10.1111/j.1469-7793.2000.t01-1-00653.x; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Lerma J, 1997, TRENDS NEUROSCI, V20, P9, DOI 10.1016/S0166-2236(96)20055-4; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; Min MY, 1999, P NATL ACAD SCI USA, V96, P9932, DOI 10.1073/pnas.96.17.9932; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Paternain AV, 2000, J NEUROSCI, V20, P196, DOI 10.1523/JNEUROSCI.20-01-00196.2000; ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0; Rodriguez-Moreno A, 2000, P NATL ACAD SCI USA, V97, P1293, DOI 10.1073/pnas.97.3.1293; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; RUANO D, 1995, NEURON, V14, P1009, DOI 10.1016/0896-6273(95)90339-9; Sailer A, 1999, J NEUROSCI, V19, P8757, DOI 10.1523/JNEUROSCI.19-20-08757.1999; Schiffer HH, 1997, NEURON, V19, P1141, DOI 10.1016/S0896-6273(00)80404-3; Vignes M, 1998, NEUROPHARMACOLOGY, V37, P1269, DOI 10.1016/S0028-3908(98)00148-8; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; WENTHOLD RJ, 1994, J BIOL CHEM, V269, P1332; WISDEN W, 1993, J NEUROSCI, V13, P3582	40	168	173	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	2000	28	2					475	484		10.1016/S0896-6273(00)00126-4	http://dx.doi.org/10.1016/S0896-6273(00)00126-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	377CE	11144357	Bronze			2022-12-24	WOS:000165493700022
J	Di Cunto, F; Imarisio, S; Hirsch, E; Broccoli, V; Bulfone, A; Migheli, A; Atzori, C; Turco, E; Triolo, R; Dotto, GP; Silengo, L; Altruda, F				Di Cunto, F; Imarisio, S; Hirsch, E; Broccoli, V; Bulfone, A; Migheli, A; Atzori, C; Turco, E; Triolo, R; Dotto, GP; Silengo, L; Altruda, F			Defective neurogenesis in citron kinase knockout mice by altered cytokinesis and massive apoptosis	NEURON			English	Article							RHO-ASSOCIATED KINASE; SMALL GTPASE RHO; ACTIN CYTOSKELETON; CEREBRAL-CORTEX; CLEAVAGE FURROW; PROTEIN-RHO; MUTANT MICE; CELL-DEATH; RAC GTPASE; PHOSPHORYLATION	Citron-kinase (Citron-K) has been proposed by in vitro studies as a crucial effector of Rho in regulation of cytokinesis. To further investigate in vivo its biologic functions, we have inactivated Citron-K gene in mice by homologous recombination. Cifron-K-/- mice grow at slower rates, are severely ataxic, and die before adulthood as a consequence of fatal seizures. Their brains display defective neurogenesis, with depletion of specific neuronal populations. These abnormalities arise during development of the central nervous system due to altered cytokinesis and massive apoptosis. Our results indicate that Citron-K is essential for cytokinesis in vivo but only in specific neuronal precursors. Moreover, they suggest a novel molecular mechanism for a subset of human malformative syndromes of the CNS.	Univ Turin, Dept Genet Biol & Biochem, I-10126 Turin, Italy; Telethon Inst Genet & Med, Milan, Italy; Univ Turin, Dept Neurosci, Neuropathol Lab, I-10126 Turin, Italy; Univ Turin, Dipartimento Sci Biomed & Oncol Umana, Turin, Italy; Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA	University of Turin; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Turin; University of Turin; Harvard University; Massachusetts General Hospital; Harvard University	Di Cunto, F (corresponding author), Univ Turin, Dept Genet Biol & Biochem, Via Santena 5 Bis, I-10126 Turin, Italy.	dicunto@molinette.unito.it	Hirsch, Emilio/F-4848-2013; Di Cunto, Ferdinando/K-5575-2016; Broccoli, Vania/K-3464-2016	Hirsch, Emilio/0000-0002-9073-6024; Broccoli, Vania/0000-0003-4050-0926; di cunto, ferdinando/0000-0001-9367-6357	NATIONAL CANCER INSTITUTE [R01CA073796, P01CA016038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039190] Funding Source: NIH RePORTER; NCI NIH HHS [CA73796, CA16038] Funding Source: Medline; NIAMS NIH HHS [AR39190] Funding Source: Medline; Telethon [TGM00P13, TGM06S01, 405/BI, F.2] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Telethon(Fondazione Telethon)		Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Barrett K, 1997, CELL, V91, P905, DOI 10.1016/S0092-8674(00)80482-1; Broccoli V, 1999, NATURE, V401, P164, DOI 10.1038/43670; BULFONE A, 1995, NEURON, V15, P63, DOI 10.1016/0896-6273(95)90065-9; Bulfone A, 1998, NEURON, V21, P1273, DOI 10.1016/S0896-6273(00)80647-9; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Di Cunto F, 1998, J BIOL CHEM, V273, P29706, DOI 10.1074/jbc.273.45.29706; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Drechsel DN, 1997, CURR BIOL, V7, P12, DOI 10.1016/S0960-9822(06)00023-6; Furuyashiki T, 1999, J NEUROSCI, V19, P109, DOI 10.1523/JNEUROSCI.19-01-00109.1999; Goldowitz D, 1998, TRENDS NEUROSCI, V21, P375, DOI 10.1016/S0166-2236(98)01313-7; Goto H, 1998, J BIOL CHEM, V273, P11728, DOI 10.1074/jbc.273.19.11728; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hatten ME, 1997, CURR OPIN NEUROBIOL, V7, P40, DOI 10.1016/S0959-4388(97)80118-3; HINDS JW, 1968, J COMP NEUROL, V134, P305, DOI 10.1002/cne.901340305; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; KISHI K, 1993, J CELL BIOL, V120, P1187, DOI 10.1083/jcb.120.5.1187; Kosako H, 1999, ONCOGENE, V18, P2783, DOI 10.1038/sj.onc.1202633; Kosako H, 1997, J BIOL CHEM, V272, P10333; Kranenburg O, 1996, EMBO J, V15, P46, DOI 10.1002/j.1460-2075.1996.tb00332.x; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Leung T, 1996, MOL CELL BIOL, V16, P5313; Li FZ, 1999, NAT CELL BIOL, V1, P461, DOI 10.1038/70242; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Luo LQ, 1997, CURR OPIN NEUROBIOL, V7, P81, DOI 10.1016/S0959-4388(97)80124-9; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Madaule P, 1995, FEBS LETT, V377, P243, DOI 10.1016/0014-5793(95)01351-2; Madaule P, 1998, NATURE, V394, P491, DOI 10.1038/28873; Magie CR, 1999, DEVELOPMENT, V126, P5353; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Mercer WE, 1998, J CELL BIOCHEM, P50; Michaelidis TM, 1996, NEURON, V17, P75, DOI 10.1016/S0896-6273(00)80282-2; Migheli A, 1999, AM J PATHOL, V155, P365, DOI 10.1016/S0002-9440(10)65133-4; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Nakano K, 1997, GENES CELLS, V2, P679, DOI 10.1046/j.1365-2443.1997.1540352.x; Narumiya S, 1997, FEBS LETT, V410, P68, DOI 10.1016/S0014-5793(97)00317-7; Narumiya S, 1996, J BIOCHEM-TOKYO, V120, P215; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; Puranam RS, 1999, CURR OPIN NEUROBIOL, V9, P281, DOI 10.1016/S0959-4388(99)80041-5; Rice DS, 1999, GENE DEV, V13, P2758, DOI 10.1101/gad.13.21.2758; Srinivasan A, 1998, CELL DEATH DIFFER, V5, P1004, DOI 10.1038/sj.cdd.4400449; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Sugihara K, 1998, ONCOGENE, V17, P3427, DOI 10.1038/sj.onc.1202595; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001; VAN AL, 1997, GENE DEV, V11, P2295; Vercelli A, 2000, BRAIN RES BULL, V51, P11, DOI 10.1016/S0361-9230(99)00229-4; Walsh CA, 1999, NEURON, V23, P19, DOI 10.1016/S0896-6273(00)80749-7; Whiting S, 1999, J CHILD NEUROL, V14, P759, DOI 10.1177/088307389901401201; Wunnenberg-Stapleton K, 1999, DEVELOPMENT, V126, P5339; Yasui Y, 1998, J CELL BIOL, V143, P1249, DOI 10.1083/jcb.143.5.1249; Zhang WD, 1999, J NEUROSCI, V19, P96, DOI 10.1523/JNEUROSCI.19-01-00096.1999	54	195	200	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	2000	28	1					115	127		10.1016/S0896-6273(00)00090-8	http://dx.doi.org/10.1016/S0896-6273(00)00090-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	370VN	11086988	Bronze			2022-12-24	WOS:000165143500015
J	Pyle, JL; Kavalali, ET; Piedras-Renteria, ES; Tsien, RW				Pyle, JL; Kavalali, ET; Piedras-Renteria, ES; Tsien, RW			Rapid reuse of readily releasable pool vesicles at hippocampal synapses	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; ADRENAL CHROMAFFIN CELLS; SYNAPTIC VESICLES; FAST ENDOCYTOSIS; EXOCYTOSIS; KINETICS; CALCIUM; CYCLE; TRANSMITTER; PROBABILITY	Functional presynaptic vesicles have been subdivided into readily releasable (RRP) and reserve (RP) pools. We studied recycling properties of RRP vesicles through differential retention of FM1-43 and FM2-10 and by varying the time window for FM dye uptake. Both approaches indicated that vesicles residing in the RRP underwent rapid endocytosis (tau approximate to 1 s), whereas newly recruited RP vesicles were recycled slowly (tau approximate to s). With repeated challenges (hypertonic or electrical stimuli), the ability to release neurotransmitter recovered 10-fold more rapidly than restoration of FM2-10 destaining. Finding neurotransmission in the absence of destaining implied that rapidly endocytosed RRP Vesicles were capable of reuse, a process distinct from repopulation from the RP. Reuse would greatly expand the functional capabilities of a limited number of vesicles in CNS terminals, particularly during intermittent bursts of activity.	Stanford Univ, Beckman Ctr, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Stanford University	Tsien, RW (corresponding author), Stanford Univ, Beckman Ctr, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.			Piedras-Renteria, Erika/0000-0001-7983-585X				Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; Betz WJ, 1996, CURR OPIN NEUROBIOL, V6, P365, DOI 10.1016/S0959-4388(96)80121-8; CECCARELLI B, 1980, J CELL BIOL, V87, P297, DOI 10.1083/jcb.87.1.297; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; DECAMILLI P, 1995, FEBS LETT, V369, P3, DOI 10.1016/0014-5793(95)00739-V; Dittman JS, 1998, J NEUROSCI, V18, P6147; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Engisch KL, 1998, J PHYSIOL-LONDON, V506, P591, DOI 10.1111/j.1469-7793.1998.591bv.x; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; Henkel AW, 1995, J NEUROSCI, V15, P8246; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HEUSER JE, 1974, J NEUROCYTOL, V3, P109, DOI 10.1007/BF01111936; JAHN R, 1994, ANNU REV NEUROSCI, V17, P219, DOI 10.1146/annurev.ne.17.030194.001251; Kavalali ET, 1999, PHILOS T ROY SOC B, V354, P337, DOI 10.1098/rstb.1999.0385; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; Murthy VN, 1999, NAT NEUROSCI, V2, P503, DOI 10.1038/9149; NEHER E, 1993, NATURE, V363, P497, DOI 10.1038/363497a0; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; Neves G, 1999, J PHYSIOL-LONDON, V515, P181, DOI 10.1111/j.1469-7793.1999.181ad.x; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Schote U, 1998, BBA-BIOMEMBRANES, V1415, P135, DOI 10.1016/S0005-2736(98)00188-6; Smith C, 1997, J CELL BIOL, V139, P885, DOI 10.1083/jcb.139.4.885; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Stevens CF, 1999, NEURON, V24, P1017, DOI 10.1016/S0896-6273(00)81047-8; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; VONSCHWARZENFEL.I, 1979, NEUROSCIENCE, V4, P47; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; ZIMMERMANN H, 1993, J PHYSIOLOGY-PARIS, V87, P159, DOI 10.1016/0928-4257(93)90027-Q	46	264	272	0	17	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	2000	28	1					221	231		10.1016/S0896-6273(00)00098-2	http://dx.doi.org/10.1016/S0896-6273(00)00098-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	370VN	11086996	Bronze			2022-12-24	WOS:000165143500023
J	Feldman, DE				Feldman, DE			Timing-based LTP and LTD at vertical inputs to layer II/III pyramidal cells in rat barrel cortex	NEURON			English	Article							LONG-TERM POTENTIATION; EXPERIENCE-DEPENDENT PLASTICITY; INTRINSIC FIRING PATTERNS; VISUAL-CORTEX; SYNAPTIC PLASTICITY; SOMATOSENSORY CORTEX; THALAMOCORTICAL SYNAPSES; HIPPOCAMPAL-NEURONS; CORTICAL PLASTICITY; CRITICAL PERIOD	Experience-dependent plasticity in somatosensory (S1) and visual (V1) cortex involves rapid depression of responses to a deprived sensory input (a closed eye or a trimmed whisker). Such depression occurs first in layer II/III and may reflect plasticity at vertical inputs from layer IV to layer II/III pyramids. Here, I describe a timing-based, associative form of long-term potentiation and depression (LTP/LTD) at this synapse in S1. LTP occurred when excitatory postsynaptic potentials (EPSPs) led single postsynaptic action potentials (APs) within a narrow temporal window, and LTD occurred when APs led EPSPs within a significantly broader window. This long LTD window is unusual among timing-based learning rules and causes EPSPs that are uncorrelated with postsynaptic APs to become depressed. This behavior suggests a simple model for depression of deprived sensory responses in S1 and V1.	NINDS, Neural Dev Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Feldman, DE (corresponding author), NINDS, Neural Dev Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	dfeldman@codon.nih.gov						AGMON A, 1992, J NEUROSCI, V12, P319; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; ARMSTRONGJAMES M, 1994, J NEUROSCI, V14, P6978; AroniadouAnderjaska V, 1995, NEUROREPORT, V6, P2297, DOI 10.1097/00001756-199511270-00007; ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; BEAR MF, 1987, SCIENCE, V237, P42, DOI 10.1126/science.3037696; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; BENUSKOVA L, 1994, P NATL ACAD SCI USA, V91, P4791, DOI 10.1073/pnas.91.11.4791; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; CASTROALAMANCOS MA, 1995, J NEUROSCI, V15, P5324; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Cynader M, 2000, SCIENCE, V287, P1943, DOI 10.1126/science.287.5460.1943; de No RL, 1922, TRAB LAB BIOL U MADR, V20, P41; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Debarbieux F, 1998, J NEUROPHYSIOL, V79, P2911, DOI 10.1152/jn.1998.79.6.2911; DIAMOND ME, 1994, SCIENCE, V265, P1885, DOI 10.1126/science.8091215; DIAMOND ME, 1993, P NATL ACAD SCI USA, V90, P2082, DOI 10.1073/pnas.90.5.2082; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; Feldman DE, 1998, NEURON, V21, P347, DOI 10.1016/S0896-6273(00)80544-9; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; FOX K, 1992, J NEUROSCI, V12, P1826; FREGNAC Y, 1994, J NEUROPHYSIOL, V71, P1403, DOI 10.1152/jn.1994.71.4.1403; Glazewski S, 1998, EUR J NEUROSCI, V10, P2107, DOI 10.1046/j.1460-9568.1998.00222.x; Glazewski S, 1996, J NEUROPHYSIOL, V75, P1714, DOI 10.1152/jn.1996.75.4.1714; Goldreich D, 1999, J NEUROPHYSIOL, V82, P1311, DOI 10.1152/jn.1999.82.3.1311; Gottlieb JP, 1997, EXP BRAIN RES, V115, P47, DOI 10.1007/PL00005684; Hansel C, 1997, EUR J NEUROSCI, V9, P2309, DOI 10.1111/j.1460-9568.1997.tb01648.x; HARRIS RM, 1983, J COMP NEUROL, V220, P63, DOI 10.1002/cne.902200107; HARRIS RM, 1979, BRAIN RES, V161, P143, DOI 10.1016/0006-8993(79)90201-4; Hebb Donald O., 1949, ORG BEHAV; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; KAAS JH, 1991, ANNU REV NEUROSCI, V14, P137, DOI 10.1146/annurev.neuro.14.1.137; Kitagawa H, 1997, BRAIN RES, V751, P339, DOI 10.1016/S0006-8993(97)00052-8; Kondo H, 1999, EUR J NEUROSCI, V11, P4197, DOI 10.1046/j.1460-9568.1999.00844.x; KOSSUT M, 1992, PROG NEUROBIOL, V39, P389, DOI 10.1016/0301-0082(92)90013-5; LEE SM, 1991, BRAIN RES, V544, P303, DOI 10.1016/0006-8993(91)90069-8; Linden DJ, 1999, NEURON, V22, P661, DOI 10.1016/S0896-6273(00)80726-6; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; MIOCHE L, 1989, J NEUROPHYSIOL, V62, P185, DOI 10.1152/jn.1989.62.1.185; Ngezahayo A, 2000, J NEUROSCI, V20, P2451; Rittenhouse CD, 1999, NATURE, V397, P347, DOI 10.1038/16922; Sejnowski TJ, 1999, NEURON, V24, P773, DOI 10.1016/S0896-6273(00)81025-9; SIMONS DJ, 1987, NATURE, V326, P694, DOI 10.1038/326694a0; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; SINGER W, 1995, SCIENCE, V270, P758, DOI 10.1126/science.270.5237.758; STENT GS, 1973, P NATL ACAD SCI USA, V95, P3245; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Wallace H, 1999, SOMATOSENS MOT RES, V16, P122; WANG XQ, 1995, NATURE, V378, P71, DOI 10.1038/378071a0; WIESEL TN, 1965, J NEUROPHYSIOL, V40, P891; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	65	475	483	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	2000	27	1					45	56		10.1016/S0896-6273(00)00008-8	http://dx.doi.org/10.1016/S0896-6273(00)00008-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339XU	10939330	Bronze			2022-12-24	WOS:000088503800009
J	Mallamaci, A; Muzio, L; Chan, CH; Parnavelas, J; Boncinelli, E				Mallamaci, A; Muzio, L; Chan, CH; Parnavelas, J; Boncinelli, E			Area identity shifts in the early cerebral cortex of Emx2-/- mutant mice	NATURE NEUROSCIENCE			English	Article							SOMATOSENSORY CORTEX; MEMBRANE-PROTEIN; DENTATE GYRUS; CELL-CYCLE; NEURONS; EXPRESSION; SYSTEM; MOUSE; SPECIFICATION; NEOCORTEX	The specification of area identities in the cerebral cortex is a complex process, primed by intrinsic cortical cues and refined after the arrival of afferent fibers from the thalamus. Little is known about the genetic control of the early steps of this process, but the distinctive expression pattern of the homeogene Emx2 in the developing cortex has prompted suggestions that it is critical in this context. We tested this hypothesis using Emx2(-/-) mice. We found that the normal spectrum of cortical areal identities was encoded in these mutants, but areas with caudal-medial identities were reduced and those with anterior-lateral identities were relatively expanded in the cortex.	Ist Sci H San Raffaele, Dept Biol & Technol Res DIBIT, I-20132 Milan, Italy; UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; Univ Vita Salute San Raffaele, Fac Psychol, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of London; University College London; Vita-Salute San Raffaele University	Mallamaci, A (corresponding author), Ist Sci H San Raffaele, Dept Biol & Technol Res DIBIT, Via Olgettina 58, I-20132 Milan, Italy.	mallamaci.antanio@hsr.it	Mallamaci, Antonello/A-2975-2015; Chan, Chun-Hung/F-5358-2015; Muzio, Luca/AAB-2308-2022	Mallamaci, Antonello/0000-0002-3621-1307; Chan, Chun-Hung/0000-0001-9646-2944; Muzio, Luca/0000-0002-1068-865X	Telethon [D.078] Funding Source: Medline	Telethon(Fondazione Telethon)		ALLENDOERFER KL, 1990, P NATL ACAD SCI USA, V87, P187, DOI 10.1073/pnas.87.1.187; ARIMATSU Y, 1992, P NATL ACAD SCI USA, V89, P8879, DOI 10.1073/pnas.89.19.8879; BARBE MF, 1992, P NATL ACAD SCI USA, V89, P3706, DOI 10.1073/pnas.89.9.3706; BARBE MF, 1991, J NEUROSCI, V11, P519; Bayer S.A., 1991, NEOCORTICAL DEV; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Briata P, 1996, MECH DEVELOP, V57, P169, DOI 10.1016/0925-4773(96)00544-8; COHENTANNOUDJI M, 1992, MOL REPROD DEV, V33, P149, DOI 10.1002/mrd.1080330206; COHENTANNOUDJI M, 1994, NATURE, V368, P460, DOI 10.1038/368460a0; Eagleson KL, 1997, DEVELOPMENT, V124, P1623; FERRI RT, 1993, CEREB CORTEX, V3, P187, DOI 10.1093/cercor/3.3.187; Fukuda T, 1997, J COMP NEUROL, V382, P141; Gitton Y, 1999, J NEUROSCI, V19, P4889; Gulisano M, 1996, EUR J NEUROSCI, V8, P1037, DOI 10.1111/j.1460-9568.1996.tb01590.x; LEVITT P, 1984, SCIENCE, V223, P299, DOI 10.1126/science.6199842; Li FZ, 1999, NAT CELL BIOL, V1, P461, DOI 10.1038/70242; Mackarehtschian K, 1999, CEREB CORTEX, V9, P601, DOI 10.1093/cercor/9.6.601; Mallamaci A, 1998, MECH DEVELOP, V77, P165, DOI 10.1016/S0925-4773(98)00141-5; Mallamaci A, 2000, J NEUROSCI, V20, P1109, DOI 10.1523/JNEUROSCI.20-03-01109.2000; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; Molnar Z, 1998, J NEUROSCI, V18, P5723; Nakagawa Y, 1999, J NEUROSCI, V19, P10877, DOI 10.1523/JNEUROSCI.19-24-10877.1999; Pellegrini M, 1996, DEVELOPMENT, V122, P3893; PIMENTA AF, 1995, NEURON, V15, P287, DOI 10.1016/0896-6273(95)90034-9; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RIECHMANN V, 1995, CELL GROWTH DIFFER, V6, P837; Rubenstein JLR, 1999, CEREB CORTEX, V9, P524, DOI 10.1093/cercor/9.6.524; SCHLESSINGER AR, 1978, ANAT EMBRYOL, V154, P153, DOI 10.1007/BF00304660; STANFIELD BB, 1979, J COMP NEUROL, V185, P423, DOI 10.1002/cne.901850303; TAKAHASHI T, 1995, J NEUROSCI, V15, P6058; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; WALTHER C, 1991, DEVELOPMENT, V113, P1435; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; ZACCO A, 1990, J NEUROSCI, V10, P73	35	210	213	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2000	3	7					679	686		10.1038/76630	http://dx.doi.org/10.1038/76630			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TT	10862700				2022-12-24	WOS:000167177200014
J	Inglis, FM; Zuckerman, KE; Kalb, RG				Inglis, FM; Zuckerman, KE; Kalb, RG			Experience-dependent development of spinal motor neurons	NEURON			English	Editorial Material							NMDA RECEPTOR; POSTNATAL-DEVELOPMENT; SPACE-FLIGHT; SYNAPTIC ACTIVITY; CRITICAL PERIOD; STRIATE CORTEX; VISUAL-CORTEX; RAT; CORD; GROWTH	Locomotor activity in many species undergoes pronounced alterations in early postnatal life, and environmental cues may be responsible for modifying this process. To determine how these events are reflected in the nervous system, we studied rats reared under two different conditions-the presence or absence of gravity-in which the performance of motor operations differed. We found a significant effect of rearing environment on the size and complexity of dendritic architecture of spinal motor neurons, particularly those that are likely to participate in postural control. These results provide evidence that neurons subserving motor function undergo activity-dependent maturation in early postnatal life in a manner analogous to sensory systems.	Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University; Yale University	Kalb, RG (corresponding author), Yale Univ, Sch Med, Dept Neurol, 333 Cedar St, New Haven, CT 06520 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029837, U01NS033467] Funding Source: NIH RePORTER; NINDS NIH HHS [NS33467, NS29837] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTMAN J, 1975, ANIM BEHAV, V23, P896, DOI 10.1016/0003-3472(75)90114-1; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; BEAR MF, 1990, J NEUROSCI, V10, P909; BODNARENKO SR, 1993, NATURE, V364, P144, DOI 10.1038/364144a0; BROWN JL, 1961, AEROSPACE MED, V32, P209; BROWN MC, 1976, J PHYSIOL-LONDON, V261, P387, DOI 10.1113/jphysiol.1976.sp011565; Clarac F, 1998, BRAIN RES REV, V28, P35, DOI 10.1016/S0165-0173(98)00024-1; CLARK B, 1964, Acta Otolaryngol, V58, P143, DOI 10.3109/00016486409121371; CLEMENT G, 1984, EXP BRAIN RES, V57, P61; CLINE HT, 1989, NEURON, V3, P413, DOI 10.1016/0896-6273(89)90201-8; CLINE HT, 1990, J NEUROSCI, V10, P1197; CLINE HT, 1987, P NATL ACAD SCI USA, V84, P4342, DOI 10.1073/pnas.84.12.4342; CUMMINGS JP, 1984, EXP NEUROL, V83, P155, DOI 10.1016/0014-4886(84)90054-2; CURFS MHJM, 1994, DEV BRAIN RES, V78, P182, DOI 10.1016/0165-3806(94)90025-6; CYNADER M, 1980, J NEUROPHYSIOL, V43, P1026, DOI 10.1152/jn.1980.43.4.1026; DONATELLE JM, 1977, J COMP NEUROL, V175, P207, DOI 10.1002/cne.901750205; GHEZ C, 1991, PRINCIPLES NEURAL SC, P539; GHEZ C, 1991, PRINCIPLES NEURAL SC, P564; GREENWOOD R, 1976, J PHYSIOL-LONDON, V254, P507, DOI 10.1113/jphysiol.1976.sp011242; GRIBNAU AAM, 1986, ANAT EMBRYOL, V175, P101, DOI 10.1007/BF00315460; HICKS SP, 1975, AM J ANAT, V143, P1, DOI 10.1002/aja.1001430102; HORNICK JL, 1977, NASA, P104; HUME RI, 1981, NATURE, V293, P469, DOI 10.1038/293469a0; Inglis FM, 1998, J NEUROSCI, V18, P10493; JAKOWEC MW, 1995, NEUROSCIENCE, V67, P893, DOI 10.1016/0306-4522(95)00026-F; JAWEED MM, 1994, SPACE PHYSL MED, P317; KALB RG, 1992, P NATL ACAD SCI USA, V89, P8502, DOI 10.1073/pnas.89.18.8502; KALB RG, 1994, DEVELOPMENT, V120, P3063; KALB RG, 1988, J NEUROSCI, V8, P2350; KALB RG, 1990, SCIENCE, V250, P294, DOI 10.1126/science.2145629; KATZ LC, 1988, J NEUROSCI, V8, P3160; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; Layne CS, 1997, EXP BRAIN RES, V113, P104, DOI 10.1007/BF02454146; LAYNE CS, 1990, AVIAT SPACE ENVIR MD, V61, P994; Leterme D, 1998, AVIAT SPACE ENVIR MD, V69, P1065; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; MOWER GD, 1991, DEV BRAIN RES, V58, P151, DOI 10.1016/0165-3806(91)90001-Y; Newman DJ, 1997, EXP BRAIN RES, V117, P30, DOI 10.1007/PL00005788; PELLIS VC, 1991, DEV PSYCHOBIOL, V24, P237, DOI 10.1002/dev.420240405; PURVES D, 1981, J NEUROSCI, V1, P441; PURVES D, 1983, TRENDS NEUROSCI, V6, P10, DOI 10.1016/0166-2236(83)90007-3; REDFERN PA, 1970, J PHYSIOL-LONDON, V209, P701, DOI 10.1113/jphysiol.1970.sp009187; Reschke MF, 1998, BRAIN RES REV, V28, P102, DOI 10.1016/S0165-0173(98)00031-9; RESCHKE MF, 1984, SCIENCE, V225, P212, DOI 10.1126/science.6729475; Ross MD, 1998, BRAIN RES REV, V28, P44, DOI 10.1016/S0165-0173(98)00025-3; ROSS MD, 1994, ACTA OTOLARYNGOL S, V516, P3; Sawin CF, 1999, AVIAT SPACE ENVIR MD, V70, P169; SCHILLING K, 1991, NEURON, V7, P891, DOI 10.1016/0896-6273(91)90335-W; Sebastian C, 1996, EXP BRAIN RES, V112, P213; SEEBACH BS, 1994, J NEUROSCI, V14, P4520; SHOLL DA, 1953, J ANAT, V87, P387; Silver MA, 1999, J NEUROSCI, V19, P10829, DOI 10.1523/JNEUROSCI.19-24-10829.1999; VAUGHN JE, 1988, SYNAPSE, V2, P69, DOI 10.1002/syn.890020110; Walton K, 1998, BRAIN RES REV, V28, P25, DOI 10.1016/S0165-0173(98)00023-X; WALTON KD, 1992, NEUROSCIENCE, V51, P763, DOI 10.1016/0306-4522(92)90517-6; WALTON KD, 1991, J PHYSIOL-LONDON, V433, P283, DOI 10.1113/jphysiol.1991.sp018426	58	46	47	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	2000	26	2					299	305		10.1016/S0896-6273(00)81164-2	http://dx.doi.org/10.1016/S0896-6273(00)81164-2			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318QZ	10839350	Bronze			2022-12-24	WOS:000087296500008
J	Pierce, JP; van Leyen, K; McCarthy, JB				Pierce, JP; van Leyen, K; McCarthy, JB			Translocation machinery for synthesis of integral membrane and secretory proteins in dendritic spines	NATURE NEUROSCIENCE			English	Article							ENDOPLASMIC-RETICULUM; STORAGE; RNAS		Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Cornell University; Memorial Sloan Kettering Cancer Center; Yale University	McCarthy, JB (corresponding author), Cornell Univ, Weill Med Coll, Dept Neurobiol, Room 410,411 E 69th St, New York, NY 10021 USA.	jbm2001@med.cornell.edu	van Leyen, Klaus/C-9126-2013	van Leyen, Klaus/0000-0003-1032-3754				Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; CHAN J, 1990, J NEUROSCI METH, V33, P113, DOI 10.1016/0165-0270(90)90015-8; Gao FB, 1998, BIOESSAYS, V20, P70, DOI 10.1002/(SICI)1521-1878(199801)20:1<70::AID-BIES10>3.0.CO;2-5; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Hazelrigg T, 1998, CELL, V95, P451, DOI 10.1016/S0092-8674(00)81613-X; Huang EP, 1999, CURR BIOL, V9, pR168, DOI 10.1016/S0960-9822(99)80104-3; Kuhl D, 1998, CURR OPIN NEUROBIOL, V8, P600, DOI 10.1016/S0959-4388(98)80087-1; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Matlack KES, 1998, CELL, V92, P381, DOI 10.1016/S0092-8674(00)80930-7; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; PELHAM HRB, 1990, TRENDS BIOCHEM SCI, V15, P483, DOI 10.1016/0968-0004(90)90303-S; Schuman EM, 1997, NEURON, V18, P339, DOI 10.1016/S0896-6273(00)81234-9; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Tiedge H, 1999, SCIENCE, V283, P186, DOI 10.1126/science.283.5399.186	15	99	101	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2000	3	4					311	313		10.1038/73868	http://dx.doi.org/10.1038/73868			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330CN	10725917				2022-12-24	WOS:000087945400008
J	Schwappach, B; Zerangue, N; Jan, YN; Jan, LY				Schwappach, B; Zerangue, N; Jan, YN; Jan, LY			Molecular basis for K-ATP assembly: Transmembrane interactions mediate association of a K+ channel with an ABC transporter	NEURON			English	Article							SENSITIVE POTASSIUM CHANNELS; PORE-FORMING SUBUNIT; SULFONYLUREA RECEPTOR; MULTIDRUG-RESISTANCE; N-TERMINUS; MEMBRANE TOPOLOGY; INHIBITION; PROTEIN; KIR6.2; DOMAINS	K-ATP channels are large heteromultimeric complexes containing four subunits from the inwardly rectifying K+ channel family (Kir6.2) and four regulatory sulphonylurea receptor subunits from the ATP-binding cassette (ABC) transporter family (SUR1 and SUR2A/B). The molecular basis for interactions between these two unrelated protein families is poorly understood. Using novel trafficking-based interaction assays, coimmunoprecipitation, and current measurements, we show that the first transmembrane segment (M1) and the N terminus of Kir6.2 are involved in K-ATP assembly and gating. Additionally, the transmembrane domains, but not the nucleotide-binding domains, of SUR1 are required for interaction with Kir6.2. The identification of specific transmembrane interactions involved in K-ATP assembly may provide a clue as to how ABC proteins that transport hydrophobic substrates evolved to regulate other membrane proteins.	Univ Calif San Francisco, Grad Program Neurosci, Dept Physiol, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Program Neurosci, Dept Biochem, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Jan, LY (corresponding author), Univ Calif San Francisco, Grad Program Neurosci, Dept Physiol, Howard Hughes Med Inst, San Francisco, CA 94143 USA.			Schwappach, Blanche/0000-0003-0225-6432; Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015963] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-15963] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; ALLIKMETS R, 1993, GENE, V136, P231, DOI 10.1016/0378-1119(93)90470-N; Babenko AP, 1999, BIOCHEM BIOPH RES CO, V255, P231, DOI 10.1006/bbrc.1999.0172; Cole SPC, 1998, BIOESSAYS, V20, P931, DOI 10.1002/(SICI)1521-1878(199811)20:11<931::AID-BIES8>3.0.CO;2-J; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Collins A, 1997, P NATL ACAD SCI USA, V94, P5456, DOI 10.1073/pnas.94.10.5456; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Decottignies A, 1997, NAT GENET, V15, P137, DOI 10.1038/ng0297-137; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Drain P, 1998, P NATL ACAD SCI USA, V95, P13953, DOI 10.1073/pnas.95.23.13953; Giblin JP, 1999, J BIOL CHEM, V274, P22652, DOI 10.1074/jbc.274.32.22652; GREEN WN, 1993, CELL, V74, P57, DOI 10.1016/0092-8674(93)90294-Z; Gribble FM, 1997, J PHYSIOL-LONDON, V498, P87, DOI 10.1113/jphysiol.1997.sp021843; Gribble FM, 1997, EMBO J, V16, P1145, DOI 10.1093/emboj/16.6.1145; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Kast C, 1998, BIOCHEMISTRY-US, V37, P2305, DOI 10.1021/bi972332v; Kool M, 1999, P NATL ACAD SCI USA, V96, P6914, DOI 10.1073/pnas.96.12.6914; Koster JC, 1999, J PHYSIOL-LONDON, V515, P19, DOI 10.1111/j.1469-7793.1999.019ad.x; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Loots E, 1998, J GEN PHYSIOL, V112, P377, DOI 10.1085/jgp.112.4.377; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; Proks P, 1999, J PHYSIOL-LONDON, V514, P19, DOI 10.1111/j.1469-7793.1999.019af.x; Raab-Graham KF, 1999, J BIOL CHEM, V274, P29122, DOI 10.1074/jbc.274.41.29122; Reimann F, 1999, J PHYSIOL-LONDON, V518, P325, DOI 10.1111/j.1469-7793.1999.0325p.x; Ruknudin A, 1998, J BIOL CHEM, V273, P14165, DOI 10.1074/jbc.273.23.14165; Saurin W, 1999, J MOL EVOL, V48, P22, DOI 10.1007/PL00006442; Schwanstecher M, 1998, EMBO J, V17, P5529, DOI 10.1093/emboj/17.19.5529; Schwiebert Erik M., 1999, Physiological Reviews, V79, pS145; Shyng SL, 1997, J GEN PHYSIOL, V110, P643, DOI 10.1085/jgp.110.6.643; Stride BD, 1999, J BIOL CHEM, V274, P22877, DOI 10.1074/jbc.274.32.22877; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tinker A, 1996, CELL, V87, P857, DOI 10.1016/S0092-8674(00)81993-5; Trapp S, 1998, J GEN PHYSIOL, V112, P333, DOI 10.1085/jgp.112.3.333; Tucker SJ, 1998, EMBO J, V17, P3290, DOI 10.1093/emboj/17.12.3290; Tucker SJ, 1996, J BIOL CHEM, V271, P5866, DOI 10.1074/jbc.271.10.5866; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Tucker SJ, 1999, J BIOL CHEM, V274, P33393, DOI 10.1074/jbc.274.47.33393; Tusnady GE, 1997, FEBS LETT, V402, P1, DOI 10.1016/S0014-5793(96)01478-0; Uhde I, 1999, J BIOL CHEM, V274, P28079, DOI 10.1074/jbc.274.40.28079; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zheng J, 1998, J GEN PHYSIOL, V112, P457, DOI 10.1085/jgp.112.4.457	43	141	141	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	2000	26	1					155	167		10.1016/S0896-6273(00)81146-0	http://dx.doi.org/10.1016/S0896-6273(00)81146-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309MA	10798400	Bronze			2022-12-24	WOS:000086770500016
J	Cassata, G; Kagoshima, H; Andachi, Y; Kohara, Y; Durrenberger, MB; Hall, DH; Burglin, TR				Cassata, G; Kagoshima, H; Andachi, Y; Kohara, Y; Durrenberger, MB; Hall, DH; Burglin, TR			The LIM homeobox gene ceh-14 confers thermosensory function to the AFD neurons in Caenorhabditis elegans	NEURON			English	Article							NUCLEOTIDE-GATED CHANNEL; C-ELEGANS; HOMEODOMAIN PROTEINS; SENSORY NEURONS; MOTOR-NEURONS; EXPRESSION; PATHWAY; DIFFERENTIATION; MUTATIONS; RECEPTOR	In Caenorhabditis elegans three pairs of neurons, AFD, AIY, and AIZ, play a key role in thermosensation. The LIM homeobox gene ceh-14 is expressed in the AFD thermosensory neurons. ceh-14 mutant animals display athermotactic behaviors, although the neurons are still present and differentiated. Two other LIM homeobox genes, ttx-3 and lin-11, function in the two interneurons AIY and AIZ, respectively. Thus, the three key thermosensory neurons are specified by three different LIM homeobox genes. ceh-14 ttx-3 lin-11 triple mutant animals have a basic cryophilic thermotaxis behavior indicative of a second thermotaxis pathway. Misexpression of ceh-14 in chemosensory neurons can restore thermotactic behavior without impairing the chemosensory function. Thus, ceh-14 confers thermosensory function to neurons.	Univ Basel, Biozentrum, Div Cell Biol, CH-4056 Basel, Switzerland; Univ Basel, Biozentrum, Interdept Electron Microscopy, CH-4056 Basel, Switzerland; Natl Inst Genet, Gene Lib Lab, Mishima, Shizuoka 411, Japan; Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Ctr C Elegans Anat, Bronx, NY 10461 USA	University of Basel; University of Basel; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Yeshiva University; Albert Einstein College of Medicine	Burglin, TR (corresponding author), Univ Basel, Biozentrum, Div Cell Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.	buerglin@unibas.ch			NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR012596] Funding Source: NIH RePORTER; NCRR NIH HHS [R24 RR012596, RR12596] Funding Source: Medline; NIH HHS [R24 OD010943] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; Appel B, 1995, DEVELOPMENT, V121, P4117; Ashton FT, 1999, VET PARASITOL, V84, P297, DOI 10.1016/S0304-4017(99)00037-0; Bach I, 1997, GENE DEV, V11, P1370, DOI 10.1101/gad.11.11.1370; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; BURGLIN TR, 1989, NATURE, V341, P239, DOI 10.1038/341239a0; BURGLIN TR, 1995, BIODIVERSITY EVOLUTI, P291; BURKE B, 1982, EMBO J, V1, P1621, DOI 10.1002/j.1460-2075.1982.tb01364.x; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cassata G, 1998, GENE, V212, P127, DOI 10.1016/S0378-1119(98)00137-1; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Coburn CM, 1998, DEVELOPMENT, V125, P249; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Colbert HA, 1997, J NEUROSCI, V17, P8259; DAWID IB, 1995, CR ACAD SCI III-VIE, V318, P295; Dawid IB, 1998, TRENDS GENET, V14, P156, DOI 10.1016/S0168-9525(98)01424-3; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; GREENSTEIN D, 1994, GENE DEV, V8, P1935, DOI 10.1101/gad.8.16.1935; HAN M, 1991, GENE DEV, V5, P2188, DOI 10.1101/gad.5.12a.2188; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; Hobert O, 1998, J NEUROSCI, V18, P2084; Jurata LW, 1996, P NATL ACAD SCI USA, V93, P11693, DOI 10.1073/pnas.93.21.11693; KALIONIS B, 1993, MECH DEVELOP, V43, P57, DOI 10.1016/0925-4773(93)90023-Q; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; LUNDGREN SE, 1995, DEVELOPMENT, V121, P1769; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Sagasti A, 1999, GENE DEV, V13, P1794, DOI 10.1101/gad.13.14.1794; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Thor S, 1997, NEURON, V18, P397, DOI 10.1016/S0896-6273(00)81241-6; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; VarelaEchavarria A, 1996, MOL CELL NEUROSCI, V8, P242, DOI 10.1006/mcne.1996.0061; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; WAY JC, 1988, CELL, V54, P5, DOI 10.1016/0092-8674(88)90174-2; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384; ZWAAL RR, 1993, P NATL ACAD SCI USA, V90, P7431, DOI 10.1073/pnas.90.16.7431	45	63	68	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	2000	25	3					587	597		10.1016/S0896-6273(00)81062-4	http://dx.doi.org/10.1016/S0896-6273(00)81062-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	301CY	10774727	Bronze			2022-12-24	WOS:000086291700012
J	Downar, J; Crawley, AP; Mikulis, DJ; Davis, KD				Downar, J; Crawley, AP; Mikulis, DJ; Davis, KD			A multimodal cortical network for the detection of changes in the sensory environment	NATURE NEUROSCIENCE			English	Article							POSITRON-EMISSION TOMOGRAPHY; TEMPORAL-PARIETAL JUNCTION; VISUAL AWARENESS; ATTENTION; NEGLECT; CORTEX; FMRI; RESPONSES; LESIONS; STIMULI	Sensory stimuli undergoing sudden changes draw attention and preferentially enter our awareness. We used event-related functional magnetic-resonance imaging (fMRI) to identify brain regions responsive to changes in visual, auditory and tactile stimuli. Unimodally responsive areas included visual, auditory and somatosensory association cortex. Multimodally responsive areas comprised a right-lateralized network including the temporoparietal junction, inferior frontal gyrus, insula and left cingulate and supplementary motor areas. These results reveal a distributed, multimodal network for involuntary attention to events in the sensory environment. This network contains areas thought to underlie the P300 event-related potential and closely corresponds to the set of cortical regions damaged in patients with hemineglect syndromes.	Univ Toronto, Inst Med Sci, Toronto, ON M5T 2S8, Canada; Toronto Western Res Inst, Toronto, ON M5T 2S8, Canada; Univ Toronto, Dept Med Imaging, Toronto, ON M5T 2S8, Canada; Univ Toronto, Toronto Western Hosp, Dept Surg, Div Neurosurg, Toronto, ON M5T 2S8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Davis, KD (corresponding author), Univ Toronto, Inst Med Sci, MP14-322,399 Bathurst St, Toronto, ON M5T 2S8, Canada.	kdavis@playfair.utoronto.ca	Downar, Jonathan/I-9002-2016; Mikulis, David J/H-5167-2019	Downar, Jonathan/0000-0002-5140-174X; Mikulis, David/0000-0003-3956-0892				Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Alain C, 1998, BRAIN RES, V812, P23, DOI 10.1016/S0006-8993(98)00851-8; Buckner RL, 1998, HUM BRAIN MAPP, V6, P373, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<373::AID-HBM8>3.3.CO;2-G; Coull JT, 1998, PROG NEUROBIOL, V55, P343, DOI 10.1016/S0301-0082(98)00011-2; DONG WK, 1989, BRAIN RES, V484, P314, DOI 10.1016/0006-8993(89)90375-2; Driver J, 1998, NAT NEUROSCI, V1, P17, DOI 10.1038/217; Friedrich FJ, 1998, NEUROPSYCHOLOGY, V12, P193, DOI 10.1037/0894-4105.12.2.193; GLOVER GH, 1995, MAGNET RESON MED, V33, P624, DOI 10.1002/mrm.1910330507; Halligan PW, 1998, CONSCIOUS COGN, V7, P356, DOI 10.1006/ccog.1998.0362; Ikeda A, 1999, BRAIN, V122, P915, DOI 10.1093/brain/122.5.915; Katayama J, 1998, PSYCHOPHYSIOLOGY, V35, P23, DOI 10.1111/1469-8986.3510023; KAWASHIMA R, 1995, P NATL ACAD SCI USA, V92, P5969, DOI 10.1073/pnas.92.13.5969; Kim YH, 1999, NEUROIMAGE, V9, P269, DOI 10.1006/nimg.1999.0408; KNIGHT RT, 1984, ELECTROEN CLIN NEURO, V59, P9, DOI 10.1016/0168-5597(84)90016-9; KNIGHT RT, 1989, BRAIN RES, V502, P109, DOI 10.1016/0006-8993(89)90466-6; Knight RT, 1998, REV NEUROSCIENCE, V9, P57; Maldjian JA, 1999, BRAIN RES, V824, P291, DOI 10.1016/S0006-8993(99)01126-9; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Opitz B, 1999, CEREB CORTEX, V9, P379, DOI 10.1093/cercor/9.4.379; Pollmann S, 1998, NEUROIMAGE, V8, P327, DOI 10.1006/nimg.1998.0373; Ro T, 1998, BRAIN COGNITION, V37, P461, DOI 10.1006/brcg.1998.1008; ROBINSON CJ, 1980, J COMP NEUROL, V192, P43, DOI 10.1002/cne.901920104; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Swick D, 1998, ATTENTIVE BRAIN, P143; Talairach J., 1988, COPLANAR STEREOTAXIC; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; TULVING E, 1994, NEUROREPORT, V5, P2525, DOI 10.1097/00001756-199412000-00030; Vallar G, 1998, TRENDS COGN SCI, V2, P87, DOI 10.1016/S1364-6613(98)01145-0; YAMAGUCHI S, 1991, ELECTROEN CLIN NEURO, V78, P50, DOI 10.1016/0013-4694(91)90018-Y; YAMAGUCHI S, 1991, J NEUROSCI, V11, P2039	31	711	717	3	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2000	3	3					277	283		10.1038/72991	http://dx.doi.org/10.1038/72991			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TE	10700261				2022-12-24	WOS:000085810500018
J	Aizenman, CD; Linden, DJ				Aizenman, CD; Linden, DJ			Rapid, synaptically driven increases in the intrinsic excitability of cerebellar deep nuclear neurons	NATURE NEUROSCIENCE			English	News Item							EPSP-SPIKE POTENTIATION; LONG-TERM POTENTIATION; RAT HIPPOCAMPAL SLICES; PYRAMIDAL NEURONS; CA1 REGION; CONDUCTANCE		Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Linden, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.				NIMH NIH HHS [MH01590] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABRAHAM WC, 1987, J PHYSIOL-LONDON, V394, P367, DOI 10.1113/jphysiol.1987.sp016875; Aizenman CD, 1999, J NEUROPHYSIOL, V82, P1697, DOI 10.1152/jn.1999.82.4.1697; Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; ALKON DL, 1984, J EXP BIOL, V112, P95; BARABAN JM, 1985, P NATL ACAD SCI USA, V82, P2538, DOI 10.1073/pnas.82.8.2538; Cull-Candy SG, 1998, NEUROPHARMACOLOGY, V37, P1369, DOI 10.1016/S0028-3908(98)00119-1; DEJONGE MC, 1990, EXP BRAIN RES, V80, P456, DOI 10.1007/BF00227987; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; HESS G, 1990, NEUROSCIENCE, V37, P61, DOI 10.1016/0306-4522(90)90192-7; JESTER JM, 1995, J PHYSIOL-LONDON, V484, P689, DOI 10.1113/jphysiol.1995.sp020696; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P221, DOI 10.1113/jphysiol.1986.sp016006; MURI R, 1994, J NEUROPHYSIOL, V71, P420, DOI 10.1152/jn.1994.71.1.420; PUGLIESE AM, 1994, NEUROSCIENCE, V62, P1021, DOI 10.1016/0306-4522(94)90340-9; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157	15	206	207	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2000	3	2					109	111		10.1038/72049	http://dx.doi.org/10.1038/72049			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TC	10649564				2022-12-24	WOS:000085810300006
J	Hesslow, G; Svensson, P; Ivarsson, M				Hesslow, G; Svensson, P; Ivarsson, M			Learned movements elicited by direct stimulation of cerebellar mossy fiber afferents	NEURON			English	Article							NICTITATING-MEMBRANE RESPONSE; EYELID RESPONSE; DENTATE NUCLEUS; PONTINE-NUCLEUS; RABBIT; CORTEX; MEMORY; CAT; ORGANIZATION; LESIONS	Definitive evidence is presented that the conditioned stimulus (CS) in classical conditioning reaches the cerebellum via the mossy fiber system. Decerebrate ferrets received paired forelimb and periocular stimulation until they responded with blinks to the forelimb stimulus. When direct mossy fiber stimulation was then given, the animals responded with conditioned blinks immediately, that is, without ever having been trained to the mossy fiber stimulation. Antidromic: activation was prevented by blocking mossy fibers with lignocaine ventral to the stimulation site. It could be excluded that cerebellar output functioned as the CS. Analysis of latencies suggests that conditioned responses (CRs) are not generated by mossy fiber collaterals to the deep nuclei. Hence, the memory trace is probably located in the cerebellar cortex.	Univ Lund, Dept Physiol Sci, S-22362 Lund, Sweden	Lund University	Hesslow, G (corresponding author), Univ Lund, Dept Physiol Sci, Solvegatan 19, S-22362 Lund, Sweden.							ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; BLOEDEL JR, 1995, BEHAV BRAIN RES, V68, P1, DOI 10.1016/0166-4328(94)00171-B; BRODAL P, 1992, NEUROSCI RES, V13, P83, DOI 10.1016/0168-0102(92)90092-Q; DeSchutter E, 1996, CURR OPIN NEUROBIOL, V6, P759; Doty R W, 1969, Annu Rev Psychol, V20, P289, DOI 10.1146/annurev.ps.20.020169.001445; DOTY RW, 1956, J NEUROPHYSIOL, V19, P401, DOI 10.1152/jn.1956.19.5.401; GORMEZANO I, 1983, PROG PSYCHOB PHYSIOL, V10, P197; HESSLOW G, 1994, J PHYSIOL-LONDON, V476, P245, DOI 10.1113/jphysiol.1994.sp020127; Houk JC, 1996, BEHAV BRAIN SCI, V19, P368, DOI 10.1017/S0140525X00081474; Ito M., 1984, CEREBELLUM NEURONAL; Ivarsson M, 1997, J PHYSIOL-LONDON, V502, P189, DOI 10.1111/j.1469-7793.1997.189bl.x; IVARSSON M, 1993, NEUROREPORT, V4, P1127; KRUPA DJ, 1995, P NATL ACAD SCI USA, V92, P5097, DOI 10.1073/pnas.92.11.5097; LAVOND DG, 1987, EXP BRAIN RES, V67, P569; Llinas R, 1997, LEARN MEMORY, V3, P445, DOI 10.1101/lm.3.6.445; Loucks RB, 1933, J COMP PSYCHOL, V16, P439, DOI 10.1037/h0073424; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MAUK MD, 1987, BRAIN RES, V403, P89, DOI 10.1016/0006-8993(87)90126-0; MCCORMICK DA, 1984, SCIENCE, V223, P296, DOI 10.1126/science.6701513; NORMAN RJ, 1974, EXP NEUROL, V44, P363, DOI 10.1016/0014-4886(74)90202-7; OAKLEY DA, 1972, PHYSIOL BEHAV, V8, P915, DOI 10.1016/0031-9384(72)90305-8; Pavlov I.P., 1927, CONDITIONED REFLEXES; Rogers RF, 1998, NEUROBIOL LEARN MEM, V69, P307, DOI 10.1006/nlme.1998.3826; SHINODA Y, 1992, J NEUROPHYSIOL, V67, P547, DOI 10.1152/jn.1992.67.3.547; SHINODA Y, 1987, EXP BRAIN RES, V67, P299; STEINMETZ JE, 1990, PSYCHOL SCI, V1, P378, DOI 10.1111/j.1467-9280.1990.tb00245.x; STEINMETZ JE, 1986, BEHAV NEUROSCI, V100, P878, DOI 10.1037/0735-7044.100.6.878; SVENSSON P, 1997, LEARN MEMORY, V3, P105; Thach W. T., 1996, Behavioral and Brain Sciences, V19, P411; THOMPSON RF, 1959, J COMP PHYSIOL PSYCH, V52, P183, DOI 10.1037/h0042250; THOMPSON RF, 1994, ANNU REV NEUROSCI, V17, P519, DOI 10.1146/annurev.neuro.17.1.519; YEO CH, 1985, EXP BRAIN RES, V60, P114, DOI 10.1007/BF00237024; YEO CH, 1985, EXP BRAIN RES, V60, P99, DOI 10.1007/BF00237023	33	88	89	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	1999	24	1					179	185		10.1016/S0896-6273(00)80831-4	http://dx.doi.org/10.1016/S0896-6273(00)80831-4			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241QC	10677036	Bronze			2022-12-24	WOS:000082893200018
J	Roskies, AL				Roskies, AL			The binding problem - Introduction	NEURON			English	Editorial Material							CAT VISUAL-CORTEX; RECEPTIVE-FIELD PROPERTIES; SUPERIOR TEMPORAL SULCUS; OSCILLATORY NEURONAL RESPONSES; NEOCORTICAL PYRAMIDAL NEURONS; LATERAL GENICULATE-NUCLEUS; FEATURE-INTEGRATION-THEORY; POSTERIOR PARIETAL CORTEX; PRIMATE STRIATE CORTEX; INVARIANT PATTERN-RECOGNITION					aroskies@cell.com						ABELES M, 1982, ISRAEL J MED SCI, V18, P83; ABELES M, 1994, PROG BRAIN RES, V102, P395; ADELSON EH, 1993, SCIENCE, V262, P2042, DOI 10.1126/science.8266102; ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; Aertsen A, 1996, J PHYSIOLOGY-PARIS, V90, P243, DOI 10.1016/S0928-4257(97)81432-5; AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; AIPLE F, 1988, EXP BRAIN RES, V72, P141, DOI 10.1007/BF00248509; Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; Andersen RA, 1997, PHILOS T ROY SOC B, V352, P1421, DOI 10.1098/rstb.1997.0128; ANDERSON CH, 1987, P NATL ACAD SCI USA, V84, P6297, DOI 10.1073/pnas.84.17.6297; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Ashby FG, 1996, PSYCHOL REV, V103, P165, DOI 10.1037/0033-295X.103.1.165; ASSAD JA, 1995, NATURE, V373, P518, DOI 10.1038/373518a0; BAIR W, 1994, J NEUROSCI, V14, P2870; Baldi P, 1990, NEURAL COMPUT, V2, P458, DOI 10.1162/neco.1990.2.4.458; BALLARD DH, 1983, NATURE, V306, P21, DOI 10.1038/306021a0; BARBAS H, 1989, J COMP NEUROL, V286, P353, DOI 10.1002/cne.902860306; BARBAS H, 1988, J COMP NEUROL, V276, P313, DOI 10.1002/cne.902760302; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; BARLOW HB, 1985, Q J EXP PSYCHOL-A, V37, P121, DOI 10.1080/14640748508400927; BAYLIS GC, 1987, J NEUROSCI, V7, P330; BAYLIS GC, 1985, BRAIN RES, V342, P91, DOI 10.1016/0006-8993(85)91356-3; BECK J, 1967, PERCEPT PSYCHOPHYS, V2, P491, DOI 10.3758/BF03210252; BECK J, 1966, SCIENCE, V154, P538, DOI 10.1126/science.154.3748.538; BERGEN JR, 1988, NATURE, V333, P363, DOI 10.1038/333363a0; BERGEN JR, 1983, NATURE, V303, P696, DOI 10.1038/303696a0; BEST J, 1986, BRAIN RES, V385, P356, DOI 10.1016/0006-8993(86)91082-6; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Biederman I, 1997, PHILOS T ROY SOC B, V352, P1203, DOI 10.1098/rstb.1997.0103; BIENENSTOCK E, 1995, NETWORK-COMP NEURAL, V6, P179, DOI 10.1088/0954-898X/6/2/004; Blake R, 1997, P NATL ACAD SCI USA, V94, P7115, DOI 10.1073/pnas.94.13.7115; Booth MCA, 1998, CEREB CORTEX, V8, P510, DOI 10.1093/cercor/8.6.510; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; BorgGraham L, 1996, J PHYSIOLOGY-PARIS, V90, P185, DOI 10.1016/S0928-4257(97)81421-0; Bosking WH, 1997, J NEUROSCI, V17, P2112; BOUSSAOUD D, 1990, J COMP NEUROL, V296, P462, DOI 10.1002/cne.902960311; BOUYER JJ, 1981, ELECTROEN CLIN NEURO, V51, P244, DOI 10.1016/0013-4694(81)90138-3; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; BRAGIN A, 1995, J NEUROSCI, V15, P47; Braun J, 1998, PERCEPT PSYCHOPHYS, V60, P1, DOI 10.3758/BF03211915; Brecht M, 1998, J NEUROPHYSIOL, V79, P2394, DOI 10.1152/jn.1998.79.5.2394; BRESSLER SL, 1993, NATURE, V366, P153, DOI 10.1038/366153a0; BRIAND KA, 1987, J EXP PSYCHOL HUMAN, V13, P228, DOI 10.1037/0096-1523.13.2.228; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; Buracas GT, 1998, NEURON, V20, P959, DOI 10.1016/S0896-6273(00)80477-8; BURR DC, 1979, VISION RES, V19, P835, DOI 10.1016/0042-6989(79)90162-7; Bush P, 1996, J COMPUT NEUROSCI, V3, P91, DOI 10.1007/BF00160806; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; Caminiti R, 1996, CEREB CORTEX, V6, P319, DOI 10.1093/cercor/6.3.319; CARNEY T, 1989, VISION RES, V29, P155, DOI 10.1016/0042-6989(89)90121-1; CARNEY T, 1995, VISION RES, V35, P1951, DOI 10.1016/0042-6989(94)00288-W; CAVE KR, 1990, COGNITIVE PSYCHOL, V22, P225, DOI 10.1016/0010-0285(90)90017-X; CAVE KR, 1989, J EXP PSYCHOL GEN, V118, P148, DOI 10.1037/0096-3445.118.2.148; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; CHENG K, 1994, J NEUROPHYSIOL, V71, P2269, DOI 10.1152/jn.1994.71.6.2269; CHINO YM, 1991, J NEUROPHYSIOL, V65, P841, DOI 10.1152/jn.1991.65.4.841; CHINO YM, 1983, J NEUROPHYSIOL, V50, P265, DOI 10.1152/jn.1983.50.1.265; Chrobak JJ, 1998, J NEUROSCI, V18, P388; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; COHEN A, 1991, J EXP PSYCHOL HUMAN, V17, P891, DOI 10.1037/0096-1523.17.4.891; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Connor CE, 1996, J NEUROPHYSIOL, V75, P1306, DOI 10.1152/jn.1996.75.3.1306; CONNORS BW, 1982, J NEUROPHYSIOL, V48, P1302, DOI 10.1152/jn.1982.48.6.1302; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; CORBETTA M, 1993, J NEUROSCI, V13, P1202; CREUTZFELDT OD, 1977, EXP BRAIN RES, V27, P419; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; DAS A, 1995, J NEUROPHYSIOL, V74, P779, DOI 10.1152/jn.1995.74.2.779; DEAN P, 1976, PSYCHOL BULL, V83, P41, DOI 10.1037/0033-2909.83.1.41; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DESIMONE R, 1986, J COMP NEUROL, V248, P164, DOI 10.1002/cne.902480203; DESIMONE R, 1985, VISION RES, V25, P441, DOI 10.1016/0042-6989(85)90069-0; DESIMONE R, 1984, J NEUROSCI, V4, P2051; DESIMONE R, 1991, J COGNITIVE NEUROSCI, V3, P1, DOI 10.1162/jocn.1991.3.1.1; DEV P, 1975, INT J MAN MACH STUD, V7, P511, DOI 10.1016/S0020-7373(75)80030-7; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; DEYOE EA, 1985, NATURE, V317, P58, DOI 10.1038/317058a0; DIXON P, 1987, PERCEPT PSYCHOPHYS, V42, P457, DOI 10.3758/BF03209752; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; Doupe AJ, 1997, J NEUROSCI, V17, P1147; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; DUNCAN J, 1983, PERCEPT PSYCHOPHYS, V34, P221, DOI 10.3758/BF03202949; ECKHORN R, 1993, NEUROREPORT, V4, P243, DOI 10.1097/00001756-199303000-00004; ECKHORN R, 1988, BIOL CYBERN, V60, P121, DOI 10.1007/BF00202899; EDWARDS DP, 1995, VISION RES, V35, P1501, DOI 10.1016/0042-6989(94)00253-I; EGGERS HM, 1978, SCIENCE, V201, P264, DOI 10.1126/science.663654; ELDER J, 1993, VISION RES, V33, P981, DOI 10.1016/0042-6989(93)90080-G; ENGEL AK, 1992, TRENDS NEUROSCI, V15, P387, DOI 10.1016/0166-2236(92)90187-D; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P6048, DOI 10.1073/pnas.88.14.6048; Engel AK, 1997, CEREB CORTEX, V7, P571, DOI 10.1093/cercor/7.6.571; ENGEL AK, 1991, SCIENCE, V252, P1177, DOI 10.1126/science.252.5009.1177; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P9136, DOI 10.1073/pnas.88.20.9136; FAHLE M, 1981, PROC R SOC SER B-BIO, V213, P451, DOI 10.1098/rspb.1981.0075; FAHLE M, 1995, VISION RES, V35, P491, DOI 10.1016/0042-6989(94)00126-7; FANG SP, 1989, J EXP PSYCHOL HUMAN, V15, P434, DOI 10.1037/0096-1523.15.3.434; FELLEMAN DJ, 1987, J NEUROPHYSIOL, V57, P889, DOI 10.1152/jn.1987.57.4.889; FERRERA VP, 1994, J NEUROSCI, V14, P6171; FODOR JA, 1988, COGNITION, V28, P3, DOI 10.1016/0010-0277(88)90031-5; FOLK CL, 1989, J EXP PSYCHOL HUMAN, V15, P97, DOI 10.1037/0096-1523.15.1.97; FOSTER KH, 1985, J PHYSIOL-LONDON, V365, P331, DOI 10.1113/jphysiol.1985.sp015776; FREEMAN WJ, 1985, BRAIN RES REV, V10, P147, DOI 10.1016/0165-0173(85)90022-0; Freiwald WA, 1995, NEUROREPORT, V6, P2348, DOI 10.1097/00001756-199511270-00018; FRIEDMANHILL SR, 1995, SCIENCE, V269, P853, DOI 10.1126/science.7638604; FRIEN A, 1994, NEUROREPORT, V5, P2273, DOI 10.1097/00001756-199411000-00017; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; Fujii H, 1996, NEURAL NETWORKS, V9, P1303, DOI 10.1016/S0893-6080(96)00054-8; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; Gallant JL, 1996, J NEUROPHYSIOL, V76, P2718, DOI 10.1152/jn.1996.76.4.2718; Gawne TJ, 1996, J NEUROPHYSIOL, V76, P1356, DOI 10.1152/jn.1996.76.2.1356; Geesaman BJ, 1996, J NEUROSCI, V16, P4716; GEISLER WS, 1995, VISION RES, V35, P2723, DOI 10.1016/0042-6989(95)00029-Y; GEORGOPOULOS AP, 1992, SCIENCE, V256, P1692, DOI 10.1126/science.256.5064.1692; GERSTEIN GL, 1989, IEEE T BIO-MED ENG, V36, P4, DOI 10.1109/10.16444; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Ghose GM, 1997, VISUAL NEUROSCI, V14, P963, DOI 10.1017/S0952523800011676; Ghose GM, 1997, J NEUROPHYSIOL, V77, P2191, DOI 10.1152/jn.1997.77.4.2191; GHOSE GM, 1992, J NEUROPHYSIOL, V68, P1558, DOI 10.1152/jn.1992.68.5.1558; Gibson JR, 1997, J NEUROPHYSIOL, V78, P1263, DOI 10.1152/jn.1997.78.3.1263; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GILBERT CD, 1983, J NEUROSCI, V3, P1116; GIVRE SJ, 1995, VISUAL NEUROSCI, V12, P229, DOI 10.1017/S0952523800007914; Goldsmith M, 1998, J EXP PSYCHOL GEN, V127, P189, DOI 10.1037/0096-3445.127.2.189; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Goodale M A, 1993, Curr Opin Neurobiol, V3, P578, DOI 10.1016/0959-4388(93)90059-8; GOODALE MA, 1994, CURR BIOL, V4, P604, DOI 10.1016/S0960-9822(00)00132-9; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Gray CM, 1996, SCIENCE, V274, P109, DOI 10.1126/science.274.5284.109; GRAY CM, 1990, EUR J NEUROSCI, V2, P607, DOI 10.1111/j.1460-9568.1990.tb00450.x; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Gray CM, 1997, J NEUROSCI, V17, P3239; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; GREEN M, 1992, PERCEPTION, V21, P765, DOI 10.1068/p210765; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; GROSS CG, 1971, J COMP PHYSIOL PSYCH, V76, P1, DOI 10.1037/h0031039; GROSSBERG S, 1995, AM SCI, V83, P438; GROSSBERG S, 1991, NEURAL NETWORKS, V4, P453, DOI 10.1016/0893-6080(91)90041-3; HAENNY PE, 1988, EXP BRAIN RES, V69, P245, DOI 10.1007/BF00247570; HELLWIG B, 1994, BIOL CYBERN, V71, P1, DOI 10.1007/BF00198906; HESS RF, 1978, PFLUG ARCH EUR J PHY, V377, P201, DOI 10.1007/BF00584273; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; HOFFMAN JE, 1979, PERCEPT PSYCHOPHYS, V25, P319, DOI 10.3758/BF03198811; Hommel B, 1998, VIS COGN, V5, P183, DOI 10.1080/713756773; HOPFIELD JJ, 1995, P NATL ACAD SCI USA, V92, P6655, DOI 10.1073/pnas.92.15.6655; HOUCK MR, 1986, J EXP PSYCHOL HUMAN, V12, P186, DOI 10.1037/0096-1523.12.2.186; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1974, J COMP NEUROL, V158, P267, DOI 10.1002/cne.901580304; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; JONES JP, 1987, J NEUROPHYSIOL, V58, P1233, DOI 10.1152/jn.1987.58.6.1233; JONIDES J, 1972, PERCEPT PSYCHOPHYS, V12, P457, DOI 10.3758/BF03210934; KAHNEMAN D, 1992, COGNITIVE PSYCHOL, V24, P175, DOI 10.1016/0010-0285(92)90007-O; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; Kiorpes L, 1998, J NEUROSCI, V18, P6411; Kiper DC, 1996, VISION RES, V36, P539, DOI 10.1016/0042-6989(95)00135-2; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; KOCH C, 1985, HUM NEUROBIOL, V4, P219; KONEN W, 1993, NEURAL COMPUT, V5, P719, DOI 10.1162/neco.1993.5.5.719; KONEN WK, 1994, NEURAL NETWORKS, V7, P1019, DOI 10.1016/S0893-6080(05)80157-1; KREITER AK, 1992, EUR J NEUROSCI, V4, P369, DOI 10.1111/j.1460-9568.1992.tb00884.x; Kreiter AK, 1996, J NEUROSCI, V16, P2381; KWAK HW, 1991, PERCEPT PSYCHOPHYS, V49, P473, DOI 10.3758/BF03212181; LADES M, 1993, IEEE T COMPUT, V42, P300, DOI 10.1109/12.210173; LAMME VAF, 1995, J NEUROSCI, V15, P1605; LAUFER M, 1967, VISION RES, V7, P215, DOI 10.1016/0042-6989(67)90086-7; Laurent G, 1996, J NEUROSCI, V16, P3837; Laurent G, 1996, TRENDS NEUROSCI, V19, P489, DOI 10.1016/S0166-2236(96)10054-0; LEE CK, 1988, NATURE, V332, P357, DOI 10.1038/332357a0; LENNIE P, 1981, VISION RES, V21, P815, DOI 10.1016/0042-6989(81)90180-2; LENNIE P, 1990, J NEUROSCI, V10, P649; Leon MI, 1998, NEURON, V21, P669, DOI 10.1016/S0896-6273(00)80584-X; Leonards U, 1996, VISION RES, V36, P2689, DOI 10.1016/0042-6989(96)86829-5; Leonards U, 1998, VISION RES, V38, P101, DOI 10.1016/S0042-6989(97)00148-X; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Levi DM, 1998, VISION RES, V38, P775, DOI 10.1016/S0042-6989(97)00334-9; Levitt JB, 1996, BEHAV BRAIN RES, V76, P5, DOI 10.1016/0166-4328(95)00188-3; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Livingstone MS, 1996, J NEUROPHYSIOL, V75, P2467, DOI 10.1152/jn.1996.75.6.2467; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; LOGOTHETIS NK, 1995, CEREB CORTEX, V5, P270, DOI 10.1093/cercor/5.3.270; Logothetis NK, 1998, PHILOS T R SOC B, V353, P1801, DOI 10.1098/rstb.1998.0333; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Luck SJ, 1997, COGNITIVE PSYCHOL, V33, P64, DOI 10.1006/cogp.1997.0660; Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7; LYTTON WW, 1991, J NEUROPHYSIOL, V66, P1059, DOI 10.1152/jn.1991.66.3.1059; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; MacLeod K, 1998, NATURE, V395, P693, DOI 10.1038/27201; MADLER C, 1987, NATURWISSENSCHAFTEN, V74, P42, DOI 10.1007/BF00367044; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; MARCELJA S, 1980, J OPT SOC AM, V70, P1297, DOI 10.1364/JOSA.70.001297; Margulis M, 1998, J NEUROPHYSIOL, V79, P2809, DOI 10.1152/jn.1998.79.5.2809; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MASON A, 1991, J NEUROSCI, V11, P72; Matsumura M, 1996, J NEUROSCI, V16, P7757; MAUNSELL JHR, 1992, J NEUROPHYSIOL, V68, P1332, DOI 10.1152/jn.1992.68.4.1332; MAUNSELL JHR, 1991, VISUAL NEUROSCI, V7, P561, DOI 10.1017/S095252380001035X; MAUNSELL JHR, 1987, ANNU REV NEUROSCI, V10, P363, DOI 10.1146/annurev.ne.10.030187.002051; MCCLELLAND JL, 1986, J EXP PSYCHOL HUMAN, V12, P18, DOI 10.1037/0096-1523.12.1.18; MCCOLLOUGH C, 1965, SCIENCE, V149, P1115, DOI 10.1126/science.149.3688.1115; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; McCulloch W. S., 1943, B MATH BIOPHYS, VBMB-5, P115, DOI DOI 10.1007/BF02478259; MCLEOD P, 1988, NATURE, V332, P154, DOI 10.1038/332154a0; MCLEOD P, 1991, J EXP PSYCHOL HUMAN, V17, P55, DOI 10.1037/0096-1523.17.1.55; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; MICHALSKI A, 1983, EXP BRAIN RES, V51, P97; MIKAMI A, 1986, J NEUROPHYSIOL, V55, P1308, DOI 10.1152/jn.1986.55.6.1308; MILLER EK, 1993, BRAIN RES, V616, P25, DOI 10.1016/0006-8993(93)90187-R; MILNER AD, 1993, PROG BRAIN RES, V95, P317, DOI 10.1016/S0079-6123(08)60379-9; MINSKY M, 1961, P IRE, V49, P8, DOI 10.1109/JRPROC.1961.287775; Missal M, 1997, CEREB CORTEX, V7, P758, DOI 10.1093/cercor/7.8.758; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1981, J NEUROSCI, V1, P3, DOI 10.1523/JNEUROSCI.01-01-00003.1981; MOVSHON JA, 1987, J NEUROSCI, V7, P1340; Munk MHJ, 1996, SCIENCE, V272, P271, DOI 10.1126/science.272.5259.271; Murata A, 1996, J NEUROPHYSIOL, V75, P2180, DOI 10.1152/jn.1996.75.5.2180; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3968, DOI 10.1152/jn.1996.76.6.3968; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3949, DOI 10.1152/jn.1996.76.6.3949; NAKAYAMA K, 1986, NATURE, V320, P264, DOI 10.1038/320264a0; NEISSER U, 1975, COGNITIVE PSYCHOL, V7, P480, DOI 10.1016/0010-0285(75)90019-5; NEISSER U, 1963, AM J PSYCHOL, V76, P376, DOI 10.2307/1419778; NELSON JI, 1992, VISUAL NEUROSCI, V9, P21, DOI 10.1017/S0952523800006349; Neuenschwander S, 1996, NATURE, V379, P728, DOI 10.1038/379728a0; NEVEN H, 1992, BIOL CYBERN, V67, P309, DOI 10.1007/BF02414887; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Nicolelis MAL, 1998, NAT NEUROSCI, V1, P621, DOI 10.1038/2855; NICOLELIS MAL, 1994, J NEUROSCI, V14, P3511; NICOLL A, 1993, NEUROREPORT, V4, P167, DOI 10.1097/00001756-199302000-00013; NIEBUR E, 1993, VISION RES, V33, P2789, DOI 10.1016/0042-6989(93)90236-P; NOTHDURFT HC, 1993, PERCEPTION, V22, P1287, DOI 10.1068/p221287; NOTHDURFT HC, 1992, PERCEPT PSYCHOPHYS, V52, P355, DOI 10.3758/BF03206697; NOWAK LG, 1995, VISUAL NEUROSCI, V12, P371, DOI 10.1017/S095252380000804X; Nowak LG, 1995, J NEUROPHYSIOL, V74, P2379, DOI 10.1152/jn.1995.74.6.2379; NOWLAN SJ, 1995, J NEUROSCI, V15, P1195; O'Keefe LP, 1998, VISUAL NEUROSCI, V15, P305, DOI 10.1017/S0952523898152094; Oliva A, 1997, COGNITIVE PSYCHOL, V34, P72, DOI 10.1006/cogp.1997.0667; OLSHAUSEN BA, 1995, J COMPUT NEUROSCI, V2, P45, DOI 10.1007/BF00962707; OLSHAUSEN BA, 1993, J NEUROSCI, V13, P4700; ORBAN GA, 1986, J NEUROPHYSIOL, V56, P462, DOI 10.1152/jn.1986.56.2.462; PAL NR, 1993, PATTERN RECOGN, V26, P1277, DOI 10.1016/0031-3203(93)90135-J; PALM G, 1981, BIOL CYBERN, V39, P181, DOI 10.1007/BF00342771; PALM G, 1988, BIOL CYBERN, V59, P1, DOI 10.1007/BF00336885; Palm G, 1990, CONC NEUROSCI, V1, P133; PERKEL DH, 1967, BIOPHYS J, V7, P391, DOI 10.1016/S0006-3495(67)86596-2; PERRETT DI, 1991, EXP BRAIN RES, V86, P159; PERRETT DI, 1987, TRENDS NEUROSCI, V10, P358, DOI 10.1016/0166-2236(87)90071-3; Perrett DI, 1998, Z NATURFORSCH C, V53, P518; PERRETT DI, 1993, IMAGE VISION COMPUT, V11, P317, DOI 10.1016/0262-8856(93)90011-5; Phillips WA, 1997, BEHAV BRAIN SCI, V20, P657, DOI 10.1017/S0140525X9700160X; Platt ML, 1997, J NEUROPHYSIOL, V78, P1574, DOI 10.1152/jn.1997.78.3.1574; Plenz D, 1996, J NEUROPHYSIOL, V76, P4180, DOI 10.1152/jn.1996.76.6.4180; POGGIO GF, 1977, J NEUROPHYSIOL, V40, P1392, DOI 10.1152/jn.1977.40.6.1392; POGGIO T, 1981, NATURWISSENSCHAFTEN, V68, P443, DOI 10.1007/BF01047513; POGGIO T, 1990, NATURE, V343, P263, DOI 10.1038/343263a0; Polat U, 1997, VISION RES, V37, P737, DOI 10.1016/S0042-6989(96)00154-X; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; POTTER MC, 1969, J EXP PSYCHOL, V81, P10, DOI 10.1037/h0027470; Pouget A, 1997, PHILOS T R SOC B, V352, P1449, DOI 10.1098/rstb.1997.0131; PRINZMETAL W, 1995, J EXP PSYCHOL HUMAN, V21, P1362, DOI 10.1037/0096-1523.21.6.1362; PRINZMETAL W, 1989, J EXP PSYCHOL GEN, V118, P165, DOI 10.1037/0096-3445.118.2.165; QIAN N, 1994, J NEUROSCI, V14, P7367; QUINLAN PT, 1987, PERCEPT PSYCHOPHYS, V41, P455, DOI 10.3758/BF03203039; Rager G, 1998, EUR J NEUROSCI, V10, P1856, DOI 10.1046/j.1460-9568.1998.00197.x; Rainer G, 1998, P NATL ACAD SCI USA, V95, P15008, DOI 10.1073/pnas.95.25.15008; Recanzone GH, 1997, J NEUROPHYSIOL, V78, P2904, DOI 10.1152/jn.1997.78.6.2904; RENSINK RA, 1995, PSYCHOL REV, V102, P101, DOI 10.1037/0033-295X.102.1.101; REYES AD, 1994, J NEUROSCI, V14, P5352; Reyes AD, 1996, J NEUROSCI, V16, P993; RHODES PA, 1994, NEURAL COMPUT, V6, P1086, DOI 10.1162/neco.1994.6.6.1086; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Robertson L, 1997, J COGNITIVE NEUROSCI, V9, P295, DOI 10.1162/jocn.1997.9.3.295; ROCK I, 1964, J EXP PSYCHOL, V67, P531, DOI 10.1037/h0046557; ROCKEL AJ, 1980, BRAIN, V103, P221, DOI 10.1093/brain/103.2.221; RODMAN HR, 1989, EXP BRAIN RES, V75, P53; ROELFSEMA PR, 1994, EUR J NEUROSCI, V6, P1645, DOI 10.1111/j.1460-9568.1994.tb00556.x; Roelfsema PR, 1996, J COGNITIVE NEUROSCI, V8, P603, DOI 10.1162/jocn.1996.8.6.603; Roelfsema PR, 1998, CEREB CORTEX, V8, P385, DOI 10.1093/cercor/8.5.385; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; ROLLS ET, 1995, EXP BRAIN RES, V103, P409; ROLLS ET, 1994, P ROY SOC B-BIOL SCI, V257, P9, DOI 10.1098/rspb.1994.0087; ROUGEUL A, 1979, ELECTROEN CLIN NEURO, V46, P310, DOI 10.1016/0013-4694(79)90205-0; Saarinen J, 1996, PERCEPTION, V25, P305, DOI 10.1068/p250305; Saarinen J, 1996, VISION RES, V36, P313, DOI 10.1016/0042-6989(95)00093-F; SAGI D, 1985, SCIENCE, V228, P1217, DOI 10.1126/science.4001937; SAITO H, 1986, J NEUROSCI, V6, P145; SAKAI K, 1994, NEUROREPORT, V5, P829, DOI 10.1097/00001756-199403000-00023; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; SALIN PA, 1995, PHYSIOL REV, V75, P107, DOI 10.1152/physrev.1995.75.1.107; SANES JN, 1993, P NATL ACAD SCI USA, V90, P4470, DOI 10.1073/pnas.90.10.4470; SCHEIN SJ, 1990, J NEUROSCI, V10, P3369; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Schmidt KE, 1997, EUR J NEUROSCI, V9, P1083, DOI 10.1111/j.1460-9568.1997.tb01459.x; Schmidt KE, 1997, J NEUROSCI, V17, P5480; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Schroeder CE, 1998, CEREB CORTEX, V8, P575, DOI 10.1093/cercor/8.7.575; SCHWARZ C, 1991, J NEUROSCI, V11, P2995; SCHWINDT PC, 1995, J NEUROPHYSIOL, V74, P2220, DOI 10.1152/jn.1995.74.5.2220; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; SESTOKAS AK, 1988, J NEUROPHYSIOL, V59, P317, DOI 10.1152/jn.1988.59.2.317; Shadlen M N, 1995, Curr Opin Neurobiol, V5, P248, DOI 10.1016/0959-4388(95)80033-6; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SHASTRI L, 1993, BEHAV BRAIN SCI, V16, P417, DOI 10.1017/S0140525X00030910; SILVERMAN MS, 1989, P NATL ACAD SCI USA, V86, P711, DOI 10.1073/pnas.86.2.711; Simons DJ, 1997, TRENDS COGN SCI, V1, P261, DOI 10.1016/S1364-6613(97)01080-2; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; SINGER W, 1995, SCIENCE, V270, P758, DOI 10.1126/science.270.5237.758; SOMPOLINSKY H, 1990, P NATL ACAD SCI USA, V87, P7200, DOI 10.1073/pnas.87.18.7200; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; STEMMLER M, 1995, SCIENCE, V269, P1877, DOI 10.1126/science.7569930; Steriade M, 1998, J NEUROPHYSIOL, V79, P483, DOI 10.1152/jn.1998.79.1.483; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; STONER GR, 1992, NATURE, V358, P412, DOI 10.1038/358412a0; STONER GR, 1990, NATURE, V344, P153, DOI 10.1038/344153a0; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; STORM JF, 1990, PROG BRAIN RES, V83, P161; STRYKER MP, 1989, NATURE, V338, P297, DOI 10.1038/338297a0; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; SUZUKI S, 1995, J EXP PSYCHOL HUMAN, V21, P901, DOI 10.1037/0096-1523.21.4.901; Tallon-Baudry C, 1998, J NEUROSCI, V18, P4244; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; TANAKA K, 1989, J NEUROPHYSIOL, V62, P642, DOI 10.1152/jn.1989.62.3.642; TANAKA K, 1993, SCIENCE, V262, P685, DOI 10.1126/science.8235589; TANAKA K, 1989, J NEUROPHYSIOL, V62, P626, DOI 10.1152/jn.1989.62.3.626; TANAKA K, 1986, J NEUROSCI, V6, P134; TANAKA M, 1986, EXP BRAIN RES, V65, P11; THEEUWES J, 1994, VISION RES, V34, P3013, DOI 10.1016/0042-6989(94)90274-7; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; TIPPER SP, 1994, J EXP PSYCHOL HUMAN, V20, P478, DOI 10.1037/0096-1523.20.3.478; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; TONONI G, 1992, CEREB CORTEX, V2, P310, DOI 10.1093/cercor/2.4.310; Tononi G, 1998, SCIENCE, V282, P1846, DOI 10.1126/science.282.5395.1846; Tononi G, 1998, P NATL ACAD SCI USA, V95, P3198, DOI 10.1073/pnas.95.6.3198; Tootell RBH, 1996, TRENDS NEUROSCI, V19, P481, DOI 10.1016/S0166-2236(96)10053-9; TOVEE MJ, 1992, NEUROREPORT, V3, P369, DOI 10.1097/00001756-199204000-00020; TOVEE MJ, 1992, TRENDS NEUROSCI, V15, P387, DOI 10.1016/0166-2236(92)90185-B; TOYAMA K, 1981, J NEUROPHYSIOL, V46, P202, DOI 10.1152/jn.1981.46.2.202; TOYAMA K, 1981, J NEUROPHYSIOL, V46, P191, DOI 10.1152/jn.1981.46.2.191; TRAUB RD, 1991, J NEUROPHYSIOL, V66, P635, DOI 10.1152/jn.1991.66.2.635; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; TREISMAN A, 1982, COGNITIVE PSYCHOL, V14, P107, DOI 10.1016/0010-0285(82)90006-8; TREISMAN A, 1988, PSYCHOL REV, V95, P15, DOI 10.1037/0033-295X.95.1.15; TREISMAN A, 1986, J EXP PSYCHOL HUMAN, V12, P3, DOI 10.1037/0096-1523.12.1.3; TREISMAN A, 1988, Q J EXP PSYCHOL-A, V40, P201, DOI 10.1080/02724988843000104; TREISMAN A, 1992, J EXP PSYCHOL HUMAN, V18, P589, DOI 10.1037/0096-1523.18.2.589; Treisman A, 1998, PHILOS T ROY SOC B, V353, P1295, DOI 10.1098/rstb.1998.0284; Treisman A, 1996, CURR OPIN NEUROBIOL, V6, P171, DOI 10.1016/S0959-4388(96)80070-5; TREISMAN A, 1990, J EXP PSYCHOL HUMAN, V16, P459, DOI 10.1037/0096-1523.16.3.459; TREISMAN A, 1992, AM PSYCHOL, V47, P862, DOI 10.1037/0003-066X.47.7.862; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Treue S, 1996, VISUAL NEUROSCI, V13, P797, DOI 10.1017/S095252380000866X; TSAL Y, 1989, J EXP PSYCHOL HUMAN, V15, P394, DOI 10.1037/0096-1523.15.2.394; TSO DY, 1988, J NEUROSCI, V8, P1712; TSO DY, 1986, J NEUROSCI, V6, P1160; TSOTSOS JK, 1995, ARTIF INTELL, V78, P507, DOI 10.1016/0004-3702(95)00025-9; TSOTSOS JK, 1990, BEHAV BRAIN SCI, V13, P423, DOI 10.1017/S0140525X00079577; UNGERLEIDER LG, 1989, EXP BRAIN RES, V76, P473, DOI 10.1007/BF00248903; Usher M, 1998, NATURE, V394, P179, DOI 10.1038/28166; Varela Francisco J., 1995, Biological Research, V28, P81; VOGELS R, 1994, J NEUROPHYSIOL, V71, P1428, DOI 10.1152/jn.1994.71.4.1428; Volgushev M, 1998, NEUROSCIENCE, V83, P15, DOI 10.1016/S0306-4522(97)00380-1; Wallis G, 1997, PROG NEUROBIOL, V51, P167, DOI 10.1016/S0301-0082(96)00054-8; Wang DL, 1990, NEURAL COMPUT, V2, P94, DOI 10.1162/neco.1990.2.1.94; WANG QQ, 1994, PERCEPT PSYCHOPHYS, V56, P495, DOI 10.3758/BF03206946; Wang XJ, 1996, J NEUROSCI, V16, P6402; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; Wertheimer M, 1923, PSYCHOL FORSCH, V4, P301, DOI 10.1007/BF00410640; WICKELGR.WA, 1969, PSYCHOL REV, V76, P1, DOI 10.1037/h0026823; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; WOLFE JM, 1992, VISION RES, V32, P757, DOI 10.1016/0042-6989(92)90190-T; YANTIS S, 1994, CAN J EXP PSYCHOL, V48, P182, DOI 10.1037/1196-1961.48.2.182; Yen SC, 1998, VISION RES, V38, P719, DOI 10.1016/S0042-6989(97)00197-1; Yeshurun Y, 1998, NATURE, V396, P72, DOI 10.1038/23936; YLINEN A, 1995, J NEUROSCI, V15, P30; Yoshioka T, 1996, CEREB CORTEX, V6, P297, DOI 10.1093/cercor/6.2.297; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577; YOUNG MP, 1992, J NEUROPHYSIOL, V67, P1464, DOI 10.1152/jn.1992.67.6.1464; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4; ZEKI S, 1983, PROC R SOC SER B-BIO, V217, P449, DOI 10.1098/rspb.1983.0020; ZEKI S, 1988, NATURE, V335, P311, DOI 10.1038/335311a0; ZEKI SM, 1978, NATURE, V274, P423, DOI 10.1038/274423a0; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zipser K, 1996, J NEUROSCI, V16, P7376; ZOHARY E, 1989, PERCEPTION, V18, P191, DOI 10.1068/p180191; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	401	217	222	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1999	24	1					7	+		10.1016/S0896-6273(00)80817-X	http://dx.doi.org/10.1016/S0896-6273(00)80817-X			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	241QC	10677022	Bronze			2022-12-24	WOS:000082893200004
J	Daw, MI; Chittajallu, R; Bortolotto, ZA; Dev, KK; Duprat, F; Henley, JM; Collingridge, GL; Isaac, JTR				Daw, MI; Chittajallu, R; Bortolotto, ZA; Dev, KK; Duprat, F; Henley, JM; Collingridge, GL; Isaac, JTR			PDZ proteins interacting with C-terminal GluR2/3 are involved in a PKC-dependent regulation of AMPA receptors at hippocampal synapses	NEURON			English	Article							DOMAIN-CONTAINING PROTEIN; KINASE M ZETA; BINDING-PROTEIN; AREA CA1; SYNAPTIC-TRANSMISSION; PHOSPHORYLATION SITES; SELECTIVE INHIBITORS; GLUTAMATE RECEPTORS; CA2+ PERMEABILITY; SILENT SYNAPSES	We investigated the role of PDZ proteins (GRIP, ABP, and PICK1) interacting with the C-terminal GluR2 by infusing a ct-GluR2 peptide ("pep2-SVKI") into CA1 pyramidal neurons in hippocampal slices using whole-cell recordings. Pep2-SVKI, but not a control or PICK1 selective peptide, caused AMPAR-mediated EPSC amplitude to increase in approximately one-third of control neurons and in most neurons following the prior induction of LTD. Pep2-SVKI also blocked LTD; however, this occurred in all neurons. A PKC inhibitor prevented these effects of pep2-SVKI on synaptic transmission and LTD. We propose a model in which the maintenance of LTD involves the binding of AMPARs to PDZ proteins to prevent their reinsertion. We also present evidence that PKC regulates AMPAR reinsertion during dedepression.	Univ Bristol, MRC, Ctr Synapt Plast, Dept Anat, Bristol BS8 1TD, Avon, England	University of Bristol	Isaac, JTR (corresponding author), Univ Bristol, MRC, Ctr Synapt Plast, Dept Anat, Univ Walk, Bristol BS8 1TD, Avon, England.	j.t.r.isaac@bristo.ac.uk	collingridge, graham/AAI-8362-2020; Duprat, Fabrice/D-1221-2013; Collingridge, Graham L/C-4605-2015; Chittajallu, Ramesh/AAX-3749-2020; Henley, Jeremy M/A-2776-2009	Duprat, Fabrice/0000-0001-8774-1220; Collingridge, Graham L/0000-0002-9572-5359; Chittajallu, Ramesh/0000-0002-9794-0052; Dev, Kumlesh/0000-0003-4274-9119; Henley, Jeremy/0000-0003-3589-8335; Daw, Michael/0000-0002-8374-5977	Medical Research Council [G9629038] Funding Source: Medline; MRC [G9629038] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bortolotto ZA, 2000, EUR J NEUROSCI, V12, P4055, DOI 10.1046/j.1460-9568.2000.00291.x; Braithwaite SP, 2000, NEUROPHARMACOLOGY, V39, P919, DOI 10.1016/S0028-3908(99)00171-9; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; Carroll RC, 1998, J NEUROPHYSIOL, V80, P2797, DOI 10.1152/jn.1998.80.5.2797; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Chung HJ, 2000, J NEUROSCI, V20, P7258; COLLEY PA, 1990, J NEUROSCI, V10, P3353; DAVIS PD, 1989, FEBS LETT, V259, P61, DOI 10.1016/0014-5793(89)81494-2; Dev KK, 1999, NEUROPHARMACOLOGY, V38, P635, DOI 10.1016/S0028-3908(98)00230-5; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Dong HL, 1999, J NEUROSCI, V19, P6930, DOI 10.1523/JNEUROSCI.19-16-06930.1999; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; FABER DS, 1991, BIOPHYS J, V60, P1288, DOI 10.1016/S0006-3495(91)82162-2; Feldmeyer D, 1999, NAT NEUROSCI, V2, P57, DOI 10.1038/4561; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hjelmstad GO, 1997, NEURON, V19, P1309, DOI 10.1016/S0896-6273(00)80421-3; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hrabetova S, 1996, J NEUROSCI, V16, P5324; HVALBY O, 1994, P NATL ACAD SCI USA, V91, P4761, DOI 10.1073/pnas.91.11.4761; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; KLANN E, 1991, J BIOL CHEM, V266, P24253; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Li P, 1999, NAT NEUROSCI, V2, P972, DOI 10.1038/14771; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; LOPEZMOLINA L, 1993, N-S ARCH PHARMACOL, V348, P1, DOI 10.1007/BF00168529; LOVINGER DM, 1987, BRAIN RES, V436, P177, DOI 10.1016/0006-8993(87)91573-3; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; Matsuda S, 2000, EMBO J, V19, P2765, DOI 10.1093/emboj/19.12.2765; MCGLADEMCCULLOH E, 1993, NATURE, V362, P640, DOI 10.1038/362640a0; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULLER D, 1992, NEUROSCI LETT, V135, P18, DOI 10.1016/0304-3940(92)90126-R; NISHIMUNE A, 1998, FASEB J, V9, P484; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Osten P, 1996, J NEUROSCI, V16, P2444; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; PARFITT KD, 1993, J PHYSIOL-LONDON, V471, P245, DOI 10.1113/jphysiol.1993.sp019900; REYMANN KG, 1988, BRAIN RES, V440, P305, DOI 10.1016/0006-8993(88)91000-1; REYMANN KG, 1990, EUR J NEUROSCI, V2, P481, DOI 10.1111/j.1460-9568.1990.tb00439.x; Roberson ED, 1996, LEARN MEMORY, V3, P1, DOI 10.1101/lm.3.1.1; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; SACKTOR TC, 1993, P NATL ACAD SCI USA, V90, P8342, DOI 10.1073/pnas.90.18.8342; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; WANG JH, 1992, P NATL ACAD SCI USA, V89, P2576, DOI 10.1073/pnas.89.7.2576; WANG LY, 1994, J PHYSIOL-LONDON, V475, P431, DOI 10.1113/jphysiol.1994.sp020083; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; WATKINS JC, 1981, ANNU REV PHARMACOL, V21, P165, DOI 10.1146/annurev.pa.21.040181.001121; WILKINSON SE, 1993, BIOCHEM J, V294, P335, DOI 10.1042/bj2940335; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3	75	266	276	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	2000	28	3					873	886		10.1016/S0896-6273(00)00160-4	http://dx.doi.org/10.1016/S0896-6273(00)00160-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386JJ	11163273	Bronze, Green Published			2022-12-24	WOS:000166057500023
J	Stickgold, R; James, L; Hobson, JA				Stickgold, R; James, L; Hobson, JA			Visual discrimination learning requires sleep after training	NATURE NEUROSCIENCE			English	Article							MEMORY; IMPROVEMENT; SKILL		Harvard Univ, Sch Med, Dept Psychiat, Neurophysiol Lab, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Stickgold, R (corresponding author), Harvard Univ, Sch Med, Dept Psychiat, Neurophysiol Lab, 74 Fenwood Rd, Boston, MA 02115 USA.				NIMH NIH HHS [MH-48832, MH-13923] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092638, R37MH013923, R01MH013923, T32MH013923] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AJILORE O, 1995, PSYCHOPHYSIOLOGY, V32, P92, DOI 10.1111/j.1469-8986.1995.tb03410.x; Heine R, 1914, Z PSYCHOL PHYSIOL SI, V68, P161; HENNEVIN E, 1995, BEHAV BRAIN RES, V69, P125, DOI 10.1016/0166-4328(95)00013-J; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; Muller G. E., 1900, Z PSYCHOLOGIE, V1, P1; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; SMITH C, 1985, NEUROSCI BIOBEHAV R, V9, P157, DOI 10.1016/0149-7634(85)90042-9; Squire Larry R., 1994, P203; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; Stickgold R, 1998, TRENDS COGN SCI, V2, P484, DOI 10.1016/S1364-6613(98)01258-3	14	484	494	2	62	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2000	3	12					1237	1238		10.1038/81756	http://dx.doi.org/10.1038/81756			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UA	11100141	Bronze			2022-12-24	WOS:000167177900008
J	Zheng, J; Zagotta, WN				Zheng, J; Zagotta, WN			Gating rearrangements in cyclic nucleotide-gated channels revealed by patch-clamp fluorometry	NEURON			English	Article							LIGAND-BINDING DOMAIN; ION CHANNELS; POTASSIUM CHANNEL; FUNCTIONAL EXPRESSION; ACTIVATED CHANNELS; OLFACTORY NEURONS; MOVEMENT; FLUORESCENCE; CELLS	Site-specific fluorescence recordings have shown great promise in understanding conformational changes in signaling proteins. The reported applications on ion channels have been limited to extracellular sites in whole oocyte preparations. We are now able to directly monitor gating movements of the intracellular domains of cyclic nucleotide-gated channels using simultaneous site-specific fluorescence recording and patch-clamp current recording from inside-out patches. Fluorescence signals were reliably observed when fluorophore was covalently attached to a site between the cyclic nucleotide-binding domain and the pore. While iodide, an anionic quencher, has a higher quenching efficiency in the channel's closed state, thallium ion, a cationic quencher, has a higher quenching efficiency in the open state. The state and charge dependence of quenching suggests movements of charged or dipolar residues near the fluorophore during CNG channel activation.	Univ Washington, Howard Hughes Med Inst, Dept Physiol & Biophys, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Physiol & Biophys, Seattle, WA 98195 USA.				NEI NIH HHS [R01 EY010329-07, R01 EY010329, EY10329] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010329] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Brown RL, 1998, BIOPHYS J, V75, P825, DOI 10.1016/S0006-3495(98)77571-X; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Gordon SE, 1997, NEURON, V19, P431, DOI 10.1016/S0896-6273(00)80951-4; Gordon SE, 1996, BIOCHEMISTRY-US, V35, P3994, DOI 10.1021/bi952607b; GORDON SE, 1995, NEURON, V14, P857, DOI 10.1016/0896-6273(95)90229-5; GORDON SE, 1995, NEURON, V14, P177; GOULDING EH, 1992, NEURON, V8, P45, DOI 10.1016/0896-6273(92)90107-O; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; LUDWIG J, 1990, FEBS LETT, V270, P24, DOI 10.1016/0014-5793(90)81226-E; MacLean JJ, 2000, BIOPHYS J, V78, P1441, DOI 10.1016/S0006-3495(00)76697-5; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Matulef K, 1999, NEURON, V24, P443, DOI 10.1016/S0896-6273(00)80857-0; Paoletti P, 1999, J GEN PHYSIOL, V113, P17, DOI 10.1085/jgp.113.1.17; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; Zong XG, 1998, EMBO J, V17, P353, DOI 10.1093/emboj/17.2.353; ZUFALL F, 1994, ANNU REV BIOPH BIOM, V23, P577, DOI 10.1146/annurev.bb.23.060194.003045	26	78	82	3	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	2000	28	2					369	374		10.1016/S0896-6273(00)00117-3	http://dx.doi.org/10.1016/S0896-6273(00)00117-3			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	377CE	11144348	Bronze			2022-12-24	WOS:000165493700013
J	Feng, GP; Mellor, RH; Bernstein, M; Keller-Peck, C; Nguyen, QT; Wallace, M; Nerbonne, JM; Lichtman, JW; Sanes, JR				Feng, GP; Mellor, RH; Bernstein, M; Keller-Peck, C; Nguyen, QT; Wallace, M; Nerbonne, JM; Lichtman, JW; Sanes, JR			Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP	NEURON			English	Article							GREEN FLUORESCENT PROTEIN; GENE-EXPRESSION; NEUROMUSCULAR-JUNCTIONS; THY-1 GENE; CELLS; GROWTH; ELEMENTS; MOUSE; DROSOPHILA; SYSTEM	We generated transgenic mice in which red, green, yellow, or cyan fluorescent proteins (together termed XFPs) were selectively expressed in neurons. All four XFPs labeled neurons in their entirety, including axons, nerve terminals, dendrites, and dendritic spines. Remarkably, each of 25 independently generated transgenic lines expressed XFP in a unique pattern, even though all incorporated identical regulatory elements (from the thy1 gene). For example, all retinal ganglion cells or many cortical neurons were XFP positive in some lines, whereas only a few ganglion cells or only layer 5 cortical pyramids were labeled in others. In some lines, intense labeling of small neuronal subsets provided a Golgi-like vital stain. In double transgenic mice expressing two different XFPs, it was possible to differentially label 3 neuronal subsets in a single animal.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Sanes, JR (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	sanesj@pcg.wustl.edu	Feng, Guoping/Y-2827-2019; Brunn, Anna/N-2524-2013	Keller-Peck, Cynthia/0000-0001-8216-9632				AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; ALLEN ND, 1990, CELL, V61, P853, DOI 10.1016/0092-8674(90)90195-K; Andra K, 1996, NEUROBIOL AGING, V17, P183, DOI 10.1016/0197-4580(95)02066-7; BALICEGORDON RJ, 1990, J NEUROSCI, V10, P894; BARNSTABLE CJ, 1984, NEUROSCIENCE, V11, P847, DOI 10.1016/0306-4522(84)90195-7; Callahan CA, 1998, CURR OPIN NEUROBIOL, V8, P582, DOI 10.1016/S0959-4388(98)80084-6; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; CARROLL SL, 1995, J NEUROSCI, V15, P3342; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHALFIE M, 1998, GREEN FLORESCENT PRO; CONN PM, 1999, METHODS ENZYMOLOGY, V302; DABIN I, 1995, GLIA, V14, P23, DOI 10.1002/glia.440140105; Dynes JL, 1998, NEURON, V20, P1081, DOI 10.1016/S0896-6273(00)80490-0; Festenstein R, 2000, CURR OPIN GENET DEV, V10, P199, DOI 10.1016/S0959-437X(00)00060-5; Festenstein R, 1996, SCIENCE, V271, P1123, DOI 10.1126/science.271.5252.1123; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; GLOSTER A, 1994, J NEUROSCI, V14, P7319; GORDON JW, 1987, CELL, V50, P445, DOI 10.1016/0092-8674(87)90498-3; GOSSLER A, 1989, SCIENCE, V244, P463, DOI 10.1126/science.2497519; Graubert TA, 1998, NUCLEIC ACIDS RES, V26, P2849, DOI 10.1093/nar/26.12.2849; Henikoff S, 1998, BIOESSAYS, V20, P532, DOI 10.1002/(SICI)1521-1878(199807)20:7<532::AID-BIES3>3.3.CO;2-0; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; HOGAN B, 1994, MANIPULATING MOUSE E, P217; Huang WY, 2000, NAT MED, V6, P482, DOI 10.1038/74914; KELLEY KA, 1994, MOL BRAIN RES, V24, P261, DOI 10.1016/0169-328X(94)90139-2; Knobel KM, 1999, DEVELOPMENT, V126, P4489; KOLLIAS G, 1987, CELL, V51, P21, DOI 10.1016/0092-8674(87)90006-7; Lawson SN., 1992, SENSORY NEURONS DIVE, P27; LICHTMAN JW, 1987, J NEUROSCI, V7, P1215; Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Miller DM, 1999, BIOTECHNIQUES, V26, P914, DOI 10.2144/99265rr01; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; MORRIS R, 1985, DEV NEUROSCI-BASEL, V7, P133, DOI 10.1159/000112283; Murray MJ, 1998, J NEUROBIOL, V37, P607, DOI 10.1002/(SICI)1097-4695(199812)37:4<607::AID-NEU9>3.3.CO;2-H; NOAKES PG, 1993, DEV BIOL, V155, P275, DOI 10.1006/dbio.1993.1025; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; PERRY VH, 1984, J NEUROCYTOL, V13, P809, DOI 10.1007/BF01148495; RAFF MC, 1979, BRAIN RES, V174, P283, DOI 10.1016/0006-8993(79)90851-5; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; RUSSO AF, 1988, NEURON, V1, P311, DOI 10.1016/0896-6273(88)90079-7; SANES JR, 1991, DEVELOPMENT, V113, P1181; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; van den Pol AN, 1998, J NEUROSCI, V18, P10640; VIDAL M, 1990, EMBO J, V9, P833, DOI 10.1002/j.1460-2075.1990.tb08180.x; WALTERS MC, 1995, P NATL ACAD SCI USA, V92, P7125, DOI 10.1073/pnas.92.15.7125; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	52	2303	2384	5	170	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	2000	28	1					41	51		10.1016/S0896-6273(00)00084-2	http://dx.doi.org/10.1016/S0896-6273(00)00084-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	370VN	11086982	Bronze			2022-12-24	WOS:000165143500009
J	Shen, K; Teruel, MN; Connor, JH; Shenolikar, S; Meyer, T				Shen, K; Teruel, MN; Connor, JH; Shenolikar, S; Meyer, T			Molecular memory by reversible translocation of calcium/calmodulin-dependent protein kinase II	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; CA-2+ CALMODULIN; MUTANT MICE; AUTOPHOSPHORYLATION; BINDING; STIMULATION; MECHANISM; SUBUNIT; NEURONS	Synaptic plasticity is thought to be a key process for learning, memory and other cognitive functions of the nervous system. The initial events of plasticity require the conversion of brief electrical signals into alterations of the biochemical properties of synapses that last for much longer than the initial stimuli. Here we show that a regulator of synaptic plasticity, calcium/calmodulin-dependent protein kinase II alpha (CaMKII), sequentially translocates to postsynaptic sites, undergoes autophosphorylation and gets trapped for several minutes until its dissociation is induced by secondary autophosphorylation and phosphatase 1 action. Once dissociated, CaMKII shows facilitated translocation for several minutes. This suggests that trapping of CaMKII by its targets and priming of CaMKII translocation may function as biochemical memory mechanisms that change the signaling capacity of synapses.	Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University; Stanford University; Duke University	Meyer, T (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	tobias1@stanford.edu		Meyer, Tobias/0000-0003-4339-3804; Teruel, Mary/0000-0002-2854-3598; Connor, John/0000-0002-8867-7256	NIGMS NIH HHS [R01-GM48113] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048113] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; BENNETT MK, 1983, J BIOL CHEM, V258, P2735; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Cho YH, 1998, SCIENCE, V279, P867, DOI 10.1126/science.279.5352.867; COLBRAN RJ, 1990, J BIOL CHEM, V265, P11213; ERONDU NE, 1985, J NEUROSCI, V5, P3270; FONG YL, 1989, J BIOL CHEM, V264, P16759; Gardoni F, 1999, FEBS LETT, V456, P394, DOI 10.1016/S0014-5793(99)00985-0; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; HANSON PI, 1992, J BIOL CHEM, V267, P17216; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; Ouyang Y, 1997, J NEUROSCI, V17, P5416; PATTON BL, 1990, J BIOL CHEM, V265, P11204; PETTIT DL, 1994, SCIENCE, V266, P1881, DOI 10.1126/science.7997883; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; SHENOLIKAR S, 1994, ANNU REV CELL BIOL, V10, P55, DOI 10.1146/annurev.cellbio.10.1.55; SHIELDS SM, 1985, J NEUROSCI, V5, P3414; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Strack S, 1997, J NEUROCHEM, V68, P2119; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Teruel MN, 1999, J NEUROSCI METH, V93, P37, DOI 10.1016/S0165-0270(99)00112-0; WALDMANN R, 1990, BIOCHEMISTRY-US, V29, P1679, DOI 10.1021/bi00459a002	31	161	170	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2000	3	9					881	886		10.1038/78783	http://dx.doi.org/10.1038/78783			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TV	10966618				2022-12-24	WOS:000167177400014
J	Gad, H; Ringstad, N; Low, P; Kjaerulff, O; Gustafsson, J; Wenk, M; Di Paolo, G; Nemoto, Y; Crum, J; Ellisman, MH; De Camilli, P; Shupliakov, O; Brodin, L				Gad, H; Ringstad, N; Low, P; Kjaerulff, O; Gustafsson, J; Wenk, M; Di Paolo, G; Nemoto, Y; Crum, J; Ellisman, MH; De Camilli, P; Shupliakov, O; Brodin, L			Fission and uncoating of synaptic clathrin-coated vesicles are perturbed by disruption of interactions with the SH3 domain of endophilin	NEURON			English	Article							MEDIATED ENDOCYTOSIS; RETICULOSPINAL AXONS; TRANSMITTER RELEASE; NERVE-TERMINALS; DYNAMIN; MEMBRANE; AMPHIPHYSIN; BINDING; SYNAPTOJANIN; PROTEINS	Coordination between sequential steps in synaptic vesicle endocytosis, including clathrin coat formation, fission, and uncoating, appears to involve protein-protein interactions. Here, we show that compounds that disrupt interactions of the SH3 domain of endophilin with dynamin and synaptojanin impair synaptic vesicle endocytosis in a living synapse. Two distinct endocytic intermediates accumulated. Free clathrin-coated vesicles were induced by a peptide-blocking endophilin's SH3 domain and by antibodies to the proline-rich domain (PRD) of synaptojanin. Invaginated clathrin-coated pits were induced by the same peptide and by the SH3 domain of endophilin. We suggest that the SH3 domain of endophilin participates in both fission and uncoating and that it may be a key component of a molecular switch that couples the fission reaction to uncoating.	Karolinska Inst, Nobel Inst Neurophysiol, Dept Neurosci, S-17177 Stockholm, Sweden; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Univ Calif San Diego, Sch Med, Ctr Res Biol Struct, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA	Karolinska Institutet; Yale University; Howard Hughes Medical Institute; Yale University; University of California System; University of California San Diego; University of California System; University of California San Diego	Brodin, L (corresponding author), Karolinska Inst, Nobel Inst Neurophysiol, Dept Neurosci, S-17177 Stockholm, Sweden.		Crum, John/B-2477-2009; Gad, Helge/J-2238-2014; Shupliakov, Oleg/R-9148-2016; Kjaerulff, Ole/Q-6996-2018	Shupliakov, Oleg/0000-0001-5352-6848; Kjaerulff, Ole/0000-0002-8654-1435; Gad, Helge/0000-0001-6530-1443				Arneson LS, 1999, J BIOL CHEM, V274, P17794, DOI 10.1074/jbc.274.25.17794; BECK KA, 1991, J BIOL CHEM, V266, P4442; Betz WJ, 1998, ANNU REV PHYSIOL, V60, P347, DOI 10.1146/annurev.physiol.60.1.347; Brodin L, 2000, CURR OPIN NEUROBIOL, V10, P312, DOI 10.1016/S0959-4388(00)00097-0; BRODIN L, 1994, J NEUROPHYSIOL, V72, P592, DOI 10.1152/jn.1994.72.2.592; Cestra G, 1999, J BIOL CHEM, V274, P32001, DOI 10.1074/jbc.274.45.32001; CHAPPELL TG, 1986, CELL, V45, P3, DOI 10.1016/0092-8674(86)90532-5; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; Corvera S, 1999, CURR OPIN CELL BIOL, V11, P460, DOI 10.1016/S0955-0674(99)80066-0; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331; deHeuvel E, 1997, J BIOL CHEM, V272, P8710, DOI 10.1074/jbc.272.13.8710; Faundez V, 1998, CELL, V93, P423, DOI 10.1016/S0092-8674(00)81170-8; Gad H, 1998, NEURON, V21, P607, DOI 10.1016/S0896-6273(00)80570-X; Gaidarov I, 1999, J CELL BIOL, V146, P755, DOI 10.1083/jcb.146.4.755; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Guo SL, 1999, J BIOL CHEM, V274, P12990, DOI 10.1074/jbc.274.19.12990; Hao WH, 1997, J BIOL CHEM, V272, P6393, DOI 10.1074/jbc.272.10.6393; HEUSER J, 1989, CELL BIOL INT REP, V13, P1063, DOI 10.1016/0309-1651(89)90020-9; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Martin TFJ, 1998, ANNU REV CELL DEV BI, V14, P231, DOI 10.1146/annurev.cellbio.14.1.231; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Micheva KD, 1997, J BIOL CHEM, V272, P27239, DOI 10.1074/jbc.272.43.27239; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; Owen DJ, 1998, EMBO J, V17, P5273, DOI 10.1093/emboj/17.18.5273; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; Ramjaun AR, 1996, J BIOL CHEM, V271, P24856, DOI 10.1074/jbc.271.40.24856; Ramjaun AR, 1998, J NEUROCHEM, V70, P2369; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; ROVAINEN CM, 1979, PHYSIOL REV, V59, P1007, DOI 10.1152/physrev.1979.59.4.1007; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Sever S, 2000, TRAFFIC, V1, P385, DOI 10.1034/j.1600-0854.2000.010503.x; SHUPLIAKOV O, 1995, EUR J NEUROSCI, V7, P1111, DOI 10.1111/j.1460-9568.1995.tb01099.x; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Slepnev VI, 1998, SCIENCE, V281, P821, DOI 10.1126/science.281.5378.821; Sparks AB, 1996, NAT BIOTECHNOL, V14, P741, DOI 10.1038/nbt0696-741; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; WICKELGREN WO, 1985, J NEUROSCI, V5, P1188; Wigge P, 1998, TRENDS NEUROSCI, V21, P339, DOI 10.1016/S0166-2236(98)01264-8	51	227	232	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG	2000	27	2					301	312		10.1016/S0896-6273(00)00038-6	http://dx.doi.org/10.1016/S0896-6273(00)00038-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	347YD	10985350	Bronze			2022-12-24	WOS:000088956000014
J	Gotter, AL; Manganaro, T; Weaver, DR; Kolakowski, LF; Possidente, B; Sriram, S; MacLaughlin, DT; Reppert, SM				Gotter, AL; Manganaro, T; Weaver, DR; Kolakowski, LF; Possidente, B; Sriram, S; MacLaughlin, DT; Reppert, SM			A time-less function for mouse Timeless	NATURE NEUROSCIENCE			English	Article							CIRCADIAN CLOCK; TRANSCRIPTION; LOOP		Massachusetts Gen Hosp, Lab Dev Chronobiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Surg, Pediat Surg Res Lab, Boston, MA 02114 USA; Univ Texas, Hlth Sci Ctr, Dept Pharmacol, San Antonio, TX 78284 USA; Skidmore Coll, Dept Biol, Saratoga Springs, NY 12866 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Texas System; University of Texas Health San Antonio; Skidmore College	Reppert, SM (corresponding author), Massachusetts Gen Hosp, Lab Dev Chronobiol, Boston, MA 02114 USA.			Weaver, David/0000-0001-7941-6719	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD014427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039303] Funding Source: NIH RePORTER; NICHD NIH HHS [R37HD14427] Funding Source: Medline; NIMH NIH HHS [MH12117] Funding Source: Medline; NINDS NIH HHS [R01NS39303] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Koike N, 1998, FEBS LETT, V441, P427, DOI 10.1016/S0014-5793(98)01597-X; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 1999, MOL CELL BIOL, V19, P5316; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; TISCHKAU SA, 1999, J NEUROSCI, V19, P1; TOTHENFLUH A, IN PRESS GENETICS	11	134	138	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2000	3	8					755	756		10.1038/77653	http://dx.doi.org/10.1038/77653			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TU	10903565				2022-12-24	WOS:000167177300007
J	Swindale, NV; Shoham, D; Grinvald, A; Bonhoeffer, T; Hubener, M				Swindale, NV; Shoham, D; Grinvald, A; Bonhoeffer, T; Hubener, M			Visual cortex maps are optimized for uniform coverage	NATURE NEUROSCIENCE			English	Article							OCULAR-DOMINANCE COLUMNS; MONKEY STRIATE CORTEX; RECEPTIVE-FIELD; CAT AREA-17; ORIENTATION; ORGANIZATION; DIRECTION; PREFERENCE; GEOMETRY	Cat visual cortex contains a topographic map of visual space, plus superimposed, spatially periodic maps of ocular dominance, spatial frequency and orientation. It is hypothesized that the layout of these maps is determined by two constraints: continuity or smooth mapping of stimulus properties across the cortical surface, and coverage uniformity or uniform representation of combinations of map features over visual space. Here we use a quantitative measure of coverage uniformity (c') to test the hypothesis that cortical maps are optimized for coverage. When we perturbed the spatial relationships between ocular dominance, spatial frequency and orientation maps obtained in single regions of cortex, we found that cortical maps are at a local minimum for c'. This suggests that coverage optimization is an important organizing principle governing cortical map development.	Univ British Columbia, Dept Ophthalmol, Vancouver, BC V5Z 3N9, Canada; Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	University of British Columbia; Weizmann Institute of Science; Max Planck Society	Swindale, NV (corresponding author), Univ British Columbia, Dept Ophthalmol, 2550 Willow St, Vancouver, BC V5Z 3N9, Canada.		Bonhoeffer, Tobias/B-9481-2009	Bonhoeffer, Tobias/0000-0001-7897-6634				ALBUS K, 1975, EXP BRAIN RES, V24, P159, DOI 10.1007/BF00234061; BARTFELD E, 1992, P NATL ACAD SCI USA, V89, P11905, DOI 10.1073/pnas.89.24.11905; Das A, 1997, NATURE, V387, P594, DOI 10.1038/42461; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; DURBIN R, 1990, NATURE, V343, P644, DOI 10.1038/343644a0; DURBIN R, 1987, NATURE, V326, P698; Hetherington PA, 1999, VISUAL NEUROSCI, V16, P637, DOI 10.1017/S0952523899164046; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; HUBEL DH, 1974, J COMP NEUROL, V158, P267, DOI 10.1002/cne.901580304; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hubener M, 1997, J NEUROSCI, V17, P9270; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; OBERMAYER K, 1992, PHYS REV A, V45, P7568, DOI 10.1103/PhysRevA.45.7568; OBERMAYER K, 1990, P NATL ACAD SCI USA, V87, P8345, DOI 10.1073/pnas.87.21.8345; OBERMAYER K, 1993, J NEUROSCI, V13, P4114; Shmuel A, 1996, J NEUROSCI, V16, P6945; Shoham D, 1997, NATURE, V385, P529, DOI 10.1038/385529a0; SWINDALE N V, 1992, Current Biology, V2, P429, DOI 10.1016/0960-9822(92)90326-6; SWINDALE NV, 1991, BIOL CYBERN, V65, P415, DOI 10.1007/BF00204654; Swindale NV, 1996, NETWORK-COMP NEURAL, V7, P161, DOI 10.1088/0954-898X/7/2/002; SWINDALE NV, 1987, J NEUROSCI, V7, P1414; SWINDALE NV, IN PRESS CEREB CORTE; THOMPSON ID, 1981, J PHYSL, V300, P58; TOOTELL RB, 1981, SCIENCE, V214, P813, DOI 10.1126/science.7292014; TOOTELL RBH, 1988, J NEUROSCI, V8, P1569; Weliky M, 1996, NATURE, V379, P725, DOI 10.1038/379725a0	27	123	123	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2000	3	8					822	826		10.1038/77731	http://dx.doi.org/10.1038/77731			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TU	10903576				2022-12-24	WOS:000167177300018
J	Friedman, HV; Bresler, T; Garner, CC; Ziv, NE				Friedman, HV; Bresler, T; Garner, CC; Ziv, NE			Assembly of new individual excitatory synapses: Time course and temporal order of synaptic molecule recruitment	NEURON			English	Article							CULTURED HIPPOCAMPAL-NEURONS; CYTOMATRIX PROTEIN BASSOON; POSTSYNAPTIC DENSITY; AMPA RECEPTORS; NMDA RECEPTOR; NEUROMUSCULAR-JUNCTION; GLUTAMATE RECEPTORS; PRESYNAPTIC BOUTONS; CALCIUM INFLUX; CELL-CULTURE	Time-lapse microscopy, retrospective immunohistochemistry, and cultured hippocampal neurons were used to determine the time frame of individual glutamatergic synapse assembly and the temporal order in which specific molecules accumulate at new synaptic junctions. New presynaptic boutons capable of activity-evoked vesicle recycling were observed to form within 30 min of initial axodendritic contact. Clusters of the presynaptic active zone protein Bassoon were present in all new boutons. Conversely, clusters of the postsynaptic molecule SAP90/PSD-95 and glutamate receptors were found on average only similar to 45 min after such boutons were first detected. AMPA- and NMDA-type glutamate receptors displayed similar clustering kinetics. These findings suggest that glutamatergic synapse assembly can occur within 1-2 hr after initial contact and that presynaptic differentiation may precede postsynaptic differentiation.	Technion Israel Inst Technol, Bruce Rappaport Fac Med, Rappaport Inst, IL-31096 Haifa, Israel; Technion Israel Inst Technol, Bruce Rappaport Fac Med, Dept Anat & Cell Biol, IL-31096 Haifa, Israel; Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Alabama System; University of Alabama Birmingham	Ziv, NE (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Rappaport Inst, POB 9649, IL-31096 Haifa, Israel.	noamz@netvision.net.il	Ziv, Noam/ABA-6551-2020	Ziv, Noam/0000-0001-9197-326X; Garner, Craig/0000-0003-1970-5417	NIA NIH HHS [AG 12978-02, AG 06569-09] Funding Source: Medline; NICHD NIH HHS [P50 HD32901] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD032901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG006569, R01AG012978] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; BASARSKY TA, 1994, J NEUROSCI, V14, P6402; Brandstatter JH, 1999, EUR J NEUROSCI, V11, P3683, DOI 10.1046/j.1460-9568.1999.00793.x; BUCHANAN J, 1989, J NEUROSCI, V9, P1540; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; COOPER MW, 1992, J NEUROBIOL, V23, P814, DOI 10.1002/neu.480230704; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; CRAIG AM, 1994, P NATL ACAD SCI USA, V91, P12373, DOI 10.1073/pnas.91.26.12373; Dai ZS, 1996, MOL CELL NEUROSCI, V7, P443, DOI 10.1006/mcne.1996.0032; Dailey ME, 1996, J NEUROSCI, V16, P2983; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Feldman DE, 1998, NEURON, V20, P1067, DOI 10.1016/S0896-6273(00)80488-2; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; FLETCHER TL, 1994, J NEUROSCI, V14, P6695; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Garner CC, 2000, CURR OPIN NEUROBIOL, V10, P321, DOI 10.1016/S0959-4388(00)00093-3; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; Henkel AW, 1995, J NEUROSCI, V15, P8246; Hoch W, 1999, EUR J BIOCHEM, V265, P1, DOI 10.1046/j.1432-1327.1999.00765.x; Horch HW, 1999, NEURON, V23, P353; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Kannenberg K, 1999, EUR J NEUROSCI, V11, P1256, DOI 10.1046/j.1460-9568.1999.00533.x; Kim JH, 1999, CURR OPIN CELL BIOL, V11, P248, DOI 10.1016/S0955-0674(99)80033-7; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kossel AH, 1997, J NEUROSCI, V17, P9634; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; Lee SH, 2000, CURR OPIN NEUROBIOL, V10, P125, DOI 10.1016/S0959-4388(99)00046-X; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Ma L, 1999, NAT NEUROSCI, V2, P24, DOI 10.1038/4525; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Mammen AL, 1997, J NEUROSCI, V17, P7351; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; OBrien RJ, 1997, J NEUROSCI, V17, P7339; Okabe S, 1999, NAT NEUROSCI, V2, P804, DOI 10.1038/12175; Passafaro M, 1999, NAT NEUROSCI, V2, P1063, DOI 10.1038/15990; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Rao A, 1998, J NEUROSCI, V18, P1217; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Righter K, 1999, J COMP NEUROL, V408, P437, DOI 10.1002/(SICI)1096-9861(19990607)408:3<437::AID-CNE9>3.0.CO;2-5; Ryan TA, 1996, NEURON, V17, P125, DOI 10.1016/S0896-6273(00)80286-X; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; SCHRAMM M, 1990, P NATL ACAD SCI USA, V87, P1193, DOI 10.1073/pnas.87.3.1193; Serpinskaya AS, 1999, DEV BIOL, V205, P65, DOI 10.1006/dbio.1998.9112; Shapiro L, 1999, NEURON, V23, P427, DOI 10.1016/S0896-6273(00)80796-5; Sheng M, 1999, ANN NY ACAD SCI, V868, P483, DOI 10.1111/j.1749-6632.1999.tb11317.x; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Verderio C, 1999, CELL MOL LIFE SCI, V55, P1448, DOI 10.1007/s000180050384; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Winter C, 1999, GENOMICS, V57, P389, DOI 10.1006/geno.1999.5788; Xia ZG, 1996, J NEUROSCI, V16, P5425; Zhai R, 2000, MOL CELL NEUROSCI, V15, P417, DOI 10.1006/mcne.2000.0839; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4; [No title captured]	65	381	402	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	2000	27	1					57	69		10.1016/S0896-6273(00)00009-X	http://dx.doi.org/10.1016/S0896-6273(00)00009-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339XU	10939331	Bronze			2022-12-24	WOS:000088503800010
J	Anderson, J; Lampl, I; Reichova, I; Carandini, M; Ferster, D				Anderson, J; Lampl, I; Reichova, I; Carandini, M; Ferster, D			Stimulus dependence of two-state fluctuations of membrane potential in cat visual cortex	NATURE NEUROSCIENCE			English	Article							NEURONS IN-VIVO; LESS-THAN-1 HZ OSCILLATION; SPINY NEURONS; CORTICAL-NEURONS; INTRACELLULAR ANALYSIS; NEOCORTICAL NEURONS; NUCLEUS BASALIS; FIRING PATTERNS; COMPLEX CELLS; VARIABILITY	Membrane potentials of cortical neurons fluctuate between a hyperpolarized ('down') state and a depolarized ('up') state which may be separated by up to 30 mV, reflecting rapid but infrequent transitions between two patterns of synaptic input. Here we show that such fluctuations may contribute to representation of visual stimuli by cortical cells. In complex cells of anesthetized cats, where such fluctuations are most prominent, prolonged visual stimulation increased the probability of the up state. This probability increase was related to stimulus strength: its dependence on stimulus orientation and contrast matched each cell's averaged membrane potential. Thus targe fluctuations in membrane potential are not simply noise on which visual responses are superimposed, but may provide a substrate for encoding sensory information.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Univ Zurich, ETH, Inst Neuroinformat, CH-8057 Zurich, Switzerland	Northwestern University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Ferster, D (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 N Campus Dr, Evanston, IL 60208 USA.	ferster@nwu.edu	Carandini, Matteo/ABD-8296-2021; Carandini, Matteo/C-1922-2008	Carandini, Matteo/0000-0003-4880-7682; Carandini, Matteo/0000-0003-4880-7682; Anderson, Jeffrey/0000-0002-9669-3846; Lampl, Ilan/0000-0002-9380-0730	NEI NIH HHS [R01EY04726, P32EY07128] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY004726] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Azouz R, 1999, J NEUROSCI, V19, P2209; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; BLANTON MG, 1989, J NEUROSCI METH, P30; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P659, DOI 10.1113/jphysiol.1991.sp018730; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; GUSTAFSSON B, 1984, J PHYSIOL-LONDON, V347, P431, DOI 10.1113/jphysiol.1984.sp015074; JAGADEESH B, 1992, SCIENCE, V257, P552, DOI 10.1126/science.1636094; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; METHERATE R, 1993, J NEUROSCI, V13, P5312, DOI 10.1523/JNEUROSCI.13-12-05312.1993; METHERATE R, 1992, J NEUROSCI, V12, P4701; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Plenz D, 1998, J NEUROSCI, V18, P266; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; SOMERS DC, 1995, J NEUROSCI, V15, P5448; STERIADE M, 1993, J NEUROSCI, V13, P3284; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stern EA, 1998, NATURE, V394, P475, DOI 10.1038/28848; Stern EA, 1997, J NEUROPHYSIOL, V77, P1697, DOI 10.1152/jn.1997.77.4.1697; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; WILSON CJ, 1981, BRAIN RES, V220, P67, DOI 10.1016/0006-8993(81)90211-0; WILSON CJ, 1993, PROG BRAIN RES, V99, P277; Wilson CJ, 1996, J NEUROSCI, V16, P2397	32	168	173	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2000	3	6					617	621		10.1038/75797	http://dx.doi.org/10.1038/75797			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	317WG	10816319				2022-12-24	WOS:000087249500019
J	Lu, T; Trussell, LO				Lu, T; Trussell, LO			Inhibitory transmission mediated by asynchronous transmitter release	NEURON			English	Article							FROG NEUROMUSCULAR JUNCTION; SUPERIOR OLIVARY NUCLEUS; PURKINJE-CELL SYNAPSE; SQUID GIANT SYNAPSE; HIPPOCAMPAL-NEURONS; DELAYED RELEASE; BRAIN-STEM; POSTTETANIC POTENTIATION; NEUROTRANSMITTER RELEASE; COINCIDENCE DETECTION	At fast CNS synapses, the role of asynchronous release following initial synchronous release is poorly understood. We examined the contribution of asynchronous release to GABAergic transmission in the cochlear nucleus across a 40-fold range of electrical stimulus frequencies. Whereas quantal release was highly synchronized at low frequencies, it was largely continous and desynchronized at high frequencies. Despite the change in release mode, intense and steady inhibitory transmission was virtually maintained. Experimental analyses and modeling studies indicated that this "desynchronization" process was dependent on presynaptic Ca2+ accumulation, facilitation of vesicle release, and short-term depletion of available vesicles. Asynchronous release at high frequencies may help generate a smooth inhibitory "tone" by minimizing the consequences of random timing of presynaptic action potentials.	Oregon Hlth Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Trussell, LO (corresponding author), Oregon Hlth Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA.				NIDCD NIH HHS [DC02004] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002004] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; AbdulGhani MA, 1996, J PHYSIOL-LONDON, V495, P113, DOI 10.1113/jphysiol.1996.sp021578; Atluri PP, 1998, J NEUROSCI, V18, P8214; Atluri PP, 1996, J NEUROSCI, V16, P5661; BAIN AI, 1992, J PHYSIOL-LONDON, V450, P63, DOI 10.1113/jphysiol.1992.sp019116; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P665, DOI 10.1113/jphysiol.1972.sp010053; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; Bekkers JM, 1999, J PHYSIOL-LONDON, V516, P227, DOI 10.1111/j.1469-7793.1999.227aa.x; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; Bellingham MC, 1999, NEURON, V23, P159, DOI 10.1016/S0896-6273(00)80762-X; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Canepari M, 1998, J NEUROPHYSIOL, V79, P1977, DOI 10.1152/jn.1998.79.4.1977; CHRISTENSEN BN, 1970, J PHYSIOL-LONDON, V210, P933, DOI 10.1113/jphysiol.1970.sp009250; CLEMENTS JD, 1990, J NEUROSCI METH, V31, P75, DOI 10.1016/0165-0270(90)90012-5; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; CODE RA, 1989, J COMP NEUROL, V284, P504, DOI 10.1002/cne.902840403; COHEN IS, 1986, J NEUROSCI, V6, P2366; Cummings DD, 1996, J NEUROSCI, V16, P5312; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P574, DOI 10.1113/jphysiol.1954.sp005130; Dittman JS, 1998, J NEUROSCI, V18, P6147; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; ELIOT LS, 1994, J NEUROSCI, V14, P3280; ELMQVIST D, 1965, J PHYSIOL-LONDON, V178, P505, DOI 10.1113/jphysiol.1965.sp007639; FUJITA I, 1991, J NEUROSCI, V11, P722; Funabiki K, 1998, J PHYSIOL-LONDON, V508, P851, DOI 10.1111/j.1469-7793.1998.851bp.x; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Hill AAV, 1998, J NEUROPHYSIOL, V79, P1277, DOI 10.1152/jn.1998.79.3.1277; Hjelmstad GO, 1997, NEURON, V19, P1309, DOI 10.1016/S0896-6273(00)80421-3; HUBBARD JI, 1963, J PHYSIOL-LONDON, V169, P641, DOI 10.1113/jphysiol.1963.sp007286; HYSON RL, 1995, BRAIN RES, V677, P117, DOI 10.1016/0006-8993(95)00130-I; Jensen K, 1999, J PHYSIOL-LONDON, V519, P71, DOI 10.1111/j.1469-7793.1999.0071o.x; KATZ B, 1965, J PHYSIOL-LONDON, V181, P656, DOI 10.1113/jphysiol.1965.sp007790; Klug A, 1999, J NEUROPHYSIOL, V82, P593, DOI 10.1152/jn.1999.82.2.593; KORN H, 1990, J NEUROPHYSIOL, V63, P198, DOI 10.1152/jn.1990.63.1.198; KUSANO K, 1975, J PHYSIOL-LONDON, V245, P13, DOI 10.1113/jphysiol.1975.sp010832; LACHICA EA, 1994, J COMP NEUROL, V348, P403, DOI 10.1002/cne.903480307; LILEY AW, 1953, J NEUROPHYSIOL, V16, P505; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; Otis T, 1996, J NEUROSCI, V16, P7496; PARKS TN, 1981, J COMP NEUROL, V203, P425, DOI 10.1002/cne.902030307; RAHAMIMOFF R, 1973, J PHYSIOL-LONDON, V228, P241, DOI 10.1113/jphysiol.1973.sp010084; Ravin R, 1997, J PHYSIOL-LONDON, V501, P251, DOI 10.1111/j.1469-7793.1997.tb00001.x; Rice J., 1995, MATH STAT DATA ANAL; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROTHMAN JS, 1993, J NEUROPHYSIOL, V70, P2562, DOI 10.1152/jn.1993.70.6.2562; Sabatini BL, 1999, ANNU REV PHYSIOL, V61, P521, DOI 10.1146/annurev.physiol.61.1.521; Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Sodickson DL, 1998, J NEUROSCI, V18, P8153; STANLEY EF, 1986, J NEUROSCI, V6, P782; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; THIES RE, 1965, J NEUROPHYSIOL, V28, P427, DOI 10.1152/jn.1965.28.3.427; THOMAS P, 1990, NEURON, V5, P723, DOI 10.1016/0896-6273(90)90226-6; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Voets T, 1999, NEURON, V23, P607, DOI 10.1016/S0896-6273(00)80812-0; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Worden MK, 1997, J NEUROPHYSIOL, V78, P417, DOI 10.1152/jn.1997.78.1.417; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; YAMADA WM, 1992, BIOPHYS J, V61, P671, DOI 10.1016/S0006-3495(92)81872-6; Yang LC, 1999, J NEUROSCI, V19, P2313; ZHANG S, 1994, J NEUROPHYSIOL, V72, P705, DOI 10.1152/jn.1994.72.2.705; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	67	178	180	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	2000	26	3					683	694		10.1016/S0896-6273(00)81204-0	http://dx.doi.org/10.1016/S0896-6273(00)81204-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330ZH	10896163	Bronze			2022-12-24	WOS:000087991600018
J	Scheetz, AJ; Nairn, AC; Constantine-Paton, M				Scheetz, AJ; Nairn, AC; Constantine-Paton, M			NMDA receptor-mediated control of protein synthesis at developing synapses	NATURE NEUROSCIENCE			English	Article							ELONGATION FACTOR-II; MESSENGER-RNA COMPETITION; D-ASPARTATE RECEPTOR; REGULATING TRANSLATION; SUPERIOR COLLICULUS; KINASE-II; CYTOPLASMIC POLYADENYLATION; SYNAPTIC PLASTICITY; RAT-BRAIN; PHOSPHORYLATION	We demonstrate a rapid and complex effect of N-methyl-D-aspartate receptor (NMDAR) activation on synaptic protein synthesis in the superior colliculi of young rats. Within minutes of receptor activation, translation of alpha Ca2+/calmodulin dependent kinase II (alpha CamK II) was increased, whereas total protein synthesis was reduced. NMDAR activation also increased phosphorylation of eukaryotic elongation factor 2 (eEF2), a process known to inhibit protein translation by reducing peptide chain elongation. Low doses of cycloheximide, which reduce elongation rate independently of eEF2 phosphorylation, decreased overall protein synthesis but increased alpha CaMK II synthesis. These observations suggest that regulation of peptide elongation via eEF2 phosphorylation can link NMDAR activation to local increases in the synthesis of specific proteins during activity-dependent synaptic change.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA	Yale University; Rockefeller University	Scheetz, AJ (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 333 Cedar St,POB 208024, New Haven, CT 06520 USA.			Nairn, Angus/0000-0002-7075-0195	NATIONAL EYE INSTITUTE [R37EY006039, R01EY006039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050402] Funding Source: NIH RePORTER; NEI NIH HHS [EY 06039] Funding Source: Medline; NIGMS NIH HHS [GM 50402] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAITINGER C, 1990, J CELL BIOL, V111, P1763, DOI 10.1083/jcb.111.5.1763; BRENDLER T, 1981, J BIOL CHEM, V256, P1747; BRENDLER T, 1981, J BIOL CHEM, V256, P1755; BROCKE L, 1995, J NEUROSCI, V15, P6797; BURGIN KE, 1990, J NEUROSCI, V10, P1788; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Crino PB, 1996, NEURON, V17, P1173, DOI 10.1016/S0896-6273(00)80248-2; FEIG S, 1993, J NEUROSCI, V13, P1010; GODEFROYCOLBURN T, 1981, J BIOL CHEM, V256, P1762; HOLLINGSWORTH EB, 1985, J NEUROSCI, V5, P2240; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; KELLY PT, 1991, MOL NEUROBIOL, V5, P153, DOI 10.1007/BF02935544; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Leski ML, 1996, NEUROCHEM RES, V21, P681, DOI 10.1007/BF02527725; LUND RD, 1972, BRAIN RES, V42, P1, DOI 10.1016/0006-8993(72)90038-8; Marin P, 1997, J NEUROSCI, V17, P3445; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; MCGREW LL, 1990, EMBO J, V9, P3743, DOI 10.1002/j.1460-2075.1990.tb07587.x; NAIRN AC, 1987, J BIOL CHEM, V262, P17299; NAIRN AC, 1996, TRANSLATIONAL CONTRO, P295; Ouyang Y, 1999, J NEUROSCI, V19, P7823; REDPATH NT, 1989, BIOCHEM J, V262, P69, DOI 10.1042/bj2620069; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Scheetz AJ, 1997, P NATL ACAD SCI USA, V94, P14770, DOI 10.1073/pnas.94.26.14770; Scheetz AJ, 1996, J NEUROSCI, V16, P1460; Scheetz AJ, 1996, EUR J NEUROSCI, V8, P1322, DOI 10.1111/j.1460-9568.1996.tb01594.x; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Shi J, 1997, J NEUROSCI, V17, P6264; SIMON DK, 1990, DEV BIOL, V137, P125, DOI 10.1016/0012-1606(90)90013-9; SIMON DK, 1992, J NEUROSCI, V12, P1212; SIMON DK, 1992, P NATL ACAD SCI USA, V89, P10593, DOI 10.1073/pnas.89.22.10593; Steward O, 1999, J NEUROSCI, V19, P7834; STEWARD O, 1986, J NEUROSCI, V6, P412; STEWARD O, 1991, J COMP NEUROL, V314, P545, DOI 10.1002/cne.903140311; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; WALDEN WE, 1986, BIOCHEMISTRY-US, V25, P2033, DOI 10.1021/bi00356a030; WALDEN WE, 1981, J BIOL CHEM, V256, P1739; WEILER IJ, 1993, P NATL ACAD SCI USA, V90, P7168, DOI 10.1073/pnas.90.15.7168; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3	40	283	290	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2000	3	3					211	216		10.1038/72915	http://dx.doi.org/10.1038/72915			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TE	10700251				2022-12-24	WOS:000085810500008
J	Lee, TM; Winter, C; Marticke, SS; Lee, A; Luo, LQ				Lee, TM; Winter, C; Marticke, SS; Lee, A; Luo, LQ			Essential roles of Drosophila RhoA in the regulation of neuroblast proliferation and dendritic but not axonal morphogenesis	NEURON			English	Article							GROWTH CONE GUIDANCE; CELL-CYCLE; ADP-RIBOSYLATION; FUSION PROTEINS; MUSHROOM BODIES; GTPASES; EXPRESSION; EMBRYOGENESIS; MELANOGASTER; TRANSITION	The pleiotropic functions of small GTPase Rho present a challenge to its genetic analysis in multicellular organisms. We report here the use of the MARCM (mosaic analysis with a repressible cell marker) system to analyze the function of RhoA in the developing Drosophila brain. Clones of cells homozygous for null RhoA mutations were specifically labeled in the mushroom body (MB) neurons of mosaic brains. We found that RhoA is required for neuroblast (Nb) proliferation but not for neuronal survival. Surprisingly, RhoA is not required for MB neurons to establish normal axon projections. However, neurons lacking RhoA overextend their dendrites, and expression of activated RhoA causes a reduction of dendritic complexity. Thus, RhoA is an important regulator of dendritic morphogenesis, while distinct mechanisms are used for axonal morphogenesis.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Luo, LQ (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.			Luo, Liqun/0000-0001-5467-9264	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036623] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS36623] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barrett K, 1997, CELL, V91, P905, DOI 10.1016/S0092-8674(00)80482-1; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; BRAND AH, 1993, DEVELOPMENT, V118, P401; BYERS TJ, 1987, J CELL BIOL, V105, P2103, DOI 10.1083/jcb.105.5.2103; Clark IE, 1997, DEVELOPMENT, V124, P461; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Crittenden JR, 1998, LEARN MEMORY, V5, P38; EDGAR BA, 1994, GENE DEV, V8, P440, DOI 10.1101/gad.8.4.440; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Han KA, 1998, J NEUROSCI, V18, P3650; HARIHARAN IK, 1995, EMBO J, V14, P292, DOI 10.1002/j.1460-2075.1995.tb07003.x; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Ito K, 1998, LEARN MEMORY, V5, P52; Ito K, 1997, DEVELOPMENT, V124, P761; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; KISHI K, 1993, J CELL BIOL, V120, P1187, DOI 10.1083/jcb.120.5.1187; KNOBLICH JA, 1993, EMBO J, V12, P65, DOI 10.1002/j.1460-2075.1993.tb05632.x; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lu Y, 1999, GENE DEV, V13, P1168, DOI 10.1101/gad.13.9.1168; Luo LQ, 1997, CURR OPIN NEUROBIOL, V7, P81, DOI 10.1016/S0959-4388(97)80124-9; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Mabuchi I, 1993, ZYGOTE, V1, P325, DOI 10.1017/S0967199400001659; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; Narumiya S, 1996, J BIOCHEM-TOKYO, V120, P215; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Prokopenko SN, 1999, GENE DEV, V13, P2301, DOI 10.1101/gad.13.17.2301; ROBINOW S, 1991, J NEUROBIOL, V22, P443, DOI 10.1002/neu.480220503; SELLECK SB, 1992, NATURE, V355, P253, DOI 10.1038/355253a0; SMITH AV, 1991, DEVELOPMENT, V112, P997; SMITH DE, 1989, J CELL BIOL, V108, P255, DOI 10.1083/jcb.108.2.255; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; XU T, 1993, DEVELOPMENT, V117, P1223; YAMAMOTO M, 1993, ONCOGENE, V8, P1449; YANG MY, 1995, NEURON, V15, P45	45	241	243	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	2000	25	2					307	316		10.1016/S0896-6273(00)80896-X	http://dx.doi.org/10.1016/S0896-6273(00)80896-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	288EL	10719887	Bronze			2022-12-24	WOS:000085549100010
J	Schilling, G; Wood, JD; Kui, DA; Slunt, HH; Gonzales, V; Yamada, M; Cooper, JK; Margolis, RL; Jenkins, NA; Copeland, NG; Takahashi, H; Tsuji, S; Price, DL; Borchelt, DR; Ross, CA				Schilling, G; Wood, JD; Kui, DA; Slunt, HH; Gonzales, V; Yamada, M; Cooper, JK; Margolis, RL; Jenkins, NA; Copeland, NG; Takahashi, H; Tsuji, S; Price, DL; Borchelt, DR; Ross, CA			Nuclear accumulation of truncated atrophin-1 fragments in a transgenic mouse model of DRPLA	NEURON			English	Article							DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; NEURONAL INTRANUCLEAR INCLUSIONS; TRINUCLEOTIDE CAG REPEAT; HUNTINGTONS-DISEASE; TRIPLET-REPEAT; EXPANDED POLYGLUTAMINE; GENE-PRODUCT; SPINOCEREBELLAR ATAXIA; AGGREGATE FORMATION; HUMAN BRAIN	Dentatorubral and pallidoluysian atrophy (DRPLA) is a member of a family of progressive neurodegenerative diseases caused by polyglutamine repeat expansion. Transgenic mice expressing full-length human atrophin-1 with 65 consecutive glutamines exhibit ataxia, tremors, abnormal movements, seizures, and premature death. These mice accumulate atrophin-1 immunoreactivity and inclusion bodies in the nuclei of multiple populations of neurons. Subcellular fractionation revealed 120 kDa nuclear fragments of mutant atrophin-1, whose abundance increased with age and phenotypic severity. Brains of DRPLA patients contained apparently identical 120 kDa nuclear fragments. By contrast, mice overexpressing atrophin-1 with 26 glutamines were phenotypically normal and did not accumulate the 120 kDa fragments. We conclude that the evolution of neuropathology in DRPLA involves proteolytic processing of mutant atrophin-1 and nuclear accumulation of truncated fragments.	Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Div Neuropathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD 21205 USA; NCI, Mammalian Genet Lab, Ctr Canc, Frederick, MD 21702 USA; Niigata Univ, Brain Res Inst, Dept Pathol, Niigata 951, Japan; Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 951, Japan	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Niigata University; Niigata University	Borchelt, DR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	drbor@welchlink.welch.jhu.edu; caross@jhu.edu	Wood, Jonathan D/A-5060-2009		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034172, P50NS016375, P01NS016375] Funding Source: NIH RePORTER; NINDS NIH HHS [NS16375, NS34172] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; Becher MW, 1997, MOVEMENT DISORD, V12, P519, DOI 10.1002/mds.870120408; Becher MW, 1998, NEUROBIOL DIS, V4, P387, DOI 10.1006/nbdi.1998.0168; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Davies SW, 1998, LANCET, V351, P131, DOI 10.1016/S0140-6736(97)08360-8; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Ellerby LM, 1999, J NEUROCHEM, V72, P185, DOI 10.1046/j.1471-4159.1999.0720185.x; Ellerby LM, 1999, J BIOL CHEM, V274, P8730, DOI 10.1074/jbc.274.13.8730; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Gusella JF, 1996, ANNU REV MED, V47, P201; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hayashi Y, 1998, ACTA NEUROPATHOL, V96, P547, DOI 10.1007/s004010050933; HODGSON GJ, 1999, NEURON, V23, P1; Igarashi S, 1998, NAT GENET, V18, P111, DOI 10.1038/ng0298-111; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; IKEUCHI T, 1995, ANN NEUROL, V37, P769, DOI 10.1002/ana.410370610; ILZUKA R, 1984, J NEUROL NEUROSUR PS, V47, P1288; Kahlem P, 1998, MOL CELL, V1, P595, DOI 10.1016/S1097-2765(00)80059-3; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Knight SP, 1997, J NEUROL SCI, V146, P19, DOI 10.1016/S0022-510X(96)00266-3; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KOMURE O, 1995, NEUROLOGY, V45, P143, DOI 10.1212/WNL.45.1.143; LI SH, 1993, GENOMICS, V16, P572, DOI 10.1006/geno.1993.1232; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Margolis RL, 1996, MOL BRAIN RES, V36, P219, DOI 10.1016/0169-328X(95)00241-J; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; Matilla A, 1997, NATURE, V389, P974, DOI 10.1038/40159; Miyashita T, 1998, BIOCHEM BIOPH RES CO, V249, P96, DOI 10.1006/bbrc.1998.9096; Miyashita T, 1997, J BIOL CHEM, V272, P29238, DOI 10.1074/jbc.272.46.29238; Moulder KL, 1999, J NEUROSCI, V19, P705; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; NAGAFUCHI S, 1994, NAT GENET, V8, P177, DOI 10.1038/ng1094-177; NAITO H, 1982, NEUROLOGY, V32, P798, DOI 10.1212/WNL.32.8.798; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Paulson HL, 1996, ANNU REV NEUROSCI, V19, P79; Perez MK, 1998, J CELL BIOL, V143, P1457, DOI 10.1083/jcb.143.6.1457; PERUTZ MF, 1995, MOL MED, V1, P718, DOI 10.1007/BF03401886; PETERS MF, 1999, IN PRESS MOL CELL NE; Reddy PH, 1998, NAT GENET, V20, P198, DOI 10.1038/2510; Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5; Ross CA, 1997, BRAIN PATHOL, V7, P1003, DOI 10.1111/j.1750-3639.1997.tb00898.x; Ross CA, 1997, MEDICINE, V76, P305, DOI 10.1097/00005792-199709000-00001; Sanchez I, 1999, NEURON, V22, P623, DOI 10.1016/S0896-6273(00)80716-3; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; SMITH JK, 1958, NEUROLOGY, V8, P205, DOI 10.1212/WNL.8.3.205; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Tait D, 1998, HUM MOL GENET, V7, P991, DOI 10.1093/hmg/7.6.991; TAKAHASHI H, 1988, NEUROLOGY, V38, P1065, DOI 10.1212/WNL.38.7.1065; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Wood JD, 1998, MOL CELL NEUROSCI, V11, P149, DOI 10.1006/mcne.1998.0677; YAZAWA I, 1995, NAT GENET, V10, P99, DOI 10.1038/ng0595-99	60	138	141	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1999	24	1					275	286		10.1016/S0896-6273(00)80839-9	http://dx.doi.org/10.1016/S0896-6273(00)80839-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241QC	10677044	hybrid			2022-12-24	WOS:000082893200026
J	Fries, P; Neuenschwander, S; Engel, AK; Goebel, R; Singer, W				Fries, P; Neuenschwander, S; Engel, AK; Goebel, R; Singer, W			Rapid feature selective neuronal synchronization through correlated latency shifting	NATURE NEUROSCIENCE			English	Article							LOCAL-FIELD POTENTIALS; PRIMARY VISUAL-CORTEX; CORTICAL-NEURONS; RESPONSE VARIABILITY; NEOCORTICAL NEURONS; SHORT-RANGE; CAT; OSCILLATIONS; FLUCTUATIONS; DISCHARGE	Spontaneous brain activity could affect processing if it were structured,. We show that neuron pairs in cat primary visual cortex exhibited correlated fluctuations in response latency, particularly when they had overlapping receptive fields or similar orientation preferences. Correlations occurred within and across hemispheres, but only when local field potentials (LFPs) oscillated in the gamma-frequency range (40-70 Hz). In this range, LFP fluctuations preceding response onset predicted response latencies; negative (positive) LFPs were associated with early (late) responses. Oscillations below 10 Hz caused covariations in response amplitude, but exhibited no columnar selectivity or coordinating effect on latencies. Thus, during high gamma activity, spontaneous activity exhibits distinct, column-specific correlation patterns. Consequently, cortical cells undergo coherent fluctuations in excitability that enhance temporal coherence of responses to contours that are spatially contiguous or have similar orientation. Because synchronized responses are more likely than dispersed responses to undergo rapid and joint processing, spontaneous activity may be important in early visual processes.	Max Planck Inst Brain Res, D-60528 Frankfurt, Germany; Univ Frankfurt, Dept Psychiat, D-60528 Frankfurt, Germany	Max Planck Society; Goethe University Frankfurt	Singer, W (corresponding author), Max Planck Inst Brain Res, Deutschcordenstr 46, D-60528 Frankfurt, Germany.		Engel, Andreas K./AAH-6384-2019; Engel, Andreas K/C-7781-2012; Singer, Wolf/D-6874-2012; Fries, Pascal/E-3196-2010	Engel, Andreas K./0000-0003-4899-8466; Engel, Andreas K/0000-0003-4899-8466; Fries, Pascal/0000-0002-4270-1468; NEUENSCHWANDER, Sergio/0000-0001-7493-121X				Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; AMZICA F, 1995, J NEUROPHYSIOL, V73, P20, DOI 10.1152/jn.1995.73.1.20; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Azouz R, 1999, J NEUROSCI, V19, P2209; BOUYER JJ, 1981, ELECTROEN CLIN NEURO, V51, P244, DOI 10.1016/0013-4694(81)90138-3; Brecht M, 1998, J NEUROPHYSIOL, V79, P2394, DOI 10.1152/jn.1998.79.5.2394; Contreras D, 1997, NEUROSCIENCE, V76, P25; Das A, 1999, NATURE, V399, P655, DOI 10.1038/21371; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; ENGEL AK, 1991, SCIENCE, V252, P1177, DOI 10.1126/science.252.5009.1177; FRIES P, IN PRESS SCIENCE; Gawne TJ, 1996, J NEUROPHYSIOL, V76, P1356, DOI 10.1152/jn.1996.76.2.1356; Gur M, 1997, J NEUROSCI, V17, P2914; Herculano-Houzel S, 1999, J NEUROSCI, V19, P3992; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; LAMPL I, 1993, J NEUROPHYSIOL, V70, P2181, DOI 10.1152/jn.1993.70.5.2181; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Makeig S, 1996, COGNITIVE BRAIN RES, V4, P15, DOI 10.1016/0926-6410(95)00042-9; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3949, DOI 10.1152/jn.1996.76.6.3949; Nowak LG, 1997, CEREB CORTEX, V7, P487, DOI 10.1093/cercor/7.6.487; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; SANES JN, 1993, P NATL ACAD SCI USA, V90, P4470, DOI 10.1073/pnas.90.10.4470; Schmidt KE, 1997, J NEUROSCI, V17, P5480; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Volgushev M, 1998, NEUROSCIENCE, V83, P15, DOI 10.1016/S0306-4522(97)00380-1	31	232	236	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2001	4	2					194	200		10.1038/84032	http://dx.doi.org/10.1038/84032			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UC	11175881				2022-12-24	WOS:000167178100019
J	Zhai, RG; Vardinon-Friedman, H; Cases-Langhoff, C; Becker, B; Gundelfinger, ED; Ziv, NE; Garner, CC				Zhai, RG; Vardinon-Friedman, H; Cases-Langhoff, C; Becker, B; Gundelfinger, ED; Ziv, NE; Garner, CC			Assembling the presynaptic active zone: A characterization of an active zone precursor vesicle	NEURON			English	Article							HIPPOCAMPAL-NEURONS; MOLECULAR-STRUCTURE; SYNAPTOGENESIS; PROTEIN; EXPRESSION; DENDRITES; DYNAMICS; ORGANIZATION; ARCHITECTURE; TRANSPORT	The active zone is a specialized region of the presynaptic plasma membrane where synaptic vesicles dock and fuse. In this study, we have investigated the cellular mechanism underlying the transport and recruitment of the active zone protein Piccolo into nascent synapses. Our results show that Piccolo is transported to nascent synapses on an similar to 80 nm dense core granulated vesicle together with other constituents of the active zone, including Bassoon, Syntaxin, SNAP-25, and N-cadherin, as well as chromogranin B. Components of synaptic vesicles, such as VAMP 2/synaptobrevin II, synaptophysin, synaptotagmin, or proteins of the perisynaptic plasma membrane such as GABA transporter 1 (GAT1), were not present. These studies demonstrate that the presynaptic active zone is formed in part by the fusion of an active zone precursor vesicle with the presynaptic plasma membrane.	Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; Technion Israel Inst Technol, Rappaport Inst, Haifa, Israel; Technion Israel Inst Technol, Bruce Rappaport Fac Med, Dept Anat & Cell Biol, IL-31096 Haifa, Israel; Leibniz Inst Neurobiol, D-39118 Magdeburg, Germany	University of Alabama System; University of Alabama Birmingham; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Leibniz Institut fur Neurobiologie (LIN)	Garner, CC (corresponding author), Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA.	garner@nrc.uab.edu	Zhai, R. Grace/AGZ-3936-2022; Ziv, Noam/ABA-6551-2020	Ziv, Noam/0000-0001-9197-326X; Garner, Craig/0000-0003-1970-5417; Zhai, Rong/0000-0002-7599-1430	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG006569] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG06569] Funding Source: Medline; NINDS NIH HHS [R01 NS39471] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; Bradke F, 1998, BBA-MOL CELL RES, V1404, P245, DOI 10.1016/S0167-4889(98)00060-3; Brandstatter JH, 1999, EUR J NEUROSCI, V11, P3683, DOI 10.1046/j.1460-9568.1999.00793.x; BURNS ME, 1995, CELL, V83, P187, DOI 10.1016/0092-8674(95)90160-4; CasesLanghoff C, 1996, EUR J CELL BIOL, V69, P214; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Dailey ME, 1996, J NEUROSCI, V16, P2983; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; GARCIA EP, 1995, J CELL BIOL, V129, P105, DOI 10.1083/jcb.129.1.105; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Garner CC, 2000, CURR OPIN NEUROBIOL, V10, P321, DOI 10.1016/S0959-4388(00)00093-3; Gautam M, 1999, DEV BRAIN RES, V114, P171, DOI 10.1016/S0165-3806(99)00013-9; Goldstein LSB, 1999, ANNU REV CELL DEV BI, V15, P141, DOI 10.1146/annurev.cellbio.15.1.141; Goslin K., 1991, CULTURING NERVE CELL, P251; GOTOW T, 1991, NEUROSCIENCE, V40, P587, DOI 10.1016/0306-4522(91)90143-C; Grosse G, 2000, J NEUROSCI, V20, P1869; Hannah MJ, 1999, ANNU REV CELL DEV BI, V15, P733, DOI 10.1146/annurev.cellbio.15.1.733; Henley JR, 1996, J CELL BIOL, V133, P761, DOI 10.1083/jcb.133.4.761; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Horch HW, 1999, NEURON, V23, P353; Huttner WB, 1995, COLD SPRING HARB SYM, V60, P315, DOI 10.1101/SQB.1995.060.01.036; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Kay AR, 1999, NEURON, V24, P809, DOI 10.1016/S0896-6273(00)81029-6; KINDLER S, 1990, J BIOL CHEM, V265, P19679; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; LANDIS DMD, 1988, NEURON, V1, P201, DOI 10.1016/0896-6273(88)90140-7; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MATTEOLI M, 1995, J PHYSIOL-PARIS, V89, P51, DOI 10.1016/0928-4257(96)80551-1; MATUS A, 1986, NEUROSCIENCE, V17, P371, DOI 10.1016/0306-4522(86)90253-8; MELLONI RH, 1994, J COMP NEUROL, V342, P449, DOI 10.1002/cne.903420311; NASTUK MA, 1993, TRENDS NEUROSCI, V16, P72, DOI 10.1016/0166-2236(93)90020-M; Okabe S, 1999, NAT NEUROSCI, V2, P804, DOI 10.1038/12175; Rao A, 1998, J NEUROSCI, V18, P1217; Righter K, 1999, J COMP NEUROL, V408, P437, DOI 10.1002/(SICI)1096-9861(19990607)408:3<437::AID-CNE9>3.0.CO;2-5; Roos J, 2000, NAT NEUROSCI, V3, P415, DOI 10.1038/74773; SANES JS, 1997, APPROACHES NEURAL DE, P179; Schikorski T, 1997, J NEUROSCI, V17, P5858; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; Wang XL, 1999, J CELL BIOL, V147, P151, DOI 10.1083/jcb.147.1.151; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; ZHAI R, 2000, IN PRESS MOL CELL NE; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	50	322	332	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	2001	29	1					131	143		10.1016/S0896-6273(01)00185-4	http://dx.doi.org/10.1016/S0896-6273(01)00185-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	397NX	11182086	Bronze			2022-12-24	WOS:000166702700014
J	Betarbet, R; Sherer, TB; MacKenzie, G; Garcia-Osuna, M; Panov, AV; Greenamyre, JT				Betarbet, R; Sherer, TB; MacKenzie, G; Garcia-Osuna, M; Panov, AV; Greenamyre, JT			Chronic systemic pesticide exposure reproduces features of Parkinson's disease	NATURE NEUROSCIENCE			English	Article							TOXIN 3-NITROPROPIONIC ACID; ELECTRON-TRANSPORT CHAIN; ALPHA-SYNUCLEIN; COMPLEX-I; SKELETAL-MUSCLE; OXIDATIVE-PHOSPHORYLATION; MITOCHONDRIAL-FUNCTION; BRAIN MITOCHONDRIA; SUBSTANTIA-NIGRA; LEWY BODIES	The cause of Parkinson's disease (PD) is unknown, but epidemiological studies suggest an association with pesticides and other environmental toxins, and biochemical studies implicate a systemic defect in mitochondrial complex I. We report that chronic, systemic inhibition of complex I by the lipophilic pesticide, rotenone, causes highly selective nigrostriatal dopaminergic degeneration that is associated behaviorally with hypokinesia and rigidity. Nigral neurons in rotenone-treated rats accumulate fibrillar cytoplasmic inclusions that contain ubiquitin and alpha -synuclein. These results indicate that chronic exposure to a common pesticide can reproduce the anatomical, neurochemical, behavioral and neuropathological features of PD.	Emory Univ, Dept Neurol, Atlanta, GA 30322 USA	Emory University	Greenamyre, JT (corresponding author), Emory Univ, Dept Neurol, 1639 Pierce Dr,WMB 6000, Atlanta, GA 30322 USA.	jgreena@emory.edu	Greenamyre, J. Timothy/B-4049-2011	Sherer, Todd/0000-0001-9667-6600; Greenamyre, J. Timothy/0000-0003-3468-7878	NIA NIH HHS [P30AG10133] Funding Source: Medline; NINDS NIH HHS [NS33779, NS38399] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038399, R01NS033779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010133] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baba M, 1998, AM J PATHOL, V152, P879; BEAL MF, 1993, J NEUROSCI, V13, P4181; BINDOFF LA, 1989, LANCET, V2, P49, DOI 10.1016/S0140-6736(89)90291-2; BLIN O, 1994, J NEUROL SCI, V125, P95, DOI 10.1016/0022-510X(94)90248-8; BUTTERFIELD PG, 1993, NEUROLOGY, V43, P1150, DOI 10.1212/WNL.43.6.1150; CARDELLACH F, 1993, NEUROLOGY, V43, P2258, DOI 10.1212/WNL.43.11.2258; Davey GP, 1996, J NEUROCHEM, V66, P1617; DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x; Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2; Ferrante RJ, 1997, BRAIN RES, V753, P157, DOI 10.1016/S0006-8993(97)00008-5; Forno LS, 1996, ADV NEUROL, V69, P217; Gorell JM, 1998, NEUROLOGY, V50, P1346, DOI 10.1212/WNL.50.5.1346; Hashimoto M, 1999, J BIOL CHEM, V274, P28849, DOI 10.1074/jbc.274.41.28849; HEDREEN JC, 1985, J HISTOCHEM CYTOCHEM, V33, P134, DOI 10.1177/33.2.2578498; Hensley K, 1998, J NEUROCHEM, V71, P2549; Higgins DS, 1996, J NEUROSCI, V16, P3807; HORNYKIEWICZ O, 1966, PHARMACOL REV, V18, P925; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; MANN VM, 1992, BRAIN, V115, P333, DOI 10.1093/brain/115.2.333; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Menegon A, 1998, LANCET, V352, P1344, DOI 10.1016/S0140-6736(98)03453-9; Miller GW, 1997, ANN NEUROL, V41, P530, DOI 10.1002/ana.410410417; Mizuno Y, 1998, ANN NEUROL, V44, pS99, DOI 10.1002/ana.410440715; NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8; Ouary S, 2000, NEUROSCIENCE, V97, P521, DOI 10.1016/S0306-4522(00)00020-8; Panos G, 1996, J CHEMOTHERAPY, V8, P270, DOI 10.1179/joc.1996.8.4.270; PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; PORTER RHP, 1994, J NEUROSCI, V14, P7192; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Seaton TA, 1997, BRAIN RES, V777, P110; SHOFFNER JM, 1991, ANN NEUROL, V30, P332, DOI 10.1002/ana.410300304; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Swerdlow RH, 1998, ANN NEUROL, V44, P873, DOI 10.1002/ana.410440605; Tanner CM, 1999, JAMA-J AM MED ASSOC, V281, P341, DOI 10.1001/jama.281.4.341; TIPTON KF, 1993, J NEUROCHEM, V61, P1191, DOI 10.1111/j.1471-4159.1993.tb13610.x; Tolwani RJ, 1999, LAB ANIM SCI, V49, P363	41	2685	2821	5	349	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2000	3	12					1301	1306		10.1038/81834	http://dx.doi.org/10.1038/81834			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UA	11100151	Bronze			2022-12-24	WOS:000167177900016
J	Feng, YY; Olson, EC; Stukenberg, PT; Flanagan, LA; Kirschner, MW; Walsh, CA				Feng, YY; Olson, EC; Stukenberg, PT; Flanagan, LA; Kirschner, MW; Walsh, CA			LIS1 regulates CNS lamination by interacting with mNudE, a central component of the centrosome	NEURON			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; MILLER-DIEKER SYNDROME; IN-SITU HYBRIDIZATION; ASPERGILLUS-NIDULANS; NEURONAL MIGRATION; NUCLEAR MIGRATION; GAMMA-TUBULIN; CYTOPLASMIC DYNEIN; LISSENCEPHALY SYNDROME; BAND HETEROTOPIA	LIS1, a microtubule-associated protein, is required for neuronal migration, but the precise mechanism of LIS1 function is unknown. We identified a LIS1 interacting protein encoded by a mouse homolog of NUDE, a nuclear distribution gene in A. nidulans and a multicopy suppressor of the LIS1 homolog, NUDF. mNudE is located in the centrosome or microtubule organizing center (MTOC), and interacts with six different centrosomal proteins. Overexpression of mNudE dissociates gamma -tubulin from the centrosome and disrupts microtubule organization. Missense mutations that disrupt LIS1 function block LIS1-mNudE binding. Moreover, misexpression of the LIS1 binding domain of mNudE in Xenopus embryos disrupts the architecture and lamination of the CNS. Thus, LIS1-mNudE interactions may regulate neuronal migration through dynamic reorganization of the MTOC.	Harvard Inst Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Walsh, CA (corresponding author), Harvard Inst Med, Beth Israel Deaconess Med Ctr, Dept Neurol, 77 Ave Louis Pasteur, Boston, MA USA.	cwalsh@caregroup.harvard.edu		Walsh, Christopher/0000-0002-0156-2238; Stukenberg, Todd/0000-0002-6788-2111	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010730, P01NS040043, P01NS039404] Funding Source: NIH RePORTER; NINDS NIH HHS [F32-NS 10730, P01-NS 39404, P01-NS 40043] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALVAREZ LA, 1986, NEUROLOGY, V36, P489, DOI 10.1212/WNL.36.4.489; Berg MJ, 1998, NEUROLOGY, V50, P1143, DOI 10.1212/WNL.50.4.1143; BREEDEN L, 1985, COLD SPRING HARB SYM, V50, P643, DOI 10.1101/SQB.1985.050.01.078; Brown CR, 1996, J BIOL CHEM, V271, P824, DOI 10.1074/jbc.271.2.824; CAMPBELL AM, 1992, J BIOL CHEM, V267, P9321; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Dick T, 1996, MOL CELL BIOL, V16, P1966; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Dobyns WB, 1999, NEUROLOGY, V53, P270, DOI 10.1212/WNL.53.2.270; DOXSEY SJ, 1994, CELL, V76, P639, DOI 10.1016/0092-8674(94)90504-5; EFIMOV VP, 2000, IN PRESS J CELL BIOL; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Geiser JR, 1997, MOL BIOL CELL, V8, P1035, DOI 10.1091/mbc.8.6.1035; Ghosh MM, 1995, BIOREMED SER, V3, P15; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Guasch G, 2000, BLOOD, V95, P1788, DOI 10.1182/blood.V95.5.1788.005k15_1788_1796; Guzzo RM, 1999, MOL BIOL CELL, V10, p16A; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; JELLINGER K, 1976, NEUROPADIATRIE, V7, P66, DOI 10.1055/s-0028-1091611; Kitagawa M, 2000, FEBS LETT, V479, P57, DOI 10.1016/S0014-5793(00)01856-1; KOMURO H, 1995, J NEUROSCI, V15, P1110; KUBIAK JZ, 1992, J CELL SCI, V102, P457; KUCHELMEISTER K, 1993, CHILD NERV SYST, V9, P394, DOI 10.1007/BF00306191; LI QQ, 1995, BIOCHEM BIOPH RES CO, V212, P220, DOI 10.1006/bbrc.1995.1959; Liu Z, 1999, DEVELOPMENT, V126, P4477; LoNigro C, 1997, HUM MOL GENET, V6, P157, DOI 10.1093/hmg/6.2.157; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Minke PF, 1999, MOL MICROBIOL, V32, P1065, DOI 10.1046/j.1365-2958.1999.01421.x; Morris NR, 1998, TRENDS CELL BIOL, V8, P467, DOI 10.1016/S0962-8924(98)01389-0; MORRIS NR, 1979, CELL, V16, P437; Morris SM, 1998, CURR BIOL, V8, P603, DOI 10.1016/S0960-9822(98)70232-5; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; OAKLEY CE, 1989, NATURE, V338, P662, DOI 10.1038/338662a0; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Pilz DT, 1999, HUM MOL GENET, V8, P1757, DOI 10.1093/hmg/8.9.1757; Purohit A, 1999, J CELL BIOL, V147, P481, DOI 10.1083/jcb.147.3.481; Rakic P, 1996, P NATL ACAD SCI USA, V93, P9218, DOI 10.1073/pnas.93.17.9218; RAKIC P, 1978, POSTGRAD MED J, V54, P25; RATTNER JB, 1993, CELL MOTIL CYTOSKEL, V26, P214, DOI 10.1002/cm.970260305; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Reinsch S, 1998, J CELL SCI, V111, P2283; Sapir T, 1999, EUR J BIOCHEM, V265, P181, DOI 10.1046/j.1432-1327.1999.00711.x; Sapir T, 1999, EUR J BIOCHEM, V266, P1011, DOI 10.1046/j.1432-1327.1999.00942.x; Sapir T, 1997, EMBO J, V16, P6977, DOI 10.1093/emboj/16.23.6977; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; SHU HB, 1995, J CELL BIOL, V130, P1137, DOI 10.1083/jcb.130.5.1137; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; STEARNS T, 1991, CELL, V65, P825, DOI 10.1016/0092-8674(91)90390-K; Stukenberg PT, 1997, CURR BIOL, V7, P338, DOI 10.1016/S0960-9822(06)00157-6; Swan A, 1999, NAT CELL BIOL, V1, P444, DOI 10.1038/15680; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Ueda M, 1997, P NATL ACAD SCI USA, V94, P9674, DOI 10.1073/pnas.94.18.9674; Ueda M, 1999, MOL BIOL CELL, V10, P151, DOI 10.1091/mbc.10.1.151; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Walsh CA, 1999, NEURON, V23, P19, DOI 10.1016/S0896-6273(00)80749-7; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WILLINS DA, 1995, GENETICS, V141, P1287; Xiang X, 1999, CURR GENET, V35, P626, DOI 10.1007/s002940050461; XIANG X, 1995, MOL BIOL CELL, V6, P297, DOI 10.1091/mbc.6.3.297; XIANG X, 1994, P NATL ACAD SCI USA, V91, P2100, DOI 10.1073/pnas.91.6.2100; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0; Zhou SY, 1998, METH MOL B, V87, P87	68	241	250	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	2000	28	3					665	679		10.1016/S0896-6273(00)00145-8	http://dx.doi.org/10.1016/S0896-6273(00)00145-8			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386JJ	11163258	Bronze			2022-12-24	WOS:000166057500008
J	Fricker, D; Miles, R				Fricker, D; Miles, R			EPSP amplification and the precision of spike timing in hippocampal neurons	NEURON			English	Article							CA1 PYRAMIDAL NEURONS; GUINEA-PIG; IN-VIVO; SYNAPTIC POTENTIALS; NEOCORTICAL NEURONS; FIRING THRESHOLD; INHIBITORY CELLS; RAT HIPPOCAMPUS; NA+ CHANNELS; K+ CHANNELS	The temporal precision with which EPSPs initiate action potentials in postsynaptic cells determines how activity spreads in neuronal networks. We found that small EPSPs evoked from just subthreshold potentials initiated firing with short latencies in most CA1 hippocampal inhibitory cells, while action potential timing in pyramidal cells was more variable due to plateau potentials that amplified and prolonged EPSPs. Action potential timing apparently depends on the balance of subthreshold intrinsic currents. In interneurons, outward currents dominate responses to somatically injected EPSP waveforms, while inward currents are larger than outward currents close to threshold in pyramidal cells. Suppressing outward potassium currents increases the variability in latency of synaptically induced firing in interneurons. These differences in precision of EPSP-spike coupling in inhibitory and pyramidal cells will enhance inhibitory control of the spread of excitation in the hippocampus.	Inst Pasteur, INSERM, U261, Lab Neurobiol Cellulaire, F-75724 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Fricker, D (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.		Fricker, Desdemona/ABD-2279-2020	Fricker, Desdemona/0000-0001-7328-9480	NIMH NIH HHS [MH54671] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Andreasen M, 1998, J PHYSIOL-LONDON, V507, P441, DOI 10.1111/j.1469-7793.1998.441bt.x; Andreasen M, 1999, J PHYSIOL-LONDON, V519, P85, DOI 10.1111/j.1469-7793.1999.0085o.x; Astman N, 1998, J NEUROPHYSIOL, V80, P1547, DOI 10.1152/jn.1998.80.3.1547; Azouz R, 1999, J NEUROSCI, V19, P2209; Brew HM, 1995, J NEUROSCI, V15, P8011; CASSELL JF, 1986, J PHYSIOL-LONDON, V374, P273, DOI 10.1113/jphysiol.1986.sp016079; CHAVEZNORIEGA LE, 1990, EXP BRAIN RES, V79, P633; CHEN QX, 1991, J NEUROSCI, V11, P337; COOMBS JS, 1955, J PHYSIOL-LONDON, V130, P374, DOI 10.1113/jphysiol.1955.sp005413; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; DEBANNE D, 1995, J NEUROPHYSIOL, V73, P1282, DOI 10.1152/jn.1995.73.3.1282; DEISZ RA, 1991, J NEUROPHYSIOL, V65, P371, DOI 10.1152/jn.1991.65.2.371; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; FETZ EE, 1983, J PHYSIOL-LONDON, V341, P387, DOI 10.1113/jphysiol.1983.sp014812; Fricker D, 1999, J PHYSIOL-LONDON, V517, P791, DOI 10.1111/j.1469-7793.1999.0791s.x; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; Gillessen T, 1997, J NEUROPHYSIOL, V77, P1639, DOI 10.1152/jn.1997.77.3.1639; Gulyas AI, 1998, EUR J NEUROSCI, V10, P3813, DOI 10.1046/j.1460-9568.1998.00402.x; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hoffman DA, 1998, J NEUROSCI, V18, P3521; Holt GR, 1996, J NEUROPHYSIOL, V75, P1806, DOI 10.1152/jn.1996.75.5.1806; HU GY, 1992, J PHYSIOL-LONDON, V453, P663, DOI 10.1113/jphysiol.1992.sp019250; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P205, DOI 10.1113/jphysiol.1984.sp015153; Karnup S, 1999, J PHYSIOL-LONDON, V516, P485, DOI 10.1111/j.1469-7793.1999.0485v.x; KNOX CK, 1974, BIOPHYS J, V14, P567, DOI 10.1016/S0006-3495(74)85936-9; Koyano K, 1996, NEUROSCI RES, V26, P29, DOI 10.1016/S0168-0102(96)01071-1; KUO CC, 1994, NEURON, V12, P819, DOI 10.1016/0896-6273(94)90335-2; Lipowsky R, 1996, J NEUROPHYSIOL, V76, P2181, DOI 10.1152/jn.1996.76.4.2181; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Martina M, 1998, J NEUROSCI, V18, P8111; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; MILES R, 1990, J PHYSIOL-LONDON, V428, P61, DOI 10.1113/jphysiol.1990.sp018200; NUMANN RE, 1987, J PHYSIOL-LONDON, V393, P331, DOI 10.1113/jphysiol.1987.sp016826; Parra P, 1998, NEURON, V20, P983, DOI 10.1016/S0896-6273(00)80479-1; Schneidman E, 1998, NEURAL COMPUT, V10, P1679, DOI 10.1162/089976698300017089; Schoppa NE, 1999, NAT NEUROSCI, V2, P1106, DOI 10.1038/16033; Segal MM, 1997, J NEUROPHYSIOL, V77, P3021, DOI 10.1152/jn.1997.77.6.3021; Serodio P, 1998, J NEUROPHYSIOL, V79, P1081, DOI 10.1152/jn.1998.79.2.1081; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Softky W R, 1995, Curr Opin Neurobiol, V5, P239, DOI 10.1016/0959-4388(95)80032-8; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Wang XJ, 1999, J NEUROSCI, V19, P9587; White JA, 1998, J NEUROPHYSIOL, V80, P262, DOI 10.1152/jn.1998.80.1.262; Wickens JR, 1998, J NEUROPHYSIOL, V79, P2358, DOI 10.1152/jn.1998.79.5.2358; ZHANG L, 1995, J PHYSIOL-LONDON, V488, P647, DOI 10.1113/jphysiol.1995.sp020997	46	188	192	1	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	2000	28	2					559	569		10.1016/S0896-6273(00)00133-1	http://dx.doi.org/10.1016/S0896-6273(00)00133-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	377CE	11144364	Bronze			2022-12-24	WOS:000165493700029
J	Kuruvilla, R; Ye, HH; Ginty, DD				Kuruvilla, R; Ye, HH; Ginty, DD			Spatially and functionally distinct roles of the PI3-K effector pathway during NGF signaling in sympathetic neurons	NEURON			English	Article							NERVE GROWTH-FACTOR; RETROGRADE AXONAL-TRANSPORT; AKT PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; RECEPTOR TRAFFICKING; NEUROTROPHIN RECEPTORS; SELECTIVE INHIBITOR; TYROSINE KINASE; SURVIVAL; TRKA	NGF is a target-derived growth factor for developing sympathetic neurons. Here, we show that application of NGF exclusively to distal axons of sympathetic neurons leads to an increase in PI3-K signaling in both distal axons and cell bodies. In addition, there is a more critical dependence on PI3-K for survival of neurons supported by NGF acting exclusively on distal axons as compared to neurons supported by NGF acting directly on cell bodies. Interestingly, PI3-K signaling within both cell bodies and distal axons contributes to survival of neurons. The requirement for PI3-K signaling in distal axons for survival may be explained by the finding that inhibition of PI3-K in the distal axons attenuates retrograde signaling. Therefore, a single TrkA effector, PI3-K, has multiple roles within spatially distinct cellular locales during retrograde NGF signaling.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA.			Ye, Haihong/0000-0001-7282-6280; Kuruvilla, Rejji/0000-0002-2851-675X	PHS HHS [N534814] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Achiriloaie M, 1999, MOL CELL BIOL, V19, P1410; Bartlett SE, 1997, BRAIN RES, V761, P257, DOI 10.1016/S0006-8993(97)00329-6; BERG MM, 1992, J BIOL CHEM, V267, P13; CAMPENOT RB, 1977, P NATL ACAD SCI USA, V74, P4516, DOI 10.1073/pnas.74.10.4516; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Gaidarov I, 1999, J CELL BIOL, V146, P755, DOI 10.1083/jcb.146.4.755; Grimes ML, 1997, P NATL ACAD SCI USA, V94, P9909, DOI 10.1073/pnas.94.18.9909; Grimes ML, 1996, J NEUROSCI, V16, P7950; HENDRY IA, 1974, BRAIN RES, V68, P103, DOI 10.1016/0006-8993(74)90536-8; JOHNSON EM, 1978, BRAIN RES, V150, P319, DOI 10.1016/0006-8993(78)90283-4; JOLY M, 1995, J BIOL CHEM, V270, P13225, DOI 10.1074/jbc.270.22.13225; JOLY M, 1994, SCIENCE, V263, P684, DOI 10.1126/science.8303278; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KORSCHING S, 1983, NEUROSCI LETT, V39, P1, DOI 10.1016/0304-3940(83)90155-6; Kotani K, 1999, J BIOL CHEM, V274, P21305, DOI 10.1074/jbc.274.30.21305; Lockhart ST, 1997, J NEUROSCI, V17, P9573; Mazzoni IE, 1999, J NEUROSCI, V19, P9716; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; NAGATA Y, 1987, J NEUROCHEM, V49, P296, DOI 10.1111/j.1471-4159.1987.tb03429.x; OHMICHI M, 1992, BIOCHEMISTRY-US, V31, P404; PALMATIER MA, 1984, J NEUROSCI, V4, P751; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Philpott KL, 1997, J CELL BIOL, V139, P809, DOI 10.1083/jcb.139.3.809; POWIS G, 1994, CANCER RES, V54, P2419; Reichardt L. F., 1997, MOL CELLULAR APPROAC, P220; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Sasaoka T, 1999, ENDOCRINOLOGY, V140, P3826, DOI 10.1210/en.140.8.3826; Srinivasan A, 1998, CELL DEATH DIFFER, V5, P1004, DOI 10.1038/sj.cdd.4400449; STOCKEL K, 1975, BRAIN RES, V99, P1, DOI 10.1016/0006-8993(75)90604-6; TAPLEY P, 1992, ONCOGENE, V7, P371; Tsui-Pierchala BA, 1999, J NEUROSCI, V19, P8207; TSUIPIERCHALA BA, 2000, IN PRESS J NEUROSCI; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Watson FL, 1999, J NEUROSCI, V19, P7889; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324	39	189	191	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	2000	27	3					499	512		10.1016/S0896-6273(00)00061-1	http://dx.doi.org/10.1016/S0896-6273(00)00061-1			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	359FR	11055433	Bronze			2022-12-24	WOS:000089601300014
J	Yoo, AS; Cheng, I; Chung, S; Grenfell, TZ; Lee, H; Pack-Chung, E; Handler, M; Shen, J; Xia, WM; Tesco, G; Saunders, AJ; Ding, K; Frosch, MP; Tanzi, RE; Kim, TW				Yoo, AS; Cheng, I; Chung, S; Grenfell, TZ; Lee, H; Pack-Chung, E; Handler, M; Shen, J; Xia, WM; Tesco, G; Saunders, AJ; Ding, K; Frosch, MP; Tanzi, RE; Kim, TW			Presenilin-mediated modulation of capacitative calcium entry	NEURON			English	Article							AMYLOID-BETA-PROTEIN; FAMILIAL ALZHEIMERS-DISEASE; OPERATED HTRP3 CHANNELS; CA2+ ENTRY; IN-VIVO; INTRACELLULAR CA2+; PRECURSOR PROTEIN; SENILE PLAQUES; MUTATION N141I; T-LYMPHOCYTES	We studied a novel function of the presenilins (PS1 and PS2) in governing capacitative calcium entry (CCE), a refilling mechanism for depleted intracellular calcium stores. Abrogation of functional PS1, by either knocking out PS1 or expressing inactive PS1, markedly potentiated CCE, suggesting a role for PS1 in the modulation of CCE. In contrast, familial Alzheimer's disease (FAD)-linked mutant PS1 or PS2 significantly attenuated CCE and store depletion-activated currents. While inhibition of CCE selectively increased the amyloidogenic amyloid beta peptide (Ap42), increased accumulation of the peptide had no effect on CCE. Thus, reduced CCE is most likely an early cellular event leading to increased A beta 42 generation associated with FAD mutant presenilins. Our data indicate that the CCE pathway is a novel therapeutic target for Alzheimer's disease.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol,Genet & Aging Res Unit, Charlestown, MA 02129 USA; Sungkyunkwan Univ, Sch Med, Dept Physiol, Suwon 440746, South Korea; Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Sungkyunkwan University (SKKU); Harvard University; Brigham & Women's Hospital	Kim, TW (corresponding author), Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, 630 W 168th St,P&S 14-511, New York, NY 10032 USA.	twk16@columbia.edu	Tanzi, Rudolph/AAE-9622-2019; xia, weiming/E-5465-2016; Frosch, Matthew P/ABD-7456-2021	Tanzi, Rudolph/0000-0002-7032-1454; xia, weiming/0000-0002-7463-3295; Frosch, Matthew P/0000-0002-3940-9861; Saunders, Aleister/0000-0002-7298-7823; Yoo, Andrew/0000-0002-0304-3247	NATIONAL INSTITUTE ON AGING [R01AG018026, P01AG015379] Funding Source: NIH RePORTER; NIA NIH HHS [AG05845, AG15379, AG18026] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Annaert W, 1999, TRENDS NEUROSCI, V22, P439, DOI 10.1016/S0166-2236(99)01455-1; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Berridge MJ, 2000, SCIENCE, V287, P1604, DOI 10.1126/science.287.5458.1604; Birnbaumer L, 1996, P NATL ACAD SCI USA, V93, P15195, DOI 10.1073/pnas.93.26.15195; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Boulay G, 1999, P NATL ACAD SCI USA, V96, P14955, DOI 10.1073/pnas.96.26.14955; Bouron A, 2000, FEBS LETT, V470, P269, DOI 10.1016/S0014-5793(00)01340-5; Capell A, 1998, J BIOL CHEM, V273, P3205, DOI 10.1074/jbc.273.6.3205; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Cook DG, 1996, P NATL ACAD SCI USA, V93, P9223, DOI 10.1073/pnas.93.17.9223; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Deng GM, 1996, FEBS LETT, V397, P50, DOI 10.1016/S0014-5793(96)01142-8; Doan A, 1996, NEURON, V17, P1023, DOI 10.1016/S0896-6273(00)80232-9; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Etcheberrigaray R, 1998, NEUROBIOL DIS, V5, P37, DOI 10.1006/nbdi.1998.0176; Gibson GE, 1996, BBA-MOL BASIS DIS, V1316, P71, DOI 10.1016/0925-4439(96)00002-6; Grudt TJ, 1996, MOL BRAIN RES, V36, P93, DOI 10.1016/0169-328X(95)00248-Q; Guo Q, 1996, NEUROREPORT, V8, P379, DOI 10.1097/00001756-199612200-00074; Hofer AM, 1998, J CELL BIOL, V140, P325, DOI 10.1083/jcb.140.2.325; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; ITO E, 1994, P NATL ACAD SCI USA, V91, P534, DOI 10.1073/pnas.91.2.534; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Janicki S, 1997, J CELL BIOL, V139, P485, DOI 10.1083/jcb.139.2.485; Jayadev S, 1999, J BIOL CHEM, V274, P8261, DOI 10.1074/jbc.274.12.8261; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Kerschbaum HH, 1999, SCIENCE, V283, P836, DOI 10.1126/science.283.5403.836; Kim SH, 2000, NEUROBIOL DIS, V7, P99, DOI 10.1006/nbdi.1999.0280; Kim TW, 1997, J BIOL CHEM, V272, P11006; Kimberly WT, 2000, J BIOL CHEM, V275, P3173, DOI 10.1074/jbc.275.5.3173; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Kiselyov K, 1999, MOL CELL, V4, P423, DOI 10.1016/S1097-2765(00)80344-5; Kovacs DM, 1996, NAT MED, V2, P224, DOI 10.1038/nm0296-224; Leissring MA, 1999, J BIOL CHEM, V274, P32535, DOI 10.1074/jbc.274.46.32535; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Li XJ, 1998, P NATL ACAD SCI USA, V95, P7109, DOI 10.1073/pnas.95.12.7109; Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; MASON MJ, 1993, AM J PHYSIOL, V264, pC564; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Mignen O, 2000, J BIOL CHEM, V275, P9114, DOI 10.1074/jbc.275.13.9114; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; Niwa M, 1999, CELL, V99, P691, DOI 10.1016/S0092-8674(00)81667-0; Oyama F, 1998, J NEUROCHEM, V71, P313; Pack-Chung E, 2000, J BIOL CHEM, V275, P14440, DOI 10.1074/jbc.M909882199; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Philipp S, 2000, CRC METH SIG TRANS, P321; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Putney JW, 1999, P NATL ACAD SCI USA, V96, P14669, DOI 10.1073/pnas.96.26.14669; Putney JW, 1999, CELL, V99, P5, DOI 10.1016/S0092-8674(00)80056-2; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; Ribeiro CMP, 1997, J BIOL CHEM, V272, P26555, DOI 10.1074/jbc.272.42.26555; Saura CA, 1999, J BIOL CHEM, V274, P13818, DOI 10.1074/jbc.274.20.13818; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Seeger M, 1997, P NATL ACAD SCI USA, V94, P5090, DOI 10.1073/pnas.94.10.5090; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; Selkoe DJ, 2000, CURR OPIN NEUROBIOL, V10, P50, DOI 10.1016/S0959-4388(99)00054-9; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shuttleworth TJ, 1996, J BIOL CHEM, V271, P21720, DOI 10.1074/jbc.271.36.21720; Steiner H, 1999, J BIOL CHEM, V274, P28669, DOI 10.1074/jbc.274.40.28669; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; TANZI RE, 1998, SCI AM MOL NEUROLOGY, P55; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Thinakaran G, 1998, NEUROBIOL DIS, V4, P438, DOI 10.1006/nbdi.1998.0171; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tomita T, 1999, J NEUROSCI, V19, P10627, DOI 10.1523/JNEUROSCI.19-24-10627.1999; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Vazquez G, 1998, J BIOL CHEM, V273, P33954, DOI 10.1074/jbc.273.51.33954; Waldron RT, 1997, J BIOL CHEM, V272, P6440, DOI 10.1074/jbc.272.10.6440; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wolozin B, 1996, SCIENCE, V274, P1710, DOI 10.1126/science.274.5293.1710; Xia WM, 1997, J BIOL CHEM, V272, P7977, DOI 10.1074/jbc.272.12.7977; Yao Y, 1999, CELL, V98, P475, DOI 10.1016/S0092-8674(00)81976-5; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Yoo ASJ, 1999, BRAIN RES, V827, P19, DOI 10.1016/S0006-8993(99)01282-2; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	81	256	284	0	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	2000	27	3					561	572		10.1016/S0896-6273(00)00066-0	http://dx.doi.org/10.1016/S0896-6273(00)00066-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	359FR	11055438	Bronze			2022-12-24	WOS:000089601300019
J	Liu, D; Diorio, J; Day, JC; Francis, DD; Meaney, MJ				Liu, D; Diorio, J; Day, JC; Francis, DD; Meaney, MJ			Maternal care, hippocampal synaptogenesis and cognitive development in rats	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH-FACTOR; LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; MESSENGER-RNA; NMDA RECEPTOR; MEMORY; BRAIN; EXPRESSION; RESPONSES; STRESS	We report that variations in maternal care in the rat promote hippocampal synaptogenesis and spatial learning and memory through systems known to mediate experience-dependent neural development. Thus, the offspring of mothers that show high levels of pup licking and grooming and arched-back nursing showed increased expression of NMDA receptor subunit and brain-derived neurotrophic factor (BDNF) mRNA, increased cholinergic innervation of the hippocampus and enhanced spatial learning and memory. A cross-fostering study provided evidence for a direct relationship between maternal behavior and hippocampal development, although not all neonates were equally sensitive to variations in maternal care.	McGill Univ, Dept Psychiat, Douglas Hosp, Res Ctr,Dev Neuroendocrinol Lab, Verdun, PQ H4H 1R3, Canada; McGill Univ, Dept Neurol & Neurosurg, Douglas Hosp, Res Ctr,Dev Neuroendocrinol Lab, Verdun, PQ H4H 1R3, Canada	McGill University; McGill University	Meaney, MJ (corresponding author), McGill Univ, Dept Psychiat, Douglas Hosp, Res Ctr,Dev Neuroendocrinol Lab, 6875 Boul LaSalle, Verdun, PQ H4H 1R3, Canada.	mdmm@musica.mcgill.ca	Meaney, Michael/N-5931-2019					AINSWORTH MDS, 1991, AM PSYCHOL, V46, P333, DOI 10.1037/0003-066X.46.4.333; ALBERTS JR, 1989, HDB BEHAV NEUROBIOLO, V9, P1; ALDERSON RF, 1990, NEURON, V5, P297, DOI 10.1016/0896-6273(90)90166-D; AMMERMAN RT, 1986, CLIN PSYCHOL REV, V6, P291, DOI 10.1016/0272-7358(86)90003-6; Anisman H, 1998, INT J DEV NEUROSCI, V16, P149, DOI 10.1016/S0736-5748(98)00025-2; ARAUJO DM, 1988, J NEUROCHEM, V50, P1914, DOI 10.1111/j.1471-4159.1988.tb02497.x; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calabresi P, 1998, EUR J NEUROSCI, V10, P3020, DOI 10.1046/j.1460-9568.1998.00348.x; Chao HM, 1998, ENDOCRINOLOGY, V139, P3112, DOI 10.1210/en.139.7.3112; COGILL SR, 1986, BMJ-BRIT MED J, V292, P1165, DOI 10.1136/bmj.292.6529.1165; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; DIAMOND ME, 1993, P NATL ACAD SCI USA, V90, P2082, DOI 10.1073/pnas.90.5.2082; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; Fields RD, 1996, TRENDS NEUROSCI, V19, P473, DOI 10.1016/S0166-2236(96)30013-1; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; FRIEDMAN B, 1995, J NEUROSCI, V15, P1044; GAGE FH, 1986, J NEUROSCI, V6, P2837; Jablonska B, 1996, NEUROBIOL LEARN MEM, V66, P36, DOI 10.1006/nlme.1996.0041; KIRKWOOD A, 1993, SCIENCE, V260, P1518, DOI 10.1126/science.8502997; KUCHEL GA, 1992, EXP NEUROL, V118, P73, DOI 10.1016/0014-4886(92)90024-K; Levine S, 1994, ANN NY ACAD SCI, V746, P260; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; MACCARI S, 1995, J NEUROSCI, V15, P110; Marini AM, 1998, J BIOL CHEM, V273, P29394, DOI 10.1074/jbc.273.45.29394; McCarty Richard, 1996, Physiology and Behavior, V59, P71, DOI 10.1016/0031-9384(95)02034-9; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; Mesulam M, 1982, TRACING NEURAL CONNE, P1; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; QUIRION R, 1995, J NEUROSCI, V15, P1455; SCHANBERG SM, 1987, CHILD DEV, V58, P1431, DOI 10.1111/j.1467-8624.1987.tb03856.x; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; Stern JM, 1997, DEV PSYCHOBIOL, V31, P19, DOI 10.1002/(SICI)1098-2302(199707)31:1<19::AID-DEV3>3.0.CO;2-X; Suomi SJ, 1997, BRIT MED BULL, V53, P170; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRICKETT PK, 1995, DEV REV, V15, P311, DOI 10.1006/drev.1995.1012; van Oers HJJ, 1998, J NEUROSCI, V18, P10171; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Whishaw IQ, 1998, NEUROSCI BIOBEHAV R, V22, P209, DOI 10.1016/S0149-7634(97)00002-X; WHITTEMORE SR, 1988, J NEUROSCI RES, V20, P403, DOI 10.1002/jnr.490200402; WILLIAMS K, 1991, MOL PHARMACOL, V40, P774; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605	50	827	852	2	103	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2000	3	8					799	806		10.1038/77702	http://dx.doi.org/10.1038/77702			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TU	10903573				2022-12-24	WOS:000167177300015
J	Lin, DM; Wang, F; Lowe, G; Gold, GH; Axel, R; Ngai, J; Brunet, L				Lin, DM; Wang, F; Lowe, G; Gold, GH; Axel, R; Ngai, J; Brunet, L			Formation of precise connections in the olfactory bulb occurs in the absence of odorant-evoked neuronal activity	NEURON			English	Article							RETINAL GANGLION-CELLS; OCULAR DOMINANCE COLUMNS; LATERAL GENICULATE-NUCLEUS; MEDIATED AFFERENT ACTIVITY; CAT VISUAL-CORTEX; SOMATOSENSORY CORTEX; IMPULSE BLOCKADE; AXON GUIDANCE; IN-VIVO; MICE	Olfactory neurons expressing the-same odorant receptor converge to a small number of glomeruli in the olfactory bulb. In turn, mitral and tufted cells receive and relay this information to higher cortical regions. In other sensory systems, correlated neuronal activity is thought to refine synaptic connections during development. We asked whether the pattern of connections between olfactory sensory axons and mitral cell dendrites is affected when odor-evoked signaling is eliminated in mice lacking functional olfactory cyclic nucleotide-gated (CNG) channels. We demonstrate that olfactory sensory axons converge normally in the CNG channel mutant background. We further show that the pruning of mitral cell dendrites, although slowed during development, is ultimately unperturbed in mutant animals. Thus, the olfactory CNG channel-and by inference correlated neural activity-is not required for generating synaptic specificity in the olfactory bulb.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA; Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	University of California System; University of California Berkeley; Columbia University; Howard Hughes Medical Institute; Monell Chemical Senses Center	Ngai, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, 229 Stanley Hall, Berkeley, CA 94720 USA.			Axel, Richard/0000-0002-3141-4076				Baker H, 1999, J NEUROSCI, V19, P9313; Barth AL, 1997, NEURON, V19, P359, DOI 10.1016/S0896-6273(00)80945-9; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Bisti S, 1998, J NEUROSCI, V18, P5019; BODNARENKO SR, 1993, NATURE, V364, P144, DOI 10.1038/364144a0; BODNARENKO SR, 1995, J NEUROSCI, V15, P7037; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BRUNJES PC, 1994, BRAIN RES REV, V19, P146; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Campbell G, 1997, VISUAL NEUROSCI, V14, P779, DOI 10.1017/S0952523800012724; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Fox K, 1996, P NATL ACAD SCI USA, V93, P5584, DOI 10.1073/pnas.93.11.5584; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Glazewski S, 1996, SCIENCE, V272, P421, DOI 10.1126/science.272.5260.421; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GUBBAY J, 1992, P NATL ACAD SCI USA, V89, P7953, DOI 10.1073/pnas.89.17.7953; HINDS JW, 1973, J COMP NEUROL, V151, P281, DOI 10.1002/cne.901510305; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Hubener M, 1999, NAT NEUROSCI, V2, P1043, DOI 10.1038/15964; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; LAU KC, 1990, J COMP NEUROL, V300, P583, DOI 10.1002/cne.903000411; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; LEVENTHAL AG, 1983, J NEUROSCI, V3, P332; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; Lin DM, 1999, CURR OPIN NEUROBIOL, V9, P74, DOI 10.1016/S0959-4388(99)80009-9; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Malun D, 1996, J COMP NEUROL, V368, P1, DOI 10.1002/(SICI)1096-9861(19960422)368:1<1::AID-CNE1>3.0.CO;2-7; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MORI K, 1987, PROG NEUROBIOL, V29, P275, DOI 10.1016/0301-0082(87)90024-4; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; OKANO M, 1974, J PHYSIOL-LONDON, V242, P353, DOI 10.1113/jphysiol.1974.sp010711; OTTOSON D, 1956, ACTA PHYSIOL SC S122, V35, P1; POMEROY SL, 1990, J NEUROSCI, V10, P1952; Rajan I, 1998, J NEUROSCI, V18, P7836; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; ROCHA M, 1995, P NATL ACAD SCI USA, V92, P8026, DOI 10.1073/pnas.92.17.8026; Royal SJ, 1999, J NEUROSCI, V19, P9856; SANTACANA M, 1992, DEV BRAIN RES, V65, P75, DOI 10.1016/0165-3806(92)90010-T; SCHLAGGAR BL, 1993, NATURE, V364, P623, DOI 10.1038/364623a0; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; Shepherd G.M., 1979, SYNAPTIC ORG BRAIN; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; STRYKER MP, 1986, J NEUROSCI, V6, P2117; STUERMER CAO, 1990, J NEUROSCI, V10, P3615; Sur M, 1999, J NEUROBIOL, V41, P33, DOI 10.1002/(SICI)1097-4695(199910)41:1<33::AID-NEU6>3.0.CO;2-1; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; WANG HW, 1993, SCIENCE, V260, P998, DOI 10.1126/science.8493539; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; WILKINSON DG, 1987, DEVELOPMENT, V99, P493; WONG ROL, 1991, J NEUROBIOL, V22, P685, DOI 10.1002/neu.480220704	58	158	159	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	2000	26	1					69	80		10.1016/S0896-6273(00)81139-3	http://dx.doi.org/10.1016/S0896-6273(00)81139-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309MA	10798393	Bronze			2022-12-24	WOS:000086770500009
J	Lu, QR; Yuk, DI; Alberta, JA; Zhu, ZM; Pawlitzky, I; Chan, J; McMahon, AP; Stiles, CD; Rowitch, DH				Lu, QR; Yuk, DI; Alberta, JA; Zhu, ZM; Pawlitzky, I; Chan, J; McMahon, AP; Stiles, CD; Rowitch, DH			Sonic hedgehog-regulateld oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system	NEURON			English	Article							VENTRAL NEURAL-TUBE; ZONE PROGENITOR CELLS; SPINAL-CORD; FLOOR PLATE; VENTRICULAR ZONE; STEM-CELLS; HOMEODOMAIN PROTEIN; NEURONAL FATE; MESSENGER-RNA; GROWTH-FACTOR	During development, basic helix-loop-helix (bHLH) proteins regulate formation of neurons from multipotent progenitor cells. However, bHLH factors linked to gliogenesis have not been described. We have isolated a pair of oligodendrocyte lineage genes (Olg-1 and Olg-2) that encode bHLH proteins and are tightly associated with development of oligodendrocytes in the vertebrate central nervous system (CNS). Ectopic expression of Olg-1 in rat cortical progenitor cell cultures promotes formation of oligodendrocyte precursors. In developing mouse embryos, Olg gene expression overlaps but precedes the earliest known markers of the oligodendrocyte lineage. Olg genes are expressed at the tetencephalon-diencephalon border and adjacent to the floor plate, a source of the secreted signaling molecule Sonic hedgehog (Shh). Gain- and loss-of-function analyses in transgenic mice demonstrate that Shh is both necessary and sufficient for Olg gene expression in vivo.	Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University	Stiles, CD (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.		McMahon, Andrew P/ABE-7520-2020; Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763; Rowitch, David/0000-0002-0079-0060	NICHD NIH HHS [HD01182, HD24296] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Barres BA, 1996, MOL CELL NEUROSCI, V8, P146, DOI 10.1006/mcne.1996.0053; BARRES BA, 1994, DEVELOPMENT, V120, P1097; Bhat RV, 1996, GLIA, V17, P169; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; BOWENPOPE DF, 1991, TRENDS GENET, V7, P413, DOI 10.1016/0168-9525(91)90222-C; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dutton R, 1999, J NEUROSCI, V19, P2601; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; ECHELARD Y, 1994, DEVELOPMENT, V120, P2213; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ericson J, 1997, COLD SPRING HARB SYM, V62, P451; Fruttiger M, 1999, DEVELOPMENT, V126, P457; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; GROVES AK, 1995, DEVELOPMENT, V121, P887; Hall A, 1996, DEVELOPMENT, V122, P4085; Hardy RJ, 1997, J NEUROSCI RES, V50, P139, DOI 10.1002/(SICI)1097-4547(19971015)50:2<139::AID-JNR3>3.0.CO;2-G; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HELDIN CH, 1993, GROWTH FACTORS, V8, P245, DOI 10.3109/08977199308991570; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; Kim JS, 1998, P NATL ACAD SCI USA, V95, P12364, DOI 10.1073/pnas.95.21.12364; KLAES A, 1994, CELL, V78, P149, DOI 10.1016/0092-8674(94)90581-9; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; LEVINE JM, 1989, NEURON, V3, P103, DOI 10.1016/0896-6273(89)90119-0; Levine JM, 1996, PERSPECT DEV NEUROBI, V3, P245; Lo LC, 1999, NEURON, V22, P693, DOI 10.1016/S0896-6273(00)80729-1; Ma QF, 1997, J NEUROSCI, V17, P3644; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; MARTI E, 1995, DEVELOPMENT, V121, P2537; MERCOLA M, 1990, DEV BIOL, V138, P114, DOI 10.1016/0012-1606(90)90181-H; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; NOLL E, 1993, DEVELOPMENT, V118, P563; ONO K, 1995, DEVELOPMENT, V121, P1743; Orentas DM, 1999, DEVELOPMENT, V126, P2419; ORNITZ DM, 1991, P NATL ACAD SCI USA, V88, P698, DOI 10.1073/pnas.88.3.698; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Poncet C, 1996, MECH DEVELOP, V60, P13, DOI 10.1016/S0925-4773(96)00595-3; PRICE M, 1992, NEURON, V8, P241, DOI 10.1016/0896-6273(92)90291-K; Pringle NP, 1998, NEURON, V20, P883, DOI 10.1016/S0896-6273(00)80470-5; Pringle NP, 1996, DEV BIOL, V177, P30, DOI 10.1006/dbio.1996.0142; PRINGLE NP, 1993, DEVELOPMENT, V117, P525; Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9; REDDY UR, 1992, J NEUROSCI RES, V31, P670, DOI 10.1002/jnr.490310411; REYNOLDS R, 1997, J NEUROSCI RES, V47, P55; RICHARDSON WD, 1999, IN PRESS GLIA; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; ROWITCH DH, 1999, IN PRESS J NEUROSCI; SAITO T, 1995, MOL CELL NEUROSCI, V6, P280, DOI 10.1006/mcne.1995.1022; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Stemple DL, 1997, NEURON, V18, P1, DOI 10.1016/S0896-6273(01)80018-0; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; Sun T, 1998, MOL CELL NEUROSCI, V12, P228, DOI 10.1006/mcne.1998.0711; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; TANABE Y, 1995, CURR BIOL, V5, P651, DOI 10.1016/S0960-9822(95)00130-8; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; TIMSIT S, 1995, J NEUROSCI, V15, P1012; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Williams BP, 1997, NEURON, V18, P553, DOI 10.1016/S0896-6273(00)80297-4; WILLIAMS BP, 1995, NEURON, V14, P1181, DOI 10.1016/0896-6273(95)90265-1; YU WP, 1994, NEURON, V12, P1353, DOI 10.1016/0896-6273(94)90450-2	66	666	696	0	17	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	2000	25	2					317	329		10.1016/S0896-6273(00)80897-1	http://dx.doi.org/10.1016/S0896-6273(00)80897-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	288EL	10719888	Bronze			2022-12-24	WOS:000085549100011
J	Cowley, MA; Pronchuk, N; Fan, W; Dinulescu, DM; Colmers, WF; Cone, RD				Cowley, MA; Pronchuk, N; Fan, W; Dinulescu, DM; Colmers, WF; Cone, RD			Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: Evidence of a cellular basis for the adipostat	NEURON			English	Article							AGOUTI-RELATED PROTEIN; NEUROPEPTIDE-Y; FRAMESHIFT MUTATION; ENERGY HOMEOSTASIS; LEPTIN RECEPTOR; ARCUATE NUCLEUS; MESSENGER-RNA; IN-VIVO; NEURONS; OBESITY	Energy stores are held relatively constant in many mammals. The circuitry necessary for maintaining energy homeostasis should (1) sense the amount of energy stored in adipose tissue, (2) sense and integrate the multiple opposing signals regarding nutritional state, and (3) provide output regulating energy intake and expenditure to maintain energy homeostasis. We demonstrate that individual neurons within the paraventricular nucleus of the hypothalamus (PVH) are capable of detection and integration of orexigenic (neuropeptide Y [NPY]) and anorexigenic (melanocortin) signals, that NPY and melanocortins are functional antagonists of each other within the PVH in the regulation of feeding behavior, and that melanocortin administration within the PVH regulates both feeding behavior and energy expenditure. These data provide a cellular basis for the adipostat within neurons in the PVH that appear to be jointly regulated by NPY- and melanocortin-responsive neurons.	Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2H7, Canada; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	University of Alberta; Oregon Health & Science University	Colmers, WF (corresponding author), Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2H7, Canada.	william.colmers@ualberta.ca; cone@ohsu.edu	Colmers, William/C-3106-2013; Cowley, Michael A/B-9428-2008	Colmers, William/0000-0001-7902-3560; Cowley, Michael A/0000-0001-7811-134X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051730] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK51730] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BILLINGTON CJ, 1991, AM J PHYSIOL, V260, pR321, DOI 10.1152/ajpregu.1991.260.2.R321; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Cheung CC, 1997, ENDOCRINOLOGY, V138, P4489, DOI 10.1210/en.138.10.4489; Chieng B, 1998, J NEUROSCI, V18, P7033; COLMERS WF, 1994, TRENDS NEUROSCI, V17, P373, DOI 10.1016/0166-2236(94)90046-9; Cone RD, 1996, RECENT PROG HORM RES, V51, P287; EGAWA M, 1991, AM J PHYSIOL, V260, P328; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Fong TM, 1997, BIOCHEM BIOPH RES CO, V237, P629, DOI 10.1006/bbrc.1997.7200; Giraudo SQ, 1998, BRAIN RES, V809, P302, DOI 10.1016/S0006-8993(98)00837-3; Glaum SR, 1996, MOL PHARMACOL, V50, P230; Graham M, 1997, NAT GENET, V17, P273, DOI 10.1038/ng1197-273; Gu GB, 1997, J COMP NEUROL, V384, P142; Hakansson ML, 1996, NEUROREPORT, V7, P3087, DOI 10.1097/00001756-199611250-00059; Haskell-Luevano C, 1999, ENDOCRINOLOGY, V140, P1408, DOI 10.1210/en.140.3.1408; Haynes WG, 1999, HYPERTENSION, V33, P542, DOI 10.1161/01.HYP.33.1.542; HERZOG H, 1992, P NATL ACAD SCI USA, V89, P5794, DOI 10.1073/pnas.89.13.5794; HOFFMAN NW, 1991, J COMP NEUROL, V307, P405, DOI 10.1002/cne.903070306; HRUBY VJ, 1995, J MED CHEM, V38, P3454, DOI 10.1021/jm00018a005; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Ingram SL, 1998, J NEUROSCI, V18, P10269; Kalra SP, 1999, ENDOCR REV, V20, P68, DOI 10.1210/er.20.1.68; KENNEDY GC, 1953, P ROY SOC LOND B BIO, V140, P579; KLAPSTEIN GJ, 1990, ANN NY ACAD SCI, V611, P457; KONDA Y, 1994, J BIOL CHEM, V269, P13162; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; LARSEN PJ, 1992, BRAIN RES, V573, P181, DOI 10.1016/0006-8993(92)90761-W; LEE WS, 1993, ENDOCRINOLOGY, V133, P2248, DOI 10.1210/en.133.5.2248; MCQUISTON AR, 1992, NEUROSCI LETT, V138, P261, DOI 10.1016/0304-3940(92)90929-2; Mercer JG, 1996, J NEUROENDOCRINOL, V8, P733, DOI 10.1046/j.1365-2826.1996.05161.x; MITCHEL JS, 1977, PHYSIOL BEHAV, V18, P1121, DOI 10.1016/0031-9384(77)90020-8; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; NILAVER G, 1979, J CELL BIOL, V81, P50; Obrietan K, 1996, J NEUROSCI, V16, P3521; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Qian J, 1997, J NEUROSCI, V17, P8169; ROSELLIREHFUSS L, 1993, P NATL ACAD SCI USA, V90, P8856, DOI 10.1073/pnas.90.19.8856; Rossi M, 1998, ENDOCRINOLOGY, V139, P4428, DOI 10.1210/en.139.10.4428; SAWCHENKO PE, 1985, J COMP NEUROL, V241, P138, DOI 10.1002/cne.902410203; Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593; Stanley B.G., 1993, BIOL NEUROPEPTIDE RE, P457, DOI [10.1007/978-1-59259-465-8_11, DOI 10.1007/978-1-59259-465-8_11]; STEFFENS AB, 1975, AM J PHYSIOL, V228, P1738, DOI 10.1152/ajplegacy.1975.228.6.1738; Tomaszuk A, 1996, HORM RES, V46, P53, DOI 10.1159/000184996; TOTH PT, 1993, NATURE, V364, P635, DOI 10.1038/364635a0; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; WATSON SJ, 1978, NATURE, V275, P226, DOI 10.1038/275226a0; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404	52	487	503	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1999	24	1					155	163		10.1016/S0896-6273(00)80829-6	http://dx.doi.org/10.1016/S0896-6273(00)80829-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241QC	10677034	Bronze			2022-12-24	WOS:000082893200016
J	Shi, J; Townsend, M; Constantine-Paton, M				Shi, J; Townsend, M; Constantine-Paton, M			Activity-dependent induction of tonic calcineurin activity mediates a rapid developmental downregulation of NMDA receptor currents	NEURON			English	Article							NR2A SUBUNIT EXPRESSION; RAT SUPERIOR COLLICULUS; LONG-TERM POTENTIATION; PROTEIN-KINASE-A; SYNAPTIC CURRENTS; VISUAL-CORTEX; FUNCTIONAL-PROPERTIES; RESPONSES; PHOSPHORYLATION; CYCLOSPORINE	Whole-cell recording in the superficial layers of the developing superior colliculus (sSC) reveals a large drop in NMDA receptor (NMDAR) current decay time synchronized across all neurons and occurring consistently between p10 and P11. We show that blocking the Ca2+/calmodulin-dependent phosphatase calcineurin (CaN) in the postsynaptic neuron can abolish this drop. The regulation is induced prematurely by 1-2 hr of electrical stimulation in pig collicular slices only if CaN and NMDAR currents can be activated in the neuron. These data suggest that a long-lasting, CaN-mediated control of NMDAR kinetics is rapidly initiated by heightened activity of the NMDAR itself and demonstrate a novel developmental and tonic function of CaN that can play an important role in modulating the plasticity of the developing CNS.	MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Yale Univ, Interdept Neurosci Program, New Haven, CT 06520 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Yale University	Constantine-Paton, M (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mcpaton@mit.edu			NEI NIH HHS [5T32EY07115] Funding Source: Medline; NIDA NIH HHS [5T32DA07290] Funding Source: Medline; NINDS NIH HHS [NS32290] Funding Source: Medline; NATIONAL EYE INSTITUTE [T32EY007115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007290] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Aamodt S M, 1999, Adv Neurol, V79, P133; Aamodt SM, 2000, J NEUROPHYSIOL, V83, P1580, DOI 10.1152/jn.2000.83.3.1580; Antoni FA, 1998, J NEUROSCI, V18, P9650; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; DANGELO E, 1994, EUR J NEUROSCI, V6, P640, DOI 10.1111/j.1460-9568.1994.tb00309.x; DAW NW, 1993, ANNU REV NEUROSCI, V16, P207, DOI 10.1146/annurev.ne.16.030193.001231; DONEVAN SD, 1993, NEURON, V10, P51, DOI 10.1016/0896-6273(93)90241-I; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Feldman DE, 1996, SCIENCE, V271, P525, DOI 10.1126/science.271.5248.525; Flint AC, 1997, J NEUROSCI, V17, P2469; Fortin S, 1999, DEV BRAIN RES, V112, P55, DOI 10.1016/S0165-3806(98)00157-6; FOX K, 1991, NATURE, V350, P342, DOI 10.1038/350342a0; Halpain S, 1998, J NEUROSCI, V18, P9835; HASHIMOTO Y, 1990, J BIOL CHEM, V265, P1924; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; HOLLINGSWORTH EB, 1985, J NEUROSCI, V5, P2240; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Itaya SK, 1995, CAN J PHYSIOL PHARM, V73, P1372, DOI 10.1139/y95-192; Kashishian A, 1998, J BIOL CHEM, V273, P27412, DOI 10.1074/jbc.273.42.27412; KOMURO H, 1993, SCIENCE, V260, P95, DOI 10.1126/science.8096653; KONNERTH BU, 1990, J PHYSL, V435, P275; LEGRENDE P, 1991, MOL PHARMACOL, V40, P289; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; Lin X, 1999, J BIOL CHEM, V274, P36125, DOI 10.1074/jbc.274.51.36125; Lindlbauer R, 1998, J PHYSIOL-LONDON, V508, P495, DOI 10.1111/j.1469-7793.1998.00495.x; LIU J, 1993, IMMUNOL TODAY, V14, P290, DOI 10.1016/0167-5699(93)90048-P; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Nase G, 1999, EUR J NEUROSCI, V11, P4320, DOI 10.1046/j.1460-9568.1999.00859.x; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Ramoa AS, 1997, DEV BRAIN RES, V101, P165, DOI 10.1016/S0165-3806(97)00061-8; Roberts EB, 1999, J NEUROPHYSIOL, V81, P2587, DOI 10.1152/jn.1999.81.5.2587; Rumbaugh G, 2000, J NEUROPHYSIOL, V83, P1300, DOI 10.1152/jn.2000.83.3.1300; Scheetz AJ, 1997, P NATL ACAD SCI USA, V94, P14770, DOI 10.1073/pnas.94.26.14770; SCHEETZ AJ, 1994, FASEB J, V8, P745, DOI 10.1096/fasebj.8.10.8050674; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Shi J, 1997, J NEUROSCI, V17, P6264; SIMON DK, 1992, J NEUROSCI, V12, P1212; Snyder GL, 1998, J NEUROSCI, V18, P10297; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Sun L, 1998, IMMUNITY, V8, P703, DOI 10.1016/S1074-7613(00)80575-0; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; Tovar KR, 1999, J NEUROSCI, V19, P4180; Wang XT, 1996, NATURE, V383, P434, DOI 10.1038/383434a0; WILLIAMS K, 1993, NEURON, V10, P267, DOI 10.1016/0896-6273(93)90317-K; Wong WT, 2000, J NEUROSCI, V20, P351, DOI 10.1523/JNEUROSCI.20-01-00351.2000; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; ZORUMSKI CF, 1993, NEURON, V10, P61, DOI 10.1016/0896-6273(93)90242-J	53	79	82	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	2000	28	1					103	114		10.1016/S0896-6273(00)00089-1	http://dx.doi.org/10.1016/S0896-6273(00)00089-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	370VN	11086987	Bronze			2022-12-24	WOS:000165143500014
J	Han, VZ; Grant, K; Bell, CC				Han, VZ; Grant, K; Bell, CC			Reversible associative depression and nonassociative potentiation at a parallel fiber synapse	NEURON			English	Article							LONG-TERM POTENTIATION; MORMYRID ELECTROSENSORY LOBE; PURKINJE-CELL TRANSMISSION; LATERAL-LINE LOBE; HIPPOCAMPAL-NEURONS; CEREBELLAR CULTURE; ELECTRIC FISH; PLASTICITY; MECHANISMS; REAFFERENCE	The electrosensory robe (ELL) of mormyrid electric fish is one of several cerebellum-like sensory structures in fish that remove predictable features of the sensory inflow. This adaptive process obeys anti-Hebbian rules and appears to be mediated by associative depression at the synapses between parallel fibers and Purkinje-like cells of ELL. We show here that there is also a nonassociative potentiation at this synapse that depends only on the repeated occurrence of the EPSP. The depression can be reversed by the potentiation and vice versa. Finally, we show that the associative depression requires NMDA receptor activation, changes in postsynaptic calcium, and the occurrence of a postsynaptic dendritic spike within a few milliseconds following EPSP onset.	Oregon Hlth Sci Univ, Inst Neurol Sci, Portland, OR 97209 USA; CNRS, Inst Alfred Fessard, F-91190 Gif Sur Yvette, France	Oregon Health & Science University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Bell, CC (corresponding author), Oregon Hlth Sci Univ, Inst Neurol Sci, Portland, OR 97209 USA.							BASTIAN J, 1995, J COMP PHYSIOL A, V176, P63; Bastian J, 1998, J NEUROPHYSIOL, V80, P3352, DOI 10.1152/jn.1998.80.6.3352; Bastian J, 1998, J NEUROPHYSIOL, V79, P1839, DOI 10.1152/jn.1998.79.4.1839; Bell C, 1997, BRAIN BEHAV EVOLUT, V50, P17, DOI 10.1159/000113352; BELL CC, 1993, P NATL ACAD SCI USA, V90, P4650, DOI 10.1073/pnas.90.10.4650; Bell CC, 1997, J NEUROSCI, V17, P6409; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; BELL CC, 1981, SCIENCE, V214, P450, DOI 10.1126/science.7291985; Berman NJ, 1998, J NEUROPHYSIOL, V80, P3214, DOI 10.1152/jn.1998.80.6.3214; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BODZNICK D, 1993, BIOL BULL, V185, P312, DOI 10.1086/BBLv185n2p312b; Bodznick D, 1999, J EXP BIOL, V202, P1357; DUDEK SM, 1993, J NEUROSCI, V13, P2910; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; Fregnac Y., 1995, HDB BRAIN THEORY NEU, P459; Grant K, 1998, J NEUROSCI, V18, P6009; Hebb Donald O., 1949, ORG BEHAV; HEMART N, 1994, NEUROSCI RES, V19, P213, DOI 10.1016/0168-0102(94)90145-7; HIRANO T, 1991, SYNAPSE, V7, P321, DOI 10.1002/syn.890070408; Houk J., 1990, NEURAL NETWORKS CONT, P301; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; KANO M, 1988, NEUROSCI RES, V5, P325, DOI 10.1016/0168-0102(88)90034-X; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; Linden DJ, 1997, NEURON, V18, P983, DOI 10.1016/S0896-6273(00)80337-2; Manis PB, 1996, J NEUROPHYSIOL, V76, P1639, DOI 10.1152/jn.1996.76.3.1639; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mauk MD, 1997, LEARN MEMORY, V4, P130, DOI 10.1101/lm.4.1.130; Meek J, 1996, J COMP NEUROL, V375, P43, DOI 10.1002/(SICI)1096-9861(19961104)375:1<43::AID-CNE3>3.0.CO;2-O; Montgomery J. C., 1995, AUDIT NEUROSCI, P207; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; NELSON ME, 1995, J COMP PHYSIOL A, V177, P723; Raymond JL, 1998, J NEUROSCI, V18, P9112; Roberts PD, 2000, J COMPUT NEUROSCI, V9, P67, DOI 10.1023/A:1008938428112; SAKURAI M, 1987, J PHYSIOL-LONDON, V394, P463, DOI 10.1113/jphysiol.1987.sp016881; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; SEJNOWSKI IJ, 1977, J THEOR BIOL, V69, P385, DOI 10.1016/0022-5193(77)90146-1; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Willshaw D, 1990, NEURAL COMPUT, V2, P85, DOI 10.1162/neco.1990.2.1.85; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	43	110	112	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	2000	27	3					611	622		10.1016/S0896-6273(00)00070-2	http://dx.doi.org/10.1016/S0896-6273(00)00070-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	359FR	11055442	Bronze			2022-12-24	WOS:000089601300023
J	Castellani, V; Chedotal, A; Schachner, M; Faivre-Sarrailh, C; Rougon, G				Castellani, V; Chedotal, A; Schachner, M; Faivre-Sarrailh, C; Rougon, G			Analysis of the L1-deficient mouse phenotype reveals cross-talk between Sema3A and L1 signaling pathways in axonal guidance	NEURON			English	Article							ADHESION MOLECULE L1; NEURITE OUTGROWTH; SEMAPHORIN-III; NERVOUS-SYSTEM; SPINAL-CORD; IMMUNOGLOBULIN SUPERFAMILY; EPH RECEPTOR; NEUROPILIN; ATTRACTION; REPULSION	In humans, defects of the corticospinal tract have been attributed to mutations in the gene encoding L1 CAM, a phenotype that is reproduced in L1-deficient mice. Using coculture assays, we report that Sema3A secreted from the ventral spinal cord repels cortical axons from wild-type but not from L1-deficient mice. L1 and neuropilin-1 (NP-1) form a stable complex, and their extracellular domains can directly associate. Thus, L1 is a component of the Sema3A receptor complex, and L1 mutations may disrupt Sema3A signaling in the growth cone, leading to guidance errors. Addition of soluble L1Fc chimeric molecules does not restore Sema3A responsiveness of L1-deficient axons; instead, it converts the repulsion of wild-type axons into an attraction, further supporting a function for L1 in the Sema3A transducing pathways within the growth cone.	IBDM, Lab Genet & Physiol Dev, UMR 6545 CNRS, F-13288 Marseille 9, France; Hop La Pitie Salpetriere, INSERM, U106, F-75013 Paris, France; Univ Hamburg, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Hamburg; University Medical Center Hamburg-Eppendorf	Rougon, G (corresponding author), IBDM, Lab Genet & Physiol Dev, UMR 6545 CNRS, Parc Sci Luminy, F-13288 Marseille 9, France.		Chedotal, Alain/F-2750-2017; Faivre-Sarrailh, Catherine/M-6738-2016; ROUGON, Genevieve/G-2578-2013; castellani, valérie/H-3100-2017	Chedotal, Alain/0000-0001-7577-3794; castellani, valérie/0000-0001-9623-9312; Faivre-Sarrailh, Catherine/0000-0002-1718-0533; ROUGON, Genevieve/0000-0003-1316-8200				Bagnard D, 1998, DEVELOPMENT, V125, P5043; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Brummendorf T, 1996, CURR OPIN NEUROBIOL, V6, P584, DOI 10.1016/S0959-4388(96)80089-4; BurdenGulley SM, 1997, CELL TISSUE RES, V290, P415, DOI 10.1007/s004410050948; Castellani V, 1999, DEVELOPMENT, V126, P3335; Castellani V, 1998, J NEUROSCI, V18, P4663; Chedotal A, 1998, DEVELOPMENT, V125, P4313; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Chen TT, 1999, MAR BIOTECHNOL, V1, P1; Cohen NR, 1998, CURR BIOL, V8, P26, DOI 10.1016/S0960-9822(98)70017-X; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; DAVIS JQ, 1994, J BIOL CHEM, V269, P27163; Demyanenko GP, 1999, J NEUROSCI, V19, P4907; DOHERTY P, 1995, NEURON, V14, P57, DOI 10.1016/0896-6273(95)90240-6; FaivreSarrailh C, 1997, MOL CELL NEUROSCI, V9, P109, DOI 10.1006/mcne.1997.0609; FITZGERALD M, 1993, DEVELOPMENT, V117, P1377; Hall H, 1996, CELL ADHES COMMUN, V3, P441, DOI 10.3109/15419069609081021; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hillenbrand R, 1999, EUR J NEUROSCI, V11, P813, DOI 10.1046/j.1460-9568.1999.00496.x; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; JOOSTEN EAJ, 1989, NEUROSCI LETT, V100, P94, DOI 10.1016/0304-3940(89)90666-6; Kamiguchi H, 1998, MOL CELL NEUROSCI, V12, P48, DOI 10.1006/mcne.1998.0702; Kawakami A, 1996, J NEUROBIOL, V29, P1, DOI 10.1002/(SICI)1097-4695(199601)29:1<1::AID-NEU1>3.0.CO;2-F; Kenwrick S, 1998, BIOESSAYS, V20, P668, DOI 10.1002/(SICI)1521-1878(199808)20:8<668::AID-BIES10>3.0.CO;2-X; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Kunz S, 1996, J CELL BIOL, V135, P253, DOI 10.1083/jcb.135.1.253; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; MILEV P, 1994, J CELL BIOL, V127, P1703, DOI 10.1083/jcb.127.6.1703; MILLER MW, 1988, BRAIN RES, V457, P44, DOI 10.1016/0006-8993(88)90055-8; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Montgomery AMP, 1996, J CELL BIOL, V132, P475, DOI 10.1083/jcb.132.3.475; OLEARY DDM, 1993, NEURON, V10, P991, DOI 10.1016/0896-6273(93)90049-W; OLIVE S, 1995, J NEUROCHEM, V65, P2307; Polleux F, 1998, SCIENCE, V282, P1904, DOI 10.1126/science.282.5395.1904; Puschel AW, 1996, MOL CELL NEUROSCI, V7, P419, DOI 10.1006/mcne.1996.0030; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; SCHACHNER M, 1991, ANN NY ACAD SCI, V633, P105; Seeger MA, 1999, CELL, V97, P821, DOI 10.1016/S0092-8674(00)80793-X; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Stein E, 1998, J BIOL CHEM, V273, P1303, DOI 10.1074/jbc.273.3.1303; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wong JTW, 1999, NAT NEUROSCI, V2, P798, DOI 10.1038/12168; WRIGHT DE, 1995, J COMP NEUROL, V361, P321, DOI 10.1002/cne.903610209	49	336	341	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG	2000	27	2					237	249		10.1016/S0896-6273(00)00033-7	http://dx.doi.org/10.1016/S0896-6273(00)00033-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	347YD	10985345	Bronze			2022-12-24	WOS:000088956000009
J	Zhang, LI; Tao, HW; Poo, M				Zhang, LI; Tao, HW; Poo, M			Visual input induces long-term potentiation of developing retinotectal synapses	NATURE NEUROSCIENCE			English	Article							OCULAR DOMINANCE COLUMNS; RECEPTOR ANTAGONISTS DISRUPT; SYNAPTIC PLASTICITY; CRITICAL PERIOD; CORTEX; NMDA; EXPERIENCE; MAP; TRANSMISSION; GOLDFISH	Early visual experience is essential in the refinement of developing neural connections. In vivo whole-cell recording from the tectum of Xenopus tadpoles showed that repetitive dimming-light stimulation applied to the contralateral eye resulted in persistent enhancement of glutamatergic inputs, but not GABAergic or glycinergic inputs, on tectal neurons. This enhancement can be attributed to potentiation of retinotectal synapses. It required spiking of postsynaptic tectal cells as well as activation of NMDA receptors, and effectively occluded long-term potentiation (LTP) of retinotectal synapses induced by direct electrical stimulation of retinal ganglion cells. Thus, LTP-like synaptic modification can be induced by natural visual inputs and may be part of the underlying mechanism for the activity-dependent refinement of developing connections.	Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Poo, M (corresponding author), Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA.		Tao, Huizhong W/HDM-9767-2022					Aamodt S M, 1999, Adv Neurol, V79, P133; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; BEAR MF, 1990, J NEUROSCI, V10, P909; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; CLINE HT, 1989, NEURON, V3, P413, DOI 10.1016/0896-6273(89)90201-8; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Edwards JA, 1999, J NEUROPHYSIOL, V81, P895, DOI 10.1152/jn.1999.81.2.895; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; FAWCETT JW, 1982, NATURE, V296, P350, DOI 10.1038/296350a0; GAZE RM, 1974, PROC R SOC SER B-BIO, V185, P301, DOI 10.1098/rspb.1974.0021; HAHM JO, 1991, NATURE, V351, P568, DOI 10.1038/351568a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOLT CE, 1983, NATURE, V301, P150, DOI 10.1038/301150a0; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; KOMATSU Y, 1988, J NEUROPHYSIOL, V59, P124, DOI 10.1152/jn.1988.59.1.124; LETTVIN JP, 1959, P IRE, V47, P1950; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MOONEY R, 1993, NEURON, V10, P815, DOI 10.1016/0896-6273(93)90198-Z; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Oda Y, 1998, NATURE, V394, P182, DOI 10.1038/28172; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; PERKINS AT, 1988, BRAIN RES, V439, P222; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; REH TA, 1985, J NEUROSCI, V5, P1132; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Rittenhouse CD, 1999, NATURE, V397, P347, DOI 10.1038/16922; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; SCHERER WJ, 1989, J NEUROSCI, V9, P3837; SCHLAGGAR BL, 1993, NATURE, V364, P623, DOI 10.1038/364623a0; SCHMIDT JT, 1993, J NEUROBIOL, V24, P384, DOI 10.1002/neu.480240310; SCHMIDT JT, 1990, J NEUROSCI, V10, P233; SIMON DK, 1992, P NATL ACAD SCI USA, V89, P10593, DOI 10.1073/pnas.89.22.10593; STRYKER MP, 1986, J NEUROSCI, V6, P2117; UDIN SB, 1983, NATURE, V301, P336, DOI 10.1038/301336a0; Weliky M, 1997, NATURE, V386, P680, DOI 10.1038/386680a0; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Xu L, 1998, NATURE, V394, P891, DOI 10.1038/29783; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	49	98	101	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2000	3	7					708	715		10.1038/76665	http://dx.doi.org/10.1038/76665			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TT	10862704				2022-12-24	WOS:000167177200018
J	Dalton, P; Doolittle, N; Nagata, H; Breslin, PAS				Dalton, P; Doolittle, N; Nagata, H; Breslin, PAS			The merging of the senses: integration of subthreshold taste and smell	NATURE NEUROSCIENCE			English	Article							CORTEX		Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	Monell Chemical Senses Center	Dalton, P (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.			Breslin, Paul/0000-0001-5988-8401	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003704, R29DC002995] Funding Source: NIH RePORTER; NIDCD NIH HHS [R29-DC02995, R01-DC03704] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		FOWLER CA, 1991, J EXP PSYCHOL HUMAN, V17, P816, DOI 10.1037/0096-1523.17.3.816; FRANK RA, 1988, CHEM SENSES, V13, P445, DOI 10.1093/chemse/13.3.445; GIELEN SCAM, 1983, PERCEPT PSYCHOPHYS, V34, P161, DOI 10.3758/BF03211343; GUADAGNI DG, 1963, NATURE, V200, P1288, DOI 10.1038/2001288a0; KAPP B S, 1992, P229; KRUSHEL LA, 1988, J COMP NEUROL, V270, P39, DOI 10.1002/cne.902700105; MURPHY C, 1977, SENS PROCESS, V1, P204; ROLLS ET, 1994, J NEUROSCI, V14, P5437; Schifferstein HNJ, 1996, ACTA PSYCHOL, V94, P87, DOI 10.1016/0001-6918(95)00040-2; Schul R, 1996, BEHAV NEUROSCI, V110, P760; Sparks David L., 1995, P565; Stevens JC, 1997, PHYSIOL BEHAV, V62, P1137, DOI 10.1016/S0031-9384(97)00270-9; Wallace MT, 1996, J NEUROPHYSIOL, V76, P1246, DOI 10.1152/jn.1996.76.2.1246; WETHERILL GB, 1965, BRIT J MATH STAT PSY, V18, P1, DOI 10.1111/j.2044-8317.1965.tb00689.x; Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912	15	275	285	1	91	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2000	3	5					431	432		10.1038/74797	http://dx.doi.org/10.1038/74797			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	309DG	10769380				2022-12-24	WOS:000086752000009
J	Gillespie, CS; Sherman, DL; Fleetwood-Walker, SM; Cottrell, DF; Tait, S; Garry, EM; Wallace, VCJ; Ure, J; Griffiths, IR; Smith, A; Brophy, PJ				Gillespie, CS; Sherman, DL; Fleetwood-Walker, SM; Cottrell, DF; Tait, S; Garry, EM; Wallace, VCJ; Ure, J; Griffiths, IR; Smith, A; Brophy, PJ			Peripheral demyelination and neuropathic pain behavior in periaxin-deficient mice	NEURON			English	Article							MYELINATING SCHWANN-CELLS; GUILLAIN-BARRE-SYNDROME; PDZ DOMAIN PROTEINS; GENE-EXPRESSION; ANIMAL-MODELS; NMDA RECEPTOR; MAJOR MYELIN; AXONS; HYPERALGESIA; RAT	The Prx gene in Schwann cells encodes L- and S-periaxin, two abundant PDZ domain proteins thought to have a role in the stabilization of myelin in the peripheral nervous system (PNS). Mice lacking a functional Prx gene assemble compact PNS myelin. However, the sheath is unstable, leading to demyelination and reflex behaviors that are associated with the painful conditions caused by peripheral nerve damage. Older Prx(-/-) animals display extensive peripheral demyelination and a severe clinical phenotype with mechanical allodynia and thermal hyperalgesia, which can be reversed by intrathecal administration of a selective NMDA receptor antagonist. We conclude that the periaxins play an essential role in stabilizing the Schwann cell-axon unit and that the periaxin-deficient mouse will be an important model for studying neuropathic pain in late onset demyelinating disease.	Univ Edinburgh, Dept Preclin Vet Sci, Edinburgh EH9 1QH, Midlothian, Scotland; Univ Edinburgh, Ctr Genome Res, Gene Targeting Lab, Edinburgh EH9 3JQ, Midlothian, Scotland; Univ Glasgow, Dept Vet Clin Studies, Appl Neurobiol Grp, Glasgow G61 1QH, Lanark, Scotland	University of Edinburgh; University of Edinburgh; University of Glasgow	Brophy, PJ (corresponding author), Univ Edinburgh, Dept Preclin Vet Sci, Edinburgh EH9 1QH, Midlothian, Scotland.	peter.brophy@ed.ac.uk		Smith, Austin/0000-0002-3029-4682				ADLKOFER K, 1995, NAT GENET, V11, P274, DOI 10.1038/ng1195-274; AGUAYO AJ, 1977, NATURE, V268, P753, DOI 10.1038/268753a0; Ahlgren SC, 1997, NEUROSCIENCE, V76, P285; Anzini P, 1997, J NEUROSCI, V17, P4545; BAKER M, 1992, J PHYSIOL-LONDON, V451, P539, DOI 10.1113/jphysiol.1992.sp019178; BENNETT GJ, 1994, PROG PAIN RES MANAG, V2, P495; Bunge R P, 1993, Curr Opin Neurobiol, V3, P805, DOI 10.1016/0959-4388(93)90157-T; CALVIN WH, 1982, EXP NEUROL, V75, P755, DOI 10.1016/0014-4886(82)90040-1; Carter GT, 1998, ARCH PHYS MED REHAB, V79, P1560, DOI 10.1016/S0003-9993(98)90421-X; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; Chaplan SR, 1997, J PHARMACOL EXP THER, V280, P829; CHAPLAN SR, 1994, J NEUROSCI METH, V50, P9193; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Devor M, 1989, TXB PAIN, P63; DICKENSON AH, 1987, NEUROPHARMACOLOGY, V26, P1235, DOI 10.1016/0028-3908(87)90275-9; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Dyck P.J, 1993, PNP, P1094; Dytrych L, 1998, J BIOL CHEM, V273, P5794, DOI 10.1074/jbc.273.10.5794; FernandezValle C, 1997, J NEUROSCI, V17, P241, DOI 10.1523/JNEUROSCI.17-01-00241.1997; FREDERICKSON RM, 1989, NUCLEIC ACIDS RES, V17, P253, DOI 10.1093/nar/17.1.253; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; GILLESPIE CS, 1994, NEURON, V12, P497, DOI 10.1016/0896-6273(94)90208-9; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; IGGO A, 1958, J PHYSIOL-LONDON, V142, P110, DOI 10.1113/jphysiol.1958.sp006002; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; KOLTZENBURG M, 1994, BRAIN, V117, P579, DOI 10.1093/brain/117.3.579; Koltzenburg M, 1998, CURR OPIN NEUROL, V11, P515, DOI 10.1097/00019052-199810000-00014; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; LEHMANN J, 1987, J PHARMACOL EXP THER, V240, P737; LEMKE G, 1988, DEVELOPMENT, V102, P499; Lynch DR, 1997, NEUROLOGIST, V3, P277, DOI 10.1097/00127893-199709000-00001; MAO JR, 1993, BRAIN RES, V605, P164, DOI 10.1016/0006-8993(93)91368-3; Martini R, 1997, J ANAT, V191, P321, DOI 10.1046/j.1469-7580.1997.19130321.x; MARTINI R, 1995, NAT GENET, V11, P281, DOI 10.1038/ng1195-281; Meyer O A, 1979, Neurobehav Toxicol, V1, P233; Mirsky R, 1996, CURR OPIN NEUROBIOL, V6, P89, DOI 10.1016/S0959-4388(96)80013-4; MOUNTFORD P, 1994, P NATL ACAD SCI USA, V91, P4303, DOI 10.1073/pnas.91.10.4303; PENTLAND B, 1994, PAIN, V59, P159, DOI 10.1016/0304-3959(94)90068-X; PODUSLO JF, 1985, P NATL ACAD SCI USA, V82, P5987, DOI 10.1073/pnas.82.17.5987; RASMINSKY M, 1981, DEMYELINATING DISEAS, P289; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; ROPPER AH, 1984, ARCH NEUROL-CHICAGO, V41, P511, DOI 10.1001/archneur.1984.04050170057018; Scherer S.S., 1996, GLIAL CELL DEV, P165; Scherer SS, 1995, DEVELOPMENT, V121, P4265; SHARMA AK, 1974, J NEUROL SCI, V23, P1, DOI 10.1016/0022-510X(74)90136-1; Sheng M, 1997, BIOESSAYS, V19, P847, DOI 10.1002/bies.950191004; SMITH KJ, 1980, NATURE, V286, P154, DOI 10.1038/286154a0; Sobair ATH, 1997, VET RES COMMUN, V21, P149, DOI 10.1023/A:1005877310597; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; SUTER U, 1995, ANNU REV NEUROSCI, V18, P45, DOI 10.1146/annurev.ne.18.030195.000401; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Woolf CJ, 1999, P NATL ACAD SCI USA, V96, P7723, DOI 10.1073/pnas.96.14.7723; Woolf CJ, 1997, PROG PAIN RES MANAG, V9, P171; Yin XH, 1998, J NEUROSCI, V18, P1953, DOI 10.1523/jneurosci.18-06-01953.1998	56	157	164	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY	2000	26	2					523	531		10.1016/S0896-6273(00)81184-8	http://dx.doi.org/10.1016/S0896-6273(00)81184-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318QZ	10839370	Bronze			2022-12-24	WOS:000087296500028
J	Rypma, B; D'Esposito, M				Rypma, B; D'Esposito, M			Isolating the neural mechanisms of age-related changes in human working memory	NATURE NEUROSCIENCE			English	Article							POSITRON EMISSION TOMOGRAPHY; BRAIN-REGIONS; CORTEX; STORAGE; MODEL; BEHAVIOR; ROLES; LOAD; FMRI	Working memory (WM), the process by which information is coded into memory, actively maintained and subsequently retrieved, declines with age. To test the hypothesis that age-related changes in prefrontal cortex (PFC) may mediate this WM decline, we used functional MRI to investigate age differences in PFC activity during separate WM task components (encoding, maintenance, retrieval). We found greater PFC activity in younger than older adults only in dorsolateral PFC during memory retrieval. Fast younger subjects showed less dorsolateral PFC activation during retrieval than slow younger subjects, whereas older adults showed the opposite pattern. Thus age-related changes in dorsolateral PFC and not ventrolateral PFC account for WM decline with normal aging.	Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Rypma, B (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, 3210 Tolman Hall, Berkeley, CA 94720 USA.	rypma@socrates.berkeley.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015793, R01AG013483] Funding Source: NIH RePORTER; NIA NIH HHS [AG15793, AG13483] Funding Source: Medline; NINDS NIH HHS [NS01762] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; ANDERS TR, 1972, DEV PSYCHOL, V6, P214, DOI 10.1037/h0032103; Awh E, 1996, PSYCHOL SCI, V7, P25, DOI 10.1111/j.1467-9280.1996.tb00662.x; BELSLEY DA, 1980, REGRESSOIN DIAGNOSTI; COHEN JD, 1992, PSYCHOL REV, V99, P45, DOI 10.1037/0033-295X.99.1.45; Craik F. I. M., 1992, HDB AGING COGNITION, P51, DOI DOI 10.1016/S0022-5371(72)80001-X; D'Esposito M, 1999, NEUROIMAGE, V10, P6, DOI 10.1006/nimg.1999.0444; DESPOSITO M, 1989, BRAIN COGNITION, V41, P66; Fuster J., 1989, DISSERT ABSTRACTS IN, V60, P255; GLANZER M, 1974, J VERB LEARN VERB BE, V13, P114, DOI 10.1016/S0022-5371(74)80036-8; GOLDBERG HI, 1977, STROKE, V8, P6; HAUG H, 1991, NEUROBIOL AGING, V12, P336, DOI 10.1016/0197-4580(91)90013-A; HEILBRONER PL, 1990, ACTA NEUROPATHOL, V81, P60, DOI 10.1007/BF00662638; Kimberg DY, 1997, NEUROREPORT, V8, P3581, DOI 10.1097/00001756-199711100-00032; Kleinbaum D, 1988, APPL REGRESSION ANAL; MITCHELL KJ, IN PRESS PSYCHOL AGI; MYERSON J, 1990, PSYCHOL REV, V97, P475, DOI 10.1037/0033-295X.97.4.475; Owen AM, 1996, CEREB CORTEX, V6, P31, DOI 10.1093/cercor/6.1.31; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; PETRIDES M, 1989, HDB NEUROPSYCHOLOGY, V3, P75; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Rypma B, 1999, NEUROIMAGE, V9, P216, DOI 10.1006/nimg.1998.0404; Rypma B, 1999, P NATL ACAD SCI USA, V96, P6558, DOI 10.1073/pnas.96.11.6558; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; SERVANSCHREIBER D, 1990, SCIENCE, V249, P892, DOI 10.1126/science.2392679; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Talairach J., 1988, COPLANAR STEREOTAXIC; VANDERLINDEN M, 1994, BRIT J PSYCHOL, V85, P145; WAUGH NC, 1965, PSYCHOL REV, V72, P89, DOI 10.1037/h0021797; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Zarahn E, 1997, NEUROIMAGE, V6, P122, DOI 10.1006/nimg.1997.0279	32	424	433	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2000	3	5					509	515		10.1038/74889	http://dx.doi.org/10.1038/74889			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	309DG	10769393				2022-12-24	WOS:000086752000022
J	Bateman, J; Shu, H; Van Vactor, D				Bateman, J; Shu, H; Van Vactor, D			The guanine nucleotide exchange factor trio mediates axonal development in the Drosophila embryo	NEURON			English	Article							TRANSMEMBRANE TYROSINE PHOSPHATASE; GROWTH CONE GUIDANCE; ACTIN STRESS FIBERS; CELL-SHAPE CHANGES; BINDING PROTEIN; CAENORHABDITIS-ELEGANS; SIGNALING PATHWAY; FACTOR DOMAINS; C-ELEGANS; MOTOR	Recent analysis of Rho subfamily GTPases in Drosophila revealed roles for Rac and Cdc42 during axonogenesis. Here, we describe the identification and characterization of the Drosophila counterpart of Trio, a guanine nucleotide exchange factor (GEF) that associates with the receptor phosphatase LAR and regulates GTPase activation in vertebrate cells. Mutants deficient in trio activity display defects in both central and peripheral axon pathways reminiscent of phenotypes observed in embryos deficient in small GTPase function. Double mutant analysis shows that trio interacts with Rac in a dose-sensitive manner but not with Rho. Moreover, reduction of trio activity potentiates the phenotype of mutations in the LAR homolog Dlar, suggesting that these proteins collaborate in orchestrating the cytoskeletal events that underlie normal axonogenesis.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Van Vactor, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	Davie@hms.harvard.edu		Van Vactor, Jr., David L./0000-0001-8156-9482	NIGMS NIH HHS [GM08042] Funding Source: Medline; NINDS NIH HHS [NS35909] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035909] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alam MR, 1997, J BIOL CHEM, V272, P12667, DOI 10.1074/jbc.272.19.12667; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Barrett K, 1997, CELL, V91, P905, DOI 10.1016/S0092-8674(00)80482-1; Bate Michael, 1993, P1013; Bellanger Jean-Michel, 1998, Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales, V192, P367; Bellanger JM, 1998, ONCOGENE, V16, P147, DOI 10.1038/sj.onc.1201532; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; BRAND AH, 1993, DEVELOPMENT, V118, P401; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CHANT J, 1995, CELL, V81, P1, DOI 10.1016/0092-8674(95)90363-1; CHIEN CB, 1993, NEURON, V11, P237, DOI 10.1016/0896-6273(93)90181-P; COX D, 1992, J CELL BIOL, V116, P943, DOI 10.1083/jcb.116.4.943; Cox D, 1996, MOL BIOL CELL, V7, P803, DOI 10.1091/mbc.7.5.803; Deak P, 1997, GENETICS, V147, P1697; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; Desai CJ, 1997, DEVELOPMENT, V124, P1941; Eaton S, 1996, J CELL BIOL, V135, P1277, DOI 10.1083/jcb.135.5.1277; EATON S, 1995, J CELL BIOL, V131, P151, DOI 10.1083/jcb.131.1.151; Fambrough D, 1996, CELL, V87, P1049, DOI 10.1016/S0092-8674(00)81799-7; FAN JH, 1995, NEURON, V14, P263, DOI 10.1016/0896-6273(95)90284-8; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Fischer KD, 1998, SEMIN IMMUNOL, V10, P317, DOI 10.1006/smim.1998.0124; FITZPATRICK KA, 1995, MECH DEVELOP, V53, P171, DOI 10.1016/0925-4773(95)00432-Z; FOX J, 1998, NEURON, V21, P1; Gallo G, 1999, CURR BIOL, V9, pR490, DOI 10.1016/S0960-9822(99)80304-2; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; GERTLER FB, 1990, SCIENCE, V248, P857, DOI 10.1126/science.2188361; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; Gregory SL, 1998, J CELL BIOL, V143, P1271, DOI 10.1083/jcb.143.5.1271; HALL A, 1990, SCIENCE, V249, P635, DOI 10.1126/science.2116664; HARDEN N, 1995, DEVELOPMENT, V121, P903; HARTWIG JH, 1975, J BIOL CHEM, V250, P5696; Jin Z, 1997, J NEUROSCI, V17, P6256; Kaufmann N, 1998, DEVELOPMENT, V125, P453; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; LANIER LM, 2000, IN PRESS CURR OPIN C; Li MG, 1999, J CELL BIOL, V146, P1061, DOI 10.1083/jcb.146.5.1061; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; Liu XH, 1998, CELL, V95, P269, DOI 10.1016/S0092-8674(00)81757-2; Lu Y, 1999, Mol Cell Biol Res Commun, V1, P87, DOI 10.1006/mcbr.1999.0119; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Machesky LM, 1996, TRENDS CELL BIOL, V6, P304, DOI 10.1016/0962-8924(96)10026-X; MARSH L, 1984, J CELL BIOL, V99, P2041, DOI 10.1083/jcb.99.6.2041; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; Murphy AM, 1996, J CELL BIOL, V133, P617, DOI 10.1083/jcb.133.3.617; NEWSOME TP, 2000, IN PRESS CELL, V101; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; OCHMAN H, 1988, GENETICS, V120, P621; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; PISTOR S, 1995, CURR BIOL, V5, P517, DOI 10.1016/S0960-9822(95)00104-7; REINHARD M, 1995, EMBO J, V14, P1583, DOI 10.1002/j.1460-2075.1995.tb07146.x; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; SHARMA CP, 1995, J IMMUNOL, V154, P3461; SIDDIQUI SS, 1991, J NEUROGENET, V7, P193, DOI 10.3109/01677069109167433; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; Sokol NS, 1999, CURR BIOL, V9, P1221, DOI 10.1016/S0960-9822(99)80502-8; Sone M, 1997, SCIENCE, V275, P543, DOI 10.1126/science.275.5299.543; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Strumpf D, 1998, J CELL BIOL, V143, P1259, DOI 10.1083/jcb.143.5.1259; Suter DM, 1998, CURR OPIN NEUROBIOL, V8, P106, DOI 10.1016/S0959-4388(98)80014-7; Tear G, 1999, TRENDS GENET, V15, P113, DOI 10.1016/S0168-9525(98)01686-2; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Van Vactor D, 1999, CURR BIOL, V9, pR201; Van Vactor D, 1999, CURR BIOL, V9, pR797; Van Vactor D, 1999, ADV MOLEC BIOL, P490; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X; Zipkin ID, 1997, CELL, V90, P883, DOI 10.1016/S0092-8674(00)80353-0	76	180	182	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	2000	26	1					93	106		10.1016/S0896-6273(00)81141-1	http://dx.doi.org/10.1016/S0896-6273(00)81141-1			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309MA	10798395	Bronze			2022-12-24	WOS:000086770500011
J	Banks, MI; White, JA; Pearce, RA				Banks, MI; White, JA; Pearce, RA			Interactions between distinct GABA(A) circuits in hippocampus	NEURON			English	Article							LONG-TERM POTENTIATION; PATCH-CLAMP RECORDINGS; CORTEX COMBINED SLICE; PYRAMIDAL CELLS; RAT HIPPOCAMPUS; ENTORHINAL CORTEX; THETA-RHYTHM; IN-VIVO; GAMMA-OSCILLATION; BEHAVING RAT	Synchronous activity among synaptically connected interneurons is thought to organize temporal patterns such as gamma and theta rhythms in cortical circuits. Interactions between distinct interneuron circuits may underlie more complex patterns, such as nested rhythms. Here, we demonstrate such an interaction between two groups of CA1 interneurons, GAB(A,) (slow) and GABA(A,fast) cells, that may contribute to theta and gamma rhythms, respectively. Stratum lacunosum-moleculare (SL-M) stimuli that activate GABA(A,slow) inhibitory postsynaptic currents (IPSCs) in pyramidal cells simultaneously depress the rate and amplitude of spontaneous GABA(A,fast) IPSCs for several hundred milliseconds. This suppression has a similar pharmacological profile to GABA(A,slow) IPSCs, and SL-M stimuli elicit GABA(A,slow) IPSCs in interneurons. We conclude that GABA(A,slow) cells inhibit both pyramidal cells and GABA(A,fast) interneurons and postulate that this interaction contributes to nested theta/gamma rhythms in hippocampus.	Univ Wisconsin, Dept Anesthesiol, Madison, WI 53706 USA; Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	University of Wisconsin System; University of Wisconsin Madison; Boston University	Pearce, RA (corresponding author), Univ Wisconsin, Dept Anesthesiol, Madison, WI 53706 USA.		Pearce, Robert/B-4044-2011	Banks, Matthew/0000-0002-1936-7529; White, John/0000-0003-1073-2638; Pearce, Robert/0000-0002-1516-6260	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055719] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM55719] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Banks MI, 1998, J NEUROSCI, V18, P1305; BRAGIN A, 1995, J NEUROSCI, V15, P47; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; BUZSAKI G, 1982, J NEUROPHYSIOL, V48, P597, DOI 10.1152/jn.1982.48.3.597; Chapman CA, 1999, J NEUROPHYSIOL, V81, P1296, DOI 10.1152/jn.1999.81.3.1296; Chrobak JJ, 1998, J NEUROSCI, V18, P388; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; COLBERT CM, 1992, J NEUROPHYSIOL, V68, P1; Cook EP, 1997, J NEUROPHYSIOL, V78, P2116, DOI 10.1152/jn.1997.78.4.2116; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; DAVIES CH, 1991, NATURE, V349, P609, DOI 10.1038/349609a0; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; EMPSON RM, 1995, HIPPOCAMPUS, V5, P104, DOI 10.1002/hipo.450050203; EMPSON RM, 1995, J PHYSIOL-LONDON, V484, P707, DOI 10.1113/jphysiol.1995.sp020697; ERMENTROUT GB, 1990, PHASEPLANE DYNAMICAL; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Fischer Y, 1999, J PHYSIOL-LONDON, V519, P405, DOI 10.1111/j.1469-7793.1999.0405m.x; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; FREUND TF, 1988, NATURE, V336, P170, DOI 10.1038/336170a0; Fukuda T, 1996, NEUROSCI RES, V26, P181, DOI 10.1016/S0168-0102(96)01102-9; GUTFREUND Y, 1995, J PHYSIOL-LONDON, V483, P621, DOI 10.1113/jphysiol.1995.sp020611; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; JAROLIMEK W, 1993, NEUROSCI LETT, V154, P31, DOI 10.1016/0304-3940(93)90164-G; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Kapur A, 1997, J NEUROPHYSIOL, V78, P2546, DOI 10.1152/jn.1997.78.5.2546; Kocsis B, 1999, J NEUROSCI, V19, P6200, DOI 10.1523/JNEUROSCI.19-14-06200.1999; LEUNG LS, 1995, J NEUROPHYSIOL, V73, P2392, DOI 10.1152/jn.1995.73.6.2392; LLINAS RR, 1991, P NATL ACAD SCI USA, V88, P897, DOI 10.1073/pnas.88.3.897; Mangan PS, 1996, J NEUROPHYSIOL, V76, P1282, DOI 10.1152/jn.1996.76.2.1282; Marder E, 1998, ANN NY ACAD SCI, V860, P226, DOI 10.1111/j.1749-6632.1998.tb09052.x; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; MOTT DD, 1991, SCIENCE, V252, P1718, DOI 10.1126/science.1675489; OTIS TS, 1993, J PHYSIOL-LONDON, V463, P391, DOI 10.1113/jphysiol.1993.sp019600; Ouardouz M, 1997, J NEUROPHYSIOL, V77, P1939, DOI 10.1152/jn.1997.77.4.1939; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; PEARCE RA, 1995, J PHYSIOL-LONDON, V484, P425, DOI 10.1113/jphysiol.1995.sp020675; Penttonen M, 1998, EUR J NEUROSCI, V10, P718, DOI 10.1046/j.1460-9568.1998.00096.x; SIK A, 1995, J NEUROSCI, V15, P6651; SOLTESZ I, 1993, J NEUROPHYSIOL, V70, P97, DOI 10.1152/jn.1993.70.1.97; SPRUSTON N, 1993, J NEUROPHYSIOL, V70, P781, DOI 10.1152/jn.1993.70.2.781; STEWARD O, 1976, J COMP NEUROL, V169, P347, DOI 10.1002/cne.901690306; STEWART M, 1990, TRENDS NEUROSCI, V13, P163, DOI 10.1016/0166-2236(90)90040-H; Toth K, 1997, J PHYSIOL-LONDON, V500, P463, DOI 10.1113/jphysiol.1997.sp022033; Vida I, 1998, J PHYSIOL-LONDON, V506, P755, DOI 10.1111/j.1469-7793.1998.755bv.x; VINOGRADOVA OS, 1995, PROG NEUROBIOL, V45, P523, DOI 10.1016/0301-0082(94)00051-I; Wang XJ, 1996, J NEUROSCI, V16, P6402; White JA, 1998, J COMPUT NEUROSCI, V5, P5, DOI 10.1023/A:1008841325921; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; WITTER MP, 1988, NEUROSCI LETT, V85, P193, DOI 10.1016/0304-3940(88)90350-3; WOODSON W, 1989, J COMP NEUROL, V280, P254, DOI 10.1002/cne.902800207; YLINEN A, 1995, HIPPOCAMPUS, V5, P78, DOI 10.1002/hipo.450050110	51	102	106	1	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	2000	25	2					449	457		10.1016/S0896-6273(00)80907-1	http://dx.doi.org/10.1016/S0896-6273(00)80907-1			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	288EL	10719898	Bronze			2022-12-24	WOS:000085549100021
J	Lin, X; Antalffy, B; Kang, D; Orr, HT; Zoghbi, HY				Lin, X; Antalffy, B; Kang, D; Orr, HT; Zoghbi, HY			Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1	NATURE NEUROSCIENCE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; CEREBELLAR PURKINJE-CELLS; ENDOPLASMIC-RETICULUM; MESSENGER-RNA; TRANSGENIC MICE; POLYPHOSPHATE 5-PHOSPHATASES; CARBOXYL METHYLTRANSFERASE; GLUTAMATE TRANSPORTER; INSITU HYBRIDIZATION; MOUSE-BRAIN	The expansion of an unstable CAG repeat causes spinocerebellar ataxia type 1 (SCA1) and several other neurodegenerative diseases. How polyglutamine expansions render the resulting proteins toxic to neurons, however, remains elusive. Hypothesizing that long polyglutamine tracts alter gene expression, we found certain neuronal genes involved in signal transduction and calcium homeostasis sequentially downregulated in SCA1 mice. These genes were abundant in Purkinje cells, the primary site of SCA1 pathogenesis; moreover, their downregulation was mediated by expanded ataxin-1 and occured before detectable pathology. Similar downregulation occurred in SCA1 human tissues. Altered gene expression may be the earliest mediator of polyglutamine toxicity.	Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Univ Minnesota, Inst Human Genet, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; University of Minnesota System; University of Minnesota Twin Cities	Zoghbi, HY (corresponding author), Baylor Coll Med, Howard Hughes Med Inst, 1 Baylor Plaza, Houston, TX 77030 USA.			Orr, Harry/0000-0001-6118-741X; Zoghbi, Huda/0000-0002-0700-3349	NINDS NIH HHS [NS27699, NS22920] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027699, R01NS022920, R37NS027699, R37NS022920] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; AKAABOUNE M, 1994, J NEUROBIOL, V25, P503, DOI 10.1002/neu.480250505; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Birnbaumer L, 1996, P NATL ACAD SCI USA, V93, P15195, DOI 10.1073/pnas.93.26.15195; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Clark HB, 1997, J NEUROSCI, V17, P7385; CLARKE S, 1992, ANNU REV BIOCHEM, V61, P355, DOI 10.1146/annurev.bi.61.070192.002035; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Dai Q, 1998, J BIOL CHEM, V273, P15030, DOI 10.1074/jbc.273.24.15030; DAS S, 1995, NEURON, V14, P447, DOI 10.1016/0896-6273(95)90300-3; DESMEDT F, 1994, FEBS LETT, V347, P69, DOI 10.1016/0014-5793(94)00509-5; Doucas V, 1999, P NATL ACAD SCI USA, V96, P2627, DOI 10.1073/pnas.96.6.2627; Drayer AL, 1996, BIOCHEM SOC T, V24, P1001, DOI 10.1042/bst0241001; HRYCYNA CA, 1993, PHARMACOL THERAPEUT, V59, P281, DOI 10.1016/0163-7258(93)90071-K; Imai Y, 1997, MOL CELL BIOL, V17, P1543, DOI 10.1128/MCB.17.3.1543; INGLIS JD, 1991, GENE, V106, P213, DOI 10.1016/0378-1119(91)90201-L; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; KOO EH, 1991, NEUROBIOL AGING, V12, P495, DOI 10.1016/0197-4580(91)90079-Y; Kotera J, 1997, EUR J BIOCHEM, V249, P434, DOI 10.1111/j.1432-1033.1997.t01-1-00434.x; Liu BF, 1996, J BIOL CHEM, V271, P5536, DOI 10.1074/jbc.271.10.5536; MAILLEUX P, 1992, NEUROSCIENCE, V49, P577, DOI 10.1016/0306-4522(92)90228-T; Masuyama H, 1998, J CELL BIOCHEM, V71, P429, DOI 10.1002/(SICI)1097-4644(19981201)71:3<429::AID-JCB11>3.0.CO;2-P; Matilla A, 1998, J NEUROSCI, V18, P5508, DOI 10.1523/JNEUROSCI.18-14-05508.1998; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; MILLER KK, 1991, NEUROSCIENCE, V43, P1, DOI 10.1016/0306-4522(91)90410-P; Mitchell CA, 1996, BIOCHEM SOC T, V24, P994, DOI 10.1042/bst0240994; Mori Y, 1998, NEUROREPORT, V9, P507; NAKANISHI S, 1991, J NEUROSCI, V11, P2075; Nawaz Z, 1999, P NATL ACAD SCI USA, V96, P1858, DOI 10.1073/pnas.96.5.1858; Rando RR, 1996, BBA-LIPID LIPID MET, V1300, P5, DOI 10.1016/0005-2760(95)00233-2; ROSS CA, 1992, P NATL ACAD SCI USA, V89, P4265, DOI 10.1073/pnas.89.10.4265; ROUSTAN P, 1995, NEUROREPORT, V6, P1837, DOI 10.1097/00001756-199510020-00004; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; Street VA, 1997, J NEUROSCI, V17, P635; TAKEI K, 1992, J NEUROSCI, V12, P489; Tanaka J, 1997, NEUROREPORT, V8, P2461, DOI 10.1097/00001756-199707280-00010; Verkhratsky A, 1998, TRENDS NEUROSCI, V21, P2, DOI 10.1016/S0166-2236(97)01156-9; VILLA A, 1992, NEUROSCIENCE, V49, P467, DOI 10.1016/0306-4522(92)90111-E; VOLPE P, 1993, COMP BIOCHEM PHYS A, V105, P205, DOI 10.1016/0300-9629(93)90196-B; Woscholski R, 1997, TRENDS BIOCHEM SCI, V22, P427, DOI 10.1016/S0968-0004(97)01120-1; Yamada K, 1996, NEUROREPORT, V7, P2013, DOI 10.1097/00001756-199608120-00032; Zhang JS, 1998, GENE DEV, V12, P1775, DOI 10.1101/gad.12.12.1775; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7; ZOGHBI HY, 1995, SEMIN CELL BIOL, V6, P29, DOI 10.1016/1043-4682(95)90012-8	47	293	301	1	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2000	3	2					157	163		10.1038/72101	http://dx.doi.org/10.1038/72101			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TC	10649571				2022-12-24	WOS:000085810300013
J	Giger, RJ; Cloutier, JF; Sahay, A; Prinjha, RK; Levengood, DV; Moore, SE; Pickering, S; Simmons, D; Rastan, S; Walsh, FS; Kolodkin, AL; Ginty, DD; Geppert, M				Giger, RJ; Cloutier, JF; Sahay, A; Prinjha, RK; Levengood, DV; Moore, SE; Pickering, S; Simmons, D; Rastan, S; Walsh, FS; Kolodkin, AL; Ginty, DD; Geppert, M			Neuropilin-2 is required in vivo for selective axon guidance responses to secreted semaphorins	NEURON			English	Article							PERIPHERAL-NERVE PROJECTION; CELL-SURFACE MOLECULE; STEM-CELLS; IN-SITU; RECEPTOR; SYSTEM; EXPRESSION; MICE; IV; GLYCOPROTEIN	Neuropilins are receptors for class 3 secreted semaphorins, most of which can function as potent repulsive axon guidance cues. We have generated mice with a targeted deletion in the neuropilin-2 (Npn-2) locus. Many Npn-2 mutant mice are viable into adulthood, allowing us to assess the role of Npn-2 in axon guidance events throughout neural development. Npn-P is required for the organization and fasciculation of several cranial nerves and spinal nerves. In addition, several major fiber tracts in the brains of adult mutant mice are either severely disorganized or missing. Our results show that Npn-2 is a selective receptor for class 3 semaphorins in vivo and that Npn-1 and Npn-2 are required for development of an overlapping but distinct set of CNS and PNS projections.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; SmithKline Beecham, Dept Neurosci, Harlow CM19 5AW, Essex, England; SmithKline Beecham, Dept Comparat Genet, Harlow CM19 5AW, Essex, England	Johns Hopkins University; GlaxoSmithKline; GlaxoSmithKline	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.		Sahay, Amar/J-3696-2014; Cloutier, Jean-François/K-2003-2012		NIMH NIH HHS [R01MH59199] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059199] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; Chedotal A, 1998, DEVELOPMENT, V125, P4313; CHEN G, 1994, BIOL CONTROL, V4, P157, DOI 10.1006/bcon.1994.1025; Chen H, 1998, NEURON, V21, P1283, DOI 10.1016/S0896-6273(00)80648-0; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; Feiner L, 1997, NEURON, V19, P539, DOI 10.1016/S0896-6273(00)80370-0; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Giger RJ, 1998, NEURON, V21, P1079, DOI 10.1016/S0896-6273(00)80625-X; Goodman CS, 1999, CELL, V97, P551, DOI 10.1016/S0092-8674(00)80766-7; HE S, 1997, CELL, V90, P739; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Kawakami A, 1996, J NEUROBIOL, V29, P1, DOI 10.1002/(SICI)1097-4695(199601)29:1<1::AID-NEU1>3.0.CO;2-F; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Kitsukawa T, 1995, DEVELOPMENT, V121, P4309; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Mark MD, 1997, CELL TISSUE RES, V290, P299, DOI 10.1007/s004410050934; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; OHTA K, 1992, NEURON, V9, P151, DOI 10.1016/0896-6273(92)90230-B; OHTA K, 1995, NEURON, V14, P1189, DOI 10.1016/0896-6273(95)90266-X; Polleux F, 1998, SCIENCE, V282, P1904, DOI 10.1126/science.282.5395.1904; PRINCE JT, 1992, DEV BRAIN RES, V68, P193, DOI 10.1016/0165-3806(92)90061-Z; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Sambrook J., 2002, MOL CLONING LAB MANU; SATODA M, 1995, J NEUROSCI, V15, P942; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Steup A, 1999, EUR J NEUROSCI, V11, P729, DOI 10.1046/j.1460-9568.1999.00517.x; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; WOLFER DP, 1994, J COMP NEUROL, V345, P1, DOI 10.1002/cne.903450102	40	339	343	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	2000	25	1					29	41		10.1016/S0896-6273(00)80869-7	http://dx.doi.org/10.1016/S0896-6273(00)80869-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279KP	10707970	Bronze			2022-12-24	WOS:000085043200008
J	Goulding, SE; zur Lage, P; Jarman, AP				Goulding, SE; zur Lage, P; Jarman, AP			amos, a proneural gene for Drosophila olfactory sense organs that is regulated by lozenge	NEURON			English	Article							LOOP-HELIX DOMAIN; TRANSCRIPTION FACTORS; CRYSTAL-STRUCTURE; CELL-INTERACTIONS; NERVOUS-SYSTEM; SCUTE PROTEIN; EYE; PHOTORECEPTORS; DAUGHTERLESS; MELANOGASTER	In a variety of organisms, early neurogenesis requires the function of basic-helix-loop-helix (bHLH) transcription factors. For the Drosophila PNS, such transcription factors are encoded by the proneural genes (atonal and the achaete-scute complex, AS-C). We have identified a proneural gene, amos, that has strong similarity with atonal in its bHLH domain. We present evidence that amos is required for olfactory sensilla and is regulated by the prepattern gene lozenge. Between them, amos, atonal, and the AS-C can potentially account for the origin of the entire PNS.	Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Jarman, AP (corresponding author), Univ Edinburgh, Inst Cell & Mol Biol, Kings Bldg, Edinburgh EH9 3JR, Midlothian, Scotland.	jarman@ed.ac.uk		Jarman, Andrew/0000-0003-4036-5701				BRAND M, 1993, DEVELOPMENT, V119, P1; CABRERA CV, 1994, DEVELOPMENT, V120, P3595; CABRERA CV, 1991, EMBO J, V10, P965; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; CAMPUZANO S, 1992, TRENDS GENET, V8, P202, DOI 10.1016/0168-9525(92)90234-U; Carlson JR, 1996, TRENDS GENET, V12, P175, DOI 10.1016/0168-9525(96)10015-9; Chien CT, 1996, P NATL ACAD SCI USA, V93, P13239, DOI 10.1073/pnas.93.23.13239; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Daga A, 1996, GENE DEV, V10, P1194, DOI 10.1101/gad.10.10.1194; DAMBLYCHAUDIERE C, 1988, ROUX ARCH DEV BIOL, V197, P419, DOI 10.1007/BF00398993; ELLENBERGER T, 1994, GENE DEV, V8, P970, DOI 10.1101/gad.8.8.970; Flores GV, 1998, DEVELOPMENT, V125, P3681; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; GHYSEN A, 1993, GENE DEV, V7, P723, DOI 10.1101/gad.7.5.723; Gupta BP, 1998, DEV BIOL, V203, P400, DOI 10.1006/dbio.1998.9064; Gupta BP, 1997, GENES CELLS, V2, P225, DOI 10.1046/j.1365-2443.1997.d01-312.x; HINZ U, 1994, CELL, V76, P77, DOI 10.1016/0092-8674(94)90174-0; Huang ML, 2000, NEURON, V25, P57, DOI 10.1016/S0896-6273(00)80871-5; Jan Yuh Nung, 1993, P1207; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; Jarman AP, 1998, MECH DEVELOP, V76, P117, DOI 10.1016/S0925-4773(98)00116-6; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; JARMAN AP, 1995, ALTSCHUL SY, V3, P97; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; MA PCM, 1994, CELL, V77, P451, DOI 10.1016/0092-8674(94)90159-7; RAY K, 1995, DEV BIOL, V167, P426, DOI 10.1006/dbio.1995.1039; Reddy GV, 1997, DEVELOPMENT, V124, P703; RiesgoEscovar JR, 1997, J COMP PHYSIOL A, V180, P151, DOI 10.1007/s003590050036; RODRIGUEZ I, 1990, EMBO J, V9, P3583, DOI 10.1002/j.1460-2075.1990.tb07569.x; SIDDIQI O, 1987, TRENDS GENET, V3, P137, DOI 10.1016/0168-9525(87)90204-6; STOCKER RF, 1993, J NEUROGENET, V9, P29, DOI 10.3109/01677069309167274; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; VANDOREN M, 1991, DEVELOPMENT, V113, P245; zur Lage P, 1999, DEVELOPMENT, V126, P3149; zurLage P, 1997, CURR BIOL, V7, P166, DOI 10.1016/S0960-9822(97)70087-3	36	122	126	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN	2000	25	1					69	78		10.1016/S0896-6273(00)80872-7	http://dx.doi.org/10.1016/S0896-6273(00)80872-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279KP	10707973	Bronze			2022-12-24	WOS:000085043200011
J	Janz, R; Goda, Y; Geppert, M; Missler, M; Sudhof, TC				Janz, R; Goda, Y; Geppert, M; Missler, M; Sudhof, TC			SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release	NEURON			English	Article							SYNAPTIC VESICLE PROTEIN; TRANSMITTER RELEASE; PROBABILITY; IDENTIFICATION; SYNAPTOTAGMIN; TRANSPORTER; EXOCYTOSIS; TERMINALS; CALCIUM; CELLS	SV2 proteins are abundant synaptic vesicle proteins expressed in two major (SV2A and SV2B) and one minor isoform (SV2C) that resemble transporter proteins. We now show that SV2B knockout mice are phenotypically normal while SV2A- and SV2A/SV2B double knockout mice exhibit severe seizures and die postnatally. In electrophysiological recordings from cultured hippocampal neurons, SV2A- or SV2B-deficient cells exhibited no detectable abnormalities. Neurons lacking both SV2 isoforms, however, experienced sustained increases in Ca2+-dependent synaptic transmission when two or more action potentials were triggered in succession. These increases could be reversed by EGTA-AM. Our data suggest that without SV2 proteins, presynaptic Ca2+ accumulation during consecutive action potentials causes abnormal increases in neurotransmitter release that destabilize synaptic circuits and induce epilepsy.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Ctr Basic Neurosci, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75235 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego; Max Planck Society	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Ctr Basic Neurosci, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.		Goda, Yukiko/AAR-5641-2020; Goda, Yukiko/A-6576-2016	Goda, Yukiko/0000-0003-0352-9498; Goda, Yukiko/0000-0003-0352-9498; Janz, Roger/0000-0002-9872-0596; Missler, Markus/0000-0001-8008-984X				Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; BAJJALIEH SM, 1992, SCIENCE, V257, P1271, DOI 10.1126/science.1519064; BAJJALIEH SM, 1993, P NATL ACAD SCI USA, V90, P2150, DOI 10.1073/pnas.90.6.2150; BAJJALIEH SM, 1994, J NEUROSCI, V14, P5223, DOI 10.1523/jneurosci.14-09-05223.1994; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; FEANY MB, 1992, CELL, V70, P861, DOI 10.1016/0092-8674(92)90319-8; Fernandez-Chacon R, 1999, ANNU REV PHYSIOL, V61, P753, DOI 10.1146/annurev.physiol.61.1.753; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; GINGRICH JA, 1992, FEBS LETT, V312, P115, DOI 10.1016/0014-5793(92)80917-6; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Hsu SF, 1996, NEURON, V17, P501, DOI 10.1016/S0896-6273(00)80182-8; Janz R, 1999, NEUROSCIENCE, V94, P1279, DOI 10.1016/S0306-4522(99)00370-X; Janz R, 1998, J NEUROSCI, V18, P9269; Katz B., 1969, RELEASE NEURAL TRANS; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWE AW, 1988, J CELL BIOL, V106, P51, DOI 10.1083/jcb.106.1.51; McMahon HT, 1996, P NATL ACAD SCI USA, V93, P4760, DOI 10.1073/pnas.93.10.4760; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Schivell AE, 1996, J BIOL CHEM, V271, P27770, DOI 10.1074/jbc.271.44.27770; Schluter OM, 1999, J NEUROSCI, V19, P5834, DOI 10.1523/JNEUROSCI.19-14-05834.1999; SCRANTON TW, 1993, J NEUROCHEM, V61, P29, DOI 10.1111/j.1471-4159.1993.tb03535.x; SWANDULLA D, 1991, NEURON, V7, P915, DOI 10.1016/0896-6273(91)90337-Y; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Varela JA, 1999, J NEUROSCI, V19, P4293; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	30	268	281	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1999	24	4					1003	1016		10.1016/S0896-6273(00)81046-6	http://dx.doi.org/10.1016/S0896-6273(00)81046-6			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	269UE	10624962	Bronze			2022-12-24	WOS:000084495300027
J	Louie, K; Wilson, MA				Louie, K; Wilson, MA			Temporally structured replay of awake hippocampal ensemble activity during rapid eye movement sleep	NEURON			English	Article							SPATIOTEMPORAL FIRING PATTERNS; PREFRONTAL CORTEX; MEMORY; NEURONS; REACTIVATION; TEMPERATURE; EXPERIENCE; SEQUENCES; DYNAMICS; STATES	Human dreaming occurs during rapid eye movement (REM) sleep. To investigate the structure of neural activity during REM sleep, we simultaneously recorded the activity of multiple neurons in the rat hippocampus during both sleep and awake behavior. We show that temporally sequenced ensemble firing rate patterns reflecting tens of seconds to minutes of behavioral experience are reproduced during REM episodes at an equivalent timescale. Furthermore, within such REM episodes behavior-dependent modulation of the subcortically driven theta rhythm is also reproduced. These results demonstrate that long temporal sequences of patterned multineuronal activity suggestive of episodic memory traces are reactivated during REM sleep. Such reactivation may be important for memory processing and provides a basis for the electrophysiological examination of the content of dream states.	MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, Ctr Learning & Memory, Cambridge, MA 02139 USA; MIT, RIKEN MIT Neurosci Res Ctr, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); RIKEN	Wilson, MA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.			Louie, Kenway/0000-0002-9665-5436; Wilson, Melissa/0000-0002-5391-7838				ABELES M, 1988, J NEUROPHYSIOL, V60, P909, DOI 10.1152/jn.1988.60.3.909; ABELES M, 1993, J NEUROPHYSIOL, V70, P1629, DOI 10.1152/jn.1993.70.4.1629; Andersen P, 1995, HIPPOCAMPUS, V5, P491, DOI 10.1002/hipo.450050602; Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Deadwyler SA, 1996, J NEUROSCI, V16, P354; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; HENNEVIN E, 1995, BEHAV BRAIN RES, V69, P125, DOI 10.1016/0166-4328(95)00013-J; Hobson JA, 1998, CURR OPIN NEUROBIOL, V8, P239, DOI 10.1016/S0959-4388(98)80146-3; Jung MW, 1998, CEREB CORTEX, V8, P437, DOI 10.1093/cercor/8.5.437; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; PAVLIDES C, 1989, J NEUROSCI, V9, P2907; Poe GR, 2000, BRAIN RES, V855, P176, DOI 10.1016/S0006-8993(99)02310-0; QUINTANA J, 1992, NEUROREPORT, V3, P721, DOI 10.1097/00001756-199208000-00018; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; SMITH C, 1995, BEHAV BRAIN RES, V69, P137, DOI 10.1016/0166-4328(95)00024-N; SQUIRE LR, 1992, PSYCHOL REV, V68, P185; STEWART M, 1990, TRENDS NEUROSCI, V13, P163, DOI 10.1016/0166-2236(90)90040-H; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; WHISHAW IQ, 1971, PHYSIOL BEHAV, V6, P391, DOI 10.1016/0031-9384(71)90172-7; WIENER SI, 1989, J NEUROSCI, V9, P2737; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; ZOLAMORGAN S, 1993, ANNU REV NEUROSCI, V16, P547, DOI 10.1146/annurev.ne.16.030193.002555	34	747	758	6	98	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	2001	29	1					145	156		10.1016/S0896-6273(01)00186-6	http://dx.doi.org/10.1016/S0896-6273(01)00186-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	397NX	11182087	Bronze			2022-12-24	WOS:000166702700015
J	Concha, ML; Burdine, RD; Russell, C; Schier, AF; Wilson, SW				Concha, ML; Burdine, RD; Russell, C; Schier, AF; Wilson, SW			A nodal signaling pathway regulates the laterality of neuroanatomical asymmetries in the zebrafish forebrain	NEURON			English	Article							ONE-EYED-PINHEAD; LEFT-RIGHT AXIS; PINEAL EYE; VERTEBRATE DEVELOPMENT; SITUS-INVERSUS; BRAIN; GENE; GASTRULATION; EXPRESSION; ORGANIZER	Animals show behavioral asymmetries that are mediated by differences between the left and right sides of the brain. We report that the laterality of asymmetric development of the diencephalic habenular nuclei and the photoreceptive pineal complex is regulated by the Nodal signaling pathway and by midline tissue. Analysis of zebrafish embryos with compromised Nodal signaling reveals an early role for this pathway in the repression of asymmetrically expressed genes in the diencephalon. Later signaling mediated by the EGF-CFC protein One-eyed pinhead and the forkhead transcription factor Schmalspur is required to overcome this repression. When expression of Nodal pathway genes is either absent or symmetrical, neuroanatomical asymmetries are still established but are randomized. This indicates that Nodal signaling is not required for asymmetric development per se but is essential to determine the laterality of the asymmetry.	NYU, Sch Med, Dept Cell Biol, Dev Genet Program,Skirball Inst Biomol Med, New York, NY 10016 USA; UCL, Dept Anat & Dev Biol, London WC1E 6BT, England	New York University; University of London; University College London	Wilson, SW (corresponding author), NYU, Sch Med, Dept Cell Biol, Dev Genet Program,Skirball Inst Biomol Med, 540 1st Ave, New York, NY 10016 USA.	schier@satum.med.nyu.edu; s.wilson@ucl.ac.uk	Zebrafish, UCL/A-3125-2009; Wilson, Stephen W/B-9404-2008; Russell, Claire/A-4879-2012; Concha, Miguel/I-2551-2013	Wilson, Stephen W/0000-0002-8557-5940; Russell, Claire/0000-0002-6748-9301; Concha, Miguel/0000-0003-3353-9398; Burdine, Rebecca/0000-0001-6620-5015; Schier, Alexander Franz/0000-0001-7645-5325				Andrew RJ, 2000, BRAIN LANG, V73, P220, DOI 10.1006/brln.2000.2304; ANDREW RJ, 2001, COMP VERTEBRATE LATE; [Anonymous], 1992, EVOLUTION LATERAL AS; Bamford RN, 2000, NAT GENET, V26, P365, DOI 10.1038/81695; Bisazza A, 1999, ANIM BEHAV, V57, P1145, DOI 10.1006/anbe.1998.1075; Bisazza A, 1998, NEUROSCI BIOBEHAV R, V22, P411, DOI 10.1016/S0149-7634(97)00050-X; Bisgrove BW, 2000, DEVELOPMENT, V127, P3567; Bisgrove BW, 1999, DEVELOPMENT, V126, P3253; BORG B, 1983, ACTA ZOOL-STOCKHOLM, V64, P211, DOI 10.1111/j.1463-6395.1983.tb00802.x; BRAITENBERG V, 1970, Journal of Comparative Neurology, V138, P137, DOI 10.1002/cne.901380203; Burdine RD, 2000, GENE DEV, V14, P763; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; Chen JN, 1997, DEVELOPMENT, V124, P4373; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; CHI JG, 1977, ARCH NEUROL-CHICAGO, V34, P346, DOI 10.1001/archneur.1977.00500180040008; Corballis MC, 1997, PSYCHOL REV, V104, P714, DOI 10.1037/0033-295X.104.4.714; EKSTROM P, 1988, NEUROSCI LETT, V91, P121, DOI 10.1016/0304-3940(88)90754-9; Essner JJ, 2000, DEVELOPMENT, V127, P1081; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; FOSTER RG, 1982, J COMP PHYSIOL, V145, P413, DOI 10.1007/BF00619346; Gaio U, 1999, CURR BIOL, V9, P1339, DOI 10.1016/S0960-9822(00)80059-7; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Guglielmotti V, 1999, J COMP NEUROL, V411, P441, DOI 10.1002/(SICI)1096-9861(19990830)411:3<441::AID-CNE7>3.0.CO;2-N; Gunturkun O, 2000, CURR BIOL, V10, P1079, DOI 10.1016/S0960-9822(00)00671-0; Harris JA, 1996, NEUROSCI BIOBEHAV R, V20, P637, DOI 10.1016/0149-7634(95)00077-1; Jamieson D, 1999, BRAIN BEHAV EVOLUT, V54, P323, DOI 10.1159/000006632; Kennedy DN, 1999, NEUROLOGY, V53, P1260, DOI 10.1212/WNL.53.6.1260; KORZH V, 1993, DEVELOPMENT, V118, P417; Masai I, 1997, NEURON, V18, P43, DOI 10.1016/S0896-6273(01)80045-3; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Meno C, 1998, CELL, V94, P287, DOI 10.1016/S0092-8674(00)81472-5; Miklosi A, 1999, BEHAV BRAIN RES, V105, P199, DOI 10.1016/S0166-4328(99)00071-6; Miklosi A, 1997, PHYSIOL BEHAV, V63, P127, DOI 10.1016/S0031-9384(97)00418-6; OSTHOLM T, 1987, CELL TISSUE RES, V249, P641; OSTHOLM T, 1988, DEV BRAIN RES, V42, P1, DOI 10.1016/0165-3806(88)90197-6; Pogoda HM, 2000, CURR BIOL, V10, P1041, DOI 10.1016/S0960-9822(00)00669-2; Rebagliati MR, 1998, P NATL ACAD SCI USA, V95, P9932, DOI 10.1073/pnas.95.17.9932; ROBERTS A, 1978, NATURE, V273, P774, DOI 10.1038/273774a0; ROGERS LJ, 1990, BEHAV BRAIN RES, V38, P211, DOI 10.1016/0166-4328(90)90176-F; Saijoh Y, 2000, MOL CELL, V5, P35, DOI 10.1016/S1097-2765(00)80401-3; Sampath K, 1998, NATURE, V395, P185, DOI 10.1038/26020; Saude L, 2000, DEVELOPMENT, V127, P3407; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Schier AF, 1997, DEVELOPMENT, V124, P327; Shen MM, 2000, TRENDS GENET, V16, P303, DOI 10.1016/S0168-9525(00)02006-0; Sirotkin HI, 2000, CURR BIOL, V10, P1051, DOI 10.1016/S0960-9822(00)00679-5; TALBOT WS, 1995, NATURE, V378, P150, DOI 10.1038/378150a0; Tanaka S, 1999, NEUROPSYCHOLOGIA, V37, P869, DOI 10.1016/S0028-3932(98)00144-4; Thisse C, 1999, DEVELOPMENT, V126, P229; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; WARRENLEWIS D, 1996, BRAIN ASYMMETRY, P31; Watanabe M, 1999, DEVELOPMENT, V126, P5621; Wood WB, 1997, ANNU REV CELL DEV BI, V13, P53; Yan YT, 1999, GENE DEV, V13, P2527, DOI 10.1101/gad.13.19.2527; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6	55	199	201	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	2000	28	2					399	409		10.1016/S0896-6273(00)00120-3	http://dx.doi.org/10.1016/S0896-6273(00)00120-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	377CE	11144351	Bronze			2022-12-24	WOS:000165493700016
J	Ehlers, MD				Ehlers, MD			Reinsertion or degradation of AMPA receptors determined by activity-dependent endocytic sorting	NEURON			English	Article							LONG-TERM DEPRESSION; GLUTAMATE RECEPTORS; PHOSPHORYLATION SITES; SURFACE EXPRESSION; SILENT SYNAPSES; SYNAPTIC AMPA; GLUR1 SUBUNIT; REDISTRIBUTION; DOMAINS; LTP	Both acute and chronic changes in AMPA receptor (AMPAR) localization are critical for synaptic formation, maturation, and plasticity. Here I report that AMPARs are differentially sorted between recycling and degradative pathways following endocytosis. AMPAR sorting occurs in early endosomes and is regulated by synaptic activity and activation of AMPA and NMDA receptors. AMPAR internalization triggered by NMDAR activation is Ca2+-dependent, requires protein phosphatases, and is followed by rapid membrane reinsertion. Furthermore, NMDAR-mediated AMPAR trafficking is regulated by PKA and accompanied by dephosphorylation and rephosphorylation of GluR1 subunits at a PKA site. In contrast, activation of AMPARs without NMDAR activation targets AMPARs to late endosomes and lysosomes, independent of Ca2+, protein phosphatases, or PKA. These results demonstrate that activity regulates AMPAR endocytic sorting, providing a potential mechanistic link between rapid and chronic changes in synaptic strength.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	ehlers@neuro.duke.edu			NINDS NIH HHS [R01-NS39402] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039402] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Buckley KM, 2000, J PHYSIOL-LONDON, V525, P11, DOI 10.1111/j.1469-7793.2000.t01-2-00011.x; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Gomperts SN, 1998, NEURON, V21, P1443, DOI 10.1016/S0896-6273(00)80662-5; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lee SH, 2000, CURR OPIN NEUROBIOL, V10, P125, DOI 10.1016/S0959-4388(99)00046-X; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Lin JW, 1998, NEURON, V21, P267, DOI 10.1016/S0896-6273(00)80534-6; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Lissin DV, 1999, J NEUROSCI, V19, P1263; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Mammen AL, 1997, J NEUROSCI, V17, P7351; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Rodman JS, 2000, J CELL SCI, V113, P183; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7	36	836	862	1	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	2000	28	2					511	525		10.1016/S0896-6273(00)00129-X	http://dx.doi.org/10.1016/S0896-6273(00)00129-X			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	377CE	11144360	Bronze			2022-12-24	WOS:000165493700025
J	Eldridge, LL; Knowlton, BT; Furmanski, CS; Bookheimer, SY; Engel, SA				Eldridge, LL; Knowlton, BT; Furmanski, CS; Bookheimer, SY; Engel, SA			Remembering episodes: a selective role for the hippocampus during retrieval	NATURE NEUROSCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; ENDURING MEMORY IMPAIRMENT; RECOGNITION MEMORY; SEMANTIC MEMORY; BRAIN ACTIVITY; AMNESIA; FMRI; CONSCIOUSNESS; EXPERIENCE; HYPOTHESIS	Some memories are linked to a specific time and place, allowing one to re-experience the original event, whereas others are accompanied only by a feeling of familiarity. To uncover the distinct neural bases for these two types of memory, we measured brain activity during memory retrieval using event-related functional magnetic resonance imaging. We show that activity in the hippocampus increased only when retrieval was accompanied by conscious recollection of the learning episode. Hippocampal activity did not increase for items recognized based on familiarity or for unrecognized items. These results indicate that the hippocampus selectively supports the retrieval of episodic memories.	Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Mapping Div, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Eldridge, LL (corresponding author), Univ Calif Los Angeles, Dept Psychol, Box 951563,Franz Hall, Los Angeles, CA 90095 USA.			Bookheimer, Susan/0000-0002-3417-5891				Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Buckner RL, 1998, NEUROIMAGE, V7, P163, DOI 10.1006/nimg.1998.0328; Buckner RL, 1998, NEUROIMAGE, V7, P151, DOI 10.1006/nimg.1998.0327; Dolan RJ, 1999, HIPPOCAMPUS, V9, P25, DOI 10.1002/(SICI)1098-1063(1999)9:1<25::AID-HIPO3>3.0.CO;2-4; Fernandez G, 1998, J NEUROSCI, V18, P1841; GARDINER JM, 1990, MEM COGNITION, V18, P579, DOI 10.3758/BF03197100; Henson RNA, 1999, J NEUROSCI, V19, P3962; Hicks JL, 1999, PSYCHON B REV, V6, P117, DOI 10.3758/BF03210818; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Knowlton BJ, 1998, ACTA PSYCHOL, V98, P253, DOI 10.1016/S0001-6918(97)00045-0; MOSCOVITCH M, 1995, J CLIN EXP NEUROPSYC, V17, P276, DOI 10.1080/01688639508405123; Murray EA, 1998, J NEUROSCI, V18, P6568; OSTERGAARD A, 1990, BRAIN COGNITION, V14, P127, DOI 10.1016/0278-2626(90)90024-I; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Rombouts SARB, 1997, HIPPOCAMPUS, V7, P594, DOI 10.1002/(SICI)1098-1063(1997)7:6<594::AID-HIPO2>3.3.CO;2-I; Rudy JW, 1999, BEHAV NEUROSCI, V113, P867, DOI 10.1037/0735-7044.113.5.867; Rugg MD, 1998, NEUROIMAGE, V8, P262, DOI 10.1006/nimg.1998.0363; Saykin AJ, 1999, BRAIN, V122, P1963, DOI 10.1093/brain/122.10.1963; Schacter DL, 1999, HIPPOCAMPUS, V9, P7, DOI 10.1002/(SICI)1098-1063(1999)9:1<7::AID-HIPO2>3.0.CO;2-K; Squire LR, 1998, HIPPOCAMPUS, V8, P205, DOI 10.1002/(SICI)1098-1063(1998)8:3<205::AID-HIPO3>3.0.CO;2-I; SQUIRE LR, 1999, NEW COGNITIVE NEUROS, P765; Talairach J., 1988, COPLANAR STEREOTAXIC; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.3.CO;2-J; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; TULVING E, 1991, J EXP PSYCHOL LEARN, V17, P595, DOI 10.1037/0278-7393.17.4.595; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Woods RP, 1999, HUM BRAIN MAPP, V8, P73, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<73::AID-HBM1>3.0.CO;2-7; Zola SM, 2000, J NEUROSCI, V20, P451, DOI 10.1523/JNEUROSCI.20-01-00451.2000; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	33	685	690	3	76	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11					1149	1152		10.1038/80671	http://dx.doi.org/10.1038/80671			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TX	11036273				2022-12-24	WOS:000167177600021
J	Heynen, AJ; Quinlan, EM; Bae, DC; Bear, MF				Heynen, AJ; Quinlan, EM; Bae, DC; Bear, MF			Bidirectional, activity-dependent regulation of glutamate receptors in the adult hippocampus in vivo	NEURON			English	Article							LONG-TERM POTENTIATION; SILENT SYNAPSES; AMPA RECEPTORS; VISUAL-CORTEX; CA1 REGION; DEPRESSION; LTP; EXPRESSION; INDUCTION; MEMORY	Experience-dependent regulation of synaptic strength has been suggested as a physiological mechanism by which memory storage occurs in the brain. Although modifications in postsynaptic glutamate receptor levels have long been hypothesized to be a molecular basis for long-lasting regulation of synaptic strength, direct evidence obtained in the intact brain has been lacking. Here we show that in the adult brain in vivo, synaptic glutamate receptor trafficking is bidirectionally, and reversibly, modified by NMDA receptor-dependent synaptic plasticity and that changes in glutamate receptor protein levels accurately predict changes in synaptic strength. These findings support the idea that memories can be encoded by the precise experience-dependent assignment of glutamate receptors to synapses in the brain.	Brown Univ, Howard Hughes Med Inst, Dept Neurosci, Providence, RI 02912 USA; Brown Univ, Sch Med, Providence, RI 02912 USA	Brown University; Howard Hughes Medical Institute; Brown University	Bear, MF (corresponding author), Brown Univ, Howard Hughes Med Inst, Dept Neurosci, Providence, RI 02912 USA.	mbear@brown.edu		Bear, Mark/0000-0002-9903-2541				ABRAHAM WC, 1988, BRAIN RES, V462, P40, DOI 10.1016/0006-8993(88)90582-3; BARNES CA, 1994, J NEUROSCI, V14, P5793; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Bear MF, 1996, P NATL ACAD SCI USA, V93, P13453, DOI 10.1073/pnas.93.24.13453; Bi RF, 1998, BRAIN RES, V797, P154, DOI 10.1016/S0006-8993(98)00433-8; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BREESE CR, 1989, J NEUROSCI, V9, P1097; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; DUDEK SM, 1993, J NEUROSCI, V13, P2910; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; HAMPSON DR, 1992, NEUROSCIENCE, V50, P11, DOI 10.1016/0306-4522(92)90378-F; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Heynen AJ, 1996, NATURE, V381, P163, DOI 10.1038/381163a0; HOLLINGSWORTH EB, 1985, J NEUROSCI, V5, P2240; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Kandler K, 1998, NAT NEUROSCI, V1, P119, DOI 10.1038/368; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; ManahanVaughan D, 1997, J NEUROSCI, V17, P3303; MAREN S, 1993, P NATL ACAD SCI USA, V90, P9654, DOI 10.1073/pnas.90.20.9654; MORI H, 1995, NEUROPHARMACOLOGY, V34, P1219, DOI 10.1016/0028-3908(95)00109-J; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULLER D, 1988, P NATL ACAD SCI USA, V85, P9346, DOI 10.1073/pnas.85.23.9346; Nayak A, 1998, NATURE, V394, P680, DOI 10.1038/29305; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; PETRALIA RS, 1994, J NEUROSCI, V14, P667; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Reilly D. L., 1995, WE LEARN WE REMEMBER, P300; SELIG DK, 1995, NEURON, V15, P417, DOI 10.1016/0896-6273(95)90045-4; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Thiels E, 1998, NEUROSCIENCE, V86, P1023, DOI 10.1016/S0306-4522(98)00135-3; THIELS E, 1994, J NEUROPHYSIOL, V72, P3009, DOI 10.1152/jn.1994.72.6.3009; Thomas KL, 1996, LEARN MEMORY, V3, P197, DOI 10.1101/lm.3.2-3.197; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Williams JM, 1998, MOL BRAIN RES, V60, P21, DOI 10.1016/S0169-328X(98)00154-5; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; XIAO MY, 1994, EUR J NEUROSCI, V6, P1055, DOI 10.1111/j.1460-9568.1994.tb00600.x	46	162	168	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	2000	28	2					527	536		10.1016/S0896-6273(00)00130-6	http://dx.doi.org/10.1016/S0896-6273(00)00130-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	377CE	11144361	Bronze			2022-12-24	WOS:000165493700026
J	Beierlein, M; Gibson, JR; Connors, BW				Beierlein, M; Gibson, JR; Connors, BW			A network of electrically coupled interneurons drives synchronized inhibition in neocortex	NATURE NEUROSCIENCE			English	Article							GABAERGIC CELL SUBTYPES; HIPPOCAMPUS IN-VITRO; RAT FRONTAL-CORTEX; CAT VISUAL-CORTEX; CORTICAL-NEURONS; CEREBRAL-CORTEX; GAP-JUNCTIONS; OSCILLATIONS; ACTIVATION; COORDINATION	The neocortex has at least two different networks of electrically coupled inhibitory interneurons: fast-spiking (FS) and low-threshold-spiking (LTS) cells. Agonists of metabotropic glutamate or acetylcholine receptors induced synchronized spiking and membrane fluctuations, with irregular or rhythmic patterns, in networks of LTS cells. LTS activity was closely correlated with inhibitory postsynaptic potentials in neighboring FS interneurons and excitatory neurons. Synchronized LTS activity required electrical synapses, but not fast chemical synapses. Tetanic stimulation of local circuitry induced effects similar to those of metabotropic agonists. We conclude that an electrically coupled network of LTS interneurons can mediate synchronized inhibition when activated by modulatory neurotransmitters.	Brown Univ, Dept Neurosci, Div Biol & Med, Providence, RI 02912 USA	Brown University	Connors, BW (corresponding author), Brown Univ, Dept Neurosci, Div Biol & Med, Box 1953, Providence, RI 02912 USA.	bwc@brown.edu	Connors, Barry/AAX-1975-2020	Beierlein, Michael/0000-0003-2210-3118; Connors, Barry/0000-0002-3739-3157	NIDA NIH HHS [DA12500] Funding Source: Medline; NINDS NIH HHS [NS10478, NS25983] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025983, F32NS010478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012500] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Azouz R, 1999, J NEUROSCI, V19, P2209; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Benardo LS, 1997, J NEUROPHYSIOL, V77, P3134, DOI 10.1152/jn.1997.77.6.3134; Bennett MVL, 1997, J NEUROCYTOL, V26, P349, DOI 10.1023/A:1018560803261; Buhl EH, 1998, J PHYSIOL-LONDON, V513, P117, DOI 10.1111/j.1469-7793.1998.117by.x; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; Engel AK, 1997, CEREB CORTEX, V7, P571, DOI 10.1093/cercor/7.6.571; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Flint AC, 1999, P NATL ACAD SCI USA, V96, P12144, DOI 10.1073/pnas.96.21.12144; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gray CM, 1999, NEURON, V24, P31, DOI 10.1016/S0896-6273(00)80820-X; Hatsopoulos NG, 1998, P NATL ACAD SCI USA, V95, P15706, DOI 10.1073/pnas.95.26.15706; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Holt GR, 1996, J NEUROPHYSIOL, V75, P1806, DOI 10.1152/jn.1996.75.5.1806; Kandler K, 1998, J NEUROSCI, V18, P1419; Kawaguchi Y, 1998, J NEUROSCI, V18, P6963; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kawaguchi Y, 1997, J NEUROPHYSIOL, V78, P1743, DOI 10.1152/jn.1997.78.3.1743; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; LYTTON WW, 1991, J NEUROPHYSIOL, V66, P1059, DOI 10.1152/jn.1991.66.3.1059; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Manor Y, 1997, J NEUROPHYSIOL, V77, P2736, DOI 10.1152/jn.1997.77.5.2736; MICHELSON HB, 1994, J PHYSIOL-LONDON, V477, P35, DOI 10.1113/jphysiol.1994.sp020169; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; SCHOLLHORN V, 1993, LECTINS BIOL BIOCH C, V8, P14; Skinner FK, 1999, J NEUROPHYSIOL, V81, P1274, DOI 10.1152/jn.1999.81.3.1274; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Steriade M, 1997, CEREB CORTEX, V7, P583, DOI 10.1093/cercor/7.6.583; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Thomson AM, 1997, J PHYSIOL-LONDON, V502, P131, DOI 10.1111/j.1469-7793.1997.131bl.x; Traub RD, 1999, FAST OSCILLATIONS CO; Van Vreeswijk C, 1994, J Comput Neurosci, V1, P313; WANG XJ, 1993, NEUROSCIENCE, V53, P899, DOI 10.1016/0306-4522(93)90474-T; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Xiang ZX, 1998, SCIENCE, V281, P985, DOI 10.1126/science.281.5379.985; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; Zhang Y, 1998, J NEUROSCI, V18, P9256	43	374	383	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2000	3	9					904	910		10.1038/78809	http://dx.doi.org/10.1038/78809			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TV	10966621				2022-12-24	WOS:000167177400017
J	Cox, CL; Sherman, SM				Cox, CL; Sherman, SM			Control of dendritic outputs of inhibitory interneurons in the lateral geniculate nucleus	NEURON			English	Article							EXCITATORY POSTSYNAPTIC POTENTIALS; MUSCARINIC ACETYLCHOLINE-RECEPTOR; METABOTROPIC GLUTAMATE RECEPTORS; PATCH-CLAMP RECORDINGS; CHOLINERGIC RECEPTORS; GUINEA-PIG; CAT; NEURONS; CELLS; BRAIN	The thalamic relay to neocortex is dynamically gated. The inhibitory interneuron, which we have studied in the lateral geniculate nucleus, is important to this process. In addition to axonal outputs, these cells have dendritic terminals that are both presynaptic and postsynaptic. Even with action potentials blocked, activation of ionotropic and metabotropic glutamate receptors on these terminals increases their output, whereas activation of metabotropic (M-2 muscarinic) but not nicotinic cholinergic receptors decreases their output. These actions can strongly affect retinogeniculate transmission.	SUNY Stony Brook, Dept Neurobiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Sherman, SM (corresponding author), SUNY Stony Brook, Dept Neurobiol, Stony Brook, NY 11794 USA.			Cox, Charles/0000-0002-1179-7014	NATIONAL EYE INSTITUTE [R01EY003038] Funding Source: NIH RePORTER; NEI NIH HHS [EY03038] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Arcelli P, 1997, BRAIN RES BULL, V42, P27, DOI 10.1016/S0361-9230(96)00107-4; BLOOMFIELD SA, 1989, P NATL ACAD SCI USA, V86, P3911, DOI 10.1073/pnas.86.10.3911; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; Carden WB, 1999, J COMP NEUROL, V410, P431; CAULFIELD MP, 1993, PHARMACOL THERAPEUT, V58, P319, DOI 10.1016/0163-7258(93)90027-B; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Cox CL, 1998, NATURE, V394, P478, DOI 10.1038/28855; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; Erisir A, 1997, J COMP NEUROL, V377, P535; FAMIGLIETTI EV, 1972, J COMP NEUROL, V144, P285, DOI 10.1002/cne.901440304; FRIEDLANDER MJ, 1981, J NEUROPHYSIOL, V46, P80, DOI 10.1152/jn.1981.46.1.80; Godwin DW, 1996, J NEUROSCI, V16, P8181; GUILLERY RW, 1969, Z ZELLFORSCH MIK ANA, V96, P1, DOI 10.1007/BF00321474; HAMMER R, 1980, NATURE, V283, P90, DOI 10.1038/283090a0; HAMOS JE, 1985, NATURE, V317, P618, DOI 10.1038/317618a0; KAPLAN E, 1987, J PHYSIOL-LONDON, V391, P267, DOI 10.1113/jphysiol.1987.sp016737; KUBO T, 1986, NATURE, V323, P411, DOI 10.1038/323411a0; LINDSTROM S, 1982, BRAIN RES, V234, P447, DOI 10.1016/0006-8993(82)90885-X; LUTHIN GR, 1984, J PHARMACOL EXP THER, V228, P648; MCCORMICK DA, 1986, NATURE, V319, P402, DOI 10.1038/319402a0; MCCORMICK DA, 1987, J PHYSIOL-LONDON, V392, P147, DOI 10.1113/jphysiol.1987.sp016774; MCCORMICK DA, 1988, NATURE, V334, P246, DOI 10.1038/334246a0; MCCORMICK DA, 1992, P NATL ACAD SCI USA, V89, P2774, DOI 10.1073/pnas.89.7.2774; MONTERO VM, 1986, J COMP NEUROL, V254, P228, DOI 10.1002/cne.902540207; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; OTTERSEN OP, 1984, ANAT EMBRYOL, V170, P197, DOI 10.1007/BF00319005; PAPE HC, 1995, NEUROSCIENCE, V68, P1105, DOI 10.1016/0306-4522(95)00205-W; Plummer KL, 1999, J COMP NEUROL, V404, P408; RALSTON HJ, 1971, NATURE, V230, P585, DOI 10.1038/230585a0; SCHARFMAN HE, 1990, P NATL ACAD SCI USA, V87, P4548, DOI 10.1073/pnas.87.12.4548; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; STECKLER T, 1994, BRAIN RES REV, V19, P298; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Van Horn SC, 2000, J COMP NEUROL, V416, P509; VANHORN SC, 1995, SOC NEUR ABSTR, V21; Von Krosigk M, 1999, NEUROSCIENCE, V91, P7, DOI 10.1016/S0306-4522(98)00557-0; WATSON M, 1982, LIFE SCI, V31, P2019, DOI 10.1016/0024-3205(82)90041-8; WATSON M, 1983, LIFE SCI, V32, P3001, DOI 10.1016/0024-3205(83)90652-5; WILSON JR, 1984, PROC R SOC SER B-BIO, V221, P411, DOI 10.1098/rspb.1984.0042	40	84	85	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	2000	27	3					597	610		10.1016/S0896-6273(00)00069-6	http://dx.doi.org/10.1016/S0896-6273(00)00069-6			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	359FR	11055441	Bronze			2022-12-24	WOS:000089601300022
J	Larsson, HP; Elinder, F				Larsson, HP; Elinder, F			A conserved glutamate is important for slow inactivation in K+ channels	NEURON			English	Article							C-TYPE INACTIVATION; SHAKER POTASSIUM CHANNELS; MOLECULAR-BASIS; PORE; SELECTIVITY; CONDUCTION; MUTATIONS; REGION; SITE	Voltage-gated ion channels undergo slow inactivation during prolonged depolarizations. We investigated the role of a conserved glutamate at the extracellular end of segment 5 (S5) in slow inactivation by mutating it to a cysteine (E418C in Shaker). We could lock the channel in two different conformations by disulfide-linking 418C to two different cysteines, introduced in the Pore-S6 (P-S6) loop. Our results suggest that E418 is normally stabilizing the open conformation of the slow inactivation gate by forming hydrogen bonds with the P-S6 loop. Breaking these bonds allows the P-S6 loop to rotate, which closes the slow inactivation gate. Our results also suggest a mechanism of how the movement of the voltage sensor can induce slow inactivation by destabilizing these bonds.	Karolinska Inst, Nobel Inst Neurophysiol, Dept Neurosci, SE-17177 Stockholm, Sweden	Karolinska Institutet	Larsson, HP (corresponding author), Karolinska Inst, Nobel Inst Neurophysiol, Dept Neurosci, SE-17177 Stockholm, Sweden.			Elinder, Fredrik/0000-0001-9125-5583				Basso C, 1998, FEBS LETT, V429, P375, DOI 10.1016/S0014-5793(98)00635-8; BEZANILLA F, 1991, SCIENCE, V254, P679, DOI 10.1126/science.1948047; BUSCH AE, 1991, BIOCHEM BIOPH RES CO, V179, P1384, DOI 10.1016/0006-291X(91)91726-S; DEBIASI M, 1993, PFLUG ARCH EUR J PHY, V422, P354, DOI 10.1007/BF00374291; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Elinder F, 1999, BIOPHYS J, V77, P1358, DOI 10.1016/S0006-3495(99)76984-5; GUTMAN GA, 1995, HDB RECEPTORS CHANNE, P1; Harris RE, 1998, BIOPHYS J, V74, P1808, DOI 10.1016/S0006-3495(98)77891-9; Hille B., 1992, IONIC CHANNELS EXCIT; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; KAMB A, 1987, CELL, V50, P405, DOI 10.1016/0092-8674(87)90494-6; Kiss L, 1999, BIOPHYS J, V76, P253, DOI 10.1016/S0006-3495(99)77194-8; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Lodish H., 1995, MOL CELL BIOL; Loots E, 1998, J GEN PHYSIOL, V112, P377, DOI 10.1085/jgp.112.4.377; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MEVES H, 1978, PROG BIOPHYS MOL BIO, V33, P207; Molina A, 1997, J PHYSIOL-LONDON, V499, P361, DOI 10.1113/jphysiol.1997.sp021933; Ogielska EM, 1995, BIOPHYS J, V69, P2449, DOI 10.1016/S0006-3495(95)80114-1; Olcese R, 1997, J GEN PHYSIOL, V110, P579, DOI 10.1085/jgp.110.5.579; PANYI G, 1995, BIOPHYS J, V69, P896, DOI 10.1016/S0006-3495(95)79963-5; PARDO LA, 1992, P NATL ACAD SCI USA, V89, P2466, DOI 10.1073/pnas.89.6.2466; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; Starkus JG, 1997, J GEN PHYSIOL, V110, P539, DOI 10.1085/jgp.110.5.539; VOLLHARDT KPC, 1987, ORGANIC CHEM, P340; Wei A, 1996, NEUROPHARMACOLOGY, V35, P805, DOI 10.1016/0028-3908(96)00126-8; Yang YS, 1997, J GEN PHYSIOL, V109, P779, DOI 10.1085/jgp.109.6.779	30	86	89	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	2000	27	3					573	583		10.1016/S0896-6273(00)00067-2	http://dx.doi.org/10.1016/S0896-6273(00)00067-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	359FR	11055439	Bronze			2022-12-24	WOS:000089601300020
J	Wood, ER; Dudchenko, PA; Robitsek, RJ; Eichenbaum, H				Wood, ER; Dudchenko, PA; Robitsek, RJ; Eichenbaum, H			Hippocampal neurons encode information about different types of memory episodes occurring in the same location	NEURON			English	Article							FREELY-MOVING RATS; PLACE CELLS; PATH INTEGRATION; UNIT-ACTIVITY; SPACE; TASK	Firing patterns of hippocampal complex-spike neurons were examined for the capacity to encode information important to the memory demands of a task even when the overt behavior and location of the animal are held constant. Neuronal activity was recorded as rats continuously alternated left and right turns from the central stem of a modified T maze. Two-thirds of the cells fired differentially as the rat traversed the common stem on left-turn and right-turn trials, even when potentially confounding variations in running speed, heading, and position on the stem were taken into account. Other cells fired differentially on the two trial types in combination with behavioral and spatial factors or appeared to fire similarly on both trial types. This pattern of results suggests that hippocampal representations encode some of the information necessary for representing specific memory episodes.	Boston Univ, Lab Cognit Neurobiol, Boston, MA 02215 USA	Boston University	Wood, ER (corresponding author), Univ Edinburgh, Dept Neurosci, Edinburgh EH8 9JZ, Midlothian, Scotland.	emma.wood@ed.ac.uk		Robitsek, R. Jonathan/0000-0002-6766-9134				[Anonymous], 1983, CANADIAN PSYCHOL; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Czurko A, 1999, EUR J NEUROSCI, V11, P344, DOI 10.1046/j.1460-9568.1999.00446.x; Deadwyler SA, 1996, J NEUROSCI, V16, P354; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Gabrieli JDE, 1997, SCIENCE, V276, P264, DOI 10.1126/science.276.5310.264; Gothard KM, 1996, J NEUROSCI, V16, P8027; Gothard KM, 1996, J NEUROSCI, V16, P823; Hampson RE, 1999, NATURE, V402, P610, DOI 10.1038/45154; Hampson RE, 1996, HIPPOCAMPUS, V6, P281, DOI 10.1002/(SICI)1098-1063(1996)6:3<281::AID-HIPO6>3.0.CO;2-Q; Henke K, 1997, HIPPOCAMPUS, V7, P249, DOI 10.1002/(SICI)1098-1063(1997)7:3<249::AID-HIPO1>3.0.CO;2-G; JARRARD LE, 1986, HIPPOCAMPUS, V4, P93; Jung MW, 1998, CEREB CORTEX, V8, P437, DOI 10.1093/cercor/8.5.437; KUBIE JL, 1984, PHYSIOL BEHAV, V32, P115, DOI 10.1016/0031-9384(84)90080-5; Levy WB, 1996, HIPPOCAMPUS, V6, P579, DOI 10.1002/(SICI)1098-1063(1996)6:6<579::AID-HIPO3>3.0.CO;2-C; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; McNaughton BL, 1996, J EXP BIOL, V199, P173; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Muller R, 1996, NEURON, V17, P813, DOI 10.1016/S0896-6273(00)80214-7; MULLER RU, 1994, J NEUROSCI, V14, P7235; MULLER RU, 1987, J NEUROSCI, V7, P1935; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; OLTON DS, 1986, HIPPOCAMPUS, V4, P281; Quirk MC, 1999, J NEUROSCI METH, V94, P41, DOI 10.1016/S0165-0270(99)00124-7; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Tanila H, 1997, J NEUROSCI, V17, P5155; Touretzky DS, 1996, HIPPOCAMPUS, V6, P247; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; WIBLE CG, 1986, BRAIN RES, V399, P97, DOI 10.1016/0006-8993(86)90604-9; Wiebe SP, 1999, J NEUROSCI, V19, P10562; WIENER SI, 1989, J NEUROSCI, V9, P2737; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605	37	601	608	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	2000	27	3					623	633		10.1016/S0896-6273(00)00071-4	http://dx.doi.org/10.1016/S0896-6273(00)00071-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	359FR	11055443	Bronze			2022-12-24	WOS:000089601300024
J	Flechsig, E; Shmerling, D; Hegyi, I; Raeber, AJ; Fischer, M; Cozzio, A; von Mering, C; Aguzzi, A; Weissmann, C				Flechsig, E; Shmerling, D; Hegyi, I; Raeber, AJ; Fischer, M; Cozzio, A; von Mering, C; Aguzzi, A; Weissmann, C			Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice	NEURON			English	Article							TRANSGENIC MICE; SPONGIFORM ENCEPHALOPATHIES; MOLECULAR-GENETICS; INCUBATION-TIME; COPPER-BINDING; DISEASES; TRANSMISSION; EXPRESSION; STRAIN; AGENT	Mice devoid of PrP are resistant to scrapie and fail to replicate the agent. Introduction of transgenes expressing PrP into such mice restores susceptibility to scrapie. We find that truncated PrP devoid of the five copper binding octarepeats still sustains scrapie infection; however, incubation times are longer and prion titers and protease-resistant PrP are about 30-fold lower than in wild-type mice. Surprisingly, brains of terminally ill animals show no histopathology typical for scrapie. However, in the spinal cord, infectivity, gliosis, and motor neuron loss are as in scrapie-infected wild-type controls. Thus, while the region comprising the octarepeats is not essential for mediating pathogenesis and prion replication, it modulates the extent of these events and of disease presentation.	Univ Zurich, Inst Mol Biol, Abt 1, CH-8057 Zurich, Switzerland; Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital	Weissmann, C (corresponding author), Univ London Imperial Coll Sci Technol & Med, St Marys, MRC, Prion Unit Neurogenet,Sch Med, London W2 1PG, England.	c.weissmann@ic.ac.uk	von Mering, Christian/B-3300-2008; Aguzzi, Adriano/A-3351-2008	von Mering, Christian/0000-0001-7734-9102; Aguzzi, Adriano/0000-0002-0344-6708				BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1994, MOL MED, V1, P19; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; CHANDLER RL, 1961, LANCET, V1, P1378; CHESEBRO B, 1985, NATURE, V315, P331, DOI 10.1038/315331a0; CLARKE PGH, 1995, METHOD CELL BIOL, V46, P277; COLLINGE J, 1994, PHILOS T R SOC B, V343, P371, DOI 10.1098/rstb.1994.0031; COLLINGE J, 1995, LANCET, V346, P569, DOI 10.1016/S0140-6736(95)91405-6; Collinge J, 1997, HUM MOL GENET, V6, P1699, DOI 10.1093/hmg/6.10.1699; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; HORNSHAW MP, 1995, BIOCHEM BIOPH RES CO, V207, P621, DOI 10.1006/bbrc.1995.1233; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; Isenmann S, 1996, HISTOL HISTOPATHOL, V11, P1063; KIMBERLIN RH, 1987, MICROB PATHOGENESIS, V2, P405, DOI 10.1016/0882-4010(87)90047-7; KIMBERLIN RH, 1987, J GEN VIROL, V68, P1875, DOI 10.1099/0022-1317-68-7-1875; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; KRASEMANN S, 1995, MOL BRAIN RES, V34, P173, DOI 10.1016/0169-328X(95)00175-R; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Manson JC, 1999, EMBO J, V18, P6855, DOI 10.1093/emboj/18.23.6855; MANSON JC, 1994, NEURODEGENERATION, V3, P331; Manuelidis L, 1997, SCIENCE, V277, P94, DOI 10.1126/science.277.5322.94; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; PARCHI P, 1995, CURR OPIN NEUROL, V8, P286, DOI 10.1097/00019052-199508000-00007; Prusiner SB, 1996, COLD SPRING HARB SYM, V61, P473; PRUSINER SB, 1989, ANNU REV MICROBIOL, V43, P345, DOI 10.1146/annurev.mi.43.100189.002021; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner SB, 1997, ANNU REV GENET, V31, P139, DOI 10.1146/annurev.genet.31.1.139; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; REED L. J., 1938, AMER JOUR HYG, V27, P493; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; SAILER A, 1994, CELL, V77, P967, DOI 10.1016/0092-8674(94)90436-7; SAKAGUCHI S, 1995, J VIROL, V69, P7586, DOI 10.1128/JVI.69.12.7586-7592.1995; SCOTT M, 1993, CELL, V73, P979, DOI 10.1016/0092-8674(93)90275-U; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Supattapone S, 1999, CELL, V96, P869, DOI 10.1016/S0092-8674(00)80596-6; TARABOULOS A, 1992, P NATL ACAD SCI USA, V89, P7620, DOI 10.1073/pnas.89.16.7620; Telling GC, 1996, GENE DEV, V10, P1736, DOI 10.1101/gad.10.14.1736; Viles JH, 1999, P NATL ACAD SCI USA, V96, P2042, DOI 10.1073/pnas.96.5.2042; Vital C, 1998, NEUROPATH APPL NEURO, V24, P125, DOI 10.1046/j.1365-2990.1998.00098.x; Weissmann C, 1996, COLD SPRING HARB SYM, V61, P511; WEISSMANN C, 1991, NATURE, V349, P569, DOI 10.1038/349569a0; Weissmann C, 1999, J BIOL CHEM, V274, P3, DOI 10.1074/jbc.274.1.3; WILMUT I, 1991, J REPROD FERTIL, V92, P245, DOI 10.1530/jrf.0.0920245; Zanusso G, 1998, P NATL ACAD SCI USA, V95, P8812, DOI 10.1073/pnas.95.15.8812; Zulianello L, 2000, J VIROL, V74, P4351, DOI 10.1128/JVI.74.9.4351-4360.2000	51	226	229	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	2000	27	2					399	408		10.1016/S0896-6273(00)00046-5	http://dx.doi.org/10.1016/S0896-6273(00)00046-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	347YD	10985358	Green Submitted, Green Accepted, Bronze			2022-12-24	WOS:000088956000022
J	Gao, Q; Yuan, BB; Chess, A				Gao, Q; Yuan, BB; Chess, A			Convergent projections of Drosophila olfactory neurons to specific glomeruli in the antennal lobe	NATURE NEUROSCIENCE			English	Article							PUTATIVE PHEROMONE RECEPTORS; ODORANT RECEPTORS; MULTIGENE FAMILY; GENE-EXPRESSION; MELANOGASTER; ORGANIZATION; MAP; INFORMATION; EPITHELIUM; MAMMALS	Candidate Drosophila olfactory receptors (ORs) provide molecular tools to investigate how the organization of the Drosophila olfactory system determines the coding of olfactory stimuli. Neurons in the third antennal segment and maxillary palp appear to express different ORs. Individual olfactory neurons send axonal projections to glomeruli in the antennal lobe. Using transgenic flies, we provide evidence that the neurons expressing a given OR gene, which have cell bodies distributed among neurons expressing other ORs, converge in their projections to topographically fixed glomeruli in the antennal lobe. This convergence allows for the formation of an odotopic map in the antennal robe whose organization could provide a basis for olfactory discrimination in Drosophila.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Chess, A (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.							Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CALLAHAN CA, 1994, P NATL ACAD SCI USA, V91, P5972, DOI 10.1073/pnas.91.13.5972; Carlson JR, 1996, TRENDS GENET, V12, P175, DOI 10.1016/0168-9525(96)10015-9; CHARRO MJ, 1994, J COMP PHYSIOL A, V175, P761; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Ebrahimi FAW, 1998, CURR OPIN NEUROBIOL, V8, P453, DOI 10.1016/S0959-4388(98)80031-7; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; Galizia CG, 1999, NAT NEUROSCI, V2, P473, DOI 10.1038/8144; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; HAFEN E, 1986, DROSOPHILA PRACTICAL, P139; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Ito K, 1998, LEARN MEMORY, V5, P52; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; Laissue PP, 1999, J COMP NEUROL, V405, P543; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; NEF P, 1992, P NATL ACAD SCI USA, V89, P8948, DOI 10.1073/pnas.89.19.8948; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; RODRIGUES V, 1988, BRAIN RES, V453, P299, DOI 10.1016/0006-8993(88)90170-9; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Smith DP, 1996, CURR OPIN NEUROBIOL, V6, P500, DOI 10.1016/S0959-4388(96)80056-0; STOCKER RF, 1983, CELL TISSUE RES, V232, P237, DOI 10.1007/BF00213783; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; STROTMANN J, 1992, NEUROREPORT, V3, P1053, DOI 10.1097/00001756-199212000-00005; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6	38	328	331	4	29	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2000	3	8					780	785		10.1038/77680	http://dx.doi.org/10.1038/77680			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TU	10903570				2022-12-24	WOS:000167177300012
J	Canales, JJ; Graybiel, AM				Canales, JJ; Graybiel, AM			A measure of striatal function predicts motor stereotypy	NATURE NEUROSCIENCE			English	Article							MESSENGER-RNA EXPRESSION; RECEPTOR MUTANT MICE; GENE-EXPRESSION; C-FOS; CREB PHOSPHORYLATION; TRANSCRIPTION FACTOR; DOPAMINE-RECEPTORS; CHRONIC COCAINE; NMDA RECEPTORS; BASAL GANGLIA	To identify basal ganglia circuit dysfunctions that might produce repetitive behaviors known as motor stereotypies, we applied psychomotor stimulants and a direct dopamine receptor agonist to induce different levels of stereotypy in rats. We then used a gene induction assay to measure the functional activation of neurons in the neurochemically distinct compartments of the striatum, the striosomes and the extrastriosomal matrix. The amount by which activation in the striosomes exceeded activation in the matrix predicted the degree of motor stereotypy induced by the drug treatments. These results suggest that imbalance between compartmentally organized basal ganglia circuits may represent a neural correlate of motor stereotypy.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Graybiel, AM (corresponding author), MIT, Dept Brain & Cognit Sci, 45 Carleton St,E25-618, Cambridge, MA 02139 USA.			Canales, Juan J./0000-0003-2884-5227; Graybiel, Ann/0000-0002-4326-7720	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008037] Funding Source: NIH RePORTER; NIDA NIH HHS [R01DA08037] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ANTONY MM, 1988, OBSESSIVE COMPULSIVE, P3; AOSAKI T, 1995, J NEUROPHYSIOL, V73, P1234, DOI 10.1152/jn.1995.73.3.1234; ARNT J, 1985, N-S ARCH PHARMACOL, V330, P97, DOI 10.1007/BF00499901; BHAT RV, 1992, J PSYCHIATR NEUROSCI, V17, P94; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Calabresi P, 1999, J NEUROSCI, V19, P2489; COSTALL B, 1976, EUR J PHARMACOL, V36, P423, DOI 10.1016/0014-2999(76)90096-0; CREESE I, 1972, NATURE-NEW BIOL, V238, P247, DOI 10.1038/newbio238247a0; Cummings JL, 1995, ANN NY ACAD SCI, V769, P1, DOI 10.1111/j.1749-6632.1995.tb38127.x; CURRAN T, 1995, J NEUROBIOL, V26, P403, DOI 10.1002/neu.480260312; Dragunow M, 1996, BEHAV GENET, V26, P293, DOI 10.1007/BF02359385; FIBIGER HC, 1973, BRIT J PHARMACOL, V47, P683, DOI 10.1111/j.1476-5381.1973.tb08194.x; Fog R, 1972, Acta Neurol Scand Suppl, V50, P3; GERFEN CR, 1992, TRENDS NEUROSCI, V15, P133, DOI 10.1016/0166-2236(92)90355-C; Gold L H, 1989, NIDA Res Monogr, V94, P101; GRAYBIEL AM, 1990, TRENDS NEUROSCI, V13, P244, DOI 10.1016/0166-2236(90)90104-I; Graybiel AM, 1997, SCHIZOPHRENIA BULL, V23, P459, DOI 10.1093/schbul/23.3.459; GRAYBIEL AM, 1990, P NATL ACAD SCI USA, V87, P6912, DOI 10.1073/pnas.87.17.6912; Hiroi N, 1996, J COMP NEUROL, V374, P70, DOI 10.1002/(SICI)1096-9861(19961007)374:1<70::AID-CNE5>3.0.CO;2-K; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; HUGHES P, 1995, PHARMACOL REV, V47, P133; Konradi C, 1996, J NEUROSCI, V16, P4231; LAHOSTE GJ, 1993, BRAIN RES, V611, P108, DOI 10.1016/0006-8993(93)91782-N; Liu FC, 1996, NEURON, V17, P1133, DOI 10.1016/S0896-6273(00)80245-7; Lyon M., 1975, CURRENT DEV PSYCHOPH, V2, P80; Manschrek T.C., 1986, HDB SCHIZOPHRENIA, P65; MELLO CV, 1994, J NEUROSCI, V14, P6652; Moratalla R, 1996, NEURON, V17, P147, DOI 10.1016/S0896-6273(00)80288-3; PAUL ML, 1992, J NEUROSCI, V12, P3729, DOI 10.1523/jneurosci.12-10-03729.1992; Pierce RC, 1997, BRAIN RES REV, V25, P192, DOI 10.1016/S0165-0173(97)00021-0; Ramamoorthy S, 1999, SCIENCE, V285, P763, DOI 10.1126/science.285.5428.763; RANDRUP A, 1972, PSYCHIAT NEUROL NEUR, V75, P193; RIDLEY RM, 1994, PROG NEUROBIOL, V44, P221, DOI 10.1016/0301-0082(94)90039-6; ROBBINS TW, 1982, B BRIT PSYCHOL SOC, V35, P297; ROSEN JB, 1994, MOL BRAIN RES, V25, P168, DOI 10.1016/0169-328X(94)90295-X; Rosenberg DR, 1997, J PSYCHIATR NEUROSCI, V22, P29; SCHEELKRUGER J, 1972, EUR J PHARMACOL, V18, P63, DOI 10.1016/0014-2999(72)90132-X; Segal D S, 1980, Science, V207, P905, DOI 10.1126/science.7188815; SHARP FR, 1993, CRIT REV NEUROBIOL, V7, P205; Steiner H, 1998, EXP BRAIN RES, V123, P60, DOI 10.1007/s002210050545; TORRES G, 1993, BRAIN RES BULL, V30, P173, DOI 10.1016/0361-9230(93)90055-G; VOLKOW ND, 1991, NIDA RES MONOGR, V105, P47; WANG JQ, 1994, SYNAPSE, V18, P343, DOI 10.1002/syn.890180410; WANG JQ, 1995, BRAIN RES, V673, P262, DOI 10.1016/0006-8993(94)01422-E; WICHMANN T, NEUROSURG CLIN N AM, V9; WIRTSHAFTER D, 1994, BRAIN RES BULL, V35, P85, DOI 10.1016/0361-9230(94)90220-8; XU M, 1994, CELL, V79, P945, DOI 10.1016/0092-8674(94)90026-4; XU M, 1994, CELL, V79, P729, DOI 10.1016/0092-8674(94)90557-6	49	306	308	1	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2000	3	4					377	383		10.1038/73949	http://dx.doi.org/10.1038/73949			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330CN	10725928				2022-12-24	WOS:000087945400019
J	Jagota, A; de la Iglesia, HO; Schwartz, WJ				Jagota, A; de la Iglesia, HO; Schwartz, WJ			Morning and evening circadian oscillations in the suprachiasmatic nucleus in vitro	NATURE NEUROSCIENCE			English	Article							LONG-TERM MULTIUNIT; GOLDEN-HAMSTER; IN-VITRO; N-ACETYLTRANSFERASE; ACTIVITY RECORDINGS; NEURONAL-ACTIVITY; SYRIAN-HAMSTER; CLOCK; RHYTHMS; PHASE	Daily biological rhythms are governed by an innate timekeeping mechanism, or 'circadian clock'. In mammals, a clock in the suprachiasmatic nucleus (SCN) comprises multiple autonomous single-cell oscillators, but it is unclear how SCN cells interact to form a tissue with coherent metabolic and electrical rhythms that might account for circadian animal behaviors. Here we demonstrate that the circadian rhythm of SCN electrophysiological activity, recorded as a single daytime peak in hamster hypothalamic coronal slices, shows two distinct peaks when slices are cut in the horizontal plane. Substantiating an idea initially derived from behavioral observations, the properties of these two peaks indicate functional organization of SCN tissue as a clock with two oscillating components.	Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Schwartz, WJ (corresponding author), Univ Massachusetts, Sch Med, Dept Neurol, 55 Lake Ave N, Worcester, MA 01655 USA.							BOUSKILA Y, 1993, P NATL ACAD SCI USA, V90, P3207, DOI 10.1073/pnas.90.8.3207; DAAN S, 1978, J THEOR BIOL, V70, P297, DOI 10.1016/0022-5193(78)90378-8; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; Ebling FJP, 1996, PROG NEUROBIOL, V50, P109, DOI 10.1016/S0301-0082(96)00032-9; ELLIOTT JA, 1994, J COMP PHYSIOL A, V174, P469; Franken P, 1999, BRAIN RES, V818, P34, DOI 10.1016/S0006-8993(98)01261-X; GILLETTE MU, 1995, CIRCADIAN CLOCKS THE, P134; Gribkoff VK, 1998, J NEUROSCI, V18, P3014; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; HONMA K, 1985, JPN J PHYSIOL, V35, P643, DOI 10.2170/jjphysiol.35.643; Honma S, 1998, NEUROSCI LETT, V250, P157, DOI 10.1016/S0304-3940(98)00464-9; ILLNEROVA H, 1985, J PINEAL RES, V2, P67, DOI 10.1111/j.1600-079X.1985.tb00628.x; ILLNEROVA H, 1982, J COMP PHYSIOL, V145, P539, DOI 10.1007/BF00612819; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; KALSBEEK A, 1993, J COMP NEUROL, V332, P293, DOI 10.1002/cne.903320304; Liu C, 1997, NEURON, V19, P91, DOI 10.1016/S0896-6273(00)80350-5; MASON R, 1991, NEUROSCI LETT, V123, P160, DOI 10.1016/0304-3940(91)90920-O; MEIJER JH, 1995, J BIOL RHYTHM, V10, P4, DOI 10.1177/074873049501000101; Meijer JH, 1997, BRAIN RES, V753, P322, DOI 10.1016/S0006-8993(97)00150-9; Meijer JH, 1998, J NEUROSCI, V18, P9078; MORIN LP, 1994, NEUROSCIENCE, V61, P391, DOI 10.1016/0306-4522(94)90240-2; MRUGALA MM, IN PRESS AM J PHYSL; PICKARD GE, 1982, J COMP NEUROL, V211, P65, DOI 10.1002/cne.902110107; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; Prosser RA, 1998, J BIOL RHYTHM, V13, P30, DOI 10.1177/074873098128999899; SHINOHARA K, 1995, P NATL ACAD SCI USA, V92, P7396, DOI 10.1073/pnas.92.16.7396; SUMOVA A, 1995, P NATL ACAD SCI USA, V92, P7754, DOI 10.1073/pnas.92.17.7754; Tcheng TK, 1996, J NEUROSCI METH, V69, P163, DOI 10.1016/S0165-0270(96)00039-8; Vuillez P, 1996, NEUROSCI LETT, V208, P37, DOI 10.1016/0304-3940(96)12535-0; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yamazaki S, 1998, J NEUROSCI, V18, P10709; ZLOMANCZUK P, 1991, BRAIN RES, V559, P94, DOI 10.1016/0006-8993(91)90291-3	32	184	189	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2000	3	4					372	376		10.1038/73943	http://dx.doi.org/10.1038/73943			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330CN	10725927				2022-12-24	WOS:000087945400018
J	Lao, GF; Scheuss, V; Gerwin, CM; Su, QN; Mochida, S; Rettig, J; Sheng, ZH				Lao, GF; Scheuss, V; Gerwin, CM; Su, QN; Mochida, S; Rettig, J; Sheng, ZH			Syntaphilin: A syntaxin-1 clamp that controls SNARE assembly	NEURON			English	Article							PROTEIN-PROTEIN INTERACTIONS; RAT HIPPOCAMPAL-NEURONS; TRANSMITTER RELEASE; MEMBRANE-FUSION; NEUROTRANSMITTER RELEASE; ADAPTER PROTEINS; CALCIUM CHANNELS; COMPLEX; SYNAPTOTAGMIN; SYNAPSES	Syntaxin-1 is a key component of the synaptic vesicle docking/fusion machinery that forms the SNARE complex with VAMP/synaptobrevin and SNAP-25. Identifying proteins that modulate SNARE complex formation is critical for understanding the molecular mechanisms underlying neurotransmitter release and its modulation. We have cloned and characterized a protein called syntaphilin that is selectively expressed in brain. Syntaphilin competes with SNAP-25 for binding to syntaxin-1 and inhibits SNARE complex formation by absorbing free syntaxin-1. Transient overexpression of syntaphilin in cultured hippocampal neurons significantly reduces neurotransmitter release. Furthermore, introduction of syntaphilin into presynaptic superior cervical ganglion neurons in culture inhibits synaptic transmission. These findings suggest that syntaphilin may function as a molecular clamp that controls free syntaxin-1 availability for the assembly of the SNARE complex, and thereby regulates synaptic vesicle exocytosis.	NINDS, Synapt Funct Unit, NIH, Bethesda, MD 20892 USA; Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany; Tokyo Med Univ, Dept Physiol, Tokyo 1608402, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Max Planck Society; Tokyo Medical University	Sheng, ZH (corresponding author), NINDS, Synapt Funct Unit, NIH, Bethesda, MD 20892 USA.		Rettig, Jens/K-5103-2013; Volker, Scheuss/G-7846-2015	Rettig, Jens/0000-0001-6160-3954; Scheuss, Volker/0000-0002-0659-3228	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002946, ZIANS002946] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; BAJJALIEH SM, 1995, J BIOL CHEM, V270, P1971, DOI 10.1074/jbc.270.5.1971; Beites CL, 1999, NAT NEUROSCI, V2, P434, DOI 10.1038/8100; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BERRETT EF, 1972, J PHYSIOL-LONDON, V227, P691; BOMMERT K, 1993, NATURE, V363, P163, DOI 10.1038/363163a0; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; COHEN GB, 1995, CELL, V80, P237, DOI 10.1016/0092-8674(95)90406-9; DUNKLEY PR, 1988, BRAIN RES, V441, P59, DOI 10.1016/0006-8993(88)91383-2; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; GARCIA EP, 1995, J CELL BIOL, V129, P105, DOI 10.1083/jcb.129.1.105; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Hilfiker S, 1999, NAT NEUROSCI, V2, P104, DOI 10.1038/5659; Ilardi JM, 1999, NAT NEUROSCI, V2, P119, DOI 10.1038/5673; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; LILJESTROM P, 1991, BIO-TECHNOL, V9, P1356, DOI 10.1038/nbt1291-1356; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; MENNERICK S, 1995, J PHYSIOL-LONDON, V488, P85, DOI 10.1113/jphysiol.1995.sp020948; MOCHIDA S, 1995, NEUROSCIENCE, V65, P905, DOI 10.1016/0306-4522(94)00508-3; MOCHIDA S, 1994, NEURON, V13, P1131, DOI 10.1016/0896-6273(94)90051-5; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; Nagase T, 1997, DNA Res, V4, P141, DOI 10.1093/dnares/4.2.141; Nguyen JT, 1998, SCIENCE, V282, P2088, DOI 10.1126/science.282.5396.2088; OLKKONEN VM, 1993, J NEUROSCI RES, V35, P445, DOI 10.1002/jnr.490350412; Owe-Larsson B, 1999, EUR J NEUROSCI, V11, P1981, DOI 10.1046/j.1460-9568.1999.00614.x; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Sheng ZH, 1996, NATURE, V379, P451, DOI 10.1038/379451a0; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; Verhage M, 1997, NEURON, V18, P453, DOI 10.1016/S0896-6273(00)81245-3; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimbs T, 1997, P NATL ACAD SCI USA, V94, P3046, DOI 10.1073/pnas.94.7.3046; Weis WI, 1998, NATURE, V395, P328, DOI 10.1038/26354; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649; YOSHIDA A, 1992, J BIOL CHEM, V267, P24925	50	76	85	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	2000	25	1					191	201		10.1016/S0896-6273(00)80882-X	http://dx.doi.org/10.1016/S0896-6273(00)80882-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279KP	10707983	Bronze			2022-12-24	WOS:000085043200021
J	Solis, MM; Doupe, AJ				Solis, MM; Doupe, AJ			Compromised neural selectivity for song in birds with impaired sensorimotor learning	NEURON			English	Article							VOCAL CONTROL-SYSTEM; ZEBRA FINCH SONG; ANTERIOR FOREBRAIN; SYRINGEAL MUSCLES; REWARD EXPECTATION; NEURONAL-ACTIVITY; PRIMATE STRIATUM; AIR-FLOW; RESPONSES; NUCLEUS	Anterior forebrain (AF) neurons become selective for song as songbirds learn to produce a copy of a memorized tutor song. We report that development of selectivity is compromised when birds are prevented from matching their output to the tutor song. Finches with denervated vocal organs developed stable song, but it usually did not resemble the tutor song. In those birds, numerous neurons in Area X responded selectively to both tutor and bird's own song (BOS), indicating the importance of both in shaping AF responses. The degree of selectivity for BOS was less, however, than that of normal adults. In contrast, neurons in denervated birds that successfully mimicked tutor song exhibited normal adult selectivity for BOS. Thus, during sensorimotor learning, selectivity for complex stimuli may be influenced by how well motor output matches internal sensory models.	Univ Calif San Francisco, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Doupe, AJ (corresponding author), Univ Calif San Francisco, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA.				NIMH NIH HHS [MH55987] Funding Source: Medline; NINDS NIH HHS [NS34835] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH055987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS034835] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AOSAKI T, 1994, SCIENCE, V265, P412, DOI 10.1126/science.8023166; Basham ME, 1996, NEUROBIOL LEARN MEM, V66, P295, DOI 10.1006/nlme.1996.0071; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Bottjer SW, 1997, J NEUROBIOL, V33, P602, DOI 10.1002/(SICI)1097-4695(19971105)33:5<602::AID-NEU8>3.0.CO;2-8; BOTTJER SW, 1993, J NEUROBIOL, V24, P51, DOI 10.1002/neu.480240105; BRAINARD MS, 1995, J NEUROPHYSIOL, V73, P595, DOI 10.1152/jn.1995.73.2.595; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Dave AS, 1998, SCIENCE, V282, P2250, DOI 10.1126/science.282.5397.2250; DOUPE AJ, 1991, P NATL ACAD SCI USA, V88, P11339, DOI 10.1073/pnas.88.24.11339; Doupe AJ, 1997, J NEUROSCI, V17, P1147; EALES LA, 1989, ANIM BEHAV, V37, P507, DOI 10.1016/0003-3472(89)90097-3; EALES LA, 1987, ANIM BEHAV, V35, P1347, DOI 10.1016/S0003-3472(87)80007-6; EALES LA, 1985, ANIM BEHAV, V33, P1293, DOI 10.1016/S0003-3472(85)80189-5; Goller F, 1996, J NEUROPHYSIOL, V75, P867, DOI 10.1152/jn.1996.75.2.867; Goller F, 1996, J NEUROPHYSIOL, V76, P287, DOI 10.1152/jn.1996.76.1.287; GREEN DM, 1966, SIGNAL DETECTION THE; HARTLEY RS, 1989, J COMP PHYSIOL A, V165, P15, DOI 10.1007/BF00613795; Hessler NA, 1999, J NEUROSCI, V19, P10461; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; Hollerman JR, 1998, J NEUROPHYSIOL, V80, P947, DOI 10.1152/jn.1998.80.2.947; Immelmann K., 1969, P61; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Leonardo A, 1999, NATURE, V399, P466, DOI 10.1038/20933; Lewicki MS, 1996, J NEUROSCI, V16, P6987; LEWIS JW, 1981, J COMP NEUROL, V196, P347, DOI 10.1002/cne.901960212; Luo MM, 1999, J COMP NEUROL, V403, P68; MARGOLIASH D, 1992, J NEUROSCI, V12, P4309; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; MCCASLAND JS, 1981, P NATL ACAD SCI-BIOL, V78, P7815, DOI 10.1073/pnas.78.12.7815; MIOCHE L, 1989, J NEUROPHYSIOL, V62, P185, DOI 10.1152/jn.1989.62.1.185; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; MORRISON RG, 1993, J NEUROBIOL, V24, P1045, DOI 10.1002/neu.480240805; Nelson RJ, 1996, CURR OPIN NEUROBIOL, V6, P801, DOI 10.1016/S0959-4388(96)80031-6; NORDEEN KW, 1992, BEHAV NEURAL BIOL, V57, P58, DOI 10.1016/0163-1047(92)90757-U; Ohlemiller KK, 1996, NEUROREPORT, V7, P1749, DOI 10.1097/00001756-199607290-00011; PEARSON KG, 1993, ANNU REV NEUROSCI, V16, P265, DOI 10.1146/annurev.ne.16.030193.001405; PRICE PH, 1979, J COMP PHYSIOL PSYCH, V93, P260, DOI 10.1037/h0077553; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Schmidt MF, 1998, NAT NEUROSCI, V1, P513, DOI 10.1038/2232; Soha JA, 1996, J NEUROBIOL, V29, P473, DOI 10.1002/(SICI)1097-4695(199604)29:4<473::AID-NEU5>3.0.CO;2-5; SOHRABJI F, 1990, BEHAV NEURAL BIOL, V53, P51, DOI 10.1016/0163-1047(90)90797-A; Solis MM, 1999, J NEUROSCI, V19, P4559; Solis MM, 1997, J NEUROSCI, V17, P6447; Theunissen FE, 1998, J NEUROSCI, V18, P3786; Tremblay L, 1998, J NEUROPHYSIOL, V80, P964, DOI 10.1152/jn.1998.80.2.964; VATES GE, 1995, P NATL ACAD SCI USA, V92, P5139, DOI 10.1073/pnas.92.11.5139; VICARIO DS, 1991, J NEUROBIOL, V22, P63, DOI 10.1002/neu.480220107; VOLMAN SF, 1993, J NEUROSCI, V13, P4737; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029; Wild JM, 1997, J NEUROBIOL, V33, P653, DOI 10.1002/(SICI)1097-4695(19971105)33:5<653::AID-NEU11>3.0.CO;2-A; WILLIAMS H, 1990, ANIM BEHAV, V39, P745, DOI 10.1016/S0003-3472(05)80386-0	52	56	59	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	2000	25	1					109	121		10.1016/S0896-6273(00)80875-2	http://dx.doi.org/10.1016/S0896-6273(00)80875-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279KP	10707976	Green Published, Bronze			2022-12-24	WOS:000085043200014
J	Zhou, C; Qiu, YH; Pereira, FA; Crair, MC; Tsai, SY; Tsai, MJ				Zhou, C; Qiu, YH; Pereira, FA; Crair, MC; Tsai, SY; Tsai, MJ			The nuclear orphan receptor COUP-TFI is required for differentiation of subplate neurons and guidance of thalamocortical axons	NEURON			English	Article							PROMOTER TRANSCRIPTION FACTOR; CENTRAL-NERVOUS-SYSTEM; CEREBRAL-CORTEX; CORTICAL DEVELOPMENT; VISUAL-CORTEX; HUMAN BRAIN; CELLS; MOUSE; CONNECTIONS; EXPRESSION	Chicken ovalbumin upstream promotor-transcription factor I (COUP-TFI), an orphan member of the nuclear receptor superfamily, is highly expressed in the developing nervous systems. In the cerebral cortex of Coup-tfl mutants, cortical layer IV was absent due to excessive cell death, a consequence of the failure of thalamocortical projections. Moreover, subplate neurons underwent improper differentiation and premature cell death during corticogenesis. Our results indicate that the subplate neuron defects lead to the failure of guidance and innervation of thalamocortical projections. Thus, our findings demonstrate a critical role of the subplate in early corticothalamic connectivity and confirm the importance of afferent innervation for the survival of layer IV neurons. These results also substantiate COUP-TFI as an important regulator of neuronal development and differentiation.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Tsai, SY (corresponding author), RW Johnson Pharmaceut Res Inst, Raritan, NJ 08869 USA.	stsai@bcm.tmc.edu; mtsai@bcm.tmc.edu		Pereira, Fred/0000-0003-2100-0280				AKBARIAN S, 1993, ARCH GEN PSYCHIAT, V50, P169; ALLENDOERFER KL, 1994, ANNU REV NEUROSCI, V17, P185, DOI 10.1146/annurev.neuro.17.1.185; ALLENDOERFER KL, 1990, P NATL ACAD SCI USA, V87, P187, DOI 10.1073/pnas.87.1.187; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; BECKERANDRE M, 1994, J BIOL CHEM, V269, P28531; BERRY M, 1965, J ANAT, V99, P691; BLOOM FE, 1993, ARCH GEN PSYCHIAT, V50, P224; Brodmann K., 1909, LOKALISATIONSLEHRE G; Caviness V S Jr, 1982, Brain Res, V256, P293; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; DECARLOS JA, 1992, J NEUROSCI, V12, P1194; FIGDOR MC, 1993, NATURE, V363, P630, DOI 10.1038/363630a0; FONSECA M, 1995, J COMP NEUROL, V361, P177, DOI 10.1002/cne.903610114; GHOSH A, 1990, NATURE, V347, P179, DOI 10.1038/347179a0; GHOSH A, 1993, DEVELOPMENT, V117, P1031; GRAY GE, 1990, EXPERIENTIA, V46, P929, DOI 10.1007/BF01939386; HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B; Jones EG, 1995, CIBA F SYMP, V193, P277; JONK LJC, 1994, MECH DEVELOP, V47, P81, DOI 10.1016/0925-4773(94)90098-1; KAGEYAMA GH, 1993, J COMP NEUROL, V335, P123, DOI 10.1002/cne.903350109; KOSTOVIC I, 1990, J COMP NEUROL, V297, P441, DOI 10.1002/cne.902970309; KOSTOVIC I, 1974, ANAT REC, V178, P395; MCCONNELL SK, 1988, BRAIN RES REV, V13, P1, DOI 10.1016/0165-0173(88)90002-1; MCCONNELL SK, 1989, SCIENCE, V245, P978, DOI 10.1126/science.2475909; Miller B, 1991, CEREB CORTEX, V1, P241, DOI 10.1093/cercor/1.3.241; Misson JP, 1991, CEREB CORTEX, V1, P221, DOI 10.1093/cercor/1.3.221; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; MOLNAR Z, 1995, TRENDS NEUROSCI, V18, P389, DOI 10.1016/0166-2236(95)93935-Q; Molnar Z, 1998, J NEUROSCI, V18, P5723; Molnar Z, 1998, J NEUROSCI, V18, P5746; OLEARY DDM, 1994, ANNU REV NEUROSCI, V17, P419, DOI 10.1146/annurev.neuro.17.1.419; OROURKE NA, 1995, DEVELOPMENT, V121, P2165; Park HT, 1997, BRAIN RES, V747, P332, DOI 10.1016/S0006-8993(96)01320-0; PEREIRA FA, 1995, J STEROID BIOCHEM, V53, P503, DOI 10.1016/0960-0760(95)00097-J; Pipaon C, 1999, MOL CELL BIOL, V19, P2734; Price DJ, 1996, J NEUROSCI, V16, P3247; Qiu YH, 1997, GENE DEV, V11, P1925, DOI 10.1101/gad.11.15.1925; QIU YH, 1994, P NATL ACAD SCI USA, V91, P4451, DOI 10.1073/pnas.91.10.4451; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1978, POSTGRAD MED J, V54, P25; Rodriguez JC, 1997, BIOCHEM J, V326, P587, DOI 10.1042/bj3260587; Rohr O, 1997, J BIOL CHEM, V272, P31149, DOI 10.1074/jbc.272.49.31149; ROSS MH, 1984, NEUROLOGY, V34, P909, DOI 10.1212/WNL.34.7.909; Sawaya BE, 1996, J BIOL CHEM, V271, P23572, DOI 10.1074/jbc.271.38.23572; Sheppard AM, 1997, J COMP NEUROL, V378, P173, DOI 10.1002/(SICI)1096-9861(19970210)378:2<173::AID-CNE2>3.0.CO;2-0; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; WILKINSON DG, 1987, DEVELOPMENT, V99, P493; Windrem MS, 1991, CEREB CORTEX, V1, P230, DOI 10.1093/cercor/1.3.230; ZAHS KR, 1985, J COMP NEUROL, V241, P210, DOI 10.1002/cne.902410208	51	148	150	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1999	24	4					847	859		10.1016/S0896-6273(00)81032-6	http://dx.doi.org/10.1016/S0896-6273(00)81032-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	269UE	10624948	Bronze			2022-12-24	WOS:000084495300013
J	Lu, T; Ting, AY; Mainland, J; Jan, LY; Schultz, PG; Yang, J				Lu, T; Ting, AY; Mainland, J; Jan, LY; Schultz, PG; Yang, J			Probing ion permeation and gating in a K+ channel with backbone mutations in the selectivity filter	NATURE NEUROSCIENCE			English	Article							SHAKER POTASSIUM CHANNELS; SITE-SPECIFIC INCORPORATION; UNNATURAL AMINO-ACIDS; GUINEA-PIG HEART; INWARD-RECTIFIER; MOLECULAR-DYNAMICS; INACTIVATION; PORE; ACTIVATION; MECHANISM	Potassium channels selectively conduct K+ ions across cell membranes, and use diverse mechanisms to control their gating. We studied ion permeation and gating of an inwardly rectifying K+ channel by individually changing the amide carbonyls of two conserved glycines lining the selectivity filter to ester carbonyls using nonsense suppression. Surprisingly, these backbone mutations do not significantly alter ion selectivity. However, they dramatically change the kinetics of single-channel gating and produce distinct subconductance levels. The mutation at the glycine closer to the inner mouth of the pore also abolishes high-affinity binding of Ba2+ to the channel, indicating the importance of this position in ion stabilization in the selectivity filter. Our results demonstrate that K+ ion selectivity can be retained even with significant reduction of electronegativity in the selectivity filter, and that conformational changes of the filter arising from interactions between permeant ions and the backbone carbonyls contribute directly to channel gating.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Univ Calif San Francisco, Dept Physiol, HHMI, San Francisco, CA 94143 USA	Columbia University; Scripps Research Institute; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Yang, J (corresponding author), Columbia Univ, Dept Biol Sci, 915 Fairchild Ctr,MC2462, New York, NY 10027 USA.		Mainland, Joel/C-5171-2009	Mainland, Joel/0000-0002-5056-4598; Jan, Lily/0000-0003-3938-8498				Aqvist J, 2000, NATURE, V404, P881, DOI 10.1038/35009114; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; Berneche S, 2000, BIOPHYS J, V78, P2900, DOI 10.1016/S0006-3495(00)76831-7; Capener CE, 2000, BIOPHYS J, V78, P2929, DOI 10.1016/S0006-3495(00)76833-0; Chapman ML, 1997, BIOPHYS J, V72, P708, DOI 10.1016/S0006-3495(97)78707-1; Choe H, 1998, J GEN PHYSIOL, V112, P433, DOI 10.1085/jgp.112.4.433; Choe H, 1999, BIOPHYS J, V76, P1988, DOI 10.1016/S0006-3495(99)77357-1; Creighton T. E., 1993, PROTEINS STRUCTURES; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; DEMO SD, 1992, BIOPHYS J, V61, P639, DOI 10.1016/S0006-3495(92)81869-6; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; ELLMAN JA, 1992, SCIENCE, V255, P197, DOI 10.1126/science.1553546; England PM, 1999, CELL, V96, P89, DOI 10.1016/S0092-8674(00)80962-9; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Hille B., 1992, IONIC CHANNELS EXCIT; Holmgren M, 1997, J GEN PHYSIOL, V109, P527, DOI 10.1085/jgp.109.5.527; Holmgren M, 1996, J GEN PHYSIOL, V108, P195, DOI 10.1085/jgp.108.3.195; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; Jiang YX, 2000, J GEN PHYSIOL, V115, P269, DOI 10.1085/jgp.115.3.269; Jin WL, 1998, BIOCHEMISTRY-US, V37, P13291, DOI 10.1021/bi981178p; Khakh BS, 1999, NEURON, V23, P653, DOI 10.1016/S0896-6273(01)80025-8; Kiss L, 1999, BIOPHYS J, V76, P253, DOI 10.1016/S0006-3495(99)77194-8; Kofuji P, 1996, NEURON, V16, P941, DOI 10.1016/S0896-6273(00)80117-8; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; Lu T, 1999, NEURON, V22, P571, DOI 10.1016/S0896-6273(00)80711-4; MENDEL D, 1995, ANNU REV BIOPH BIOM, V24, P435, DOI 10.1146/annurev.biophys.24.1.435; NEYTON J, 1991, J GEN PHYSIOL, V97, P641, DOI 10.1085/jgp.97.4.641; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; NOWAK MW, 1995, SCIENCE, V268, P439, DOI 10.1126/science.7716551; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; SAKMANN B, 1984, J PHYSIOL-LONDON, V347, P659, DOI 10.1113/jphysiol.1984.sp015089; SAKMANN B, 1984, J PHYSIOL-LONDON, V347, P641, DOI 10.1113/jphysiol.1984.sp015088; Saks ME, 1996, J BIOL CHEM, V271, P23169, DOI 10.1074/jbc.271.38.23169; Shieh RC, 1998, BIOPHYS J, V75, P2313, DOI 10.1016/S0006-3495(98)77675-1; Shrivastava IH, 2000, BIOPHYS J, V78, P557, DOI 10.1016/S0006-3495(00)76616-1; Silverman SK, 1996, P NATL ACAD SCI USA, V93, P15429, DOI 10.1073/pnas.93.26.15429; Slesinger PA, 1996, NEURON, V16, P321, DOI 10.1016/S0896-6273(00)80050-1; STANFIELD PR, 1994, J PHYSIOL-LONDON, V478, P1; SWENSON RP, 1981, NATURE, V291, P427, DOI 10.1038/291427a0; WIBERG KB, 1987, J AM CHEM SOC, V109, P5935, DOI 10.1021/ja00254a006; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Zheng J, 1997, J GEN PHYSIOL, V110, P101, DOI 10.1085/jgp.110.2.101; Zheng J, 1998, J GEN PHYSIOL, V112, P457, DOI 10.1085/jgp.112.4.457	50	109	146	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2001	4	3					239	246		10.1038/85080	http://dx.doi.org/10.1038/85080			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UE	11224539				2022-12-24	WOS:000167178300010
J	Philpot, BD; Sekhar, AK; Shouval, HZ; Bear, MF				Philpot, BD; Sekhar, AK; Shouval, HZ; Bear, MF			Visual experience and deprivation bidirectionally modify the composition and function of NMDA receptors in visual cortex	NEURON			English	Article							D-ASPARTATE RECEPTORS; LONG-TERM DEPRESSION; MEDIATED SYNAPTIC CURRENTS; NR2A SUBUNIT EXPRESSION; MONOCULAR DEPRIVATION; CRITICAL PERIOD; PHARMACOLOGICAL PROPERTIES; THALAMOCORTICAL SYNAPSES; ORIENTATIONAL PROPERTIES; IFENPRODIL SENSITIVITY	The receptive fields of visual cortical neurons are bidirectionally modified by sensory deprivation and experience, but the synaptic basis for these changes is unknown. Here we demonstrate bidirectional, experience-dependent regulation of the composition and function of synaptic NMDA receptors (NMDARs) in visual cortex layer 2/3 pyramidal cells of young rats. Visual experience decreases the proportion of NR2B- only receptors, shortens the duration of NMDAR-mediated synaptic currents, and reduces summation of synaptic NMDAR currents during bursts of high-frequency stimulation. Visual deprivation exerts an opposite effect. Although the effects of experience and deprivation are reversible, the rates of synaptic modification vary. Experience can induce a detectable change in synaptic transmission within hours, while deprivation-induced changes take days. We suggest that experience-dependent changes in NMDAR composition and function regulate the development of receptive field organization in visual cortex.	Brown Univ, Dept Neurosci, Howard Hughes Med Inst, Providence, RI 02912 USA; Brown Univ, Dept Phys, Providence, RI 02912 USA; Brown Univ, Inst Brain & Neural Syst, Providence, RI 02912 USA	Brown University; Howard Hughes Medical Institute; Brown University; Brown University	Bear, MF (corresponding author), Brown Univ, Dept Neurosci, Howard Hughes Med Inst, Box 1953, Providence, RI 02912 USA.			Bear, Mark/0000-0002-9903-2541				BEAR MF, 1987, SCIENCE, V237, P42, DOI 10.1126/science.3037696; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLAKEMORE C, 1975, J PHYSIOL-LONDON, V248, P663, DOI 10.1113/jphysiol.1975.sp010995; Boeckman FA, 1996, J PHARMACOL EXP THER, V279, P515; Brimecombe JC, 1997, P NATL ACAD SCI USA, V94, P11019, DOI 10.1073/pnas.94.20.11019; BUISSERET P, 1982, DEV BRAIN RES, V4, P417, DOI 10.1016/0165-3806(82)90185-7; BUISSERET P, 1978, NATURE, V272, P816, DOI 10.1038/272816a0; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; CHENARD BL, 1995, J MED CHEM, V38, P3138, DOI 10.1021/jm00016a017; CHURCH J, 1994, BRIT J PHARMACOL, V113, P499, DOI 10.1111/j.1476-5381.1994.tb17017.x; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; CYNADER M, 1980, J NEUROPHYSIOL, V43, P1026, DOI 10.1152/jn.1980.43.4.1026; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Feldman DE, 1998, NEURON, V21, P347, DOI 10.1016/S0896-6273(00)80544-9; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; Flint AC, 1997, J NEUROSCI, V17, P2469; FOX K, 1992, J NEUROSCI, V12, P2672; FOX K, 1991, NATURE, V350, P342, DOI 10.1038/350342a0; FREEMAN RD, 1981, J NEUROPHYSIOL, V45, P1074, DOI 10.1152/jn.1981.45.6.1074; GOTTMANN K, 1995, J NEUROSCI, V15, P2766; Hensch TK, 1998, J NEUROSCI, V18, P2108; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Kew JNC, 1998, J NEUROSCI, V18, P1935; KIRKWOOD A, 1994, J NEUROSCI, V14, P3404; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; KIRKWOOD A, 1994, J NEUROSCI, V14, P1634, DOI 10.1523/JNEUROSCI.14-03-01634.1994; KIRKWOOD A, 1993, SCIENCE, V260, P1518, DOI 10.1126/science.8502997; Krupp JJ, 1996, MOL PHARMACOL, V50, P1680; LAURIE DJ, 1994, EUR J PHARM-MOLEC PH, V268, P335, DOI 10.1016/0922-4106(94)90058-2; LEGENDRE P, 1993, J NEUROSCI, V13, P674; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LESTER RAJ, 1992, J NEUROSCI, V12, P635; Livingston FS, 1997, J NEUROSCI, V17, P8997; Luo JH, 1997, MOL PHARMACOL, V51, P79, DOI 10.1124/mol.51.1.79; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MOWER GD, 1991, DEV BRAIN RES, V58, P151, DOI 10.1016/0165-3806(91)90001-Y; Nase G, 1999, EUR J NEUROSCI, V11, P4320, DOI 10.1046/j.1460-9568.1999.00859.x; PRIESTLEY T, 1995, MOL PHARMACOL, V48, P841; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Ramoa AS, 1997, DEV BRAIN RES, V101, P165, DOI 10.1016/S0165-3806(97)00061-8; Rittenhouse CD, 1999, NATURE, V397, P347, DOI 10.1038/16922; Roberts EB, 1999, J NEUROPHYSIOL, V81, P2587, DOI 10.1152/jn.1999.81.5.2587; Rumbaugh G, 1999, J NEUROSCI, V19, P10603, DOI 10.1523/JNEUROSCI.19-24-10603.1999; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Shi J, 2000, NEURON, V28, P103, DOI 10.1016/S0896-6273(00)00089-1; Tovar KR, 1999, J NEUROSCI, V19, P4180; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; White SA, 1999, J NEUROPHYSIOL, V82, P2221, DOI 10.1152/jn.1999.82.5.2221; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851	59	313	328	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	2001	29	1					157	169		10.1016/S0896-6273(01)00187-8	http://dx.doi.org/10.1016/S0896-6273(01)00187-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	397NX	11182088	Bronze			2022-12-24	WOS:000166702700016
J	Yang, F; He, XP; Feng, LY; Mizuno, K; Liu, XW; Russell, J; Xiong, WC; Lu, B				Yang, F; He, XP; Feng, LY; Mizuno, K; Liu, XW; Russell, J; Xiong, WC; Lu, B			PI-3 kinase and IP3 are both necessary and sufficient to mediate NT3-induced synaptic potentiation	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; DEVELOPING NEUROMUSCULAR SYNAPSES; NEUROTROPHIN SIGNAL-TRANSDUCTION; NERVE GROWTH-FACTOR; BDNF KNOCKOUT MICE; PHOSPHATIDYLINOSITOL 3-KINASE; HIPPOCAMPAL-NEURONS; CORTICAL-NEURONS; TRANSMISSION; RECEPTOR	Signaling mechanisms underlying neurotrophic regulation of synaptic transmission are not fully understood. Here we show that neurotrophin-3 (NT3)-induced potentiation of synaptic transmission at the neuromuscular synapses is blocked by inhibition of phosphoinositide-3 kinase, phospholipase C-gamma or the downstream IP3 receptors of phospholipase C-gamma, but not by inhibition of MAP kinase. However, neither stimulation of Ca2+ release from intracellular stores by photolysis of caged IP3, nor expression of a constitutively active phosphoinositide-3 kinase (PI3K(star)) in presynaptic motoneurons alone is sufficient to enhance transmission. Photo-uncaging of IP3 in neurons expressing PI3K(star) elicits a marked synaptic potentiation, mimicking the NT3 effect. These results reveal an involvement of PI3 kinase in transmitter release, and suggest that concomitant activation of PI3 kinase and IP3 receptors is both necessary and sufficient to mediate the NTS-induced synaptic potentiation.	NICHD, Unit Synapse Dev & Plast, Dev Neurobiol Lab, NIH, Bethesda, MD 20892 USA; Inst Neurosci, Shanghai 200031, Peoples R China; NICHD, Sect Cell Biol & Signal Transduct, Lab Mol & Cellular Neurophysiol, NIH, Bethesda, MD 20892 USA; Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Alabama System; University of Alabama Birmingham	Lu, B (corresponding author), NICHD, Unit Synapse Dev & Plast, Dev Neurobiol Lab, NIH, Bethesda, MD 20892 USA.	lub@codon.nih.gov	Lu, Bai/A-4018-2012; Yang, Feng/C-9530-2011	Lu, Bai/0000-0001-5418-9759; Yang, Feng/0000-0003-1275-6641				ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; BARBACID M, 1993, ONCOGENE, V8, P2033; Chang SH, 1999, P NATL ACAD SCI USA, V96, P4095, DOI 10.1073/pnas.96.7.4095; Dolcet X, 1999, J NEUROCHEM, V73, P521, DOI 10.1046/j.1471-4159.1999.0730521.x; ESCANDON E, 1994, J NEUROSCI, V14, P2054; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; GHOSH TK, 1988, J BIOL CHEM, V263, P11075; Gottschalk W, 1998, J NEUROSCI, V18, P6830; Gottschalk WA, 1999, LEARN MEMORY, V6, P243; GunnMoore FJ, 1997, BIOCHEM J, V322, P193, DOI 10.1042/bj3220193; He XP, 2000, J CELL BIOL, V149, P783, DOI 10.1083/jcb.149.4.783; Holm NR, 1997, P NATL ACAD SCI USA, V94, P1002, DOI 10.1073/pnas.94.3.1002; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KAPLAN DR, 1994, J NEUROBIOL, V25, P1404, DOI 10.1002/neu.480251108; Kelly A, 2000, NEUROPHARMACOLOGY, V39, P643, DOI 10.1016/S0028-3908(99)00169-0; KIM HG, 1994, P NATL ACAD SCI USA, V91, P12341, DOI 10.1073/pnas.91.25.12341; Klippel A, 1996, MOL CELL BIOL, V16, P4117; Kokaia M, 1998, J NEUROSCI, V18, P8730; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; Leissring MA, 1999, J BIOL CHEM, V274, P32535, DOI 10.1074/jbc.274.46.32535; LESSMANN V, 1994, NEUROREPORT, V6, P21; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; Lewis G, 1996, INT REV PSYCHIATR, V8, P289, DOI 10.3109/09540269609051546; Liou HC, 1996, NEUROSCIENCE, V75, P325, DOI 10.1016/0306-4522(96)00280-1; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; Lu B, 1999, J NEUROSCI RES, V58, P76, DOI 10.1002/(SICI)1097-4547(19991001)58:1<76::AID-JNR8>3.0.CO;2-0; LU B, 1992, NEURON, V8, P521, DOI 10.1016/0896-6273(92)90280-Q; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Pettmann B, 1998, NEURON, V20, P633, DOI 10.1016/S0896-6273(00)81004-1; POWIS G, 1994, CANCER RES, V54, P2419; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Skaper SD, 1998, J NEUROCHEM, V70, P1859, DOI 10.1046/j.1471-4159.1998.70051859.x; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Stoop R, 1996, J NEUROSCI, V16, P3256; STOOP R, 1995, SCIENCE, V267, P695, DOI 10.1126/science.7839148; Takei N, 1997, J NEUROCHEM, V68, P370; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang XH, 1997, NEURON, V19, P825, DOI 10.1016/S0896-6273(00)80964-2; Xie KW, 1997, J NEUROSCI, V17, P2947; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000	48	95	97	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2001	4	1					19	28		10.1038/82858	http://dx.doi.org/10.1038/82858			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UB	11135641				2022-12-24	WOS:000167178000010
J	Crosio, C; Cermakian, N; Allis, CD; Sassone-Corsi, P				Crosio, C; Cermakian, N; Allis, CD; Sassone-Corsi, P			Light induces chromatin modification in cells of the mammalian circadian clock	NATURE NEUROSCIENCE			English	Article							HAMSTER SUPRACHIASMATIC NUCLEUS; INDUCED PHASE-SHIFTS; C-FOS EXPRESSION; HISTONE H3; SUPRAOPTIC NUCLEUS; PHOTIC REGULATION; GENE-EXPRESSION; PHOSPHORYLATION; RAT; RHYTHMS	The mammalian circadian clock resides in neurons of the hypothalamic suprachiasmatic nucleus (SCN). Light entrains phase resetting of the clock using the retino-hypothalamic tract, via release of glutamate. Nighttime light exposure causes rapid, transient induction of clock and immediate-early genes implicated in phase-shifting the pacemaker. Here we show that a nighttime light pulse caused phosphorylation of Ser10 in histone H3's tail, in SCN clock cells. The effect of light was specific, and the kinetics of H3 phosphorylation were characteristic of the early response, paralleling c-fos and Per1 induction. Using fos-lacZ transgenic mice, we found that H3 phosphorylation and Fos induction occurRed in the same SCN neurons. Systemic treatment with the GABA(B) receptor agonist baclofen prevented light-induced c-fos and Per1 expression and H3 phosphorylation, indicating that one signaling pathway governs both events. Our results suggest that dynamic chromatin remodeling in the SCN occurs in response to a physiological stimulus in vivo.	Univ Strasbourg 1, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, F-67404 Illkirch, France; Univ Virginia, Hlth Sci Ctr, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Virginia	Sassone-Corsi, P (corresponding author), Univ Strasbourg 1, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, 1 Rue Laurent Fries, F-67404 Illkirch, France.		Sassone-Corsi, Paolo/H-6182-2011; Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; CROSIO, Claudia/0000-0003-2452-1145; Cermakian, Nicolas/0000-0003-4517-9131				Akiyama M, 1999, J NEUROSCI, V19, P1115; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Belvin MP, 1999, NEURON, V22, P777, DOI 10.1016/S0896-6273(00)80736-9; Berquin P, 2000, BRAIN RES, V857, P30, DOI 10.1016/S0006-8993(99)02304-5; Bormann J, 2000, TRENDS PHARMACOL SCI, V21, P16, DOI 10.1016/S0165-6147(99)01413-3; Bourque CW, 1997, ANNU REV PHYSIOL, V59, P601, DOI 10.1146/annurev.physiol.59.1.601; CARD JP, 1989, J COMP NEUROL, V284, P135, DOI 10.1002/cne.902840110; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Cermakian N, 2000, NAT REV MOL CELL BIO, V1, P59, DOI 10.1038/35036078; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; COLWELL CS, 1993, NEUROSCI LETT, V163, P177, DOI 10.1016/0304-3940(93)90376-V; COLWELL CS, 1993, J NEUROSCI, V13, P1454; Cui LN, 1997, J PHYSIOL-LONDON, V502, P149, DOI 10.1111/j.1469-7793.1997.149bl.x; Cui LN, 2000, AM J PHYSIOL-REG I, V278, pR1210, DOI 10.1152/ajpregu.2000.278.5.R1210; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; De Cesare D, 1999, TRENDS BIOCHEM SCI, V24, P281, DOI 10.1016/S0968-0004(99)01414-0; De Cesare D, 1998, P NATL ACAD SCI USA, V95, P12202, DOI 10.1073/pnas.95.21.12202; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Gillespie CF, 1999, J COMP NEUROL, V411, P683; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Harrington M E, 1986, J Biol Rhythms, V1, P309, DOI 10.1177/074873048600100405; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Honrado GI, 1996, J COMP PHYSIOL A, V178, P563; JOHNSON RF, 1988, BRAIN RES, V460, P297, DOI 10.1016/0006-8993(88)90374-5; Klein D.C., 1991, SUPRACHIASMATIC NUCL; KORNHAUSER JM, 1990, NEURON, V5, P127, DOI 10.1016/0896-6273(90)90303-W; Liu C, 2000, NEURON, V25, P123, DOI 10.1016/S0896-6273(00)80876-4; MOORE RY, 1972, J COMP NEUROL, V146, P1, DOI 10.1002/cne.901460102; MOORE RY, 1993, NEUROSCI LETT, V150, P112, DOI 10.1016/0304-3940(93)90120-A; Morris ME, 1998, SCIENCE, V279, P1544, DOI 10.1126/science.279.5356.1544; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Obrietan K, 1999, J BIOL CHEM, V274, P17748, DOI 10.1074/jbc.274.25.17748; Pickard GE, 1997, BIOL CELL, V89, P513, DOI 10.1016/S0248-4900(98)80007-5; ROBERTSON LM, 1995, NEURON, V14, P241, DOI 10.1016/0896-6273(95)90282-1; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; SHIBATA K, 1990, EUR J BIOCHEM, V192, P87, DOI 10.1111/j.1432-1033.1990.tb19199.x; Shinohara K, 2000, NEUROSCIENCE, V96, P591, DOI 10.1016/S0306-4522(99)00556-4; Silver R, 1999, NEUROREPORT, V10, P3165, DOI 10.1097/00001756-199910190-00008; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Wang K, 1997, BRAIN RES, V746, P117, DOI 10.1016/S0006-8993(96)01216-4; WEBER ET, 1995, BRAIN RES, V692, P137; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; WOLLNIK F, 1995, EUR J NEUROSCI, V7, P388, DOI 10.1111/j.1460-9568.1995.tb00334.x; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959	50	208	214	1	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2000	3	12					1241	1247		10.1038/81767	http://dx.doi.org/10.1038/81767			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UA	11100144	Bronze			2022-12-24	WOS:000167177900009
J	Garcia-Alonso, L; Romani, S; Jimenez, F				Garcia-Alonso, L; Romani, S; Jimenez, F			The EGF and FGF receptors mediate neuroglian function to control growth cone decisions during sensory axon guidance in Drosophila	NEURON			English	Article							CELL-ADHESION MOLECULES; NERVOUS-SYSTEM; NEURITE OUTGROWTH; EMBRYONIC MESODERM; L1; EXPRESSION; HEARTLESS; SPECIFICATION; REQUIREMENTS; MIGRATION	Cell adhesion molecules (CAMs) implement the process of axon guidance by promoting specific selection and attachment to substrates. We show that, in Drosophila, loss-of-function conditions of either the Neuroglian CAM, the FGF receptor coded by the gene heartless, or the EGF receptor coded by DER display a similar phenotype of abnormal substrate selection and axon guidance by peripheral sensory neurons. Moreover, neuroglian loss-of-function phenotype can be suppressed by the expression of gain-of-function conditions of heartless or DER. The results are consistent with a scenario where the activity of these receptor tyrosine kinases is controlled by Neuroglian at choice points where sensory axons select between alternative substrates for extension.	Univ Miguel Hernandez, CSIC, Inst Neurociencias, San Juan De Alicante 03550, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Garcia-Alonso, L (corresponding author), Univ Miguel Hernandez, CSIC, Inst Neurociencias, San Juan De Alicante 03550, Spain.		Garcia-Alonso, Luis A/A-3403-2008	Garcia-Alonso, Luis A/0000-0001-5866-3542				Archer FR, 1999, EUR J NEUROSCI, V11, P3565, DOI 10.1046/j.1460-9568.1999.00773.x; Beiman M, 1996, GENE DEV, V10, P2993, DOI 10.1101/gad.10.23.2993; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; Bouley M, 2000, J NEUROSCI, V20, P4515, DOI 10.1523/JNEUROSCI.20-12-04515.2000; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brittis PA, 1996, MOL CELL NEUROSCI, V8, P120, DOI 10.1006/mcne.1996.0051; Brodie C, 1999, CELL GROWTH DIFFER, V10, P183; Buff E, 1998, DEVELOPMENT, V125, P2075; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; Carmena A, 1998, GENE DEV, V12, P3910, DOI 10.1101/gad.12.24.3910; Chen P, 1996, J CELL BIOL, V134, P689, DOI 10.1083/jcb.134.3.689; COHEN NR, 1997, CURR BIOL, V8, P26; CUBAS P, 1991, GENE DEV, V5, P996, DOI 10.1101/gad.5.6.996; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; Doherty P, 1996, MOL CELL NEUROSCI, V8, P99, DOI 10.1006/mcne.1996.0049; EMORI Y, 1993, FEBS LETT, V332, P111, DOI 10.1016/0014-5793(93)80494-F; Garcia-Alonso LA, 1999, CELL MOL LIFE SCI, V55, P1386, DOI 10.1007/s000180050379; GarciaAlonso L, 1996, DEVELOPMENT, V122, P2611; Ghiglione C, 1999, CELL, V96, P847, DOI 10.1016/S0092-8674(00)80594-2; Gisselbrecht S, 1996, GENE DEV, V10, P3003, DOI 10.1101/gad.10.23.3003; Hall SG, 1997, J NEUROBIOL, V32, P325, DOI 10.1002/(SICI)1097-4695(199703)32:3<325::AID-NEU6>3.3.CO;2-N; Hortsch M, 1998, J CELL BIOL, V142, P251, DOI 10.1083/jcb.142.1.251; HORTSCH M, 1995, J BIOL CHEM, V270, P18809, DOI 10.1074/jbc.270.32.18809; HORTSCH M, 1990, NEURON, V4, P697, DOI 10.1016/0896-6273(90)90196-M; Kenwrick S, 1998, BIOESSAYS, V20, P668, DOI 10.1002/(SICI)1521-1878(199808)20:8<668::AID-BIES10>3.0.CO;2-X; Lesokhin AM, 1999, DEV BIOL, V205, P129, DOI 10.1006/dbio.1998.9121; McFarlane S, 1996, NEURON, V17, P245, DOI 10.1016/S0896-6273(00)80156-7; Meiri KF, 1998, J NEUROSCI, V18, P10429; Michelson AM, 1998, DEVELOPMENT, V125, P4379; Michelson AM, 1998, DEV GENET, V22, P212, DOI 10.1002/(SICI)1520-6408(1998)22:3<212::AID-DVG4>3.0.CO;2-9; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; SAFFELL JL, 1997, NEURON, V18, P1; Schaefer AW, 1999, J BIOL CHEM, V274, P37965, DOI 10.1074/jbc.274.53.37965; Schmid RS, 2000, J NEUROSCI, V20, P4177; Scotland P, 1998, J CELL BIOL, V143, P1305, DOI 10.1083/jcb.143.5.1305; Sepp KJ, 1999, GENETICS, V151, P1093; Shishido E, 1997, DEVELOPMENT, V124, P2119; SHISHIDO E, 1993, DEVELOPMENT, V117, P751; Speicher S, 1998, NEURON, V20, P221, DOI 10.1016/S0896-6273(00)80451-1; Suter DM, 1998, CURR OPIN NEUROBIOL, V8, P106, DOI 10.1016/S0959-4388(98)80014-7; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2	43	60	61	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	2000	28	3					741	752		10.1016/S0896-6273(00)00150-1	http://dx.doi.org/10.1016/S0896-6273(00)00150-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386JJ	11163263	Bronze			2022-12-24	WOS:000166057500013
J	van Turennout, M; Ellmore, T; Martin, A				van Turennout, M; Ellmore, T; Martin, A			Long-lasting cortical plasticity in the object naming system	NATURE NEUROSCIENCE			English	Article							EVENT-RELATED FMRI; PREFRONTAL CORTEX; MEMORY STORAGE; TERM-MEMORY; MECHANISMS; HUMANS; ACTIVATION; CIRCUITRY	A single exposure to an object can produce long-lasting behavioral change. Here, using event-related functional magnetic resonance imaging (fMRI), we provide evidence for long-lasting changes in cortical activity associated with perceiving and naming objects. In posterior regions, we observed an immediate (30-second) and long-lasting (3-day) decrease in neural activity after brief (200-ms) exposure to nameable and nonsense objects. In addition, slower-developing decreases in left inferior frontal activity were observed concurrently with increases in left insula activity, only for nameable objects. These time-dependent cortical changes may reflect two distinct learning mechanisms: the formation of sparser, yet more object-form-specific, representations in posterior regions, and experience-induced reorganization of the brain circuitry underlying lexical retrieval in anterior regions.	NIMH, Lab Brain & Cognit, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	van Turennout, M (corresponding author), Max Planck Inst Psycholinguist, Wundtlaan 1, NL-6525 XD Nijmegen, Netherlands.		martin, alex/B-6176-2009; Ellmore, Timothy M./I-3760-2019	Ellmore, Timothy M./0000-0001-6125-0044	NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002588, Z01MH002588] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Buchel C, 1999, SCIENCE, V283, P1538, DOI 10.1126/science.283.5407.1538; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; CAVE CB, 1992, J EXP PSYCHOL LEARN, V18, P509, DOI 10.1037/0278-7393.18.3.509; Cave CB, 1997, PSYCHOL SCI, V8, P322, DOI 10.1111/j.1467-9280.1997.tb00446.x; DAMASIO H, 1980, BRAIN, V103, P337, DOI 10.1093/brain/103.2.337; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Dronkers NF, 1996, NATURE, V384, P159, DOI 10.1038/384159a0; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; LEVELT WJM, 1989, SPEAKING INTENTION A; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; MILLER EK, 1994, SCIENCE, V263, P520, DOI 10.1126/science.8290960; MITCHELL DB, 1988, J EXP PSYCHOL LEARN, V14, P213, DOI 10.1037/0278-7393.14.2.213; Paulesu E, 1996, BRAIN, V119, P143, DOI 10.1093/brain/119.1.143; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; PRICE C, 1999, NEUROCOGNITION LANGU, P211; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; RECANZONE GH, 2000, NEW COGNITIVE NEUROS, P237; Ringo JL, 1996, BEHAV BRAIN RES, V76, P191, DOI 10.1016/0166-4328(95)00197-2; SINGER W, 1995, SCIENCE, V270, P758, DOI 10.1126/science.270.5237.758; SQUIRE LR, 1992, P NATL ACAD SCI USA, V89, P1837, DOI 10.1073/pnas.89.5.1837; Talairach I., 1988, COPLANAR STEREOTACTI; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; van Turennout M, 1998, SCIENCE, V280, P572, DOI 10.1126/science.280.5363.572; WHEELDON LR, 1992, Q J EXP PSYCHOL-A, V44, P723, DOI 10.1080/14640749208401307; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	32	196	198	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2000	3	12					1329	1334		10.1038/81873	http://dx.doi.org/10.1038/81873			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UA	11100155	Bronze			2022-12-24	WOS:000167177900020
J	Fee, MS				Fee, MS			Active stabilization of electrodes for intracellular recording in awake behaving animals	NEURON			English	Article							OPTICAL COHERENCE TOMOGRAPHY; SYNAPTIC RESPONSES; PYRAMIDAL CELLS; NEURONS; CORTEX; RAT; PATTERNS; CAT	Intracellular recording is a powerful electrophysiology technique that has revealed much of what is known about the biophysical properties of neurons. However, neuronal properties are strongly affected by activity dependent and modulatory influences, making it essential, ultimately, to study these properties in behaving animals. Unfortunately, intracellular recording has only been widely applied in vitro, since cardiac and respiratory pulsations make intracellular recording difficult in vivo. In awake behaving animals, spontaneous movements make intracellular recording nearly impossible. Here I present a novel technique to dynamically stabilize the position of a recording electrode relative to the brain. Physiological signals that are predictive of brain motion at the recording site, such as the electrocardiogram (EKG), respiratory pressure, or cranial motion, are used to control a piezoelectric manipulator, making possible stable intracellular recordings in awake active animals.	Bell Labs, Lucent Technol, Biol Computat Res Dept, Murray Hill, NJ 07974 USA	Alcatel-Lucent; Lucent Technologies; AT&T	Fee, MS (corresponding author), Bell Labs, Lucent Technol, Biol Computat Res Dept, 600 Mt Ave, Murray Hill, NJ 07974 USA.			Fee, Michale/0000-0001-7539-1745				AVEZAAT CJJ, 1986, NEUROSURG REV, V9, P113, DOI 10.1007/BF01743061; BARANYI A, 1993, J NEUROPHYSIOL, V69, P1850, DOI 10.1152/jn.1993.69.6.1850; Bazhenov M, 1999, NAT NEUROSCI, V2, P168, DOI 10.1038/5729; Bermejo R, 1996, SOMATOSENS MOT RES, V13, P225, DOI 10.3109/08990229609052578; BRACKENBURY JH, 1973, COMP BIOCHEM PHYSIOL, V44, P599, DOI 10.1016/0300-9629(73)90511-2; BRITT RH, 1982, J NEUROSCI METH, V6, P219, DOI 10.1016/0165-0270(82)90085-1; Czurko A, 1999, EUR J NEUROSCI, V11, P344, DOI 10.1046/j.1460-9568.1999.00446.x; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DICHTER M, 1973, INTRACELLULAR SING A, P3; GLENN LL, 1988, BRAIN RES, V439, P396, DOI 10.1016/0006-8993(88)91502-8; GLOTZNER FL, 1973, ELECTROEN CLIN NEURO, V34, P329, DOI 10.1016/0013-4694(73)90262-9; GOLDSTEIN SR, 1975, ELECTROEN CLIN NEURO, V39, P667, DOI 10.1016/0013-4694(75)90081-4; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Kim U, 1998, J NEUROSCI, V18, P9500; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; MATSUMURA M, 1988, EXP BRAIN RES, V70, P463; MORALES FR, 1981, PHYSIOL BEHAV, V27, P355, DOI 10.1016/0031-9384(81)90280-8; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; PERCIVAL DB, 1993, SPECTRAL ANAL PHYSIC; Roper SN, 1998, J NEUROSCI METH, V80, P91, DOI 10.1016/S0165-0270(97)00202-1; SCHMIDT EM, 1977, ELECTROEN CLIN NEURO, V42, P581, DOI 10.1016/0013-4694(77)90222-X; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Swadlow HA, 1998, J NEUROPHYSIOL, V79, P567, DOI 10.1152/jn.1998.79.2.567; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Torterolo P, 1995, ARCH ITAL BIOL, V134, P57; YLINEN A, 1995, HIPPOCAMPUS, V5, P78, DOI 10.1002/hipo.450050110; YOKOTA T, 1970, J NEUROPHYSIOL, V33, P96, DOI 10.1152/jn.1970.33.1.96; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171	28	69	72	1	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	2000	27	3					461	468		10.1016/S0896-6273(00)00057-X	http://dx.doi.org/10.1016/S0896-6273(00)00057-X			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	359FR	11055429	Bronze			2022-12-24	WOS:000089601300010
J	Magee, JC; Cook, EP				Magee, JC; Cook, EP			Somatic EPSP amplitude is independent of synapse location in hippocampal pyramidal neurons	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; DENDRITIC SYNAPSES; QUANTAL AMPLITUDE; RECEPTOR NUMBER; VARIABILITY; CHANNELS; SLICES; CELLS; AMPA; ARCHITECTURE	Most neurons receive thousands of synaptic inputs onto widely spread dendrites. Because of dendritic filtering, distant synapses should have less efficacy than proximal ones. To investigate this, we characterized the amplitude and kinetics of excitatory synaptic input across the apical dendrites of CA1 pyramidal neurons using dual whole-cell recordings. We found that dendritic EPSP amplitude increases with distance from the soma, counterbalancing the filtering effects of the dendrites and reducing the location dependence of somatic EPSP amplitude. Dendritic current injections and a multi-compartmental computer model demonstrated that dendritic membrane properties have only a minor role in elevating the local EPSP. Instead a progressive increase in synaptic conductance seems to be primarily responsible for normalizing the amplitudes of individual inputs.	Louisiana State Univ, Med Ctr, Ctr Neurosci, New Orleans, LA 70112 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77050 USA	Louisiana State University System; Baylor College of Medicine; Howard Hughes Medical Institute	Magee, JC (corresponding author), Louisiana State Univ, Med Ctr, Ctr Neurosci, 2020 Gravier St, New Orleans, LA 70112 USA.				NINDS NIH HHS [NS39458, NS35865] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS035865, R01NS035865, R01NS039458] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSEN P, 1980, J PHYSIOL-LONDON, V307, P273, DOI 10.1113/jphysiol.1980.sp013435; Archie KA, 2000, NAT NEUROSCI, V3, P54, DOI 10.1038/71125; BANNISTER NJ, 1995, J COMP NEUROL, V360, P161, DOI 10.1002/cne.903600112; Bekkers JM, 1999, J PHYSIOL-LONDON, V516, P227, DOI 10.1111/j.1469-7793.1999.227aa.x; Bekkers JM, 1996, J NEUROPHYSIOL, V75, P1250, DOI 10.1152/jn.1996.75.3.1250; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; Bykhovskaia M, 1999, J NEUROPHYSIOL, V81, P2234, DOI 10.1152/jn.1999.81.5.2234; Cook EP, 1997, J NEUROPHYSIOL, V78, P2116, DOI 10.1152/jn.1997.78.4.2116; Gillessen T, 1997, J NEUROPHYSIOL, V77, P1639, DOI 10.1152/jn.1997.77.3.1639; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; INASEK R, 1973, J PHYSIOL-LONDON, V234, P665; JACK JJB, 1971, J PHYSIOL-LONDON, V215, P283, DOI 10.1113/jphysiol.1971.sp009472; JACK JJB, 1981, J PHYSIOL-LONDON, V321, P65, DOI 10.1113/jphysiol.1981.sp013972; Jaffe DB, 1999, J NEUROPHYSIOL, V82, P3268, DOI 10.1152/jn.1999.82.6.3268; Johnston D, 1999, CURR OPIN NEUROBIOL, V9, P288, DOI 10.1016/S0959-4388(99)80042-7; JOHNSTON D, 1995, FDN CELLULAR NEUROPH, P294; KORN H, 1993, J NEUROPHYSIOL, V70, P1249, DOI 10.1152/jn.1993.70.3.1249; KULLMANN DM, 1992, NATURE, V357, P240, DOI 10.1038/357240a0; LARKMAN A, 1991, NATURE, V350, P344, DOI 10.1038/350344a0; Larkman AU, 1997, J PHYSIOL-LONDON, V505, P457, DOI 10.1111/j.1469-7793.1997.457bb.x; LIAO D, 1992, NEURON, V9, P1089, DOI 10.1016/0896-6273(92)90068-O; Lim R, 1999, J PHYSIOL-LONDON, V516, P505, DOI 10.1111/j.1469-7793.1999.0505v.x; Lipowsky R, 1996, J NEUROPHYSIOL, V76, P2181, DOI 10.1152/jn.1996.76.4.2181; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 1998, J NEUROSCI, V18, P7613; Mainen ZF, 1996, J NEUROPHYSIOL, V76, P1904, DOI 10.1152/jn.1996.76.3.1904; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Pettit DL, 2000, J NEUROPHYSIOL, V84, P28, DOI 10.1152/jn.2000.84.1.28; Prange O, 1999, J NEUROPHYSIOL, V81, P1810, DOI 10.1152/jn.1999.81.4.1810; RALL W, 1962, ANN NY ACAD SCI, V96, P1071, DOI 10.1111/j.1749-6632.1962.tb54120.x; RALL W, 1967, J NEUROPHYSIOL, V30, P1138, DOI 10.1152/jn.1967.30.5.1138; RINZEL J, 1974, BIOPHYS J, V14, P759, DOI 10.1016/S0006-3495(74)85948-5; SORRA KE, 1993, J NEUROSCI, V13, P3736; Stricker C, 1996, J PHYSIOL-LONDON, V490, P419, DOI 10.1113/jphysiol.1996.sp021155; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172	41	427	430	0	25	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2000	3	9					895	903		10.1038/78800	http://dx.doi.org/10.1038/78800			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TV	10966620				2022-12-24	WOS:000167177400016
J	Brown, SP; He, SG; Masland, RH				Brown, SP; He, SG; Masland, RH			Receptive field microstructure and dendritic geometry of retinal ganglion cells	NEURON			English	Article							STARBURST AMACRINE CELLS; RABBIT RETINA; CAT RETINA; X-CELLS; Y-CELLS; FUNCTIONAL ARCHITECTURE; SPATIAL SUMMATION; MAMMALIAN RETINA; BIPOLAR CELLS; W-CELLS	We studied the fine spatial structure of the receptive fields of retinal ganglion cells and its relationship to the dendritic geometry of these cells. Cells from which recordings had been made were microinjected with Lucifer yellow, so that responses generated at precise locations within the receptive field center could be directly compared with that cell's dendritic structure. While many cells with small receptive fields had dome-shaped sensitivity profiles, the majority of large receptive fields were composed of multiple regions of high sensitivity. The density of dendritic branches at any one location did not predict the regions of high sensitivity. Instead, the interactions between a ganglion cell's dendritic tree and the local mosaic of bipolar cell axons seem to define the fine structure of the receptive field center.	Harvard Univ, Sch Med, Neurosci Program, Boston, MA 02115 USA; Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute	Masland, RH (corresponding author), Harvard Univ, Sch Med, Neurosci Program, Boston, MA 02115 USA.		Brown, Solange/H-1615-2012					AMES A, 1981, J NEUROCHEM, V37, P867, DOI 10.1111/j.1471-4159.1981.tb04473.x; AMES A, 1969, J NEUROPHYSIOL, V32, P424, DOI 10.1152/jn.1969.32.3.424; Boycott B, 1999, INVEST OPHTH VIS SCI, V40, P1313; Brown SP, 1999, J COMP NEUROL, V408, P97; Chichilnisky EJ, 1999, NAT NEUROSCI, V2, P889, DOI 10.1038/13189; CITRON MC, 1988, ANN BIOMED ENG, V16, P65, DOI 10.1007/BF02367381; COHEN E, 1992, EUR J NEUROSCI, V4, P506, DOI 10.1111/j.1460-9568.1992.tb00901.x; COHEN E, 1991, J NEUROPHYSIOL, V65, P352, DOI 10.1152/jn.1991.65.2.352; CREUTZFELDT OD, 1970, J NEUROPHYSIOL, V33, P654, DOI 10.1152/jn.1970.33.5.654; DAWIS S, 1984, VISION RES, V24, P549, DOI 10.1016/0042-6989(84)90109-3; DEBOER E, 1968, IEEE T BIO-MED ENG, VBM15, P169, DOI 10.1109/TBME.1968.4502561; DERRINGTON AM, 1982, J PHYSIOL-LONDON, V333, P343, DOI 10.1113/jphysiol.1982.sp014457; DeVries SH, 1997, J NEUROPHYSIOL, V78, P2048, DOI 10.1152/jn.1997.78.4.2048; ENROTHCUGELL C, 1983, J PHYSIOL-LONDON, V341, P279, DOI 10.1113/jphysiol.1983.sp014806; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; ENROTHCUGELL C, 1987, J PHYSIOL-LONDON, V384, P49, DOI 10.1113/jphysiol.1987.sp016443; FREED MA, 1992, P NATL ACAD SCI USA, V89, P236, DOI 10.1073/pnas.89.1.236; FREED MA, 1988, J NEUROSCI, V8, P2303; HAWKEN MJ, 1987, PROC R SOC SER B-BIO, V231, P251, DOI 10.1098/rspb.1987.0044; He SG, 1997, NATURE, V389, P378, DOI 10.1038/38723; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P265, DOI 10.1113/jphysiol.1976.sp011595; Isayama T, 2000, J COMP NEUROL, V417, P32, DOI 10.1002/(SICI)1096-9861(20000131)417:1<32::AID-CNE3>3.0.CO;2-S; KIER CK, 1995, J NEUROSCI, V15, P7673; KOCH C, 1982, PHILOS T R SOC B, V298, P227, DOI 10.1098/rstb.1982.0084; KOLB H, 1979, J NEUROCYTOL, V8, P295, DOI 10.1007/BF01236124; KOLB H, 1993, J COMP NEUROL, V329, P85, DOI 10.1002/cne.903290107; LEVICK WR, 1972, MED BIOL ENG, V10, P510, DOI 10.1007/BF02474199; Levick WR, 1996, PROG RETIN EYE RES, V15, P457, DOI 10.1016/1350-9462(96)00011-0; Linberg KA, 1996, J COMP NEUROL, V365, P173, DOI 10.1002/(SICI)1096-9861(19960205)365:2<173::AID-CNE1>3.0.CO;2-2; LINSENMEIER RA, 1982, VISION RES, V22, P1173, DOI 10.1016/0042-6989(82)90082-7; Massey SC, 1996, J COMP NEUROL, V366, P15; MILLS SL, 1992, J COMP NEUROL, V321, P133, DOI 10.1002/cne.903210112; MILLS SL, 1995, NATURE, V377, P734, DOI 10.1038/377734a0; MIZUNO M, 1985, IEEE T BIO-MED ENG, V32, P56, DOI 10.1109/TBME.1985.325628; PARK SK, 1988, COMMUN ACM, V31, P1192, DOI 10.1145/63039.63042; PEICHL L, 1987, PROC R SOC SER B-BIO, V231, P169, DOI 10.1098/rspb.1987.0040; PEICHL L, 1987, J COMP NEUROL, V263, P25, DOI 10.1002/cne.902630103; Peters BN, 1996, J NEUROPHYSIOL, V75, P469, DOI 10.1152/jn.1996.75.1.469; Reid RC, 1997, VISUAL NEUROSCI, V14, P1015, DOI 10.1017/S0952523800011743; RODIECK R. W., 1965, VISION RES, V5, P583, DOI 10.1016/0042-6989(65)90033-7; ROWE MH, 1993, VISUAL NEUROSCI, V10, P765, DOI 10.1017/S0952523800005459; ROWE MH, 1995, VISUAL NEUROSCI, V12, P117, DOI 10.1017/S0952523800007367; SOODAK RE, 1988, J NEUROPHYSIOL, V60, P2037, DOI 10.1152/jn.1988.60.6.2037; SOODAK RE, 1991, VISUAL NEUROSCI, V6, P621, DOI 10.1017/S0952523800002613; SOODAK RE, 1986, P NATL ACAD SCI USA, V83, P9259, DOI 10.1073/pnas.83.23.9259; Sterling Peter, 1995, P325; STEVENS JK, 1980, SCIENCE, V207, P317, DOI 10.1126/science.7350663; Sutter E.E., 1992, NONLINEAR VISION, P171, DOI [10.1201/9781351075060-6, DOI 10.1201/9781351075060-6]; THIBOS LN, 1983, VISION RES, V23, P1561, DOI 10.1016/0042-6989(83)90170-0; VANEY DI, 1994, PROG RETIN EYE RES, V13, P301, DOI 10.1016/1350-9462(94)90014-0; VANEY DI, 1999, PROCESSING VISUAL MO; VANHOF MW, 1967, VISION RES, V7, P749, DOI 10.1016/0042-6989(67)90037-5; VELTE TJ, 1995, VISUAL NEUROSCI, V12, P165, DOI 10.1017/S0952523800007392; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; YANG G, 1994, J NEUROSCI, V14, P5267; YANG G, 1992, SCIENCE, V258, P1949, DOI 10.1126/science.1470920	56	57	58	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG	2000	27	2					371	383		10.1016/S0896-6273(00)00044-1	http://dx.doi.org/10.1016/S0896-6273(00)00044-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	347YD	10985356	Bronze			2022-12-24	WOS:000088956000020
J	Husi, H; Ward, MA; Choudhary, JS; Blackstock, WP; Grant, SGN				Husi, H; Ward, MA; Choudhary, JS; Blackstock, WP; Grant, SGN			Proteomic analysis of NMDA receptor-adhesion protein signaling complexes	NATURE NEUROSCIENCE			English	Review							LONG-TERM POTENTIATION; POSTSYNAPTIC DENSITY PROTEINS; D-ASPARTATE RECEPTOR; MASS-SPECTROMETRY; SYNAPTIC TRANSMISSION; GLUTAMATE RECEPTORS; POLYACRYLAMIDE GELS; MAP KINASE; PLASTICITY; MOLECULES	N-methyl-D-aspartate receptors (NMDAR) mediate long-lasting changes in synapse strength via downstream signaling pathways. We report proteomic characterization with mass spectrometry and immunoblotting of NMDAR multiprotein complexes (NRC) isolated from mouse brain. The NRC comprised 77 proteins organized into receptor, adaptor, signaling, cytoskeletal and novel proteins, of which 30 are implicated from binding studies and another 19 participate in NMDAR signaling. NMDAR and metabotropic glutamate receptor subtypes were linked to cadherins and L1 cell-adhesion molecules in complexes lacking AMPA receptors. These neurotransmitter-adhesion receptor complexes were bound to kinases, phosphatases, GTPase-activating proteins and Ras with effecters including MAPK pathway components. Several proteins were encoded by activity-dependent genes. Genetic or pharmacological interference with 15 NRC proteins impairs learning and with 22 proteins alters synaptic plasticity in rodents. Mutations in three human genes (NF1, Rsk-2 L1) are associated with learning impairments, indicating the NRC also participates in human cognition.	Univ Edinburgh, Ctr Neurosci, Ctr Genome Res, Edinburgh EH9 3JQ, Midlothian, Scotland; Glaxo Wellcome Res & Dev Ltd, Stevenage SG1 2NY, Herts, England	University of Edinburgh; GlaxoSmithKline	Grant, SGN (corresponding author), Univ Edinburgh, Ctr Neurosci, Ctr Genome Res, W Mains Rd, Edinburgh EH9 3JQ, Midlothian, Scotland.		; choudhary, jyoti/S-1232-2017	Grant, Seth/0000-0001-8732-8735; choudhary, jyoti/0000-0003-0881-5477				Allison DW, 1998, J NEUROSCI, V18, P2423; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Blackstock WP, 1999, TRENDS BIOTECHNOL, V17, P121, DOI 10.1016/S0167-7799(98)01245-1; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Fransen E, 1998, J MED GENET, V35, P399, DOI 10.1136/jmg.35.5.399; Garcia EP, 1998, NEURON, V21, P727, DOI 10.1016/S0896-6273(00)80590-5; Gille H, 1999, J BIOL CHEM, V274, P22033, DOI 10.1074/jbc.274.31.22033; GRANT SGN, 1999, HDB MOL GENETIC TECH, P315; Heresco-Levy U, 1998, EUR NEUROPSYCHOPHARM, V8, P141, DOI 10.1016/S0924-977X(97)00050-3; Hisatsune C, 1999, GENES CELLS, V4, P657, DOI 10.1046/j.1365-2443.1999.00287.x; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hsueh YP, 1998, PROG BRAIN RES, V116, P123, DOI 10.1016/S0079-6123(08)60434-3; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Kim CH, 1999, J NEUROSCI, V19, P4314; Kim JH, 1999, CURR OPIN CELL BIOL, V11, P248, DOI 10.1016/S0955-0674(99)80033-7; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Lin SY, 1999, MOL BRAIN RES, V70, P18, DOI 10.1016/S0169-328X(99)00122-9; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Mendelsohn AR, 1999, SCIENCE, V284, P1948, DOI 10.1126/science.284.5422.1948; Merienne K, 1999, NAT GENET, V22, P13, DOI 10.1038/8719; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Murase S, 1999, CURR OPIN CELL BIOL, V11, P549, DOI 10.1016/S0955-0674(99)00019-8; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; ODELL TJ, 1991, NATURE, V353, P558, DOI 10.1038/353558a0; Ozonoff S, 1999, AM J MED GENET, V89, P45, DOI 10.1002/(SICI)1096-8628(19990326)89:1<45::AID-AJMG9>3.0.CO;2-J; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Silva AJ, 1997, NAT GENET, V15, P281, DOI 10.1038/ng0397-281; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Wechsler A, 1998, EMBO J, V17, P3931, DOI 10.1093/emboj/17.14.3931; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0	50	952	989	0	47	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2000	3	7					661	669		10.1038/76615	http://dx.doi.org/10.1038/76615			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TT	10862698	Green Published			2022-12-24	WOS:000167177200012
J	Littleton, JT; Ganetzky, B				Littleton, JT; Ganetzky, B			Ion channels and synaptic organization: Analysis of the Drosophila genome	NEURON			English	Editorial Material							POTASSIUM CHANNEL; NEUROMUSCULAR-JUNCTION; CALCIUM CHANNELS; SEIZURE LOCUS; RECEPTOR; GENE; MELANOGASTER; MUTATION; SUBUNIT; CLONING		MIT, Ctr Learning & Memory, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Univ Wisconsin, Genet Lab, Madison, WI 53705 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Wisconsin System; University of Wisconsin Madison	Littleton, JT (corresponding author), MIT, Ctr Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	troy@mit.edu		Littleton, J. Troy/0000-0001-5576-2887	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040296] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS040296, R01 NS040296-01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acharya JK, 1997, NEURON, V18, P881, DOI 10.1016/S0896-6273(00)80328-1; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ashcroft FM, 2000, ION CHANNELS DIS; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; Bargmann CI, 1998, ANNU REV NEUROSCI, V21, P279, DOI 10.1146/annurev.neuro.21.1.279; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Budnik V, 1999, NEUROMUSCULAR JUNCTI; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CHOUINARD SW, 1995, P NATL ACAD SCI USA, V92, P6763, DOI 10.1073/pnas.92.15.6763; DiAntonio A, 1999, J NEUROSCI, V19, P3023; FENG GP, 1995, CELL, V82, P1001, DOI 10.1016/0092-8674(95)90279-1; FFRENCHCONSTANT RH, 1993, NATURE, V363, P449, DOI 10.1038/363449a0; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; KAPLAN WD, 1969, GENETICS, V61, P399; KRISHNAN SN, 1993, CELL, V73, P967, DOI 10.1016/0092-8674(93)90274-T; Lee JH, 1999, FEBS LETT, V445, P231, DOI 10.1016/S0014-5793(99)00082-4; PAPAZIAN DM, 1988, ANNU REV PHYSIOL, V50, P379; Ren DJ, 1998, J NEUROSCI, V18, P2335; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Smith L A, 1998, J Neurogenet, V12, P227; Smith LA, 1998, GENETICS, V149, P1407; SUZUKI DT, 1971, P NATL ACAD SCI USA, V68, P890, DOI 10.1073/pnas.68.5.890; Titus SA, 1997, J NEUROSCI, V17, P875; Venkatesh K, 1997, CURR BIOL, V7, P500, DOI 10.1016/S0960-9822(06)00221-1; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Wang XJ, 1997, J NEUROSCI, V17, P882; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; WATANABE T, 1992, DEV BIOL, V152, P172, DOI 10.1016/0012-1606(92)90167-F; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; Wei A, 1996, NEUROPHARMACOLOGY, V35, P805, DOI 10.1016/0028-3908(96)00126-8; Wu C F, 1992, Ion Channels, V3, P261	32	352	366	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	2000	26	1					35	43		10.1016/S0896-6273(00)81135-6	http://dx.doi.org/10.1016/S0896-6273(00)81135-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309MA	10798390	Bronze			2022-12-24	WOS:000086770500006
J	Raghu, P; Usher, K; Jonas, S; Chyb, S; Polyanovsky, A; Hardie, RC				Raghu, P; Usher, K; Jonas, S; Chyb, S; Polyanovsky, A; Hardie, RC			Constitutive activity of the light-sensitive channels TRP and TRPL in the Drosophila diacylglycerol kinase mutant, rdgA	NEURON			English	Article							RETINAL-DEGENERATION-B; PDZ-DOMAIN PROTEIN; ARACHIDONIC-ACID; IN-VIVO; PHOTORECEPTOR MUTANT; SIGNALING COMPLEX; CALCIUM STORES; FATTY-ACIDS; CA2+ INFLUX; PHOTOTRANSDUCTION	Mutations in the Drosophila retinal degeneration A (rdgA) gene, which encodes diacylglycerol kinase (DGK), result in early onset retinal degeneration and blindness. Whole-cell recordings revealed that light-sensitive Ca2+ channels encoded by the trp gene were constitutively active in rdgA photoreceptors. Early degeneration was rescued in rdgA;trp double mutants, lacking TRP channels; however, the less Ca2+-permeable light-sensitive channels (TRPL) were constitutively active instead. No constitutive activity was seen in rdgA;trpl;trp mutants lacking both classes of channel, although, like rdgA;trp, these still showed a residual slow degeneration. Responses to light were restored in rdgA;frp but deactivated abnormally slowly, indicating that DGK is required for response termination. The findings suggest that early degeneration in rdgA is caused by uncontrolled Ca2+ influx and support the proposal that diacylglycerol or its metabolites are messengers of excitation in Drosophila photoreceptors.	Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England; Dept Biochem, Cambridge CB2 1GA, England; Russian Acad Sci, IM Sechenov Evolutionary Physiol & Biochem Inst, St Petersburg 194223, Russia	University of Cambridge; North-Western State Medical University named after I.I. Mechnikov; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry	Hardie, RC (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge CB2 3DY, England.		Chyb, Sylwester/B-5783-2009; Padinjat, Raghu/Z-5578-2019	Hardie, Roger/0000-0001-5531-3264; Polyanovsky, Andrey/0000-0002-8116-022X				Acharya JK, 1997, NEURON, V18, P881, DOI 10.1016/S0896-6273(00)80328-1; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Broad LM, 1999, J PHYSIOL-LONDON, V517, P121, DOI 10.1111/j.1469-7793.1999.0121z.x; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Cook B, 1999, CELL CALCIUM, V25, P161, DOI 10.1054/ceca.1998.0018; COSENS DJ, 1969, NATURE, V224, P285, DOI 10.1038/224285a0; Ding L, 1998, J BIOL CHEM, V273, P32746, DOI 10.1074/jbc.273.49.32746; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; FRANCESCHINI N, 1971, KYBERNETIK, V9, P159, DOI 10.1007/BF02215177; FUCHS S, 1995, NAT GENET, V10, P360, DOI 10.1038/ng0795-360; Hardie RC, 1995, J NEUROPHYSIOL, V74, P2590, DOI 10.1152/jn.1995.74.6.2590; Hardie RC, 1998, CELL CALCIUM, V24, P153, DOI 10.1016/S0143-4160(98)90125-7; Hardie RC, 1996, J NEUROSCI, V16, P2924; HARDIE RC, 1995, CELL CALCIUM, V18, P256, DOI 10.1016/0143-4160(95)90023-3; HARDIE RC, 1993, P ROY SOC B-BIOL SCI, V252, P223, DOI 10.1098/rspb.1993.0069; HARDIE RC, 1991, J NEUROSCI, V11, P3079; HARDIE RC, 1994, J GEN PHYSIOL, V103, P409, DOI 10.1085/jgp.103.3.409; HARDIE RC, 1991, P ROY SOC B-BIOL SCI, V245, P203, DOI 10.1098/rspb.1991.0110; HARDIE RC, 1994, J GEN PHYSIOL, V103, P389, DOI 10.1085/jgp.103.3.389; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; HARRIS WA, 1977, J GEN PHYSIOL, V69, P261, DOI 10.1085/jgp.69.3.261; HOCHSTRATE P, 1989, J COMP PHYSIOL A, V166, P179, DOI 10.1007/BF00193462; HOTTA Y, 1970, P NATL ACAD SCI USA, V67, P1156, DOI 10.1073/pnas.67.3.1156; INOUE H, 1989, J BIOL CHEM, V264, P5996; JOHNSON MA, 1982, J INSECT PHYSIOL, V28, P233, DOI 10.1016/0022-1910(82)90082-8; Kiselyov K, 1999, TRENDS NEUROSCI, V22, P334, DOI 10.1016/S0166-2236(99)01426-5; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; LEONARD DS, 1992, J NEUROBIOL, V23, P605, DOI 10.1002/neu.480230602; Masai I, 1997, J NEUROBIOL, V32, P695, DOI 10.1002/(SICI)1097-4695(19970620)32:7<695::AID-NEU5>3.0.CO;2-#; MASAI I, 1993, P NATL ACAD SCI USA, V90, P11157, DOI 10.1073/pnas.90.23.11157; MATSUMOTO E, 1988, CELL TISSUE RES, V252, P293; Minke B, 1996, CURR OPIN NEUROBIOL, V6, P459, DOI 10.1016/S0959-4388(96)80050-X; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; OTousa JE, 1997, PROG RETIN EYE RES, V16, P691, DOI 10.1016/S1350-9462(96)00035-3; PAK WL, 1976, SCIENCE, V194, P956, DOI 10.1126/science.824732; PERETZ A, 1994, NEURON, V12, P1257, DOI 10.1016/0896-6273(94)90442-1; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; POLLOCK JA, 1995, J NEUROSCI, V15, P3747; RAO PN, 1995, AM J HUM GENET, V57, P173; Reuss H, 1997, NEURON, V19, P1249, DOI 10.1016/S0896-6273(00)80416-X; RUBENSTEIN CT, 1989, VIS NEUROSCI, V2, P529; SAHLY I, 1992, P NATL ACAD SCI USA, V89, P435, DOI 10.1073/pnas.89.1.435; Scott K, 1998, NATURE, V395, P805, DOI 10.1038/27448; Scott K, 1997, CELL, V91, P375, DOI 10.1016/S0092-8674(00)80421-3; Scott K, 1998, CURR OPIN NEUROBIOL, V8, P383, DOI 10.1016/S0959-4388(98)80065-2; Shuttleworth TJ, 1996, J BIOL CHEM, V271, P21720, DOI 10.1074/jbc.271.36.21720; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; STARK WS, 1989, J NEUROGENET, V5, P49, DOI 10.3109/01677068909167264; Topham MK, 1999, J BIOL CHEM, V274, P11447, DOI 10.1074/jbc.274.17.11447; Trump BF, 1996, BBA-MOL CELL RES, V1313, P173, DOI 10.1016/0167-4889(96)00086-9; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; VANDERZEE L, 1995, BIOCHEM J, V305, P859, DOI 10.1042/bj3050859; VIHTELIC TS, 1993, J CELL BIOL, V122, P1013, DOI 10.1083/jcb.122.5.1013; WU L, 1995, NATURE, V373, P216, DOI 10.1038/373216a0; Yoon J, 2000, J NEUROSCI, V20, P649, DOI 10.1523/JNEUROSCI.20-02-00649.2000	60	129	130	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	2000	26	1					169	179		10.1016/S0896-6273(00)81147-2	http://dx.doi.org/10.1016/S0896-6273(00)81147-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309MA	10798401	Bronze			2022-12-24	WOS:000086770500017
J	Hassan, BA; Bermingham, NA; He, YC; Sun, Y; Jan, YN; Zoghbi, HY; Bellen, HJ				Hassan, BA; Bermingham, NA; He, YC; Sun, Y; Jan, YN; Zoghbi, HY; Bellen, HJ			Atonal regulates neurite arborization but does not act as a proneural gene in the Drosophila brain	NEURON			English	Article							PERIPHERAL NERVOUS-SYSTEM; SENSE ORGAN; TRANSCRIPTION FACTOR; MUSHROOM BODIES; EXPRESSION; NEUROGENESIS; LOCALIZATION; NOTCH; PHOTORECEPTORS; PROGENITORS	Drosophila atonal (ato) is the proneural gene of the chordotonal organs (CHOs) in the peripheral nervous system (PNS) and the larval and adult photoreceptor organs. Here, we show that ato is expressed at multiple stages during the development of a lineage of central brain neurons that innervate the optic lobes and are required for eclosion. A novel fate mapping approach shows that ato is expressed in the embryonic precursors of these neurons and that its expression is reactivated in third instar larvae (L3). In contrast to its function in the PNS, ato does not act as a proneural gene in the embryonic brain. Instead, ato performs a novel function, regulating arborization during larval and pupal development by interacting with Notch.	Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Human & Mol Genet, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Univ Calif San Francisco, Dept Physiol & Biochem, San Francisco, CA 94143 USA	Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of California System; University of California San Francisco	Bellen, HJ (corresponding author), Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA.	bhassan@bcm.tmc.edu; hbellen@bcm.tmc.edu	Hassan, Bassem A/D-5221-2012	Hassan, Bassem A/0000-0001-9533-4908; Zoghbi, Huda/0000-0002-0700-3349; Bellen, Hugo/0000-0001-5992-5989; Jan, Yuh Nung/0000-0003-1367-6299				Ahmad I, 1998, J MOL NEUROSCI, V11, P165, DOI 10.1385/JMN:11:2:165; AKAZAWA C, 1995, J BIOL CHEM, V270, P8730, DOI 10.1074/jbc.270.15.8730; Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; Bauer H., 1943, Zeitschrift fuer Induktive Abstammungs- und Vererbungslehre, V81, P374, DOI 10.1007/BF01847454; BAUSENWEIN B, 1992, CELL TISSUE RES, V267, P17, DOI 10.1007/BF00318687; Ben-Arie N, 2000, DEVELOPMENT, V127, P1039; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; BenArie N, 1996, HUM MOL GENET, V5, P1207, DOI 10.1093/hmg/5.9.1207; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brown NL, 1998, DEVELOPMENT, V125, P4821; Cau E, 1997, DEVELOPMENT, V124, P1611; Clark IE, 1997, DEVELOPMENT, V124, P461; Daniel A, 1999, DEVELOPMENT, V126, P2945; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; DRELLER C, 1993, J COMP PHYSIOL A, V173, P275, DOI 10.1007/BF00212691; Eberl DF, 1999, CURR OPIN NEUROBIOL, V9, P389, DOI 10.1016/S0959-4388(99)80058-0; FISCHBACH KF, 1981, NEUROSCI LETT S, V7, pS288; Franklin JL, 1999, CURR BIOL, V9, P1448, DOI 10.1016/S0960-9822(00)80114-1; GINIGER E, 1993, DEVELOPMENT, V117, P431; Giniger E, 1998, NEURON, V20, P667, DOI 10.1016/S0896-6273(00)81007-7; HIDALGO A, 1995, DEVELOPMENT, V121, P3703; Jacobsen TL, 1998, DEVELOPMENT, V125, P4531; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; Jarman AP, 1998, MECH DEVELOP, V76, P117, DOI 10.1016/S0925-4773(98)00116-6; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; Kim P, 1997, DEV BIOL, V187, P1, DOI 10.1006/dbio.1997.8572; Kolb B, 1998, ANNU REV PSYCHOL, V49, P43, DOI 10.1146/annurev.psych.49.1.43; Kunes S, 1999, NEURON, V22, P639, DOI 10.1016/S0896-6273(00)80719-9; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; MARDON G, 1994, DEVELOPMENT, V120, P3473; McIver S.B., 1985, P71; MOFFAT KG, 1992, DEVELOPMENT, V114, P681; MOULINS M, 1976, ULTRASTRUCTURE CHORD; Nieto MA, 1996, NEURON, V17, P1039, DOI 10.1016/S0896-6273(00)80237-8; Okabe M, 1997, DEVELOPMENT, V124, P1045; PFLUGFELDER GO, 1992, P NATL ACAD SCI USA, V89, P1199, DOI 10.1073/pnas.89.4.1199; Phelps CB, 1998, METHODS, V14, P367, DOI 10.1006/meth.1998.0592; Roztocil T, 1997, DEVELOPMENT, V124, P3263; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; SHELLENBARGER DL, 1971, GENETICS, V68, pS61; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Sun Y, 1998, DEVELOPMENT, V125, P3731; Takebayashi K, 1997, EMBO J, V16, P384, DOI 10.1093/emboj/16.2.384; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tsuda H, 1998, J BIOL CHEM, V273, P6327, DOI 10.1074/jbc.273.11.6327; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; YANG MY, 1995, NEURON, V15, P45; Yoshihara Y, 1999, NEURON, V22, P33, DOI 10.1016/S0896-6273(00)80676-5; YounossiHartenstein A, 1997, DEV BIOL, V182, P270, DOI 10.1006/dbio.1996.8475; ZHAO C, 1995, NATURE, V373, P74, DOI 10.1038/373074a0; zur Lage P, 1999, DEVELOPMENT, V126, P3149; zurLage P, 1997, CURR BIOL, V7, P166, DOI 10.1016/S0960-9822(97)70087-3	57	131	135	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	2000	25	3					549	561		10.1016/S0896-6273(00)81059-4	http://dx.doi.org/10.1016/S0896-6273(00)81059-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	301CY	10774724	Bronze			2022-12-24	WOS:000086291700009
J	Patel, TD; Jackman, A; Rice, FL; Kucera, J; Snider, WD				Patel, TD; Jackman, A; Rice, FL; Kucera, J; Snider, WD			Development of sensory neurons in the absence of NGF/TrkA signaling in vivo	NEURON			English	Article							NERVE GROWTH-FACTOR; DORSAL-ROOT GANGLION; BAX-DEFICIENT MICE; PROTEIN-KINASE; SPINAL-CORD; DEVELOPING AXONS; SUBSTANCE-P; DRG NEURONS; ALPHA-CGRP; CELL-DEATH	The neurotrophin survival dependence of peripheral neurons in vitro is regulated by the proapoptotic BCL-2 homolog BAX. To study peripheral neuron development in the absence of neurotrophin signaling, we have generated mice that are double null for BAX and nerve growth factor (NGF), and BAX and the NGF receptor TrkA. All dorsal root ganglion (DRG) neurons that normally die in the absence of NGF/TrkA signaling survive if BAX is also eliminated. These neurons extend axons through the dorsal roots and collateral branches into the dorsal horn. In contrast, superficial cutaneous innervation is absent. Furthermore, rescued sensory neurons fail to express biochemical markers characteristic of the nociceptive phenotype. These findings establish that NGF/TrkA signaling regulates peripheral target field innervation and is required for the full phenotypic differentiation of sensory neurons.	Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; Albany Med Coll, Dept Pharmacol & Neurosci, Albany, NY 12054 USA; Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA	University of North Carolina; University of North Carolina Chapel Hill; Albany Medical College; Boston University	Snider, WD (corresponding author), Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA.				NINDS NIH HHS [NS34692, NS31768] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031768, R01NS034692] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AVERILL S, 1995, EUR J NEUROSCI, V7, P1484, DOI 10.1111/j.1460-9568.1995.tb01143.x; Bennett DLH, 1996, EUR J NEUROSCI, V8, P2204; BROAD PM, 1989, NUCLEIC ACIDS RES, V17, P6999, DOI 10.1093/nar/17.17.6999; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; DAVIES AM, 1994, TRENDS NEUROSCI, V17, P195; DAVIES AM, 1987, NATURE, V326, P353, DOI 10.1038/326353a0; Davies AM, 1996, PHILOS T ROY SOC B, V351, P389, DOI 10.1098/rstb.1996.0033; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Durham PL, 1998, MOL ENDOCRINOL, V12, P1002, DOI 10.1210/me.12.7.1002; Farinas I, 1998, NEURON, V21, P325, DOI 10.1016/S0896-6273(00)80542-5; Farinas I, 1996, NEURON, V17, P1065, DOI 10.1016/S0896-6273(00)80240-8; Fundin BT, 1999, DEVELOPMENT, V126, P2597; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; Huang EJ, 1999, DEVELOPMENT, V126, P2191; JACKMAN A, 2000, IN PRESS J COMP NEUR; KAGEYAMA R, 1991, J BIOL CHEM, V266, P15525; Kennedy Timothy E., 1995, Current Opinion in Neurobiology, V5, P83, DOI 10.1016/0959-4388(95)80091-3; KESSLER JA, 1980, P NATL ACAD SCI-BIOL, V77, P649, DOI 10.1073/pnas.77.1.649; Kitao Y, 1996, J COMP NEUROL, V371, P249, DOI 10.1002/(SICI)1096-9861(19960722)371:2<249::AID-CNE5>3.0.CO;2-2; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; LAWSON SN, 1979, J NEUROCYTOL, V8, P265, DOI 10.1007/BF01236122; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; Lentz SI, 1999, J NEUROSCI, V19, P1038; LEWIN GR, 1994, EUR J NEUROSCI, V6, P1903, DOI 10.1111/j.1460-9568.1994.tb00581.x; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; LINDSAY RM, 1989, NATURE, V337, P362, DOI 10.1038/337362a0; LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0; Maina F, 1997, GENE DEV, V11, P3341, DOI 10.1101/gad.11.24.3341; MARTI E, 1987, J COMP NEUROL, V266, P332, DOI 10.1002/cne.902660304; Merry DE, 1997, ANNU REV NEUROSCI, V20, P245, DOI 10.1146/annurev.neuro.20.1.245; MOLLIVER DC, 1995, J COMP NEUROL, V361, P404, DOI 10.1002/cne.903610305; Molliver DC, 1997, J COMP NEUROL, V381, P428, DOI 10.1002/(SICI)1096-9861(19970519)381:4<428::AID-CNE3>3.0.CO;2-4; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; NOGUCHI K, 1990, NEUROSCI LETT, V108, P1, DOI 10.1016/0304-3940(90)90696-7; O'Connor R, 1999, NEURON, V24, P165, DOI 10.1016/S0896-6273(00)80830-2; Ozaki S, 1997, J COMP NEUROL, V380, P215; Patapoutian A, 1999, SCIENCE, V283, P1180, DOI 10.1126/science.283.5405.1180; Pettmann B, 1998, NEURON, V20, P633, DOI 10.1016/S0896-6273(00)81004-1; Redmond L, 1997, DEV BIOL, V182, P205, DOI 10.1006/dbio.1996.8488; Reichardt L. F., 1997, MOL CELLULAR APPROAC, P220; Rice FL, 1998, DEV BIOL, V198, P57, DOI 10.1006/dbio.1998.8861; SCOTT SA, 1992, SENSORY NEURONS DIVE, P242; Sharma K, 1998, DEVELOPMENT, V125, P635; SILOSSANTIAGO I, 1995, J NEUROSCI, V15, P5929; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; Snider WD, 1996, PHILOS T ROY SOC B, V351, P395, DOI 10.1098/rstb.1996.0034; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; TESSIERLAVIGNE M, 1991, TRENDS NEUROSCI, V14, P303, DOI 10.1016/0166-2236(91)90142-H; Tonra JR, 1998, J COMP NEUROL, V392, P489; VERGE VMK, 1989, J NEUROCYTOL, V18, P583, DOI 10.1007/BF01187079; VERGE VMK, 1995, J NEUROSCI, V15, P2081, DOI 10.1523/JNEUROSCI.15-03-02081.1995; Wang H, 1999, NATURE, V401, P765, DOI 10.1038/44521; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; WATSON A, 1995, J BIOL CHEM, V270, P9655, DOI 10.1074/jbc.270.16.9655; Wenner P, 1995, J NEUROSCI, V15, P8191; White FA, 1996, J NEUROSCI, V16, P4662; White FA, 1998, J NEUROSCI, V18, P1428; Wright DE, 1997, NEURON, V19, P503, DOI 10.1016/S0896-6273(00)80367-0; WRIGHT DE, 1995, J COMP NEUROL, V351, P329, DOI 10.1002/cne.903510302; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; YAMAGATA M, 1995, DEVELOPMENT, V121, P189; Zigmond RE, 1997, ANN NY ACAD SCI, V814, P181, DOI 10.1111/j.1749-6632.1997.tb46157.x	65	291	298	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	2000	25	2					345	357		10.1016/S0896-6273(00)80899-5	http://dx.doi.org/10.1016/S0896-6273(00)80899-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	288EL	10719890	Bronze, Green Published			2022-12-24	WOS:000085549100013
J	Ramon-Cueto, A; Cordero, MI; Santos-Benito, FF; Avila, J				Ramon-Cueto, A; Cordero, MI; Santos-Benito, FF; Avila, J			Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; NEURITE GROWTH-INHIBITORS; SCHWANN-CELL GRAFTS; ADULT-RAT; CORTICOSPINAL TRACT; RE-INNERVATION; INJURY; TRANSPLANTS; REPAIR; BULB	Axonal regeneration in the lesioned mammalian central nervous system is abortive, and this causes permanent disabilities in individuals with spinal cord injuries. In adult rats, olfactory ensheathing glia (OEG) transplants successfully led to functional and structural recovery after complete spinal cord transection. From 3 to 7 months post surgery, all OEG-transplanted animals recovered locomotor functions and sensorimotor reflexes. They presented Voluntary hindlimb movements, they supported their body weight, and their hindlimbs responded to light skin contact and proprioceptive stimuli. In addition, relevant motor axons (corticospinal, raphespinal, and coeruleospinal) regenerated for long distances within caudal cord stumps. Therefore, OEG transplantation provides a useful repair strategy in adult mammals with traumatic spinal cord injuries. Our results with these cells could lead to new therapies for the treatment of spinal cord lesions in humans.	Univ Autonoma Madrid, Fac Ciencias, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; Univ Nacl Educ Distancia, Dept Psychobiol, E-28040 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Universidad Nacional de Educacion a Distancia (UNED)	Ramon-Cueto, A (corresponding author), CSIC, Inst Biomed, Neural Regenerat Grp, Jaime Roig 11, Valencia 46010, Spain.		Cordero, Maria Isabel/AAF-2935-2019; Cordero, Maria Isabel/A-2532-2013; Avila, Jesus/I-2610-2015	Cordero, Maria Isabel/0000-0003-0692-8064; Cordero, Maria Isabel/0000-0003-0692-8064; Avila, Jesus/0000-0002-6288-0571				Aston-Jones Gary, 1995, P183; BARONVANEVERCOOREN A, 1991, NEUROSCI LETT, V131, P241, DOI 10.1016/0304-3940(91)90623-2; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; BOVOLENTA P, 1992, PROG BRAIN RES, V94, P367; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Bregman BS, 1998, CURR OPIN NEUROBIOL, V8, P800, DOI 10.1016/S0959-4388(98)80124-4; Bregman BS, 1998, EXP NEUROL, V149, P13, DOI 10.1006/exnr.1997.6669; Cajal S., 1928, DEGENERATION REGENER; Cassam AK, 1999, NEUROSCIENCE, V88, P1275, DOI 10.1016/S0306-4522(98)00262-0; Cheng H, 1996, SCIENCE, V273, P510, DOI 10.1126/science.273.5274.510; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; DOUCETTE JR, 1983, J ANAT, V137, P1; DOUCETTE R, 1991, J COMP NEUROL, V312, P451, DOI 10.1002/cne.903120311; Dyer JK, 1998, EXP NEUROL, V154, P12, DOI 10.1006/exnr.1998.6905; Fawcett JW, 1998, SPINAL CORD, V36, P811, DOI 10.1038/sj.sc.3100769; Fitch MT, 1997, EXP NEUROL, V148, P587, DOI 10.1006/exnr.1997.6701; GOLDBERGER ME, 1990, EXP NEUROL, V107, P113, DOI 10.1016/0014-4886(90)90149-M; GRAZIADEI PPC, 1980, J NEUROCYTOL, V9, P145, DOI 10.1007/BF01205155; Grill R, 1997, J NEUROSCI, V17, P5560; Guest JD, 1997, EXP NEUROL, V148, P502, DOI 10.1006/exnr.1997.6693; Holstege Gert, 1995, P137; Jakeman LB, 1998, EXP NEUROL, V154, P170, DOI 10.1006/exnr.1998.6924; KUNKELBAGDEN E, 1993, EXP NEUROL, V119, P153, DOI 10.1006/exnr.1993.1017; LAYWELL ED, 1992, P NATL ACAD SCI USA, V89, P2634, DOI 10.1073/pnas.89.7.2634; Li Y, 1997, SCIENCE, V277, P2000, DOI 10.1126/science.277.5334.2000; Li Y, 1998, J NEUROSCI, V18, P10514; LIUZZI FJ, 1987, SCIENCE, V237, P642, DOI 10.1126/science.3603044; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Menei P, 1998, EUR J NEUROSCI, V10, P607, DOI 10.1046/j.1460-9568.1998.00071.x; Miranda JD, 1999, EXP NEUROL, V156, P218, DOI 10.1006/exnr.1998.7012; Nakahara Y, 1996, CELL TRANSPLANT, V5, P191, DOI 10.1016/0963-6897(95)02028-4; Navarro X, 1999, ANN NEUROL, V45, P207, DOI 10.1002/1531-8249(199902)45:2<207::AID-ANA11>3.0.CO;2-K; NEWTON BW, 1989, J COMP NEUROL, V279, P68, DOI 10.1002/cne.902790107; Olson L, 1997, NAT MED, V3, P1329, DOI 10.1038/nm1297-1329; Pasterkamp RJ, 1998, J NEUROSCI, V18, P9962; Rabchevsky AG, 1997, J NEUROSCI RES, V47, P34; Ramon-Cueto A, 1998, J NEUROSCI, V18, P3803; Ramon-Cueto A, 1998, BRAIN RES BULL, V46, P175, DOI 10.1016/S0361-9230(97)00463-2; RAMONCUETO A, 1995, GLIA, V14, P163, DOI 10.1002/glia.440140302; RAMONCUETO A, 1993, EUR J NEUROSCI, V5, P1172, DOI 10.1111/j.1460-9568.1993.tb00971.x; RAMONCUETO A, 1994, EXP NEUROL, V127, P232, DOI 10.1006/exnr.1994.1099; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0; SCHWAB ME, 1993, ANNU REV NEUROSCI, V16, P565, DOI 10.1146/annurev.ne.16.030193.003025; SILVER J, 1994, J NEUROL, V242, P22; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; Tracey David J., 1995, P67; TUSZYNSKI MH, 1994, EXP NEUROL, V126, P1, DOI 10.1006/exnr.1994.1037; VEENMAN CL, 1992, J NEUROSCI METH, V41, P239, DOI 10.1016/0165-0270(92)90089-V; WANG JJ, 1995, NEUROSCIENCE, V65, P973, DOI 10.1016/0306-4522(94)00519-B; XU XM, 1995, EXP NEUROL, V134, P261, DOI 10.1006/exnr.1995.1056; Zhang Y, 1997, J NEUROSCI RES, V49, P433; Zuo J, 1998, EXP NEUROL, V154, P654, DOI 10.1006/exnr.1998.6951; Zuo J, 1998, J NEUROSCI, V18, P5203, DOI 10.1523/JNEUROSCI.18-14-05203.1998	56	669	790	0	44	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	2000	25	2					425	435		10.1016/S0896-6273(00)80905-8	http://dx.doi.org/10.1016/S0896-6273(00)80905-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	288EL	10719896	Bronze, Green Published			2022-12-24	WOS:000085549100019
J	Abeliovich, A; Schmitz, Y; Farinas, I; Choi-Lundberg, D; Ho, WH; Castillo, PE; Shinsky, N; Verdugo, JMG; Armanini, M; Ryan, A; Hynes, M; Phillips, H; Sulzer, D; Rosenthal, A				Abeliovich, A; Schmitz, Y; Farinas, I; Choi-Lundberg, D; Ho, WH; Castillo, PE; Shinsky, N; Verdugo, JMG; Armanini, M; Ryan, A; Hynes, M; Phillips, H; Sulzer, D; Rosenthal, A			Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system	NEURON			English	Article							LONG-TERM POTENTIATION; A-BETA COMPONENT; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; SYNAPTIC VESICLES; NERVOUS-SYSTEM; AMPHETAMINE ACTION; PRECURSOR PROTEIN; PREFRONTAL CORTEX; NEURONS	alpha-Synuclein (alpha-Syn) is a 14 kDa protein of unknown function that has been implicated in the pathophysiology of Parkinson's disease (PD). Here, we show that alpha-Syn(-/-) mice are viable and fertile, exhibit intact brain architecture, and possess a normal complement of dopaminergic cell bodies, fibers, and synapses. Nigrostriatal terminals of alpha-Syn(-/-) mice display a standard pattern of dopamine (DA) discharge and reuptake in response to simple electrical stimulation. However, they exhibit an increased release with paired stimuli that can be mimicked by elevated Ca2+. Concurrent with the altered DA release, alpha-Syn(-/-) mice display a reduction in striatal DA and an attenuation of DA-dependent locomotor response to amphetamine. These findings support the hypothesis that alpha-Syn is an essential presynaptic, activity-dependent negative regulator of DA neurotransmission.	Genentech Inc, Dept Neurosci, S San Francisco, CA 94080 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Valencia, Dept Biol Celular, E-46100 Burjassot, Spain; Columbia Univ, New York State Psychiat Inst, Dept Neurol, New York, NY 10032 USA; Columbia Univ, New York State Psychiat Inst, Dept Psychiat, New York, NY 10032 USA; Stanford Univ, Sch Med, Dept Psychiat, Nancy Friend Pritzker Lab, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Dept Behav Sci, Palo Alto, CA 94304 USA; Columbia Univ, New York State Psychiat Inst, Dept Neurosci, New York, NY 10032 USA	Roche Holding; Genentech; University of California System; University of California San Francisco; University of Valencia; Columbia University; New York State Psychiatry Institute; Columbia University; New York State Psychiatry Institute; Stanford University; Stanford University; Columbia University; New York State Psychiatry Institute	Rosenthal, A (corresponding author), Genentech Inc, Dept Neurosci, S San Francisco, CA 94080 USA.		García-Verdugo, José Manuel/L-8421-2017; Schmitz, Yvonne/L-6183-2013; Choi-Lundberg, Derek L/J-7670-2014; Farinas, Isabel/L-7118-2014	García-Verdugo, José Manuel/0000-0001-9872-6499; Choi-Lundberg, Derek L/0000-0002-3594-8585; Castillo, Pablo/0000-0002-9834-1801; Hynes, Mary/0000-0001-6623-6727; Farinas, Isabel/0000-0003-2903-4960				Buchman VL, 1998, J NEUROSCI, V18, P9335; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dittman JS, 1998, J NEUROSCI, V18, P6147; Fon EA, 1997, NEURON, V19, P1271, DOI 10.1016/S0896-6273(00)80418-3; Frohman MA, 1996, CURR BIOL, V6, P945, DOI 10.1016/S0960-9822(02)00634-6; GARRIS PA, 1994, NEUROSCIENCE, V59, P417, DOI 10.1016/0306-4522(94)90606-8; Garris PA, 1999, NATURE, V398, P67, DOI 10.1038/18019; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Goda Y, 1997, CURR OPIN CELL BIOL, V9, P513, DOI 10.1016/S0955-0674(97)80027-0; Gomis A, 1999, J NEUROSCI, V19, P6309; GRACE AA, 1984, J NEUROSCI, V4, P2877; Horger BA, 1998, J NEUROSCI, V18, P4929; HYNES M, 1995, CELL, V80, P95, DOI 10.1016/0092-8674(95)90454-9; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jenco JM, 1998, BIOCHEMISTRY-US, V37, P4901, DOI 10.1021/bi972776r; Jensen PH, 1997, BIOCHEM J, V323, P539, DOI 10.1042/bj3230539; JENSEN PH, 1995, BIOCHEM J, V310, P91, DOI 10.1042/bj3100091; Jones SR, 1998, J NEUROSCI, V18, P1979; KENNEDY RT, 1992, J NEUROCHEM, V59, P449, DOI 10.1111/j.1471-4159.1992.tb09391.x; KLEIN J, 1995, J NEUROCHEM, V65, P1445; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lavedan C, 1998, GENOME RES, V8, P871, DOI 10.1101/gr.8.9.871; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Mezey E, 1998, NAT MED, V4, P755, DOI 10.1038/nm0798-755; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Ostrerova N, 1999, J NEUROSCI, V19, P5782, DOI 10.1523/JNEUROSCI.19-14-05782.1999; Paik SR, 1998, FEBS LETT, V421, P73, DOI 10.1016/S0014-5793(97)01537-8; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rebec GV, 1997, NEUROSCIENCE, V76, P707, DOI 10.1016/S0306-4522(96)00382-X; Schluter OM, 1999, J NEUROSCI, V19, P5834, DOI 10.1523/JNEUROSCI.19-14-05834.1999; SEIDEN LS, 1993, ANN REV PHARM TOXICO, V32, P639; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; STARKE K, 1989, J NEUROCHEM, V2, P449; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; SULZER D, 1995, J NEUROSCI, V15, P4102; Tong G, 1996, NEURON, V16, P1147, DOI 10.1016/S0896-6273(00)80141-5; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; WIGHTMAN RM, 1990, BRAIN RES REV, V15, P135, DOI 10.1016/0165-0173(90)90015-G; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; Wise RA, 1996, ANNU REV NEUROSCI, V19, P319, DOI 10.1146/annurev.ne.19.030196.001535	50	1294	1335	2	98	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	2000	25	1					239	252		10.1016/S0896-6273(00)80886-7	http://dx.doi.org/10.1016/S0896-6273(00)80886-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279KP	10707987	Bronze			2022-12-24	WOS:000085043200025
J	Liu, Z; Murray, EA; Richmond, BJ				Liu, Z; Murray, EA; Richmond, BJ			Learning motivational significance of visual cues for reward schedules requires rhinal cortex	NATURE NEUROSCIENCE			English	Article							MONKEYS MACACA-MULATTA; LONG-TERM-MEMORY; RHESUS-MONKEYS; PERIRHINAL CORTEX; PARAHIPPOCAMPAL CORTICES; OBJECT-DISCRIMINATION; STIMULUS ASSOCIATION; AMYGDALOID COMPLEX; TEMPORAL CORTEX; MACAQUE MONKEY	The limbic system is necessary to associate stimuli with their motivational and emotional significance. The perirhinal cortex is directly connected to this system, and neurons in this region carry signals related to a monkey's progress through visually cued reward schedules. This task manipulates motivation by displaying different visual cues to indicate the amount of work remaining until reward delivery. We asked whether rhinal (that is, entorhinal and perirhinal) cortex is necessary to associate the visual cues with reward schedules. When faced with new visual cues in reward schedules, intact monkeys adjusted their motivation in the schedules, whereas monkeys with rhinal cortex removals failed to do so. Thus, the rhinal cortex is critical for forming associations between visual stimuli and their motivational significance.	NIMH, Neuropsychol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Richmond, BJ (corresponding author), NIMH, Neuropsychol Lab, NIH, Bethesda, MD 20892 USA.	bjr@ln.nimh.nih.gov	Murray, Elisabeth A./X-2051-2019	Murray, Elisabeth/0000-0003-1450-1642	NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002032, ZIAMH002619, Z01MH002619, ZIAMH002032] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AGGLETON JP, 1980, BRAIN RES, V190, P347, DOI 10.1016/0006-8993(80)90279-6; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Bachevalier J, 1999, BEHAV NEUROSCI, V113, P1127, DOI 10.1037/0735-7044.113.6.1127; BAIZER JS, 1993, VISUAL NEUROSCI, V10, P59, DOI 10.1017/S0952523800003229; Bowman EM, 1996, J NEUROPHYSIOL, V75, P1061, DOI 10.1152/jn.1996.75.3.1061; Buckley MJ, 1997, BEHAV NEUROSCI, V111, P467, DOI 10.1037/0735-7044.111.3.467; EACOTT MJ, 1994, EUR J NEUROSCI, V6, P1466, DOI 10.1111/j.1460-9568.1994.tb01008.x; Erickson CA, 1999, J NEUROSCI, V19, P10404; EVERITT BJ, 2000, NEUROSCIENCE, V42, P411; GAFFAN D, 1992, BEHAV NEUROSCI, V106, P30, DOI 10.1037/0735-7044.106.1.30; GOULET S, IN PRESS BEHAV NEURO; Higuchi S, 1996, P NATL ACAD SCI USA, V93, P739, DOI 10.1073/pnas.93.2.739; Liu Z, 2000, J NEUROPHYSIOL, V83, P1677, DOI 10.1152/jn.2000.83.3.1677; MEUNIER M, 1993, J NEUROSCI, V13, P5418, DOI 10.1523/JNEUROSCI.13-12-05418.1993; MISHKIN M, 1982, PHILOS T R SOC B, V298, P85, DOI 10.1098/rstb.1982.0074; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; Miyashita Y, 1996, COGNITIVE BRAIN RES, V5, P81, DOI 10.1016/S0926-6410(96)00043-2; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Murray EA, 1999, TRENDS COGN SCI, V3, P142, DOI 10.1016/S1364-6613(99)01303-0; Murray EA, 1998, BEHAV NEUROSCI, V112, P1291, DOI 10.1037/0735-7044.112.6.1291; MURRAY EA, 1993, J NEUROSCI, V13, P4549; MURRAY EA, 1994, BEHAV NEUROSCI, V108, P494; MURRAY EA, 2000, NEW COGNITIVE NEUROS, P753; Parker A, 1998, BEHAV BRAIN RES, V93, P99, DOI 10.1016/S0166-4328(97)00148-4; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; SAINTCYR JA, 1990, J COMP NEUROL, V298, P129, DOI 10.1002/cne.902980202; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Sakai K, 1994, Learn Mem, V1, P83; Saleem KS, 1996, J NEUROSCI, V16, P4757; Shidara M, 1998, J NEUROSCI, V18, P2613; Stefanacci L, 1996, J COMP NEUROL, V375, P552; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; Suzuki WA, 1996, SEMIN NEUROSCI, V8, P3, DOI 10.1006/smns.1996.0002; Thornton JA, 1997, J NEUROSCI, V17, P8536; Thornton JA, 1998, BEHAV NEUROSCI, V112, P1020, DOI 10.1037/0735-7044.112.4.1020; Van Hoesen G., 1981, AMYGDALOID COMPLEX, P77; VANHOESEN GW, 1981, J COMP NEUROL, V199, P205, DOI 10.1002/cne.901990205; WITTER MP, 1986, J COMP NEUROL, V252, P51, DOI 10.1002/cne.902520104	38	72	72	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2000	3	12					1307	1315		10.1038/81841	http://dx.doi.org/10.1038/81841			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UA	11100152	Bronze			2022-12-24	WOS:000167177900017
J	Armstrong, N; Gouaux, E				Armstrong, N; Gouaux, E			Mechanisms for activation and antagonism of an AMPA-Sensitive glutamate receptor: Crystal structures of the GluR2 ligand binding core	NEURON			English	Article							NMDA RECEPTOR; ANOMALOUS DIFFRACTION; SYNAPTIC TRANSMISSION; HIPPOCAMPAL-NEURONS; CHANNEL PROPERTIES; STABLE EXPRESSION; KAINATE RECEPTORS; ESCHERICHIA-COLI; ACID RECEPTORS; ION CHANNELS	Crystal structures of the GluR2 ligand binding core (S1S2) have been determined in the apo state and in the presence of the antagonist DNQX, the partial agonist kainate, and the full agonists AMPA and glutamate. The domains of the S1S2 ligand binding core are expanded in the apo state and contract upon ligand binding with the extent of domain separation decreasing in the order of apo > DNQX > kainate > glutamate congruent to AMPA. These results suggest that agonist-induced domain closure gates the transmembrane channel and the extent of receptor activation depends upon the degree of domain closure. AMPA and glutamate also promote a 180 degrees flip of a trans peptide bond in the ligand binding site. The crystal packing of the ligand binding cores suggests modes for subunit-subunit contact in the intact receptor and mechanisms by which allosteric effecters modulate receptor activity.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University	Gouaux, E (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.	jeg52@columbia.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360				Abele R, 2000, J BIOL CHEM, V275, P21355, DOI 10.1074/jbc.M909883199; Abele R, 1999, BIOCHEMISTRY-US, V38, P10949, DOI 10.1021/bi982928y; Andersen PH, 1996, EUR J PHARMACOL, V311, P95, DOI 10.1016/0014-2999(96)00399-8; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Borges K, 1998, PROG BRAIN RES, V116, P153, DOI 10.1016/S0079-6123(08)60436-7; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Brauner-Osborne H, 2000, J MED CHEM, V43, P2609, DOI 10.1021/jm000007r; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; Chen GQ, 1998, PROTEIN SCI, V7, P2623, DOI 10.1002/pro.5560071216; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Chen GQ, 1997, P NATL ACAD SCI USA, V94, P13431, DOI 10.1073/pnas.94.25.13431; Chittajallu R, 1999, TRENDS PHARMACOL SCI, V20, P26, DOI 10.1016/S0165-6147(98)01286-3; Dingledine R, 1999, PHARMACOL REV, V51, P7; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; DREIXLER JC, 1994, MOL BRAIN RES, V22, P144, DOI 10.1016/0169-328X(94)90042-6; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; FLOCCO MM, 1994, J BIOL CHEM, V269, P8931; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Hennegriff M, 1997, J NEUROCHEM, V68, P2424; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; HONORE T, 1980, ACTA CHEM SCAND B, V34, P235, DOI 10.3891/acta.chem.scand.34b-0235; Hsiao CD, 1996, J MOL BIOL, V262, P225, DOI 10.1006/jmbi.1996.0509; Ivanovic A, 1998, J BIOL CHEM, V273, P19933, DOI 10.1074/jbc.273.32.19933; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Kawamoto S, 1997, MOL BRAIN RES, V47, P339; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Keinanen K, 1998, BIOCHEM J, V330, P1461, DOI 10.1042/bj3301461; Kessler M, 1996, MOL PHARMACOL, V49, P123; KISKIN NI, 1986, NEUROSCI LETT, V63, P225, DOI 10.1016/0304-3940(86)90360-5; Kleywegt GJ, 1994, CCP4 ESF EACBM NEWSL, P9; Kohda K, 2000, NAT NEUROSCI, V3, P315, DOI 10.1038/73877; Koike M, 2000, J NEUROSCI, V20, P2166; Kubicki M, 1996, ACTA CRYSTALLOGR B, V52, P487, DOI 10.1107/S0108768195011773; Kuusinen A, 1999, J BIOL CHEM, V274, P28937, DOI 10.1074/jbc.274.41.28937; Kuusinen A, 1995, EMBO J, V14, P6327, DOI 10.1002/j.1460-2075.1995.tb00323.x; Lampinen M, 1998, EMBO J, V17, P4704, DOI 10.1093/emboj/17.16.4704; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; Lerma J, 1997, TRENDS NEUROSCI, V20, P9, DOI 10.1016/S0166-2236(96)20055-4; Leuschner WD, 1999, J BIOL CHEM, V274, P16907, DOI 10.1074/jbc.274.24.16907; Lo Conte L, 1999, J MOL BIOL, V285, P2177; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; LOMELI H, 1993, FEBS LETT, V315, P318, DOI 10.1016/0014-5793(93)81186-4; Mano I, 1996, J BIOL CHEM, V271, P15299, DOI 10.1074/jbc.271.26.15299; Matzen L, 1997, J MED CHEM, V40, P520, DOI 10.1021/jm9607212; MAYER ML, 1989, J PHYSIOL-LONDON, V415, P351, DOI 10.1113/jphysiol.1989.sp017725; Moller EH, 1999, CHIRALITY, V11, P752, DOI 10.1002/(SICI)1520-636X(1999)11:10<752::AID-CHIR3>3.0.CO;2-T; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; NAKANISHI S, 1994, ANNU REV BIOPH BIOM, V23, P319, DOI 10.1146/annurev.bb.23.060194.001535; NAR H, 1991, J MOL BIOL, V221, P765, DOI 10.1016/0022-2836(91)80173-R; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; North RA, 1997, CURR OPIN NEUROBIOL, V7, P346, DOI 10.1016/S0959-4388(97)80062-1; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Okamoto T, 1998, J BIOL CHEM, V273, P13089, DOI 10.1074/jbc.273.21.13089; OLAH GA, 1993, J BIOL CHEM, V268, P16241; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paas Y, 1998, TRENDS NEUROSCI, V21, P117, DOI 10.1016/S0166-2236(97)01184-3; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; PARTIN KM, 1995, NEURON, V14, P833, DOI 10.1016/0896-6273(95)90227-9; PARTIN KM, 1994, MOL PHARMACOL, V46, P129; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; PEREZCLAUSELL J, 1985, BRAIN RES, V337, P91, DOI 10.1016/0006-8993(85)91612-9; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Romero A, 1996, EUR J BIOCHEM, V239, P190, DOI 10.1111/j.1432-1033.1996.0190u.x; SACK JS, 1989, J MOL BIOL, V206, P193, DOI 10.1016/0022-2836(89)90532-9; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Smith TC, 2000, J NEUROSCI, V20, P2073; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; STEMBACH Y, 1994, NEURON, V13, P1345; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; Sun YJ, 1998, J MOL BIOL, V278, P219, DOI 10.1006/jmbi.1998.1675; Swanson GT, 1997, NEURON, V19, P913, DOI 10.1016/S0896-6273(00)80972-1; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Taverna F, 2000, J BIOL CHEM, V275, P8475, DOI 10.1074/jbc.275.12.8475; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Todeschi N, 1997, BIOORGAN MED CHEM, V5, P1943, DOI 10.1016/S0968-0896(97)00132-6; TRUSSELL LO, 1988, P NATL ACAD SCI USA, V85, P4562, DOI 10.1073/pnas.85.12.4562-a; Unwin N, 1998, J STRUCT BIOL, V121, P181, DOI 10.1006/jsbi.1997.3949; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WHEAL H, 1995, EXCITORY AMINO ACIDS; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; WOLF A, 1994, J BIOL CHEM, V269, P23051; Wriggers W, 1997, PROTEINS, V29, P1; Yamakura T, 1999, PROG NEUROBIOL, V59, P279, DOI 10.1016/S0301-0082(99)00007-6; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	92	775	784	0	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	2000	28	1					165	181		10.1016/S0896-6273(00)00094-5	http://dx.doi.org/10.1016/S0896-6273(00)00094-5			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	370VN	11086992	Bronze			2022-12-24	WOS:000165143500019
J	Kawasaki, H; Mizuseki, K; Nishikawa, S; Kaneko, S; Kuwana, Y; Nakanishi, S; Nishikawa, S; Sasai, Y				Kawasaki, H; Mizuseki, K; Nishikawa, S; Kaneko, S; Kuwana, Y; Nakanishi, S; Nishikawa, S; Sasai, Y			Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity	NEURON			English	Article							BONE MORPHOGENETIC PROTEIN-4; EMBRYONIC STEM-CELLS; NEURAL INDUCTION; IN-VITRO; VERTEBRATE EMBRYOS; DIFFERENTIATION; MOUSE; PROTEOGLYCANS; EXPRESSION; MESODERM		Kyoto Univ, Inst Frontier Med Sci, Dept Med Embryol & Neurobiol, Kyoto 6068507, Japan; Kyoto Univ, Fac Med, Dept Mol Genet, Kyoto 6068507, Japan; Kyoto Univ, Fac Med, Dept Biol Sci, Kyoto 6068507, Japan; Kyowa Hakko Kogyo Co Ltd, Pharmaceut Res Inst, Shizuoka 4118731, Japan; RIKEN, Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan	Kyoto University; Kyoto University; Kyoto University; Kyowa Kirin Ltd; RIKEN	Sasai, Y (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Med Embryol & Neurobiol, Kyoto 6068507, Japan.		Kawasaki, Hiroshi/C-4404-2015; Mizuseki, Kenji/A-9214-2011; KAWASAKI, Hiroshi/L-3736-2015	Mizuseki, Kenji/0000-0002-1456-2149; Kawasaki, Hiroshi/0000-0002-2514-1497				Bachiller D, 2000, NATURE, V403, P658, DOI 10.1038/35001072; BADER D, 1982, J CELL BIOL, V95, P763, DOI 10.1083/jcb.95.3.763; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; BEDDINGTON RSP, 1994, DEVELOPMENT, V120, P613; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; BRADLEY RS, 1990, EMBO J, V9, P1569, DOI 10.1002/j.1460-2075.1990.tb08276.x; DALE L, 1992, DEVELOPMENT, V115, P573; FOSTER GA, 1988, INT J DEV NEUROSCI, V6, P367, DOI 10.1016/0736-5748(88)90020-2; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; FUCHS E, 1980, CELL, V19, P1033, DOI 10.1016/0092-8674(80)90094-X; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; HemmatiBrivanlou A, 1997, ANNU REV NEUROSCI, V20, P43, DOI 10.1146/annurev.neuro.20.1.43; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Hynes M, 1999, CURR OPIN NEUROBIOL, V9, P26, DOI 10.1016/S0959-4388(99)80004-X; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; JOHANSSON BM, 1995, MOL CELL BIOL, V15, P141, DOI 10.1128/MCB.15.1.141; Kanatsu M, 1996, DEVELOPMENT, V122, P823; Kaneko S, 2000, SCIENCE, V289, P633, DOI 10.1126/science.289.5479.633; Kataoka H, 1997, DEV GROWTH DIFFER, V39, P729; KAUFMAN MH, 1999, ANATOMICAL BASIS MOU, P18; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Klingensmith J, 1999, DEV BIOL, V216, P535, DOI 10.1006/dbio.1999.9525; KODAMA HA, 1986, J CELL PHYSIOL, V129, P20, DOI 10.1002/jcp.1041290104; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Li M, 1998, CURR BIOL, V8, P971, DOI 10.1016/S0960-9822(98)70399-9; Lindvall O, 1999, NAT BIOTECHNOL, V17, P635, DOI 10.1038/10844; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Sasai Y, 1998, NEURON, V21, P455, DOI 10.1016/S0896-6273(00)80554-1; SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; Sasai Y, 1997, DEV BIOL, V182, P5, DOI 10.1006/dbio.1996.8445; Smidt MP, 1997, P NATL ACAD SCI USA, V94, P13305, DOI 10.1073/pnas.94.24.13305; SOPRANO DR, 1995, ANNU REV NUTR, V15, P111, DOI 10.1146/annurev.nu.15.070195.000551; SUCOV HM, 1995, MOL NEUROBIOL, V10, P169, DOI 10.1007/BF02740674; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	42	989	1120	3	55	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	2000	28	1					31	40		10.1016/S0896-6273(00)00083-0	http://dx.doi.org/10.1016/S0896-6273(00)00083-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	370VN	11086981	Bronze			2022-12-24	WOS:000165143500008
J	Elson, GCA; Lelievre, E; Guillet, C; Chevalier, S; Plun-Favreau, H; Froger, J; Suard, I; de Coignac, AB; Delneste, Y; Bonnefoy, JY; Gauchat, JF; Gascan, H				Elson, GCA; Lelievre, E; Guillet, C; Chevalier, S; Plun-Favreau, H; Froger, J; Suard, I; de Coignac, AB; Delneste, Y; Bonnefoy, JY; Gauchat, JF; Gascan, H			CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex	NATURE NEUROSCIENCE			English	Article							CILIARY NEUROTROPHIC FACTOR; AMYOTROPHIC-LATERAL-SCLEROSIS; LEUKEMIA INHIBITORY FACTOR; MOTOR-NEURONS; MICE LACKING; LIFR-BETA; CYTOKINE; FAMILY; SURVIVAL; DISEASE	Ciliary neurotrophic factor (CNTF) is a cytokine supporting the differentiation and survival of various cell types in the peripheral and central nervous systems. Its receptor complex consists of a non-signaling alpha chain, CNTFR, and two signaling beta chains, gp130 and the leukemia inhibitory factor receptor (LIFR). Striking phenotypic differences between CNTF- and CNTFR-deficient mice suggest that CNTFR serves as a receptor for a second, developmentally important ligand. We have identified this factor as a stable secreted complex of cardiotrophin-like cytokine (CLC) and the soluble receptor cytokine-like factor-1 (CLF). CLF expression was required for CLC secretion, and the complex acted only on cells expressing functional CNTF receptors. The CLF/CLC complex activated gp130, LIFR and signal transducer and activator of transcription 3 (STAT3) and supported motor neuron survival. Our results indicate that the CLF/CLC complex is a second ligand for CNTFR with potentially important implications in nervous system development.	Ctr Immunol Pierre Fabre, F-74164 St Julien Genevois, France; CHU Angers, INSERM, E9928, F-49033 Angers, France	Centre d'Immunologie Pierre Fabre; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Gauchat, JF (corresponding author), Ctr Immunol Pierre Fabre, 5 Ave Napoleon III, F-74164 St Julien Genevois, France.		Lelievre, Eric/M-2878-2015; DELNESTE, Yves/K-7367-2015; Plun-Favreau, Helene/Q-4111-2016; Delneste, Yves/O-3956-2016; PLUN-FAVREAU, Helene/C-8513-2009	DELNESTE, Yves/0000-0002-2142-596X; Plun-Favreau, Helene/0000-0002-1401-9656; lelievre, eric/0000-0002-4132-4023				Aebischer P, 1996, NAT MED, V2, P696, DOI 10.1038/nm0696-696; Alexander WS, 1999, CURR BIOL, V9, P605, DOI 10.1016/S0960-9822(99)80266-8; Anderson KD, 1996, P NATL ACAD SCI USA, V93, P7346, DOI 10.1073/pnas.93.14.7346; ARAKAWA Y, 1990, J NEUROSCI, V10, P3507; Arce V, 1999, J NEUROSCI RES, V55, P119, DOI 10.1002/(SICI)1097-4547(19990101)55:1<119::AID-JNR13>3.3.CO;2-Y; CURTIS R, 1993, NATURE, V365, P253, DOI 10.1038/365253a0; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265; DECHIARA TM, 1995, CELL, V83, P313, DOI 10.1016/0092-8674(95)90172-8; Elson GCA, 1998, J IMMUNOL, V161, P1371; Guillet C, 1999, J NEUROSCI, V19, P1257; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; HELGREN ME, 1994, CELL, V76, P493, DOI 10.1016/0092-8674(94)90113-9; IP NY, 1993, NEURON, V10, P89, DOI 10.1016/0896-6273(93)90245-M; Kallen KJ, 1999, J BIOL CHEM, V274, P11859, DOI 10.1074/jbc.274.17.11859; LI M, 1995, NATURE, V378, P724, DOI 10.1038/378724a0; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; Miller RG, 1996, ANN NEUROL, V39, P256, DOI 10.1002/ana.410390215; MITSUMOTO H, 1994, SCIENCE, V265, P1107, DOI 10.1126/science.8066451; Mittoux V, 2000, HUM GENE THER, V11, P1177, DOI 10.1089/10430340050015220; OPPENHEIM RW, 1991, SCIENCE, V251, P1616, DOI 10.1126/science.2011743; Penn RD, 1997, NEUROSURGERY, V40, P94, DOI 10.1097/00006123-199701000-00021; Robledo O, 1997, J BIOL CHEM, V272, P4855, DOI 10.1074/jbc.272.8.4855; Robledo O, 1996, J NEUROCHEM, V66, P1391; Senaldi G, 1999, P NATL ACAD SCI USA, V96, P11458, DOI 10.1073/pnas.96.20.11458; SENDTNER M, 1992, NATURE, V358, P502, DOI 10.1038/358502a0; SENDTNER M, 1994, J NEUROBIOL, V25, P1436, DOI 10.1002/neu.480251110; Shi Y, 1999, BIOCHEM BIOPH RES CO, V262, P132, DOI 10.1006/bbrc.1999.1181; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; TAKAHASHI R, 1994, NAT GENET, V7, P79, DOI 10.1038/ng0594-79; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.immunol.13.1.251; Zurn AD, 1996, J NEUROSCI RES, V44, P133, DOI 10.1002/(SICI)1097-4547(19960415)44:2<133::AID-JNR5>3.0.CO;2-E	33	207	220	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2000	3	9					867	872		10.1038/78765	http://dx.doi.org/10.1038/78765			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TV	10966616				2022-12-24	WOS:000167177400012
J	Kreiman, G; Koch, C; Fried, I				Kreiman, G; Koch, C; Fried, I			Category-specific visual responses of single neurons in the human medial temporal lobe	NATURE NEUROSCIENCE			English	Article							FUSIFORM FACE AREA; HUMAN EXTRASTRIATE CORTEX; INFEROTEMPORAL CORTEX; PERIRHINAL CORTEX; HUMAN HIPPOCAMPUS; RECOGNITION; MEMORY; AMYGDALA; OBJECT; MONKEY	The hippocampus, amygdala and entorhinal cortex receive convergent input from temporal neocortical regions specialized for processing complex visual stimuli and are important in the representation and recognition of visual images. Recording from 427 single neurons in the human hippocampus, entorhinal cortex and amygdala, we found a remarkable degree of category-specific firing of individual neurons on a trial-by-trial basis. Of the recorded neurons, 14% responded selectively to visual stimuli from different categories, including faces, natural scenes and houses, famous people and animals. Based on the firing rate of individual neurons, stimulus category could be predicted with a mean probability of error of 0.24. In the hippocampus, the proportion of neurons responding to spatial layouts was greater than to other categories. Our data provide direct support for the role of human medial temporal regions in the representation of different categories of visual stimuli.	Univ Calif Los Angeles, Sch Med, Div Neurosurg, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Psychiat & Behav Sci, Los Angeles, CA 90095 USA; CALTECH, Computat & Neural Syst Program, Pasadena, CA 91125 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; California Institute of Technology	Fried, I (corresponding author), Univ Calif Los Angeles, Sch Med, Div Neurosurg, 740 Westwood Plaza,Box 957039, Los Angeles, CA 90095 USA.			Koch, Christof/0000-0001-6482-8067; Kreiman, Gabriel/0000-0003-3505-8475				ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; ALLISON T, 1994, J NEUROPHYSIOL, V71, P821, DOI 10.1152/jn.1994.71.2.821; Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P7041, DOI 10.1073/pnas.91.15.7041; Buckley MJ, 1998, J NEUROSCI, V18, P2268; DAMASIO AR, 1990, ANNU REV NEUROSCI, V13, P89, DOI 10.1146/annurev.ne.13.030190.000513; Efron B., 1994, INTRO BOOTSTRAP; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; FRIED I, 1982, BRAIN, V105, P349, DOI 10.1093/brain/105.2.349; Fried I, 1999, J NEUROSURG, V91, P697, DOI 10.3171/jns.1999.91.4.0697; Fried I, 1997, NEURON, V18, P753, DOI 10.1016/S0896-6273(00)80315-3; GREEN DM, 1966, SIGNAL DETECTION THE; Halgren E, 2000, CEREB CORTEX, V10, P69, DOI 10.1093/cercor/10.1.69; HEIT G, 1988, NATURE, V333, P773, DOI 10.1038/333773a0; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Keeping ES, 1995, INTRO STAT INFERENCE; Klopp J, 1999, CLIN NEUROPHYSIOL, V110, P676, DOI 10.1016/S1388-2457(98)00039-X; LEONARD CM, 1985, BEHAV BRAIN RES, V15, P159, DOI 10.1016/0166-4328(85)90062-2; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; LOGOTHETIS NK, 1995, CEREB CORTEX, V3, P270; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; McNaughton BL, 1990, NEUROSCIENCE CONNECT, P1; MEUNIER M, 1993, J NEUROSCI, V13, P5418, DOI 10.1523/JNEUROSCI.13-12-05418.1993; MISHKIN M, 1978, NATURE, V273, P297, DOI 10.1038/273297a0; MIYASHITA Y, 1989, J NEUROPHYSIOL, V61, P669, DOI 10.1152/jn.1989.61.3.669; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; Muller R, 1996, NEURON, V17, P813, DOI 10.1016/S0896-6273(00)80214-7; NOBRE AC, 1994, NATURE, V372, P260, DOI 10.1038/372260a0; Ojemann GA, 1998, NEUROSCIENTIST, V4, P285, DOI 10.1177/107385849800400417; OJEMANN JG, 1992, BRAIN, V115, P1, DOI 10.1093/brain/115.1.1; PENFIELD W, 1958, ARCH NEURO PSYCHIATR, V79, P475, DOI 10.1001/archneurpsyc.1958.02340050003001; Penfield W, 1954, EPILEPSY FUNCTIONAL; Saleem KS, 1996, J NEUROSCI, V16, P4757; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Suzuki WA, 1997, J NEUROPHYSIOL, V78, P1062, DOI 10.1152/jn.1997.78.2.1062; Suzuki WA, 1996, SEMIN NEUROSCI, V8, P3, DOI 10.1006/smns.1996.0002; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tong F, 2000, COGNITIVE NEUROPSYCH, V17, P257, DOI 10.1080/026432900380607; Treisman AM, 1998, CURR OPIN NEUROBIOL, V8, P218, DOI 10.1016/S0959-4388(98)80143-8; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; WARRINGTON E, 1987, BRAIN, V110, P1275; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Yakovlev V, 1998, NAT NEUROSCI, V1, P310, DOI 10.1038/1131; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577; ZOLAMORGAN S, 1993, ANNU REV NEUROSCI, V16, P547, DOI 10.1146/annurev.ne.16.030193.002555; [No title captured]	50	355	359	0	31	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2000	3	9					946	953		10.1038/78868	http://dx.doi.org/10.1038/78868			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TV	10966627				2022-12-24	WOS:000167177400023
J	Salehi, AH; Roux, PP; Kubu, CJ; Zeindler, C; Bhakar, A; Tannis, LL; Verdi, JM; Barker, PA				Salehi, AH; Roux, PP; Kubu, CJ; Zeindler, C; Bhakar, A; Tannis, LL; Verdi, JM; Barker, PA			NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and facilitates nerve growth factor-dependent apoptosis	NEURON			English	Article							PRADER-WILLI-SYNDROME; ZINC-FINGER PROTEIN; TUMOR-REJECTION ANTIGENS; PROGRAMMED CELL-DEATH; HUMAN GENE MAGE-1; NF-KAPPA-B; NECDIN GENE; SYMPATHETIC NEURONS; NUCLEAR-PROTEIN; FUNCTIONAL INTERACTIONS	The mechanisms employed by the p75 neurotrophin receptor (p75NTR) to mediate neurotrophin-dependent apoptosis are poorly defined. Two-hybrid analyses were used to identify proteins involved in p75NTR apoptotic signaling, and a p75NTR binding partner termed NRAGE (for (n) under bar eurotrophin (r) under bar eceptor-interacting M (A) under bar (G) under bar (E) under bar homolog) was identified. NRAGE binds p75NTR in vitro and in vivo, and NRAGE associates with the plasma membrane when NGF is bound to p75NTR. NRAGE blocks the physical association of p75NTR with TrkA, and, conversely, TrkA overexpression eliminates NRAGE-mediated NGF-dependent death, indicating that interactions of NRAGE or TrkA with p75NTR are functionally and physically exclusive. NRAGE over-expression facilitates cell cycle arrest and permits NGF-dependent apoptosis within sympathetic neuron precursors cells. Our results show that NRAGE contributes to p75NTR-dependent cell death and suggest novel functions for MAGE family proteins.	McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ H3A 2B4, Canada; John P Robarts Res Inst, London, ON N6A 5K8, Canada	McGill University; Western University (University of Western Ontario)	Barker, PA (corresponding author), McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	mdpb@musica.mcgill.ca	Roux, Philippe P./J-3996-2012	Roux, Philippe P./0000-0002-5962-0250				AIZAWA T, 1992, DEV BRAIN RES, V68, P265, DOI 10.1016/0165-3806(92)90069-9; Baker SJ, 1998, ONCOGENE, V17, P3261, DOI 10.1038/sj.onc.1202568; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Barker PA, 1998, CELL DEATH DIFFER, V5, P346, DOI 10.1038/sj.cdd.4400375; BARKER PA, 1994, NEURON, V13, P203, DOI 10.1016/0896-6273(94)90470-7; Barrett GL, 2000, PROG NEUROBIOL, V61, P205, DOI 10.1016/S0301-0082(99)00056-8; BARRETT GL, 1994, P NATL ACAD SCI USA, V91, P6501, DOI 10.1073/pnas.91.14.6501; Bhakar AL, 1999, J BIOL CHEM, V274, P21443, DOI 10.1074/jbc.274.30.21443; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; Brennan C, 1999, NAT NEUROSCI, V2, P699, DOI 10.1038/11158; Bueler H, 1996, MOL MED, V2, P545, DOI 10.1007/BF03401639; Carter BD, 1996, SCIENCE, V272, P542, DOI 10.1126/science.272.5261.542; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; Casademunt E, 1999, EMBO J, V18, P6050, DOI 10.1093/emboj/18.21.6050; CHAPMAN BS, 1995, FEBS LETT, V374, P216, DOI 10.1016/0014-5793(95)01113-S; Chittka A, 1999, P NATL ACAD SCI USA, V96, P10705, DOI 10.1073/pnas.96.19.10705; Coulson EJ, 1999, J BIOL CHEM, V274, P16387, DOI 10.1074/jbc.274.23.16387; De Smet C, 1997, BIOCHEM BIOPH RES CO, V241, P653, DOI 10.1006/bbrc.1997.7868; De Smet C, 1999, MOL CELL BIOL, V19, P7327; DeSmet C, 1996, P NATL ACAD SCI USA, V93, P7149, DOI 10.1073/pnas.93.14.7149; DOBROWSKY RT, 1994, SCIENCE, V265, P1596, DOI 10.1126/science.8079174; DOBROWSKY RT, 1995, J BIOL CHEM, V270, P22135, DOI 10.1074/jbc.270.38.22135; Farinas I, 1999, MICROSC RES TECHNIQ, V45, P233, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<233::AID-JEMT7>3.0.CO;2-Y; Frade JM, 2000, J CELL SCI, V113, P1139; Frade JM, 1999, DEVELOPMENT, V126, P683; Frade JM, 1998, BIOESSAYS, V20, P137, DOI 10.1002/(SICI)1521-1878(199802)20:2<137::AID-BIES6>3.0.CO;2-Q; Frade JM, 1996, NATURE, V383, P166; FREEMAN RS, 1994, NEURON, V12, P343, DOI 10.1016/0896-6273(94)90276-3; Gargano N, 1997, J NEUROSCI RES, V50, P1; Gentry JJ, 2000, J BIOL CHEM, V275, P7558, DOI 10.1074/jbc.275.11.7558; Gerard M, 1999, NAT GENET, V23, P199, DOI 10.1038/13828; GROVES AK, 1995, DEVELOPMENT, V121, P887; HANTZOPOULOS PA, 1994, NEURON, V13, P187, DOI 10.1016/0896-6273(94)90469-3; HAYASHI Y, 1995, BIOCHEM BIOPH RES CO, V213, P317, DOI 10.1006/bbrc.1995.2132; HERRUP K, 1995, DEVELOPMENT, V121, P2385; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; Huang EJ, 1999, DEVELOPMENT, V126, P2191; IMAI Y, 1995, GENE, V160, P287, DOI 10.1016/0378-1119(94)00680-Q; Itoh K, 1997, Int Rev Immunol, V14, P153, DOI 10.3109/08830189709116850; Itoh K, 1996, J BIOCHEM-TOKYO, V119, P385; James P, 1996, GENETICS, V144, P1425; Jay P, 1997, NAT GENET, V17, P357, DOI 10.1038/ng1197-357; Jurk M, 1998, INT J CANCER, V75, P762, DOI 10.1002/(SICI)1097-0215(19980302)75:5<762::AID-IJC16>3.0.CO;2-8; Kawakami Yutaka, 1996, Keio Journal of Medicine, V45, P100; Khursigara G, 1999, J BIOL CHEM, V274, P2597, DOI 10.1074/jbc.274.5.2597; Kirkin AF, 1998, EXP CLIN IMMUNOGENET, V15, P19, DOI 10.1159/000019050; KOCHER T, 1995, CANCER RES, V55, P2236; Kong H, 1999, CELL DEATH DIFFER, V6, P1133, DOI 10.1038/sj.cdd.4400587; Kryl D, 1999, J NEUROSCI, V19, P5823, DOI 10.1523/JNEUROSCI.19-14-05823.1999; Liepinsh E, 1997, EMBO J, V16, P4999, DOI 10.1093/emboj/16.16.4999; MacDonald HR, 1997, HUM MOL GENET, V6, P1873, DOI 10.1093/hmg/6.11.1873; MacPhee IJ, 1997, J BIOL CHEM, V272, P23547, DOI 10.1074/jbc.272.38.23547; Majdan M, 1999, INT J DEV NEUROSCI, V17, P153, DOI 10.1016/S0736-5748(99)00016-7; Majdan M, 1997, J NEUROSCI, V17, P6988; Maruyama E, 1996, BIOCHEM J, V314, P895, DOI 10.1042/bj3140895; MARUYAMA K, 1991, BIOCHEM BIOPH RES CO, V178, P291, DOI 10.1016/0006-291X(91)91812-Q; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Nichols A, 1998, APOPTOSIS, V3, P289, DOI 10.1023/A:1009617426753; Park DS, 1997, J NEUROSCI, V17, P8975; Park DS, 1997, J NEUROSCI, V17, P1256, DOI 10.1523/jneurosci.17-04-01256.1997; Ross AH, 1996, J CELL BIOL, V132, P945, DOI 10.1083/jcb.132.5.945; Ryden M, 1997, J BIOL CHEM, V272, P16322, DOI 10.1074/jbc.272.26.16322; SHARP AH, 1993, J NEUROSCI, V13, P3051; Spengler D, 1997, EMBO J, V16, P2814, DOI 10.1093/emboj/16.10.2814; Sutcliffe JS, 1997, LANCET, V350, P1520, DOI 10.1016/S0140-6736(05)63943-8; Taniura H, 1999, J BIOL CHEM, V274, P16242, DOI 10.1074/jbc.274.23.16242; Taniura H, 1998, J BIOL CHEM, V273, P720, DOI 10.1074/jbc.273.2.720; TRAVERSARI C, 1992, J EXP MED, V176, P1453, DOI 10.1084/jem.176.5.1453; VandenEynde BJ, 1997, INT J CLIN LAB RES, V27, P81, DOI 10.1007/BF02912440; Varfolomeev EE, 1996, J EXP MED, V183, P1271, DOI 10.1084/jem.183.3.1271; VERDI JM, 1994, NEURON, V13, P1359, DOI 10.1016/0896-6273(94)90421-9; VERDI JM, 1994, NEURON, V12, P733, DOI 10.1016/0896-6273(94)90327-1; Wajant H, 1999, CYTOKINE GROWTH F R, V10, P15, DOI 10.1016/S1359-6101(98)00023-9; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; Ye X, 1999, J BIOL CHEM, V274, P30202, DOI 10.1074/jbc.274.42.30202; Yoon SO, 1998, J NEUROSCI, V18, P3273	76	234	262	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	2000	27	2					279	288		10.1016/S0896-6273(00)00036-2	http://dx.doi.org/10.1016/S0896-6273(00)00036-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	347YD	10985348	Bronze			2022-12-24	WOS:000088956000012
J	Featherstone, DE; Rushton, EM; Hilderbrand-Chae, M; Phillips, AM; Jackson, FR; Broadie, K				Featherstone, DE; Rushton, EM; Hilderbrand-Chae, M; Phillips, AM; Jackson, FR; Broadie, K			Presynaptic glutamic acid decarboxylase is required for induction of the postsynaptic receptor field at a glutamatergic synapse	NEURON			English	Article							DROSOPHILA GABAERGIC SYSTEMS; GAMMA-AMINOBUTYRIC-ACID; TOXIN LIGHT-CHAIN; NEUROMUSCULAR-JUNCTION; NERVOUS-SYSTEM; TRANSMITTER RELEASE; GENETIC-ANALYSIS; MICE LACKING; CLEFT-PALATE; MOTOR AXONS	We have systematically screened EMS-mutagenized Drosophila for embryonic lethal strains with defects in glutamatergic synaptic transmission. Surprisingly, this screen led to the identification of several alleles with missense mutations in highly conserved regions of Dgad1. Analysis of these gad mutants reveals that they are paralyzed owing to defects in glutamatergic transmission at the neuromuscular junction. Further electrophysiological and immunohistochemical examination reveals that these mutants have greatly reduced numbers of postsynaptic glutamate receptors in an otherwise morphologically normal synapse. By overexpressing wild-type Dgad1 in selected neurons, we show that GAD is specifically required in the presynaptic neuron to induce a postsynaptic glutamate receptor field,and that the level of postsynaptic receptors is closely dependent on presynaptic GAD function. These data demonstrate that GAD plays an unexpected role in glutamatergic synaptogenesis.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; Univ Melbourne, Dept Genet, Parkville, Vic 3052, Australia	Utah System of Higher Education; University of Utah; Tufts University; University of Melbourne	Broadie, K (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	broadie@biology.utah.edu			NHLBI NIH HHS [R01 HL59873] Funding Source: Medline; NIGMS NIH HHS [GM54544] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054544] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Aronstein K, 1996, INVERTEBR NEUROSCI, V2, P115, DOI 10.1007/BF02214114; Aronstein K, 1995, INVERTEBR NEUROSCI, V1, P25, DOI 10.1007/BF02331829; Asada H, 1996, BIOCHEM BIOPH RES CO, V229, P891, DOI 10.1006/bbrc.1996.1898; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; Baines RA, 1999, CURR BIOL, V9, P1267, DOI 10.1016/S0960-9822(99)80510-7; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; BEHAR TN, 1995, J NEUROSCI RES, V42, P97, DOI 10.1002/jnr.490420111; Bergles DE, 1999, CURR OPIN NEUROBIOL, V9, P293, DOI 10.1016/S0959-4388(99)80043-9; Besson MT, 1999, FEBS LETT, V449, P293; Besson MT, 1999, FEBS LETT, V443, P97, DOI 10.1016/S0014-5793(98)01695-0; Beumer KJ, 1999, DEVELOPMENT, V126, P5833; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; BROADIE K, 1993, NEURON, V11, P607, DOI 10.1016/0896-6273(93)90073-Z; BROADIE K, 1993, NATURE, V361, P350, DOI 10.1038/361350a0; BROADIE KS, 1993, J NEUROSCI, V13, P144; BUDNIK V, 1990, J NEUROSCI, V10, P3754; CHUDE O, 1976, J NEUROCHEM, V27, P83, DOI 10.1111/j.1471-4159.1976.tb01547.x; Colledge M, 1998, CURR OPIN NEUROBIOL, V8, P357, DOI 10.1016/S0959-4388(98)80061-5; Condie BG, 1997, P NATL ACAD SCI USA, V94, P11451, DOI 10.1073/pnas.94.21.11451; DAVIS GW, 1994, J NEUROBIOL, V25, P740, DOI 10.1002/neu.480250612; Davis GW, 1996, NEURON, V17, P669, DOI 10.1016/S0896-6273(00)80199-3; DiAntonio A, 1999, J NEUROSCI, V19, P3023; Fergestad T, 1999, J NEUROSCI, V19, P5847, DOI 10.1523/JNEUROSCI.19-14-05847.1999; GRINNELL AD, 1995, PHYSIOL REV, V75, P789, DOI 10.1152/physrev.1995.75.4.789; HALTER DA, 1995, DEVELOPMENT, V121, P317; HARRISON SD, 1995, GENETICS, V139, P1701; HONMOU O, 1995, EPILEPSY RES, V20, P193, DOI 10.1016/0920-1211(94)00076-9; Hosie AM, 1997, TRENDS NEUROSCI, V20, P578, DOI 10.1016/S0166-2236(97)01127-2; Israel M, 1999, CAN J PHYSIOL PHARM, V77, P689, DOI 10.1139/cjpp-77-9-689; Jabaudon D, 1999, P NATL ACAD SCI USA, V96, P8733, DOI 10.1073/pnas.96.15.8733; JACKSON FR, 1990, J NEUROCHEM, V54, P1068, DOI 10.1111/j.1471-4159.1990.tb02359.x; JAN LY, 1976, J PHYSIOL-LONDON, V262, P215, DOI 10.1113/jphysiol.1976.sp011593; KATZ B, 1977, PROC R SOC SER B-BIO, V196, P59, DOI 10.1098/rspb.1977.0029; Koh YH, 1999, CELL, V98, P353, DOI 10.1016/S0092-8674(00)81964-9; Koushika SP, 1996, CURR BIOL, V6, P1634, DOI 10.1016/S0960-9822(02)70787-2; Krisch J, 1999, CURR OPIN NEUROBIOL, V9, P329, DOI 10.1016/S0959-4388(99)80048-8; KULKARNI SJ, 1994, MOL GEN GENET, V243, P555, DOI 10.1007/BF00284204; Landgraf M, 1999, NEURON, V22, P43, DOI 10.1016/S0896-6273(00)80677-7; Landgraf M, 1997, J NEUROSCI, V17, P9642; Lissin DV, 1999, J NEUROSCI, V19, P3275; Lissin DV, 1999, J NEUROSCI, V19, P1263; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Martin DL, 1998, PERSPECT DEV NEUROBI, V5, P119; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; Meier T, 1998, BIOESSAYS, V20, P819, DOI 10.1002/(SICI)1521-1878(199810)20:10<819::AID-BIES7>3.0.CO;2-N; MESSERSMITH EK, 1993, NEUROCHEM RES, V18, P463, DOI 10.1007/BF00967250; NEWBY LM, 1993, J NEUROCHEM, V60, P982, DOI 10.1111/j.1471-4159.1993.tb03245.x; Nishikawa K, 1995, J NEUROSCI, V15, P7905; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; PHILLIPS AM, 1993, J NEUROCHEM, V61, P1291, DOI 10.1111/j.1471-4159.1993.tb13621.x; Pinal CS, 1998, PERSPECT DEV NEUROBI, V5, P109; Rohrbough J, 1999, NEURON, V23, P55, DOI 10.1016/S0896-6273(00)80753-9; RUSHTON E, 1995, DEVELOPMENT, V121, P1979; Saitoe M, 1998, J NEUROSCI METH, V80, P163, DOI 10.1016/S0165-0270(97)00203-3; Saitoe M, 1997, DEV BIOL, V184, P48, DOI 10.1006/dbio.1996.8480; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981; ZHONG Y, 1995, J NEUROSCI, V15, P6679	61	84	84	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	2000	27	1					71	84		10.1016/S0896-6273(00)00010-6	http://dx.doi.org/10.1016/S0896-6273(00)00010-6			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339XU	10939332	Bronze			2022-12-24	WOS:000088503800011
J	Brenner, N; Bialek, W; van Steveninck, RD				Brenner, N; Bialek, W; van Steveninck, RD			Adaptive rescaling maximizes information transmission	NEURON			English	Article							NEURAL SPIKE TRAINS; SENSITIVE NEURON; VISUAL-SYSTEM; ADAPTATION; CONTRAST; SUMMATION	Adaptation is a widespread phenomenon in nervous systems, providing flexibility to function under Varying external conditions. Here, we relate an adaptive property of a sensory system directly to its function as a carrier of information about input signals. We show that the input/output relation of a sensory system in a dynamic environment changes with the statistical properties of the environment. Specifically, when the dynamic range of inputs changes, the input/output relation rescales so as to match the dynamic range of responses to that of the inputs. We give direct evidence that the scaling of the input/output relation is set to maximize information transmission for each distribution of signals. This adaptive behavior should be particularly useful in dealing with the intermittent statistics of natural signals.	NEC Res Inst, Princeton, NJ 08540 USA	NEC Corporation	Bialek, W (corresponding author), NEC Res Inst, 4 Independence Way, Princeton, NJ 08540 USA.			Brenner, Naama/0000-0002-8021-1208				Adrian E.D., 1928, BASIS SENSATION; ATICK JJ, 1992, PRINCETON LECTURES ON BIOPHYSICS, P223; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; BORST A, 1987, BIOL CYBERN, V56, P209, DOI 10.1007/BF00365215; BRENNER N, 2000, IN PRESS NEURAL COMP; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; DEBOER E, 1968, IEEE T BIO-MED ENG, VBM15, P169, DOI 10.1109/TBME.1968.4502561; DeWeese M, 1998, NEURAL COMPUT, V10, P1179, DOI 10.1162/089976698300017403; Franceschini N., 1989, P360; Hausen K., 1989, P391; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; MADDESS T, 1985, PROC R SOC SER B-BIO, V225, P251, DOI 10.1098/rspb.1985.0061; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; Nelken I, 1999, NATURE, V397, P154, DOI 10.1038/16456; Rieke F., 1997, SPIKES EXPLORING NEU; RUDERMAN DL, 1994, PHYS REV LETT, V73, P814, DOI 10.1103/PhysRevLett.73.814; SHAPLEY R, 1979, VISION RES, V19, P431, DOI 10.1016/0042-6989(79)90109-3; SHAPLEY RM, 1980, J PHYSIOL-LONDON, V302, P535; SHAPLEY RM, 1979, J PHYSIOL-LONDON, V290, P141, DOI 10.1113/jphysiol.1979.sp012765; Simoncelli EP, 1999, ADV NEUR IN, V11, P153; SMIMAKIS SM, 1997, NATURE, V386, P69; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; VanHateren JH, 1997, VISION RES, V37, P3407, DOI 10.1016/S0042-6989(97)00105-3; VANSTEVENINCK RD, 1988, PROC R SOC SER B-BIO, V234, P379; vanSteveninck RD, 1996, PROCEEDINGS OF THE IEEE TWENTY-SECOND ANNUAL NORTHEAST BIOENGINEERING CONFERENCE, P40, DOI 10.1109/NEBC.1996.503207; VANSTEVENINCK RRD, 1986, BIOL CYBERN, V54, P223, DOI 10.1007/BF00318418; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; vanSteveninck RRD, 1996, NATURAL & ARTIFICIAL PARALLEL COMPUTATION, P21; Wiener Norbert, 1949, TIME SERIES	30	445	451	0	17	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	2000	26	3					695	702		10.1016/S0896-6273(00)81205-2	http://dx.doi.org/10.1016/S0896-6273(00)81205-2			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330ZH	10896164	Bronze			2022-12-24	WOS:000087991600019
J	Hall, J; Thomas, KL; Everitt, BJ				Hall, J; Thomas, KL; Everitt, BJ			Rapid and selective induction of BDNF expression in the hippocampus during contextual learning	NATURE NEUROSCIENCE			English	Article							TRANSCRIPTION; MEMORY; MICE; LTP; CA1		Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	University of Cambridge	Thomas, KL (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing Site,Tennis Court Rd, Cambridge CB2 3EB, England.		Thomas, Kerrie L/A-6509-2010	Thomas, Kerrie L/0000-0003-3355-9583; Everitt, Barry/0000-0003-4431-6536; Hall, Jeremy/0000-0002-0403-3278	MRC [G9537855] Funding Source: UKRI; Medical Research Council [G9537855] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BANNERMAN DM, 1995, NATURE, V378, P182, DOI 10.1038/378182a0; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; FANSELOW MS, 1990, ANIM LEARN BEHAV, V18, P264, DOI 10.3758/BF03205285; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; KIERNAN MJ, 1993, Q J EXP PSYCHOL-B, V46, P271, DOI 10.1080/14640749308401089; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Linnarsson S, 1997, EUR J NEUROSCI, V9, P2581, DOI 10.1111/j.1460-9568.1997.tb01687.x; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; THOMAS KL, 1996, CORTICAL PLASTICITY, P103; WISDEN W, 1994, IN SITU HYBRIDIZATIO, P9	15	487	514	0	38	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2000	3	6					533	535		10.1038/75698	http://dx.doi.org/10.1038/75698			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	317WG	10816306				2022-12-24	WOS:000087249500006
J	Tavazoie, SF; Reid, RC				Tavazoie, SF; Reid, RC			Diverse receptive fields in the lateral geniculate nucleus during thalamocortical development	NATURE NEUROSCIENCE			English	Article							ORIENTATION PREFERENCE MAPS; OCULAR DOMINANCE COLUMNS; LONG-TERM POTENTIATION; RETINAL GANGLION-CELLS; POST-NATAL DEVELOPMENT; PRIMARY VISUAL-CORTEX; POSTNATAL-DEVELOPMENT; CAT RETINA; FERRET; KITTENS	Most models of thalamocortical development in the visual system assume a homogeneous population of thalamic inputs to the cortex, each with concentric on- or off-center receptive fields. To test this, we made high-resolution spatial maps of receptive fields in the developing ferret lateral geniculate nucleus (LGN). Developing receptive fields (RFs), had a variety of shapes: some concentric, others elongated (like adult cortical receptive fields) and some with 'hot spots' of sensitivity. These receptive fields seemed to arise from convergence of multiple retinal afferents onto LGN neurons. We present a Hebbian model whereby imprecise retinogeniculate connections help refine geniculocortical connections, sharpening both thalamocortical topography and perhaps orientation selectivity.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Reid, RC (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.				NEI NIH HHS [EY12196, EY10115] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY012196, R01EY010115] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALBUS K, 1984, J PHYSIOL-LONDON, V348, P153, DOI 10.1113/jphysiol.1984.sp015104; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; ARTOLA A, 1987, NATURE, V330, P649, DOI 10.1038/330649a0; BARLOW HB, 1971, J PHYSIOL-LONDON, V218, P98; BEAR MF, 1990, J NEUROSCI, V10, P909; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLAKEMORE C, 1986, J PHYSIOL-LONDON, V380, P453, DOI 10.1113/jphysiol.1986.sp016297; Cai DQ, 1997, J NEUROPHYSIOL, V78, P1045, DOI 10.1152/jn.1997.78.2.1045; CHAPMAN B, 1993, J NEUROSCI, V13, P5251, DOI 10.1523/JNEUROSCI.13-12-05251.1993; Chapman B, 1996, J NEUROSCI, V16, P6443; CLELAND BG, 1971, NATURE-NEW BIOL, V231, P191, DOI 10.1038/newbio231191a0; CLELAND BG, 1986, VISUAL NEUROSCI, P111; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; DANIELS JD, 1978, J NEUROPHYSIOL, V41, P1373, DOI 10.1152/jn.1978.41.6.1373; GALLI L, 1988, SCIENCE, V242, P90, DOI 10.1126/science.3175637; Godecke I, 1997, EUR J NEUROSCI, V9, P1754; HAMMOND P, 1974, J PHYSIOL-LONDON, V242, P99, DOI 10.1113/jphysiol.1974.sp010696; HAMOS JE, 1985, NATURE, V317, P618, DOI 10.1038/317618a0; HENDERSON Z, 1988, J NEUROSCI, V8, P1194; HUBEL DH, 1961, J PHYSIOL-LONDON, V155, P385, DOI 10.1113/jphysiol.1961.sp006635; Issa NP, 1999, J NEUROSCI, V19, P6965, DOI 10.1523/JNEUROSCI.19-16-06965.1999; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; LINDEN DC, 1981, J COMP NEUROL, V203, P189, DOI 10.1002/cne.902030204; MASON CA, 1982, NEUROSCIENCE, V7, P541, DOI 10.1016/0306-4522(82)90063-X; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P350, DOI 10.1152/jn.1983.49.2.350; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MILLER KD, 1994, J NEUROSCI, V14, P409; Mooney R, 1996, NEURON, V17, P863, DOI 10.1016/S0896-6273(00)80218-4; MURPHY PC, 1987, NATURE, V329, P727, DOI 10.1038/329727a0; PEICHL L, 1979, J PHYSIOL-LONDON, V291, P117, DOI 10.1113/jphysiol.1979.sp012803; PETERS A, 1993, CEREB CORTEX, V3, P69, DOI 10.1093/cercor/3.1.69; PRICE DJ, 1987, EXP BRAIN RES, V68, P28; RAKIC P, 1976, NATURE, V261, P467, DOI 10.1038/261467a0; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Reid RC, 1997, VISUAL NEUROSCI, V14, P1015, DOI 10.1017/S0952523800011743; SHERK H, 1976, J NEUROPHYSIOL, V39, P63, DOI 10.1152/jn.1976.39.1.63; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; SOODAK RE, 1987, J NEUROPHYSIOL, V58, P267, DOI 10.1152/jn.1987.58.2.267; SRETAVAN DW, 1986, J NEUROSCI, V6, P234; STRYKER MP, 1986, J NEUROSCI, V6, P2117; SUR M, 1984, NATURE, V310, P246, DOI 10.1038/310246a0; TOOTLE JS, 1989, J NEUROSCI, V9, P1325; Usrey WM, 1999, J NEUROPHYSIOL, V82, P3527, DOI 10.1152/jn.1999.82.6.3527; Usrey WM, 1998, NATURE, V395, P384, DOI 10.1038/26487; VIDYASAGAR TR, 1982, EXP BRAIN RES, V46, P157; VONDERMALSBURG C, 1982, BIOL CYBERN, V45, P49, DOI 10.1007/BF00387213; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; ZAHS KR, 1985, J COMP NEUROL, V241, P210, DOI 10.1002/cne.902410208	50	78	79	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2000	3	6					608	616		10.1038/75786	http://dx.doi.org/10.1038/75786			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	317WG	10816318				2022-12-24	WOS:000087249500018
J	Sharma, V; Levi, DM; Klein, SA				Sharma, V; Levi, DM; Klein, SA			Undercounting features and missing features: evidence for a high-level deficit in strabismic amblyopia	NATURE NEUROSCIENCE			English	Article							VISUAL-CORTEX; BINOCULAR INTERACTIONS; CONTRAST SENSITIVITY; ATTENTION; VISION; MONKEYS; PERCEPTION; NUMBERS; ACUITY; CATS	Abnormal visual development in strabismic amblyopia drastically affects visual perception and properties of neurons in primary visual cortex (V1). To test the notion that amblyopia also has consequences for higher visual areas, we asked humans with amblyopia to count briefly presented features. Using the amblyopic eye, strabismic amblyopes counted inaccurately, markedly underestimating the number of features. This inaccuracy was not due to low-level considerations (blur, visibility crowding, undersampling or topographical jitter), as they also underestimated the number of features missing from a uniform grid. Rather, counting deficits in strabismic amblyopes reflected a higher-level limitation in the number of features the amblyopic Visual system can individuate.	Univ Houston, Coll Optometry, Houston, TX 77204 USA; Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA	University of Houston System; University of Houston; University of California System; University of California Berkeley	Levi, DM (corresponding author), Univ Houston, Coll Optometry, 4901 Calhoun Blvd, Houston, TX 77204 USA.	dlevi@uh.edu	Levi, Dennis/J-7836-2019	Levi, Dennis/0000-0002-5350-8639	NEI NIH HHS [P30EY07551, R01 EY04776, R01EY01728] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY007551, R01EY001728, R01EY004776] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ATKINSON J, 1976, PERCEPTION, V5, P335, DOI 10.1068/p050335; BALAKRISHNAN JD, 1992, PSYCHOL RES-PSYCH FO, V54, P80, DOI 10.1007/BF00937136; BRADLEY A, 1981, INVEST OPHTH VIS SCI, V21, P467; CHINO YM, 1994, J NEUROSCI, V14, P5050; ERIKSEN CW, 1987, PERCEPT PSYCHOPHYS, V42, P299, DOI 10.3758/BF03203082; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Hess R F, 1982, Hum Neurobiol, V1, P17; HESS RF, 1977, VISION RES, V17, P1049, DOI 10.1016/0042-6989(77)90009-8; HYVARINEN J, 1981, EXP BRAIN RES, V42, P1; Imamura K, 1997, NEUROSCI LETT, V225, P173, DOI 10.1016/S0304-3940(97)00211-5; JEVONS WS, 1871, NATURE, V3, P281, DOI DOI 10.1038/003281A0; Kiorpes L, 1998, J NEUROSCI, V18, P6411; KOOI FL, 1994, SPATIAL VISION, V8, P255, DOI 10.1163/156856894X00350; LEVI DM, 1986, NATURE, V320, P360, DOI 10.1038/320360a0; LEVI DM, 1977, INVEST OPHTH VIS SCI, V16, P90; LEVI DM, 1994, VISION RES, V34, P3315, DOI 10.1016/0042-6989(94)90067-1; Levi DM, 1999, VISION RES, V39, P445, DOI 10.1016/S0042-6989(98)00125-4; LEVI DM, 1985, VISION RES, V25, P979, DOI 10.1016/0042-6989(85)90208-1; LEVI DM, 1991, VISION VISUAL DYSFUN, V10, P212; Lu ZL, 1998, VISION RES, V38, P1183, DOI 10.1016/S0042-6989(97)00273-3; Nakayama K., 1990, VISION CODING EFFICI, P411; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; PYLYSHYN Z, 1994, CAN J EXP PSYCHOL, V48, P260, DOI 10.1037/1196-1961.48.2.260; ROELFSEMA PR, 1994, EUR J NEUROSCI, V6, P1645, DOI 10.1111/j.1460-9568.1994.tb00556.x; Sathian K, 1999, J COGNITIVE NEUROSCI, V11, P36, DOI 10.1162/089892999563238; Smith EL, 1997, J NEUROPHYSIOL, V78, P1353, DOI 10.1152/jn.1997.78.3.1353; Treisman A, 1998, PHILOS T ROY SOC B, V353, P1295, DOI 10.1098/rstb.1998.0284; TRICK LM, 1994, PSYCHOL REV, V101, P80, DOI 10.1037/0033-295X.101.1.80; Vuilleumier P, 1999, NAT NEUROSCI, V2, P783, DOI 10.1038/12150; Wang H, 1998, VISION RES, V38, P1239, DOI 10.1016/S0042-6989(97)00278-2; WATSON AB, 1979, VISION RES, V19, P515, DOI 10.1016/0042-6989(79)90136-6; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0	32	115	118	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2000	3	5					496	501		10.1038/74872	http://dx.doi.org/10.1038/74872			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	309DG	10769391				2022-12-24	WOS:000086752000020
J	Dityatev, A; Dityateva, G; Schachner, M				Dityatev, A; Dityateva, G; Schachner, M			Synaptic strength as a function of post- versus presynaptic expression of the neural cell adhesion molecule NCAM	NEURON			English	Article							LONG-TERM POTENTIATION; N-CAM; HIPPOCAMPAL-FORMATION; GENETIC DISSECTION; ENTORHINAL CORTEX; IN-VITRO; L1; NEURONS; PLASTICITY; GROWTH	To evaluate the contributions of the pre- versus postsynaptic expression of NCAM in regulation of synaptic efficacy, we cultured dissociated hippocampal cells from NCAM-deficient and wild-type mice in homo- and heterogenotypic combinations. Double recordings from synaptically coupled neurons maintained in heterogenotypic cocultures showed that synaptic strength of excitatory but not inhibitory synapses depended on expression of NCAM post- but not presynaptically. This correlated with higher levels of potentiation and synaptic coverage of NCAM-expressing neurons compared to NCAM-deficient neurons in heterogenotypic cocultures. Synaptic density was the same in homogenotypic cultures of NCAM-deficient and wild-type neurons as well as in heterogenotypic cocultures in which glutamate receptors were blocked. These observations indicate that the relative levels of postsynaptic NCAM expression control synaptic strength in an activity-dependent manner by regulating the number of synapses.	Univ Hamburg, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Schachner, M (corresponding author), Univ Hamburg, Zentrum Mol Neurobiol, Martinistr 52, D-20246 Hamburg, Germany.	melitta.schachner@zmnh.uni-hamburg.de	Dityatev, Alexander/A-4034-2008	Dityatev, Alexander/0000-0002-0472-0553				Arami S, 1996, BEHAV BRAIN RES, V81, P81, DOI 10.1016/S0166-4328(96)00046-0; Aubert I, 1998, J COMP NEUROL, V399, P1; Bahr BA, 1997, J NEUROSCI, V17, P1320; Bailey CH, 1997, NEURON, V18, P913, DOI 10.1016/S0896-6273(00)80331-1; BARBEAU D, 1995, P NATL ACAD SCI USA, V92, P2785, DOI 10.1073/pnas.92.7.2785; Becker CG, 1996, J NEUROSCI RES, V45, P143, DOI 10.1002/(SICI)1097-4547(19960715)45:2<143::AID-JNR6>3.0.CO;2-A; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Cremer H, 1998, P NATL ACAD SCI USA, V95, P13242, DOI 10.1073/pnas.95.22.13242; Cremer H, 1997, MOL CELL NEUROSCI, V8, P323, DOI 10.1006/mcne.1996.0588; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Davis GW, 1997, NEURON, V19, P561, DOI 10.1016/S0896-6273(00)80372-4; DITYATEV A, 1999, CELL BIOL INT, V23, P129; Endo A, 1998, NEUROSCI LETT, V246, P37, DOI 10.1016/S0304-3940(98)00204-3; FAZELI MS, 1994, NEUROSCI LETT, V169, P77, DOI 10.1016/0304-3940(94)90360-3; Holst BD, 1998, P NATL ACAD SCI USA, V95, P2597, DOI 10.1073/pnas.95.5.2597; JUCKER M, 1995, MOL BRAIN RES, V28, P149, DOI 10.1016/0169-328X(94)00206-T; KADMON G, 1990, J CELL BIOL, V110, P209, DOI 10.1083/jcb.110.1.209; KADMON G, 1990, J CELL BIOL, V110, P193, DOI 10.1083/jcb.110.1.193; Krisch J, 1999, CURR OPIN NEUROBIOL, V9, P329, DOI 10.1016/S0959-4388(99)80048-8; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; Malhotra JD, 1998, J BIOL CHEM, V273, P33354, DOI 10.1074/jbc.273.50.33354; Mayford M, 1997, CURR BIOL, V7, pR580, DOI 10.1016/S0960-9822(06)00287-9; Mikkonen M, 1998, ANN NEUROL, V44, P923, DOI 10.1002/ana.410440611; MILLER PD, 1993, J COMP NEUROL, V327, P341, DOI 10.1002/cne.903270303; Moscoso LM, 1998, J NEUROSCI, V18, P1465; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; PERSOHN E, 1990, J NEUROCYTOL, V19, P807, DOI 10.1007/BF01186812; PERSOHN E, 1989, J COMP NEUROL, V288, P92, DOI 10.1002/cne.902880108; REUTER H, 1995, NEURON, V14, P773, DOI 10.1016/0896-6273(95)90221-X; RIVAS RJ, 1995, J NEUROSCI, V15, P981; RONN LCB, 1995, BRAIN RES, V677, P145, DOI 10.1016/0006-8993(95)00147-I; SCHMIDT CE, 1995, J NEUROSCI, V15, P3400; Schulz PE, 1997, P NATL ACAD SCI USA, V94, P5888, DOI 10.1073/pnas.94.11.5888; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Schuster T, 1998, J NEUROBIOL, V37, P359, DOI 10.1002/(SICI)1097-4695(19981115)37:3<359::AID-NEU2>3.0.CO;2-4; Seki T, 1998, J NEUROSCI, V18, P3757; SHINE HD, 1984, J CELL BIOL, V98, P1291, DOI 10.1083/jcb.98.4.1291; Staple JK, 1997, EUR J NEUROSCI, V9, P721, DOI 10.1111/j.1460-9568.1997.tb01420.x; Staubli U, 1998, J NEUROSCI, V18, P3460; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; UEDA S, 1994, BRAIN RES, V633, P284, DOI 10.1016/0006-8993(94)91550-4; WANG S, 1992, J NEUROSCI RES, V33, P626, DOI 10.1002/jnr.490330415; ZHU H, 1995, J NEUROSCI, V15, P4173	46	136	139	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	2000	26	1					207	217		10.1016/S0896-6273(00)81151-4	http://dx.doi.org/10.1016/S0896-6273(00)81151-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309MA	10798405	Bronze			2022-12-24	WOS:000086770500021
J	Xu, BJ; Zang, KL; Ruff, NL; Zhang, YA; McConnell, SK; Stryker, MP; Reichardt, LF				Xu, BJ; Zang, KL; Ruff, NL; Zhang, YA; McConnell, SK; Stryker, MP; Reichardt, LF			Cortical degeneration in the absence of neurotrophin signaling: Dendritic retraction and neuronal loss after removal of the receptor TrkB	NEURON			English	Article							TRANSGENIC MICE; SYNAPTIC PLASTICITY; TARGETED DISRUPTION; SENSORY NEURONS; NERVOUS-SYSTEM; VISUAL-CORTEX; CELL-DEATH; BDNF; HIPPOCAMPAL; SURVIVAL	To examine functions of TrkB in the adult CNS, TrkB has been removed from neurons expressing CaMKII, primarily pyramidal neurons, using Cre-mediated recombination. A floxed trkB allele was designed so that neurons lacking TrkB express tau-beta-galactosidase. Following trkB deletion in pyramidal cells, their dendritic arbors are altered, and cortical layers II/III and V are compressed, after which there is an apparent loss of mutant neurons expressing the transcription factor SCIP but not of those expressing Otx-1. Loss of neurons expressing SCIP requires deletion of trkB within affected neurons; reduction of neuronal ER81 expression does not, suggesting both direct and indirect effects of TrkB loss. Thus, TrkB is required for the maintenance of specific populations of cells in the adult neocortex.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Stanford Univ, Dept Sci Biol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University	Reichardt, LF (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.			Stryker, Michael/0000-0003-1546-5831	NINDS NIH HHS [P01 NS016033-190017, P01 NS016033] Funding Source: Medline; PHS HHS [P01-16033] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016033] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0; Alcantara S, 1997, J NEUROSCI, V17, P3623; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Cabelli RJ, 1997, NEURON, V19, P63, DOI 10.1016/S0896-6273(00)80348-7; Cellerino A, 1996, PROG NEUROBIOL, V49, P53, DOI 10.1016/0301-0082(96)00008-1; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Farinas I, 1996, NEURON, V17, P1065, DOI 10.1016/S0896-6273(00)80240-8; FRANTZ GD, 1994, J NEUROSCI, V14, P472; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; HENDRY SHC, 1989, EXP BRAIN RES, V76, P467; Horch HW, 1999, NEURON, V23, P353; Huang EJ, 1999, DEVELOPMENT, V126, P2191; JIANG XP, 1993, J NEUROSCI METH, V50, P45, DOI 10.1016/0165-0270(93)90055-V; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KORSCHING S, 1993, J NEUROSCI, V13, P2739; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Minichiello L, 1996, GENE DEV, V10, P2849, DOI 10.1101/gad.10.22.2849; Reddy PH, 1998, NAT GENET, V20, P198, DOI 10.1038/2510; Reichardt L. F., 1997, MOL CELLULAR APPROAC, P220; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; SHOLL DA, 1953, J ANAT, V87, P387; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; Yan Q, 1997, J COMP NEUROL, V378, P135	33	210	213	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	2000	26	1					233	245		10.1016/S0896-6273(00)81153-8	http://dx.doi.org/10.1016/S0896-6273(00)81153-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309MA	10798407	Bronze			2022-12-24	WOS:000086770500023
J	L'Etoile, ND; Bargmann, CI				L'Etoile, ND; Bargmann, CI			Olfaction and odor discrimination are mediated by the C-elegans guanylyl cyclase ODR-1	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; NUCLEOTIDE-GATED CHANNEL; SENSORY NEURONS; CHEMOSENSORY RECEPTORS; SIGNALING SPECIFICITY; LARVAL DEVELOPMENT; CATION CHANNEL; KINASE; FAMILY; DOMAIN	Animals in complex environments must discriminate between salient and uninformative sensory cues. Caenorhabditis elegans uses one pair of olfactory neurons called AWC to sense many different odorants, yet the animal can distinguish each odorant from the others in discrimination assays. We demonstrate that the transmembrane guanylyl cyclase ODR-1 is essential for responses to all AWC-sensed odorants. ODR-1 appears to be a shared signaling component downstream of odorant receptors. Overexpression of ODR-1 protein indicates that ODR-1 can influence odor discrimination and adaptation as well as olfaction. Adaptation to one odorant, butanone, is disrupted by ODR-1 overexpression. Olfactory discrimination is also disrupted by ODR-1 overexpression, probably by overproduction of the shared second messenger cGMP. We propose that AWC odorant signaling pathways are insulated to permit odor discrimination.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bargmann, CI (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA.	cori@itsa.ucsf.edu		Bargmann, Cornelia/0000-0002-8484-0618				AGHAJANIAN GK, 1987, NEUROPHARMACOLOGY, V26, P793, DOI 10.1016/0028-3908(87)90054-2; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Arshavsky VY, 1998, NEURON, V20, P11, DOI 10.1016/S0896-6273(00)80430-4; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P69, DOI 10.1113/jphysiol.1953.sp004829; Baylor D, 1996, P NATL ACAD SCI USA, V93, P560, DOI 10.1073/pnas.93.2.560; BIRNBY DA, 2000, IN PRESS GENETICS; BRENNER S, 1974, GENETICS, V77, P71; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CHINKERS M, 1989, SCIENCE, V245, P1392, DOI 10.1126/science.2571188; Chuang TT, 1996, TRENDS PHARMACOL SCI, V17, P416, DOI 10.1016/S0165-6147(96)10048-1; CLARK SG, 1994, GENETICS, V137, P987; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; Falke JJ, 1997, ANNU REV CELL DEV BI, V13, P457, DOI 10.1146/annurev.cellbio.13.1.457; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; FULLE HJ, 1995, P NATL ACAD SCI USA, V92, P3571, DOI 10.1073/pnas.92.8.3571; GARBERS DL, 1994, MOL BIOL CELL, V5, P1; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Iacovelli L, 1999, FASEB J, V13, P1; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Komatsu H, 1999, BRAIN RES, V821, P160, DOI 10.1016/S0006-8993(99)01111-7; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Laura RP, 1998, BIOCHEMISTRY-US, V37, P11264, DOI 10.1021/bi9809674; LIU MY, 1994, SCIENCE, V266, P1348, DOI 10.1126/science.266.5189.1348; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Mello C, 1995, METHOD CELL BIOL, V48, P451; Montell C, 1998, CURR OPIN NEUROBIOL, V8, P389, DOI 10.1016/S0959-4388(98)80066-4; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; PARKINSON JS, 1993, CELL, V73, P857, DOI 10.1016/0092-8674(93)90267-T; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Sokal I, 1999, BIOCHEMISTRY-US, V38, P1387, DOI 10.1021/bi982512k; Speca DJ, 1999, NEURON, V23, P487, DOI 10.1016/S0896-6273(00)80802-8; Sprague GF, 1998, GENE DEV, V12, P2817, DOI 10.1101/gad.12.18.2817; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Tsunoda S, 1998, CURR OPIN GENET DEV, V8, P419, DOI 10.1016/S0959-437X(98)80112-3; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; WARE RW, 1975, J COMP NEUROL, V162, P71, DOI 10.1002/cne.901620106; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Xiong WH, 1998, NAT NEUROSCI, V1, P359, DOI 10.1038/nn0998_359; Yochem J, 1998, GENETICS, V149, P1323; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157	59	185	190	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	2000	25	3					575	586		10.1016/S0896-6273(00)81061-2	http://dx.doi.org/10.1016/S0896-6273(00)81061-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	301CY	10774726	Bronze			2022-12-24	WOS:000086291700011
J	Grady, RM; Zhou, H; Cunningham, JM; Henry, MD; Campbell, KP; Sanes, JR				Grady, RM; Zhou, H; Cunningham, JM; Henry, MD; Campbell, KP; Sanes, JR			Maturation and maintenance of the neuromuscular synapse: Genetic evidence for roles of the dystrophin-glycoprotein complex	NEURON			English	Article							ACETYLCHOLINE-RECEPTOR AGGREGATION; DUCHENNE MUSCULAR-DYSTROPHY; UTROPHIN-DEFICIENT MICE; TORPEDO ELECTRIC ORGAN; SKELETAL-MUSCLE; ALPHA-DYSTROGLYCAN; AGRIN RECEPTOR; MUTANT MICE; DYSTROBREVIN ISOFORMS; BETA-DYSTROBREVIN	The dystrophin-glycoprotein complex (DGC) links the cytoskeleton of muscle fibers to their extracellular matrix. Using knockout mice, we show that a cytoplasmic DGC component, alpha-dystrobrevin (alpha-DB), is dispensable for formation of the neuromuscular junction (NMJ) but required for maturation of its postsynaptic apparatus. We also analyzed double and triple mutants lacking other cytoskeletal DGC components (utrophin and dystrophin) and myotubes lacking a alpha-DB or a transmembrane DGC component (dystroglycan). Our results suggest that alpha-DB acts via its linkage to the DGC to enhance the stability of postsynaptic specializations following their DGC-independent formation; dystroglycan may play additional roles in assembling synaptic basal lamina. Together, these results demonstrate involvement of distinct protein complexes in the formation and maintenance of the synapse and implicate the DGC in the latter process.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Univ Iowa, Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Neurol, Iowa City, IA 52242 USA	Washington University (WUSTL); Washington University (WUSTL); University of Iowa; University of Iowa	Sanes, JR (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.			Henry, Michael/0000-0002-7871-245X; Campbell, Kevin/0000-0003-2066-5889				APEL ED, 1995, NEURON, V15, P115, DOI 10.1016/0896-6273(95)90069-1; Balasubramanian S, 1998, FEBS LETT, V432, P133, DOI 10.1016/S0014-5793(98)00804-7; Blake DJ, 1998, P NATL ACAD SCI USA, V95, P241, DOI 10.1073/pnas.95.1.241; Blake DJ, 1996, J BIOL CHEM, V271, P7802, DOI 10.1074/jbc.271.13.7802; Blank M, 1999, EUR J NEUROSCI, V11, P2121, DOI 10.1046/j.1460-9568.1999.00636.x; BOWE MA, 1994, NEURON, V12, P1173, DOI 10.1016/0896-6273(94)90324-7; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Burden SJ, 1998, GENE DEV, V12, P133, DOI 10.1101/gad.12.2.133; Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5; Campanelli JT, 1996, DEVELOPMENT, V122, P1663; CAMPANELLI JT, 1994, CELL, V77, P663, DOI 10.1016/0092-8674(94)90051-5; CARR C, 1989, J CELL BIOL, V109, P1753, DOI 10.1083/jcb.109.4.1753; Cartaud A, 1998, J BIOL CHEM, V273, P11321, DOI 10.1074/jbc.273.18.11321; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Deconinck AE, 1997, J CELL BIOL, V136, P883, DOI 10.1083/jcb.136.4.883; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; FERNS MJ, 1993, NEURON, V11, P491, DOI 10.1016/0896-6273(93)90153-I; FERTUCK HC, 1976, J CELL BIOL, V69, P144, DOI 10.1083/jcb.69.1.144; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Gautam M, 1999, DEV BRAIN RES, V114, P171, DOI 10.1016/S0165-3806(99)00013-9; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; Gesemann M, 1996, NEURON, V16, P755, DOI 10.1016/S0896-6273(00)80096-3; Grady RM, 1999, NAT CELL BIOL, V1, P215, DOI 10.1038/12034; Grady RM, 1997, J CELL BIOL, V136, P871, DOI 10.1083/jcb.136.4.871; Hack AA, 1998, J CELL BIOL, V142, P1279, DOI 10.1083/jcb.142.5.1279; Henry MD, 1998, CELL, V95, P859, DOI 10.1016/S0092-8674(00)81708-0; Henry MD, 1999, CURR OPIN CELL BIOL, V11, P602, DOI 10.1016/S0955-0674(99)00024-1; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hopf C, 1996, J BIOL CHEM, V271, P5231; Jacobson C, 1998, J NEUROSCI, V18, P6340; LIDOV HGW, 1990, NATURE, V348, P725, DOI 10.1038/348725a0; LYONS PR, 1991, J NEUROCYTOL, V20, P969, DOI 10.1007/BF01187915; MARTIN PT, 1995, NEURON, V14, P743, DOI 10.1016/0896-6273(95)90218-X; Martin PT, 1997, DEVELOPMENT, V124, P3909; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; Missias AC, 1997, DEVELOPMENT, V124, P5075; Montanaro F, 1999, J CELL BIOL, V145, P1325, DOI 10.1083/jcb.145.6.1325; Namba T, 1996, GENES CELLS, V1, P755, DOI 10.1111/j.1365-2443.1996.tb00015.x; Nawrotzki R, 1998, J CELL SCI, V111, P2595; OHLENDIECK K, 1991, NEURON, V7, P499, DOI 10.1016/0896-6273(91)90301-F; Ozawa E, 1998, MUSCLE NERVE, V21, P421, DOI 10.1002/(SICI)1097-4598(199804)21:4<421::AID-MUS1>3.3.CO;2-W; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; Peters MF, 1998, J CELL BIOL, V142, P1269, DOI 10.1083/jcb.142.5.1269; Peters MF, 1997, J BIOL CHEM, V272, P31561, DOI 10.1074/jbc.272.50.31561; PETERS MF, 1994, NEUROREPORT, V5, P1577, DOI 10.1097/00001756-199408150-00009; Peters MF, 1997, J CELL BIOL, V138, P81, DOI 10.1083/jcb.138.1.81; ROHWEDEL J, 1994, DEV BIOL, V164, P87, DOI 10.1006/dbio.1994.1182; Rohwedel J, 1998, EXP CELL RES, V239, P214, DOI 10.1006/excr.1997.3903; SadouletPuccio HM, 1997, P NATL ACAD SCI USA, V94, P12413, DOI 10.1073/pnas.94.23.12413; SadouletPuccio HM, 1996, HUM MOL GENET, V5, P489, DOI 10.1093/hmg/5.4.489; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SCOTT LJC, 1988, J NEUROSCI, V8, P932; SLATER CR, 1982, DEV BIOL, V94, P11, DOI 10.1016/0012-1606(82)90063-X; STEINBACH JH, 1981, DEV BIOL, V84, P267, DOI 10.1016/0012-1606(81)90394-8; Straub V, 1997, CURR OPIN NEUROL, V10, P168, DOI 10.1097/00019052-199704000-00016; SUGIYAMA J, 1994, NEURON, V13, P103, DOI 10.1016/0896-6273(94)90462-6; TINSLEY JM, 1994, P NATL ACAD SCI USA, V91, P8307, DOI 10.1073/pnas.91.18.8307; WAGNER KR, 1993, NEURON, V10, P511, DOI 10.1016/0896-6273(93)90338-R; WALLACE BG, 1988, J CELL BIOL, V107, P267, DOI 10.1083/jcb.107.1.267; Williamson RA, 1997, HUM MOL GENET, V6, P831, DOI 10.1093/hmg/6.6.831	63	238	248	0	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	2000	25	2					279	293		10.1016/S0896-6273(00)80894-6	http://dx.doi.org/10.1016/S0896-6273(00)80894-6			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	288EL	10719885	Bronze			2022-12-24	WOS:000085549100008
J	Wolpowitz, D; Mason, TBA; Dietrich, P; Mendelsohn, M; Talmage, DA; Role, LW				Wolpowitz, D; Mason, TBA; Dietrich, P; Mendelsohn, M; Talmage, DA; Role, LW			Cysteine-rich domain isoforms of the neuregulin-1 gene are required for maintenance of peripheral synapses	NEURON			English	Article							SCHWANN-CELL APOPTOSIS; NEUROMUSCULAR-JUNCTION; CARDIAC DEVELOPMENT; NERVOUS-SYSTEM; NEURONAL DEVELOPMENT; MYOTUBULAR MYOPATHY; TYROSINE KINASES; GROWTH-FACTORS; MESSENGER-RNA; RECEPTOR	Neuregulin-1 (NRG-1) signaling has been implicated in inductive interactions between pre- and postsynaptic partners during synaptogenesis. We used gene targeting to selectively disrupt (c) under bar ysteine-(r) under bar ich (d) under bar omain(CRD-) containing NRG-1 isoforms. In CRD-NRG-1(-/-) mice, peripheral projections defasciculated and displayed aberrant branching patterns within their targets. Motor nerve terminals were transiently associated with broad bands of postsynaptic ACh receptor (AChR) clusters. Initially, Schwann cell precursors accompanied peripheral projections, but later, Schwann cells were absent from axons in the periphery. Following initial stages of synapse formation, sensory and motor nerves withdrew and degenerated. Our data demonstrate the essential role of CRD-NRG-1-mediated signaling for coordinating nerve, target, and Schwann cell interactions in the normal maintenance of peripheral synapses, and ultimately in the survival of CRD-NRG-1-expressing neurons.	Columbia Univ Coll Phys & Surg, Program Neurobiol & Surg, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Anat & Cell Biol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Integrated Program Mol & Cellular Biol & Biophys, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Inst Human Nutr, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Role, LW (corresponding author), Columbia Univ Coll Phys & Surg, Program Neurobiol & Surg, 630 W 168th St, New York, NY 10032 USA.		Role, LW/Q-7371-2018	Role, LW/0000-0001-5851-212X; Talmage, David/0000-0003-4627-3007; Wolpowitz, Deon/0000-0003-3951-575X	NCRR NIH HHS [1S10RR10506] Funding Source: Medline; NIDA NIH HHS [DA09366] Funding Source: Medline; NINDS NIH HHS [R01 NS029071-16, R01 NS029071-14, R01 NS029071-11, R01 NS029071-12, R01 NS029071, R01 NS029071-15, NS29071, R01 NS029071-13, R01 NS029071-13S1, R01 NS029071-17] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR010506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009366] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ALTIOK N, 1995, EMBO J, V14, P4258, DOI 10.1002/j.1460-2075.1995.tb00100.x; ASHBY PR, 1993, DEV BIOL, V156, P519, DOI 10.1006/dbio.1993.1098; Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825; Bunge R P, 1993, Curr Opin Neurobiol, V3, P805, DOI 10.1016/0959-4388(93)90157-T; Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4; Busfield SJ, 1997, MOL CELL BIOL, V17, P4007, DOI 10.1128/MCB.17.7.4007; Carraway KL, 1997, NATURE, V387, P512, DOI 10.1038/387512a0; Chang H, 1997, NATURE, V387, P509, DOI 10.1038/387509a0; Crovello CS, 1998, J BIOL CHEM, V273, P26954, DOI 10.1074/jbc.273.41.26954; ENGEL WK, 1968, ARCH NEUROL-CHICAGO, V18, P435, DOI 10.1001/archneur.1968.00470340121011; Erickson SL, 1997, DEVELOPMENT, V124, P4999; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; Fischbach GD, 1997, ANNU REV NEUROSCI, V20, P429, DOI 10.1146/annurev.neuro.20.1.429; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Grieshammer U, 1998, DEV BIOL, V197, P234, DOI 10.1006/dbio.1997.8859; GRIGGS RC, 1995, EVALUATION PATIENT M, P56; Grinspan JB, 1996, J NEUROSCI, V16, P6107; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; Harari D, 1999, ONCOGENE, V18, P2681, DOI 10.1038/sj.onc.1202631; Helliwell TR, 1998, NEUROMUSCULAR DISORD, V8, P152, DOI 10.1016/S0960-8966(98)00010-8; HO WH, 1995, J BIOL CHEM, V270, P14523, DOI 10.1074/jbc.270.24.14523; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; Ishiguro H, 1998, Nihon Shinkei Seishin Yakurigaku Zasshi, V18, P137; Jessen KR, 1998, MICROSC RES TECHNIQ, V41, P393, DOI 10.1002/(SICI)1097-0029(19980601)41:5<393::AID-JEMT6>3.0.CO;2-R; JO SA, 1995, NATURE, V373, P158, DOI 10.1038/373158a0; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; KOKAI Y, 1987, P NATL ACAD SCI USA, V84, P8498, DOI 10.1073/pnas.84.23.8498; Kramer R, 1996, P NATL ACAD SCI USA, V93, P4833, DOI 10.1073/pnas.93.10.4833; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lemke G, 1996, MOL CELL NEUROSCI, V7, P247, DOI 10.1006/mcne.1996.0019; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Liu XF, 1998, P NATL ACAD SCI USA, V95, P13024, DOI 10.1073/pnas.95.22.13024; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082; Meyer D, 1997, DEVELOPMENT, V124, P3575; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; MOROSOV A, 1994, J BIOL CHEM, V269, P18434; Morris JK, 1999, NEURON, V23, P273, DOI 10.1016/S0896-6273(00)80779-5; Naciff JM, 1997, NEUROREPORT, V8, P3467, DOI 10.1097/00001756-199711100-00011; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Oppenheim RW, 1996, NEURON, V17, P195, DOI 10.1016/S0896-6273(00)80151-8; Pinkas-Kramarski R, 1998, MOL CELL BIOL, V18, P6090, DOI 10.1128/MCB.18.10.6090; Rice FL, 1998, DEV BIOL, V198, P57, DOI 10.1006/dbio.1998.8861; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; Sandrock AW, 1997, SCIENCE, V276, P599, DOI 10.1126/science.276.5312.599; Sanes JR, 1997, CURR OPIN NEUROBIOL, V7, P93, DOI 10.1016/S0959-4388(97)80126-2; Si JT, 1998, LIFE SCI, V62, P1497, DOI 10.1016/S0024-3205(98)00096-4; Srinivasan R, 1998, J PATHOL, V185, P236, DOI 10.1002/(SICI)1096-9896(199807)185:3<236::AID-PATH118>3.0.CO;2-7; Streit A, 1997, DEVELOPMENT, V124, P1191; Trachtenberg JT, 1996, NATURE, V379, P174, DOI 10.1038/379174a0; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; WEN DZ, 1992, CELL, V69, P559, DOI 10.1016/0092-8674(92)90456-M; WIEDEMANN LM, 1984, MOL CELL BIOL, V4, P2518, DOI 10.1128/MCB.4.11.2518; Woldeyesus MT, 1999, GENE DEV, V13, P2538, DOI 10.1101/gad.13.19.2538; WRIGHT DE, 1995, J COMP NEUROL, V351, P329, DOI 10.1002/cne.903510302; Yang X, 1998, NEURON, V20, P255, DOI 10.1016/S0896-6273(00)80454-7; Zhang DX, 1997, P NATL ACAD SCI USA, V94, P9562, DOI 10.1073/pnas.94.18.9562; ZHU XJ, 1995, EMBO J, V14, P5842, DOI 10.1002/j.1460-2075.1995.tb00272.x; Zorick TS, 1996, CURR OPIN CELL BIOL, V8, P870, DOI 10.1016/S0955-0674(96)80090-1	64	238	241	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	2000	25	1					79	91		10.1016/S0896-6273(00)80873-9	http://dx.doi.org/10.1016/S0896-6273(00)80873-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279KP	10707974	Bronze			2022-12-24	WOS:000085043200012
J	Luo, Y; Bolon, B; Kahn, S; Bennett, BD; Babu-Khan, S; Denis, P; Fan, W; Kha, H; Zhang, JH; Gong, YH; Martin, L; Louis, JC; Yan, Q; Richards, WG; Citron, M; Vassar, R				Luo, Y; Bolon, B; Kahn, S; Bennett, BD; Babu-Khan, S; Denis, P; Fan, W; Kha, H; Zhang, JH; Gong, YH; Martin, L; Louis, JC; Yan, Q; Richards, WG; Citron, M; Vassar, R			Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation	NATURE NEUROSCIENCE			English	Article							PRECURSOR PROTEIN; PEPTIDE; DISEASE		Amgen Inc, Thousand Oaks, CA 91320 USA	Amgen	Vassar, R (corresponding author), Northwestern Univ, Sch Med, Dept Cell & Mol Biol, 303 E Chicago Ave, Chicago, IL 60611 USA.	r-vassar@northwestern.edu						Bennett BD, 2000, J BIOL CHEM, V275, P20647, DOI 10.1074/jbc.M002688200; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; Gouras GK, 1998, J NEUROCHEM, V71, P1920; Haass C, 1999, SCIENCE, V286, P916, DOI 10.1126/science.286.5441.916; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Saunders AJ, 1999, SCIENCE, V286; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sisodia SS, 1999, AM J HUM GENET, V65, P7, DOI 10.1086/302475; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2000, NEURON, V27, P419, DOI 10.1016/S0896-6273(00)00051-9; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Younkin SG, 1998, J PHYSIOLOGY-PARIS, V92, P289, DOI 10.1016/S0928-4257(98)80035-1	15	878	994	1	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2001	4	3					231	232		10.1038/85059	http://dx.doi.org/10.1038/85059			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UE	11224535				2022-12-24	WOS:000167178300006
J	Vissel, B; Royle, GA; Christie, BR; Schiffer, HH; Ghetti, A; Tritto, T; Perez-Otano, I; Radcliffe, RA; Seamans, J; Sejnowski, T; Wehner, JM; Collins, AC; O'Gorman, S; Heinemann, SF				Vissel, B; Royle, GA; Christie, BR; Schiffer, HH; Ghetti, A; Tritto, T; Perez-Otano, I; Radcliffe, RA; Seamans, J; Sejnowski, T; Wehner, JM; Collins, AC; O'Gorman, S; Heinemann, SF			The role of RNA editing of kainate receptors in synaptic plasticity and seizures	NEURON			English	Article							LONG-TERM POTENTIATION; CA2+-PERMEABLE AMPA RECEPTORS; CULTURED HIPPOCAMPAL-NEURONS; TEMPORAL-LOBE EPILEPSY; CALCIUM-PERMEABLE AMPA; GLUTAMATE RECEPTORS; RAT-BRAIN; KAINIC ACID; Q/R SITE; GLUR6-DEFICIENT MICE	The ionotropic glutamate receptor subunit GluR6 undergoes developmentally and regionally regulated Q/R site RNA editing that reduces the calcium permeability of GluR6-containing kainate receptors. To investigate the functional significance of this editing in vivo, we engineered mice deficient in GIuR6 Q/R site editing. In these mutant mice but not in wild types, NMDA receptor-independent long-term potentiation (LTP) could be induced at the medial perforant path-dentate gyrus synapse. This indicates that kainate receptors with unedited GluR6 subunits can mediate LTP. Behavioral analyses revealed no differences from wild types, but mutant mice were more vulnerable to kainate-induced seizures. Together, these results suggest that GluR6 Q/R site RNA editing may modulate synaptic plasticity and seizure vulnerability.	Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Computat Neurobiol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; Univ S Dakota, Sch Med, Vermillion, SD 57069 USA; Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA	Salk Institute; Salk Institute; Salk Institute; University of South Dakota; University of Colorado System; University of Colorado Boulder	Vissel, B (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA.		Perez-Otano, Isabel/S-9613-2017; Christie, Brian Ross/AAF-3766-2019; Sejnowski, Terrence/AAV-5558-2021	Perez-Otano, Isabel/0000-0002-7222-8202; Christie, Brian Ross/0000-0002-6830-0160; Vissel, Bryce/0000-0001-8860-8050	NIDA NIH HHS [DA-10156] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010156] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; Bernard A, 1999, EUR J NEUROSCI, V11, P604, DOI 10.1046/j.1460-9568.1999.00479.x; BERNARD A, 1994, J NEUROCHEM, V62, P2057, DOI 10.1046/j.1471-4159.1994.62052057.x; Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; Bureau I, 2000, P NATL ACAD SCI USA, V97, P6838, DOI 10.1073/pnas.97.12.6838; Bureau I, 1999, J NEUROSCI, V19, P653; Chergui K, 2000, J NEUROSCI, V20, P2175; Chittajallu R, 1999, TRENDS PHARMACOL SCI, V20, P26, DOI 10.1016/S0165-6147(98)01286-3; CHRISTIE BR, 1992, SYNAPSE, V10, P1, DOI 10.1002/syn.890100102; Christie BR, 1996, LEARN MEMORY, V3, P160, DOI 10.1101/lm.3.2-3.160; COLINO A, 1993, J NEUROPHYSIOL, V69, P1150, DOI 10.1152/jn.1993.69.4.1150; Contractor A, 2000, J NEUROSCI, V20, P8269, DOI 10.1523/JNEUROSCI.20-22-08269.2000; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Dingledine R, 1999, PHARMACOL REV, V51, P7; EGEBJERG J, 1993, P NATL ACAD SCI USA, V90, P755, DOI 10.1073/pnas.90.2.755; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; Feldmeyer D, 1999, NAT NEUROSCI, V2, P57, DOI 10.1038/4561; Frerking M, 2000, CURR OPIN NEUROBIOL, V10, P342, DOI 10.1016/S0959-4388(00)00094-5; Gerlai R, 1998, BEHAV BRAIN RES, V95, P37, DOI 10.1016/S0166-4328(98)00002-3; Ghetti A, 2000, J NEUROSCI, V20, P2766; Grigorenko EV, 1998, NEUROREPORT, V9, P2219, DOI 10.1097/00001756-199807130-00013; Gu JG, 1996, NATURE, V381, P793, DOI 10.1038/381793a0; Herb A, 1996, P NATL ACAD SCI USA, V93, P1875, DOI 10.1073/pnas.93.5.1875; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Johnston MV, 1996, EPILEPSIA, V37, pS2, DOI 10.1111/j.1528-1157.1996.tb06018.x; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; Kask K, 1998, P NATL ACAD SCI USA, V95, P13777, DOI 10.1073/pnas.95.23.13777; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; LERMA J, 1993, P NATL ACAD SCI USA, V90, P11688, DOI 10.1073/pnas.90.24.11688; Lerma J, 1997, TRENDS NEUROSCI, V20, P9, DOI 10.1016/S0166-2236(96)20055-4; Logue SF, 1997, NEUROSCIENCE, V80, P1075, DOI 10.1016/S0306-4522(97)00164-4; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MARKS MJ, 1985, PHARMACOL BIOCHEM BE, V23, P325, DOI 10.1016/0091-3057(85)90577-5; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; MCNAUGHTON BL, 1977, J COMP NEUROL, V175, P439, DOI 10.1002/cne.901750404; Mulle C, 2000, NEURON, V28, P475, DOI 10.1016/S0896-6273(00)00126-4; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; NADLER JV, 1978, NATURE, V271, P676, DOI 10.1038/271676a0; NADLER JV, 1981, LIFE SCI, V29, P2031; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; RAYMOND LA, 1993, NATURE, V361, P637, DOI 10.1038/361637a0; ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0; RUANO D, 1995, NEURON, V14, P1009, DOI 10.1016/0896-6273(95)90339-9; Sailer A, 1999, J NEUROSCI, V19, P8757, DOI 10.1523/JNEUROSCI.19-20-08757.1999; Schiffer HH, 1999, ANAL BIOCHEM, V276, P257, DOI 10.1006/abio.1999.4369; Schmitt J, 1996, DEV BRAIN RES, V91, P153, DOI 10.1016/0165-3806(95)00175-1; Seeburg PH, 2000, NEURON, V25, P261, DOI 10.1016/S0896-6273(00)80891-0; Seeburg PH, 1998, BRAIN RES REV, V26, P217, DOI 10.1016/S0165-0173(97)00062-3; Sillanpaa M, 1998, NEW ENGL J MED, V338, P1715, DOI 10.1056/NEJM199806113382402; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; Sprengel R, 1999, Adv Neurol, V79, P525; Swanson GT, 1996, J PHYSIOL-LONDON, V492, P129, DOI 10.1113/jphysiol.1996.sp021295; Toth K, 1998, NAT NEUROSCI, V1, P572, DOI 10.1038/2807; Wehner JM, 1997, NAT GENET, V17, P331, DOI 10.1038/ng1197-331; WISDEN W, 1993, J NEUROSCI, V13, P3582	60	102	108	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	2001	29	1					217	227		10.1016/S0896-6273(01)00192-1	http://dx.doi.org/10.1016/S0896-6273(01)00192-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	397NX	11182093	Bronze			2022-12-24	WOS:000166702700021
J	Rajagopalan, S; Nicolas, E; Vivancos, V; Berger, J; Dickson, BJ				Rajagopalan, S; Nicolas, E; Vivancos, V; Berger, J; Dickson, BJ			Crossing the midline: Roles and regulation of robo receptors	NEURON			English	Article							GROWTH CONE GUIDANCE; CNS MIDLINE; COMMISSURAL AXONS; GENETIC-ANALYSIS; NERVOUS-SYSTEM; EMBRYONIC CNS; MOTOR AXONS; DROSOPHILA; NETRINS; SLIT	In the Drosophila CNS, the midline repellent Slit acts at short range through its receptor Robe to control midline crossing. Longitudinal axons express high levels of Robe and avoid the midline; commissural axons that cross the midline express only low levels of Robe. Robe levels are in turn regulated by Comm. Here, we show that the Slit receptors Robo2 and Robo3 ensure the fidelity of this crossing decision: rare crossing errors occur in both robo2 and robo3 single mutants. In addition, low levels of either Robo or Robo2 are required to drive commissural axons through the midline: only in robo,robo2 double mutants do axons linger at the midline as they do in silt mutants. Robo2 and Robo3 levers are also tightly regulated, most likely by a mechanism similar to but distinct from the regulation of Robe by Comm.	Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Dickson, BJ (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	dickson@nt.imp.univie.ac.at	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X				Battye R, 1999, DEVELOPMENT, V126, P2475; Bonkowsky JL, 1999, NATURE, V402, P540, DOI 10.1038/990122; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; Hummel T, 1999, DEVELOPMENT, V126, P771; Hummel T, 1999, DEV BIOL, V209, P381, DOI 10.1006/dbio.1999.9235; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; MYERS PZ, 1993, J NEUROSCI, V13, P127; Raikova OI, 1998, ZOOMORPHOLOGY, V118, P69, DOI 10.1007/s004350050058; RAJAGOPALAN S, 2000, IN PRESS CELL, V103; Rorth P, 1998, DEVELOPMENT, V125, P1049; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; SAMAT H, 1981, EVOLUTION NERVOUS SY; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; SIMPSON JH, 2000, IN PRESS CELL, V103; Stoeckli ET, 1997, NEURON, V18, P209, DOI 10.1016/S0896-6273(00)80262-7; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Wolf BD, 2000, DEVELOPMENT, V127, P2001; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	32	165	166	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	2000	28	3					767	777		10.1016/S0896-6273(00)00152-5	http://dx.doi.org/10.1016/S0896-6273(00)00152-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386JJ	11163265	Bronze			2022-12-24	WOS:000166057500015
J	Polonsky, A; Blake, R; Braun, T; Heeger, DJ				Polonsky, A; Blake, R; Braun, T; Heeger, DJ			Neuronal activity in human primary visual cortex correlates with perception during binocular rivalry	NATURE NEUROSCIENCE			English	Article							NEUROMAGNETIC RESPONSES; CONSCIOUS PERCEPTION; FUNCTIONAL MRI; SUPPRESSION; MOTION; VISION; COLOR; BRAIN; SYNCHRONIZATION; ORGANIZATION	During binocular rivalry, two incompatible monocular images compete for perceptual dominance, with one pattern temporarily suppressed from conscious awareness. We measured fMRI signals in early visual cortex while subjects viewed rival dichoptic images of two different contrasts; the contrast difference served as a 'tag' for the neuronal representations of the two monocular images. Activity in primary visual cortex (V1) increased when subjects perceived the higher contrast pattern and decreased when subjects perceived the lower contrast pattern. These fluctuations in V1 activity during rivalry were about 55% as large as those evoked by alternately presenting the two monocular images without rivalry. The rivalry-related fluctuations in V1 activity were roughly equal to those observed in other visual areas (V2, V3, V3a and V4v). These results challenge the view that the neuronal mechanisms responsible for binocular rivalry occur primarily in later visual areas.	Stanford Univ, Dept Psychol, Palo Alto, CA 94303 USA; Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; Univ Plymouth, Inst Neurosci, Plymouth PL4 8AA, Devon, England	Stanford University; Vanderbilt University; University of Plymouth	Heeger, DJ (corresponding author), Stanford Univ, Dept Psychol, Jordan Hall,Bldg 420, Palo Alto, CA 94303 USA.	heeger@stanford.edu	Braun, Jochen/F-1370-2013	Braun, Jochen/0000-0002-8886-078X	NEI NIH HHS [R01EY12741] Funding Source: Medline; NIGMS NIH HHS [2T32GM08294] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008294] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Alais D, 1998, VISION RES, V38, P637, DOI 10.1016/S0042-6989(97)00190-9; Andrews TJ, 1999, NAT NEUROSCI, V2, P405, DOI 10.1038/8068; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; BLAKE R, 1979, J EXP PSYCHOL HUMAN, V5, P315, DOI 10.1037/0096-1523.5.2.315; BLAKE R, 1992, VISUAL NEUROSCI, V8, P469, DOI 10.1017/S0952523800004971; BLAKE R, 1974, NATURE, V249, P488, DOI 10.1038/249488a0; BLAKE R, 1979, PERCEPTION, V8, P143, DOI 10.1068/p080143; Brown RJ, 1997, VISION RES, V37, P2401, DOI 10.1016/S0042-6989(97)00045-X; Engel AK, 1999, CONSCIOUS COGN, V8, P128, DOI 10.1006/ccog.1999.0389; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; Glover GH, 1999, MAGNET RESON MED, V42, P412, DOI 10.1002/(SICI)1522-2594(199908)42:2<412::AID-MRM25>3.0.CO;2-U; GROSSBERG S, 1987, PERCEPT PSYCHOPHYS, V41, P117, DOI 10.3758/BF03204875; Heeger DJ, 2000, NAT NEUROSCI, V3, P631, DOI 10.1038/76572; Kovacs I, 1996, P NATL ACAD SCI USA, V93, P15508, DOI 10.1073/pnas.93.26.15508; Lee SH, 1999, VISION RES, V39, P1447, DOI 10.1016/S0042-6989(98)00269-7; LEHMKUHLE SW, 1975, VISION RES, V15, P855, DOI 10.1016/0042-6989(75)90266-7; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Leopold DA, 1997, THESIS BAYLOR COLL M; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; Logothetis NK, 1998, PHILOS T R SOC B, V353, P1801, DOI 10.1098/rstb.1998.0333; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; Lumer ED, 1999, P NATL ACAD SCI USA, V96, P1669, DOI 10.1073/pnas.96.4.1669; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Lumer ED, 1998, CEREB CORTEX, V8, P553, DOI 10.1093/cercor/8.6.553; MUELLER TJ, 1990, VISUAL NEUROSCI, V4, P63, DOI 10.1017/S0952523800002777; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; OSHEA RP, 1994, PERCEPTION, V23, P771, DOI 10.1068/p230771; OSHEA RP, 1987, VISION RES, V27, P781, DOI 10.1016/0042-6989(87)90075-7; OSHEA RP, 1981, VISION RES, V21, P801, DOI 10.1016/0042-6989(81)90177-2; Preuss TM, 1999, P NATL ACAD SCI USA, V96, P11601, DOI 10.1073/pnas.96.20.11601; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Sengpiel F, 1997, CURR BIOL, V7, pR447, DOI 10.1016/S0960-9822(06)00215-6; SENGPIEL F, 1995, VISION RES, V35, P179, DOI 10.1016/0042-6989(94)00125-6; SENGPIEL F, 1994, NATURE, V368, P847, DOI 10.1038/368847a0; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435; SMITH EL, 1982, SCIENCE, V218, P802, DOI 10.1126/science.7134975; Srinivasan R, 1999, J NEUROSCI, V19, P5435; Teo PC, 1997, IEEE T MED IMAGING, V16, P852, DOI 10.1109/42.650881; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tononi G, 1998, P NATL ACAD SCI USA, V95, P3198, DOI 10.1073/pnas.95.6.3198; Valle-Inclan F, 1999, NEUROREPORT, V10, P21, DOI 10.1097/00001756-199901180-00004; WADE NJ, 1978, VISION RES, V18, P827, DOI 10.1016/0042-6989(78)90123-2; WANDELL B, IN PRESS J COGN NEUR; WIESENFELDER H, 1991, VISION RES, V31, P1589, DOI 10.1016/0042-6989(91)90135-R; YU K, 1992, J EXP PSYCHOL HUMAN, V18, P1158, DOI 10.1037/0096-1523.18.4.1158	49	381	386	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11					1153	1159		10.1038/80676	http://dx.doi.org/10.1038/80676			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TX	11036274				2022-12-24	WOS:000167177600022
J	Wang, Y; Fujita, I; Murayama, Y				Wang, Y; Fujita, I; Murayama, Y			Neuronal mechanisms of selectivity for object features revealed by blocking inhibition in inferotemporal cortex	NATURE NEUROSCIENCE			English	Article							INFERIOR TEMPORAL CORTEX; PRIMARY VISUAL-CORTEX; ORIENTATION SELECTIVITY; DIRECTION SELECTIVITY; CORTICAL-NEURONS; CEREBRAL-CORTEX; MACAQUE; MONKEY	The inferotemporal cortex (area TE) of monkeys, a higher station of the visual information stream for object recognition, contains neurons selective for particular object features. Little is known about how and where this selectivity is generated. We show that blockade of inhibition mediated by gamma -aminobutyric acid (GABA) markedly altered the selectivity of TE neurons by augmenting their responses to some stimuli but not to others. The effects were observed for particular groups of stimuli related to the originally effective stimuli or those that did not originally excite the neurons but activated nearby neurons. Intrinsic neuronal interactions within area TE thus determine the final characteristic of their selectivity, and GABAergic inhibition contributes to this process.	Osaka Univ, Sch Med, Dept Cognit Neurosci, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Engn Sci, Dept Biophys Engn, Osaka 5608537, Japan	Osaka University; Osaka University	Fujita, I (corresponding author), Osaka Univ, Sch Med, Dept Cognit Neurosci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.							Crook JM, 1998, EUR J NEUROSCI, V10, P2056, DOI 10.1046/j.1460-9568.1998.00218.x; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FUJITA I, 1991, J NEUROSCI, V11, P722; Fujita I, 1996, J COMP NEUROL, V368, P467, DOI 10.1002/(SICI)1096-9861(19960513)368:4<467::AID-CNE1>3.0.CO;2-2; FUJITA I, 1992, NATURE, V360, P342; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; GOCHIN PM, 1991, EXP BRAIN RES, V84, P505; Gross C. G., 1973, HDB SENSORY PHYSIOLO, P451; HENDRY SHC, 1987, J NEUROSCI, V7, P1503; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; LI BM, 1990, NEUROSCI RES, V8, P214, DOI 10.1016/0168-0102(90)90023-8; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; MERRILL EG, 1972, MED BIOL ENG, V10, P662, DOI 10.1007/BF02476084; SATO H, 1994, J NEUROPHYSIOL, V72, P163, DOI 10.1152/jn.1994.72.1.163; Sato H, 1996, J PHYSIOL-LONDON, V494, P757, DOI 10.1113/jphysiol.1996.sp021530; SATO H, 1995, J NEUROPHYSIOL, V74, P1382, DOI 10.1152/jn.1995.74.4.1382; SILLITO AM, 1980, BRAIN RES, V194, P517, DOI 10.1016/0006-8993(80)91234-2; Sompolinsky H, 1997, CURR OPIN NEUROBIOL, V7, P514, DOI 10.1016/S0959-4388(97)80031-1; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Tanigawa H, 1998, J COMP NEUROL, V401, P129, DOI 10.1002/(SICI)1096-9861(19981109)401:1<129::AID-CNE8>3.0.CO;2-D; TSUMOTO T, 1979, EXP BRAIN RES, V34, P351; Vidyasagar TR, 1996, TRENDS NEUROSCI, V19, P272, DOI 10.1016/S0166-2236(96)20027-X; Wang G, 1996, SCIENCE, V272, P1665, DOI 10.1126/science.272.5268.1665	26	99	99	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2000	3	8					807	813		10.1038/77712	http://dx.doi.org/10.1038/77712			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TU	10903574				2022-12-24	WOS:000167177300016
J	Colledge, M; Dean, RA; Scott, GK; Langeberg, LK; Huganir, RL; Scott, JD				Colledge, M; Dean, RA; Scott, GK; Langeberg, LK; Huganir, RL; Scott, JD			Targeting of PKA to glutamate receptors through a MAGUK-AKAP complex	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; DOMAIN-CONTAINING PROTEIN; LONG-TERM POTENTIATION; POSTSYNAPTIC DENSITY; AMPA RECEPTORS; GLUR1 SUBUNIT; REGULATORY SUBUNIT; HIPPOCAMPAL-NEURONS; EXCITATORY SYNAPSES; ANCHORING PROTEIN	Compartmentalization of glutamate receptors with the signaling enzymes that regulate their activity supports synaptic transmission. Two classes of binding proteins organize these complexes: the MAGUK proteins that cluster glutamate receptors and AKAPs that anchor kinases and phosphatases. In this report, we demonstrate that glutamate receptors and PKA are recruited into a macromolecular signaling complex through direct interaction between the MAGUK proteins, PSD-95 and SAP97, and AKAP79/150. The SH3 and GK regions of the MAGUKs mediate binding to the AKAP. Cell-based studies indicate that phosphorylation of AMPA receptors is enhanced by a SAP97-AKAP79 complex that directs PKA to GluR1 via a PDZ domain interaction. As AMPA receptor phosphorylation is implicated in regulating synaptic plasticity, these data suggest that a MAGUK-AKAP complex may be centrally involved.	Oregon Hlth & Sci Univ, Vollum Inst, Howard Hughes Med Inst, Portland, OR 97201 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Oregon Health & Science University; Howard Hughes Medical Institute; Johns Hopkins University	Scott, JD (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Howard Hughes Med Inst, L474, Portland, OR 97201 USA.	scott@ohsu.edu			NIGMS NIH HHS [GM48231] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048231, R37GM048231] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson JM, 1996, CURR BIOL, V6, P382, DOI 10.1016/S0960-9822(02)00501-8; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; CARR DW, 1992, J BIOL CHEM, V267, P16816; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Dong HL, 1999, ANN NY ACAD SCI, V868, P535, DOI 10.1111/j.1749-6632.1999.tb11323.x; Dunah AW, 1998, MOL PHARMACOL, V53, P429, DOI 10.1124/mol.53.3.429; ERPEL T, 1995, EMBO J, V14, P963, DOI 10.1002/j.1460-2075.1995.tb07077.x; Fanning AS, 1999, CURR OPIN CELL BIOL, V11, P432, DOI 10.1016/S0955-0674(99)80062-3; Faux MC, 1999, BIOCHEM J, V343, P443, DOI 10.1042/0264-6021:3430443; FRASER I, 2000, IN PRESS CURR BIOL; Fraser IDC, 1998, EMBO J, V17, P2261, DOI 10.1093/emboj/17.8.2261; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; GLANTZ SB, 1992, MOL BIOL CELL, V3, P1215, DOI 10.1091/mbc.3.11.1215; GREENGARD P, 1991, SCIENCE, V253, P1135, DOI 10.1126/science.1716001; Hausken ZE, 1998, METH MOL B, V88, P47; HAUSKEN ZE, 1994, J BIOL CHEM, V269, P24245; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Kashishian A, 1998, J BIOL CHEM, V273, P27412, DOI 10.1074/jbc.273.42.27412; KELLER BU, 1992, EMBO J, V11, P891, DOI 10.1002/j.1460-2075.1992.tb05127.x; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Lau LF, 1996, J BIOL CHEM, V271, P21622, DOI 10.1074/jbc.271.35.21622; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; LISMAN J, 1994, TRENDS NEUROSCI, V17, P406, DOI 10.1016/0166-2236(94)90014-0; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; McGee AW, 1999, J BIOL CHEM, V274, P17431, DOI 10.1074/jbc.274.25.17431; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; RUBINO HM, 1989, NEURON, V3, P631, DOI 10.1016/0896-6273(89)90273-0; Sheng M, 1997, BIOESSAYS, V19, P847, DOI 10.1002/bies.950191004; Sheng M, 1999, ANN NY ACAD SCI, V868, P483, DOI 10.1111/j.1749-6632.1999.tb11317.x; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Swope SL, 1999, ADV SEC MESS PHOSPH, V33, P49; VALLEE RB, 1981, J CELL BIOL, V90, P568, DOI 10.1083/jcb.90.3.568; WANG LY, 1991, SCIENCE, V253, P1132, DOI 10.1126/science.1653455; WENTHOLD RJ, 1992, J BIOL CHEM, V267, P501; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; Wyszynski M, 1999, J NEUROSCI, V19, P6528; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2	60	375	382	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	2000	27	1					107	119		10.1016/S0896-6273(00)00013-1	http://dx.doi.org/10.1016/S0896-6273(00)00013-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339XU	10939335	Bronze			2022-12-24	WOS:000088503800014
J	Serizawa, S; Ishii, T; Nakatani, H; Tsuboi, A; Nagawa, F; Asano, M; Sudo, K; Sakagami, J; Sakano, H; Ijiri, T; Matsuda, Y; Suzuki, M; Yamamori, T; Iwakura, Y; Sakano, H				Serizawa, S; Ishii, T; Nakatani, H; Tsuboi, A; Nagawa, F; Asano, M; Sudo, K; Sakagami, J; Sakano, H; Ijiri, T; Matsuda, Y; Suzuki, M; Yamamori, T; Iwakura, Y; Sakano, H			Mutually exclusive expression of odorant receptor transgenes	NATURE NEUROSCIENCE			English	Article							ORGANIZATION; INFORMATION; PROJECTIONS; NEURONS; FAMILY; GENES; MICE; MAP	To study the mutually exclusive expression of odorant receptor (OW) genes, we generated transgenic mice that carried the murine OR gene MOR28. Expression of the transgene and the endogenous MOR28 was distinguished by using two different markers, beta -galactosidase and green fluorescent protein (GFP), respectively. Double staining of the olfactory epithelium revealed that the two genes were rarely expressed simultaneously in individual olfactory neurons. A similar exclusion was also observed between differently tagged but identical transgenes integrated into the same locus of one particular chromosome. Although allelic inactivation has been reported for the choice between the maternal and paternal alleles, this is the first demonstration of mutually exclusive activation among non-allelic OR gene members with identical coding and regulatory sequences. Such an unusual mode of gene expression, monoallelic and mutually exclusive, has previously been shown only for the antigen-receptor genes of the immune system.	Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan; Univ Tokyo, Inst Med Sci, Ctr Med Expt, Tokyo 1088639, Japan; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Hokkaido Univ, Grad Sch Environm Earth Sci, Div Biosci, Lab Cytogenet, Sapporo, Hokkaido 0600810, Japan; Kumamoto Univ, Ctr Anim Resources & Dev, Kumamoto 8620976, Japan; Natl Inst Basic Biol, Div Speciat Mech 1, Okazaki, Aichi 4448585, Japan	University of Tokyo; University of Tokyo; University of California System; University of California Berkeley; Hokkaido University; Kumamoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Sakano, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan.	sakano@mail.ecc.u-tokyo.ac.jp	Yamamori, Tetsuo/N-6536-2015; Iwakura, Yoichiro/E-5457-2011; Tsuboi, Akio/R-6793-2019	Yamamori, Tetsuo/0000-0001-5016-0078; Iwakura, Yoichiro/0000-0002-9934-5775; Tsuboi, Akio/0000-0002-4790-4512; Sakano, Hitomi/0000-0002-7471-8352				Asano M, 1997, EMBO J, V16, P1850, DOI 10.1093/emboj/16.8.1850; Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; BENARIE N, 1994, HUM MOL GENET, V3, P229, DOI 10.1093/hmg/3.2.229; BORST P, 1991, IMMUNOL TODAY, V12, P29; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Bungert J, 1995, GENE DEV, V9, P3083, DOI 10.1101/gad.9.24.3083; CALLAHAN CA, 1994, P NATL ACAD SCI USA, V91, P5972, DOI 10.1073/pnas.91.13.5972; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Ebrahimi FAW, 2000, DEV DYNAM, V217, P225, DOI 10.1002/(SICI)1097-0177(200002)217:2<225::AID-DVDY9>3.0.CO;2-3; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Kraus L, 1998, J PHYS IV, V8, P95, DOI 10.1051/jp4:1998222; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; Qasba P, 1998, J NEUROSCI, V18, P227; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Rouquier S, 1998, NAT GENET, V18, P243, DOI 10.1038/ng0398-243; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; STRATHERN JN, 1982, CELL, V31, P183, DOI 10.1016/0092-8674(82)90418-4; Sullivan SL, 1996, P NATL ACAD SCI USA, V93, P884, DOI 10.1073/pnas.93.2.884; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Tsuboi A, 1999, J NEUROSCI, V19, P8409; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459	33	196	198	1	18	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2000	3	7					687	693		10.1038/76641	http://dx.doi.org/10.1038/76641			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TT	10862701				2022-12-24	WOS:000167177200015
J	Lloyd, TE; Verstreken, P; Ostrin, EJ; Phillippi, A; Lichtarge, O; Bellen, HJ				Lloyd, TE; Verstreken, P; Ostrin, EJ; Phillippi, A; Lichtarge, O; Bellen, HJ			A genome-wide search for synaptic vesicle cycle proteins in Drosophila	NEURON			English	Editorial Material							NEUROTRANSMITTER RELEASE; MEMBRANE-FUSION; EXOCYTOSIS; TRANSMISSION; SECRETION; TRANSPORT; MUTATIONS; COMPLEX	The recent completion of the Drosophila genome sequence opens new avenues for neurobiology research. We screened the fly genome sequence for homologs of mammalian genes implicated directly or indirectly in exocytosis and endocytosis of synaptic vesicles. We identified fly homologs for 93% of the vertebrate genes that were screened. These are on average 60% identical and 74% similar to their vertebrate counterparts. This high degree of conservation suggests that little protein diversification has been tolerated in the evolution of synaptic transmission. Finally, and perhaps most exciting for Drosophila neurobiologists, the genomic sequence allows us to identify P element transposon insertions in or near genes, thereby allowing rapid isolation of mutations in genes of interest. Analysis of the phenotypes of these mutants should accelerate our understanding of the role of numerous proteins implicated in synaptic transmission.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Bellen, HJ (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	hbellen@born.tmc.edu	Verstreken, Patrik/AAC-7591-2022; Philippi, Anne/M-9853-2017	Verstreken, Patrik/0000-0002-5073-5393; Philippi, Anne/0000-0003-2184-6008; Bellen, Hugo/0000-0001-5992-5989; Lloyd, Thomas/0000-0003-4756-3700				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Bean AJ, 1997, NATURE, V385, P826, DOI 10.1038/385826a0; Bellen HJ, 1999, PLANT CELL, V11, P2271, DOI 10.1105/tpc.11.12.2271; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chavrier P, 1999, CURR OPIN CELL BIOL, V11, P466, DOI 10.1016/S0955-0674(99)80067-2; Edwardson JM, 1997, CELL, V90, P325, DOI 10.1016/S0092-8674(00)80340-2; Fernandez-Chacon R, 1999, J BIOL CHEM, V274, P32551, DOI 10.1074/jbc.274.46.32551; Gelbart WM, 1999, NUCLEIC ACIDS RES, V27, P85, DOI 10.1093/nar/27.1.85; Geppert M, 1998, ANNU REV NEUROSCI, V21, P75, DOI 10.1146/annurev.neuro.21.1.75; HARRISON SD, 1994, NEURON, V13, P555, DOI 10.1016/0896-6273(94)90025-6; HAZUKA CD, 1999, FR MOLEC B, V23, P81; Jahn R, 1998, NATURE, V393, P14, DOI 10.1038/29871; Janz R, 1998, J NEUROSCI, V18, P9269; Littleton JT, 1998, NEURON, V21, P401, DOI 10.1016/S0896-6273(00)80549-8; LLOYD TE, 1999, FR MOLEC B, V23, P352; McMahon HT, 1996, P NATL ACAD SCI USA, V93, P4760, DOI 10.1073/pnas.93.10.4760; Mochida S, 2000, NEUROSCI RES, V36, P175, DOI 10.1016/S0168-0102(99)00128-5; NONET ML, 1999, FR MOLEC B, V23, P265; PENNETTA G, 1999, FR MOLEC B, V23, P304; Robinson LJ, 1998, CURR OPIN CELL BIOL, V10, P483, DOI 10.1016/S0955-0674(98)80063-X; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Sakaguchi G, 1999, EUR J NEUROSCI, V11, P4262, DOI 10.1046/j.1460-9568.1999.00855.x; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Spradling AC, 1999, GENETICS, V153, P135; Stowers RS, 1999, GENETICS, V152, P1631; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; ZHANG B, 1999, FR MOLEC B, V23, P389	31	90	96	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	2000	26	1					45	50		10.1016/S0896-6273(00)81136-8	http://dx.doi.org/10.1016/S0896-6273(00)81136-8			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309MA	10798391	Bronze			2022-12-24	WOS:000086770500007
J	Vogt, K; Mellor, J; Tong, G; Nicoll, R				Vogt, K; Mellor, J; Tong, G; Nicoll, R			The actions of synaptically released zinc at hippocampal mossy fiber synapses	NEURON			English	Article							METHYL-D-ASPARTATE; LONG-TERM POTENTIATION; NMDA RECEPTOR; GUINEA-PIG; SELECTIVELY BLOCKS; CORTICAL-NEURONS; INHIBITION; CHANNELS; RESPONSES; MECHANISM	Zn2+ is present at high concentrations in the synaptic Vesicles of hippocampal mossy fibers. We have used Zn2+ chelators and the mocha mutant mouse to address the physiological role of Zn2+ in this pathway. Zn2+ is not involved in the unique presynaptic plasticities observed at mossy fiber synapses but is coreleased with glutamate from these synapses, both spontaneously and with electrical stimulation, where it exerts a strong modulatory effect on the NMDA receptors. Zn2+ tonically occupies the high-affinity binding site of NMDA receptors at mossy fiber synapses, whereas the lower affinity voltage-dependent Zn2+ binding site is occupied during action potential driven-release. We conclude that Zn2+ is a modulatory neurotransmitter released from mossy fiber synapses and plays an important role in shaping the NMDA receptor response at these synapses.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nicoll, R (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	nicoli@phy.ucsf.edu	MELLOR, Jack/B-4548-2019; Tong, Gary/AAC-9426-2022	MELLOR, Jack/0000-0002-7706-8105; Vogt, Kaspar/0000-0002-0859-876X				ANIKSZTEJN L, 1987, BRAIN RES, V404, P58, DOI 10.1016/0006-8993(87)91355-2; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; ATAR D, 1995, J BIOL CHEM, V270, P2473, DOI 10.1074/jbc.270.6.2473; BERS DM, 1994, METHOD CELL BIOL, V40, P3; BREWER GJ, 1979, AM J HEMATOL, V7, P53, DOI 10.1002/ajh.2830070107; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; Chen NS, 1997, MOL PHARMACOL, V51, P1015, DOI 10.1124/mol.51.6.1015; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; COTMAN CW, 1986, J PHYSIOL-LONDON, V378, P403, DOI 10.1113/jphysiol.1986.sp016227; Dawson R. M. C., 1986, DATA BIOCH RES, V3rd; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; FREDERICKSON CJ, 1981, EXP NEUROL, V73, P812, DOI 10.1016/0014-4886(81)90214-4; Fritschy JM, 1998, J COMP NEUROL, V390, P194; GAARSKJAER FB, 1986, BRAIN RES REV, V11, P335, DOI 10.1016/0165-0173(86)90004-4; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; Haugland HP, 1996, HDB FLUORESCENT PROB; HESSE GW, 1979, SCIENCE, V205, P1005, DOI 10.1126/science.224456; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; HUBBARD SR, 1991, SCIENCE, V254, P1776; Kantheti P, 1998, NEURON, V21, P111, DOI 10.1016/S0896-6273(00)80519-X; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; KOH JY, 1994, NEUROSCIENCE, V60, P1049, DOI 10.1016/0306-4522(94)90282-8; LANTHORN TH, 1984, BRAIN RES, V290, P174, DOI 10.1016/0006-8993(84)90750-9; MASKE H, 1955, NATURWISSENSCHAFTEN, V42, P424, DOI 10.1007/BF00601955; MCLARDY T, 1962, NATURE, V194, P300, DOI 10.1038/194300a0; MONAGHAN DT, 1985, J NEUROSCI, V5, P2909; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Paoletti P, 1997, J NEUROSCI, V17, P5711; Park JA, 1999, J NEUROCHEM, V73, P450, DOI 10.1046/j.1471-4159.1999.0730450.x; PEARSON RG, 1973, COORD CHEM, V2, P175; PETERS S, 1987, SCIENCE, V236, P589, DOI 10.1126/science.2883728; REGEHR WG, 1994, J NEUROSCI, V14, P523; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; SEGAL MM, 1990, J NEUROPHYSIOL, V64, P1390, DOI 10.1152/jn.1990.64.5.1390; Shumilla JA, 1998, ARCH BIOCHEM BIOPHYS, V349, P356, DOI 10.1006/abbi.1997.0470; SMART TG, 1994, PROG NEUROBIOL, V42, P393, DOI 10.1016/0301-0082(94)90082-5; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; Tong G, 1996, NEURON, V16, P1147, DOI 10.1016/S0896-6273(00)80141-5; Traynelis SF, 1998, J NEUROSCI, V18, P6163; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; WEISS JH, 1993, NEURON, V10, P43, DOI 10.1016/0896-6273(93)90240-R; WEISSKOPF MG, 1995, NATURE, V376, P256, DOI 10.1038/376256a0; Wenzel HJ, 1997, P NATL ACAD SCI USA, V94, P12676, DOI 10.1073/pnas.94.23.12676; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; Williams K, 1996, NEUROSCI LETT, V215, P9, DOI 10.1016/S0304-3940(96)12924-4; Wu SL, 1997, INORG CHEM, V36, P1884, DOI 10.1021/ic960649y; Yang RB, 1999, J NEUROSCI, V19, P5889, DOI 10.1523/JNEUROSCI.19-14-05889.1999; Yin HZ, 1995, NEUROREPORT, V6, P2553, DOI 10.1097/00001756-199512150-00025; Zheng F, 1998, NAT NEUROSCI, V1, P185, DOI 10.1038/634; ZIMMER J, 1978, J COMP NEUROL, V179, P581, DOI 10.1002/cne.901790309	51	380	387	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	2000	26	1					187	196		10.1016/S0896-6273(00)81149-6	http://dx.doi.org/10.1016/S0896-6273(00)81149-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309MA	10798403	Bronze			2022-12-24	WOS:000086770500019
J	Talley, EM; Lei, QB; Sirois, JE; Bayliss, DA				Talley, EM; Lei, QB; Sirois, JE; Bayliss, DA			TASK-1, a two-pore domain K+ channel, is modulated by multiple neurotransmitters in motoneurons	NEURON			English	Article							THYROTROPIN-RELEASING-HORMONE; RAT HYPOGLOSSAL MOTONEURONS; RECTIFIER POTASSIUM CHANNEL; CENTRAL-NERVOUS-SYSTEM; FACIAL MOTONEURONS; G-PROTEINS; IN-VITRO; IONIC MECHANISMS; SUBSTANCE-P; RESPIRATORY MOTONEURONS	Inhibition of "leak" potassium (K+) channels is a widespread CNS mechanism by which transmitters induce slow excitation. We show that TASK-1, a two pore domain K+ channel, provides a prominent leak K+ current and target for neurotransmitter modulation in hypoglossal motoneurons (HMs). TASK-1 mRNA is present at high levels in motoneurons, including HMs, which express a K+ current with pH- and voltage-dependent properties virtually identical to those of the cloned channel. This pH-sensitive K+ channel was fully inhibited by serotonin, norepinephrine, substance P, thyrotropin-releasing hormone, and 3,5-dihydroxy-phenylglycine, a group I metabotropic glutamate receptor agonist. The neurotransmitter effect was entirely reconstituted in HEK 293 cells coexpressing TASK-1 and the TRH-R1 receptor. Given its expression patterns and the widespread prevalence of this neuromodulatory mechanism, TASK-1 also likely supports this action in other CNS neurons.	Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA	University of Virginia	Talley, EM (corresponding author), Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL010271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH012091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033583, R29NS033583] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL10271] Funding Source: Medline; NIMH NIH HHS [MH12091] Funding Source: Medline; NINDS NIH HHS [R01 NS033583, NS33583] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGHAJANIAN GK, 1990, BRAIN RES, V524, P171, DOI 10.1016/0006-8993(90)90509-A; AXELROD J, 1995, TRENDS NEUROSCI, V18, P64; BAYLISS DA, 1992, J NEUROPHYSIOL, V68, P1733, DOI 10.1152/jn.1992.68.5.1733; BAYLISS DA, 1994, J NEUROPHYSIOL, V71, P119, DOI 10.1152/jn.1994.71.1.119; BAYLISS DA, 1994, BRAIN RES, V668, P220, DOI 10.1016/0006-8993(94)90527-4; BENSON DM, 1988, J PHYSIOL-LONDON, V404, P479, DOI 10.1113/jphysiol.1988.sp017301; BROWN LD, 1993, BRAIN RES, V612, P200, DOI 10.1016/0006-8993(93)91661-B; CAULFIELD MP, 1994, J PHYSIOL-LONDON, V477, P415, DOI 10.1113/jphysiol.1994.sp020203; Chavez RA, 1999, J BIOL CHEM, V274, P7887, DOI 10.1074/jbc.274.12.7887; CHESLER M, 1994, J NEUROSCI METH, V53, P129, DOI 10.1016/0165-0270(94)90169-4; COULTER KL, 1995, NEURON, V15, P1157, DOI 10.1016/0896-6273(95)90103-5; Cowan AI, 1995, J NEUROPHYSIOL, V74, P2713, DOI 10.1152/jn.1995.74.6.2713; Cruzblanca H, 1998, P NATL ACAD SCI USA, V95, P7151, DOI 10.1073/pnas.95.12.7151; DEL N, 1998, J NEUROSCI, V18, P9216; del Rio E, 1999, J PHYSIOL-LONDON, V520, P101, DOI 10.1111/j.1469-7793.1999.00101.x; Dong XW, 1996, J NEUROSCI, V16, P4971; Dong XW, 1999, J NEUROSCI, V19, P5173; DOUPNIK CA, 1995, CURR OPIN NEUROBIOL, V5, P268, DOI 10.1016/0959-4388(95)80038-7; Fink M, 1998, EMBO J, V17, P3297, DOI 10.1093/emboj/17.12.3297; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; FISHER ND, 1993, EUR J NEUROSCI, V5, P1360, DOI 10.1111/j.1460-9568.1993.tb00922.x; FISHER ND, 1994, NEUROSCI LETT, V165, P84, DOI 10.1016/0304-3940(94)90715-3; FISHER ND, 1993, NEUROSCI LETT, V153, P115, DOI 10.1016/0304-3940(93)90090-8; GUERINEAU NC, 1994, J PHYSIOL-LONDON, V474, P27, DOI 10.1113/jphysiol.1994.sp019999; HADDAD GG, 1993, PROG NEUROBIOL, V40, P277, DOI 10.1016/0301-0082(93)90014-J; Hille B., 1992, IONIC CHANNELS EXCIT; Hsiao CF, 1997, J NEUROPHYSIOL, V77, P2910, DOI 10.1152/jn.1997.77.6.2910; JODKOWSKI JS, 1986, BRAIN RES, V386, P296, DOI 10.1016/0006-8993(86)90166-6; Kaila Kai, 1998, P3; Karschin C, 1996, J NEUROSCI, V16, P3559; Kim D, 1998, CIRC RES, V82, P513, DOI 10.1161/01.RES.82.4.513; LARKMAN PM, 1992, J PHYSIOL-LONDON, V456, P473, DOI 10.1113/jphysiol.1992.sp019347; Larkman PM, 1998, J PHYSIOL-LONDON, V508, P67, DOI 10.1111/j.1469-7793.1998.067br.x; LEE SB, 1995, CURR OPIN CELL BIOL, V7, P183, DOI 10.1016/0955-0674(95)80026-3; Leonoudakis D, 1998, J NEUROSCI, V18, P868; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; Li YW, 1996, CIRC RES, V78, P274, DOI 10.1161/01.RES.78.2.274; Marrion NV, 1997, ANNU REV PHYSIOL, V59, P483, DOI 10.1146/annurev.physiol.59.1.483; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; Munsch T, 1999, J PHYSIOL-LONDON, V519, P493, DOI 10.1111/j.1469-7793.1999.0493m.x; Nattie E., 1995, REGULATION BREATHING, P473; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; PAN ZZ, 1994, J PHYSIOL-LONDON, V478, P437, DOI 10.1113/jphysiol.1994.sp020263; PARKIS MA, 1995, J NEUROPHYSIOL, V74, P1911, DOI 10.1152/jn.1995.74.5.1911; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Pierrefiche O, 1997, J PHYSIOL-LONDON, V505, P785, DOI 10.1111/j.1469-7793.1997.785ba.x; RASMUSSEN K, 1990, SYNAPSE, V5, P324, DOI 10.1002/syn.890050409; REKLING JC, 1990, BRAIN RES, V510, P175, DOI 10.1016/0006-8993(90)90749-2; Reyes R, 1998, J BIOL CHEM, V273, P30863, DOI 10.1074/jbc.273.47.30863; Schramm WW, 1997, BRIT J ANAESTH, V78, P342; SEROOGY KB, 1997, NEUROCHEMISTRY PRACT; SHEN KZ, 1992, NEUROSCIENCE, V50, P345, DOI 10.1016/0306-4522(92)90428-5; SHEN KZ, 1993, J PHYSIOL-LONDON, V462, P483, DOI 10.1113/jphysiol.1993.sp019565; Sirois JE, 1998, J PHYSIOL-LONDON, V512, P851, DOI 10.1111/j.1469-7793.1998.851bd.x; STRAUB RE, 1990, P NATL ACAD SCI USA, V87, P9514, DOI 10.1073/pnas.87.24.9514; Talley EM, 1999, J NEUROSCI, V19, P1895; Tombaugh Geoffrey C., 1998, P395; Topert C, 1998, J NEUROSCI, V18, P4096; Traynelis Stephen F., 1998, P417; VIANA F, 1990, NEUROSCIENCE, V38, P829, DOI 10.1016/0306-4522(90)90075-F; VOIPIO J, 1993, PFLUG ARCH EUR J PHY, V423, P193, DOI 10.1007/BF00374394; Voipio J, 1997, J PHYSIOL-LONDON, V499, P527, DOI 10.1113/jphysiol.1997.sp021946; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; ZABAVNIK J, 1993, NEUROSCIENCE, V53, P877, DOI 10.1016/0306-4522(93)90632-P	65	347	353	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	2000	25	2					399	410		10.1016/S0896-6273(00)80903-4	http://dx.doi.org/10.1016/S0896-6273(00)80903-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	288EL	10719894	Bronze			2022-12-24	WOS:000085549100017
J	Poliak, S; Gollan, L; Martinez, R; Custer, A; Einheber, S; Salzer, JL; Trimmer, JS; Shrager, P; Peles, E				Poliak, S; Gollan, L; Martinez, R; Custer, A; Einheber, S; Salzer, JL; Trimmer, JS; Shrager, P; Peles, E			Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels	NEURON			English	Article							CELL-SURFACE PROTEINS; SODIUM-CHANNELS; SEPTATE JUNCTION; BETA-NEUREXINS; NODE; RANVIER; DOMAIN; ALPHA; RECEPTOR; BINDING	Rapid conduction in myelinated axons depends on the generation of specialized subcellular domains to which different sets of ion channels are localized. Here, we describe the identification of Caspr2, a mammalian homolog of Drosophila Neurexin IV (Nrx-IV), and show that this neurexin-like protein and the closely related molecule Caspr/Paranodin demarcate distinct subdomains in myelinated axons. While contactin-associated protein (Caspr) is present at the paranodal junctions, Caspr2 is precisely colocalized with Shaker-like K+ channels in the juxtaparanodal region. We further show that Caspr2 specifically associates with Kv1.1, Kv1.2, and their Kv beta 2 subunit. This association involves the C-terminal sequence of Caspr2, which contains a putative PDZ binding site. These results suggest a role for Caspr family members in the local differentiation of the axon into distinct functional subdomains.	NYU Med Ctr, Dept Cell Biol & Neurol, New York, NY 10016 USA; SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; Univ Rochester, Med Ctr, Dept Neurobiol & Anat, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Grad Program Neurosci, Rochester, NY 14642 USA; SUGEN Inc, San Francisco, CA 94080 USA; Weizmann Inst Sci, Dept Mol & Cell Biol, IL-76100 Rehovot, Israel	New York University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Rochester; University of Rochester; Pfizer; Weizmann Institute of Science	Peles, E (corresponding author), NYU Med Ctr, Dept Cell Biol & Neurol, New York, NY 10016 USA.	peles@wiccmail.weizmann.ac.il		Salzer, James/0000-0001-9126-7197; Peles, Elior/0000-0002-3325-0597	NINDS NIH HHS [NS38208, NS17965, NS34383] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038208, R37NS034383, R01NS017965, R01NS034383] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; BekeleArcuri Z, 1996, NEUROPHARMACOLOGY, V35, P851, DOI 10.1016/0028-3908(96)00128-1; Bellen HJ, 1998, TRENDS NEUROSCI, V21, P444, DOI 10.1016/S0166-2236(98)01267-3; Berthold Claes-Henric, 1995, P13; Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; DUGANDZIJANOVAKOVIC S, 1995, J NEUROSCI, V15, P492; Einheber S, 1996, J COMP NEUROL, V370, P105; Einheber S, 1997, J CELL BIOL, V139, P1495, DOI 10.1083/jcb.139.6.1495; ELLISMAN MH, 1984, NODE RANVIER, P154; Gatzinsky KP, 1996, MICROSC RES TECHNIQ, V34, P492, DOI 10.1002/(SICI)1097-0029(19960815)34:6<492::AID-JEMT2>3.0.CO;2-M; HILDEBRAND C, 1993, PROG NEUROBIOL, V40, P319, DOI 10.1016/0301-0082(93)90015-K; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; JOE EH, 1992, NATURE, V356, P333, DOI 10.1038/356333a0; Kaplan MR, 1997, NATURE, V386, P724, DOI 10.1038/386724a0; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Lambert S, 1997, J NEUROSCI, V17, P7025; Littleton JT, 1997, J CELL BIOL, V137, P793, DOI 10.1083/jcb.137.4.793; Marfatia SM, 1997, J BIOL CHEM, V272, P24191, DOI 10.1074/jbc.272.39.24191; Menegoz M, 1997, NEURON, V19, P319, DOI 10.1016/S0896-6273(00)80942-3; Milner TA, 1998, J COMP NEUROL, V395, P310; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; PELES E, 1995, CELL, V82, P251, DOI 10.1016/0092-8674(95)90312-7; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; Petrenko AG, 1996, J NEUROSCI, V16, P4360; Rasband M, 1998, J NEUROSCI, V18, P36; Rasband MN, 1999, J NEUROSCI, V19, P7516, DOI 10.1523/JNEUROSCI.19-17-07516.1999; Rhodes KJ, 1997, J NEUROSCI, V17, P8246; ROSENBLUTH J, 1984, NODE RANVIER, P31; ROSENBLUTH J, 1995, GLIAL MEMBRANES AXOG, P613; Salzer JL, 1997, NEURON, V18, P843, DOI 10.1016/S0896-6273(00)80323-2; Scherer SS, 1996, MICROSC RES TECHNIQ, V34, P452, DOI 10.1002/(SICI)1097-0029(19960801)34:5<452::AID-JEMT5>3.0.CO;2-O; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; Sugita S, 1999, NEURON, V22, P489, DOI 10.1016/S0896-6273(00)80704-7; SUZUKI M, 1994, GLIA, V12, P294, DOI 10.1002/glia.440120406; TAOCHENG JH, 1982, DEV BRAIN RES, V3, P577, DOI 10.1016/0165-3806(82)90055-4; TAOCHENG JH, 1984, BRAIN RES, V308, P289, DOI 10.1016/0006-8993(84)91068-0; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1994, J BIOL CHEM, V269, P11987; USHKARYOV YA, 1993, P NATL ACAD SCI USA, V90, P6410, DOI 10.1073/pnas.90.14.6410; Vabnick I, 1996, J NEUROSCI, V16, P4914; Vabnick I, 1999, J NEUROSCI, V19, P747; Wang H, 1995, NEURON, V15, P1337, DOI 10.1016/0896-6273(95)90012-8; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; Ward RE, 1998, J CELL BIOL, V140, P1463, DOI 10.1083/jcb.140.6.1463; WAXMAN SG, 1993, ANN NEUROL, V33, P121, DOI 10.1002/ana.410330202; Waxman SG, 1997, CURR BIOL, V7, pR406, DOI 10.1016/S0960-9822(06)00203-X; Yuan LL, 1999, SCIENCE, V283, P1343, DOI 10.1126/science.283.5406.1343; Zhou L, 1998, J NEUROSCI, V18, P7200; Zimmermann H, 1996, MICROSC RES TECHNIQ, V34, P462, DOI 10.1002/(SICI)1097-0029(19960801)34:5<462::AID-JEMT6>3.0.CO;2-O; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1	53	379	390	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1999	24	4					1037	1047		10.1016/S0896-6273(00)81049-1	http://dx.doi.org/10.1016/S0896-6273(00)81049-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	269UE	10624965	Bronze			2022-12-24	WOS:000084495300030
J	Fiez, JA; Balota, DA; Raichle, ME; Petersen, SE				Fiez, JA; Balota, DA; Raichle, ME; Petersen, SE			Effects of lexicality, frequency, and spelling-to-sound consistency on the functional anatomy of reading	NEURON			English	Article							POSITRON-EMISSION TOMOGRAPHY; VISUAL WORD-RECOGNITION; INFERIOR PREFRONTAL CORTEX; PHONOLOGICAL ALEXIA; WORKING-MEMORY; PET IMAGES; BLOOD-FLOW; ACCESS; BRAIN; TASK	Functional neuroimaging was used to investigate three factors that affect reading performance: first, whether a stimulus is a word or pronounceable nonword (lexicality), second, how often a word is encountered (frequency), and third, whether the pronunciation has a predictable spelling-to-sound correspondence (consistency). Comparisons between word naming (reading) and visual fixation scans revealed stimulus-related activation differences in seven regions. A left frontal region showed effects of consistency and lexicality, indicating a role in orthographic to phonological transformation. Motor cortex showed an effect of consistency bilaterally, suggesting that motoric processes beyond high-level representations of word phonology influence reading performance. Implications for the integration of these results into theoretical models of word reading are discussed.	Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15260 USA; Washington Univ, Sch Med, Dept Neurol & Neurol Surg, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; Washington Univ, Dept Psychol, St Louis, MO 63110 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Fiez, JA (corresponding author), Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA.		Petersen, Steve/ABF-1368-2020		NEI NIH HHS [EY08775] Funding Source: Medline; NHLBI NIH HHS [HL13851] Funding Source: Medline; NINDS NIH HHS [NS06833] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008775] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL013851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS006833, P50NS006833] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDREWS S, 1982, MEM COGNITION, V10, P565, DOI 10.3758/BF03202439; Balota DA, 1996, NEUROPSYCHOLOGY, V10, P82, DOI 10.1037/0894-4105.10.1.82; BALOTA DA, 1985, J MEM LANG, V24, P89, DOI 10.1016/0749-596X(85)90017-8; BALOTA DA, 1984, J EXP PSYCHOL HUMAN, V10, P340, DOI 10.1037/0096-1523.10.3.340; BENSON DF, 1979, APHASIA ALEXIA AGRAP; BESNER D, 1992, J EXP PSYCHOL LEARN, V18, P468, DOI 10.1037/0278-7393.18.3.468; BESNER D, 1999, IN PRESS CONVERGING; Buckner RL, 1996, J NEUROSCI, V16, P6219; COLTHEART M, 1993, PSYCHOL REV, V100, P589, DOI 10.1037/0033-295X.100.4.589; COLTHEART M, 1983, Q J EXP PSYCHOL-A, V35, P469, DOI 10.1080/14640748308402483; COLTHEART V, 1993, MEM COGNITION, V21, P539, DOI 10.3758/BF03197185; DEMB JB, 1995, J NEUROSCI, V15, P5870; Farah MJ, 1996, COGNITIVE NEUROPSYCH, V13, P849, DOI 10.1080/026432996381836; Fiez JA, 1998, P NATL ACAD SCI USA, V95, P914, DOI 10.1073/pnas.95.3.914; Fiez JA, 1996, J NEUROSCI, V16, P808; FIEZ JA, 1995, J COGNITIVE NEUROSCI, V7, P357, DOI 10.1162/jocn.1995.7.3.357; Fiez JA, 1997, HUM BRAIN MAPP, V5, P79, DOI 10.1002/(SICI)1097-0193(1997)5:2<79::AID-HBM1>3.3.CO;2-M; FORSTER KI, 1973, J VERB LEARN VERB BE, V12, P627, DOI 10.1016/S0022-5371(73)80042-8; FOX PT, 1985, J COMPUT ASSIST TOMO, V9, P141, DOI 10.1097/00004728-198501000-00025; FOX PT, 1989, J NUCL MED, V30, P141; FOX PT, 1988, J CEREBR BLOOD F MET, V8, P642, DOI 10.1038/jcbfm.1988.111; FOX PT, 1987, J NEUROSCI, V7, P913; FREDERIKSEN JR, 1976, J EXP PSYCHOL HUMAN, V2, P361, DOI 10.1037/0096-1523.2.3.361; GLUSHKO RJ, 1979, J EXP PSYCHOL HUMAN, V5, P674, DOI 10.1037/0096-1523.5.4.674; HAGOORT P, 1999, IN PRESS J COGN NEUR; Herbster AN, 1997, HUM BRAIN MAPP, V5, P84, DOI 10.1002/(SICI)1097-0193(1997)5:2<84::AID-HBM2>3.0.CO;2-I; HERSCOVITCH P, 1983, J NUCL MED, V24, P782; Hunton DL, 1996, HUM BRAIN MAPP, V4, P122, DOI 10.1002/(SICI)1097-0193(1996)4:2<122::AID-HBM4>3.0.CO;2-5; INHOFF AW, 1994, J MEM LANG, V33, P689, DOI 10.1006/jmla.1994.1033; Jared D, 1997, J MEM LANG, V36, P505, DOI 10.1006/jmla.1997.2496; JESCHENIAK JD, 1994, J EXP PSYCHOL LEARN, V20, P824, DOI 10.1037/0278-7393.20.4.824; Jonides J, 1998, J NEUROSCI, V18, P5026; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; KUCERA H, 1967, COMPUTATIONAL ANAL D; LEVELT WJM, 1994, COGNITION, V50, P239, DOI 10.1016/0010-0277(94)90030-2; MARCEL AJ, 1980, DEEP DYSLEXIA, P227; Marshall, 1980, DEEP DYSLEXIA, P91; MARSHALL JC, 1973, J PSYCHOLINGUIST RES, V2, P175, DOI 10.1007/BF01067101; MCQUADE DV, 1981, LANG SPEECH, V24, P99, DOI 10.1177/002383098102400107; MEYER DE, 1974, MEM COGNITION, V2, P309, DOI 10.3758/BF03209002; MINTUN MA, 1989, J CEREBR BLOOD F MET, V9, P96, DOI 10.1038/jcbfm.1989.13; MISH F, 1996, WEBSTERS 9 NEW COLLE; MONSELL S, 1992, J EXP PSYCHOL LEARN, V18, P452, DOI 10.1037/0278-7393.18.3.452; Patterson K, 1996, COGNITIVE NEUROPSYCH, V13, P803, DOI 10.1080/026432996381818; Patterson K., 1992, ANAL APPROACHES HUMA, P259; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Petersen S E, 1989, J Cogn Neurosci, V1, P153, DOI 10.1162/jocn.1989.1.2.153; Plaut DC, 1996, PSYCHOL REV, V103, P56, DOI 10.1037/0033-295X.103.1.56; Pugh KR, 1997, J EXP PSYCHOL HUMAN, V23, P299, DOI 10.1037/0096-1523.23.2.299; RACZKOWSKI D, 1974, NEUROPSYCHOLOGIA, V12, P43, DOI 10.1016/0028-3932(74)90025-6; Rumsey JM, 1997, BRAIN, V120, P739, DOI 10.1093/brain/120.5.739; Sasanuma S, 1996, COGNITIVE NEUROPSYCH, V13, P823, DOI 10.1080/026432996381827; SCARBOROUGH DL, 1977, J EXP PSYCHOL HUMAN, V3, P1, DOI 10.1037/0096-1523.3.1.1; SEIDENBERG MS, 1989, PSYCHOL REV, V96, P523, DOI 10.1037/0033-295X.96.4.523; SEIDENBERG MS, 1984, MEM COGNITION, V12, P315, DOI 10.3758/BF03198291; Seidenberg MS, 1996, J EXP PSYCHOL LEARN, V22, P48, DOI 10.1037/0278-7393.22.1.48; SHULMAN GL, 1997, CEREB CORTEX, V7, P1047; Taft M, 1998, J MEM LANG, V38, P203, DOI 10.1006/jmla.1997.2538; TALAIRACH J, 1988, COPLANAR STEEOTAXIC; TARABAN R, 1987, J MEM LANG, V26, P608, DOI 10.1016/0749-596X(87)90105-7; TERPOGOSSIAN MM, 1982, J COMPUT ASSIST TOMO, V6, P125, DOI 10.1097/00004728-198202000-00021; VENEZKY R, 1970, STRUCTURE ENGLISH OR; WELCH MJ, 1985, J LABELLED COMPD RAD, V22, P1193, DOI 10.1002/jlcr.2580221114; YAMAMOTO M, 1982, IEEE T NUCL SCI, V29, P529, DOI 10.1109/TNS.1982.4335901; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767	65	315	323	0	24	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	1999	24	1					205	218		10.1016/S0896-6273(00)80833-8	http://dx.doi.org/10.1016/S0896-6273(00)80833-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	241QC	10677038	Bronze			2022-12-24	WOS:000082893200020
J	Majercak, J; Sidote, D; Hardin, PE; Edery, I				Majercak, J; Sidote, D; Hardin, PE; Edery, I			How a circadian clock adapts to seasonal decreases in temperature and day length	NEURON			English	Article							PERIOD GENE-EXPRESSION; MESSENGER-RNA LEVELS; DROSOPHILA CLOCK; BEHAVIORAL RHYTHMS; DISCONNECTED MUTANTS; TIMELESS PROTEIN; 3'-END FORMATION; FEEDBACK LOOP; DARK CYCLES; TIM COMPLEX	We show that a thermosensitive splicing event in the 3' untranslated region of the mRNA from the period (per) gene plays an important role in how a circadian clock in Drosophila adapts to seasonally cold days (low temperatures and short day lengths). The enhanced splicing of this intron at low temperatures advances the steady state phases of the per mRNA and protein cycles, events that significantly contribute to the preferential daytime activity of flies on cold days. Because the accumulation of PER is also dependent on the photosensitive TIMELESS (TIM) protein, long photoperiods partially counteract the cold-induced advances in the oscillatory mechanism by delaying the daily increases in the levels of TIM. Our findings also indicate that there is a temperature-dependent switch in the molecular logic governing cycles in per mRNA levels.	Rutgers State Univ, Grad Program Biochem, Piscataway, NJ 08854 USA; Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Houston System; University of Houston	Edery, I (corresponding author), Rutgers State Univ, Grad Program Biochem, Piscataway, NJ 08854 USA.		Sidote, David/B-2666-2009	Hardin, Paul/0000-0002-3370-9011				Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Cheng YZ, 1998, MOL CELL BIOL, V18, P6505, DOI 10.1128/MCB.18.11.6505; CROSTHWAITE SK, 1995, CELL, V81, P1003, DOI 10.1016/S0092-8674(05)80005-4; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Edery I, 1999, CHRONOBIOL INT, V16, P377, DOI 10.3109/07420529908998716; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; EWER J, 1992, J NEUROSCI, V12, P3321; EWER J, 1990, J NEUROGENET, V7, P31, DOI 10.3109/01677069009084151; FRISCH B, 1994, NEURON, V12, P555, DOI 10.1016/0896-6273(94)90212-7; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; GEKAKIS N, 1995, SCIENCE, V270, P811, DOI 10.1126/science.270.5237.811; GREEN MR, 1986, ANNU REV GENET, V20, P671, DOI 10.1146/annurev.ge.20.120186.003323; Hall JC, 1998, ADV GENET, V38, P135, DOI 10.1016/S0065-2660(08)60143-1; HAMBLENCOYLE MJ, 1992, J INSECT BEHAV, V5, P417, DOI 10.1007/BF01058189; HANDLER AM, 1979, NATURE, V279, P236, DOI 10.1038/279236a0; Hao HP, 1999, J NEUROSCI, V19, P987; Hao HP, 1997, MOL CELL BIOL, V17, P3687, DOI 10.1128/MCB.17.7.3687; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; HARDIN PE, 1992, EMBO J, V11, P1; Hardin PE, 1998, CURR OPIN NEUROBIOL, V8, P642, DOI 10.1016/S0959-4388(98)80093-7; HARDIN PE, 1992, P NATL ACAD SCI USA, V89, P11711, DOI 10.1073/pnas.89.24.11711; HECKROTTE CARLTON, 1962, ANIMAL BEHAVIOUR, V10, P193, DOI 10.1016/0003-3472(62)90038-6; Helfrich-Forster C, 1998, J COMP PHYSIOL A, V182, P435, DOI 10.1007/s003590050192; HUANG ZJ, 1995, SCIENCE, V267, P1169, DOI 10.1126/science.7855598; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; JACKSON RJ, 1993, CELL, V74, P9, DOI 10.1016/0092-8674(93)90290-7; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Lee C, 1999, MOL CELL BIOL, V19, P5316; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Liu Y, 1998, SCIENCE, V281, P825, DOI 10.1126/science.281.5378.825; Liu Y., 1997, CELL, V89, P1; Marrus SB, 1996, EMBO J, V15, P6877, DOI 10.1002/j.1460-2075.1996.tb01080.x; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; NESIC D, 1995, MOL CELL BIOL, V15, P488, DOI 10.1128/MCB.15.1.488; NESIC D, 1994, GENE DEV, V8, P363, DOI 10.1101/gad.8.3.363; PITTENDRIGH CS, 1954, P NATL ACAD SCI USA, V40, P1018, DOI 10.1073/pnas.40.10.1018; PRICE JL, 1995, EMBO J, V14, P4044, DOI 10.1002/j.1460-2075.1995.tb00075.x; Qiu J, 1996, MOL CELL BIOL, V16, P4182; Reppert SM, 1998, NEURON, V21, P1, DOI 10.1016/S0896-6273(00)80234-2; Rutila JE, 1996, NEURON, V17, P921, DOI 10.1016/S0896-6273(00)80223-8; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Saez L, 1996, NEURON, V17, P911, DOI 10.1016/S0896-6273(00)80222-6; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Sawyer LA, 1997, SCIENCE, V278, P2117, DOI 10.1126/science.278.5346.2117; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Sidote D, 1998, MOL CELL BIOL, V18, P2004, DOI 10.1128/MCB.18.4.2004; So WV, 1997, EMBO J, V16, P7146, DOI 10.1093/emboj/16.23.7146; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stanewsky R, 1997, EMBO J, V16, P5006, DOI 10.1093/emboj/16.16.5006; Suri V, 1999, EMBO J, V18, P675, DOI 10.1093/emboj/18.3.675; Suri VP, 1998, NEURON, V21, P225, DOI 10.1016/S0896-6273(00)80529-2; SWEENEY BM, 1960, COLD SPRING HARB SYM, V25, P87, DOI 10.1101/SQB.1960.025.01.009; VOSSHALL LB, 1995, NEURON, V15, P345, DOI 10.1016/0896-6273(95)90039-X; VOSSHALL LB, 1994, SCIENCE, V263, P1606, DOI 10.1126/science.8128247; WHEELER DA, 1993, J BIOL RHYTHM, V8, P67, DOI 10.1177/074873049300800106; Yang ZH, 1998, NEURON, V21, P215, DOI 10.1016/S0896-6273(00)80528-0; Young MW, 1998, ANNU REV BIOCHEM, V67, P135, DOI 10.1146/annurev.biochem.67.1.135; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0; Zylka MJ, 1998, NEURON, V21, P1115, DOI 10.1016/S0896-6273(00)80628-5	63	290	295	0	31	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	1999	24	1					219	230		10.1016/S0896-6273(00)80834-X	http://dx.doi.org/10.1016/S0896-6273(00)80834-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241QC	10677039	Bronze			2022-12-24	WOS:000082893200021
J	Barth, AL; Malenka, RC				Barth, AL; Malenka, RC			NMDAR EPSC kinetics do not regulate the critical period for LTP at thalamocortical synapses	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; VISUAL-CORTEX; IN-VIVO; RECEPTORS; EXPERIENCE; EXPRESSION; SUBTYPES		Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Friend Pritzker Lab, Palo Alto, CA 94304 USA	Stanford University	Barth, AL (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Friend Pritzker Lab, 1201 Welch Rd,Room P105, Palo Alto, CA 94304 USA.							CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Fox K, 1999, NAT NEUROSCI, V2, P297, DOI 10.1038/7203; GOLD JI, 1994, P NATL ACAD SCI USA, V91, P3941, DOI 10.1073/pnas.91.9.3941; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Shi J, 1997, J NEUROSCI, V17, P6264; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tovar KR, 1999, J NEUROSCI, V19, P4180; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851	15	147	150	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2001	4	3					235	236		10.1038/85070	http://dx.doi.org/10.1038/85070			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UE	11224537				2022-12-24	WOS:000167178300008
J	Crump, JG; Zhen, M; Jin, Y; Bargmann, CI				Crump, JG; Zhen, M; Jin, Y; Bargmann, CI			The SAD-1 kinase regulates presynaptic vesicle clustering and axon termination	NEURON			English	Article							C-ELEGANS; CAENORHABDITIS-ELEGANS; PROTEIN-KINASE; NEUROMUSCULAR-JUNCTION; CHEMOSENSORY NEURONS; LARVAL DEVELOPMENT; SYNAPTIC VESICLES; CELL-ADHESION; SYNAPSIN-I; S-LAMININ	During synapse formation, presynaptic axon outgrowth is terminated, presynaptic clusters of vesicles are associated with active zone proteins, and active zones are aligned with postsynaptic neurotransmitter receptors. We report here the identification of a novel serine/threonine kinase, SAD-1,that regulates several aspects of presynaptic differentiation in C. elegans. In sad-1 mutant animals presynaptic vesicle clusters in sensory neurons and motor neurons are diffuse and disorganized. Sensory axons fail to terminate in sad-1 mutants, whereas overexpression of SAD-1 causes sensory axons to terminate prematurely. SAD-1 protein is expressed in the nervous system and localizes to synapse-rich regions of the axons. SAD-1 is related to PAR-1, a kinase that regulates cell polarity during asymmetric cell division. Overexpression of SAD-1 causes mislocalization of vesicle proteins to dendrites, suggesting that sad-1 affects axonal-dendritic polarity as well as synaptic development.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif Santa Cruz, Sinsheimer Labs, Dept Biol, Santa Cruz, CA 95064 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California Santa Cruz	Bargmann, CI (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA.	cori@itsa.ucsf.edu	Zhen, Mei/A-4967-2012	Zhen, Mei/0000-0003-0086-9622; Crump, Gage/0000-0002-3209-0026; Jin, Yishi/0000-0002-9371-9860; Bargmann, Cornelia/0000-0002-8484-0618				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; AVERY L, 1993, GENETICS, V134, P454; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; Bohm H, 1997, CURR BIOL, V7, P603, DOI 10.1016/S0960-9822(06)00260-0; BRENNER S, 1974, GENETICS, V77, P71; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CARLING D, 1994, J BIOL CHEM, V269, P11442; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; DREWES G, 1995, J BIOL CHEM, V270, P7679, DOI 10.1074/jbc.270.13.7679; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Grady RM, 2000, NEURON, V25, P279, DOI 10.1016/S0896-6273(00)80894-6; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Hallam SJ, 1998, NATURE, V395, P78, DOI 10.1038/25757; Hosaka M, 1999, NEURON, V24, P377, DOI 10.1016/S0896-6273(00)80851-X; HUANG LS, 1994, MOL BIOL CELL, V5, P395, DOI 10.1091/mbc.5.4.395; Jin YS, 1999, J NEUROSCI, V19, P539; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; LU B, 1992, NEURON, V8, P521, DOI 10.1016/0896-6273(92)90280-Q; Lundquist EA, 1998, NEURON, V21, P385, DOI 10.1016/S0896-6273(00)80547-4; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; Mello C, 1995, METHOD CELL BIOL, V48, P451; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; OGURA K, 1994, GENE DEV, V8, P2389, DOI 10.1101/gad.8.20.2389; OTSUKA AJ, 1991, NEURON, V6, P113, DOI 10.1016/0896-6273(91)90126-K; PARSA I, 1988, CANCER RES, V48, P2265; Peckol EL, 1999, DEVELOPMENT, V126, P1891; Peng CY, 1998, CELL GROWTH DIFFER, V9, P197; PORTER BE, 1995, NEURON, V14, P549, DOI 10.1016/0896-6273(95)90311-9; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sasakura Y, 1998, MECH DEVELOP, V76, P161, DOI 10.1016/S0925-4773(98)00100-2; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schlesinger A, 1999, GENE DEV, V13, P2028, DOI 10.1101/gad.13.15.2028; Serpinskaya AS, 1999, DEV BIOL, V205, P65, DOI 10.1006/dbio.1998.9112; Serra-Pages C, 1998, J BIOL CHEM, V273, P15611, DOI 10.1074/jbc.273.25.15611; Shapiro L, 1999, NEURON, V23, P427, DOI 10.1016/S0896-6273(00)80796-5; Shulman JM, 2000, CELL, V101, P377, DOI 10.1016/S0092-8674(00)80848-X; Suter DM, 1998, CURR OPIN NEUROBIOL, V8, P106, DOI 10.1016/S0959-4388(98)80014-7; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WILLIAMS BD, 1995, METHOD CELL BIOL, V48, P31; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	60	139	161	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	2001	29	1					115	129		10.1016/S0896-6273(01)00184-2	http://dx.doi.org/10.1016/S0896-6273(01)00184-2			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	397NX	11182085	Bronze			2022-12-24	WOS:000166702700013
J	Gais, S; Plihal, W; Wagner, U; Born, J				Gais, S; Plihal, W; Wagner, U; Born, J			Early sleep triggers memory for early visual discrimination skills	NATURE NEUROSCIENCE			English	Article							LATE NOCTURNAL SLEEP; PARADOXICAL SLEEP; REM-SLEEP; CONSOLIDATION; IMPROVEMENT; MODULATION; HYPOTHESIS; CORTEX; STATES	Improvement after practicing visual texture discrimination does not occur until several hours after practice has ended. We show that this improvement strongly depends on sleep. To specify the process responsible for sleep-related improvement, we compared the effects of 'early' and 'late' sleep, dominated respectively by slow-wave and rapid eye movement (REM) sleep. Discrimination skills significantly improved over early sleep, improved even more over a whole night's sleep, but did not improve after late sleep alone. These findings suggest that procedural memory formation is prompted by slow-wave sleep-related processes. Late REM sleep may promote memory formation at a second stage, only after periods of early sleep have occurred.	Med Univ Lubeck, Clin Neuroendocrinol, D-23538 Lubeck, Germany	University of Lubeck	Born, J (corresponding author), Med Univ Lubeck, Clin Neuroendocrinol, Ratzeburger Allee 160-Hs 23A, D-23538 Lubeck, Germany.	born@kfg.mu-luebeck.de	Born, Jan/K-2596-2016	Born, Jan/0000-0002-1847-6248				Aubrey JB, 1999, SLEEP RES ONLINE, V2, P220; BORN J, 1988, PSYCHONEUROENDOCRINO, V13, P233, DOI 10.1016/0306-4530(88)90021-2; BORN J, IN PRESS BEHAV BRAIN; Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; Cahill L, 1996, CURR OPIN NEUROBIOL, V6, P237, DOI 10.1016/S0959-4388(96)80078-X; CIPOLLI C, 1995, J SLEEP RES, V4, P2, DOI 10.1111/j.1365-2869.1995.tb00143.x; Edagawa Y, 1998, PROG NEURO-PSYCHOPH, V22, P983, DOI 10.1016/S0278-5846(98)00055-4; EMPSON JAC, 1970, NATURE, V227, P287, DOI 10.1038/227287a0; GIUDITTA A, 1995, BEHAV BRAIN RES, V69, P157, DOI 10.1016/0166-4328(95)00012-I; Heine R, 1914, Z PSYCHOL PHYSIOL SI, V68, P161; HENNEVIN E, 1995, BEHAV BRAIN RES, V69, P125, DOI 10.1016/0166-4328(95)00013-J; HORNE JA, 1984, BIOL PSYCHOL, V18, P165, DOI 10.1016/0301-0511(84)90001-2; Jenkins JG, 1924, AM J PSYCHOL, V35, P605, DOI 10.2307/1414040; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Kirkwood A, 1999, J NEUROSCI, V19, P1599; MAQUET P, 1999, SLEEP RES ONLINE, V2, P694; Marshall L, 1998, EUR J NEUROSCI, V10, P1167, DOI 10.1046/j.1460-9568.1998.00131.x; MCCORMICK DA, 1992, J CLIN NEUROPHYSIOL, V9, P212, DOI 10.1097/00004691-199204010-00004; McEwen BS, 1999, CONT ENDOCRINOL, V21, P233; Muller G. E., 1900, Z PSYCHOLOGIE, V1, P1; ONIANI TN, 1984, PHYSIOL BEHAV, V33, P687, DOI 10.1016/0031-9384(84)90032-5; PASCUALLEONE A, 1993, ANN NEUROL, V34, P594, DOI 10.1002/ana.410340414; PASCUALLEONE A, 1994, SCIENCE, V263, P1287, DOI 10.1126/science.8122113; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Plihal W, 1999, NEUROREPORT, V10, P2741, DOI 10.1097/00001756-199909090-00009; Plihal W, 1999, PSYCHOPHYSIOLOGY, V36, P571, DOI 10.1111/1469-8986.3650571; Plihal W, 1999, PSYCHONEUROENDOCRINO, V24, P313, DOI 10.1016/S0306-4530(98)00080-8; Roozendaal B, 2000, PSYCHONEUROENDOCRINO, V25, P213, DOI 10.1016/S0306-4530(99)00058-X; Schoups AA, 1996, P NATL ACAD SCI USA, V93, P7358, DOI 10.1073/pnas.93.14.7358; SMITH C, 1995, BEHAV BRAIN RES, V69, P137, DOI 10.1016/0166-4328(95)00024-N; Smith C, 1996, BEHAV BRAIN RES, V78, P49, DOI 10.1016/0166-4328(95)00218-9; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; VERTES P, IN PRESS BEHAV BRAIN; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; YAROUSH R, 1971, J EXP PSYCHOL, V88, P361, DOI 10.1037/h0030914	39	365	373	6	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2000	3	12					1335	1339		10.1038/81881	http://dx.doi.org/10.1038/81881			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	405UA	11100156	Bronze			2022-12-24	WOS:000167177900021
J	Peng, YW; Hao, Y; Petters, RM; Wong, F				Peng, YW; Hao, Y; Petters, RM; Wong, F			Ectopic synaptogenesis in the mammalian retina caused by rod photoreceptor-specific mutations	NATURE NEUROSCIENCE			English	Article							C-LIKE IMMUNOREACTIVITY; BIPOLAR CELLS; MORPHOMETRIC ANALYSIS; HORIZONTAL CELLS; TRANSGENIC MICE; AMACRINE CELLS; OUTER SEGMENTS; ANIMAL-MODEL; MUTANT MICE; RIM PROTEIN	In addition to rod photoreceptor loss, many mutations in rod photoreceptor-specific genes cause degeneration of other neuronal types. Identifying mechanisms of cell-cell interactions initiated by rod-specific mutations and affecting other retinal cells is important for understanding the pathogenesis and progression of retinal degeneration. Here we show in animals with rod and cone degeneration due to mutations in the genes encoding rhodopsin and cGMP phosphodiesterase beta -subunit (PDE-beta) respectively, that rod bipolar cells received ectopic synapses from cones in the absence of rods. Thus, synaptic plasticity links certain rod-specific mutations to retina-wide structural alterations that involve different types of neurons.	Duke Univ, Sch Med, Dept Ophthalmol, Durham, NC 27710 USA; Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA; N Carolina State Univ, Dept Anim Sci, Raleigh, NC 27695 USA; Duke Univ, Sch Med, Dept Pathol, Durham, NC 27710 USA	Duke University; Duke University; University of North Carolina; North Carolina State University; Duke University	Wong, F (corresponding author), Duke Univ, Sch Med, Dept Ophthalmol, Durham, NC 27710 USA.				NATIONAL EYE INSTITUTE [P30EY005722, R01EY011498] Funding Source: NIH RePORTER; NEI NIH HHS [R01EY11498, P30EY05722] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Banin E, 1999, NEURON, V23, P549, DOI 10.1016/S0896-6273(00)80807-7; BERSON EL, 1979, ARCH OPHTHALMOL-CHIC, V97, P1286, DOI 10.1001/archopht.1979.01020020028006; BERSON EL, 1969, ARCH OPHTHALMOL-CHIC, V81, P226; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; BIRD AC, 1995, AM J OPHTHALMOL, V119, P543, DOI 10.1016/S0002-9394(14)70212-0; BLANKS JC, 1974, J COMP NEUROL, V156, P95, DOI 10.1002/cne.901560108; BLANKS JC, 1974, J COMP NEUROL, V156, P81, DOI 10.1002/cne.901560107; Brandstatter JH, 1996, J COMP NEUROL, V370, P1, DOI 10.1002/(SICI)1096-9861(19960617)370:1<1::AID-CNE1>3.0.CO;2-7; Brandstatter JH, 1998, VISION RES, V38, P1385, DOI 10.1016/S0042-6989(97)00176-4; CASINI G, 1995, J COMP NEUROL, V356, P132, DOI 10.1002/cne.903560109; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; CIDECIYAN AV, 1993, INVEST OPHTH VIS SCI, V34, P3253; COWAN WM, 1984, SCIENCE, V225, P1258, DOI 10.1126/science.6474175; Dowling J. E., 1987, RETINA APPROACHABLE; DRYJA TP, 1995, INVEST OPHTH VIS SCI, V36, P1197; FARBER DB, 1994, PROG RETIN EYE RES, V13, P31, DOI 10.1016/1350-9462(94)90004-3; Fariss RN, 2000, AM J OPHTHALMOL, V129, P215, DOI 10.1016/S0002-9394(99)00401-8; Gal A, 1997, PROG RETIN EYE RES, V16, P51, DOI 10.1016/S1350-9462(96)00021-3; GREFERATH U, 1990, J COMP NEUROL, V301, P433, DOI 10.1002/cne.903010308; GRUNERT U, 1994, J COMP NEUROL, V348, P607, DOI 10.1002/cne.903480410; HUANG PC, 1993, P NATL ACAD SCI USA, V90, P8484, DOI 10.1073/pnas.90.18.8484; Humayun MS, 1999, INVEST OPHTH VIS SCI, V40, P143; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; Kedzierski W, 1998, J NEUROSCI, V18, P4076; Lam BL, 1999, OPHTHALMOLOGY, V106, P1109, DOI 10.1016/S0161-6420(99)90263-4; Lewis GP, 1998, INVEST OPHTH VIS SCI, V39, P424; LI ZY, 1995, J NEUROSCI, V15, P5429; LOLLEY RN, 1994, INVEST OPHTH VIS SCI, V35, P358; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; NEGISHI K, 1988, NEUROSCI LETT, V94, P247, DOI 10.1016/0304-3940(88)90025-0; ONG OC, 1995, J BIOL CHEM, V270, P8495, DOI 10.1074/jbc.270.15.8495; PEICHL L, 1984, SCIENCE, V223, P503, DOI 10.1126/science.6691162; Petters RM, 1997, NAT BIOTECHNOL, V15, P965, DOI 10.1038/nbt1097-965; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Rattner A, 1999, ANNU REV GENET, V33, P89, DOI 10.1146/annurev.genet.33.1.89; Santos A, 1997, ARCH OPHTHALMOL-CHIC, V115, P511, DOI 10.1001/archopht.1997.01100150513011; Sharpe LT, 1999, TRENDS NEUROSCI, V22, P497, DOI 10.1016/S0166-2236(99)01458-7; Sieving P A, 1993, Trans Am Ophthalmol Soc, V91, P701; Soucy E, 1998, NEURON, V21, P481, DOI 10.1016/S0896-6273(00)80560-7; STERLING P, 1998, SYNAPTIC ORG BRAIN, P205; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Sun H, 1997, NAT GENET, V17, P15, DOI 10.1038/ng0997-15; Vardi N, 1998, J COMP NEUROL, V395, P43; WASSLE H, 1991, VISUAL NEUROSCI, V7, P99, DOI 10.1017/S095252380001097X; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; WASSLE H, 1993, J COMP NEUROL, V332, P407; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Ying SX, 2000, MOL VIS, V6, P101	49	132	135	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11					1121	1127		10.1038/80639	http://dx.doi.org/10.1038/80639			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TX	11036269				2022-12-24	WOS:000167177600017
J	Sanchez-Vives, MV; McCormick, DA				Sanchez-Vives, MV; McCormick, DA			Cellular and network mechanisms of rhythmic recurrent activity in neocortex	NATURE NEUROSCIENCE			English	Article							CAT VISUAL-CORTEX; MEMBRANE-POTENTIAL FLUCTUATIONS; NEURONS IN-VIVO; CORTICAL RESPONSES; ONGOING ACTIVITY; WORKING-MEMORY; HZ OSCILLATION; NMDA RECEPTORS; ELECTROENCEPHALOGRAM; EXCITABILITY	The neocortex generates periods of recurrent activity, such as the slow (0.1-0.5 Hz) oscillation during slow-wave sleep. Here we demonstrate that slices of ferret neocortex maintained in vitro generate this slow (< 1 Hz) rhythm when placed in a bathing medium that mimics the extracellular ionic composition in situ. This slow oscillation seems to be initiated in layer 5 as an excitatory interaction between pyramidal neurons and propagates through the neocortex. Our results demonstrate that the cerebral cortex generates an 'up' or depolarized state through recurrent excitation that is regulated by inhibitory networks, thereby allowing local cortical circuits to enter into temporarily activated and self-maintained excitatory states. The spontaneous generation and failure of this self-excited state may account for the generation of a subset of cortical rhythms during sleep.	Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06510 USA	Yale University	McCormick, DA (corresponding author), Yale Univ, Sch Med, Neurobiol Sect, 333 Cedar St, New Haven, CT 06510 USA.		Sanchez-Vives, Maria/J-8526-2014; McCormick, David A/J-2649-2015; Kobelt, Liza/F-5926-2011	Sanchez-Vives, Maria/0000-0002-8437-9083; McCormick, David A/0000-0002-9803-8335; 				Achermann P, 1997, NEUROSCIENCE, V81, P213, DOI 10.1016/S0306-4522(97)00186-3; AMZICA F, 1995, J NEUROPHYSIOL, V73, P20, DOI 10.1152/jn.1995.73.1.20; Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; AVOLI M, 1991, ANN NEUROL, V30, P589, DOI 10.1002/ana.410300412; CHAGNACAMITAI Y, 1989, J NEUROPHYSIOL, V61, P747, DOI 10.1152/jn.1989.61.4.747; CONNORS BW, 1984, NATURE, V310, P685, DOI 10.1038/310685a0; Contreras D, 1996, J PHYSIOL-LONDON, V494, P251, DOI 10.1113/jphysiol.1996.sp021488; De No RL, 1938, J NEUROPHYSIOL, V1, P207; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; FOEHRING RC, 1989, J NEUROPHYSIOL, V61, P245, DOI 10.1152/jn.1989.61.2.245; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Haj-Dahmane S, 1998, J NEUROPHYSIOL, V80, P1197, DOI 10.1152/jn.1998.80.3.1197; Hebb Donald O., 1949, ORG BEHAV; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; LEWANDOWSKI MH, 1993, EXP BRAIN RES, V96, P1; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; METHERATE R, 1993, J NEUROSCI, V13, P5312, DOI 10.1523/JNEUROSCI.13-12-05312.1993; MOUNTCASTLE VB, 1987, J NEUROSCI, V7, P2239; Nowak LG, 1997, CEREBR CORT, V12, P205; PHILLIS J W, 1968, Brain Research, V7, P378, DOI 10.1016/0006-8993(68)90004-8; Raman IM, 1999, J NEUROSCI, V19, P1663; Reid RC, 1996, CURR OPIN NEUROBIOL, V6, P475, DOI 10.1016/S0959-4388(96)80052-3; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; SCHWINDT PC, 1989, J NEUROPHYSIOL, V61, P233, DOI 10.1152/jn.1989.61.2.233; SNODDERLY DM, 1995, J NEUROPHYSIOL, V74, P2100, DOI 10.1152/jn.1995.74.5.2100; SOMERS D, 1995, J NEUROSCI, V15, P5449; Staley KJ, 1998, NAT NEUROSCI, V1, P201, DOI 10.1038/651; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1993, J NEUROPHYSIOL, V70, P1385, DOI 10.1152/jn.1993.70.4.1385; STERIADE M, 1995, J NEUROSCI, V15, P623; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stern EA, 1997, J NEUROPHYSIOL, V77, P1697, DOI 10.1152/jn.1997.77.4.1697; Telfeian AE, 1999, EPILEPSIA, V40, P1499, DOI 10.1111/j.1528-1157.1999.tb02032.x; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; Wang XJ, 1999, J NEUROSCI, V19, P9587; YAMAGUCHI T, 1986, Bulletin of Tokyo Medical and Dental University, V33, P1; ZHANG ET, 1990, J CEREBR BLOOD F MET, V10, P136, DOI 10.1038/jcbfm.1990.18	43	1055	1064	0	57	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2000	3	10					1027	1034		10.1038/79848	http://dx.doi.org/10.1038/79848			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TW	11017176				2022-12-24	WOS:000167177500021
J	Wann, JP; Swapp, DK				Wann, JP; Swapp, DK			Why you should look where you are going	NATURE NEUROSCIENCE			English	Article							SELF-MOTION; PERCEPTION; FLOW; DIRECTION		Univ Reading, Dept Psychol, Reading GR6 6AL, Berks, England	University of Reading	Wann, JP (corresponding author), Univ Reading, Dept Psychol, 3 Earley Gate, Reading GR6 6AL, Berks, England.	j.p.wann@rdg.ac.uk		Swapp, David/0000-0002-9335-8663				Crowell JA, 1998, NAT NEUROSCI, V1, P732, DOI 10.1038/3732; GIBSON JJ, 1958, BRIT J PSYCHOL, V49, P182, DOI 10.1111/j.2044-8295.1958.tb00656.x; LAND MF, 1998, VISION ACTION, P163; Lappe M, 1999, TRENDS COGN SCI, V3, P329, DOI 10.1016/S1364-6613(99)01364-9; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; *MOT SAF FDN, 1992, EXP RID COURS; PERRONE JA, 1994, VISION RES, V34, P2917, DOI 10.1016/0042-6989(94)90060-4; ROYDEN CS, 1994, VISION RES, V34, P3215, DOI 10.1016/0042-6989(94)90085-X; ROYDEN CS, 1992, NATURE, V360, P583, DOI 10.1038/360583a0; Rushton SK, 1998, CURR BIOL, V8, P1191, DOI 10.1016/S0960-9822(07)00492-7; WANN JP, 1995, STUD PERCEPT ACTION, V3, P171; Warren WH, 1998, NAT NEUROSCI, V1, P647, DOI 10.1038/3646; WARREN WH, 1988, NATURE, V336, P162, DOI 10.1038/336162a0; WARREN WH, 1991, BIOL CYBERN, V65, P311, DOI 10.1007/BF00216964; 1998, POLICE DRIVERS HDB	15	117	117	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2000	3	7					647	648		10.1038/76602	http://dx.doi.org/10.1038/76602			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TT	10862695				2022-12-24	WOS:000167177200009
J	van den Berg, AV; Beintema, JA				van den Berg, AV; Beintema, JA			The mechanism of interaction between visual flow and eye velocity signals for heading perception	NEURON			English	Article							OPTIC FLOW; SELF-MOTION; GAIN FIELDS; MST NEURONS; CORTEX; MOVEMENTS; TEMPLATES; MODEL	A translating eye receives a radial pattern of motion that is centered on the direction of heading. If the eye is rotating and translating, visual and extraretinal signals help to cancel the rotation and to perceive heading correctly. This involves (1) an interaction between visual and eye movement signals and (2) a motion template stage that analyzes the pattern of visual motion. Early interaction leads to motion templates that integrate head-centered motion signals in the visual field. Integration of retinal motion signals leads to late interaction. Here, we show that retinal flow limits precision of heading. This result argues against an early, vector subtraction type of interaction, but is consistent with a late, gain field type of interaction with eye velocity signals and neurophysiological findings in area MST of the monkey.	Erasmus Univ, Fac Med, Dept Physiol, Helmholtz Sch Autonomous Syst Res, NL-3000 DR Rotterdam, Netherlands	Erasmus University Rotterdam	van den Berg, AV (corresponding author), Erasmus Univ, Fac Med, Dept Physiol, Helmholtz Sch Autonomous Syst Res, POB 1738, NL-3000 DR Rotterdam, Netherlands.	vandenberg@fys.fgg.eur.nl	van den Berg, Albert/G-3108-2012	van den Berg, Albert Victor/0000-0002-1543-5408				ANDERSEN RA, 1990, J NEUROSCI, V10, P1176; Banks MS, 1996, VISION RES, V36, P431, DOI 10.1016/0042-6989(95)00122-0; Beintema JA, 1998, VISION RES, V38, P2155, DOI 10.1016/S0042-6989(97)00428-8; Bradley DC, 1996, SCIENCE, V273, P1544, DOI 10.1126/science.273.5281.1544; Bremmer F, 1997, J NEUROPHYSIOL, V77, P944, DOI 10.1152/jn.1997.77.2.944; Britten KH, 1998, NAT NEUROSCI, V1, P59, DOI 10.1038/259; CROWELL JA, 1993, PERCEPT PSYCHOPHYS, V53, P325, DOI 10.3758/BF03205187; Crowell JA, 1998, NAT NEUROSCI, V1, P732, DOI 10.1038/3732; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; GARDING J, 1995, VISION RES, V35, P703, DOI 10.1016/0042-6989(94)00162-F; GIBSON JJ, 1966, PERCEPTION VISUAL WO; GRAZIANO MSA, 1994, J NEUROSCI, V14, P54; KOENDERINK JJ, 1987, BIOL CYBERN, V56, P247, DOI 10.1007/BF00365219; Lappe M, 1998, NEURAL NETWORKS, V11, P397, DOI 10.1016/S0893-6080(98)00013-6; Lappe M, 1996, J NEUROSCI, V16, P6265; MORRONE MC, 1995, NATURE, V376, P507, DOI 10.1038/376507a0; Page WK, 1999, J NEUROPHYSIOL, V81, P596, DOI 10.1152/jn.1999.81.2.596; PERRONE JA, 1994, VISION RES, V34, P2917, DOI 10.1016/0042-6989(94)90060-4; ROYDEN CS, 1994, VISION RES, V34, P3197, DOI 10.1016/0042-6989(94)90084-1; ROYDEN CS, 1992, NATURE, V360, P583, DOI 10.1038/360583a0; vandenBerg AV, 1997, NEUROREPORT, V8, P835, DOI 10.1097/00001756-199703030-00006; VANDENBERG AV, 1992, VISION RES, V32, P1285, DOI 10.1016/0042-6989(92)90223-6; vandenBerg AV, 1996, VISION RES, V36, P2337, DOI 10.1016/0042-6989(95)00247-2; WARREN WH, 1988, NATURE, V336, P162, DOI 10.1038/336162a0; WURTZ RH, 1990, NEUROSCI IN, P233	25	16	16	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	2000	26	3					747	752		10.1016/S0896-6273(00)81210-6	http://dx.doi.org/10.1016/S0896-6273(00)81210-6			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330ZH	10896169	Bronze			2022-12-24	WOS:000087991600024
J	Bito, H; Furuyashiki, T; Ishihara, H; Shibasaki, Y; Ohashi, K; Mizuno, K; Maekawa, M; Ishizaki, T; Narumiya, S				Bito, H; Furuyashiki, T; Ishihara, H; Shibasaki, Y; Ohashi, K; Mizuno, K; Maekawa, M; Ishizaki, T; Narumiya, S			A critical role for a Rho-associated kinase, p160ROCK, in determining axon outgrowth in mammalian CNS neurons	NEURON			English	Article							CEREBELLAR GRANULE NEURONS; BINDING PROTEIN-RHO; LIM-KINASE; ACTIN CYTOSKELETON; ROK-ALPHA; NEURITE RETRACTION; FAMILY GTPASES; RAC GTPASE; IN-VIVO; GUIDANCE	We tested the contribution of the small GTPase Rho and its downstream target p160ROCK during the early stages of axon formation in cultured cerebellar granule neurons, p160ROCK inhibition, presumably by reducing the stability of the cortical actin network, triggered immediate outgrowth of membrane ruffles and filopodia, followed by the generation of initial growth cone-like membrane domains from which axonal processes arose. Furthermore, a potentiation in both the size and the motility of growth cones was evident, though the overall axon elongation rate remained stable. Conversely, overexpression of dominant active forms of Rho or ROCK was suggested to prevent initiation of axon outgrowth. Taken together, our data indicate a novel role for the Rho/ROCK pathway as a gate critical for the initiation of axon outgrowth and the control of growth cone dynamics.	Kyoto Univ, Fac Med, Dept Pharmacol, Sakyo Ku, Kyoto 6068315, Japan; Univ Tokyo, Grad Sch Med, Dept Metab Dis, Bunkyo Ku, Tokyo 1138655, Japan; Tohoku Univ, Grad Sch Sci, Inst Biol, Sendai, Miyagi 9808578, Japan	Kyoto University; University of Tokyo; Tohoku University	Bito, H (corresponding author), Kyoto Univ, Fac Med, Dept Pharmacol, Sakyo Ku, Kyoto 6068315, Japan.		Furuyashiki, Tomoyuki/B-8760-2014; Ohashi, Kazumasa/U-7028-2019; Mizuno, Kensaku/G-8631-2015; Bito, Haruhiko/A-8635-2008; Furuyashiki, Tomoyuki/AAG-5283-2019	Furuyashiki, Tomoyuki/0000-0001-8089-8399; Ohashi, Kazumasa/0000-0001-7617-403X; Furuyashiki, Tomoyuki/0000-0001-8089-8399; Bito, Haruhiko/0000-0001-6315-9594				Aizawa H, 1997, J CELL SCI, V110, P2333; Albertinazzi C, 1998, J CELL BIOL, V142, P815, DOI 10.1083/jcb.142.3.815; ALTMAN J, 1996, DEV CEREBELLAR SYSTE, P324; Amano M, 1998, GENES CELLS, V3, P177, DOI 10.1046/j.1365-2443.1998.00181.x; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Busca R, 1998, MOL BIOL CELL, V9, P1367, DOI 10.1091/mbc.9.6.1367; Culotti JG, 1996, CURR OPIN NEUROBIOL, V6, P81, DOI 10.1016/S0959-4388(96)80012-2; Dong JM, 1998, J BIOL CHEM, V273, P22554, DOI 10.1074/jbc.273.35.22554; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Frangiskakis JM, 1996, CELL, V86, P59, DOI 10.1016/S0092-8674(00)80077-X; Fujisawa K, 1998, J BIOL CHEM, V273, P18943, DOI 10.1074/jbc.273.30.18943; Gallo G, 1998, CURR BIOL, V8, pR80, DOI 10.1016/S0960-9822(98)70051-X; GAO WQ, 1991, NEURON, V6, P705, DOI 10.1016/0896-6273(91)90168-Y; Goodhill GJ, 1998, TRENDS NEUROSCI, V21, P226, DOI 10.1016/S0166-2236(97)01203-4; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Jin Z, 1997, J NEUROSCI, V17, P6256; Katoh H, 1998, J BIOL CHEM, V273, P2489, DOI 10.1074/jbc.273.5.2489; Kaufmann N, 1998, DEVELOPMENT, V125, P453; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Krendel M, 1999, P NATL ACAD SCI USA, V96, P9666, DOI 10.1073/pnas.96.17.9666; Lamoureux P, 1997, J CELL SCI, V110, P635; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Leung T, 1996, MOL CELL BIOL, V16, P5313; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Lim L, 1996, EUR J BIOCHEM, V242, P171, DOI 10.1111/j.1432-1033.1996.0171r.x; LINDNER J, 1985, NEUROSCI LETT, V55, P145, DOI 10.1016/0304-3940(85)90010-2; Liu JP, 1998, DEVELOPMENT, V125, P5055; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; NAKAYAMA A, 2000, IN PRESS J NEUROSCI; Narumiya S, 1997, FEBS LETT, V410, P68, DOI 10.1016/S0014-5793(97)00317-7; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Powell SK, 1997, J NEUROBIOL, V32, P223, DOI 10.1002/(SICI)1097-4695(199702)32:2<223::AID-NEU7>3.0.CO;2-A; RIVAS RJ, 1995, J NEUROSCI, V15, P981; Ruchhoeft ML, 1999, J NEUROSCI, V19, P8454; Sebok A, 1999, J NEUROCHEM, V73, P949, DOI 10.1046/j.1471-4159.1999.0730949.x; Shibasaki Y, 1997, J BIOL CHEM, V272, P7578, DOI 10.1074/jbc.272.12.7578; Sone M, 1997, SCIENCE, V275, P543, DOI 10.1126/science.275.5299.543; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2; Tassabehji M, 1996, NAT GENET, V13, P272, DOI 10.1038/ng0796-272; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Van Vactor D, 1999, NEURON, V22, P649, DOI 10.1016/S0896-6273(00)80723-0; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zipkin ID, 1997, CELL, V90, P883, DOI 10.1016/S0092-8674(00)80353-0	61	254	264	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	2000	26	2					431	441		10.1016/S0896-6273(00)81175-7	http://dx.doi.org/10.1016/S0896-6273(00)81175-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318QZ	10839361	Bronze			2022-12-24	WOS:000087296500019
J	Emery, P; Stanewsky, R; Helfrich-Forster, C; Emery-Le, M; Hall, JC; Rosbash, M				Emery, P; Stanewsky, R; Helfrich-Forster, C; Emery-Le, M; Hall, JC; Rosbash, M			Drosophila CRY is a deep brain circadian photoreceptor	NEURON			English	Article							PERIOD CLOCK GENE; NERVOUS-SYSTEM; BEHAVIORAL RHYTHMS; LIGHT-ENTRAINMENT; VISUAL-SYSTEM; DARK CYCLES; DOUBLE-TIME; PROTEIN; MELANOGASTER; MUTANTS	cry (cryptochrome) is an important clock gene, and recent data indicate that it encodes a critical circadian photoreceptor in Drosophila. A mutant allele, cry(b), inhibits circadian photoresponses. Restricting CRY expression to specific fly tissues shows that CRY expression is needed in a cell-autonomous fashion for oscillators present in different locations. CRY overexpression in brain pacemaker cells increases behavioral photosensitivity, and this restricted CRY expression also rescues all circadian defects of cryb behavior. As wild-type pacemaker neurons express CRY, the results indicate that they make a striking contribution to all aspects of behavioral circadian rhythms and are directly light responsive. These brain neurons therefore contain an identified deep brain photoreceptor, as well as the other circadian elements: a central pacemaker and a behavioral output system.	Brandeis Univ, Dept Biol, Natl Sci Fdn, Ctr Biol Timing, Waltham, MA 02454 USA; Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02454 USA; Univ Regensburg, Inst Zool, D-93040 Regensburg, Germany; Univ Tubingen, Inst Zool, D-72076 Tubingen, Germany	Brandeis University; National Science Foundation (NSF); NSF - Center for Biological Timing; Brandeis University; Howard Hughes Medical Institute; University of Regensburg; Eberhard Karls University of Tubingen	Rosbash, M (corresponding author), Brandeis Univ, Dept Biol, Natl Sci Fdn, Ctr Biol Timing, Waltham, MA 02454 USA.	rosbash@brandeis.edu	Stanewsky, Ralf/ABB-9193-2021	Helfrich-Forster, Charlotte/0000-0002-0859-9092; Stanewsky, Ralf/0000-0001-8238-6864				Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Blackshaw S, 1999, J NEUROSCI, V19, P3681; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; DUSHAY MS, 1989, J BIOL RHYTHM, V4, P1, DOI 10.1177/074873048900400101; Earnest DJ, 1999, SCIENCE, V283, P693, DOI 10.1126/science.283.5402.693; Edery I, 1999, CHRONOBIOL INT, V16, P377, DOI 10.3109/07420529908998716; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Egan ES, 1999, J NEUROSCI, V19, P3665; Emery IF, 1997, P NATL ACAD SCI USA, V94, P4092, DOI 10.1073/pnas.94.8.4092; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; EWER J, 1992, J NEUROSCI, V12, P3321; FRISCH B, 1994, NEURON, V12, P555, DOI 10.1016/0896-6273(94)90212-7; Giebultowicz JM, 1997, NATURE, V386, P664, DOI 10.1038/386664a0; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; HAMBLENCOYLE MJ, 1992, J INSECT BEHAV, V5, P417, DOI 10.1007/BF01058189; Helfrich-Forster C, 2000, J BIOL RHYTHM, V15, P135, DOI 10.1177/074873040001500208; Helfrich-Forster C, 1998, J COMP PHYSIOL A, V182, P435, DOI 10.1007/s003590050192; HelfrichForster C, 1996, SEMIN CELL DEV BIOL, V7, P791, DOI 10.1006/scdb.1996.0097; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; Ishikawa T, 1999, GENES CELLS, V4, P57, DOI 10.1046/j.1365-2443.1999.00237.x; Kanai S, 1997, J MOL EVOL, V45, P535, DOI 10.1007/PL00006258; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Kaneko M, 1997, J NEUROSCI, V17, P6745; Kaneko M, 1998, CURR OPIN NEUROBIOL, V8, P652, DOI 10.1016/S0959-4388(98)80095-0; Klein DC, 1991, SUPRACHIASMATIC NUCL, P1; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 1999, MOL CELL BIOL, V19, P5316; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; LEVINE JD, 1994, NEURON, V13, P967, DOI 10.1016/0896-6273(94)90262-3; LopezMolina L, 1997, EMBO J, V16, P6762, DOI 10.1093/emboj/16.22.6762; MENAKER M, 1970, P NATL ACAD SCI USA, V67, P320, DOI 10.1073/pnas.67.1.320; Mollereau B, 2000, MECH DEVELOP, V93, P151, DOI 10.1016/S0925-4773(00)00287-2; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; Ohata K, 1998, INT CONGR SER, V1152, P167; Okano S, 1999, PHOTOCHEM PHOTOBIOL, V69, P108; OKANO T, 1994, NATURE, V372, P94, DOI 10.1038/372094a0; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rutila JE, 1998, J BIOL RHYTHM, V13, P380, DOI 10.1177/074873098129000200; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; SAUNDERS DS, 1994, J INSECT PHYSIOL, V40, P957, DOI 10.1016/0022-1910(94)90134-1; Suri VP, 1998, NEURON, V21, P225, DOI 10.1016/S0896-6273(00)80529-2; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; WHEELER DA, 1993, J BIOL RHYTHM, V8, P67, DOI 10.1177/074873049300800106; Yang ZH, 1998, NEURON, V21, P215, DOI 10.1016/S0896-6273(00)80528-0; Young MW, 1998, ANNU REV BIOCHEM, V67, P135, DOI 10.1146/annurev.biochem.67.1.135; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0; ZENG HK, 1994, EMBO J, V13, P3590, DOI 10.1002/j.1460-2075.1994.tb06666.x; ZERR DM, 1990, J NEUROSCI, V10, P2749	63	319	327	1	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	2000	26	2					493	504		10.1016/S0896-6273(00)81181-2	http://dx.doi.org/10.1016/S0896-6273(00)81181-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318QZ	10839367	Bronze			2022-12-24	WOS:000087296500025
J	Chen, WR; Xiong, WH; Shepherd, GM				Chen, WR; Xiong, WH; Shepherd, GM			Analysis of relations between NMDA receptors and GABA release at olfactory bulb reciprocal synapses	NEURON			English	Article							HIPPOCAMPAL SYNAPTIC TRANSMISSION; DENDRODENDRITIC INHIBITION; TRANSMITTER RELEASE; GLUTAMATE-RECEPTOR; GRANULE CELLS; MITRAL CELLS; PYRAMIDAL NEURONS; DENDRITIC SPINES; RAT HIPPOCAMPUS; CALCIUM-CHANNEL	In the mammalian olfactory bulb, signal processing is mediated by synaptic interactions between dendrites. Glutamate released from mitral cell dendrites excites dendritic spines of granule cells, which in turn release GABA back onto the mitral cell dendrites, forming a reciprocal synaptic pair. This feedback synaptic circuit was shown to be mediated predominantly by NMDA receptors. We further utilized caged Ca2+ compounds to obtain insight into the mechanism that couples NMDA receptor activation to GABA release. Feedback inhibition elicited by photo-release of caged Ca2+ in mitral cell secondary dendrites persisted when voltage-gated Ca2+ channels were blocked by cadmium (Cd2+) and nickel (Ni2+). These results indicate that Ca2+ influx through NMDA receptors can directly trigger presynaptic GABA release for local dendrodendritic feedback inhibition.	Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06520 USA	Yale University	Chen, WR (corresponding author), Yale Univ, Sch Med, Neurobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.				NIDCD NIH HHS [R01 DC03918, R01 DC 03972, R01 DC 00086] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000086, R01DC003918, R01DC003972] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ali AB, 1998, J PHYSIOL-LONDON, V507, P185, DOI 10.1111/j.1469-7793.1998.185bu.x; AOKI C, 1994, J NEUROSCI, V14, P5202; Aroniadou-Anderjaska V, 1999, J NEUROPHYSIOL, V81, P15, DOI 10.1152/jn.1999.81.1.15; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; Brennan PA, 1997, PROG NEUROBIOL, V51, P457, DOI 10.1016/S0301-0082(96)00069-X; Breukel AIM, 1998, EUR J NEUROSCI, V10, P106, DOI 10.1046/j.1460-9568.1998.00008.x; CHAD JE, 1984, BIOPHYS J, V45, P993, DOI 10.1016/S0006-3495(84)84244-7; Chen WR, 1997, BRAIN RES, V745, P189, DOI 10.1016/S0006-8993(96)01150-X; Chen WR, 1997, SCIENCE, V278, P463, DOI 10.1126/science.278.5337.463; CHEN WR, 1998, ACHEMS P, V20, P274; Chen YH, 1998, J NEUROSCI, V18, P2982; Cochilla AJ, 1999, J NEUROSCI, V19, P193, DOI 10.1523/JNEUROSCI.19-01-00193.1999; DeBiasi S, 1996, NEUROREPORT, V7, P2773, DOI 10.1097/00001756-199611040-00073; Feinstein N, 1998, J NEUROPHYSIOL, V80, P2893, DOI 10.1152/jn.1998.80.6.2893; Glitsch M, 1999, J NEUROSCI, V19, P511; Gracy KN, 1997, J NEUROSCI, V17, P4839; Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0; Gu JGG, 1997, NATURE, V389, P749, DOI 10.1038/39639; HARRISON NL, 1985, BRIT J PHARMACOL, V323, P132; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; JAHR CE, 1980, SCIENCE, V207, P1473, DOI 10.1126/science.7361098; JAHR CE, 1982, J PHYSIOL-LONDON, V326, P213, DOI 10.1113/jphysiol.1982.sp014187; Jardemark K, 1997, J NEUROPHYSIOL, V77, P702, DOI 10.1152/jn.1997.77.2.702; Johnson RR, 1996, J COMP NEUROL, V368, P335, DOI 10.1002/(SICI)1096-9861(19960506)368:3<335::AID-CNE2>3.0.CO;2-6; Lagnado L, 1996, NEURON, V17, P957, DOI 10.1016/S0896-6273(00)80226-3; LANDIS DMD, 1983, J CELL BIOL, V97, P1169, DOI 10.1083/jcb.97.4.1169; LANDO L, 1994, J NEUROPHYSIOL, V72, P825, DOI 10.1152/jn.1994.72.2.825; LISMAN J, 1994, J PHYSIOLOGY-PARIS, V88, P193, DOI 10.1016/0928-4257(94)90005-1; Liu HT, 1997, NATURE, V386, P721, DOI 10.1038/386721a0; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; MAYER ML, 1989, J PHYSIOL-LONDON, V415, P329, DOI 10.1113/jphysiol.1989.sp017724; MAYER ML, 1985, J PHYSIOL-LONDON, V361, P65, DOI 10.1113/jphysiol.1985.sp015633; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; Montague AA, 1999, J COMP NEUROL, V405, P233, DOI 10.1002/(SICI)1096-9861(19990308)405:2<233::AID-CNE7>3.0.CO;2-A; MORI K, 1981, J PHYSIOL-LONDON, V314, P281, DOI 10.1113/jphysiol.1981.sp013707; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; NICOLL RA, 1969, BRAIN RES, V14, P157, DOI 10.1016/0006-8993(69)90037-7; NOWYCKY MC, 1981, J NEUROPHYSIOL, V46, P639, DOI 10.1152/jn.1981.46.3.639; Petralia RS, 1996, J COMP NEUROL, V372, P356; PETROZZINO JJ, 1995, NEURON, V14, P1223, DOI 10.1016/0896-6273(95)90269-4; PRICE J L, 1968, Brain Research, V11, P697; PRICE JL, 1970, J CELL SCI, V7, P157; PRICE JL, 1970, J CELL SCI, V7, P125; RALL W, 1968, J NEUROPHYSIOL, V31, P884, DOI 10.1152/jn.1968.31.6.884; RALL W, 1966, EXP NEUROL, V14, P44, DOI 10.1016/0014-4886(66)90023-9; REGEHR WG, 1994, NEURON, V12, P605, DOI 10.1016/0896-6273(94)90216-X; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Robert A, 1998, J NEUROPHYSIOL, V80, P196, DOI 10.1152/jn.1998.80.1.196; Rouze NC, 1998, J NEUROSCI, V18, P8614; Rusakov DA, 1998, J NEUROSCI, V18, P3158; Schoppa NE, 1998, J NEUROSCI, V18, P6790; Schoppa NE, 1999, NAT NEUROSCI, V2, P1106, DOI 10.1038/16033; SCHWEIZER FE, 1995, NEURON, V14, P689, DOI 10.1016/0896-6273(95)90213-9; SHEPHERD GM, 1963, J PHYSIOL-LONDON, V168, P89, DOI 10.1113/jphysiol.1963.sp007179; SHEPHERD GM, 1979, BRAIN RES, V175, P377, DOI 10.1016/0006-8993(79)91020-5; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; SMIRNOVA T, 1993, SCIENCE, V262, P430, DOI 10.1126/science.8105537; Stanley EF, 1997, TRENDS NEUROSCI, V20, P404, DOI 10.1016/S0166-2236(97)01091-6; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; VanBockstaele EJ, 1996, J COMP NEUROL, V369, P483, DOI 10.1002/(SICI)1096-9861(19960610)369:4<483::AID-CNE1>3.0.CO;2-0; WELLIS DP, 1994, J PHYSIOL-LONDON, V475, P419, DOI 10.1113/jphysiol.1994.sp020082; WELLIS DP, 1993, J PHYSIOL-LONDON, V469, P315, DOI 10.1113/jphysiol.1993.sp019816; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WOOLF TB, 1991, SYNAPSE, V7, P181, DOI 10.1002/syn.890070303; WOOLF TB, 1991, J NEUROSCI, V11, P1837; Wu LG, 1998, P NATL ACAD SCI USA, V95, P4720, DOI 10.1073/pnas.95.8.4720; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; Yuste R, 1999, J NEUROSCI, V19, P1976; ZUCKER RS, 1993, CELL CALCIUM, V14, P87, DOI 10.1016/0143-4160(93)90079-L	71	181	184	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR	2000	25	3					625	633		10.1016/S0896-6273(00)81065-X	http://dx.doi.org/10.1016/S0896-6273(00)81065-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	301CY	10774730	Bronze			2022-12-24	WOS:000086291700015
J	Beaumont, V; Zucker, RS				Beaumont, V; Zucker, RS			Enhancement of synaptic transmission by cyclic AMP modulation of presynaptic I-h channels	NATURE NEUROSCIENCE			English	Article							CRAYFISH NEUROMUSCULAR-JUNCTION; ACTIVATED CATION CURRENT; SEROTONIN-INDUCED FACILITATION; TIME-DEPENDENT RECTIFICATION; PROTEIN-KINASE-C; TRANSMITTER RELEASE; INWARD RECTIFICATION; SINOATRIAL NODE; NERVE-TERMINALS; CENTRAL NEURONS	Presynaptic activation of adenylyl cyclase and subsequent generation of cAMP represent an important mechanism in the modulation of synaptic transmission. In many cases, short- to medium-term modulation of synaptic strength by cAMP is due to activation of protein kinase A and subsequent covalent modification of presynaptic ion channels or synaptic proteins. Here we show that presynaptic cAMP generation via serotonin receptor activation directly modulated hyperpolarization-activated cation channels (I-h channels) in axons. This modulation of I-h produced an increase in synaptic strength that could not be explained solely by depolarization of the presynaptic membrane. These studies identify a mechanism by which cAMP and I-h regulate synaptic plasticity.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Beaumont, V (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.		Zucker, Robert S/J-9995-2012	Zucker, Robert S/0000-0003-1068-2343; Beaumont, Vahri/0000-0002-6488-2175				Bal T, 1996, NEURON, V17, P297, DOI 10.1016/S0896-6273(00)80161-0; BIRCH BD, 1991, J NEUROPHYSIOL, V66, P719, DOI 10.1152/jn.1991.66.3.719; BOBKER DH, 1989, NEURON, V2, P1535, DOI 10.1016/0896-6273(89)90041-X; BOSMITH RE, 1993, BRIT J PHARMACOL, V110, P343, DOI 10.1111/j.1476-5381.1993.tb13815.x; BOULIS NM, 1990, BRAIN RES, V525, P198, DOI 10.1016/0006-8993(90)90864-8; DEKIN MS, 1993, J NEUROPHYSIOL, V70, P590, DOI 10.1152/jn.1993.70.2.590; DELANEY K, 1991, J NEUROSCI, V11, P2631; DiFrancesco D, 1999, J PHYSIOL-LONDON, V515, P367, DOI 10.1111/j.1469-7793.1999.367ac.x; DIFRANCESCO D, 1994, J PHYSIOL-LONDON, V474, P473, DOI 10.1113/jphysiol.1994.sp020038; DIXON D, 1985, J NEUROBIOL, V16, P409, DOI 10.1002/neu.480160602; DIXON D, 1989, J NEUROPHYSIOL, V62, P239, DOI 10.1152/jn.1989.62.1.239; DIXON D, 1989, J NEUROPHYSIOL, V62, P1251, DOI 10.1152/jn.1989.62.6.1251; DUDEL, 1971, PFLUGERS ARCH, V324, P227; DUDEL J., 1965, ARCH EXP PATHOL PHARMAKOL [NAUNYN SCHMIEDEBERGS], V249, P515; ENG DL, 1990, J PHYSIOL-LONDON, V421, P185, DOI 10.1113/jphysiol.1990.sp017940; ENYEART J, 1981, J NEUROBIOL, V12, P505, DOI 10.1002/neu.480120509; FISCHER L, 1983, J EXP BIOL, V102, P187; GLUSMAN S, 1982, J PHYSIOL-LONDON, V325, P223, DOI 10.1113/jphysiol.1982.sp014147; GOLOWASCH J, 1992, J NEUROPHYSIOL, V67, P318, DOI 10.1152/jn.1992.67.2.318; GOY MF, 1989, J NEUROSCI, V9, P369; Grafe P, 1997, J NEUROPHYSIOL, V77, P421, DOI 10.1152/jn.1997.77.1.421; Harris NC, 1995, J NEUROPHYSIOL, V74, P2366, DOI 10.1152/jn.1995.74.6.2366; Hori Y, 1996, J PHYSIOL-LONDON, V492, P867, DOI 10.1113/jphysiol.1996.sp021352; HUBBARD JI, 1962, J PHYSIOL-LONDON, V163, P115, DOI 10.1113/jphysiol.1962.sp006961; Ingram G I, 1979, Clin Lab Haematol, V1, P13; Ingram SL, 1996, J PHYSIOL-LONDON, V492, P97, DOI 10.1113/jphysiol.1996.sp021292; KIEHN O, 1992, J NEUROPHYSIOL, V68, P496, DOI 10.1152/jn.1992.68.2.496; LERESCHE N, 1991, J PHYSIOL-LONDON, V441, P155, DOI 10.1113/jphysiol.1991.sp018744; Luthi A, 1998, NEURON, V20, P553, DOI 10.1016/S0896-6273(00)80994-0; LUTHI A, NAT NEUROSCI, V2634, P99; MACCAFERRI G, 1993, J NEUROPHYSIOL, V69, P2129, DOI 10.1152/jn.1993.69.6.2129; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P319, DOI 10.1113/jphysiol.1990.sp018332; MINTZ I, 1991, J NEUROSCI, V11, P3359; MITOMA H, 1994, NEUROSCI LETT, V173, P127, DOI 10.1016/0304-3940(94)90165-1; PAPE HC, 1992, J PHYSIOL-LONDON, V447, P729, DOI 10.1113/jphysiol.1992.sp019026; PAPE HC, 1994, NEUROSCIENCE, V59, P363, DOI 10.1016/0306-4522(94)90602-5; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; PAPE HC, 1989, NATURE, V340, P715, DOI 10.1038/340715a0; QUICK J, 1992, BIOCHEM BIOPH RES CO, V187, P657, DOI 10.1016/0006-291X(92)91245-L; SCHUMAN EM, 1994, J NEUROSCI, V14, P1613, DOI 10.1523/JNEUROSCI.14-03-01613.1994; STAUBLI U, 1994, BRAIN RES, V643, P10, DOI 10.1016/0006-8993(94)90003-5; SUGITA S, 1992, J NEUROPHYSIOL, V68, P643, DOI 10.1152/jn.1992.68.2.643; Sun ZY, 1998, J NEUROSCI, V18, P3991; TOKIMASA T, 1990, J PHYSIOL-LONDON, V420, P409, DOI 10.1113/jphysiol.1990.sp017920; TRAVAGLI RA, 1994, J NEUROPHYSIOL, V71, P1308, DOI 10.1152/jn.1994.71.4.1308; Vyshedskiy A, 1998, J NEUROSCI, V18, P5160, DOI 10.1523/JNEUROSCI.18-14-05160.1998; Wang C, 1998, NEURON, V21, P155, DOI 10.1016/S0896-6273(00)80523-1; WOJTOWICZ JM, 1984, J NEUROPHYSIOL, V52, P99, DOI 10.1152/jn.1984.52.1.99	49	198	202	2	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2000	3	2					133	141		10.1038/72072	http://dx.doi.org/10.1038/72072			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TC	10649568				2022-12-24	WOS:000085810300010
J	Kim, DS; Duong, TQ; Kim, SG				Kim, DS; Duong, TQ; Kim, SG			High-resolution mapping of iso-orientation columns by fMRI	NATURE NEUROSCIENCE			English	Article							CAT VISUAL-CORTEX; FUNCTIONAL-ORGANIZATION; SENSORY STIMULATION; INTRINSIC SIGNALS; OCULAR DOMINANCE; NEURONAL-ACTIVITY; STRIATE CORTEX; BRAIN ACTIVITY; BLOOD-FLOW; SELECTIVITY	Blood-oxygenation level-dependent (BOLD) functional magnetic resonance imaging (fMRI) is an important tool for localizing brain functions in vivo. However, the ability of BOLD fMRI to map cortical columnar structures is highly controversial, as the ultimate functional specificity of BOLD remains unknown. Here we report a biphasic BOLD response to visual stimulation in the primary visual cortex of cats. In functional imaging, the initial BOLD signal decrease accurately labeled individual iso-orientation columns. In contrast, the delayed positive BOLD changes indicated the pattern of overall activation in the visual cortex, but were less suited to discriminate active from inactive columns.	Univ Minnesota, Sch Med, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Kim, SG (corresponding author), Univ Minnesota, Sch Med, Ctr Magnet Resonance Res, 2021 6th St SE, Minneapolis, MN 55455 USA.		Kim, Seong-Gi/A-2691-2008; Duong, Tim/AAL-8357-2021; Kim, Dae-Shik/C-2071-2011; Duong, Timothy/B-8525-2008	Duong, Tim/0000-0001-6403-2827; 	NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH057180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038295] Funding Source: NIH RePORTER; NIMH NIH HHS [MH57180] Funding Source: Medline; NINDS NIH HHS [NS10930, NS38295] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BLASDEL GG, 1992, J NEUROSCI, V12, P3115, DOI 10.1523/JNEUROSCI.12-08-03115.1992; BONHOEFFER T, 1993, J NEUROSCI, V13, P4157; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Brodmann, 1909, VERGLEICHENDE LOKALI; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; DIAO YC, 1990, EXP BRAIN RES, V79, P271, DOI 10.1007/BF00608236; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; ERNST T, 1994, MAGN RESON MED, V32, P146, DOI 10.1002/mrm.1910320122; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Hu XP, 1997, MAGNET RESON MED, V37, P877, DOI 10.1002/mrm.1910370612; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Janz C, 1997, NMR BIOMED, V10, P222, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<222::AID-NBM462>3.0.CO;2-M; Jezzard P, 1997, MAGNET RESON MED, V38, P699, DOI 10.1002/mrm.1910380504; KIM DS, 1994, NATURE, V370, P370, DOI 10.1038/370370a0; KIM SG, 1993, SCIENCE, V261, P615, DOI 10.1126/science.8342027; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; LEVAY S, 1991, VISION VISUAL DYSFUN, P266; LOEWEL S, 1987, Journal of Comparative Neurology, V255, P401; LOEWEL S, 1990, DEV BRAIN RES, V56, P99; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Maldonado PE, 1997, SCIENCE, V276, P1551, DOI 10.1126/science.276.5318.1551; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Malonek D, 1997, P NATL ACAD SCI USA, V94, P14826, DOI 10.1073/pnas.94.26.14826; Marota JJA, 1999, MAGNET RESON MED, V41, P247, DOI 10.1002/(SICI)1522-2594(199902)41:2<247::AID-MRM6>3.0.CO;2-U; Menon RS, 1997, J NEUROPHYSIOL, V77, P2780, DOI 10.1152/jn.1997.77.5.2780; MENON RS, 1995, MAGNET RESON MED, V33, P453, DOI 10.1002/mrm.1910330323; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P101, DOI 10.1113/jphysiol.1978.sp012490; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Ogawa S, 1998, ANNU REV BIOPH BIOM, V27, P447, DOI 10.1146/annurev.biophys.27.1.447; Posner M. I., 1994, IMAGES MIND; Press W. H., 1992, ART SCI COMPUTING; ROJER AS, 1990, BIOL CYBERN, V62, P381, DOI 10.1007/BF00197644; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shmuel A, 1996, J NEUROSCI, V16, P6945; Silva AC, 2000, J CEREBR BLOOD F MET, V20, P201, DOI 10.1097/00004647-200001000-00025; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Stetter M, 1999, J OPT SOC AM A, V16, P58, DOI 10.1364/JOSAA.16.000058; SWINDALE NV, 1987, J NEUROSCI, V7, P1414; TOOTELL RB, 1997, J NEUROSCI, V17, P7070; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; Vanzetta I, 1999, SCIENCE, V286, P1555, DOI 10.1126/science.286.5444.1555; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Yacoub E, 1999, MAGNET RESON MED, V41, P1088, DOI 10.1002/(SICI)1522-2594(199906)41:6<1088::AID-MRM3>3.0.CO;2-Q	48	299	308	1	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2000	3	2					164	169		10.1038/72109	http://dx.doi.org/10.1038/72109			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TC	10649572				2022-12-24	WOS:000085810300014
J	Amorapanth, P; LeDoux, JE; Nader, K				Amorapanth, P; LeDoux, JE; Nader, K			Different lateral amygdala outputs mediate reactions and actions elicited by a fear-arousing stimulus	NATURE NEUROSCIENCE			English	Article							PHASEOLUS-VULGARIS-LEUKOAGGLUTININ; CENTRAL NUCLEUS; NEUROTOXIC LESIONS; PROJECTIONS; RAT; INVOLVEMENT; STARTLE	Fear-arousing stimuli elicit innate reactions and can reinforce acquisition of new responses. We tested whether mechanisms mediating these conditioned stimulus (CS) properties were isomorphic or dissociable within the amygdala. Rats trained on a fear-conditioning task (CS paired with footshock) were then trained on an escape-from-fear task (EFF) in which the CS reinforced a locomotor response terminating the CS. Lateral nucleus (LA) lesions blocked acquisition of both conditioned freezing responses and the CS's reinforcement of a new response in the EFF task. Central nucleus (CE) lesions blocked conditioned freezing but not the EFF, whereas basal nucleus (B) lesions blocked the EFF but not conditioned freezing. Thus, activation of the LA by a CS seems to trigger conditioned reactions via CE and conditioned aversion via B activation, reduction of which reinforces new actions.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Nader, K (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.			Amorapanth, Prin/0000-0002-4260-7826	NIMH NIH HHS [MH46516, R37 MH38774, K02 MH00956] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046516, R37MH038774, K02MH000956] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ARNARAF DG, 1992, AMYGDALA NEUROBIOLOG, P1; BLANCHARD R J, 1971, Learning and Motivation, V2, P351, DOI 10.1016/0023-9690(71)90016-6; BOLLES RC, 1980, BEHAV BRAIN SCI, V3, P291, DOI 10.1017/S0140525X0000491X; BOLLES RC, 1972, PSYCHOL REV, V79, P394, DOI 10.1037/h0033120; Cahill L, 1999, NEURON, V23, P227, DOI 10.1016/S0896-6273(00)80774-6; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; CAMPEAU S, 1995, J NEUROSCI, V15, P2301, DOI 10.1523/JNEUROSCI.15-03-02301.1995; DAVIS M, 1994, INT REV NEUROBIOL, V36, P225, DOI 10.1016/S0074-7742(08)60305-0; EVERITT B J, 1992, P401; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; FANSELOW MS, 1987, EVOLUTION LEARNING, P185; Hatfield T, 1996, J NEUROSCI, V16, P5256; HELMSTETTER FJ, 1992, BEHAV NEUROSCI, V106, P518, DOI 10.1037/0735-7044.106.3.518; KAPP BS, 1979, PHYSIOL BEHAV, V23, P1109, DOI 10.1016/0031-9384(79)90304-4; KILLCROSS AS, 1997, TRENDS COGN SCI, V1, P244; Killcross S, 1997, NATURE, V388, P377, DOI 10.1038/41097; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Mackintosh N. J, 1983, CONDITIONING ASS LEA; Maren S, 1996, NEURON, V16, P237, DOI 10.1016/S0896-6273(00)80041-0; Maren S, 1998, J NEUROSCI, V18, P3088; MASCAGNI F, 1993, NEUROSCIENCE, V57, P697, DOI 10.1016/0306-4522(93)90016-9; McAllister WR, 1971, AVERSIVE CONDITION, P105; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; Miller N. E., 1951, HDB EXPT PSYCHOL, P435; MILLER NE, 1948, J EXP PSYCHOL, V38, P89, DOI 10.1037/h0058455; Mowrer OH, 1946, J COMP PSYCHOL, V39, P29, DOI 10.1037/h0060150; Mowrer OH, 1960, LEARNING THEORY BEHA, DOI DOI 10.1037/10802-000; Nader K, 1997, TRENDS COGN SCI, V1, P241, DOI 10.1016/S1364-6613(97)01078-4; PARE D, 1995, NEUROSCIENCE, V69, P567, DOI 10.1016/0306-4522(95)00272-K; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; ROBBINS TW, 1989, NEUROSCI BIOBEHAV R, V13, P155, DOI 10.1016/S0149-7634(89)80025-9; ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037/0735-7044.107.3.444; ROOZENDAAL B, 1991, PHYSIOL BEHAV, V50, P777, DOI 10.1016/0031-9384(91)90017-I; TURNER BH, 1991, J COMP NEUROL, V313, P295, DOI 10.1002/cne.903130208; Walker DL, 1997, J NEUROSCI, V17, P9375	38	274	279	0	25	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2000	3	1					74	79		10.1038/71145	http://dx.doi.org/10.1038/71145			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TB	10607398				2022-12-24	WOS:000085810200015
J	Hendricks, JC; Finn, SM; Panckeri, KA; Chavkin, J; Williams, JA; Sehgal, A; Pack, AI				Hendricks, JC; Finn, SM; Panckeri, KA; Chavkin, J; Williams, JA; Sehgal, A; Pack, AI			Rest in Drosophila is a sleep-like state	NEURON			English	Article							CIRCADIAN PHASE; DEPRIVATION; BRAIN; COCKROACH; DURATION; LESIONS; RATS	To facilitate the genetic study of sleep, we documented that rest behavior in Drosophila melanogaster is a sleep-like state. The animals choose a preferred location, become immobile for periods of up to 157 min at a particular time in the circadian day, and are relatively unresponsive to sensory stimuli. Rest is affected by both homeostatic and circadian influences: when rest is prevented, the flies increasingly tend to rest despite stimulation and then exhibit a rest rebound. Drugs acting on a mammalian adenosine receptor alter rest as they do sleep, suggesting conserved neural mechanisms. Finally, normal homeostatic regulation depends on the timeless but not the period central clock gene. Understanding the molecular features of Drosophila rest should shed new light on the mechanisms and function of sleep.	Univ Penn, Sch Med, Ctr Sleep & Resp Neurobiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Hendricks, JC (corresponding author), Univ Penn, Sch Med, Ctr Sleep & Resp Neurobiol, Philadelphia, PA 19104 USA.			Pack, Allan/0000-0002-2879-0484	NHLBI NIH HHS [R01 HL 59496, HL 60287] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL060287] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ACHERMANN P, 1993, BRAIN RES BULL, V31, P97, DOI 10.1016/0361-9230(93)90016-5; Andretic R, 1999, SCIENCE, V285, P1066, DOI 10.1126/science.285.5430.1066; BENINGTON JH, 1995, PROG NEUROBIOL, V45, P347, DOI 10.1016/0301-0082(94)00057-O; BORBELY AA, 1989, J BIOL RHYTHM, V4, P149; CAMPBELL SS, 1984, NEUROSCI BIOBEHAV R, V8, P269, DOI 10.1016/0149-7634(84)90054-X; Carew TJ, 1996, NEURON, V16, P5, DOI 10.1016/S0896-6273(00)80016-1; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; CHOI OH, 1988, LIFE SCI, V43, P387, DOI 10.1016/0024-3205(88)90517-6; DIJK DJ, 1995, J NEUROSCI, V15, P3526; DRUCKERCOLIN R, 1995, BEHAV BRAIN RES, V69, P117, DOI 10.1016/0166-4328(95)00008-H; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; EDGAR DM, 1993, J NEUROSCI, V13, P1065; HAMBLEN M, 1986, J NEUROGENET, V3, P249, DOI 10.3109/01677068609106855; HAY DA, 1973, BEHAV GENET, V3, P107, DOI 10.1007/BF01067651; HENDRICKS JC, 2000, IN PRESS PROG NEUROB; HORNE JA, 1985, ANN CLIN RES, V17, P199; HORNE JA, 1984, BIOL PSYCHOL, V18, P165, DOI 10.1016/0301-0511(84)90001-2; KAISER W, 1988, J COMP PHYSIOL A, V163, P565, DOI 10.1007/BF00603841; KAISER W, 1983, NATURE, V301, P231; LANCEL M, 1991, BRAIN RES, V548, P206, DOI 10.1016/0006-8993(91)91123-I; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; MANNING AUBREY, 1959, BEHAVIOUR, V15, P123; NASSEL DR, 1991, PROG NEUROBIOL, V37, P179, DOI 10.1016/0301-0082(91)90027-X; NASSEL DR, 1993, CELL TISSUE RES, V273, P1, DOI 10.1007/BF00304608; PARMEGGIANI PL, 1980, ELECTROEN CLIN NEURO, V50, P293, DOI 10.1016/0013-4694(80)90157-1; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; Rechtschaffen A, 1998, PERSPECT BIOL MED, V41, P359, DOI 10.1353/pbm.1998.0051; SAUDOU F, 1994, NEUROCHEM INT, V25, P503, DOI 10.1016/0197-0186(94)90150-3; Schwierin B, 1999, NEUROSCI LETT, V261, P61, DOI 10.1016/S0304-3940(98)01006-4; TOBLER I, 1992, J SLEEP RES, V1, P231, DOI 10.1111/j.1365-2869.1992.tb00044.x; TOBLER I, 1983, NEUROSCI LETT, V42, P49, DOI 10.1016/0304-3940(83)90420-2; TOBLER I, 1983, BEHAV BRAIN RES, V8, P351, DOI 10.1016/0166-4328(83)90180-8; TRACHSEL L, 1986, AM J PHYSIOL, V251, pR1037, DOI 10.1152/ajpregu.1986.251.6.R1037	34	621	643	3	86	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	2000	25	1					129	138		10.1016/S0896-6273(00)80877-6	http://dx.doi.org/10.1016/S0896-6273(00)80877-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279KP	10707978	Bronze			2022-12-24	WOS:000085043200016
J	Gotter, AL; Levine, JD; Reppert, SM				Gotter, AL; Levine, JD; Reppert, SM			Sex-linked period genes in the silkmoth, Antheraea pernyi: Implications for circadian clock regulation and the evolution of sex chromosomes	NEURON			English	Article							DROSOPHILA CLOCK; DOSAGE COMPENSATION; ANTISENSE RNA; PROTEIN; TIMELESS; RHYTHMS; TRANSCRIPTION; MELANOGASTER; MUTATION; TIM	Regulation of the period (per) gene is a critical feature of circadian clock function in insects. Here, we show that per is sex-linked in the silkmoth, Antheraea pernyi. The previously described silkmoth per gene is found on the Z chromosome. Silkmoth per is not dosage compensated at either the RNA or the protein level. Although earlier studies showed the presence of an oscillating endogenous antisense per transcript, we show that this transcript comes from a locus on the female-specific W chromosome. We further demonstrate the presence of a homolog of per on W that encodes a truncated protein. Rhythmicity of male (ZZ) moths demonstrates that neither of the W-linked per-like genes is essential for clock function. The presence of a per allele with duplications on W provides insight into the evolution of the sex chromosomes.	Massachusetts Gen Hosp, Lab Dev Chronobiol, Serv Pediat, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Reppert, SM (corresponding author), Massachusetts Gen Hosp, Lab Dev Chronobiol, Serv Pediat, Boston, MA 02114 USA.				NIGMS NIH HHS [GM55820] Funding Source: Medline; NIMH NIH HHS [MH12117] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055820] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abe H, 1998, GENES GENET SYST, V73, P243, DOI 10.1266/ggs.73.243; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Charlesworth B, 1998, GENETICA, V102-3, P3, DOI 10.1023/A:1017066304739; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Charlesworth B, 1996, CURR BIOL, V6, P149, DOI 10.1016/S0960-9822(02)00448-7; CITRI Y, 1987, NATURE, V326, P42, DOI 10.1038/326042a0; COOPER MK, 1994, GENETICS, V138, P721; Crow JF, 1997, NAT GENET, V17, P129, DOI 10.1038/ng1097-129; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; DARNELL J, 1990, MOL CELL BIOL, P261; Davis PS, 1995, DROSOPH INF SERV, V76, P134; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Fridolfsson AK, 1998, P NATL ACAD SCI USA, V95, P8147, DOI 10.1073/pnas.95.14.8147; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Goldsmith Marian R., 1995, P21, DOI 10.1017/CBO9780511529931.003; GRAVES JAM, 1995, BIOESSAYS, V17, P311, DOI 10.1002/bies.950170407; Hao HP, 1999, J NEUROSCI, V19, P987; Hao HP, 1997, MOL CELL BIOL, V17, P3687, DOI 10.1128/MCB.17.7.3687; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; HENIKOFF S, 1993, CELL, V72, P1, DOI 10.1016/0092-8674(93)90040-W; INOUYE M, 1988, GENE, V72, P25, DOI 10.1016/0378-1119(88)90124-2; JACKSON FR, 1986, NATURE, V320, P185, DOI 10.1038/320185a0; Jegalian K, 1998, NATURE, V394, P776, DOI 10.1038/29522; Knee R, 1997, NEUROCHEM INT, V31, P379, DOI 10.1016/S0197-0186(96)00108-8; Krystal G. W., 1992, Gene regulation: biology of antisense RNA and DNA., P11; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; Leloup JC, 1998, J BIOL RHYTHM, V13, P70, DOI 10.1177/074873098128999934; LEVINE JD, 1995, NEURON, V15, P147, DOI 10.1016/0896-6273(95)90072-1; Lucchesi JC, 1999, BIOESSAYS, V21, P188, DOI 10.1002/(SICI)1521-1878(199903)21:3<188::AID-BIES2>3.3.CO;2-Z; PETERSEN G, 1988, EMBO J, V7, P3939, DOI 10.1002/j.1460-2075.1988.tb03280.x; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; PRICE JL, 1995, EMBO J, V14, P4044, DOI 10.1002/j.1460-2075.1995.tb00075.x; Regier JC, 1998, MOL BIOL EVOL, V15, P1172, DOI 10.1093/oxfordjournals.molbev.a026024; Reppert SM, 1998, NEURON, V21, P1, DOI 10.1016/S0896-6273(00)80234-2; REPPERT SM, 1994, NEURON, V13, P1167, DOI 10.1016/0896-6273(94)90054-X; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Saez L, 1996, NEURON, V17, P911, DOI 10.1016/S0896-6273(00)80222-6; SassoneCorsi P, 1996, NATURE, V384, P613, DOI 10.1038/384613a0; Sauman I, 1996, NEURON, V17, P901, DOI 10.1016/S0896-6273(00)80221-4; Sauman I, 1996, NEURON, V17, P889, DOI 10.1016/S0896-6273(00)80220-2; Sauman I, 1998, NEURON, V20, P741, DOI 10.1016/S0896-6273(00)81012-0; Sauman I, 1996, DEV BIOL, V178, P418, DOI 10.1006/dbio.1996.0228; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; SMITH RF, 1981, MOL GEN GENET, V183, P243, DOI 10.1007/BF00270625; So WV, 1997, EMBO J, V16, P7146, DOI 10.1093/emboj/16.23.7146; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Suri V, 1999, EMBO J, V18, P675, DOI 10.1093/emboj/18.3.675; Suzuki MG, 1999, HEREDITY, V82, P170, DOI 10.1038/sj.hdy.6884570; Suzuki MG, 1998, HEREDITY, V81, P275, DOI 10.1046/j.1365-2540.1998.00356.x; TRUMAN JW, 1974, J COMP PHYSIOL, V95, P281, DOI 10.1007/BF00609702; TRUMAN JW, 1970, SCIENCE, V167, P1624, DOI 10.1126/science.167.3925.1624; TRUMAN JW, 1971, P NATL ACAD SCI USA, V68, P595, DOI 10.1073/pnas.68.3.595; TRUMAN JW, 1972, J COMP PHYSL, V81, P91; Tuskes PM, 1996, WILD SILK MOTHS N AM; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; VOSSHALL LB, 1994, SCIENCE, V263, P1606, DOI 10.1126/science.8128247; WHEELER DA, 1991, SCIENCE, V251, P1082, DOI 10.1126/science.1900131; WILLIAMS CM, 1964, BIOL BULL, V127, P511, DOI 10.2307/1539252; ZENG HK, 1994, EMBO J, V13, P3590, DOI 10.1002/j.1460-2075.1994.tb06666.x	62	50	52	0	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1999	24	4					953	965		10.1016/S0896-6273(00)81042-9	http://dx.doi.org/10.1016/S0896-6273(00)81042-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	269UE	10624958	Bronze			2022-12-24	WOS:000084495300023
J	Pesenti, M; Zago, L; Crivello, F; Mellet, E; Samson, D; Duroux, B; Seron, X; Mazoyer, B; Tzourio-Mazoyer, N				Pesenti, M; Zago, L; Crivello, F; Mellet, E; Samson, D; Duroux, B; Seron, X; Mazoyer, B; Tzourio-Mazoyer, N			Mental calculation in a prodigy is sustained by right prefrontal and medial temporal areas	NATURE NEUROSCIENCE			English	Article							FUNCTIONAL-MRI EVIDENCE; CORTEX; ACTIVATION; RETRIEVAL; MEMORY; BRAIN; RECOGNITION; PET	Calculating prodigies are individuals who are exceptional at quickly and accurately solving complex mental calculations. With positron emission tomography (PET), we investigated the neural bases of the cognitive abilities of an expert calculator and a group of non-experts, contrasting complex mental calculation to memory retrieval of arithmetic facts. We demonstrated that calculation expertise was not due to increased activity of processes that exist in non-experts; rather, the expert and the non-experts used different brain areas for calculation. We found that the expert could switch between short-term effort-requiring storage strategies and highly efficient episodic memory encoding and retrieval, a process that was sustained by right prefrontal and medial temporal areas.	Univ Paris 05, GIP Cyceron, F-14074 Caen, France; Catholic Univ Louvain, Unite Neuropsychol Cognit, B-1348 Louvain, Belgium	UDICE-French Research Universities; Universite Paris Cite; Universite de Caen Normandie; Universite Catholique Louvain	Tzourio-Mazoyer, N (corresponding author), Univ Caen, CNRS, CEA, UMR 6095,Grp Imagerie Neurofonct, F-14074 Caen, France.	tzourio@cyceron.fr	GINSPAN, All/B-8714-2008; Samson, Dana/A-8692-2008; Crivello, Fabrice/B-5569-2008; Mazoyer, Bernard M/B-6303-2012; Mellet, Emmanuel/B-7125-2008; Zago, Laure/B-7124-2008; Crivello, Fabrice/ABB-4531-2021; Tzourio-Mazoyer, Nathalie/B-5598-2008; mazoyer, bernard m/A-5369-2009	Mazoyer, Bernard M/0000-0003-0970-2837; Mellet, Emmanuel/0000-0002-2676-9112; Tzourio-Mazoyer, Nathalie/0000-0002-6236-4390; mazoyer, bernard m/0000-0003-0970-2837; Samson, Dana/0000-0001-7428-0031; Crivello, Fabrice/0000-0001-6950-984X; Zago, Laure/0000-0001-8235-2154				ASHCRAFT MH, 1992, COGNITION, V44, P75, DOI 10.1016/0010-0277(92)90051-I; Baddeley A., 2007, WORKING MEMORY THOUG; Briars D.J., 1988, CHILDRENS COUNTING C, P63; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Butterworth B, 1999, SCIENCE, V284, P928, DOI 10.1126/science.284.5416.928; Butterworth B., 1999, MATH BRAIN; Cabeza R, 1997, J COGNITIVE NEUROSCI, V9, P254, DOI 10.1162/jocn.1997.9.2.254; Campbell, 1995, MATH COGNITION, V1, P121, DOI DOI 10.3758/BF03197037; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; Dehaene S, 1996, NEUROPSYCHOLOGIA, V34, P1097, DOI 10.1016/0028-3932(96)00027-9; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; ERICSSON KA, 1995, PSYCHOL REV, V102, P211, DOI 10.1037/0033-295X.102.2.211; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; Faust M. W., 1996, MATH COGNITION, V2, P25, DOI DOI 10.1080/135467996387534; Fayol M, 1998, COGNITION, V68, pB63, DOI 10.1016/S0010-0277(98)00046-8; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Gerstmann J, 1930, NERVENARZT, V3, P691; Grafton ST, 1997, NEUROIMAGE, V6, P231, DOI 10.1006/nimg.1997.0293; GRAFTON ST, 1995, J COGNITIVE NEUROSCI, V7, P497, DOI 10.1162/jocn.1995.7.4.497; Heun R, 1999, HUM BRAIN MAPP, V8, P157, DOI 10.1002/(SICI)1097-0193(1999)8:4<157::AID-HBM1>3.0.CO;2-G; KARNI A, 1995, NATURE, V377, P155; KOSSLYN SM, 1993, J COGNITIVE NEUROSCI, V5, P263, DOI 10.1162/jocn.1993.5.3.263; Krause BJ, 1999, BRAIN, V122, P255, DOI 10.1093/brain/122.2.255; LeFevre JA, 1996, J EXP PSYCHOL GEN, V125, P284, DOI 10.1037/0096-3445.125.3.284; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mellet E, 1998, NEUROIMAGE, V8, P129, DOI 10.1006/nimg.1998.0355; Pesenti M, 2000, J COGNITIVE NEUROSCI, V12, P461, DOI 10.1162/089892900562273; Pesenti M., 1999, MATH COGNITION, V5, P97, DOI DOI 10.1080/135467999387270); Poldrack RA, 1998, CEREB CORTEX, V8, P1, DOI 10.1093/cercor/8.1.1; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; Simon TJ, 1999, TRENDS COGN SCI, V3, P363, DOI 10.1016/S1364-6613(99)01383-2; Smith Steven B., 1983, GREAT MENTAL CALCULA; Wagner AD, 1998, BRAIN, V121, P1985, DOI 10.1093/brain/121.10.1985; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; Young BJ, 1997, J NEUROSCI, V17, P5183; ZAGO L, IN PRESS NEUROIMAGE	37	115	121	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2001	4	1					103	107		10.1038/82831	http://dx.doi.org/10.1038/82831			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	405UB	11135652				2022-12-24	WOS:000167178000021
J	Magga, JM; Jarvis, SE; Arnot, MI; Zamponi, GW; Braun, JEA				Magga, JM; Jarvis, SE; Arnot, MI; Zamponi, GW; Braun, JEA			Cysteine string protein regulates G protein modulation of N-type calcium channels	NEURON			English	Article							BETA-GAMMA-SUBUNITS; CA2+ CHANNELS; KINASE-C; DEPENDENT MODULATION; DROSOPHILA; SYNTAXIN; INHIBITION; NEUROTRANSMITTER; COMPLEX; DETERMINANTS	Cysteine string proteins (CSPs) are secretory vesicle proteins bearing a "J domain" and a palmitoylated cysteine-rich "string" region that are critical for neurotransmitter release. The precise role of CSP in neurotransmission is controversial. Here, we demonstrate a novel interaction between CSP, receptor-coupled trimeric GTP binding proteins (G proteins), and N-type Ca2+ channels. G(alpha) subunits interact with the J domain of CSP in an ATP-dependent manner; in contrast, G(beta gamma) subunits interact with the C terminus of CSP in both the presence and absence of ATP. The interaction of CSP with both G proteins and N-type Ca2+ channels results in a tonic G protein inhibition of the channels. In view of the crucial importance of N-type Ca2+ channels in presynaptic Vesicle release, our data attribute a key role to CSP in the fine tuning of neurotransmission.	Univ Calgary, Dept Physiol & Biophys, Neurosci Res Grp, Calgary, AB T2N 4N1, Canada; Univ Calgary, Dept Pharmacol & Therapeut, Neurosci Res Grp, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	Braun, JEA (corresponding author), Univ Calgary, Dept Physiol & Biophys, Neurosci Res Grp, Calgary, AB T2N 4N1, Canada.	braunj@uoalgary.ca		Zamponi, Gerald W./0000-0002-0644-9066; Magga, Johanna/0000-0003-4688-9098				Arnot MI, 2000, J PHYSIOL-LONDON, V527, P203, DOI 10.1111/j.1469-7793.2000.00203.x; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Braun JEA, 2000, J NEUROSCI, V20, P5997, DOI 10.1523/JNEUROSCI.20-16-05997.2000; BRAUN JEA, 1995, NEUROPHARMACOLOGY, V34, P1361, DOI 10.1016/0028-3908(95)00114-L; Braun JEA, 1996, J BIOL CHEM, V271, P25989, DOI 10.1074/jbc.271.42.25989; Brown H, 1998, EMBO J, V17, P5048, DOI 10.1093/emboj/17.17.5048; Bunemann M, 1998, J BIOL CHEM, V273, P31186, DOI 10.1074/jbc.273.47.31186; Chamberlain LH, 1998, MOL BIOL CELL, V9, P2259, DOI 10.1091/mbc.9.8.2259; Chamberlain LH, 1997, BIOCHEM J, V322, P853, DOI 10.1042/bj3220853; Chamberlain LH, 1996, J BIOL CHEM, V271, P19514, DOI 10.1074/jbc.271.32.19514; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; Dolphin AC, 1998, J PHYSIOL-LONDON, V506, P3, DOI 10.1111/j.1469-7793.1998.003bx.x; Fernandez-Chacon R, 1999, ANNU REV PHYSIOL, V61, P753, DOI 10.1146/annurev.physiol.61.1.753; Graham ME, 2000, J NEUROSCI, V20, P1281; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; GUNDERSEN CB, 1992, NEURON, V9, P527, DOI 10.1016/0896-6273(92)90190-O; Hamid J, 1999, J BIOL CHEM, V274, P6195, DOI 10.1074/jbc.274.10.6195; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Herlitze S, 1997, P NATL ACAD SCI USA, V94, P1512, DOI 10.1073/pnas.94.4.1512; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Jarvis SE, 2000, J BIOL CHEM, V275, P6388, DOI 10.1074/jbc.275.9.6388; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; Leveque C, 1998, J BIOL CHEM, V273, P13488, DOI 10.1074/jbc.273.22.13488; MASTROGIACOMO A, 1994, SCIENCE, V263, P981, DOI 10.1126/science.7906056; Morales M, 1999, EUR J NEUROSCI, V11, P1818, DOI 10.1046/j.1460-9568.1999.00604.x; Nie ZP, 1999, J NEUROSCI, V19, P10270; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Ranjan R, 1998, J NEUROSCI, V18, P956; Rettig J, 1996, P NATL ACAD SCI USA, V93, P7363, DOI 10.1073/pnas.93.14.7363; Ruiz-Velasco V, 2000, J NEUROSCI, V20, P2183; SCHELLER RH, 1995, NEURON, V14, P893; Sheng ZH, 1996, NATURE, V379, P451, DOI 10.1038/379451a0; SILVER PA, 1993, CELL, V74, P5, DOI 10.1016/0092-8674(93)90287-Z; Stahl B, 1999, EUR J CELL BIOL, V78, P375, DOI 10.1016/S0171-9335(99)80079-X; Stanley EF, 1997, NATURE, V385, P340, DOI 10.1038/385340a0; STEA A, 1995, NEURON, V15, P929, DOI 10.1016/0896-6273(95)90183-3; SWARTZ KJ, 1993, NEURON, V11, P305, DOI 10.1016/0896-6273(93)90186-U; Umbach JA, 1997, J NEUROSCI, V17, P7203; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; Wu MN, 1999, NEURON, V23, P593, DOI 10.1016/S0896-6273(00)80811-9; Yokoyama CT, 1997, J NEUROSCI, V17, P6929; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; Zamponi GW, 1998, P NATL ACAD SCI USA, V95, P4035, DOI 10.1073/pnas.95.7.4035; Zhang JF, 1996, NEURON, V17, P991, DOI 10.1016/S0896-6273(00)80229-9; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297	49	97	97	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	2000	28	1					195	204		10.1016/S0896-6273(00)00096-9	http://dx.doi.org/10.1016/S0896-6273(00)00096-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	370VN	11086994	Bronze			2022-12-24	WOS:000165143500021
J	Applebury, ML; Antoch, MP; Baxter, LC; Chun, LLY; Falk, JD; Farhangfar, F; Kage, K; Krzystolik, MG; Lyass, LA; Robbins, JT				Applebury, ML; Antoch, MP; Baxter, LC; Chun, LLY; Falk, JD; Farhangfar, F; Kage, K; Krzystolik, MG; Lyass, LA; Robbins, JT			The murine cone photoreceptor: A single cone type expresses both S and M opsins with retinal spatial patterning	NEURON			English	Article							IN-SITU HYBRIDIZATION; HUMAN COLOR-VISION; MOUSE RETINA; VISUAL PIGMENTS; MOLECULAR-GENETICS; HUMAN RED; GREEN; CELL; MECHANISMS; ANTIBODIES	Mice express S and M opsins that form visual pigments for the detection of light and visual signaling in cones. Here, we show that S opsin transcription is higher than that of M opsin, which supports ultraviolet (UV) sensitivity greater than midwavelength sensitivity. Surprisingly, most cones coexpress both S and M opsins in a common cone cell type throughout the retina. All cones express M opsin, but the levels are graded from dorsal to ventral. The levels of S opsin are relatively constant. However, in the far dorsal retina, S opsin is repressed stochastically, such that some cones express M opsin only. These observations indicate that two different mechanisms control M and S opsin expression. We suggest that a common cone type is patterned across the retinal surface to produce phenotypic cone subtypes.	Harvard Univ, Sch Med, Howe Lab, Boston, MA 02114 USA	Harvard University; Harvard Medical School	Applebury, ML (corresponding author), Harvard Univ, Sch Med, Howe Lab, Boston, MA 02114 USA.			Antoch, mantoch/0000-0003-3001-8511; Baxter, Leslie/0000-0002-3971-863X	NEI NIH HHS [R01-EY04801, R01 EY004801-18] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY004801] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALUBAIDI MR, 1990, J BIOL CHEM, V265, P20563; ARCHER SN, 1990, VISION RES, V30, P225, DOI 10.1016/0042-6989(90)90038-M; Ausubel F., 1999, CURRENT PROTOCOLS MO; BAEHR W, 1988, FEBS LETT, V238, P253, DOI 10.1016/0014-5793(88)80490-3; Brennan CA, 2000, CELL MOL LIFE SCI, V57, P195, DOI 10.1007/PL00000684; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P263, DOI 10.1002/cne.901880205; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chan YM, 1999, CURR OPIN NEUROBIOL, V9, P582, DOI 10.1016/S0959-4388(99)00017-3; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CONLON RA, 1993, METHOD ENZYMOL, V225, P373; Deeb SS, 1996, BEHAV GENET, V26, P195, DOI 10.1007/BF02359380; Drager UC, 1997, PROG RETIN EYE RES, V16, P323, DOI 10.1016/S1350-9462(96)00029-8; FEKETE DM, 1983, J NEUROCYTOL, V12, P785, DOI 10.1007/BF01258151; FRISCHAUF AM, 1983, J MOL BIOL, V170, P827, DOI 10.1016/S0022-2836(83)80190-9; Glosmann Martin, 1998, IOVS, V39, pS1059; HARGRAVE PA, 1986, EXP EYE RES, V42, P363, DOI 10.1016/0014-4835(86)90030-8; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Harris WA, 1997, CURR OPIN GENET DEV, V7, P651, DOI 10.1016/S0959-437X(97)80013-5; HASSL A, 1988, J IMMUNOL METHODS, V110, P225, DOI 10.1016/0022-1759(88)90107-X; Hemmi JM, 1999, VISUAL NEUROSCI, V16, P291, DOI 10.1017/S0952523899162102; Hope AJ, 1998, P ROY SOC B-BIOL SCI, V265, P869, DOI 10.1098/rspb.1998.0372; JACOBS GH, 1991, NATURE, V353, P655, DOI 10.1038/353655a0; JACOBS GH, 1993, BIOL REV, V68, P413, DOI 10.1111/j.1469-185X.1993.tb00738.x; Jacobs GH, 1999, J NEUROSCI, V19, P3258; JENSENIUS JC, 1981, J IMMUNOL METHODS, V46, P63, DOI 10.1016/0022-1759(81)90333-1; Jeon CJ, 1998, J NEUROSCI, V18, P8936; KIRSCHFELD K, 1983, BIOPHYS STRUCT MECH, V10, P81, DOI 10.1007/BF00535544; KIRSCHFELD K, 1988, J COMP PHYSIOL A, V163, P421, DOI 10.1007/BF00604896; Kitamoto J, 1998, J EXP BIOL, V201, P1255; LEM J, 1991, NEURON, V6, P200; Loew ER, 1996, VISUAL NEUROSCI, V13, P247, DOI 10.1017/S0952523800007483; Lyubarsky AL, 1999, J NEUROSCI, V19, P442, DOI 10.1523/JNEUROSCI.19-01-00442.1999; Makino CL, 1996, J GEN PHYSIOL, V108, P27, DOI 10.1085/jgp.108.1.27; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MAX M, 1995, SCIENCE, V267, P1502, DOI 10.1126/science.7878470; MCCAFFERY P, 1992, DEVELOPMENT, V115, P371; MOLLON JD, 1992, NATURE, V360, P677, DOI 10.1038/360677a0; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NOLTE J, 1972, J GEN PHYSIOL, V59, P186, DOI 10.1085/jgp.59.2.186; Perrimon N, 1999, CELL, V97, P13, DOI 10.1016/S0092-8674(00)80710-2; Perron M, 2000, CELL MOL LIFE SCI, V57, P215, DOI 10.1007/PL00000685; Rodieck R.W., 1998, 1 STEPS SEEING; ROHLICH P, 1994, NEURON, V13, P1159, DOI 10.1016/0896-6273(94)90053-1; ROHLICH P, 1993, CURR EYE RES, V12, P935, DOI 10.3109/02713689309020400; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Scott MP, 2000, CELL, V100, P27, DOI 10.1016/S0092-8674(00)81681-5; Shaaban SA, 1998, INVEST OPHTH VIS SCI, V39, P1036; Sun H, 1997, P NATL ACAD SCI USA, V94, P8860, DOI 10.1073/pnas.94.16.8860; SZEL A, 1992, EXP EYE RES, V55, P47; SZEL A, 1994, CELL TISSUE RES, V276, P143, DOI 10.1007/BF00354793; Szel A, 1996, MICROSC RES TECHNIQ, V35, P445; SZEL A, 1992, J COMP NEUROL, V325, P327, DOI 10.1002/cne.903250302; SZEL A, 1993, J COMP NEUROL, V331, P561; TOVEE MJ, 1995, TRENDS ECOL EVOL, V10, P455, DOI 10.1016/S0169-5347(00)89179-X; Wang Y, 1999, P NATL ACAD SCI USA, V96, P5251, DOI 10.1073/pnas.96.9.5251; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO; WOOD P, 1993, P ROY SOC B-BIOL SCI, V254, P227, DOI 10.1098/rspb.1993.0150; Yokoyama S, 1998, MOL BIOL EVOL, V15, P560, DOI 10.1093/oxfordjournals.molbev.a025956; Yokoyama S, 1998, FEBS LETT, V423, P155, DOI 10.1016/S0014-5793(98)00086-6	60	412	418	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	2000	27	3					513	523		10.1016/S0896-6273(00)00062-3	http://dx.doi.org/10.1016/S0896-6273(00)00062-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	359FR	11055434	Bronze			2022-12-24	WOS:000089601300015
J	Morales, M; Colicos, MA; Goda, Y				Morales, M; Colicos, MA; Goda, Y			Actin-dependent regulation of neurotransmitter release at central synapses	NEURON			English	Article							TERM SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; DENDRITIC SPINES; TRANSMITTER RELEASE; CEREBELLAR CORTEX; EXOCYTOSIS; CURRENTS; VESICLES; FILAMENT; CULTURE	Depolymerization of actin by latrunculin A transiently promotes neurotransmitter release. The mean rate of mEPSCs increases by a Ca2+-independent process, without a concomitant change in the mean amplitude. The readily releasable vesicle pool size and the rate of refilling of the readily releasable pool remain unaltered by latrunculin treatment. Evoked neurotransmitter release also increases in a manner consistent with an increase in vesicle release probability. The observed enhancement of neurotransmitter release is specific to actin depolymerization mediated by latrunculin A and is not caused by cytochalasin D. Our findings indicate that actin participates in a regulatory mechanism that restrains fusion of synaptic vesicles at the active zone.	Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Goda, Y (corresponding author), Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA.	ygoda@biomail.ucsd.edu	Goda, Yukiko/AAR-5641-2020; Morales, Miguel/G-8995-2014; Goda, Yukiko/A-6576-2016	Goda, Yukiko/0000-0003-0352-9498; Morales, Miguel/0000-0002-8885-2333; Goda, Yukiko/0000-0003-0352-9498				Allison DW, 1998, J NEUROSCI, V18, P2423; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Bi GQ, 1997, J CELL BIOL, V138, P999, DOI 10.1083/jcb.138.5.999; CHEEK TR, 1987, J BIOL CHEM, V262, P11663; COHEN MW, 1991, J NEUROSCI, V11, P1032; Cole JC, 2000, J PHYSIOL-LONDON, V525, P579, DOI 10.1111/j.1469-7793.2000.t01-2-00579.x; DANDREA L, 1994, J CELL SCI, V107, P2081; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Doussau F, 2000, J BIOL CHEM, V275, P7764, DOI 10.1074/jbc.275.11.7764; FAIVRESARRAILH C, 1993, J NEUROCYTOL, V22, P1060, DOI 10.1007/BF01235749; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; FIFKOVA E, 1982, J CELL BIOL, V95, P345, DOI 10.1083/jcb.95.1.345; FIFKOVA E, 1992, INT REV CYTOL, V139, P267, DOI 10.1016/S0074-7696(08)61414-X; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; FORSYTHE ID, 1988, J PHYSIOL-LONDON, V396, P515, DOI 10.1113/jphysiol.1988.sp016975; GOTOW T, 1991, NEUROSCIENCE, V40, P587, DOI 10.1016/0306-4522(91)90143-C; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; ICHIMURA T, 1988, J NEUROCYTOL, V17, P3, DOI 10.1007/BF01735373; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; Katz B., 1969, RELEASE NEURAL TRANS; Kim CH, 1999, J NEUROSCI, V19, P4314; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; LANDIS DMD, 1988, NEURON, V1, P201, DOI 10.1016/0896-6273(88)90140-7; Lerma J, 1998, CURR TOP DEV BIOL, V36, P293; MALLART A, 1968, J PHYSIOL-LONDON, V196, P593, DOI 10.1113/jphysiol.1968.sp008525; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; MENNERICK S, 1995, J PHYSIOL-LONDON, V488, P85, DOI 10.1113/jphysiol.1995.sp020948; Missler M, 1998, J NEUROCHEM, V71, P1339; MOCHIDA S, 1994, NEURON, V13, P1131, DOI 10.1016/0896-6273(94)90051-5; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; Sattler R, 2000, J NEUROSCI, V20, P22, DOI 10.1523/JNEUROSCI.20-01-00022.2000; Spector I, 1999, MICROSC RES TECHNIQ, V47, P18, DOI 10.1002/(SICI)1097-0029(19991001)47:1<18::AID-JEMT3>3.0.CO;2-E; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; VITALE ML, 1995, NEURON, V14, P353, DOI 10.1016/0896-6273(95)90291-0; Wang XH, 1996, J PHYSIOL-LONDON, V491, P187, DOI 10.1113/jphysiol.1996.sp021206; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	45	236	241	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	2000	27	3					539	550		10.1016/S0896-6273(00)00064-7	http://dx.doi.org/10.1016/S0896-6273(00)00064-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	359FR	11055436	Bronze			2022-12-24	WOS:000089601300017
J	Furmanski, CS; Engel, SA				Furmanski, CS; Engel, SA			An oblique effect in human primary visual cortex	NATURE NEUROSCIENCE			English	Article							ORIENTATION DISCRIMINATION; PERCEPTION; STRIATE; CELLS; AREAS		Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Furmanski, CS (corresponding author), Univ Calif Los Angeles, Dept Psychol, Box 951563,Franz Hall, Los Angeles, CA 90095 USA.							BUCHANANSMITH HM, 1993, PERCEPTION, V22, P1389, DOI 10.1068/p221389; CAMPBELL FW, 1966, J PHYSIOL-LONDON, V187, P427, DOI 10.1113/jphysiol.1966.sp008100; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P2621, DOI 10.1073/pnas.95.5.2621; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; FINLAY BL, 1976, J NEUROPHYSIOL, V39, P1352, DOI 10.1152/jn.1976.39.6.1352; HEELEY DW, 1988, VISION RES, V28, P337, DOI 10.1016/0042-6989(88)90162-9; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; MAFFEI L, 1970, SCIENCE, V167, P386, DOI 10.1126/science.167.3917.386; MANSFIELD RJ, 1974, SCIENCE, V186, P1133, DOI 10.1126/science.186.4169.1133; MATIN E, 1984, PERCEPT PSYCHOPHYS, V35, P589, DOI 10.3758/BF03205959; ORBAN GA, 1984, VISION RES, V24, P121, DOI 10.1016/0042-6989(84)90097-X; Orban GA, 1997, EUR J NEUROSCI, V9, P246, DOI 10.1111/j.1460-9568.1997.tb01395.x; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376	15	260	267	2	40	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2000	3	6					535	536		10.1038/75702	http://dx.doi.org/10.1038/75702			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	317WG	10816307				2022-12-24	WOS:000087249500007
J	Schmolesky, MT; Wang, YC; Pu, ML; Leventhal, AG				Schmolesky, MT; Wang, YC; Pu, ML; Leventhal, AG			Degradation of stimulus selectivity of visual cortical cells in senescent rhesus monkeys	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; LATERAL GENICULATE NEURONS; STRIATE CORTEX; ORIENTATION SELECTIVITY; CEREBRAL-CORTEX; DIRECTION SELECTIVITY; CONTRAST SENSITIVITY; PRIMATE RETINA; NEURAL BASES; LIFE-SPAN	Human visual function declines with age. Much of this decline is probably mediated by changes in the central visual pathways. We compared the stimulus selectivity of cells in primary visual cortex (striate cortex or V1) in young adult and very old macaque monkeys using single-neuron in vivo electrophysiology. Our results provide evidence for a significant degradation of orientation and direction selectivity in senescent animals. The decreased selectivity of cells in old animals was accompanied by increased responsiveness to all orientations and directions as well as an increase in spontaneous activity. The decreased selectivities and increased excitability of cells in old animals are consistent with an age-related degeneration of intracortical inhibition. The neural changes described here could underlie declines in visual function during senescence.	Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Leventhal, AG (corresponding author), Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA.	audie.leventhal@m.cc.u.utah.edu		Schmolesky, Matthew/0000-0002-3536-3333	NEI NIH HHS [EY04951] Funding Source: Medline; NIA NIH HHS [AG16148] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY004951] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG016148] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AHMAD A, 1993, J COMP NEUROL, V334, P631, DOI 10.1002/cne.903340410; Crook JM, 1998, EUR J NEUROSCI, V10, P2056, DOI 10.1046/j.1460-9568.1998.00218.x; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; Dustman RE, 1996, BRAIN COGNITION, V30, P109, DOI 10.1006/brcg.1996.0007; Eysel UT, 1998, NEUROSCIENCE, V84, P25, DOI 10.1016/S0306-4522(97)00378-3; FITZPATRICK D, 1987, J COMP NEUROL, V264, P73, DOI 10.1002/cne.902640107; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Kim CBY, 1997, ANAT REC, V247, P119, DOI 10.1002/(SICI)1097-0185(199701)247:1<119::AID-AR14>3.0.CO;2-S; KLINE DW, 1983, J GERONTOL, V38, P211, DOI 10.1093/geronj/38.2.211; KLINE DW, 1991, VISION VISUAL DYSFUN, V16, P150; KLINE DW, 1985, HDB PSYCHOL AGING, P296; LEVENTHAL AG, 1993, J COMP NEUROL, V338, P242, DOI 10.1002/cne.903380208; LEVENTHAL AG, 1980, J NEUROPHYSIOL, V43, P1111, DOI 10.1152/jn.1980.43.4.1111; LEVENTHAL AG, 1988, SCIENCE, V240, P66, DOI 10.1126/science.3353708; LEVENTHAL AG, 1981, SCIENCE, V213, P1139, DOI 10.1126/science.7268423; LEVENTHAL AG, 1995, J NEUROSCI, V15, P1808, DOI 10.1523/JNEUROSCI.15-03-01808.1995; MCGEER E, 1976, NEUROBIOL AGING, P389; ORBAN GA, 1991, NEURAL BASIS VISUAL, P173; ORDY JM, 1979, SENSORY SYSTEMS COMM, P13; OWSLEY C, 1987, BRIT J OPHTHALMOL, V71, P791, DOI 10.1136/bjo.71.10.791; OWSLEY C, 1981, INVEST OPHTH VIS SCI, V21, P362; PERRY VH, 1981, EXP BRAIN RES, V43, P226; PETERS A, 1993, ANAT REC, V236, P721, DOI 10.1002/ar.1092360416; Peters A, 1998, CEREB CORTEX, V8, P295, DOI 10.1093/cercor/8.4.295; PETERS A, 1991, ANAT REC, V229, P384, DOI 10.1002/ar.1092290311; Peters A, 1997, NEUROBIOL AGING, V18, P29, DOI 10.1016/S0197-4580(96)00208-4; Porciatti V, 1999, VISION RES, V39, P2157, DOI 10.1016/S0042-6989(98)00288-0; PORCIATTI V, 1992, VISION RES, V32, P1199, DOI 10.1016/0042-6989(92)90214-4; PU M, 1992, J NEUROSCI METH, V41, P45, DOI 10.1016/0165-0270(92)90122-T; Pu ML, 1999, J COMP NEUROL, V414, P267; Ross RG, 1999, BIOL PSYCHIAT, V46, P383, DOI 10.1016/S0006-3223(98)00369-2; SAMORAJSKI T, 1977, J AM GERIATR SOC, V25, P337, DOI 10.1111/j.1532-5415.1977.tb00657.x; Sato H, 1996, J PHYSIOL-LONDON, V494, P757, DOI 10.1113/jphysiol.1996.sp021530; SCHEIBEL ME, 1975, EXP NEUROL, V47, P392, DOI 10.1016/0014-4886(75)90072-2; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1288, DOI 10.1152/jn.1976.39.6.1288; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; SHERMAN SM, 1982, PHYSIOL REV, V62, P738, DOI 10.1152/physrev.1982.62.2.738; SILLITO AM, 1979, J PHYSIOL-LONDON, V289, P33, DOI 10.1113/jphysiol.1979.sp012723; SILLITO AM, 1977, J PHYSIOL-LONDON, V271, P699, DOI 10.1113/jphysiol.1977.sp012021; SPEAR PD, 1994, J NEUROPHYSIOL, V72, P402, DOI 10.1152/jn.1994.72.1.402; SPEAR PD, 1993, VISION RES, V33, P2589, DOI 10.1016/0042-6989(93)90218-L; TIGGES J, 1988, AM J PRIMATOL, V15, P263, DOI 10.1002/ajp.1350150308; TOMODA H, 1991, DOC OPHTHALMOL, V77, P201, DOI 10.1007/BF00161368; Tran DB, 1998, GRAEF ARCH CLIN EXP, V236, P269, DOI 10.1007/s004170050076; TRICK GL, 1986, CURR EYE RES, V5, P717, DOI 10.3109/02713688609000011; VINCENT SL, 1989, ANAT REC, V223, P329, DOI 10.1002/ar.1092230312; VOLGUSHEV M, 1993, VISUAL NEUROSCI, V10, P1151, DOI 10.1017/S0952523800010257; Walker EP., 1975, MAMMALS WORLD; WATANABE M, 1989, J COMP NEUROL, V289, P434, DOI 10.1002/cne.902890308; WESTON HC, 1948, BRIT J OPHTHALMOL, V32, P645, DOI 10.1136/bjo.32.9.645	50	279	298	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2000	3	4					384	390		10.1038/73957	http://dx.doi.org/10.1038/73957			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330CN	10725929				2022-12-24	WOS:000087945400020
J	Seung, HS; Lee, DD; Reis, BY; Tank, DW				Seung, HS; Lee, DD; Reis, BY; Tank, DW			Stability of the memory of eye position in a recurrent network of conductance-based model neurons	NEURON			English	Article							NUCLEUS-PREPOSITUS-HYPOGLOSSI; MEDIAL VESTIBULAR NUCLEUS; OCULOMOTOR NEURAL INTEGRATOR; IBOTENIC ACID LESIONS; BRAIN-STEM; ALERT CAT; VESTIBULOOCULAR REFLEX; ABDUCENS NUCLEUS; MUSCIMOL MICROINJECTIONS; ANATOMICAL CONNECTIONS	Studies of the neural correlates of short-term memory in a wide variety of brain areas have found that transient inputs can cause persistent changes in rates of action potential firing, through a mechanism that remains unknown. In a premotor area that is responsible for holding the eyes still during fixation, persistent neural firing encodes the angular position of the eyes in a characteristic manner: below a threshold position the neuron is silent, and above it the firing rate is linearly related to position. Both the threshold and linear slope vary from neuron to neuron. We have reproduced this behavior in a biophysically plausible network model. Persistence depends on precise tuning of the strength of synaptic feedback, and a relatively long synaptic time constant improves the robustness to mistuning.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Lucent Technol, Bell Labs, Murray Hill, NJ 07974 USA	Massachusetts Institute of Technology (MIT); Alcatel-Lucent; Lucent Technologies; AT&T	Seung, HS (corresponding author), MIT, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.		Lee, Daniel D./B-5753-2013	Lee, Daniel/0000-0003-4239-8777				Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; ANASTASIO TJ, 1991, NEUROSCI LETT, V127, P82, DOI 10.1016/0304-3940(91)90900-E; Arnold DB, 1997, EXP BRAIN RES, V113, P57, DOI 10.1007/BF02454142; ARNOLD DB, 1991, BIOL CYBERN, V64, P447, DOI 10.1007/BF00202608; ARNOLD DB, 1992, PHILOS T ROY SOC B, V337, P327, DOI 10.1098/rstb.1992.0110; BECKER W, 1973, VISION RES, V13, P1021, DOI 10.1016/0042-6989(73)90141-7; BELKNAP DB, 1988, J COMP NEUROL, V268, P13, DOI 10.1002/cne.902680103; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Camperi M, 1998, J COMPUT NEUROSCI, V5, P383, DOI 10.1023/A:1008837311948; CANNON SC, 1985, BIOL CYBERN, V53, P93, DOI 10.1007/BF00337026; CANNON SC, 1983, BIOL CYBERN, V49, P127, DOI 10.1007/BF00320393; CANNON SC, 1987, J NEUROPHYSIOL, V57, P1383, DOI 10.1152/jn.1987.57.5.1383; CHERON G, 1986, J PHYSIOL-LONDON, V372, P75, DOI 10.1113/jphysiol.1986.sp015998; CHERON G, 1986, J PHYSIOL-LONDON, V372, P95, DOI 10.1113/jphysiol.1986.sp015999; CHERON G, 1987, J PHYSIOL-LONDON, V394, P267, DOI 10.1113/jphysiol.1987.sp016870; DULAC S, 1995, J COMP PHYSIOL A, V176, P641; Ermentrout B, 1998, NEURAL COMPUT, V10, P1721, DOI 10.1162/089976698300017106; ERMENTROUT B, 1994, NEURAL COMPUT, V6, P679, DOI 10.1162/neco.1994.6.4.679; Ermentrout B, 1998, REP PROG PHYS, V61, P353, DOI 10.1088/0034-4885/61/4/002; ESCUDERO M, 1988, EXP BRAIN RES, V71, P218; ESCUDERO M, 1992, J PHYSIOL-LONDON, V458, P539, DOI 10.1113/jphysiol.1992.sp019433; Fuster JM, 1995, MEMORY CEREBRAL CORT; GALIANA HL, 1984, J NEUROPHYSIOL, V51, P210, DOI 10.1152/jn.1984.51.2.210; GODAUX E, 1989, EXP BRAIN RES, V77, P94; GODAUX E, 1993, J PHYSIOL-LONDON, V472, P459, DOI 10.1113/jphysiol.1993.sp019956; GROSSBERG S, 1988, NEURAL NETWORKS, V1, P17, DOI 10.1016/0893-6080(88)90021-4; HESS K, 1985, NEURO-OPHTHALMOLOGY, V5, P247, DOI 10.3109/01658108509004937; HOPFIELD JJ, 1986, SCIENCE, V233, P625, DOI 10.1126/science.3755256; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; KAMATH BY, 1976, MATH BIOSCI, V30, P341, DOI 10.1016/0025-5564(76)90073-0; Kaneko CRS, 1997, J NEUROPHYSIOL, V78, P1753, DOI 10.1152/jn.1997.78.4.1753; Kaneko CRS, 1999, J NEUROPHYSIOL, V81, P668, DOI 10.1152/jn.1999.81.2.668; LOPEZBARNEO J, 1982, J NEUROPHYSIOL, V47, P329, DOI 10.1152/jn.1982.47.2.329; MCCREA RA, 1985, J COMP NEUROL, V237, P377, DOI 10.1002/cne.902370308; MCFARLAND JL, 1992, J NEUROPHYSIOL, V68, P319, DOI 10.1152/jn.1992.68.1.319; METTENS P, 1994, NEUROREPORT, V5, P1333, DOI 10.1097/00001756-199406270-00009; METTENS P, 1994, J NEUROPHYSIOL, V72, P785, DOI 10.1152/jn.1994.72.2.785; Moschovakis A K, 1997, Front Biosci, V2, pd552; PASTOR AM, 1994, P NATL ACAD SCI USA, V91, P807, DOI 10.1073/pnas.91.2.807; RINZEL J, 1992, NEURAL COMPUT, V4, P534, DOI 10.1162/neco.1992.4.4.534; ROBINSON DA, 1964, J PHYSIOL-LONDON, V174, P245, DOI 10.1113/jphysiol.1964.sp007485; ROBINSON DA, 1989, ANNU REV NEUROSCI, V12, P33, DOI 10.1146/annurev.neuro.12.1.33; ROSEN MJ, 1972, IEEE T BIO-MED ENG, VBM19, P362, DOI 10.1109/TBME.1972.324139; SCUDDER CA, 1992, J NEUROPHYSIOL, V68, P244, DOI 10.1152/jn.1992.68.1.244; SERAFIN M, 1991, EXP BRAIN RES, V84, P417, DOI 10.1007/BF00231464; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; SEUNG HS, 2000, IN PRESS J COMPUT NE; SPENCER RF, 1989, J NEUROSCI, V9, P2718; STRAUBE A, 1991, EXP BRAIN RES, V86, P347; TILIKET C, 1994, EXP BRAIN RES, V100, P316; Verhulst F., 1985, AVERAGING METHODS NO, DOI 10.1007/978-1-4757-4575-7; Wang XJ, 1998, J NEUROPHYSIOL, V79, P1549, DOI 10.1152/jn.1998.79.3.1549; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; XIE X, 2000, IN PRESS ADV NEURAL, V12; YOKOTA J, 1992, EXP BRAIN RES, V92, P123; Zhang K, 1996, J NEUROSCI, V16, P2112; [No title captured]	57	238	242	1	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	2000	26	1					259	271		10.1016/S0896-6273(00)81155-1	http://dx.doi.org/10.1016/S0896-6273(00)81155-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309MA	10798409	Bronze			2022-12-24	WOS:000086770500025
J	Tansey, MG; Baloh, RH; Milbrandt, J; Johnson, EM				Tansey, MG; Baloh, RH; Milbrandt, J; Johnson, EM			GFR alpha-mediated localization of RET to lipid rafts is required for effective downstream signaling, differentiation, and neuronal survival	NEURON			English	Article							MIDBRAIN DOPAMINERGIC-NEURONS; RECEPTOR TYROSINE KINASE; GPI-ANCHORED PROTEINS; NEUROTROPHIC FACTOR; CELL-SURFACE; GDNFR-ALPHA; FUNCTIONAL RECEPTOR; CAVEOLAE MEMBRANE; NEURTURIN; ACTIVATION	The GDNF family ligands (GFLs: GDNF, neurturin, persephin, and artemin) signal through RET and a glycosyl-phosphatidylinositol (GPI)-anchored coreceptor (GFR alpha 1-alpha 4) that binds ligand with high affinity and provides specificity. The importance of the GPI anchor is not fully understood; however, GPI-linked proteins cluster into lipid rafts, structures that may represent highly specialized signaling organelles. Here, we report that GPI-anchored GFR alpha 1 recruits RET to lipid rafts after GDNF stimulation and results in RET/Src association. Disruption of RET localization using either transmembrane-anchored or soluble GFR alpha 1 results in RET phosphorylation, but GDNF-induced intracellular signaling events are markedly attenuated as are neuronal differentiation and survival responses. Therefore, proper membrane localization of RET via interaction with a raft-localized, GPI-linked coreceptor is of fundamental importance in GFL signaling.	Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Milbrandt, J (corresponding author), Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA.			Milbrandt, Jeffrey/0000-0002-5477-7689	NATIONAL INSTITUTE ON AGING [R01AG013729, R01AG013730] Funding Source: NIH RePORTER; NIA NIH HHS [AG-13730, AG-13729] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Baloh RH, 1998, P NATL ACAD SCI USA, V95, P5801, DOI 10.1073/pnas.95.10.5801; Baloh RH, 1997, NEURON, V18, P793, DOI 10.1016/S0896-6273(00)80318-9; Baloh RH, 1998, NEURON, V21, P1291, DOI 10.1016/S0896-6273(00)80649-2; BOHUSLAV J, 1995, J EXP MED, V181, P1381, DOI 10.1084/jem.181.4.1381; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; BujBello A, 1997, NATURE, V387, P721, DOI 10.1038/42729; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; CINEK T, 1992, J IMMUNOL, V149, P2262; Creedon DJ, 1997, P NATL ACAD SCI USA, V94, P7018, DOI 10.1073/pnas.94.13.7018; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; DeMali KA, 1998, MOL CELL BIOL, V18, P2014, DOI 10.1128/MCB.18.4.2014; Durbec P, 1996, NATURE, V381, P789, DOI 10.1038/381789a0; EBENDAL T, 1995, J NEUROSCI RES, V40, P276, DOI 10.1002/jnr.490400217; Eigenbrot C, 1997, NAT STRUCT BIOL, V4, P435, DOI 10.1038/nsb0697-435; Enokido Y, 1998, CURR BIOL, V8, P1019, DOI 10.1016/S0960-9822(07)00422-8; Golden JP, 1998, J COMP NEUROL, V398, P139, DOI 10.1002/(SICI)1096-9861(19980817)398:1<139::AID-CNE9>3.0.CO;2-2; Green JM, 1997, J CELL BIOL, V139, P1209, DOI 10.1083/jcb.139.5.1209; HANSBROUGH JR, 1991, AM J PHYSIOL, V260, P929; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Heuckeroth RO, 1998, DEV BIOL, V200, P116, DOI 10.1006/dbio.1998.8955; Hooper NM, 1997, CLIN CHIM ACTA, V266, P3, DOI 10.1016/S0009-8981(97)00161-7; Hope HR, 1996, MOL BIOL CELL, V7, P843, DOI 10.1091/mbc.7.6.843; Horger BA, 1998, J NEUROSCI, V18, P4929; IWAMOTO T, 1993, ONCOGENE, V8, P1087; Jacobson K, 1999, TRENDS CELL BIOL, V9, P87, DOI 10.1016/S0962-8924(98)01495-0; Jing SQ, 1997, J BIOL CHEM, V272, P33111, DOI 10.1074/jbc.272.52.33111; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Klein RD, 1997, NATURE, V387, P717, DOI 10.1038/42722; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Melillo RM, 1999, CANCER RES, V59, P1120; Milbrandt J, 1998, NEURON, V20, P245, DOI 10.1016/S0896-6273(00)80453-5; Miller TM, 1996, J NEUROSCI, V16, P7487; Moran M, 1998, IMMUNITY, V9, P787, DOI 10.1016/S1074-7613(00)80644-5; Moulder KL, 1999, J NEUROSCI, V19, P705; Naveilhan P, 1997, EUR J NEUROSCI, V9, P1450, DOI 10.1111/j.1460-9568.1997.tb01499.x; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; Sanicola M, 1997, P NATL ACAD SCI USA, V94, P6238, DOI 10.1073/pnas.94.12.6238; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; STEFANOVA I, 1991, SCIENCE, V254, P1016, DOI 10.1126/science.1719635; Suvanto P, 1997, HUM MOL GENET, V6, P1267, DOI 10.1093/hmg/6.8.1267; TANIUCHI M, 1986, P NATL ACAD SCI USA, V83, P4094, DOI 10.1073/pnas.83.11.4094; Taraviras S, 1999, DEVELOPMENT, V126, P2785; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Trupp M, 1999, J BIOL CHEM, V274, P20885, DOI 10.1074/jbc.274.30.20885; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; Trupp M, 1997, J NEUROSCI, V17, P3554; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Worby CA, 1996, J BIOL CHEM, V271, P23619, DOI 10.1074/jbc.271.39.23619; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yancey PG, 1996, J BIOL CHEM, V271, P16026, DOI 10.1074/jbc.271.27.16026; Yu T, 1998, J NEUROSCI, V18, P4684	59	245	251	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR	2000	25	3					611	623		10.1016/S0896-6273(00)81064-8	http://dx.doi.org/10.1016/S0896-6273(00)81064-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	301CY	10774729	Bronze			2022-12-24	WOS:000086291700014
J	Seidemann, E; Poirson, AB; Wandell, BA; Newsome, WT				Seidemann, E; Poirson, AB; Wandell, BA; Newsome, WT			Color signals in area MT of the macaque monkey	NEURON			English	Article							MIDDLE TEMPORAL AREA; HUMAN VISUAL-CORTEX; FUNCTIONAL SPECIALIZATION; MOTION; PERCEPTION; FORM; MOVEMENT; DEPTH; SEGREGATION; RESPONSES	The relationship between the neural processing of color and motion information has been a contentious issue in visual neuroscience. We examined this relationship directly by measuring neural responses to isoluminant S cone signals in extrastriate area MT of the macaque monkey. S cone stimuli produced robust, direction-selective responses at most recording sites, indicating that color signals are present in MT. While these responses were unequivocal, S cone contrast sensitivity was, on average, 1.0-1.3 log units lower than luminance contrast sensitivity. The presence of S cone responses and the relative sensitivity of MT neurons to S cone and luminance signals agree with functional magnetic resonance imaging (fMRI) measurements in human MT+. The results are consistent with the hypothesis that color signals in MT influence behavior in speed judgment tasks.	Stanford Univ, Howard Hughes Med Inst, Dept Neurobiol, Stanford, CA 94305 USA; Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Newsome, WT (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Neurobiol, Stanford, CA 94305 USA.	bill@monkeybiz.stanford.edu	Newsome, William T./W-7171-2019	Seidemann, Eyal/0000-0003-2841-5948	NATIONAL EYE INSTITUTE [R01EY003164, R37EY005603, R01EY005603] Funding Source: NIH RePORTER; NEI NIH HHS [EY03164, EY05603] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aguilar M., 1954, OPT ACTA, V1, DOI [10.1080/713818657, DOI 10.1080/713818657]; ALBRIGHT TD, 1992, SCIENCE, V255, P1141, DOI 10.1126/science.1546317; CAVANAGH P, 1991, VISION RES, V31, P2109, DOI 10.1016/0042-6989(91)90169-6; CRIST CF, 1988, J NEUROSCI METH, V26, P117, DOI 10.1016/0165-0270(88)90160-4; Croner LJ, 1999, J NEUROSCI, V19, P3935; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; DeAngelis GC, 1998, NATURE, V394, P677, DOI 10.1038/29299; DOBKINS K, 1998, HIGH LEVEL MOTION PR; DOBKINS KR, 1994, J NEUROSCI, V14, P4854; Dougherty RF, 1999, NEURON, V24, P893, DOI 10.1016/S0896-6273(00)81036-3; Gegenfurtner KR, 1996, TRENDS NEUROSCI, V19, P394, DOI 10.1016/S0166-2236(96)10036-9; GEGENFURTNER KR, 1994, VISUAL NEUROSCI, V11, P455, DOI 10.1017/S095252380000239X; HAWKEN MJ, 1994, NATURE, V367, P268, DOI 10.1038/367268a0; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; HOOD DC, 1986, HDB PERCEPTION HUMAN; HUBEL DH, 1987, J NEUROSCI, V7, P3378; KLUG KY, 1993, INVEST OPHTH VIS SCI, V34, pA1398; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; Martin PR, 1997, EUR J NEUROSCI, V9, P1536, DOI 10.1111/j.1460-9568.1997.tb01509.x; MAUNSELL JHR, 1990, J NEUROSCI, V10, P3323; MULLEN KT, 1992, OPHTHAL PHYSL OPT, V12, P201, DOI 10.1111/j.1475-1313.1992.tb00290.x; MULLEN KT, 1992, VISION RES, V32, P483, DOI 10.1016/0042-6989(92)90240-J; OLAVARRIA JF, 1992, J NEUROPHYSIOL, V68, P164, DOI 10.1152/jn.1992.68.1.164; Rodieck R.W., 1998, 1 STEPS SEEING; SAITO H, 1989, EXP BRAIN RES, V75, P1; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; Seidemann E, 1999, J NEUROPHYSIOL, V81, P1783, DOI 10.1152/jn.1999.81.4.1783; Thiele A, 1999, J NEUROSCI, V19, P6571; Wandell B.A., 1995, FDN VISION; Wandell BA, 1999, NEURON, V24, P901, DOI 10.1016/S0896-6273(00)81037-5; ZEKI S, 1991, J NEUROSCI, V11, P641; ZEKI S, 1990, COLD SPRING HARB SYM, V55, P651	33	90	96	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1999	24	4					911	917		10.1016/S0896-6273(00)81038-7	http://dx.doi.org/10.1016/S0896-6273(00)81038-7			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	269UE	10624954	Bronze			2022-12-24	WOS:000084495300019
J	Zilberter, Y; Kaiser, KMM; Sakmann, B				Zilberter, Y; Kaiser, KMM; Sakmann, B			Dendritic GABA release depresses excitatory transmission between layer 2/3 pyramidal and bitufted neurons in rat neocortex	NEURON			English	Article							LONG-TERM POTENTIATION; TRANSMITTER RELEASE; SYNAPTIC PLASTICITY; CALCIUM CHANNELS; NEUROTRANSMITTER RELEASE; PRESYNAPTIC INHIBITION; RETROGRADE MESSENGER; RECEPTOR ACTIVATION; CHROMAFFIN CELLS; EXOCYTOSIS	GABAergic, somatostatin-containing bitufted interneurons in layer 2/3 of rat neocortex are excited via glutamatergic excitatory postsynaptic potentials (EPSPs) by pyramidal neurons located in the same cortical layer. Pair recordings showed that short bursts of backpropagating dendritic action potentials (APs) reduced the amplitude of unitary EPSPs. EPSP depression was dependent on a rise in dendritic [Ca2+]. The effect was blocked by the GABA(B) receptor (GABA(B)-R) antagonist CGP55845A and was mimicked by the GABA(B)-R agonist baclofen. As presynaptic GABA(B)-Rs were activated neither by somatostatin nor by GABA released from axon collaterals of the bitufted cell, we conclude that GABA(B)-Rs were activated by a retrograde messenger, most likely GABA, released from the dendrite. Because synaptic depression was prevented by loading bitufted neurons with GDP-beta-S, it is likely to be caused by exocytotic GABA release from dendrites.	Max Planck Inst Med Forsch, Zellphysiol Abt, D-69120 Heidelberg, Germany	Max Planck Society	Zilberter, Y (corresponding author), Karolinska Inst, Dept Neurosci, Div Neuroanat & Brain Dev, Berzellus Vag 3,Plan 5, S-17177 Stockholm, Sweden.							ALGER BE, 1995, TRENDS NEUROSCI, V18, P333, DOI 10.1016/0166-2236(95)93923-L; ATTWELL D, 1993, NEURON, V11, P401, DOI 10.1016/0896-6273(93)90145-H; Attwell David, 1994, Current Opinion in Neurobiology, V4, P353, DOI 10.1016/0959-4388(94)90096-5; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; Bajjalieh SM, 1999, CURR OPIN NEUROBIOL, V9, P321, DOI 10.1016/S0959-4388(99)80047-6; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bean AJ, 1997, NEURON, V19, P751, DOI 10.1016/S0896-6273(00)80957-5; Boehm S, 1997, J NEUROSCI, V17, P4066; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Chen G, 1998, J NEUROSCI, V18, P1913; DAVIES CH, 1993, NEUROPHARMACOLOGY, V32, P1071, DOI 10.1016/0028-3908(93)90073-C; Dittman JS, 1997, J NEUROSCI, V17, P9048; FAZELI MS, 1992, TRENDS NEUROSCI, V15, P115, DOI 10.1016/0166-2236(92)90350-H; Fitzsimonds RM, 1998, PHYSIOL REV, V78, P143, DOI 10.1152/physrev.1998.78.1.143; Glitsch M, 1996, J PHYSIOL-LONDON, V497, P531, DOI 10.1113/jphysiol.1996.sp021786; Greene JRT, 1996, J NEUROPHYSIOL, V76, P1657, DOI 10.1152/jn.1996.76.3.1657; Harayama N, 1998, J PHYSIOL-LONDON, V509, P371, DOI 10.1111/j.1469-7793.1998.371bn.x; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HESS SD, 1993, SCIENCE, V259, P1169, DOI 10.1126/science.8438167; Huang LYM, 1996, NEURON, V17, P135, DOI 10.1016/S0896-6273(00)80287-1; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; Jaffe EH, 1998, J NEUROSCI, V18, P3548; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; Maletic-Savatic M, 1998, J NEUROSCI, V18, P6803; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MONTAGUE PR, 1994, LEARN MEMORY, V1, P1; Morishita W, 1998, J NEUROSCI, V18, P4870; Naraghi M, 1997, J NEUROSCI, V17, P6961; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Ohana O, 1998, J PHYSIOL-LONDON, V513, P135, DOI 10.1111/j.1469-7793.1998.135by.x; PETERS A, 1988, J COMP NEUROL, V267, P409, DOI 10.1002/cne.902670310; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Roche Katherine W., 1994, Current Opinion in Neurobiology, V4, P383, DOI 10.1016/0959-4388(94)90100-7; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; SMITH SJ, 1988, TRENDS NEUROSCI, V11, P458, DOI 10.1016/0166-2236(88)90199-3; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sudhof TC, 1997, NEURON, V18, P519, DOI 10.1016/S0896-6273(00)80292-5; Takahashi T, 1998, J NEUROSCI, V18, P3138; Viana F, 1996, J NEUROSCI, V16, P6000; WANG HL, 1990, NEUROSCIENCE, V38, P335, DOI 10.1016/0306-4522(90)90032-Y; WU LG, 1995, J PHYSIOL-LONDON, V485, P649, DOI 10.1113/jphysiol.1995.sp020759; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	48	115	116	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1999	24	4					979	988		10.1016/S0896-6273(00)81044-2	http://dx.doi.org/10.1016/S0896-6273(00)81044-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	269UE	10624960	Bronze			2022-12-24	WOS:000084495300025
J	Paoletti, P; Perin-Dureau, F; Fayyazuddin, A; Le Goff, A; Callebaut, I; Neyton, J				Paoletti, P; Perin-Dureau, F; Fayyazuddin, A; Le Goff, A; Callebaut, I; Neyton, J			Molecular organization of a zinc binding N-terminal modulatory domain in a NMDA receptor subunit	NEURON			English	Article							D-ASPARTATE RECEPTOR; METABOTROPIC GLUTAMATE-RECEPTOR; CALCIUM-SENSING RECEPTOR; LIGAND-BINDING; EXTRACELLULAR DOMAIN; PROTEIN-STRUCTURE; INHIBITION; DESENSITIZATION; IDENTIFICATION; IFENPRODIL	Ionotropic glutamate receptors (iGluRs) bind agonists in a domain that has been crystallized and shown to have a bilobed structure. Eukaryotic iGluRs also possess a second extracellular N-terminal domain related to the bacterial periplasmic binding protein LIVBP. In NMDA receptors, the high-affinity Zn inhibition is eliminated by mutations in the LIVBP-like domain of the NR2A subunit. Using LIVBP structure, we have modeled this domain as two lobes connected by a hinge and show that six residues controlling Zn inhibition form two clusters facing each other across a central cleft. Upon Zn binding the two lobes close tightly around the divalent cation. Thus, the extracellular region of NR2A consists of a tandem of Venus flytrap domains, one binding the agonist and the other a modulatory ligand. Such a functional organization may apply to other eukaryotic iGluRs.	Ecole Normale Super, Neurobiol Lab, CNRS, UMR 8544, F-75005 Paris, France; CNRS, UMR C7590, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS)	Paoletti, P (corresponding author), Ecole Normale Super, Neurobiol Lab, CNRS, UMR 8544, 46 Rue Ulm, F-75005 Paris, France.		Paoletti, Pierre/L-7358-2013	Paoletti, Pierre/0000-0002-3681-4845				AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Brauner-Osborne H, 1999, J BIOL CHEM, V274, P18382, DOI 10.1074/jbc.274.26.18382; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Chen NS, 1997, MOL PHARMACOL, V51, P1015, DOI 10.1124/mol.51.6.1015; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; Dingledine R, 1999, PHARMACOL REV, V51, P7; Fayyazuddin A, 2000, NEURON, V25, P683, DOI 10.1016/S0896-6273(00)81070-3; Gallagher MJ, 1996, J BIOL CHEM, V271, P9603, DOI 10.1074/jbc.271.16.9603; Galvez T, 1999, J BIOL CHEM, V274, P13362, DOI 10.1074/jbc.274.19.13362; GALVEZ T, 2000, IN PRESS J BIOL CHEM; GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P1; Hampson DR, 1999, J BIOL CHEM, V274, P33488, DOI 10.1074/jbc.274.47.33488; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; KAKANISHI N, 1990, NEURON, V5, P569; Krovetz HS, 1997, BIOPHYS J, V72, P117, DOI 10.1016/S0006-3495(97)78651-X; Krupp JJ, 1998, NEURON, V20, P317, DOI 10.1016/S0896-6273(00)80459-6; Kuusinen A, 1999, J BIOL CHEM, V274, P28937, DOI 10.1074/jbc.274.41.28937; Leuschner WD, 1999, J BIOL CHEM, V274, P16907, DOI 10.1074/jbc.274.24.16907; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Masuko T, 1999, MOL PHARMACOL, V55, P957, DOI 10.1124/mol.55.6.957; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Okamoto T, 1998, J BIOL CHEM, V273, P13089, DOI 10.1074/jbc.273.21.13089; Pace AJ, 1999, J BIOL CHEM, V274, P11629, DOI 10.1074/jbc.274.17.11629; PAOLETTI P, 1995, NEURON, V15, P1109, DOI 10.1016/0896-6273(95)90099-3; Paoletti P, 1997, J NEUROSCI, V17, P5711; Poupon A, 1998, PROTEINS, V33, P329, DOI 10.1002/(SICI)1097-0134(19981115)33:3<329::AID-PROT3>3.0.CO;2-E; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; SACK JS, 1989, J MOL BIOL, V206, P171, DOI 10.1016/0022-2836(89)90531-7; SACK JS, 1989, J MOL BIOL, V206, P193, DOI 10.1016/0022-2836(89)90532-9; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Traynelis SF, 1998, J NEUROSCI, V18, P6163; Villarroel A, 1998, NEURON, V20, P329, DOI 10.1016/S0896-6273(00)80460-2; Williams K, 1996, NEUROSCI LETT, V215, P9, DOI 10.1016/S0304-3940(96)12924-4	38	183	188	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	2000	28	3					911	925		10.1016/S0896-6273(00)00163-X	http://dx.doi.org/10.1016/S0896-6273(00)00163-X			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386JJ	11163276	Bronze			2022-12-24	WOS:000166057500026
J	Glazewski, S; Giese, KP; Silva, A; Fox, K				Glazewski, S; Giese, KP; Silva, A; Fox, K			The role of alpha-CaMKII autophosphorylation in neocortical experience-dependent plasticity	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-II; LONG-TERM POTENTIATION; RAT BARREL CORTEX; GLUTAMIC-ACID DECARBOXYLASE; MUTANT MICE; SOMATOSENSORY CORTEX; HIPPOCAMPAL-NEURONS; SYNAPTIC PLASTICITY; TETANIC STIMULATION; GENE-EXPRESSION	Calcium/calmodulin kinase type II (CaMKII) is a major postsynaptic density protein. CaMKII is postulated to act as a 'molecular switch', which, when triggered by a transient rise in calcium influx, becomes active for prolonged periods because of its ability to autophosphorylate. We studied experience-dependent plasticity in the barrel cortex of mice carrying a point mutation of the alpha -CaMKII gene (T286A), which abolishes this enzyme's ability to autophosphorylate. Plasticity was prevented in adult and adolescent mice homozygous for the mutation, but was normal in heterozygotes and wild-type littermates. These results provide evidence that the molecular switch hypothesis is valid for neocortical experience-dependent plasticity.	Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3US, S Glam, Wales; UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat & Psychol, Los Angeles, CA 90095 USA	Cardiff University; University of London; University College London; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Fox, K (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Museum Ave, Cardiff CF10 3US, S Glam, Wales.	foxkd@cardiff.ac.uk	Giese, Karl P/A-3112-2011; Fox, Kevin/E-8836-2010	Giese, Karl P/0000-0003-4503-7344; Fox, Kevin/0000-0002-2563-112X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R55NS027759, R01NS027759] Funding Source: NIH RePORTER; NINDS NIH HHS [NS27759] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; BENSON DL, 1991, J NEUROSCI, V11, P1540; BENSON DL, 1992, NEUROSCIENCE, V46, P825, DOI 10.1016/0306-4522(92)90188-8; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; BURGIN KE, 1990, J NEUROSCI, V10, P1788; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; FOX K, 1992, J NEUROSCI, V12, P1826; Fox K, 1996, P NATL ACAD SCI USA, V93, P5584, DOI 10.1073/pnas.93.11.5584; FOX K, 1994, J NEUROSCI, V14, P7665; FUKUNAGA K, 1995, J BIOL CHEM, V270, P6119, DOI 10.1074/jbc.270.11.6119; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Glazewski S, 1998, EUR J NEUROSCI, V10, P2107, DOI 10.1046/j.1460-9568.1998.00222.x; Glazewski S, 1999, CEREB CORTEX, V9, P249, DOI 10.1093/cercor/9.3.249; Glazewski S, 1996, SCIENCE, V272, P421, DOI 10.1126/science.272.5260.421; Glazewski S, 1996, J NEUROPHYSIOL, V75, P1714, DOI 10.1152/jn.1996.75.4.1714; Gordon JA, 1996, NEURON, V17, P491, DOI 10.1016/S0896-6273(00)80181-6; HENDRY SHC, 1986, P NATL ACAD SCI USA, V83, P1536, DOI 10.1073/pnas.83.5.1536; Hinds HL, 1998, LEARN MEMORY, V5, P344; JONES EG, 1994, J NEUROSCI, V14, P611; KENNEDY MB, 1983, P NATL ACAD SCI-BIOL, V80, P7357, DOI 10.1073/pnas.80.23.7357; Kirkwood A, 1997, P NATL ACAD SCI USA, V94, P3380, DOI 10.1073/pnas.94.7.3380; LI XR, 1995, J COMP NEUROL, V357, P465, DOI 10.1002/cne.903570310; LISMAN J, 1988, J PHYSIOL-PARIS, V83, P187; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; Liu XB, 1996, P NATL ACAD SCI USA, V93, P7332, DOI 10.1073/pnas.93.14.7332; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; MILLER SG, 1985, J BIOL CHEM, V260, P9039; Ouyang Y, 1997, J NEUROSCI, V17, P5416; Ouyang Y, 1999, J NEUROSCI, V19, P7823; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Sik A, 1998, P NATL ACAD SCI USA, V95, P3245, DOI 10.1073/pnas.95.6.3245; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Strack S, 1997, J NEUROCHEM, V68, P2119; Wallace H, 1999, SOMATOSENS MOT RES, V16, P122; Welker E, 1996, SCIENCE, V271, P1864, DOI 10.1126/science.271.5257.1864; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5	40	94	95	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2000	3	9					911	918		10.1038/78820	http://dx.doi.org/10.1038/78820			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TV	10966622				2022-12-24	WOS:000167177400018
J	Masai, I; Stemple, DL; Okamoto, H; Wilson, SW				Masai, I; Stemple, DL; Okamoto, H; Wilson, SW			Midline signals regulate retinal neurogenesis in zebrafish	NEURON			English	Article							MUTATIONS AFFECTING DEVELOPMENT; ONE-EYED PINHEAD; EMBRYONIC ZEBRAFISH; SONIC HEDGEHOG; CELL-DIFFERENTIATION; VERTEBRATE RETINA; BRACHYDANIO-RERIO; PRECHORDAL PLATE; NERVOUS-SYSTEM; HOMEOBOX GENE	In zebrafish, neuronal differentiation progresses across the retina in a pattern that is reminiscent of the neurogenic wave that sweeps across the developing eye in Drosophila. We show that expression of a zebrafish homolog of Drosophila atonal, ath5, sweeps across the eye predicting the wave of neuronal differentiation. By analyzing the regulation of ath5 expression, we have elucidated the mechanisms that regulate initiation and spread of neurogenesis in the retina. ath5 expression is lost in Nodal pathway mutant embryos lacking axial tissues that include the prechordal plate. A likely role for axial tissue is to induce optic stalk cells that subsequently regulate ath5 expression. Our results suggest that a series of inductive events, initiated from the prechordal plate and progressing from the optic stalks, regulates the spread of neuronal differentiation across the zebrafish retina.	RIKEN, Inst Phys & Chem Res, Brain Sci Inst, Lab Dev Gene Regulat, Wako, Saitama 3510198, Japan; Natl Inst Med Res, London NW7 1AA, England; UCL, Dept Anat & Dev Biol, London WC1E 6BT, England	RIKEN; MRC National Institute for Medical Research; University of London; University College London	Masai, I (corresponding author), RIKEN, Inst Phys & Chem Res, Brain Sci Inst, Lab Dev Gene Regulat, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	imasai@brain.riken.go.jp; s.wilson@ucl.ac.uk	Masai, Ichiro/N-1130-2014; Wilson, Stephen W/B-9404-2008; Masai, Ichiro/N-3085-2019; Zebrafish, UCL/A-3125-2009; Okamoto, Hitoshi/P-9767-2015	Masai, Ichiro/0000-0002-6626-6595; Wilson, Stephen W/0000-0002-8557-5940; Masai, Ichiro/0000-0002-6626-6595; Okamoto, Hitoshi/0000-0002-7512-8549				Adelmann HB, 1930, J EXP ZOOL, V57, P223, DOI 10.1002/jez.1400570204; Brand M, 1996, DEVELOPMENT, V123, P129; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Chuang JC, 1999, MECH DEVELOP, V84, P195, DOI 10.1016/S0925-4773(99)00077-5; EKKER SC, 1995, CURR BIOL, V5, P944, DOI 10.1016/S0960-9822(95)00185-0; Feldman B, 2000, CURR BIOL, V10, P531, DOI 10.1016/S0960-9822(00)00469-3; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; Fulwiler C, 1997, J COMP NEUROL, V381, P449; Glasgow E, 1997, DEV BIOL, V192, P405, DOI 10.1006/dbio.1997.8761; Gritsman K, 2000, DEVELOPMENT, V127, P921; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Hammerschmidt M, 1996, DEVELOPMENT, V123, P143; Harris WA, 1997, CURR OPIN GENET DEV, V7, P651, DOI 10.1016/S0959-437X(97)80013-5; HATTA K, 1991, NATURE, V350, P339, DOI 10.1038/350339a0; HEBERLEIN U, 1995, CELL, V81, P987, DOI 10.1016/S0092-8674(05)80003-0; Heisenberg CP, 1997, DEV BIOL, V184, P85, DOI 10.1006/dbio.1997.8511; Heisenberg CP, 1999, DEVELOPMENT, V126, P2129; Hu M, 1999, DEV BIOL, V207, P309, DOI 10.1006/dbio.1998.9031; INOUE A, 1994, DEV DYNAM, V199, P1, DOI 10.1002/aja.1001990102; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; Kanekar S, 1997, NEURON, V19, P981, DOI 10.1016/S0896-6273(00)80391-8; Karlstrom RO, 1999, GENE DEV, V13, P388, DOI 10.1101/gad.13.4.388; Kim CH, 1996, NEUROSCI LETT, V216, P109, DOI 10.1016/0304-3940(96)13021-4; Korzh V, 1998, DEV DYNAM, V213, P92, DOI 10.1002/(SICI)1097-0177(199809)213:1<92::AID-AJA9>3.0.CO;2-T; KORZH V, 1993, DEVELOPMENT, V118, P417; Laessing U, 1996, J NEUROBIOL, V29, P65, DOI 10.1002/(SICI)1097-4695(199601)29:1<65::AID-NEU5>3.0.CO;2-5; LARISON KD, 1990, DEVELOPMENT, V109, P567; Levine EM, 1997, J NEUROSCI, V17, P6277; Li HS, 1997, DEVELOPMENT, V124, P603; Macdonald R, 1997, DEV GENES EVOL, V206, P363, DOI 10.1007/s004270050065; Macdonald R, 1997, DEVELOPMENT, V124, P2397; MACDONALD R, 1995, DEVELOPMENT, V121, P3267; Malicki J, 1996, DEVELOPMENT, V123, P263; Marlow F, 1998, DEV BIOL, V203, P382, DOI 10.1006/dbio.1998.9032; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; McCabe KL, 1999, DEVELOPMENT, V126, P5713; McFarlane S, 1998, DEVELOPMENT, V125, P3967; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Pera EM, 1997, DEVELOPMENT, V124, P4153; Perron M, 1998, DEV BIOL, V199, P185, DOI 10.1006/dbio.1998.8939; Peyrieras N, 1998, CURR BIOL, V8, P783, DOI 10.1016/S0960-9822(98)70303-3; Picker A, 1999, DEVELOPMENT, V126, P2967; PRADA C, 1991, EUR J NEUROSCI, V3, P559, DOI 10.1111/j.1460-9568.1991.tb00843.x; RAYMOND PA, 1995, J COMP NEUROL, V359, P537, DOI 10.1002/cne.903590403; Rebagliati MR, 1998, P NATL ACAD SCI USA, V95, P9932, DOI 10.1073/pnas.95.17.9932; Renucci A, 1996, DEVELOPMENT, V122, P3735; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Rubenstein JLR, 1998, CURR OPIN NEUROBIOL, V8, P18, DOI 10.1016/S0959-4388(98)80004-4; Sampath K, 1998, NATURE, V395, P185, DOI 10.1038/26020; SANDELL JH, 1994, J COMP NEUROL, V345, P596, DOI 10.1002/cne.903450409; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Schier AF, 1997, DEVELOPMENT, V124, P327; Schmitt EA, 1996, J COMP NEUROL, V371, P222, DOI 10.1002/(SICI)1096-9861(19960722)371:2<222::AID-CNE3>3.0.CO;2-4; Shanmugalingam S, 2000, DEVELOPMENT, V127, P2549; Thisse B, 2000, NATURE, V403, P425, DOI 10.1038/35000200; THISSE C, 1994, DEV BIOL, V164, P420, DOI 10.1006/dbio.1994.1212; Thisse C, 1999, DEVELOPMENT, V126, P229; Varga ZM, 1999, DEVELOPMENT, V126, P5533; Wei Y, 1998, TRENDS CELL BIOL, V8, P266; WILSON SW, 1990, DEVELOPMENT, V108, P121; WOO K, 1995, DEVELOPMENT, V121, P2595; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6	63	175	179	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG	2000	27	2					251	263		10.1016/S0896-6273(00)00034-9	http://dx.doi.org/10.1016/S0896-6273(00)00034-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	347YD	10985346	Bronze			2022-12-24	WOS:000088956000010
J	Mauk, MD				Mauk, MD			The potential effectiveness of simulations versus phenomenological models	NATURE NEUROSCIENCE			English	Editorial Material								Computational models ean potentially be a very effective way to understand how the brain processes information. However, their power depends on the location of artificial features and errors of omission within the simulation, and on whether it is possible for the model to fail.	Univ Texas, Sch Med, Dept Neurobiol & Anat, Houston, TX 77030 USA	University of Texas System	Mauk, MD (corresponding author), Univ Texas, Sch Med, Dept Neurobiol & Anat, Houston, TX 77030 USA.				PHS HHS [57051, 46904] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764	1	12	12	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2000	3	7					649	651		10.1038/76606	http://dx.doi.org/10.1038/76606			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TT	10862696				2022-12-24	WOS:000167177200010
J	Muller, U				Muller, U			Prolonged activation of cAMP-dependent protein kinase during conditioning induces long-term memory in honeybees	NEURON			English	Article							APLYSIA SENSORY NEURONS; APIS-MELLIFERA; NITRIC-OXIDE; MUSHROOM BODIES; ANTENNAL LOBE; LATE-PHASE; CREB PHOSPHORYLATION; OLFACTORY MEMORIES; ADENYLYL-CYCLASE; GENE-EXPRESSION	To investigate the function cAMP-dependent protein kinase (PKA) exerts in the induction of long-term memory, changes in PKA activity induced by associative learning in vivo were measured in the antennal lobes (ALs) of honeybees. The temporal dynamics of PKA activation depend on both the sequence of conditioned and unconditioned stimuli and the number of conditioning trials. Only multiple-trial conditioning, which induces long-term memory (LTM), leads to a profound prolongation of PKA activation mediated by the NO/cGMP system. Imitation of this prolonged PKA activation in the ALs in combination with single-trial conditioning is sufficient to induce LTM. These findings not only demonstrate the close connection between conditioning procedure and temporal dynamics in PKA activation but also reveal that already during conditioning a distinct temporal pattern of PKA activation is critical for LTM induction in intact animals.	Free Univ Berlin, Inst Neurobiol, D-14195 Berlin, Germany	Free University of Berlin	Muller, U (corresponding author), Free Univ Berlin, Inst Neurobiol, Konigin Luise Str 28-30, D-14195 Berlin, Germany.							Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Abel T, 1998, SCIENCE, V279, P338, DOI 10.1126/science.279.5349.338; Abrams TW, 1998, LEARN MEMORY, V4, P496, DOI 10.1101/lm.4.6.496; ALTFELDER K, 1991, INSECT BIOCHEM, V21, P487, DOI 10.1016/0020-1790(91)90102-K; BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; BYRNE JH, 1987, PHYSIOL REV, V67, P329, DOI 10.1152/physrev.1987.67.2.329; CAREW TJ, 1972, SCIENCE, V175, P451, DOI 10.1126/science.175.4020.451; Chain DG, 1999, NEURON, V22, P147, DOI 10.1016/S0896-6273(00)80686-8; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DAVIS RL, 1995, MOL CELL BIOCHEM, V149, P271, DOI 10.1007/BF01076588; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; DEZAZZO J, 1995, TRENDS NEUROSCI, V18, P212, DOI 10.1016/0166-2236(95)93905-D; Dudai Y, 1997, NEURON, V18, P179, DOI 10.1016/S0896-6273(00)80257-3; ERBER J, 1980, PHYSIOL ENTOMOL, V5, P343, DOI 10.1111/j.1365-3032.1980.tb00244.x; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; Fiala A, 1999, J NEUROSCI, V19, P10125; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; GRIDER JR, 1993, AM J PHYSIOL, V264, P334; Grunbaum L, 1998, J NEUROSCI, V18, P4384; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; Hammer M, 1998, LEARN MEMORY, V5, P146; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; HILDEBRANDT H, 1995, J NEUROBIOL, V27, P44, DOI 10.1002/neu.480270105; HILDEBRANDT H, 1995, BRAIN RES, V679, P281, DOI 10.1016/0006-8993(95)00246-M; Huang Y Y, 1994, Learn Mem, V1, P74; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; Kendrick KM, 1997, NATURE, V388, P670, DOI 10.1038/41765; Kingston PA, 1999, SYNAPSE, V32, P1, DOI 10.1002/(SICI)1098-2396(199904)32:1<1::AID-SYN1>3.0.CO;2-M; Kogan JH, 1997, CURR BIOL, V7, P1, DOI 10.1016/S0960-9822(06)00022-4; Lechner HA, 1998, NEURON, V20, P355, DOI 10.1016/S0896-6273(00)80977-0; Liu L, 1999, NATURE, V400, P753, DOI 10.1038/23456; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; Menzel R., 1974, P195; Menzel R, 1999, J COMP PHYSIOL A, V185, P323, DOI 10.1007/s003590050392; Menzel R., 1990, NEUROBIOLOGY COMP CO, P237; Muller U, 1996, NEURON, V16, P541, DOI 10.1016/S0896-6273(00)80073-2; Muller U, 1998, NEURON, V21, P1423, DOI 10.1016/S0896-6273(00)80660-1; Muller U, 1997, PROG NEUROBIOL, V51, P363, DOI 10.1016/S0301-0082(96)00067-6; Muller U, 1997, J NEUROBIOL, V33, P33, DOI 10.1002/(SICI)1097-4695(199707)33:1<33::AID-NEU4>3.0.CO;2-E; Okere CO, 1996, NEUROSCIENCE, V71, P349, DOI 10.1016/0306-4522(95)00467-X; RUPPERT D, 1982, LIFE SCI, V31, P2037, DOI 10.1016/0024-3205(82)90095-9; SassoneCorsi P, 1995, ANNU REV CELL DEV BI, V11, P355, DOI 10.1146/annurev.cellbio.11.1.355; SCHACHER S, 1988, SCIENCE, V240, P1667, DOI 10.1126/science.2454509; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Wustenberg D, 1998, EUR J NEUROSCI, V10, P2742, DOI 10.1046/j.1460-9568.1998.t01-1-00319.x; Yin JCP, 1996, CURR OPIN NEUROBIOL, V6, P264, DOI 10.1016/S0959-4388(96)80082-1; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	60	185	187	4	19	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL	2000	27	1					159	168		10.1016/S0896-6273(00)00017-9	http://dx.doi.org/10.1016/S0896-6273(00)00017-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339XU	10939339	Bronze			2022-12-24	WOS:000088503800018
J	Rainer, G; Miller, EK				Rainer, G; Miller, EK			Effects of visual experience on the representation of objects in the prefrontal cortex	NEURON			English	Article							INFERIOR TEMPORAL CORTEX; LONG-TERM-MEMORY; WORKING-MEMORY; MOTION DISCRIMINATION; CONTEXTUAL INFLUENCES; RESPONSE PROPERTIES; RECOGNITION MEMORY; NEURAL MECHANISMS; NEURONAL-ACTIVITY; NATURAL IMAGES	The perception and recognition of objects are improved by experience. Here, we show that monkeys' ability to recognize degraded objects was improved by several days of practice with these objects. This improvement was reflected in the activity of neurons in the prefrontal (PF) cortex, a brain region critical for a wide range of visual behaviors. Familiar objects activated fewer neurons than did novel objects, but these neurons were more narrowly tuned, and the object representation was more resistant to the effects of degradation, after experience. These results demonstrate a neural correlate of visual learning in the PF cortex of adult monkeys.	MIT, Ctr Learning & Memory, RIKEN MIT Neurosci Ctr, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); RIKEN; Massachusetts Institute of Technology (MIT)	Rainer, G (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	gregor.rainer@tuebingen.mpg.de	Rainer, Gregor/B-5876-2012; Miller, Earl K./AAE-8187-2019	Miller, Earl K./0000-0002-0582-6958; Rainer, Gregor/0000-0002-5805-2220				Amit DJ, 1997, NEURAL COMPUT, V9, P1071, DOI 10.1162/neco.1997.9.5.1071; Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; BALL K, 1982, SCIENCE, V218, P697, DOI 10.1126/science.7134968; BALL K, 1987, VISION RES, V27, P953, DOI 10.1016/0042-6989(87)90011-3; BARBAS H, 1985, NEUROSCIENCE, V15, P619, DOI 10.1016/0306-4522(85)90064-8; Bichot NP, 1996, NATURE, V381, P697, DOI 10.1038/381697a0; Brady N, 1997, PERCEPTION, V26, P1089, DOI 10.1068/p261089; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1101, DOI 10.1152/jn.1995.73.3.1101; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Dosher BA, 1999, VISION RES, V39, P3197, DOI 10.1016/S0042-6989(99)00059-0; FAHLE M, 1995, VISION RES, V35, P3003, DOI 10.1016/0042-6989(95)00044-Z; FAHY FL, 1993, EXP BRAIN RES, V96, P457; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Furmanski CS, 2000, VISION RES, V40, P473, DOI 10.1016/S0042-6989(99)00134-0; FUSTER JM, 1997, PREFRNTAL CORTEX ANA; Gilbert CD, 1996, CURR OPIN NEUROBIOL, V6, P269, DOI 10.1016/S0959-4388(96)80083-3; Gold J, 1999, NATURE, V402, P176, DOI 10.1038/46027; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Green DM, 1966, SIGNAL DETECTION THE; Gross C. G., 1973, HDB SENSORY PHYSIOLO, P451; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Ito M, 1998, NEURON, V20, P1191, DOI 10.1016/S0896-6273(00)80499-7; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; KNIGHT RT, 1995, ADV NEUROL, V66, P21; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; LI L, 1993, J NEUROPHYSIOL, V69, P1918, DOI 10.1152/jn.1993.69.6.1918; Logothetis N, 1998, CURR OPIN NEUROBIOL, V8, P536; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Miller EK, 1999, NEURON, V22, P15, DOI 10.1016/S0896-6273(00)80673-X; Miller EK, 1996, J NEUROSCI, V16, P5154; Miyashita Y, 2000, CURR OPIN NEUROBIOL, V10, P187, DOI 10.1016/S0959-4388(00)00071-4; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; PANDYA DN, 1990, PROG BRAIN RES, V85, P63; Parker A, 1998, J COGNITIVE NEUROSCI, V10, P691, DOI 10.1162/089892998563103; Petrides M, 1999, EUR J NEUROSCI, V11, P1011, DOI 10.1046/j.1460-9568.1999.00518.x; PETRIDES M, 1994, HDB NEUROPSYCHOLOGY, P59; QUINTANA J, 1992, NEUROREPORT, V3, P721, DOI 10.1097/00001756-199208000-00018; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Rainer G, 1999, J NEUROSCI, V19, P5493; Ranganath C, 1999, NEURON, V22, P605, DOI 10.1016/S0896-6273(00)80714-X; ROLLS ET, 1989, EXP BRAIN RES, V76, P153; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; SAGI D, 1994, CURR OPIN NEUROBIOL, V4, P195, DOI 10.1016/0959-4388(94)90072-8; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; Sigman M, 2000, NAT NEUROSCI, V3, P264, DOI 10.1038/72979; TADMOR Y, 1993, VISION RES, V33, P141, DOI 10.1016/0042-6989(93)90067-7; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; VOGELS R, 1994, EUR J NEUROSCI, V6, P1680, DOI 10.1111/j.1460-9568.1994.tb00560.x; VOGELS R, 1990, J NEUROSCI, V10, P3543; Wallis G, 1999, TRENDS COGN SCI, V3, P22, DOI 10.1016/S1364-6613(98)01261-3; WEINBERGER NM, 1995, ANNU REV NEUROSCI, V18, P129; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; ZOHARY E, 1994, SCIENCE, V263, P1289, DOI 10.1126/science.8122114	59	218	218	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	2000	27	1					179	189		10.1016/S0896-6273(00)00019-2	http://dx.doi.org/10.1016/S0896-6273(00)00019-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339XU	10939341	Bronze			2022-12-24	WOS:000088503800020
J	McKernan, RM; Rosahl, TW; Reynolds, DS; Sur, C; Wafford, KA; Atack, JR; Farrar, S; Myers, J; Cook, G; Ferris, P; Garrett, L; Bristow, L; Marshall, G; Macaulay, A; Brown, N; Howell, O; Moore, KW; Carling, RW; Street, LJ; Castro, JL; Ragan, CI; Dawson, GR; Whiting, PJ				McKernan, RM; Rosahl, TW; Reynolds, DS; Sur, C; Wafford, KA; Atack, JR; Farrar, S; Myers, J; Cook, G; Ferris, P; Garrett, L; Bristow, L; Marshall, G; Macaulay, A; Brown, N; Howell, O; Moore, KW; Carling, RW; Street, LJ; Castro, JL; Ragan, CI; Dawson, GR; Whiting, PJ			Sedative but not anxiolytic properties of benzodiazepines ave mediated by the GABA(A) receptor alpha(1) subtype	NATURE NEUROSCIENCE			English	Article							AMINOBUTYRIC ACID(A) RECEPTOR; SUBUNIT-SPECIFIC ANTIBODIES; ELEVATED PLUS-MAZE; RAT-BRAIN; MESSENGER-RNAS; SYNAPSIN-I; PHARMACOLOGY; EXPRESSION; CELLS; ANTAGONIST	GInhibitory neurotransmission in the brain is largely mediated by GABA(A) receptors. Potentiation of GABA receptor activation through an allosteric benzodiazepine (BZ) site produces the sedative, anxiolytic, muscle relaxant, anticonvulsant and cognition-impairing effects of clinically used BZs such as diazepam. We created genetically modified mice (alpha(1) H101R) with a diazepam-insensitive alpha(1) subtype and a selective BZ site ligand, L-838,417, to explore GABA(A) receptor subtypes mediating specific physiological effects. These two complimentary approaches revealed that the alpha(1) subtype mediated the sedative, but not the anxiolytic effects of benzodiazepines. This finding suggests ways to improve anxiolytics and to develop drugs for other neurological disorders based on their specificity for GABA(A) receptor subtypes in distinct neuronal circuits.	Merck Sharp & Dohme Ltd, Res Labs, Neurosci Res Ctr, Harlow CM20 2QR, Essex, England	Merck & Company	McKernan, RM (corresponding author), Merck Sharp & Dohme Ltd, Res Labs, Neurosci Res Ctr, Terlings Pk,Eastwick Rd, Harlow CM20 2QR, Essex, England.	Ruth_McKernan@Merck.com	Sur, Cyrille/G-1154-2010	Whiting, Paul/0000-0002-4121-1379; Atack, John/0000-0002-3410-791X; Howell, Owain/0000-0003-2157-9157				Atack JR, 1999, NEUROPSYCHOPHARMACOL, V20, P255, DOI 10.1016/S0893-133X(98)00052-9; Barnard EA, 1998, PHARMACOL REV, V50, P291; Bayley PJ, 1996, J PSYCHOPHARMACOL, V10, P206, DOI 10.1177/026988119601000305; BROUGHTON H, 1998, Patent No. 04559; Collinson N, 1997, PSYCHOPHARMACOLOGY, V132, P35, DOI 10.1007/s002130050317; DAWSON GR, 1995, TRENDS PHARMACOL SCI, V16, P33, DOI 10.1016/S0165-6147(00)88973-7; DUGGAN MJ, 1990, J BIOL CHEM, V265, P3831; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; FRITSCHY JM, 1992, P NATL ACAD SCI USA, V89, P6726, DOI 10.1073/pnas.89.15.6726; GAO B, 1993, NEUROSCIENCE, V54, P881, DOI 10.1016/0306-4522(93)90582-Z; HADINGHAM KL, 1992, P NATL ACAD SCI USA, V89, P6378, DOI 10.1073/pnas.89.14.6378; HADINGHAM KL, 1993, MOL PHARMACOL, V43, P970; KEHNE JH, 1988, PSYCHOPHARMACOLOGY, V94, P8, DOI 10.1007/BF00735872; LAURIE DJ, 1992, J NEUROSCI, V12, P1063; LUDDENS H, 1990, NATURE, V346, P648, DOI 10.1038/346648a0; MCKERNAN RM, 1991, NEURON, V7, P667, DOI 10.1016/0896-6273(91)90379-E; PRITCHETT DB, 1990, J NEUROCHEM, V54, P1802, DOI 10.1111/j.1471-4159.1990.tb01237.x; PRITCHETT DB, 1989, SCIENCE, V245, P1389, DOI 10.1126/science.2551039; QUIRK K, 1994, J BIOL CHEM, V269, P16020; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; ROSAHL TW, 1993, CELL, V75, P661, DOI 10.1016/0092-8674(93)90487-B; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; SAUER B, 1993, METHOD ENZYMOL, V225, P890; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; SIEGHART W, 1995, PHARMACOL REV, V47, P181; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Sur C, 1999, MOL PHARMACOL, V56, P110, DOI 10.1124/mol.56.1.110; Sur C, 1999, BRAIN RES, V822, P265, DOI 10.1016/S0006-8993(99)01152-X; TREIT D, 1985, NEUROSCI BIOBEHAV R, V9, P203, DOI 10.1016/0149-7634(85)90046-6; Whiting PJ, 1997, J NEUROSCI, V17, P5027; WIELAND HA, 1992, J BIOL CHEM, V267, P1426; WISDEN W, 1991, FEBS LETT, V289, P227, DOI 10.1016/0014-5793(91)81076-K; WISDEN W, 1992, J NEUROSCI, V12, P1040; Wisden W, 1999, NATURE, V401, P751, DOI 10.1038/44482	34	757	782	1	35	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2000	3	6					587	592		10.1038/75761	http://dx.doi.org/10.1038/75761			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	317WG	10816315				2022-12-24	WOS:000087249500015
J	Zheng, JL; Gao, WQ				Zheng, JL; Gao, WQ			Overexpression of Math1 induces robust production of extra hair cells in postnatal rat inner ears	NATURE NEUROSCIENCE			English	Article							SENSORY EPITHELIA; MORPHOLOGICAL EVIDENCE; MAMMALIAN COCHLEA; DEVELOPING ORGAN; SUPPORTING CELL; ACOUSTIC TRAUMA; PRONEURAL GENE; NERVOUS-SYSTEM; GROWTH-FACTORS; GUINEA-PIGS	For mammalian cochlear hair cells, fate determination is normally completed by birth. We report here that overexpression of Math1, a mouse homolog of the Drosophila gene atonal, in postnatal rat cochlear explant cultures resulted in extra hair cells. Surprisingly, we found that the source of the ectopic hair cells was columnar epithelial cells located outside the sensory epithelium in the greater epithelial ridge, which normally give rise to inner sulcus cells. Moreover, Math1 expression also facilitated conversion of postnatal utricular supporting cells into hair cells. Thus Math1 was sufficient for the production of hair cells in the ear, and immature postnatal mammalian inner ears retained the competence to generate new hair cells.	Genentech Inc, Dept Neurosci, S San Francisco, CA 94080 USA	Roche Holding; Genentech	Gao, WQ (corresponding author), Genentech Inc, Dept Neurosci, MS 72,1 DNA Way, S San Francisco, CA 94080 USA.							ABDOUH A, 1993, NEUROREPORT, V5, P33, DOI 10.1097/00001756-199310000-00008; AKAZAWA C, 1995, J BIOL CHEM, V270, P8730, DOI 10.1074/jbc.270.15.8730; BALAK KJ, 1990, J NEUROSCI, V10, P2502; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Chen P, 1999, DEVELOPMENT, V126, P1581; Corwin JT, 1996, CIBA F SYMP, V196, P167; CORWIN JT, 1988, SCIENCE, V240, P1772, DOI 10.1126/science.3381100; Corwin JT, 1997, NEURON, V19, P951, DOI 10.1016/S0896-6273(00)80386-4; Cotanche Douglas A., 1994, Current Opinion in Neurobiology, V4, P509, DOI 10.1016/0959-4388(94)90051-5; Erkman L, 1996, NATURE, V381, P603, DOI 10.1038/381603a0; Fekete DM, 1998, J NEUROSCI, V18, P7811; Fekete DM, 1999, TRENDS NEUROSCI, V22, P263, DOI 10.1016/S0166-2236(98)01366-6; Fekete DM, 1996, CURR OPIN NEUROBIOL, V6, P533, DOI 10.1016/S0959-4388(96)80061-4; Forge A, 1998, J COMP NEUROL, V397, P69; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Haddon C, 1998, DEVELOPMENT, V125, P4637; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; KELLEY MW, 1993, DEVELOPMENT, V119, P1041; Kim P, 1997, DEV BIOL, V187, P1, DOI 10.1006/dbio.1997.8572; Kuntz AL, 1998, J COMP NEUROL, V399, P413; Lanford PJ, 1999, NAT GENET, V21, P289, DOI 10.1038/6804; Lewis AK, 1998, MECH DEVELOP, V78, P159, DOI 10.1016/S0925-4773(98)00165-8; Li L, 1997, INT J DEV NEUROSCI, V15, P433, DOI 10.1016/S0736-5748(96)00102-5; LIM J, 1992, DEV AUDITORY VESTIBU, P33; Lowenheim H, 1999, P NATL ACAD SCI USA, V96, P4084, DOI 10.1073/pnas.96.7.4084; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; RUBEL EW, 1995, SCIENCE, V267, P701, DOI 10.1126/science.7839150; Ruben R.J., 1967, ACTA OTO-LARYNGOL, DOI DOI 10.3109/00016486709127790; RYALS BM, 1988, SCIENCE, V240, P1774, DOI 10.1126/science.3381101; SOBKOWICZ HM, 1975, J NEUROCYTOL, V4, P543, DOI 10.1007/BF01351537; Stone JS, 1999, DEVELOPMENT, V126, P961; Stone JS, 1998, CURR OPIN NEUROL, V11, P17, DOI 10.1097/00019052-199802000-00004; Sundaresan S, 1998, ENDOCRINOLOGY, V139, P4756, DOI 10.1210/en.139.12.4756; VANDEWATER TR, 1983, DEV AUDITORY VESTIBU, P337; WARCHOL ME, 1995, SCIENCE, V267, P704, DOI 10.1126/science.267.5198.704; WARCHOL ME, 1993, SCIENCE, V259, P1619, DOI 10.1126/science.8456285; Xiang MQ, 1997, P NATL ACAD SCI USA, V94, P9445, DOI 10.1073/pnas.94.17.9445; Xiang MQ, 1998, DEVELOPMENT, V125, P3935; Zheng JL, 1999, J NEUROBIOL, V39, P29, DOI 10.1002/(SICI)1097-4695(199904)39:1<29::AID-NEU3>3.0.CO;2-E; Zheng JL, 1996, EUR J NEUROSCI, V8, P1897, DOI 10.1111/j.1460-9568.1996.tb01333.x; Zheng JL, 1999, J NEUROSCI, V19, P2161; Zheng JL, 1997, J NEUROSCI, V17, P8270; Zheng JL, 1997, J NEUROSCI, V17, P216, DOI 10.1523/JNEUROSCI.17-01-00216.1997	45	486	555	0	22	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2000	3	6					580	586		10.1038/75753	http://dx.doi.org/10.1038/75753			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	317WG	10816314				2022-12-24	WOS:000087249500014
J	Harada, T; Harada, C; Nakayama, N; Okuyama, S; Yoshida, K; Kohsaka, S; Matsuda, H; Wada, K				Harada, T; Harada, C; Nakayama, N; Okuyama, S; Yoshida, K; Kohsaka, S; Matsuda, H; Wada, K			Modification of glial-neuronal cell interactions prevents photoreceptor apoptosis during light-induced retinal degeneration	NEURON			English	Article							FIBROBLAST GROWTH-FACTOR; MESSENGER-RNA EXPRESSION; AFFINITY NGF RECEPTOR; DEVELOPING RAT RETINA; BASIC FIBROBLAST; IN-VITRO; MULLER CELLS; VERTEBRATE RETINA; GENE-EXPRESSION; TRK RECEPTOR	Prolonged or high-intensity exposure to visible light leads to photoreceptor cell death. In this study, we demonstrate a novel pathway of light-induced photoreceptor apoptosis involving the low-affinity neurotrophin receptor p75 (p75(NTR)). Retinal degeneration upregulated both p75(NTR) and the high-affinity neurotrophin receptor TrkC in different parts of Muller glial cells. Exogenous neurotrophin-3 (NT-3) increased, but nerve growth factor (NGF) decreased basic fibroblast growth factor (bFGF) production in Muller cells, which can directly rescue photoreceptor apoptosis. Blockade of p75(NTR) prevented bFGF reduction and resulted in both structural and functional photoreceptor survival in vivo. Furthermore, the absence of p75(NTR) significantly prevented light-induced photoreceptor apoptosis. These observations implicate glial cells in the determination of neural cell survival, and suggest functional glial-neuronal cell interactions as new therapeutic targets for neurodegeneration.	Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Tokyo 1878502, Japan; Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neurochem, Tokyo 1878502, Japan; Hokkaido Univ, Sch Med, Dept Ophthalmol, Sapporo, Hokkaido 0608638, Japan; Taisho Pharmaceut Co Ltd, Pharmaceut Res Labs, Toxicol Lab, Ohmiya, Saitama 3308530, Japan; Taisho Pharmaceut Co Ltd, Med Res Labs, Lab 1, Ohmiya, Saitama 3308530, Japan	National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; Hokkaido University; Taisho Pharmaceutical Holdings Co Ltd; Taisho Pharmaceutical Holdings Co Ltd	Harada, T (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Tokyo 1878502, Japan.							BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Brash DE, 1996, J INVEST DERMATOL S, V1, P136; Bredesen DE, 1997, TRENDS NEUROSCI, V20, P287, DOI 10.1016/S0166-2236(96)01049-1; CAFFE AR, 1993, CURR EYE RES, V12, P719, DOI 10.3109/02713689308995767; Cao W, 1997, INVEST OPHTH VIS SCI, V38, P1358; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; Cellerino A, 1997, J COMP NEUROL, V386, P149; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; CHAKRABARTI S, 1990, BRAIN RES, V523, P11, DOI 10.1016/0006-8993(90)91630-Y; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; Cheng T, 1998, INVEST OPHTH VIS SCI, V39, P581; Cotinet A, 1997, GLIA, V20, P59, DOI 10.1002/(SICI)1098-1136(199705)20:1<59::AID-GLIA6>3.0.CO;2-0; Davidson FF, 1998, NATURE, V391, P587, DOI 10.1038/35385; DRYJA TP, 1995, HUM MOL GENET, V4, P1739, DOI 10.1093/hmg/4.suppl_1.1739; FAKTOROVICH EG, 1990, NATURE, V347, P83, DOI 10.1038/347083a0; Farinas I, 1998, NEURON, V21, P325, DOI 10.1016/S0896-6273(00)80542-5; FISHMAN GA, 1986, SURV OPHTHALMOL, V31, P119, DOI 10.1016/0039-6257(86)90079-2; Fontaine V, 1998, J NEUROSCI, V18, P9662; Frade JM, 1998, NEURON, V20, P35, DOI 10.1016/S0896-6273(00)80432-8; FUHRMANN S, 1995, DEVELOPMENT, V121, P2695; GLASS P, 1990, DOC OPHTHALMOL, V74, P195, DOI 10.1007/BF02482609; GOUREAU O, 1994, J NEUROCHEM, V63, P310; GREENE LA, 1995, CURR OPIN NEUROBIOL, V5, P579, DOI 10.1016/0959-4388(95)80062-X; Hafezi F, 1997, NAT MED, V3, P346, DOI 10.1038/nm0397-346; Harada T, 1996, INVEST OPHTH VIS SCI, V37, P1250; Harada T, 1998, J NEUROSCI, V18, P3336; HECKENLIVELY JR, 1991, ARCH OPHTHALMOL-CHIC, V109, P84, DOI 10.1001/archopht.1991.01080010086038; HICKS D, 1990, EXP EYE RES, V51, P119, DOI 10.1016/0014-4835(90)90063-Z; KAPLAN DR, 1994, J NEUROBIOL, V25, P1404, DOI 10.1002/neu.480251108; KHWARG SG, 1987, AM J OPHTHALMOL, V103, P255; Lambiase A, 1996, GRAEF ARCH CLIN EXP, V234, pS96, DOI 10.1007/BF02343055; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; LaVail MM, 1998, INVEST OPHTH VIS SCI, V39, P592; LEIST M, 1994, J IMMUNOL, V153, P1778; Lewin AS, 1998, NAT MED, V4, P967, DOI 10.1038/nm0898-967; Luo L, 1999, NAT MED, V5, P117, DOI 10.1038/4806; Minckler D, 1995, OPHTHALMOLOGY, V102, P1741, DOI 10.1016/S0161-6420(95)30799-3; Neophytou C, 1997, DEVELOPMENT, V124, P2345; Newman E, 1996, TRENDS NEUROSCI, V19, P307, DOI 10.1016/0166-2236(96)10040-0; NOELL WK, 1980, VISION RES, V20, P1163, DOI 10.1016/0042-6989(80)90055-3; PAPERMASTER DS, 1995, INVEST OPHTH VIS SCI, V36, P977; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P3273; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; Reme CE, 1998, PROG RETIN EYE RES, V17, P443, DOI 10.1016/S1350-9462(98)00009-3; Rickman DW, 1996, P NATL ACAD SCI USA, V93, P12564, DOI 10.1073/pnas.93.22.12564; RICKMAN DW, 1995, VISUAL NEUROSCI, V12, P215, DOI 10.1017/S0952523800007896; STEELE F, 1990, NEURON, V4, P883, DOI 10.1016/0896-6273(90)90141-2; TSO MOM, 1994, INVEST OPHTH VIS SCI, V35, P2693; Ugolini G, 1995, BRAIN RES, V704, P121, DOI 10.1016/0006-8993(95)01191-9; Vecino E, 1998, GEN PHARMACOL-VASC S, V30, P305, DOI 10.1016/S0306-3623(97)00361-3; von Bartheld CS, 1998, HISTOL HISTOPATHOL, V13, P437, DOI 10.14670/HH-13.437; WESKAMP G, 1991, NEURON, V6, P649, DOI 10.1016/0896-6273(91)90067-A; Wexler EM, 1998, VISUAL NEUROSCI, V15, P211, DOI 10.1017/S095252389815201X; Yoon SO, 1998, J NEUROSCI, V18, P3273	55	192	200	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	2000	26	2					533	541		10.1016/S0896-6273(00)81185-X	http://dx.doi.org/10.1016/S0896-6273(00)81185-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318QZ	10839371	Bronze			2022-12-24	WOS:000087296500029
J	Jovanovic, JN; Czernik, AJ; Fienberg, AA; Greengard, P; Sihra, TS				Jovanovic, JN; Czernik, AJ; Fienberg, AA; Greengard, P; Sihra, TS			Synapsins as mediators of BDNF-enhanced neurotransmitter release	NATURE NEUROSCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; SYNAPTIC VESICLE PHOSPHOPROTEINS; ACTIVATED PROTEIN-KINASE; NEUROTROPHIC FACTOR; GLUTAMATE EXOCYTOSIS; TRANSMISSION; POTENTIATION; PHOSPHORYLATION; RECEPTORS; SYNAPTOSOMES	We examined enhancement of synaptic transmission by neurotrophins at the presynaptic level. In a synaptosomal preparation, brain-derived neurotrophic factor (BDNF) increased mitogen-activated protein (MAP) kinase-dependent synapsin I phosphorylation and acutely facilitated evoked glutamate release. PD98059, used to inhibit MAP kinase activity, markedly decreased synapsin I phosphorylation and concomitantly reduced neurotransmitter release. The stimulation of glutamate release by BDNF was strongly attenuated in mice lacking synapsin I and/or synapsin II. These results indicate at causal link of synapsin phosphorylation via BDNF, TrkB receptors and MAP kinase with downstream facilitation of neurotransmitter release.	UCL, Dept Pharmacol, London WC1E 6BT, England; Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA	University of London; University College London; Rockefeller University	Sihra, TS (corresponding author), UCL, Dept Pharmacol, Mortimer St, London WC1E 6BT, England.	t.sihra@ucl.ac.uk	Sihra, Talvinder S/A-4581-2009		NIA NIH HHS [AG15072] Funding Source: Medline; NIMH NIH HHS [MH39327] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH039327, R37MH039327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG015072] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Barrie A, 1996, MOL PHARMACOL, V49, P399; Boulanger L, 1999, NAT NEUROSCI, V2, P346, DOI 10.1038/7258; Carmignoto G, 1997, J PHYSIOL-LONDON, V498, P153, DOI 10.1113/jphysiol.1997.sp021848; Fawcett JP, 1997, J BIOL CHEM, V272, P8837; Ferreira A, 1998, MOL MED, V4, P22, DOI 10.1007/BF03401726; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Gottschalk W, 1998, J NEUROSCI, V18, P6830; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Hilfiker S, 1998, NAT NEUROSCI, V1, P29, DOI 10.1038/229; Hosaka M, 1998, J BIOL CHEM, V273, P13371, DOI 10.1074/jbc.273.22.13371; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Kao HT, 1998, P NATL ACAD SCI USA, V95, P4667, DOI 10.1073/pnas.95.8.4667; KIM HG, 1994, P NATL ACAD SCI USA, V91, P12341, DOI 10.1073/pnas.91.25.12341; LESSMANN V, 1994, NEUROREPORT, V6, P21; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; LEVINE ES, 1995, J NEUROSCI, V15, P3084; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LI L, 1995, P NATL ACAD SCI USA, V92, P9235, DOI 10.1073/pnas.92.20.9235; Li YX, 1998, J NEUROSCI, V18, P10231; Li YX, 1998, P NATL ACAD SCI USA, V95, P10884, DOI 10.1073/pnas.95.18.10884; LLINAS R, 1991, J PHYSIOL-LONDON, V436, P257, DOI 10.1113/jphysiol.1991.sp018549; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; LU B, 1991, P NATL ACAD SCI USA, V88, P6289, DOI 10.1073/pnas.88.14.6289; Matsubara M, 1996, J BIOL CHEM, V271, P21108, DOI 10.1074/jbc.271.35.21108; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; MCMAHON HT, 1991, BIOCHIM BIOPHYS ACTA, V1059, P243, DOI 10.1016/S0005-2728(05)80210-5; Messaoudi E, 1998, J NEUROPHYSIOL, V79, P496, DOI 10.1152/jn.1998.79.1.496; Nicholls D G, 1987, Soc Gen Physiol Ser, V42, P31; NICHOLLS DG, 1986, NATURE, V321, P772, DOI 10.1038/321772a0; NIKODIJEVIC B, 1992, J NEUROSCI RES, V31, P591, DOI 10.1002/jnr.490310402; Otto H, 1997, P NATL ACAD SCI USA, V94, P6197, DOI 10.1073/pnas.94.12.6197; Perkinton MS, 1998, J NEUROCHEM, V70, P1513; Perkinton MS, 1999, NEUROSCIENCE, V90, P1281, DOI 10.1016/S0306-4522(98)00573-9; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; Ryan TA, 1996, J CELL BIOL, V134, P1219, DOI 10.1083/jcb.134.5.1219; SanchezPrieto J, 1996, TRENDS NEUROSCI, V19, P235, DOI 10.1016/0166-2236(96)10031-X; SANGHERA JS, 1990, J BIOL CHEM, V265, P52; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; SIHRA TS, 1992, J BIOL CHEM, V267, P1983; SIHRA TS, 1997, POSTTRANSLATIONAL MO, P67; Stoop R, 1996, J NEUROSCI, V16, P3256; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; TOLEDOARAL JJ, 1995, NEURON, V14, P607, DOI 10.1016/0896-6273(95)90317-8; WETMORE C, 1994, J NEUROSCI, V14, P1688, DOI 10.1523/JNEUROSCI.14-03-01688.1994	50	451	472	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2000	3	4					323	329		10.1038/73888	http://dx.doi.org/10.1038/73888			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330CN	10725920				2022-12-24	WOS:000087945400011
J	Feng, GP; Laskowski, MB; Feldheim, DA; Wang, HM; Lewis, R; Frisen, J; Flanagan, JG; Sanes, JR				Feng, GP; Laskowski, MB; Feldheim, DA; Wang, HM; Lewis, R; Frisen, J; Flanagan, JG; Sanes, JR			Roles for ephrins in positionally selective synaptogenesis between motor neurons and muscle fibers	NEURON			English	Article							DIFFERENT SEGMENTAL LEVELS; RECEPTOR TYROSINE KINASE; NEURAL CREST MIGRATION; ADULT SKELETAL-MUSCLE; RETINAL AXON GUIDANCE; GANGLION-CELL AXONS; GENE-EXPRESSION; EPH RECEPTORS; IN-VITRO; INTERCOSTAL MUSCLES	Motor axons form topographic maps on muscles: rostral motor pools innervate rostral muscles, and rostral portions of motor pools innervate rostral fibers within their targets. Here, we implicate A subfamily ephrins in this topographic mapping. First, developing muscles express all five of the ephrin-A genes. Second, rostrally and caudally derived motor axons differ in sensitivity to outgrowth inhibition by ephrin-A5. Third, the topographic map of motor axons on the gluteus muscle is degraded in transgenic mice that overexpress ephrin-A5 in muscles. Fourth, topographic mapping is impaired in muscles of mutant mice lacking ephrin-A2 plus ephrin-A5. Thus, ephrins mediate or modulate positionally selective synapse formation. In addition, the rostrocaudal position of at least one motor pool is altered in ephrin-A5 mutant mice, indicating that ephrins affect nerve-muscle matching by intraspinal as well as intramuscular mechanisms.	Washington Univ, Sch Med, Dept Anat, St Louis, MO 63110 USA; Univ Idaho, WWAMI Med Program, Moscow, ID 83844 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden	Washington University (WUSTL); Idaho; University of Idaho; Harvard University; Harvard Medical School; Karolinska Institutet	Sanes, JR (corresponding author), Washington Univ, Sch Med, Dept Anat, St Louis, MO 63110 USA.	sanesj@thalamus.wustl.edu	Feng, Guoping/Y-2827-2019; Flanagan, John/AAM-2995-2020					Araujo M, 1998, DEVELOPMENT, V125, P4195; BAIER H, 1992, SCIENCE, V255, P472, DOI 10.1126/science.1734526; BENNETT MR, 1988, J PHYSIOL-LONDON, V396, P471, DOI 10.1113/jphysiol.1988.sp016973; BENNETT MR, 1984, J NEUROSCI, V4, P2204; Brambilla R, 1996, MOL CELL NEUROSCI, V8, P199, DOI 10.1006/mcne.1996.0057; BROWN MC, 1983, NATURE, V304, P741, DOI 10.1038/304741a0; BROWNE KM, 1950, J COMP NEUROL, V93, P441, DOI 10.1002/cne.900930308; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; Buchert M, 1999, J CELL BIOL, V144, P361, DOI 10.1083/jcb.144.2.361; Carpenter EM, 1997, DEVELOPMENT, V124, P4505; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Ciossek T, 1998, EUR J NEUROSCI, V10, P1574, DOI 10.1046/j.1460-9568.1998.00180.x; COVAULT J, 1985, P NATL ACAD SCI USA, V82, P4544, DOI 10.1073/pnas.82.13.4544; DESANTIS M, 1992, EXP NEUROL, V116, P229, DOI 10.1016/0014-4886(92)90002-8; DONOGHUE MJ, 1991, P NATL ACAD SCI USA, V88, P5847, DOI 10.1073/pnas.88.13.5847; DONOGHUE MJ, 1991, J CELL BIOL, V115, P423, DOI 10.1083/jcb.115.2.423; Donoghue MJ, 1996, MOL CELL NEUROSCI, V8, P185, DOI 10.1006/mcne.1996.0056; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Durbin L, 1998, GENE DEV, V12, P3096, DOI 10.1101/gad.12.19.3096; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; FREEMAN RS, 1994, NEURON, V12, P343, DOI 10.1016/0896-6273(94)90276-3; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; HAHN CG, 1992, J NEUROSCI, V12, P4677; HARDMAN VJ, 1987, J NEUROSCI, V7, P1031; Holder N, 1999, DEVELOPMENT, V126, P2033; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; JUYNHDO U, 1999, EMBO J, V18, P2165; KILPATRICK J, 1996, KLUW HB EDU 1-2, V4, P7; Krull CE, 1997, CURR BIOL, V7, P571, DOI 10.1016/S0960-9822(06)00256-9; LASKOWSKI MB, 1989, J NEUROSCI, V9, P175; Laskowski MB, 1998, J NEUROSCI, V18, P7328; LASKOWSKI MB, 1988, J NEUROSCI, V8, P3094; LASKOWSKI MB, 1987, J NEUROSCI, V7, P252; LASKOWSKI MB, 1994, DEV BIOL, V166, P502, DOI 10.1006/dbio.1994.1333; Monschau B, 1997, EMBO J, V16, P1258, DOI 10.1093/emboj/16.6.1258; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; Ohta K, 1997, MECH DEVELOP, V64, P127, DOI 10.1016/S0925-4773(97)00056-7; Ohta K, 1996, MECH DEVELOP, V54, P59, DOI 10.1016/0925-4773(95)00461-0; Olivieri G, 1999, J HISTOCHEM CYTOCHEM, V47, P855, DOI 10.1177/002215549904700702; Park S, 1997, EMBO J, V16, P3106, DOI 10.1093/emboj/16.11.3106; Rao MV, 1996, MOL CELL BIOL, V16, P3909; ROSENTHAL N, 1989, P NATL ACAD SCI USA, V86, P7780, DOI 10.1073/pnas.86.20.7780; Sanes J R, 1993, Curr Opin Neurobiol, V3, P67, DOI 10.1016/0959-4388(93)90037-Y; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Studer M, 1998, DEVELOPMENT, V125, P1025; SWETT JE, 1970, AM J PHYSIOL, V219, P762, DOI 10.1152/ajplegacy.1970.219.3.762; Tiret L, 1998, DEVELOPMENT, V125, P279; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; WALTER J, 1987, DEVELOPMENT, V101, P685; WALTER J, 1987, DEVELOPMENT, V101, P909; Wang H, 1999, J NEUROSCI, V19, P4984; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; WIGSTON DJ, 1985, J NEUROSCI, V5, P1208; WIGSTON DJ, 1982, NATURE, V299, P464, DOI 10.1038/299464a0; Zhou RP, 1998, PHARMACOL THERAPEUT, V77, P151, DOI 10.1016/S0163-7258(97)00112-5	60	101	106	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	2000	25	2					295	306		10.1016/S0896-6273(00)80895-8	http://dx.doi.org/10.1016/S0896-6273(00)80895-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	288EL	10719886	Bronze			2022-12-24	WOS:000085549100009
J	Tanigaki, K; Nogaki, F; Takahashi, J; Tashiro, K; Kurooka, H; Honjo, T				Tanigaki, K; Nogaki, F; Takahashi, J; Tashiro, K; Kurooka, H; Honjo, T			Notch1 and Notch3 instructively restrict bFGF-responsive multipotent neural progenitor cells to an astroglial fate	NEURON			English	Article							LEUKEMIA INHIBITORY FACTOR; CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; INTRACELLULAR DOMAIN; TRANSCRIPTION FACTOR; SUBVENTRICULAR ZONE; LINEAGE COMMITMENT; CEREBRAL-CORTEX; ADULT BRAIN; RBP-J	Notch1 has been shown to induce glia in the peripheral nervous system. However, it has not been known whether Notch can direct commitment to glia from multipotent progenitors of the central nervous system. Here we present evidence that activated Notch1 and Notch3 promotes the differentiation of astroglia from the rat adult hippocampus-derived multipotent progenitors (AHPs). Quantitative clonal analysis indicates that the action of Notch is likely to be instructive. Transient activation of Notch can direct commitment of AHPs irreversibly to astroglia. Astroglial induction by Notch signaling was shown to be independent of STAT3, which is a key regulatory transcriptional factor when ciliary neurotrophic factor (CNTF) induces astroglia. These data suggest that Notch provides a CNTF-independent instructive signal of astroglia differentiation in CNS multipotent progenitor cells.	Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Ctr Mol Biol & Genet, Kyoto 6068501, Japan	Kyoto University; Kyoto University; Kyoto University	Honjo, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Yoshida Konoe Sakyo, Kyoto 6068501, Japan.	honjo@mfour.med.kyoto-u.ac.jp	Honjo, Tasuku/N-4470-2016					Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Barres BA, 1999, CELL, V97, P667, DOI 10.1016/S0092-8674(00)80777-1; Beatus P, 1999, DEVELOPMENT, V126, P3925; Bellavia D, 2000, EMBO J, V19, P3337, DOI 10.1093/emboj/19.13.3337; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; FORTINI ME, 1993, NATURE, V365, P555, DOI 10.1038/365555a0; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; GRAY GE, 1992, DEVELOPMENT, V114, P271; GREENWALD I, 1994, CURR OPIN GENET DEV, V4, P556, DOI 10.1016/0959-437X(94)90072-B; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Hojo M, 2000, DEVELOPMENT, V127, P2515; Honjo T, 1996, GENES CELLS, V1, P1, DOI 10.1046/j.1365-2443.1996.10010.x; Jacobson M., 1991, DEV NEUROBIOLOGY; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kato H, 1997, DEVELOPMENT, V124, P4133; KILPATRICK TJ, 1995, J NEUROSCI, V15, P3653; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; Koblar SA, 1998, P NATL ACAD SCI USA, V95, P3178, DOI 10.1073/pnas.95.6.3178; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; LARDELLI M, 1994, MECH DEVELOP, V46, P123, DOI 10.1016/0925-4773(94)90081-7; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; METCALF D, 1991, P NATL ACAD SCI USA, V88, P11310, DOI 10.1073/pnas.88.24.11310; METCALF D, 1980, P NATL ACAD SCI-BIOL, V77, P5327, DOI 10.1073/pnas.77.9.5327; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; MUSKAVITCH MAT, 1994, DEV BIOL, V166, P415, DOI 10.1006/dbio.1994.1326; Nakashima K, 1999, J NEUROSCI, V19, P5429; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Parnavelas JG, 1991, CEREB CORTEX, V1, P463, DOI 10.1093/cercor/1.6.463; RAEDLER E, 1980, ANAT EMBRYOL, V158, P253, DOI 10.1007/BF00301816; RAY J, 1993, P NATL ACAD SCI USA, V90, P3602, DOI 10.1073/pnas.90.8.3602; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Richards LJ, 1996, EUR J NEUROSCI, V8, P291, DOI 10.1111/j.1460-9568.1996.tb01213.x; Sakurada K, 1999, DEVELOPMENT, V126, P4017; Schroeder T, 2000, EMBO J, V19, P2558, DOI 10.1093/emboj/19.11.2558; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Taga T, 1996, J NEUROCHEM, V67, P1; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.3.CO;2-H; Takahashi M, 1998, MOL CELL NEUROSCI, V12, P340, DOI 10.1006/mcne.1998.0721; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Temple S, 1996, CURR OPIN NEUROBIOL, V6, P11, DOI 10.1016/S0959-4388(96)80003-1; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; WILLIAMS BP, 1995, NEURON, V14, P1181, DOI 10.1016/0896-6273(95)90265-1	58	306	335	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	2001	29	1					45	55		10.1016/S0896-6273(01)00179-9	http://dx.doi.org/10.1016/S0896-6273(01)00179-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	397NX	11182080	Green Submitted, Bronze			2022-12-24	WOS:000166702700008
J	Tucker, KL; Meyer, M; Barde, YA				Tucker, KL; Meyer, M; Barde, YA			Neurotrophins are required for nerve growth during development	NATURE NEUROSCIENCE			English	Article							SENSORY NEURONS; MICE LEADS; CELL-DEATH; EXPRESSION; NGF; SURVIVAL; GANGLIA; TRK; OVEREXPRESSION; INNERVATION	Although the requirement of neurotrophins for the prevention of cell death in the peripheral nervous system is well established, their physiological involvement in nerve growth is still unclear. To address this question, we generated a mouse that expresses the green fluorescent protein in post-mitotic neurons, allowing the repeated visualization of all motor and sensory axons during development. We imaged the growth of these axons into the limb bud of day 10.5 embryos. Sensory axons, but rarely motor axons, were targeted to ectopically placed beads containing any of the neurotrophins NGF, BDNF, NT-3 or NT-4/5. Conversely, a combination of function-blocking monoclonal antibodies to NGF, BDNF and NT-3 dramatically inhibited elongation of both sensory and motor axons in the limb bud, indicating that the growth of mixed nerves is dependent upon neurotrophins during development.	Max Planck Inst Neurobiol, Dept Neurobiochem, D-82152 Martinsried, Germany	Max Planck Society	Barde, YA (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.	yves.barde@fmi.ch	Barde, Yves/F-6019-2011	Barde, Yves/0000-0002-7627-461X				ALBERS KM, 1994, J NEUROSCI, V14, P1422, DOI 10.1523/JNEUROSCI.14-03-01422.1994; Albers KM, 1996, J CELL BIOL, V134, P487, DOI 10.1083/jcb.134.2.487; BANDTLOW CE, 1987, EMBO J, V6, P891, DOI 10.1002/j.1460-2075.1987.tb04835.x; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; CHEN MGM, 1978, ARCH ITAL BIOL, V116, P53; COHEN S, 1954, P NATL ACAD SCI USA, V40, P1014, DOI 10.1073/pnas.40.10.1014; DAVIES AM, 1987, NATURE, V326, P353, DOI 10.1038/326353a0; Dechant G, 1997, CURR OPIN NEUROBIOL, V7, P413, DOI 10.1016/S0959-4388(97)80071-2; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; EDWARDS RH, 1989, CELL, V58, P161, DOI 10.1016/0092-8674(89)90412-1; Elshamy WM, 1996, DEVELOPMENT, V122, P491; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Fagan AM, 1996, J NEUROSCI, V16, P6208; Farinas I, 1998, NEURON, V21, P325, DOI 10.1016/S0896-6273(00)80542-5; Farinas I, 1996, NEURON, V17, P1065, DOI 10.1016/S0896-6273(00)80240-8; Frade JM, 1999, DEVELOPMENT, V126, P683; Frade JM, 1998, NEURON, V20, P35, DOI 10.1016/S0896-6273(00)80432-8; GAESE F, 1994, DEVELOPMENT, V120, P1613; Gallo G, 1997, J NEUROSCI, V17, P5445; GOTZ R, 1992, EUR J BIOCHEM, V204, P745, DOI 10.1111/j.1432-1033.1992.tb16689.x; GUNDERSEN RW, 1979, SCIENCE, V206, P1079, DOI 10.1126/science.493992; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; HASSANKHANI A, 1995, DEV BIOL, V169, P309, DOI 10.1006/dbio.1995.1146; Hogan B, 1994, MANIPULATING MOUSE E; Hotary KB, 1996, METHOD CELL BIOL, V51, P109, DOI 10.1016/S0091-679X(08)60625-1; HOYLE GW, 1993, NEURON, V10, P1019, DOI 10.1016/0896-6273(93)90051-R; KATZ LC, 1987, J NEUROSCI, V7, P1223; Kolbeck R, 1999, J NEUROCHEM, V72, P1930, DOI 10.1046/j.1471-4159.1999.0721930.x; KORSCHING S, 1987, METHOD ENZYMOL, V147, P167; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Maina F, 1997, GENE DEV, V11, P3341, DOI 10.1101/gad.11.24.3341; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; Ming GL, 1997, J NEUROSCI, V17, P7860; MOODY SA, 1989, J COMP NEUROL, V279, P567, DOI 10.1002/cne.902790406; MORRISKAY GM, 1993, ESSENTIAL DEV BIOL P, P55; NOSRAT CA, 1995, J COMP NEUROL, V360, P698, DOI 10.1002/cne.903600413; O'Connor R, 1999, NEURON, V24, P165, DOI 10.1016/S0896-6273(00)80830-2; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Phillips HS, 1996, PHILOS T ROY SOC B, V351, P413, DOI 10.1098/rstb.1996.0036; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Theiler K, 1972, HOUSE MOUSE DEV NORM; Tucker KL, 1996, GENE DEV, V10, P1008, DOI 10.1101/gad.10.8.1008; White FA, 1996, J NEUROSCI, V16, P4662; WRIGHT EM, 1992, NEURON, V9, P139, DOI 10.1016/0896-6273(92)90229-7; Xue Y, 1999, J COMP NEUROL, V408, P299, DOI 10.1002/(SICI)1096-9861(19990607)408:3<299::AID-CNE1>3.0.CO;2-N; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9	50	403	411	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2001	4	1					29	37		10.1038/82868	http://dx.doi.org/10.1038/82868			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UB	11135642				2022-12-24	WOS:000167178000011
J	Beattie, EC; Carroll, RC; Yu, X; Morishita, W; Yasuda, H; von Zastrow, M; Malenka, RC				Beattie, EC; Carroll, RC; Yu, X; Morishita, W; Yasuda, H; von Zastrow, M; Malenka, RC			Regulation of AMPA receptor endocytosis by a signaling mechanism shared with LTD	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; SYNAPTIC VESICLE ENDOCYTOSIS; STIMULATION-DEPENDENT DEPHOSPHORYLATION; IONOTROPIC GLUTAMATE RECEPTORS; HIPPOCAMPAL PYRAMIDAL CELLS; SILENT SYNAPSES; NERVE-TERMINALS; NMDA RECEPTOR; PROTEIN PHOSPHATASES; EXPRESSION	The endocytosis of AMPA receptors is thought to be important in the expression of long-term depression (LTD) triggered by NMDA receptor activation. Although signaling pathways necessary for LTD induction have been identified, those responsible for the regulated internalization of AMPA receptors are unknown. Here we show that activation of NMDA receptors alone can trigger AMPA receptor endocytosis through calcium influx and activation of the calcium-dependent protein phosphatase calcineurin. A distinct signaling mechanism mediates the AMPA receptor endocytosis stimulated by insulin. These results demonstrate that although multiple signaling pathways can induce AMPA receptor internalization, NMDA receptor activation enhances AMPA receptor endocytosis via a signaling mechanism required for the induction of LTD.	Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA.			Yasuda, Hiroki/0000-0001-5911-609X				Bauerfeind R, 1997, J BIOL CHEM, V272, P30984, DOI 10.1074/jbc.272.49.30984; Brodin L, 2000, CURR OPIN NEUROBIOL, V10, P312, DOI 10.1016/S0959-4388(00)00097-0; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chen H, 1999, J BIOL CHEM, V274, P3257, DOI 10.1074/jbc.274.6.3257; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; ENAN E, 1992, BIOCHEM PHARMACOL, V43, P1777, DOI 10.1016/0006-2952(92)90710-Z; Feldman DE, 1998, NEURON, V20, P1067, DOI 10.1016/S0896-6273(00)80488-2; Gasparini S, 2000, P NATL ACAD SCI USA, V97, P9741, DOI 10.1073/pnas.170032297; Halpain S, 1998, J NEUROSCI, V18, P9835; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HEIDENREICH KA, 1993, ANN NY ACAD SCI, V692, P72; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; Lai MM, 1999, J BIOL CHEM, V274, P25963, DOI 10.1074/jbc.274.37.25963; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; LIN JW, 2000, NAT NEUROSCI, V3; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Lissin DV, 1999, J NEUROSCI, V19, P1263; LIU J, 1993, TRENDS PHARMACOL SCI, V14, P182, DOI 10.1016/0165-6147(93)90206-Y; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; Matsuda S, 2000, EMBO J, V19, P2765, DOI 10.1093/emboj/19.12.2765; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; O'Dell T J, 1994, Learn Mem, V1, P129; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; ROBINSON PJ, 1993, NATURE, V365, P163, DOI 10.1038/365163a0; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Slepnev VI, 1998, SCIENCE, V281, P821, DOI 10.1126/science.281.5378.821; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1	50	567	582	1	33	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2000	3	12					1291	1300		10.1038/81823	http://dx.doi.org/10.1038/81823			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UA	11100150	Bronze			2022-12-24	WOS:000167177900015
J	Calder, AJ; Keane, J; Manes, F; Antoun, N; Young, AW				Calder, AJ; Keane, J; Manes, F; Antoun, N; Young, AW			Impaired recognition and experience of disgust following brain injury	NATURE NEUROSCIENCE			English	Article							FACIAL EXPRESSIONS; HUNTINGTONS-DISEASE; AMYGDALA; FEAR; EMOTIONS; DAMAGE		MRC, Cognit & Brain Sci Unit, Cambridge CB2 2EF, England; Addenbrookes Hosp, Dept Radiol, Cambridge CB2 2QQ, England; Univ York, Dept Psychol, York YO1 5DD, N Yorkshire, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of York - UK	Calder, AJ (corresponding author), MRC, Cognit & Brain Sci Unit, 15 Chaucer Rd, Cambridge CB2 2EF, England.		Young, Andy/G-2189-2011	Young, Andy/0000-0002-1202-6297				ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Calder AJ, 1996, COGNITIVE NEUROPSYCH, V13, P699, DOI 10.1080/026432996381890; Chikama M, 1997, J NEUROSCI, V17, P9686; Ekman P., 1976, PICTURES FACIAL AFFE; Gray JM, 1997, BRAIN, V120, P2029, DOI 10.1093/brain/120.11.2029; Lang PJ, 1995, INT AFFECTIVE PICTUR; Matsumoto D, 1988, JAPANESE CAUCASIAN F; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; Phillips ML, 1998, P ROY SOC B-BIOL SCI, V265, P1809, DOI 10.1098/rspb.1998.0506; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Rozin P., 1993, HDB EMOTIONS, P575; Scott SK, 1997, NATURE, V385, P254, DOI 10.1038/385254a0; Small DM, 1999, NEUROREPORT, V10, P7, DOI 10.1097/00001756-199901180-00002; Sprengelmeyer R, 1996, BRAIN, V119, P1647, DOI 10.1093/brain/119.5.1647; Sprengelmeyer R, 1998, P ROY SOC B-BIOL SCI, V265, P1927, DOI 10.1098/rspb.1998.0522	15	551	569	1	60	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11					1077	1078		10.1038/80586	http://dx.doi.org/10.1038/80586			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TX	11036262				2022-12-24	WOS:000167177600010
J	Ganguly, K; Kiss, L; Poo, MM				Ganguly, K; Kiss, L; Poo, MM			Enhancement of presynaptic neuronal excitability by correlated presynaptic and postsynaptic spiking	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; RABBIT FOLLOWING STIMULATION; PROTEIN-KINASE-C; SYNAPTIC PLASTICITY; INTRINSIC EXCITABILITY; PERFORANT PATH; LASTING POTENTIATION; HIPPOCAMPAL-NEURONS; PYRAMIDAL CELLS; DENTATE AREA	Use-dependent modifications, such as long-term potentiation (LTP) of synaptic efficacy, are believed to be essential for information storage in the nervous system. Repetitive correlated spiking of presynaptic and postsynaptic neurons can induce LTP at excitatory glutamatergic synapses. In cultured hippocampal neurons, we show that repetitive correlated activity also results in a rapid and persistent enhancement of presynaptic excitability, decreasing the threshold for spiking and reducing the variability of interspike intervals. Furthermore, we found that correlated activity modified sodium channel gating in the presynaptic neuron. This modification of presynaptic excitability required a temporal order between presynaptic and postsynaptic spiking and activation of postsynaptic NMDA receptors. Presynaptic inhibition of protein kinase C abolished the change in excitability without affecting LTP. Such rapid activity-dependent changes in the efficacy of presynaptic spiking may be involved in the processing and storage of information within the nervous system.	Univ Calif San Diego, Program Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Poo, MM (corresponding author), Univ Calif San Diego, Program Neurosci, La Jolla, CA 92093 USA.							ABRAHAM WC, 1987, J PHYSIOL-LONDON, V394, P367, DOI 10.1113/jphysiol.1987.sp016875; ABRAHAM WC, 1985, J PHYSIOL-LONDON, V363, P335, DOI 10.1113/jphysiol.1985.sp015714; Aizenman CD, 2000, NAT NEUROSCI, V3, P109, DOI 10.1038/72049; Armano S, 2000, J NEUROSCI, V20, P5208, DOI 10.1523/JNEUROSCI.20-14-05208.2000; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CHAVEZNORIEGA LE, 1990, EXP BRAIN RES, V79, P633; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; HU GY, 1987, NATURE, V328, P426, DOI 10.1038/328426a0; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; McBain CJ, 1999, TRENDS NEUROSCI, V22, P228, DOI 10.1016/S0166-2236(98)01347-2; MCNAUGHTON BL, 1994, P NATL ACAD SCI USA, V91, P4830, DOI 10.1073/pnas.91.11.4830; Moyer JR, 1996, J NEUROSCI, V16, P5536; Nick TA, 2000, NAT NEUROSCI, V3, P142, DOI 10.1038/72082; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Schneidman E, 1998, NEURAL COMPUT, V10, P1679, DOI 10.1162/089976698300017089; Sik A, 1998, P NATL ACAD SCI USA, V95, P3245, DOI 10.1073/pnas.95.6.3245; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; TAUBE JS, 1988, J NEUROSCI, V8, P1632; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; WEST JW, 1991, SCIENCE, V254, P866, DOI 10.1126/science.1658937; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	39	107	111	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2000	3	10					1018	1026		10.1038/79838	http://dx.doi.org/10.1038/79838			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TW	11017175				2022-12-24	WOS:000167177500020
J	Cohen, YE; Andersen, RA				Cohen, YE; Andersen, RA			Reaches to sounds encoded in an eye-centered reference frame	NEURON			English	Article							POSTERIOR PARIETAL CORTEX; LIP; POSITION; MACAQUE; NEURONS; SPACE; ENHANCEMENT; MOVEMENTS; LOCATIONS; RESPONSES	A recent hypothesis suggests that neurons in the lateral intraparietal area (LIP) and the parietal reach region (PRR) encode movement plans in a common eye-centered reference frame. To test this hypothesis further, we examined how PRR neurons encode reach plans to auditory stimuli. We found that PRR activity was affected by eye and initial hand position. Population analyses, however, indicated that PRR neurons were affected more strongly by eye position than by initial hand position. These eye position effects were appropriate to maintain coding in eye coordinates. Indeed, a significant population of PRR neurons encoded reaches to auditory stimuli in an eye-centered reference frame. These results extend the hypothesis that, regardless of the modality of the sensory input or the eventual action, PRR and LIP neurons represent movement plans in a common, eye-centered representation.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Andersen, RA (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.							ANDERSEN RA, 1990, J NEUROSCI, V10, P1176; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; ANDERSEN RA, 1990, J COMP NEUROL, V296, P65, DOI 10.1002/cne.902960106; Andersen RA, 1998, NOVART FDN SYMP, V218, P109; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; BROTCHIE PR, 1995, NATURE, V375, P232, DOI 10.1038/375232a0; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Cohen YE, 1999, TRENDS NEUROSCI, V22, P128, DOI 10.1016/S0166-2236(98)01295-8; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Driver J, 1996, NATURE, V381, P66, DOI 10.1038/381066a0; GNADT JW, 1988, EXP BRAIN RES, V70, P216; GOLDBERG ME, 1990, COLD SPRING HARB SYM, V55, P729; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; Grunewald A, 1999, J NEUROPHYSIOL, V82, P330, DOI 10.1152/jn.1999.82.1.330; Irvine DRF, 1986, AUDITORY BRAINSTEM; Lewald J, 1996, EXP BRAIN RES, V108, P473; Lewald J, 1998, HEARING RES, V115, P206, DOI 10.1016/S0378-5955(97)00190-1; PANDYA DN, 1969, BRAIN RES, V13, P49; Sabes PN, 1997, J NEUROSCI, V17, P7119; Shenoy KV, 1999, J NEUROPHYSIOL, V81, P2764, DOI 10.1152/jn.1999.81.6.2764; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Snyder LH, 2000, VISION RES, V40, P1433, DOI 10.1016/S0042-6989(00)00052-3; Stricanne B, 1996, J NEUROPHYSIOL, V76, P2071, DOI 10.1152/jn.1996.76.3.2071; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	24	107	109	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	2000	27	3					647	652		10.1016/S0896-6273(00)00073-8	http://dx.doi.org/10.1016/S0896-6273(00)00073-8			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	359FR	11055445	Bronze			2022-12-24	WOS:000089601300026
J	Tanaka, K				Tanaka, K			Curvature in depth for object representation	NEURON			English	Editorial Material							MONKEY INFEROTEMPORAL CORTEX; CONNECTIONS; MACAQUE		RIKEN, Brain Sci Inst, Lab Cognit Brain Mapping, Wako, Saitama 3510198, Japan	RIKEN	Tanaka, K (corresponding author), RIKEN, Brain Sci Inst, Lab Cognit Brain Mapping, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.		Tanaka, Keiji/N-5917-2015	Tanaka, Keiji/0000-0002-1910-3427				BOUSSAOUD D, 1990, J COMP NEUROL, V296, P462, DOI 10.1002/cne.902960311; DEYOE EA, 1985, NATURE, V317, P58, DOI 10.1038/317058a0; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; Janssen P, 2000, NEURON, V27, P385, DOI 10.1016/S0896-6273(00)00045-3; Janssen P, 2000, SCIENCE, V288, P2054, DOI 10.1126/science.288.5473.2054; Sakata H, 1997, TRENDS NEUROSCI, V20, P350, DOI 10.1016/S0166-2236(97)01067-9; Saleem KS, 2000, J NEUROSCI, V20, P5083; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Taira M, 2000, J NEUROPHYSIOL, V83, P3140, DOI 10.1152/jn.2000.83.5.3140; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Uka T, 2000, J NEUROPHYSIOL, V84, P120, DOI 10.1152/jn.2000.84.1.120; Wang G, 1998, NEUROSCI RES, V32, P33, DOI 10.1016/S0168-0102(98)00062-5	12	4	4	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	2000	27	2					195	196		10.1016/S0896-6273(00)00027-1	http://dx.doi.org/10.1016/S0896-6273(00)00027-1			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	347YD	10985339	Bronze			2022-12-24	WOS:000088956000003
J	Messer, CJ; Eisch, AJ; Carlezon, WA; Whisler, K; Shen, L; Wolf, DH; Westphal, H; Collins, F; Russell, DS; Nestler, EJ				Messer, CJ; Eisch, AJ; Carlezon, WA; Whisler, K; Shen, L; Wolf, DH; Westphal, H; Collins, F; Russell, DS; Nestler, EJ			Role for GDNF in biochemical and behavioral adaptations to drugs of abuse	NEURON			English	Article							MESOLIMBIC DOPAMINE SYSTEM; VENTRAL TEGMENTAL AREA; MICE LACKING GDNF; CHOLERA-TOXIN INFUSION; MESSENGER-RNA LEVELS; C-RET PROTOONCOGENE; NERVE GROWTH-FACTOR; CYCLIC-AMP SYSTEM; NEUROTROPHIC FACTOR; NUCLEUS-ACCUMBENS	The present study examined a role for GDNF in adaptations to drugs of abuse. Infusion of GDNF into the ventral tegmental area (VTA), a dopaminergic brain region important for addiction, blocks certain biochemical adaptations to chronic cocaine or morphine as well as the rewarding effects of cocaine. Conversely, responses to cocaine are enhanced in rats by intra-VTA infusion of an anti-GDNF antibody and in mice heterozygous for a null mutation in the GDNF gene. Chronic morphine or cocaine exposure decreases levels of phosphoRet, the protein kinase that mediates GDNF signaling, in the VTA. Together, these results suggest a feedback loop, whereby drugs of abuse decrease signaling through endogenous GDNF pathways in the VTA, which then increases the behavioral sensitivity to subsequent drug exposure.	Yale Univ, Sch Med, Lab Mol Psychiat, New Haven, CT 06508 USA; Yale Univ, Sch Med, Yale Ctr Genes & Behav, New Haven, CT 06508 USA; Connecticut Mental Hlth Ctr, New Haven, CT 06508 USA; NIH, Lab Mammalian Genes & Dev, Bethesda, MD 20892 USA; Amgen Inc, Thousand Oaks, CA 91320 USA	Yale University; Yale University; National Institutes of Health (NIH) - USA; Amgen	Nestler, EJ (corresponding author), Yale Univ, Sch Med, Lab Mol Psychiat, New Haven, CT 06508 USA.		; Wolf, Daniel/H-2581-2013	/0000-0002-4162-3947; Wolf, Daniel/0000-0002-9731-8781; Eisch, Amelia/0000-0001-6476-5385	NIDA NIH HHS [K08 DA000302-05] Funding Source: Medline; DIVISION OF BASIC SCIENCES - NCI [Z01BC010415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K08DA000302] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Akerud P, 1999, J NEUROCHEM, V73, P70, DOI 10.1046/j.1471-4159.1999.0730070.x; BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; BEITNERJOHNSON D, 1992, J NEUROSCI, V12, P2165; BEITNERJOHNSON D, 1991, J NEUROCHEM, V57, P344, DOI 10.1111/j.1471-4159.1991.tb02133.x; BEITNERJOHNSON D, 1993, J NEUROCHEM, V61, P1766, DOI 10.1111/j.1471-4159.1993.tb09814.x; Berhow MT, 1996, J NEUROSCI, V16, P4707; BERHOW MT, 1995, NEUROSCIENCE, V68, P969, DOI 10.1016/0306-4522(95)00207-Y; Boundy VA, 1998, J NEUROSCI, V18, P9989; Carlezon WA, 1997, SCIENCE, V277, P812, DOI 10.1126/science.277.5327.812; CHEAH TB, 1973, J NEUROBIOL, V4, P443, DOI 10.1002/neu.480040505; CUNNINGHAM ST, 1993, J NEUROSCI, V13, P2342, DOI 10.1523/JNEUROSCI.13-06-02342.1993; Fitzgerald LW, 1996, J NEUROSCI, V16, P274; GALL CM, 1989, SCIENCE, V245, P758, DOI 10.1126/science.2549634; Gash D M, 1998, Adv Pharmacol, V42, P911; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; GRAFSTEIN B, 1975, EXP NEUROL, V48, P32, DOI 10.1016/0014-4886(75)90170-3; Griesbeck O, 1996, COLD SPRING HARB SYM, V61, P77; Hebert MA, 1997, J PHARMACOL EXP THER, V282, P760; Hiroi N, 1997, P NATL ACAD SCI USA, V94, P10397, DOI 10.1073/pnas.94.19.10397; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; Horger BA, 1999, J NEUROSCI, V19, P4110; HURD YL, 1992, BRAIN RES, V578, P317, DOI 10.1016/0006-8993(92)90264-A; KEARNS CM, 1995, BRAIN RES, V672, P104, DOI 10.1016/0006-8993(94)01366-P; Kelley AE, 1997, SYNAPSE, V26, P46, DOI 10.1002/(SICI)1098-2396(199705)26:1<46::AID-SYN5>3.0.CO;2-E; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; KOKAIA Z, 1993, MOL BRAIN RES, V19, P277, DOI 10.1016/0169-328X(93)90126-A; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; LaneLadd SB, 1997, J NEUROSCI, V17, P7890; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Lu X, 1997, J COMP NEUROL, V388, P484; MISERENDINO MJD, 1995, BRAIN RES, V674, P299, DOI 10.1016/0006-8993(95)00030-T; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Nestler EJ, 1996, MOL PSYCHIATR, V1, P190; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; NESTLER EJ, 1993, NEURON, V11, P995, DOI 10.1016/0896-6273(93)90213-B; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Numan S, 1998, J NEUROSCI, V18, P10700; Nye HE, 1995, J PHARMACOL EXP THER, V275, P1671; Nye HE, 1996, MOL PHARMACOL, V49, P636; ORTIZ J, 1995, SYNAPSE, V21, P289, DOI 10.1002/syn.890210403; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Pich EM, 1997, SCIENCE, V275, P83; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Pilotte NS, 1997, CURR OPIN NEUROL, V10, P534, DOI 10.1097/00019052-199712000-00017; Robinson TE, 1997, J NEUROSCI, V17, P8491; Robinson TE, 1999, SYNAPSE, V33, P160; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Self DW, 1998, J NEUROSCI, V18, P1848; SklairTavron L, 1996, P NATL ACAD SCI USA, V93, P11202, DOI 10.1073/pnas.93.20.11202; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; SORG BA, 1993, J PHARMACOL EXP THER, V266, P424; TAKAHASHI M, 1991, ONCOGENE, V6, P297; TERWILLIGER RZ, 1991, BRAIN RES, V548, P100, DOI 10.1016/0006-8993(91)91111-D; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; Trupp M, 1998, MOL CELL NEUROSCI, V11, P47, DOI 10.1006/mcne.1998.0667; Trupp M, 1997, J NEUROSCI, V17, P3554; Vaidya VA, 1999, NEUROSCIENCE, V89, P157, DOI 10.1016/S0306-4522(98)00289-9; VRANA SL, 1993, J NEUROCHEM, V61, P2262, DOI 10.1111/j.1471-4159.1993.tb07468.x; Winkler C, 1996, J NEUROSCI, V16, P7206; Wise RA, 1998, DRUG ALCOHOL DEPEN, V51, P13, DOI 10.1016/S0376-8716(98)00063-5; Wolf DH, 1999, J NEUROCHEM, V73, P1520, DOI 10.1046/j.1471-4159.1999.0731520.x; Xu RY, 1998, J NEUROCHEM, V70, P1383, DOI 10.1046/j.1471-4159.1998.70041383.x; ZAFRA F, 1991, P NATL ACAD SCI USA, V88, P10037, DOI 10.1073/pnas.88.22.10037	64	133	163	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	2000	26	1					247	257		10.1016/S0896-6273(00)81154-X	http://dx.doi.org/10.1016/S0896-6273(00)81154-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309MA	10798408	Green Accepted, Bronze			2022-12-24	WOS:000086770500024
J	Zheng, C; Feinstein, P; Bozza, T; Rodriguez, I; Mombaerts, P				Zheng, C; Feinstein, P; Bozza, T; Rodriguez, I; Mombaerts, P			Peripheral olfactory projections are differentially affected in mice deficient in a cyclic nucleotide-gated channel subunit	NEURON			English	Article							RECEPTOR GENE-EXPRESSION; ODORANT RECEPTORS; FUNCTIONAL EXPRESSION; MOLECULAR-BIOLOGY; CALCIUM-ENTRY; SENSORY MAP; C-ELEGANS; NEURONS; SYSTEM; MOUSE	Axons of olfactory sensory neurons expressing a given odorant receptor converge to a few glomeruli in the olfactory bulb. We have generated mice with unresponsive olfactory sensory neurons by targeted mutagenesis of a cyclic nucleotide-gated channel subunit gene, OCNC1. When these anosmic mice were crossed with mice in which neurons expressing a given odorant receptor can be visualized by coexpression of an axonal marker, the pattern of convergence was affected for one but not another receptor. In a novel paradigm, termed monoallelic deprivation, axons from channel positive or negative neurons that express the same odorant receptor segregate into distinct glomeruli within the same bulb. Thus, the peripheral olfactory projections are in part influenced by mechanisms that depend on neuronal activity.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Mombaerts, P (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.			rodriguez, ivan/0000-0002-6468-0565				BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Bozza TC, 1998, J NEUROSCI, V18, P4560; Bradley J, 1997, J NEUROSCI, V17, P1993; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 1996, COLD SPRING HARB SYM, V61, P147; Bulfone A, 1998, NEURON, V21, P1273, DOI 10.1016/S0896-6273(00)80647-9; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; DELAY RJ, 1999, ACHEMS, V21; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; GESTELAND RC, 1982, NEUROSCIENCE, V7, P3127, DOI 10.1016/0306-4522(82)90235-4; Gold GH, 1999, ANNU REV PHYSIOL, V61, P857, DOI 10.1146/annurev.physiol.61.1.857; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; LeindersZufall T, 1997, J NEUROSCI, V17, P4136; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Matsuzaki O, 1999, NEUROSCIENCE, V94, P131, DOI 10.1016/S0306-4522(99)00228-6; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Mombaerts P, 1996, CURR OPIN NEUROBIOL, V6, P481, DOI 10.1016/S0959-4388(96)80053-5; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 1996, COLD SPRING HARB SYM, V61, P135; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Mombaerts P, 1999, ANNU REV NEUROSCI, V22, P487, DOI 10.1146/annurev.neuro.22.1.487; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; O'Leary DDM, 1999, CELL, V96, P255, DOI 10.1016/S0092-8674(00)80565-6; Parent A, 1998, J NEUROPHYSIOL, V79, P3295, DOI 10.1152/jn.1998.79.6.3295; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; SCHILD D, 1994, CELL CALCIUM, V15, P341, DOI 10.1016/0143-4160(94)90009-4; Schild D, 1998, PHYSIOL REV, V78, P429, DOI 10.1152/physrev.1998.78.2.429; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wei JY, 1998, PROG NEUROBIOL, V56, P37, DOI 10.1016/S0301-0082(98)00029-X; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; Zufall F, 1997, CURR OPIN NEUROBIOL, V7, P404, DOI 10.1016/S0959-4388(97)80070-0	51	202	204	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	2000	26	1					81	91		10.1016/S0896-6273(00)81140-X	http://dx.doi.org/10.1016/S0896-6273(00)81140-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309MA	10798394	Bronze			2022-12-24	WOS:000086770500010
J	Castet, E; Masson, GS				Castet, E; Masson, GS			Motion perception during saccadic eye movements	NATURE NEUROSCIENCE			English	Article							MONKEY VISUAL-CORTEX; AREA MT; MAGNOCELLULAR PATHWAY; MACAQUE MONKEY; LOW-LEVEL; SUPPRESSION; DIRECTION; NEURONS; SELECTIVITY; STABILITY	During rapid eye movements, motion of the stationary world is generally not perceived despite displacement of the whole image on the retina. Here we report: that during saccades, human observers sensed visual motion of patterns with low spatial frequency. The effect was greatest when the stimulus was spatiotemporally optimal for motion detection by the magnocellular pathway. Adaptation experiments demonstrated dependence of this intrasaccadic motion percept on activation of direction-selective mechanisms. Even two-dimensional complex motion percepts requiring spatial integration of early motion signals were observed during saccades. These results indicate that the magnocellular pathway functions during saccades, and that only spatiotemporal limitations of visual motion perception are important in suppressing awareness of intrasaccadic motion signals.	Ctr Rech Neurosci Cognit, UPR 9012 CNRS 31, Marseille 20, France		Castet, E (corresponding author), Ctr Rech Neurosci Cognit, UPR 9012 CNRS 31, Chemin J Aiguieri 13402, Marseille 20, France.	castet@lnf.cnrs-mrs.fr	MASSON, Guillaume S/G-4615-2012	MASSON, Guillaume S/0000-0001-9227-0777				ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; ALBRIGHT TD, 1995, P NATL ACAD SCI USA, V92, P2433, DOI 10.1073/pnas.92.7.2433; ANDERSON SJ, 1985, VISION RES, V25, P1147, DOI 10.1016/0042-6989(85)90104-X; BAHILL A T, 1975, Mathematical Biosciences, V24, P191, DOI 10.1016/0025-5564(75)90075-9; Bair W, 1998, VISUAL NEUROSCI, V15, P779, DOI 10.1017/S0952523898154160; Bockisch CJ, 1999, VISION RES, V39, P1025, DOI 10.1016/S0042-6989(98)00205-3; BRADDICK OJ, 1980, PHILOS T ROY SOC B, V290, P137, DOI 10.1098/rstb.1980.0087; BREITMEYER BG, 1976, PSYCHOL REV, V83, P1, DOI 10.1037/0033-295X.83.1.1; BRIDGEMAN B, 1994, BEHAV BRAIN SCI, V17, P247, DOI 10.1017/S0140525X00034361; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; BURR DC, 1981, PROC R SOC SER B-BIO, V211, P321, DOI 10.1098/rspb.1981.0010; BURR DC, 1994, NATURE, V371, P511, DOI 10.1038/371511a0; BURR DC, 1982, VISION RES, V22, P479, DOI 10.1016/0042-6989(82)90196-1; CAMPBELL FW, 1978, VISION RES, V18, P1297, DOI 10.1016/0042-6989(78)90219-5; Castet E, 1999, VISION RES, V39, P915, DOI 10.1016/S0042-6989(98)00146-1; CAVANAGH P, 1992, SCIENCE, V257, P1563, DOI 10.1126/science.1523411; COLLEWIJN H, 1988, J PHYSIOL-LONDON, V404, P157, DOI 10.1113/jphysiol.1988.sp017284; CORBETTA M, 1993, J NEUROSCI, V13, P1202; DEUBEL H, 1987, BIOL CYBERN, V57, P37, DOI 10.1007/BF00318714; Deubel H, 1998, VISION RES, V38, P3147, DOI 10.1016/S0042-6989(98)00048-0; ERICKSON RG, 1991, EXP BRAIN RES, V86, P608; GRUSSER OJ, 1987, VISION RES, V27, P215, DOI 10.1016/0042-6989(87)90184-2; Haarmeier T, 1997, NATURE, V389, P849, DOI 10.1038/39872; Hawken MJ, 1996, VISUAL NEUROSCI, V13, P477, DOI 10.1017/S0952523800008154; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; ILG UJ, 1993, VISION RES, V33, P211, DOI 10.1016/0042-6989(93)90159-T; JUDGE SJ, 1980, J NEUROPHYSIOL, V43, P1133, DOI 10.1152/jn.1980.43.4.1133; KOOI FL, 1993, VISION RES, V33, P2347, DOI 10.1016/0042-6989(93)90112-A; LEVINSON E, 1975, J PHYSIOL-LONDON, V250, P347, DOI 10.1113/jphysiol.1975.sp011058; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Li WX, 1997, VISION RES, V37, P1779, DOI 10.1016/S0042-6989(96)00301-X; MATIN L, 1982, SCIENCE, V216, P198, DOI 10.1126/science.7063881; MAUNSELL JHR, 1990, J NEUROSCI, V10, P3323; MERIGAN WH, 1991, J NEUROSCI, V11, P3422; MORGAN MJ, 1980, PHILOS T ROY SOC B, V290, P117, DOI 10.1098/rstb.1980.0086; MOVSHON AJ, 1985, PATTERN RECOGN, P117; Movshon JA, 1996, J NEUROSCI, V16, P7733; NEWSOME WT, 1988, TRENDS NEUROSCI, V11, P394, DOI 10.1016/0166-2236(88)90076-8; OREGAN JK, 1992, CAN J PSYCHOL, V46, P461, DOI 10.1037/h0084327; PASTERNAK T, 1994, CEREB CORTEX, V4, P247, DOI 10.1093/cercor/4.3.247; ROBSON JG, 1966, J OPT SOC AM, V56, P1141, DOI 10.1364/JOSA.56.001141; Ross J, 1996, BEHAV BRAIN RES, V80, P1, DOI 10.1016/0166-4328(96)00012-5; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; SHIOIRI S, 1989, VISION RES, V29, P915, DOI 10.1016/0042-6989(89)90106-5; Van Essen David C., 1995, P383; VANSANTEN JPH, 1985, J OPT SOC AM A, V2, P300, DOI 10.1364/JOSAA.2.000300; VOLKMANN FC, 1986, VISION RES, V26, P1401, DOI 10.1016/0042-6989(86)90164-1; WATSON AB, 1985, J OPT SOC AM A, V2, P322, DOI 10.1364/JOSAA.2.000322; Wuerger S, 1996, PERCEPTION, V25, P1317, DOI 10.1068/p251317; YUILLE AL, 1988, NATURE, V333, P71, DOI 10.1038/333071a0	50	94	95	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2000	3	2					177	183		10.1038/72124	http://dx.doi.org/10.1038/72124			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TC	10649574				2022-12-24	WOS:000085810300016
J	Reenan, RA; Hanrahan, CJ; Ganetzky, B				Reenan, RA; Hanrahan, CJ; Ganetzky, B			The mle(napts) RNA helicase mutation in Drosophila results in a splicing catastrophe of the para Na+ channel transcript in a region of RNA editing	NEURON			English	Article							MESSENGER-RNA; SECONDARY STRUCTURE; DOSAGE COMPENSATION; NERVE EXCITABILITY; RECEPTOR CHANNELS; MALELESS PROTEIN; X-CHROMOSOME; GENE; MUTANTS; DETERMINANTS	The mle(napts) mutation causes temperature-de pendent blockade of action potentials resulting from decreased abundance of para-encoded Na+ channels. Although maleless (mle) encodes a double-stranded RNA (dsRNA) helicase, exactly how mle(napts) affects para expression remained uncertain. Here, we show that para transcripts undergo adenosine-to-inosine (A-to-I) RNA editing via a mechanism that apparently requires dsRNA secondary structure formation encompassing the edited exon and the downstream intron. In an mle(napts) background, >80% of para transcripts are aberrant, owing to internal deletions that include the edited exon. We propose that the Mle helicase is required to resolve the dsRNA structure and that failure to do so in an mle(napts) background causes exon skipping because the normal splice donor is occluded. These results explain how mle(napts) affects Na+ channel expression and provide new insights into the mechanism of RNA editing.	Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA; Univ Wisconsin, Genet Lab, Madison, WI 53706 USA	University of Connecticut; University of Wisconsin System; University of Wisconsin Madison	Reenan, RA (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA.				NIGMS NIH HHS [GM43100] Funding Source: Medline; NINDS NIH HHS [NS15390] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015390] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; Bass BL, 1997, TRENDS BIOCHEM SCI, V22, P157, DOI 10.1016/S0968-0004(97)01035-9; Bass BL, 1997, RNA, V3, P947; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Chabot B, 1997, MOL CELL BIOL, V17, P1776, DOI 10.1128/MCB.17.4.1776; ENG FJ, 1991, CELL, V65, P797, DOI 10.1016/0092-8674(91)90387-E; GANETZKY B, 1982, J NEUROPHYSIOL, V47, P501, DOI 10.1152/jn.1982.47.3.501; GANETZKY B, 1984, GENETICS, V108, P897; GANETZKY B, 1982, GENETICS, V100, P597; GIBSON TJ, 1994, NUCLEIC ACIDS RES, V22, P2552, DOI 10.1093/nar/22.13.2552; GOGUEL V, 1993, MOL CELL BIOL, V13, P6841, DOI 10.1128/MCB.13.11.6841; Herb A, 1996, P NATL ACAD SCI USA, V93, P1875, DOI 10.1073/pnas.93.5.1875; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; HONG CS, 1994, J NEUROSCI, V14, P5160; KELLEY RL, 1995, SCIENCE, V270, P1607, DOI 10.1126/science.270.5242.1607; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KERNAN MJ, 1991, CELL, V66, P949, DOI 10.1016/0092-8674(91)90440-A; KHARRAT A, 1995, EMBO J, V14, P3572, DOI 10.1002/j.1460-2075.1995.tb07363.x; KOHLER M, 1993, NEURON, V10, P491, DOI 10.1016/0896-6273(93)90336-P; KRAWCZAK M, 1992, HUM GENET, V90, P41; KURODA MI, 1991, CELL, V66, P935, DOI 10.1016/0092-8674(91)90439-6; LEE CG, 1993, J BIOL CHEM, V268, P16822; Lee CG, 1997, EMBO J, V16, P2671, DOI 10.1093/emboj/16.10.2671; Lee CG, 1998, P NATL ACAD SCI USA, V95, P13709, DOI 10.1073/pnas.95.23.13709; LEE CG, 1992, J BIOL CHEM, V267, P4398; Lin J, 1996, RNA, V2, P835; LIU HX, 1995, EMBO J, V14, P377, DOI 10.1002/j.1460-2075.1995.tb07012.x; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; LOUGHNEY K, 1989, CELL, V58, P1143, DOI 10.1016/0092-8674(89)90512-6; Machesky LM, 1998, CURR BIOL, V8, P607, DOI 10.1016/S0960-9822(98)70233-7; Niswender CM, 1999, J BIOL CHEM, V274, P9472, DOI 10.1074/jbc.274.14.9472; Parkansky N, 1995, SURF COAT TECH, V76, P197, DOI 10.1016/0257-8972(95)02588-X; POLSON AG, 1994, EMBO J, V13, P5701, DOI 10.1002/j.1460-2075.1994.tb06908.x; Powell J. R., 1997, PROGR PROSPECTS EVOL; Rueter S.M., 1998, MODIFICATION EDITING, P343; SOLNICK D, 1985, CELL, V43, P667, DOI 10.1016/0092-8674(85)90239-9; SOLNICK D, 1987, MOL CELL BIOL, V7, P3194, DOI 10.1128/MCB.7.9.3194; STERN M, 1990, GENETICS, V124, P133; THACKERAY JR, 1994, J NEUROSCI, V14, P2569; WU CF, 1978, P NATL ACAD SCI USA, V75, P4047, DOI 10.1073/pnas.75.8.4047; Zaffran S, 1998, DEVELOPMENT, V125, P3571; ZHANG SS, 1995, J BIOL CHEM, V270, P16422, DOI 10.1074/jbc.270.27.16422	43	137	143	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	2000	25	1					139	149		10.1016/S0896-6273(00)80878-8	http://dx.doi.org/10.1016/S0896-6273(00)80878-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279KP	10707979	Bronze			2022-12-24	WOS:000085043200017
J	Grill-Spector, K; Kushnir, T; Edelman, S; Avidan, G; Itzchak, Y; Malach, R				Grill-Spector, K; Kushnir, T; Edelman, S; Avidan, G; Itzchak, Y; Malach, R			Differential processing of objects under various viewing conditions in the human lateral occipital complex	NEURON			English	Article							INFERIOR TEMPORAL CORTEX; HUMAN CEREBRAL-CORTEX; MONKEY INFEROTEMPORAL CORTEX; FACE PERCEPTION; EXTRASTRIATE CORTEX; VISUAL RECOGNITION; REPRESENTATION; INVARIANCE; NEURONS; SIZE	The invariant properties of human cortical neurons cannot be studied directly by fMRI due to its limited spatial resolution. Here, we circumvented this limitation by using fMR adaptation, namely, reduction of the fMR signal due to repeated presentation of identical images. Object-selective regions (lateral occipital complex [LOC]) showed a monotonic signal decrease as repetition frequency increased. The invariant properties of fMR adaptation were studied by presenting the same object in different viewing conditions. LOC exhibited stronger fMR adaptation to changes in size and position (more invariance) compared to illumination and viewpoint. The effect revealed two putative subdivisions within LOG: caudal-dorsal (LO), which exhibited substantial recovery from adaptation under all transformations, and posterior fusiform (PF/LOa), which displayed stronger adaptation. This study demonstrates the utility of fMR adaptation for revealing functional characteristics of neurons in fMRI studies.	Weizmann Inst Sci, IL-76100 Rehovot, Israel; Chaim Sheba Med Ctr, Dept Diagnost Imaging, IL-52621 Tel Hashomer, Israel; Hebrew Univ Jerusalem, IL-91904 Jerusalem, Israel; Cornell Univ, Dept Psychol, Ithaca, NY 14850 USA	Weizmann Institute of Science; Chaim Sheba Medical Center; Hebrew University of Jerusalem; Cornell University	Malach, R (corresponding author), Weizmann Inst Sci, IL-76100 Rehovot, Israel.		Avidan, Galia/B-9347-2011	Avidan, Galia/0000-0003-2293-3859; Grill-Spector, Kalanit/0000-0002-5404-9606				Bar M, 1999, P NATL ACAD SCI USA, V96, P1790, DOI 10.1073/pnas.96.4.1790; BIEDERMAN I, 1991, PERCEPTION, V20, P585, DOI 10.1068/p200585; BUCKNER RL, 1995, J NEUROSCI, V15, P12; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; DESIMONE R, 1984, J NEUROSCI, V4, P2051; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; DILL M, 1997, ARTIFICIAL INTELLIGE, V1610; EDELMAN S, 1998, 500 U SUSS; Edelman S, 1997, TRENDS COGN SCI, V1, P296, DOI 10.1016/S1364-6613(97)01090-5; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; FARAH MJ, 1995, NEUROPSYCHOLOGIA, V33, P661, DOI 10.1016/0028-3932(95)00002-K; FISER J, 1995, PERCEPTION, V24, P741, DOI 10.1068/p240741; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; GRILLSPECTOR K, 1998, SOC NEUR 28 ANN M, P531; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; Halgren E, 1999, HUM BRAIN MAPP, V7, P29; HUMPHREY NK, 1969, Q J EXP PSYCHOL, V21, P225, DOI 10.1080/14640746908400217; ITO M, 1995, J NEUROPHYSIOL, V73, P218, DOI 10.1152/jn.1995.73.1.218; Kanwisher N, 1996, COGNITIVE BRAIN RES, V5, P55, DOI 10.1016/S0926-6410(96)00041-9; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KARNI A, 1995, NATURE, V377, P155; LEHKY SR, 1988, NATURE, V333, P452, DOI 10.1038/333452a0; LI L, 1993, J NEUROPHYSIOL, V69, P1918, DOI 10.1152/jn.1993.69.6.1918; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; MALACH R, 1998, NEUROIMAGE, V7, pS43; Martin A., 1995, Society for Neuroscience Abstracts, V21, P1497; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; MOSES Y, 1994, P EUR C COMP VIS, P286; PERRETT DI, 1985, PROC R SOC SER B-BIO, V223, P293, DOI 10.1098/rspb.1985.0003; Reyment R. A., 1993, APPL FACTOR ANAL NAT; ROLLS ET, 1989, EXP BRAIN RES, V76, P153; Rugg MD, 1995, COGNITIVE BRAIN RES, V3, P17, DOI 10.1016/0926-6410(95)00014-3; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; SCHILLER PH, 1995, NATURE, V376, P342, DOI 10.1038/376342a0; SERENO MI, 1994, CEREB CORTEX, V4, P601, DOI 10.1093/cercor/4.6.601; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; Talairach J., 1988, COPLANAR STEREOTAXIC; Tarr MJ, 1998, VISION RES, V38, P2259, DOI 10.1016/S0042-6989(98)00041-8; Tootell RBH, 1998, TRENDS COGN SCI, V2, P174, DOI 10.1016/S1364-6613(98)01171-1; Tootell RBH, 1996, TRENDS NEUROSCI, V19, P481, DOI 10.1016/S0166-2236(96)10053-9; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P818, DOI 10.1073/pnas.95.3.818; Tovee MJ, 1998, NEURON, V21, P1239, DOI 10.1016/S0896-6273(00)80644-3; UNGERLEIDER LG, 1977, EXP BRAIN RES, V27, P251; VALENTINE T, 1988, BRIT J PSYCHOL, V79, P471, DOI 10.1111/j.2044-8295.1988.tb02747.x; VanEssen DC, 1997, J NEUROSCI, V17, P7079; Wang G, 1996, SCIENCE, V272, P1665, DOI 10.1126/science.272.5268.1665; WEISKRANTZ L, 1984, BRAIN, V107, P1033, DOI 10.1093/brain/107.4.1033; WEISKRANTZ L, 1990, VISION, MEMORY AND THE TEMPORAL LOBE, P13; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X	53	943	949	1	44	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	1999	24	1					187	203		10.1016/S0896-6273(00)80832-6	http://dx.doi.org/10.1016/S0896-6273(00)80832-6			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241QC	10677037	Bronze, Green Published			2022-12-24	WOS:000082893200019
J	Brown, SP; Masland, RH				Brown, SP; Masland, RH			Spatial scale and cellular substrate of contrast adaptation by retinal ganglion cells	NATURE NEUROSCIENCE			English	Article							STARBURST AMACRINE CELLS; RECEPTIVE-FIELD PROPERTIES; MACAQUE MONKEY RETINA; RABBIT RETINA; BIPOLAR CELLS; GAIN-CONTROL; GABA(C) RECEPTORS; PRIMATE RETINA; VISUAL-CORTEX; MORPHOLOGY	Human visual perception and many visual system neurons adapt to the luminance and contrast of the stimulus. Here we describe a form of contrast adaptation that occurs in the retina. This adaptation had a local scale smaller than the dendritic or receptive fields of single ganglion cells and was insensitive to pharmacological manipulation of amacrine cell function. These results implicate the bipolar cell pathway as a site of contrast adaptation. The time required for contrast adaptation varied with stimulus size, ranging from approximately 100 ms for the smallest stimuli, to seconds for stimuli the size of the receptive field. The differing scales and time courses of these effects suggest that:multiple types of contrast adaptation are used in viewing natural scenes.	Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute	Masland, RH (corresponding author), Harvard Univ, Sch Med, Program Neurosci, Goldenson 228, Boston, MA 02115 USA.		Brown, Solange/H-1615-2012					ALBRECHT DG, 1984, J PHYSIOL-LONDON, V347, P713, DOI 10.1113/jphysiol.1984.sp015092; AMTHOR FR, 1989, J COMP NEUROL, V280, P72, DOI 10.1002/cne.902800107; AMTHOR FR, 1989, J COMP NEUROL, V280, P97, DOI 10.1002/cne.902800108; BENARDETE EA, 1992, VISUAL NEUROSCI, V8, P483, DOI 10.1017/S0952523800004995; Brown SP, 1999, J COMP NEUROL, V408, P97; Brown SP, 2000, NEURON, V27, P371, DOI 10.1016/S0896-6273(00)00044-1; BUHL EH, 1986, J COMP NEUROL, V253, P163, DOI 10.1002/cne.902530204; CLELAND BG, 1988, J PHYSIOL-LONDON, V404, P591, DOI 10.1113/jphysiol.1988.sp017308; Crook DK, 1997, VISUAL NEUROSCI, V14, P751, DOI 10.1017/S0952523800012700; DEBOER E, 1968, IEEE T BIO-MED ENG, VBM15, P169, DOI 10.1109/TBME.1968.4502561; DeVries SH, 1997, J NEUROPHYSIOL, V78, P2048, DOI 10.1152/jn.1997.78.4.2048; EHINGER B, 1988, P NATL ACAD SCI USA, V85, P8321, DOI 10.1073/pnas.85.21.8321; ENROTHCUGELL C, 1980, J PHYSIOL-LONDON, V302, P49; He SG, 1998, VISUAL NEUROSCI, V15, P369, DOI 10.1017/S095252389815215X; He SG, 1997, NATURE, V389, P378, DOI 10.1038/38723; Kalloniatis M, 1996, J NEUROSCI, V16, P6807; KOONTZ MA, 1993, VISION RES, V33, P2617, DOI 10.1016/0042-6989(93)90220-Q; LEVICK WR, 1972, MED BIOL ENG, V10, P510, DOI 10.1007/BF02474199; LEVICK WR, 1967, J PHYSIOL-LONDON, V188, P285, DOI 10.1113/jphysiol.1967.sp008140; Lukasiewicz PD, 1997, VISUAL NEUROSCI, V14, P989, DOI 10.1017/S095252380001169X; Macneil MA, 1999, J COMP NEUROL, V413, P305; MacNeil MA, 1998, NEURON, V20, P971, DOI 10.1016/S0896-6273(00)80478-X; MADDESS T, 1988, BIOL CYBERN, V59, P229, DOI 10.1007/BF00332911; Massey SC, 1997, VISUAL NEUROSCI, V14, P939, DOI 10.1017/S0952523800011652; Massey SC, 1996, J COMP NEUROL, V366, P15; MILLS SL, 1994, VISUAL NEUROSCI, V11, P549, DOI 10.1017/S0952523800002455; MILLS SL, 1992, J COMP NEUROL, V321, P133, DOI 10.1002/cne.903210112; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; PARK SK, 1988, COMMUN ACM, V31, P1192, DOI 10.1145/63039.63042; PEICHL L, 1987, J COMP NEUROL, V263, P25, DOI 10.1002/cne.902630103; Perlman I, 1998, PROG RETIN EYE RES, V17, P523, DOI 10.1016/S1350-9462(98)00005-6; Peters BN, 1996, J NEUROPHYSIOL, V75, P469, DOI 10.1152/jn.1996.75.1.469; Reid RC, 1997, VISUAL NEUROSCI, V14, P1015, DOI 10.1017/S0952523800011743; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Shapley R, 1997, CURR BIOL, V7, pR421, DOI 10.1016/S0960-9822(06)00207-7; Shapley R, 1984, PROG RETIN RES, V3, P263, DOI DOI 10.1016/0278-4327(84)90011-7; SHAPLEY RM, 1981, J PHYSIOL-LONDON, V318, P161; SHAPLEY RM, 1980, J PHYSIOL-LONDON, V302, P535; SHAPLEY RM, 1979, J PHYSIOL-LONDON, V290, P141, DOI 10.1113/jphysiol.1979.sp012765; SHAPLEY RM, 1978, J PHYSIOL-LONDON, V285, P275, DOI 10.1113/jphysiol.1978.sp012571; Smirnakis SM, 1997, NATURE, V386, P69, DOI 10.1038/386069a0; Stafford DK, 1997, VISUAL NEUROSCI, V14, P507, DOI 10.1017/S0952523800012165; STERLING P, 1998, SYNAPTIC ORG BRAIN, P205; TAYLOR WR, 1995, EUR J NEUROSCI, V7, P2308, DOI 10.1111/j.1460-9568.1995.tb00652.x; Taylor WR, 1996, VISUAL NEUROSCI, V13, P599, DOI 10.1017/S0952523800008506; Taylor WR, 1999, VISUAL NEUROSCI, V16, P285, DOI 10.1017/S0952523899162096; Vaney D.I., 1990, PROGR RETINAL RES, V9, P49, DOI [10.1016/0278-4327(90)90004-2, DOI 10.1016/0278-4327(90)90004-2]; WITKOVSKY P, 1991, PROG RETIN RES, V11, P247, DOI 10.1016/0278-4327(91)90031-V; YANG G, 1994, J NEUROSCI, V14, P5267; ZHOU ZJ, 1995, J NEUROSCI, V15, P5334	50	106	110	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2001	4	1					44	51		10.1038/82888	http://dx.doi.org/10.1038/82888			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UB	11135644				2022-12-24	WOS:000167178000013
J	Kullander, K; Mather, NK; Diella, F; Dottori, M; Boyd, AW; Klein, R				Kullander, K; Mather, NK; Diella, F; Dottori, M; Boyd, AW; Klein, R			Kinase-dependent and kinase-independent functions of EphA4 receptors in major axon tract formation in vivo	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; TYROSINE KINASE; NEURAL DEVELOPMENT; SAM DOMAIN; CARDIOVASCULAR DEVELOPMENT; TRANSMEMBRANE LIGANDS; COMMISSURAL AXONS; EPHRINB LIGANDS; CELL-CONTACT; FAMILY	The EphA4 receptor tyrosine kinase regulates the formation of the corticospinal tract (CST), a pathway controlling voluntary movements, and of the anterior commissure (AC), connecting the neocortical temporal robes. To study EphA4 kinase signaling in these processes, we generated mice expressing mutant EphA4 receptors either lacking kinase activity or with severely downregulated kinase activity. We demonstrate that EphA4 is required for CST formation as a receptor for which it requires an active kinase domain. In contrast, the formation of the AC is rescued by kinase-dead EphA4, suggesting that in this structure EphA4 acts as a ligand for which its kinase activity is not required. Unexpectedly, the cytoplasmic sterile-alpha motif (SAM) domain is not required for EphA4 functions. Our findings establish both kinase-dependent and kinase-independent functions of EphA4 in the formation of major axon tracts.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Dept Human Anat & Genet, Oxford OX1 3QX, England; Univ Queensland, Royal Brisbane Hosp, Queensland Inst Med Res, Herston, Qld 4029, Australia	European Molecular Biology Laboratory (EMBL); QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Queensland	Klein, R (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.		Boyd, Andrew/G-2083-2010; Klein, Ruediger/C-6147-2008	Klein, Ruediger/0000-0002-3109-0163; Dottori, Mirella/0000-0003-0598-4195; Kullander, Klas/0000-0001-6418-5460				Adams RH, 2001, CELL, V104, P57, DOI 10.1016/S0092-8674(01)00191-X; Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Binns KL, 2000, MOL CELL BIOL, V20, P4791, DOI 10.1128/MCB.20.13.4791-4805.2000; Birgbauer E, 2000, DEVELOPMENT, V127, P1231; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Bruckner K, 1998, CURR OPIN NEUROBIOL, V8, P375, DOI 10.1016/S0959-4388(98)80064-0; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; Buchert M, 1999, J CELL BIOL, V144, P361, DOI 10.1083/jcb.144.2.361; Chin-Sang ID, 1999, CELL, V99, P781, DOI 10.1016/S0092-8674(00)81675-X; COURTNEIDGE SA, 1993, EMBO J, V12, P943, DOI 10.1002/j.1460-2075.1993.tb05735.x; Cowan CA, 2000, NEURON, V26, P417, DOI 10.1016/S0896-6273(00)81174-5; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; de Hoop MJ, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 1, P154; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Feng GP, 2000, NEURON, V25, P295, DOI 10.1016/S0896-6273(00)80895-8; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Hock B, 1998, P NATL ACAD SCI USA, V95, P9779, DOI 10.1073/pnas.95.17.9779; Holder N, 1999, DEVELOPMENT, V126, P2033; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Holland SJ, 1998, CURR OPIN NEUROBIOL, V8, P117, DOI 10.1016/S0959-4388(98)80015-9; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Imondi R, 2000, DEVELOPMENT, V127, P1397; Joosten EAJ, 1999, J ANAT, V194, P15, DOI 10.1046/j.1469-7580.1999.19410015.x; Kalo MS, 1999, CELL TISSUE RES, V298, P1, DOI 10.1007/PL00008807; Klein R, 1999, CURR BIOL, V9, pR691, DOI 10.1016/S0960-9822(99)80441-2; KLUVER H, 1953, J NEUROPATH EXP NEUR, V12, P400; LEIGHTON PA, 2001, IN PRESS NATURE; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; Martone ME, 1997, BRAIN RES, V771, P238, DOI 10.1016/S0006-8993(97)00792-0; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; OOI J, 1995, ONCOGENE, V10, P1621; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; Park S, 1997, EMBO J, V16, P3106, DOI 10.1093/emboj/16.11.3106; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Schultz J, 1997, PROTEIN SCI, V6, P249; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Smalla M, 1999, PROTEIN SCI, V8, P1954, DOI 10.1110/ps.8.10.1954; Stapleton D, 1999, NAT STRUCT BIOL, V6, P44; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wang XM, 1999, MOL CELL, V4, P903, DOI 10.1016/S1097-2765(00)80220-8; Wilkinson DG, 2000, INT REV CYTOL, V196, P177; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9; Zisch AH, 2000, ONCOGENE, V19, P177, DOI 10.1038/sj.onc.1203304	55	199	201	1	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	2001	29	1					73	84		10.1016/S0896-6273(01)00181-7	http://dx.doi.org/10.1016/S0896-6273(01)00181-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	397NX	11182082	Bronze			2022-12-24	WOS:000166702700010
J	Pantages, E; Dulac, C				Pantages, E; Dulac, C			A novel family of candidate pheromone receptors in mammals	NEURON			English	Article							ACCESSORY OLFACTORY-BULB; VOMERONASAL SYSTEM; GABA(B) RECEPTOR; MULTIGENE FAMILY; G-PROTEINS; BINDING; LOCALIZATION; PROJECTIONS; EXPRESSION; NEURONS	Pheromonal activation of the vomeronasal organ (VNO) elicits genetically preprogrammed behaviors and physiological changes in mammals. We have identified a novel gene family encoding over one hundred VNO specific receptors, the V3Rs. V3R sequences are highly similar to each other and appear distantly related to the putative pheromone receptors, V1Rs, and the taste receptors, T2Rs. Within the VNO, VER-positive neurons are distinct from neurons expressing the pheromone receptor families V1R and V2R. The V3Rs are likely to represent a new large family of pheromone receptors in mammals. Multiple V3R-related human sequences have been identified, including one clone retaining the capacity to create a complete and functional transcript. Our data uncover a striking complexity in the molecular and cellular organization of the VNO and provide an essential framework for the study of pheromone signaling in mammals.	Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Biolabs, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute	Dulac, C (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Biolabs, 16 Divin Ave, Cambridge, MA 02138 USA.			Dulac, Catherine/0000-0001-5024-5418	PHS HHS [3903-01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; Buck LB, 2000, CELL, V100, P611, DOI 10.1016/S0092-8674(00)80698-4; Cao YX, 1998, P NATL ACAD SCI USA, V95, P11987, DOI 10.1073/pnas.95.20.11987; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Dulac C, 2000, CURR OPIN NEUROBIOL, V10, P511, DOI 10.1016/S0959-4388(00)00121-5; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; FARBMAN AI, 1992, CELL BIOL OLFACTION; FIRESTEIN S, 1993, J PHYSIOL-LONDON, V468, P1; HALPERN M, 1995, BRAIN RES, V677, P157, DOI 10.1016/0006-8993(95)00159-N; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325, DOI 10.1146/annurev.ne.10.030187.001545; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; HOLY T, 2000, IN PRESS SCIENCE, V26; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640; ICHIKAWA M, 1994, DEV BRAIN RES, V78, P1, DOI 10.1016/0165-3806(94)90002-7; IMAMURA K, 1985, BRAIN RES, V328, P362, DOI 10.1016/0006-8993(85)91050-9; JEMIOLO B, 1986, P NATL ACAD SCI USA, V83, P4576, DOI 10.1073/pnas.83.12.4576; Jia CP, 1996, BRAIN RES, V719, P117, DOI 10.1016/0006-8993(96)00110-2; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Martinez-Marcos A, 1999, EUR J NEUROSCI, V11, P3789, DOI 10.1046/j.1460-9568.1999.00797.x; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Naito T, 1998, P NATL ACAD SCI USA, V95, P5178, DOI 10.1073/pnas.95.9.5178; NOVOTNY M, 1985, P NATL ACAD SCI USA, V82, P2059, DOI 10.1073/pnas.82.7.2059; Novotny MV, 1999, P ROY SOC B-BIOL SCI, V266, P2017, DOI 10.1098/rspb.1999.0880; Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; SICARD G, 1984, BRAIN RES, V292, P283, DOI 10.1016/0006-8993(84)90764-9; Sugai T, 1997, NEUROSCIENCE, V79, P871, DOI 10.1016/S0306-4522(96)00690-2; Sugai T, 2000, NEUROSCIENCE, V95, P23; Trotier D, 2000, CHEM SENSES, V25, P369, DOI 10.1093/chemse/25.4.369; von Campenhausen H, 2000, EUR J NEUROSCI, V12, P33, DOI 10.1046/j.1460-9568.2000.00879.x; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; WYSOCKI CJ, 1989, NEURAL CONTROL REPRO, P545	43	86	91	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	2000	28	3					835	845		10.1016/S0896-6273(00)00157-4	http://dx.doi.org/10.1016/S0896-6273(00)00157-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386JJ	11163270	Bronze			2022-12-24	WOS:000166057500020
J	Fang, M; Jaffrey, SR; Sawa, A; Ye, KQ; Luo, XJ; Snyder, SH				Fang, M; Jaffrey, SR; Sawa, A; Ye, KQ; Luo, XJ; Snyder, SH			Dexras1: A G protein specifically coupled to neuronal nitric oxide synthase via CAPON	NEURON			English	Article							PHOSPHOTYROSINE-BINDING DOMAIN; RELAXING FACTOR; S-NITROSOGLUTATHIONE; GUANYLATE-CYCLASE; NMDA RECEPTORS; SMOOTH-MUSCLE; MAP KINASE; L-ARGININE; B-RAF; ACTIVATION	Because nitric oxide (NO) is a highly reactive signaling molecule, chemical inactivation by reaction with oxygen, superoxide, and glutathione competes with specific interactions with target proteins. NO signaling may be enhanced by adaptor proteins that couple neuronal NO synthase (nNOS) to specific target proteins. Here we identify a selective interaction of the nNOS adaptor protein CAPON with Dexras1, a brain-enriched member of the Pas family of small monomeric G proteins. We find that Dexras1 is activated by NO donors as well as by NMDA receptor-stimulated NO synthesis in cortical neurons. The importance of Dexras1 as a physiologic target of nNOS is established by the selective decrease of Dexras1 activation, but not H-Ras or four other Pas family members, in the brains of mice harboring a targeted genomic deletion of nNOS (nNOS(-/-)). We also find that nNOS, CAPON, and Dexras1 form a ternary complex that enhances the ability of nNOS to activate Dexras1. These findings identity Dexras1 as a novel physiologic NO effector and suggest that anchoring of nNOS to specific targets is a mechanism by which NO signaling is enhanced.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.			Jaffrey, Samie/0000-0003-3615-6958	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH018501, R37MH018501] Funding Source: NIH RePORTER; NIDA NIH HHS [DA00074] Funding Source: Medline; NIMH NIH HHS [MH-18501] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Borjigin J, 1999, J NEUROSCI, V19, P1018; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; BREDT DS, 1994, NEURON, V13, P301, DOI 10.1016/0896-6273(94)90348-4; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Chien CT, 1998, MOL CELL BIOL, V18, P598, DOI 10.1128/MCB.18.1.598; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Choi YB, 2000, NAT NEUROSCI, V3, P15, DOI 10.1038/71090; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; Curtis J, 1999, J NEUROSCI RES, V58, P88, DOI 10.1002/(SICI)1097-4547(19991001)58:1<88::AID-JNR9>3.3.CO;2-I; DAWSON VL, 1993, J NEUROSCI, V13, P2651; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; Dho SE, 1998, J BIOL CHEM, V273, P9179, DOI 10.1074/jbc.273.15.9179; Dugan LL, 1999, J BIOL CHEM, V274, P25842, DOI 10.1074/jbc.274.36.25842; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; GASTON B, 1993, P NATL ACAD SCI USA, V90, P10957, DOI 10.1073/pnas.90.23.10957; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; HIBBS JB, 1987, SCIENCE, V235, P473, DOI 10.1126/science.2432665; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; IGNARRO LJ, 1981, J PHARMACOL EXP THER, V218, P739; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Inglis FM, 1998, J NEUROSCI, V18, P10493; Jaffrey SR, 1998, NEURON, V20, P115, DOI 10.1016/S0896-6273(00)80439-0; JAFFREY SR, 2000, IN PRESS NAT CELL BI; Kemppainen RJ, 1998, J BIOL CHEM, V273, P3129, DOI 10.1074/jbc.273.6.3129; Kluge I, 1997, J NEUROCHEM, V69, P2599; KNOWLES RG, 1989, P NATL ACAD SCI USA, V86, P5159, DOI 10.1073/pnas.86.13.5159; LANDER HM, 1995, J BIOL CHEM, V270, P7017, DOI 10.1074/jbc.270.13.7017; Lander HM, 1996, NATURE, V381, P380, DOI 10.1038/381380a0; Mayer B, 1998, J BIOL CHEM, V273, P3264, DOI 10.1074/jbc.273.6.3264; Mott HR, 1997, BIOCHEMISTRY-US, V36, P3640, DOI 10.1021/bi962790o; Ohtsuka T, 1996, J BIOL CHEM, V271, P1258, DOI 10.1074/jbc.271.3.1258; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; PEUNOVA N, 1995, NATURE, V375, P68, DOI 10.1038/375068a0; PONTING CP, 1995, TRENDS BIOCHEM SCI, V20, P102, DOI 10.1016/S0968-0004(00)88973-2; Richards MK, 1996, BIOCHEMISTRY-US, V35, P7772, DOI 10.1021/bi952582g; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; STUEHR DJ, 1989, J EXP MED, V169, P1011, DOI 10.1084/jem.169.3.1011; Teng KK, 1999, J BIOL CHEM, V274, P37315, DOI 10.1074/jbc.274.52.37315; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Yun HY, 1998, P NATL ACAD SCI USA, V95, P5773, DOI 10.1073/pnas.95.10.5773; ZHOU MM, 1995, NATURE, V378, P584, DOI 10.1038/378584a0	47	263	278	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	2000	28	1					183	193		10.1016/S0896-6273(00)00095-7	http://dx.doi.org/10.1016/S0896-6273(00)00095-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	370VN	11086993	Bronze			2022-12-24	WOS:000165143500020
J	Ritzenthaler, S; Suzuki, E; Chiba, A				Ritzenthaler, S; Suzuki, E; Chiba, A			Postsynaptic filopodia in muscle cells interact with innervating motoneuron axons	NATURE NEUROSCIENCE			English	Article							DROSOPHILA NEUROMUSCULAR-JUNCTION; GROWTH CONE GUIDANCE; DENDRITIC SPINES; IN-VIVO; DYNAMICS; PLASTICITY; PROTEIN; OUTGROWTH; PROSPERO; NEURONS	Precise synaptogenesis is crucial to brain development, and depends on the ability of specific partner cells to locate and communicate with one another. Dynamic properties of axonal filopodia during synaptic targeting are well documented, but the cytomorphological dynamics of postsynaptic cells have received less attention. In Drosophila embryos, muscle cells bear numerous postsynaptic filopodia ('myopodia') during motoneuron targeting. Here we show that myopodia are actin-filled microprocesses, which progressively clustered at the site of motoneuron innervation while intermingling with presynaptic filopodia. In prospero mutants, which have severe delays in axon outgrowth from the CNS, myopodia were present initially but clustering behavior was not observed, demonstrating that clustering depends on innervating axons. Thus, postsynaptic filopodia are capable of intimate interaction with innervating presynaptic axons. We propose that, by contributing to direct long-distance cellular communication, they are dynamically involved in synaptic matchmaking.	Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA; Univ Illinois, Program Neurosci, Urbana, IL 61801 USA; Univ Tokyo, Inst Med Sci, Dept Fine Morphol, Tokyo 1088639, Japan	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Tokyo	Chiba, A (corresponding author), Univ Illinois, Dept Cell & Struct Biol, B605 CLS Lab,601 S Goodwin Ave, Urbana, IL 61801 USA.	a-chiba@uiuc.edu		Suzuki, Emiko/0000-0002-4005-0542				BATE M, 1990, DEVELOPMENT, V110, P791; Bate Michael, 1993, P1013; BROADIE KS, 1993, J NEUROSCI, V13, P144; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; Chiba A, 1999, INT REV NEUROBIOL, V43, P1, DOI 10.1016/S0074-7742(08)60538-3; CHIBA A, 1999, CELL TECHNOL, V18, P852; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; Grabham PW, 1997, J NEUROSCI, V17, P5455; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; JOHANSEN J, 1989, J NEUROSCI, V9, P4318; Kater S. B., 1995, Current Opinion in Neurobiology, V5, P68, DOI 10.1016/0959-4388(95)80089-1; Kaufmann N, 1998, DEVELOPMENT, V125, P453; Keshishian H, 1996, ANNU REV NEUROSCI, V19, P545, DOI 10.1146/annurev.ne.19.030196.002553; Landgraf M, 1997, J NEUROSCI, V17, P9642; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; Murray MJ, 1999, J NEUROSCI, V19, P7901; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Saito Y, 1997, J NEUROSCI, V17, P8792; Smith SJ, 1999, SCIENCE, V283, P1860, DOI 10.1126/science.283.5409.1860; Suzuki E, 2000, J NEUROBIOL, V42, P448, DOI 10.1002/(SICI)1097-4695(200003)42:4<448::AID-NEU6>3.0.CO;2-H; SUZUKI E, 1994, J ELECTRON MICROSC, V43, P183; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; Verkhusha VV, 1999, FEBS LETT, V445, P395, DOI 10.1016/S0014-5793(99)00124-6; Wolf BD, 2000, DEVELOPMENT, V127, P2001; Wu GY, 1999, J NEUROSCI, V19, P4472; Yoshihara M, 1997, J NEUROSCI, V17, P8408; Zheng JQ, 1996, J NEUROSCI, V16, P1140; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	36	121	121	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2000	3	10					1012	1017		10.1038/79833	http://dx.doi.org/10.1038/79833			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TW	11017174				2022-12-24	WOS:000167177500019
J	Ying, LT; Chin, C				Ying, LT; Chin, C			Specification of ventral neuron types is mediated by an antagonistic interaction between Shh and Gli3	NATURE NEUROSCIENCE			English	Article							FLOOR PLATE DIFFERENTIATION; DEVELOPING SPINAL-CORD; CENTRAL-NERVOUS-SYSTEM; SONIC HEDGEHOG; CUBITUS-INTERRUPTUS; MOTOR-NEURONS; GENE-FUNCTION; CHICK-EMBRYO; IN-VITRO; EXPRESSION	Specification of distinct neuron types in the ventral spinal cord is thought to be mediated by a graded concentration of Sonic hedgehog (Shh), a secreted signaling protein. Shh is made in the notochord, the most ventral part of the spinal cord, and in mice lacking Shh, ventral cell types are reduced or absent. The response to Shh depends on transcription factors of the Gli family, but the detailed mechanism is not understood. Here we show that Gli3 represses ventral fates in a dose-dependent manner. Whereas Shh(-/-) mutant mice show reductions in several classes of ventral interneurons and a complete absence of motor neurons, these cell types were rescued in Shh(-/-);Gli3(-/-) double mutants. This rescue of the Shh null phenotype depended on the level of Gli3 function; a partial rescue was observed in Shh(-/-);Gli3(+/-) embryos. We propose that Shh is required to antagonize Gli3, which would otherwise repress ventral fates. Differences between rostral and caudal regions suggest that other signaling molecules-in addition to Shh-may be involved in specifying ventral fates, particularly in the caudal region of the spinal cord.	Vanderbilt Univ, Med Ctr, Dept Cell Biol, Nashville, TN 37232 USA	Vanderbilt University	Chin, C (corresponding author), Vanderbilt Univ, Med Ctr, Dept Cell Biol, B2120 MCN, Nashville, TN 37232 USA.	chin.chiang@mcmail.vanderbilt.edu			NICHD NIH HHS [N01-HD-7-3263, HD37489] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD073263, R01HD037489] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Altaba ARI, 1998, DEVELOPMENT, V125, P2203; Berggren K, 1999, DEV BIOL, V210, P288, DOI 10.1006/dbio.1999.9286; BLANC PA, 1999, TRENDS GENET, V15, P458; Borycki AG, 1999, DEVELOPMENT, V126, P4053; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Burrill JD, 1997, DEVELOPMENT, V124, P4493; Buscher D, 1998, MAMM GENOME, V9, P676, DOI 10.1007/s003359900845; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Ding Q, 1998, DEVELOPMENT, V125, P2533; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Ericson J, 1997, COLD SPRING HARB SYM, V62, P451; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Goodrich LV, 1998, NEURON, V21, P1243, DOI 10.1016/S0896-6273(00)80645-5; GOULDING MD, 1993, DEVELOPMENT, V117, P1001; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Hynes M, 1997, NEURON, V19, P15, DOI 10.1016/S0896-6273(00)80344-X; Ingham PW, 1998, EMBO J, V17, P3505, DOI 10.1093/emboj/17.13.3505; KINZLER KW, 1988, NATURE, V332, P371, DOI 10.1038/332371a0; Krishnan V, 1997, SCIENCE, V278, P1947, DOI 10.1126/science.278.5345.1947; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; Mansouri A, 1998, MECH DEVELOP, V78, P171, DOI 10.1016/S0925-4773(98)00168-3; Matise MP, 1998, DEVELOPMENT, V125, P2759; Matise MP, 1997, J NEUROSCI, V17, P7805; Muhr J, 1999, NEURON, V23, P689, DOI 10.1016/S0896-6273(01)80028-3; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; OPPENHEIM RW, 1989, DEV BIOL, V133, P468, DOI 10.1016/0012-1606(89)90050-X; Park HL, 2000, DEVELOPMENT, V127, P1593; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Renoncourt Y, 1998, MECH DEVELOP, V79, P185, DOI 10.1016/S0925-4773(98)00189-0; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; RUPPERT JM, 1990, MOL CELL BIOL, V10, P5408, DOI 10.1128/MCB.10.10.5408; Sasaki H, 1997, DEVELOPMENT, V124, P1313; SASAKI H, 1994, CELL, V76, P103, DOI 10.1016/0092-8674(94)90176-7; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Shin SH, 1999, P NATL ACAD SCI USA, V96, P2880, DOI 10.1073/pnas.96.6.2880; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Swindell EC, 1999, DEV BIOL, V216, P282, DOI 10.1006/dbio.1999.9487; Tabin CJ, 1997, TRENDS CELL BIOL, V7, P442, DOI 10.1016/S0962-8924(97)01159-8; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; Theil T, 1999, DEVELOPMENT, V126, P3561; Tremblay P, 1996, DEVELOPMENT, V122, P2555; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9	49	302	308	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2000	3	10					979	985		10.1038/79916	http://dx.doi.org/10.1038/79916			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TW	11017169				2022-12-24	WOS:000167177500014
J	Gan, WB; Grutzendler, J; Wong, WT; Wong, ROL; Lichtman, JW				Gan, WB; Grutzendler, J; Wong, WT; Wong, ROL; Lichtman, JW			Multicolor "DiOlistic" labeling of the nervous system using lipophilic dye combinations	NEURON			English	Article							GREEN FLUORESCENT PROTEIN; TERMINAL FIELDS; NEURONS; GENE; EXPRESSION; RECEPTORS; SLICES; PROBES; ARBOR	We describe a technique for rapid labeling of a large number of cells in the nervous system with many different colors. By delivering lipophilic dye-coated particles to neuronal preparations with a "gene gun," individual neurons and glia whose membranes are contacted by the particles are quickly labeled. Using particles that are each coated with different combinations of various lipophilic dyes, many cells within a complex neuronal network can be simultaneously labeled with a wide variety of colors. This approach is most effective in living material but also labels previously fixed material. In living material, labeled neurons continue to show normal synaptic responses and undergo dendritic remodeling. This technique is thus useful for studying structural plasticity of neuronal circuits in living preparations. In addition, the Golgi-like labeling of neurons with many different colors provides a novel way to study neuronal connectivity.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Neurol & Alzheimer Dis Res Ctr, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Gan, WB (corresponding author), NYU, Sch Med, Mol Neurobiol Program, Skirball Inst, New York, NY 10016 USA.		Grutzendler, Jaime/F-3691-2010; Wong, Wai/B-6118-2017	Wong, Wai/0000-0003-0681-4016				BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CLINE HT, 2000, IMAGING NEURONS LAB, pCH13; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; GAN WB, 1995, J NEUROSCI, V15, P3243; Gan WB, 1998, SCIENCE, V282, P1508, DOI 10.1126/science.282.5393.1508; Gan WB, 1999, J NEUROSCI METH, V93, P13, DOI 10.1016/S0165-0270(99)00096-5; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; Kirov SA, 1999, J NEUROSCI, V19, P2876; LICHTMAN JW, 1985, NATURE, V314, P357, DOI 10.1038/314357a0; LIU DWC, 1990, J NEUROSCI, V10, P3947, DOI 10.1523/JNEUROSCI.10-12-03947.1990; LO DC, 1994, NEURON, V13, P1263, DOI 10.1016/0896-6273(94)90412-X; Lukasiewicz PD, 1997, VISUAL NEUROSCI, V14, P989, DOI 10.1017/S095252380001169X; MAGRASSI L, 1987, J NEUROSCI, V7, P1207; OROURKE NA, 1994, NEURON, V12, P921, DOI 10.1016/0896-6273(94)90343-3; ROSE K, 1993, METHODS TOXICOLOGY, V1, P46; van den Pol AN, 1998, J NEUROSCI, V18, P10640; Vasquez EC, 1998, EXP NEUROL, V154, P353, DOI 10.1006/exnr.1998.6917; Wong WT, 2000, CURR OPIN NEUROBIOL, V10, P118, DOI 10.1016/S0959-4388(99)00059-8; Wong WT, 1998, J NEUROSCI, V18, P8839; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4	22	250	259	0	22	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG	2000	27	2					219	225		10.1016/S0896-6273(00)00031-3	http://dx.doi.org/10.1016/S0896-6273(00)00031-3			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	347YD	10985343	Bronze			2022-12-24	WOS:000088956000007
J	Frank, LM; Brown, EN; Wilson, M				Frank, LM; Brown, EN; Wilson, M			Trajectory encoding in the hippocampus and entorhinal cortex	NEURON			English	Article							FREELY-MOVING RATS; SPATIAL FIRING PATTERNS; SINGLE UNIT-ACTIVITY; PLACE CELLS; NEURONAL-ACTIVITY; WORKING-MEMORY; DIRECTION; SYSTEM; SPACE; POSTSUBICULUM	We recorded from single neurons in the hippocampus and entorhinal cortex (EC) of rats to investigate the role of these structures in navigation and memory representation. Our results revealed two novel phenomena: first, many cells in CA1 and the EC fired at significantly different rates when the animal was in the same position depending on where the animal had come from or where it was going. Second, cells in deep layers of the EC, the targets of hippocampal outputs, appeared to represent the similarities between locations on spatially distinct trajectories through the environment. Our findings suggest that the hippocampus represents the animal's position in the context of a trajectory through space and that the EC represents regularities across different trajectories that could allow for generalization across experiences.	MIT, Ctr Learning & Memory, RIKEN MIT Neurosci Res Ctr, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med,Dept Anesthesia & Crit Care, MIT Div Hlth Sci & Technol,Stat Res Lab, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); RIKEN; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts General Hospital	Frank, LM (corresponding author), MIT, Ctr Learning & Memory, RIKEN MIT Neurosci Res Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	loren@srlb4.mgh.harvard.edu; wilson@ai.mit.edu		Frank, Loren/0000-0002-1752-5677	NIMH NIH HHS [R01 MH059733, K02 MH061637, MH59733, MH61637] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH061637, R01MH059733] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AGGLETON JP, 1986, BEHAV BRAIN RES, V19, P133, DOI 10.1016/0166-4328(86)90011-2; BARNES CA, 1990, PROG BRAIN RES, V83, P287; BERGER TW, 1978, BRAIN RES, V145, P323, DOI 10.1016/0006-8993(78)90866-1; Cho YH, 1996, BEHAV NEUROSCI, V110, P436, DOI 10.1037/0735-7044.110.3.436; Deadwyler SA, 1996, J NEUROSCI, V16, P354; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McCullaugh P., 1989, GEN LINEAR MODELS; McNaughton BL, 1996, J EXP BIOL, V199, P173; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; MIZUMORI SJY, 1992, BRAIN RES, V570, P188, DOI 10.1016/0006-8993(92)90581-S; Muller FO, 1996, BIOPHARM DRUG DISPOS, V17, P81; MULLER RU, 1989, J NEUROSCI, V9, P4101; MULLER RU, 1987, J NEUROSCI, V7, P1935; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; QUIRK GJ, 1992, J NEUROSCI, V12, P1945; Rainer G, 1999, J NEUROSCI, V19, P5493; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; RASMUSSEN M, 1989, PSYCHOBIOLOGY, V17, P335; RAWLINS JNP, 1982, BEHAV BRAIN RES, V5, P331, DOI 10.1016/0166-4328(82)90039-0; Sharp PE, 1997, BEHAV BRAIN RES, V85, P71, DOI 10.1016/S0166-4328(96)00165-9; SHARP PE, 1994, J NEUROSCI, V14, P2339; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; Suzuki WA, 1997, J NEUROPHYSIOL, V78, P1062, DOI 10.1152/jn.1997.78.2.1062; Taube JS, 1998, HIPPOCAMPUS, V8, P87, DOI 10.1002/(SICI)1098-1063(1998)8:2<87::AID-HIPO1>3.0.CO;2-4; Taube JS, 1996, BRAIN RES BULL, V40, P477, DOI 10.1016/0361-9230(96)00145-1; TAUBE JS, 1990, J NEUROSCI, V10, P420; Touretzky DS, 1996, HIPPOCAMPUS, V6, P247; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605	34	455	458	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	2000	27	1					169	178		10.1016/S0896-6273(00)00018-0	http://dx.doi.org/10.1016/S0896-6273(00)00018-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339XU	10939340	Bronze			2022-12-24	WOS:000088503800019
J	Oliver, D; Klocker, N; Schuck, J; Baukrowitz, T; Ruppersberg, JP; Fakler, B				Oliver, D; Klocker, N; Schuck, J; Baukrowitz, T; Ruppersberg, JP; Fakler, B			Gating of Ca2+-activated K+ channels controls fast inhibitory synaptic transmission at auditory outer hair cells	NEURON			English	Article							ACTIVATED POTASSIUM CHANNELS; GUINEA-PIG COCHLEA; SMALL-CONDUCTANCE; CHOLINERGIC INHIBITION; ACETYLCHOLINE; RECEPTOR; CURRENTS; NEURONS; MICRODOMAINS; CALMODULIN	Fast inhibitory synaptic transmission in the central nervous system is mediated by ionotropic GABA or glycine receptors. Auditory outer hair cells present a unique inhibitory synapse that uses a Ca2+-permeable excitatory acetylcholine receptor to activate a hyperpolarizing potassium current mediated by small conductance calcium-activated potassium (SK) channels. It is shown here that unitary inhibitory postsynaptic currents at this synapse are mediated by SK2 channels and occur rapidly, with rise and decay time constants of similar to 6 ms and similar to 30 ms, respectively. This time course is determined by the Ca2+ gating of SK channels rather than by the changes in intracellular Ca2+. The results demonstrate fast coupling between an excitatory ionotropic neurotransmitter receptor and an inhibitory ion channel and imply rapid, localized changes in subsynaptic calcium levels.	Univ Tubingen, Dept Physiol 2, D-72074 Tubingen, Germany	Eberhard Karls University of Tubingen	Fakler, B (corresponding author), Univ Tubingen, Dept Physiol 2, Ob Himmelreich 7, D-72074 Tubingen, Germany.	bernd.fakler@uni-tuebingen.de	Oliver, Dominik/F-5845-2013	Oliver, Dominik/0000-0002-8368-0923; Baukrowitz, Thomas/0000-0003-4562-0505				ALGER BE, 1991, ANN NY ACAD SCI, V627, P249; ART JJ, 1984, J PHYSIOL-LONDON, V356, P525, DOI 10.1113/jphysiol.1984.sp015481; Betz H, 1999, ANN NY ACAD SCI, V868, P667, DOI 10.1111/j.1749-6632.1999.tb11343.x; Blanchet C, 1996, J NEUROSCI, V16, P2574; DREWE JA, 1988, SCIENCE, V241, P1810, DOI 10.1126/science.2459774; Dulon D, 1998, EUR J NEUROSCI, V10, P907, DOI 10.1046/j.1460-9568.1998.00098.x; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; Evans MG, 1996, J PHYSIOL-LONDON, V491, P563, DOI 10.1113/jphysiol.1996.sp021240; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; Fanger CM, 1999, J BIOL CHEM, V274, P5746, DOI 10.1074/jbc.274.9.5746; FUCHS PA, 1992, J NEUROSCI, V12, P800; Guinan Jr J. J., 1996, PHYSL OLIVOCOCHLEAR, P435; Hirschberg B, 1999, BIOPHYS J, V77, P1905, DOI 10.1016/S0006-3495(99)77032-3; HOUSLEY GD, 1992, J PHYSIOL-LONDON, V448, P73, DOI 10.1113/jphysiol.1992.sp019030; HOUSLEY GD, 1991, P ROY SOC B-BIOL SCI, V244, P161, DOI 10.1098/rspb.1991.0065; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; Jones MV, 1996, TRENDS NEUROSCI, V19, P96, DOI 10.1016/S0166-2236(96)80037-3; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; Klingauf J, 1997, BIOPHYS J, V72, P674, DOI 10.1016/S0006-3495(97)78704-6; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Marcotti W, 1999, J PHYSIOL-LONDON, V520, P653, DOI 10.1111/j.1469-7793.1999.00653.x; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Oliver D, 1999, J PHYSIOL-LONDON, V519, P791, DOI 10.1111/j.1469-7793.1999.0791n.x; ROBERTS WM, 1994, J NEUROSCI, V14, P3246; Stocker M, 2000, MOL CELL NEUROSCI, V15, P476, DOI 10.1006/mcne.2000.0842; Strobaek D, 2000, BRIT J PHARMACOL, V129, P991, DOI 10.1038/sj.bjp.0703120; TAKAHASHI T, 1991, NEURON, V7, P965, DOI 10.1016/0896-6273(91)90341-V; Vetter DE, 1999, NEURON, V23, P93, DOI 10.1016/S0896-6273(00)80756-4; Wu YC, 1996, BIOPHYS J, V71, P2256, DOI 10.1016/S0006-3495(96)79429-8; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yuhas WA, 1999, J COMP PHYSIOL A, V185, P455, DOI 10.1007/s003590050406	32	191	204	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	2000	26	3					595	601		10.1016/S0896-6273(00)81197-6	http://dx.doi.org/10.1016/S0896-6273(00)81197-6			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330ZH	10896156	Bronze			2022-12-24	WOS:000087991600011
J	Ahmari, SE; Buchanan, J; Smith, SJ				Ahmari, SE; Buchanan, J; Smith, SJ			Assembly of presynaptic active zones from cytoplasmic transport packets	NATURE NEUROSCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; SYNAPTIC-LIKE MICROVESICLES; SECRETORY GRANULES; MEMBRANE-PROTEINS; PLASMA-MEMBRANE; FINE-STRUCTURE; VESICLES; AXONS; SYNAPTOGENESIS; CELLS	Little is known about presynaptic assembly during central nervous system synaptogenesis. Here we used time-lapse fluorescence imaging, immunocytochemistry and electron microscopy to study hippocampal neuronal cultures transfected with a fusion construct of the presynaptic vesicle protein VAMP and green fluorescent protein. Our results suggest that major cytoplasmic and membrane-associated protein precursors of the presynaptic active zone are transported along developing axons together as discrete packets. Retrospective electron microscopy demonstrated varied vesicular and tubulovesicular membrane structures. Packets containing these heterogeneous structures were stabilized specifically at new sites of dendrite- and axon-initiated cell-cell contact; within less than one hour, evoked vesicle recycling was observed at these putative nascent synapses. These observations suggest that substantial membrane remodeling may be necessary to produce the uniform vesicles typical of the mature active zone, and that many presynaptic proteins may be united early in their biogenesis and sorting pathways.	Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Stanford University	Smith, SJ (corresponding author), Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.	sjsmith@leland.stanford.edu	Ahmari, Susanne E./J-5812-2013	Ahmari, Susanne E./0000-0003-4576-076X	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028587] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM07365] Funding Source: Medline; NIMH NIH HHS [MH48108] Funding Source: Medline; NINDS NIH HHS [NS28587] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; BARTLETT WP, 1984, J NEUROSCI, V4, P1944; BUCHANAN J, 1989, J NEUROSCI, V9, P1540; Colman DR, 1997, MOL CELL NEUROSCI, V10, P1, DOI 10.1006/mcne.1997.0648; FLETCHER TL, 1994, J NEUROSCI, V14, P6695; Goslin K., 1998, CULTURING NERVE CELL, P339; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hagler DJ, 1998, NEURON, V20, P1059, DOI 10.1016/S0896-6273(00)80486-9; HOLTZMAN E, 1977, NEUROSCIENCE, V2, P327, DOI 10.1016/0306-4522(77)90001-X; JANETZKO A, 1989, NEUROSCIENCE, V32, P65, DOI 10.1016/0306-4522(89)90108-5; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; LIU Y, 1995, AM J HYPERTENS, V8, P404, DOI 10.1016/0895-7061(94)00205-P; LOWE AW, 1988, J CELL BIOL, V106, P51, DOI 10.1083/jcb.106.1.51; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; PAPINI E, 1995, J BIOL CHEM, V270, P1332, DOI 10.1074/jbc.270.3.1332; REGNIERVIGOUROUX A, 1991, EMBO J, V10, P3589, DOI 10.1002/j.1460-2075.1991.tb04925.x; Ryan TA, 1997, NATURE, V388, P478, DOI 10.1038/41335; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Salem N, 1998, NAT NEUROSCI, V1, P551, DOI 10.1038/2787; Smith SJ, 1999, SCIENCE, V283, P1860, DOI 10.1126/science.283.5409.1860; Stefani G, 1997, J PHYSIOL-LONDON, V504, P501, DOI 10.1111/j.1469-7793.1997.501bd.x; Strasser JE, 1999, MOL BIOL CELL, V10, P2619, DOI 10.1091/mbc.10.8.2619; TIXIERVIDAL A, 1988, NEUROSCIENCE, V26, P847, DOI 10.1016/0306-4522(88)90104-2; TSUKITA S, 1980, J CELL BIOL, V84, P513, DOI 10.1083/jcb.84.3.513; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; WINKLER H, 1987, ANN NY ACAD SCI, V493, P3, DOI 10.1111/j.1749-6632.1987.tb27176.x; Xia ZG, 1996, J NEUROSCI, V16, P5425; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	30	439	460	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2000	3	5					445	451		10.1038/74814	http://dx.doi.org/10.1038/74814			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309DG	10769383				2022-12-24	WOS:000086752000012
J	Kim, HA; Pomeroy, SL; Whoriskey, W; Pawlitzky, I; Benowitz, LI; Sicinski, P; Stiles, CD; Roberts, TM				Kim, HA; Pomeroy, SL; Whoriskey, W; Pawlitzky, I; Benowitz, LI; Sicinski, P; Stiles, CD; Roberts, TM			A developmentally regulated switch directs regenerative growth of Schwann cells through cyclin D1	NEURON			English	Article							AXONALLY TRANSPORTED PROTEINS; RETINAL GANGLION-CELLS; TRANSCRIPTION FACTOR; ESTROGEN-RECEPTOR; SCIATIC-NERVE; EXPRESSION; PROLIFERATION; GAP-43; AXONS; RAT	Sciatic nerve axons in cyclin D1 knockout mice develop normally, become properly ensheathed by Schwann cells, and appear to function normally. However, in the Wallerian degeneration model of nerve injury, the mitotic response of Schwann cells is completely inhibited. The mitotic block is Schwann cell autonomous and developmentally regulated. Rescue analysis (by "knockin" of cyclin E) indicates that D1 protein, rather than regulatory elements of the D1 gene, provides the essential Schwann cell function. Genetic inhibition of the Schwann cell cycle shows that neuronal responses to nerve injury are surprisingly independent of Schwann cell mitotic responses. Even axonal regrowth into the distal zone of a nerve crush injury is not markedly impaired in cyclin D1(-/-) mice.	Childrens Hosp, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; Childrens Hosp, Dept Neurosurg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Stiles, CD (corresponding author), Childrens Hosp, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.			Benowitz, Larry/0000-0002-0277-7222	NICHD NIH HHS [HD24926] Funding Source: Medline; NINDS NIH HHS [NS35701] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD024926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035701] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baserga R, 1985, BIOL CELL REPRODUCTI, P3; Berger Alan R., 1995, P648; CURTIS R, 1992, J CELL BIOL, V116, P1455, DOI 10.1083/jcb.116.6.1455; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; Geng Y, 1999, CELL, V97, P767, DOI 10.1016/S0092-8674(00)80788-6; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; Grana X, 1998, ONCOGENE, V17, P3365, DOI 10.1038/sj.onc.1202575; Hirai H, 1996, MOL CELL BIOL, V16, P6457; Huard JMT, 1999, DEVELOPMENT, V126, P1927; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; Inoue K, 1998, MOL CELL BIOL, V18, P1590, DOI 10.1128/MCB.18.3.1590; Kim HA, 1997, J NEUROSCI RES, V49, P236; Kim HA, 1997, MOL CELL BIOL, V17, P862, DOI 10.1128/MCB.17.2.862; LEAH JD, 1991, BRAIN RES, V566, P198, DOI 10.1016/0006-8993(91)91699-2; MATA M, 1990, J NEUROCYTOL, V19, P432, DOI 10.1007/BF01188409; MATSUSHIME H, 1991, COLD SH Q B, V56, P69; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Mulligan G, 1998, TRENDS GENET, V14, P223, DOI 10.1016/S0168-9525(98)01470-X; Neuman E, 1997, MOL CELL BIOL, V17, P5338, DOI 10.1128/MCB.17.9.5338; NORDLUND M, 1992, GLIA, V5, P182, DOI 10.1002/glia.440050304; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; PLANTINGA LC, 1993, BRAIN RES, V602, P69, DOI 10.1016/0006-8993(93)90243-G; Rahmatullah M, 1998, MOL CELL BIOL, V18, P6245, DOI 10.1128/MCB.18.11.6245; RICCARDI VM, 1991, NEW ENGL J MED, V324, P1283, DOI 10.1056/NEJM199105023241812; SCHADEN H, 1994, J NEUROBIOL, V25, P1570, DOI 10.1002/neu.480251209; SCHERER SS, 1994, J NEUROSCI, V14, P1930; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; SKENE JHP, 1986, SCIENCE, V233, P783, DOI 10.1126/science.3738509; SKENE JHP, 1981, J CELL BIOL, V89, P86, DOI 10.1083/jcb.89.1.86; SKENE JHP, 1981, J CELL BIOL, V89, P96, DOI 10.1083/jcb.89.1.96; SKETELJ J, 1989, J NEUROSCI RES, V24, P153, DOI 10.1002/jnr.490240205; TETZLAFF W, 1989, J NEUROSCI, V9, P1303; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; VANDERZEE CEEM, 1989, J NEUROSCI, V9, P3505; Waller Augustus, 1851, Edinb Med Surg J, V76, P369; XIONG Y, 1992, GENOMICS, V13, P575, DOI 10.1016/0888-7543(92)90127-E; Zwijsen RML, 1998, GENE DEV, V12, P3488, DOI 10.1101/gad.12.22.3488	40	75	75	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	2000	26	2					405	416		10.1016/S0896-6273(00)81173-3	http://dx.doi.org/10.1016/S0896-6273(00)81173-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318QZ	10839359	Bronze			2022-12-24	WOS:000087296500017
J	Beneken, J; Tu, JC; Xiao, B; Nuriya, M; Yuan, JP; Worley, PF; Leahy, DJ				Beneken, J; Tu, JC; Xiao, B; Nuriya, M; Yuan, JP; Worley, PF; Leahy, DJ			Structure of the Homer EVH1 domain-peptide complex reveals a new twist in polyproline recognition	NEURON			English	Article							WISKOTT-ALDRICH-SYNDROME; METABOTROPIC GLUTAMATE RECEPTORS; VASODILATOR-STIMULATED PHOSPHOPROTEIN; PLECKSTRIN-HOMOLOGY DOMAIN; ACTIN-BASED MOTILITY; POSTSYNAPTIC DENSITY PROTEINS; PROLINE-RICH PEPTIDES; LISTERIA-MONOCYTOGENES; CRYSTAL-STRUCTURES; TYROSINE KINASES	Homer EVH1 (Ena/VASP Homology 1) domains interact with proline-rich motifs in the cytoplasmic regions of group 1 metabotropic glutamate receptors (mGluRs), inositol-1,4,5-trisphosphate receptors (IP3Rs), and Shank proteins. We have determined the crystal structure of the Homer EVH1 domain complexed with a peptide from mGluR (TPPSPF). In contrast to other EVH1 domains, the bound mGluR ligand assumes an unusual conformation in which the side chains of the Ser-Pro tandem are oriented away from the Homer surface, and the Phe forms a unique contact. This unusual binding mode rationalizes conserved features of both Homer and Homer ligands that are not shared by other EVH1 domains. Site-directed mutagenesis confirms the importance of specific Homer residues for ligand binding. These results establish a molecular basis for understanding the biological properties of Homer-ligand complexes.	Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Leahy, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.	leahy@groucho.med.jhmi.edu	Nuriya, Mutsuo/J-5928-2013	Nuriya, Mutsuo/0000-0002-5689-8222; Xiao, Bo/0000-0002-6161-9478				Ahern-Djamali SM, 1998, MOL BIOL CELL, V9, P2157, DOI 10.1091/mbc.9.8.2157; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aspenstrom P, 1996, CURR BIOL, V6, P70, DOI 10.1016/S0960-9822(02)00423-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banin S, 1996, CURR BIOL, V6, P981, DOI 10.1016/S0960-9822(02)00642-5; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bunnell SC, 1996, J BIOL CHEM, V271, P25646, DOI 10.1074/jbc.271.41.25646; CHAKRABORTY T, 1995, EMBO J, V14, P1314, DOI 10.1002/j.1460-2075.1995.tb07117.x; Cory GOC, 1996, J IMMUNOL, V157, P3791; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Fedorov AA, 1999, NAT STRUCT BIOL, V6, P661, DOI 10.1038/10717; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; Hall TMT, 1997, CELL, V91, P85, DOI 10.1016/S0092-8674(01)80011-8; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kato A, 1997, FEBS LETT, V412, P183, DOI 10.1016/S0014-5793(97)00775-8; Kato A, 1998, J BIOL CHEM, V273, P23969, DOI 10.1074/jbc.273.37.23969; Kirchhausen T, 1998, MOL MED TODAY, V4, P300, DOI 10.1016/S1357-4310(98)01268-4; Kolluri R, 1996, P NATL ACAD SCI USA, V93, P5615, DOI 10.1073/pnas.93.11.5615; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; KURTZ J, 1956, NATURE, V178, P1066, DOI 10.1038/1781066a0; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laurent V, 1999, J CELL BIOL, V144, P1245, DOI 10.1083/jcb.144.6.1245; Lemmon MA, 1998, CURR TOP MICROBIOL, V228, P39; MACIAS MJ, 1994, NATURE, V369, P675, DOI 10.1038/369675a0; Macias MJ, 1996, NATURE, V382, P646, DOI 10.1038/382646a0; Mahoney NM, 1999, NAT STRUCT BIOL, V6, P666, DOI 10.1038/10722; Miki H, 1998, BIOCHEM BIOPH RES CO, V243, P73, DOI 10.1006/bbrc.1997.8064; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; MUSACCHIO A, 1994, NAT STRUCT BIOL, V1, P546, DOI 10.1038/nsb0894-546; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Niebuhr K, 1997, EMBO J, V16, P5433, DOI 10.1093/emboj/16.17.5433; Nonoyama S, 1998, CURR OPIN IMMUNOL, V10, P407, DOI 10.1016/S0952-7915(98)80113-1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petrella EC, 1996, BIOCHEMISTRY-US, V35, P16535, DOI 10.1021/bi961498d; Ponting CP, 1997, J MOL MED-JMM, V75, P769, DOI 10.1007/s001090050166; Prehoda KE, 1999, CELL, V97, P471, DOI 10.1016/S0092-8674(00)80757-6; Purich DL, 1997, BIOCHEM BIOPH RES CO, V231, P686, DOI 10.1006/bbrc.1997.6158; Ramesh N, 1997, P NATL ACAD SCI USA, V94, P14671, DOI 10.1073/pnas.94.26.14671; Ramesh N, 1999, TRENDS CELL BIOL, V9, P15, DOI 10.1016/S0962-8924(98)01411-1; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; REINHARD M, 1995, P NATL ACAD SCI USA, V92, P7956, DOI 10.1073/pnas.92.17.7956; REINHARD M, 1992, EMBO J, V11, P2063, DOI 10.1002/j.1460-2075.1992.tb05264.x; RIVEROLEZCANO OM, 1995, MOL CELL BIOL, V15, P5725; Schwarz K, 1996, IMMUNOL TODAY, V17, P496, DOI 10.1016/0167-5699(96)30061-3; She HY, 1997, MOL BIOL CELL, V8, P1709, DOI 10.1091/mbc.8.9.1709; Smith GA, 1996, J CELL BIOL, V135, P647, DOI 10.1083/jcb.135.3.647; Sone M, 1997, SCIENCE, V275, P543, DOI 10.1126/science.275.5299.543; Stapley BJ, 1999, PROTEIN SCI, V8, P587; Stewart DM, 1999, J IMMUNOL, V162, P5019; Sun J, 1998, FEBS LETT, V437, P304, DOI 10.1016/S0014-5793(98)01256-3; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Tadokoro S, 1999, P NATL ACAD SCI USA, V96, P13801, DOI 10.1073/pnas.96.24.13801; TERWILLIGER TC, 1983, ACTA CRYSTALLOGR A, V39, P813, DOI 10.1107/S0108767383001592; Terwilliger TC, 1997, ACTA CRYSTALLOGR D, V53, P571, DOI 10.1107/S0907444997005398; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; WLODAWER A, 1975, P NATL ACAD SCI USA, V72, P777, DOI 10.1073/pnas.72.3.777; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; YOON HS, 1994, NATURE, V369, P672, DOI 10.1038/369672a0; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; Zhang Z, 1998, NUCLEIC ACIDS RES, V26, P3986, DOI 10.1093/nar/26.17.3986; ZHOU MM, 1995, NATURE, V378, P584, DOI 10.1038/378584a0; Zhu QL, 1997, BLOOD, V90, P2680, DOI 10.1182/blood.V90.7.2680.2680_2680_2689	74	137	145	0	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	2000	26	1					143	154		10.1016/S0896-6273(00)81145-9	http://dx.doi.org/10.1016/S0896-6273(00)81145-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309MA	10798399	Bronze			2022-12-24	WOS:000086770500015
J	Sutton, MA; Carew, TJ				Sutton, MA; Carew, TJ			Parallel molecular pathways mediate expression of distinct forms of intermediate-term facilitation at tail sensory-motor synapses in Aplysia	NEURON			English	Article							PROTEIN-KINASE-C; PRE-SYNAPTIC FACILITATION; PRESYNAPTIC FACILITATION; HETEROSYNAPTIC FACILITATION; TRANSMITTER RELEASE; CELLULAR MECHANISM; NEURON SYNAPSES; CRITICAL PERIOD; MEMORY; SEROTONIN	Three distinct temporal phases of synaptic facilitation (short-, intermediate-, and long-term) are induced by serotonin (5-HT) at sensory (SN) to motor (MN) synapses in Aplysia. Here, we characterize two mechanistically distinct forms of intermediate-term faciliation (ITF) at tail SN-MN synapses. One form, activity-independent ITF, is produced by five spaced pulses of 5-HT in the absence of SN activity. Its induction requires protein synthesis, and its expression requires persistent activation of PKA but not PKC. The other form, activity-dependent ITF, is produced by a single pulse of 5-HT coincident with SN activation. Its induction does not require protein synthesis, and its expression requires persistent activation of PKC but not PKA. These results demonstrate that SN-MN synapses can exhibit two distinct forms of ITF that are mediated by parallel molecular pathways.	Yale Univ, Interdept Neurosci Program, New Haven, CT 06520 USA; Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA	Yale University; University of California System; University of California Irvine	Carew, TJ (corresponding author), Yale Univ, Interdept Neurosci Program, New Haven, CT 06520 USA.		Sutton, Michael/C-6264-2011	Sutton, Michael/0000-0002-0692-6459	NIMH NIH HHS [R01 MH-14-1083] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABRAMS TW, 1991, J NEUROSCI, V11, P2655; Bao JX, 1998, J NEUROSCI, V18, P458; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; BRAHA O, 1990, P NATL ACAD SCI USA, V87, P2040, DOI 10.1073/pnas.87.5.2040; BUONOMANO DV, 1990, SCIENCE, V249, P420, DOI 10.1126/science.2165631; Byrne JH, 1996, J NEUROSCI, V16, P425; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; CASTELLUCCI VF, 1982, J NEUROSCI, V2, P1673; CASTELLUCCI VF, 1980, P NATL ACAD SCI-BIOL, V77, P7492, DOI 10.1073/pnas.77.12.7492; Cleary LJ, 1998, J NEUROSCI, V18, P5988; CONN PJ, 1989, J NEUROSCI, V9, P473; Crow T, 1999, J NEUROPHYSIOL, V82, P495, DOI 10.1152/jn.1999.82.1.495; CROW T, 1997, NEUROBIOL LEARN MEM, V68, P340; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DEZAZZO J, 1995, TRENDS NEUROSCI, V18, P212, DOI 10.1016/0166-2236(95)93905-D; EMPTAGE NJ, 1993, SCIENCE, V262, P253, DOI 10.1126/science.8211146; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; FROST WN, 1985, P NATL ACAD SCI USA, V82, P8266, DOI 10.1073/pnas.82.23.8266; GHIRARDI M, 1995, NEURON, V14, P413, DOI 10.1016/0896-6273(95)90297-X; GHIRARDI M, 1992, NEURON, V9, P479, DOI 10.1016/0896-6273(92)90185-G; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; HAWKINS RD, 1983, SCIENCE, V219, P400, DOI 10.1126/science.6294833; MACKEY SL, 1989, J NEUROSCI, V9, P4227; Manseau F, 1998, J NEUROPHYSIOL, V79, P1210, DOI 10.1152/jn.1998.79.3.1210; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Mauelshagen J, 1998, LEARN MEMORY, V5, P246; Mauelshagen J, 1996, J NEUROSCI, V16, P7099; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; MERCER AR, 1991, SCIENCE, V254, P1811, DOI 10.1126/science.1662413; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; Muller U, 1998, NEURON, V21, P1423, DOI 10.1016/S0896-6273(00)80660-1; Murphy GG, 1997, SCIENCE, V278, P467, DOI 10.1126/science.278.5337.467; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; OLEARY FA, 1995, J NEUROSCI, V15, P3519; SCHACHER S, 1988, SCIENCE, V240, P1667, DOI 10.1126/science.2454509; Schacher S, 1997, J NEUROSCI, V17, P597; Sherff CM, 1999, SCIENCE, V285, P1911, DOI 10.1126/science.285.5435.1911; Sossin W S, 1994, Learn Mem, V1, P189; SOSSIN WS, 1992, J NEUROSCI, V12, P1160; Sossin WS, 1997, LEARN MEMORY, V3, P389, DOI 10.1101/lm.3.5.389; SUGITA S, 1992, J NEUROPHYSIOL, V68, P643, DOI 10.1152/jn.1992.68.2.643; WALTERS ET, 1983, J NEUROPHYSIOL, V50, P1543, DOI 10.1152/jn.1983.50.6.1543; WALTERS ET, 1983, SCIENCE, V219, P405, DOI 10.1126/science.6294834; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; Yanow SK, 1998, J NEUROCHEM, V70, P572; Zhang F, 1997, SCIENCE, V275, P1318, DOI 10.1126/science.275.5304.1318	48	111	116	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	2000	26	1					219	231		10.1016/S0896-6273(00)81152-6	http://dx.doi.org/10.1016/S0896-6273(00)81152-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	309MA	10798406	Bronze			2022-12-24	WOS:000086770500022
J	Fenster, SD; Chung, WJ; Zhai, R; Cases-Langhoff, C; Voss, B; Garner, AM; Kaempf, U; Kindler, S; Gundelfinger, ED; Garner, CC				Fenster, SD; Chung, WJ; Zhai, R; Cases-Langhoff, C; Voss, B; Garner, AM; Kaempf, U; Kindler, S; Gundelfinger, ED; Garner, CC			Piccolo, a presynaptic zinc finger protein structurally related to bassoon	NEURON			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; NEUROTRANSMITTER RELEASE; WILLIAMS-SYNDROME; NERVE-TERMINALS; EPS15 HOMOLOGY; ACTIVE ZONE; BINDING; DOMAIN; MULTIPLE; DYNAMIN	Piccolo is a novel component of the presynaptic cytoskeletal matrix (PCM) assembled at the active zone of neurotransmitter release. Analysis of its primary structure reveals that Piccolo is a multidomain zinc finger protein structurally related to Bassoon, another PCM protein. Both proteins were found to be shared components of glutamatergic and GABAergic CNS synapses but not of the cholinergic neuromuscular junction. The Piccolo zinc fingers were found to interact with the dual prenylated rab3A and VAMP2/Synaptobrevin II receptor PRA1. We show that PRA1 is a synaptic vesicle-associated protein that is colocalized with Piccolo in nerve terminals of hippocampal primary neurons. These data suggest that Piccolo plays a role in the trafficking of synaptic vesicles (SVs) at the active zone.	Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; Univ Hamburg, Ctr Mol Neurobiol, D-20246 Hamburg, Germany; Univ Hamburg, Inst Cellular Biochem & Clin Neurobiol, D-20246 Hamburg, Germany; Leibniz Inst Neurobiol, D-39118 Magdeburg, Germany	University of Alabama System; University of Alabama Birmingham; University of Hamburg; University of Hamburg; Leibniz Institut fur Neurobiologie (LIN)	Garner, CC (corresponding author), Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA.	garner@nrc.uab.edu	Zhai, R. Grace/AGZ-3936-2022	Garner, Craig/0000-0003-1970-5417; Fenster, Steven/0000-0002-4470-8145; Zhai, Rong/0000-0002-7599-1430	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD032901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG006569, R01AG012978] Funding Source: NIH RePORTER; NIA NIH HHS [AG 12978-02, AG 06569-09] Funding Source: Medline; NICHD NIH HHS [P50 HD32901] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ausubel FM, 1998, CURRENT PROTOCOLS MO; BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; BOYCOTT BB, 1973, J COMP NEUROL, V148, P91, DOI 10.1002/cne.901480106; BRANDSTAETTER JH, 1999, IN PRESS EUR J NEURO; Bucci C, 1999, BIOCHEM BIOPH RES CO, V258, P657, DOI 10.1006/bbrc.1999.0651; BURNS ME, 1995, CELL, V83, P187, DOI 10.1016/0092-8674(95)90160-4; CasesLanghoff C, 1996, EUR J CELL BIOL, V69, P214; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Daniels DL, 1998, NAT STRUCT BIOL, V5, P317, DOI 10.1038/nsb0498-317; David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331; DeCamilli P, 1996, NEURON, V16, P481, DOI 10.1016/S0896-6273(00)80068-9; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; FERRONOVICK S, 1993, ANNU REV CELL BIOL, V9, P575; Garner CC, 1996, TRENDS CELL BIOL, V6, P429, DOI 10.1016/S0962-8924(96)10036-2; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; GOTOW T, 1991, NEUROSCIENCE, V40, P587, DOI 10.1016/0306-4522(91)90143-C; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; Hashida H, 1998, GENOMICS, V54, P50, DOI 10.1006/geno.1998.5516; HESS SD, 1993, SCIENCE, V259, P1169, DOI 10.1126/science.8438167; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; Jin MJ, 1996, J BIOL CHEM, V271, P30105, DOI 10.1074/jbc.271.47.30105; Kotake K, 1997, J BIOL CHEM, V272, P29407, DOI 10.1074/jbc.272.47.29407; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; Kuhlendahl S, 1998, EUR J BIOCHEM, V252, P305, DOI 10.1046/j.1432-1327.1998.2520305.x; LANDIS DMD, 1988, NEURON, V1, P201, DOI 10.1016/0896-6273(88)90140-7; Langnaese K, 1996, MOL BRAIN RES, V42, P118, DOI 10.1016/S0169-328X(96)00147-7; LI C, 1994, NEURON, V13, P885, DOI 10.1016/0896-6273(94)90254-2; Lonart G, 1998, NEURON, V21, P1141, DOI 10.1016/S0896-6273(00)80631-5; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Martincic I, 1997, J BIOL CHEM, V272, P26991, DOI 10.1074/jbc.272.43.26991; Meng X, 1998, HUM GENET, V103, P590, DOI 10.1007/s004390050874; MORRIS CA, 1988, J PEDIATR-US, V113, P318, DOI 10.1016/S0022-3476(88)80272-5; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Nagase T, 1998, DNA Res, V5, P31, DOI 10.1093/dnares/5.1.31; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; Qualmann B, 1999, MOL BIOL CELL, V10, P501, DOI 10.1091/mbc.10.2.501; Righter K, 1999, J COMP NEUROL, V408, P437, DOI 10.1002/(SICI)1096-9861(19990607)408:3<437::AID-CNE9>3.0.CO;2-5; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; SANCHEZGARCIA I, 1994, TRENDS GENET, V10, P315, DOI 10.1016/0168-9525(94)90034-5; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; Sugita S, 1996, J BIOL CHEM, V271, P1262, DOI 10.1074/jbc.271.3.1262; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Winter C, 1999, GENOMICS, V57, P389, DOI 10.1006/geno.1999.5788; Yamabhai M, 1998, J BIOL CHEM, V273, P31401, DOI 10.1074/jbc.273.47.31401; Ye ZC, 1998, GLIA, V22, P237, DOI 10.1002/(SICI)1098-1136(199803)22:3<237::AID-GLIA3>3.0.CO;2-2	49	214	223	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	2000	25	1					203	214		10.1016/S0896-6273(00)80883-1	http://dx.doi.org/10.1016/S0896-6273(00)80883-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279KP	10707984	Bronze			2022-12-24	WOS:000085043200022
